data_5owj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5owj _Structure_validation_residue.Date_analyzed 2017-11-24 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.233 0.209 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.3 m -124.1 116.87 23.48 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.661 0.267 . . . . 0.0 110.881 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -134.93 135.87 52.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 47.8 mt-10 -111.7 175.86 5.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.102 0.477 . . . . 0.0 111.727 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 t -124.27 141.46 52.05 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.674 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.0 m -99.71 -75.91 0.56 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.917 0.389 . . . . 0.0 111.197 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -162.21 148.23 13.14 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.52 -123.02 29.75 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.037 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.425 HD12 HG11 ' A' ' 111' ' ' VAL . 1.2 mm? -100.27 4.54 44.25 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 120.974 0.416 . . . . 0.0 110.072 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.26 139.82 25.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.596 -0.729 . . . . 0.0 113.085 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -133.93 151.67 51.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.048 0.539 . . . . 0.0 109.895 -178.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -120.32 130.15 54.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.51 -89.95 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.276 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.5 p 40.17 81.27 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.7 tp -107.85 134.5 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.219 0.533 . . . . 0.0 111.897 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.0 p -94.37 126.51 39.67 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.771 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.468 HG13 HG12 ' A' ' 24' ' ' ILE . 14.2 pt -126.69 161.21 33.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.356 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.541 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -70.67 155.07 41.21 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.379 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.5 -39.39 83.66 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.952 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.61 -25.66 65.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.3 t -80.64 -42.2 22.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.428 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 20' ' ' ALA . 75.0 mt -59.16 -69.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.321 -176.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.494 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 77.1 mm-40 -67.37 -6.95 21.27 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.5 m -95.64 -64.19 1.08 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.988 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.21 66.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.5 t -65.01 -43.87 96.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.354 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 22.3 ttmm -61.78 -47.2 86.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.6 m -68.85 -36.59 78.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.811 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -60.93 -39.05 87.97 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.113 0.483 . . . . 0.0 110.652 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.56 -38.44 90.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.819 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.22 -44.02 99.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.171 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.76 -43.64 98.28 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.136 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.38 -35.68 74.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.24 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.24 94.9 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.068 0.461 . . . . 0.0 110.285 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.34 -34.09 77.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.013 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -61.09 -35.92 78.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.955 0.407 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 t -90.61 -5.85 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.412 0.625 . . . . 0.0 109.77 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 64.96 27.5 12.68 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.329 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -103.67 7.98 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.069 0.461 . . . . 0.0 111.457 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.62 -34.81 79.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.514 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.02 -4.54 86.15 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.816 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -89.17 -8.2 54.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.792 0.329 . . . . 0.0 111.463 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -92.38 95.79 9.88 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.82 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -78.29 109.35 12.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.57 96.77 1.62 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 115.734 1.054 . . . . 0.0 115.734 -169.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -66.52 -43.24 85.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.6 t -104.79 115.12 63.11 Favored Pre-proline 0 N--CA 1.44 -0.929 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.265 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.12 139.95 86.25 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.188 1.926 . . . . 0.0 111.124 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.505 ' HA ' HG12 ' A' ' 54' ' ' VAL . 22.7 ttt -61.39 -40.08 93.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.507 -173.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -60.81 -47.77 84.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.047 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 HH22 ' B' ' 193' ' ' ARG . 74.9 mt -69.42 -44.97 79.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 51' ' ' MET . 14.6 p -64.11 -44.35 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.7 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.406 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -66.73 -24.06 66.18 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.381 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -85.61 -36.92 20.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.127 0.489 . . . . 0.0 110.3 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -76.54 -49.27 16.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.499 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -105.21 9.58 34.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.883 0.373 . . . . 0.0 110.483 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.621 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -59.18 -47.51 90.46 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.9 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.0 -25.49 65.43 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -61.84 -44.99 95.73 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.813 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' HG21 ' A' ' 66' ' ' VAL . 10.7 p -126.98 24.89 2.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.564 0.697 . . . . 0.0 110.703 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 21.1 ttm180 -58.8 -33.19 70.07 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.506 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -60.49 -50.02 75.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.535 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' HB2' HG23 ' A' ' 62' ' ' VAL . 1.7 m-20 -75.24 -21.61 58.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.04 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 62' ' ' VAL . 66.7 t -63.58 -43.77 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 173.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.62 -39.01 92.43 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.107 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.97 -42.61 99.81 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.238 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.706 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 32.0 t70 -63.01 -43.91 97.43 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.197 0.498 . . . . 0.0 110.006 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.7 -41.3 97.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.299 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 49.5 ttp -60.69 -43.22 98.01 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -62.55 -44.05 97.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.284 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.706 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 32.7 mtp85 -66.08 -41.5 90.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.932 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -66.07 -41.09 91.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.388 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -60.4 -48.08 83.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.678 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.0 tt -67.41 -39.7 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.201 0.524 . . . . 0.0 111.347 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.11 -40.85 91.03 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.388 0.613 . . . . 0.0 110.185 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.68 87.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.633 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.3 pt -64.21 -39.27 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.913 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.97 -44.09 99.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 120.638 0.256 . . . . 0.0 111.275 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.58 ' HB3' ' HZ1' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -74.89 -29.32 60.96 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -86.54 -2.57 58.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 66.22 34.55 6.54 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.242 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.1 mt -96.06 113.43 30.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -110.48 100.84 46.65 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.908 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.14 136.34 9.01 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.076 1.85 . . . . 0.0 111.347 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.93 132.98 36.57 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.62 -125.09 7.4 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.055 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.22 130.07 18.13 Favored Pre-proline 0 C--N 1.313 -1.018 0 O-C-N 122.834 -0.215 . . . . 0.0 110.455 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.88 150.07 60.77 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.132 1.888 . . . . 0.0 110.828 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 m -94.96 116.81 29.16 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.108 0.48 . . . . 0.0 110.021 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.552 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 95.9 m-85 -91.82 114.24 26.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.94 99.56 23.27 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.138 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 58.5 Cg_endo -95.52 161.8 1.52 Allowed 'Trans proline' 0 N--CA 1.437 -1.826 0 C-N-CA 123.461 2.774 . . . . 0.0 111.65 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.82 -174.86 33.61 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.176 -1.011 . . . . 0.0 110.874 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.72 133.47 38.31 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -89.24 125.4 35.07 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.938 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -102.48 131.31 49.25 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.4 tp -81.48 102.42 10.55 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.14 -27.54 5.32 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.243 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -103.0 177.02 4.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.677 0.275 . . . . 0.0 110.707 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -81.61 168.17 18.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -125.28 139.99 53.22 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.095 0.474 . . . . 0.0 111.313 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.0 m -120.01 134.4 55.26 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.158 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -140.51 167.16 22.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.572 0.225 . . . . 0.0 111.582 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -87.05 -91.01 0.11 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.2 t 64.92 100.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.358 0.599 . . . . 0.0 110.564 -174.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -99.65 146.09 26.87 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.588 -175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -159.39 -87.39 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -90.12 156.64 18.21 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.425 HG11 HD12 ' A' ' 11' ' ' LEU . 28.8 m -125.82 161.56 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.846 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -166.14 102.44 0.7 Allowed Pre-proline 0 N--CA 1.479 0.99 0 CA-C-O 120.577 0.227 . . . . 0.0 111.272 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -94.39 158.49 2.02 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 C-N-CA 123.39 2.727 . . . . 0.0 114.373 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -143.29 139.64 30.24 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.735 0.814 . . . . 0.0 109.888 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 116' ' ' GLU . 20.6 t -133.9 160.89 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 120.897 0.379 . . . . 0.0 111.78 -176.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.4 ' N ' HG13 ' A' ' 115' ' ' VAL . 43.5 mt-10 -140.66 153.03 45.84 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.842 0.857 . . . . 0.0 109.209 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.8 mt -112.47 130.58 55.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -141.85 154.4 45.13 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.133 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.54 22.91 74.46 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.903 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.49 -39.94 95.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.916 0.389 . . . . 0.0 111.199 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -70.24 -10.78 59.92 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.87 1.48 55.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.147 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.57 109.01 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.124 0.488 . . . . 0.0 109.957 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -104.37 119.64 39.41 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.062 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.83 127.07 59.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.883 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.7 119.04 32.19 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.571 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.531 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 78.6 tttt -111.62 106.29 56.77 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.43 128.61 12.1 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.962 1.775 . . . . 0.0 111.639 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.38 114.67 39.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.17 161.58 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -150.73 166.19 31.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.553 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.3 127.44 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.722 0.296 . . . . 0.0 110.25 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.0 p -108.15 176.41 5.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.394 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.86 -38.94 87.3 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.019 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.67 80.2 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.7 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -64.94 -43.38 92.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.327 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.49 -47.24 92.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.955 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.04 -42.61 99.36 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.003 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.26 -42.58 99.26 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.611 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.524 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -61.83 -44.92 95.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.695 0.284 . . . . 0.0 110.59 178.329 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.43 -42.44 98.69 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.272 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.87 -43.84 98.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.82 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.9 m -63.0 -41.2 99.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.553 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.6 mt -60.82 -42.23 97.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.448 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -66.14 -37.21 85.13 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.05 0.453 . . . . 0.0 110.518 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -68.46 -13.92 62.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.162 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -89.62 -6.92 55.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.432 0.634 . . . . 0.0 110.151 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -89.59 93.47 9.5 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.726 0.774 . . . . 0.0 111.952 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.81 126.17 10.07 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.416 ' HB ' ' H ' ' A' ' 151' ' ' TRP . 23.6 p -100.43 -163.76 1.05 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.51 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 4.4 p-90 -70.17 119.68 14.72 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 151' ' ' TRP . 26.5 mttp -174.52 168.34 3.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.691 1.197 . . . . 0.0 109.132 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -114.92 164.21 14.46 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -172.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 153' ' ' GLU . 9.9 pttp 71.28 -179.42 0.23 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.861 1.665 . . . . 0.0 113.807 175.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.445 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 13.0 t70 72.92 -90.32 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 124.966 1.306 . . . . 0.0 111.055 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 142.76 102.48 0.44 Allowed Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.954 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -132.75 64.51 1.61 Allowed 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.58 127.05 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.122 -176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 162' ' ' ASP . 9.2 tp10 -95.63 154.11 17.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.75 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.89 13.8 6.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 189' ' ' MET . 37.8 tt0 -155.47 26.08 0.4 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.585 0.707 . . . . 0.0 110.511 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 159' ' ' GLU . 2.9 t70 -109.39 -170.2 1.61 Allowed 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.781 -0.575 . . . . 0.0 111.036 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -103.55 118.71 37.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.4 t -114.72 121.66 67.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.002 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.4 m -83.4 109.66 17.5 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.9 mt -115.08 128.46 72.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.106 0.479 . . . . 0.0 112.141 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 236' ' ' ASN . 5.0 p-10 -103.03 113.33 26.72 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 172.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -142.46 162.57 35.13 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.228 0.537 . . . . 0.0 112.216 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.1 m -133.6 134.09 42.84 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.219 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.31 103.56 1.84 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.209 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 29.0 m -128.1 121.31 29.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 46.1 t -94.13 -87.13 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.833 0.349 . . . . 0.0 111.147 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -94.38 42.08 1.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.207 0.527 . . . . 0.0 109.822 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 81.33 12.45 82.09 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -123.99 139.28 54.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -92.09 137.42 32.38 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.372 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -107.26 -176.88 3.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.655 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.38 -39.74 88.38 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.402 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.21 -175.52 39.15 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.964 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 84.63 16.68 65.47 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.138 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -105.74 97.87 7.64 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.02 145.8 32.44 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.844 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 38.3 m -136.1 145.29 45.75 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.803 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 54.41 31.15 14.03 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.801 0.688 . . . . 0.0 110.543 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -85.98 127.31 34.61 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.3 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.5 115.03 39.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.49 0.662 . . . . 0.0 110.336 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 56.7 tp -103.33 126.22 50.37 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.98 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -90.65 111.88 23.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.636 ' HE2' ' O ' ' A' ' 199' ' ' GLU . 88.2 mtp -81.24 150.68 28.48 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.95 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.38 -14.62 64.25 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.595 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -95.13 0.49 54.28 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.802 0.334 . . . . 0.0 111.207 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.97 55.98 6.8 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -100.01 -5.96 27.26 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.197 0.522 . . . . 0.0 110.55 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.494 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -135.5 178.13 7.28 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.076 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.7 mm -68.38 133.87 91.12 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.37 134.55 45.31 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.095 1.864 . . . . 0.0 111.499 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.77 -42.87 1.79 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.958 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -67.45 -52.92 33.62 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.636 ' O ' ' HE2' ' A' ' 189' ' ' MET . 11.7 pt-20 -74.2 -17.21 60.93 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.847 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.51 -30.0 22.29 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.891 0.377 . . . . 0.0 110.512 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.7 -19.05 76.31 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.008 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.4 mt -62.39 -38.07 80.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-O 120.883 0.373 . . . . 0.0 110.407 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -51.51 131.26 29.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.7 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.42 -10.66 63.23 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.353 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -95.26 159.23 15.11 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -103.21 156.41 17.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.104 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.57 134.69 51.69 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.941 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 78.86 34.56 33.91 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.637 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -124.68 130.17 51.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.879 0.371 . . . . 0.0 111.06 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -102.42 118.17 36.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.53 ' O ' ' HB ' ' A' ' 212' ' ' THR . 44.3 t80 -135.24 -36.84 0.79 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 99.6 m 77.65 143.94 0.08 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.339 0.256 . . . . 0.0 110.423 -176.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.2 tp -130.11 144.61 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.934 0.397 . . . . 0.0 110.909 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.79 104.68 16.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.092 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 65.7 t -119.31 128.5 75.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.5 m -98.42 -16.84 19.1 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -175.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 66.62 154.43 0.13 Allowed Pre-proline 0 N--CA 1.487 1.381 0 CA-C-O 121.117 0.484 . . . . 0.0 111.615 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.33 150.87 53.43 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.154 1.903 . . . . 0.0 111.532 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -65.82 -38.44 88.92 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.18 77.1 7.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.602 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -120.06 140.61 50.76 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -61.06 -29.86 69.98 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.76 108.1 20.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.594 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.2 tt0 -63.42 -33.59 75.88 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.408 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 30.8 p-10 -63.97 -25.16 68.01 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.737 0.303 . . . . 0.0 110.995 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 90.4 mt -109.8 -3.39 16.72 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.6 ptmt -67.85 119.12 12.02 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.951 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.8 21.91 71.56 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.94 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 225' ' ' ASN . 35.0 mmtp -100.93 135.52 42.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -86.26 110.38 19.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.004 0.43 . . . . 0.0 110.85 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.36 149.54 23.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.082 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -105.21 -47.17 4.04 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -175.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 58.59 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.02 0.438 . . . . 0.0 111.041 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.55 -49.2 77.15 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.0 mm 62.8 93.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 123.493 0.496 . . . . 0.0 110.842 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.47 ' HB3' ' OD2' ' A' ' 167' ' ' ASP . 9.6 t-20 -82.99 -47.29 11.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.545 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 12.6 tp 57.46 86.8 0.07 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.151 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.25 -58.06 2.67 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -101.49 -78.97 0.52 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 24.9 t 70.43 142.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 123.482 0.489 . . . . 0.0 110.512 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -75.1 -46.79 32.26 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.277 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 64.75 163.24 0.14 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -162.0 94.18 0.91 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 10.1 tp10 -123.37 157.14 33.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.379 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.1 tt 72.72 118.5 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.456 0.703 . . . . 0.0 110.932 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -87.03 115.74 1.2 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.879 2.386 . . . . 0.0 113.82 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.28 -161.54 1.13 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 8.0 mp -87.02 102.91 14.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.299 0.571 . . . . 0.0 111.892 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 251' ' ' GLU . 37.9 m -134.39 132.43 39.41 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -90.15 7.28 38.75 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . 0.435 ' H ' HG22 ' A' ' 249' ' ' THR . 45.9 mt-10 -88.15 -15.22 36.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -73.3 -7.31 51.01 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.293 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 261' ' ' GLY . 41.8 pt -105.13 -4.3 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.629 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -136.96 11.52 3.1 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -129.92 8.25 5.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.062 0.458 . . . . 0.0 109.939 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -124.43 137.0 54.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.742 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 67.79 -129.9 27.65 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 116.13 -0.486 . . . . 0.0 114.041 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.4 t -116.98 131.69 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 122.693 0.397 . . . . 0.0 110.932 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.621 ' HG2' ' H ' ' A' ' 260' ' ' ASP . 22.1 tt0 58.28 -155.01 0.35 Allowed 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.795 0.684 . . . . 0.0 109.222 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.621 ' H ' ' HG2' ' A' ' 259' ' ' GLU . 1.7 p-10 -128.89 136.93 51.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 253' ' ' ILE . . . -131.82 171.74 21.2 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.238 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.0 p -82.85 177.44 8.65 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.076 0.55 . . . . 0.0 110.44 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 94.9 t -60.7 -48.24 89.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.116 0.484 . . . . 0.0 110.791 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -81.4 -33.5 32.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.766 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.1 -40.3 99.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.374 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.418 ' O ' HG21 ' A' ' 270' ' ' VAL . 54.2 tp -62.16 -45.3 94.05 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -62.89 -44.96 94.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.577 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.27 -47.34 79.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.347 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -66.66 -38.61 87.22 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 266' ' ' LEU . 67.1 t -65.13 -42.7 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.232 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -57.94 -48.1 80.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.792 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.7 ptmt -66.33 -42.91 87.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.763 0.316 . . . . 0.0 111.413 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.31 -36.64 83.44 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.6 mmm -62.88 -42.28 99.71 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.207 0.527 . . . . 0.0 109.964 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 278' ' ' LEU . 56.9 mt-10 -69.36 -30.88 68.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.27 177.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -62.57 -43.42 98.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.609 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -69.93 -28.21 65.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.114 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 275' ' ' GLU . 65.3 tp -61.08 -37.72 83.71 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -58.14 -45.84 86.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.73 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -45.06 95.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.432 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.58 -50.67 72.61 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.663 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.8 -45.17 95.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.17 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.547 HH12 ' HG3' ' A' ' 409' ' ' GLU . 2.2 tpt180 -61.44 -46.37 90.39 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.897 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -64.14 -39.85 94.91 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.242 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . 0.533 HH21 ' CG ' ' A' ' 285' ' ' ARG . 0.0 OUTLIER -60.27 -44.22 95.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.587 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.03 -43.55 85.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.001 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -61.12 -45.79 93.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.39 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 22.6 p -59.73 -43.64 94.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.03 -41.17 91.25 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.856 0.36 . . . . 0.0 111.189 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.55 87.03 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.8 mm -64.65 -44.46 96.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.466 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.528 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 33.1 tp10 -62.58 -40.73 97.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.95 0.405 . . . . 0.0 110.588 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.38 -43.73 97.87 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.495 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.5 -42.87 98.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.68 -46.98 93.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.227 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . 0.528 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.0 mttm -65.41 -41.57 93.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.898 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.76 -41.2 79.21 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -122.64 98.43 5.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.025 0.441 . . . . 0.0 112.182 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.52 114.7 27.31 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 301' ' ' ASP . 10.7 tp -128.43 161.65 36.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.553 0.216 . . . . 0.0 110.984 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.452 ' N ' HG13 ' A' ' 300' ' ' ILE . 25.4 m-20 -65.26 140.54 58.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.846 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.7 t -115.04 123.6 31.57 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.283 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.53 124.21 14.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.211 1.941 . . . . 0.0 111.535 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.89 85.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.46 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.07 -42.34 76.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.268 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.24 -41.26 85.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.552 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.14 -46.2 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.855 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.46 -43.49 88.88 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.635 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 313' ' ' VAL . 49.9 m -60.89 -45.92 92.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.201 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.562 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 60.2 mm-40 -69.05 -37.44 78.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.404 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 95.8 mt -62.29 -44.14 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.115 0.483 . . . . 0.0 109.975 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.41 -39.3 93.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.647 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 309' ' ' SER . 86.2 t -65.52 -43.09 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.296 176.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 80.4 mt -61.21 -39.01 88.65 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.812 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.468 ' NH1' HD13 ' A' ' 330' ' ' LEU . 65.9 mtm180 -61.41 -37.91 85.16 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.625 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -64.63 -43.05 94.95 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.771 0.319 . . . . 0.0 111.037 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -64.74 -41.81 95.67 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.21 0.528 . . . . 0.0 110.511 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.75 -41.93 78.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.159 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.72 -35.43 80.73 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.999 0.428 . . . . 0.0 110.979 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -56.21 -44.08 79.14 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.759 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.68 -36.63 60.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.931 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -60.1 -45.05 94.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.324 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . 0.402 ' HA2' HG23 ' B' ' 54' ' ' VAL . . . -170.61 17.64 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.096 -1.05 . . . . 0.0 112.857 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 70.79 26.65 73.66 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.209 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -97.9 154.03 17.93 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.292 0.568 . . . . 0.0 112.306 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.0 -178.49 5.47 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 70.28 -60.98 0.47 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.124 0.57 . . . . 0.0 111.592 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -69.83 -15.33 63.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.112 0.482 . . . . 0.0 110.856 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . 0.444 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -61.66 -19.48 62.36 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.584 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.468 HD13 ' NH1' ' A' ' 315' ' ' ARG . 45.3 tp -62.19 -34.67 76.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.771 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -77.92 -0.54 27.91 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.961 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.62 144.2 85.83 Favored Pre-proline 0 C--O 1.238 0.454 0 O-C-N 122.142 -0.349 . . . . 0.0 110.715 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.65 132.43 51.7 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.777 2.318 . . . . 0.0 113.114 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -67.24 -44.46 79.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.521 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.8 pm0 -64.6 -31.55 72.82 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.62 -28.62 69.25 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.584 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -107.6 -20.62 13.18 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.08 -33.26 75.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.9 -44.77 96.11 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.129 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -80.83 -24.63 38.32 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.259 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.35 -38.4 90.89 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.329 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.405 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.3 tttt -57.92 -44.92 87.15 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.733 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.496 ' O ' HG23 ' A' ' 347' ' ' VAL . 9.1 mmt180 -62.28 -44.21 97.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.947 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -65.51 -39.99 92.47 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.097 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.8 t -63.29 -45.96 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.101 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 342' ' ' LYS . 98.5 t -63.74 -43.64 98.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 343' ' ' ARG . 78.0 t -60.43 -45.5 96.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.543 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.6 -42.84 99.83 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.02 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.47 -44.13 95.3 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.638 0.256 . . . . 0.0 111.313 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.97 -45.59 88.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.059 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.56 -39.98 88.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.022 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.48 -40.23 97.42 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.125 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.59 -36.62 83.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 110.648 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.91 -43.57 96.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.26 -44.33 99.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.894 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -68.2 -48.92 63.93 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.8 m -64.73 -44.61 89.61 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -88.14 -7.69 56.53 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.735 0.303 . . . . 0.0 111.142 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 60.58 60.31 1.98 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.122 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.1 mt -79.29 153.61 29.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.529 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -130.43 154.15 48.03 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.968 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -78.72 105.98 10.39 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 172.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 367' ' ' VAL . 31.7 t70 -82.18 111.5 18.34 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.376 -0.529 . . . . 0.0 112.054 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 5.1 mm-40 -62.73 -34.33 76.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.038 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -63.64 -44.11 94.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -65.48 -38.88 91.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.193 0.521 . . . . 0.0 109.978 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 363' ' ' ASP . 84.2 t -61.64 -36.77 75.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.578 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 27.2 mmmt -54.81 -47.87 73.5 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.633 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.95 -41.26 99.93 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.521 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.94 -42.86 99.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 0.0 110.713 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.58 -43.43 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.253 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.45 -37.77 87.88 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.276 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -65.38 -41.23 93.94 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.546 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.4 ttm -64.82 -42.42 95.0 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.011 0.434 . . . . 0.0 110.548 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.68 -24.4 67.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.756 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 55.0 m -75.19 -5.13 42.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.65 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.52 5.44 49.52 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.903 0.383 . . . . 0.0 111.18 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -116.93 171.75 7.71 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.762 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -60.61 -44.69 96.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.013 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -130.04 114.41 17.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.793 0.33 . . . . 0.0 110.239 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.69 -27.27 27.02 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.499 2.133 . . . . 0.0 113.123 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -65.1 -45.72 84.04 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.8 -36.29 83.09 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.567 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.74 -42.39 94.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.473 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.77 -44.18 98.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 50.2 mt-10 -66.05 -43.21 88.15 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.56 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.34 -47.84 82.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.959 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -65.64 -45.66 82.17 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.433 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 59.1 p -73.17 -16.38 61.44 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 99.3 mttt -91.06 9.08 32.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.115 0.483 . . . . 0.0 111.291 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -131.24 113.36 13.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.489 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.37 -41.69 98.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.72 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -60.69 -45.3 94.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.041 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.1 -42.68 99.63 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.482 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.557 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 94.5 mtp -63.16 -45.47 91.71 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.051 0.453 . . . . 0.0 110.56 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -64.98 -43.98 90.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.268 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -62.83 -41.76 99.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.395 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 49.0 tpp -63.98 -40.3 96.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.775 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.557 ' HG3' ' O ' ' A' ' 395' ' ' MET . 73.1 mtm180 -63.63 -35.15 79.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.837 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -62.8 -42.9 99.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.098 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.52 -43.57 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -61.4 -39.69 91.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.605 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 40.8 tp -63.79 -38.71 92.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.033 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.436 ' O ' HG21 ' A' ' 408' ' ' VAL . 75.2 tt0 -54.53 -50.9 66.78 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.267 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 35.2 mt-10 -66.78 -36.34 82.19 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.45 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -61.61 -44.83 96.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.833 0.349 . . . . 0.0 110.701 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.443 ' O ' HG21 ' A' ' 411' ' ' VAL . . . -62.81 -41.85 99.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.719 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.56 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 89.1 t -65.73 -43.7 93.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.753 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.547 ' HG3' HH12 ' A' ' 283' ' ' ARG . 96.3 mt-10 -63.21 -36.79 84.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.199 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.12 -41.32 99.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.145 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 407' ' ' ALA . 97.7 t -65.38 -42.51 93.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.313 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 68.4 mt -60.3 -42.02 94.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.734 -176.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.15 -23.28 67.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.771 0.32 . . . . 0.0 111.432 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -97.98 -3.97 37.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.464 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -109.51 -179.57 3.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.393 0.616 . . . . 0.0 112.399 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.69 102.24 13.95 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.215 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.8 t -94.81 128.45 46.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.373 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -120.34 128.96 53.74 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.531 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 40.1 mt-10 -100.55 118.79 37.43 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.382 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -130.03 134.51 47.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.097 0.475 . . . . 0.0 111.543 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.87 142.23 46.04 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -149.1 170.06 19.26 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.554 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 67.7 p -86.63 164.31 16.89 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.28 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -67.05 -26.11 66.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.982 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -61.88 -38.61 88.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.694 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -67.02 -30.11 70.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.778 0.323 . . . . 0.0 110.838 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.6 mp -80.92 -8.56 59.77 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 111.363 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.0 mmt -81.2 -7.3 59.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.133 0.492 . . . . 0.0 110.529 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -78.19 71.79 4.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.543 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -121.71 28.86 7.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.609 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -66.62 -38.35 86.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.52 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.765 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.465 -179.494 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.661 0.267 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -100.03 105.04 16.66 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.88 162.44 38.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.857 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 47.2 m -124.91 119.3 28.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.887 0.375 . . . . 0.0 111.23 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -136.73 137.08 47.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 49.8 mt-10 -114.3 176.35 5.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.01 0.433 . . . . 0.0 111.125 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -124.21 148.8 47.03 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.46 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 24.1 m -107.46 -82.12 0.55 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.868 0.366 . . . . 0.0 110.949 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -155.74 146.77 22.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.25 -123.65 28.2 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.141 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.415 HD12 HG11 ' B' ' 111' ' ' VAL . 1.2 mm? -100.08 5.84 44.96 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' B' ' 107' ' ' VAL . . . -73.48 142.6 31.52 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.376 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 0.3 OUTLIER -137.14 149.94 47.64 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.079 0.551 . . . . 0.0 109.938 -178.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -116.74 128.9 55.75 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.44 -92.31 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.039 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.1 p 40.75 81.66 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.031 0.532 . . . . 0.0 112.294 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 8.4 tp -108.0 136.84 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.05 0.452 . . . . 0.0 111.725 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 9.2 p -96.13 130.5 43.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.122 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 14.6 pt -131.43 162.45 39.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.501 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.534 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -74.28 157.53 35.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.304 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.61 80.4 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -65.91 -37.95 87.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.69 0.281 . . . . 0.0 110.662 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t -65.71 -43.62 88.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.933 0.397 . . . . 0.0 110.671 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.534 HG13 ' O ' ' B' ' 20' ' ' ALA . 77.0 mt -58.42 -69.04 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.26 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.511 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 76.7 mm-40 -68.53 -7.94 36.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -172.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 45.9 m -96.13 -63.98 1.1 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.946 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.2 -45.43 73.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.03 -43.42 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.925 0.393 . . . . 0.0 110.935 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.511 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.6 ttmm -61.97 -46.9 87.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.928 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.4 m -69.73 -36.39 75.83 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.468 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.85 -38.35 90.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.941 0.4 . . . . 0.0 110.725 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.33 -38.68 90.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.88 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.76 -43.46 97.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.108 0.48 . . . . 0.0 109.905 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -63.14 -42.73 99.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.49 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.07 -33.98 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.309 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.83 96.13 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.18 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.425 ' O ' ' HD3' ' B' ' 40' ' ' ARG . 98.5 mttt -65.63 -34.25 77.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.97 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.56 -37.18 82.86 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.779 0.323 . . . . 0.0 111.001 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 t -87.97 -8.42 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.243 0.544 . . . . 0.0 109.835 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' B' ' 37' ' ' LYS . 35.1 mmt180 66.26 31.44 8.54 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.216 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.81 6.34 9.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.399 . . . . 0.0 111.51 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.23 -35.22 80.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.512 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.64 -3.52 79.07 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.942 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -91.15 -8.67 48.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.701 0.251 . . . . 0.0 111.646 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -91.81 93.25 8.76 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.742 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -76.82 106.45 8.5 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.23 99.36 2.1 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 -169.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.99 -45.89 79.98 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.422 ' CG1' ' HB ' ' B' ' 54' ' ' VAL . 15.1 t -100.27 115.22 65.68 Favored Pre-proline 0 C--O 1.249 1.044 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.311 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.0 139.76 85.26 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.428 2.085 . . . . 0.0 111.143 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.489 ' HA ' HG12 ' B' ' 54' ' ' VAL . 23.5 ttt -63.28 -38.57 91.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.596 -174.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' B' ' 29' ' ' LYS . 31.3 p-10 -64.28 -32.02 73.45 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.331 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 92.5 mt -87.51 -45.05 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.822 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' B' ' 51' ' ' MET . 12.0 p -62.55 -42.2 94.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.711 0.291 . . . . 0.0 111.382 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.87 -14.67 62.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.8 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -97.09 -41.28 8.43 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.164 0.507 . . . . 0.0 109.686 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.438 ' NH1' ' SD ' ' A' ' 194' ' ' MET . 67.9 ttt180 -70.87 -44.91 65.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.166 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -110.0 10.83 24.15 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 120.924 0.392 . . . . 0.0 110.09 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.638 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -58.75 -45.69 94.49 Favored Glycine 0 C--O 1.215 -1.054 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.147 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.06 -24.86 60.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 37.4 t -61.64 -44.17 97.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 111.511 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.493 ' O ' HG21 ' B' ' 66' ' ' VAL . 9.1 p -123.25 21.85 4.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.312 0.577 . . . . 0.0 110.75 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.638 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 23.5 ttm180 -59.09 -33.21 70.56 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.728 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -61.18 -49.65 76.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.972 0.415 . . . . 0.0 110.515 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.5 -22.77 58.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.538 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.493 HG21 ' O ' ' B' ' 62' ' ' VAL . 53.8 t -63.89 -43.88 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 99.4 mt -62.77 -39.21 93.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.018 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.04 -42.7 99.88 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.202 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . 0.725 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 33.8 t70 -63.66 -44.01 95.06 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.972 0.386 . . . . 0.0 109.989 177.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.35 -41.34 96.91 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.063 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 49.9 ttp -60.91 -41.88 96.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.502 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -62.97 -44.37 96.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.925 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.725 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 32.8 mtp85 -66.68 -40.95 88.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.928 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -65.31 -41.33 94.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.192 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.56 -48.86 79.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.798 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 18.7 tt -68.0 -40.15 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.873 0.368 . . . . 0.0 111.705 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -65.69 -39.79 91.64 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.284 0.564 . . . . 0.0 110.134 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.14 -47.02 75.43 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.662 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 45.5 pt -62.45 -36.75 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.05 -43.97 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 120.686 0.279 . . . . 0.0 111.139 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.535 ' HZ1' ' HB3' ' B' ' 81' ' ' LYS . 0.1 OUTLIER -78.52 -28.03 46.11 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.617 -178.273 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.88 -4.43 58.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.655 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 62.85 42.45 7.8 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.933 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.3 mt -105.05 118.31 52.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -112.46 109.94 53.3 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.404 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -88.44 124.23 1.64 Allowed 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 122.544 2.163 . . . . 0.0 111.274 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.65 117.76 29.56 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.977 0.418 . . . . 0.0 110.505 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.7 -130.18 10.15 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.67 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.45 123.79 17.74 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-O 120.433 0.158 . . . . 0.0 110.625 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.31 131.46 19.11 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.797 1.664 . . . . 0.0 110.554 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 11.3 m -78.38 111.92 14.87 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.628 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.645 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 96.2 m-85 -83.9 105.19 14.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.14 102.73 11.51 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.47 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.4 Cg_endo -98.61 170.06 0.6 Allowed 'Trans proline' 0 N--CA 1.439 -1.723 0 C-N-CA 123.429 2.753 . . . . 0.0 111.402 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.43 -174.06 26.08 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -79.95 133.36 36.19 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -87.9 128.41 35.36 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.007 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.98 133.76 49.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 tp -86.79 88.61 7.72 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.328 0.585 . . . . 0.0 110.138 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.59 -20.9 3.65 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.174 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -108.54 178.07 4.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.496 0.189 . . . . 0.0 110.719 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -80.53 165.3 22.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.007 0.432 . . . . 0.0 111.185 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -124.1 141.92 51.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.957 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 27.7 m -122.91 135.82 54.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.041 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -142.69 165.51 27.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.366 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.8 m -85.4 -90.9 0.1 Allowed 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . 0.441 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 85.3 t 64.94 99.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.347 0.594 . . . . 0.0 110.672 -175.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -101.11 145.6 28.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.702 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -158.11 -80.34 0.06 Allowed 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -95.97 157.02 16.09 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.415 HG11 HD12 ' B' ' 11' ' ' LEU . 24.9 m -124.97 163.98 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.925 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -171.24 101.02 0.4 Allowed Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 122.252 0.221 . . . . 0.0 110.961 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -96.37 162.82 1.22 Allowed 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 123.701 2.934 . . . . 0.0 114.306 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -143.19 147.29 34.66 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.738 0.815 . . . . 0.0 110.765 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.8 156.68 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 120.675 0.274 . . . . 0.0 111.072 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.14 153.13 51.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.83 131.89 55.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -144.71 155.07 43.37 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.46 22.89 78.15 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.33 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.05 -42.1 99.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.093 0.473 . . . . 0.0 111.232 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.11 -15.7 63.88 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.201 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.33 0.41 57.26 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.427 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 81.4 mt -79.73 113.82 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.11 0.481 . . . . 0.0 109.791 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -106.42 117.53 34.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.647 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 57.7 t -103.4 126.36 57.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -93.13 119.01 31.88 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.532 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.48 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 77.3 tttt -113.39 105.86 54.85 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.26 130.11 13.75 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.967 1.778 . . . . 0.0 111.9 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -101.46 115.37 43.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.44 161.29 41.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.941 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -150.37 159.57 44.36 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.852 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.67 131.05 35.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.159 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 81.7 p -110.77 175.53 5.39 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.924 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -62.16 -35.75 79.77 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.755 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.06 89.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.601 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.18 -42.17 99.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.716 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -63.86 -46.76 93.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.793 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.78 -44.19 97.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.624 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.88 -41.58 98.7 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.085 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' MET . . . . . 0.477 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.0 OUTLIER -62.68 -46.0 90.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.904 0.383 . . . . 0.0 110.683 179.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.9 mt -63.61 -40.76 97.74 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.675 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.32 -45.96 91.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.382 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.0 m -63.13 -41.61 99.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.813 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' B' ' 140' ' ' MET . 97.7 mt -60.67 -43.56 97.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.618 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -67.18 -35.97 80.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.874 0.369 . . . . 0.0 110.936 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.19 -21.04 65.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.089 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -85.56 -4.98 59.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 110.544 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -90.27 90.55 8.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.704 0.764 . . . . 0.0 112.216 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.88 132.49 18.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.373 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' B' ' 247' ' ' GLU . 20.5 p -103.63 -165.97 1.21 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . 0.497 ' O ' ' HG3' ' B' ' 152' ' ' LYS . 6.0 p-90 -68.6 127.94 34.84 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.345 -174.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' B' ' 151' ' ' TRP . 21.4 mttp -178.36 -167.84 0.14 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.231 1.012 . . . . 0.0 109.896 176.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' B' ' 154' ' ' LYS . 0.0 OUTLIER -132.59 163.71 28.27 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -172.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' B' ' 153' ' ' GLU . 11.2 pttp 66.13 -178.61 0.2 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.884 1.674 . . . . 0.0 114.323 174.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 14.8 t70 71.54 -94.48 0.03 OUTLIER 'General case' 0 C--N 1.341 0.235 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.189 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 148.63 97.8 0.19 Allowed Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.551 -1.309 . . . . 0.0 113.463 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -128.21 67.41 1.36 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 23.1 t -72.0 127.67 34.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.428 -176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 8.9 tp10 -93.53 153.54 18.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.87 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -89.52 23.2 2.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.622 -177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' B' ' 189' ' ' MET . 34.1 tt0 -163.28 25.81 0.09 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.406 0.622 . . . . 0.0 110.539 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.532 ' HB2' ' HB3' ' B' ' 159' ' ' GLU . 3.7 t70 -113.08 -172.16 2.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.316 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -99.39 124.67 44.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.6 t -120.14 126.42 75.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.337 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 10.3 m -87.58 109.8 19.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 67.6 mt -114.45 126.59 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.142 0.496 . . . . 0.0 112.264 -174.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -101.05 110.2 22.19 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -139.53 160.29 40.21 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.385 0.612 . . . . 0.0 112.11 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.9 m -131.79 136.26 47.4 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.884 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.46 104.86 2.31 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.697 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 33.2 m -130.04 124.67 33.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.63 -89.66 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.003 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -99.62 44.74 1.01 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.197 0.522 . . . . 0.0 110.149 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.91 12.85 67.79 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.297 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -126.8 138.95 53.42 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.39 134.68 34.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.719 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -105.34 -178.28 3.61 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.776 0.322 . . . . 0.0 111.82 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.74 -39.92 82.32 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.076 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.14 -176.17 37.73 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.147 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.49 16.8 67.8 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.073 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.17 94.77 5.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.68 144.46 31.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.68 0.276 . . . . 0.0 110.976 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -135.4 146.74 48.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.085 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 56.46 30.18 16.61 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 123.589 0.556 . . . . 0.0 110.786 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -83.94 126.54 33.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.463 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 17.3 m -98.76 115.47 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.955 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 63.7 tp -106.1 127.8 53.44 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.361 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.29 106.72 18.66 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 189' ' ' MET . . . . . 0.623 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 68.1 mtp -78.95 148.38 32.66 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.758 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.3 -15.05 63.55 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.039 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -94.97 -1.15 53.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.799 0.333 . . . . 0.0 111.384 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.88 56.71 5.22 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.738 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.413 HH22 HD11 ' A' ' 53' ' ' ILE . 17.8 mmt85 -99.64 -6.31 27.48 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.198 0.523 . . . . 0.0 109.789 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.478 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -136.27 173.02 12.16 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.904 -178.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 31.2 mm -62.83 131.32 94.43 Favored Pre-proline 0 N--CA 1.437 -1.12 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.82 125.74 11.78 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.495 2.13 . . . . 0.0 111.956 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.14 -42.7 1.89 Allowed Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.288 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -63.32 -52.22 62.77 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.055 0.427 . . . . 0.0 111.866 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . 0.472 ' O ' ' HE2' ' B' ' 189' ' ' MET . 10.5 pt-20 -71.79 -31.23 66.38 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.854 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.85 -39.56 76.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.888 0.375 . . . . 0.0 111.098 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -62.97 -20.34 62.28 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.688 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.5 -41.74 93.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 120.804 0.335 . . . . 0.0 110.289 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -47.5 128.39 12.39 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.8 0.84 . . . . 0.0 111.671 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.51 -19.44 45.1 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.165 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -87.53 163.68 16.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.867 0.365 . . . . 0.0 111.816 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -105.78 155.12 19.6 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.989 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.18 137.47 57.02 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' B' ' 237' ' ' LEU . . . 74.41 38.19 45.68 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.504 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -127.64 128.48 45.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.224 0.535 . . . . 0.0 111.783 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -99.23 120.17 39.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.68 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . 0.468 ' O ' ' HB ' ' B' ' 212' ' ' THR . 36.0 t80 -139.65 -35.71 0.53 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -176.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' B' ' 211' ' ' PHE . 94.8 m 75.32 142.46 0.07 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.706 0.288 . . . . 0.0 110.799 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -132.56 141.07 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 111.594 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.19 109.47 18.33 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.681 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 64.5 t -121.38 122.3 66.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' THR . . . . . 0.431 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 3.4 m -92.01 -21.15 20.67 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -174.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' B' ' 216' ' ' THR . 44.0 m-85 68.05 149.52 0.12 Allowed Pre-proline 0 N--CA 1.482 1.156 0 CA-C-O 120.779 0.323 . . . . 0.0 110.839 -175.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 15.6 Cg_exo -71.15 150.4 59.68 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.311 2.007 . . . . 0.0 111.767 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.43 -37.45 87.56 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.84 76.47 6.33 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.206 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -121.6 141.98 50.56 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -62.93 -29.09 70.52 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.98 110.9 22.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 43.8 tt0 -65.23 -33.54 76.25 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.728 -176.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.406 ' O ' ' HG3' ' B' ' 229' ' ' LYS . 30.4 p-10 -66.33 -23.37 66.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.118 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.7 mt -110.69 -4.25 15.46 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.9 ptmt -69.05 119.74 13.81 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.875 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.89 34.6 90.32 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.327 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' B' ' 225' ' ' ASN . 34.7 mmtp -114.91 133.87 55.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -84.16 107.72 16.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.901 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.37 148.21 22.69 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.142 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.18 -48.99 3.71 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 58.98 102.52 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.169 0.509 . . . . 0.0 110.892 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.47 89.82 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm 61.54 102.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.175 0.59 . . . . 0.0 112.095 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -90.17 -51.51 5.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . 0.558 ' O ' ' HA2' ' B' ' 208' ' ' GLY . 13.0 tp 61.99 81.66 0.19 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.27 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -82.36 -48.58 10.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -110.18 -79.82 0.58 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t 70.18 142.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.096 0.559 . . . . 0.0 110.839 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -73.76 -47.23 40.6 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.094 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 65.58 162.18 0.14 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -158.69 91.4 1.06 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.254 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' B' ' 152' ' ' LYS . 7.8 tp10 -122.79 153.4 39.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.188 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 9.0 tt 76.24 116.07 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 C-N-CA 124.027 0.931 . . . . 0.0 110.58 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.38 113.12 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.543 2.162 . . . . 0.0 113.653 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . 0.484 ' HG2' ' OG1' ' B' ' 150' ' ' THR . 12.6 pt-20 -125.89 -163.57 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.0 mp -89.25 104.42 16.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.342 0.591 . . . . 0.0 111.817 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 34.2 m -132.67 133.64 43.82 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.99 15.4 13.31 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.06 -12.21 25.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -75.16 -2.51 28.07 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.821 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' B' ' 261' ' ' GLY . 43.5 pt -109.93 -3.63 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.576 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -138.76 10.56 2.66 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -131.64 13.83 4.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.041 0.448 . . . . 0.0 109.97 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -131.42 138.56 49.12 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.361 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 69.5 -129.06 22.13 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.212 -0.518 . . . . 0.0 114.073 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 75.8 t -121.03 130.02 75.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . 0.634 ' HG2' ' H ' ' B' ' 260' ' ' ASP . 22.0 tt0 59.5 -166.79 0.17 Allowed 'General case' 0 CA--C 1.552 1.039 0 O-C-N 123.709 0.63 . . . . 0.0 110.091 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . 0.634 ' H ' ' HG2' ' B' ' 259' ' ' GLU . 5.1 p-10 -110.24 144.9 38.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' B' ' 253' ' ' ILE . . . -146.43 166.19 28.19 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.138 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 12.8 p -80.32 176.89 9.36 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 122.768 0.427 . . . . 0.0 111.205 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.81 -48.0 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.749 0.309 . . . . 0.0 110.942 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.11 -33.3 29.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 110.591 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.54 -41.35 99.8 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.061 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.43 ' O ' HG21 ' B' ' 270' ' ' VAL . 63.6 tp -61.58 -46.33 90.3 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 120.522 0.201 . . . . 0.0 110.595 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -65.04 -41.72 94.94 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.728 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.606 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.16 -45.92 86.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -67.88 -38.76 83.44 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.43 HG21 ' O ' ' B' ' 266' ' ' LEU . 58.8 t -64.38 -42.11 94.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.35 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -58.04 -48.41 80.17 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.611 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 11.9 ptmt -66.65 -42.61 86.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.741 0.305 . . . . 0.0 111.292 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.6 -38.26 90.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.007 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.8 mmm -63.33 -42.14 98.95 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.994 0.426 . . . . 0.0 109.997 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' B' ' 278' ' ' LEU . 79.1 mt-10 -70.51 -28.77 65.21 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.738 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -64.41 -42.74 95.91 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -67.59 -27.94 67.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.711 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' B' ' 275' ' ' GLU . 63.9 tp -61.02 -38.72 87.09 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.37 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -58.21 -46.76 85.27 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.626 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 32.2 m -62.22 -44.76 95.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.895 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.71 72.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.339 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.29 -44.06 97.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.062 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . 0.522 HH12 ' HG3' ' B' ' 409' ' ' GLU . 1.7 tpt180 -62.25 -46.16 90.06 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.781 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -64.69 -39.88 94.43 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . 0.559 HH21 ' CG ' ' B' ' 285' ' ' ARG . 0.0 OUTLIER -60.85 -43.78 97.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.074 0.464 . . . . 0.0 110.588 179.03 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 76.1 t -67.75 -43.91 86.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.946 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.63 -46.47 90.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.22 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 32.2 p -60.37 -43.47 96.51 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -66.53 -41.14 89.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.363 . . . . 0.0 111.137 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.65 -48.22 78.12 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.46 -44.52 97.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.322 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -62.65 -40.28 96.55 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.61 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.34 -42.75 99.1 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.12 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.33 -42.22 98.96 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.03 -45.34 96.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 123.201 0.313 . . . . 0.0 111.196 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.87 -41.96 95.24 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.379 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -69.77 -43.13 72.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -117.89 100.83 7.83 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -96.65 113.58 25.16 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . 0.426 HG13 ' N ' ' B' ' 301' ' ' ASP . 10.6 tp -126.98 160.52 35.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.8 0.333 . . . . 0.0 111.117 -176.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . 0.426 ' N ' HG13 ' B' ' 300' ' ' ILE . 14.1 m-20 -65.71 135.95 55.63 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.629 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 16.0 t -112.64 123.07 34.7 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.533 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.66 123.96 14.08 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.141 1.894 . . . . 0.0 111.527 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.81 81.65 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.714 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.62 -45.6 73.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.113 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.79 -41.85 95.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.718 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.67 -45.74 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -43.54 86.71 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.527 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 309' ' ' SER . . . . . 0.464 ' O ' HG22 ' B' ' 313' ' ' VAL . 20.3 m -62.59 -45.39 93.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.205 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . 0.513 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 55.3 mm-40 -66.17 -39.19 89.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.051 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.17 -44.22 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.995 0.426 . . . . 0.0 110.345 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.69 -38.02 89.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.811 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . 0.464 HG22 ' O ' ' B' ' 309' ' ' SER . 96.9 t -66.6 -42.48 89.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.955 176.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 90.3 mt -61.42 -39.88 92.37 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.03 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.446 ' NH1' HD13 ' B' ' 330' ' ' LEU . 63.5 mtm180 -61.74 -37.68 85.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.316 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 -63.38 -43.89 96.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.795 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.99 -41.49 95.35 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.335 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.87 -42.5 76.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.372 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.2 -37.01 84.56 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 120.862 0.363 . . . . 0.0 111.319 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -55.4 -42.95 74.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.578 0.704 . . . . 0.0 109.539 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -74.41 -38.22 63.15 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.885 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -58.12 -46.87 84.85 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.169 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . -168.95 17.56 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.435 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 72.2 25.54 74.3 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.168 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -94.07 151.0 19.83 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -175.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -135.58 -179.7 5.8 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 68.8 -62.85 0.38 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.32 0.648 . . . . 0.0 112.084 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -67.02 -16.61 64.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.99 0.424 . . . . 0.0 111.141 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . 0.423 ' O ' ' HD2' ' B' ' 315' ' ' ARG . . . -60.85 -18.74 57.7 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.621 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . 0.446 HD13 ' NH1' ' B' ' 315' ' ' ARG . 45.7 tp -61.88 -37.56 85.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.809 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -74.43 -6.17 46.72 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.976 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.6 140.6 96.54 Favored Pre-proline 0 C--O 1.241 0.606 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.934 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -55.08 130.62 41.74 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.951 2.434 . . . . 0.0 113.296 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -65.74 -44.01 87.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.074 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.5 pm0 -66.53 -24.48 66.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 11.0 mp -76.06 -18.94 59.0 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -116.09 -20.61 9.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -64.43 -32.22 73.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -63.49 -46.7 84.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.537 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -76.9 -26.56 54.3 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.734 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.96 93.05 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.614 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . 0.425 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.8 tttt -57.76 -44.87 86.42 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.939 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . 0.502 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.2 mmt85 -61.64 -44.1 97.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.783 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -65.63 -39.45 91.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.597 0.237 . . . . 0.0 111.242 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . . . . . . . . . 77.6 t -63.58 -45.72 96.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.148 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.425 HG23 ' O ' ' B' ' 342' ' ' LYS . 96.9 t -63.37 -44.25 98.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . 0.502 HG23 ' O ' ' B' ' 343' ' ' ARG . 78.6 t -60.54 -45.26 97.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.445 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.11 -43.08 99.87 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.368 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.09 -44.11 93.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.664 0.269 . . . . 0.0 111.359 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.85 -44.84 91.97 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.757 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.04 -39.25 89.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.05 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.53 97.83 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.015 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.29 -35.25 79.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.967 0.383 . . . . 0.0 110.851 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.18 -44.59 95.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.1 -44.13 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.704 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -68.73 -47.28 66.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 26.4 m -65.51 -45.42 83.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -88.47 -9.4 52.61 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.916 0.389 . . . . 0.0 111.069 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 60.94 61.51 1.62 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.077 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.1 mt -78.76 156.54 28.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.304 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -131.25 158.86 39.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.672 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -81.28 108.2 14.7 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 172.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . 0.461 ' O ' HG22 ' B' ' 367' ' ' VAL . 18.0 t70 -81.72 107.57 14.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.327 0.584 . . . . 0.0 111.825 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 5.6 mm-40 -61.39 -35.25 76.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.846 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.17 -43.28 92.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.967 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -64.27 -39.37 93.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.302 0.572 . . . . 0.0 109.836 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . 0.461 HG22 ' O ' ' B' ' 363' ' ' ASP . 94.6 t -61.81 -39.54 83.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.633 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 24.9 mmmt -55.89 -46.53 78.31 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.035 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.59 -42.26 99.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.333 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 98.5 mt -63.09 -42.13 99.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.854 0.359 . . . . 0.0 110.705 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 92.1 mt -63.92 -43.09 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.286 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.27 -40.94 97.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.94 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.89 -40.02 94.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.798 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 59.9 ttm -66.65 -41.46 88.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.074 0.464 . . . . 0.0 110.796 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.75 -25.1 68.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.861 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 47.9 m -75.74 3.32 10.05 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.987 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -103.02 11.24 37.54 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.324 0.583 . . . . 0.0 110.827 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -118.18 170.8 8.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.118 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.2 -35.02 79.43 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.543 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -138.22 111.8 8.59 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.024 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.91 -30.77 32.52 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.352 2.035 . . . . 0.0 113.223 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.78 -44.27 90.54 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -65.64 -36.02 82.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.747 0.308 . . . . 0.0 110.383 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.13 -41.47 91.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.606 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.6 mt -61.43 -44.25 98.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.802 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 52.9 mt-10 -66.54 -42.32 87.36 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.559 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -58.05 -46.91 84.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.958 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -67.97 -44.07 77.52 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.656 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 41.7 p -73.75 -17.69 61.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.5 mttt -89.06 1.66 55.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.901 0.381 . . . . 0.0 111.253 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -123.11 112.61 17.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.719 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.71 -41.89 98.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.507 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -61.91 -45.18 94.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 5.8 mp -62.65 -43.06 99.77 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.675 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.533 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.8 mtp -63.2 -46.82 85.27 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.032 0.444 . . . . 0.0 110.963 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . 0.433 ' HA ' ' HE ' ' B' ' 399' ' ' ARG . 19.5 t70 -65.01 -43.95 90.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.784 -176.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -63.55 -40.34 96.76 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.742 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 47.4 tpp -62.78 -39.83 95.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' B' ' 395' ' ' MET . 80.8 mtm180 -64.13 -35.51 81.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.695 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.11 -43.31 99.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 98.0 t -66.53 -44.04 90.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.586 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.73 95.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.943 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 47.5 tp -62.82 -38.33 90.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.03 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . 0.492 ' O ' HG21 ' B' ' 408' ' ' VAL . 43.8 tt0 -54.47 -51.39 65.16 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.07 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 37.3 mt-10 -65.89 -37.98 87.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.453 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -60.4 -43.54 96.58 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.576 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.439 ' O ' HG21 ' B' ' 411' ' ' VAL . . . -64.23 -42.56 96.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.634 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . 0.572 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 93.0 t -65.34 -43.3 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.583 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . 0.522 ' HG3' HH12 ' B' ' 283' ' ' ARG . 95.2 mt-10 -63.91 -35.69 81.5 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.064 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.2 98.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.089 0.471 . . . . 0.0 110.286 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . 0.439 HG21 ' O ' ' B' ' 407' ' ' ALA . 92.1 t -65.27 -42.64 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.421 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 81.4 mt -61.15 -40.68 94.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.532 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.49 -16.78 64.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.617 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -102.75 -22.76 13.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.44 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.44 179.55 5.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.257 0.551 . . . . 0.0 112.001 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.18 108.03 20.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.33 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.3 127.29 52.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.73 0.3 . . . . 0.0 110.254 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 13.6 t -119.96 130.94 55.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . 0.48 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 41.5 mt-10 -102.3 120.7 40.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.356 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -131.85 138.62 48.54 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.418 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.26 144.91 35.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 13.4 t -151.3 171.72 17.02 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.231 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 36.1 p -86.95 166.1 15.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.338 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -67.34 -25.95 66.25 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -62.9 -38.42 90.86 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.86 -31.67 72.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 0.0 110.672 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.24 -12.95 60.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 5.5 mmt -81.03 -7.3 59.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.001 0.429 . . . . 0.0 110.995 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -78.1 78.27 4.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.309 0.576 . . . . 0.0 110.509 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -126.06 23.63 7.09 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.63 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.39 -30.15 70.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.234 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.826 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.691 -178.673 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.232 0.167 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.7 t -117.41 113.63 22.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.935 0.398 . . . . 0.0 110.821 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 p -154.72 140.65 11.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -122.34 157.69 31.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.981 0.419 . . . . 0.0 111.204 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 m -104.44 115.56 30.59 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.857 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.7 m -68.2 -53.42 25.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.738 0.304 . . . . 0.0 111.01 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 168.31 130.05 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.82 0.848 . . . . 0.0 109.586 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.22 -105.7 1.36 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.784 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.424 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 4.0 mp -97.04 -16.01 20.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.692 0.282 . . . . 0.0 110.343 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.404 ' O ' ' HD3' ' A' ' 13' ' ' ARG . . . -71.79 133.58 21.15 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.635 -175.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -135.92 143.44 44.95 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -116.23 134.02 55.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 t -79.56 -94.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 m 54.54 91.48 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.336 0.589 . . . . 0.0 110.85 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 tp -106.87 134.32 48.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.004 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.3 p -81.3 132.62 35.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.412 HD11 HD13 ' A' ' 24' ' ' ILE . 1.9 pp -129.56 161.88 38.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.663 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -108.11 155.85 19.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.005 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.17 -53.15 57.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.4 -34.39 74.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.987 0.422 . . . . 0.0 110.662 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.6 t -63.01 -34.44 77.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.038 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.663 HG13 ' O ' ' A' ' 20' ' ' ALA . 62.7 mt -59.62 -70.2 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.207 0.527 . . . . 0.0 111.269 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.495 ' CD ' ' HZ2' ' A' ' 29' ' ' LYS . 4.2 tp10 -63.71 -44.87 92.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.724 -172.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.3 m -64.66 -49.01 72.68 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.4 -45.25 18.01 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.0 t -63.32 -44.47 99.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.531 0.196 . . . . 0.0 111.531 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.495 ' HZ2' ' CD ' ' A' ' 25' ' ' GLU . 17.7 ttmm -61.32 -46.7 89.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.832 0.348 . . . . 0.0 110.735 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.9 m -61.72 -41.58 97.8 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.085 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -65.45 -42.6 92.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.984 0.421 . . . . 0.0 110.567 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.421 ' CD2' HH22 ' A' ' 73' ' ' ARG . 97.1 mt -63.81 -44.09 94.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.24 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -68.05 -37.6 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -62.79 -39.67 94.95 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.463 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.49 -44.16 98.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.822 0.344 . . . . 0.0 110.311 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.05 87.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.945 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.9 -34.11 77.07 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.833 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -59.29 -42.83 92.21 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.834 0.35 . . . . 0.0 110.483 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.1 t -85.99 -4.72 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.056 0.455 . . . . 0.0 110.16 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 62.74 27.56 16.15 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.457 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.72 5.29 10.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -64.46 -30.51 71.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.986 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.15 -23.65 68.15 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.339 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -74.83 -12.2 60.33 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.429 ' HG3' ' NE2' ' B' ' 320' ' ' GLN . 71.8 ttt-85 -91.06 103.08 15.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.58 -176.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HZ2' ' HB3' ' A' ' 46' ' ' LYS . 0.9 OUTLIER -79.13 109.6 13.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.288 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.81 67.61 2.12 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 115.949 1.139 . . . . 0.0 115.949 -170.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.62 -44.16 91.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.3 t -98.33 102.74 15.1 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HB2' ' OD1' ' A' ' 52' ' ' ASN . 13.4 Cg_endo -57.36 144.03 92.41 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.315 2.01 . . . . 0.0 111.779 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.423 ' O ' HG11 ' A' ' 54' ' ' VAL . 17.5 ttt -61.13 -38.57 86.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.244 -173.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.508 ' OD1' ' HB2' ' A' ' 50' ' ' PRO . 16.7 p-10 -62.56 -43.21 99.37 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.833 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.477 HG12 ' NH2' ' B' ' 193' ' ' ARG . 1.8 mp -68.67 -44.12 82.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.434 HG23 ' HA2' ' B' ' 323' ' ' GLY . 2.6 p -63.84 -36.85 78.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 120.63 0.252 . . . . 0.0 111.619 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.19 89.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.258 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -83.45 -32.69 25.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.371 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -63.44 -42.47 98.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.177 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -109.91 17.83 20.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.391 0.615 . . . . 0.0 111.186 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.18 145.81 49.91 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.072 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 72.66 -35.06 0.31 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.378 0.671 . . . . 0.0 112.555 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -61.23 -45.89 92.66 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -122.97 22.17 4.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.903 0.858 . . . . 0.0 110.246 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -63.87 -23.25 67.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.374 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -63.83 -45.17 90.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.847 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -75.2 -24.01 57.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.129 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.88 -42.22 94.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.0 mt -61.91 -38.41 88.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.935 175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.7 -41.06 98.85 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.658 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.439 ' OD1' ' HE2' ' B' ' 327' ' ' LYS . 20.9 t70 -60.75 -46.34 90.81 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.954 0.407 . . . . 0.0 110.434 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.18 -42.59 99.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.282 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.6 ttp -63.32 -42.87 99.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.976 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -62.83 -44.04 97.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.331 0.586 . . . . 0.0 110.997 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.421 HH22 ' CD2' ' A' ' 32' ' ' LEU . 69.7 mtp180 -64.42 -40.77 96.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.046 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -63.93 -40.24 96.0 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 120.954 0.407 . . . . 0.0 110.519 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -62.43 -48.28 80.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.874 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.445 ' O ' HG13 ' A' ' 79' ' ' ILE . 15.7 tt -68.96 -41.48 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.879 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -65.16 -37.91 88.88 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.141 0.496 . . . . 0.0 110.095 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.66 83.16 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.922 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.8 pp -65.64 -30.5 50.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.541 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.0 mt -65.44 -43.63 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.932 0.396 . . . . 0.0 111.034 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -81.24 -32.57 33.3 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.901 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -83.27 -2.94 56.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.124 0.487 . . . . 0.0 110.407 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt 64.23 38.93 7.78 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.674 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 81.3 mt -102.66 123.87 56.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.827 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -110.32 103.56 54.16 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.388 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.65 146.59 34.39 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.51 2.14 . . . . 0.0 112.295 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.14 98.23 11.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.049 0.452 . . . . 0.0 111.424 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.55 -106.48 2.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.591 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.09 129.71 24.65 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.449 ' HG2' ' CE1' ' A' ' 92' ' ' TYR . 81.0 Cg_endo -73.95 156.42 47.8 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.681 2.254 . . . . 0.0 111.928 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.0 m -76.94 119.39 20.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.017 0.437 . . . . 0.0 111.534 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.449 ' CE1' ' HG2' ' A' ' 90' ' ' PRO . 73.6 m-85 -113.82 118.81 35.3 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.01 100.57 53.84 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.443 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -90.19 145.31 4.26 Favored 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 122.555 2.17 . . . . 0.0 111.29 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.98 175.3 41.5 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.301 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.72 125.17 26.43 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -80.51 127.82 32.88 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.971 0.415 . . . . 0.0 110.563 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -117.56 115.52 25.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.595 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.4 tp -65.37 107.27 1.59 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.334 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.47 -8.71 13.43 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.383 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.93 173.39 8.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.803 0.335 . . . . 0.0 111.026 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.87 141.25 44.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.558 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -98.08 141.18 31.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.385 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.8 m -124.26 133.99 53.35 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -141.03 154.91 46.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.255 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 m -84.21 -86.44 0.12 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.0 t 68.89 111.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 122.98 0.512 . . . . 0.0 110.498 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -113.95 137.66 51.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.825 -175.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -151.34 -74.75 0.15 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -143.24 157.49 44.44 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.553 0.615 . . . . 0.0 111.297 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.424 ' CG1' ' HG ' ' A' ' 11' ' ' LEU . 28.8 m -128.78 -172.46 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -140.25 118.02 8.27 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.88 147.32 39.02 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.821 2.347 . . . . 0.0 114.623 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -135.87 143.06 44.85 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.597 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.6 t -128.37 132.17 68.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -104.7 -90.15 0.4 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.519 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.0 mt 64.1 130.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.114 0.966 . . . . 0.0 113.397 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -136.97 152.34 50.04 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.818 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.96 22.14 74.85 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.418 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.66 -28.8 68.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.808 0.337 . . . . 0.0 111.897 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -83.16 -9.02 59.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.852 0.358 . . . . 0.0 111.28 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -102.51 17.29 24.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.911 0.386 . . . . 0.0 111.342 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.2 mt -90.47 123.7 42.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.908 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -108.99 127.02 53.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.3 t -115.16 136.07 53.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.017 0.437 . . . . 0.0 112.073 -172.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -86.99 139.1 30.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.844 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -134.47 101.03 12.23 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.5 137.79 40.37 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.046 1.831 . . . . 0.0 111.527 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.98 123.13 70.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.919 0.39 . . . . 0.0 110.481 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.99 162.25 39.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.534 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -142.35 158.99 43.11 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.6 t -81.17 116.77 26.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.1 p -100.39 176.36 5.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.665 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -65.02 -30.62 71.61 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.476 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.54 97.72 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.895 0.378 . . . . 0.0 110.355 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -64.21 -44.43 91.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.949 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.478 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 90.1 t -64.47 -46.13 93.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.433 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.71 -48.4 81.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.721 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.63 -39.48 97.61 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.945 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.478 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -63.07 -44.79 94.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 0.0 110.337 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 86.6 mt -63.2 -42.26 99.28 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.74 -45.15 93.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.367 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.8 m -62.95 -42.72 99.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.614 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -60.92 -42.54 98.3 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -72.81 -20.89 61.06 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.418 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.17 -12.4 59.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.079 0.466 . . . . 0.0 110.608 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -93.61 2.99 56.19 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.498 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -117.14 75.09 0.95 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.888 0.852 . . . . 0.0 111.976 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.71 73.24 0.76 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 151' ' ' TRP . 4.1 m -144.76 173.01 12.22 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.903 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.448 ' H ' HG23 ' A' ' 150' ' ' THR . 31.5 t-105 80.72 17.52 0.57 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.395 1.078 . . . . 0.0 112.315 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.454 ' HG2' ' HB2' ' A' ' 245' ' ' LEU . 6.3 mptp? -101.89 160.01 14.85 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -94.93 4.88 53.29 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -142.23 154.37 44.73 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.986 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 78.2 -175.22 0.09 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.733 1.213 . . . . 0.0 111.304 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -138.29 99.45 0.28 Allowed Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 119.577 -1.297 . . . . 0.0 114.865 -174.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.413 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . . . -110.45 -57.0 2.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.5 t 60.89 123.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 114.592 -1.186 . . . . 0.0 113.589 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -99.95 158.14 16.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.753 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.84 86.39 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -77.12 -0.12 23.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.53 142.38 27.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.508 0.194 . . . . 0.0 110.757 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -91.61 120.09 32.08 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.95 129.98 74.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.754 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.0 m -75.91 110.32 10.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 79.9 mt -122.37 120.28 60.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.348 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -98.48 101.4 12.83 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -120.15 154.22 35.08 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.074 0.464 . . . . 0.0 111.667 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 30.8 m -123.43 129.73 51.69 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.662 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.35 125.43 7.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.903 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 25.2 m -142.38 125.83 16.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.45 -78.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.653 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -132.77 80.31 1.89 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.55 7.3 73.43 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.096 -0.574 . . . . 0.0 112.903 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -140.69 143.72 35.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.793 0.33 . . . . 0.0 110.12 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -87.27 156.73 19.52 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.193 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -122.64 174.04 7.34 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.71 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.21 -38.84 74.34 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -101.19 -178.22 28.91 Favored Glycine 0 C--N 1.318 -0.435 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.091 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.02 30.5 38.07 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.704 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -107.18 102.92 12.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -124.45 142.67 51.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 111.948 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.4 m -150.52 132.24 14.96 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.2 31.04 20.9 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.374 0.421 . . . . 0.0 110.343 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -95.84 123.42 39.41 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.99 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.2 m -91.48 116.5 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.539 0.685 . . . . 0.0 110.598 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 56.3 tp -110.13 130.51 55.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.396 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.665 ' HB2' ' NH1' ' A' ' 193' ' ' ARG . . . -121.22 135.29 55.16 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 73.9 mtm -102.19 178.21 4.66 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.149 0.5 . . . . 0.0 112.001 -172.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.61 -10.64 73.73 Favored Glycine 0 CA--C 1.505 -0.531 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.235 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -102.83 -9.23 20.11 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.618 0.247 . . . . 0.0 111.173 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.63 42.45 21.65 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.853 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.665 ' NH1' ' HB2' ' A' ' 188' ' ' ALA . 48.3 mtm180 -93.27 0.41 57.01 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.343 0.592 . . . . 0.0 110.632 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.451 ' HB2' ' HG3' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -130.17 172.95 11.23 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.445 173.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.529 HD11 ' H ' ' A' ' 195' ' ' ILE . 4.4 mp -69.07 137.47 89.56 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.98 134.75 49.94 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.984 1.789 . . . . 0.0 111.416 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.91 -38.94 2.9 Favored Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.51 ' O ' HG12 ' A' ' 202' ' ' ILE . 47.9 t80 -63.57 -49.77 72.08 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 194' ' ' MET . 88.0 mt-10 -67.11 -36.11 81.22 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.492 0.663 . . . . 0.0 109.938 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.85 -36.08 82.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.627 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.16 -8.95 77.64 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.889 -0.672 . . . . 0.0 114.095 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 198' ' ' PHE . 47.8 mm -65.14 -45.27 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 117.275 0.538 . . . . 0.0 111.194 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -58.99 130.54 47.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.167 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.9 -15.02 48.85 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.451 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -83.37 143.51 30.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 117.06 0.43 . . . . 0.0 111.724 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -96.01 160.51 14.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.274 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.47 121.44 14.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.563 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 82.51 24.13 54.59 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.393 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -105.8 113.07 26.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.374 0.607 . . . . 0.0 111.482 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -91.37 130.94 37.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.559 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.483 ' O ' ' HB ' ' A' ' 212' ' ' THR . 61.5 t80 -150.52 -29.84 0.21 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -176.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 91.1 m 79.77 143.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.839 0.455 . . . . 0.0 110.279 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.3 tp -115.75 -42.01 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 72.12 100.11 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.329 0.585 . . . . 0.0 112.03 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 63.8 t -121.89 133.96 66.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.891 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 9.4 m -93.1 -23.49 18.6 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.452 ' CE2' HG12 ' A' ' 195' ' ' ILE . 96.4 m-85 71.94 145.59 0.11 Allowed Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 122.817 0.447 . . . . 0.0 111.459 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.56 154.02 60.09 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.621 2.214 . . . . 0.0 111.846 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -65.38 -40.04 93.01 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.947 0.403 . . . . 0.0 110.775 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -88.11 32.34 0.76 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.486 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -69.25 132.71 46.91 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.728 -0.389 . . . . 0.0 109.994 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -56.67 -40.4 75.45 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.57 101.85 7.62 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -61.53 -33.26 73.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -68.36 -14.11 62.76 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.18 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.0 mt -117.48 -0.34 11.95 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -71.54 124.21 24.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.311 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.91 17.96 77.3 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.544 -0.753 . . . . 0.0 114.492 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -127.5 132.05 50.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.711 0.755 . . . . 0.0 110.663 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.21 151.71 25.54 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.73 135.89 33.6 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.501 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.92 -48.05 67.04 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 54.46 91.83 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.082 0.468 . . . . 0.0 111.067 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.88 89.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mm 69.7 90.14 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.106 0.479 . . . . 0.0 111.522 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -67.88 -47.5 68.68 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.29 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.461 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 8.0 tp 55.26 100.37 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.86 0.864 . . . . 0.0 113.034 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -95.58 -70.91 0.69 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -80.5 -86.87 0.08 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.487 HG13 ' H ' ' A' ' 242' ' ' GLU . 65.6 t 76.84 140.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.111 0.564 . . . . 0.0 111.053 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.51 ' HB3' ' NH1' ' A' ' 243' ' ' ARG . 50.8 mm-40 -64.16 -37.03 85.98 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.344 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.487 ' H ' HG13 ' A' ' 240' ' ' VAL . 36.2 mt-10 66.97 129.3 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.535 0.734 . . . . 0.0 111.881 -176.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.51 ' NH1' ' HB3' ' A' ' 241' ' ' GLU . 8.6 ptp180 173.55 114.27 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.967 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.416 ' CG ' ' H ' ' A' ' 245' ' ' LEU . 0.4 OUTLIER -142.66 -153.96 0.49 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.454 ' HB2' ' HG2' ' A' ' 152' ' ' LYS . 10.5 mp 70.18 146.09 0.11 Allowed Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.527 ' O ' ' HG2' ' A' ' 247' ' ' GLU . 95.7 Cg_endo -82.94 -159.08 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.175 2.583 . . . . 0.0 112.931 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 246' ' ' PRO . 3.4 pt-20 87.96 -176.47 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.188 1.795 . . . . 0.0 111.043 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.76 135.73 48.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.105 0.479 . . . . 0.0 111.639 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 41.2 p -88.39 -168.52 2.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.036 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.23 -51.39 66.75 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.931 0.396 . . . . 0.0 109.935 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -132.54 94.23 3.38 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -72.97 -10.22 59.56 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.297 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.25 -44.55 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.72 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.508 ' HD2' ' HB2' ' A' ' 260' ' ' ASP . 58.2 pttt -150.88 151.74 32.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.879 0.371 . . . . 0.0 111.756 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.525 ' HG3' ' H ' ' A' ' 256' ' ' PHE . 28.1 tpt180 -168.93 -175.21 2.28 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -174.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.525 ' H ' ' HG3' ' A' ' 255' ' ' ARG . 91.9 m-85 90.47 -39.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.356 1.062 . . . . 0.0 113.67 172.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 133.43 -132.13 6.37 Favored Glycine 0 C--N 1.313 -0.695 0 C-N-CA 119.326 -1.416 . . . . 0.0 113.234 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.7 m 38.18 48.26 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.933 0.893 . . . . 0.0 111.389 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 260' ' ' ASP . 33.6 tt0 66.94 -84.8 0.03 OUTLIER 'General case' 0 C--O 1.235 0.329 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.334 -174.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.508 ' HB2' ' HD2' ' A' ' 254' ' ' LYS . 4.0 p30 174.2 151.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.112 0.565 . . . . 0.0 110.434 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.39 -171.76 31.03 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.933 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.2 p -79.81 168.74 18.89 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.604 0.362 . . . . 0.0 110.911 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . 0.415 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 94.0 t -61.94 -49.56 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.785 0.326 . . . . 0.0 111.578 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -71.14 -41.33 70.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.129 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.27 95.6 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.389 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 270' ' ' VAL . 58.1 tp -61.8 -45.67 92.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.555 0.217 . . . . 0.0 111.117 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 263' ' ' VAL . 66.1 mtp180 -66.73 -41.41 87.93 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.573 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.602 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.91 -43.3 83.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.202 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -66.5 -39.81 88.89 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.705 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 266' ' ' LEU . 76.0 t -64.35 -42.35 95.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.938 176.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -57.56 -47.62 81.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.564 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 12.8 ptmt -66.99 -39.62 87.2 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -63.79 -41.03 98.01 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.987 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 98.7 mmm -64.43 -41.87 96.33 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.852 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.22 -34.92 75.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.762 0.315 . . . . 0.0 111.122 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -61.96 -43.09 99.58 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -67.07 -37.96 84.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.494 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.6 tp -61.96 -41.07 97.57 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.834 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -57.7 -46.12 84.77 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.654 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.3 m -63.65 -44.72 93.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.576 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.74 93.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.076 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.62 -43.94 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.24 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -62.53 -42.62 99.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.893 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -62.97 -41.34 99.52 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.104 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -60.26 -44.1 95.59 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.117 0.484 . . . . 0.0 110.327 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.0 t -70.02 -43.79 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.946 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.96 -47.39 86.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.299 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.9 p -62.25 -43.23 99.29 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.643 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -65.79 -42.49 90.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.842 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.615 ' O ' ' HG ' ' A' ' 294' ' ' LEU . . . -64.26 -45.62 87.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.044 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 295' ' ' VAL . 35.1 mm -63.98 -43.99 97.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.058 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.507 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 29.7 tp10 -60.52 -43.68 96.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.438 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.52 -40.3 98.6 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.278 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 290' ' ' ALA . 69.8 mt -63.38 -43.07 98.64 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.711 0.291 . . . . 0.0 111.155 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 291' ' ' ILE . 93.7 t -65.01 -44.8 95.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.941 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . 0.507 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.1 mttm -64.37 -39.8 94.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.326 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.97 95.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.921 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -137.93 102.27 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -90.02 107.38 19.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 8.7 tp -114.48 140.04 37.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.82 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -68.72 129.01 38.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.477 0.656 . . . . 0.0 110.05 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 94.0 t -99.56 135.54 20.58 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.687 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.74 132.81 53.86 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.498 2.132 . . . . 0.0 111.828 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.0 87.54 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.46 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.0 -41.74 83.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 111.537 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.2 -42.3 93.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.31 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.02 -44.58 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.817 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.09 -42.56 85.89 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.873 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.1 m -62.04 -44.64 96.27 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.055 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.487 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 74.0 mm-40 -69.37 -38.79 78.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.707 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.473 HD12 ' HG3' ' A' ' 334' ' ' ARG . 94.2 mt -62.19 -44.34 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -177.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.431 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 26.9 t70 -62.55 -43.1 99.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.037 0.446 . . . . 0.0 110.638 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.11 -43.31 95.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.293 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 95.8 mt -62.41 -41.81 98.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.037 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 85.3 mtm180 -63.72 -42.25 97.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -64.34 -41.14 96.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.554 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -63.46 -40.92 98.4 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.004 0.431 . . . . 0.0 110.603 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.42 91.76 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.223 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . . . -64.92 -37.09 86.48 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.799 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . 0.43 ' NE2' ' HG3' ' B' ' 45' ' ' ARG . 47.1 tt0 -60.64 -39.39 88.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.77 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -89.74 2.29 55.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.693 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -99.0 -2.95 36.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.342 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' B' ' 54' ' ' VAL . . . 139.98 -1.55 2.26 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.567 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 91.71 29.13 12.37 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.461 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 43.7 t-20 -72.39 124.04 24.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 0.6 OUTLIER -119.61 153.45 35.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 0.1 OUTLIER 61.37 -30.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 126.03 1.732 . . . . 0.0 114.608 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.503 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 15.9 mm100 -79.8 -5.31 55.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.301 0.572 . . . . 0.0 110.38 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.58 -18.39 63.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.38 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.92 -37.93 86.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.503 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.83 -20.13 65.13 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.853 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.02 147.03 91.01 Favored Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.275 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.443 ' O ' ' HD1' ' A' ' 337' ' ' PHE . 32.5 Cg_exo -61.04 142.08 96.22 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.804 2.336 . . . . 0.0 112.82 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.473 ' HG3' HD12 ' A' ' 311' ' ' ILE . 21.4 ttt180 -84.49 -41.07 16.93 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.836 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -60.14 -39.48 86.48 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.05 -2.88 58.73 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.444 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.443 ' HD1' ' O ' ' A' ' 333' ' ' PRO . 60.2 m-85 -109.83 -21.33 12.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.132 0.491 . . . . 0.0 109.875 173.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.74 -29.22 67.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.08 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -60.8 -47.44 86.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 110.639 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -78.42 -22.88 47.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.598 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -62.68 -41.77 99.27 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.197 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.499 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.8 tttt -59.73 -48.29 82.26 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.551 ' O ' HG21 ' A' ' 347' ' ' VAL . 13.4 mmt85 -61.25 -45.32 95.0 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.038 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.406 HH21 ' HD3' ' A' ' 344' ' ' ARG . 67.7 mtt-85 -65.89 -38.94 90.1 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 341' ' ' ALA . 97.4 t -66.63 -43.23 90.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.031 0.444 . . . . 0.0 109.998 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 342' ' ' LYS . 59.7 t -60.24 -43.48 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.566 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 343' ' ' ARG . 71.0 t -59.51 -45.09 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.32 -43.89 98.44 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.032 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.97 -42.77 97.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.557 0.218 . . . . 0.0 111.437 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.9 mt -62.75 -45.92 90.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.94 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.12 -38.91 82.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.241 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.57 97.07 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.146 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.78 -35.05 79.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.886 0.374 . . . . 0.0 110.837 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.62 -43.69 95.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.93 -44.89 99.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.899 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -69.48 -46.28 67.0 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.0 m -63.31 -44.18 95.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -97.11 5.71 49.78 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.059 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 52.83 53.19 12.51 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.846 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.91 145.57 32.59 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.7 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.25 148.26 44.54 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.765 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.88 127.54 32.91 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.5 ' O ' HG21 ' A' ' 367' ' ' VAL . 25.2 t70 -96.9 110.68 23.14 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.784 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -59.23 -34.6 72.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.775 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.447 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 46.7 mm-40 -67.05 -40.93 87.21 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.12 0.486 . . . . 0.0 110.591 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -63.4 -38.97 93.19 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 363' ' ' ASP . 93.6 t -62.51 -41.03 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.087 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 372' ' ' GLU . 25.9 mmmt -55.34 -45.15 76.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.066 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.16 -41.31 99.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.399 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.93 -42.66 99.87 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.09 0.471 . . . . 0.0 110.38 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.79 -44.04 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.738 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 368' ' ' LYS . 47.5 mt-10 -64.87 -40.26 94.85 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.718 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.91 -38.35 86.05 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.491 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 57.6 ttm -65.49 -41.49 93.2 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.076 0.465 . . . . 0.0 110.34 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -63.23 -26.3 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.844 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.8 m -72.35 -6.77 45.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.29 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -92.09 1.25 57.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.913 0.387 . . . . 0.0 110.789 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -119.87 172.59 7.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.23 -46.2 78.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.758 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -120.97 108.82 36.21 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.958 0.409 . . . . 0.0 110.576 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.404 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 51.8 Cg_exo -56.55 -39.41 91.53 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.91 2.406 . . . . 0.0 113.233 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.84 -43.84 91.72 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.88 -37.78 88.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.451 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.45 -42.73 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.217 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.48 -44.92 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.212 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.14 -38.6 78.9 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.265 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -58.97 -46.52 87.88 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.936 0.398 . . . . 0.0 110.355 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 4.6 t80 -68.65 -44.22 74.6 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.527 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.9 p -73.45 -17.32 61.26 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -176.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.12 4.14 54.51 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.108 0.48 . . . . 0.0 111.076 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.407 ' O ' ' HG3' ' A' ' 395' ' ' MET . 16.2 t-20 -122.51 111.45 16.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.033 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -61.39 -42.08 98.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -58.56 -48.89 79.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.776 0.322 . . . . 0.0 110.636 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.27 -40.44 97.4 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.492 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.441 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 95.9 mtp -61.72 -48.86 78.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.712 0.292 . . . . 0.0 111.62 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.51 -37.65 74.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 -175.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -62.25 -44.06 97.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.203 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.477 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 51.6 tpp -66.29 -39.74 89.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.146 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 395' ' ' MET . 55.7 mtm180 -64.17 -35.96 82.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.797 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -61.74 -43.84 98.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.001 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.2 -44.48 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.912 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.72 -40.48 97.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.903 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 45.9 tp -64.47 -37.74 88.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.462 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.84 -44.27 90.92 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.165 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -65.96 -37.0 84.88 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.595 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -60.06 -42.25 94.11 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.47 82.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.926 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 85.1 t -63.55 -46.41 95.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.02 -33.06 74.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.383 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.93 96.08 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 110.569 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 93.7 t -65.16 -42.23 93.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.314 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 95.5 mt -60.49 -40.16 90.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.643 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.58 -22.61 66.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.352 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -94.39 -40.44 9.93 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.919 0.39 . . . . 0.0 111.423 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -80.36 177.99 8.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.372 0.606 . . . . 0.0 112.36 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -87.25 118.23 26.54 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.362 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.1 t -103.36 105.95 19.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.1 t -105.13 134.72 47.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.975 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.19 111.57 23.25 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.757 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -117.79 128.13 54.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.992 0.425 . . . . 0.0 110.893 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -72.06 147.43 46.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.167 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -157.13 169.64 24.32 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 120.834 0.35 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 29.6 p -91.29 165.34 13.49 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.339 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -66.35 -30.34 70.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.479 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -62.46 -38.27 89.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.862 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.57 -33.5 75.81 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.08 0.466 . . . . 0.0 110.364 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 11.2 mp -72.43 -21.34 61.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.9 mmt -73.46 -6.65 47.7 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.031 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -78.79 71.69 5.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -102.49 17.42 23.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.268 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -64.17 -39.79 94.75 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.441 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.218 178.823 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 120.95 0.405 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.14 134.67 56.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.193 0.52 . . . . 0.0 111.711 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.02 159.76 42.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.27 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 40.2 t -115.85 107.73 15.4 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.998 0.428 . . . . 0.0 110.582 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.83 139.88 21.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.137 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -122.15 154.45 37.4 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.974 0.416 . . . . 0.0 111.137 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 61.5 m -104.35 119.79 39.74 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.912 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.8 m -70.67 -66.09 0.65 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.039 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -179.46 131.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.577 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.22 -106.37 1.65 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.507 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.445 ' HG ' ' CG1' ' B' ' 111' ' ' VAL . 2.5 mp -96.99 -14.5 21.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.687 0.28 . . . . 0.0 110.364 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.1 132.62 19.35 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.552 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.9 143.83 47.16 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 122.703 0.401 . . . . 0.0 109.997 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -117.9 133.94 55.44 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 19.8 t -81.04 -93.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.1 m 55.58 90.35 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.27 0.557 . . . . 0.0 110.679 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.1 tp -106.59 133.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.075 0.464 . . . . 0.0 111.921 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 25.5 p -81.76 132.09 35.28 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.824 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.415 HD11 HD13 ' B' ' 24' ' ' ILE . 1.8 pp -128.58 164.76 29.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.653 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -111.12 156.6 21.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.14 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.25 -52.87 57.61 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -173.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -71.05 -34.14 70.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.907 0.384 . . . . 0.0 110.963 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 33.4 t -64.87 -29.1 70.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.443 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.653 HG13 ' O ' ' B' ' 20' ' ' ALA . 64.9 mt -63.25 -71.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.29 0.567 . . . . 0.0 111.302 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.483 ' CD ' ' HZ2' ' B' ' 29' ' ' LYS . 4.4 tp10 -64.35 -42.72 96.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.646 -172.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 18.1 m -63.1 -47.43 82.87 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.06 -44.3 15.33 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -174.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 81.4 t -62.44 -44.66 99.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.55 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.483 ' HZ2' ' CD ' ' B' ' 25' ' ' GLU . 17.4 ttmm -61.71 -47.16 86.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.706 0.289 . . . . 0.0 111.036 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 21.8 m -61.75 -42.42 98.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.467 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.411 ' O ' HG22 ' B' ' 35' ' ' VAL . 13.6 tp10 -65.25 -40.99 94.72 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.868 0.366 . . . . 0.0 110.562 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 96.2 mt -63.71 -44.07 94.7 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.67 -37.2 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.74 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.16 -40.49 97.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.288 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.411 HG22 ' O ' ' B' ' 31' ' ' GLU . 83.9 t -64.05 -44.07 97.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.794 0.331 . . . . 0.0 110.511 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -46.37 89.97 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.855 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.74 -33.99 76.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.088 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.83 -43.84 90.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.854 0.359 . . . . 0.0 110.448 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 t -84.84 -4.7 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.289 0.566 . . . . 0.0 110.314 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 61.98 28.53 17.33 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.499 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -105.04 5.77 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.974 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -65.06 -28.61 69.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.264 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.2 -19.26 72.03 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.273 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -76.24 -17.55 59.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.43 ' HG3' ' NE2' ' A' ' 320' ' ' GLN . 71.5 ttt-85 -87.15 93.54 9.4 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.115 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.473 ' HZ2' ' HB3' ' B' ' 46' ' ' LYS . 1.2 ptpm? -69.37 115.85 9.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 173.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.94 70.74 0.49 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 -170.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.19 -44.56 83.63 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.61 105.96 26.64 Favored Pre-proline 0 N--CA 1.439 -1.005 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.125 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.473 ' HB2' ' OD1' ' B' ' 52' ' ' ASN . 14.0 Cg_endo -58.44 145.74 93.07 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.198 1.932 . . . . 0.0 111.396 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.413 ' O ' HG11 ' B' ' 54' ' ' VAL . 19.4 ttt -63.47 -38.84 92.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.151 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' B' ' 50' ' ' PRO . 21.8 p-10 -62.02 -43.25 99.23 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.899 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.474 HG12 HH21 ' A' ' 193' ' ' ARG . 1.8 mp -68.5 -44.64 82.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.416 HG23 ' HA2' ' A' ' 323' ' ' GLY . 4.3 p -63.89 -37.35 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.502 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.49 87.41 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.341 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -84.27 -33.66 23.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -62.53 -42.82 99.77 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.982 0.42 . . . . 0.0 110.946 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.6 18.21 21.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.412 0.625 . . . . 0.0 110.805 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' B' ' 61' ' ' SER . . . -64.43 145.68 49.74 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.426 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 72.75 -33.98 0.28 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.458 0.703 . . . . 0.0 112.263 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' SER . . . . . 0.408 ' H ' ' C ' ' B' ' 59' ' ' GLY . 38.7 t -61.63 -47.27 86.17 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.68 21.34 5.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 122.079 0.943 . . . . 0.0 109.899 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -63.27 -21.3 66.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.035 -177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -64.02 -47.06 81.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.774 0.321 . . . . 0.0 110.807 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.94 -23.86 55.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.268 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.74 -42.16 94.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.0 -38.47 88.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.17 -41.71 98.3 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.637 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . 0.553 ' OD1' ' HE2' ' A' ' 327' ' ' LYS . 21.1 t70 -60.23 -46.92 88.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.22 -42.91 99.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.409 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 61.0 ttp -63.03 -43.09 99.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.174 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -62.17 -43.8 98.02 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.256 0.551 . . . . 0.0 110.807 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.401 ' NH1' HG21 ' B' ' 35' ' ' VAL . 71.5 mtp180 -64.78 -40.61 95.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.314 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -63.85 -40.8 97.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.898 0.38 . . . . 0.0 110.473 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -61.09 -48.98 79.19 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.099 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . 0.46 ' O ' HG13 ' B' ' 79' ' ' ILE . 15.5 tt -68.74 -41.25 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.39 -38.0 89.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.212 0.529 . . . . 0.0 110.072 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.66 -47.22 84.65 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.092 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.46 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.8 pp -66.69 -29.55 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.865 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.5 mt -65.46 -43.95 94.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.782 0.325 . . . . 0.0 111.07 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -81.31 -33.06 32.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -80.18 -7.91 59.17 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.064 0.459 . . . . 0.0 110.388 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt 66.93 38.08 3.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.262 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.9 mt -101.19 121.44 52.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.473 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -107.54 102.72 45.85 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.835 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.71 146.79 38.98 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 122.376 2.051 . . . . 0.0 112.085 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.35 100.63 12.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.609 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.59 -118.11 6.45 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.012 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.27 130.65 23.44 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-O 120.544 0.212 . . . . 0.0 110.883 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . 0.426 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 73.1 Cg_endo -75.25 161.6 37.78 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.982 2.455 . . . . 0.0 111.984 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -77.98 117.71 19.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.127 0.489 . . . . 0.0 111.899 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.426 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 81.6 m-85 -112.22 122.0 46.49 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 52.7 t -120.89 99.89 46.61 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-O 120.878 0.37 . . . . 0.0 110.713 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -89.66 145.24 4.72 Favored 'Trans proline' 0 N--CA 1.438 -1.791 0 C-N-CA 122.412 2.074 . . . . 0.0 111.213 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.14 174.92 40.92 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.326 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.63 126.42 29.29 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -81.27 125.19 30.03 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.023 0.44 . . . . 0.0 110.352 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -112.95 112.46 23.94 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.036 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 48.5 tp -65.43 107.11 1.56 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.047 0.451 . . . . 0.0 110.105 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.73 -16.32 8.37 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.257 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.37 -179.74 4.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.957 0.408 . . . . 0.0 111.629 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.8 138.52 37.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.744 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -96.11 143.1 27.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.473 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 45.4 m -124.92 134.67 52.57 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -140.68 155.7 46.42 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.392 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 3.0 m -84.66 -86.06 0.13 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 84.0 t 67.86 108.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.992 0.517 . . . . 0.0 110.692 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -111.51 138.69 47.71 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.639 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -152.81 -75.13 0.13 Allowed 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -142.43 157.2 45.03 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.798 -0.564 . . . . 0.0 111.32 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.445 ' CG1' ' HG ' ' B' ' 11' ' ' LEU . 27.5 m -129.94 -175.2 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 121.351 0.596 . . . . 0.0 112.342 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -138.16 119.32 10.37 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.01 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.72 148.54 32.71 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.019 2.479 . . . . 0.0 114.583 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -138.74 142.25 38.87 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.38 133.21 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -103.0 -92.25 0.34 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.451 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.4 mt 64.13 133.79 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.898 0.879 . . . . 0.0 113.337 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -141.83 152.47 43.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.469 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.2 19.42 78.47 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.465 175.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 75.3 mt -63.62 -37.2 86.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.986 0.422 . . . . 0.0 111.352 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' B' ' 121' ' ' GLU . 1.6 mp0 -72.64 -12.91 61.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.593 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.44 18.0 18.89 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.878 0.37 . . . . 0.0 111.37 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 83.6 mt -92.66 122.23 43.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -104.37 133.11 49.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.45 136.0 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 112.027 -172.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -87.21 139.21 30.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.915 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -134.3 99.88 13.07 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.8 137.18 37.68 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.968 1.779 . . . . 0.0 111.492 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.72 123.66 69.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.848 0.356 . . . . 0.0 110.349 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.14 162.86 39.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.233 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -145.24 159.16 43.44 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.815 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.46 118.0 28.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 69.9 p -101.03 174.96 5.77 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.991 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.45 -31.81 72.59 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.657 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.13 99.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.481 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -65.08 -44.61 88.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.274 0.559 . . . . 0.0 110.268 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.435 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.4 t -63.8 -46.91 93.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.723 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -64.12 -42.71 96.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.646 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.75 -39.96 95.49 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.095 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' MET . . . . . 0.554 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.0 OUTLIER -62.68 -42.97 99.91 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 94.4 mt -63.63 -41.13 98.29 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.842 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -59.23 -48.72 80.56 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.68 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.9 m -61.8 -40.55 95.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.63 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.1 mt -61.04 -41.76 97.19 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.457 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -74.02 -18.05 60.9 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.467 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.5 -8.66 59.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.256 0.551 . . . . 0.0 110.394 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -95.83 4.61 52.7 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.342 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -119.07 75.33 1.03 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.754 0.788 . . . . 0.0 112.052 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -157.31 74.66 0.78 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' THR . . . . . 0.424 HG23 ' H ' ' B' ' 151' ' ' TRP . 4.9 m -145.83 171.86 14.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.102 -172.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . 0.424 ' H ' HG23 ' B' ' 150' ' ' THR . 44.8 t-105 82.02 10.68 0.73 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.79 1.236 . . . . 0.0 112.393 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . 0.507 ' HG2' ' HB2' ' B' ' 245' ' ' LEU . 6.1 mptp? -94.3 158.16 15.71 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.048 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.27 -1.56 58.1 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -141.05 156.32 46.03 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 120.444 -0.503 . . . . 0.0 112.02 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 4.6 t70 82.98 178.08 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.065 1.346 . . . . 0.0 111.136 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.0 89.62 0.26 Allowed Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 119.403 -1.379 . . . . 0.0 115.134 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . 0.458 ' HB2' ' HG3' ' B' ' 244' ' ' GLU . . . -103.38 -59.92 1.64 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 58.5 t 62.6 125.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.872 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -101.06 160.16 14.62 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.963 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.86 86.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.45 -4.38 42.19 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.79 143.48 32.82 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -96.82 121.23 38.45 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 49.5 t -119.53 129.46 75.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.773 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 25.5 m -76.42 104.28 6.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 77.1 mt -117.27 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.869 0.366 . . . . 0.0 111.582 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -99.04 91.9 5.24 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -110.78 154.17 24.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 111.462 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 38.8 m -124.72 129.54 50.68 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.646 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.35 127.38 9.17 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.84 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 27.2 m -143.26 124.61 14.67 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.93 -78.22 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.609 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -133.41 81.03 1.91 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.101 0.477 . . . . 0.0 111.423 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.3 2.72 80.25 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.247 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -140.82 149.7 42.37 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 117.043 0.422 . . . . 0.0 110.874 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -89.16 150.18 22.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.9 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -115.74 177.14 4.78 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.164 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -57.28 -40.43 77.75 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.892 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -102.2 -173.28 27.45 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.061 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.14 30.53 46.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.785 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -106.82 107.47 18.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -126.6 141.64 51.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.071 0.462 . . . . 0.0 111.957 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 50.0 m -149.34 130.44 14.45 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 57.08 31.33 19.77 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.594 0.559 . . . . 0.0 110.6 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -96.06 124.25 39.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.561 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 5.7 m -91.78 117.2 34.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.535 0.683 . . . . 0.0 110.645 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 53.2 tp -110.91 131.74 54.79 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.619 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . 0.661 ' HB2' ' NH1' ' B' ' 193' ' ' ARG . . . -121.42 137.39 54.73 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 71.1 mtm -103.65 179.14 4.36 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.153 0.501 . . . . 0.0 112.002 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.46 -20.36 44.65 Favored Glycine 0 CA--C 1.503 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.009 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -91.25 -13.69 32.29 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.767 0.317 . . . . 0.0 111.248 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.72 40.58 10.62 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.095 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.661 ' NH1' ' HB2' ' B' ' 188' ' ' ALA . 51.8 mtm180 -94.47 0.52 55.42 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.432 0.634 . . . . 0.0 110.962 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.426 ' HB2' ' HG3' ' B' ' 199' ' ' GLU . 0.0 OUTLIER -129.26 165.73 20.82 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.389 173.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.543 HD11 ' H ' ' B' ' 195' ' ' ILE . 4.5 mp -61.23 136.59 94.07 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.71 133.67 51.06 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 121.957 1.771 . . . . 0.0 111.434 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.13 -39.01 2.88 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.193 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . 0.522 ' O ' HG12 ' B' ' 202' ' ' ILE . 52.1 t80 -62.35 -48.69 78.69 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' B' ' 194' ' ' MET . 93.0 mt-10 -67.0 -36.44 82.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.283 0.563 . . . . 0.0 110.416 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.76 -35.71 81.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.218 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.38 -7.95 71.87 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.838 -0.696 . . . . 0.0 114.324 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.522 HG12 ' O ' ' B' ' 198' ' ' PHE . 48.1 mm -64.96 -44.23 96.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 117.57 0.685 . . . . 0.0 110.984 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -60.01 133.62 56.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.087 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.26 -15.04 51.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.179 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -84.24 141.18 31.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.26 0.552 . . . . 0.0 111.905 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -90.94 161.32 15.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.889 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.83 130.1 42.77 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' B' ' 237' ' ' LEU . . . 69.98 34.27 70.81 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.498 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -113.65 114.05 25.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.251 0.548 . . . . 0.0 111.59 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -91.24 137.35 32.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -156.48 -27.34 0.1 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 28.0 m 77.48 135.59 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.906 0.482 . . . . 0.0 110.988 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -106.58 -40.3 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 68.26 96.41 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.242 0.544 . . . . 0.0 112.364 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 66.4 t -119.25 135.71 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.071 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 6.5 m -93.78 -23.08 18.31 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.462 ' CE2' HG12 ' B' ' 195' ' ' ILE . 95.2 m-85 71.81 142.93 0.09 OUTLIER Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 122.892 0.477 . . . . 0.0 111.992 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.42 153.58 60.91 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.737 2.291 . . . . 0.0 111.899 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.29 -40.77 94.27 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.867 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -84.81 29.73 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.318 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -68.6 133.25 48.23 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.945 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -57.63 -40.65 79.67 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.61 101.24 8.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.34 -32.38 71.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.793 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -67.52 -14.24 62.76 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 94.7 mt -119.21 3.29 11.39 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -73.76 125.45 28.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 119.736 -0.785 . . . . 0.0 112.372 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.95 16.04 76.41 Favored Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.283 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -125.44 128.88 48.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.59 0.695 . . . . 0.0 111.244 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.94 150.53 30.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.59 137.22 35.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.614 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -68.53 -48.31 64.66 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 54.39 91.93 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.165 0.507 . . . . 0.0 111.266 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.81 92.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mm 70.38 90.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 122.869 0.468 . . . . 0.0 111.249 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.65 -48.19 67.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.322 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . 0.52 ' O ' ' HA2' ' B' ' 208' ' ' GLY . 8.1 tp 57.42 110.49 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.987 0.915 . . . . 0.0 112.917 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -105.36 -75.59 0.62 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 34.3 mmtp -77.86 -83.76 0.08 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.444 HG13 ' H ' ' B' ' 242' ' ' GLU . 86.2 t 74.51 139.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.368 0.604 . . . . 0.0 111.288 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.518 ' HB3' ' NH1' ' B' ' 243' ' ' ARG . 56.3 mm-40 -63.48 -40.15 96.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.206 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.444 ' H ' HG13 ' B' ' 240' ' ' VAL . 31.1 mt-10 66.76 129.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.303 0.641 . . . . 0.0 111.809 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.518 ' NH1' ' HB3' ' B' ' 241' ' ' GLU . 5.6 ptp180 174.44 109.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.054 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.511 ' CG ' ' H ' ' B' ' 245' ' ' LEU . 2.4 tt0 -137.03 -150.88 0.38 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.511 ' H ' ' CG ' ' B' ' 244' ' ' GLU . 10.0 mp 69.16 145.76 0.11 Allowed Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 123.538 0.735 . . . . 0.0 112.714 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . 0.553 ' O ' ' HG2' ' B' ' 247' ' ' GLU . 84.5 Cg_endo -83.28 -158.79 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.059 2.506 . . . . 0.0 112.47 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' B' ' 246' ' ' PRO . 4.0 pt-20 85.68 -176.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.934 1.694 . . . . 0.0 111.004 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.13 136.0 49.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.124 0.487 . . . . 0.0 111.824 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 20.0 p -89.78 -170.14 2.7 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.213 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.61 -52.85 62.41 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.015 0.436 . . . . 0.0 110.017 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -131.09 92.18 3.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.482 0.658 . . . . 0.0 109.241 173.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -70.63 -13.64 62.16 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.563 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 4.0 mp -63.3 -44.51 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.493 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' LYS . . . . . 0.529 ' HD2' ' HB2' ' B' ' 260' ' ' ASP . 54.9 pttt -149.84 150.84 32.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 111.459 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . 0.543 ' HG3' ' H ' ' B' ' 256' ' ' PHE . 27.5 tpt180 -166.02 -174.61 3.05 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -175.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 256' ' ' PHE . . . . . 0.543 ' H ' ' HG3' ' B' ' 255' ' ' ARG . 94.1 m-85 88.85 -41.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.463 1.105 . . . . 0.0 113.395 172.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 133.51 -129.86 5.5 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.304 -1.427 . . . . 0.0 113.183 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 26.8 m 37.85 49.58 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.669 0.788 . . . . 0.0 111.458 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' B' ' 260' ' ' ASP . 34.9 tt0 67.68 -85.17 0.03 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.518 -175.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . 0.529 ' HB2' ' HD2' ' B' ' 254' ' ' LYS . 2.6 p30 174.26 150.34 0.09 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.276 0.63 . . . . 0.0 109.959 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.5 -177.89 37.5 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.098 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 22.9 p -75.38 167.29 22.19 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 122.79 0.436 . . . . 0.0 110.859 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . 0.519 ' O ' ' HG3' ' B' ' 267' ' ' ARG . 99.4 t -61.93 -48.89 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -70.82 -40.3 72.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.769 0.319 . . . . 0.0 111.021 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -67.34 -40.69 91.77 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.407 ' O ' HG23 ' B' ' 270' ' ' VAL . 51.2 tp -61.78 -46.07 91.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.614 0.245 . . . . 0.0 110.961 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . 0.519 ' HG3' ' O ' ' B' ' 263' ' ' VAL . 44.8 mtp180 -66.17 -40.39 90.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.402 -177.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.54 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -68.34 -42.57 79.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.295 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -67.0 -40.15 87.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.646 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.1 t -64.35 -41.87 93.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -56.97 -47.82 79.83 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.47 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 16.2 ptmt -67.48 -38.6 84.63 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -63.67 -41.45 98.18 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.927 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.9 mmm -65.11 -42.42 93.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.973 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.19 -35.76 78.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.873 0.368 . . . . 0.0 110.973 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -63.3 -42.81 99.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -65.94 -38.64 89.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.491 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.78 -40.77 96.36 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.699 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -57.29 -48.61 78.48 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.164 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.3 m -62.9 -44.26 96.57 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.776 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.75 95.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.067 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.58 -44.25 98.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 120.969 0.414 . . . . 0.0 110.347 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -62.15 -42.53 99.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.88 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -62.9 -41.35 99.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 110.916 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -60.96 -43.92 98.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.479 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 94.9 t -69.49 -43.85 80.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.926 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . 0.406 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.1 tttt -61.12 -46.81 89.05 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.145 -176.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 75.4 p -62.04 -43.36 99.01 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -64.88 -43.73 91.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.779 0.323 . . . . 0.0 110.685 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . 0.661 ' O ' ' HG ' ' B' ' 294' ' ' LEU . . . -63.45 -46.84 84.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.076 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . 0.406 HG12 ' O ' ' B' ' 287' ' ' LYS . 38.1 mm -64.04 -44.16 97.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.646 0.26 . . . . 0.0 110.648 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . 0.492 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 32.8 tp10 -60.22 -42.61 95.53 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.352 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.91 99.16 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.382 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' B' ' 290' ' ' ALA . 65.6 mt -63.5 -42.53 98.5 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.552 0.215 . . . . 0.0 111.413 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.92 -44.57 96.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.957 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . 0.492 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 67.8 mttm -63.78 -39.57 94.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.073 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -65.09 -40.76 95.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.125 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -137.06 100.86 4.39 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.05 98.81 11.98 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 8.6 tp -104.64 142.6 17.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.193 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.21 135.7 54.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.097 0.475 . . . . 0.0 109.799 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 90.3 t -109.88 132.91 21.14 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.37 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.58 132.27 51.1 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.421 2.081 . . . . 0.0 111.885 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.06 86.57 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.404 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.58 82.01 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.882 0.372 . . . . 0.0 111.399 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.29 -41.87 93.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.437 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . 0.405 ' O ' HG13 ' B' ' 311' ' ' ILE . 65.3 mt -65.12 -44.55 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.947 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -43.82 82.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.016 0.436 . . . . 0.0 110.958 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 31.8 m -61.56 -44.43 97.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.125 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . 0.53 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 52.0 mm-40 -68.29 -39.05 82.23 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.882 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.2 mt -62.29 -44.39 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.429 -177.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.44 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 20.3 t70 -62.38 -43.13 99.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.011 0.434 . . . . 0.0 110.872 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 91.5 t -64.88 -43.47 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.252 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 95.0 mt -62.24 -40.43 96.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 85.9 mtm180 -63.34 -40.94 98.68 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -63.83 -39.93 95.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.717 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -63.02 -40.16 96.92 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.278 0.561 . . . . 0.0 109.914 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 -42.99 81.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.29 -37.35 86.88 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.333 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . 0.429 ' NE2' ' HG3' ' A' ' 45' ' ' ARG . 48.3 tt0 -62.43 -39.6 93.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.139 0.495 . . . . 0.0 110.431 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -86.99 -0.62 56.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.59 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -97.57 -2.41 41.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.166 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . 0.434 ' HA2' HG23 ' A' ' 54' ' ' VAL . . . 140.01 -6.51 2.86 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.608 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 95.22 29.16 9.15 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.71 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 43.5 t-20 -72.38 123.33 22.83 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 0.7 OUTLIER -116.72 152.71 33.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 0.1 OUTLIER 62.06 -34.3 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.832 1.653 . . . . 0.0 114.773 177.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . 0.472 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.9 mm100 -76.72 -5.62 48.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.259 0.552 . . . . 0.0 110.454 177.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -66.23 -13.76 60.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.273 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.99 -35.97 81.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.417 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -66.86 -24.55 66.15 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.707 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . 0.45 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 72.3 mt -58.2 142.43 80.84 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.707 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . 0.478 ' O ' ' HD1' ' B' ' 337' ' ' PHE . 36.5 Cg_exo -60.86 137.62 73.73 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.287 2.658 . . . . 0.0 113.778 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . 0.405 HH21 ' HD2' ' B' ' 334' ' ' ARG . 26.7 ttt85 -74.14 -43.42 57.52 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.143 177.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.1 -37.42 85.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -170.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 71.5 mt -87.01 -3.57 59.1 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.524 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . 0.478 ' HD1' ' O ' ' B' ' 333' ' ' PRO . 56.5 m-85 -108.48 -22.09 12.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.084 0.468 . . . . 0.0 110.34 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.55 -29.1 67.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.33 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.66 -46.93 87.64 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.826 0.346 . . . . 0.0 110.814 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -76.72 -25.43 53.53 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.33 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . 0.41 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.97 -42.09 99.73 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.469 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . 0.5 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.1 tttt -59.55 -47.09 86.9 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . 0.524 ' O ' HG21 ' B' ' 347' ' ' VAL . 13.7 mmt85 -61.87 -45.3 94.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.201 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -66.6 -37.85 85.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' 341' ' ' ALA . 96.0 t -65.2 -43.71 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.5 HG23 ' O ' ' B' ' 342' ' ' LYS . 71.1 t -60.78 -43.52 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.661 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . 0.524 HG21 ' O ' ' B' ' 343' ' ' ARG . 75.1 t -59.23 -45.31 93.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.3 -43.92 98.4 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.069 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.83 -43.0 97.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.62 0.248 . . . . 0.0 111.448 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 346' ' ' VAL . 97.0 mt -62.76 -46.26 88.87 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.895 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.39 -39.14 85.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.186 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.74 -42.15 97.85 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.357 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.26 -34.32 77.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.942 0.371 . . . . 0.0 110.923 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.2 -43.43 93.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.29 -44.51 99.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.748 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -70.64 -45.91 64.28 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 96.2 m -63.68 -45.0 92.09 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -95.23 4.17 53.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.245 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 53.48 54.19 10.46 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.95 0.5 . . . . 0.0 112.019 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.97 147.85 27.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.427 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.45 149.51 45.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.63 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.79 128.2 35.81 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . 0.5 ' O ' HG21 ' B' ' 367' ' ' VAL . 15.6 t70 -95.9 111.25 23.29 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.403 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 52.9 mm-40 -61.64 -33.26 73.63 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.814 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . 0.413 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 68.3 mm-40 -66.99 -40.26 87.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.937 0.399 . . . . 0.0 110.366 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -64.14 -38.19 90.18 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.664 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . 0.5 HG21 ' O ' ' B' ' 363' ' ' ASP . 97.8 t -61.82 -41.16 89.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.788 176.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.8 mmmt -56.56 -44.26 80.79 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.269 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.8 -41.53 99.63 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.245 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.2 -42.8 99.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.808 0.337 . . . . 0.0 110.252 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.55 -44.43 96.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.775 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.38 -42.79 98.84 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.763 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.89 -38.32 86.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.988 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 58.6 ttm -65.79 -40.91 92.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.972 0.415 . . . . 0.0 110.289 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.0 -26.59 68.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.69 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.2 m -71.89 -7.17 46.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.031 0.443 . . . . 0.0 111.229 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.0 -0.27 57.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.711 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -118.23 173.56 6.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.802 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.16 -45.89 83.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.979 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . 0.499 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 21.4 t70 -122.54 109.37 32.77 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 121.017 0.437 . . . . 0.0 110.663 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.01 -41.36 77.82 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.692 2.262 . . . . 0.0 113.132 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' B' ' 382' ' ' LYS . 32.1 mmtp -65.75 -41.99 91.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 15.9 pt-20 -62.47 -39.07 92.25 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.029 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.19 -42.64 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.784 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.17 -44.53 99.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.28 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.46 -39.26 77.85 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.826 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.95 -42.12 84.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.248 0.547 . . . . 0.0 110.018 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . 0.493 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 5.0 t80 -73.75 -41.72 62.11 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.005 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 31.3 p -80.33 -7.85 59.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.88 4.9 45.36 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.368 0.604 . . . . 0.0 110.721 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -124.47 112.65 17.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.857 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.56 -41.11 96.89 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -60.23 -48.91 79.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.631 0.253 . . . . 0.0 111.199 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.45 -40.85 98.23 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.371 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.565 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 93.5 mtp -60.94 -48.16 83.08 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.352 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.03 -38.82 72.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.264 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.98 -42.86 99.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.5 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 398' ' ' MET . . . . . 0.493 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 53.7 tpp -65.31 -39.48 92.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.668 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' B' ' 395' ' ' MET . 70.2 mtm180 -64.1 -36.48 84.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.755 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.1 -44.05 97.49 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.19 -45.45 90.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.864 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.95 -40.79 98.72 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.932 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 46.9 tp -64.16 -38.08 89.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.647 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.39 -43.13 96.94 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.441 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -65.48 -38.01 88.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.424 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -59.27 -41.34 88.66 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 120.758 0.313 . . . . 0.0 110.327 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.442 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.8 -47.36 81.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.17 -45.66 95.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.948 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -65.65 -34.54 78.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.117 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.03 -40.18 94.45 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.923 0.392 . . . . 0.0 110.638 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 407' ' ' ALA . 94.3 t -64.92 -42.29 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.338 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.67 -37.8 82.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.172 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -67.8 -14.94 63.37 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.913 0.387 . . . . 0.0 111.537 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -100.74 -37.89 8.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 110.86 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.65 175.66 9.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.156 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.47 113.98 22.16 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.094 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.9 t -99.22 107.86 21.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.039 0.447 . . . . 0.0 109.878 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -110.43 134.66 52.12 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -94.06 114.1 26.2 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.153 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -116.26 131.84 56.83 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.905 0.383 . . . . 0.0 110.598 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -76.92 147.63 36.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.229 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.0 t -157.58 165.83 34.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.61 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 26.7 p -86.73 166.51 15.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.967 0.413 . . . . 0.0 110.98 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -64.05 -28.61 69.9 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.8 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -62.41 -39.29 92.8 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.921 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.27 -33.94 76.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.029 0.442 . . . . 0.0 110.628 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.85 -31.09 69.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.686 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.5 mmt -65.6 -10.44 35.59 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.809 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -74.93 69.58 1.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.5 0.667 . . . . 0.0 109.21 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -100.77 17.88 20.88 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.519 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -63.99 -40.64 96.83 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.143 178.486 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.996 0.427 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 p -115.63 145.84 42.34 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.799 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.9 -52.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 66.5 179.21 0.21 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.114 0.483 . . . . 0.0 110.862 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 m -136.72 128.58 29.17 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.235 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.6 m -76.59 -68.49 0.59 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.831 0.348 . . . . 0.0 110.743 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -177.42 128.62 0.15 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.085 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.45 -115.94 8.46 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.932 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.42 -7.83 57.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 106' ' ' SER . . . -68.64 126.69 21.99 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.541 -177.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -135.59 159.22 42.28 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 122.909 0.484 . . . . 0.0 110.055 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.429 ' HG3' ' CE2' ' A' ' 105' ' ' TYR . 58.7 ttp180 -131.65 149.36 52.52 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.0 -83.64 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.006 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 m 46.84 79.31 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.059 0.457 . . . . 0.0 111.184 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.4 tp -113.33 135.25 53.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.894 0.378 . . . . 0.0 111.261 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.5 m -101.9 124.24 47.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.111 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.8 pt -128.92 160.68 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.549 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -73.17 155.78 39.28 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.905 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.69 83.79 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -64.18 -39.21 93.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.205 0.526 . . . . 0.0 110.446 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -65.8 -40.33 91.8 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.69 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 20' ' ' ALA . 77.3 mt -61.24 -48.83 87.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.53 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.538 ' CD ' ' HZ3' ' A' ' 29' ' ' LYS . 4.3 tp10 -64.03 -50.87 66.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.647 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.0 m -68.68 -51.06 45.98 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.6 -49.19 22.59 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -173.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.7 t -64.21 -43.39 97.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.59 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HZ3' ' CD ' ' A' ' 25' ' ' GLU . 17.2 ttmm -58.98 -48.98 79.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.936 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -62.85 -42.14 99.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.266 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -66.62 -42.03 87.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.997 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.63 -42.86 99.83 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.89 -39.6 80.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.212 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -64.91 -42.0 95.11 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.5 m -67.05 -33.72 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.139 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.92 -41.12 95.82 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.087 0.47 . . . . 0.0 109.91 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.13 -29.57 69.33 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.37 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -58.75 -42.84 89.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.83 0.347 . . . . 0.0 110.593 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 t -92.27 -1.57 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.18 0.514 . . . . 0.0 110.241 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 61.62 29.72 18.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.844 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -101.51 5.56 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.914 0.388 . . . . 0.0 111.598 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -63.92 -31.24 72.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.601 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.68 -22.1 65.76 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.824 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -80.76 -6.11 58.04 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.584 ' HA ' ' NE2' ' B' ' 320' ' ' GLN . 22.7 ttt180 -97.46 90.57 5.1 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -92.59 76.43 5.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 169.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.69 105.65 3.12 Favored Glycine 0 N--CA 1.428 -1.841 0 CA-C-N 114.992 -1.003 . . . . 0.0 114.629 -172.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.523 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 88.4 tttt -64.46 -34.99 79.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 171.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.453 HG13 ' HB ' ' A' ' 54' ' ' VAL . 16.2 t -99.52 100.08 9.94 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.439 175.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 48' ' ' LYS . 17.2 Cg_exo -66.66 159.34 51.53 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.044 2.496 . . . . 0.0 112.495 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.508 ' HA ' HG12 ' A' ' 54' ' ' VAL . 45.7 mtt -60.05 -40.97 91.29 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.412 ' HB3' ' HZ2' ' A' ' 29' ' ' LYS . 14.1 p-10 -65.92 -21.04 66.41 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.17 -50.16 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.9 0.381 . . . . 0.0 110.928 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 51' ' ' MET . 12.6 p -67.46 -36.86 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.33 83.38 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -89.83 -1.71 58.05 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.571 -0.451 . . . . 0.0 112.212 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -101.33 -42.99 6.1 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 120.715 0.293 . . . . 0.0 111.556 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -97.49 5.1 50.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.469 0.652 . . . . 0.0 110.114 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.87 145.83 49.74 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.472 ' H ' ' HB2' ' A' ' 63' ' ' ARG . . . 72.52 -41.09 0.49 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.219 0.608 . . . . 0.0 111.699 -177.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 t -60.68 -46.62 89.65 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.856 0.462 . . . . 0.0 111.303 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 p -124.97 18.77 4.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.662 0.744 . . . . 0.0 110.045 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.472 ' HB2' ' H ' ' A' ' 60' ' ' ALA . 13.2 ttt180 -65.89 -20.24 66.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.393 -174.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.58 -48.53 77.03 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.3 -31.0 71.01 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.068 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.35 -43.34 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 99.3 mt -62.3 -39.72 93.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.77 97.7 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.446 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -62.69 -45.67 91.68 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 120.773 0.32 . . . . 0.0 110.984 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.64 -41.97 98.23 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.3 ttp -61.22 -46.06 91.97 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.965 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.2 m -63.37 -51.54 65.44 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.338 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -69.41 -38.21 77.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -65.37 -39.24 92.05 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.932 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.45 -47.17 87.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.46 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.409 ' HA ' HG12 ' A' ' 79' ' ' ILE . 15.6 tt -66.16 -38.63 82.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.25 -41.98 99.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.93 -45.33 89.74 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.435 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 76' ' ' ILE . 42.4 pt -65.74 -41.35 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.47 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.43 -42.11 95.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.472 0.653 . . . . 0.0 109.379 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -59.41 -47.85 83.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.273 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -89.82 -0.86 57.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.425 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 65.4 36.8 6.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.81 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 98.1 mt -86.64 124.62 40.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.603 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -110.15 98.18 33.89 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.576 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.94 141.75 59.68 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.531 2.154 . . . . 0.0 111.819 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.29 103.3 15.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.913 0.387 . . . . 0.0 110.538 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -127.72 8.88 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.897 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.66 128.44 25.62 Favored Pre-proline 0 C--N 1.318 -0.786 0 O-C-N 122.916 -0.167 . . . . 0.0 110.613 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.16 144.76 82.59 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.451 2.101 . . . . 0.0 111.542 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.7 m -102.46 109.04 20.56 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.6 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 94.9 m-85 -86.45 91.59 8.58 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.68 106.59 2.54 Favored Pre-proline 0 C--N 1.324 -0.532 0 O-C-N 123.546 0.529 . . . . 0.0 111.189 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 91.0 Cg_endo -97.94 166.87 0.77 Allowed 'Trans proline' 0 N--CA 1.43 -2.214 0 C-N-CA 123.026 2.484 . . . . 0.0 111.299 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.06 -136.11 6.7 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 174.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.93 130.44 51.26 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -80.8 106.37 12.75 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.246 0.546 . . . . 0.0 110.771 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -84.87 147.71 26.65 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.65 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.6 tp -82.93 116.42 22.21 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.081 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.0 21.98 53.94 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.363 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -140.01 161.6 37.22 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.289 0.544 . . . . 0.0 109.793 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.97 142.79 54.58 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.853 0.359 . . . . 0.0 111.296 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -102.34 145.01 30.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.152 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.2 m -121.84 136.54 54.93 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.561 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 43.0 p90 -136.87 162.16 34.01 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.968 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.474 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 14.9 m -93.69 -69.9 0.73 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.2 p 49.28 101.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.179 0.99 . . . . 0.0 111.888 -173.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.32 113.98 23.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -172.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -156.27 145.8 20.84 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.858 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 65.97 143.64 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.4 m -129.4 157.44 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.842 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -165.11 100.79 0.8 Allowed Pre-proline 0 N--CA 1.466 0.372 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -88.23 158.91 6.95 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.973 2.449 . . . . 0.0 113.991 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -130.95 134.17 46.49 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -125.34 132.86 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -103.8 -78.92 0.55 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.549 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.6 mt 66.55 125.9 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.707 0.803 . . . . 0.0 112.964 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.22 155.47 47.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.4 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.11 9.56 86.5 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.04 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.22 -39.8 94.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.201 0.524 . . . . 0.0 110.885 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.2 -10.51 59.88 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.116 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.61 13.42 33.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.746 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 94.8 mt -81.76 125.49 39.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.24 0.543 . . . . 0.0 110.936 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.24 122.58 47.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.35 134.01 67.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.608 ' OE1' ' HE3' ' A' ' 420' ' ' LYS . 41.1 tt0 -82.13 146.93 29.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.499 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -135.2 91.86 18.71 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.47 113.97 3.5 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.237 1.958 . . . . 0.0 112.1 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.9 mm -97.19 112.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.74 155.91 18.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.129 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -129.93 145.31 51.62 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.304 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.12 123.46 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.882 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 64.0 p -107.81 175.59 5.43 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.583 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -67.38 -23.61 65.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.7 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.57 97.0 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.106 0.479 . . . . 0.0 109.95 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.41 -40.73 97.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.454 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.07 -45.24 99.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.703 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.24 -43.13 96.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.52 0.2 . . . . 0.0 111.068 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.33 -42.83 99.08 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.602 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.572 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.8 tpt -63.38 -46.43 86.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.641 0.258 . . . . 0.0 110.803 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.58 -41.84 98.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.483 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.38 -47.68 84.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.218 0.532 . . . . 0.0 110.399 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.8 m -63.24 -41.06 99.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.909 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 140' ' ' MET . 92.6 mt -60.48 -42.44 96.26 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -73.06 -14.59 61.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.172 0.51 . . . . 0.0 111.11 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.18 -10.23 33.8 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.802 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -99.83 -27.9 13.4 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.612 ' OE1' ' HG2' ' A' ' 255' ' ' ARG . 11.3 mm-40 -137.38 168.14 20.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -168.77 -90.18 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.429 -1.714 . . . . 0.0 108.45 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.559 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 23.7 m -162.61 159.16 24.24 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.419 ' HA ' ' CB ' ' A' ' 243' ' ' ARG . 20.5 p-90 -109.02 147.62 32.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.604 ' H ' ' HA ' ' A' ' 243' ' ' ARG . 84.0 tttt -170.41 -75.88 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.48 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -172.27 163.98 5.82 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 43.2 tttp 58.59 62.45 1.94 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.968 1.307 . . . . 0.0 114.516 174.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 244' ' ' GLU . 28.8 t70 -173.22 141.31 0.92 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.593 0.357 . . . . 0.0 110.901 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.32 53.59 0.6 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.838 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.11 -28.58 15.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.225 0.513 . . . . 0.0 110.065 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.415 ' N ' ' HD2' ' A' ' 243' ' ' ARG . 23.7 t 66.62 135.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.106 0.962 . . . . 0.0 113.227 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' A' ' 243' ' ' ARG . 6.7 mm-40 -86.8 170.22 11.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.444 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.427 ' HB1' ' OE1' ' A' ' 161' ' ' GLU . . . -71.0 -64.61 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.173 0.511 . . . . 0.0 109.901 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.427 ' OE1' ' HB1' ' A' ' 160' ' ' ALA . 1.3 pm0 -86.94 37.54 0.76 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.291 0.567 . . . . 0.0 110.551 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.61 -42.83 99.81 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.926 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 64.24 72.32 0.46 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.153 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 17.4 t -84.06 127.38 39.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.825 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.3 m -78.2 103.98 8.49 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 62.6 mt -120.62 122.51 68.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.709 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.84 89.77 5.79 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 171.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -114.77 156.73 24.32 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.307 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 29.9 m -129.79 132.2 46.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.617 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.55 131.64 10.64 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.298 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.7 m -135.85 135.74 40.03 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.822 0.344 . . . . 0.0 110.769 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 90.6 t -111.86 103.16 15.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.566 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 53.16 34.88 18.43 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.957 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.2 -11.01 47.85 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.979 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.88 138.72 50.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.901 0.85 . . . . 0.0 110.949 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -86.31 148.08 25.77 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.456 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -110.75 179.65 4.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.426 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -55.8 -52.55 63.6 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -90.44 -159.78 35.9 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.888 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . 75.29 27.7 63.35 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.827 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -116.48 102.9 9.9 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.17 141.23 51.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.812 0.339 . . . . 0.0 111.065 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.2 m -138.61 128.08 24.61 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 59.93 29.83 19.38 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.005 0.431 . . . . 0.0 110.874 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -94.94 133.66 38.46 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.429 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.3 m -97.55 122.73 49.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.421 0.629 . . . . 0.0 111.283 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 54.6 tp -109.84 125.5 52.83 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.755 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -104.66 141.46 36.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 69.8 mtm -116.62 160.42 20.72 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.228 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.88 8.04 65.55 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.741 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.413 ' HB2' ' HG2' ' A' ' 193' ' ' ARG . 98.1 mt-30 -119.7 0.36 10.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.7 29.09 55.89 Favored Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.067 -1.063 . . . . 0.0 111.128 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.413 ' HG2' ' HB2' ' A' ' 191' ' ' GLN . 32.0 mmm-85 -70.06 -30.35 67.59 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 123.248 0.619 . . . . 0.0 110.341 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.02 169.6 10.05 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.773 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.6 mm -50.76 132.66 28.23 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.987 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.68 124.39 8.23 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.669 2.246 . . . . 0.0 112.325 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.46 -37.76 3.58 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.771 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -62.21 -47.65 83.5 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -77.77 -10.14 59.39 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.805 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -88.34 -34.3 17.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.165 0.507 . . . . 0.0 109.874 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.62 -28.83 73.96 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.461 -0.791 . . . . 0.0 113.581 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.88 -26.33 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.853 0.358 . . . . 0.0 110.956 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -57.46 125.21 21.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.126 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.95 3.45 63.91 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.711 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -97.71 134.97 40.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.423 0.63 . . . . 0.0 111.883 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -90.77 160.24 15.9 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.258 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.88 138.26 57.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 110.706 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 73.53 24.04 75.7 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.898 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -118.74 101.95 8.47 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.398 0.618 . . . . 0.0 110.745 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.4 110.23 21.52 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.611 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -127.01 -10.78 5.97 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 75.3 p 57.24 164.78 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.792 0.837 . . . . 0.0 112.617 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.55 160.77 16.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -94.89 107.27 19.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.723 0.297 . . . . 0.0 110.645 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 71.3 t -121.49 122.41 67.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 6.5 m -95.55 -28.98 14.6 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -175.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 216' ' ' THR . 54.4 m-85 68.62 147.39 0.11 Allowed Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 121.009 0.433 . . . . 0.0 111.121 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.44 151.77 65.39 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.236 1.957 . . . . 0.0 111.926 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -65.12 -35.53 81.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.198 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.86 25.49 2.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.996 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -64.88 134.95 55.11 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -59.92 -15.64 23.31 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.78 105.68 17.85 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -56.61 -35.39 68.23 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.412 0.685 . . . . 0.0 111.158 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.437 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 16.0 p30 -76.91 -15.86 59.55 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.437 ' HG ' ' OD1' ' A' ' 225' ' ' ASN . 91.6 mt -115.37 5.68 14.65 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -69.53 114.53 7.84 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.434 0.635 . . . . 0.0 112.255 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.25 22.06 72.51 Favored Glycine 0 C--O 1.238 0.366 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.584 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 225' ' ' ASN . 99.1 mttt -107.7 138.77 43.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.981 0.391 . . . . 0.0 110.679 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -81.31 128.62 34.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.424 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -112.67 134.05 54.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.929 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -81.01 -44.57 17.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 212' ' ' THR . 76.0 m-85 56.58 95.73 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 121.057 0.456 . . . . 0.0 111.858 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.58 72.83 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.3 mm 61.87 92.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.109 0.564 . . . . 0.0 111.882 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -74.61 -43.48 55.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.117 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 13.2 tp 47.99 77.31 0.1 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.563 0.745 . . . . 0.0 111.567 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -71.18 -48.82 49.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -112.93 -81.17 0.59 Allowed 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.499 HG13 ' H ' ' A' ' 242' ' ' GLU . 41.2 t 81.23 150.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.713 0.805 . . . . 0.0 109.015 -173.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.79 -33.55 72.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.801 0.334 . . . . 0.0 110.466 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.499 ' H ' HG13 ' A' ' 240' ' ' VAL . 63.6 mt-10 74.62 152.75 0.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.089 0.955 . . . . 0.0 112.669 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.631 ' O ' ' HD3' ' A' ' 243' ' ' ARG . 0.0 OUTLIER -153.03 114.17 4.17 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.472 ' HG2' ' H ' ' A' ' 245' ' ' LEU . 39.1 tt0 -159.58 171.15 20.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.485 ' O ' ' HB ' ' A' ' 150' ' ' THR . 6.4 mp 70.81 108.17 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 123.59 0.756 . . . . 0.0 111.305 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.559 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 61.4 Cg_endo -81.16 101.02 1.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.026 1.817 . . . . 0.0 112.269 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.91 162.35 33.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.367 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.9 mp -84.28 88.55 7.24 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.822 0.344 . . . . 0.0 111.214 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 7.4 m -85.26 -75.89 0.34 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.724 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -177.95 -56.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.989 0.423 . . . . 0.0 110.558 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -73.71 14.64 0.35 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -78.06 -15.26 59.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.058 0.456 . . . . 0.0 110.302 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 43.0 pt -88.35 -14.23 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.098 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -138.34 94.11 2.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.628 0.728 . . . . 0.0 111.654 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.612 ' HG2' ' OE1' ' A' ' 148' ' ' GLN . 7.0 tpp180 -140.01 30.12 2.03 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.31 1.052 . . . . 0.0 108.923 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.15 15.16 9.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.201 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 77.02 15.97 81.19 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.119 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 55.9 t -99.87 141.29 17.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -54.86 -51.17 66.78 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 123.02 0.2 . . . . 0.0 111.069 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -175.61 162.44 2.77 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.265 0.353 . . . . 0.0 110.515 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -174.65 168.22 40.8 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.762 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 86.8 p -88.14 173.81 8.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.45 -48.7 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.56 -33.5 21.7 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.935 0.398 . . . . 0.0 110.322 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.4 -41.23 99.44 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.381 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.401 ' O ' HG23 ' A' ' 270' ' ' VAL . 53.4 tp -62.17 -44.45 96.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.588 0.233 . . . . 0.0 110.906 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -63.95 -42.64 97.26 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.211 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.4 -42.93 87.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.438 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -67.27 -40.14 86.15 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.906 0.384 . . . . 0.0 110.811 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 266' ' ' LEU . 78.8 t -64.85 -42.75 95.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.785 0.326 . . . . 0.0 110.15 176.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -55.76 -51.94 65.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.674 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.7 ptmt -65.63 -42.7 91.21 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.12 -39.45 94.05 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 96.5 mmm -63.9 -41.66 97.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 110.73 178.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -69.59 -31.65 69.93 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.972 0.415 . . . . 0.0 110.656 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -62.36 -42.2 99.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.98 -37.42 87.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.482 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 42.6 tp -62.39 -38.97 91.69 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.295 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -55.88 -46.92 78.16 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.209 0.528 . . . . 0.0 109.691 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.0 m -63.67 -43.92 95.27 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.65 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.56 92.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.184 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.47 -44.47 98.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.91 0.386 . . . . 0.0 110.465 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -64.64 -42.35 95.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.049 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -62.96 -41.32 99.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.155 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . 0.459 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.2 tpm_? -60.18 -44.53 95.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.938 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.14 -43.85 78.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.903 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.416 ' HZ2' ' CD ' ' A' ' 404' ' ' GLU . 88.3 tttt -61.95 -47.41 84.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.418 -176.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.1 p -62.2 -44.38 96.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -65.96 -41.51 91.15 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.134 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.61 87.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.651 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 295' ' ' VAL . 32.5 mm -64.32 -44.02 97.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.307 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.406 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 19.5 tp10 -61.08 -46.35 91.02 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.615 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.91 -40.23 95.33 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.363 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.409 HD11 HD12 ' A' ' 350' ' ' LEU . 0.7 OUTLIER -63.86 -42.61 97.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.443 0.297 . . . . 0.0 111.121 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 291' ' ' ILE . 75.1 t -64.13 -42.98 97.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 120.962 0.411 . . . . 0.0 110.687 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . 0.406 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.4 mttm -62.71 -38.77 91.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.686 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.83 -47.7 77.03 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.069 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -130.03 99.35 5.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.656 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -94.82 107.74 19.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.3 tp -110.73 143.12 21.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.725 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -73.44 121.97 21.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.236 0.541 . . . . 0.0 109.807 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 43.9 t -86.74 134.18 38.04 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.066 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.09 138.12 84.33 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.527 2.152 . . . . 0.0 112.118 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.32 -29.99 70.84 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.904 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.01 68.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.619 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.4 mt -91.34 -34.19 14.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.27 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.404 ' O ' HG13 ' A' ' 311' ' ' ILE . 71.4 mt -63.21 -51.88 65.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.723 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.36 -37.8 88.78 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 68.0 p -65.22 -46.65 79.78 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.72 0.295 . . . . 0.0 111.518 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.537 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 17.9 mm-40 -72.04 -33.21 67.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.43 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 70.7 mt -61.58 -43.74 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.516 0.198 . . . . 0.0 111.194 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.597 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 33.2 t70 -62.95 -40.93 99.15 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.687 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.54 -42.77 96.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.257 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 90.2 mt -61.64 -41.28 97.28 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.136 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 66.0 mtm180 -62.55 -39.72 94.51 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.916 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 90.8 mtt180 -63.27 -43.28 98.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.397 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -65.05 -44.67 88.26 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.03 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.53 -39.7 88.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.401 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.465 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . . . -64.62 -36.27 83.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.779 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . 0.686 ' NE2' ' HA ' ' B' ' 45' ' ' ARG . 48.1 tt0 -62.83 -43.27 99.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.549 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.49 -23.6 61.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.183 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -77.29 -4.02 42.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.77 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 140.5 -22.58 2.7 Favored Glycine 0 CA--C 1.502 -0.733 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.687 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 116.25 29.45 2.33 Favored Glycine 0 CA--C 1.497 -1.066 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.54 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 41.6 t-20 -70.72 124.0 23.24 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . 0.716 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.7 tm-20 -127.24 145.5 50.75 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.716 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 1.7 ptpp? 69.4 -37.97 0.39 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 125.574 1.55 . . . . 0.0 113.158 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.54 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 14.7 mm100 -73.63 -9.06 58.29 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.299 0.571 . . . . 0.0 110.369 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -64.02 -18.9 64.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.332 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.49 -37.63 86.73 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.22 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.88 -16.44 63.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.904 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.7 145.58 98.7 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.14 134.74 57.87 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 123.018 2.479 . . . . 0.0 112.951 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -70.7 -39.49 73.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.133 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -58.83 -33.79 70.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.06 -6.5 57.74 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.963 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -117.13 -30.78 5.55 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.608 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.55 -34.95 79.44 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -63.06 -51.06 68.16 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.995 0.426 . . . . 0.0 110.822 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.72 -28.0 65.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.48 -41.75 97.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.416 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.496 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.2 tttt -59.87 -47.14 86.96 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.533 ' O ' HG23 ' A' ' 347' ' ' VAL . 18.6 mmt85 -63.25 -45.59 90.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -66.42 -38.65 87.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.0 t -64.76 -43.34 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.645 0.259 . . . . 0.0 110.706 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 342' ' ' LYS . 77.3 t -60.31 -42.9 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.519 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 343' ' ' ARG . 87.4 t -59.53 -45.68 93.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.69 98.97 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.412 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.92 -44.44 96.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.82 0.343 . . . . 0.0 111.19 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.409 HD12 HD11 ' A' ' 294' ' ' LEU . 96.5 mt -63.92 -45.14 90.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.094 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.77 -40.99 92.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.9 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.5 98.59 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.86 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -66.3 -38.8 88.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.802 0.301 . . . . 0.0 110.723 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.96 -44.43 98.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.37 -43.83 98.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.805 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -66.54 -52.46 45.44 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.686 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.7 m -66.58 -46.17 76.86 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -87.35 -5.02 59.05 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.628 0.252 . . . . 0.0 111.377 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 59.11 70.22 0.66 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.276 0.56 . . . . 0.0 110.81 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.8 mt -101.46 124.36 47.02 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.783 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 144.15 44.06 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.082 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.04 114.96 4.48 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.487 ' O ' HG22 ' A' ' 367' ' ' VAL . 17.7 t70 -84.19 110.6 18.65 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.278 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.649 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 65.8 mm-40 -58.8 -39.1 80.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.068 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -64.65 -43.65 92.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 110.789 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -61.59 -41.25 97.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.021 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 363' ' ' ASP . 93.2 t -64.11 -35.62 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.704 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 31.0 mmmt -57.81 -45.01 86.7 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.657 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.88 -38.07 95.57 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.979 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.0 -42.68 99.91 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.068 0.461 . . . . 0.0 110.16 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.7 -43.3 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.939 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.48 -39.96 89.55 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.729 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.79 -40.72 92.23 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.702 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.8 ttm -66.59 -40.11 88.75 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 110.446 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.86 -27.14 69.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.657 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 49.3 m -74.98 4.23 6.96 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.686 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -97.62 3.94 50.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.796 0.331 . . . . 0.0 110.979 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -120.85 177.42 5.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.014 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.15 -46.14 90.29 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.642 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -128.92 120.11 20.24 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.274 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.56 -29.65 30.0 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.486 2.124 . . . . 0.0 112.896 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -65.83 -43.17 89.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -64.0 -37.39 87.25 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.349 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.35 -42.09 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.488 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.8 -44.24 98.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.093 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.86 -32.54 72.28 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -58.56 -46.72 86.29 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.128 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -68.49 -46.64 69.14 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.5 p -68.77 -17.01 63.96 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 7.91 45.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.074 0.464 . . . . 0.0 110.896 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -132.84 108.61 9.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.336 178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -62.98 -38.17 90.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -58.92 -50.76 72.82 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.827 0.346 . . . . 0.0 110.7 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.71 -39.56 94.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.399 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 90.9 mtp -61.69 -44.02 97.74 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.781 0.324 . . . . 0.0 111.278 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.57 -45.52 65.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.31 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -63.88 -42.58 97.45 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.008 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 43.6 tpp -64.9 -43.23 93.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.897 0.379 . . . . 0.0 111.132 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -66.02 -33.23 75.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.267 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.77 -44.96 93.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.26 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.52 -43.63 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.118 0.485 . . . . 0.0 110.57 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.63 -40.72 95.86 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.169 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.32 -38.46 91.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.625 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.416 ' CD ' ' HZ2' ' A' ' 287' ' ' LYS . 42.7 tt0 -59.84 -43.97 94.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.72 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -65.42 -35.15 80.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.763 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -60.99 -43.97 98.09 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.59 -45.9 84.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.165 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.1 -45.85 97.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.188 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -68.57 -27.99 66.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.018 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.54 -37.96 88.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.137 0.494 . . . . 0.0 109.84 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 89.6 t -66.19 -41.44 89.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.137 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.09 -26.44 66.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.019 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -77.39 -9.14 58.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.363 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -113.45 -31.73 6.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.82 169.23 18.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.674 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -84.59 108.61 17.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.788 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 64.4 t -84.58 128.72 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.122 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -130.38 146.8 52.01 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -121.91 123.18 41.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.705 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . 0.608 ' HE3' ' OE1' ' A' ' 126' ' ' GLU . 20.7 pttp -132.68 145.83 51.38 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.68 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -82.85 153.02 25.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -155.64 172.32 18.48 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 27.1 p -84.96 165.04 17.94 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.907 0.384 . . . . 0.0 111.161 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.78 -26.04 68.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.343 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -62.33 -40.42 96.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.608 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -65.77 -33.05 74.97 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.837 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.0 mp -74.66 -18.54 60.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.346 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.3 mmt -83.03 3.78 28.86 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -82.88 74.51 9.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.368 0.604 . . . . 0.0 109.607 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -101.28 17.75 21.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.238 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -69.93 -25.58 63.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.238 0.542 . . . . 0.0 109.685 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.729 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.69 179.392 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 120.685 0.279 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -108.68 114.85 28.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.087 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 22.4 m -123.68 135.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.092 0.472 . . . . 0.0 111.723 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 29.6 p -113.87 148.61 36.4 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.506 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.438 HG13 ' H ' ' B' ' 6' ' ' GLU . 6.4 p -151.41 -61.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.438 ' H ' HG13 ' B' ' 5' ' ' VAL . 54.2 mt-10 69.09 169.0 0.29 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.241 0.543 . . . . 0.0 111.494 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.3 m -128.78 127.76 42.62 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.171 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 23.0 m -74.51 -69.95 0.43 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.504 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -178.37 129.99 0.13 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.756 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.1 -119.03 11.0 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.697 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.66 -9.25 56.42 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' B' ' 106' ' ' SER . . . -67.49 126.62 25.19 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.283 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' B' ' 12' ' ' GLY . 0.0 OUTLIER -135.14 158.88 43.23 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 122.937 0.495 . . . . 0.0 109.898 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -129.04 151.38 49.8 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 54.1 t -102.52 -82.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.016 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m 46.51 82.38 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.184 0.516 . . . . 0.0 111.457 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 tp -116.77 135.14 58.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.985 0.421 . . . . 0.0 111.096 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.5 m -104.52 126.03 51.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.932 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 16.8 pt -129.27 160.18 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.702 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.568 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -73.2 156.02 38.99 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.573 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.07 -46.01 79.12 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -64.82 -38.66 91.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.387 . . . . 0.0 110.354 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 35.5 m -63.75 -39.73 94.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.718 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.568 HG13 ' O ' ' B' ' 20' ' ' ALA . 81.0 mt -61.23 -49.67 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.807 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.496 ' CD ' ' HZ3' ' B' ' 29' ' ' LYS . 5.3 tp10 -66.73 -48.24 69.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.729 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 20.0 m -65.83 -50.95 62.76 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.96 -49.34 18.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.21 -43.13 97.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.496 ' HZ3' ' CD ' ' B' ' 25' ' ' GLU . 18.7 ttmm -59.03 -48.67 80.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.719 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 33.3 m -63.07 -42.82 99.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.891 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -68.37 -40.08 81.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.761 0.315 . . . . 0.0 110.899 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.32 -43.1 99.62 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.68 -39.82 80.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.057 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -64.85 -42.01 95.23 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.59 -32.51 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.132 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.18 92.58 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.069 0.461 . . . . 0.0 110.033 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.88 -30.5 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.286 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -57.98 -41.52 83.12 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.038 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.8 -0.05 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.188 0.518 . . . . 0.0 110.407 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 61.09 29.1 18.71 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -101.57 4.94 10.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.143 0.497 . . . . 0.0 111.425 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.06 -33.02 74.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.598 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.14 -22.62 63.07 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.941 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -80.33 -6.56 58.17 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.63 0.252 . . . . 0.0 111.525 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.686 ' HA ' ' NE2' ' A' ' 320' ' ' GLN . 47.2 ttt85 -94.73 88.35 5.34 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 119.408 -0.917 . . . . 0.0 113.13 -177.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -89.86 86.53 6.66 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 169.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.15 102.59 2.91 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-N 115.134 -0.939 . . . . 0.0 114.84 -170.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 88.2 tttt -65.44 -34.95 79.5 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 19.3 t -101.87 100.2 14.08 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.278 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' B' ' 48' ' ' LYS . 18.6 Cg_exo -65.96 158.43 54.16 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.045 2.497 . . . . 0.0 112.607 -177.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.486 ' HA ' HG12 ' B' ' 54' ' ' VAL . 44.3 mtt -58.69 -41.69 86.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -65.99 -20.08 66.08 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.812 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -91.68 -50.33 12.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.079 0.466 . . . . 0.0 110.931 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' B' ' 51' ' ' MET . 13.0 p -67.51 -36.76 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.38 87.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -90.61 -1.64 57.88 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.281 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -100.53 -42.15 6.69 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.638 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -98.17 5.37 48.58 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.545 0.688 . . . . 0.0 109.946 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.97 146.87 49.76 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.438 ' H ' ' HB2' ' B' ' 63' ' ' ARG . . . 72.76 -41.56 0.51 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.154 0.582 . . . . 0.0 111.443 -176.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 47.0 t -60.52 -48.74 80.43 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.813 0.445 . . . . 0.0 111.428 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' B' ' 65' ' ' ASP . 7.9 p -122.03 18.64 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.771 0.796 . . . . 0.0 109.859 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.438 ' HB2' ' H ' ' B' ' 60' ' ' ALA . 12.6 ttt180 -65.58 -20.23 66.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.59 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.68 -49.53 70.6 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . 0.43 ' HB2' HG21 ' B' ' 62' ' ' VAL . 5.5 m-20 -65.78 -32.41 73.93 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.93 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.58 -43.42 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.99 -40.01 94.16 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.79 -39.32 97.31 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.728 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.96 -44.99 94.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.681 0.277 . . . . 0.0 111.072 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.65 -41.93 98.2 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.7 ttp -60.65 -45.99 92.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.86 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 55.3 m -64.2 -51.75 62.2 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.375 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -69.32 -38.06 78.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -65.06 -39.53 93.4 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.597 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -60.26 -47.21 86.96 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.54 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 17.7 tt -66.02 -38.57 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.143 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.37 -41.67 98.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.76 93.0 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.597 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -66.73 -41.25 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.46 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.69 -42.64 96.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.573 0.701 . . . . 0.0 109.419 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -60.16 -47.78 84.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.576 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -89.24 -2.03 58.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.616 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 63.24 46.64 4.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.928 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.44 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 91.4 mt -98.45 122.21 49.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.118 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -107.46 100.1 32.07 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.709 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 22.8 Cg_exo -65.17 142.74 75.1 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.434 2.089 . . . . 0.0 111.443 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.37 110.89 23.35 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.882 0.373 . . . . 0.0 110.39 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.6 -113.99 4.0 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.121 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.43 125.67 14.52 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.55 144.34 78.68 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.428 2.086 . . . . 0.0 111.586 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 46.8 m -103.47 111.91 24.57 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.056 0.455 . . . . 0.0 109.824 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.523 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.1 m-85 -87.58 89.91 8.17 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.98 108.97 3.91 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.539 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.9 Cg_endo -100.98 169.3 0.35 Allowed 'Trans proline' 0 N--CA 1.433 -2.081 0 C-N-CA 123.178 2.585 . . . . 0.0 111.256 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.82 -120.73 3.17 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -141.94 133.04 26.15 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -80.08 107.58 12.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.366 0.603 . . . . 0.0 111.066 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.79 145.68 30.32 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 38.7 tp -82.78 108.31 16.04 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.868 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.49 14.64 49.87 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.778 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -134.06 161.29 35.24 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.409 0.605 . . . . 0.0 109.923 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -66.73 143.03 57.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.011 0.434 . . . . 0.0 111.53 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -103.44 144.45 31.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.15 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.1 m -121.51 135.91 54.99 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.748 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -135.55 161.95 34.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.059 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.433 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 12.6 m -92.72 -70.44 0.7 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -175.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p 47.88 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.132 0.968 . . . . 0.0 111.811 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.55 116.61 24.79 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -172.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -157.98 147.52 19.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.562 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 65.02 143.16 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.08 157.0 42.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.75 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -165.64 97.08 0.8 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.054 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -84.56 158.58 12.46 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.972 2.448 . . . . 0.0 113.348 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -132.82 135.22 45.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 70.3 t -123.47 136.13 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -103.61 -79.74 0.53 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.537 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt 65.53 128.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.888 0.875 . . . . 0.0 113.113 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -143.39 156.51 44.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.047 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.73 8.46 87.69 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.05 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.83 -39.82 95.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.598 . . . . 0.0 110.229 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.55 -21.23 66.15 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.497 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.27 13.76 34.09 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 96.8 mt -77.65 125.41 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.223 0.535 . . . . 0.0 110.683 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -113.52 123.25 49.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.146 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.7 144.65 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.653 0.263 . . . . 0.0 111.263 -174.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . 0.561 ' OE1' ' HE3' ' B' ' 420' ' ' LYS . 38.4 tt0 -93.75 142.8 26.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.594 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -128.93 93.23 37.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.63 112.64 3.28 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.218 1.945 . . . . 0.0 111.903 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 48.6 mm -95.43 111.47 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.63 158.39 16.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.116 -178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -132.79 146.52 51.91 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.035 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 85.5 t -85.22 123.1 39.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 72.8 p -107.28 177.73 4.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.981 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -66.04 -28.42 68.84 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.8 -40.07 93.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.025 0.441 . . . . 0.0 110.361 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.01 -41.53 99.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.606 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.48 -44.94 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.016 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.38 -44.22 92.8 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.84 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.83 -42.0 98.63 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.763 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' MET . . . . . 0.556 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.8 tpt -63.02 -45.45 92.27 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.603 0.239 . . . . 0.0 110.967 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.17 -42.54 99.43 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.499 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -61.83 -45.57 93.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.422 ' O ' ' HG3' ' B' ' 147' ' ' GLN . 20.6 m -63.45 -41.21 98.64 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.833 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' B' ' 140' ' ' MET . 91.8 mt -60.43 -42.22 95.61 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -72.08 -17.34 62.01 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.066 0.46 . . . . 0.0 111.335 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.92 -9.28 40.64 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.801 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' B' ' 143' ' ' THR . 63.4 mt-30 -100.48 -27.55 13.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . 0.588 ' OE1' ' HG2' ' B' ' 255' ' ' ARG . 9.8 mm-40 -137.79 167.87 20.85 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -167.56 -90.97 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.664 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' B' ' 245' ' ' LEU . 26.8 m -163.15 155.28 18.09 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . 0.471 ' HA ' ' CB ' ' B' ' 243' ' ' ARG . 26.3 p-90 -106.28 147.66 28.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . 0.585 ' H ' ' HA ' ' B' ' 243' ' ' ARG . 83.9 tttt -170.62 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.602 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -172.21 164.29 5.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 46.4 tttp 58.0 66.39 1.12 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.838 1.255 . . . . 0.0 114.281 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' B' ' 244' ' ' GLU . 27.8 t70 -177.96 146.48 0.42 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.182 0.593 . . . . 0.0 110.65 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.53 47.05 1.06 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.51 -0.853 . . . . 0.0 114.095 -176.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.03 -29.96 21.55 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.186 174.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' B' ' 243' ' ' ARG . 22.5 t 67.31 135.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.267 1.027 . . . . 0.0 113.172 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . 0.476 ' HG2' ' HG2' ' B' ' 243' ' ' ARG . 6.8 mm-40 -87.67 169.36 12.19 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.833 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . 0.403 ' HB1' ' OE1' ' B' ' 161' ' ' GLU . . . -70.53 -66.17 0.64 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . 0.403 ' OE1' ' HB1' ' B' ' 160' ' ' ALA . 1.7 pm0 -86.06 40.18 0.85 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.447 0.641 . . . . 0.0 110.282 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.95 -43.46 95.75 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.305 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 63.65 74.75 0.41 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.952 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 17.3 t -87.55 125.82 41.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.745 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.2 m -74.91 103.6 5.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 71.0 mt -119.52 123.27 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.044 0.45 . . . . 0.0 111.598 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . 0.488 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 23.9 m-20 -96.41 88.28 4.69 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 172.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -112.49 156.12 23.13 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.633 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 36.7 m -130.54 131.71 45.2 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.849 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.2 128.94 8.72 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.181 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 18.5 m -136.19 131.38 34.54 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.828 0.347 . . . . 0.0 110.786 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.48 105.32 18.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.823 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . 0.503 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 69.5 m-20 52.64 30.36 8.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.09 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 108.5 -12.26 36.08 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.858 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -110.7 142.48 42.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.784 0.792 . . . . 0.0 110.422 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -88.94 148.45 23.8 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.33 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -113.25 177.2 4.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.194 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -55.88 -49.37 73.56 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -89.18 -165.16 40.92 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.798 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' B' ' 169' ' ' THR . . . 77.2 24.65 65.62 Favored Glycine 0 C--O 1.22 -0.734 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.245 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -115.52 102.45 9.8 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.7 144.16 48.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.847 0.356 . . . . 0.0 110.933 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.488 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 47.2 m -139.6 132.54 29.36 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.646 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 59.97 30.55 20.04 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.684 0.615 . . . . 0.0 111.415 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -95.69 133.88 39.26 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.801 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.7 122.59 50.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.352 0.596 . . . . 0.0 111.325 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 61.4 tp -109.43 127.72 54.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.758 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -106.39 140.75 38.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 71.6 mtm -116.24 162.53 17.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.883 0.373 . . . . 0.0 111.445 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 88.21 13.8 63.31 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . 0.408 ' HB2' ' HG2' ' B' ' 193' ' ' ARG . 97.9 mt-30 -125.33 -3.16 7.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.519 0.199 . . . . 0.0 111.376 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.16 33.21 33.16 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.89 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.408 ' HG2' ' HB2' ' B' ' 191' ' ' GLN . 37.8 mmm-85 -76.33 -24.41 54.27 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.486 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.9 169.65 11.38 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.288 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 47.0 mm -51.67 133.41 36.39 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.04 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -47.18 126.33 11.47 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.526 2.151 . . . . 0.0 112.118 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.66 -38.03 3.4 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.718 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -62.5 -48.58 78.94 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.112 0.456 . . . . 0.0 112.203 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -78.08 -9.95 59.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.826 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . 0.41 ' O ' ' HD3' ' B' ' 203' ' ' LYS . 31.0 t70 -90.45 -26.35 19.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.17 0.509 . . . . 0.0 110.204 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.23 -22.78 67.26 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.285 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.92 -26.86 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.602 -0.352 . . . . 0.0 111.093 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' B' ' 200' ' ' ASP . 24.3 mtpt -55.1 126.68 25.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.038 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.48 -9.06 71.83 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.757 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -85.86 134.47 33.9 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 117.466 0.633 . . . . 0.0 111.584 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -91.6 161.38 14.95 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.354 -176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.55 139.29 58.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.723 0.297 . . . . 0.0 110.325 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 75.89 17.65 79.95 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.798 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -113.45 97.4 6.44 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.547 0.689 . . . . 0.0 111.141 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -88.91 108.06 19.34 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.947 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -129.13 -11.09 4.72 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -173.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 58.2 p 58.89 166.87 0.05 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.73 0.812 . . . . 0.0 112.655 -176.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.6 tp -146.0 153.81 13.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.465 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -88.1 105.88 17.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.771 0.319 . . . . 0.0 111.259 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 76.2 t -118.22 129.31 74.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 10.3 m -100.45 -34.95 9.73 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -175.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.6 m-85 70.64 144.08 0.1 Allowed Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 122.71 0.404 . . . . 0.0 110.917 -175.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 15.1 Cg_exo -69.02 152.18 73.17 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.259 1.973 . . . . 0.0 111.795 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -67.15 -33.46 75.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.411 0.624 . . . . 0.0 109.709 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -88.44 21.93 2.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.655 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -65.75 134.73 53.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.019 0.438 . . . . 0.0 110.57 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -61.53 -10.21 7.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.11 105.31 15.59 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -56.04 -36.48 68.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.41 0.684 . . . . 0.0 111.685 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.432 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 18.7 p30 -80.38 -11.81 59.65 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.404 ' HG ' ' OD1' ' B' ' 225' ' ' ASN . 93.3 mt -115.47 1.69 13.7 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -66.69 116.38 7.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.232 0.539 . . . . 0.0 111.722 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.26 26.51 70.58 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.928 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.432 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 98.9 mttt -111.74 134.9 53.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.083 0.441 . . . . 0.0 110.585 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -77.29 131.82 38.34 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.897 0.38 . . . . 0.0 111.245 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.02 135.17 54.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.484 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . 0.503 ' HE2' ' OD1' ' B' ' 173' ' ' ASP . 68.9 mttm -80.8 -44.8 17.95 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' B' ' 212' ' ' THR . 76.4 m-85 56.35 95.09 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.015 0.436 . . . . 0.0 111.894 -177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.36 -50.17 74.0 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.8 mm 61.52 91.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 123.472 0.482 . . . . 0.0 111.953 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -72.69 -42.48 64.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.338 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 12.4 tp 48.21 84.83 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.821 0.848 . . . . 0.0 111.295 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.76 -59.74 2.66 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -174.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -102.55 -79.23 0.53 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.476 HG13 ' H ' ' B' ' 242' ' ' GLU . 39.3 t 77.32 150.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -172.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.97 -33.35 71.96 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.737 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.476 ' H ' HG13 ' B' ' 240' ' ' VAL . 62.5 mt-10 73.89 154.33 0.15 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.721 0.808 . . . . 0.0 112.168 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.628 ' O ' ' HD3' ' B' ' 243' ' ' ARG . 0.0 OUTLIER -156.1 110.36 2.81 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' B' ' 245' ' ' LEU . 31.9 tt0 -153.42 170.25 21.17 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.523 ' O ' ' HB ' ' B' ' 150' ' ' THR . 6.4 mp 73.64 112.23 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 123.582 0.753 . . . . 0.0 111.557 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . 0.505 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 74.5 Cg_endo -83.07 97.28 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.292 1.994 . . . . 0.0 112.711 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -132.12 163.47 28.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.733 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.2 mp -86.32 90.2 8.1 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.049 0.452 . . . . 0.0 110.797 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 5.3 m -85.88 -75.52 0.37 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.719 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 177.74 -50.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.06 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.3 3.44 3.66 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.642 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -71.49 -17.92 62.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.221 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 40.5 pt -87.15 -15.85 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.117 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -138.06 90.92 2.52 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.608 0.718 . . . . 0.0 111.986 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . 0.588 ' HG2' ' OE1' ' B' ' 148' ' ' GLN . 6.9 tpp180 -137.36 35.43 2.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.284 1.04 . . . . 0.0 108.968 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -127.87 17.65 6.76 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.825 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 72.98 23.63 77.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.545 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.12 137.21 40.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -52.7 -49.37 65.49 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.517 0.51 . . . . 0.0 111.378 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.6 p30 176.95 152.93 0.21 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.847 0.459 . . . . 0.0 111.043 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -169.39 167.32 40.4 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.983 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 26.9 p -83.38 170.93 14.01 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.597 0.199 . . . . 0.0 110.691 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 96.9 t -62.13 -51.85 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -36.38 51.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.04 0.448 . . . . 0.0 110.618 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.77 -39.79 97.81 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.48 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.405 ' O ' HG23 ' B' ' 270' ' ' VAL . 54.7 tp -61.7 -45.3 94.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.6 0.238 . . . . 0.0 110.861 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -64.72 -41.24 96.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.661 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.563 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -67.76 -43.29 80.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.556 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -67.89 -39.89 83.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.823 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.405 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.2 t -64.83 -41.72 92.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -55.43 -51.8 65.69 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.589 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.5 ptmt -66.0 -42.84 89.23 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -64.9 -38.26 90.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.0 mmm -63.67 -41.35 98.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.877 0.37 . . . . 0.0 110.164 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.3 -31.27 69.64 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.558 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -61.87 -42.77 99.46 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.4 -38.13 89.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.34 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.04 -38.2 87.84 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.272 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -56.51 -47.5 79.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.014 0.435 . . . . 0.0 109.947 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.2 m -64.61 -43.76 92.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.809 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.05 87.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.262 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.24 -44.56 99.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.968 0.413 . . . . 0.0 110.471 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -65.02 -42.01 94.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.58 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -62.82 -40.85 98.65 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.674 0.273 . . . . 0.0 110.859 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . 0.457 ' HA ' ' HE ' ' B' ' 285' ' ' ARG . 1.5 tpm_? -59.7 -44.43 93.69 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.642 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 99.4 t -70.22 -43.61 78.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.871 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.92 -47.52 84.54 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.333 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 78.0 p -61.94 -44.82 95.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.69 -41.24 92.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.62 87.9 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.539 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . 0.467 ' O ' HG23 ' B' ' 295' ' ' VAL . 33.1 mm -64.9 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.201 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . 0.468 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 34.6 tp10 -60.29 -48.19 82.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.36 -41.06 96.75 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.515 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.33 -42.07 98.94 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.467 HG23 ' O ' ' B' ' 291' ' ' ILE . 78.0 t -63.98 -42.74 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.954 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . 0.468 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 68.4 mttm -62.53 -40.83 98.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.871 0.367 . . . . 0.0 110.544 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.6 -50.23 67.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.533 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.47 99.86 6.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.713 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -96.5 112.03 23.92 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.5 tp -116.26 144.02 24.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.6 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.54 127.14 31.92 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.33 132.83 31.07 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.464 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.45 135.59 70.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.367 2.045 . . . . 0.0 112.042 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.45 -28.96 69.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.171 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.77 79.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.817 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 99.2 mt -82.42 -36.8 26.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.628 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . 0.463 ' O ' HG13 ' B' ' 311' ' ' ILE . 73.8 mt -61.93 -50.62 79.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.689 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.59 -38.76 92.11 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 59.0 p -64.1 -44.9 90.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.952 0.406 . . . . 0.0 111.165 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . 0.518 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 52.2 mm-40 -72.86 -32.48 65.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.275 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.463 HG13 ' O ' ' B' ' 307' ' ' ILE . 85.4 mt -62.11 -43.82 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.661 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.608 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 36.3 t70 -62.59 -41.72 99.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.365 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.21 -42.9 96.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.348 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 91.0 mt -61.55 -41.24 97.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.348 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 75.2 mtm180 -62.82 -39.77 95.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.771 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 90.6 mtt180 -63.16 -43.57 97.92 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.462 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -64.71 -44.02 91.58 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.14 85.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.34 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' B' ' 325' ' ' ASN . . . -64.65 -35.81 82.22 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.034 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . 0.584 ' NE2' ' HA ' ' A' ' 45' ' ' ARG . 49.8 tt0 -63.82 -41.87 97.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.349 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -72.19 -23.92 61.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.103 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -76.32 -3.83 38.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.284 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 139.68 -29.93 2.43 Favored Glycine 0 CA--C 1.501 -0.827 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.25 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 124.31 34.38 0.72 Allowed Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . 0.527 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 39.6 t-20 -73.83 118.11 16.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . 0.725 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 3.6 tm-20 -120.91 143.31 49.02 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 2.0 ptpp? 70.33 -38.93 0.43 Allowed 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 125.581 1.552 . . . . 0.0 113.019 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . 0.527 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.4 mm100 -73.85 -8.33 55.63 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.293 0.568 . . . . 0.0 110.767 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -67.13 -14.43 62.9 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.26 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.34 -36.39 83.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.468 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -71.39 -15.42 62.37 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.956 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.57 142.43 98.46 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.71 135.47 69.53 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.11 2.54 . . . . 0.0 112.898 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 27.7 ttt85 -70.42 -40.13 74.02 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.935 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -58.61 -34.59 71.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.55 -9.25 59.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.037 0.446 . . . . 0.0 111.755 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -114.57 -30.63 6.45 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.705 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -66.48 -34.21 77.42 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.98 -52.37 64.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.051 0.453 . . . . 0.0 110.707 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -70.46 -25.63 63.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . 0.414 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.54 -42.28 99.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.329 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . 0.509 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.5 tttt -59.61 -47.12 86.84 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . 0.492 ' O ' HG23 ' B' ' 347' ' ' VAL . 17.3 mmt85 -63.57 -45.53 90.05 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -66.71 -38.88 87.6 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 341' ' ' ALA . 76.7 t -64.69 -43.0 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.655 0.264 . . . . 0.0 110.785 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.509 HG23 ' O ' ' B' ' 342' ' ' LYS . 78.1 t -60.05 -43.2 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.424 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . 0.492 HG23 ' O ' ' B' ' 343' ' ' ARG . 88.0 t -59.68 -45.57 94.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.05 -42.28 99.64 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.313 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.71 -44.02 97.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 111.005 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.14 -45.71 87.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.387 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.28 -40.66 90.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.027 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.92 -39.82 97.5 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.706 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.3 -38.74 88.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 110.836 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.28 -43.85 97.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.53 -43.78 98.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.882 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -68.54 -50.22 53.61 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.76 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 98.6 m -67.9 -47.16 69.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -85.79 -9.02 57.73 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.764 0.316 . . . . 0.0 110.964 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 59.42 73.0 0.5 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.684 0.754 . . . . 0.0 111.406 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.64 128.05 49.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 142.64 47.19 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.904 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -62.42 116.02 4.72 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . 0.441 ' O ' HG22 ' B' ' 367' ' ' VAL . 20.7 t70 -84.27 112.48 20.33 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.113 0.482 . . . . 0.0 110.846 -176.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 17.0 mm-40 -58.06 -43.21 86.78 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.376 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -66.92 -37.82 85.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.826 0.346 . . . . 0.0 111.267 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -63.31 -41.71 98.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.039 0.447 . . . . 0.0 110.078 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 363' ' ' ASP . 97.6 t -64.06 -37.61 80.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.556 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.7 mmmt -56.4 -45.04 80.81 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.806 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.86 -38.22 95.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.094 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.44 -41.43 98.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.09 0.471 . . . . 0.0 110.388 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . 0.416 HG13 ' O ' ' B' ' 367' ' ' VAL . 62.2 mt -65.47 -42.98 94.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.509 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.38 -39.47 90.79 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.457 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -61.77 -43.13 99.45 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.079 0.466 . . . . 0.0 110.282 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 57.7 ttm -67.15 -39.25 86.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.913 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.0 -33.86 75.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.721 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 66.2 m -70.82 4.7 2.36 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -97.51 2.89 50.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.061 0.458 . . . . 0.0 110.712 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -122.24 174.89 6.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.733 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -61.95 -48.8 78.8 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.825 0.345 . . . . 0.0 111.002 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 27.0 t70 -123.79 115.22 28.07 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.48 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . 0.492 ' O ' HG13 ' B' ' 385' ' ' ILE . 37.3 Cg_endo -66.61 -29.56 43.61 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 122.231 1.954 . . . . 0.0 112.928 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.47 -42.9 91.77 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 12.3 pt-20 -64.34 -36.44 84.12 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.282 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.42 -42.01 92.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.388 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . 0.492 HG13 ' O ' ' B' ' 381' ' ' PRO . 89.6 mt -61.74 -44.1 98.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.985 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.35 -33.71 74.78 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.63 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -58.14 -47.05 84.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.277 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -69.44 -46.11 67.52 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 31.0 p -68.98 -18.1 64.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.75 7.15 46.4 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.926 0.393 . . . . 0.0 111.04 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -131.47 109.62 10.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.869 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -64.25 -38.51 91.32 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -59.9 -48.31 82.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.797 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.78 -39.86 95.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.048 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 90.8 mtp -62.58 -44.26 96.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.811 0.338 . . . . 0.0 110.905 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.74 -49.28 66.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.185 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.93 -43.23 96.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.546 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 44.0 tpp -64.22 -43.16 95.85 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.805 0.336 . . . . 0.0 111.084 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -66.27 -32.91 74.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.474 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.94 -44.75 96.82 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.769 0.319 . . . . 0.0 110.295 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 85.6 t -67.18 -43.65 88.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.458 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.31 93.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.958 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.81 -38.92 92.88 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.324 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.48 -43.24 97.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.872 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.48 -35.65 81.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.73 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -61.11 -42.74 99.07 Favored 'General case' 0 C--O 1.228 -0.06 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.402 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.85 -46.78 83.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.224 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 89.9 t -62.99 -46.18 96.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -67.03 -31.18 71.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.689 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.27 93.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.111 0.481 . . . . 0.0 110.311 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 407' ' ' ALA . 99.0 t -65.36 -41.53 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.168 177.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 97.9 mt -59.87 -27.05 66.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.206 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -78.17 -6.77 55.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 111.486 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -114.83 -22.95 9.39 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.881 0.372 . . . . 0.0 110.972 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.06 169.45 12.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.057 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -83.08 116.51 22.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.619 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 60.5 t -90.24 121.72 40.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.231 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.1 t -124.04 137.79 54.54 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.1 125.2 50.91 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.576 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . 0.561 ' HE3' ' OE1' ' B' ' 126' ' ' GLU . 20.3 pttp -135.44 149.91 49.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.578 0.227 . . . . 0.0 110.653 176.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.11 159.2 20.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.8 t -158.96 172.23 18.59 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.782 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 17.0 p -85.26 164.6 17.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.015 0.436 . . . . 0.0 111.355 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -65.32 -26.21 67.95 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.543 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -61.29 -39.96 92.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.649 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.42 -36.17 82.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.419 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.51 -22.67 62.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.203 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.8 mmt -77.03 -5.75 50.01 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -76.67 78.53 3.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.34 0.591 . . . . 0.0 109.636 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -105.12 14.72 28.73 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.124 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -64.12 -37.54 87.83 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.092 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.213 178.505 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.236 0.368 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.508 ' OG ' ' HA ' ' A' ' 17' ' ' ILE . 11.8 p -97.95 137.12 37.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.791 0.329 . . . . 0.0 110.736 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -153.83 138.4 9.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 69.7 mm-40 -122.4 152.56 40.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.112 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.1 m -107.35 121.5 44.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.757 0.313 . . . . 0.0 110.168 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 m -78.29 -67.36 0.74 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.461 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -170.2 110.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.629 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.65 -110.95 3.31 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.081 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.12 -39.18 93.48 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 122.655 0.382 . . . . 0.0 111.31 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -69.23 138.15 30.48 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 115.086 0.794 . . . . 0.0 115.086 -174.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 12' ' ' GLY . 7.9 mpt_? -140.85 170.31 15.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.057 0.943 . . . . 0.0 110.532 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 6.2 ttm180 -134.42 137.99 44.46 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -95.4 -84.76 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.183 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 p 43.12 91.87 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.508 ' HA ' ' OG ' ' A' ' 4' ' ' SER . 85.0 mt -113.0 131.47 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.162 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.7 m -103.01 122.89 45.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.9 pt -129.1 162.48 36.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -70.04 150.57 46.48 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.264 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.34 82.84 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -64.95 -25.34 67.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.472 . . . . 0.0 110.414 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -87.53 -32.23 19.51 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.55 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.1 mt -62.26 -50.41 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.956 0.408 . . . . 0.0 112.007 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.462 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 32.3 mm-40 -82.32 -5.02 58.3 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.7 m -100.29 -69.43 0.77 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.029 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.68 -47.58 72.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 96.3 t -63.86 -44.13 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.798 0.332 . . . . 0.0 111.349 -176.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 18.1 ttmm -61.43 -45.72 93.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.969 0.414 . . . . 0.0 110.74 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.53 ' O ' HG13 ' A' ' 33' ' ' VAL . 18.1 m -63.51 -41.29 98.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.415 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -61.23 -38.22 85.88 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.053 0.454 . . . . 0.0 110.4 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.78 -41.58 99.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.954 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 30' ' ' SER . 8.9 p -71.54 -31.65 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.569 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -62.85 -44.03 97.21 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.491 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -71.29 -31.28 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.93 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.96 -44.61 92.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.203 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.93 -33.84 76.76 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.675 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.0 -35.47 76.93 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 110.327 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.2 t -91.9 -4.88 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.321 0.581 . . . . 0.0 110.119 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 63.61 26.55 14.69 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.687 0.795 . . . . 0.0 111.435 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.17 4.55 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.851 0.358 . . . . 0.0 111.564 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.57 -33.82 76.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.936 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.65 -6.61 67.08 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.894 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -90.12 -1.0 57.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.864 0.364 . . . . 0.0 110.769 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.4 ttt-85 -94.22 82.83 4.16 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.264 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.5 94.06 6.17 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.4 101.44 2.73 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -170.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -65.36 -40.78 94.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 168.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG13 ' HB ' ' A' ' 54' ' ' VAL . 23.9 t -96.04 111.32 55.88 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.504 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.35 142.87 97.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.501 2.134 . . . . 0.0 111.65 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.559 ' HA ' HG11 ' A' ' 54' ' ' VAL . 24.1 ttt -64.43 -39.19 93.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.556 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -66.99 -20.89 65.96 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.142 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.581 HG12 HH11 ' B' ' 193' ' ' ARG . 1.7 mp -92.85 -46.56 13.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 51' ' ' MET . 9.0 p -63.79 -32.44 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 120.753 0.311 . . . . 0.0 111.358 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.43 82.15 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.66 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -93.05 -25.29 17.99 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.305 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -63.04 -43.43 98.69 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.853 0.359 . . . . 0.0 110.596 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.97 13.98 18.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.565 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.603 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -49.52 -73.07 0.39 Allowed Glycine 0 C--O 1.221 -0.703 0 CA-C-N 115.598 -0.728 . . . . 0.0 114.569 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.26 -19.3 62.37 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.862 0.331 . . . . 0.0 111.807 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 t -63.03 -45.63 91.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.032 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 66' ' ' VAL . 8.4 p -123.91 17.14 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.317 0.58 . . . . 0.0 111.121 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.603 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 37.2 ttm180 -58.92 -26.62 64.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.758 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -61.86 -52.45 64.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.304 0.574 . . . . 0.0 110.232 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.418 ' HB3' ' HG3' ' B' ' 328' ' ' GLN . 1.2 m-20 -71.85 -27.05 62.63 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.563 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 62' ' ' VAL . 88.5 t -63.78 -43.63 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.11 -39.84 93.88 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.49 -42.7 99.82 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.788 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.743 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 31.1 t70 -63.54 -43.94 95.64 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.737 0.269 . . . . 0.0 111.033 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.08 -43.85 98.26 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.476 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -67.23 -37.28 83.3 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.082 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.4 m -61.75 -43.3 99.12 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.406 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.743 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 46.2 mtp85 -64.59 -42.96 95.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.086 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -64.65 -40.44 95.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.95 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -59.81 -49.53 77.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.731 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 tt -69.03 -39.66 79.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.789 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 21.8 t0 -66.9 -41.82 86.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.258 0.551 . . . . 0.0 109.896 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.67 -41.24 92.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.727 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -65.68 -32.22 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.234 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.73 -43.55 96.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.176 0.512 . . . . 0.0 109.811 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 77' ' ' ASP . 58.7 mttm -63.83 -42.07 97.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.774 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -86.52 -4.24 59.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.895 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 64.14 36.34 9.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.367 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 98.2 mt -88.49 123.45 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.636 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -106.79 107.66 60.67 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -78.82 134.17 11.82 Favored 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 121.88 1.72 . . . . 0.0 111.406 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.94 88.28 7.26 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.165 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.72 -102.95 2.86 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.325 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.94 128.45 21.52 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 120.593 0.235 . . . . 0.0 110.924 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.07 -20.32 57.01 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.804 2.336 . . . . 0.0 112.154 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 51.3 m 68.35 95.68 0.06 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.335 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.485 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 97.4 m-85 -81.12 113.28 19.18 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.025 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.29 107.6 30.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.752 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 69.4 Cg_endo -95.65 163.71 1.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.323 2.682 . . . . 0.0 112.187 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -100.02 176.93 28.61 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.384 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.06 134.41 41.37 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -90.38 103.09 15.81 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.75 117.44 25.51 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.54 107.76 1.0 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.347 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.52 -15.71 19.72 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.988 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.93 173.79 6.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.991 0.395 . . . . 0.0 111.42 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.91 145.62 48.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.036 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -106.6 138.83 42.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.281 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.6 m -123.32 134.7 54.02 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.041 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -130.87 168.03 17.96 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.561 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.51 ' O ' HG13 ' A' ' 107' ' ' VAL . 37.7 m -87.04 -80.46 0.25 Allowed 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 106' ' ' SER . 3.7 p 56.37 121.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 C-N-CA 124.524 1.13 . . . . 0.0 111.376 -172.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -116.54 145.64 43.2 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.878 -0.513 . . . . 0.0 112.313 -172.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -155.4 -88.37 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -134.74 161.3 35.56 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -175.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.88 164.63 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.076 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -136.58 92.42 15.06 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -97.99 162.9 0.82 Allowed 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.471 2.781 . . . . 0.0 114.804 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.34 149.36 33.65 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.2 t -127.18 135.72 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -101.99 127.73 48.72 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.929 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.0 mt -118.33 134.79 54.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.603 0.239 . . . . 0.0 110.456 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -129.84 158.37 39.65 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.12 12.29 82.61 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.536 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.12 -41.24 97.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.945 0.402 . . . . 0.0 111.491 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -75.39 -8.29 56.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.051 0.453 . . . . 0.0 111.269 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.07 7.86 44.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.583 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 74.7 mt -83.89 119.0 32.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.01 0.433 . . . . 0.0 110.672 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -110.56 114.03 27.11 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.61 136.82 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.882 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -85.4 135.64 33.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.293 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -127.39 95.97 34.58 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.42 121.55 8.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.161 1.908 . . . . 0.0 112.1 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.2 mm -103.79 112.64 38.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.49 159.83 37.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.784 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.71 165.45 27.23 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.415 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -84.72 110.75 19.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.2 p -92.06 173.59 7.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.396 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -62.99 -36.67 84.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.668 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.14 -36.11 80.8 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.893 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -62.78 -39.27 93.69 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.741 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.02 -43.58 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.085 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -59.4 -44.94 92.73 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.347 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.69 -41.26 99.85 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.013 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.621 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.3 tpt -62.19 -46.78 87.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.716 0.293 . . . . 0.0 110.605 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.08 -42.17 99.59 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.266 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.45 -45.74 92.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.527 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.0 m -63.64 -43.61 96.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.669 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 140' ' ' MET . 98.5 mt -61.32 -44.64 96.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.067 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -70.48 -37.81 74.29 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.994 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.35 -36.98 85.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.428 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -84.79 33.92 0.53 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -122.78 115.64 22.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.447 0.641 . . . . 0.0 111.877 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.08 -170.44 3.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.455 ' CB ' ' H ' ' A' ' 247' ' ' GLU . 15.3 m -141.91 167.48 22.04 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 21.8 p-90 -105.1 132.5 51.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 120.678 0.275 . . . . 0.0 111.376 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -160.55 -47.19 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.335 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -154.26 -175.67 5.51 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' A' ' 240' ' ' VAL . 33.0 mmtp -52.75 154.67 2.63 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 76.22 -168.85 0.08 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.307 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 243' ' ' ARG . . . 113.5 0.74 24.78 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.504 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 74.41 -40.51 0.45 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.891 0.876 . . . . 0.0 112.407 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.3 t 73.32 -61.19 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.399 0.68 . . . . 0.0 112.447 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.492 ' HB2' ' HG2' ' A' ' 203' ' ' LYS . 10.2 pt-20 54.15 -166.18 0.09 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.905 1.282 . . . . 0.0 112.729 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.461 ' HB2' ' CA ' ' A' ' 190' ' ' GLY . . . -78.6 93.18 4.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.784 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -151.13 -65.71 0.19 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.327 0.584 . . . . 0.0 111.181 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -110.93 -168.76 1.34 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.381 -172.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 20.2 ptt180 -106.11 133.5 50.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.841 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.4 m -128.58 144.74 37.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.137 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.5 m -78.69 111.28 14.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.047 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.5 mt -123.63 122.07 64.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.02 0.438 . . . . 0.0 111.058 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.35 78.84 2.24 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -97.42 153.64 17.98 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.293 0.568 . . . . 0.0 112.183 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.3 m -119.05 128.38 54.29 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.877 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.58 126.42 9.11 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.742 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 21.1 p -137.27 134.32 36.0 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.93 -84.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.889 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -108.86 -0.04 20.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.399 0.618 . . . . 0.0 109.959 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.2 -21.82 0.97 Allowed Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.927 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -99.93 151.88 20.81 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -81.12 153.81 27.09 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.697 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -118.05 167.67 11.25 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.708 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -57.95 -32.26 67.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.57 -175.29 32.55 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.35 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.17 30.47 46.22 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.187 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.36 104.5 14.24 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -121.09 142.4 49.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.271 0.558 . . . . 0.0 112.197 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.7 m -147.1 118.4 7.84 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.252 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.83 33.68 23.5 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.596 0.56 . . . . 0.0 110.798 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -91.88 124.68 36.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.22 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 6.6 m -93.61 116.16 34.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.388 0.614 . . . . 0.0 110.992 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 163' ' ' ARG . 63.4 tp -101.88 117.57 35.12 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.804 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.555 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -91.01 108.15 19.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 76.9 mtm -89.83 149.56 22.62 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.808 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.461 ' CA ' ' HB2' ' A' ' 160' ' ' ALA . . . 98.38 12.19 45.83 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.275 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -127.21 -1.93 6.37 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.431 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 75.53 57.97 4.03 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.617 HH11 HG12 ' B' ' 53' ' ' ILE . 33.8 mmm-85 -103.72 -3.88 24.44 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.463 0.649 . . . . 0.0 109.613 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.453 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -142.66 176.29 9.15 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.997 177.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.4 mm -58.27 130.47 83.96 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.29 130.15 27.92 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.301 2.001 . . . . 0.0 111.993 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.45 -36.62 4.21 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.937 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -63.81 -47.43 80.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.175 0.487 . . . . 0.0 111.664 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.71 -8.86 59.49 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.255 0.55 . . . . 0.0 111.212 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -92.62 -31.74 15.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.605 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -65.32 -30.23 77.19 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.912 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.74 -25.97 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.912 0.387 . . . . 0.0 111.043 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.492 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 54.1 mtpt -55.95 132.71 50.53 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.397 0.679 . . . . 0.0 111.552 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.35 -12.78 66.35 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.674 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -84.71 154.73 22.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.984 0.421 . . . . 0.0 112.133 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -93.86 163.98 13.29 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.32 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.17 92.73 1.76 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.119 0.485 . . . . 0.0 110.429 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.478 ' H ' HD21 ' A' ' 237' ' ' LEU . . . 113.19 18.35 7.27 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.52 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -102.19 116.02 31.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.915 0.388 . . . . 0.0 110.795 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -95.95 119.25 34.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.611 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -138.41 -15.17 1.26 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 30.1 p 60.98 162.79 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.978 0.911 . . . . 0.0 112.292 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -149.03 133.07 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.826 0.346 . . . . 0.0 110.729 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.54 112.09 16.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.96 0.41 . . . . 0.0 111.207 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 65.1 t -113.21 129.3 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 3.2 m -95.62 -22.98 17.24 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -173.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.431 ' HD1' ' O ' ' A' ' 229' ' ' LYS . 89.1 m-85 67.74 154.47 0.14 Allowed Pre-proline 0 N--CA 1.489 1.51 0 CA-C-O 121.005 0.431 . . . . 0.0 111.452 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.66 158.11 28.31 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.309 2.006 . . . . 0.0 111.54 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -66.21 -37.55 85.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.216 0.532 . . . . 0.0 110.08 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.31 45.96 1.31 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.058 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -82.72 135.87 34.88 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -60.16 -22.25 62.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.24 105.27 17.29 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 42.2 tt0 -60.99 -24.57 66.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.22 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -73.65 -24.21 59.96 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.512 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.0 mt -113.01 3.11 16.02 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.4 ptmt -68.27 118.11 10.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.731 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.83 29.0 74.13 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.389 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.431 ' O ' ' HD1' ' A' ' 217' ' ' PHE . 99.4 mttt -124.63 140.39 52.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 117.139 0.47 . . . . 0.0 110.483 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -85.74 130.2 34.62 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.7 130.71 56.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.734 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -72.12 -39.35 68.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 59.64 105.27 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.107 0.479 . . . . 0.0 112.031 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.55 -45.82 88.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.995 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.3 mm 60.75 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.766 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -106.3 125.99 51.68 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.677 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.478 HD21 ' H ' ' A' ' 208' ' ' GLY . 4.3 mp -98.55 114.5 26.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.95 0.405 . . . . 0.0 110.867 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -94.86 -59.35 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.594 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -91.06 -88.87 0.18 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.513 ' O ' ' HE2' ' A' ' 154' ' ' LYS . 58.5 t 65.61 120.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 122.829 0.452 . . . . 0.0 110.351 -175.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -79.17 -99.96 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -166.91 155.03 9.74 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.647 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 14.2 ptp180 169.11 77.48 0.0 OUTLIER 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.668 1.187 . . . . 0.0 112.856 171.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.01 158.64 43.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.4 tp 71.95 107.53 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 123.831 0.852 . . . . 0.0 111.773 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.2 109.11 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.194 1.929 . . . . 0.0 112.368 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.455 ' H ' ' CB ' ' A' ' 150' ' ' THR . 7.8 tp10 -111.37 -21.2 11.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.053 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 42.8 tp 74.47 126.53 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.558 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.8 m -130.7 -110.68 0.26 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.904 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -175.29 -44.82 0.01 OUTLIER 'General case' 0 C--N 1.352 0.702 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.06 -29.43 65.38 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -66.55 -17.65 64.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.772 0.32 . . . . 0.0 111.711 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.09 -42.8 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 110.998 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.489 ' HD2' ' H ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -95.99 21.47 8.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.004 -177.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -69.12 -17.02 63.79 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.506 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.47 ' CE1' HD22 ' A' ' 266' ' ' LEU . 80.7 m-85 -59.02 -35.43 73.27 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.74 -28.44 15.41 Favored Glycine 0 C--N 1.322 -0.202 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.76 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.16 83.88 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 260' ' ' ASP . 13.8 tt0 55.09 -163.91 0.13 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.157 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.506 ' H ' ' HG2' ' A' ' 259' ' ' GLU . 4.0 p-10 -124.94 110.2 13.94 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.031 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -93.15 164.97 27.56 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.622 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.6 p -87.06 -173.26 4.35 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 122.465 0.306 . . . . 0.0 110.267 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.9 -47.74 92.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 120.862 0.363 . . . . 0.0 111.289 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.2 -34.25 17.86 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.768 0.318 . . . . 0.0 111.02 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.66 -40.11 98.24 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.352 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.47 HD22 ' CE1' ' A' ' 256' ' ' PHE . 53.5 tp -62.46 -42.55 99.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.505 0.193 . . . . 0.0 111.092 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -60.89 -43.83 97.93 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.953 0.406 . . . . 0.0 110.083 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -67.88 -42.25 81.52 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.236 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 24.9 tp10 -66.74 -39.98 88.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.963 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.459 ' O ' ' HG2' ' A' ' 274' ' ' MET . 75.2 t -65.03 -43.22 96.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.943 0.402 . . . . 0.0 110.054 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -58.13 -47.39 83.45 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.127 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 16.3 ptmt -67.93 -41.5 82.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.622 0.249 . . . . 0.0 111.357 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -64.12 -39.24 93.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 270' ' ' VAL . 98.8 mmm -63.5 -41.92 98.53 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.567 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -67.68 -35.04 78.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.855 0.36 . . . . 0.0 110.228 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -61.56 -43.7 98.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 109.977 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -68.88 -37.49 79.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.064 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 38.9 tp -63.17 -38.62 91.91 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.794 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -56.1 -45.62 79.37 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.151 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.5 m -61.51 -40.52 94.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.496 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.56 -45.74 92.87 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.912 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.58 -45.21 98.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 110.179 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.481 ' HD2' ' OE2' ' A' ' 405' ' ' GLU . 0.8 OUTLIER -59.77 -46.71 88.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.136 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -64.91 -41.56 95.48 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.667 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -65.32 -41.43 94.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.873 0.368 . . . . 0.0 111.404 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.92 -44.06 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.166 0.508 . . . . 0.0 109.857 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.483 ' HZ2' ' CD ' ' A' ' 404' ' ' GLU . 88.4 tttt -62.6 -47.54 83.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.629 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 55.2 p -62.41 -43.91 97.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -64.24 -42.15 96.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.768 0.318 . . . . 0.0 111.059 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.6 85.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 37.9 mm -65.42 -44.39 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.427 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.492 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 20.0 tp10 -62.56 -42.87 99.82 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.607 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.3 -43.51 98.98 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.98 -43.21 96.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.0 -44.99 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.391 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . 0.492 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 67.5 mttm -64.33 -41.42 96.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.548 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.22 -43.96 69.56 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -127.59 98.8 5.34 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.683 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -93.23 103.15 15.43 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.2 tp -107.98 139.27 30.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.975 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -67.73 131.34 45.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.213 0.53 . . . . 0.0 110.706 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.16 135.75 21.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.062 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.0 138.35 85.53 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.388 2.058 . . . . 0.0 111.987 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.37 85.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.307 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.38 -45.85 80.36 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.025 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.68 -43.3 93.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.84 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 71.4 mt -62.34 -49.98 81.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.66 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -41.63 98.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.949 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 24.6 m -61.94 -45.63 92.86 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.616 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.635 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 27.2 mm-40 -73.11 -38.05 66.48 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -176.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.499 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 82.0 mt -61.74 -43.8 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -175.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 24.9 t70 -61.45 -42.62 99.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.097 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.4 -42.55 93.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 90.3 mt -62.15 -39.67 93.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.43 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 82.5 mtm180 -62.6 -37.46 86.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.071 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 91.3 mtt180 -64.09 -38.95 92.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -63.09 -46.1 88.98 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.383 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.8 -39.53 91.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.657 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.51 94.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.409 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -65.02 -38.86 92.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.175 0.512 . . . . 0.0 110.234 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.84 -17.93 59.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.922 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -78.16 -3.57 43.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.317 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.56 -11.27 4.62 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.356 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 111.88 34.62 1.99 Allowed Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.241 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -74.75 126.6 31.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.953 0.406 . . . . 0.0 110.097 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.48 159.36 36.53 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.508 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.1 OUTLIER 69.17 -47.07 0.58 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.27 -4.9 55.13 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.18 -24.64 66.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.442 0.639 . . . . 0.0 109.807 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 38.7 tp -63.94 -33.75 76.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.705 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -80.47 -9.58 59.76 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.905 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 94.4 mt -63.83 129.03 93.57 Favored Pre-proline 0 C--O 1.24 0.572 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.476 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.84 127.24 25.39 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.848 2.365 . . . . 0.0 113.142 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -65.51 -43.97 88.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.002 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -65.25 -24.76 67.41 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.0 -10.32 55.28 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -118.1 -15.95 9.82 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.976 0.417 . . . . 0.0 111.251 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.22 -25.17 65.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.497 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.8 -50.78 67.6 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.705 0.288 . . . . 0.0 111.06 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -78.91 -20.72 48.67 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.208 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.98 -41.85 98.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -60.41 -44.24 95.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.031 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.478 ' O ' HG23 ' A' ' 347' ' ' VAL . 17.9 mmt85 -62.41 -42.78 99.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.068 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.48 ' NH2' HD22 ' A' ' 314' ' ' LEU . 73.4 mtt180 -64.81 -41.77 95.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.675 0.274 . . . . 0.0 111.061 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 89.2 t -64.89 -44.62 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.769 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 342' ' ' LYS . 72.5 t -61.13 -44.22 97.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.934 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 343' ' ' ARG . 77.4 t -60.5 -44.67 96.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.09 99.73 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.175 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 93.7 mt -63.47 -42.71 98.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.899 0.38 . . . . 0.0 110.614 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.405 ' O ' HG21 ' A' ' 354' ' ' VAL . 98.6 mt -63.13 -44.95 94.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.763 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.38 -42.02 96.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.968 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.18 -42.53 99.72 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.131 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.54 -39.24 85.02 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 117.053 0.426 . . . . 0.0 111.287 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 350' ' ' LEU . 73.0 t -60.79 -45.05 98.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.93 -44.22 97.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.687 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -65.48 -46.55 79.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 37.5 m -73.11 -44.25 60.57 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -89.27 0.63 56.63 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.777 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 56.99 67.01 1.05 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.304 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 91.0 mt -98.83 153.77 18.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.777 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -132.96 155.35 49.28 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.806 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.15 100.24 8.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 171.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.448 ' O ' HG21 ' A' ' 367' ' ' VAL . 26.8 t70 -83.16 115.96 22.14 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.127 0.489 . . . . 0.0 112.269 -173.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.605 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 68.7 mm-40 -61.35 -35.52 77.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.299 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.439 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 65.4 mm-40 -64.39 -41.71 96.53 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.093 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -63.13 -39.15 93.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.18 0.514 . . . . 0.0 109.842 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 363' ' ' ASP . 89.6 t -61.78 -39.64 84.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.332 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.5 mmmt -57.68 -44.31 85.68 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.487 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.51 -40.09 98.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.848 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.6 -43.05 99.78 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.981 0.419 . . . . 0.0 110.281 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.27 -43.92 97.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.406 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.15 -41.0 97.33 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.56 -37.25 84.55 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.351 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 48.4 ttm -66.98 -43.61 82.6 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.091 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.87 75.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.123 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.6 m -68.27 -5.29 17.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.839 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -83.45 -12.48 56.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.498 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -106.35 172.99 6.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.533 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.24 -47.31 83.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.825 0.345 . . . . 0.0 110.985 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -123.62 113.55 28.86 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.545 ' O ' HG13 ' A' ' 385' ' ' ILE . 38.1 Cg_endo -66.75 -31.19 40.12 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.229 1.953 . . . . 0.0 113.402 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -66.27 -42.96 87.71 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.28 -36.19 83.3 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.994 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.38 -42.56 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.234 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 381' ' ' PRO . 68.1 mt -61.23 -46.76 95.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.279 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 46.2 mt-10 -63.32 -44.0 96.19 Favored 'General case' 0 C--O 1.215 -0.752 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.773 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.61 -46.76 86.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -66.28 -40.84 90.34 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.429 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 51.3 p -81.58 -2.44 50.05 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 98.6 mttt -103.48 10.64 37.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.049 0.452 . . . . 0.0 110.789 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -134.42 117.51 16.39 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.259 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -63.78 -40.64 97.17 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -58.1 -49.48 76.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.674 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.55 -42.73 98.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.2 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.525 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 89.5 mtp -63.9 -48.3 77.16 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -73.58 -39.39 64.68 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -174.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -62.36 -40.72 97.35 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 44.4 tpp -64.13 -41.47 97.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.66 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 395' ' ' MET . 69.1 mtm180 -64.35 -36.44 84.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.008 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -60.95 -43.77 98.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.583 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.17 -44.09 88.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.488 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -61.65 -41.83 98.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.95 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.87 -39.5 94.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.683 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.483 ' CD ' ' HZ2' ' A' ' 287' ' ' LYS . 37.6 tt0 -59.66 -43.93 93.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.906 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.481 ' OE2' ' HD2' ' A' ' 283' ' ' ARG . 29.7 mt-10 -65.18 -37.44 87.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.541 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -60.45 -43.35 96.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.526 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.42 -44.35 91.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.968 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 86.5 t -64.73 -45.11 96.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.989 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -65.32 -33.56 76.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.32 97.49 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.865 0.364 . . . . 0.0 110.482 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.91 -42.74 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.076 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.0 mt -61.45 -41.85 97.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.183 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.04 -23.85 67.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.706 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -95.18 -8.27 36.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.32 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.53 179.43 4.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.139 0.495 . . . . 0.0 111.757 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -82.41 133.46 35.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.689 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.09 131.34 73.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -131.49 138.81 49.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.1 0.476 . . . . 0.0 110.921 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -93.58 118.82 31.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.663 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -136.33 132.93 36.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.843 0.354 . . . . 0.0 111.368 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -81.01 153.23 27.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.165 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 12.9 t -157.72 171.66 19.92 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 26.2 p -81.34 165.54 21.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.772 0.32 . . . . 0.0 110.21 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -66.04 -18.13 65.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.021 0.438 . . . . 0.0 111.26 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -62.25 -39.45 92.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.97 -38.31 90.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.19 0.519 . . . . 0.0 110.057 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.35 -36.2 83.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.488 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 5.9 mmt -65.31 -14.28 60.41 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.301 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -75.6 83.37 2.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -103.64 6.48 37.13 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.315 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -72.32 -44.83 62.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.532 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.149 -178.548 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.92 103.86 2.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 111.361 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.86 161.59 38.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.396 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.488 ' OG ' ' HA ' ' B' ' 17' ' ' ILE . 7.9 p -101.59 130.56 47.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.787 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.78 133.66 13.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 57.9 mm-40 -118.45 149.75 40.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.962 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 98.0 m -106.6 122.71 46.86 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 27.7 m -78.74 -68.54 0.64 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.363 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -166.23 110.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.582 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.81 -106.55 1.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.354 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 83.8 mt -70.34 -36.69 74.39 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.708 0.403 . . . . 0.0 112.048 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.443 ' C ' ' HD2' ' B' ' 13' ' ' ARG . . . -70.09 135.81 26.39 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 114.486 0.554 . . . . 0.0 114.486 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.443 ' HD2' ' C ' ' B' ' 12' ' ' GLY . 7.6 mpt_? -138.13 171.26 14.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.69 0.796 . . . . 0.0 110.415 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 9.8 ttm180 -135.75 138.54 42.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.77 -83.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.038 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p 42.23 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.488 ' HA ' ' OG ' ' B' ' 4' ' ' SER . 83.8 mt -110.91 130.56 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.23 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 37.6 m -103.17 123.61 47.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 20.6 pt -129.08 163.23 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.0 111.979 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.503 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -71.93 152.69 42.34 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.087 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.65 77.62 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -63.02 -32.3 73.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.241 0.544 . . . . 0.0 110.217 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 17.3 m -82.51 -32.99 28.44 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.034 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.503 HG13 ' O ' ' B' ' 20' ' ' ALA . 81.5 mt -60.59 -49.98 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 120.881 0.372 . . . . 0.0 111.834 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.479 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 28.0 mm-40 -82.99 -7.51 59.66 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 53.2 m -97.97 -69.34 0.76 Allowed 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.41 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.99 -48.3 66.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 89.7 t -64.17 -43.62 97.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.513 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.1 ttmm -61.33 -46.49 90.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 0.0 110.564 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.51 ' O ' HG13 ' B' ' 33' ' ' VAL . 21.2 m -63.53 -40.39 96.92 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.451 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -60.68 -38.93 86.59 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.021 0.438 . . . . 0.0 110.609 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.78 -41.85 99.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.839 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.51 HG13 ' O ' ' B' ' 30' ' ' SER . 9.2 p -70.93 -32.9 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 120.224 -0.591 . . . . 0.0 110.894 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -63.56 -43.84 95.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.431 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 25.7 m -70.69 -31.76 47.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.054 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.64 -42.54 98.12 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.989 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.21 -33.68 76.3 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.689 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.07 -36.63 80.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.942 0.401 . . . . 0.0 110.447 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 t -89.34 -6.39 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.3 0.571 . . . . 0.0 109.967 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 63.05 30.4 16.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.939 0.896 . . . . 0.0 111.215 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -105.72 4.11 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -64.35 -34.19 77.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.808 0.337 . . . . 0.0 110.799 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.78 -19.72 65.57 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.686 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -80.69 -3.48 50.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.677 0.275 . . . . 0.0 111.502 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 66.4 ttt-85 -91.88 83.46 5.23 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 119.946 -0.701 . . . . 0.0 112.026 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.55 95.99 6.01 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.12 98.1 2.23 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 115.319 0.888 . . . . 0.0 115.319 -171.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -64.67 -40.8 96.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 14.7 t -94.06 111.34 52.8 Favored Pre-proline 0 N--CA 1.437 -1.121 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.245 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.76 141.54 92.19 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.413 2.076 . . . . 0.0 111.665 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.478 ' HA ' HG13 ' B' ' 54' ' ' VAL . 26.1 ttt -65.63 -38.92 90.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.699 -175.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -67.47 -18.36 65.04 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.617 HG12 HH11 ' A' ' 193' ' ' ARG . 1.8 mp -96.76 -46.05 12.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.52 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' B' ' 51' ' ' MET . 8.4 p -63.85 -32.19 56.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 111.093 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.29 81.46 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.464 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -95.19 -20.84 18.9 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.34 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -63.99 -44.0 94.0 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.769 0.318 . . . . 0.0 110.513 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -113.9 12.32 18.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.242 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.644 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -50.72 -69.25 1.15 Allowed Glycine 0 C--O 1.218 -0.845 0 CA-C-N 115.488 -0.778 . . . . 0.0 114.75 -175.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.65 -18.19 61.59 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 117.0 0.4 . . . . 0.0 111.759 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 29.2 t -67.37 -52.68 37.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.969 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.476 ' O ' HG22 ' B' ' 66' ' ' VAL . 7.3 p -114.02 17.03 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.468 0.651 . . . . 0.0 111.193 -175.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 36.3 ttm180 -59.1 -33.26 70.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.986 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -59.28 -50.68 73.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.023 0.44 . . . . 0.0 110.275 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.61 -34.03 76.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.36 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 62' ' ' VAL . 81.6 t -61.16 -43.66 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.62 -39.59 91.82 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.27 -41.99 99.72 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.707 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . 0.687 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 28.4 t70 -64.22 -43.48 94.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.613 0.244 . . . . 0.0 111.076 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.37 -44.02 96.02 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.383 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -66.44 -37.24 84.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.101 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.6 m -62.25 -42.86 99.7 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.233 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.687 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 44.3 mtp85 -63.36 -43.71 96.87 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.031 0.443 . . . . 0.0 110.205 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -64.89 -40.75 95.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.092 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.8 -49.27 78.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.034 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.6 tt -68.63 -39.6 80.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.716 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.511 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 7.7 t0 -65.91 -42.51 90.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.293 0.568 . . . . 0.0 109.88 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.23 93.96 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.762 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 pt -66.53 -31.71 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.149 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.83 -43.31 96.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.112 0.482 . . . . 0.0 109.837 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' B' ' 77' ' ' ASP . 64.5 mttm -63.43 -45.2 92.01 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.849 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -81.62 -9.19 59.73 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.308 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 69.47 33.36 3.15 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.628 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 96.1 mt -84.84 128.87 38.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.955 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -112.29 101.4 52.08 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.632 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.42 143.62 53.1 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.503 2.135 . . . . 0.0 111.461 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.31 88.56 4.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.032 0.444 . . . . 0.0 110.752 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.22 -98.28 2.15 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.465 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.15 129.16 19.8 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.574 0.226 . . . . 0.0 110.948 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.78 -19.56 46.95 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.795 2.33 . . . . 0.0 112.034 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 34.1 m 71.02 95.51 0.07 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.192 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.486 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 98.5 m-85 -81.67 110.98 17.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.023 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.3 t -93.95 107.9 31.34 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.977 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 68.9 Cg_endo -96.2 159.28 1.33 Allowed 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 123.208 2.605 . . . . 0.0 111.707 177.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.94 177.6 34.19 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.089 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.48 136.16 44.14 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -88.14 106.43 18.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.659 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.65 117.09 28.27 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.68 111.35 2.71 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.006 0.432 . . . . 0.0 110.725 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.73 -10.58 35.09 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.023 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -114.44 175.68 5.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.998 0.399 . . . . 0.0 111.663 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -72.35 144.43 48.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.803 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -106.79 137.51 44.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.358 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.5 m -122.84 135.26 54.47 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.36 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -131.77 166.63 21.1 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.484 ' O ' HG13 ' B' ' 107' ' ' VAL . 32.1 m -84.16 -81.04 0.18 Allowed 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . 0.484 HG13 ' O ' ' B' ' 106' ' ' SER . 3.6 p 55.62 117.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 C-N-CA 124.441 1.096 . . . . 0.0 111.709 -173.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -112.45 150.86 30.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -157.36 -90.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -134.42 162.32 32.56 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 33.8 m -137.32 164.97 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.89 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -138.9 94.84 9.89 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -97.57 163.43 0.89 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.52 2.814 . . . . 0.0 114.495 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -145.71 146.28 31.2 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 61.1 t -125.34 133.1 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.94 126.11 44.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.551 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 88.1 mt -115.03 136.07 53.53 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -132.31 159.44 39.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.489 0.185 . . . . 0.0 110.503 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.02 13.62 82.84 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.382 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.5 -40.18 95.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.012 0.434 . . . . 0.0 111.539 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -74.52 -4.91 39.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.321 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.33 12.75 35.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.853 0.359 . . . . 0.0 110.976 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 80.5 mt -87.3 114.7 26.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.163 0.506 . . . . 0.0 110.832 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -108.98 116.65 32.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 28.5 t -116.64 135.4 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.871 -173.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . 0.457 ' CD ' ' HZ1' ' B' ' 420' ' ' LYS . 40.6 tt0 -79.67 143.2 34.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.187 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -133.37 98.08 15.62 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -67.77 118.44 5.6 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.321 2.014 . . . . 0.0 112.259 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.7 mm -102.82 114.34 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.25 161.15 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.851 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -141.72 155.06 45.66 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.876 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.04 120.92 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.9 p -103.49 177.67 4.77 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.206 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -62.29 -36.9 83.53 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.229 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.74 84.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.484 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -63.18 -39.73 95.48 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 96.7 t -63.34 -44.69 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.812 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -58.93 -47.37 85.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.347 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.95 -41.3 99.65 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.071 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' MET . . . . . 0.67 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.1 OUTLIER -62.33 -45.67 92.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.672 0.273 . . . . 0.0 110.534 178.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.12 -42.26 99.51 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.949 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -59.07 -49.09 79.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.464 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.9 m -63.48 -43.85 96.11 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.796 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' B' ' 140' ' ' MET . 97.5 mt -61.14 -45.04 96.28 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -175.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -71.08 -37.86 72.43 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.893 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -61.78 -36.31 80.71 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.028 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -82.21 29.95 0.41 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.244 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -118.51 114.34 22.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.356 0.598 . . . . 0.0 112.179 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.92 -167.35 2.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.24 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' THR . . . . . 0.504 ' CB ' ' H ' ' B' ' 247' ' ' GLU . 22.8 m -144.38 165.98 26.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . 0.621 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 15.3 p-90 -102.08 131.97 48.22 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 120.723 0.297 . . . . 0.0 111.336 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 5.9 mtpp -162.48 -50.55 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.44 -175.09 4.95 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -54.26 155.29 3.83 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . 0.402 ' HB3' ' H ' ' B' ' 156' ' ' GLY . 35.3 m-20 73.98 -168.33 0.11 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.487 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' B' ' 243' ' ' ARG . . . 113.86 1.18 24.19 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.548 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . 75.11 -40.3 0.43 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.834 0.853 . . . . 0.0 112.239 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 57.7 t 71.39 -59.73 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.584 0.754 . . . . 0.0 112.768 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . 0.505 ' HB2' ' HG2' ' B' ' 203' ' ' LYS . 9.4 pt-20 53.02 -164.73 0.08 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.688 1.195 . . . . 0.0 112.787 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.75 92.8 6.09 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.699 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.97 -64.03 0.23 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.297 0.57 . . . . 0.0 110.902 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -111.0 -167.89 1.24 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.291 -173.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' B' ' 187' ' ' LEU . 24.0 ptt180 -107.79 132.17 53.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.818 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.92 140.85 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.63 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 9.5 m -76.15 109.93 10.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.217 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 84.3 mt -124.4 119.14 55.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.911 0.386 . . . . 0.0 110.794 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -95.47 75.99 3.32 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -90.59 150.64 21.64 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.349 0.595 . . . . 0.0 112.279 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 34.3 m -117.18 127.33 54.01 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.283 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.84 131.58 11.5 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.677 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 30.6 p -140.28 133.15 29.17 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 30.3 t -81.95 -84.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.954 0.407 . . . . 0.0 110.791 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -103.96 -21.3 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.505 0.669 . . . . 0.0 109.546 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.05 -16.41 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.808 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -100.34 148.53 24.59 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -82.69 149.34 27.39 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -116.37 172.18 7.36 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.35 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.31 -33.86 71.63 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.81 -178.23 32.15 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.546 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.05 29.49 41.46 Favored Glycine 0 C--O 1.224 -0.47 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.968 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.37 101.71 11.23 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -117.46 143.13 46.35 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 50.8 m -147.48 119.74 8.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.172 176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 58.07 29.97 18.6 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.429 0.456 . . . . 0.0 110.758 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -90.35 123.4 34.07 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.453 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 6.7 m -94.6 117.08 37.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.396 0.617 . . . . 0.0 110.832 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' B' ' 163' ' ' ARG . 55.2 tp -100.35 118.67 37.09 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.731 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' B' ' 193' ' ' ARG . . . -92.79 112.46 24.43 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 77.2 mtm -95.14 149.4 21.34 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.935 0.398 . . . . 0.0 111.906 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 101.55 4.28 52.63 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.396 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -119.24 -4.21 10.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.42 4.31 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.972 -1.109 . . . . 0.0 110.422 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.581 HH11 HG12 ' A' ' 53' ' ' ILE . 33.5 mmm-85 -100.89 -2.76 31.16 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.474 0.654 . . . . 0.0 109.925 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.423 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -142.63 175.07 10.09 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.981 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 45.4 mm -57.5 130.31 81.15 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.59 131.14 32.15 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.251 1.967 . . . . 0.0 111.793 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.42 -37.38 3.76 Favored Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.114 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -63.6 -47.76 80.12 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.051 0.426 . . . . 0.0 111.591 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.89 -9.42 59.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.038 0.446 . . . . 0.0 111.111 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -93.6 -30.07 15.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.247 0.546 . . . . 0.0 109.848 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.32 73.23 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.699 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.5 -26.06 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.065 0.46 . . . . 0.0 110.896 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.505 ' HG2' ' HB2' ' B' ' 159' ' ' GLU . 49.7 mtpt -54.73 130.73 41.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.571 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.55 -9.13 66.66 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.64 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -88.57 151.0 22.78 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 122.453 -0.44 . . . . 0.0 111.876 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -91.86 165.89 13.01 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.537 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.68 102.87 4.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . 0.511 ' H ' HD21 ' B' ' 237' ' ' LEU . . . 106.48 2.07 37.76 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -87.95 119.44 28.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.162 0.506 . . . . 0.0 110.973 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.52 136.32 38.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.24 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -156.18 -15.2 0.1 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 30.0 p 61.6 159.17 0.05 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.959 0.904 . . . . 0.0 112.087 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.0 tp -146.47 129.96 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.984 0.421 . . . . 0.0 110.522 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -78.58 115.63 18.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.596 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 67.2 t -113.8 132.08 63.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 7.1 m -96.05 -30.57 13.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' B' ' 216' ' ' THR . 74.6 m-85 72.7 151.06 0.14 Allowed Pre-proline 0 N--CA 1.484 1.267 0 C-N-CA 122.708 0.403 . . . . 0.0 111.084 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.67 159.2 25.07 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.284 1.99 . . . . 0.0 111.49 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -65.0 -39.05 92.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.3 0.572 . . . . 0.0 109.987 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -88.75 52.45 2.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.66 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . 0.402 ' CE2' ' HB2' ' B' ' 223' ' ' ALA . 25.7 t80 -91.26 132.94 35.81 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.402 ' HB2' ' CE2' ' B' ' 221' ' ' TYR . . . -90.87 103.61 16.3 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 45.4 tt0 -59.25 -30.42 68.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.323 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.468 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 31.2 p-10 -67.58 -24.43 65.5 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.671 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.8 mt -112.5 3.0 16.56 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.6 ptmt -66.89 112.75 4.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.129 -177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.06 23.18 76.15 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.045 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 99.1 mttt -117.98 128.85 55.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.9 0.35 . . . . 0.0 110.407 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -70.94 137.84 49.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.142 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.86 127.49 47.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.491 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -69.76 -40.24 76.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 58.95 103.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.045 0.45 . . . . 0.0 111.981 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.5 83.96 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.755 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 45.5 mm 62.58 83.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.739 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -109.0 128.08 54.64 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.564 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . 0.511 HD21 ' H ' ' B' ' 208' ' ' GLY . 3.8 mp -100.65 120.28 39.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.629 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -98.66 -56.25 2.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.439 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -94.86 -89.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 59.3 t 67.43 120.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 120.994 0.426 . . . . 0.0 110.177 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -77.46 -92.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -174.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -173.04 155.78 3.11 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.621 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 14.8 ptp180 166.92 78.12 0.0 OUTLIER 'General case' 0 C--N 1.364 1.207 0 C-N-CA 124.782 1.233 . . . . 0.0 113.129 170.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.08 160.49 40.13 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 55.4 tp 70.1 108.06 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 123.67 0.788 . . . . 0.0 111.92 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.44 111.51 2.55 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.251 1.967 . . . . 0.0 112.082 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . 0.504 ' H ' ' CB ' ' B' ' 150' ' ' THR . 6.4 tp10 -117.77 -13.09 10.16 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.438 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 41.7 tp 71.41 130.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.29 1.036 . . . . 0.0 112.848 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' THR . . . . . 0.517 HG23 ' H ' ' B' ' 250' ' ' ALA . 0.5 OUTLIER -142.96 -163.28 1.6 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.517 ' H ' HG23 ' B' ' 249' ' ' THR . . . -130.3 -21.63 2.88 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.59 -35.6 80.59 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -65.41 -17.29 64.42 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.95 -42.57 97.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.968 0.413 . . . . 0.0 111.195 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' LYS . . . . . 0.498 ' H ' ' HD2' ' B' ' 254' ' ' LYS . 0.0 OUTLIER -97.76 18.58 15.37 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -68.9 -16.83 63.86 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.007 0.432 . . . . 0.0 111.61 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 256' ' ' PHE . . . . . 0.424 ' CE1' HD22 ' B' ' 266' ' ' LEU . 85.3 m-85 -59.74 -30.63 68.96 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.1 -31.14 9.05 Favored Glycine 0 CA--C 1.51 -0.245 0 C-N-CA 120.196 -1.002 . . . . 0.0 114.048 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 26.2 t -81.23 85.57 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . 0.504 ' HG2' ' H ' ' B' ' 260' ' ' ASP . 12.5 tt0 53.72 -163.88 0.1 Allowed 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.681 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . 0.504 ' H ' ' HG2' ' B' ' 259' ' ' GLU . 1.4 p-10 -123.31 113.07 18.38 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.621 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -95.74 169.77 27.42 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.367 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 15.1 p -89.62 -173.75 4.07 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.9 t -60.53 -48.57 87.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.901 0.381 . . . . 0.0 111.339 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.42 -34.09 20.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.905 0.383 . . . . 0.0 110.523 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.96 -39.98 98.73 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.481 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.424 HD22 ' CE1' ' B' ' 256' ' ' PHE . 54.8 tp -62.62 -43.28 99.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.736 0.303 . . . . 0.0 110.846 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -62.4 -44.01 97.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.61 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.83 -43.83 87.38 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.053 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -66.35 -40.79 90.05 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' B' ' 274' ' ' MET . 73.6 t -64.85 -43.32 96.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.034 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . 0.423 HH21 ' HD3' ' B' ' 271' ' ' ARG . 9.8 tpt180 -57.47 -49.32 76.66 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.616 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 16.1 ptmt -67.41 -41.92 84.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.65 0.262 . . . . 0.0 111.581 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -64.58 -39.39 93.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.789 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 274' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.0 mmm -62.33 -41.61 98.7 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -68.69 -34.94 76.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.752 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -61.85 -43.91 97.9 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -69.0 -38.21 79.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.199 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 45.0 tp -62.35 -38.34 89.14 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.79 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -56.55 -44.26 80.74 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.197 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 20.4 m -62.13 -41.59 98.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.533 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.27 93.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.84 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . 0.413 ' O ' HG22 ' B' ' 286' ' ' VAL . 67.8 mt -63.04 -45.71 98.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.271 178.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . 0.496 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.9 OUTLIER -59.47 -45.84 90.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.05 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -63.91 -42.73 97.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.725 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -66.11 -39.58 90.04 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.54 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . 0.413 HG22 ' O ' ' B' ' 282' ' ' ILE . 97.9 t -65.78 -44.39 93.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.178 0.514 . . . . 0.0 110.01 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . 0.406 ' HZ2' ' CD ' ' B' ' 404' ' ' GLU . 87.9 tttt -63.28 -46.85 84.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.373 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 76.6 p -62.87 -42.78 99.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -64.05 -42.81 96.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 111.101 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.32 82.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.061 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . 0.434 ' O ' HG22 ' B' ' 295' ' ' VAL . 38.0 mm -65.28 -44.19 95.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.318 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . 0.406 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 18.1 tp10 -62.83 -43.48 98.67 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.972 0.415 . . . . 0.0 110.853 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.22 98.14 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.527 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 51.8 mt -63.25 -43.08 99.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.434 HG22 ' O ' ' B' ' 291' ' ' ILE . 84.1 t -65.34 -44.67 94.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.45 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . 0.406 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 67.3 mttm -64.35 -41.95 96.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.332 . . . . 0.0 111.685 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.88 82.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.651 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -127.6 96.6 4.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.643 0.259 . . . . 0.0 111.538 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -91.24 93.54 9.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.319 0.58 . . . . 0.0 109.591 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.0 tp -100.95 136.9 30.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.66 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.81 135.06 50.58 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.161 0.505 . . . . 0.0 110.54 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.08 134.09 20.59 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.194 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.58 134.98 67.16 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 122.353 2.035 . . . . 0.0 112.244 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.85 78.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.151 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.86 -45.2 82.61 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.002 0.43 . . . . 0.0 111.035 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.97 -43.08 88.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.93 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . 0.422 ' O ' HG13 ' B' ' 311' ' ' ILE . 71.7 mt -62.45 -49.55 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.731 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.22 -42.98 99.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.82 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 42.7 m -62.48 -45.84 91.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.903 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . 0.633 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 65.2 mm-40 -72.01 -36.68 69.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.473 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 85.0 mt -61.82 -43.94 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.569 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 25.2 t70 -60.99 -42.75 99.03 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.718 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.25 -42.65 91.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.655 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 91.0 mt -61.94 -39.9 93.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.813 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 84.1 mtm180 -62.62 -36.77 83.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.097 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 93.0 mtt180 -63.4 -39.81 95.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.576 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -63.16 -44.74 94.65 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.455 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.59 -39.66 88.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.749 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.84 92.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.4 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.9 -40.38 94.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.287 0.565 . . . . 0.0 110.143 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -72.38 -19.72 61.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.939 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -76.09 -6.78 52.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.744 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 136.85 -12.46 3.92 Favored Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.939 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 113.21 35.61 1.6 Allowed Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.102 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -76.48 123.26 25.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.978 0.418 . . . . 0.0 110.007 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . 0.401 ' CD ' ' HZ3' ' B' ' 327' ' ' LYS . 0.1 OUTLIER -125.25 160.43 29.26 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.517 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.1 OUTLIER 69.49 -52.24 0.61 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.157 0.583 . . . . 0.0 112.534 -178.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . 0.418 ' HG3' ' HB3' ' A' ' 65' ' ' ASP . 15.4 mm100 -74.82 -4.32 37.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.96 -24.7 64.6 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.354 0.597 . . . . 0.0 109.624 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . 0.411 HD13 HH12 ' B' ' 315' ' ' ARG . 39.1 tp -63.83 -33.89 76.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.623 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -80.99 -9.97 59.77 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.034 -177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . 0.415 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 93.9 mt -63.53 128.66 92.92 Favored Pre-proline 0 C--O 1.242 0.708 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.032 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.38 126.82 23.8 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.744 2.296 . . . . 0.0 113.025 -176.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -65.13 -44.03 89.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.062 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.89 -24.74 67.62 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.9 -8.02 57.65 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.829 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -121.21 -17.22 7.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.922 0.392 . . . . 0.0 111.506 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.05 -25.65 65.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.619 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.4 -51.53 68.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.822 0.344 . . . . 0.0 110.522 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -76.79 -23.06 52.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.124 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . 0.476 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -61.74 -40.59 95.65 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.121 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . 0.435 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.2 tttt -59.82 -45.3 92.78 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.89 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . 0.506 ' O ' HG23 ' B' ' 347' ' ' VAL . 19.0 mmt85 -62.94 -43.21 99.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.246 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . 0.478 ' NH2' HD22 ' B' ' 314' ' ' LEU . 90.8 mtt180 -64.62 -41.36 96.24 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.114 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 90.5 t -65.2 -44.16 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.588 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 342' ' ' LYS . 76.6 t -61.5 -43.62 97.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.802 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . 0.506 HG23 ' O ' ' B' ' 343' ' ' ARG . 70.4 t -60.22 -45.5 95.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.79 99.66 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.961 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 93.3 mt -63.28 -43.66 97.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.786 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.412 ' O ' HG21 ' B' ' 354' ' ' VAL . 97.6 mt -63.6 -45.64 89.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.967 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.1 -41.54 94.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.091 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.74 -42.86 99.81 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.115 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -67.48 -37.81 83.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.851 0.325 . . . . 0.0 110.948 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . 0.412 HG21 ' O ' ' B' ' 350' ' ' LEU . 70.9 t -61.0 -45.54 98.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.18 -44.68 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.915 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.6 -51.8 56.94 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 96.6 m -66.47 -45.83 78.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -86.58 -6.86 58.77 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -175.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 63.37 69.57 0.56 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.295 0.569 . . . . 0.0 111.516 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.1 mt -101.25 160.03 14.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.87 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -137.07 155.0 50.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.461 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.64 104.61 11.28 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 171.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 32.8 t70 -87.05 114.74 23.92 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -173.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 57.8 mm-40 -59.73 -36.63 76.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.059 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . 0.441 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 6.1 mm-40 -63.31 -42.51 99.03 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 111.013 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -63.24 -39.72 95.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.091 0.472 . . . . 0.0 110.072 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . 0.431 HG21 ' O ' ' B' ' 363' ' ' ASP . 70.5 t -62.81 -37.32 78.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.416 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.2 mmmt -57.4 -44.71 84.78 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.6 -38.85 96.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.082 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.76 -43.06 99.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.65 -44.19 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.095 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.51 -42.18 98.5 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.15 -37.65 81.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.894 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.4 ttm -65.83 -42.21 90.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.049 0.452 . . . . 0.0 110.719 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.28 72.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.044 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 50.6 m -71.6 -4.58 27.89 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.918 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -88.96 -4.02 58.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.877 0.37 . . . . 0.0 111.637 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -112.04 172.64 6.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.217 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.64 -48.38 72.35 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.717 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 21.4 t70 -127.82 116.4 20.78 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.041 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.48 -31.07 42.88 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.368 2.045 . . . . 0.0 113.165 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.1 -43.74 86.38 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 11.4 pt-20 -62.96 -38.86 92.8 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.891 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.91 -42.11 93.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.602 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.19 -44.19 98.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.413 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 36.7 mt-10 -64.95 -44.96 87.72 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.85 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.94 -45.77 89.62 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.16 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -66.59 -39.87 88.64 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.745 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 58.3 p -81.58 -3.36 53.1 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.3 mttt -104.13 13.34 32.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.003 0.43 . . . . 0.0 110.98 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -138.49 118.04 12.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.272 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.64 -41.52 98.24 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -56.17 -50.26 71.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.968 0.413 . . . . 0.0 110.93 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.07 -42.1 99.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.397 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.2 mtp -64.68 -53.94 39.49 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.05 -39.54 83.01 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -61.98 -40.67 96.41 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 48.6 tpp -65.26 -40.63 94.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.838 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' B' ' 395' ' ' MET . 66.8 mtm180 -64.06 -36.21 83.25 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.121 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -61.39 -42.84 99.37 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.728 0.299 . . . . 0.0 110.206 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.33 -44.85 94.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.447 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.98 -41.3 99.51 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.097 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.31 -40.09 96.39 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.649 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . 0.406 ' CD ' ' HZ2' ' B' ' 287' ' ' LYS . 38.0 tt0 -60.45 -43.44 96.85 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . 0.496 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 26.6 mt-10 -65.13 -38.17 89.79 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.616 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.73 -43.32 94.25 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 120.803 0.335 . . . . 0.0 110.38 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.95 90.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.224 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.32 -44.89 94.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.16 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 45.2 mt-10 -66.03 -33.12 75.07 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.004 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.02 96.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.386 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 95.4 t -67.45 -42.92 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.324 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.54 -41.21 97.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.002 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.83 -20.88 66.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.708 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -97.4 -6.87 33.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.301 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -111.21 179.98 3.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.267 0.556 . . . . 0.0 111.801 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.12 130.39 35.11 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.357 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 70.4 t -117.82 130.34 72.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 6.0 t -129.87 135.74 48.73 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.089 0.471 . . . . 0.0 110.674 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -93.32 123.56 36.69 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.238 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . 0.457 ' HZ1' ' CD ' ' B' ' 126' ' ' GLU . 8.9 ptmm? -138.88 133.41 31.91 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.807 0.337 . . . . 0.0 111.155 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -83.64 150.53 25.84 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.795 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -157.29 170.65 21.98 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 20.0 p -79.34 164.3 24.18 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.745 0.307 . . . . 0.0 110.284 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -64.33 -19.47 65.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.059 0.457 . . . . 0.0 111.009 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -61.31 -38.02 85.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.831 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -65.13 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.1 0.476 . . . . 0.0 110.238 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 8.2 mp -73.63 -20.47 60.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.7 mmt -78.25 -9.87 59.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -78.21 83.16 4.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.286 0.565 . . . . 0.0 109.841 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -106.09 4.02 28.72 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.532 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -67.47 -44.86 77.55 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.607 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.951 -179.536 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.235 0.295 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.8 m -125.43 97.33 5.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.896 0.379 . . . . 0.0 111.286 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.79 140.65 23.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.742 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.598 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 41.1 tt0 -145.18 169.95 17.18 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.6 t -103.93 157.16 17.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.806 0.276 . . . . 0.0 111.204 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.4 m -123.87 -71.19 0.73 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.835 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -153.56 120.76 5.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.45 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.74 -120.38 20.05 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.733 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 6.8 mp -87.75 -5.5 58.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -71.22 130.1 18.5 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.78 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 4.7 tpp180 -119.03 -161.81 0.87 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -146.38 128.32 15.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.29 -94.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.056 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 m 52.89 87.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.12 0.486 . . . . 0.0 111.603 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 tp -108.65 139.2 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.935 0.398 . . . . 0.0 111.567 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.6 m -106.65 125.73 51.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.1 pt -127.83 157.87 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.703 0.287 . . . . 0.0 111.587 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.537 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -77.3 161.83 27.78 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.479 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.03 -49.06 76.99 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.09 -34.7 78.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.961 0.41 . . . . 0.0 110.608 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -62.21 -40.1 94.97 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.758 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.3 mt -62.13 -48.96 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.168 0.508 . . . . 0.0 110.812 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.51 ' CD ' ' HZ2' ' A' ' 29' ' ' LYS . 39.3 tp10 -67.64 -40.11 84.6 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.008 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -79.65 -67.73 0.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.37 79.28 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -172.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 98.0 t -61.81 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.688 0.28 . . . . 0.0 111.694 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HZ2' ' CD ' ' A' ' 25' ' ' GLU . 12.2 ttmm -63.4 -44.89 93.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.032 0.444 . . . . 0.0 110.306 -178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.5 m -62.79 -42.24 99.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.254 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -63.51 -36.41 83.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.776 0.322 . . . . 0.0 110.584 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.2 mt -62.48 -43.55 98.54 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.706 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.46 -35.02 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.936 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -63.49 -43.07 98.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.46 -29.32 34.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.923 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.95 -39.7 87.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.004 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.43 -21.55 58.1 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.075 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.81 -44.45 96.85 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.06 0.457 . . . . 0.0 109.876 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.4 t -91.75 -2.33 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.075 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 63.37 26.81 15.12 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.998 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -101.12 7.64 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.578 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -63.57 -33.56 75.87 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.952 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.53 -0.58 67.96 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.749 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -94.47 -3.74 49.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.764 0.316 . . . . 0.0 111.192 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -88.04 122.66 31.88 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -66.92 -7.24 20.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -173.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.55 -34.95 3.7 Favored Glycine 0 C--N 1.315 -0.62 0 C-N-CA 120.381 -0.914 . . . . 0.0 114.212 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -63.69 133.87 54.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 117.49 0.645 . . . . 0.0 109.36 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.478 HG11 HG12 ' A' ' 54' ' ' VAL . 20.0 t 64.27 72.62 0.5 Allowed Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.55 ' O ' HG11 ' A' ' 54' ' ' VAL . 58.8 Cg_endo -69.62 161.42 45.98 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.381 2.72 . . . . 0.0 113.691 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.491 ' HA ' HG21 ' A' ' 54' ' ' VAL . 49.3 mtt -62.32 -34.65 77.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -175.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.502 ' HA ' ' HZ1' ' A' ' 29' ' ' LYS . 32.8 p-10 -62.96 -25.61 68.44 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.541 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -92.73 -39.6 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.183 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 50' ' ' PRO . 8.6 m -62.59 -33.05 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 120.659 0.266 . . . . 0.0 111.118 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.43 -32.9 72.88 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.707 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -100.33 -34.35 10.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.619 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -65.54 -43.08 91.08 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -125.61 20.54 7.87 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.737 0.303 . . . . 0.0 111.117 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.649 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -57.38 -45.64 92.69 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 114.536 0.575 . . . . 0.0 114.536 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.02 -19.64 20.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 117.538 0.669 . . . . 0.0 111.369 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 t -63.13 -44.68 94.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.125 -177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.5 p -120.58 19.47 5.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.496 0.665 . . . . 0.0 110.702 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.649 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 39.5 ttm180 -58.12 -29.51 65.57 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.627 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -61.08 -50.48 73.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.538 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.99 -20.74 57.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.046 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.7 t -63.66 -44.2 98.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 99.2 mt -62.63 -40.43 96.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.173 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.2 -43.85 98.54 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.283 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.713 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 37.2 t70 -64.16 -43.23 95.81 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.983 0.391 . . . . 0.0 110.279 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 98.1 mt -61.11 -42.25 98.19 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.871 0.367 . . . . 0.0 110.265 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.3 ttp -61.4 -45.56 93.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.815 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 m -62.43 -44.62 95.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.042 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.713 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 37.6 mtp85 -65.86 -43.65 87.77 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.078 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -65.87 -40.5 91.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.061 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -61.17 -48.16 82.83 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.502 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.4 ' HA ' HG12 ' A' ' 79' ' ' ILE . 20.0 tt -68.53 -39.47 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.498 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.433 ' O ' ' HE3' ' A' ' 81' ' ' LYS . 10.6 t70 -62.35 -41.68 98.78 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.332 0.587 . . . . 0.0 109.431 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -66.05 -45.62 80.74 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.703 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.4 HG12 ' HA ' ' A' ' 76' ' ' ILE . 40.2 pt -65.46 -29.75 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.933 -176.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.26 -44.22 97.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.096 0.474 . . . . 0.0 110.766 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 77' ' ' ASP . 16.2 ptpt -81.79 -24.41 35.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.59 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -87.82 -5.96 58.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.99 0.424 . . . . 0.0 110.437 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 64.2 40.55 6.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.669 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.4 mt -101.75 118.82 49.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.408 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -107.7 102.29 44.24 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.153 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.87 141.59 65.74 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.517 2.145 . . . . 0.0 112.159 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.98 90.5 8.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.375 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.1 -109.89 3.49 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.029 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.14 127.62 24.27 Favored Pre-proline 0 C--N 1.318 -0.775 0 O-C-N 122.852 -0.205 . . . . 0.0 110.991 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.64 161.39 45.42 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.737 2.291 . . . . 0.0 111.298 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -93.61 116.09 28.58 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.316 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.441 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 93.0 m-85 -94.11 127.66 40.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.62 98.31 36.58 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 120.893 0.377 . . . . 0.0 111.334 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 90.6 Cg_endo -97.3 171.69 0.77 Allowed 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 123.471 2.78 . . . . 0.0 110.981 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.66 -175.97 22.4 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.46 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -85.07 135.07 34.15 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -90.95 125.34 35.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.391 0.615 . . . . 0.0 110.876 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -113.49 124.05 51.48 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.1 tp -69.77 123.51 21.62 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.32 -16.3 56.91 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.231 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -113.34 178.83 4.14 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -86.44 168.64 13.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.972 0.415 . . . . 0.0 111.549 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -124.0 146.88 48.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.094 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.0 m -131.54 143.21 50.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.958 0.408 . . . . 0.0 111.241 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -138.43 154.12 48.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.558 ' O ' HG13 ' A' ' 107' ' ' VAL . 21.1 m -93.79 -74.87 0.52 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -175.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 65.41 142.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 124.012 0.925 . . . . 0.0 110.119 -172.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 42.8 mt-10 -119.87 129.9 54.61 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -164.17 146.01 8.82 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 64.31 158.76 0.09 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 175.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.48 156.42 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.548 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -158.19 106.12 1.71 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -82.9 151.63 14.41 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.897 2.398 . . . . 0.0 113.983 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -123.36 145.74 48.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.44 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.75 131.04 73.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.779 0.323 . . . . 0.0 111.801 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -108.22 -85.49 0.52 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.815 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.9 mt 57.44 114.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -132.34 153.66 50.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.146 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.06 19.16 70.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.52 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.43 -41.28 98.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.135 0.493 . . . . 0.0 111.079 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -73.9 -4.72 36.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.565 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -105.41 16.27 25.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.794 0.33 . . . . 0.0 110.99 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 89.7 mt -90.86 122.48 42.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.135 0.493 . . . . 0.0 111.091 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -110.47 124.06 51.06 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.54 133.91 62.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.772 0.32 . . . . 0.0 111.425 -175.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.38 134.0 36.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.54 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -128.0 98.2 27.76 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.871 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.86 126.95 11.76 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.358 2.039 . . . . 0.0 112.386 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.2 mm -109.94 120.92 61.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.622 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.59 162.55 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.334 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -136.7 149.85 48.13 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.088 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.2 t -76.03 127.48 37.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.2 p -113.84 177.25 4.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.245 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -63.29 -34.75 78.37 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.719 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.03 90.91 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.402 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -63.47 -41.99 98.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.572 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.44 -45.5 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.403 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.93 -43.12 99.06 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.543 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.81 99.72 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.307 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.578 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 3.3 tpt -62.65 -46.93 85.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.846 0.355 . . . . 0.0 110.621 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.75 -42.04 97.9 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.598 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -62.14 -43.32 99.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.148 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.7 m -62.66 -41.55 99.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.151 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.2 mt -61.23 -42.67 99.0 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -71.26 -22.17 62.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.369 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.77 -0.55 54.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.519 0.676 . . . . 0.0 110.077 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -116.47 20.95 13.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.954 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -122.33 95.68 4.74 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.52 ' HB2' ' OE1' ' A' ' 159' ' ' GLU . . . -140.68 159.08 42.98 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 173.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.575 HG21 ' O ' ' A' ' 247' ' ' GLU . 6.9 m -122.37 142.82 50.11 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.194 -1.003 . . . . 0.0 112.055 -175.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 41.0 p-90 -74.43 132.12 41.67 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.253 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 244' ' ' GLU . 64.5 tttp -162.84 -63.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 242' ' ' GLU . 40.8 mt-10 -116.17 -96.28 0.46 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -176.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' ' 155' ' ' ASP . 23.3 tptm -92.34 -113.34 0.09 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -167.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 3.5 t70 -152.84 154.93 36.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.529 -172.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 164.22 -34.61 0.28 Allowed Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -152.76 140.2 19.65 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.9 125.98 61.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.225 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.52 ' OE1' ' HB2' ' A' ' 149' ' ' ALA . 4.4 mp0 -88.48 158.86 18.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.22 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -83.39 52.62 2.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.826 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -162.53 9.1 0.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.181 0.515 . . . . 0.0 110.665 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 163' ' ' ARG . 15.8 t70 -104.12 -172.89 2.19 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.528 -175.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.431 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 42.8 ttm180 -121.96 117.44 26.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.601 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.11 130.03 63.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.449 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 55.9 m -86.76 117.56 25.59 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 83.5 mt -126.89 123.04 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.099 0.476 . . . . 0.0 111.702 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -95.13 105.47 17.4 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -124.52 149.58 46.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.476 0.655 . . . . 0.0 112.438 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.5 m -124.52 128.37 48.85 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.423 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.63 142.98 18.95 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.887 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 m -139.53 146.25 39.69 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.54 -86.21 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.328 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -99.44 -45.65 5.76 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.026 0.441 . . . . 0.0 110.003 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.2 15.29 0.23 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.766 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -138.81 148.63 44.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.561 0.219 . . . . 0.0 110.564 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.91 161.79 30.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.468 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -131.31 177.55 7.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.033 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.86 -35.19 72.55 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -105.39 -172.59 24.01 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.863 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.68 32.54 41.01 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.502 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -113.47 114.57 26.74 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.99 146.47 49.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.947 0.404 . . . . 0.0 111.534 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -143.03 122.08 12.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.727 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 59.99 34.82 21.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.665 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -89.08 132.52 34.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.847 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 88.3 t -96.19 124.46 48.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.901 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 63.5 tp -111.5 123.96 51.31 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.019 0.438 . . . . 0.0 111.285 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -111.22 112.23 23.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 73.0 mtm -84.64 160.04 20.46 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.684 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.34 -24.83 28.99 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.411 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -91.36 -6.34 53.12 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.25 46.12 13.47 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.035 -1.079 . . . . 0.0 111.662 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -85.44 -11.75 53.62 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.22 170.51 12.92 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.425 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.2 mp -55.66 132.31 71.92 Favored Pre-proline 0 C--N 1.323 -0.559 0 O-C-N 123.385 0.428 . . . . 0.0 110.063 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -48.36 129.31 19.16 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.264 1.976 . . . . 0.0 111.681 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.68 -33.86 5.91 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.699 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -62.27 -44.7 95.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.602 0.239 . . . . 0.0 110.655 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.56 -40.55 95.76 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.93 -33.25 75.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.006 0.431 . . . . 0.0 110.847 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.03 -22.77 70.82 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.183 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.16 -43.46 97.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -52.17 115.78 1.89 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.446 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 113.78 -10.81 23.22 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.188 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.612 ' HA ' ' OE1' ' A' ' 209' ' ' GLU . 47.7 m80 -98.6 139.03 34.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.036 0.418 . . . . 0.0 111.201 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -98.26 168.94 9.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.62 132.16 48.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.5 33.13 61.35 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.118 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.612 ' OE1' ' HA ' ' A' ' 205' ' ' HIS . 41.9 tt0 -117.86 117.37 29.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.173 0.511 . . . . 0.0 110.388 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -105.1 130.81 53.2 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.815 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -153.36 -23.02 0.15 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 234' ' ' ALA . 80.4 p 60.05 167.88 0.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.776 0.831 . . . . 0.0 112.031 -175.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 19.2 tt -160.41 144.68 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.225 -0.297 . . . . 0.0 110.896 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.99 108.46 15.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.805 0.336 . . . . 0.0 111.381 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.55 122.54 64.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 16.3 p -90.36 -22.69 21.38 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -173.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 70.6 m-85 67.89 140.37 0.07 OUTLIER Pre-proline 0 N--CA 1.483 1.219 0 CA-C-O 121.068 0.461 . . . . 0.0 111.581 -176.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 14.4 Cg_exo -69.54 150.4 69.52 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.455 2.103 . . . . 0.0 112.0 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.422 ' O ' ' HE2' ' A' ' 227' ' ' LYS . 81.0 mm-40 -66.56 -38.56 87.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.992 0.425 . . . . 0.0 110.171 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -86.45 33.3 0.63 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.732 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.482 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 10.9 t80 -70.01 131.4 44.3 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -65.02 -17.23 64.26 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.482 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -98.95 99.62 10.69 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 38.9 tt0 -56.52 -33.07 65.69 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.897 -175.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -66.24 -18.41 65.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.904 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.24 -1.11 9.25 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 14.1 ptmm? -67.81 121.44 15.99 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.397 0.617 . . . . 0.0 112.301 -175.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 82.06 8.43 86.56 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.589 -0.732 . . . . 0.0 114.097 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -118.48 137.94 52.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.528 0.664 . . . . 0.0 110.879 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -91.21 155.4 18.61 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.49 144.57 32.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.733 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 3.4 mppt? -98.74 -15.82 19.19 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 56.37 -149.96 0.45 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.133 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.434 ' HA ' HG23 ' A' ' 212' ' ' THR . . . -141.0 -68.43 0.4 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.753 0.311 . . . . 0.0 110.56 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.2 mt 64.74 91.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.954 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -98.19 -27.68 14.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.291 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.0 tp 52.1 67.01 1.04 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.882 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -65.34 -43.44 90.87 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.424 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 30.7 mtpp -96.98 -80.02 0.45 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -173.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 85.4 t 77.96 139.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -171.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -91.6 -84.05 0.27 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -172.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 153' ' ' GLU . 43.0 tt0 -165.23 103.8 0.75 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 19.6 ttm-85 -166.81 113.92 0.82 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 175.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -177.92 155.24 0.97 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 42.3 tp 67.89 100.8 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.321 0 O-C-N 124.135 0.897 . . . . 0.0 111.18 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.01 111.93 2.8 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.229 1.953 . . . . 0.0 112.889 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.575 ' O ' HG21 ' A' ' 150' ' ' THR . 44.5 tt0 -137.13 147.64 46.14 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.5 mp -73.48 98.88 2.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.984 0.421 . . . . 0.0 111.108 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.9 p -95.24 -89.02 0.25 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.428 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -170.79 -51.41 0.02 OUTLIER 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.9 0.381 . . . . 0.0 111.342 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -81.14 89.39 5.99 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.994 0.426 . . . . 0.0 111.882 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.476 ' CD1' HG22 ' A' ' 253' ' ' ILE . 51.5 p90 -159.02 -13.48 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.214 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.476 HG22 ' CD1' ' A' ' 252' ' ' PHE . 19.0 pt -121.17 -41.28 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.022 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -83.36 -2.95 56.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.35 0.595 . . . . 0.0 110.327 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -124.7 98.26 5.64 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -148.72 -61.2 0.24 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -166.0 -75.64 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.54 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 68.0 t -104.25 117.74 50.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 122.832 -0.216 . . . . 0.0 111.12 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 58.1 -170.0 0.11 Allowed 'General case' 0 CA--C 1.544 0.733 0 O-C-N 123.989 0.806 . . . . 0.0 110.656 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -104.7 112.71 25.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.323 0.582 . . . . 0.0 109.789 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -98.01 167.72 23.02 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.203 -0.998 . . . . 0.0 113.774 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 56.1 p -108.63 -167.39 1.22 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.91 -54.17 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.358 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.3 -38.81 29.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.26 98.18 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.634 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.488 ' O ' HG22 ' A' ' 270' ' ' VAL . 49.0 tp -63.89 -43.21 96.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.555 0.216 . . . . 0.0 110.59 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -63.54 -40.41 96.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.391 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.23 -44.11 89.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.802 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -68.07 -38.12 82.04 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.133 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 266' ' ' LEU . 79.3 t -64.0 -43.35 97.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.656 0.265 . . . . 0.0 110.507 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -59.27 -46.37 88.71 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.993 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.5 ptmt -66.34 -44.49 83.15 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -63.95 -39.47 94.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 270' ' ' VAL . 99.3 mmm -64.47 -40.67 96.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.76 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.99 -35.3 79.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 110.795 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -62.71 -41.77 99.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.759 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -64.61 -37.49 87.75 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.734 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 46.0 tp -61.83 -38.29 87.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.876 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -57.58 -45.53 85.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.861 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.9 m -62.35 -42.39 99.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.605 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.13 82.95 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.057 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.85 -43.73 97.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.297 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.452 ' HD3' ' HG2' ' A' ' 405' ' ' GLU . 1.4 tpm_? -59.54 -46.99 87.27 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.022 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -65.61 -40.69 92.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.398 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -61.09 -43.34 99.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.26 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.43 -44.12 90.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.348 0.594 . . . . 0.0 110.19 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.439 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.5 tttt -62.05 -48.84 78.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.264 -177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.9 p -64.63 -41.38 96.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -65.86 -42.3 90.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.46 -47.23 82.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.959 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 287' ' ' LYS . 48.0 mm -64.57 -44.18 96.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.41 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.414 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 17.1 tp10 -60.16 -45.11 94.21 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 110.681 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.74 -42.7 98.51 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.246 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.48 -41.69 96.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 291' ' ' ILE . 71.3 t -63.16 -45.09 99.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.452 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . 0.414 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.7 mttm -63.83 -42.54 97.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 111.064 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.32 -42.7 62.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -118.75 92.52 3.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -98.54 99.22 10.35 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -106.1 159.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.742 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -64.13 137.5 57.99 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.22 128.52 25.54 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.242 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.439 ' O ' HG13 ' A' ' 307' ' ' ILE . 47.0 Cg_exo -56.6 128.5 30.3 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.344 2.029 . . . . 0.0 111.712 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.37 83.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.735 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.5 -41.53 90.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.9 mt -67.88 -41.65 82.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 311' ' ' ILE . 69.4 mt -61.93 -51.27 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.704 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.85 -43.81 98.1 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 41.6 m -61.6 -45.47 93.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.601 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.67 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 72.9 mm-40 -71.58 -34.1 69.64 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 307' ' ' ILE . 95.1 mt -61.4 -43.79 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.663 0.268 . . . . 0.0 110.723 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 32.7 t70 -62.3 -40.98 98.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.1 t -62.98 -44.67 99.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.275 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 46.1 mt -63.03 -39.39 94.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.956 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 83.9 mtm180 -63.08 -39.82 95.84 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.902 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 84.3 mtt180 -66.02 -38.98 89.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.786 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.58 -43.02 99.86 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.109 0.481 . . . . 0.0 109.943 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.49 -36.62 79.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.326 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.423 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . . . -62.54 -36.94 84.2 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.628 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -62.07 -42.29 99.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.434 0.635 . . . . 0.0 109.876 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -78.23 -6.96 56.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.599 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -91.37 -3.74 56.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.313 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 135.33 -21.41 3.65 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.519 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 118.15 34.11 1.17 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.455 -0.878 . . . . 0.0 111.241 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.46 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 42.0 t-20 -71.97 126.87 30.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . 0.588 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.7 tm-20 -127.8 150.57 49.77 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 6.5 ptpp? 61.94 -39.38 0.14 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.667 1.587 . . . . 0.0 114.057 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.46 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 16.0 mm100 -71.79 -11.58 60.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.271 0.558 . . . . 0.0 110.438 177.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.69 -21.23 66.28 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.987 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.443 HD11 HH12 ' A' ' 315' ' ' ARG . 63.1 tp -62.54 -37.48 86.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.131 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -80.97 -2.85 49.5 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.864 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 74.8 mt -69.42 149.08 97.26 Favored Pre-proline 0 C--O 1.239 0.541 0 O-C-N 122.265 -0.272 . . . . 0.0 110.394 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.6 143.77 99.46 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.658 2.239 . . . . 0.0 113.113 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 25.5 ttt85 -83.31 -42.17 17.44 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.808 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -57.99 -43.74 86.78 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.413 ' HB2' ' OE2' ' A' ' 224' ' ' GLU . 88.7 mt -85.74 -3.27 58.85 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.808 -176.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -104.64 -27.58 11.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.948 0.404 . . . . 0.0 110.151 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.1 -25.56 67.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.661 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -60.14 -48.04 83.38 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.845 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -80.79 -22.11 40.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.599 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.29 -41.95 99.03 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.429 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.467 ' O ' HG22 ' A' ' 346' ' ' VAL . 87.8 tttt -60.06 -46.2 90.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.16 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.537 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.0 mmt85 -62.01 -45.64 92.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.418 ' NH2' HD21 ' A' ' 314' ' ' LEU . 91.1 mtt180 -67.14 -38.09 84.94 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.451 -178.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 341' ' ' ALA . 78.7 t -64.44 -44.24 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.648 0.261 . . . . 0.0 110.599 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 342' ' ' LYS . 69.5 t -61.71 -43.34 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.572 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 343' ' ' ARG . 76.4 t -60.17 -45.2 96.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.9 -42.53 99.75 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.141 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.77 -44.75 92.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.659 0.266 . . . . 0.0 111.334 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.03 -46.71 83.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.275 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.26 -38.69 78.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.412 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.72 -42.92 96.6 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.196 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.08 -36.48 79.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.831 0.316 . . . . 0.0 110.881 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.81 -44.67 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.63 -44.23 98.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.841 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -69.87 -46.25 65.92 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.9 m -66.73 -44.98 80.12 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -90.71 4.77 50.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.967 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 53.06 47.61 24.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.109 0.48 . . . . 0.0 111.632 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.9 mt -73.37 140.26 46.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.877 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -119.86 153.63 35.53 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.851 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.13 110.04 15.16 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.459 ' O ' HG21 ' A' ' 367' ' ' VAL . 23.1 t70 -83.46 112.46 19.98 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.918 -174.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 15.7 mm-40 -59.36 -38.73 81.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.629 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.76 -42.85 90.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.431 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -62.33 -38.32 89.0 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 363' ' ' ASP . 99.0 t -64.42 -40.08 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.632 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.8 mmmt -56.65 -44.54 81.44 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.59 -40.14 98.35 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.197 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.97 -42.26 99.78 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.694 0.283 . . . . 0.0 110.639 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.13 -44.3 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.713 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.11 -39.23 89.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.45 -36.14 80.61 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.488 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 51.0 ttm -65.61 -39.8 91.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.103 0.478 . . . . 0.0 110.202 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.54 -29.79 70.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.86 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 13.2 m -72.53 -5.58 37.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.585 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.51 -8.73 52.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 0.0 110.843 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -107.36 171.09 7.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.235 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.28 -36.78 85.23 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.338 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -133.67 109.12 12.06 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 120.878 0.37 . . . . 0.0 110.736 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.96 -39.64 89.95 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.058 2.505 . . . . 0.0 113.728 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -64.36 -42.69 96.06 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.28 -37.96 87.5 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.061 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.24 -43.43 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.0 -44.94 99.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.463 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 53.9 mt-10 -68.75 -42.12 77.99 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.976 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -59.36 -46.52 88.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.828 0.347 . . . . 0.0 111.119 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.18 -41.43 94.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.664 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 32.9 p -80.23 -6.47 57.9 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 97.9 mttt -101.0 5.23 43.03 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.876 0.37 . . . . 0.0 111.0 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -126.06 119.38 27.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -62.62 -43.69 98.17 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -57.67 -49.82 75.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.762 0.315 . . . . 0.0 111.169 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.2 -42.64 99.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.545 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.2 mtp -65.44 -44.38 87.46 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.52 -42.23 71.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.459 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.99 -41.56 99.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.57 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 51.4 tpp -62.98 -41.37 99.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.843 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.444 ' HG2' HG23 ' A' ' 367' ' ' VAL . 73.4 mtm180 -65.38 -37.49 87.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.908 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.55 -44.32 96.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.41 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.65 -45.2 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.083 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.51 94.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.728 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 51.3 tp -63.08 -40.49 97.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.327 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.45 -42.56 98.95 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.598 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.452 ' HG2' ' HD3' ' A' ' 283' ' ' ARG . 29.0 mt-10 -64.96 -40.21 94.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.737 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -59.93 -41.67 92.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.554 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.33 87.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.024 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.58 -43.87 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.191 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.45 -33.58 76.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.439 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.77 98.21 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.98 0.419 . . . . 0.0 110.149 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 97.4 t -65.44 -43.07 94.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.329 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.17 -39.82 91.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -70.3 -13.02 61.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.462 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -108.83 3.04 22.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.102 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.37 173.27 6.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.337 0.589 . . . . 0.0 111.766 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -84.84 107.42 16.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.245 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.2 133.37 36.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.383 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.8 t -137.48 148.4 46.03 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.118 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -97.57 128.47 44.33 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.009 0.433 . . . . 0.0 110.965 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -134.52 127.98 32.44 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.627 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -101.16 144.12 30.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.388 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.4 t -152.4 -176.27 5.63 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.871 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.8 p -81.66 162.58 22.98 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.961 0.41 . . . . 0.0 110.836 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -67.89 -17.78 64.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.804 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -61.53 -41.67 97.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.928 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.39 -26.74 63.84 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.518 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.1 -21.35 59.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.158 0.504 . . . . 0.0 110.064 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.5 mmt -79.65 -7.11 58.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.997 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -80.48 87.39 5.69 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.503 0.668 . . . . 0.0 109.659 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -120.73 30.43 6.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.105 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -65.9 -37.14 85.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.948 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.753 179.551 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.553 0.216 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -83.77 101.29 11.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.82 160.55 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.928 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -114.42 106.59 14.48 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.858 0.361 . . . . 0.0 110.777 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -155.55 136.99 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.61 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.574 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 43.5 tt0 -142.99 169.27 17.88 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.0 t -101.02 153.8 19.24 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 117.705 0.23 . . . . 0.0 111.218 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 57.7 m -120.44 -65.76 1.12 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -162.1 123.95 2.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.465 0.174 . . . . 0.0 110.549 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.1 -120.09 18.46 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.814 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' B' ' 108' ' ' GLU . 6.8 mp -89.23 -5.86 57.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' B' ' 107' ' ' VAL . . . -70.52 132.57 22.82 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.088 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.574 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 3.5 tpp180 -121.25 -162.64 0.98 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -145.45 127.78 15.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.64 -94.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.135 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m 52.28 89.29 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.202 0.525 . . . . 0.0 111.479 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 tp -111.22 136.29 47.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.014 0.435 . . . . 0.0 111.693 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 46.1 m -101.72 126.9 48.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 17.2 pt -126.24 160.8 33.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.869 0.366 . . . . 0.0 111.794 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.566 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -81.02 161.27 24.29 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.333 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.81 77.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.322 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -65.8 -35.62 81.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.999 0.428 . . . . 0.0 110.407 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -63.01 -40.13 96.84 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.02 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.566 HG13 ' O ' ' B' ' 20' ' ' ALA . 74.8 mt -61.52 -48.65 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.328 0.585 . . . . 0.0 110.552 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.553 ' CD ' ' HZ2' ' B' ' 29' ' ' LYS . 40.7 tp10 -68.72 -44.39 73.98 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.133 -177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 12.3 m -77.69 -56.86 4.17 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.11 -46.84 55.1 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 97.6 t -63.03 -45.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.553 ' HZ2' ' CD ' ' B' ' 25' ' ' GLU . 12.7 ttmm -62.92 -45.7 91.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.993 0.425 . . . . 0.0 110.695 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 20.8 m -64.42 -36.64 84.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.287 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.4 -39.91 92.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.213 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.41 -43.24 99.3 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.714 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -70.3 -37.7 71.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.181 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.47 -41.39 96.53 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.19 -32.22 50.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.804 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.23 -40.99 94.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.021 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.03 -28.21 65.29 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.402 177.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.52 -44.35 89.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.69 -3.33 9.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.358 0.599 . . . . 0.0 109.939 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 63.67 27.48 14.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.909 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.9 pp -103.18 6.94 10.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.056 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -64.83 -29.15 70.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.951 0.405 . . . . 0.0 110.888 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.82 -2.62 82.12 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.603 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -92.98 -4.17 53.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.696 0.284 . . . . 0.0 111.533 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -87.37 128.93 35.19 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -73.78 -2.31 22.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -173.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.97 -37.23 2.84 Favored Glycine 0 C--N 1.314 -0.69 0 C-N-CA 120.473 -0.87 . . . . 0.0 114.246 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -61.26 132.48 53.75 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 117.482 0.641 . . . . 0.0 109.525 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.496 HG11 HG12 ' B' ' 54' ' ' VAL . 21.3 t 64.5 71.69 0.55 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -172.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.526 ' O ' HG11 ' B' ' 54' ' ' VAL . 59.0 Cg_endo -69.59 161.4 46.06 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.373 2.715 . . . . 0.0 113.755 -176.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.508 ' HA ' HG21 ' B' ' 54' ' ' VAL . 50.6 mtt -61.94 -33.97 75.24 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . 0.445 ' HA ' ' HZ1' ' B' ' 29' ' ' LYS . 31.7 p-10 -63.14 -24.43 67.89 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.552 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 99.1 mt -95.45 -38.9 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.465 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.526 HG11 ' O ' ' B' ' 50' ' ' PRO . 10.2 m -62.46 -33.78 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.329 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.421 ' O ' ' HA3' ' B' ' 59' ' ' GLY . . . -60.33 -32.91 71.69 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.645 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -100.64 -34.05 10.04 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.688 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -65.7 -42.82 90.73 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -126.33 19.03 7.56 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.682 0.277 . . . . 0.0 110.979 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.639 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -57.21 -47.97 83.64 Favored Glycine 0 C--O 1.222 -0.629 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.281 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.8 -23.14 22.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.283 0.541 . . . . 0.0 111.683 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -62.08 -45.65 92.57 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.149 -176.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.514 ' O ' HG23 ' B' ' 66' ' ' VAL . 10.5 p -119.11 21.45 5.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.545 0.688 . . . . 0.0 110.592 -177.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.639 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 35.1 ttm180 -59.86 -26.65 66.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.737 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -63.33 -49.59 73.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.451 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . 0.43 ' HB2' HG21 ' B' ' 62' ' ' VAL . 2.9 m-20 -75.84 -21.52 57.17 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.027 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.514 HG23 ' O ' ' B' ' 62' ' ' VAL . 79.6 t -63.24 -44.1 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.5 -40.39 96.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.345 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.53 -43.27 99.26 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.361 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . 0.756 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 37.6 t70 -64.06 -43.63 94.89 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 117.085 0.442 . . . . 0.0 110.192 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.15 -42.64 98.92 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 110.245 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.5 ttp -60.92 -45.31 95.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.862 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -62.34 -44.69 95.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.117 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.756 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 34.2 mtp85 -66.66 -43.16 85.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.046 -176.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -65.13 -40.97 95.18 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.88 0.371 . . . . 0.0 111.073 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.3 -48.25 82.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.499 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 20.1 tt -68.51 -38.75 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.36 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.91 -41.92 99.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.185 0.516 . . . . 0.0 109.81 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' B' ' 81' ' ' LYS . . . -66.08 -45.57 80.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.595 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 46.0 pt -64.95 -30.67 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.99 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.59 -44.32 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.019 0.437 . . . . 0.0 110.773 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' B' ' 78' ' ' ALA . 16.4 ptpt -81.03 -28.71 35.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.633 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -81.82 -6.88 59.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.971 0.415 . . . . 0.0 110.248 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 65.5 38.87 5.36 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.509 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.407 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 84.4 mt -100.58 118.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.678 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -106.78 100.88 33.79 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.356 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 24.0 Cg_exo -63.63 139.83 71.74 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.591 2.194 . . . . 0.0 112.208 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.64 94.13 8.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.024 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.92 -125.34 7.15 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.642 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.67 127.19 27.1 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-O 120.517 0.199 . . . . 0.0 110.935 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.77 158.11 53.88 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.618 2.212 . . . . 0.0 110.98 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 54.2 m -92.2 118.84 31.26 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.189 0.518 . . . . 0.0 110.744 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.466 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.7 m-85 -98.14 125.35 43.12 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.42 102.09 42.39 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-O 120.899 0.381 . . . . 0.0 110.971 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.8 Cg_endo -96.75 -167.81 0.12 Allowed 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 123.228 2.619 . . . . 0.0 110.854 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -130.36 -176.28 14.36 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -86.06 126.89 34.51 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -85.76 127.95 34.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.095 0.474 . . . . 0.0 110.852 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -113.63 140.99 47.74 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 38.0 tp -85.56 112.06 20.59 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.16 -177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.85 -7.68 27.62 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.688 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -120.37 172.63 7.67 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -82.16 168.44 17.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.297 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -121.28 143.68 49.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.45 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 85.6 m -125.67 136.86 53.68 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.007 0.432 . . . . 0.0 111.601 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -134.71 154.22 51.65 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.555 ' O ' HG13 ' B' ' 107' ' ' VAL . 21.4 m -95.97 -74.17 0.57 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . 0.555 HG13 ' O ' ' B' ' 106' ' ' SER . 0.3 OUTLIER 65.36 142.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.9 0.88 . . . . 0.0 110.251 -172.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' B' ' 11' ' ' LEU . 45.2 mt-10 -119.18 130.79 55.69 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -173.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -164.62 143.67 7.1 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.759 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.66 157.19 0.06 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 m -136.04 162.29 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.75 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -161.5 106.26 1.2 Allowed Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.399 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.29 154.43 41.12 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.261 2.64 . . . . 0.0 113.923 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -127.54 142.63 51.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.078 0.951 . . . . 0.0 108.77 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 64.2 t -126.77 131.68 70.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.847 0.356 . . . . 0.0 111.746 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -110.67 -86.22 0.54 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.699 176.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 97.5 mt 59.32 121.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -137.6 157.39 46.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.147 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.48 19.63 77.85 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.909 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.91 -39.91 95.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.282 0.563 . . . . 0.0 110.672 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -74.25 -5.71 43.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.346 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -105.82 17.28 23.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.94 0.4 . . . . 0.0 110.93 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 86.9 mt -91.62 119.39 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.242 0.544 . . . . 0.0 111.199 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -108.52 122.8 47.81 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.43 135.5 57.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.625 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -78.7 138.6 38.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.568 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -133.28 97.75 16.04 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.73 121.12 6.8 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.232 1.955 . . . . 0.0 112.418 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.8 mm -105.67 116.01 48.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.859 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.82 163.49 37.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.352 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -136.51 156.77 48.12 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.96 125.84 39.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.4 p -111.89 175.08 5.57 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.458 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.02 -36.59 82.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.4 82.97 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.635 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.86 -42.09 97.63 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.367 0.604 . . . . 0.0 109.569 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.78 -45.43 98.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.517 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.3 -43.01 99.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.867 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.58 -41.94 99.75 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.449 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' MET . . . . . 0.557 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 3.5 tpt -62.55 -46.76 86.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.796 0.332 . . . . 0.0 110.452 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.52 -41.66 98.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.3 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.67 -44.19 96.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.318 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.9 m -62.83 -41.92 99.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.261 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.3 mt -60.9 -42.57 98.28 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -70.93 -20.44 62.47 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.451 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.68 1.28 54.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.375 0.607 . . . . 0.0 110.096 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.5 23.57 11.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.817 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -125.31 86.27 2.52 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . 0.504 ' HB2' ' OE1' ' B' ' 159' ' ' GLU . . . -131.54 159.42 38.22 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 172.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' THR . . . . . 0.558 HG21 ' O ' ' B' ' 247' ' ' GLU . 6.3 m -121.1 143.39 49.11 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.112 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . 0.553 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 44.7 p-90 -74.74 132.28 41.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.034 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . 0.49 ' HG2' ' HG3' ' B' ' 153' ' ' GLU . 65.1 tttp -163.19 -64.71 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . 0.49 ' HG3' ' HG2' ' B' ' 152' ' ' LYS . 64.3 mt-10 -117.42 -92.6 0.52 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' B' ' 155' ' ' ASP . 22.2 tptm -94.5 -117.85 0.1 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -169.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . 0.424 ' N ' ' HG3' ' B' ' 154' ' ' LYS . 14.2 t70 -147.52 154.87 41.28 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 122.923 0.489 . . . . 0.0 110.85 -174.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 166.21 -34.56 0.23 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.238 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.35 140.44 18.4 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' B' ' 243' ' ' ARG . 59.3 t -129.35 127.5 65.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.354 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . 0.504 ' OE1' ' HB2' ' B' ' 149' ' ' ALA . 4.7 mp0 -88.38 159.2 18.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.184 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.26 49.3 1.63 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.776 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -158.49 6.39 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.78 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' B' ' 163' ' ' ARG . 13.1 t70 -102.53 -170.38 1.8 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.601 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . 0.504 ' H ' ' CG ' ' B' ' 162' ' ' ASP . 42.7 ttm180 -124.13 117.98 25.88 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.115 0.566 . . . . 0.0 110.727 -176.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.29 128.49 64.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.289 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 73.1 m -84.23 116.9 23.19 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 87.3 mt -126.27 124.52 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.126 0.489 . . . . 0.0 111.835 -176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . 0.453 ' OD2' ' HA ' ' B' ' 183' ' ' SER . 6.2 m-20 -95.24 109.35 21.48 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -127.67 150.54 49.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.444 0.64 . . . . 0.0 112.439 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.6 m -124.88 128.05 48.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.571 177.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.7 141.06 20.8 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.747 -0.74 . . . . 0.0 113.672 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 41.1 m -141.02 144.27 34.9 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 42.0 t -84.44 -83.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.94 0.4 . . . . 0.0 110.841 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -105.38 -40.58 5.77 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.18 0.514 . . . . 0.0 110.054 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.5 21.05 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.259 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -142.8 149.6 38.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 120.779 0.323 . . . . 0.0 110.404 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.41 151.49 32.73 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.976 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -120.69 -179.23 3.93 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.457 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.52 -42.54 87.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.03 -172.07 31.32 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.972 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.37 29.65 48.64 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.551 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -110.48 113.81 26.73 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -137.39 147.02 45.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.042 0.449 . . . . 0.0 111.59 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.453 ' HA ' ' OD2' ' B' ' 167' ' ' ASP . 67.8 m -146.51 129.41 16.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.313 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 58.56 31.85 21.49 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.564 0.54 . . . . 0.0 110.126 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -89.63 135.26 33.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.709 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 93.1 t -99.69 123.52 52.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.922 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.81 122.73 48.56 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.129 0.49 . . . . 0.0 111.457 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . 0.434 ' HB2' ' CZ ' ' B' ' 193' ' ' ARG . . . -111.33 111.6 22.76 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 73.9 mtm -83.86 163.69 19.93 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.303 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.54 -13.86 60.99 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.606 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -102.67 -8.22 21.09 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 79.15 48.56 6.83 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 119.928 -1.13 . . . . 0.0 111.403 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.434 ' CZ ' ' HB2' ' B' ' 188' ' ' ALA . 95.0 mtt180 -89.53 -10.35 46.5 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.51 170.32 13.87 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.06 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.468 ' H ' HD12 ' B' ' 195' ' ' ILE . 4.1 mp -54.84 133.18 66.43 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 123.347 0.404 . . . . 0.0 110.162 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -48.55 129.93 20.95 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.359 2.04 . . . . 0.0 111.776 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.04 -32.66 6.64 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.913 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -62.27 -44.38 96.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.677 0.275 . . . . 0.0 110.639 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.75 -40.63 97.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.734 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.85 -34.8 78.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.086 0.469 . . . . 0.0 110.676 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -63.52 -26.43 69.67 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.366 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.62 -43.35 98.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 109.676 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -50.86 119.59 4.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.477 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 108.2 -10.62 36.76 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.598 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.633 ' HA ' ' OE1' ' B' ' 209' ' ' GLU . 46.6 m80 -96.2 141.09 29.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.11 0.455 . . . . 0.0 111.422 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -100.46 166.69 10.81 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.8 131.98 51.63 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.02 27.55 70.19 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.701 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . 0.633 ' OE1' ' HA ' ' B' ' 205' ' ' HIS . 44.5 tt0 -112.27 111.7 22.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.273 0.559 . . . . 0.0 110.365 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.14 129.31 44.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.687 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -148.94 -26.51 0.3 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.455 HG23 ' HA ' ' B' ' 234' ' ' ALA . 50.8 p 60.67 160.33 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.935 0.894 . . . . 0.0 111.975 -176.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' B' ' 232' ' ' LYS . 18.9 tt -153.06 148.65 13.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 122.135 -0.353 . . . . 0.0 110.825 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -81.27 109.59 15.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.217 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 59.8 t -112.87 122.81 67.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 11.9 p -93.5 -21.62 19.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 68.12 137.4 0.05 OUTLIER Pre-proline 0 N--CA 1.482 1.142 0 CA-C-O 121.037 0.446 . . . . 0.0 111.75 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' B' ' 221' ' ' TYR . 16.5 Cg_exo -67.72 149.57 78.83 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.433 2.089 . . . . 0.0 112.006 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . 0.438 ' O ' ' HE2' ' B' ' 227' ' ' LYS . 75.1 mm-40 -66.71 -39.36 88.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.522 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -86.03 32.51 0.61 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.895 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 9.2 t80 -66.72 134.63 52.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -67.66 -15.32 63.59 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.448 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -101.18 105.0 16.09 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.42 ' OE1' ' HG2' ' B' ' 333' ' ' PRO . 42.1 tt0 -60.11 -33.24 71.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.672 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -66.82 -19.03 65.66 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.064 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.7 mt -121.39 0.62 10.05 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' B' ' 219' ' ' GLU . 14.9 ptmm? -68.34 119.27 12.58 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.48 0.657 . . . . 0.0 112.118 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.85 17.24 75.45 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.339 -0.846 . . . . 0.0 114.106 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -123.85 129.63 51.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.774 0.787 . . . . 0.0 111.182 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.39 153.16 29.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.005 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.96 143.55 31.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.315 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' B' ' 213' ' ' ILE . 3.9 mppt? -100.13 -14.31 18.6 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 55.45 -148.67 0.48 Allowed 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.346 0.404 . . . . 0.0 111.516 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.455 ' HA ' HG23 ' B' ' 212' ' ' THR . . . -142.75 -69.22 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.893 0.378 . . . . 0.0 110.496 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 86.2 mt 65.89 87.25 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.992 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -92.35 -27.09 17.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.19 176.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 12.3 tp 51.65 66.92 1.05 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.806 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -66.09 -43.09 88.27 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . 0.418 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 29.9 mtpp -97.14 -77.78 0.49 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -173.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' B' ' 239' ' ' LYS . 87.7 t 76.62 142.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -95.3 -86.15 0.3 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -173.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -163.53 104.13 0.94 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 119.876 -0.729 . . . . 0.0 112.79 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 19.0 ttm-85 -168.72 115.1 0.63 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.954 0.407 . . . . 0.0 111.949 175.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' B' ' 152' ' ' LYS . 0.1 OUTLIER -178.31 155.4 0.9 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 46.8 tp 67.95 100.13 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 124.041 0.838 . . . . 0.0 111.343 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.15 111.3 2.43 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.523 2.149 . . . . 0.0 112.717 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . 0.558 ' O ' HG21 ' B' ' 150' ' ' THR . 43.1 tt0 -135.18 148.74 49.78 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.39 94.54 3.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.803 0.335 . . . . 0.0 111.173 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 22.1 p -91.09 -88.22 0.19 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.599 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -172.75 -47.97 0.02 OUTLIER 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.952 0.406 . . . . 0.0 111.218 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.97 94.77 7.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.076 0.465 . . . . 0.0 111.839 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . 0.521 ' CD1' HG22 ' B' ' 253' ' ' ILE . 51.5 p90 -164.89 -22.43 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.464 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 253' ' ' ILE . . . . . 0.521 HG22 ' CD1' ' B' ' 252' ' ' PHE . 19.6 pt -110.93 -42.39 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -82.06 -7.59 59.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.481 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -121.22 97.61 5.6 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -149.96 -59.77 0.2 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.161 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -164.61 -84.18 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.636 -1.269 . . . . 0.0 113.54 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 66.4 t -99.0 121.25 49.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.472 0.177 . . . . 0.0 111.038 -177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 57.91 -169.41 0.12 Allowed 'General case' 0 CA--C 1.547 0.831 0 O-C-N 123.975 0.797 . . . . 0.0 110.439 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -106.1 114.63 28.88 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -100.64 164.03 18.76 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.108 -1.044 . . . . 0.0 114.057 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 33.8 p -105.85 -175.43 2.79 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.68 -49.26 85.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.06 -36.89 20.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.0 -43.36 97.49 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.731 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.473 ' O ' HG22 ' B' ' 270' ' ' VAL . 49.6 tp -63.57 -43.4 97.11 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 120.612 0.244 . . . . 0.0 110.618 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -61.71 -43.01 99.67 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.786 0.327 . . . . 0.0 111.153 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.49 -44.66 86.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.064 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -67.74 -37.21 81.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.915 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.473 HG22 ' O ' ' B' ' 266' ' ' LEU . 69.0 t -64.69 -43.08 96.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.595 0.236 . . . . 0.0 110.476 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -59.01 -46.82 87.23 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.4 ptmt -67.26 -43.66 81.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 0.0 111.62 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -64.48 -39.89 94.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.773 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.6 mmm -63.67 -42.06 98.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 110.736 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -68.97 -31.76 70.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.8 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -63.61 -41.78 98.28 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -65.8 -35.15 79.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.565 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 47.7 tp -61.95 -37.77 85.96 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.815 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -57.87 -44.98 86.97 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.805 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 19.4 m -61.86 -42.98 99.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.382 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.0 83.59 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.329 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.36 -44.12 98.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.795 0.331 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . 0.523 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.7 OUTLIER -60.14 -46.49 89.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.215 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -65.61 -40.29 92.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.523 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -60.69 -44.17 96.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.183 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.09 -44.62 91.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.177 0.513 . . . . 0.0 110.1 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . 0.467 ' HZ2' ' CD ' ' B' ' 404' ' ' GLU . 88.3 tttt -61.42 -48.17 82.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.856 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 74.8 p -65.01 -42.37 94.51 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -65.28 -42.88 92.72 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.025 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.63 -47.0 83.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.029 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . 0.459 ' O ' HG23 ' B' ' 295' ' ' VAL . 34.7 mm -64.41 -44.0 97.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.102 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -60.14 -46.19 90.49 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.925 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.24 -42.44 99.32 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.202 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.37 -41.46 96.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 291' ' ' ILE . 74.1 t -62.29 -45.33 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 O-C-N 123.114 0.259 . . . . 0.0 111.327 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -64.71 -41.95 95.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.852 0.358 . . . . 0.0 111.286 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.84 -39.65 63.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -121.7 82.92 2.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.63 94.44 9.03 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.9 tp -104.03 156.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.232 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.21 134.09 56.72 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 41.0 t -106.87 129.08 24.92 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.501 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . 0.417 ' O ' HG13 ' B' ' 307' ' ' ILE . 50.0 Cg_exo -55.92 128.3 29.67 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.427 2.085 . . . . 0.0 111.832 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.51 85.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.195 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.32 87.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.376 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.75 -41.88 95.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.786 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . 0.503 ' O ' HG13 ' B' ' 311' ' ' ILE . 69.1 mt -62.03 -49.88 82.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.502 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -42.33 99.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.55 -176.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.3 m -62.99 -45.85 90.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.97 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . 0.666 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 63.6 mm-40 -70.86 -34.02 71.22 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.503 HG13 ' O ' ' B' ' 307' ' ' ILE . 95.2 mt -61.46 -44.29 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.836 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.505 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 35.5 t70 -63.17 -39.89 95.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.985 0.421 . . . . 0.0 110.826 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.04 -43.8 97.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.458 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 56.7 mt -62.74 -39.34 93.79 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.864 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 81.5 mtm180 -63.23 -38.92 93.05 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 87.5 mtt180 -65.49 -39.55 92.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.729 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -63.25 -43.21 98.64 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.172 0.51 . . . . 0.0 110.183 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.81 80.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.237 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' B' ' 325' ' ' ASN . . . -62.5 -37.06 84.54 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.769 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -62.41 -42.41 99.41 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.567 0.699 . . . . 0.0 109.691 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.16 -6.98 56.44 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.702 -177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -89.75 -3.46 58.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.885 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.62 -33.93 2.42 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.099 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 133.27 43.21 0.15 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . 0.469 ' O ' ' HB3' ' B' ' 319' ' ' ALA . 42.5 t-20 -81.65 118.98 23.25 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.094 0.473 . . . . 0.0 109.861 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 2.4 tm-20 -120.53 151.28 39.59 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 5.7 ptpp? 61.66 -39.19 0.13 Allowed 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.774 1.63 . . . . 0.0 114.145 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . 0.465 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.3 mm100 -72.79 -11.27 60.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.349 0.595 . . . . 0.0 110.577 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -64.13 -20.91 66.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.171 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . 0.435 HD11 HH12 ' B' ' 315' ' ' ARG . 52.3 tp -62.74 -36.88 84.47 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.077 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.14 -6.43 54.71 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.582 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . 0.436 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 77.4 mt -68.65 149.7 97.88 Favored Pre-proline 0 C--O 1.24 0.564 0 O-C-N 122.33 -0.231 . . . . 0.0 110.85 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . 0.42 ' HG2' ' OE1' ' B' ' 224' ' ' GLU . 38.7 Cg_exo -60.75 145.32 99.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.851 2.367 . . . . 0.0 113.281 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . 0.418 HH21 ' HD2' ' B' ' 334' ' ' ARG . 24.8 ttt85 -85.78 -41.62 14.91 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.417 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -57.96 -39.62 78.57 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -172.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . 0.403 ' HB2' ' OE2' ' B' ' 224' ' ' GLU . 93.6 mt -89.63 -3.88 58.06 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.757 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -105.63 -25.12 12.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.983 0.42 . . . . 0.0 110.206 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.2 -26.23 66.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.909 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.34 -51.26 70.26 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 120.931 0.396 . . . . 0.0 110.548 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -73.69 -27.28 61.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.659 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . 0.435 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -60.95 -43.6 98.48 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . 0.489 ' O ' HG22 ' B' ' 346' ' ' VAL . 87.8 tttt -59.73 -45.88 90.84 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . 0.571 ' O ' HG23 ' B' ' 347' ' ' VAL . 11.1 mmt85 -61.44 -46.25 90.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.833 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . 0.445 ' NH2' HD21 ' B' ' 314' ' ' LEU . 92.0 mtt180 -67.12 -37.63 84.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 341' ' ' ALA . 69.2 t -64.99 -44.03 96.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.708 0.289 . . . . 0.0 110.374 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.489 HG22 ' O ' ' B' ' 342' ' ' LYS . 74.3 t -61.61 -43.97 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.765 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . 0.571 HG23 ' O ' ' B' ' 343' ' ' ARG . 85.8 t -59.65 -45.0 94.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.14 99.42 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.382 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.55 -44.14 95.05 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.679 0.276 . . . . 0.0 111.225 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.416 ' O ' HG22 ' B' ' 354' ' ' VAL . 96.2 mt -64.2 -46.77 82.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.18 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.06 -39.75 82.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.385 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.65 -41.47 97.4 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.971 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -67.3 -36.7 82.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.979 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . 0.416 HG22 ' O ' ' B' ' 350' ' ' LEU . 94.3 t -61.49 -44.37 98.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.379 0.609 . . . . 0.0 109.362 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.44 -44.42 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.932 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -70.38 -46.51 63.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.927 0.394 . . . . 0.0 112.02 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 100.0 m -65.7 -42.98 90.51 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -95.14 6.24 49.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 53.02 52.13 14.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.49 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 99.2 mt -77.23 133.8 38.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.116 0.484 . . . . 0.0 111.395 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -110.71 153.33 25.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.05 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.38 109.4 14.84 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . 0.486 ' O ' HG21 ' B' ' 367' ' ' VAL . 18.3 t70 -81.75 110.86 17.46 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.201 0.524 . . . . 0.0 112.039 -173.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . 0.525 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 50.8 mm-40 -59.18 -40.73 86.6 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.237 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.51 -39.75 88.84 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.481 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -62.12 -38.81 90.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . 0.486 HG21 ' O ' ' B' ' 363' ' ' ASP . 99.1 t -63.76 -40.09 87.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.65 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 30.2 mmmt -56.49 -44.61 80.83 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.416 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.59 97.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.031 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.52 -42.47 99.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.905 0.384 . . . . 0.0 110.739 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.51 -45.1 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.28 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.81 -37.97 87.69 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -66.58 -39.45 88.45 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.524 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.7 ttm -64.54 -40.71 96.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.171 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.86 -27.01 68.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.328 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 50.6 m -75.74 -3.41 34.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.286 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -94.08 -1.25 54.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.946 0.403 . . . . 0.0 110.928 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.54 169.88 8.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.267 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.72 -40.43 87.98 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.414 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 19.6 t70 -131.69 109.64 14.54 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-O 120.914 0.388 . . . . 0.0 111.041 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.28 -40.63 83.47 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.967 2.445 . . . . 0.0 114.297 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -64.84 -43.16 93.94 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 15.7 pt-20 -62.59 -37.17 85.2 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.324 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.93 -42.84 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.339 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.23 -44.43 99.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.419 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 44.9 mt-10 -66.88 -44.35 81.13 Favored 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.997 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -59.1 -46.51 88.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.58 -41.9 92.36 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.673 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 60.2 p -79.37 -6.84 57.68 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 98.8 mttt -103.04 7.47 38.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.027 0.441 . . . . 0.0 110.922 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -125.32 118.91 26.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.77 -42.3 97.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.171 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.68 -50.72 72.26 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.878 0.37 . . . . 0.0 111.0 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.72 -42.68 97.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.867 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.429 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 90.3 mtp -65.38 -45.15 85.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.62 -39.96 66.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.221 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -62.53 -41.98 99.22 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.625 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 49.4 tpp -63.28 -40.86 98.57 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.743 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.43 ' HG2' HG23 ' B' ' 367' ' ' VAL . 71.1 mtm180 -65.11 -37.12 86.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.846 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.24 -44.39 96.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.414 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 94.3 t -66.0 -45.17 91.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.758 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.23 93.9 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.6 -40.47 97.04 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.313 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . 0.467 ' CD ' ' HZ2' ' B' ' 287' ' ' LYS . 35.7 tt0 -61.82 -43.04 99.64 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.707 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . 0.523 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 23.4 mt-10 -64.07 -40.69 96.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.467 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -60.0 -41.53 92.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.49 -46.29 86.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.128 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 95.2 t -65.94 -43.83 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.038 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.26 -34.1 77.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.0 96.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 110.198 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.25 -42.92 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.147 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.73 -39.36 91.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.952 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -68.68 -14.75 63.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.645 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -107.45 -6.59 16.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.532 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.95 170.04 9.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.169 0.509 . . . . 0.0 111.883 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -82.85 113.71 20.66 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.35 132.32 47.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.184 0.516 . . . . 0.0 111.705 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -136.1 145.28 45.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -96.38 135.03 38.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.626 0.251 . . . . 0.0 110.361 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -140.76 132.73 27.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.923 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.03 143.3 33.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.641 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.1 t -151.69 -176.84 5.78 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.633 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 50.0 p -80.48 165.51 22.1 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.099 0.476 . . . . 0.0 111.292 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -70.04 -16.7 63.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.879 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -61.74 -41.98 98.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.149 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -70.15 -27.83 64.85 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.832 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.0 -24.23 62.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.068 0.461 . . . . 0.0 109.891 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.5 mmt -79.29 -9.48 59.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.909 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -77.38 80.01 3.88 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.473 0.654 . . . . 0.0 109.928 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -115.17 29.58 7.93 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.143 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -65.91 -38.17 88.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.633 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.919 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.037 -179.33 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.452 -0.372 0 CA-C-O 120.911 0.386 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 m -86.23 106.63 17.46 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.685 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.7 137.24 27.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 34.6 tt0 -137.77 173.31 11.78 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.409 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 9.2 t -116.08 145.66 42.84 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 117.948 0.34 . . . . 0.0 111.599 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.6 m -102.87 -68.87 0.81 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -171.29 114.87 0.4 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.918 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.41 -111.94 4.59 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.718 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.34 -31.21 65.45 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 122.505 0.322 . . . . 0.0 111.456 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.55 137.07 42.09 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 116.008 -0.542 . . . . 0.0 114.127 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.21 157.13 45.67 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.222 0.609 . . . . 0.0 110.172 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.426 ' HB3' ' HB3' ' A' ' 6' ' ' GLU . 28.8 ttm-85 -115.35 137.85 51.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.96 -86.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.456 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.2 m 49.88 84.88 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.111 0.482 . . . . 0.0 111.754 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 tp -93.32 134.4 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 120.949 0.404 . . . . 0.0 111.979 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.4 m -116.64 124.06 48.82 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.389 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.476 HG13 HG12 ' A' ' 24' ' ' ILE . 17.9 pt -135.28 169.02 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 122.558 0.343 . . . . 0.0 111.817 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.618 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.77 151.98 43.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.03 0.532 . . . . 0.0 111.871 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.79 -51.2 68.27 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.7 -36.14 83.33 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.978 0.418 . . . . 0.0 110.259 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -66.67 -35.74 80.87 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.528 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.618 HG13 ' O ' ' A' ' 20' ' ' ALA . 76.9 mt -60.33 -50.19 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 111.071 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -74.49 -42.88 58.21 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.78 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.9 m -70.44 -52.92 18.75 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.62 -44.6 66.88 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.29 -42.23 94.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.043 0.449 . . . . 0.0 110.589 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -60.78 -43.87 97.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.986 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.438 ' O ' HG11 ' A' ' 33' ' ' VAL . 25.4 m -63.03 -41.63 99.58 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.335 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.58 -40.44 96.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.236 0.541 . . . . 0.0 109.878 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.89 -41.91 99.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.024 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.438 HG11 ' O ' ' A' ' 30' ' ' SER . 12.0 p -69.16 -36.08 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.776 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -63.25 -43.48 97.87 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.13 -38.2 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.802 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.76 -47.93 81.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.61 -37.23 86.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.924 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.88 -33.81 76.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.8 t -91.43 -4.47 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-O 121.47 0.653 . . . . 0.0 109.791 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 63.5 27.2 15.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.636 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -104.41 3.95 10.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.126 0.489 . . . . 0.0 110.95 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -64.66 -34.23 77.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.426 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.63 -23.37 65.0 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.983 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -73.85 -13.57 60.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.746 0.308 . . . . 0.0 111.444 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.412 ' HG3' ' NE2' ' B' ' 320' ' ' GLN . 63.4 ttt-85 -80.75 92.18 6.01 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.268 0.556 . . . . 0.0 110.201 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.79 -43.39 98.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.005 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.99 69.98 1.25 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 115.719 1.048 . . . . 0.0 115.719 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -62.99 -41.89 99.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' A' ' 54' ' ' VAL . 11.2 t -101.42 110.53 61.86 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.692 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.63 147.41 79.66 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.83 2.353 . . . . 0.0 112.066 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.481 ' HA ' HG12 ' A' ' 54' ' ' VAL . 15.3 ttt -67.11 -22.41 65.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -172.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -81.21 -8.57 59.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.872 0.368 . . . . 0.0 110.244 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.46 HD12 ' NH2' ' B' ' 193' ' ' ARG . 87.2 mt -107.74 -49.69 7.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.267 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 51' ' ' MET . 9.6 p -62.61 -40.25 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.557 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.15 94.9 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -84.91 -19.41 32.3 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.767 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.428 ' NH1' ' SD ' ' B' ' 194' ' ' MET . 61.7 ttt180 -85.65 -45.13 11.99 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.356 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -106.65 11.9 29.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.028 0.442 . . . . 0.0 110.522 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -57.39 -63.17 5.55 Favored Glycine 0 C--O 1.216 -0.978 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.181 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.55 -27.55 67.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.053 0.427 . . . . 0.0 111.631 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -61.02 -45.05 96.39 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.156 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.418 HG23 ' HB2' ' A' ' 65' ' ' ASP . 8.3 p -131.64 21.34 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 CA-C-O 121.191 0.52 . . . . 0.0 112.098 -175.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.586 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 7.5 ttt180 -64.76 -19.98 66.1 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.628 -0.67 . . . . 0.0 111.405 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -64.77 -45.68 85.35 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.496 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.418 ' HB2' HG23 ' A' ' 62' ' ' VAL . 2.2 m-20 -73.65 -28.28 61.7 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.716 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -63.66 -44.74 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.38 -39.36 94.31 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.27 -40.77 97.83 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.043 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.751 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 29.3 t70 -62.45 -46.79 86.89 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.27 -41.88 97.69 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.911 0.386 . . . . 0.0 110.149 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 ttp -61.04 -43.96 98.11 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.6 m -62.36 -42.65 99.57 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.441 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.751 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 52.2 mtp85 -62.33 -46.49 88.49 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.751 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -65.73 -40.48 92.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.314 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.06 -48.49 81.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.668 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.4 tt -68.15 -39.1 80.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.855 0.36 . . . . 0.0 111.469 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.67 -40.36 92.3 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.234 0.54 . . . . 0.0 110.471 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.95 96.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.228 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.3 pt -67.14 -37.77 79.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.574 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.46 -44.09 98.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.082 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -75.57 -23.05 56.49 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -92.98 1.32 57.36 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.978 0.418 . . . . 0.0 110.674 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 63.38 32.79 14.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.325 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.8 mt -97.78 113.13 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -107.51 107.16 60.01 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.995 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.62 134.65 33.5 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.77 1.647 . . . . 0.0 111.315 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.52 87.17 4.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.238 0.542 . . . . 0.0 110.513 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.36 -114.8 4.54 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.804 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.29 135.2 26.73 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.25 152.17 79.81 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.705 2.27 . . . . 0.0 111.339 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.3 m -87.69 105.16 17.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.066 0.46 . . . . 0.0 111.437 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -107.65 113.78 27.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.24 96.89 48.64 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.68 145.65 26.12 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.21 1.94 . . . . 0.0 111.584 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.76 174.7 51.67 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.16 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.88 123.92 23.74 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.925 0.393 . . . . 0.0 110.23 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -86.13 133.72 33.85 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.185 0.517 . . . . 0.0 111.024 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -122.58 127.13 49.04 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.6 tp -72.42 106.53 4.57 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.132 0.492 . . . . 0.0 110.607 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.07 -8.62 14.2 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.462 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -118.37 -177.56 3.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.667 0.233 . . . . 0.0 110.73 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -76.65 160.04 29.72 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 111.269 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -126.34 138.04 53.53 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.148 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.0 m -118.08 135.71 54.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.932 0.396 . . . . 0.0 110.925 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -129.08 164.25 23.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.5 m -73.92 -83.74 0.05 OUTLIER 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.6 t 56.03 101.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.297 0.57 . . . . 0.0 111.311 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.59 126.95 34.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.28 -175.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.491 ' HB3' ' OE2' ' A' ' 110' ' ' GLU . 12.8 m-85 -127.32 -165.43 1.47 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.91 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.491 ' OE2' ' HB3' ' A' ' 109' ' ' PHE . 0.9 OUTLIER -73.12 177.97 4.7 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.048 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.2 m -124.77 164.51 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.553 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -124.9 116.48 26.16 Favored Pre-proline 0 N--CA 1.466 0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -88.56 144.43 5.57 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.895 2.396 . . . . 0.0 113.152 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -142.02 151.78 42.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.828 0.451 . . . . 0.0 109.804 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.4 t -130.44 133.06 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.896 0.379 . . . . 0.0 111.837 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -107.44 -88.24 0.47 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.746 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.0 mt 64.82 117.67 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.689 0.796 . . . . 0.0 112.481 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -137.84 150.95 47.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.492 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.14 18.65 74.04 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.944 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.77 -41.4 97.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 111.03 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.86 -3.62 23.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.252 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -106.79 17.44 23.17 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.878 0.37 . . . . 0.0 111.61 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.66 107.31 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.061 0.458 . . . . 0.0 109.952 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.32 101.73 13.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.966 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.07 133.29 36.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.935 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -87.64 124.36 33.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.456 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -122.73 96.14 45.72 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -63.92 135.61 48.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.012 1.808 . . . . 0.0 111.52 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.22 112.71 40.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.8 160.2 42.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.569 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -143.01 165.37 27.55 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.196 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.5 t -78.31 129.95 36.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.749 0.309 . . . . 0.0 110.435 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.5 p -112.38 176.86 4.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.772 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.09 -35.53 78.95 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 120.692 0.282 . . . . 0.0 111.623 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.15 84.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.256 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -63.43 -40.59 97.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.292 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 95.7 t -62.25 -49.54 83.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.652 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.85 -39.08 92.98 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.713 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.72 -40.63 99.05 Favored Glycine 0 C--O 1.237 0.331 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.743 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.565 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 5.1 tpt -63.28 -42.5 99.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.139 0.495 . . . . 0.0 109.795 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.9 mt -63.02 -40.11 96.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.573 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -56.65 -48.13 78.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.577 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.2 m -63.3 -40.75 98.23 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.366 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 140' ' ' MET . 85.3 mt -60.15 -42.23 94.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.818 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -79.79 -8.51 59.31 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.834 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -92.65 -12.59 31.17 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -90.92 -52.2 4.97 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.426 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -60.58 95.85 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.63 97.96 2.17 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 113.526 -1.67 . . . . 0.0 107.848 175.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 151' ' ' TRP . 0.2 OUTLIER -67.4 176.65 2.22 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.47 ' H ' HG23 ' A' ' 150' ' ' THR . 56.0 p-90 -99.88 161.85 13.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.453 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.553 ' H ' ' HA ' ' A' ' 243' ' ' ARG . 76.7 tttt -168.68 -79.59 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.758 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 242' ' ' GLU . 10.0 pt-20 -165.97 80.18 0.28 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 155' ' ' ASP . 54.8 tttt 176.65 -152.93 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.581 175.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.431 ' H ' ' HG2' ' A' ' 154' ' ' LYS . 8.9 p-10 -140.58 162.82 34.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.303 0.501 . . . . 0.0 111.054 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 119.44 -19.07 9.97 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.303 -0.951 . . . . 0.0 114.133 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -118.52 100.55 7.53 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.58 0.69 . . . . 0.0 111.947 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.8 t -132.29 136.97 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.417 ' HB3' ' H ' ' A' ' 160' ' ' ALA . 10.7 mt-10 -97.79 -169.14 1.78 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.612 ' O ' ' HA3' ' A' ' 190' ' ' GLY . . . -95.6 23.99 5.64 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.765 ' HA ' ' O ' ' A' ' 189' ' ' MET . 11.1 pt-20 -158.88 27.64 0.22 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.436 0.636 . . . . 0.0 112.292 175.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -90.32 170.11 10.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.993 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 -106.96 123.7 48.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.96 128.74 74.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.805 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.4 m -78.84 106.39 10.82 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 72.1 mt -120.03 119.33 59.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.617 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -95.5 88.66 5.14 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -109.02 147.09 32.86 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.084 0.469 . . . . 0.0 111.834 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.0 m -116.78 127.42 54.32 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.45 123.69 6.37 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.172 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.8 m -140.65 128.6 21.97 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.455 HG22 ' CD2' ' A' ' 177' ' ' PHE . 98.0 t -102.89 108.93 25.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 60.34 -50.18 0.09 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.25 1.42 . . . . 0.0 114.121 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.89 -4.37 0.05 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.066 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.44 140.86 52.55 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.092 0.472 . . . . 0.0 110.956 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -79.33 156.56 27.97 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.455 ' CD2' HG22 ' A' ' 172' ' ' VAL . 35.4 p90 -125.37 169.28 12.5 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.534 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.86 -36.12 74.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.03 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.74 -177.49 33.79 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.65 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.27 22.06 61.42 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.163 -1.017 . . . . 0.0 113.322 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -100.81 112.1 24.45 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -136.26 145.69 45.88 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.986 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.6 m -140.5 125.18 18.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.423 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 55.89 30.59 16.21 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.578 0.548 . . . . 0.0 110.635 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -83.78 122.99 29.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.018 0.437 . . . . 0.0 110.397 -176.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.3 m -87.9 106.9 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.598 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.6 tp -94.55 121.54 36.22 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.184 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.563 ' HB1' ' CZ ' ' A' ' 193' ' ' ARG . . . -91.89 119.36 31.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.765 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 83.9 mtp -84.24 153.5 23.56 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.985 -175.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 160' ' ' ALA . . . 84.0 18.31 63.41 Favored Glycine 0 CA--C 1.505 -0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.872 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -122.54 -6.39 8.67 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.155 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.88 46.36 10.92 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.656 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.563 ' CZ ' ' HB1' ' A' ' 188' ' ' ALA . 94.0 mtt180 -92.93 -6.77 47.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.461 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -131.58 167.88 18.65 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.715 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.88 134.82 92.65 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.93 129.89 18.71 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.385 2.056 . . . . 0.0 112.025 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.15 -38.97 3.04 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.358 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -65.35 -49.54 68.98 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.54 ' O ' ' HE3' ' A' ' 189' ' ' MET . 11.4 pt-20 -82.72 -9.73 59.23 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.226 0.536 . . . . 0.0 111.06 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -89.4 -32.01 17.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -74.56 -10.01 82.43 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.102 -0.953 . . . . 0.0 113.337 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 44.4 mm -64.91 -42.89 96.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -53.01 125.93 18.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.629 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 101.28 -3.59 54.71 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.066 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -103.69 148.18 26.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.721 0.761 . . . . 0.0 111.991 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.17 166.17 12.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.491 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.28 120.52 19.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 89.12 17.71 55.29 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.678 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -105.01 117.37 33.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.121 0.486 . . . . 0.0 110.256 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -99.59 123.09 43.52 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.137 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -143.7 -15.44 0.63 Allowed 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 74.4 p 59.38 164.79 0.05 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 123.886 0.874 . . . . 0.0 112.596 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -146.95 142.58 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.858 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.97 109.1 16.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.047 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 49.3 t -117.55 108.23 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.148 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 21.2 m -71.9 -44.42 63.73 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' A' ' 216' ' ' THR . 54.8 m-85 78.73 148.49 0.12 Allowed Pre-proline 0 N--CA 1.495 1.799 0 C-N-CA 123.241 0.617 . . . . 0.0 110.763 -174.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -72.0 153.79 57.85 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.708 2.272 . . . . 0.0 111.905 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.558 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 51.7 mm-40 -65.86 -39.11 90.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.419 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -95.58 39.0 1.13 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.252 0.549 . . . . 0.0 110.935 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -71.67 147.13 47.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.208 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -62.62 -19.65 63.98 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -101.6 117.04 34.09 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.52 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 2.2 tp10 -63.0 -32.7 74.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.992 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.5 -5.96 58.57 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -176.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 84.8 mt -117.81 -11.66 10.3 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.487 -0.485 . . . . 0.0 112.08 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.583 ' NZ ' HD12 ' A' ' 336' ' ' LEU . 18.4 ptmt -68.77 122.23 18.15 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.194 0.521 . . . . 0.0 112.205 -176.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.76 13.3 78.48 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.129 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.49 117.49 29.61 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.471 -0.429 . . . . 0.0 110.487 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -68.57 133.65 48.84 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.965 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -114.61 159.31 20.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.714 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -99.29 -33.11 10.86 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 53.05 99.17 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -73.85 91.88 2.01 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.143 0.497 . . . . 0.0 110.241 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.5 mm -95.18 115.4 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -112.76 -36.64 5.11 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.278 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.3 mt 67.76 152.96 0.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.265 0.626 . . . . 0.0 111.813 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -110.85 -80.64 0.58 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.665 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -111.79 -31.23 7.02 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 18.3 t 59.15 46.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 121.843 0.83 . . . . 0.0 109.528 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 60.7 -102.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.595 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . 15.2 pt-20 178.7 103.56 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.817 0.847 . . . . 0.0 108.964 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.553 ' HA ' ' H ' ' A' ' 152' ' ' LYS . 11.1 ptm180 -157.52 122.88 4.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -179.42 165.83 1.42 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.1 mt 72.64 109.02 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.028 0.531 . . . . 0.0 111.509 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.22 117.64 3.52 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.784 2.323 . . . . 0.0 114.37 -176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.38 -179.26 5.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.646 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.5 mp -91.38 128.5 37.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.081 0.467 . . . . 0.0 111.548 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 9.3 m -136.16 142.15 44.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.43 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.79 92.11 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.12 50.5 0.21 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.327 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -132.68 -58.57 0.92 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.881 0.372 . . . . 0.0 110.8 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 261' ' ' GLY . 36.9 pt -68.97 -22.13 26.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.577 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -105.55 5.72 31.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.4 0.619 . . . . 0.0 109.923 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -111.61 -1.84 15.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.531 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -98.3 116.51 30.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.15 -173.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 51.03 -109.38 0.73 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.13 136.92 55.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.057 0.543 . . . . 0.0 110.707 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 260' ' ' ASP . 2.4 tp10 66.43 -160.16 0.25 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.415 ' H ' ' HG3' ' A' ' 259' ' ' GLU . 4.9 p-10 -133.95 134.75 42.93 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.618 ' O ' ' HB ' ' A' ' 253' ' ' ILE . . . -125.65 158.25 19.92 Favored Glycine 0 C--N 1.316 -0.563 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.74 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 11.8 p -82.19 -179.43 7.4 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.665 0.386 . . . . 0.0 110.958 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.89 -47.76 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.255 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.38 -31.86 15.88 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.758 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.55 -44.24 96.87 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.042 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 270' ' ' VAL . 40.5 tp -64.78 -41.93 95.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -61.64 -43.1 99.5 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.366 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.412 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.39 -40.82 96.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.912 0.387 . . . . 0.0 110.586 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -66.63 -41.75 87.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.376 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 266' ' ' LEU . 85.7 t -63.75 -42.77 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -55.69 -47.6 76.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.301 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 0.1 OUTLIER -70.27 -40.89 74.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -64.53 -41.25 96.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.687 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 95.1 mmm -65.04 -41.63 95.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.628 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.41 -34.86 78.11 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.815 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 53.4 ttp180 -63.65 -43.64 96.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.393 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -68.32 -34.68 76.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.048 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.404 ' O ' HG13 ' A' ' 282' ' ' ILE . 50.2 tp -62.62 -37.94 88.26 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 50.7 tttm -55.98 -46.78 78.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.165 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.9 m -62.37 -40.89 97.91 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.708 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.59 -42.71 99.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.929 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 278' ' ' LEU . 64.1 mt -65.35 -43.29 94.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.828 0.347 . . . . 0.0 110.482 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.529 ' HD2' ' OE2' ' A' ' 405' ' ' GLU . 1.1 tpm_? -58.96 -44.52 91.5 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.392 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.24 -42.74 96.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.224 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -61.86 -44.47 96.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.946 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.49 -44.69 86.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.008 0.432 . . . . 0.0 110.749 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.475 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.0 tttt -61.6 -47.18 86.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.539 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.7 p -62.31 -41.08 98.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.23 -41.78 94.06 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.762 0.315 . . . . 0.0 110.791 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.37 -48.26 76.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.039 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 287' ' ' LYS . 49.4 mm -63.2 -47.91 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.513 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.509 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 26.4 tp10 -61.87 -43.02 99.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.097 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.29 -42.93 93.83 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.702 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.81 -44.49 96.03 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.54 -44.79 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.256 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . 0.509 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 64.0 mttm -61.63 -40.52 95.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.582 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.3 80.84 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.719 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -126.45 101.47 6.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -94.78 113.85 25.67 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.4 tp -119.75 153.26 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.502 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -61.75 142.68 57.12 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.952 0.406 . . . . 0.0 110.515 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 54.2 t -120.83 126.28 26.74 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.644 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.1 131.94 48.36 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.216 1.944 . . . . 0.0 111.715 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.72 -38.23 89.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.066 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.87 -44.2 82.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.023 0.439 . . . . 0.0 111.402 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.63 -41.8 95.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.446 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 311' ' ' ILE . 68.6 mt -61.75 -48.17 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.73 -46.15 84.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.159 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 48.9 m -61.03 -44.95 96.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.685 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.411 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 56.1 mm-40 -71.42 -35.35 70.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.445 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 94.3 mt -62.42 -44.42 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.69 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 13.1 t70 -64.32 -40.98 97.0 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.268 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.61 -43.94 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.978 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 96.9 mt -62.37 -41.99 99.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.684 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.465 HH12 HD12 ' A' ' 330' ' ' LEU . 79.8 mtm180 -63.59 -39.56 94.7 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.084 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 66.6 mtt180 -64.34 -40.29 95.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.261 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -64.61 -42.64 95.39 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.291 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.47 -38.43 81.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.516 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.24 -34.92 79.21 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.979 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -60.25 -37.11 79.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.408 0.623 . . . . 0.0 109.852 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -79.11 -7.56 58.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.593 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -100.8 2.29 41.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 135.4 -3.56 3.99 Favored Glycine 0 CA--C 1.509 -0.344 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.114 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 93.9 28.97 10.26 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.638 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.493 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 45.8 t-20 -70.82 130.6 42.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.975 0.417 . . . . 0.0 110.622 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.0 tm-20 -129.95 158.25 40.06 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 6.7 ptpp? 60.04 -40.06 0.09 Allowed 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 125.682 1.593 . . . . 0.0 114.473 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.493 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 15.6 mm100 -73.0 -12.7 61.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.382 0.611 . . . . 0.0 109.806 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.45 -17.55 62.81 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.762 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.465 HD12 HH12 ' A' ' 315' ' ' ARG . 56.4 tp -61.59 -32.29 72.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.252 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.88 -15.39 60.21 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.756 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.454 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 89.9 mt -66.59 138.07 95.41 Favored Pre-proline 0 C--O 1.238 0.488 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.953 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.78 119.21 6.08 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.344 2.696 . . . . 0.0 113.593 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -63.07 -45.37 92.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.356 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.14 -18.61 65.46 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.401 -173.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.583 HD12 ' NZ ' ' A' ' 227' ' ' LYS . 85.7 mt -94.2 -5.76 46.28 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -117.35 -2.32 11.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.408 0.623 . . . . 0.0 109.731 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.43 ' HG3' HD11 ' A' ' 311' ' ' ILE . 40.5 tt0 -83.34 -16.69 45.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.534 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.92 -48.74 67.73 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.045 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -74.65 -24.72 58.86 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.197 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -60.27 -44.87 94.95 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.499 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.455 ' O ' HG22 ' A' ' 346' ' ' VAL . 87.3 tttt -60.38 -46.91 88.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.427 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.507 ' O ' HG22 ' A' ' 347' ' ' VAL . 20.3 mmt85 -62.51 -44.22 96.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -66.29 -38.62 88.19 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.721 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.409 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 76.1 t -64.2 -44.1 97.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.753 0.311 . . . . 0.0 110.335 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 75.6 t -61.5 -43.29 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.644 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 343' ' ' ARG . 72.1 t -59.92 -44.44 94.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.21 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.55 -41.2 99.52 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.98 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 91.1 mt -63.1 -43.8 97.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.955 0.407 . . . . 0.0 111.095 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.0 mt -62.8 -47.36 83.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.122 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.99 -39.44 83.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.852 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.63 -43.27 96.31 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.541 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -68.18 -37.91 81.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.356 0.578 . . . . 0.0 111.042 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.06 -45.79 97.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.74 -44.2 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.018 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -66.07 -49.79 66.39 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.912 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.4 m -66.74 -44.16 82.25 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -82.19 -4.35 56.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.853 0.359 . . . . 0.0 111.063 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 60.02 38.22 20.83 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.347 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.38 152.92 39.46 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.098 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -129.29 158.96 37.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.108 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -81.48 105.6 12.78 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.499 ' O ' HG21 ' A' ' 367' ' ' VAL . 26.6 t70 -81.18 114.47 20.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.169 0.509 . . . . 0.0 112.257 -173.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 66.4 mm-40 -62.02 -37.3 84.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.255 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.421 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 63.4 mm-40 -61.92 -45.74 92.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.286 0.565 . . . . 0.0 110.179 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -63.07 -39.15 93.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.074 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 363' ' ' ASP . 93.2 t -62.96 -40.82 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.784 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.2 mmmt -57.77 -44.13 85.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.413 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.92 -38.79 97.16 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.767 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.79 -42.19 99.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.05 0.452 . . . . 0.0 110.014 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.19 -43.39 97.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.961 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.66 -44.11 97.1 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -65.63 -39.09 91.08 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.533 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 55.7 ttm -65.09 -42.87 93.66 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.096 0.474 . . . . 0.0 110.967 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 377' ' ' ALA . . . -63.31 -31.35 72.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.562 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 37.4 m -73.68 23.84 0.07 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.939 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 375' ' ' ALA . . . -123.43 0.72 8.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.737 0.303 . . . . 0.0 110.765 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.47 175.33 5.47 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.576 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -59.29 -42.22 90.77 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.835 0.35 . . . . 0.0 110.824 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -134.06 116.17 13.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.477 ' O ' HG13 ' A' ' 385' ' ' ILE . 51.4 Cg_endo -69.5 -31.99 20.55 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.272 1.982 . . . . 0.0 113.702 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -66.62 -43.76 83.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.48 -35.02 79.66 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.576 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.82 -42.66 97.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.244 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 381' ' ' PRO . 74.5 mt -61.19 -46.72 96.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.461 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 43.0 mt-10 -65.33 -43.46 90.89 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.82 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -57.0 -46.87 81.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.832 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.425 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 3.5 t80 -64.89 -42.31 94.89 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.204 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 65.4 p -76.06 -10.44 59.42 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 99.6 mttt -98.35 6.3 47.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.024 0.44 . . . . 0.0 111.005 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -130.64 111.8 12.54 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.854 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -63.38 -36.6 84.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.239 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -56.95 -53.15 61.31 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.96 0.409 . . . . 0.0 110.283 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.68 -41.21 98.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.597 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.488 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 87.8 mtp -62.07 -46.74 87.75 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 120.836 0.35 . . . . 0.0 111.708 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.61 -39.55 64.49 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.076 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -63.36 -40.6 97.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.425 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 46.7 tpp -64.68 -40.27 95.11 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.982 0.42 . . . . 0.0 110.742 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 395' ' ' MET . 70.1 mtm180 -63.38 -33.4 75.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.092 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.6 -44.28 97.3 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.17 -45.52 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.177 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.7 99.54 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.496 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 46.3 tp -64.82 -37.61 88.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.422 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.439 ' CD ' ' HZ2' ' A' ' 287' ' ' LYS . 38.8 tt0 -57.01 -46.29 82.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.716 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.529 ' OE2' ' HD2' ' A' ' 283' ' ' ARG . 26.6 mt-10 -65.26 -38.69 91.1 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.634 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -60.5 -43.35 97.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.303 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.95 -45.36 89.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 96.2 t -63.89 -46.56 93.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.274 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -68.49 -30.56 69.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.897 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.39 98.93 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.48 -43.32 96.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.033 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.5 mt -61.95 -39.0 90.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.251 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.98 -33.05 72.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.963 0.411 . . . . 0.0 110.896 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -89.08 -10.94 45.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.846 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -93.65 176.94 6.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.295 0.569 . . . . 0.0 112.348 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -93.05 112.34 24.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.291 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.42 129.45 51.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.03 0.443 . . . . 0.0 110.945 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.5 t -118.27 139.95 50.56 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.858 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -105.29 120.05 40.6 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -137.31 145.01 42.93 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.712 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.86 148.4 26.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.98 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.9 t -150.34 177.95 9.48 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.046 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 19.7 p -86.41 159.96 19.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.991 0.424 . . . . 0.0 111.474 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -66.8 -33.37 75.47 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.2 0.524 . . . . 0.0 110.742 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 428' ' ' MET . 6.6 m-20 -60.74 -37.17 80.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.514 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.25 -32.66 74.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.558 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.16 -17.7 61.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.943 0.401 . . . . 0.0 110.474 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 425' ' ' ASN . 5.7 mmt -74.95 -8.05 55.35 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.167 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -76.72 75.8 3.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -103.73 15.25 29.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.057 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -63.89 -42.02 97.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.375 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.705 -0.664 . . . . 0.0 110.757 -179.65 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 CA--C 1.513 -0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -94.74 158.08 15.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.922 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.53 158.76 43.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.692 0.282 . . . . 0.0 110.718 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 6.4 m -86.09 107.34 17.78 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.491 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.51 138.45 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.978 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.521 ' HG2' ' H ' ' B' ' 7' ' ' THR . 25.1 tt0 -137.53 177.77 7.61 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.521 ' H ' ' HG2' ' B' ' 6' ' ' GLU . 13.1 t -118.09 152.13 36.18 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.89 0.376 . . . . 0.0 111.272 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 75.3 m -110.62 -70.74 0.79 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.074 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -168.03 111.16 0.61 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.022 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.23 -108.37 2.02 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.073 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.09 -31.92 68.42 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 122.462 0.305 . . . . 0.0 111.236 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.24 139.18 39.67 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 116.005 -0.543 . . . . 0.0 114.021 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 0.0 OUTLIER -142.17 161.23 38.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.466 0.706 . . . . 0.0 110.049 -178.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.41 ' HB3' ' HB3' ' B' ' 6' ' ' GLU . 32.0 ttm-85 -119.86 138.45 53.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 39.8 t -106.03 -86.94 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.343 176.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 17.9 m 51.1 87.29 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.331 0.586 . . . . 0.0 111.458 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 tp -94.16 136.91 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.941 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 91.7 m -117.33 121.51 41.34 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.101 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.491 HG13 HG12 ' B' ' 24' ' ' ILE . 14.3 pt -135.31 165.88 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.603 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.79 151.11 47.37 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.01 -53.03 58.58 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -173.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -65.42 -36.13 83.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.091 0.472 . . . . 0.0 110.441 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.9 m -63.65 -38.23 90.34 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.561 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.603 HG13 ' O ' ' B' ' 20' ' ' ALA . 74.9 mt -59.15 -51.04 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 111.21 -177.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -73.01 -42.59 63.05 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.856 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -67.61 -52.38 39.1 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.42 -44.59 67.6 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.78 -43.06 96.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.734 0.302 . . . . 0.0 111.307 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -61.7 -44.92 96.01 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.082 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.451 ' O ' HG11 ' B' ' 33' ' ' VAL . 19.6 m -63.92 -40.83 97.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.638 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -62.6 -41.84 99.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.031 0.443 . . . . 0.0 110.454 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.48 -41.61 98.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.086 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.451 HG11 ' O ' ' B' ' 30' ' ' SER . 9.9 p -67.99 -36.5 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.316 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -63.47 -42.78 98.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.232 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.03 -36.97 77.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.335 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.77 -48.1 80.64 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.105 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.68 -36.96 85.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.906 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.48 -34.63 75.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.666 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.46 -7.52 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.368 0.604 . . . . 0.0 109.707 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 65.91 27.84 10.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.865 0.866 . . . . 0.0 111.57 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.01 3.53 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.325 0.583 . . . . 0.0 111.001 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -65.4 -32.83 74.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.072 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -7.4 58.01 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.69 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -89.04 -6.83 56.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.834 0.35 . . . . 0.0 110.35 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 65.9 ttt-85 -87.58 91.66 8.82 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.054 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -63.17 -43.58 97.85 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.61 72.66 0.7 Allowed Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 115.997 1.159 . . . . 0.0 115.997 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.92 -43.17 98.97 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 171.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.82 112.52 63.93 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.775 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -57.41 147.49 77.51 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 111.912 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.471 ' HA ' HG12 ' B' ' 54' ' ' VAL . 19.7 ttt -67.38 -24.75 65.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.543 -172.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -77.63 -10.24 59.4 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.465 HD12 ' CZ ' ' A' ' 193' ' ' ARG . 81.5 mt -108.26 -47.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.488 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' B' ' 51' ' ' MET . 12.4 p -62.89 -38.88 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.032 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.8 92.21 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -88.41 -9.22 53.35 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.052 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.44 ' NH1' ' SD ' ' A' ' 194' ' ' MET . 62.2 ttt180 -97.36 -41.47 8.22 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.238 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.61 9.87 27.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.965 0.412 . . . . 0.0 109.893 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -57.57 -63.84 4.92 Favored Glycine 0 C--O 1.211 -1.343 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.115 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.63 -27.76 66.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.978 0.389 . . . . 0.0 111.748 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.3 t -61.61 -45.09 95.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.797 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.0 21.39 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 120.996 0.427 . . . . 0.0 111.902 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.59 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 6.7 ttt180 -64.65 -21.49 66.74 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.782 -0.574 . . . . 0.0 110.914 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -62.08 -50.3 72.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.64 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.6 -25.0 60.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.1 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.93 -43.74 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.1 -39.67 95.38 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.37 -40.3 97.36 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.634 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . 0.756 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 30.6 t70 -61.29 -46.15 91.51 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.67 -42.31 98.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.495 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 60.2 ttp -61.94 -42.4 99.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -62.54 -42.85 99.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.756 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 52.3 mtp85 -63.32 -44.98 93.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.535 -176.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -65.31 -41.33 94.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.228 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -61.3 -48.05 83.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.763 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.14 -39.07 80.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.885 0.374 . . . . 0.0 111.117 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.73 -41.24 96.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.186 0.517 . . . . 0.0 110.532 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.51 -46.42 86.16 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.989 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 41.1 pt -65.35 -38.0 81.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.85 -43.62 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.126 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -76.77 -26.26 54.3 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -88.19 3.26 49.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.399 . . . . 0.0 110.793 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 63.9 28.38 14.55 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.125 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.2 mt -94.29 114.68 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -112.09 104.36 55.96 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.01 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.53 140.77 64.32 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.175 1.917 . . . . 0.0 111.695 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.54 96.32 7.3 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.857 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.29 -112.48 4.48 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.789 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.81 139.04 31.12 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.502 0.151 . . . . 0.0 110.657 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . 0.468 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 55.7 Cg_endo -68.48 155.89 67.5 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.629 2.219 . . . . 0.0 111.29 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -90.06 99.01 12.1 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.938 0.399 . . . . 0.0 111.558 -175.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.468 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 66.8 m-85 -102.95 110.96 23.07 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.4 t -115.83 98.83 51.79 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.95 145.97 25.5 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.359 2.039 . . . . 0.0 111.958 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.76 171.9 45.62 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.131 -1.033 . . . . 0.0 110.898 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.5 123.14 20.5 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.057 0.456 . . . . 0.0 110.597 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -84.44 134.19 34.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.261 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -121.78 122.11 38.77 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 46.3 tp -69.76 106.48 3.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.975 0.417 . . . . 0.0 110.716 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.98 -18.35 9.05 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.486 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -110.27 -175.33 2.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -79.7 164.42 23.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.934 0.397 . . . . 0.0 111.707 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -131.18 141.74 50.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.459 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.2 m -120.05 133.78 55.43 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.912 0.387 . . . . 0.0 111.118 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -125.28 165.28 18.6 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.139 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.9 m -75.5 -82.76 0.07 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 46.8 t 54.27 103.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 122.955 0.502 . . . . 0.0 111.315 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -88.33 123.5 32.97 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . 0.483 ' HB3' ' OE1' ' B' ' 110' ' ' GLU . 13.7 m-85 -123.36 -167.47 1.62 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.769 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . 0.483 ' OE1' ' HB3' ' B' ' 109' ' ' PHE . 1.0 OUTLIER -72.37 176.34 5.4 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -176.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 32.1 m -125.43 166.14 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.473 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -123.61 121.06 26.74 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.796 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -90.97 134.77 1.8 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 122.87 2.38 . . . . 0.0 113.136 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -135.42 144.79 46.7 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.36 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 76.5 t -126.2 134.22 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -107.52 -86.98 0.49 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.861 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 85.0 mt 62.52 120.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.197 0.999 . . . . 0.0 113.553 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -140.18 153.07 46.5 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.948 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.68 21.85 73.73 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.584 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.55 -40.67 95.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.964 0.411 . . . . 0.0 111.486 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.55 -8.73 57.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.363 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.96 8.19 44.33 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 64.7 mt -88.4 108.8 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.197 0.522 . . . . 0.0 110.089 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.36 103.95 15.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.505 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.02 133.08 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.21 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -85.57 122.96 30.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.44 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -120.78 97.08 48.59 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -69.49 130.24 19.32 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.578 1.519 . . . . 0.0 111.823 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -102.69 115.39 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 24.2 m -132.78 159.46 43.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.299 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.43 160.72 37.9 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 66.8 t -76.25 127.7 37.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 41.3 p -105.27 173.46 6.3 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.814 0.34 . . . . 0.0 110.194 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -67.56 -25.49 65.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.162 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.55 -40.36 96.79 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.122 0.487 . . . . 0.0 109.891 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -63.66 -40.8 97.75 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.026 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.0 t -61.75 -48.43 88.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.414 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.32 -38.42 90.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.901 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.7 -40.95 99.46 Favored Glycine 0 C--O 1.237 0.294 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' MET . . . . . 0.558 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 4.1 tpt -63.27 -41.84 99.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.15 0.5 . . . . 0.0 109.826 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 87.2 mt -63.16 -40.31 97.19 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.801 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -58.98 -46.88 87.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.568 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.7 m -63.39 -41.1 98.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' B' ' 140' ' ' MET . 89.5 mt -60.56 -42.86 97.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.718 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -79.07 -8.71 59.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.773 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -94.86 -5.46 44.95 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -97.73 -55.82 2.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.149 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . 0.422 ' NE2' ' HA ' ' B' ' 148' ' ' GLN . 8.1 mm-40 -58.09 96.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.07 106.55 3.64 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.901 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' THR . . . . . 0.532 HG23 ' H ' ' B' ' 151' ' ' TRP . 0.2 OUTLIER -73.07 175.13 6.99 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -173.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . 0.532 ' H ' HG23 ' B' ' 150' ' ' THR . 53.2 p-90 -99.43 161.21 13.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.526 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . 0.547 ' H ' ' HA ' ' B' ' 243' ' ' ARG . 76.6 tttt -170.98 -81.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.584 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' B' ' 242' ' ' GLU . 11.8 pt-20 -164.24 76.16 0.33 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . 0.472 ' HG2' ' H ' ' B' ' 155' ' ' ASP . 49.7 tttt 178.06 -160.79 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . 0.472 ' H ' ' HG2' ' B' ' 154' ' ' LYS . 12.2 p-10 -135.38 163.05 30.91 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 117.996 0.362 . . . . 0.0 111.153 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 119.87 -18.97 9.71 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.182 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -115.36 100.23 7.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 117.393 0.596 . . . . 0.0 112.174 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 55.0 t -130.26 136.34 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . 0.489 ' HB2' ' OD2' ' B' ' 162' ' ' ASP . 3.4 mm-40 -95.6 -170.58 2.18 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.164 0.507 . . . . 0.0 111.899 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . 0.638 ' O ' ' HA3' ' B' ' 190' ' ' GLY . . . -98.94 24.32 7.87 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . 0.787 ' HA ' ' O ' ' B' ' 189' ' ' MET . 13.4 pt-20 -158.85 25.27 0.22 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.34 0.591 . . . . 0.0 112.422 175.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' B' ' 188' ' ' ALA . 12.8 m-20 -87.81 170.7 10.97 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.398 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -108.15 121.13 44.22 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.3 t -116.74 128.26 74.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.251 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 20.7 m -76.75 104.88 7.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.97 117.99 56.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.002 0.43 . . . . 0.0 111.393 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.95 88.44 5.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -109.14 150.92 27.14 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.332 0.587 . . . . 0.0 112.182 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 46.3 m -119.97 128.28 53.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.937 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.9 114.09 3.89 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.488 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 39.2 m -131.94 124.19 28.93 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . 0.523 HG22 ' CD2' ' B' ' 177' ' ' PHE . 93.9 t -100.14 106.77 19.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 35.2 t70 67.6 -75.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.939 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -145.37 9.95 1.72 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.608 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -132.48 139.02 47.79 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.521 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.13 148.25 26.22 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . 0.523 ' CD2' HG22 ' B' ' 172' ' ' VAL . 31.9 p90 -115.84 171.41 7.79 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.442 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -59.39 -36.83 76.54 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.62 -174.45 33.82 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.04 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.73 24.31 60.53 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.991 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -103.56 106.58 17.13 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -124.73 144.78 50.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.194 0.521 . . . . 0.0 112.144 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 42.9 m -138.35 119.55 14.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.843 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 55.01 31.11 15.43 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 123.587 0.555 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -81.17 124.54 29.34 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.441 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.72 107.48 18.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.763 0.792 . . . . 0.0 110.708 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 55.1 tp -95.08 122.17 37.46 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.6 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . 0.555 ' HB1' ' CZ ' ' B' ' 193' ' ' ARG . . . -92.1 116.69 29.16 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 189' ' ' MET . . . . . 0.787 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 54.1 mtp -84.54 154.28 22.76 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.91 -175.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.638 ' HA3' ' O ' ' B' ' 160' ' ' ALA . . . 89.28 4.31 74.32 Favored Glycine 0 CA--C 1.501 -0.831 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.71 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -111.33 -4.33 14.96 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.312 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.27 47.65 8.91 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.018 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.555 ' CZ ' ' HB1' ' B' ' 188' ' ' ALA . 96.2 mtt180 -95.47 -3.62 46.47 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.288 0.566 . . . . 0.0 109.568 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.438 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.1 OUTLIER -134.54 168.74 18.42 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.942 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 43.7 mm -61.74 135.46 94.34 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.25 129.5 19.14 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.356 2.037 . . . . 0.0 111.85 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.44 -36.63 4.28 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.343 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -67.31 -50.95 58.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.33 0.565 . . . . 0.0 112.015 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . 0.533 ' O ' ' HE3' ' B' ' 189' ' ' MET . 10.5 pt-20 -81.48 -10.95 59.37 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.005 0.431 . . . . 0.0 111.427 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -90.72 -25.86 19.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.153 0.502 . . . . 0.0 109.705 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.21 -10.93 85.98 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.143 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.5 mm -64.27 -43.0 97.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -55.41 114.6 1.89 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.905 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 115.03 -9.11 21.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.923 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -99.4 146.64 26.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 117.319 0.56 . . . . 0.0 112.158 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.49 168.84 11.53 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.007 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.34 129.28 37.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 78.29 33.36 40.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.68 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -119.77 118.94 32.19 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.913 0.387 . . . . 0.0 110.378 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -101.67 116.62 33.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.284 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -138.29 -16.21 1.23 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 62.7 p 59.66 167.86 0.07 Allowed 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 123.712 0.805 . . . . 0.0 112.844 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -151.17 144.21 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.968 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -80.21 110.91 16.07 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.687 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 43.1 t -118.77 105.5 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' THR . . . . . 0.504 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 21.0 m -71.99 -43.54 64.93 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' B' ' 216' ' ' THR . 66.3 m-85 76.67 146.91 0.12 Allowed Pre-proline 0 N--CA 1.488 1.449 0 C-N-CA 123.044 0.538 . . . . 0.0 110.748 -174.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.7 153.82 68.74 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.788 2.325 . . . . 0.0 111.863 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . 0.497 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 65.0 mm-40 -66.7 -38.12 86.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.236 0.541 . . . . 0.0 110.069 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -94.49 40.8 1.09 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.62 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -75.15 143.88 43.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.154 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -60.96 -17.63 52.66 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.39 118.48 36.85 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.415 ' HA ' ' CD ' ' B' ' 227' ' ' LYS . 5.2 tp10 -61.86 -33.23 73.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.856 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -88.96 -5.11 58.2 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 87.7 mt -117.93 -14.72 10.02 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.029 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.644 ' NZ ' HD12 ' B' ' 336' ' ' LEU . 19.7 ptmt -63.96 122.58 16.86 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.121 0.486 . . . . 0.0 111.884 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.58 9.94 66.05 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.097 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -110.92 120.4 42.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.197 0.498 . . . . 0.0 110.485 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -72.51 134.45 45.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.871 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.56 156.52 26.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.659 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.25 -31.68 13.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 51.59 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -74.52 95.4 2.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.509 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm -96.53 114.64 33.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.57 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -108.46 -31.59 7.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.212 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.2 mt 65.5 170.41 0.21 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.407 0.683 . . . . 0.0 111.382 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -128.62 -79.61 0.57 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.122 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -115.42 -31.13 6.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 17.1 t 59.89 41.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 122.13 0.967 . . . . 0.0 109.085 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 63.67 -101.1 0.09 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.765 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' B' ' 153' ' ' GLU . 9.5 pt-20 179.9 96.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.962 0.905 . . . . 0.0 109.095 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.547 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 10.5 ptm180 -152.19 120.94 6.51 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -173.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 179.46 164.89 1.02 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 98.2 mt 70.85 112.17 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.985 0 CA-C-O 121.285 0.564 . . . . 0.0 111.617 -176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.37 118.18 2.54 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.527 2.151 . . . . 0.0 114.471 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -144.64 167.23 23.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.501 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . 0.402 HD13 ' N ' ' B' ' 248' ' ' LEU . 6.7 mp -76.82 134.68 38.99 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.045 0.45 . . . . 0.0 112.19 -175.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 8.0 m -138.07 154.91 49.23 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -79.44 -36.49 38.81 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.808 0.337 . . . . 0.0 111.642 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -75.6 56.41 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.758 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -136.09 -56.92 0.77 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.937 0.399 . . . . 0.0 110.498 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 253' ' ' ILE . . . . . 0.565 ' HB ' ' O ' ' B' ' 261' ' ' GLY . 36.4 pt -68.86 -22.81 26.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.163 0.506 . . . . 0.0 110.92 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -105.85 7.83 32.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.666 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -115.12 -1.06 13.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.391 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -99.66 116.75 32.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.208 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 46.59 -115.86 2.08 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 83.2 t -113.65 136.51 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.522 0.729 . . . . 0.0 110.926 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' B' ' 260' ' ' ASP . 3.0 tp10 69.18 -173.05 0.18 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . 0.453 ' H ' ' HG3' ' B' ' 259' ' ' GLU . 5.1 p-10 -125.98 117.99 24.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . 0.565 ' O ' ' HB ' ' B' ' 253' ' ' ILE . . . -103.2 162.27 16.08 Favored Glycine 0 C--N 1.316 -0.552 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.174 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 12.0 p -85.37 -178.99 6.87 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.72 -47.98 90.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.918 0.389 . . . . 0.0 111.065 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.1 -32.02 17.73 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.782 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.02 -42.35 96.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.533 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.512 ' O ' HG23 ' B' ' 270' ' ' VAL . 47.5 tp -64.33 -42.4 96.3 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.633 0.216 . . . . 0.0 110.435 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -60.86 -44.64 96.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.638 0.256 . . . . 0.0 111.155 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.16 -41.23 97.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.003 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -69.4 -38.79 78.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.1 t -63.83 -42.0 94.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -53.15 -54.83 30.09 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.498 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 12.7 ptmt -64.59 -42.61 95.48 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -63.65 -40.71 97.53 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.473 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.6 -41.41 92.82 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.195 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -66.68 -35.08 79.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.949 0.404 . . . . 0.0 110.883 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 56.3 ttp180 -62.78 -42.63 99.78 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.385 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.34 -37.29 83.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.985 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.23 -37.81 86.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.541 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 52.5 tttm -56.34 -45.94 80.17 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.37 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 42.5 m -61.83 -41.0 97.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.592 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.2 -44.91 96.53 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.158 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.35 -44.22 98.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.285 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . 0.434 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.5 OUTLIER -60.41 -44.88 95.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 178.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -64.44 -41.87 96.31 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.672 0.272 . . . . 0.0 110.927 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -61.48 -44.64 96.73 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.099 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.15 -43.27 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.988 0.423 . . . . 0.0 110.582 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.43 -47.72 84.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.806 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 73.7 p -61.94 -41.55 98.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.738 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -64.53 -44.83 89.59 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.824 0.345 . . . . 0.0 111.073 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.38 78.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.535 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . 0.439 ' O ' HG23 ' B' ' 295' ' ' VAL . 37.5 mm -64.09 -44.24 97.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.734 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . 0.465 ' HG3' ' HE2' ' B' ' 296' ' ' LYS . 30.6 tp10 -62.91 -45.11 94.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.513 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.43 95.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.7 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 1.8 tt -62.81 -43.15 99.56 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 291' ' ' ILE . 98.8 t -66.28 -43.38 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.075 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . 0.465 ' HE2' ' HG3' ' B' ' 292' ' ' GLU . 64.3 mttm -62.21 -39.22 92.05 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.593 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.24 -37.71 66.28 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.364 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -125.45 98.53 5.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.06 115.28 27.95 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -120.28 153.64 23.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.475 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.13 142.25 58.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.151 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.85 127.42 26.0 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.207 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.5 134.0 60.56 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.568 2.179 . . . . 0.0 111.896 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.37 87.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.808 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.46 -42.75 83.14 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.474 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.65 -41.75 95.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.286 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.2 -47.45 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.114 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.12 -47.54 80.85 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.258 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 48.4 m -60.29 -44.79 95.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.897 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . 0.465 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 67.0 mm-40 -71.81 -36.69 70.33 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.551 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 92.7 mt -61.94 -44.22 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.085 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 15.0 t70 -63.34 -42.52 98.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.906 0.384 . . . . 0.0 110.322 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.34 -43.85 98.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.23 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 92.9 mt -61.91 -41.23 97.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.762 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 82.6 mtm180 -63.88 -38.64 91.83 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.141 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 62.0 mtt-85 -64.25 -40.69 96.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.926 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.1 -43.03 96.59 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.455 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.84 76.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.971 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.18 77.36 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.965 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . 0.422 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 50.7 tt0 -60.99 -34.22 74.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.332 0.587 . . . . 0.0 110.019 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -82.08 -9.22 59.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.121 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -97.09 -0.58 46.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.688 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 135.38 0.52 3.33 Favored Glycine 0 C--O 1.226 -0.403 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.85 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 90.98 29.57 12.6 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.875 -1.155 . . . . 0.0 111.822 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . 0.423 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 42.5 t-20 -71.6 125.38 26.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.126 0.489 . . . . 0.0 111.136 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -124.5 157.13 36.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? 60.12 -38.67 0.09 Allowed 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 125.882 1.673 . . . . 0.0 114.681 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . 0.423 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.2 mm100 -75.24 -10.02 59.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.19 0.519 . . . . 0.0 110.362 177.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -65.88 -12.73 56.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.353 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . 0.485 HD12 HH12 ' B' ' 315' ' ' ARG . 62.6 tp -61.62 -34.8 76.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.883 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -76.98 -11.59 59.82 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.808 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . 0.436 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 84.3 mt -66.92 134.76 94.03 Favored Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.621 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -49.93 122.26 8.79 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.445 2.763 . . . . 0.0 113.69 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . 0.41 ' HG3' HD12 ' B' ' 311' ' ' ILE . 21.9 ttt180 -65.37 -44.56 87.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.018 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -68.38 -17.35 64.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.58 -172.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . 0.644 HD12 ' NZ ' ' B' ' 227' ' ' LYS . 92.1 mt -93.53 -5.86 48.07 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -117.36 -11.83 10.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.688 0.756 . . . . 0.0 109.767 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.98 -21.99 61.5 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.944 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -65.4 -48.64 72.14 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.907 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -75.18 -25.82 58.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.681 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . 0.438 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -59.06 -44.95 91.88 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.506 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . 0.468 ' O ' HG22 ' B' ' 346' ' ' VAL . 87.7 tttt -60.37 -45.25 94.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.255 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . 0.455 ' O ' HG22 ' B' ' 347' ' ' VAL . 18.4 mmt85 -62.68 -43.75 98.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -64.97 -38.83 92.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 121.189 -0.204 . . . . 0.0 111.059 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 341' ' ' ALA . 81.5 t -64.49 -44.14 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.436 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 70.3 t -61.8 -43.98 98.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . 0.455 HG22 ' O ' ' B' ' 343' ' ' ARG . 74.0 t -59.83 -45.21 95.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.676 0.274 . . . . 0.0 110.496 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.37 -41.25 99.76 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.805 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.5 -43.2 99.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' B' ' 346' ' ' VAL . 96.2 mt -62.91 -46.43 87.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.021 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.5 -39.31 85.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.776 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.95 -45.63 93.48 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.409 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -68.84 -37.29 79.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.218 0.509 . . . . 0.0 111.234 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.24 -46.25 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.7 -44.29 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.547 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -65.89 -50.07 65.8 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 97.3 m -65.79 -45.97 80.46 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -81.9 -7.22 59.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.694 0.283 . . . . 0.0 111.547 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 63.22 45.03 5.29 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.162 0.506 . . . . 0.0 111.317 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.01 155.95 28.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.977 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -132.22 158.65 41.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.5 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -84.85 102.48 13.12 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . 0.553 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 26.1 t70 -81.69 118.6 22.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 54.8 mm-40 -61.59 -39.07 89.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.299 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . 0.553 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 63.4 mm-40 -58.44 -48.04 82.01 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.271 0.557 . . . . 0.0 110.275 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -62.36 -40.3 95.98 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.275 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . 0.455 HG21 ' O ' ' B' ' 363' ' ' ASP . 97.1 t -63.56 -41.52 92.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.036 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 29.8 mmmt -56.97 -44.61 82.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.777 0.322 . . . . 0.0 110.135 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.38 -38.38 96.3 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.103 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.84 -42.27 99.67 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.288 0.566 . . . . 0.0 110.153 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.84 -43.31 97.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.529 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -61.33 -44.19 97.62 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -66.68 -40.0 88.37 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.937 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 55.6 ttm -64.63 -42.57 95.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.964 0.412 . . . . 0.0 110.75 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.81 -29.2 70.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.256 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 44.3 m -70.37 -7.28 41.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.955 0.407 . . . . 0.0 111.581 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.12 -2.5 58.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.441 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -108.98 174.26 5.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.053 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.62 -44.45 89.99 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.316 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -132.34 113.99 14.6 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -67.61 -30.43 35.04 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.332 2.021 . . . . 0.0 113.373 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.96 -44.35 80.76 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.69 -34.73 78.89 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.933 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.85 -43.02 97.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.438 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.37 -44.86 99.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.89 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 49.9 mt-10 -66.14 -45.0 82.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.124 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -57.1 -46.78 82.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.939 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . 0.419 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 4.4 t80 -63.52 -44.37 94.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.887 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 77.4 p -72.56 -14.12 61.56 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.1 mttt -94.46 5.82 50.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.893 0.377 . . . . 0.0 111.697 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -131.39 113.87 14.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.167 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -63.63 -37.11 86.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -56.91 -51.25 69.84 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.774 0.321 . . . . 0.0 110.533 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.83 -41.02 97.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.901 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 93.4 mtp -60.83 -51.77 67.9 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -72.69 -36.15 67.8 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.369 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.63 -41.03 98.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.988 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 398' ' ' MET . . . . . 0.419 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 50.1 tpp -63.74 -40.79 97.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.631 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -62.89 -34.3 77.13 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.745 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -61.02 -45.32 95.29 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.768 0.318 . . . . 0.0 110.452 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.49 -44.99 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.07 0.462 . . . . 0.0 110.791 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.22 97.46 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.645 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.75 -36.92 85.45 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.658 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . 0.411 ' O ' HG23 ' B' ' 408' ' ' VAL . 36.3 tt0 -58.86 -43.9 90.93 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.648 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . 0.434 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 32.2 mt-10 -65.23 -40.55 94.21 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.559 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -58.37 -44.34 88.83 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.559 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.39 -42.5 96.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 89.3 t -64.8 -46.29 92.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -67.53 -31.5 71.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.312 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.68 98.08 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.855 0.359 . . . . 0.0 110.107 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 95.9 t -66.51 -42.5 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.864 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 89.6 mt -61.56 -40.15 93.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.091 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.51 -21.79 65.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.564 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -102.06 -2.56 29.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.895 0.378 . . . . 0.0 110.952 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -101.66 173.14 6.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.147 0.499 . . . . 0.0 111.704 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -88.95 114.06 25.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.425 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.22 127.03 53.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.336 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 10.1 t -118.83 131.71 56.09 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.141 0.496 . . . . 0.0 109.92 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -98.62 113.26 25.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.662 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -129.02 146.67 50.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.846 0.355 . . . . 0.0 110.464 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -89.88 146.4 24.44 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.42 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -147.99 -175.67 4.98 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.342 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 67.6 p -94.78 159.92 14.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.33 . . . . 0.0 111.37 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.76 -34.29 77.99 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.05 0.453 . . . . 0.0 110.752 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -58.97 -39.18 80.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.409 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.0 -31.48 72.06 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 120.871 0.367 . . . . 0.0 110.854 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.21 -16.94 61.4 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.852 0.358 . . . . 0.0 110.529 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.3 mmt -75.95 -8.54 57.18 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.086 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -75.72 72.17 2.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -101.12 9.95 41.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.302 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -62.2 -46.62 88.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.917 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.623 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.104 -179.904 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.401 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 11.7 p -76.42 -170.71 1.57 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.958 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 4' ' ' SER . 0.6 OUTLIER 87.48 143.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.775 0.83 . . . . 0.0 111.901 177.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -140.74 156.35 46.21 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 m -88.56 129.24 35.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.9 0.381 . . . . 0.0 111.79 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.2 m -88.42 -70.59 0.63 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.069 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -166.27 122.16 1.25 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.891 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.12 -106.16 1.24 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.078 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.8 mt -92.91 -7.91 44.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.615 0.245 . . . . 0.0 110.976 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.521 ' O ' ' HD3' ' A' ' 13' ' ' ARG . . . -81.56 137.9 18.17 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.241 -0.504 . . . . 0.0 114.23 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -134.12 148.22 50.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.062 0.945 . . . . 0.0 110.84 179.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -110.81 137.96 47.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.4 t -96.73 -83.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.665 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 p 25.06 93.91 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.0 tp -123.56 139.76 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.871 0.367 . . . . 0.0 111.965 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.2 p -68.99 139.43 55.0 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.688 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.461 HD12 HG12 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -126.79 141.61 45.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -174.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.636 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -75.51 148.73 38.74 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.073 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.15 -40.22 76.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -175.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.55 -3.58 47.53 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.878 0.37 . . . . 0.0 111.449 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -105.71 -25.63 12.14 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.914 0.388 . . . . 0.0 110.624 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 20' ' ' ALA . 74.8 mt -60.56 -49.37 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.153 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 71.4 mm-40 -102.23 3.47 38.3 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -175.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.7 m -96.66 -72.14 0.65 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.265 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.84 89.0 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.1 t -62.87 -45.34 99.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.879 0.371 . . . . 0.0 111.132 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HZ2' ' HA ' ' A' ' 52' ' ' ASN . 20.2 ttmm -63.15 -45.58 91.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.7 m -62.72 -39.71 94.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.194 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 35' ' ' VAL . 8.5 tp10 -66.23 -40.55 90.34 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.53 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.28 -43.11 99.58 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.34 -39.11 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.908 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -65.48 -38.29 89.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.244 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 31' ' ' GLU . 96.0 t -62.46 -42.13 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 110.369 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.29 -41.81 94.17 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 110.223 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.87 -30.75 71.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.096 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 35' ' ' VAL . 24.5 ttmm -57.78 -41.94 83.08 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.171 0.588 . . . . 0.0 110.255 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 t -89.29 -4.48 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.005 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 64.96 33.9 9.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.646 0.778 . . . . 0.0 111.178 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.73 13.03 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.921 0.391 . . . . 0.0 111.741 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.99 -32.75 74.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.351 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.5 -3.4 58.1 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.148 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -86.47 -6.68 58.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.917 0.389 . . . . 0.0 110.834 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.9 ttt-85 -91.61 108.16 19.71 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.812 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.12 -39.49 92.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.635 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.95 29.66 22.61 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.254 -0.974 . . . . 0.0 114.757 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -60.98 -44.69 97.0 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.05 110.06 56.84 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.471 ' O ' HG13 ' A' ' 54' ' ' VAL . 53.1 Cg_exo -56.85 141.5 92.89 Favored 'Trans proline' 0 N--CA 1.477 0.557 0 C-N-CA 122.762 2.308 . . . . 0.0 112.135 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.1 ttt -68.33 -27.76 66.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -172.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.434 ' HA ' ' HZ2' ' A' ' 29' ' ' LYS . 28.7 p-10 -72.35 -17.4 61.84 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.095 0.474 . . . . 0.0 110.151 177.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.542 HD13 ' NH2' ' B' ' 193' ' ' ARG . 84.3 mt -99.75 -34.6 4.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.864 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 50' ' ' PRO . 21.4 m -60.76 -40.15 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 120.917 0.389 . . . . 0.0 111.012 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.77 -25.94 65.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -94.16 -32.5 13.7 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.066 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.401 HH12 HD12 ' B' ' 187' ' ' LEU . 15.3 tpp180 -64.68 -41.55 95.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.767 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.61 22.5 14.96 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.644 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.75 147.96 49.84 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.835 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.71 -39.69 0.45 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.468 0.707 . . . . 0.0 112.487 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 t -60.68 -47.93 84.04 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 122.678 0.391 . . . . 0.0 111.956 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.8 p -118.29 10.58 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.288 0.566 . . . . 0.0 110.733 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -60.31 -38.81 84.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.481 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 27.2 tt0 -60.08 -45.9 91.37 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.987 0.422 . . . . 0.0 110.83 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -68.1 -34.07 75.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.242 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 62' ' ' VAL . 79.2 t -60.9 -33.82 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 109.714 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 98.0 mt -61.68 -38.77 89.04 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.77 -40.27 99.0 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.498 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.91 -45.31 93.12 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.971 0.415 . . . . 0.0 110.915 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.34 -42.17 98.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.2 ttp -61.27 -46.31 90.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.316 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.3 m -64.4 -53.01 55.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.448 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -69.55 -39.44 77.42 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -65.12 -40.51 94.59 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.486 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -61.43 -48.42 81.24 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.41 ' O ' HG13 ' A' ' 79' ' ' ILE . 16.3 tt -67.78 -39.73 82.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 120.71 0.29 . . . . 0.0 111.154 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.37 -42.75 99.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.157 0.504 . . . . 0.0 110.699 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.98 87.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.309 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.7 pp -68.44 -31.13 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.12 -44.47 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.334 0.588 . . . . 0.0 110.655 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -82.93 -18.96 38.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.888 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -88.14 -7.7 56.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.325 0.583 . . . . 0.0 109.551 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 67.51 35.96 3.98 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.149 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.2 mt -100.37 116.16 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -103.35 105.44 46.65 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.455 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.92 142.89 83.84 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.403 2.069 . . . . 0.0 111.382 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.04 99.24 9.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.046 0.45 . . . . 0.0 110.836 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.08 -104.31 3.16 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.88 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.15 130.41 9.28 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.492 0.187 . . . . 0.0 110.728 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.93 154.03 37.88 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.39 2.06 . . . . 0.0 110.97 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -99.48 120.15 39.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.138 0.494 . . . . 0.0 110.49 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.453 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 97.2 m-85 -97.81 97.5 9.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.621 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.15 107.66 39.41 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.377 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 85.2 Cg_endo -89.01 157.84 5.84 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.907 2.405 . . . . 0.0 111.089 175.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.04 178.41 33.27 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.494 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.3 112.88 9.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.272 0.558 . . . . 0.0 110.038 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -79.35 127.55 32.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.522 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -107.42 119.98 40.91 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.12 117.74 9.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.015 0.436 . . . . 0.0 110.676 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.81 -5.79 54.09 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.665 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -119.97 179.59 4.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.695 0.283 . . . . 0.0 110.764 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -72.44 157.24 38.01 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 111.254 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -123.03 136.63 54.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.934 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.8 m -120.59 137.04 54.62 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.746 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -140.29 167.8 21.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.56 0.344 . . . . 0.0 111.066 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.2 m -78.31 -86.84 0.06 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.2 t 57.21 97.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.299 0.571 . . . . 0.0 110.117 -172.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -100.82 136.04 41.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -157.7 167.42 30.14 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.802 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -52.39 145.21 11.61 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -173.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.4 m -137.89 165.27 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.904 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -121.1 103.97 41.77 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -89.03 160.4 5.88 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.074 2.516 . . . . 0.0 113.531 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.08 138.85 52.71 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.28 141.62 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.636 0.255 . . . . 0.0 111.103 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -108.68 142.21 39.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.674 0.273 . . . . 0.0 110.98 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.3 mt -118.97 146.25 45.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -134.41 147.07 50.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 111.172 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.08 14.79 80.07 Favored Glycine 0 C--N 1.33 0.227 0 N-CA-C 114.273 0.469 . . . . 0.0 114.273 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.77 -38.2 90.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.177 0.513 . . . . 0.0 110.851 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.0 -8.25 54.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.807 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.39 11.07 39.83 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.917 0.389 . . . . 0.0 111.398 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.446 ' CD1' HD21 ' A' ' 294' ' ' LEU . 75.0 mt -88.95 125.64 42.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.2 119.53 38.67 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.7 t -112.19 132.6 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 111.432 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -88.57 140.66 29.23 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.538 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -130.19 106.46 16.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -68.61 118.05 5.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.059 1.839 . . . . 0.0 111.419 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -104.2 109.48 27.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.97 161.07 40.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.558 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -133.66 166.24 23.06 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.25 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.88 113.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.4 p -95.97 173.23 7.54 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.199 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.6 -32.6 73.63 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.887 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.23 -41.93 97.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.421 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.5 -39.73 95.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.831 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.79 -46.05 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.261 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -45.1 94.9 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.545 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.65 99.61 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.083 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.592 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.2 tpt -60.9 -47.41 86.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.673 0.273 . . . . 0.0 110.765 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.7 -42.0 98.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.43 -45.31 94.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.0 m -63.39 -40.75 98.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.849 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.4 mt -61.14 -40.08 92.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.162 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -74.68 -9.99 59.1 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 110.805 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.59 9.51 43.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.52 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -118.62 27.11 9.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.892 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -138.86 106.69 5.65 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.12 150.06 36.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.791 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.56 HG23 ' H ' ' A' ' 151' ' ' TRP . 0.2 OUTLIER -118.17 -176.44 3.06 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.002 -176.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.56 ' H ' HG23 ' A' ' 150' ' ' THR . 57.7 p-90 -108.66 145.04 35.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -161.67 -71.01 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.41 -127.76 0.25 Allowed 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.289 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.458 ' HE3' ' HG2' ' A' ' 242' ' ' GLU . 9.6 ptpp? -143.25 144.04 31.98 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.236 0.925 . . . . 0.0 113.426 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 156' ' ' GLY . 12.1 t70 -164.95 -151.51 0.15 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.536 ' HA3' ' HD3' ' A' ' 206' ' ' LYS . . . -104.51 59.95 0.44 Allowed Glycine 0 CA--C 1.509 -0.32 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.311 -178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.4 115.8 14.44 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.17 129.28 70.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.437 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -84.5 158.54 20.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.022 0.439 . . . . 0.0 111.962 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.4 28.7 0.24 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.74 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -170.03 21.11 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.633 0.773 . . . . 0.0 109.045 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.451 ' CG ' ' HE ' ' A' ' 243' ' ' ARG . 46.1 t0 -64.45 -42.32 96.04 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 55.7 ttp180 68.85 86.85 0.13 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.9 t -113.88 131.86 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.875 -175.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.4 m -67.93 106.8 2.43 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 86.4 mt -118.12 130.22 73.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -174.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -101.5 109.15 20.91 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.422 0.63 . . . . 0.0 109.551 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -137.29 154.43 50.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.065 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 37.3 m -127.15 131.97 50.64 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.266 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -69.46 125.22 17.17 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.983 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.3 m -138.67 131.01 28.61 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.2 t -79.78 -77.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -114.47 -60.78 1.84 Allowed 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -144.99 22.95 1.94 Allowed Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -132.57 143.91 50.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -94.1 146.61 23.85 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -111.96 173.46 6.35 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.448 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.17 -38.08 75.95 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.28 -178.45 37.2 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.045 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.38 22.63 56.27 Favored Glycine 0 C--N 1.319 -0.381 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.895 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.89 99.32 9.51 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -119.91 138.77 53.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.163 0.506 . . . . 0.0 111.743 -176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 m -142.3 122.5 13.83 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.368 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 60.06 31.68 20.7 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.459 0.475 . . . . 0.0 110.843 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -90.72 121.09 32.31 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.836 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.7 m -91.02 114.39 28.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.5 0.666 . . . . 0.0 110.464 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 163' ' ' ARG . 61.4 tp -101.74 116.05 31.87 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.391 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.688 ' HB2' ' NH1' ' A' ' 193' ' ' ARG . . . -99.96 102.64 14.07 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 50.4 mtm -75.32 171.33 14.4 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.054 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.57 5.64 71.6 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.159 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -118.03 -8.21 10.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 120.787 0.327 . . . . 0.0 111.062 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 75.4 47.47 12.57 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.215 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.688 ' NH1' ' HB2' ' A' ' 188' ' ' ALA . 49.8 mtm180 -104.79 6.29 33.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.443 0.64 . . . . 0.0 111.06 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.475 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -128.75 159.47 35.58 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.183 173.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.451 HG13 ' CE2' ' A' ' 217' ' ' PHE . 43.6 mm -54.78 131.75 65.85 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.12 123.6 5.34 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.706 2.27 . . . . 0.0 112.32 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.95 -37.33 3.88 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.36 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -62.39 -48.2 80.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.93 0.365 . . . . 0.0 111.887 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.54 -9.33 59.3 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -93.11 -27.94 16.63 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.274 0.559 . . . . 0.0 110.063 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.48 -16.43 73.73 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.629 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.52 -43.01 98.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -57.95 114.73 2.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.31 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 114.71 2.26 22.6 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.48 -0.866 . . . . 0.0 113.596 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -111.06 146.52 36.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.156 0.478 . . . . 0.0 111.593 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.536 ' HD3' ' HA3' ' A' ' 156' ' ' GLY . 75.4 mmtt -83.97 165.02 18.99 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.877 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.03 111.2 3.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.715 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 84.45 35.01 15.02 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.235 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -111.86 127.2 55.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.13 0.49 . . . . 0.0 111.641 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -92.28 142.48 27.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.58 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.431 ' O ' ' HB ' ' A' ' 212' ' ' THR . 75.4 t80 -159.48 -30.89 0.06 Allowed 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 35.5 m 78.46 142.06 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.623 0.369 . . . . 0.0 110.905 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.3 tp -138.28 127.54 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 121.062 0.458 . . . . 0.0 111.229 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -79.79 107.09 12.29 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.461 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 67.8 t -112.34 114.22 46.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.279 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 14.0 m -72.88 -41.61 64.5 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -176.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.542 ' HB2' ' O ' ' A' ' 216' ' ' THR . 68.7 m-85 80.81 143.45 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 123.539 0.736 . . . . 0.0 110.935 -174.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.68 152.44 53.35 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.437 2.091 . . . . 0.0 112.099 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -65.39 -35.68 81.68 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -87.34 23.98 1.73 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.648 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.429 ' CE2' ' HB2' ' A' ' 223' ' ' ALA . 8.3 t80 -67.94 133.71 49.56 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.044 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -67.95 -18.49 64.77 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.429 ' HB2' ' CE2' ' A' ' 221' ' ' TYR . . . -88.81 102.5 15.08 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 175.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.496 ' OE2' HD12 ' A' ' 336' ' ' LEU . 42.6 tt0 -57.05 -33.26 67.06 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.663 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -78.07 -11.39 59.91 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 90.2 mt -121.12 -4.7 9.51 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 21.8 ptmt -68.1 116.65 8.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.173 0.511 . . . . 0.0 111.71 -177.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.2 21.85 70.42 Favored Glycine 0 C--O 1.24 0.526 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.033 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.41 ' HZ2' ' HB3' ' A' ' 229' ' ' LYS . 9.9 mtpm? -121.92 112.16 17.96 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.4 142.98 57.41 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -174.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -127.94 144.08 51.1 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.782 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -100.58 -31.79 11.08 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 61.85 126.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -81.32 -40.94 22.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.769 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.2 mm 67.97 129.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.847 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.562 ' ND2' ' HZ3' ' A' ' 238' ' ' LYS . 7.6 t30 -107.08 -67.38 0.95 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.453 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 98.0 mt 62.31 94.39 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.562 ' HZ3' ' ND2' ' A' ' 236' ' ' ASN . 62.2 mttp -100.66 -37.87 8.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.136 0.493 . . . . 0.0 110.045 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -95.4 -88.43 0.26 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 92.0 t 73.39 126.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.585 0.553 . . . . 0.0 110.197 -173.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -73.8 -179.48 3.68 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.458 ' HG2' ' HE3' ' A' ' 154' ' ' LYS . 42.3 mt-10 -113.97 112.4 23.24 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -168.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.451 ' HE ' ' CG ' ' A' ' 162' ' ' ASP . 8.9 ptp180 -148.41 143.89 27.09 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.751 167.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -172.95 156.79 3.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 4.9 tt 69.77 109.26 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.199 0.6 . . . . 0.0 111.315 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -86.42 120.23 1.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.594 2.196 . . . . 0.0 112.743 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -147.18 177.57 9.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.984 0.421 . . . . 0.0 110.451 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 5.8 mp -93.06 78.1 4.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.238 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.408 ' OG1' HG21 ' A' ' 150' ' ' THR . 7.2 m -92.12 -63.16 1.27 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.882 0.372 . . . . 0.0 111.392 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -162.05 -32.1 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.045 0.45 . . . . 0.0 110.805 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -72.08 0.5 9.39 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.215 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -103.38 -26.1 13.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.173 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 44.8 pt -103.66 -8.28 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -171.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -159.61 7.22 0.1 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 119.526 -0.87 . . . . 0.0 113.089 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -120.61 135.82 54.99 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.574 0.226 . . . . 0.0 110.445 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -177.09 36.81 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 81.0 20.3 65.48 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.6 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 24.9 t -127.7 160.04 37.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -57.47 -50.9 71.56 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.033 0.444 . . . . 0.0 110.23 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -176.68 156.74 1.48 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.846 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -170.92 174.75 44.74 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.058 -1.067 . . . . 0.0 112.674 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.6 p -98.03 -173.86 2.71 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 122.716 0.406 . . . . 0.0 110.233 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 14.8 t -70.4 -71.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 111.191 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.1 pm0 -70.19 -37.02 75.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.866 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.5 -39.65 97.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.079 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 63.8 tp -63.25 -43.8 97.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.489 0.185 . . . . 0.0 110.995 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -62.62 -42.74 99.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.957 0.408 . . . . 0.0 110.282 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.54 -45.61 82.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.44 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 30.8 tp10 -66.34 -39.81 89.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.864 0.364 . . . . 0.0 110.974 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.01 -43.7 96.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.25 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -59.17 -48.56 81.14 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.03 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.8 ptmt -64.89 -44.32 90.02 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 111.198 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -65.12 -37.57 87.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.955 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 89.4 mmm -61.93 -42.85 99.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.825 0.345 . . . . 0.0 110.224 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.37 -32.14 69.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 55.3 ttp180 -63.45 -42.0 98.63 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -65.56 -35.8 81.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.855 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 44.2 tp -61.44 -36.78 81.32 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.905 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 58.1 tttm -54.81 -47.96 73.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.862 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 20.1 m -63.83 -42.44 97.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.037 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.39 -49.4 77.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.318 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 86.1 mt -64.02 -43.02 97.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.471 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -45.12 93.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.219 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -65.41 -41.37 93.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.26 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . 0.449 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.8 tpm_? -60.83 -44.13 97.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.785 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.3 t -68.88 -44.42 81.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.93 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.491 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.1 tttt -61.99 -48.44 80.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.82 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.8 p -63.62 -42.36 98.19 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.95 -39.56 90.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.204 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.03 93.95 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.851 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 287' ' ' LYS . 48.6 mm -65.11 -44.22 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.2 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.484 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 16.0 tp10 -60.02 -42.66 94.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.51 -45.82 92.03 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.709 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.446 HD21 ' CD1' ' A' ' 123' ' ' ILE . 26.5 mt -62.86 -42.17 99.65 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.8 -43.78 96.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.716 0.293 . . . . 0.0 110.849 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . 0.484 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 67.9 mttm -62.77 -41.92 99.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.037 0.446 . . . . 0.0 110.936 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.03 -46.01 65.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.917 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -123.91 100.39 6.73 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -95.86 113.7 25.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.7 tp -122.11 156.96 26.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.17 120.07 11.41 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.978 0.418 . . . . 0.0 110.057 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.86 128.12 42.75 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.449 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.45 ' O ' HG13 ' A' ' 307' ' ' ILE . 49.9 Cg_exo -55.6 129.92 37.69 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.654 2.236 . . . . 0.0 112.215 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.22 86.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.021 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.79 -45.46 82.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.011 0.434 . . . . 0.0 111.026 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.36 -41.88 93.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.988 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 311' ' ' ILE . 73.4 mt -61.54 -49.85 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.472 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.09 -42.73 99.51 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 30.1 m -62.23 -45.52 92.98 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.5 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.456 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 65.6 mm-40 -71.01 -35.0 71.88 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 307' ' ' ILE . 94.7 mt -61.94 -43.16 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.629 0.252 . . . . 0.0 111.117 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.48 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.8 t70 -59.53 -44.26 93.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.55 -42.9 96.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.127 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 84.4 mt -62.09 -40.68 96.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.48 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.8 mtm180 -61.27 -42.43 98.62 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -64.19 -38.64 91.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.916 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -62.84 -42.72 99.85 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.159 0.505 . . . . 0.0 110.116 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.1 80.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.201 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . . . -64.33 -37.05 86.14 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.225 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -63.62 -37.92 89.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.306 0.574 . . . . 0.0 109.646 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.94 -7.81 57.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.864 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -97.4 -0.9 45.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.246 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.06 7.61 2.25 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.168 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.18 38.84 8.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.479 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 319' ' ' ALA . 25.7 t-20 -84.6 135.23 34.28 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.874 0.369 . . . . 0.0 111.137 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.79 162.92 33.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 71.9 -54.21 0.68 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.102 0.561 . . . . 0.0 111.178 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.08 -17.78 63.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.84 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.58 -22.49 45.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.78 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.08 -34.6 76.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.546 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.88 10.19 14.61 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.672 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 77.9 mt -82.68 149.37 60.25 Favored Pre-proline 0 C--O 1.239 0.52 0 O-C-N 122.008 -0.433 . . . . 0.0 110.737 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.406 ' O ' ' HD1' ' A' ' 337' ' ' PHE . 40.4 Cg_exo -56.5 124.39 16.14 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.114 2.543 . . . . 0.0 113.111 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -70.43 -43.3 70.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.536 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -58.54 -40.59 83.41 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -170.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.496 HD12 ' OE2' ' A' ' 224' ' ' GLU . 60.7 mt -86.41 -0.32 55.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 333' ' ' PRO . 47.5 m-85 -107.45 -29.33 9.29 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -65.48 -32.49 74.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.252 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.87 -50.27 74.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -77.92 -21.86 50.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.55 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -62.45 -40.93 98.2 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.016 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.456 ' O ' HG22 ' A' ' 346' ' ' VAL . 88.2 tttt -59.79 -45.02 93.6 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.201 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.555 ' O ' HG21 ' A' ' 347' ' ' VAL . 12.3 mmt85 -61.68 -46.33 90.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.737 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -66.74 -37.51 84.79 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.466 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 341' ' ' ALA . 73.2 t -64.8 -43.64 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.607 0.241 . . . . 0.0 110.406 176.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 342' ' ' LYS . 76.1 t -61.48 -41.77 91.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.555 HG21 ' O ' ' A' ' 343' ' ' ARG . 69.1 t -58.64 -44.77 90.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.3 -40.31 98.84 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.181 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.46 -44.38 94.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 110.934 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 354' ' ' VAL . 98.2 mt -63.44 -48.5 77.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.883 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.86 -41.07 87.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.488 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.73 99.81 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.254 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.38 -35.83 78.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.643 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 350' ' ' LEU . 70.4 t -61.05 -44.9 99.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.21 -45.44 98.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -67.46 -51.72 48.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.0 m -65.33 -46.86 78.6 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -83.68 -5.97 59.32 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.351 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 61.23 55.52 2.95 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.095 0.474 . . . . 0.0 111.622 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 97.1 mt -88.85 160.19 17.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.459 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -140.88 155.61 46.28 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.901 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -75.42 104.98 6.22 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.441 ' O ' HG21 ' A' ' 367' ' ' VAL . 29.6 t70 -79.08 119.35 22.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.979 0.418 . . . . 0.0 111.341 -175.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 44.7 mm-40 -61.87 -42.74 99.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.347 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -64.89 -43.34 93.2 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.79 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 40.1 ttt85 -60.64 -42.93 97.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.238 0.542 . . . . 0.0 109.649 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 363' ' ' ASP . 87.2 t -65.96 -36.89 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.371 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.0 mmmt -56.31 -43.74 79.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.719 0.295 . . . . 0.0 110.58 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.01 95.54 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.739 -0.744 . . . . 0.0 111.935 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.2 -42.51 96.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.062 0.458 . . . . 0.0 110.2 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.96 -43.5 97.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.526 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.83 -41.4 99.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.581 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -66.46 -37.86 86.06 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.589 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.5 ttm -64.31 -43.36 94.95 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 121.027 0.442 . . . . 0.0 110.332 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.2 -29.53 70.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.392 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 44.7 m -73.0 -7.78 52.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.5 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.86 -2.37 58.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.391 0.615 . . . . 0.0 110.036 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.12 171.63 7.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.611 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -64.02 -49.09 73.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.992 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -118.79 107.63 42.14 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.779 0.323 . . . . 0.0 110.148 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.02 -34.86 99.23 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.937 2.424 . . . . 0.0 112.959 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -63.76 -45.21 90.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.45 -38.97 93.17 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.802 0.334 . . . . 0.0 110.654 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.77 -43.21 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.16 -43.78 99.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 120.826 0.346 . . . . 0.0 110.534 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.425 ' HB3' ' HE3' ' A' ' 390' ' ' LYS . 45.6 mt-10 -66.56 -38.97 88.22 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.735 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -58.07 -46.64 85.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.885 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -33.46 71.19 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 35.3 p -88.58 -5.04 58.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 386' ' ' GLU . 98.4 mttt -98.32 -0.66 43.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.941 0.401 . . . . 0.0 110.952 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -123.53 114.84 20.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.778 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -63.7 -39.77 95.13 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -58.76 -46.78 86.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.85 0.357 . . . . 0.0 110.52 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.66 -40.77 97.67 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.091 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 92.6 mtp -62.6 -44.66 95.75 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.01 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -64.57 -45.87 85.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.9 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -64.36 -44.17 92.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.537 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 46.2 tpp -63.51 -42.57 98.48 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.923 0.392 . . . . 0.0 111.323 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.432 ' HG2' HG23 ' A' ' 367' ' ' VAL . 77.2 mtm180 -65.75 -34.37 78.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.127 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -63.38 -43.02 98.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.707 0.289 . . . . 0.0 110.407 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.77 -46.1 95.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.912 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.84 88.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.38 -38.33 90.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.823 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.409 ' CD ' ' HZ2' ' A' ' 287' ' ' LYS . 40.8 tt0 -60.4 -43.99 96.14 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.341 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -66.34 -37.46 85.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.959 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -59.79 -42.66 93.89 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.45 90.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.064 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.99 -45.94 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -67.79 -30.35 69.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.558 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.16 99.35 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.69 -43.76 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.412 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.58 -38.67 88.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.237 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.25 -29.88 70.11 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.025 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.23 -22.31 18.5 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.889 0.376 . . . . 0.0 111.419 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.16 174.56 7.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.191 0.52 . . . . 0.0 111.327 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -84.28 133.27 34.56 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 66.8 t -118.14 128.88 75.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -119.3 144.25 46.91 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 120.989 0.423 . . . . 0.0 110.699 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -101.53 130.48 47.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.18 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -151.61 141.53 22.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.334 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -97.09 139.36 33.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.066 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.9 t -146.72 179.24 7.71 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.8 p -80.99 156.49 25.89 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.031 0.443 . . . . 0.0 111.372 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.3 -40.07 96.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.89 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -57.23 -34.77 68.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.177 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.04 -31.86 72.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.865 0.364 . . . . 0.0 111.237 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.6 mp -83.98 -7.81 59.31 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.026 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.7 mmt -79.28 -6.86 57.64 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.082 0.467 . . . . 0.0 110.497 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -76.15 81.4 2.96 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.453 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -106.46 13.63 28.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.824 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -66.05 -37.49 85.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.944 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.308 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.102 179.7 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.486 0.184 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -70.11 116.04 10.01 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.647 0.737 . . . . 0.0 112.172 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.17 172.47 14.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.177 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.425 ' O ' ' HB ' ' B' ' 5' ' ' VAL . 9.4 p -72.7 -175.34 1.65 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.287 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' B' ' 4' ' ' SER . 0.5 OUTLIER 89.32 141.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.908 0.883 . . . . 0.0 111.705 179.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -139.5 156.06 47.16 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 90.8 m -89.54 129.91 35.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.872 0.368 . . . . 0.0 111.766 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 75.1 m -89.11 -70.19 0.67 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -166.54 124.25 1.37 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.134 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.13 -110.6 3.47 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.648 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 85.9 mt -90.29 -6.82 54.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.519 0.199 . . . . 0.0 111.203 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.545 ' O ' ' HD3' ' B' ' 13' ' ' ARG . . . -84.27 137.54 16.02 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 114.41 0.524 . . . . 0.0 114.41 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.545 ' HD3' ' O ' ' B' ' 12' ' ' GLY . 0.0 OUTLIER -133.44 146.69 51.4 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.035 0.934 . . . . 0.0 110.619 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -108.68 138.3 45.23 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.815 0.446 . . . . 0.0 110.051 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.81 -85.91 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.684 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.4 p 27.84 94.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 tp -123.07 140.11 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.913 0.387 . . . . 0.0 111.857 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -73.01 138.15 45.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.746 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.476 HD12 HG12 ' B' ' 24' ' ' ILE . 0.9 OUTLIER -126.17 152.42 33.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -175.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.674 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -87.3 151.64 22.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.277 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.39 84.33 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -77.37 -3.14 38.63 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.187 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 15.4 t -107.56 -28.4 9.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.628 0.251 . . . . 0.0 111.075 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.674 HG13 ' O ' ' B' ' 20' ' ' ALA . 71.3 mt -60.25 -49.6 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 121.027 0.441 . . . . 0.0 112.097 -175.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.467 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 69.2 mm-40 -101.32 8.61 42.28 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -175.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 40.0 m -103.74 -70.49 0.76 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.137 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.09 -47.48 79.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.824 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 86.0 t -62.11 -45.22 99.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.467 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.7 ttmm -63.33 -45.17 92.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 60.0 m -62.8 -41.52 99.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.367 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.556 ' O ' HG22 ' B' ' 35' ' ' VAL . 10.4 tp10 -66.44 -39.05 88.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.72 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 89.3 mt -61.81 -43.02 99.67 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -66.0 -38.22 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.535 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.07 -38.65 91.84 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.556 HG22 ' O ' ' B' ' 31' ' ' GLU . 89.3 t -63.17 -43.04 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.545 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.32 97.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.432 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.02 -30.06 70.04 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.068 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' B' ' 35' ' ' VAL . 23.1 ttmm -59.51 -44.75 93.04 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.202 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.16 -2.97 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 63.52 31.39 14.83 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.329 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.82 10.8 8.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.08 -25.62 67.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.13 -4.37 78.21 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.808 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -86.67 -5.4 59.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.459 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 64.0 ttt-85 -93.21 108.26 19.92 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.841 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.18 -38.12 87.88 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.293 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.42 33.16 20.56 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.247 -0.978 . . . . 0.0 114.205 175.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -63.53 -40.98 98.44 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 t -117.18 112.47 39.76 Favored Pre-proline 0 N--CA 1.448 -0.557 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.411 ' O ' HG13 ' B' ' 54' ' ' VAL . 42.4 Cg_exo -57.53 142.77 95.53 Favored 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.687 2.258 . . . . 0.0 112.255 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 18.7 ttt -67.01 -29.38 69.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.55 -172.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . 0.427 ' HA ' ' HZ2' ' B' ' 29' ' ' LYS . 29.1 p-10 -71.85 -16.43 62.15 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.094 0.473 . . . . 0.0 110.361 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.638 HD13 ' NH2' ' A' ' 193' ' ' ARG . 78.0 mt -99.76 -36.07 5.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.789 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.411 HG13 ' O ' ' B' ' 50' ' ' PRO . 23.6 m -60.58 -40.71 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.785 0.326 . . . . 0.0 111.286 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.14 -30.0 70.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.354 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -91.79 -32.77 15.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.377 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -64.61 -41.61 96.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.869 0.366 . . . . 0.0 110.436 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -110.48 23.57 14.07 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.27 0.557 . . . . 0.0 110.509 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.94 147.5 50.34 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.781 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 71.24 -41.06 0.49 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.392 0.677 . . . . 0.0 112.296 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.3 t -58.28 -53.44 58.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.758 0.423 . . . . 0.0 111.865 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.492 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -114.76 10.61 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.296 0.57 . . . . 0.0 110.827 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -60.14 -38.95 84.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.647 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -59.44 -45.51 91.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.688 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.5 -33.2 73.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.754 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.492 HG23 ' O ' ' B' ' 62' ' ' VAL . 77.3 t -60.97 -35.19 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.47 -39.43 90.88 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.31 -39.81 98.22 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.699 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.34 -46.37 88.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.966 0.413 . . . . 0.0 110.882 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.57 -42.08 98.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.453 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 55.0 ttp -60.78 -46.5 90.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.216 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 52.0 m -64.21 -52.28 59.62 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.463 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -70.11 -39.37 75.52 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -64.98 -40.53 95.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.642 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -61.09 -47.85 84.38 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.798 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . 0.414 ' O ' HG13 ' B' ' 79' ' ' ILE . 14.8 tt -68.13 -39.19 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.869 0.366 . . . . 0.0 111.035 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.12 -43.91 97.79 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.565 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.62 89.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.234 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.414 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.6 pp -67.12 -35.39 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.44 -43.94 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.997 0.427 . . . . 0.0 110.987 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -82.58 -19.65 38.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.006 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -88.13 -8.32 55.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.357 0.599 . . . . 0.0 109.54 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 69.56 34.4 2.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.172 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 73.6 mt -99.17 116.72 42.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -103.78 108.53 59.94 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.847 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.49 141.84 57.17 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.383 2.056 . . . . 0.0 111.394 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.45 104.45 15.39 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.058 0.456 . . . . 0.0 110.589 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.33 -109.2 3.36 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.188 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.09 124.93 13.3 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-O 120.51 0.195 . . . . 0.0 110.616 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.84 157.55 54.86 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.371 2.047 . . . . 0.0 111.023 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 20.2 m -98.16 115.67 28.78 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.029 0.442 . . . . 0.0 110.558 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -96.16 98.19 10.14 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.02 110.69 58.66 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -91.07 165.44 3.77 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.163 2.575 . . . . 0.0 111.112 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.28 179.48 25.83 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.517 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.13 114.02 10.82 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -81.69 124.81 29.92 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.202 0.525 . . . . 0.0 111.54 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.65 117.51 34.24 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.43 123.36 18.54 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.657 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.56 -17.82 56.09 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.498 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -106.32 -170.51 1.74 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.615 0.245 . . . . 0.0 111.229 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -81.12 165.45 21.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -128.83 135.99 49.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.872 0.368 . . . . 0.0 110.877 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 45.9 m -119.84 136.49 54.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.687 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -141.66 167.03 23.13 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.925 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -78.82 -84.95 0.08 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 99.1 t 56.7 93.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-O 121.171 0.51 . . . . 0.0 109.975 -172.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.48 135.44 38.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -158.65 170.45 22.14 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.971 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -50.77 145.88 6.49 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.56 165.42 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.521 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -121.67 106.6 37.11 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 120.894 0.378 . . . . 0.0 110.197 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -91.96 161.27 3.3 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.242 2.628 . . . . 0.0 113.805 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -131.56 134.39 46.02 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.996 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.87 136.3 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.657 0.265 . . . . 0.0 111.306 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.05 141.51 32.78 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.093 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 97.6 mt -119.1 141.86 48.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -129.84 145.38 51.59 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.96 18.62 78.56 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.097 -0.502 . . . . 0.0 114.127 174.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -63.51 -40.52 97.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.052 0.453 . . . . 0.0 111.339 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.97 -19.04 65.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.856 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.43 8.17 29.17 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.494 ' CD1' HD21 ' B' ' 294' ' ' LEU . 77.6 mt -86.26 127.66 40.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.064 0.459 . . . . 0.0 110.949 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -112.37 125.04 53.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.73 132.41 68.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.987 0.423 . . . . 0.0 111.635 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.28 137.14 32.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.389 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -126.37 105.76 24.43 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.67 119.41 6.42 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.088 1.859 . . . . 0.0 111.832 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.408 HG13 ' HG2' ' B' ' 419' ' ' GLU . 48.6 mm -104.63 108.24 24.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.42 159.28 40.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.51 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.24 161.07 37.2 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.194 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 46.1 t -69.68 121.25 18.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.766 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.4 p -105.92 -180.0 4.1 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.773 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.6 -34.82 77.77 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.303 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.61 94.87 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.559 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -64.95 -40.9 95.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.655 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.02 -47.43 92.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.798 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -61.81 -44.39 96.95 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.32 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.04 -41.33 99.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.18 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' MET . . . . . 0.608 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.8 tpt -60.98 -46.85 89.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.782 0.325 . . . . 0.0 110.838 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.28 -41.94 96.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.39 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.92 -43.13 99.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.828 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 18.5 m -63.24 -39.86 95.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.66 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.5 mt -60.22 -41.64 93.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.779 -176.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -72.23 -16.69 61.94 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.107 0.479 . . . . 0.0 111.11 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.31 8.11 43.04 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.568 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -117.79 24.79 10.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.74 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -138.17 106.51 5.8 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.25 147.43 31.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.594 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' THR . . . . . 0.548 HG23 ' H ' ' B' ' 151' ' ' TRP . 0.3 OUTLIER -111.85 -163.16 0.83 Allowed 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.104 -176.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . 0.548 ' H ' HG23 ' B' ' 150' ' ' THR . 48.4 p-90 -123.2 146.64 47.64 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.058 0.456 . . . . 0.0 112.024 -176.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -168.03 -61.81 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.01 -142.27 0.22 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.773 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . 0.458 ' HE3' ' HG2' ' B' ' 242' ' ' GLU . 9.1 ptpp? -134.5 143.06 47.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.282 0.947 . . . . 0.0 112.874 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -164.56 -152.13 0.17 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . 0.448 ' HA3' ' HD3' ' B' ' 206' ' ' LYS . . . -99.93 63.32 0.66 Allowed Glycine 0 C--O 1.235 0.193 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.49 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.47 118.9 12.18 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.74 129.8 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -86.45 157.94 19.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.085 0.469 . . . . 0.0 112.085 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.99 26.27 0.26 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.84 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -167.55 20.17 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.414 ' CG ' ' HE ' ' B' ' 243' ' ' ARG . 45.2 t0 -64.09 -45.43 88.71 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.362 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' B' ' 187' ' ' LEU . 53.4 ttp180 72.18 88.38 0.1 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.49 132.62 64.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.077 0.465 . . . . 0.0 112.016 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 24.6 m -69.0 104.19 2.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.844 173.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 88.2 mt -116.77 128.45 74.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.906 0.384 . . . . 0.0 111.934 -175.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -102.16 110.09 21.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.47 0.652 . . . . 0.0 109.381 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -137.01 154.01 50.51 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.3 m -124.04 130.18 52.14 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.023 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -70.05 131.44 22.96 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.99 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -145.6 129.59 17.41 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 43.3 t -77.91 -76.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -113.93 -70.5 0.8 Allowed 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -135.77 23.31 3.4 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -136.09 140.55 43.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.128 -0.536 . . . . 0.0 109.647 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -91.83 146.25 23.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -106.86 174.54 5.84 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.092 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.57 -37.39 78.34 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.6 -174.68 36.95 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.786 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.84 22.91 54.49 Favored Glycine 0 C--N 1.32 -0.352 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.281 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -103.1 101.25 11.21 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -123.64 140.26 53.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.114 0.483 . . . . 0.0 111.946 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 34.6 m -141.14 121.16 13.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.539 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.81 33.17 22.9 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.55 0.531 . . . . 0.0 111.15 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -87.91 123.22 32.43 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.753 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 13.8 m -92.86 113.31 27.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.566 0.698 . . . . 0.0 110.716 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' B' ' 163' ' ' ARG . 52.1 tp -102.53 116.22 32.17 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.322 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . 0.684 ' HB2' ' NH1' ' B' ' 193' ' ' ARG . . . -99.9 105.37 17.08 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 41.9 mtm -76.17 168.88 19.25 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.129 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.9 -16.41 61.01 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.876 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -98.84 -3.46 35.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.599 -0.3 . . . . 0.0 111.455 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.16 44.6 59.76 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.176 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.684 ' NH1' ' HB2' ' B' ' 188' ' ' ALA . 47.8 mtm180 -98.32 4.63 48.68 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.417 0.627 . . . . 0.0 111.672 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.459 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -128.04 159.97 33.4 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 172.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.484 HG13 ' CE2' ' B' ' 217' ' ' PHE . 43.3 mm -54.42 133.56 62.42 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -48.09 126.22 13.01 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.359 2.039 . . . . 0.0 112.326 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.46 -34.15 6.01 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.261 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -64.32 -51.06 65.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.82 -16.65 60.69 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 121.015 0.436 . . . . 0.0 112.107 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -87.69 -21.59 25.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.173 0.511 . . . . 0.0 110.034 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.45 -10.82 85.52 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.63 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.0 mm -64.81 -42.85 96.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -55.32 124.81 18.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.762 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.5 1.59 40.56 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.793 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -111.13 148.6 32.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.313 0.557 . . . . 0.0 111.586 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . 0.448 ' HD3' ' HA3' ' B' ' 156' ' ' GLY . 75.6 mmtt -86.83 163.42 17.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.412 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.56 112.21 3.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.344 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.24 39.4 11.32 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.863 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -113.92 126.4 55.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.999 0.428 . . . . 0.0 111.035 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -92.13 136.51 33.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.619 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . 0.48 ' O ' ' HB ' ' B' ' 212' ' ' THR . 65.0 t80 -155.64 -28.26 0.1 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' B' ' 211' ' ' PHE . 91.3 m 75.92 143.83 0.08 Allowed 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 120.665 0.269 . . . . 0.0 110.749 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -138.17 128.07 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.075 0.464 . . . . 0.0 111.233 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -82.72 111.92 19.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.166 0.507 . . . . 0.0 111.522 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 73.3 t -118.19 130.92 72.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 9.9 m -94.24 -29.75 14.92 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -174.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' B' ' 216' ' ' THR . 69.1 m-85 74.3 141.35 0.08 OUTLIER Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 122.702 0.401 . . . . 0.0 111.085 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.89 151.89 51.39 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.303 2.002 . . . . 0.0 111.867 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -65.44 -34.62 78.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.73 26.87 1.05 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.28 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' B' ' 223' ' ' ALA . 7.2 t80 -70.73 133.95 47.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -67.71 -17.67 64.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.413 ' HB2' ' CE2' ' B' ' 221' ' ' TYR . . . -91.28 104.69 17.2 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 33.6 tt0 -57.79 -36.1 71.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.33 -175.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.423 ' O ' ' HD3' ' B' ' 229' ' ' LYS . 28.6 p-10 -72.92 -13.26 61.22 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.4 mt -120.13 -1.54 10.32 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.1 ptmt -69.95 114.14 7.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.301 0.572 . . . . 0.0 111.592 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.26 21.81 75.94 Favored Glycine 0 C--O 1.237 0.292 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.214 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.452 ' HZ1' ' HB3' ' B' ' 229' ' ' LYS . 9.7 mtpm? -122.28 109.91 15.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.87 145.54 55.36 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -128.44 146.23 50.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.772 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -100.97 -29.16 12.35 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -173.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 57.32 107.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -67.2 -40.23 86.44 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.832 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 48.8 mm 69.3 133.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.352 0.661 . . . . 0.0 111.338 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . 0.549 ' ND2' ' HG3' ' B' ' 238' ' ' LYS . 9.7 t30 -109.01 -65.44 1.14 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.843 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.8 mt 61.04 95.99 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . 0.549 ' HG3' ' ND2' ' B' ' 236' ' ' ASN . 64.1 mttp -102.13 -31.35 10.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.799 175.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -102.55 -87.13 0.42 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 85.4 t 72.36 121.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 123.532 0.52 . . . . 0.0 109.971 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.15 179.79 3.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.458 ' HG2' ' HE3' ' B' ' 154' ' ' LYS . 36.4 mt-10 -112.38 114.79 27.71 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -167.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.414 ' HE ' ' CG ' ' B' ' 162' ' ' ASP . 7.4 ptp180 -149.64 141.82 24.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.134 167.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.492 ' H ' ' HA ' ' B' ' 151' ' ' TRP . 1.0 OUTLIER -172.82 162.22 4.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 3.9 tt 67.57 106.45 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.229 0.611 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -85.63 118.5 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.592 2.195 . . . . 0.0 112.802 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -145.41 179.03 7.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.075 0.464 . . . . 0.0 110.733 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . 0.424 ' N ' HD12 ' B' ' 248' ' ' LEU . 4.8 mp -93.55 74.36 4.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.38 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' THR . . . . . 0.435 ' OG1' HG21 ' B' ' 150' ' ' THR . 11.6 m -85.51 -72.71 0.47 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.815 0.34 . . . . 0.0 111.258 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -154.69 -34.91 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.421 . . . . 0.0 111.12 -177.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -62.3 -35.32 78.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.672 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -64.84 -28.98 69.92 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.036 0.935 . . . . 0.0 113.505 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 43.1 pt -99.41 -4.52 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -160.23 -11.9 0.05 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 119.055 -1.058 . . . . 0.0 113.621 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -102.86 134.6 46.0 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.876 0.37 . . . . 0.0 111.255 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -172.67 36.91 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.28 20.67 69.05 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.7 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.6 161.32 35.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -52.02 -59.17 4.66 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 122.894 0.477 . . . . 0.0 109.832 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -173.78 162.46 4.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.824 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -173.31 178.42 45.27 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.583 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 93.1 p -102.56 -171.25 1.93 Allowed 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 122.263 0.225 . . . . 0.0 110.508 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.8 -57.18 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.962 0.411 . . . . 0.0 112.023 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -35.74 23.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.0 111.049 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.28 -39.14 97.51 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.391 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.86 -45.43 92.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.569 0.223 . . . . 0.0 110.631 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -64.29 -42.27 96.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.587 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.518 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.34 -45.15 89.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.314 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -67.12 -39.1 86.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.452 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.7 -44.13 96.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.606 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -60.09 -47.56 85.39 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 17.7 ptmt -64.55 -45.41 87.21 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.909 0.385 . . . . 0.0 111.077 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -65.06 -36.25 83.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 89.5 mmm -61.82 -42.67 99.31 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.031 0.443 . . . . 0.0 109.98 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -70.15 -31.43 68.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.798 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . 0.507 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 57.6 ttp180 -64.73 -42.17 95.41 Favored 'General case' 0 CA--C 1.527 0.074 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -66.85 -34.03 76.9 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.69 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.53 -38.01 85.85 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.719 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 55.4 tttm -55.84 -47.16 77.74 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.303 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 20.4 m -63.47 -42.28 98.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.907 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.02 -47.45 86.39 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.062 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.18 -43.62 97.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.234 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -44.62 96.99 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.83 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.17 -41.37 97.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.035 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . 0.493 ' HA ' ' HE ' ' B' ' 285' ' ' ARG . 4.2 tpm_? -60.42 -43.86 96.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.886 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.31 -44.12 80.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.135 0.493 . . . . 0.0 111.063 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.33 -48.58 79.19 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.938 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.6 p -65.15 -41.31 94.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.72 -40.89 92.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.642 0.258 . . . . 0.0 111.274 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.06 95.33 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.091 0.472 . . . . 0.0 110.653 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 36.7 mm -65.04 -43.49 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . 0.454 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 20.5 tp10 -61.87 -42.55 99.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.682 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.82 98.31 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.51 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' B' ' 123' ' ' ILE . 24.8 mt -63.73 -42.71 97.85 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.26 -42.16 93.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.731 0.3 . . . . 0.0 111.339 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . 0.454 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 66.4 mttm -61.95 -40.47 95.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.698 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.3 -47.46 19.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.904 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -114.89 96.02 5.51 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -99.94 105.54 17.25 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -116.71 159.4 16.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.604 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.6 130.11 43.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 42.6 t -105.48 127.53 28.38 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.029 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.37 128.6 30.76 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.461 2.107 . . . . 0.0 111.882 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.61 80.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.754 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.66 -48.05 72.82 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.338 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 66.3 mt -67.03 -40.52 87.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.002 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . 0.498 ' O ' HG13 ' B' ' 311' ' ' ILE . 75.7 mt -61.04 -49.82 83.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.391 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.13 -43.27 99.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.566 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 38.9 m -63.11 -45.25 92.9 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.643 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . 0.411 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 70.2 mm-40 -71.22 -34.44 70.81 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.512 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 89.9 mt -61.74 -43.05 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.027 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.515 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 31.0 t70 -59.32 -44.92 92.54 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.961 0.41 . . . . 0.0 110.805 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.39 -43.93 98.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.163 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 79.3 mt -62.92 -40.38 97.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.268 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.515 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 83.1 mtm180 -61.33 -42.56 98.87 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -65.08 -37.91 89.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.703 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -62.87 -42.68 99.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.206 0.527 . . . . 0.0 109.88 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.59 -37.47 79.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.523 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' B' ' 325' ' ' ASN . . . -63.9 -37.35 87.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.929 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -63.43 -37.08 85.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.364 0.602 . . . . 0.0 109.482 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -79.51 -3.36 46.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.898 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -101.68 4.22 40.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.953 0.406 . . . . 0.0 111.13 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 128.01 7.1 4.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.936 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 87.96 46.01 4.92 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.396 -0.906 . . . . 0.0 111.776 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' B' ' 319' ' ' ALA . 26.2 t-20 -91.25 135.14 34.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 -177.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.87 160.99 38.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.1 OUTLIER 72.66 -53.57 0.7 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.05 0.54 . . . . 0.0 111.214 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.66 -16.83 63.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.849 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.86 -22.91 50.47 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.81 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.54 -35.78 78.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.912 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -79.51 -5.25 54.43 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.214 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.01 152.6 96.74 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.009 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . 0.479 ' O ' ' HD1' ' B' ' 337' ' ' PHE . 32.9 Cg_exo -59.86 140.53 93.54 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.817 2.344 . . . . 0.0 112.854 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -86.08 -43.78 12.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.898 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -59.18 -39.38 82.37 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -171.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 62.1 mt -86.21 0.31 54.0 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.826 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . 0.479 ' HD1' ' O ' ' B' ' 333' ' ' PRO . 50.8 m-85 -107.75 -29.55 9.05 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.31 -31.7 72.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.964 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -58.92 -49.08 79.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.044 0.449 . . . . 0.0 110.795 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -83.5 -21.03 32.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.012 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . 0.416 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.85 -40.48 97.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . 0.424 ' O ' HG22 ' B' ' 346' ' ' VAL . 87.7 tttt -59.35 -44.37 92.67 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.194 177.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . 0.551 ' O ' HG21 ' B' ' 347' ' ' VAL . 13.5 mmt85 -61.35 -45.22 95.32 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.772 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -67.22 -38.72 85.75 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.306 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.416 HG23 ' O ' ' B' ' 341' ' ' ALA . 74.2 t -64.53 -43.58 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.36 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.424 HG22 ' O ' ' B' ' 342' ' ' LYS . 57.7 t -61.32 -42.49 93.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.44 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . 0.551 HG21 ' O ' ' B' ' 343' ' ' ARG . 79.4 t -59.87 -44.86 95.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.51 -41.69 99.61 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.928 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.96 -44.54 95.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.748 0.308 . . . . 0.0 110.982 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.451 ' O ' HG22 ' B' ' 354' ' ' VAL . 92.7 mt -63.53 -47.2 82.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.997 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.54 -41.29 88.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.487 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.21 99.73 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.195 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.22 -35.75 78.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.061 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . 0.451 HG22 ' O ' ' B' ' 350' ' ' LEU . 76.1 t -60.61 -45.08 97.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 77.7 mt -63.4 -46.2 95.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.68 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.1 -54.26 32.7 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 47.7 m -65.21 -44.94 86.7 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -83.44 -8.47 59.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.265 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 65.43 45.39 2.83 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.271 0.558 . . . . 0.0 111.267 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 97.6 mt -78.79 156.3 28.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.768 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -139.02 153.45 48.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.516 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -75.07 105.77 6.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -80.83 116.48 20.84 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.978 0.418 . . . . 0.0 111.464 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 60.3 mm-40 -58.75 -42.61 89.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.308 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -62.42 -44.49 96.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.678 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -61.35 -42.64 99.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.207 0.527 . . . . 0.0 109.792 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . 0.413 HG23 ' HG2' ' B' ' 399' ' ' ARG . 94.7 t -65.96 -36.23 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.316 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.5 mmmt -56.31 -42.68 78.01 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.803 0.335 . . . . 0.0 110.663 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.95 -38.48 96.66 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.086 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.88 -42.04 97.6 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.1 0.476 . . . . 0.0 110.221 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 65.3 mt -65.7 -43.62 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.148 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -61.67 -40.0 93.39 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.693 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -67.28 -38.57 85.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.001 0.429 . . . . 0.0 110.412 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 58.1 ttm -64.28 -41.84 96.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.132 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . 0.418 ' HA ' HG13 ' B' ' 384' ' ' VAL . . . -64.39 -32.62 74.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.29 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 49.6 m -71.23 -8.02 50.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.454 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.85 -1.89 57.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.033 0.444 . . . . 0.0 110.507 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -117.81 173.23 6.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.123 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -65.87 -49.83 66.68 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -116.18 107.76 47.04 Favored Pre-proline 0 CA--C 1.518 -0.251 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.39 -29.21 71.81 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.106 1.871 . . . . 0.0 113.26 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -64.55 -45.12 88.47 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.89 -36.23 82.82 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.771 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . 0.418 HG13 ' HA ' ' B' ' 375' ' ' ALA . 57.9 t -65.11 -43.84 95.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.605 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.59 -43.89 98.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.983 0.421 . . . . 0.0 109.916 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -65.93 -38.13 87.86 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.928 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -58.34 -46.66 85.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.541 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.08 -42.1 76.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 41.9 p -78.27 -8.36 58.28 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.23 9.28 42.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.847 0.356 . . . . 0.0 111.259 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -134.66 111.27 9.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.061 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -61.66 -39.85 92.85 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -59.99 -45.07 93.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.771 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.89 -40.63 96.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.686 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 94.8 mtp -62.13 -45.41 93.59 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.265 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.39 -44.16 79.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.008 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -64.09 -44.91 90.9 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.27 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 40.7 tpp -63.03 -42.54 99.81 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.926 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.413 ' HG2' HG23 ' B' ' 367' ' ' VAL . 84.1 mtm180 -66.12 -34.8 78.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.616 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -63.02 -42.63 99.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.796 0.332 . . . . 0.0 110.383 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.75 -46.02 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.792 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.21 88.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.693 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.45 -38.95 93.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.529 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.12 -43.33 99.05 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.38 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -65.7 -37.52 86.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.645 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -59.54 -43.86 93.39 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.642 0.258 . . . . 0.0 110.437 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.91 89.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.25 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.21 -46.24 93.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.004 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.86 -30.8 70.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.745 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.48 -40.05 94.94 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.914 0.388 . . . . 0.0 110.139 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.15 -42.84 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.188 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.33 -39.79 91.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.305 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.47 68.42 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.549 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -96.89 -9.76 27.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.53 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.01 -170.25 1.79 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.182 0.515 . . . . 0.0 110.921 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -102.57 120.0 39.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.417 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 66.4 t -106.74 126.98 62.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 13.6 t -118.27 146.72 44.09 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.134 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . 0.408 ' HG2' HG13 ' B' ' 129' ' ' ILE . 41.4 mt-10 -107.84 123.22 48.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.298 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -144.64 147.76 33.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.751 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -97.11 147.72 23.77 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.451 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -155.46 178.48 10.19 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 22.1 p -82.21 153.38 25.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.988 0.423 . . . . 0.0 111.37 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -63.13 -34.07 76.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.835 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -60.6 -35.78 76.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.448 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.25 -32.0 73.45 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.944 0.402 . . . . 0.0 111.169 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.36 -7.95 59.49 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.86 0.362 . . . . 0.0 111.1 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.3 mmt -80.26 -6.9 58.65 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.05 0.452 . . . . 0.0 110.613 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -74.48 81.14 1.94 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.395 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -106.04 13.4 29.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.806 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -65.82 -40.53 91.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.034 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.751 -179.828 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.233 0.23 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 t -111.1 102.26 10.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.859 0.361 . . . . 0.0 110.255 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.29 139.49 26.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.916 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 45.7 mt-10 -124.84 177.18 6.15 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.839 0.352 . . . . 0.0 110.808 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.4 m -124.91 131.74 53.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.909 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 45.3 m -79.86 -70.38 0.52 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 177.83 139.01 0.08 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.517 0.727 . . . . 0.0 109.569 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.85 -121.19 25.05 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.242 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 108' ' ' GLU . 81.0 mt -65.12 -39.74 93.51 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.9 0.48 . . . . 0.0 110.943 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 108' ' ' GLU . . . -68.78 140.45 34.74 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 115.857 1.103 . . . . 0.0 115.857 -173.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -129.69 -163.57 1.32 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -160.28 116.94 2.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 117.888 0.313 . . . . 0.0 110.647 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t -95.77 -90.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.194 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m 51.1 83.79 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.224 0.535 . . . . 0.0 111.0 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 tp -113.58 145.15 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.6 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.0 p -99.64 129.78 45.81 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.557 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.447 ' CD1' HG12 ' A' ' 24' ' ' ILE . 6.5 pt -131.46 157.49 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.652 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -79.87 154.55 28.3 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.851 0.461 . . . . 0.0 112.04 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.76 -50.63 69.91 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.22 -37.33 86.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.487 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -63.24 -43.41 98.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.103 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 20' ' ' ALA . 67.0 mt -62.71 -52.34 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.232 0.539 . . . . 0.0 111.742 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.04 -38.38 72.57 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.453 -173.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -79.23 -59.29 2.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.71 -48.12 70.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -173.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.493 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 94.4 t -63.98 -43.89 97.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.48 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -61.55 -45.28 94.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.321 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 m -63.89 -41.64 97.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.726 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.431 ' O ' HG21 ' A' ' 35' ' ' VAL . 34.8 tp10 -66.55 -36.11 81.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.794 0.331 . . . . 0.0 111.102 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 91.9 mt -61.54 -42.31 98.64 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.63 -37.81 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.025 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -63.11 -41.42 99.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.817 0.342 . . . . 0.0 110.769 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 31' ' ' GLU . 91.1 t -63.74 -43.99 98.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.426 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.55 93.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.885 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.74 -33.01 74.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.231 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -59.0 -45.7 90.0 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 110.38 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.3 t -87.74 -2.68 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.265 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 64.1 27.52 14.11 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.131 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -105.38 8.67 9.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.002 0.43 . . . . 0.0 111.535 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.54 -34.08 77.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.322 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.86 -5.16 56.88 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.435 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -84.87 -10.26 57.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.907 0.353 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -88.55 110.1 20.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.338 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.71 -41.38 97.53 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.1 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.07 42.56 76.45 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 115.898 1.119 . . . . 0.0 115.898 172.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -61.81 -43.72 98.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.274 1.037 . . . . 0.0 108.717 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.24 100.81 39.04 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.441 ' HG2' HD12 ' A' ' 53' ' ' ILE . 30.9 Cg_endo -63.76 158.09 48.47 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.657 2.238 . . . . 0.0 112.543 -176.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.453 ' HA ' HG12 ' A' ' 54' ' ' VAL . 82.9 mtp -61.82 -32.63 72.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.981 -174.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -69.16 -18.74 63.97 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.208 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.635 HD11 ' NH2' ' B' ' 193' ' ' ARG . 89.5 mt -105.66 -48.26 9.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 51' ' ' MET . 14.8 p -63.09 -35.15 70.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 120.988 0.423 . . . . 0.0 111.138 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.61 81.36 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.297 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -91.54 -7.19 51.01 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.403 HH12 HD12 ' B' ' 187' ' ' LEU . 67.9 mtt180 -97.3 -30.33 13.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.177 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -111.74 12.72 21.06 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.678 0.751 . . . . 0.0 109.531 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 61' ' ' SER . . . -65.54 150.54 51.78 Favored Glycine 0 CA--C 1.493 -1.312 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.417 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.47 -41.5 0.5 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.356 0.663 . . . . 0.0 111.388 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 59' ' ' GLY . 39.1 t -60.01 -46.79 88.34 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.07 0.548 . . . . 0.0 111.151 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.4 p -124.52 14.2 4.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.456 0.646 . . . . 0.0 110.892 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -64.73 -19.11 65.59 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.985 0.422 . . . . 0.0 110.948 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -62.02 -52.32 64.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.623 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.87 -17.6 59.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.244 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 62' ' ' VAL . 77.7 t -64.64 -42.71 95.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 173.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.72 -39.61 94.61 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 71' ' ' MET . . . -60.31 -41.14 98.28 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.563 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.724 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 30.8 t70 -63.37 -43.83 96.5 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.45 -43.43 98.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.91 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 68' ' ' GLY . 24.8 ptt? -63.65 -40.74 97.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.6 m -64.17 -40.26 95.73 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.091 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.724 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 43.9 mtp85 -63.03 -43.57 98.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.165 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -64.26 -41.06 97.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.695 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.87 -48.57 79.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.914 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.442 ' O ' HG13 ' A' ' 79' ' ' ILE . 19.3 tt -67.81 -40.76 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.466 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.79 -43.01 97.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.128 0.489 . . . . 0.0 110.221 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.86 95.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.093 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.6 pp -67.01 -40.92 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.974 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.73 -44.59 96.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.537 0.684 . . . . 0.0 109.765 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -64.71 -45.35 86.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.086 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -86.69 0.66 54.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.708 0.29 . . . . 0.0 111.416 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm 63.76 52.23 2.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.751 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.11 126.29 64.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.738 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -101.27 109.66 59.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.552 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.21 117.98 4.23 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.331 2.021 . . . . 0.0 112.034 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.08 93.68 8.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.135 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.14 -159.01 17.83 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.992 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.74 123.67 59.09 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.69 112.5 2.21 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.115 1.877 . . . . 0.0 110.704 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -96.26 114.88 26.61 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.237 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.557 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 91.3 m-85 -87.66 137.39 32.37 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.99 96.91 16.0 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-O 120.873 0.368 . . . . 0.0 111.792 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 93.1 Cg_endo -103.43 -172.12 0.07 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 123.473 2.782 . . . . 0.0 111.418 175.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -118.76 -172.0 15.26 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.65 145.96 25.37 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -95.17 126.76 40.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.15 0.5 . . . . 0.0 111.044 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.66 128.5 54.23 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.6 tp -67.03 114.49 5.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.892 0.377 . . . . 0.0 110.851 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.62 1.89 55.37 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.915 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -123.17 167.76 13.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.939 0.369 . . . . 0.0 110.99 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -71.34 141.87 50.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.743 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -95.7 137.31 34.95 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.7 m -119.62 131.19 55.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.826 0.346 . . . . 0.0 111.334 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -129.94 148.11 51.77 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.077 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.494 ' O ' HG13 ' A' ' 107' ' ' VAL . 50.1 m -102.46 -65.74 0.97 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 70.65 152.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 124.12 0.968 . . . . 0.0 111.047 -175.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.544 ' HG2' ' HA2' ' A' ' 12' ' ' GLY . 25.0 mt-10 -133.26 151.23 51.91 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 122.239 -0.288 . . . . 0.0 110.47 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -154.85 -73.03 0.12 Allowed 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -112.4 162.56 15.44 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -171.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.431 HG11 HD23 ' A' ' 11' ' ' LEU . 3.9 m -136.82 143.22 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.224 177.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -145.64 98.48 4.53 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 121.083 0.468 . . . . 0.0 110.546 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.88 149.56 20.48 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.086 2.524 . . . . 0.0 114.213 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -144.36 120.15 10.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.979 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 66.5 t -123.42 135.44 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.635 0.255 . . . . 0.0 111.12 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -121.81 142.04 50.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.58 153.14 38.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.59 0.234 . . . . 0.0 110.859 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -136.94 158.15 45.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.59 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.34 17.53 68.81 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.563 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.52 -39.84 94.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.185 0.517 . . . . 0.0 111.004 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.78 -17.2 64.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.681 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.18 12.2 29.63 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.869 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.1 mt -87.81 111.89 22.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.18 0.514 . . . . 0.0 110.32 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -105.73 120.89 42.85 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.7 t -118.3 133.01 66.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.629 0.252 . . . . 0.0 110.861 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -81.09 142.64 33.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.579 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.47 93.36 40.88 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.31 113.47 3.47 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.23 1.953 . . . . 0.0 112.123 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.29 115.53 43.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.037 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.07 158.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.675 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -133.99 157.4 46.17 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.598 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -70.82 127.14 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 71.7 p -110.84 176.64 4.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.738 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -62.68 -33.92 76.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.348 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.24 -40.99 96.1 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.886 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -64.5 -47.45 78.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.116 0.484 . . . . 0.0 110.385 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.08 -45.76 95.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.757 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.93 -46.28 91.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.479 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.22 97.82 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.817 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.555 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.8 tpt -61.71 -46.51 89.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.616 0.246 . . . . 0.0 110.841 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.76 -41.66 97.95 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.972 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.85 -45.34 94.92 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.369 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 m -63.51 -42.83 98.46 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.177 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.4 mt -60.71 -43.41 97.83 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -65.85 -33.36 75.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.926 0.393 . . . . 0.0 110.964 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.7 -13.81 60.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.914 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -90.02 -54.32 4.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -56.42 125.68 23.07 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.82 -167.41 2.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.525 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 151' ' ' TRP . 4.4 m -146.43 170.74 16.21 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.48 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 6.8 p-90 -120.38 145.91 46.7 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 151' ' ' TRP . 56.3 tttp 173.55 -59.61 0.01 OUTLIER 'General case' 0 C--N 1.351 0.639 0 O-C-N 123.862 0.726 . . . . 0.0 110.531 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -109.64 177.14 4.82 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 120.692 0.282 . . . . 0.0 111.498 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -84.15 147.11 27.5 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 69.48 116.88 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.978 0.911 . . . . 0.0 113.259 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -167.9 -98.74 0.12 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.436 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.35 145.79 29.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.3 126.48 67.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -95.54 -176.7 3.84 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.765 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.81 -66.89 0.48 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.498 ' OE2' ' HA ' ' A' ' 256' ' ' PHE . 13.9 pt-20 -78.52 7.35 6.85 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 188' ' ' ALA . 31.1 t70 -72.74 147.66 45.39 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.354 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 163' ' ' ARG . 16.8 ptp180 -101.87 116.7 33.28 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.59 127.14 74.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.586 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.1 m -74.93 109.54 8.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.6 124.37 66.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.061 0.457 . . . . 0.0 111.633 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.13 91.1 6.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -111.81 149.34 31.89 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.349 0.595 . . . . 0.0 111.885 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 40.5 m -128.15 129.75 47.02 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.121 177.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.85 134.65 12.65 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.827 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.3 m -142.84 144.35 32.49 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 120.83 0.347 . . . . 0.0 110.731 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.2 t -98.76 94.12 3.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 64.75 -70.39 0.08 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.331 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -137.06 5.82 3.65 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.77 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -130.24 139.15 50.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.585 0.692 . . . . 0.0 111.169 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.37 153.1 30.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.144 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -117.62 -177.31 3.21 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -53.78 -49.57 67.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.833 0.853 . . . . 0.0 113.194 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -103.0 -164.97 25.84 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.016 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . 82.25 28.22 41.38 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.861 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -114.03 106.73 14.75 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.67 145.9 50.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.836 0.35 . . . . 0.0 111.263 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 69.1 m -139.43 130.37 26.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.713 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 55.34 32.24 18.34 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.717 0.636 . . . . 0.0 110.513 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -93.2 133.49 36.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.965 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.6 m -94.04 119.48 41.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.52 0.676 . . . . 0.0 111.376 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.439 HD12 HH12 ' B' ' 57' ' ' ARG . 29.8 tp -111.37 123.58 50.5 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.106 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.718 ' HB3' ' NH1' ' A' ' 193' ' ' ARG . . . -110.91 131.52 54.97 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 173.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.441 ' SD ' ' HB ' ' A' ' 202' ' ' ILE . 70.8 mtm -98.43 177.08 5.46 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.218 0.532 . . . . 0.0 112.032 -171.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.53 23.32 67.92 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.498 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -131.85 -15.04 3.08 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 121.096 -0.241 . . . . 0.0 111.561 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.4 42.48 9.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.063 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.718 ' NH1' ' HB3' ' A' ' 188' ' ' ALA . 70.9 mtm180 -100.69 -0.38 37.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.316 0.579 . . . . 0.0 110.754 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.439 ' HE3' ' HA ' ' A' ' 194' ' ' MET . 0.7 OUTLIER -132.01 168.7 17.48 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 175.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.422 HG12 ' CE2' ' A' ' 217' ' ' PHE . 3.4 mp -58.75 129.92 85.32 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.3 133.62 42.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.399 2.066 . . . . 0.0 111.929 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.84 -43.47 1.67 Allowed Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.089 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -63.54 -46.56 85.42 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.46 0.172 . . . . 0.0 111.053 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -86.68 14.17 7.47 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 121.184 0.516 . . . . 0.0 111.126 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.601 ' O ' ' HE2' ' A' ' 203' ' ' LYS . 17.3 t70 -113.62 -41.05 3.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.137 0.494 . . . . 0.0 109.866 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.9 -17.58 67.65 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.577 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.441 ' HB ' ' SD ' ' A' ' 189' ' ' MET . 69.9 mt -67.44 -26.31 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 122.632 -0.334 . . . . 0.0 111.316 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.601 ' HE2' ' O ' ' A' ' 200' ' ' ASP . 46.5 mtmt -57.9 132.74 54.28 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.971 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.6 -12.65 64.57 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.744 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -88.07 160.08 17.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.055 0.427 . . . . 0.0 111.679 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -88.02 176.18 7.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.943 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -91.31 53.29 2.28 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.429 0.633 . . . . 0.0 111.101 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 150.75 44.58 0.02 OUTLIER Glycine 0 C--N 1.307 -1.056 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -125.72 131.39 52.57 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.133 -0.534 . . . . 0.0 110.518 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -108.96 112.06 24.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.032 0.444 . . . . 0.0 109.931 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -132.39 -4.51 3.38 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.949 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 69.4 p 58.34 169.24 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.887 0.875 . . . . 0.0 112.473 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.5 tp -156.48 143.71 10.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.874 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.405 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 28.2 m-20 -95.28 114.89 26.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.373 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 67.9 t -117.99 129.9 73.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 8.7 m -91.31 -24.49 19.8 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -174.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 216' ' ' THR . 64.5 m-85 69.62 158.13 0.15 Allowed Pre-proline 0 N--CA 1.485 1.291 0 CA-C-O 120.849 0.357 . . . . 0.0 110.866 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -86.62 156.32 9.06 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 122.22 1.946 . . . . 0.0 112.089 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.511 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 67.5 mm-40 -66.16 -42.58 88.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.02 65.72 9.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.022 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -103.62 139.93 38.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.671 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -64.92 -18.91 65.63 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.74 110.43 22.52 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 43.2 tt0 -64.57 -35.14 80.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.019 0.437 . . . . 0.0 111.745 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -70.47 -15.7 62.84 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.554 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.1 mt -114.91 -3.95 12.65 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.5 ptmt -71.72 126.53 29.96 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.696 -176.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.08 29.2 74.23 Favored Glycine 0 C--O 1.24 0.483 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.459 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -125.62 135.48 52.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.907 0.354 . . . . 0.0 110.956 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -79.8 131.89 36.01 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.951 0.405 . . . . 0.0 110.347 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -117.12 157.99 24.98 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.559 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.405 ' HE2' ' OD1' ' A' ' 214' ' ' ASP . 34.4 mmtp -116.0 106.89 14.29 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -83.0 111.71 19.1 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.3 0.571 . . . . 0.0 110.564 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -81.74 90.9 6.39 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.486 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm -88.04 116.93 30.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -104.8 -52.61 2.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.351 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 98.9 mt 65.78 132.75 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.632 0.773 . . . . 0.0 112.557 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -111.44 -66.33 1.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.195 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -100.16 -67.86 0.83 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.387 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 17.1 t 71.08 155.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.279 0.632 . . . . 0.0 111.225 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -80.52 -179.13 7.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.982 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.33 143.79 50.99 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.301 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -175.49 104.63 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.964 0.506 . . . . 0.0 112.322 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -171.83 163.55 6.34 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 35.9 tp 75.67 111.13 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 123.933 0.893 . . . . 0.0 110.721 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.409 ' HA ' ' CG2' ' A' ' 150' ' ' THR . 92.6 Cg_endo -81.76 140.07 11.42 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.495 2.13 . . . . 0.0 114.315 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -136.16 10.44 3.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.446 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 8.5 mp 70.39 109.55 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.467 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.534 HG21 ' H ' ' A' ' 251' ' ' GLU . 30.6 m -125.93 131.9 52.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.112 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -70.84 -18.77 62.71 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . 0.534 ' H ' HG21 ' A' ' 249' ' ' THR . 47.8 mt-10 -61.89 -45.41 93.89 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -76.33 -26.14 55.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.766 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 250' ' ' ALA . 11.2 tp -73.36 -35.38 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.689 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 22.8 ptmt -92.12 -20.53 21.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -123.5 119.44 29.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.28 0.562 . . . . 0.0 111.953 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.498 ' HA ' ' OE2' ' A' ' 161' ' ' GLU . 56.1 t80 -156.43 83.54 0.98 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.03 -48.96 3.42 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -175.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.36 150.56 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 123.187 0.595 . . . . 0.0 109.877 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.27 -48.73 79.54 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.517 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.88 131.33 4.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.979 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -134.1 -142.86 4.78 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.748 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 21.6 p -142.38 -169.86 3.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.4 -66.14 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.374 0.607 . . . . 0.0 110.512 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.6 OUTLIER -70.91 -39.91 72.46 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.249 -178.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.28 -39.15 96.78 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.642 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.41 -43.92 97.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.616 0.246 . . . . 0.0 110.812 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -63.26 -42.46 99.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.171 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -67.89 -43.02 80.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.65 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -67.94 -39.06 83.52 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.991 0.424 . . . . 0.0 110.71 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.79 -41.73 92.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -55.22 -52.12 64.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.749 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.1 ptmt -65.33 -42.03 93.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.712 0.291 . . . . 0.0 111.689 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.92 -39.78 94.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.701 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 90.7 mmm -63.52 -42.66 98.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.59 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -69.45 -33.48 72.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.62 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -62.45 -43.39 98.94 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.319 0.58 . . . . 0.0 109.661 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -69.42 -33.57 73.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.053 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.64 -40.78 96.1 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.495 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -57.61 -44.4 85.46 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.058 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.2 m -62.69 -42.88 99.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.72 98.84 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.327 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.93 -43.74 97.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.983 0.421 . . . . 0.0 110.031 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -44.61 97.09 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.087 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -64.37 -41.92 96.45 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.449 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -60.92 -43.78 98.13 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.032 0.444 . . . . 0.0 110.447 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 94.0 t -68.44 -44.64 83.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.715 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.5 -46.32 88.99 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.122 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.7 p -61.87 -42.64 99.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -67.2 -41.11 86.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.997 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.81 86.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.812 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 295' ' ' VAL . 35.9 mm -64.09 -43.65 97.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.519 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.446 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 19.9 tp10 -61.23 -44.15 97.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.171 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.33 99.28 Favored Glycine 0 C--O 1.24 0.526 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.692 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.78 -42.13 95.31 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 291' ' ' ILE . 85.1 t -63.93 -44.36 97.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.914 -178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . 0.446 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.6 mttm -62.63 -37.64 87.1 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.78 0.324 . . . . 0.0 111.657 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.59 -30.03 27.3 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -128.84 92.21 3.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -91.28 98.46 11.73 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -103.25 149.11 7.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.391 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.04 135.37 57.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.907 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.64 120.54 44.81 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.068 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.99 131.52 44.07 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.592 2.195 . . . . 0.0 112.471 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.13 75.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.282 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.43 -29.18 63.94 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.681 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 90.4 mt -93.31 -31.76 14.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.826 0.346 . . . . 0.0 110.855 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 311' ' ' ILE . 95.6 mt -63.68 -46.91 93.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.759 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.12 -39.0 93.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 35.6 p -69.02 -42.38 76.46 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.724 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.645 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 24.6 mm-40 -72.69 -35.74 67.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.478 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 77.4 mt -61.7 -43.8 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.304 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.489 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 30.6 t70 -61.64 -41.94 98.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.928 0.394 . . . . 0.0 111.022 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.0 t -62.1 -43.87 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.899 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 61.7 mt -63.05 -39.28 94.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.818 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.489 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.5 mtm180 -62.04 -42.64 99.39 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -64.08 -37.86 88.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.668 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -61.5 -46.15 91.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.198 0.523 . . . . 0.0 110.043 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.29 -37.2 71.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.429 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.54 72.57 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 120.98 0.419 . . . . 0.0 111.223 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . 0.459 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 49.2 tt0 -62.33 -37.81 87.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.458 0.647 . . . . 0.0 109.956 176.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.36 -15.75 59.23 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.583 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -93.56 6.59 47.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.699 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.44 -22.69 3.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.521 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 109.6 37.53 1.89 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.337 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.413 HD22 ' HB2' ' A' ' 328' ' ' GLN . 27.3 t-20 -79.14 135.9 36.96 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.858 0.361 . . . . 0.0 110.792 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . 0.598 ' OE1' ' HG3' ' A' ' 327' ' ' LYS . 1.7 tm-20 -136.71 152.42 50.35 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.598 ' HG3' ' OE1' ' A' ' 326' ' ' GLU . 32.0 mtmm 70.89 -46.34 0.63 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.553 0.741 . . . . 0.0 112.419 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.413 ' HB2' HD22 ' A' ' 325' ' ' ASN . 17.3 mm100 -68.54 -16.69 63.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.252 0.548 . . . . 0.0 110.065 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.58 -19.05 34.95 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.859 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.476 HD11 HH12 ' A' ' 315' ' ' ARG . 52.8 tp -61.15 -38.7 87.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.774 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -75.34 -19.47 59.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.775 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 81.2 mt -55.52 136.75 70.26 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.425 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.68 127.73 23.81 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.93 2.42 . . . . 0.0 113.057 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -68.31 -42.17 79.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.263 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -59.07 -36.18 74.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.129 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.88 -39.02 93.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.456 ' CD1' ' HG2' ' A' ' 315' ' ' ARG . 96.9 m-85 -97.06 -15.78 20.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -68.84 -31.6 70.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.81 0.338 . . . . 0.0 111.197 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -61.32 -50.89 71.13 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.823 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -70.64 -28.83 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.838 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.407 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -61.06 -42.17 97.99 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.21 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.8 tttt -59.83 -47.2 86.67 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.187 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.533 ' O ' HG21 ' A' ' 347' ' ' VAL . 13.0 mmt85 -62.94 -44.89 94.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.142 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.457 ' NH2' HD23 ' A' ' 314' ' ' LEU . 93.5 mtt180 -66.58 -38.43 87.03 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 341' ' ' ALA . 71.2 t -65.31 -43.17 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.78 0.324 . . . . 0.0 110.35 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 342' ' ' LYS . 74.2 t -60.69 -42.82 93.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.482 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 343' ' ' ARG . 76.5 t -59.68 -44.72 94.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.29 99.59 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.202 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.96 -43.82 97.75 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.891 0.376 . . . . 0.0 110.841 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.31 -44.56 94.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.934 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.16 -41.67 94.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.285 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.97 -42.59 99.75 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.217 -0.516 . . . . 0.0 113.254 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . 0.408 ' CD ' HH22 ' A' ' 356' ' ' ARG . 32.1 tp10 -63.23 -44.3 95.62 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.866 0.365 . . . . 0.0 110.759 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.34 -46.26 95.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.029 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.66 -44.72 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.918 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . 0.408 HH22 ' CD ' ' A' ' 353' ' ' GLU . 7.5 tmm_? -69.68 -45.41 68.4 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.8 m -68.89 -43.24 75.68 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -86.15 -1.52 57.5 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.909 0.385 . . . . 0.0 110.663 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 57.63 44.76 20.27 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.08 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.66 149.3 34.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.399 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.77 148.41 32.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.728 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.38 126.75 29.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.55 ' O ' HG21 ' A' ' 367' ' ' VAL . 18.4 t70 -94.44 115.86 28.12 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.769 -176.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 54.3 mm-40 -60.52 -40.22 90.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.564 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.95 -40.11 91.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 110.883 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -64.02 -39.14 93.44 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.598 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 363' ' ' ASP . 90.5 t -62.68 -39.69 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.922 176.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.0 mmmt -57.11 -43.29 82.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.037 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.5 -40.68 99.42 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.035 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.04 -41.09 99.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 109.995 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.67 -42.95 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.453 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.99 -41.59 96.77 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.709 0.29 . . . . 0.0 111.046 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -65.37 -40.29 93.34 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 109.857 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 50.1 ttm -65.71 -41.64 92.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.646 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.9 -27.42 68.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.991 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.3 m -75.76 -3.08 32.89 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.548 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -96.4 4.39 52.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.836 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -125.59 -176.6 3.65 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.737 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.37 -52.83 60.05 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.404 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.577 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 21.3 t70 -125.68 125.58 24.96 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.502 ' O ' HG13 ' A' ' 385' ' ' ILE . 33.7 Cg_endo -64.64 -32.69 57.51 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 121.969 1.779 . . . . 0.0 113.102 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -68.22 -41.55 81.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 13.0 pt-20 -61.17 -38.21 85.69 Favored 'General case' 0 N--CA 1.46 0.068 0 CA-C-O 120.745 0.307 . . . . 0.0 110.177 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.99 -44.01 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.325 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 381' ' ' PRO . 74.0 mt -60.75 -46.86 95.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.4 -43.09 86.77 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.515 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -59.41 -46.82 87.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.946 0.403 . . . . 0.0 110.869 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -68.52 -41.86 79.33 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.813 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.9 p -80.18 -8.03 59.24 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.22 7.96 45.49 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.174 0.511 . . . . 0.0 110.563 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -133.38 110.96 10.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.798 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -62.33 -38.01 87.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.354 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.9 -50.68 71.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.035 0.445 . . . . 0.0 110.394 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.29 -41.98 96.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.442 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.517 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 88.9 mtp -63.33 -48.61 77.29 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.8 -39.46 66.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.612 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.91 -41.15 97.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.466 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 47.7 tpp -65.25 -40.03 93.46 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 395' ' ' MET . 79.2 mtm180 -63.09 -33.56 75.7 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.71 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.68 -41.83 98.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.127 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.15 -45.57 93.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.448 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.39 90.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.915 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 57.3 tp -62.58 -39.36 93.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.498 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -61.05 -43.75 98.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -65.78 -35.98 82.23 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.126 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -60.81 -41.52 95.84 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.207 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.36 94.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.687 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 90.6 t -64.2 -45.4 96.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.014 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.78 -35.87 82.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.535 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.28 98.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.914 0.388 . . . . 0.0 110.4 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 95.4 t -67.75 -43.45 86.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 94.5 mt -61.51 -41.5 97.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.998 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.8 -24.29 67.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.587 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -99.06 -1.99 38.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.334 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.49 172.27 6.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.982 0.42 . . . . 0.0 111.739 -177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.15 127.35 31.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.573 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.21 116.09 46.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 120.882 0.372 . . . . 0.0 110.588 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 10.0 t -115.54 128.84 56.26 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -112.88 123.57 50.63 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.1 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -145.23 150.4 36.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.795 0.331 . . . . 0.0 111.561 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -84.46 162.52 19.89 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.628 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.5 t -158.54 -176.71 6.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.798 0.332 . . . . 0.0 110.631 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 16.5 p -81.76 157.9 24.35 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.274 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -67.53 -35.63 79.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.175 0.512 . . . . 0.0 110.842 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -60.63 -35.85 77.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.109 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -66.37 -30.73 71.17 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.098 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.39 -15.99 58.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.968 0.413 . . . . 0.0 110.788 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 8.8 mmt -78.07 -6.3 54.2 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.77 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -76.18 68.51 2.61 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.509 0.671 . . . . 0.0 109.358 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -99.42 16.01 24.53 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.327 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -63.22 -39.52 94.85 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.754 0 CA-C-O 118.286 -0.864 . . . . 0.0 109.825 179.278 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.727 0.299 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.58 133.8 34.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.345 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.67 162.32 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.675 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 33.8 t -103.47 105.9 16.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.918 0.389 . . . . 0.0 110.326 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 p -146.77 139.52 19.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.728 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 61.2 mt-10 -129.06 172.83 11.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.699 0.285 . . . . 0.0 111.119 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 94.1 m -121.82 129.44 52.63 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.245 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 33.3 m -77.17 -68.8 0.58 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 175.79 139.53 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.512 0.725 . . . . 0.0 109.717 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.84 -122.62 28.26 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.379 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' B' ' 108' ' ' GLU . 78.1 mt -65.79 -39.56 91.08 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 122.868 0.467 . . . . 0.0 110.907 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.527 ' HA2' ' HG2' ' B' ' 108' ' ' GLU . . . -69.39 137.74 29.69 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 115.63 1.012 . . . . 0.0 115.63 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 1.5 tpp180 -126.04 -161.66 1.07 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -161.94 116.27 1.9 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 t -94.26 -91.86 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.138 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m 52.69 85.24 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 CA-C-O 121.28 0.562 . . . . 0.0 110.787 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 tp -114.68 144.84 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.683 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 14.4 p -100.34 126.44 46.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.971 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.438 ' CD1' HG12 ' B' ' 24' ' ' ILE . 6.6 pt -131.22 153.71 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.663 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -75.92 151.27 37.36 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.889 0.476 . . . . 0.0 112.0 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.17 -50.19 69.94 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -65.15 -37.54 87.73 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.596 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -63.71 -43.48 96.45 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.035 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.663 HG13 ' O ' ' B' ' 20' ' ' ALA . 68.8 mt -61.77 -52.58 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.242 0.544 . . . . 0.0 111.517 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -70.05 -39.22 75.84 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.16 -172.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 10.9 m -77.24 -55.7 5.19 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.38 -47.54 60.43 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 96.0 t -64.17 -43.34 97.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.194 -176.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -61.31 -45.22 95.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.39 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 40.4 m -63.07 -42.35 99.64 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.528 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.414 ' O ' HG21 ' B' ' 35' ' ' VAL . 49.0 tp10 -65.93 -36.63 83.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.369 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 91.9 mt -61.93 -42.1 98.71 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.24 -36.63 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.207 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -63.39 -41.13 98.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.621 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.414 HG21 ' O ' ' B' ' 31' ' ' GLU . 96.7 t -63.81 -44.12 98.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.437 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.74 93.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.113 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.04 -33.48 75.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.273 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -59.58 -41.73 90.91 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.642 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 10.8 t -91.08 -1.86 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.23 0.538 . . . . 0.0 110.343 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 65.14 25.13 12.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.259 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -103.93 6.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.622 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -65.84 -29.0 69.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.291 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.7 -3.86 68.78 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.281 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -86.48 -5.76 59.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.439 ' HG3' ' NE2' ' A' ' 320' ' ' GLN . 37.2 ttt85 -93.39 110.67 22.22 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.797 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.72 -42.84 99.49 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.488 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.13 46.1 67.37 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 115.906 1.122 . . . . 0.0 115.906 172.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -61.39 -44.61 96.85 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.174 0.987 . . . . 0.0 108.469 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.39 103.84 44.73 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.449 ' HG2' HD12 ' B' ' 53' ' ' ILE . 36.2 Cg_endo -64.07 156.36 59.39 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.736 2.291 . . . . 0.0 112.711 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.472 ' HA ' HG12 ' B' ' 54' ' ' VAL . 92.2 mtp -63.45 -24.99 68.07 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -174.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -79.15 -10.02 59.71 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.834 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.678 HD11 ' NH2' ' A' ' 193' ' ' ARG . 93.9 mt -114.94 -46.1 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' B' ' 51' ' ' MET . 14.6 p -63.66 -34.61 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.955 0.407 . . . . 0.0 110.797 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.0 82.89 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.168 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -88.9 -14.97 35.52 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.439 HH12 HD12 ' A' ' 187' ' ' LEU . 67.6 mtt180 -89.87 -30.62 17.77 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.41 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.62 13.3 22.56 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.653 0.739 . . . . 0.0 109.632 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' B' ' 61' ' ' SER . . . -65.46 149.45 51.63 Favored Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.447 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.59 -40.89 0.48 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.299 0.64 . . . . 0.0 111.559 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' SER . . . . . 0.429 ' H ' ' C ' ' B' ' 59' ' ' GLY . 38.7 t -60.71 -46.59 89.82 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.734 0.414 . . . . 0.0 110.973 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.459 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -123.15 13.08 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.313 0.577 . . . . 0.0 110.845 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -64.1 -19.52 65.32 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.132 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -62.9 -52.69 62.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.817 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.93 -18.38 60.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.08 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 62' ' ' VAL . 75.9 t -64.39 -42.68 96.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 173.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.58 -39.56 94.08 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' B' ' 71' ' ' MET . . . -60.37 -41.28 98.41 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.522 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . 0.743 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 30.7 t70 -63.51 -44.27 94.79 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.39 -43.62 98.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.988 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' B' ' 68' ' ' GLY . 24.8 ptt? -63.71 -40.43 96.77 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 44.6 m -64.45 -39.38 93.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.081 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.743 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 51.1 mtp85 -62.59 -43.81 97.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.996 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -64.02 -41.9 97.28 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.32 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.71 -48.39 80.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.306 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . 0.47 ' O ' HG13 ' B' ' 79' ' ' ILE . 19.2 tt -67.52 -40.53 84.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.484 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.82 -42.27 95.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.999 0.428 . . . . 0.0 110.139 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.73 -42.28 97.93 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.057 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.47 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.6 pp -67.35 -40.95 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.642 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.95 -44.63 96.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.628 0.728 . . . . 0.0 109.798 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -65.54 -44.63 86.27 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.891 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -89.26 2.14 54.72 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 62.79 52.8 2.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.047 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.0 mt -109.13 126.6 66.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -103.2 108.38 58.68 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.512 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.29 116.26 3.86 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.199 1.933 . . . . 0.0 111.724 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.9 86.58 6.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.069 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 132.04 -168.41 22.49 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.878 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.93 123.11 74.17 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 110.526 -0.176 . . . . 0.0 110.526 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.92 113.72 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.121 1.881 . . . . 0.0 110.713 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 18.3 m -94.96 117.29 29.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.175 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.53 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.3 m-85 -92.04 134.35 34.9 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.44 97.93 25.29 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 90.1 Cg_endo -103.99 -167.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 123.668 2.912 . . . . 0.0 111.159 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -121.07 -174.09 14.85 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.17 146.89 25.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.479 0.639 . . . . 0.0 109.535 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -91.89 127.82 37.5 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.095 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -105.43 126.33 52.0 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 46.6 tp -65.94 113.57 4.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.021 0.439 . . . . 0.0 110.914 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.04 -8.72 42.45 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.12 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -112.55 177.3 4.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 117.415 0.607 . . . . 0.0 111.215 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -80.9 141.52 34.49 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.555 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -93.07 136.42 33.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.97 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 33.1 m -118.58 130.96 56.18 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.955 0.407 . . . . 0.0 111.265 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -130.41 149.06 52.27 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.287 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.493 ' O ' HG13 ' B' ' 107' ' ' VAL . 58.4 m -101.77 -66.01 0.95 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . 0.493 HG13 ' O ' ' B' ' 106' ' ' SER . 0.3 OUTLIER 71.17 150.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 124.17 0.988 . . . . 0.0 110.964 -175.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.527 ' HG2' ' HA2' ' B' ' 12' ' ' GLY . 28.6 mt-10 -132.96 149.47 52.23 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.222 -0.299 . . . . 0.0 110.333 -175.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -155.47 -75.26 0.1 Allowed 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -108.61 162.87 13.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -171.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.424 HG11 HD23 ' B' ' 11' ' ' LEU . 3.6 m -135.68 158.83 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.125 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -161.45 104.61 1.21 Allowed Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.572 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.59 147.91 12.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.026 2.484 . . . . 0.0 114.411 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -140.32 112.54 7.76 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.428 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.4 133.92 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 111.34 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -122.37 141.36 51.65 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.333 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -120.02 150.8 39.98 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.596 0.236 . . . . 0.0 110.698 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -135.46 156.66 48.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.661 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.55 16.96 69.6 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.216 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.7 -38.96 92.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.279 0.561 . . . . 0.0 110.838 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.95 -14.73 63.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.192 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.0 21.52 13.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.878 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 76.5 mt -94.61 109.39 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.417 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -102.33 121.07 41.56 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.38 132.91 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.767 0.317 . . . . 0.0 110.844 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -83.16 139.15 33.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.406 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -123.74 94.11 46.48 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.82 113.46 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.265 1.977 . . . . 0.0 112.095 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.5 mm -102.56 118.31 49.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.048 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.87 160.61 41.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.724 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -133.7 150.27 51.52 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.943 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.71 123.37 19.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 65.2 p -106.99 176.88 5.03 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.854 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.18 -34.77 77.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.602 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.42 97.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.156 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -63.34 -45.46 91.14 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.148 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.7 -45.08 92.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.744 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -59.47 -48.71 80.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.742 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.29 -39.22 96.83 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.036 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' MET . . . . . 0.539 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 2.6 tpt -60.91 -47.43 86.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 0.0 110.65 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.66 -41.6 98.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.986 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . 0.405 ' OD1' ' HE3' ' B' ' 146' ' ' LYS . 23.0 t70 -60.95 -46.41 90.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.922 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 29.0 m -61.64 -41.74 97.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.643 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.3 mt -60.87 -41.93 96.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.758 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -71.48 -20.47 62.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.779 0.324 . . . . 0.0 111.124 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . 0.405 ' HE3' ' OD1' ' B' ' 142' ' ' ASP . 97.3 mttt -89.05 -3.01 58.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.508 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -103.42 -48.22 4.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -62.3 124.03 19.79 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -175.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.87 -167.55 1.97 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.582 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' THR . . . . . 0.427 HG21 ' HA ' ' B' ' 246' ' ' PRO . 5.5 m -146.16 169.32 18.97 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . 0.491 ' O ' ' HB2' ' B' ' 152' ' ' LYS . 7.1 p-90 -117.78 145.41 44.53 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -175.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' B' ' 151' ' ' TRP . 54.2 tttp 173.41 -65.79 0.01 OUTLIER 'General case' 0 C--N 1.344 0.367 0 O-C-N 123.94 0.775 . . . . 0.0 110.36 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -102.39 175.97 5.33 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 120.861 0.362 . . . . 0.0 111.836 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -83.57 147.2 27.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.959 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 68.44 113.61 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -165.05 -95.21 0.1 Allowed Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.651 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.02 149.69 31.56 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 62.8 t -114.35 128.15 71.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -98.11 -170.86 2.04 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.081 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.99 -67.84 0.44 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -73.96 1.51 10.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' B' ' 188' ' ' ALA . 32.1 t70 -69.61 144.86 52.87 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.629 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -102.83 119.14 38.31 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.737 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 42.1 t -117.15 126.71 74.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.561 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 24.4 m -74.4 106.32 5.96 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 88.2 mt -122.26 122.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.669 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -92.9 90.35 6.95 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -112.85 149.62 32.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.325 0.583 . . . . 0.0 112.16 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 41.5 m -128.8 128.99 45.04 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.19 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.44 135.46 13.31 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.729 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 51.0 m -142.48 145.8 34.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 120.863 0.363 . . . . 0.0 110.909 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.95 94.98 3.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.03 -68.4 0.09 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.96 0.788 . . . . 0.0 112.718 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -140.86 12.09 2.88 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.797 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -136.91 138.33 40.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.491 0.646 . . . . 0.0 110.89 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -79.38 148.98 31.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.253 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -110.89 -174.55 2.5 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -57.31 -48.87 77.84 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -103.35 -162.15 25.34 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.057 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' B' ' 169' ' ' THR . . . 78.78 29.68 50.97 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.676 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -114.85 103.05 10.57 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -131.38 141.52 49.89 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.792 0.33 . . . . 0.0 111.575 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 27.7 m -136.02 133.46 37.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.651 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 55.45 33.09 20.22 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.377 0.423 . . . . 0.0 110.91 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -98.51 133.27 43.11 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.287 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.1 m -94.3 120.68 44.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-O 121.57 0.7 . . . . 0.0 111.282 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . 0.403 HD12 HH12 ' A' ' 57' ' ' ARG . 30.0 tp -111.37 125.0 53.4 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.073 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . 0.721 ' HB3' ' NH1' ' B' ' 193' ' ' ARG . . . -111.34 132.75 54.16 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 173.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 189' ' ' MET . . . . . 0.451 ' SD ' ' HB ' ' B' ' 202' ' ' ILE . 69.3 mtm -100.29 176.74 5.27 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.226 0.536 . . . . 0.0 112.287 -171.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 79.22 18.78 73.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.593 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -127.54 -17.94 4.5 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.68 0.276 . . . . 0.0 111.604 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.39 43.38 7.44 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.128 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.721 ' NH1' ' HB3' ' B' ' 188' ' ' ALA . 69.4 mtm180 -100.19 1.11 41.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.369 0.604 . . . . 0.0 110.934 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.432 ' HE3' ' HA ' ' B' ' 194' ' ' MET . 0.5 OUTLIER -134.19 169.16 17.59 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.637 175.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.409 HG12 ' CE2' ' B' ' 217' ' ' PHE . 3.1 mp -58.07 131.04 83.61 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.03 134.76 50.33 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.216 1.944 . . . . 0.0 111.56 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.56 -43.2 1.76 Allowed Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -63.78 -47.55 80.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 120.447 0.165 . . . . 0.0 111.174 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -86.54 14.51 6.72 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.262 0.553 . . . . 0.0 110.923 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . 0.649 ' O ' ' HE2' ' B' ' 203' ' ' LYS . 21.2 t70 -113.22 -38.76 4.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.221 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -71.13 -15.51 74.51 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.546 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.451 ' HB ' ' SD ' ' B' ' 189' ' ' MET . 69.7 mt -68.63 -25.99 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 O-C-N 122.596 -0.355 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.649 ' HE2' ' O ' ' B' ' 200' ' ' ASP . 45.0 mtmt -58.09 131.33 50.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.42 -8.09 66.51 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.731 -0.747 . . . . 0.0 114.018 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -89.73 161.08 16.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.302 0.551 . . . . 0.0 111.636 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.69 176.19 7.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.061 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -91.33 55.61 2.86 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.224 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 147.68 43.16 0.03 OUTLIER Glycine 0 C--N 1.308 -0.996 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -125.36 131.41 52.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.254 -0.473 . . . . 0.0 110.766 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -105.45 112.87 26.13 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.679 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -134.09 -3.74 2.79 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.102 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 66.3 p 58.72 169.89 0.06 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.932 0.893 . . . . 0.0 112.421 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.6 tp -157.81 143.93 8.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.59 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -97.65 113.68 25.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.515 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 61.2 t -116.43 130.1 71.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 7.3 m -92.59 -23.94 18.87 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.9 m-85 69.51 159.57 0.15 Allowed Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.885 -175.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -88.3 156.92 6.77 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.177 1.918 . . . . 0.0 111.755 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . 0.433 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 70.7 mm-40 -67.61 -39.71 84.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -84.99 72.0 10.87 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.671 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -115.52 138.11 51.37 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -63.92 -19.83 65.4 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -100.78 107.56 19.15 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.588 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 37.8 tt0 -64.0 -33.17 75.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.49 -175.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -74.71 -11.63 60.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.82 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -117.92 -4.3 11.1 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.8 ptmt -69.23 125.07 25.55 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.127 0.489 . . . . 0.0 111.743 -176.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 63.65 27.12 70.53 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.572 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.14 133.57 55.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.323 0.562 . . . . 0.0 110.974 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -75.26 134.81 41.02 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.957 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.47 154.44 37.8 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.399 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -111.33 107.19 16.37 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -83.56 109.72 17.63 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.2 0.524 . . . . 0.0 110.486 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.93 98.27 7.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.509 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.2 mm -97.11 114.55 34.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.154 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -104.18 -51.89 3.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.035 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 96.1 mt 65.75 144.02 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.549 0.739 . . . . 0.0 112.076 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.04 -63.86 1.22 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.612 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -99.64 -69.36 0.77 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.668 0.27 . . . . 0.0 111.582 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 15.5 t 70.8 154.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.412 0.685 . . . . 0.0 111.166 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.42 -179.64 7.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.905 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.36 141.04 50.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.182 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.4 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 1.4 ptp180 -174.71 105.33 0.1 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.139 0.495 . . . . 0.0 112.228 177.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -170.71 163.52 8.01 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 30.6 tp 74.75 114.95 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 123.76 0.824 . . . . 0.0 110.83 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . 0.427 ' HA ' HG21 ' B' ' 150' ' ' THR . 90.9 Cg_endo -84.0 134.65 6.22 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.477 2.118 . . . . 0.0 114.624 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -130.38 13.97 5.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.528 173.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 8.3 mp 66.26 105.68 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.876 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' THR . . . . . 0.533 HG21 ' H ' ' B' ' 251' ' ' GLU . 27.6 m -123.6 133.99 53.86 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.021 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.446 ' O ' HG23 ' B' ' 253' ' ' ILE . . . -74.6 -12.98 60.59 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.533 ' H ' HG21 ' B' ' 249' ' ' THR . 51.7 mt-10 -62.44 -43.48 98.71 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -85.08 -8.95 58.44 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 253' ' ' ILE . . . . . 0.446 HG23 ' O ' ' B' ' 250' ' ' ALA . 10.9 tp -91.66 -17.52 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.498 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 254' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' B' ' 260' ' ' ASP . 21.9 ptmt -106.37 -16.49 14.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.765 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -125.18 127.9 47.52 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.043 0.449 . . . . 0.0 112.095 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -168.33 82.21 0.17 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 78.25 -47.02 2.84 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.583 -175.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.49 152.23 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 122.961 0.505 . . . . 0.0 110.264 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -58.35 -51.56 69.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' B' ' 254' ' ' LYS . 2.8 p-10 -160.95 126.18 3.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.124 0.488 . . . . 0.0 109.95 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -130.98 -154.51 7.92 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.737 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 30.7 p -127.08 -164.02 1.31 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 122.53 0.332 . . . . 0.0 110.215 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.48 -63.5 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.173 0.511 . . . . 0.0 110.536 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.86 -39.59 66.37 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.934 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.25 -38.46 95.93 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.463 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.97 -43.87 97.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.679 0.276 . . . . 0.0 110.543 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -64.23 -42.02 96.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.995 0.426 . . . . 0.0 110.155 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -68.43 -41.9 79.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.6 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -68.55 -40.11 80.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 110.701 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.36 -41.32 92.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -54.44 -51.5 64.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.624 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 15.9 ptmt -67.1 -40.25 86.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.67 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.39 -39.24 93.48 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.446 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.1 mmm -63.39 -43.61 97.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.61 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.75 -33.45 72.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.924 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -60.15 -44.37 95.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.388 0.613 . . . . 0.0 109.351 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.19 -35.07 75.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.017 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . 0.414 ' O ' HG13 ' B' ' 282' ' ' ILE . 54.2 tp -61.59 -41.26 97.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.785 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -57.78 -43.51 85.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.084 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 24.6 m -62.0 -42.66 99.4 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.511 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.46 96.13 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.435 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . 0.414 HG13 ' O ' ' B' ' 278' ' ' LEU . 63.8 mt -63.31 -44.23 99.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.465 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.93 -44.57 94.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.84 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -64.89 -42.32 94.9 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.388 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -60.71 -43.88 97.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.639 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 98.3 t -69.36 -44.44 80.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.641 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.5 -46.57 87.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.928 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 69.8 p -61.79 -43.39 98.94 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -66.46 -40.42 89.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.817 0.341 . . . . 0.0 111.156 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.14 -47.43 84.58 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.729 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . 0.44 ' O ' HG23 ' B' ' 295' ' ' VAL . 48.2 mm -64.35 -44.17 97.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.888 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -60.54 -44.08 96.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.288 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.67 99.25 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.323 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.16 -42.19 93.97 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.44 HG23 ' O ' ' B' ' 291' ' ' ILE . 76.1 t -63.82 -44.2 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.612 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.6 -41.92 99.26 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.169 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -72.25 -39.13 68.66 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -126.68 98.39 5.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -92.77 96.08 9.93 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.9 tp -100.98 148.17 7.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.828 -175.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -61.7 134.93 57.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.225 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.3 122.71 38.79 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.939 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.19 131.59 46.05 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.735 2.29 . . . . 0.0 112.555 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.98 79.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.181 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.07 67.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.443 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' B' ' 310' ' ' GLU . 92.7 mt -87.01 -33.83 19.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.413 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . 0.419 ' O ' HG13 ' B' ' 311' ' ' ILE . 97.0 mt -62.65 -48.28 88.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.787 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.05 -42.13 99.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -176.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 32.2 p -65.75 -39.98 91.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.731 0.3 . . . . 0.0 111.702 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . 0.619 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 62.3 mm-40 -72.79 -36.87 67.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.481 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 81.1 mt -62.14 -43.45 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.491 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 35.9 t70 -61.26 -41.87 97.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.869 0.366 . . . . 0.0 111.024 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.12 -43.93 99.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.991 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 64.2 mt -63.08 -38.86 92.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.894 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.491 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 74.5 mtm180 -61.36 -42.53 98.85 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -64.1 -38.54 91.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.651 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.01 -45.33 94.07 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.221 0.534 . . . . 0.0 110.31 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.8 -37.49 70.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.413 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.08 72.37 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.061 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . 0.432 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 49.2 tt0 -62.52 -39.64 94.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.337 0.589 . . . . 0.0 109.943 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -73.25 -20.38 60.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.562 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -89.95 3.87 51.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.012 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 136.42 -21.93 3.4 Favored Glycine 0 CA--C 1.508 -0.39 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.843 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 109.84 36.27 2.06 Favored Glycine 0 CA--C 1.502 -0.764 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.211 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . 0.435 HD22 ' HB2' ' B' ' 328' ' ' GLN . 26.9 t-20 -77.56 133.9 38.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.793 0.33 . . . . 0.0 110.527 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . 0.624 ' OE1' ' HG3' ' B' ' 327' ' ' LYS . 1.8 tm-20 -135.89 151.12 49.68 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.624 ' HG3' ' OE1' ' B' ' 326' ' ' GLU . 31.5 mtmm 71.39 -45.54 0.62 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.552 0.741 . . . . 0.0 112.259 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . 0.435 ' HB2' HD22 ' B' ' 325' ' ' ASN . 17.1 mm100 -70.16 -13.74 62.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.262 0.553 . . . . 0.0 110.0 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.74 -17.81 57.27 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.622 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.37 -38.02 85.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.476 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -78.03 -15.51 58.87 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.756 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 76.6 mt -57.61 137.37 82.32 Favored Pre-proline 0 C--O 1.238 0.5 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.982 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -51.3 125.62 16.97 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.051 2.501 . . . . 0.0 112.92 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -68.03 -40.78 82.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.619 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -60.39 -35.58 76.07 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.224 0.454 . . . . 0.0 112.224 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.45 -39.26 94.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.934 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -95.64 -17.13 21.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.38 -32.07 72.74 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.78 -51.04 68.65 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.686 0.279 . . . . 0.0 111.056 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -70.0 -29.32 66.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.729 0.299 . . . . 0.0 110.798 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . 0.438 ' O ' HG21 ' B' ' 345' ' ' VAL . . . -60.58 -43.99 96.73 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . 0.471 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.6 tttt -59.58 -46.55 88.6 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.469 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . 0.513 ' O ' HG21 ' B' ' 347' ' ' VAL . 13.0 mmt85 -62.03 -45.3 94.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -66.57 -38.34 86.85 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.519 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.438 HG21 ' O ' ' B' ' 341' ' ' ALA . 73.4 t -64.77 -43.46 96.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 120.724 0.297 . . . . 0.0 110.393 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 342' ' ' LYS . 79.4 t -60.7 -43.15 94.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.364 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . 0.513 HG21 ' O ' ' B' ' 343' ' ' ARG . 69.5 t -59.76 -44.8 94.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.41 -41.38 99.52 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.15 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.78 -43.48 98.68 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.732 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 97.6 mt -63.73 -44.29 94.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.891 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.5 -42.46 95.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.507 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.16 -41.69 99.63 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.431 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -64.68 -42.83 95.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.04 -45.14 97.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.82 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.42 -44.73 99.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.797 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -70.8 -45.42 64.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.958 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 98.5 m -67.48 -44.97 77.25 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -86.81 -5.25 59.17 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.604 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 57.69 74.21 0.43 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.981 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.97 144.98 31.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.13 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.63 146.99 35.07 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.205 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.84 115.31 5.19 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . 0.502 ' O ' HG21 ' B' ' 367' ' ' VAL . 16.1 t70 -84.0 117.79 23.62 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.3 -176.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 47.0 mm-40 -60.45 -39.53 87.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.313 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -65.73 -40.18 91.91 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.699 0.285 . . . . 0.0 110.759 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -62.91 -38.47 91.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.092 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . 0.502 HG21 ' O ' ' B' ' 363' ' ' ASP . 95.4 t -63.56 -40.92 90.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.636 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 29.6 mmmt -57.61 -43.43 84.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.306 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.9 -41.77 99.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.798 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.97 -41.24 99.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.398 . . . . 0.0 110.03 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.4 -43.21 98.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.375 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.44 -40.38 96.41 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.421 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.48 -39.66 88.9 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.914 0.388 . . . . 0.0 110.35 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 50.5 ttm -65.17 -40.66 94.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.562 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.59 69.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.796 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 30.5 m -79.5 16.2 1.11 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.161 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -114.18 4.49 15.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.164 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -126.63 -172.58 2.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.186 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -62.88 -62.11 1.94 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.449 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 18.9 t70 -119.03 127.24 26.62 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.075 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.14 -31.76 44.51 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.156 1.904 . . . . 0.0 112.818 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -67.06 -43.08 83.59 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 11.9 pt-20 -61.39 -37.86 84.97 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.56 -43.21 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.982 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.2 -44.59 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.854 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.88 -45.07 79.19 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.159 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -58.98 -46.76 87.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.856 0.36 . . . . 0.0 111.201 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -68.57 -41.9 79.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.919 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 70.3 p -78.3 -10.82 59.83 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.53 6.17 49.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.096 0.474 . . . . 0.0 110.623 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -129.27 111.9 13.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.327 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.75 -39.75 95.12 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -57.63 -51.06 71.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.899 0.381 . . . . 0.0 110.638 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.51 -41.71 98.52 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.386 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.542 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 88.6 mtp -63.36 -47.65 81.2 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -73.25 -40.52 64.57 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.825 -174.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -62.75 -41.25 99.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.211 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 46.9 tpp -64.22 -39.98 95.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.647 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' B' ' 395' ' ' MET . 77.3 mtm180 -64.15 -34.26 77.67 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.771 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.63 -42.7 99.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.823 0.344 . . . . 0.0 110.083 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.58 -44.78 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.512 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.29 -38.91 93.02 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.838 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.38 -38.89 92.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.343 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . 0.401 ' O ' HG23 ' B' ' 408' ' ' VAL . 39.8 tt0 -59.38 -43.75 92.87 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.452 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.44 -35.89 80.11 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.051 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -60.12 -41.68 93.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.921 0.391 . . . . 0.0 110.397 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.06 96.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.552 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 93.3 t -64.53 -45.61 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -65.92 -35.63 81.14 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.69 92.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.936 0.398 . . . . 0.0 110.242 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.38 -43.38 84.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.496 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 94.5 mt -61.6 -41.33 97.29 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.264 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.61 -19.53 64.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.744 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -102.83 1.47 34.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.185 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -113.09 172.31 7.02 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.111 0.482 . . . . 0.0 111.589 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -79.3 129.44 34.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.456 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 36.3 t -104.02 109.83 28.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.979 0.418 . . . . 0.0 110.943 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 6.7 t -108.2 128.52 54.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.929 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -116.59 121.17 40.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.252 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -144.82 153.06 41.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.22 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -86.79 163.62 17.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -159.0 -178.22 7.07 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 21.5 p -82.91 157.16 23.16 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.9 0.381 . . . . 0.0 111.263 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -67.8 -27.7 66.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.159 0.504 . . . . 0.0 110.311 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -61.9 -39.77 93.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.834 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.49 -31.23 71.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.104 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.56 -13.45 59.82 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.893 0.377 . . . . 0.0 111.022 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.8 mmt -80.39 -5.07 55.89 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.041 0.448 . . . . 0.0 110.589 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -76.28 69.47 2.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.57 0.7 . . . . 0.0 109.507 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -100.47 18.5 18.89 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.013 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -68.2 -33.38 74.31 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.989 0.423 . . . . 0.0 110.304 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.642 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.502 -179.693 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.24 0.581 0 CA-C-O 120.611 0.243 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.9 p -84.65 87.19 7.27 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.19 136.44 55.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -119.95 153.87 35.31 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.491 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 77.9 m -98.09 123.39 42.1 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.499 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 m -79.34 -56.14 4.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.138 0.494 . . . . 0.0 111.47 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -169.08 100.35 0.37 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.22 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.7 -106.21 1.21 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.863 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 109' ' ' PHE . 7.3 mp -67.36 -38.66 85.13 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 122.4 0.28 . . . . 0.0 111.081 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 106' ' ' SER . . . -57.94 137.02 50.3 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.51 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.491 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -140.69 144.3 35.56 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.532 0.206 . . . . 0.0 110.793 -177.081 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.454 ' HA ' ' HH ' ' A' ' 105' ' ' TYR . 59.5 ttp180 -115.88 129.04 56.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.5 t -89.52 -87.81 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.71 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.8 p 43.4 80.46 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 89.4 mt -109.81 132.09 58.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.5 m -97.72 123.78 41.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.8 pt -123.54 164.05 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.67 0.271 . . . . 0.0 111.474 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.48 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.24 152.18 44.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.822 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.61 -44.71 81.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.648 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.96 -36.43 84.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.203 0.525 . . . . 0.0 110.386 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 m -66.23 -34.4 77.93 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.45 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.5 mt -61.37 -48.94 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 111.624 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.503 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 55.4 mm-40 -81.47 -13.59 58.0 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -93.13 -59.83 1.94 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.099 -0.641 . . . . 0.0 111.5 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.41 -50.04 35.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 98.8 t -63.35 -43.89 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.584 0.23 . . . . 0.0 111.478 -175.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.503 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 17.1 ttmm -61.71 -45.99 91.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.54 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.8 m -66.88 -40.65 87.87 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.739 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -62.85 -41.08 99.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.731 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.4 mt -62.77 -42.64 99.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.767 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.34 -35.89 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.201 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -64.04 -42.88 96.91 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.03 -29.87 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.907 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.36 -43.19 95.31 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.52 -37.39 86.64 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.679 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -60.48 -35.57 76.23 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.471 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 t -93.02 -5.35 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 121.414 0.626 . . . . 0.0 109.939 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 62.79 28.56 16.52 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.601 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -101.83 6.1 10.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.45 0.643 . . . . 0.0 111.158 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -64.6 -29.83 70.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.71 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.6 -1.14 70.15 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.448 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -94.49 6.41 48.89 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.53 -0.394 . . . . 0.0 111.73 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.2 ttt85 -111.61 98.65 7.58 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.222 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -65.57 -43.44 89.79 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.515 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.63 70.74 1.19 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 173.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -65.63 -41.58 92.49 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 171.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.28 107.81 60.59 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.956 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HD2' HD13 ' A' ' 53' ' ' ILE . 46.1 Cg_exo -56.55 151.06 48.32 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.083 2.522 . . . . 0.0 113.114 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.417 ' O ' HG21 ' A' ' 54' ' ' VAL . 14.6 ttt -60.81 -39.39 88.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.018 -173.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -66.59 -20.74 66.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.057 0.456 . . . . 0.0 110.837 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.48 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 97.4 mt -92.22 -37.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.701 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 51' ' ' MET . 25.3 m -63.98 -36.37 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.491 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.94 -37.36 87.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.864 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.539 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.6 pt20 -80.47 -19.53 45.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.668 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.539 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 63.3 mtt180 -106.9 -27.14 10.89 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -175.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -107.74 5.31 26.56 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.519 0.675 . . . . 0.0 109.854 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 61' ' ' SER . . . -70.66 153.03 51.2 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 176.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.32 -24.84 0.16 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.211 0.604 . . . . 0.0 111.928 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 59' ' ' GLY . 36.1 t -78.2 -61.88 1.86 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.887 0.375 . . . . 0.0 110.371 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 66' ' ' VAL . 8.4 p -103.77 12.15 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.449 0.642 . . . . 0.0 110.142 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -58.96 -30.14 67.68 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.738 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -57.57 -50.28 73.64 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.063 0.459 . . . . 0.0 110.473 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.39 -23.08 54.06 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.503 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 62' ' ' VAL . 73.1 t -64.47 -43.73 96.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 174.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.06 -39.76 95.69 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.415 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.07 99.69 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.717 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 11.5 t70 -62.0 -45.6 92.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.888 0.375 . . . . 0.0 110.29 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.69 -41.87 99.33 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.458 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.9 tpt -61.57 -42.12 98.39 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -60.98 -43.04 99.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.738 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 96.9 mtt-85 -66.05 -40.61 91.1 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.333 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -63.48 -42.43 98.56 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.405 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -61.64 -51.02 70.21 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.896 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.57 -41.69 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.6 -39.97 88.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.058 0.456 . . . . 0.0 110.302 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.69 -42.85 77.19 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 pp -64.97 -32.06 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.895 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.7 -43.92 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.909 0.385 . . . . 0.0 110.886 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -78.38 -26.96 46.73 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.667 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -86.5 -5.14 59.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.892 0.377 . . . . 0.0 110.642 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 66.57 40.28 3.47 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.517 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 84.6 mt -102.23 122.22 54.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -106.73 110.76 63.9 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.48 114.55 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.288 1.992 . . . . 0.0 111.416 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.24 126.19 30.52 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.711 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.19 -116.53 7.23 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.852 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.77 114.46 6.02 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.48 156.82 60.67 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 122.635 2.223 . . . . 0.0 111.378 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.6 m -104.3 119.08 38.17 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.51 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -74.41 -21.42 59.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.234 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t 48.42 80.04 0.32 Allowed Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 123.968 0.907 . . . . 0.0 112.894 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.98 122.03 6.08 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.255 1.97 . . . . 0.0 110.725 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.84 -176.35 51.44 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.295 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.39 121.82 25.63 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.116 0.484 . . . . 0.0 110.258 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -82.6 111.9 19.0 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.488 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 98.6 mttt -91.17 129.97 37.1 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.5 tp -75.69 114.07 13.86 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.03 0.443 . . . . 0.0 110.611 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.02 4.82 59.91 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.326 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.8 mt-10 -127.38 168.32 14.99 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.717 -0.284 . . . . 0.0 110.568 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.68 142.89 54.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.074 0.464 . . . . 0.0 111.832 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -102.46 147.72 26.39 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.468 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.2 m -122.74 132.07 54.07 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.454 ' HH ' ' HA ' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -147.01 161.09 41.53 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.532 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 33.1 p -96.6 -84.48 0.36 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 106' ' ' SER . 86.9 t 75.35 112.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -173.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -103.99 122.93 46.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.08 -173.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.427 ' N ' HD23 ' A' ' 11' ' ' LEU 0.253 19.7 p90 -138.29 -95.23 0.19 Allowed 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 174.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -157.69 147.16 19.98 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.0 0.818 . . . . 0.0 111.862 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.9 m -141.28 167.81 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.078 0.551 . . . . 0.0 111.824 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -109.61 107.15 59.19 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.433 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -93.06 153.99 2.63 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.992 2.462 . . . . 0.0 112.924 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.74 143.43 17.23 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.5 t -132.23 137.8 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -175.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -84.78 141.47 30.49 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.557 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.01 143.62 50.81 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -138.38 154.33 48.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.616 0.246 . . . . 0.0 111.089 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.84 15.73 79.5 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 114.089 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.96 -40.74 97.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.974 0.416 . . . . 0.0 111.512 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -73.69 -3.68 29.76 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.704 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.59 4.99 43.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.968 0.413 . . . . 0.0 111.131 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.7 mt -87.39 126.59 41.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.53 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -107.45 116.79 32.56 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.16 133.84 47.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.136 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -85.72 144.06 28.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.478 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -132.89 101.27 14.03 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.41 138.09 58.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.251 1.967 . . . . 0.0 111.506 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 421' ' ' GLU . 48.4 mm -116.17 121.14 66.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.9 161.2 41.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.391 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -152.76 166.09 33.31 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.881 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.42 128.98 38.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.097 0.475 . . . . 0.0 111.337 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 65.8 p -109.36 173.83 6.14 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.535 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.82 -35.11 79.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.72 -37.42 81.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.374 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -63.43 -40.57 97.54 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.549 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.32 -46.04 96.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.516 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.37 -44.65 95.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.356 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.68 -41.52 99.81 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.653 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.595 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.4 tpt -61.26 -48.46 81.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.687 0.28 . . . . 0.0 110.543 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.96 -42.27 97.33 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.074 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.49 -47.64 85.25 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.945 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.6 m -62.84 -41.5 99.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.694 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 140' ' ' MET . 87.5 mt -61.34 -40.26 93.6 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -72.57 -17.09 61.74 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.978 0.418 . . . . 0.0 111.135 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.83 -0.45 55.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.901 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -116.28 30.93 7.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.662 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -134.65 79.22 1.79 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.29 121.24 37.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.322 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.605 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 35.4 m -74.72 159.93 31.41 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.398 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.411 ' N ' HG21 ' A' ' 150' ' ' THR . 36.8 t-105 -80.28 124.84 29.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.126 0.488 . . . . 0.0 110.894 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.4 ' HG3' ' OE2' ' A' ' 153' ' ' GLU . 18.5 tptm -143.53 169.13 18.28 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.4 ' OE2' ' HG3' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -82.52 -3.21 55.54 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -175.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 155' ' ' ASP . 21.8 pttp -163.78 -172.9 3.03 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.719 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 0.6 OUTLIER 91.46 122.19 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.332 1.453 . . . . 0.0 112.683 177.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -68.15 93.99 0.3 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 114.71 -1.132 . . . . 0.0 114.766 -174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -151.01 127.44 10.7 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.83 122.2 60.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -103.86 157.76 16.87 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.5 26.36 0.17 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.928 0.491 . . . . 0.0 112.22 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -139.68 -4.87 1.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.213 0.53 . . . . 0.0 109.91 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -83.58 158.17 22.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.352 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -102.72 98.46 8.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.795 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.5 t -97.86 123.01 50.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.73 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.1 m -79.49 107.49 12.31 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.1 mt -121.42 123.27 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 121.095 0.474 . . . . 0.0 111.929 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.462 ' HB2' ' HD3' ' A' ' 238' ' ' LYS . 23.5 m-20 -96.28 108.43 20.92 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -126.23 147.87 49.58 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.616 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.6 m -119.74 129.19 54.38 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.114 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.11 122.37 5.73 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.299 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.3 p -136.59 124.49 22.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.04 -85.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.787 0.327 . . . . 0.0 110.787 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -103.06 2.98 35.54 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.503 0.668 . . . . 0.0 110.006 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.26 -3.93 2.51 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.376 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -113.47 143.3 44.73 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.21 157.1 33.0 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.721 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -129.39 -177.77 4.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.246 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.19 -41.61 88.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.168 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.1 -178.59 38.85 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.312 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.05 24.99 50.73 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.449 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.0 98.89 8.52 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -130.34 143.79 50.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.095 0.474 . . . . 0.0 111.8 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.4 m -148.73 122.54 9.31 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.996 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 60.51 31.42 20.28 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.334 0.588 . . . . 0.0 109.968 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -86.18 137.68 32.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.909 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.0 m -105.01 125.33 60.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.604 0.716 . . . . 0.0 111.175 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.468 ' CD1' HH12 ' B' ' 57' ' ' ARG . 49.5 tp -114.42 118.19 33.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.212 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.431 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -93.86 110.86 22.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.616 ' HE2' ' O ' ' A' ' 199' ' ' GLU . 63.0 mtp -83.25 152.9 24.97 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.839 -175.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.9 -20.97 45.58 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.051 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -89.08 -10.91 45.63 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.92 50.95 4.97 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.15 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 188' ' ' ALA . 35.2 mmm-85 -90.49 -11.44 40.24 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.911 -0.644 . . . . 0.0 110.106 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.35 -176.74 4.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.716 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.2 mm -63.58 133.71 95.62 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.904 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.41 120.89 5.55 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.066 2.511 . . . . 0.0 112.679 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.52 -36.19 4.57 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.488 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -62.5 -48.02 81.38 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.616 ' O ' ' HE2' ' A' ' 189' ' ' MET . 12.5 pt-20 -78.85 -9.24 59.41 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.8 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -91.49 -29.26 17.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.253 0.549 . . . . 0.0 109.648 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.9 -22.63 75.78 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.881 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.21 -42.49 96.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.97 0.414 . . . . 0.0 110.171 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -53.76 131.17 38.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.118 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.67 -7.99 39.58 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.689 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -96.94 160.09 14.55 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.03 156.43 16.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.652 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.5 129.73 41.44 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.913 0.387 . . . . 0.0 110.713 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 73.63 50.99 10.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.711 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -136.02 140.96 44.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.674 0.273 . . . . 0.0 110.705 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -115.93 135.41 54.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -153.25 -13.61 0.15 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.409 -0.516 . . . . 0.0 112.276 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 30.3 p 61.71 166.87 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.97 0.908 . . . . 0.0 112.064 -175.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.6 tp -156.15 114.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.083 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.09 106.53 7.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.986 0.422 . . . . 0.0 110.873 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 78.4 t -108.95 118.91 57.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.536 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.514 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 4.8 m -69.48 -35.06 75.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' ' 216' ' ' THR . 70.5 m-85 75.69 150.99 0.13 Allowed Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 123.133 0.573 . . . . 0.0 109.498 -172.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.18 153.67 32.03 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.641 1.56 . . . . 0.0 111.474 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.546 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 64.3 mm-40 -64.02 -33.72 76.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 109.842 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -87.92 28.17 1.07 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.332 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.479 ' CE2' ' HB1' ' A' ' 223' ' ' ALA . 10.1 t80 -73.42 132.85 43.44 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -64.89 -17.42 64.3 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 221' ' ' TYR . . . -94.76 110.51 22.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 36.0 tt0 -61.56 -38.59 88.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.859 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.426 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 28.2 p30 -71.98 -9.51 58.48 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.426 ' HG ' ' OD1' ' A' ' 225' ' ' ASN . 95.5 mt -122.57 0.85 9.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.546 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.8 ptmt -70.93 110.81 5.88 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.521 0.677 . . . . 0.0 112.733 -175.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.77 12.64 83.98 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.498 -0.774 . . . . 0.0 114.097 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -118.26 127.93 54.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.357 0.578 . . . . 0.0 110.732 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -71.32 136.24 47.76 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.7 139.37 47.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.324 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -70.51 -43.37 69.8 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 212' ' ' THR . 79.5 m-85 58.39 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.078 0.551 . . . . 0.0 112.133 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.67 -50.81 72.02 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.9 mm 62.69 81.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.133 0.492 . . . . 0.0 111.235 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -66.06 -40.89 91.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.229 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.469 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 10.5 tp 50.6 82.96 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.722 0.809 . . . . 0.0 110.612 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.462 ' HD3' ' HB2' ' A' ' 167' ' ' ASP . 52.5 mtpt -93.51 -51.0 5.16 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -173.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -100.27 -92.04 0.29 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.0 t 75.43 129.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.165 0.586 . . . . 0.0 111.086 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -69.01 -35.67 76.92 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.501 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 155' ' ' ASP . 13.1 pt-20 57.86 117.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 125.34 1.456 . . . . 0.0 114.175 177.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -143.5 124.12 14.08 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.154 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 245' ' ' LEU . 0.3 OUTLIER -148.36 -175.6 4.98 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.45 ' H ' ' CD ' ' A' ' 244' ' ' GLU . 66.1 mt 73.21 105.47 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 111.099 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.605 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 64.1 Cg_endo -78.87 111.77 3.01 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.408 2.072 . . . . 0.0 113.76 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.558 ' H ' HG22 ' A' ' 150' ' ' THR . 12.6 pt-20 -135.77 17.82 3.29 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.135 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 52.7 tp 77.13 132.74 0.05 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 176.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 23.0 m -142.16 137.96 31.23 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.228 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -77.74 -9.12 58.84 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -85.26 -25.12 27.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -65.24 -22.24 66.85 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 119.779 -0.769 . . . . 0.0 113.034 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 34.8 pt -74.05 -9.57 13.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -137.67 25.67 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.919 0.39 . . . . 0.0 111.731 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -115.54 15.67 16.63 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.208 0.528 . . . . 0.0 111.63 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -94.49 14.96 19.11 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.31 -31.34 8.77 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.123 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.8 144.38 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -53.46 -47.91 69.32 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.264 0.353 . . . . 0.0 111.93 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -173.64 157.33 3.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.1 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -160.37 172.41 36.78 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.617 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 80.5 p -96.53 -134.99 0.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.711 0.255 . . . . 0.0 110.83 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 52.8 t -103.33 -68.8 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.12 0.486 . . . . 0.0 109.95 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.2 OUTLIER -70.34 -37.29 74.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.864 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.22 -37.52 94.64 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.763 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.62 -43.8 97.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.868 0.365 . . . . 0.0 110.091 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -62.73 -40.77 98.24 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.688 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.637 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.47 -47.16 85.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.146 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 272' ' ' LYS . 41.6 tp10 -65.85 -40.91 92.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.926 0.394 . . . . 0.0 111.182 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 80.2 t -64.66 -42.92 96.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.374 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -59.34 -48.82 80.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.835 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 10.0 ptmt -62.96 -44.03 97.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.756 0.312 . . . . 0.0 111.206 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -64.97 -39.25 93.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.372 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 90.5 mmm -63.8 -41.7 97.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 110.672 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.85 -35.72 80.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.417 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.5 -41.26 96.53 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.321 0.581 . . . . 0.0 109.603 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -66.59 -36.86 83.65 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.703 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 45.5 tp -62.39 -38.89 91.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.048 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -57.17 -44.14 83.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.198 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.6 m -61.7 -42.8 99.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.649 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.56 97.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.261 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.04 -44.09 97.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.175 0.512 . . . . 0.0 110.013 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -61.57 -44.47 96.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.657 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -64.04 -42.15 97.17 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.899 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . 0.459 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.4 tpm_? -61.34 -43.57 98.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.526 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 85.4 t -70.32 -44.39 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.272 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.8 -48.81 80.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.557 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 65.2 p -65.37 -42.89 92.28 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -65.81 -41.1 92.29 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.7 0.286 . . . . 0.0 111.712 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.89 80.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 295' ' ' VAL . 36.9 mm -66.05 -43.57 92.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.511 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -57.87 -44.47 86.63 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.217 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.43 -41.89 99.74 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.807 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.4 -43.31 97.92 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 291' ' ' ILE . 97.0 t -62.66 -45.74 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.35 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.37 -42.3 99.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.969 0.414 . . . . 0.0 110.987 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.74 -38.64 80.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.782 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -124.83 90.88 3.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -93.43 94.39 8.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 301' ' ' ASP . 10.9 tp -103.26 163.75 3.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.742 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.455 ' N ' HG13 ' A' ' 300' ' ' ILE . 3.8 m-20 -65.37 140.06 58.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.15 123.38 37.76 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.532 ' O ' HG13 ' A' ' 307' ' ' ILE . 46.6 Cg_exo -55.93 129.77 36.74 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.499 2.132 . . . . 0.0 111.977 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.38 -35.55 79.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.093 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.22 84.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.993 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.22 -34.5 56.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.954 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 303' ' ' PRO . 75.6 mt -61.87 -50.97 77.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.919 0.39 . . . . 0.0 111.612 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.31 -40.44 95.93 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 65.5 p -64.52 -45.94 85.08 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.509 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 43.3 mm-40 -72.01 -35.09 69.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.962 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.456 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 83.7 mt -62.08 -44.12 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.715 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.585 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 32.0 t70 -63.39 -40.85 98.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.844 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.9 t -64.05 -43.72 97.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.174 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 87.6 mt -62.53 -40.15 95.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.909 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.474 HH12 HD11 ' A' ' 330' ' ' LEU . 80.3 mtm180 -63.12 -38.91 93.06 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.266 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 90.5 mtt180 -63.73 -41.09 98.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.701 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -62.86 -44.04 97.18 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.641 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.34 -39.54 81.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.033 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.82 88.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.241 0.543 . . . . 0.0 110.435 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -62.11 -38.44 88.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.986 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.96 -37.79 79.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.07 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -74.39 39.1 0.12 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.138 0.975 . . . . 0.0 112.302 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.75 -2.87 57.24 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.155 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 92.94 33.58 7.28 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.159 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -71.47 132.0 44.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.721 0.296 . . . . 0.0 110.216 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.09 160.88 36.42 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.0 OUTLIER 68.77 -52.08 0.57 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.318 0.647 . . . . 0.0 112.102 -178.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.96 -3.58 29.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.12 -23.93 65.88 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.483 0.658 . . . . 0.0 109.714 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.474 HD11 HH12 ' A' ' 315' ' ' ARG . 42.2 tp -63.36 -35.15 79.44 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.266 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.94 -33.48 74.76 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.66 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 82.7 mt -47.56 133.99 10.39 Favored Pre-proline 0 N--CA 1.474 0.753 0 O-C-N 123.613 0.57 . . . . 0.0 112.458 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.24 129.62 35.48 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.962 2.441 . . . . 0.0 112.786 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -66.2 -43.42 86.85 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.303 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -63.46 -33.8 76.36 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.55 -37.18 86.35 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.643 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.54 -13.06 19.61 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.58 -30.09 67.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.675 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -62.0 -51.26 68.77 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.716 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -71.19 -27.1 63.28 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.809 0.338 . . . . 0.0 110.431 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.88 -43.06 99.61 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.781 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.408 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -59.66 -45.69 91.28 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.493 ' O ' HG23 ' A' ' 347' ' ' VAL . 8.3 mmt180 -61.43 -47.3 86.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.263 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.12 -37.73 84.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 341' ' ' ALA . 72.1 t -63.31 -44.44 99.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.255 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 70.3 t -62.0 -44.64 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.496 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 343' ' ' ARG . 70.4 t -60.53 -44.81 97.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.838 0.351 . . . . 0.0 110.137 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.79 -42.14 99.39 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.134 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.41 -43.9 96.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.734 0.302 . . . . 0.0 110.859 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.0 mt -62.81 -47.91 81.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.953 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 355' ' ' ILE . 94.3 mt -66.95 -40.43 87.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.159 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.96 -45.05 96.55 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.833 -0.622 . . . . 0.0 113.796 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -68.89 -35.12 76.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.293 0.547 . . . . 0.0 110.713 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 350' ' ' LEU . 78.5 t -60.47 -45.13 97.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 351' ' ' LEU . 80.4 mt -62.97 -46.5 96.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.916 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -67.45 -47.69 69.4 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 98.0 m -64.49 -44.83 89.75 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -87.6 -0.9 57.51 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.501 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 63.15 39.85 9.46 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.91 0.386 . . . . 0.0 111.626 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.7 mt -77.25 145.15 37.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.226 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.57 149.99 39.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.272 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.76 116.5 5.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.48 ' O ' HG21 ' A' ' 367' ' ' VAL . 27.3 t70 -86.24 116.07 24.19 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.532 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 25.7 mm-40 -59.52 -39.42 83.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.965 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -65.22 -42.52 93.34 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.018 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -63.74 -38.98 93.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.063 0.459 . . . . 0.0 109.954 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 363' ' ' ASP . 89.3 t -64.04 -38.95 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.485 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 26.8 mmmt -55.58 -45.3 77.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.428 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -64.21 -37.22 94.23 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.43 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.63 -42.11 98.18 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.337 0.589 . . . . 0.0 110.253 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.21 -43.21 97.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.792 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -60.59 -39.74 89.18 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.54 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.91 -40.14 87.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.777 0.322 . . . . 0.0 110.772 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.3 ttm -64.24 -41.73 96.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.0 0.428 . . . . 0.0 110.169 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.39 -27.22 69.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.572 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.7 m -75.27 -4.86 41.53 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.383 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -93.05 -0.54 57.1 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.204 0.526 . . . . 0.0 110.483 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -117.3 168.27 10.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.07 -50.22 72.82 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -117.95 117.62 35.28 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.837 0.351 . . . . 0.0 110.307 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.64 -28.91 25.25 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.345 2.03 . . . . 0.0 113.08 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -65.92 -43.89 86.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.22 -37.7 88.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.587 0.232 . . . . 0.0 110.911 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.86 -42.93 96.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.585 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.68 -44.53 99.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.254 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -67.25 -40.68 86.27 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 120.857 0.36 . . . . 0.0 110.197 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -58.43 -47.98 82.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 3.4 t80 -70.46 -40.25 73.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.12 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 59.4 p -77.7 -8.38 57.85 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -101.03 6.7 43.54 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.239 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -125.67 114.12 18.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.073 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -62.95 -41.45 99.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.373 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.11 -48.11 83.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 110.775 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.73 -40.63 97.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.626 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 94.1 mtp -61.96 -46.34 89.72 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.02 0.438 . . . . 0.0 110.997 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.87 -44.17 86.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.331 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -63.81 -40.92 97.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.573 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.479 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 53.1 tpp -62.95 -45.08 94.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.123 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -65.05 -29.22 70.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.567 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -62.24 -44.41 96.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.17 -44.26 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.817 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.37 94.75 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.986 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.68 -38.06 89.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.695 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.08 -44.81 91.92 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.905 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.51 -38.21 89.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.808 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -59.43 -41.66 90.08 Favored 'General case' 0 CA--C 1.526 0.032 0 CA-C-O 120.736 0.303 . . . . 0.0 110.62 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.07 79.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.39 -46.15 93.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.482 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -68.56 -30.55 69.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.498 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.33 -38.13 89.95 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.019 0.438 . . . . 0.0 109.93 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 91.5 t -64.69 -42.53 95.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.919 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.41 -40.13 93.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.82 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.65 67.48 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.495 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -99.38 -3.6 33.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.023 0.439 . . . . 0.0 110.962 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -107.85 178.87 4.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.45 107.86 19.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.559 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 97.0 t -99.9 118.66 46.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.902 -0.406 . . . . 0.0 109.902 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.5 t -120.81 158.35 27.76 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -104.82 132.78 50.64 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.077 0.465 . . . . 0.0 111.728 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -147.57 120.97 9.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.861 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 91.1 mt-10 -84.81 151.93 24.0 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.183 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.7 t -157.01 175.31 14.27 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.815 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 62.8 p -85.66 163.76 18.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.931 0.396 . . . . 0.0 111.392 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -64.56 -26.71 68.53 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.055 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -62.22 -39.7 93.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.781 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.6 -33.43 75.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.724 0.297 . . . . 0.0 111.468 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.57 -14.18 57.13 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.645 0.26 . . . . 0.0 111.262 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 2.9 mmt -76.84 -9.91 59.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.188 0.518 . . . . 0.0 110.331 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -80.68 85.65 6.03 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.387 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -105.84 29.27 6.79 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.214 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -66.52 -24.04 66.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.22 0.534 . . . . 0.0 109.912 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.377 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.451 178.389 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -78.03 134.13 37.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.185 0.517 . . . . 0.0 111.582 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 24.1 m -118.57 145.7 24.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.356 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.4 p -91.08 84.28 5.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 m -132.85 135.28 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -119.74 154.79 33.63 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.798 0.332 . . . . 0.0 111.557 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.484 ' HA ' ' HD3' ' B' ' 13' ' ' ARG . 90.3 m -99.47 118.08 35.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.522 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 14.9 m -72.66 -51.41 19.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.387 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -174.92 100.71 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.275 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.86 -107.43 1.54 Allowed Glycine 0 C--O 1.223 -0.567 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.136 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.434 HD23 ' N ' ' B' ' 109' ' ' PHE . 7.2 mp -66.77 -39.08 87.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.713 0.292 . . . . 0.0 110.919 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' B' ' 106' ' ' SER . . . -59.2 135.08 51.94 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.282 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.484 ' HD3' ' HA ' ' B' ' 7' ' ' THR . 0.0 OUTLIER -140.3 144.17 36.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.474 0.178 . . . . 0.0 110.749 -177.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.458 ' HA ' ' HH ' ' B' ' 105' ' ' TYR . 57.0 ttp180 -114.78 130.04 56.79 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.82 -89.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.729 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p 43.0 82.74 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 88.6 mt -112.88 131.38 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 60.5 m -95.47 126.85 41.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.966 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 41.6 pt -125.51 165.85 22.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.421 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.446 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.79 151.75 45.93 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.299 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.27 -43.1 82.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.63 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.75 -38.05 89.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.479 . . . . 0.0 110.194 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 23.0 m -63.3 -36.27 83.11 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.219 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.495 ' O ' ' HB ' ' B' ' 28' ' ' VAL . 75.7 mt -61.47 -50.8 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.282 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.524 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 50.2 mm-40 -75.59 -22.37 56.99 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -86.06 -68.57 0.73 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.693 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.62 -48.64 71.56 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 99.0 t -62.89 -45.33 99.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.523 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.524 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 16.4 ttmm -61.89 -44.85 95.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.503 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.6 m -65.34 -41.68 93.67 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.814 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -64.66 -38.27 90.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.701 0.286 . . . . 0.0 110.788 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 91.0 mt -62.31 -42.48 99.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.569 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -71.5 -35.26 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.991 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -64.32 -42.68 96.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.638 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -68.53 -32.45 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.129 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.66 98.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.66 -38.32 88.98 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.955 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -59.61 -37.18 77.9 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 18.0 t -87.79 -13.87 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 120.959 0.409 . . . . 0.0 110.038 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 70.83 28.63 3.3 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.756 0.823 . . . . 0.0 111.276 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.43 7.45 9.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.131 0.491 . . . . 0.0 111.598 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.3 -24.74 66.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.826 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.05 -1.83 88.12 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.955 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -94.44 7.38 45.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.712 0.291 . . . . 0.0 111.607 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 34.6 ttt85 -114.88 100.71 8.41 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.455 -0.498 . . . . 0.0 112.178 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -67.15 -46.72 73.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.675 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.86 65.92 1.62 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 116.561 1.384 . . . . 0.0 116.561 172.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -63.5 -42.68 98.49 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 t -107.34 106.06 57.42 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 114.725 -1.125 . . . . 0.0 107.997 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.435 ' HD2' HD13 ' B' ' 53' ' ' ILE . 28.0 Cg_exo -60.86 155.51 49.05 Favored 'Trans proline' 0 N--CA 1.476 0.476 0 C-N-CA 123.28 2.653 . . . . 0.0 112.969 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.492 ' HA ' HG21 ' B' ' 54' ' ' VAL . 92.3 mtp -61.18 -39.16 89.09 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' B' ' 50' ' ' PRO . 33.4 p-10 -65.7 -17.65 64.76 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.998 0.428 . . . . 0.0 110.859 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.435 HD13 ' HD2' ' B' ' 50' ' ' PRO . 89.0 mt -99.48 -36.29 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.004 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' B' ' 51' ' ' MET . 23.2 m -64.98 -37.46 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.633 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.07 83.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.227 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . 0.445 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 7.1 pt20 -82.04 -18.67 42.42 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.468 HH12 ' CD1' ' A' ' 187' ' ' LEU . 62.9 mtt-85 -107.37 -27.51 10.43 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.7 6.63 23.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.517 0.675 . . . . 0.0 110.164 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' B' ' 61' ' ' SER . . . -70.25 157.46 53.52 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 175.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.71 -40.72 0.48 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.082 0.553 . . . . 0.0 111.499 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' SER . . . . . 0.442 ' H ' ' C ' ' B' ' 59' ' ' GLY . 42.9 t -64.99 -63.2 1.17 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.925 0.49 . . . . 0.0 111.296 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.456 ' O ' HG22 ' B' ' 66' ' ' VAL . 8.5 p -101.41 10.44 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.469 0.652 . . . . 0.0 110.206 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -59.6 -26.07 65.15 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.693 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -62.63 -49.1 76.53 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.926 0.393 . . . . 0.0 110.382 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -77.32 -21.74 53.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.813 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.456 HG22 ' O ' ' B' ' 62' ' ' VAL . 77.0 t -63.94 -43.74 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.0 -39.4 94.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.216 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.7 -42.26 99.72 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.776 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 11.5 t70 -62.31 -45.36 93.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.998 0.428 . . . . 0.0 110.378 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.42 -41.7 98.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.367 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 15.5 tpt -61.69 -42.33 98.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 51.2 m -60.98 -43.61 98.56 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.836 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 96.4 mtt-85 -65.68 -42.0 91.77 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.497 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -63.65 -41.3 98.24 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.646 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -61.67 -50.95 70.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.962 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 tt -69.93 -41.8 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.43 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 7.8 t70 -64.57 -40.52 95.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.171 0.51 . . . . 0.0 110.098 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.38 -43.1 78.08 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.66 -33.64 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.012 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.57 -44.07 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.893 0.377 . . . . 0.0 110.899 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 17.4 ptpt -77.59 -28.3 51.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.548 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -83.38 -4.56 58.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.635 0.255 . . . . 0.0 110.84 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 66.5 36.93 4.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.366 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.1 mt -99.65 120.95 49.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.832 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -107.55 112.03 62.55 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.71 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -75.14 127.24 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.059 1.84 . . . . 0.0 111.523 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.22 100.22 9.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.069 0.461 . . . . 0.0 111.016 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.98 -109.84 3.25 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.148 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.69 113.75 8.57 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.684 0.278 . . . . 0.0 111.093 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.39 160.23 45.11 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.72 2.28 . . . . 0.0 111.066 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.4 m -107.04 118.74 37.51 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.814 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -73.38 -25.07 60.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.556 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 26.0 t 49.54 79.17 0.36 Allowed Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 123.788 0.835 . . . . 0.0 112.879 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.51 126.59 8.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.301 2.0 . . . . 0.0 110.627 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.62 -172.2 48.53 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.593 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.7 121.08 26.8 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.949 0.404 . . . . 0.0 109.998 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -82.2 118.18 22.89 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.148 0.499 . . . . 0.0 110.805 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -98.7 123.69 43.07 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 tp -68.35 105.82 2.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.577 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.42 3.31 44.1 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.588 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -126.87 172.31 10.52 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.83 0.347 . . . . 0.0 111.222 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.52 141.99 57.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.733 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -105.28 144.74 31.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.948 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 34.8 m -119.98 131.2 55.09 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.011 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.458 ' HH ' ' HA ' ' B' ' 14' ' ' ARG . 0.5 OUTLIER -145.94 162.1 38.56 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' SER . . . . . 0.548 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 46.2 p -97.9 -83.78 0.4 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -174.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' B' ' 106' ' ' SER . 94.3 t 75.02 113.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -173.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -104.94 121.94 44.79 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -172.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . 0.434 ' N ' HD23 ' B' ' 11' ' ' LEU 0.255 26.3 p90 -138.71 -92.88 0.19 Allowed 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 175.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -159.43 149.15 18.61 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.018 0.826 . . . . 0.0 112.194 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.78 168.59 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.47 0.708 . . . . 0.0 111.619 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -111.28 104.42 56.13 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.425 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -91.44 154.27 3.63 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.924 2.416 . . . . 0.0 113.139 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -158.06 139.81 13.86 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 62.2 t -127.69 136.17 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.164 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -84.84 142.23 29.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.6 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.11 146.52 47.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.746 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -139.2 154.01 47.97 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.663 0.268 . . . . 0.0 111.388 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.3 20.61 76.88 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.068 -0.515 . . . . 0.0 113.857 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.73 -40.86 92.58 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.953 0.406 . . . . 0.0 111.811 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.2 -5.12 39.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.279 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.09 12.96 36.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.814 0.34 . . . . 0.0 111.057 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.49 124.02 46.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.125 0.488 . . . . 0.0 110.346 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.84 121.9 44.64 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.336 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.1 134.43 53.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.807 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -84.65 143.71 29.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.464 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -133.41 97.44 16.12 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.94 138.08 55.82 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.409 2.072 . . . . 0.0 111.427 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' B' ' 421' ' ' GLU . 48.8 mm -117.64 124.46 73.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.78 162.11 39.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.607 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -148.29 -178.77 6.49 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 80.8 t -100.02 127.6 52.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 120.875 0.369 . . . . 0.0 110.776 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 59.2 p -104.83 171.6 7.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.771 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -64.0 -34.12 77.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.608 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.6 86.05 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.498 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -62.85 -39.66 95.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.878 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.403 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.5 t -63.11 -45.57 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.179 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.76 -44.89 96.0 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.138 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.5 -40.94 99.74 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.397 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' MET . . . . . 0.602 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.1 tpt -61.77 -48.63 79.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.688 0.28 . . . . 0.0 110.5 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 91.9 mt -63.64 -42.1 98.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.224 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.46 -49.13 78.96 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.406 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.5 m -62.79 -41.61 99.35 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.763 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' B' ' 140' ' ' MET . 89.3 mt -60.63 -35.53 76.39 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -78.3 -15.11 59.07 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.54 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.3 -6.27 41.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.313 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -107.95 30.24 6.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.865 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -134.95 94.83 3.21 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -112.0 120.11 40.75 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.705 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' THR . . . . . 0.638 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 52.7 m -71.73 158.89 35.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.826 0.346 . . . . 0.0 111.318 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -78.89 122.56 26.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -143.53 170.07 16.5 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.29 0.29 54.19 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -165.23 -175.78 3.79 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.983 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' B' ' 242' ' ' GLU . 0.9 OUTLIER 93.2 127.76 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.829 1.651 . . . . 0.0 111.822 176.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -71.45 90.02 0.45 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 115.324 0.89 . . . . 0.0 115.324 -172.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.77 135.36 18.41 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.72 128.31 70.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -108.35 158.6 17.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.921 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.49 24.44 0.2 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.033 0.533 . . . . 0.0 112.235 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -138.11 -3.73 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.155 0.503 . . . . 0.0 109.886 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -85.3 159.54 20.02 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.49 0.662 . . . . 0.0 112.626 -172.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' B' ' 163' ' ' ARG . 12.0 ptp180 -104.6 103.11 12.72 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.663 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.54 120.17 51.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.699 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 26.6 m -77.78 105.11 8.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.75 123.59 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.547 -174.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . 0.463 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 18.1 m-20 -95.15 107.05 19.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -125.03 147.7 48.83 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.605 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 29.8 m -120.13 130.3 54.55 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.759 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.63 119.52 4.89 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.45 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 25.4 p -134.94 126.52 28.8 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 t -75.36 -90.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.499 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -98.91 -4.61 32.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.378 0.609 . . . . 0.0 109.739 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.41 -18.1 0.44 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.732 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.95 146.07 27.11 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.925 0.393 . . . . 0.0 110.205 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -81.6 156.01 25.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.987 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -125.96 -175.72 3.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.521 0.2 . . . . 0.0 111.537 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.3 -38.79 84.75 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.74 -176.89 32.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.481 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.08 26.53 36.73 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.623 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -108.01 98.25 7.84 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.27 140.04 51.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.035 0.445 . . . . 0.0 111.894 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.463 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 48.8 m -148.48 125.12 11.09 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 61.16 30.66 19.46 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.596 0.56 . . . . 0.0 110.276 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -88.82 128.82 35.66 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.027 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 16.9 m -99.34 122.69 51.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.462 0.648 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . 0.43 HD11 HH12 ' A' ' 57' ' ' ARG . 35.2 tp -111.62 120.2 41.27 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.941 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.74 112.2 24.07 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 189' ' ' MET . . . . . 0.614 ' HE2' ' O ' ' B' ' 199' ' ' GLU . 84.8 mtp -83.42 152.32 25.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.008 -175.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.49 -14.2 62.25 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.055 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -95.19 -11.76 27.51 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.24 48.14 6.14 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.25 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 34.8 mmm-85 -88.23 -12.39 43.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.864 -0.668 . . . . 0.0 109.796 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.18 -179.58 5.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.908 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 49.6 mm -61.05 134.04 92.8 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.85 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.81 128.4 21.43 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.837 2.358 . . . . 0.0 112.352 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.48 -39.39 2.76 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.24 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -62.54 -47.64 82.98 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . 0.614 ' O ' ' HE2' ' B' ' 189' ' ' MET . 12.1 pt-20 -79.11 -10.05 59.72 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.09 -177.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.5 -28.3 16.88 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.952 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.77 -21.86 71.47 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.659 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.92 -41.91 94.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -54.92 134.1 48.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.665 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 100.35 3.67 55.36 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.658 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -108.4 151.93 25.36 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 120.967 0.413 . . . . 0.0 110.901 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -92.81 155.61 17.53 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.053 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.12 134.99 56.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.79 50.3 25.1 Favored Glycine 0 C--O 1.236 0.222 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.944 -178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -135.65 133.54 38.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.086 0.469 . . . . 0.0 111.264 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -108.54 127.02 53.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -144.82 -12.8 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 44.1 p 60.27 166.72 0.08 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.79 0.836 . . . . 0.0 111.926 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -155.59 119.71 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.256 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.06 106.76 11.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.83 0.347 . . . . 0.0 110.829 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 97.7 t -109.23 115.57 49.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.108 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' THR . . . . . 0.524 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 8.2 m -64.09 -41.03 97.45 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.8 m-85 77.88 141.74 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 123.113 0.565 . . . . 0.0 109.809 -172.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.63 152.23 53.33 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.818 1.679 . . . . 0.0 111.878 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . 0.539 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 39.9 mm-40 -62.67 -33.52 75.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.999 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -86.77 24.78 1.39 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.113 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . 0.477 ' CE2' ' HB1' ' B' ' 223' ' ' ALA . 9.0 t80 -73.82 135.22 43.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.496 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -67.69 -14.69 63.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.477 ' HB1' ' CE2' ' B' ' 221' ' ' TYR . . . -98.65 108.71 21.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 36.5 tt0 -60.86 -36.79 80.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.42 ' OD1' ' HG ' ' B' ' 226' ' ' LEU . 25.7 p30 -72.65 -11.9 60.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.42 ' HG ' ' OD1' ' B' ' 225' ' ' ASN . 94.6 mt -120.55 -0.01 10.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.539 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.9 ptmt -70.73 108.36 4.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.573 0.701 . . . . 0.0 112.76 -175.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.33 17.1 78.55 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.799 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -121.19 123.51 42.44 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -68.02 136.16 53.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -110.96 137.04 49.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.182 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -70.08 -41.23 74.37 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -175.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' B' ' 212' ' ' THR . 74.4 m-85 57.62 100.94 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.915 0.486 . . . . 0.0 112.122 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.55 -49.77 76.21 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 61.81 77.97 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.092 0.472 . . . . 0.0 111.051 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -65.85 -39.94 91.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.886 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 12.5 tp 51.71 83.56 0.05 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.921 0.888 . . . . 0.0 111.142 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . 0.447 ' HD3' ' HB2' ' B' ' 167' ' ' ASP . 51.9 mtpt -89.98 -64.68 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -174.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -88.52 -89.75 0.14 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 42.9 t 73.42 129.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.888 0.475 . . . . 0.0 111.07 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -69.13 -35.39 76.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.962 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' B' ' 155' ' ' ASP . 12.9 pt-20 57.49 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.432 1.493 . . . . 0.0 114.061 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -139.41 125.73 20.21 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.197 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' B' ' 245' ' ' LEU . 0.9 OUTLIER -150.68 -173.85 4.6 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.537 ' H ' ' CD ' ' B' ' 244' ' ' GLU . 46.3 mt 73.6 102.37 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 123.216 0.606 . . . . 0.0 111.042 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . 0.638 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 72.2 Cg_endo -78.97 109.89 2.66 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.569 2.179 . . . . 0.0 113.857 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . 0.496 ' H ' HG22 ' B' ' 150' ' ' THR . 12.5 pt-20 -138.11 23.34 2.8 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.632 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 51.6 tp 77.0 139.08 0.07 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' THR . . . . . 0.444 HG22 ' H ' ' B' ' 251' ' ' GLU . 27.7 m -149.78 141.51 23.62 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.145 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -80.05 -9.99 59.74 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.444 ' H ' HG22 ' B' ' 249' ' ' THR . 41.4 mt-10 -84.66 -25.19 28.65 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -63.62 -28.21 69.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 41.2 pt -70.44 -9.41 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.815 0.34 . . . . 0.0 111.89 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -136.7 30.11 2.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.846 0.355 . . . . 0.0 111.55 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -118.24 12.16 13.38 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-O 121.095 0.474 . . . . 0.0 111.49 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -96.3 27.6 3.66 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.19 -40.28 2.99 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.42 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 28.0 t -68.94 137.65 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -43.63 -59.65 2.1 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.912 0.758 . . . . 0.0 111.986 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -166.81 157.84 12.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.789 0.328 . . . . 0.0 111.087 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -156.54 -171.02 22.29 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.872 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 56.8 p -111.49 -141.3 0.38 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 59.8 t -98.16 -71.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 110.025 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.2 OUTLIER -68.51 -37.07 79.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.243 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.97 93.7 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.191 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.436 ' O ' HG22 ' B' ' 270' ' ' VAL . 53.1 tp -63.08 -43.42 98.59 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -61.59 -42.11 98.39 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.459 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.566 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -62.27 -46.01 90.69 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.204 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 38.4 tp10 -66.55 -40.07 88.87 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.853 0.358 . . . . 0.0 111.176 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.436 HG22 ' O ' ' B' ' 266' ' ' LEU . 90.9 t -65.25 -43.26 95.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.413 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -60.48 -46.98 88.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 14.1 ptmt -63.19 -44.36 95.58 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.898 0.38 . . . . 0.0 111.0 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -65.21 -38.29 89.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.406 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.8 mmm -63.82 -42.4 97.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.672 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -69.02 -33.32 73.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.059 0.457 . . . . 0.0 110.585 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -63.27 -42.49 99.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.683 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -67.37 -36.39 81.27 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.002 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . 0.455 ' O ' HG13 ' B' ' 282' ' ' ILE . 44.8 tp -62.3 -38.56 89.88 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.789 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -56.3 -45.66 80.15 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.263 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 19.4 m -61.63 -42.28 98.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.837 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.56 -42.93 99.85 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.138 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . 0.455 HG13 ' O ' ' B' ' 278' ' ' LEU . 66.5 mt -64.36 -44.36 97.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.301 178.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -60.21 -44.1 95.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.452 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -63.64 -42.79 98.11 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.166 0.291 . . . . 0.0 111.404 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -60.54 -44.74 95.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.073 0.463 . . . . 0.0 110.729 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.61 -45.2 78.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.32 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.92 -48.91 78.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.806 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -63.57 -43.4 97.1 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -65.29 -42.18 93.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.485 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.58 -47.95 81.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.994 0.426 . . . . 0.0 111.09 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . 0.403 HG22 HG21 ' B' ' 347' ' ' VAL . 51.2 mm -66.68 -43.44 90.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.92 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . 0.414 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 19.9 tp10 -57.82 -45.4 86.21 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.134 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.77 -40.62 99.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.116 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 4.8 tt -63.6 -43.9 95.56 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.32 -43.98 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.247 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . 0.414 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 66.1 mttm -60.33 -35.18 75.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.934 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.16 -11.76 40.19 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -138.63 81.01 1.82 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -91.54 93.27 8.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -105.26 157.93 5.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.58 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.22 138.25 58.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.465 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 35.0 t -106.63 126.01 31.4 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.861 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . 0.501 ' O ' HG13 ' B' ' 307' ' ' ILE . 51.6 Cg_exo -55.99 129.19 33.58 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.428 2.086 . . . . 0.0 111.914 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.28 83.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.476 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.99 84.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.52 -38.06 83.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.507 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . 0.501 HG13 ' O ' ' B' ' 303' ' ' PRO . 73.6 mt -61.07 -50.12 81.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.248 -177.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.16 -37.53 87.67 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 63.6 p -67.6 -45.17 76.23 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.501 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . 0.544 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 66.8 mm-40 -71.81 -36.32 70.21 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 87.3 mt -62.38 -44.46 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.12 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.567 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 36.6 t70 -63.24 -41.86 99.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.823 0.344 . . . . 0.0 110.965 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.47 -43.16 98.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.298 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 84.2 mt -62.21 -39.91 94.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.693 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 79.1 mtm180 -63.37 -39.04 93.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.235 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 90.2 mtt180 -62.82 -42.23 99.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.842 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -62.95 -43.16 99.55 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.496 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.05 -39.94 82.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.964 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.44 91.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.07 0.462 . . . . 0.0 110.39 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -62.15 -37.15 84.13 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.052 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -70.56 -36.95 73.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.412 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.02 42.37 0.25 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.986 0.915 . . . . 0.0 112.172 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.77 -0.11 59.24 Favored Glycine 0 C--N 1.318 -0.465 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.033 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 89.49 30.65 13.08 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.195 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -68.6 136.35 52.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.899 0.38 . . . . 0.0 110.533 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . 0.434 ' CD ' ' HZ1' ' B' ' 327' ' ' LYS . 0.9 OUTLIER -137.98 162.29 34.47 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.549 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.0 OUTLIER 68.57 -53.43 0.55 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.298 0.639 . . . . 0.0 112.359 -178.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -73.99 -3.7 30.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.44 -24.32 65.11 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.278 0.561 . . . . 0.0 109.705 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 41.9 tp -63.23 -36.23 82.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.324 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.07 -26.02 65.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.877 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 80.0 mt -54.3 132.89 61.54 Favored Pre-proline 0 C--O 1.238 0.481 0 CA-C-O 120.706 0.288 . . . . 0.0 111.556 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.67 133.19 55.78 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.986 2.457 . . . . 0.0 113.338 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . 0.428 HH21 ' HD2' ' B' ' 334' ' ' ARG . 26.1 ttt85 -67.03 -43.81 81.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.056 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -63.85 -33.01 74.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -174.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.29 -36.57 84.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.473 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -101.36 -13.82 17.85 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -68.52 -30.4 69.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.734 0.302 . . . . 0.0 111.482 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.66 -49.85 74.87 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.792 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -72.25 -29.43 63.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 110.71 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . 0.456 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -61.72 -43.66 98.42 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.108 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . 0.438 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.6 tttt -59.47 -45.19 92.35 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . 0.526 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.7 mmt85 -62.44 -45.52 92.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -66.0 -37.89 87.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 341' ' ' ALA . 82.6 t -63.4 -44.72 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.787 0.327 . . . . 0.0 110.33 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 342' ' ' LYS . 71.7 t -61.23 -45.1 99.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.513 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 343' ' ' ARG . 85.4 t -61.24 -44.57 98.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.281 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.59 -42.32 99.15 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.15 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.04 -44.03 97.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 110.701 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.463 ' O ' HG22 ' B' ' 354' ' ' VAL . 96.2 mt -63.24 -49.45 74.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.0 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.7 -41.21 88.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.6 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.39 -42.44 98.92 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.265 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.7 -35.65 75.25 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.956 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . 0.463 HG22 ' O ' ' B' ' 350' ' ' LEU . 71.8 t -60.15 -44.73 95.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.74 -44.15 98.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.127 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -68.58 -49.03 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 39.2 m -64.48 -44.9 89.56 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -88.56 5.93 40.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.367 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 56.43 45.27 22.96 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.032 0.444 . . . . 0.0 111.528 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 98.8 mt -81.48 143.77 31.84 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.125 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.23 150.53 42.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.109 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.02 120.55 13.34 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . 0.53 ' O ' HG21 ' B' ' 367' ' ' VAL . 15.1 t70 -89.59 113.59 25.05 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.032 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 58.8 mm-40 -59.0 -38.38 79.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.449 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -65.46 -41.54 93.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.839 0.352 . . . . 0.0 110.785 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -64.92 -38.66 91.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.784 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . 0.53 HG21 ' O ' ' B' ' 363' ' ' ASP . 96.0 t -63.08 -38.77 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.389 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.4 mmmt -56.35 -44.35 80.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.53 96.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.012 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.81 -42.42 99.71 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.114 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.02 -43.22 97.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.832 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -60.83 -38.95 87.22 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.197 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -65.94 -39.0 90.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.306 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 53.8 ttm -66.39 -41.77 88.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.368 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.57 -28.24 69.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.804 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 48.7 m -75.13 -5.77 46.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.562 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -93.08 -1.34 56.59 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.946 0.403 . . . . 0.0 111.234 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -114.29 169.05 9.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.156 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -64.96 -44.09 90.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.961 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -119.65 118.88 31.79 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.798 0.332 . . . . 0.0 110.198 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.83 -30.62 21.67 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.421 2.08 . . . . 0.0 113.258 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -66.14 -43.37 87.24 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.44 -37.36 85.59 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.706 0.289 . . . . 0.0 110.851 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.44 -43.25 96.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.515 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 90.4 mt -62.33 -44.25 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.943 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 48.3 mt-10 -65.66 -44.48 86.15 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.838 178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.5 -47.82 82.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.122 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . 0.467 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 2.8 t80 -69.52 -39.88 77.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.051 -177.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 62.7 p -78.93 -8.06 58.55 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.4 mttt -99.32 1.7 44.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.967 0.413 . . . . 0.0 111.536 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . 0.444 ' OD1' HD11 ' B' ' 394' ' ' LEU . 24.6 t-20 -123.9 115.25 20.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.232 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 42.1 ttmt -63.9 -40.87 97.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.407 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.23 -49.49 76.9 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.094 0.473 . . . . 0.0 110.781 -176.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . 0.444 HD11 ' OD1' ' B' ' 391' ' ' ASN . 10.3 mp -63.61 -40.18 96.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.47 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 89.7 mtp -62.55 -45.46 92.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 111.526 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.79 -43.66 75.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.223 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -62.8 -39.81 95.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.636 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 398' ' ' MET . . . . . 0.467 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 55.5 tpp -62.82 -44.07 97.12 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.868 0.366 . . . . 0.0 110.751 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -64.65 -31.69 73.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.014 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -61.24 -45.63 93.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.78 -43.83 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.043 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.2 -41.0 96.06 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.003 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.75 -37.04 86.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.693 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.2 -45.18 91.76 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.999 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -65.74 -37.81 87.39 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.656 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -58.92 -43.12 91.03 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.868 0.366 . . . . 0.0 110.421 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.71 -47.28 78.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.599 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 94.9 t -64.12 -45.62 95.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.413 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -67.57 -32.0 72.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.555 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.69 91.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.879 0.371 . . . . 0.0 110.253 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.35 -42.64 95.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.957 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.0 -38.54 86.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.749 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.32 -23.46 66.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -99.25 -2.51 36.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.916 0.389 . . . . 0.0 110.855 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -110.15 174.46 5.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.189 0.519 . . . . 0.0 111.614 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -87.39 108.06 18.82 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.692 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 65.0 t -100.41 118.93 47.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.218 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -119.97 159.57 24.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -108.17 122.16 46.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.873 0.368 . . . . 0.0 111.504 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -134.72 123.7 24.08 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.079 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' B' ' 129' ' ' ILE . 75.3 mt-10 -84.65 154.25 22.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.908 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.0 t -158.2 176.12 12.9 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.599 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 75.0 p -85.4 165.41 17.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.895 0.379 . . . . 0.0 111.231 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -66.72 -26.5 67.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.581 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -62.58 -39.57 94.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.36 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.56 -35.77 81.03 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.361 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -78.16 -14.21 59.56 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.823 0.345 . . . . 0.0 111.461 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.4 mmt -76.69 -9.5 58.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.924 0.392 . . . . 0.0 110.703 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -80.0 87.11 5.42 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -108.82 29.61 7.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.907 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -65.6 -27.35 68.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.376 0.608 . . . . 0.0 109.584 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.478 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.52 178.265 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t -135.4 131.03 35.79 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.818 0.342 . . . . 0.0 110.163 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.6 p -153.06 139.71 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.546 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -131.73 154.76 48.7 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 m -102.84 126.13 49.86 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.5 m -97.4 -58.8 1.92 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.441 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -174.3 130.42 0.37 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.571 0.224 . . . . 0.0 110.781 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.44 -112.78 5.05 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.815 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.403 ' N ' HD11 ' A' ' 11' ' ' LEU . 5.4 mp -93.61 -8.78 40.17 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.673 0.273 . . . . 0.0 110.731 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.38 122.14 5.62 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.995 -0.622 . . . . 0.0 113.646 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.05 147.5 46.63 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.432 0.693 . . . . 0.0 109.255 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -110.11 139.32 45.38 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.9 t -95.99 -89.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.9 m 68.04 100.2 0.05 Allowed 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -173.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tp -133.02 143.72 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.012 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 m -126.45 130.57 50.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.456 ' HB ' HG12 ' A' ' 24' ' ' ILE . 9.6 mt -125.79 162.11 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -177.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.554 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.7 150.09 49.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.301 0.24 . . . . 0.0 111.132 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.33 -57.08 9.87 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -174.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.11 -35.35 79.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 111.224 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 t -62.74 -41.82 99.38 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.487 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 20' ' ' ALA . 76.4 mt -60.21 -51.98 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.155 0.503 . . . . 0.0 111.354 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -70.04 -46.91 64.02 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.547 -174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.2 m -67.3 -51.33 54.01 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.93 66.5 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.87 -43.29 97.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.964 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -61.32 -45.45 94.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.16 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.2 m -62.18 -42.18 99.03 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.841 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.468 ' O ' HG21 ' A' ' 35' ' ' VAL . 10.0 tp10 -70.16 -42.03 73.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.494 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.54 -44.65 96.67 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.94 -35.43 64.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.014 0.435 . . . . 0.0 110.701 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -65.68 -41.31 92.6 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 31' ' ' GLU . 90.2 t -65.68 -41.46 90.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.398 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.34 80.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.285 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.424 ' O ' ' HD3' ' A' ' 40' ' ' ARG . 99.0 mttt -64.58 -37.58 88.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.059 177.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -61.0 -41.91 97.4 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.883 0.373 . . . . 0.0 110.598 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.87 -4.23 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.388 0.613 . . . . 0.0 110.156 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 25.6 mmt180 62.62 30.95 17.0 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.049 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -112.83 7.15 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.764 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -64.01 -35.92 82.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.081 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.23 -1.64 70.15 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.688 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -91.72 -5.19 54.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.921 0.391 . . . . 0.0 110.734 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -90.36 110.59 21.67 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.01 -39.1 91.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.615 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.83 56.45 24.76 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -62.66 -41.29 98.98 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.91 109.69 58.81 Favored Pre-proline 0 C--O 1.246 0.902 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HG2' HD13 ' A' ' 53' ' ' ILE . 47.4 Cg_exo -57.3 149.35 65.25 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.925 2.417 . . . . 0.0 112.543 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.472 ' HA ' HG13 ' A' ' 54' ' ' VAL . 15.0 ttt -60.29 -39.16 85.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.455 -173.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -69.12 -23.42 63.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.844 0.354 . . . . 0.0 110.987 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.428 HD13 ' HG2' ' A' ' 50' ' ' PRO . 96.6 mt -92.53 -41.72 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.472 HG13 ' HA ' ' A' ' 51' ' ' MET . 12.7 p -66.02 -38.78 82.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 120.936 0.398 . . . . 0.0 110.817 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.45 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -66.84 -37.37 84.36 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -72.78 -15.01 61.65 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.724 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.481 HH12 ' CD1' ' B' ' 187' ' ' LEU . 67.2 mtt180 -108.59 -52.41 2.77 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.429 ' O ' HG12 ' A' ' 62' ' ' VAL . 18.8 m-85 -108.66 -1.24 19.66 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.182 0.515 . . . . 0.0 110.646 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -63.87 -35.76 92.43 Favored Glycine 0 C--O 1.218 -0.863 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.753 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.93 -43.94 67.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.802 0.301 . . . . 0.0 111.312 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.5 m -61.19 -43.29 99.11 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.129 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -105.32 20.3 4.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.246 0.546 . . . . 0.0 110.776 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 14.1 ttm180 -63.97 -19.9 65.49 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.048 0.452 . . . . 0.0 110.147 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.37 -53.05 58.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.24 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.43 ' HB2' HG23 ' A' ' 62' ' ' VAL . 17.6 m-20 -71.02 -26.15 62.99 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.501 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 62' ' ' VAL . 91.7 t -62.05 -45.24 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.74 -40.06 95.81 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.352 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.03 99.39 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.23 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.51 -44.67 93.62 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.39 -42.76 99.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.036 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.1 ttp -60.48 -50.08 75.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.34 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.3 m -65.27 -46.38 80.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.679 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.41 ' HD3' HG12 ' A' ' 35' ' ' VAL . 58.4 ttm-85 -66.27 -46.63 76.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.792 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -66.14 -40.4 90.6 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -59.88 -48.36 81.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.908 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.508 ' O ' HG13 ' A' ' 79' ' ' ILE . 20.0 tt -68.17 -38.9 80.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.883 0.373 . . . . 0.0 111.271 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.19 -38.54 88.24 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.384 0.611 . . . . 0.0 109.767 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.69 83.73 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.766 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.7 pp -65.07 -37.33 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.076 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.32 -42.33 95.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.718 0.77 . . . . 0.0 109.156 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -59.55 -47.86 83.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.16 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -89.38 -1.43 58.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -175.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm 70.46 38.95 1.27 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.47 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 92.5 mt -93.84 121.28 44.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -110.52 101.41 48.66 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.588 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.92 131.31 6.97 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.53 2.153 . . . . 0.0 112.452 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.7 90.95 4.42 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.997 0.427 . . . . 0.0 110.4 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.46 -144.21 15.29 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.18 129.47 25.05 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 116.588 0.194 . . . . 0.0 110.678 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.21 160.2 50.4 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.827 2.352 . . . . 0.0 111.398 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.2 m -101.09 91.72 4.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.12 0.486 . . . . 0.0 112.17 -175.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -84.05 117.77 23.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.6 t -111.26 96.93 33.3 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 120.86 0.362 . . . . 0.0 111.967 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -87.99 145.14 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 122.592 2.194 . . . . 0.0 110.81 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.96 174.83 42.81 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.638 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.52 130.86 42.3 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -85.34 104.04 14.81 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.153 0.501 . . . . 0.0 110.911 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.95 111.7 19.49 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.11 112.7 2.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.118 0.485 . . . . 0.0 110.484 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.97 -14.91 19.15 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.135 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -119.0 -178.1 3.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.623 0.249 . . . . 0.0 111.035 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.52 161.18 28.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.359 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -108.8 138.81 44.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.776 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -118.31 134.54 54.95 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.198 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -136.39 162.67 32.39 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.835 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.9 m -121.8 148.78 44.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.762 0.315 . . . . 0.0 111.112 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.88 139.96 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.417 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.41 132.81 46.81 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -155.72 -159.33 0.9 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -45.96 155.22 0.2 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.557 1.543 . . . . 0.0 113.327 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.5 m -129.93 159.19 42.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.445 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -145.55 99.32 4.48 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.253 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.22 143.73 10.25 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.515 2.143 . . . . 0.0 113.124 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -159.01 125.59 4.62 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.93 162.62 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.891 0.376 . . . . 0.0 111.709 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -119.64 136.35 54.43 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.6 mt -114.23 135.3 54.2 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -128.09 133.46 49.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.626 0.251 . . . . 0.0 111.649 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.1 22.43 52.31 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.882 -0.675 . . . . 0.0 114.251 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.89 -41.42 99.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.24 0.543 . . . . 0.0 110.511 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.67 -16.77 61.88 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.619 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.05 6.98 47.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.49 127.53 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.375 0.607 . . . . 0.0 111.093 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -110.04 132.2 54.37 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.935 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.5 t -120.76 133.6 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.142 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -90.26 120.26 31.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.049 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -122.31 93.5 48.48 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.76 140.73 56.93 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.176 1.917 . . . . 0.0 112.446 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.2 mm -106.37 119.84 56.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.378 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.41 160.43 42.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.293 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.3 158.77 43.36 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.855 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.4 t -84.72 126.4 40.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.698 0.285 . . . . 0.0 110.491 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.2 p -97.74 170.02 9.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -68.57 -22.68 64.46 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.284 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.69 -38.89 92.54 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.151 0.501 . . . . 0.0 109.652 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -65.15 -36.74 85.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.336 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.45 -45.36 98.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.468 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.09 -40.48 95.99 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.438 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.81 -42.67 99.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.663 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.521 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 5.0 tpt -63.72 -45.17 91.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.922 0.391 . . . . 0.0 110.306 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.43 -41.4 98.67 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.957 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.1 -45.89 89.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.386 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.0 m -62.62 -39.55 94.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.329 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.7 mt -61.49 -41.75 97.75 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.701 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -69.43 -21.54 63.74 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.087 0.47 . . . . 0.0 110.802 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -86.56 4.13 41.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.223 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -119.8 28.54 8.06 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.664 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -138.33 95.39 3.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.57 155.99 47.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.96 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.5 HG21 ' H ' ' A' ' 151' ' ' TRP . 0.7 OUTLIER -122.29 172.35 8.37 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.766 -177.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.5 ' H ' HG21 ' A' ' 150' ' ' THR . 8.9 p-90 -55.0 136.41 47.78 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.052 0.541 . . . . 0.0 112.311 -176.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -170.32 113.87 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -73.86 85.58 1.72 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -153.0 -78.31 0.11 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.837 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -163.19 -68.21 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.434 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 243' ' ' ARG . . . 64.54 -126.92 33.59 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.198 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -146.34 -165.44 2.22 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 203' ' ' LYS . 61.2 t -119.38 126.54 75.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 57.1 mm-40 -87.88 177.93 6.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.263 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.17 -58.25 3.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.424 ' CD ' ' HE ' ' A' ' 255' ' ' ARG . 6.7 pt-20 -89.58 34.98 0.82 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.304 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.642 ' OD2' ' HD3' ' A' ' 243' ' ' ARG . 11.4 t70 -57.22 -48.7 78.14 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.412 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 65.82 88.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.607 HG23 ' OD1' ' A' ' 162' ' ' ASP . 2.9 t -109.94 132.31 58.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.694 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 m -81.15 104.62 11.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 79.7 mt -117.1 132.82 65.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -171.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -99.26 107.92 20.34 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -130.68 146.91 52.28 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.621 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 37.6 m -128.55 131.46 48.22 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.085 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.97 105.84 1.96 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.603 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.9 m -127.26 121.69 31.85 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.6 t -72.64 -76.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -109.28 -70.34 0.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.172 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -136.87 18.9 3.54 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.228 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -136.84 148.79 47.33 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -93.32 149.37 21.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.643 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -111.39 -177.8 3.29 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.24 -45.01 92.31 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.732 -176.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -93.24 -171.58 39.9 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.173 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.62 36.87 58.27 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.865 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -115.17 101.42 8.95 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.2 151.53 34.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.144 0.497 . . . . 0.0 111.54 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.8 m -139.04 126.42 21.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.471 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 56.69 38.3 29.43 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.13 0.49 . . . . 0.0 110.768 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -87.7 136.1 33.1 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.619 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.53 120.15 37.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.715 0.769 . . . . 0.0 112.15 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.437 ' CD1' HH12 ' B' ' 57' ' ' ARG . 49.0 tp -113.27 119.42 37.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.595 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.635 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -102.21 129.04 48.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 56.9 mtm -106.83 167.65 9.73 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.768 -173.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.17 14.08 61.0 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.708 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -126.62 -10.06 6.2 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.661 0.267 . . . . 0.0 111.445 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.53 40.45 9.86 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.424 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.635 ' HG3' ' O ' ' A' ' 188' ' ' ALA . 39.5 mmm-85 -79.12 -22.04 45.72 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.38 0.672 . . . . 0.0 109.939 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.424 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.1 OUTLIER -128.95 -170.0 2.19 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.185 179.494 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.439 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.2 mp -68.33 134.52 91.13 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.63 132.43 45.74 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.256 1.971 . . . . 0.0 111.918 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.47 -39.88 2.63 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.795 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -62.34 -46.31 89.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.554 0.216 . . . . 0.0 111.244 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.95 10.85 5.76 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.088 0.47 . . . . 0.0 111.894 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -114.37 -33.64 5.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.121 0.486 . . . . 0.0 110.115 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.76 -17.88 75.46 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.246 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.57 -41.97 94.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.061 0.457 . . . . 0.0 110.322 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 158' ' ' VAL . 41.5 mtpt -52.08 132.27 32.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.654 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.76 8.74 55.52 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.767 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.43 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 38.0 m80 -115.38 150.18 36.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.031 0.416 . . . . 0.0 110.72 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -87.26 163.39 16.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.169 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.95 135.49 47.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.01 15.35 79.14 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.77 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.43 ' OE2' ' HD2' ' A' ' 205' ' ' HIS . 40.7 tt0 -99.19 119.89 38.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.33 0.585 . . . . 0.0 111.362 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 235' ' ' ILE . 25.4 mt-10 -98.9 115.62 29.28 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.406 ' O ' ' HB ' ' A' ' 212' ' ' THR . 64.0 t80 -133.74 -26.09 1.6 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -173.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 77.0 m 72.42 129.96 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 120.893 0.378 . . . . 0.0 110.344 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.42 -41.07 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 70.75 97.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 122.791 0.436 . . . . 0.0 111.32 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 68.6 t -115.59 126.92 73.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.049 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.55 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 18.5 m -65.89 -41.95 90.88 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -176.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.55 ' HB2' ' O ' ' A' ' 216' ' ' THR . 27.8 m-85 77.81 134.53 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 122.957 0.503 . . . . 0.0 110.32 -173.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.16 155.7 51.84 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.369 2.046 . . . . 0.0 112.679 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -66.09 -33.78 76.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.601 0.715 . . . . 0.0 109.305 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.12 22.81 1.66 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.851 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -70.52 142.1 51.88 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.514 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -63.09 -30.37 71.54 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.67 123.62 33.3 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.419 -0.512 . . . . 0.0 109.741 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.507 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 1.5 tp10 -65.33 -31.54 72.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.381 -175.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -86.15 -5.32 59.22 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.37 -11.57 10.0 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.507 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 18.7 ptmt -71.53 119.98 16.47 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.206 0.527 . . . . 0.0 111.063 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 75.9 19.0 79.25 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.755 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -125.34 121.64 34.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.391 . . . . 0.0 110.766 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.55 138.9 45.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.615 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.54 135.47 53.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.845 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.52 -48.22 28.34 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -173.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 212' ' ' THR . 66.1 m-85 54.67 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.91 94.46 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 210' ' ' GLU . 91.6 mt 68.62 99.2 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.804 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -86.94 -51.7 5.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 32.4 tp 55.78 91.0 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.976 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -73.55 -79.33 0.08 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 54.1 mtmt -79.01 -79.11 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -170.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 92.0 t 76.9 152.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-O 120.832 0.349 . . . . 0.0 110.615 -175.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -99.12 56.53 1.04 Allowed 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -36.47 141.17 0.12 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -173.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.642 ' HD3' ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -144.6 144.83 31.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.944 177.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.401 ' HB2' ' CA ' ' A' ' 156' ' ' GLY . 38.2 tt0 -158.94 155.58 27.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.1 tt 72.09 128.03 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 123.475 0.484 . . . . 0.0 111.136 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -87.74 113.99 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.216 1.944 . . . . 0.0 113.632 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -131.37 176.24 8.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.89 111.6 23.92 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 15.6 p -104.51 -86.19 0.46 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.66 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -176.61 -49.93 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.996 0.427 . . . . 0.0 111.896 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.73 -45.11 91.39 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -62.35 -30.37 71.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 19.6 tt -85.93 -16.12 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -174.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -117.29 8.34 13.12 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.345 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.424 ' HE ' ' CD ' ' A' ' 161' ' ' GLU . 60.5 ttp180 -134.71 133.17 39.7 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.915 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -167.7 37.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 99.43 -31.54 8.2 Favored Glycine 0 C--N 1.318 -0.452 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.07 149.31 5.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.61 -47.25 80.05 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.199 0.312 . . . . 0.0 110.545 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -175.76 163.63 2.85 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.258 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -172.62 175.62 45.67 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.307 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.3 p -83.5 175.33 9.87 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.43 0.292 . . . . 0.0 110.301 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 67.4 t -61.97 -51.23 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.005 0.431 . . . . 0.0 111.054 -177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -81.06 -32.95 33.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.335 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.07 -43.24 99.42 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.19 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 270' ' ' VAL . 65.1 tp -63.14 -44.02 96.7 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.627 0.251 . . . . 0.0 110.52 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -64.12 -42.38 96.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.382 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.3 -45.02 81.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.29 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 35.5 tp10 -65.71 -38.57 89.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.998 0.427 . . . . 0.0 110.434 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 266' ' ' LEU . 75.8 t -65.49 -43.4 94.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.228 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -59.21 -46.74 87.64 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.673 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.5 ptmt -66.46 -42.62 87.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.669 0.271 . . . . 0.0 111.163 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -65.79 -37.43 86.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.5 mmm -63.52 -42.81 98.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.045 0.45 . . . . 0.0 110.111 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -70.17 -30.82 68.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.204 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -61.61 -43.79 98.19 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.39 -32.98 74.9 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.875 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.8 tp -60.8 -39.64 89.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.951 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -58.12 -46.9 84.78 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 50.4 m -62.52 -44.68 95.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.033 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.3 -51.0 69.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.83 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.45 -44.36 97.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.039 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.495 HH12 ' HG3' ' A' ' 409' ' ' GLU . 6.5 tpt180 -63.03 -45.31 92.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.79 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.43 -40.19 95.27 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.472 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -59.13 -44.4 92.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.014 0.435 . . . . 0.0 110.269 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 86.3 t -70.24 -43.11 78.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.445 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.4 tttt -59.3 -47.66 84.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.046 -177.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 74.1 p -62.88 -41.89 99.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -64.2 -42.35 96.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.583 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.432 ' O ' ' HG ' ' A' ' 294' ' ' LEU . . . -65.27 -42.6 93.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.762 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 287' ' ' LYS . 33.5 mm -64.07 -43.34 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.563 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -60.74 -43.37 98.0 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.114 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.01 -40.85 97.39 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.414 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 290' ' ' ALA . 98.5 mt -62.54 -43.13 99.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.802 0.334 . . . . 0.0 110.802 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 96.0 t -65.31 -43.78 94.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.198 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -64.23 -40.59 96.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.068 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.26 -42.74 79.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.962 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -127.21 96.34 4.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.8 105.55 17.49 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.465 HG13 ' N ' ' A' ' 301' ' ' ASP . 11.4 tp -120.1 168.68 12.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.574 -174.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.465 ' N ' HG13 ' A' ' 300' ' ' ILE . 7.3 m-20 -60.78 139.0 58.06 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.385 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.96 119.63 28.78 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.94 131.44 45.49 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.437 2.092 . . . . 0.0 111.89 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.66 84.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.102 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.55 91.1 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 111.565 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.7 mt -66.46 -40.74 89.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.833 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 311' ' ' ILE . 68.7 mt -61.66 -47.95 90.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.992 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.3 -43.04 92.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.873 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 51.0 m -62.25 -45.26 94.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.869 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.592 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 65.9 mm-40 -66.17 -39.48 89.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.234 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.54 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 95.8 mt -61.96 -43.82 98.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.548 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.6 t70 -61.62 -46.62 89.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.913 0.387 . . . . 0.0 111.306 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 91.7 t -63.35 -43.51 98.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.251 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 75.0 mt -62.49 -40.46 96.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.548 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 85.1 mtm180 -62.91 -42.15 99.69 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.132 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -64.79 -38.66 91.74 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -63.35 -44.53 94.57 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.252 0.548 . . . . 0.0 109.937 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.7 80.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.58 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.461 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -62.31 -36.29 81.7 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.944 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -63.2 -40.5 97.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.281 0.563 . . . . 0.0 109.584 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -75.06 -9.6 58.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.343 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -92.2 -7.36 48.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.845 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 136.69 -14.33 3.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.82 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 113.12 44.11 0.82 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.879 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.49 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 35.6 t-20 -87.22 127.98 35.15 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.88 0.372 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . 0.539 ' OE1' ' HG3' ' A' ' 327' ' ' LYS . 1.8 tm-20 -130.7 145.26 51.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.539 ' HG3' ' OE1' ' A' ' 326' ' ' GLU . 35.2 mtmm 72.22 -46.05 0.63 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.646 0.779 . . . . 0.0 112.422 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.49 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 12.3 mm100 -70.0 -10.98 60.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.207 0.527 . . . . 0.0 110.446 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.85 -22.54 64.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.411 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.0 tp -61.61 -33.93 74.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.679 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -79.27 -6.29 56.34 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.573 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 75.9 mt -69.24 145.63 96.17 Favored Pre-proline 0 C--O 1.241 0.623 0 O-C-N 122.186 -0.321 . . . . 0.0 110.997 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.36 127.08 23.43 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.893 2.396 . . . . 0.0 113.339 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.447 ' HG3' HD11 ' A' ' 311' ' ' ILE . 21.9 ttt180 -70.49 -41.0 73.25 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.405 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -52.16 -46.41 65.45 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -173.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.446 HD13 ' CD ' ' A' ' 224' ' ' GLU . 74.7 mt -92.27 10.13 30.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -115.72 -28.2 6.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.132 0.492 . . . . 0.0 110.228 172.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.7 -30.67 70.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.711 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -60.97 -48.24 82.75 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.471 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -78.32 -20.86 50.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.713 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.43 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.95 -40.87 97.43 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.5 ' O ' HG22 ' A' ' 346' ' ' VAL . 86.8 tttt -59.82 -45.16 93.23 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.567 ' O ' HG21 ' A' ' 347' ' ' VAL . 11.1 mmt85 -60.27 -45.8 92.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.031 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -67.46 -38.92 85.18 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.164 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 341' ' ' ALA . 82.8 t -64.27 -43.86 97.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.658 0.266 . . . . 0.0 110.351 176.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 342' ' ' LYS . 73.0 t -60.74 -43.8 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.531 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 343' ' ' ARG . 82.7 t -59.93 -45.6 94.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.45 -43.34 99.18 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.93 -43.73 94.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.59 0.233 . . . . 0.0 111.478 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.43 -44.79 93.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.924 0.393 . . . . 0.0 110.506 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 355' ' ' ILE . 95.8 mt -66.59 -39.93 88.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.816 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.84 -41.76 96.25 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.583 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -66.06 -40.46 90.92 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.889 0.344 . . . . 0.0 110.646 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.76 -45.89 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.937 178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 351' ' ' LEU . 73.6 mt -62.96 -46.98 94.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.224 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -64.07 -62.75 1.43 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.7 m -66.29 -43.86 85.14 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.3 -12.15 60.46 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.246 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 66.44 47.6 1.69 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.008 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.17 142.16 33.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.884 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.06 146.13 51.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.67 114.47 5.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.46 ' O ' HG21 ' A' ' 367' ' ' VAL . 26.8 t70 -87.01 111.48 20.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.064 0.459 . . . . 0.0 111.077 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 58.1 mm-40 -61.4 -35.04 76.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.995 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.63 -42.09 91.9 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.845 0.355 . . . . 0.0 110.764 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -63.01 -40.05 96.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.11 0.481 . . . . 0.0 110.149 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 363' ' ' ASP . 89.2 t -61.26 -39.41 82.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.335 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.0 mmmt -57.23 -43.41 82.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.508 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.65 99.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.204 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.65 -42.96 99.89 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.124 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.84 -44.85 92.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.121 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.73 -41.47 98.05 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -65.17 -42.31 93.83 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.436 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 49.6 ttp -65.25 -40.69 94.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.97 -23.45 67.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.568 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 39.6 m -73.85 -5.73 42.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.481 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -90.86 0.15 57.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.328 0.585 . . . . 0.0 110.315 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.86 170.84 8.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.542 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.06 -44.13 85.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.81 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -124.63 113.23 27.28 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.764 0.316 . . . . 0.0 110.616 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.24 -35.95 98.22 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.948 2.432 . . . . 0.0 113.221 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.28 -43.7 85.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.48 -35.8 81.67 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.884 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.93 -43.24 96.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 109.978 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.11 -43.48 98.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.88 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.45 -36.75 84.84 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.743 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -58.63 -47.43 84.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.335 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -70.66 -44.46 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 29.9 p -68.32 -15.91 63.74 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -100.77 4.74 43.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.591 0.234 . . . . 0.0 111.214 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -128.97 112.94 14.58 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 110.699 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.13 -40.56 96.43 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -56.81 -51.38 69.19 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.043 0.449 . . . . 0.0 110.794 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.37 -40.14 95.24 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.838 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 87.9 mtp -61.7 -45.63 93.17 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.638 0.256 . . . . 0.0 111.681 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.18 -44.25 63.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.367 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -63.31 -42.69 99.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.049 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 50.3 tpp -63.56 -42.07 98.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.991 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -65.59 -34.53 78.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.195 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -61.81 -42.72 99.37 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 110.106 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.99 -43.41 89.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.694 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.31 97.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.724 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.5 -36.7 84.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.489 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.22 -45.32 91.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.812 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 40.7 mt-10 -64.85 -38.46 91.06 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.419 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -60.39 -43.39 96.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.492 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.88 96.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.31 -43.51 95.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.495 ' HG3' HH12 ' A' ' 283' ' ' ARG . 80.5 mt-10 -66.02 -34.34 77.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.291 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.22 -39.12 91.74 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.15 0.5 . . . . 0.0 110.21 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.78 -42.85 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.176 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.56 -40.36 94.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.458 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.8 -27.76 68.27 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.941 0.4 . . . . 0.0 111.356 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -94.16 -8.22 40.05 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 110.821 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.35 -179.94 5.09 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.239 0.542 . . . . 0.0 111.835 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -103.41 106.39 16.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.031 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 63.9 t -92.51 132.61 36.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 120.768 0.318 . . . . 0.0 110.382 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.4 t -124.63 146.64 48.97 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.907 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.67 130.84 53.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.822 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -148.14 136.36 21.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.026 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -87.22 153.86 21.16 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.6 t -158.01 178.57 10.07 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 18.0 p -87.3 162.2 17.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.918 0.389 . . . . 0.0 111.549 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.9 -36.51 82.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.281 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -57.59 -36.94 72.39 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.893 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.2 -33.67 76.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.871 0.367 . . . . 0.0 110.939 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.5 mp -81.06 -12.45 59.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.905 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 3.2 mmt -78.49 -8.3 58.39 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -78.32 84.01 4.53 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.925 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -109.41 23.16 14.86 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.411 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -82.12 -9.0 59.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.515 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.59 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.265 -179.678 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.3 ttm . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -53.58 109.8 0.49 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.981 0.419 . . . . 0.0 111.887 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.49 161.78 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.818 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 43.7 t -136.79 130.56 32.07 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 p -152.78 137.89 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.856 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.431 ' CD ' HH11 ' B' ' 14' ' ' ARG . 41.3 mt-10 -128.17 161.06 30.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.269 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 49.9 m -110.0 125.56 53.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 16.8 m -96.66 -58.62 2.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.447 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -174.41 129.07 0.35 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.207 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.82 -114.6 6.92 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.708 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 mp -91.14 -9.84 44.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.711 0.291 . . . . 0.0 110.783 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.34 120.68 5.64 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.736 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.05 146.98 48.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.431 HH11 ' CD ' ' B' ' 6' ' ' GLU . 54.7 ttp180 -110.08 139.72 44.92 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.58 -90.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 34.9 m 68.24 99.69 0.05 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -173.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.1 tp -134.15 144.02 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.881 0.372 . . . . 0.0 111.796 -175.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.4 m -127.79 129.87 47.73 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.673 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.49 ' HB ' HG12 ' B' ' 24' ' ' ILE . 16.8 mt -123.67 162.14 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -176.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.583 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.29 148.03 52.41 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.259 0.224 . . . . 0.0 110.811 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.37 -61.54 2.12 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -66.74 -32.28 73.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.798 0.332 . . . . 0.0 110.943 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 38.6 t -63.04 -41.07 99.41 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.241 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.583 HG13 ' O ' ' B' ' 20' ' ' ALA . 76.3 mt -60.1 -52.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.124 0.488 . . . . 0.0 110.935 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -69.45 -46.11 67.48 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.594 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 21.1 m -65.46 -51.2 61.79 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.57 -47.81 62.36 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.18 -43.28 98.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.075 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -60.34 -46.51 89.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.391 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 25.4 m -62.45 -42.5 99.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.647 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.442 ' O ' HG21 ' B' ' 35' ' ' VAL . 10.0 tp10 -68.87 -42.98 76.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.571 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.96 -44.43 96.77 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -69.61 -34.51 61.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.96 0.41 . . . . 0.0 110.762 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -65.08 -42.21 94.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.56 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.443 HG12 ' HD3' ' B' ' 73' ' ' ARG . 88.2 t -65.95 -41.74 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.096 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.76 -40.76 84.84 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.377 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' B' ' 40' ' ' ARG . 98.6 mttt -65.37 -37.16 86.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.279 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.79 -44.3 96.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 110.593 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 19.7 t -78.94 -4.44 6.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.488 0.661 . . . . 0.0 109.969 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 0.452 ' HD3' ' O ' ' B' ' 37' ' ' LYS . 25.6 mmt180 64.53 25.85 13.28 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.44 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.7 11.39 8.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -63.46 -34.53 77.97 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.184 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.33 0.98 83.15 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.6 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -93.48 -1.67 55.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.042 0.448 . . . . 0.0 110.783 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -95.09 110.59 22.51 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -62.2 -38.49 89.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.371 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.29 56.4 25.26 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -63.52 -41.66 98.5 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.0 t -100.44 110.01 58.83 Favored Pre-proline 0 C--O 1.248 0.999 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.437 ' HG2' HD13 ' B' ' 53' ' ' ILE . 48.9 Cg_exo -57.01 149.04 64.71 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.822 2.348 . . . . 0.0 112.349 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.449 ' HA ' HG13 ' B' ' 54' ' ' VAL . 21.4 ttt -61.1 -37.19 81.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.182 -173.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -69.26 -24.82 64.03 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.929 0.395 . . . . 0.0 111.112 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.437 HD13 ' HG2' ' B' ' 50' ' ' PRO . 96.8 mt -92.69 -41.5 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' B' ' 51' ' ' MET . 13.1 p -65.16 -38.74 83.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.067 0.461 . . . . 0.0 111.019 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.448 ' O ' ' HA3' ' B' ' 59' ' ' GLY . . . -67.38 -37.37 83.05 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . 0.413 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 9.5 pt20 -74.67 -11.73 60.25 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.38 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.437 HH12 ' CD1' ' A' ' 187' ' ' LEU . 62.8 mtt-85 -109.42 -50.17 3.02 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . 0.412 ' O ' HG12 ' B' ' 62' ' ' VAL . 20.5 m-85 -112.64 1.25 15.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.082 0.468 . . . . 0.0 110.811 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -64.99 -37.25 94.04 Favored Glycine 0 C--O 1.217 -0.941 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.074 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.86 76.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.727 0.298 . . . . 0.0 111.249 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 48.5 m -62.15 -44.55 96.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.052 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.419 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.3 p -105.09 19.99 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.352 0.596 . . . . 0.0 111.118 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 12.7 ttm180 -63.05 -20.64 65.52 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.116 0.484 . . . . 0.0 110.182 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -64.07 -53.31 51.74 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.349 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . 0.414 ' HB2' HG23 ' B' ' 62' ' ' VAL . 20.7 m-20 -69.91 -27.39 64.74 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.847 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 62' ' ' VAL . 93.6 t -61.64 -45.09 99.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -64.01 -39.87 95.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.412 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.64 -41.31 98.85 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.162 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.04 -44.69 95.18 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.33 -42.1 98.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.005 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.8 ttp -60.16 -50.77 72.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.183 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 24.4 m -65.28 -46.02 82.11 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.788 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.443 ' HD3' HG12 ' B' ' 35' ' ' VAL . 59.0 ttm-85 -66.34 -46.61 76.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.745 -175.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -66.47 -40.11 89.17 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -60.34 -48.67 80.75 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . 0.45 ' O ' HG13 ' B' ' 79' ' ' ILE . 19.9 tt -67.45 -38.95 81.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.965 0.412 . . . . 0.0 111.259 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -66.17 -40.25 90.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.338 0.59 . . . . 0.0 109.88 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.11 85.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.828 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.7 pp -66.1 -37.2 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.37 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 -42.59 96.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.696 0.76 . . . . 0.0 109.172 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -59.95 -46.46 89.33 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.533 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -90.02 2.43 55.19 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.7 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm 65.83 41.43 3.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.69 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 87.0 mt -96.66 119.99 45.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.882 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -108.17 103.6 50.86 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -85.21 127.45 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.538 2.159 . . . . 0.0 112.328 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.46 97.94 10.51 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.069 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.64 -141.78 15.85 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.514 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.04 132.42 23.72 Favored Pre-proline 0 C--N 1.317 -0.806 0 O-C-N 122.853 -0.204 . . . . 0.0 110.695 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . 0.421 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 64.0 Cg_endo -71.78 162.02 43.32 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.826 2.351 . . . . 0.0 111.272 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 18.7 m -99.34 109.07 21.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.282 0.563 . . . . 0.0 111.17 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.421 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 87.9 m-85 -99.96 115.58 30.02 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.65 94.58 19.98 Favored Pre-proline 0 C--N 1.32 -0.717 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.931 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 90.9 Cg_endo -87.01 146.16 7.68 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.552 2.168 . . . . 0.0 110.523 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.98 172.18 39.91 Favored Glycine 0 N--CA 1.437 -1.295 0 C-N-CA 120.0 -1.095 . . . . 0.0 111.168 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.16 136.12 47.96 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -87.03 103.93 15.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.383 0.611 . . . . 0.0 111.544 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.46 111.16 18.23 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 49.3 tp -64.9 109.13 1.99 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.1 0.476 . . . . 0.0 110.408 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.06 -11.32 13.26 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.344 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.74 -177.69 3.81 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.708 0.29 . . . . 0.0 111.548 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -76.08 143.32 41.39 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.8 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -91.61 140.93 29.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.708 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 59.1 m -119.77 136.61 54.38 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.053 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -139.65 162.1 35.91 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.056 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 5.1 m -121.53 149.84 42.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.785 0.326 . . . . 0.0 111.227 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 10.8 p -133.97 142.72 40.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.307 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -105.58 128.17 53.46 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -149.68 -158.54 0.93 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -48.77 155.8 0.54 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.998 1.319 . . . . 0.0 113.318 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.18 160.81 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.114 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -144.98 97.08 4.9 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.741 0.305 . . . . 0.0 110.783 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.62 145.98 33.76 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.849 2.366 . . . . 0.0 112.801 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -164.48 123.55 1.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.5 164.86 31.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.827 0.346 . . . . 0.0 111.583 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -121.44 135.69 55.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.937 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.26 136.01 53.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -130.48 138.82 50.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.658 0.266 . . . . 0.0 111.107 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.15 19.3 61.13 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.912 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.05 -41.15 99.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.118 0.459 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.54 -5.33 32.46 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.483 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.03 13.86 27.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.903 0.382 . . . . 0.0 111.097 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 81.7 mt -102.17 128.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.152 0.501 . . . . 0.0 110.613 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -109.79 128.92 55.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.927 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 62.5 t -117.86 133.28 65.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.988 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -90.94 128.21 36.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.937 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.81 94.0 32.84 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.35 141.06 60.59 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.412 2.075 . . . . 0.0 112.503 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.7 mm -108.33 118.58 56.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.236 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.01 158.53 43.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.359 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -141.35 159.82 41.43 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.179 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -79.74 129.17 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.611 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.9 p -105.07 176.18 5.25 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.689 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -62.0 -38.09 87.3 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.35 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.95 -37.38 84.52 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.874 0.369 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -63.81 -39.03 93.26 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 89.3 t -63.65 -44.72 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.234 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.62 -42.41 92.6 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.247 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.53 98.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.959 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' MET . . . . . 0.516 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 4.6 tpt -63.11 -45.27 92.78 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.858 0.361 . . . . 0.0 110.231 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.86 -41.59 97.75 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.036 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.98 -45.46 92.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.664 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 26.5 m -61.97 -41.16 97.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.952 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.1 mt -61.21 -41.42 96.81 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.459 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -68.83 -22.5 64.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.058 0.456 . . . . 0.0 110.741 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -85.46 2.48 44.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.228 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -119.31 31.44 6.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.394 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -139.16 89.61 2.36 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.22 155.77 49.56 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' THR . . . . . 0.531 HG21 ' H ' ' B' ' 151' ' ' TRP . 1.2 m -124.04 172.14 9.22 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.676 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . 0.531 ' H ' HG21 ' B' ' 150' ' ' THR . 8.6 p-90 -53.18 137.11 34.95 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -172.71 119.45 0.37 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.88 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' B' ' 154' ' ' LYS . 7.5 pt-20 -77.5 89.72 3.86 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.44 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' B' ' 153' ' ' GLU . 63.5 mmtt -158.44 -72.08 0.09 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.921 0.888 . . . . 0.0 110.736 177.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -169.52 -70.91 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.318 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' B' ' 243' ' ' ARG . . . 66.45 -128.93 30.72 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.798 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -145.53 -165.76 2.27 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 50.5 t -117.43 124.73 73.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' B' ' 162' ' ' ASP . 62.0 mm-40 -87.9 174.44 8.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.068 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.3 -52.79 23.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.198 0.523 . . . . 0.0 109.821 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . 0.407 ' CD ' ' HE ' ' B' ' 255' ' ' ARG . 6.8 pt-20 -92.91 32.66 1.24 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.46 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.597 ' OD2' ' HD3' ' B' ' 243' ' ' ARG . 9.2 t70 -57.36 -48.85 77.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.378 -174.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 21.8 ttp85 66.0 88.47 0.11 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.791 0.805 . . . . 0.0 109.24 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . 0.543 HG23 ' OD1' ' B' ' 162' ' ' ASP . 3.0 t -111.49 133.0 58.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.005 -174.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.9 m -80.29 104.51 10.89 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 79.7 mt -116.83 131.0 70.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -97.86 106.21 18.48 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -128.56 146.6 50.79 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.441 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 36.1 m -129.84 131.46 46.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.208 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.38 110.75 3.23 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.562 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 14.6 m -130.67 122.37 27.24 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.47 -76.09 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -110.65 -71.91 0.74 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.817 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -134.37 16.02 4.4 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.067 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -135.17 147.59 49.45 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.916 0.389 . . . . 0.0 110.402 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -91.29 150.58 21.25 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.688 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -112.48 179.15 4.07 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.83 -42.12 88.5 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.1 -175.45 39.31 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.032 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 73.72 36.51 53.25 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.861 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -114.43 102.17 9.83 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.68 154.27 38.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.032 0.444 . . . . 0.0 111.744 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -142.56 133.4 25.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 56.27 35.22 25.42 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.377 0.423 . . . . 0.0 110.845 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -88.22 134.52 33.77 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.085 -175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 15.7 m -90.58 120.97 40.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.634 0.731 . . . . 0.0 112.01 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . 0.481 ' CD1' HH12 ' A' ' 57' ' ' ARG . 29.0 tp -114.32 121.28 43.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.502 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . 0.585 ' O ' ' HG3' ' B' ' 193' ' ' ARG . . . -101.64 132.18 47.46 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 172.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 57.5 mtm -109.91 165.78 11.45 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.084 -173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.13 0.33 65.83 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.967 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -112.94 -8.38 13.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.43 36.35 17.36 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.677 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' B' ' 188' ' ' ALA . 39.7 mmm-85 -74.49 -25.41 59.36 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.379 0.672 . . . . 0.0 110.138 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 194' ' ' MET . . . . . 0.433 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.1 OUTLIER -124.75 -171.27 2.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.522 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.407 ' N ' HD12 ' B' ' 195' ' ' ILE . 3.7 mp -68.54 136.92 90.69 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.67 132.86 47.88 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.164 1.909 . . . . 0.0 112.054 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.35 -39.79 2.69 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.05 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -62.39 -45.54 92.69 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.0 8.93 11.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -113.21 -33.67 5.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.179 0.514 . . . . 0.0 109.765 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.94 -19.26 73.44 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.396 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 98.6 mt -64.95 -33.54 64.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.262 0.554 . . . . 0.0 110.225 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -60.03 135.27 57.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.143 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.58 3.61 58.39 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.451 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.468 ' HD2' ' OE2' ' B' ' 209' ' ' GLU . 39.1 m80 -111.62 147.85 34.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 117.013 0.407 . . . . 0.0 110.934 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -85.01 163.63 18.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.073 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.62 137.0 51.91 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.29 20.55 77.03 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.968 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . 0.468 ' OE2' ' HD2' ' B' ' 205' ' ' HIS . 42.6 tt0 -101.37 121.81 42.59 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.23 0.538 . . . . 0.0 110.946 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' B' ' 235' ' ' ILE . 33.4 mt-10 -101.92 113.58 26.91 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -133.44 -27.62 1.54 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 30.8 m 74.56 130.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 120.9 0.381 . . . . 0.0 110.455 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.79 -40.53 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 70.38 97.93 0.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.199 0.523 . . . . 0.0 111.842 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 62.6 t -116.07 128.21 73.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 19.4 m -68.69 -40.78 79.88 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -176.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' B' ' 216' ' ' THR . 32.6 m-85 77.8 134.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 123.025 0.53 . . . . 0.0 110.699 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.46 156.1 50.21 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.606 2.204 . . . . 0.0 112.584 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -65.44 -34.93 79.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.525 0.678 . . . . 0.0 110.008 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -87.14 30.12 0.79 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.616 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -74.65 140.98 44.63 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -61.65 -29.13 69.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.05 121.9 33.25 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.971 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.561 ' HA ' ' CD ' ' B' ' 227' ' ' LYS . 1.4 tp10 -62.93 -33.66 75.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.562 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.463 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 30.8 p-10 -84.22 -5.9 59.32 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.61 -12.94 9.68 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.561 ' CD ' ' HA ' ' B' ' 224' ' ' GLU . 18.1 ptmt -69.19 118.72 12.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.275 0.559 . . . . 0.0 111.205 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.4 18.17 78.29 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.926 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.463 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 99.2 mttt -122.59 124.19 42.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.077 0.438 . . . . 0.0 110.698 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.5 140.57 44.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.298 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -126.86 134.45 50.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.915 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -73.2 -48.9 31.27 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -173.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' B' ' 212' ' ' THR . 61.6 m-85 55.03 98.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.657 0.383 . . . . 0.0 112.012 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.6 90.94 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 91.2 mt 67.71 98.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.167 0.587 . . . . 0.0 111.85 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . 0.426 ' HA ' ' HG2' ' B' ' 210' ' ' GLU . 28.6 t-20 -86.26 -51.0 6.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 33.4 tp 53.07 90.55 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.052 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 27.3 mttp -74.79 -78.37 0.1 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . 0.452 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 52.2 mtmt -75.46 -81.03 0.08 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.381 1.622 . . . . 0.0 115.381 -170.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.529 HG12 ' H ' ' B' ' 242' ' ' GLU . 67.7 t 75.22 139.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -174.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.645 ' O ' ' HG2' ' B' ' 242' ' ' GLU . 86.3 mt-10 -68.73 -27.82 66.27 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.082 -0.386 . . . . 0.0 111.312 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.645 ' HG2' ' O ' ' B' ' 241' ' ' GLU . 2.7 pt-20 64.51 132.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.552 1.541 . . . . 0.0 113.933 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.597 ' HD3' ' OD2' ' B' ' 162' ' ' ASP . 0.0 OUTLIER -154.35 144.1 21.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.358 178.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -159.54 153.89 23.87 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 tt 72.18 123.75 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.068 0.547 . . . . 0.0 111.352 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -84.21 115.91 2.01 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.546 2.164 . . . . 0.0 113.484 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -135.67 167.47 21.06 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.35 110.57 21.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 10.7 p -103.56 -83.55 0.48 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.92 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . 0.4 ' O ' HG23 ' B' ' 253' ' ' ILE . . . -177.69 -53.62 0.01 OUTLIER 'General case' 0 C--N 1.343 0.319 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.65 -47.14 86.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -61.6 -26.98 68.32 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -173.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 253' ' ' ILE . . . . . 0.4 HG23 ' O ' ' B' ' 250' ' ' ALA . 18.9 tt -91.13 -5.89 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -127.91 6.88 6.08 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.032 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 255' ' ' ARG . . . . . 0.407 ' HE ' ' CD ' ' B' ' 161' ' ' GLU . 60.0 ttp180 -131.24 134.82 46.81 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.538 0.209 . . . . 0.0 110.545 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -172.87 34.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.92 -32.28 7.7 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 42.0 t -80.65 150.84 4.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.38 -51.87 65.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.375 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -175.43 163.81 3.05 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.257 173.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -172.77 177.53 45.25 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.377 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.9 p -82.12 175.8 10.03 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.33 0.252 . . . . 0.0 111.096 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.24 -49.13 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.396 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.41 -32.22 21.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.588 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.12 -43.01 99.73 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.984 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.43 ' O ' HG23 ' B' ' 270' ' ' VAL . 63.5 tp -62.86 -43.79 97.87 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.622 0.249 . . . . 0.0 110.445 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -64.25 -41.96 96.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.882 0.372 . . . . 0.0 110.367 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -66.62 -44.95 80.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.309 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 37.2 tp10 -66.3 -39.39 89.3 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.094 0.473 . . . . 0.0 110.57 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 266' ' ' LEU . 70.7 t -65.01 -42.85 95.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.089 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -59.71 -46.54 88.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.8 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 18.3 ptmt -66.09 -42.5 89.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.843 0.354 . . . . 0.0 111.007 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -66.0 -37.16 85.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.016 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.2 mmm -63.97 -43.24 96.36 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 110.496 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -70.98 -29.52 65.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.112 0.482 . . . . 0.0 110.08 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -61.86 -43.69 98.34 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -65.1 -32.33 73.97 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.823 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 57.5 tp -60.96 -39.48 89.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.017 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -58.19 -47.79 82.33 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 17.3 m -62.59 -44.04 97.3 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.866 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.26 69.21 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.795 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.22 -45.72 92.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.607 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . 0.479 HH12 ' HG3' ' B' ' 409' ' ' GLU . 8.1 tpt180 -61.7 -45.64 93.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.898 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -64.87 -39.94 94.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.46 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -59.04 -44.42 91.76 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.046 0.45 . . . . 0.0 110.382 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.13 -42.81 79.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.537 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . 0.418 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.8 tttt -59.67 -48.13 82.88 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.081 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.7 p -62.23 -41.91 98.83 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.769 0.319 . . . . 0.0 111.542 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -65.06 -41.88 94.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.813 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' B' ' 294' ' ' LEU . . . -65.61 -42.57 91.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.998 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . 0.418 HG12 ' O ' ' B' ' 287' ' ' LYS . 32.2 mm -63.8 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.573 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . 0.418 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 27.8 tp10 -59.8 -43.78 94.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.235 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.8 -40.33 97.27 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.276 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 290' ' ' ALA . 95.5 mt -62.85 -42.63 99.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.682 0.277 . . . . 0.0 110.926 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . 0.401 HG22 ' O ' ' B' ' 291' ' ' ILE . 91.4 t -65.61 -43.59 93.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.049 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . 0.418 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 68.4 mttm -63.49 -41.94 98.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.127 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.62 -41.89 78.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.055 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -126.92 94.66 4.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -93.73 106.52 18.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . 0.437 HG13 ' N ' ' B' ' 301' ' ' ASP . 11.4 tp -122.07 166.18 17.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.005 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . 0.437 ' N ' HG13 ' B' ' 300' ' ' ILE . 33.0 m-20 -61.3 135.51 57.74 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.578 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.09 122.06 30.78 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.745 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.36 131.21 43.38 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.64 2.227 . . . . 0.0 111.939 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.05 -36.43 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.975 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.02 -43.11 91.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.298 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.06 -40.54 90.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.903 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . 0.427 ' O ' HG13 ' B' ' 311' ' ' ILE . 97.0 mt -62.75 -45.99 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.754 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.17 -41.53 98.41 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.19 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 46.8 m -62.46 -45.49 92.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.316 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . 0.549 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 62.9 mm-40 -68.25 -37.99 81.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.536 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.514 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.0 mt -62.13 -43.68 98.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.625 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.51 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 17.2 t70 -60.46 -47.14 87.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.792 0.33 . . . . 0.0 111.012 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.46 -44.33 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.536 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 84.7 mt -62.76 -40.38 97.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 85.2 mtm180 -62.18 -42.4 99.24 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 32.5 mtt85 -64.91 -38.47 91.07 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -63.1 -45.16 93.35 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.074 0.464 . . . . 0.0 109.87 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.27 -36.32 79.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.745 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -61.89 -36.18 80.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.123 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -63.13 -39.43 94.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.424 0.63 . . . . 0.0 109.506 175.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -76.25 -9.91 59.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.41 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -91.21 -7.79 50.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.817 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 137.14 -12.12 3.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.809 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 112.53 42.18 0.98 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.005 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . 0.532 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 33.5 t-20 -85.27 127.04 34.17 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.876 0.369 . . . . 0.0 110.356 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . 0.464 ' OE1' ' HG3' ' B' ' 327' ' ' LYS . 2.0 tm-20 -130.2 144.49 51.39 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.464 ' HG3' ' OE1' ' B' ' 326' ' ' GLU . 35.5 mtmm 71.33 -47.92 0.66 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.627 0.771 . . . . 0.0 112.215 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . 0.532 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 14.2 mm100 -65.9 -13.06 58.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.083 0.468 . . . . 0.0 110.707 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.38 -21.81 60.44 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.643 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 57.4 tp -61.84 -33.43 74.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.638 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -79.5 -10.04 59.73 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.591 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 75.5 mt -65.14 147.41 98.57 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.61 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.23 141.18 97.58 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.574 2.183 . . . . 0.0 112.884 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . 0.423 ' HG3' HD11 ' B' ' 311' ' ' ILE . 27.2 ttt85 -85.27 -36.33 20.96 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.511 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -56.74 -46.39 81.39 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -173.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . 0.507 HD13 ' CD ' ' B' ' 224' ' ' GLU . 73.3 mt -91.86 12.08 22.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -117.96 -28.56 5.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.131 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -66.49 -31.7 72.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.714 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.61 -49.53 77.16 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.03 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -75.94 -22.47 55.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.702 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . 0.423 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.42 -41.96 98.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . 0.506 ' O ' HG22 ' B' ' 346' ' ' VAL . 87.3 tttt -60.72 -44.56 96.46 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . 0.568 ' O ' HG21 ' B' ' 347' ' ' VAL . 10.1 mmt85 -59.93 -46.18 90.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.983 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.29 -39.29 85.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.255 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 341' ' ' ALA . 87.8 t -64.78 -43.31 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.436 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.506 HG22 ' O ' ' B' ' 342' ' ' LYS . 73.8 t -60.33 -43.12 93.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.404 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . 0.568 HG21 ' O ' ' B' ' 343' ' ' ARG . 91.1 t -60.02 -45.68 95.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.34 -42.78 99.7 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.204 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.7 -44.27 94.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.43 -45.21 92.0 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.695 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.462 ' O ' HG13 ' B' ' 355' ' ' ILE . 94.4 mt -66.66 -39.62 88.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.915 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.21 -42.53 97.25 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.628 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -64.3 -39.79 94.62 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.978 0.389 . . . . 0.0 110.559 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.3 -46.36 96.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.042 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . 0.462 HG13 ' O ' ' B' ' 351' ' ' LEU . 71.0 mt -63.6 -46.29 95.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.399 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -64.6 -64.73 0.8 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 38.5 m -65.96 -43.24 88.5 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.76 -11.42 60.16 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.168 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 62.38 64.86 0.91 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.718 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.9 mt -98.02 136.97 37.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.203 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.09 150.22 45.29 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.195 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.92 120.02 13.53 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . 0.474 ' O ' HG21 ' B' ' 367' ' ' VAL . 15.5 t70 -90.17 108.34 19.68 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.939 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 66.2 mm-40 -61.68 -34.65 76.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.67 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -66.03 -41.58 90.73 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.49 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . 0.405 HH12 ' CD ' ' B' ' 409' ' ' GLU . 45.9 ttt180 -62.47 -40.79 97.79 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.001 0.429 . . . . 0.0 110.137 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . 0.474 HG21 ' O ' ' B' ' 363' ' ' ASP . 88.4 t -61.28 -39.71 83.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.236 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.2 mmmt -56.64 -44.07 80.9 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.511 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.21 -40.2 98.81 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.2 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.33 -42.88 98.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 110.239 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.64 -43.68 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.797 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -64.04 -41.96 97.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.76 -41.73 91.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.053 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 48.6 ttp -65.43 -39.7 92.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.028 0.442 . . . . 0.0 110.511 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.28 -24.67 67.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.596 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 44.9 m -73.47 -6.34 45.78 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.45 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.02 -2.09 58.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.532 0.682 . . . . 0.0 110.284 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -113.08 172.78 6.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.976 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -65.7 -47.69 74.54 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -121.76 116.24 30.44 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.803 0.335 . . . . 0.0 110.999 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . 0.459 ' O ' HG13 ' B' ' 385' ' ' ILE . 46.5 Cg_exo -58.21 -36.49 97.74 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.909 2.406 . . . . 0.0 113.116 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -64.72 -43.42 93.48 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -174.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.81 -36.81 84.4 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.933 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.44 -42.96 94.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.302 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 381' ' ' PRO . 65.7 mt -62.23 -44.83 99.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.335 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -64.93 -37.87 89.07 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.765 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -58.75 -47.06 85.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.443 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . 0.424 ' O ' ' HG3' ' B' ' 395' ' ' MET . 2.8 m-85 -69.67 -44.78 69.81 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 18.9 p -68.88 -16.26 63.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.19 4.6 48.94 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.746 0.307 . . . . 0.0 111.19 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -129.57 112.04 13.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 110.532 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -64.72 -37.5 87.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.263 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -57.23 -53.38 58.74 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.021 0.439 . . . . 0.0 110.558 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.47 -40.5 95.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.737 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.436 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 89.1 mtp -61.62 -46.18 90.92 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.89 -44.18 64.17 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.415 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -64.13 -42.13 96.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.374 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 52.3 tpp -63.1 -41.17 99.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.838 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' B' ' 395' ' ' MET . 83.0 mtm180 -65.76 -34.8 79.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.917 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.44 -42.33 99.38 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 90.4 t -66.22 -43.77 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.622 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.44 94.99 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.544 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.25 -37.14 86.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.48 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -58.29 -47.21 84.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.855 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 44.0 mt-10 -64.09 -38.14 89.98 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.564 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -61.71 -42.25 98.69 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.209 0.318 . . . . 0.0 110.672 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.53 97.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.047 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.39 -43.14 91.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.572 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . 0.479 ' HG3' HH12 ' B' ' 283' ' ' ARG . 96.6 mt-10 -63.95 -35.84 82.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.17 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.57 94.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.474 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.0 -43.06 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.474 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.21 -39.42 92.72 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.531 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.76 67.55 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.987 0.422 . . . . 0.0 111.311 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -98.08 -7.62 29.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.697 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.37 169.58 9.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.316 0.579 . . . . 0.0 112.261 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -90.78 99.41 12.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.808 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 68.4 t -86.75 131.68 34.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.697 0.284 . . . . 0.0 110.751 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.9 t -124.28 155.3 38.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.941 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -113.41 130.71 56.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.844 0.354 . . . . 0.0 110.749 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -147.48 141.25 25.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.201 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.2 150.9 19.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.335 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.1 t -158.0 174.96 14.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.361 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 17.4 p -85.63 163.67 18.16 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 111.81 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -65.01 -36.42 84.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.449 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -57.38 -38.33 74.08 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.84 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.68 -32.8 74.56 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.858 0.361 . . . . 0.0 111.166 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.25 -12.7 59.04 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.8 mmt -78.28 -8.48 58.43 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.13 0.491 . . . . 0.0 110.785 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -75.71 79.84 2.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.193 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -108.13 26.56 10.26 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.556 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -85.06 -11.79 54.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.853 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.677 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.025 -179.537 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ptp . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 120.534 0.207 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.2 tm0? -95.24 105.45 17.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.61 159.81 34.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.322 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.3 m -124.1 116.87 23.48 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.661 0.267 . . . . 0.0 110.881 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -134.93 135.87 52.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 47.8 mt-10 -111.7 175.86 5.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.102 0.477 . . . . 0.0 111.727 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 t -124.27 141.46 52.05 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.674 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.0 m -99.71 -75.91 0.56 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.917 0.389 . . . . 0.0 111.197 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -162.21 148.23 13.14 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.52 -123.02 29.75 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.037 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.425 HD12 HG11 ' A' ' 111' ' ' VAL . 1.2 mm? -100.27 4.54 44.25 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 120.974 0.416 . . . . 0.0 110.072 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.26 139.82 25.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.596 -0.729 . . . . 0.0 113.085 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -133.93 151.67 51.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.048 0.539 . . . . 0.0 109.895 -178.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -120.32 130.15 54.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.51 -89.95 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.276 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.5 p 40.17 81.27 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.7 tp -107.85 134.5 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.219 0.533 . . . . 0.0 111.897 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.0 p -94.37 126.51 39.67 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.771 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.468 HG13 HG12 ' A' ' 24' ' ' ILE . 14.2 pt -126.69 161.21 33.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.356 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.541 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -70.67 155.07 41.21 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.379 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.5 -39.39 83.66 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.952 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.61 -25.66 65.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.3 t -80.64 -42.2 22.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.428 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 20' ' ' ALA . 75.0 mt -59.16 -69.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.321 -176.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.494 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 77.1 mm-40 -67.37 -6.95 21.27 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.5 m -95.64 -64.19 1.08 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.988 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.21 66.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.5 t -65.01 -43.87 96.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.354 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 22.3 ttmm -61.78 -47.2 86.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.6 m -68.85 -36.59 78.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.811 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -60.93 -39.05 87.97 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.113 0.483 . . . . 0.0 110.652 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.56 -38.44 90.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.819 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.22 -44.02 99.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.171 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.76 -43.64 98.28 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.136 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.38 -35.68 74.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.24 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.24 94.9 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.068 0.461 . . . . 0.0 110.285 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.34 -34.09 77.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.013 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -61.09 -35.92 78.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.955 0.407 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 t -90.61 -5.85 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.412 0.625 . . . . 0.0 109.77 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 64.96 27.5 12.68 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.329 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -103.67 7.98 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.069 0.461 . . . . 0.0 111.457 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.62 -34.81 79.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.514 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.02 -4.54 86.15 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.816 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -89.17 -8.2 54.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.792 0.329 . . . . 0.0 111.463 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -92.38 95.79 9.88 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.82 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -78.29 109.35 12.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.57 96.77 1.62 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 115.734 1.054 . . . . 0.0 115.734 -169.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -66.52 -43.24 85.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.6 t -104.79 115.12 63.11 Favored Pre-proline 0 N--CA 1.44 -0.929 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.265 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.12 139.95 86.25 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.188 1.926 . . . . 0.0 111.124 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.505 ' HA ' HG12 ' A' ' 54' ' ' VAL . 22.7 ttt -61.39 -40.08 93.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.507 -173.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -60.81 -47.77 84.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.047 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 HH22 ' B' ' 193' ' ' ARG . 74.9 mt -69.42 -44.97 79.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 51' ' ' MET . 14.6 p -64.11 -44.35 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.7 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.406 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -66.73 -24.06 66.18 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.381 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -85.61 -36.92 20.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.127 0.489 . . . . 0.0 110.3 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -76.54 -49.27 16.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.499 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -105.21 9.58 34.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.883 0.373 . . . . 0.0 110.483 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.621 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -59.18 -47.51 90.46 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.9 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.0 -25.49 65.43 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -61.84 -44.99 95.73 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.813 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' HG21 ' A' ' 66' ' ' VAL . 10.7 p -126.98 24.89 2.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.564 0.697 . . . . 0.0 110.703 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 21.1 ttm180 -58.8 -33.19 70.07 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.506 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -60.49 -50.02 75.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.535 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' HB2' HG23 ' A' ' 62' ' ' VAL . 1.7 m-20 -75.24 -21.61 58.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.04 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 62' ' ' VAL . 66.7 t -63.58 -43.77 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 173.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.62 -39.01 92.43 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.107 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.97 -42.61 99.81 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.238 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.706 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 32.0 t70 -63.01 -43.91 97.43 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.197 0.498 . . . . 0.0 110.006 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.7 -41.3 97.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.299 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 49.5 ttp -60.69 -43.22 98.01 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -62.55 -44.05 97.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.284 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.706 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 32.7 mtp85 -66.08 -41.5 90.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.932 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -66.07 -41.09 91.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.388 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -60.4 -48.08 83.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.678 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.0 tt -67.41 -39.7 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.201 0.524 . . . . 0.0 111.347 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.11 -40.85 91.03 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.388 0.613 . . . . 0.0 110.185 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.68 87.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.633 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.3 pt -64.21 -39.27 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.913 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.97 -44.09 99.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 120.638 0.256 . . . . 0.0 111.275 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.58 ' HB3' ' HZ1' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -74.89 -29.32 60.96 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -86.54 -2.57 58.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 66.22 34.55 6.54 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.242 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.1 mt -96.06 113.43 30.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -110.48 100.84 46.65 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.908 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.14 136.34 9.01 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.076 1.85 . . . . 0.0 111.347 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.93 132.98 36.57 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.62 -125.09 7.4 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.055 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.22 130.07 18.13 Favored Pre-proline 0 C--N 1.313 -1.018 0 O-C-N 122.834 -0.215 . . . . 0.0 110.455 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.88 150.07 60.77 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.132 1.888 . . . . 0.0 110.828 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 m -94.96 116.81 29.16 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.108 0.48 . . . . 0.0 110.021 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.552 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 95.9 m-85 -91.82 114.24 26.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.94 99.56 23.27 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.138 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 58.5 Cg_endo -95.52 161.8 1.52 Allowed 'Trans proline' 0 N--CA 1.437 -1.826 0 C-N-CA 123.461 2.774 . . . . 0.0 111.65 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.82 -174.86 33.61 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.176 -1.011 . . . . 0.0 110.874 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.72 133.47 38.31 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -89.24 125.4 35.07 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.938 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -102.48 131.31 49.25 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.4 tp -81.48 102.42 10.55 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.14 -27.54 5.32 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.243 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -103.0 177.02 4.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.677 0.275 . . . . 0.0 110.707 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -81.61 168.17 18.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -125.28 139.99 53.22 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.095 0.474 . . . . 0.0 111.313 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.0 m -120.01 134.4 55.26 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.158 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -140.51 167.16 22.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.572 0.225 . . . . 0.0 111.582 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -87.05 -91.01 0.11 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.2 t 64.92 100.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.358 0.599 . . . . 0.0 110.564 -174.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -99.65 146.09 26.87 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.588 -175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -159.39 -87.39 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -90.12 156.64 18.21 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.425 HG11 HD12 ' A' ' 11' ' ' LEU . 28.8 m -125.82 161.56 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.846 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -166.14 102.44 0.7 Allowed Pre-proline 0 N--CA 1.479 0.99 0 CA-C-O 120.577 0.227 . . . . 0.0 111.272 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -94.39 158.49 2.02 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 C-N-CA 123.39 2.727 . . . . 0.0 114.373 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -143.29 139.64 30.24 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.735 0.814 . . . . 0.0 109.888 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 116' ' ' GLU . 20.6 t -133.9 160.89 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 120.897 0.379 . . . . 0.0 111.78 -176.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.4 ' N ' HG13 ' A' ' 115' ' ' VAL . 43.5 mt-10 -140.66 153.03 45.84 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.842 0.857 . . . . 0.0 109.209 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.8 mt -112.47 130.58 55.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -141.85 154.4 45.13 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.133 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.54 22.91 74.46 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.903 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.49 -39.94 95.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.916 0.389 . . . . 0.0 111.199 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -70.24 -10.78 59.92 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.87 1.48 55.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.147 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.57 109.01 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.124 0.488 . . . . 0.0 109.957 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -104.37 119.64 39.41 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.062 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.83 127.07 59.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.883 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.7 119.04 32.19 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.571 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.531 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 78.6 tttt -111.62 106.29 56.77 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.43 128.61 12.1 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.962 1.775 . . . . 0.0 111.639 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.38 114.67 39.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.17 161.58 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -150.73 166.19 31.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.553 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.3 127.44 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.722 0.296 . . . . 0.0 110.25 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.0 p -108.15 176.41 5.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.394 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.86 -38.94 87.3 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.019 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.67 80.2 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.7 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -64.94 -43.38 92.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.327 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.49 -47.24 92.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.955 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.04 -42.61 99.36 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.003 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.26 -42.58 99.26 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.611 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.524 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -61.83 -44.92 95.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.695 0.284 . . . . 0.0 110.59 178.329 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.43 -42.44 98.69 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.272 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.87 -43.84 98.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.82 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.9 m -63.0 -41.2 99.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.553 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.6 mt -60.82 -42.23 97.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.448 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -66.14 -37.21 85.13 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.05 0.453 . . . . 0.0 110.518 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -68.46 -13.92 62.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.162 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -89.62 -6.92 55.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.432 0.634 . . . . 0.0 110.151 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -89.59 93.47 9.5 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.726 0.774 . . . . 0.0 111.952 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.81 126.17 10.07 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.416 ' HB ' ' H ' ' A' ' 151' ' ' TRP . 23.6 p -100.43 -163.76 1.05 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.51 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 4.4 p-90 -70.17 119.68 14.72 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 151' ' ' TRP . 26.5 mttp -174.52 168.34 3.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.691 1.197 . . . . 0.0 109.132 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -114.92 164.21 14.46 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -172.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 153' ' ' GLU . 9.9 pttp 71.28 -179.42 0.23 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.861 1.665 . . . . 0.0 113.807 175.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.445 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 13.0 t70 72.92 -90.32 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 124.966 1.306 . . . . 0.0 111.055 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 142.76 102.48 0.44 Allowed Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.954 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -132.75 64.51 1.61 Allowed 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.58 127.05 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.122 -176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 162' ' ' ASP . 9.2 tp10 -95.63 154.11 17.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.75 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.89 13.8 6.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 189' ' ' MET . 37.8 tt0 -155.47 26.08 0.4 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.585 0.707 . . . . 0.0 110.511 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 159' ' ' GLU . 2.9 t70 -109.39 -170.2 1.61 Allowed 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.781 -0.575 . . . . 0.0 111.036 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -103.55 118.71 37.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.4 t -114.72 121.66 67.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.002 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.4 m -83.4 109.66 17.5 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.9 mt -115.08 128.46 72.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.106 0.479 . . . . 0.0 112.141 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 236' ' ' ASN . 5.0 p-10 -103.03 113.33 26.72 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 172.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -142.46 162.57 35.13 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.228 0.537 . . . . 0.0 112.216 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.1 m -133.6 134.09 42.84 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.219 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.31 103.56 1.84 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.209 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 29.0 m -128.1 121.31 29.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 46.1 t -94.13 -87.13 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.833 0.349 . . . . 0.0 111.147 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -94.38 42.08 1.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.207 0.527 . . . . 0.0 109.822 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 81.33 12.45 82.09 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -123.99 139.28 54.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -92.09 137.42 32.38 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.372 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -107.26 -176.88 3.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.655 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.38 -39.74 88.38 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.402 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.21 -175.52 39.15 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.964 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 84.63 16.68 65.47 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.138 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -105.74 97.87 7.64 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.02 145.8 32.44 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.844 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 38.3 m -136.1 145.29 45.75 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.803 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 54.41 31.15 14.03 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.801 0.688 . . . . 0.0 110.543 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -85.98 127.31 34.61 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.3 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.5 115.03 39.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.49 0.662 . . . . 0.0 110.336 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 56.7 tp -103.33 126.22 50.37 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.98 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -90.65 111.88 23.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.636 ' HE2' ' O ' ' A' ' 199' ' ' GLU . 88.2 mtp -81.24 150.68 28.48 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.95 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.38 -14.62 64.25 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.595 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -95.13 0.49 54.28 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.802 0.334 . . . . 0.0 111.207 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.97 55.98 6.8 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -100.01 -5.96 27.26 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.197 0.522 . . . . 0.0 110.55 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.494 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -135.5 178.13 7.28 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.076 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.7 mm -68.38 133.87 91.12 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.37 134.55 45.31 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.095 1.864 . . . . 0.0 111.499 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.77 -42.87 1.79 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.958 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -67.45 -52.92 33.62 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.636 ' O ' ' HE2' ' A' ' 189' ' ' MET . 11.7 pt-20 -74.2 -17.21 60.93 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.847 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.51 -30.0 22.29 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.891 0.377 . . . . 0.0 110.512 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.7 -19.05 76.31 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.008 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.4 mt -62.39 -38.07 80.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-O 120.883 0.373 . . . . 0.0 110.407 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -51.51 131.26 29.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.7 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.42 -10.66 63.23 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.353 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -95.26 159.23 15.11 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -103.21 156.41 17.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.104 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.57 134.69 51.69 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.941 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 78.86 34.56 33.91 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.637 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -124.68 130.17 51.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.879 0.371 . . . . 0.0 111.06 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -102.42 118.17 36.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.53 ' O ' ' HB ' ' A' ' 212' ' ' THR . 44.3 t80 -135.24 -36.84 0.79 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 99.6 m 77.65 143.94 0.08 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.339 0.256 . . . . 0.0 110.423 -176.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.2 tp -130.11 144.61 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.934 0.397 . . . . 0.0 110.909 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.79 104.68 16.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.092 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 65.7 t -119.31 128.5 75.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.5 m -98.42 -16.84 19.1 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -175.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 66.62 154.43 0.13 Allowed Pre-proline 0 N--CA 1.487 1.381 0 CA-C-O 121.117 0.484 . . . . 0.0 111.615 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.33 150.87 53.43 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.154 1.903 . . . . 0.0 111.532 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -65.82 -38.44 88.92 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.18 77.1 7.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.602 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -120.06 140.61 50.76 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -61.06 -29.86 69.98 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.76 108.1 20.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.594 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.2 tt0 -63.42 -33.59 75.88 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.408 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 30.8 p-10 -63.97 -25.16 68.01 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.737 0.303 . . . . 0.0 110.995 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 90.4 mt -109.8 -3.39 16.72 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.6 ptmt -67.85 119.12 12.02 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.951 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.8 21.91 71.56 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.94 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 225' ' ' ASN . 35.0 mmtp -100.93 135.52 42.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -86.26 110.38 19.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.004 0.43 . . . . 0.0 110.85 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.36 149.54 23.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.082 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -105.21 -47.17 4.04 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -175.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 58.59 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.02 0.438 . . . . 0.0 111.041 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.55 -49.2 77.15 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.0 mm 62.8 93.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 123.493 0.496 . . . . 0.0 110.842 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.47 ' HB3' ' OD2' ' A' ' 167' ' ' ASP . 9.6 t-20 -82.99 -47.29 11.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.545 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 12.6 tp 57.46 86.8 0.07 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.151 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.25 -58.06 2.67 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -101.49 -78.97 0.52 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 24.9 t 70.43 142.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 123.482 0.489 . . . . 0.0 110.512 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -75.1 -46.79 32.26 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.277 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 64.75 163.24 0.14 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -162.0 94.18 0.91 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 10.1 tp10 -123.37 157.14 33.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.379 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.1 tt 72.72 118.5 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.456 0.703 . . . . 0.0 110.932 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -87.03 115.74 1.2 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.879 2.386 . . . . 0.0 113.82 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.28 -161.54 1.13 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 8.0 mp -87.02 102.91 14.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.299 0.571 . . . . 0.0 111.892 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 251' ' ' GLU . 37.9 m -134.39 132.43 39.41 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -90.15 7.28 38.75 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . 0.435 ' H ' HG22 ' A' ' 249' ' ' THR . 45.9 mt-10 -88.15 -15.22 36.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -73.3 -7.31 51.01 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.293 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 261' ' ' GLY . 41.8 pt -105.13 -4.3 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.629 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -136.96 11.52 3.1 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -129.92 8.25 5.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.062 0.458 . . . . 0.0 109.939 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -124.43 137.0 54.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.742 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 67.79 -129.9 27.65 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 116.13 -0.486 . . . . 0.0 114.041 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.4 t -116.98 131.69 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 122.693 0.397 . . . . 0.0 110.932 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.621 ' HG2' ' H ' ' A' ' 260' ' ' ASP . 22.1 tt0 58.28 -155.01 0.35 Allowed 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.795 0.684 . . . . 0.0 109.222 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.621 ' H ' ' HG2' ' A' ' 259' ' ' GLU . 1.7 p-10 -128.89 136.93 51.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 253' ' ' ILE . . . -131.82 171.74 21.2 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.238 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.0 p -82.85 177.44 8.65 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.076 0.55 . . . . 0.0 110.44 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 94.9 t -60.7 -48.24 89.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.116 0.484 . . . . 0.0 110.791 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -81.4 -33.5 32.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.766 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.1 -40.3 99.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.374 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.418 ' O ' HG21 ' A' ' 270' ' ' VAL . 54.2 tp -62.16 -45.3 94.05 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -62.89 -44.96 94.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.577 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.27 -47.34 79.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.347 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -66.66 -38.61 87.22 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 266' ' ' LEU . 67.1 t -65.13 -42.7 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.232 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -57.94 -48.1 80.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.792 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.7 ptmt -66.33 -42.91 87.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.763 0.316 . . . . 0.0 111.413 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.31 -36.64 83.44 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.6 mmm -62.88 -42.28 99.71 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.207 0.527 . . . . 0.0 109.964 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 278' ' ' LEU . 56.9 mt-10 -69.36 -30.88 68.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.27 177.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -62.57 -43.42 98.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.609 177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -69.93 -28.21 65.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.114 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 275' ' ' GLU . 65.3 tp -61.08 -37.72 83.71 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -58.14 -45.84 86.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.73 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -45.06 95.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.432 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.58 -50.67 72.61 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.663 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.8 -45.17 95.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.17 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.547 HH12 ' HG3' ' A' ' 409' ' ' GLU . 2.2 tpt180 -61.44 -46.37 90.39 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.897 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -64.14 -39.85 94.91 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.242 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . 0.533 HH21 ' CG ' ' A' ' 285' ' ' ARG . 0.0 OUTLIER -60.27 -44.22 95.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.587 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.03 -43.55 85.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.001 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -61.12 -45.79 93.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.39 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 22.6 p -59.73 -43.64 94.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.03 -41.17 91.25 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.856 0.36 . . . . 0.0 111.189 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.55 87.03 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.8 mm -64.65 -44.46 96.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.466 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.528 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 33.1 tp10 -62.58 -40.73 97.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.95 0.405 . . . . 0.0 110.588 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.38 -43.73 97.87 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.495 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.5 -42.87 98.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.68 -46.98 93.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.227 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . 0.528 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.0 mttm -65.41 -41.57 93.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.898 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.76 -41.2 79.21 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -122.64 98.43 5.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.025 0.441 . . . . 0.0 112.182 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.52 114.7 27.31 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 301' ' ' ASP . 10.7 tp -128.43 161.65 36.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.553 0.216 . . . . 0.0 110.984 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.452 ' N ' HG13 ' A' ' 300' ' ' ILE . 25.4 m-20 -65.26 140.54 58.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.846 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.7 t -115.04 123.6 31.57 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.283 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.53 124.21 14.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.211 1.941 . . . . 0.0 111.535 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.89 85.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.46 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.07 -42.34 76.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.268 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.24 -41.26 85.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.552 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.14 -46.2 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.855 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.46 -43.49 88.88 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.635 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 313' ' ' VAL . 49.9 m -60.89 -45.92 92.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.201 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.562 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 60.2 mm-40 -69.05 -37.44 78.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.404 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 95.8 mt -62.29 -44.14 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.115 0.483 . . . . 0.0 109.975 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.41 -39.3 93.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.647 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 309' ' ' SER . 86.2 t -65.52 -43.09 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.296 176.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 80.4 mt -61.21 -39.01 88.65 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.812 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.468 ' NH1' HD13 ' A' ' 330' ' ' LEU . 65.9 mtm180 -61.41 -37.91 85.16 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.625 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -64.63 -43.05 94.95 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.771 0.319 . . . . 0.0 111.037 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -64.74 -41.81 95.67 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.21 0.528 . . . . 0.0 110.511 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.75 -41.93 78.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.159 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.72 -35.43 80.73 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.999 0.428 . . . . 0.0 110.979 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -56.21 -44.08 79.14 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.759 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.68 -36.63 60.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.931 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -60.1 -45.05 94.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.324 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . 0.402 ' HA2' HG23 ' B' ' 54' ' ' VAL . . . -170.61 17.64 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.096 -1.05 . . . . 0.0 112.857 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 70.79 26.65 73.66 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.209 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -97.9 154.03 17.93 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.292 0.568 . . . . 0.0 112.306 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.0 -178.49 5.47 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 70.28 -60.98 0.47 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.124 0.57 . . . . 0.0 111.592 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -69.83 -15.33 63.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.112 0.482 . . . . 0.0 110.856 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.444 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -61.66 -19.48 62.36 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.584 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.468 HD13 ' NH1' ' A' ' 315' ' ' ARG . 45.3 tp -62.19 -34.67 76.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.771 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -77.92 -0.54 27.91 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.961 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.62 144.2 85.83 Favored Pre-proline 0 C--O 1.238 0.454 0 O-C-N 122.142 -0.349 . . . . 0.0 110.715 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.65 132.43 51.7 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.777 2.318 . . . . 0.0 113.114 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -67.24 -44.46 79.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.521 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.8 pm0 -64.6 -31.55 72.82 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.62 -28.62 69.25 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.584 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -107.6 -20.62 13.18 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.08 -33.26 75.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.9 -44.77 96.11 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.129 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -80.83 -24.63 38.32 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.259 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.35 -38.4 90.89 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.329 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.405 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.3 tttt -57.92 -44.92 87.15 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.733 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.496 ' O ' HG23 ' A' ' 347' ' ' VAL . 9.1 mmt180 -62.28 -44.21 97.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.947 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -65.51 -39.99 92.47 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.097 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.8 t -63.29 -45.96 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.101 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 342' ' ' LYS . 98.5 t -63.74 -43.64 98.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 343' ' ' ARG . 78.0 t -60.43 -45.5 96.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.543 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.6 -42.84 99.83 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.02 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.47 -44.13 95.3 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.638 0.256 . . . . 0.0 111.313 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.97 -45.59 88.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.059 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.56 -39.98 88.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.022 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.48 -40.23 97.42 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.125 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.59 -36.62 83.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 110.648 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.91 -43.57 96.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.26 -44.33 99.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.894 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -68.2 -48.92 63.93 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.8 m -64.73 -44.61 89.61 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -88.14 -7.69 56.53 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.735 0.303 . . . . 0.0 111.142 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 60.58 60.31 1.98 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.122 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.1 mt -79.29 153.61 29.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.529 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -130.43 154.15 48.03 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.968 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -78.72 105.98 10.39 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 172.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 367' ' ' VAL . 31.7 t70 -82.18 111.5 18.34 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.376 -0.529 . . . . 0.0 112.054 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 5.1 mm-40 -62.73 -34.33 76.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.038 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -63.64 -44.11 94.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -65.48 -38.88 91.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.193 0.521 . . . . 0.0 109.978 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 363' ' ' ASP . 84.2 t -61.64 -36.77 75.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.578 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 27.2 mmmt -54.81 -47.87 73.5 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.633 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.95 -41.26 99.93 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.521 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.94 -42.86 99.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 0.0 110.713 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.58 -43.43 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.253 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.45 -37.77 87.88 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.276 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -65.38 -41.23 93.94 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.546 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.4 ttm -64.82 -42.42 95.0 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.011 0.434 . . . . 0.0 110.548 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.68 -24.4 67.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.756 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 55.0 m -75.19 -5.13 42.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.65 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.52 5.44 49.52 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.903 0.383 . . . . 0.0 111.18 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -116.93 171.75 7.71 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.762 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -60.61 -44.69 96.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.013 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -130.04 114.41 17.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.793 0.33 . . . . 0.0 110.239 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.69 -27.27 27.02 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.499 2.133 . . . . 0.0 113.123 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -65.1 -45.72 84.04 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.8 -36.29 83.09 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.567 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.74 -42.39 94.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.473 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.77 -44.18 98.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 50.2 mt-10 -66.05 -43.21 88.15 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.56 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.34 -47.84 82.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.959 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -65.64 -45.66 82.17 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.433 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 59.1 p -73.17 -16.38 61.44 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 99.3 mttt -91.06 9.08 32.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.115 0.483 . . . . 0.0 111.291 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -131.24 113.36 13.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.489 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.37 -41.69 98.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.72 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -60.69 -45.3 94.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.041 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.1 -42.68 99.63 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.482 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.557 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 94.5 mtp -63.16 -45.47 91.71 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.051 0.453 . . . . 0.0 110.56 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -64.98 -43.98 90.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.268 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -62.83 -41.76 99.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.395 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 49.0 tpp -63.98 -40.3 96.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.775 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.557 ' HG3' ' O ' ' A' ' 395' ' ' MET . 73.1 mtm180 -63.63 -35.15 79.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.837 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -62.8 -42.9 99.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.098 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.52 -43.57 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -61.4 -39.69 91.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.605 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 40.8 tp -63.79 -38.71 92.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.033 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.436 ' O ' HG21 ' A' ' 408' ' ' VAL . 75.2 tt0 -54.53 -50.9 66.78 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.267 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 35.2 mt-10 -66.78 -36.34 82.19 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.45 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -61.61 -44.83 96.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.833 0.349 . . . . 0.0 110.701 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.443 ' O ' HG21 ' A' ' 411' ' ' VAL . . . -62.81 -41.85 99.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.719 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.56 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 89.1 t -65.73 -43.7 93.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.753 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.547 ' HG3' HH12 ' A' ' 283' ' ' ARG . 96.3 mt-10 -63.21 -36.79 84.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.199 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.12 -41.32 99.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.145 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 407' ' ' ALA . 97.7 t -65.38 -42.51 93.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.313 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 68.4 mt -60.3 -42.02 94.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.734 -176.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.15 -23.28 67.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.771 0.32 . . . . 0.0 111.432 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -97.98 -3.97 37.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.464 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -109.51 -179.57 3.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.393 0.616 . . . . 0.0 112.399 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.69 102.24 13.95 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.215 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.8 t -94.81 128.45 46.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.373 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -120.34 128.96 53.74 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.531 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 40.1 mt-10 -100.55 118.79 37.43 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.382 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -130.03 134.51 47.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.097 0.475 . . . . 0.0 111.543 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.87 142.23 46.04 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -149.1 170.06 19.26 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.554 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 67.7 p -86.63 164.31 16.89 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.28 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -67.05 -26.11 66.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.982 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -61.88 -38.61 88.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.694 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -67.02 -30.11 70.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.778 0.323 . . . . 0.0 110.838 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.6 mp -80.92 -8.56 59.77 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 111.363 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.0 mmt -81.2 -7.3 59.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.133 0.492 . . . . 0.0 110.529 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -78.19 71.79 4.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.543 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -121.71 28.86 7.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.609 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -66.62 -38.35 86.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.52 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.765 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.465 -179.494 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.661 0.267 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -100.03 105.04 16.66 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.88 162.44 38.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.857 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 47.2 m -124.91 119.3 28.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.887 0.375 . . . . 0.0 111.23 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -136.73 137.08 47.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 49.8 mt-10 -114.3 176.35 5.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.01 0.433 . . . . 0.0 111.125 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -124.21 148.8 47.03 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.46 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 24.1 m -107.46 -82.12 0.55 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.868 0.366 . . . . 0.0 110.949 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -155.74 146.77 22.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.25 -123.65 28.2 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.141 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.415 HD12 HG11 ' B' ' 111' ' ' VAL . 1.2 mm? -100.08 5.84 44.96 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' B' ' 107' ' ' VAL . . . -73.48 142.6 31.52 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.376 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 0.3 OUTLIER -137.14 149.94 47.64 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.079 0.551 . . . . 0.0 109.938 -178.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -116.74 128.9 55.75 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.44 -92.31 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.039 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.1 p 40.75 81.66 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.031 0.532 . . . . 0.0 112.294 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 8.4 tp -108.0 136.84 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.05 0.452 . . . . 0.0 111.725 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 9.2 p -96.13 130.5 43.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.122 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 14.6 pt -131.43 162.45 39.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.501 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.534 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -74.28 157.53 35.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.304 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.61 80.4 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -65.91 -37.95 87.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.69 0.281 . . . . 0.0 110.662 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t -65.71 -43.62 88.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.933 0.397 . . . . 0.0 110.671 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.534 HG13 ' O ' ' B' ' 20' ' ' ALA . 77.0 mt -58.42 -69.04 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.26 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.511 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 76.7 mm-40 -68.53 -7.94 36.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -172.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 45.9 m -96.13 -63.98 1.1 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.946 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.2 -45.43 73.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.03 -43.42 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.925 0.393 . . . . 0.0 110.935 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.511 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.6 ttmm -61.97 -46.9 87.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.928 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.4 m -69.73 -36.39 75.83 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.468 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.85 -38.35 90.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.941 0.4 . . . . 0.0 110.725 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.33 -38.68 90.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.88 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.76 -43.46 97.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.108 0.48 . . . . 0.0 109.905 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -63.14 -42.73 99.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.49 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.07 -33.98 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.309 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.83 96.13 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.18 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.425 ' O ' ' HD3' ' B' ' 40' ' ' ARG . 98.5 mttt -65.63 -34.25 77.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.97 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.56 -37.18 82.86 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.779 0.323 . . . . 0.0 111.001 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 t -87.97 -8.42 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.243 0.544 . . . . 0.0 109.835 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' B' ' 37' ' ' LYS . 35.1 mmt180 66.26 31.44 8.54 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.216 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.81 6.34 9.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.399 . . . . 0.0 111.51 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.23 -35.22 80.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.512 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.64 -3.52 79.07 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.942 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -91.15 -8.67 48.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.701 0.251 . . . . 0.0 111.646 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -91.81 93.25 8.76 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.742 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -76.82 106.45 8.5 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.23 99.36 2.1 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 -169.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.99 -45.89 79.98 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.422 ' CG1' ' HB ' ' B' ' 54' ' ' VAL . 15.1 t -100.27 115.22 65.68 Favored Pre-proline 0 C--O 1.249 1.044 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.311 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.0 139.76 85.26 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.428 2.085 . . . . 0.0 111.143 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.489 ' HA ' HG12 ' B' ' 54' ' ' VAL . 23.5 ttt -63.28 -38.57 91.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.596 -174.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' B' ' 29' ' ' LYS . 31.3 p-10 -64.28 -32.02 73.45 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.331 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 92.5 mt -87.51 -45.05 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.822 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' B' ' 51' ' ' MET . 12.0 p -62.55 -42.2 94.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.711 0.291 . . . . 0.0 111.382 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.87 -14.67 62.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.8 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -97.09 -41.28 8.43 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.164 0.507 . . . . 0.0 109.686 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.438 ' NH1' ' SD ' ' A' ' 194' ' ' MET . 67.9 ttt180 -70.87 -44.91 65.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.166 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -110.0 10.83 24.15 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 120.924 0.392 . . . . 0.0 110.09 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.638 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -58.75 -45.69 94.49 Favored Glycine 0 C--O 1.215 -1.054 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.147 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.06 -24.86 60.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 37.4 t -61.64 -44.17 97.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 111.511 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.493 ' O ' HG21 ' B' ' 66' ' ' VAL . 9.1 p -123.25 21.85 4.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.312 0.577 . . . . 0.0 110.75 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.638 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 23.5 ttm180 -59.09 -33.21 70.56 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.728 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -61.18 -49.65 76.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.972 0.415 . . . . 0.0 110.515 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.5 -22.77 58.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.538 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.493 HG21 ' O ' ' B' ' 62' ' ' VAL . 53.8 t -63.89 -43.88 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 99.4 mt -62.77 -39.21 93.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.018 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.04 -42.7 99.88 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.202 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . 0.725 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 33.8 t70 -63.66 -44.01 95.06 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.972 0.386 . . . . 0.0 109.989 177.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.35 -41.34 96.91 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.063 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 49.9 ttp -60.91 -41.88 96.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.502 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -62.97 -44.37 96.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.925 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.725 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 32.8 mtp85 -66.68 -40.95 88.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.928 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -65.31 -41.33 94.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.192 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.56 -48.86 79.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.798 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 18.7 tt -68.0 -40.15 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.873 0.368 . . . . 0.0 111.705 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -65.69 -39.79 91.64 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.284 0.564 . . . . 0.0 110.134 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.14 -47.02 75.43 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.662 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 45.5 pt -62.45 -36.75 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.05 -43.97 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 120.686 0.279 . . . . 0.0 111.139 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.535 ' HZ1' ' HB3' ' B' ' 81' ' ' LYS . 0.1 OUTLIER -78.52 -28.03 46.11 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.617 -178.273 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.88 -4.43 58.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.655 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 62.85 42.45 7.8 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.933 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.3 mt -105.05 118.31 52.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -112.46 109.94 53.3 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.404 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -88.44 124.23 1.64 Allowed 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 122.544 2.163 . . . . 0.0 111.274 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.65 117.76 29.56 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.977 0.418 . . . . 0.0 110.505 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.7 -130.18 10.15 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.67 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.45 123.79 17.74 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-O 120.433 0.158 . . . . 0.0 110.625 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.31 131.46 19.11 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.797 1.664 . . . . 0.0 110.554 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 11.3 m -78.38 111.92 14.87 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.628 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.645 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 96.2 m-85 -83.9 105.19 14.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.14 102.73 11.51 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.47 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.4 Cg_endo -98.61 170.06 0.6 Allowed 'Trans proline' 0 N--CA 1.439 -1.723 0 C-N-CA 123.429 2.753 . . . . 0.0 111.402 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.43 -174.06 26.08 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -79.95 133.36 36.19 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -87.9 128.41 35.36 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.007 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.98 133.76 49.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 tp -86.79 88.61 7.72 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.328 0.585 . . . . 0.0 110.138 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.59 -20.9 3.65 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.174 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -108.54 178.07 4.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.496 0.189 . . . . 0.0 110.719 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -80.53 165.3 22.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.007 0.432 . . . . 0.0 111.185 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -124.1 141.92 51.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.957 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 27.7 m -122.91 135.82 54.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.041 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -142.69 165.51 27.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.366 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.8 m -85.4 -90.9 0.1 Allowed 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.441 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 85.3 t 64.94 99.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.347 0.594 . . . . 0.0 110.672 -175.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -101.11 145.6 28.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.702 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -158.11 -80.34 0.06 Allowed 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -95.97 157.02 16.09 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.415 HG11 HD12 ' B' ' 11' ' ' LEU . 24.9 m -124.97 163.98 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.925 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -171.24 101.02 0.4 Allowed Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 122.252 0.221 . . . . 0.0 110.961 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -96.37 162.82 1.22 Allowed 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 123.701 2.934 . . . . 0.0 114.306 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -143.19 147.29 34.66 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.738 0.815 . . . . 0.0 110.765 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.8 156.68 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 120.675 0.274 . . . . 0.0 111.072 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.14 153.13 51.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.83 131.89 55.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -144.71 155.07 43.37 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.46 22.89 78.15 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.33 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.05 -42.1 99.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.093 0.473 . . . . 0.0 111.232 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.11 -15.7 63.88 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.201 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.33 0.41 57.26 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.427 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 81.4 mt -79.73 113.82 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.11 0.481 . . . . 0.0 109.791 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -106.42 117.53 34.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.647 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 57.7 t -103.4 126.36 57.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -93.13 119.01 31.88 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.532 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.48 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 77.3 tttt -113.39 105.86 54.85 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.26 130.11 13.75 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.967 1.778 . . . . 0.0 111.9 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -101.46 115.37 43.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.44 161.29 41.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.941 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -150.37 159.57 44.36 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.852 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.67 131.05 35.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.159 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 81.7 p -110.77 175.53 5.39 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.924 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -62.16 -35.75 79.77 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.755 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.06 89.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.601 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.18 -42.17 99.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.716 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -63.86 -46.76 93.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.793 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.78 -44.19 97.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.624 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.88 -41.58 98.7 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.085 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' MET . . . . . 0.477 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.0 OUTLIER -62.68 -46.0 90.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.904 0.383 . . . . 0.0 110.683 179.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.9 mt -63.61 -40.76 97.74 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.675 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.32 -45.96 91.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.382 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.0 m -63.13 -41.61 99.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.813 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' B' ' 140' ' ' MET . 97.7 mt -60.67 -43.56 97.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.618 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -67.18 -35.97 80.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.874 0.369 . . . . 0.0 110.936 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.19 -21.04 65.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.089 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -85.56 -4.98 59.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 110.544 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -90.27 90.55 8.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.704 0.764 . . . . 0.0 112.216 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.88 132.49 18.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.373 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' B' ' 247' ' ' GLU . 20.5 p -103.63 -165.97 1.21 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . 0.497 ' O ' ' HG3' ' B' ' 152' ' ' LYS . 6.0 p-90 -68.6 127.94 34.84 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.345 -174.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' B' ' 151' ' ' TRP . 21.4 mttp -178.36 -167.84 0.14 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.231 1.012 . . . . 0.0 109.896 176.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' B' ' 154' ' ' LYS . 0.0 OUTLIER -132.59 163.71 28.27 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -172.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' B' ' 153' ' ' GLU . 11.2 pttp 66.13 -178.61 0.2 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.884 1.674 . . . . 0.0 114.323 174.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 14.8 t70 71.54 -94.48 0.03 OUTLIER 'General case' 0 C--N 1.341 0.235 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.189 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 148.63 97.8 0.19 Allowed Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.551 -1.309 . . . . 0.0 113.463 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -128.21 67.41 1.36 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 23.1 t -72.0 127.67 34.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.428 -176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 8.9 tp10 -93.53 153.54 18.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.87 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -89.52 23.2 2.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.622 -177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' B' ' 189' ' ' MET . 34.1 tt0 -163.28 25.81 0.09 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.406 0.622 . . . . 0.0 110.539 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.532 ' HB2' ' HB3' ' B' ' 159' ' ' GLU . 3.7 t70 -113.08 -172.16 2.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.316 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -99.39 124.67 44.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.6 t -120.14 126.42 75.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.337 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 10.3 m -87.58 109.8 19.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 67.6 mt -114.45 126.59 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.142 0.496 . . . . 0.0 112.264 -174.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -101.05 110.2 22.19 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -139.53 160.29 40.21 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.385 0.612 . . . . 0.0 112.11 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.9 m -131.79 136.26 47.4 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.884 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.46 104.86 2.31 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.697 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 33.2 m -130.04 124.67 33.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.63 -89.66 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.003 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -99.62 44.74 1.01 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.197 0.522 . . . . 0.0 110.149 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.91 12.85 67.79 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.297 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -126.8 138.95 53.42 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.39 134.68 34.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.719 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -105.34 -178.28 3.61 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.776 0.322 . . . . 0.0 111.82 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.74 -39.92 82.32 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.076 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.14 -176.17 37.73 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.147 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.49 16.8 67.8 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.073 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.17 94.77 5.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.68 144.46 31.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.68 0.276 . . . . 0.0 110.976 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -135.4 146.74 48.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.085 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 56.46 30.18 16.61 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 123.589 0.556 . . . . 0.0 110.786 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -83.94 126.54 33.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.463 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 17.3 m -98.76 115.47 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.955 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 63.7 tp -106.1 127.8 53.44 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.361 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.29 106.72 18.66 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' MET . . . . . 0.623 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 68.1 mtp -78.95 148.38 32.66 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.758 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.3 -15.05 63.55 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.039 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -94.97 -1.15 53.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.799 0.333 . . . . 0.0 111.384 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.88 56.71 5.22 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.738 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.413 HH22 HD11 ' A' ' 53' ' ' ILE . 17.8 mmt85 -99.64 -6.31 27.48 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.198 0.523 . . . . 0.0 109.789 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.478 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -136.27 173.02 12.16 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.904 -178.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 31.2 mm -62.83 131.32 94.43 Favored Pre-proline 0 N--CA 1.437 -1.12 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.82 125.74 11.78 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.495 2.13 . . . . 0.0 111.956 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.14 -42.7 1.89 Allowed Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.288 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -63.32 -52.22 62.77 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.055 0.427 . . . . 0.0 111.866 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . 0.472 ' O ' ' HE2' ' B' ' 189' ' ' MET . 10.5 pt-20 -71.79 -31.23 66.38 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.854 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.85 -39.56 76.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.888 0.375 . . . . 0.0 111.098 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -62.97 -20.34 62.28 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.688 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.5 -41.74 93.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 120.804 0.335 . . . . 0.0 110.289 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -47.5 128.39 12.39 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.8 0.84 . . . . 0.0 111.671 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.51 -19.44 45.1 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.165 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -87.53 163.68 16.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.867 0.365 . . . . 0.0 111.816 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -105.78 155.12 19.6 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.989 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.18 137.47 57.02 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . 0.558 ' HA2' ' O ' ' B' ' 237' ' ' LEU . . . 74.41 38.19 45.68 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.504 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -127.64 128.48 45.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.224 0.535 . . . . 0.0 111.783 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -99.23 120.17 39.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.68 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . 0.468 ' O ' ' HB ' ' B' ' 212' ' ' THR . 36.0 t80 -139.65 -35.71 0.53 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -176.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' B' ' 211' ' ' PHE . 94.8 m 75.32 142.46 0.07 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.706 0.288 . . . . 0.0 110.799 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -132.56 141.07 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 111.594 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.19 109.47 18.33 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.681 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 64.5 t -121.38 122.3 66.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' THR . . . . . 0.431 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 3.4 m -92.01 -21.15 20.67 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -174.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' B' ' 216' ' ' THR . 44.0 m-85 68.05 149.52 0.12 Allowed Pre-proline 0 N--CA 1.482 1.156 0 CA-C-O 120.779 0.323 . . . . 0.0 110.839 -175.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 15.6 Cg_exo -71.15 150.4 59.68 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.311 2.007 . . . . 0.0 111.767 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.43 -37.45 87.56 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.84 76.47 6.33 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.206 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -121.6 141.98 50.56 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -62.93 -29.09 70.52 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.98 110.9 22.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 43.8 tt0 -65.23 -33.54 76.25 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.728 -176.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.406 ' O ' ' HG3' ' B' ' 229' ' ' LYS . 30.4 p-10 -66.33 -23.37 66.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.118 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.7 mt -110.69 -4.25 15.46 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.9 ptmt -69.05 119.74 13.81 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.875 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.89 34.6 90.32 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.327 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' B' ' 225' ' ' ASN . 34.7 mmtp -114.91 133.87 55.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -84.16 107.72 16.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.901 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.37 148.21 22.69 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.142 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.18 -48.99 3.71 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 58.98 102.52 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.169 0.509 . . . . 0.0 110.892 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.47 89.82 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm 61.54 102.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.175 0.59 . . . . 0.0 112.095 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -90.17 -51.51 5.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . 0.558 ' O ' ' HA2' ' B' ' 208' ' ' GLY . 13.0 tp 61.99 81.66 0.19 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.27 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -82.36 -48.58 10.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -110.18 -79.82 0.58 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t 70.18 142.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.096 0.559 . . . . 0.0 110.839 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -73.76 -47.23 40.6 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.094 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 65.58 162.18 0.14 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -158.69 91.4 1.06 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.254 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' B' ' 152' ' ' LYS . 7.8 tp10 -122.79 153.4 39.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.188 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 9.0 tt 76.24 116.07 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 C-N-CA 124.027 0.931 . . . . 0.0 110.58 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.38 113.12 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.543 2.162 . . . . 0.0 113.653 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . 0.484 ' HG2' ' OG1' ' B' ' 150' ' ' THR . 12.6 pt-20 -125.89 -163.57 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.0 mp -89.25 104.42 16.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.342 0.591 . . . . 0.0 111.817 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 34.2 m -132.67 133.64 43.82 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.99 15.4 13.31 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.06 -12.21 25.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -75.16 -2.51 28.07 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.821 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' B' ' 261' ' ' GLY . 43.5 pt -109.93 -3.63 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.576 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -138.76 10.56 2.66 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -131.64 13.83 4.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.041 0.448 . . . . 0.0 109.97 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -131.42 138.56 49.12 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.361 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 69.5 -129.06 22.13 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.212 -0.518 . . . . 0.0 114.073 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 75.8 t -121.03 130.02 75.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . 0.634 ' HG2' ' H ' ' B' ' 260' ' ' ASP . 22.0 tt0 59.5 -166.79 0.17 Allowed 'General case' 0 CA--C 1.552 1.039 0 O-C-N 123.709 0.63 . . . . 0.0 110.091 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . 0.634 ' H ' ' HG2' ' B' ' 259' ' ' GLU . 5.1 p-10 -110.24 144.9 38.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' B' ' 253' ' ' ILE . . . -146.43 166.19 28.19 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.138 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 12.8 p -80.32 176.89 9.36 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 122.768 0.427 . . . . 0.0 111.205 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.81 -48.0 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.749 0.309 . . . . 0.0 110.942 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.11 -33.3 29.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 110.591 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.54 -41.35 99.8 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.061 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.43 ' O ' HG21 ' B' ' 270' ' ' VAL . 63.6 tp -61.58 -46.33 90.3 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 120.522 0.201 . . . . 0.0 110.595 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -65.04 -41.72 94.94 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.728 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.606 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.16 -45.92 86.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -67.88 -38.76 83.44 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.43 HG21 ' O ' ' B' ' 266' ' ' LEU . 58.8 t -64.38 -42.11 94.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.35 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -58.04 -48.41 80.17 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.611 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 11.9 ptmt -66.65 -42.61 86.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.741 0.305 . . . . 0.0 111.292 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.6 -38.26 90.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.007 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.8 mmm -63.33 -42.14 98.95 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.994 0.426 . . . . 0.0 109.997 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' B' ' 278' ' ' LEU . 79.1 mt-10 -70.51 -28.77 65.21 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.738 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -64.41 -42.74 95.91 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -67.59 -27.94 67.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.711 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' B' ' 275' ' ' GLU . 63.9 tp -61.02 -38.72 87.09 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.37 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -58.21 -46.76 85.27 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.626 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 32.2 m -62.22 -44.76 95.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.895 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.71 72.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.339 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.29 -44.06 97.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.062 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . 0.522 HH12 ' HG3' ' B' ' 409' ' ' GLU . 1.7 tpt180 -62.25 -46.16 90.06 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.781 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -64.69 -39.88 94.43 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . 0.559 HH21 ' CG ' ' B' ' 285' ' ' ARG . 0.0 OUTLIER -60.85 -43.78 97.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.074 0.464 . . . . 0.0 110.588 179.03 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 76.1 t -67.75 -43.91 86.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.946 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.63 -46.47 90.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.22 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 32.2 p -60.37 -43.47 96.51 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -66.53 -41.14 89.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.363 . . . . 0.0 111.137 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.65 -48.22 78.12 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.46 -44.52 97.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.322 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -62.65 -40.28 96.55 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.61 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.34 -42.75 99.1 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.12 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.33 -42.22 98.96 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.03 -45.34 96.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 123.201 0.313 . . . . 0.0 111.196 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.87 -41.96 95.24 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.379 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -69.77 -43.13 72.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -117.89 100.83 7.83 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -96.65 113.58 25.16 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . 0.426 HG13 ' N ' ' B' ' 301' ' ' ASP . 10.6 tp -126.98 160.52 35.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.8 0.333 . . . . 0.0 111.117 -176.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . 0.426 ' N ' HG13 ' B' ' 300' ' ' ILE . 14.1 m-20 -65.71 135.95 55.63 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.629 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 16.0 t -112.64 123.07 34.7 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.533 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.66 123.96 14.08 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.141 1.894 . . . . 0.0 111.527 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.81 81.65 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.714 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.62 -45.6 73.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.113 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.79 -41.85 95.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.718 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.67 -45.74 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -43.54 86.71 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.527 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 309' ' ' SER . . . . . 0.464 ' O ' HG22 ' B' ' 313' ' ' VAL . 20.3 m -62.59 -45.39 93.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.205 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . 0.513 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 55.3 mm-40 -66.17 -39.19 89.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.051 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.17 -44.22 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.995 0.426 . . . . 0.0 110.345 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.69 -38.02 89.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.811 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . 0.464 HG22 ' O ' ' B' ' 309' ' ' SER . 96.9 t -66.6 -42.48 89.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.955 176.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 90.3 mt -61.42 -39.88 92.37 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.03 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.446 ' NH1' HD13 ' B' ' 330' ' ' LEU . 63.5 mtm180 -61.74 -37.68 85.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.316 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 -63.38 -43.89 96.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.795 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.99 -41.49 95.35 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.335 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.87 -42.5 76.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.372 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.2 -37.01 84.56 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 120.862 0.363 . . . . 0.0 111.319 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -55.4 -42.95 74.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.578 0.704 . . . . 0.0 109.539 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -74.41 -38.22 63.15 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.885 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -58.12 -46.87 84.85 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.169 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . -168.95 17.56 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.435 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 72.2 25.54 74.3 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.168 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -94.07 151.0 19.83 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -175.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -135.58 -179.7 5.8 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 68.8 -62.85 0.38 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.32 0.648 . . . . 0.0 112.084 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -67.02 -16.61 64.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.99 0.424 . . . . 0.0 111.141 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . 0.423 ' O ' ' HD2' ' B' ' 315' ' ' ARG . . . -60.85 -18.74 57.7 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.621 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . 0.446 HD13 ' NH1' ' B' ' 315' ' ' ARG . 45.7 tp -61.88 -37.56 85.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.809 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -74.43 -6.17 46.72 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.976 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.6 140.6 96.54 Favored Pre-proline 0 C--O 1.241 0.606 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.934 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -55.08 130.62 41.74 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.951 2.434 . . . . 0.0 113.296 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -65.74 -44.01 87.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.074 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.5 pm0 -66.53 -24.48 66.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 11.0 mp -76.06 -18.94 59.0 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -116.09 -20.61 9.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -64.43 -32.22 73.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -63.49 -46.7 84.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.537 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -76.9 -26.56 54.3 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.734 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.96 93.05 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.614 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . 0.425 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.8 tttt -57.76 -44.87 86.42 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.939 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . 0.502 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.2 mmt85 -61.64 -44.1 97.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.783 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -65.63 -39.45 91.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.597 0.237 . . . . 0.0 111.242 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . . . . . . . . . 77.6 t -63.58 -45.72 96.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.148 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.425 HG23 ' O ' ' B' ' 342' ' ' LYS . 96.9 t -63.37 -44.25 98.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . 0.502 HG23 ' O ' ' B' ' 343' ' ' ARG . 78.6 t -60.54 -45.26 97.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.445 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.11 -43.08 99.87 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.368 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.09 -44.11 93.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.664 0.269 . . . . 0.0 111.359 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.85 -44.84 91.97 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.757 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.04 -39.25 89.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.05 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.53 97.83 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.015 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.29 -35.25 79.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.967 0.383 . . . . 0.0 110.851 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.18 -44.59 95.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.1 -44.13 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.704 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -68.73 -47.28 66.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 26.4 m -65.51 -45.42 83.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -88.47 -9.4 52.61 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.916 0.389 . . . . 0.0 111.069 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 60.94 61.51 1.62 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.077 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.1 mt -78.76 156.54 28.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.304 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -131.25 158.86 39.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.672 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -81.28 108.2 14.7 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 172.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . 0.461 ' O ' HG22 ' B' ' 367' ' ' VAL . 18.0 t70 -81.72 107.57 14.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.327 0.584 . . . . 0.0 111.825 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 5.6 mm-40 -61.39 -35.25 76.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.846 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.17 -43.28 92.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.967 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -64.27 -39.37 93.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.302 0.572 . . . . 0.0 109.836 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . 0.461 HG22 ' O ' ' B' ' 363' ' ' ASP . 94.6 t -61.81 -39.54 83.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.633 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 24.9 mmmt -55.89 -46.53 78.31 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.035 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.59 -42.26 99.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.333 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 98.5 mt -63.09 -42.13 99.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.854 0.359 . . . . 0.0 110.705 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 92.1 mt -63.92 -43.09 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.286 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.27 -40.94 97.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.94 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.89 -40.02 94.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.798 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 59.9 ttm -66.65 -41.46 88.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.074 0.464 . . . . 0.0 110.796 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.75 -25.1 68.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.861 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 47.9 m -75.74 3.32 10.05 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.987 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -103.02 11.24 37.54 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.324 0.583 . . . . 0.0 110.827 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -118.18 170.8 8.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.118 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.2 -35.02 79.43 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.543 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -138.22 111.8 8.59 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.024 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.91 -30.77 32.52 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.352 2.035 . . . . 0.0 113.223 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.78 -44.27 90.54 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -65.64 -36.02 82.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.747 0.308 . . . . 0.0 110.383 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.13 -41.47 91.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.606 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.6 mt -61.43 -44.25 98.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.802 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 52.9 mt-10 -66.54 -42.32 87.36 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.559 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -58.05 -46.91 84.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.958 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -67.97 -44.07 77.52 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.656 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 41.7 p -73.75 -17.69 61.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.5 mttt -89.06 1.66 55.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.901 0.381 . . . . 0.0 111.253 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -123.11 112.61 17.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.719 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.71 -41.89 98.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.507 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -61.91 -45.18 94.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 5.8 mp -62.65 -43.06 99.77 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.675 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.533 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.8 mtp -63.2 -46.82 85.27 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.032 0.444 . . . . 0.0 110.963 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . 0.433 ' HA ' ' HE ' ' B' ' 399' ' ' ARG . 19.5 t70 -65.01 -43.95 90.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.784 -176.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -63.55 -40.34 96.76 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.742 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 47.4 tpp -62.78 -39.83 95.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' B' ' 395' ' ' MET . 80.8 mtm180 -64.13 -35.51 81.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.695 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.11 -43.31 99.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 98.0 t -66.53 -44.04 90.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.586 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.73 95.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.943 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 47.5 tp -62.82 -38.33 90.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.03 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . 0.492 ' O ' HG21 ' B' ' 408' ' ' VAL . 43.8 tt0 -54.47 -51.39 65.16 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.07 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 37.3 mt-10 -65.89 -37.98 87.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.453 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -60.4 -43.54 96.58 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.576 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.439 ' O ' HG21 ' B' ' 411' ' ' VAL . . . -64.23 -42.56 96.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.634 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . 0.572 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 93.0 t -65.34 -43.3 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.583 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . 0.522 ' HG3' HH12 ' B' ' 283' ' ' ARG . 95.2 mt-10 -63.91 -35.69 81.5 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.064 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.2 98.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.089 0.471 . . . . 0.0 110.286 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . 0.439 HG21 ' O ' ' B' ' 407' ' ' ALA . 92.1 t -65.27 -42.64 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.421 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 81.4 mt -61.15 -40.68 94.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.532 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.49 -16.78 64.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.617 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -102.75 -22.76 13.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.44 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.44 179.55 5.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.257 0.551 . . . . 0.0 112.001 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.18 108.03 20.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.33 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.3 127.29 52.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.73 0.3 . . . . 0.0 110.254 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 13.6 t -119.96 130.94 55.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . 0.48 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 41.5 mt-10 -102.3 120.7 40.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.356 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -131.85 138.62 48.54 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.418 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.26 144.91 35.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 13.4 t -151.3 171.72 17.02 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.231 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 36.1 p -86.95 166.1 15.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.338 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -67.34 -25.95 66.25 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -62.9 -38.42 90.86 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.86 -31.67 72.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 0.0 110.672 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.24 -12.95 60.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 5.5 mmt -81.03 -7.3 59.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.001 0.429 . . . . 0.0 110.995 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -78.1 78.27 4.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.309 0.576 . . . . 0.0 110.509 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -126.06 23.63 7.09 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.63 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.39 -30.15 70.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.234 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.826 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.691 -178.673 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 CA--C 1.545 0.752 0 CA-C-O 120.695 0.283 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -65.5 137.7 57.6 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.858 0.361 . . . . 0.0 111.183 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.33 158.31 41.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.504 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.7 t -117.41 113.63 22.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.935 0.398 . . . . 0.0 110.821 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 p -154.72 140.65 11.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -122.34 157.69 31.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.981 0.419 . . . . 0.0 111.204 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 m -104.44 115.56 30.59 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.857 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.7 m -68.2 -53.42 25.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.738 0.304 . . . . 0.0 111.01 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 168.31 130.05 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.82 0.848 . . . . 0.0 109.586 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.22 -105.7 1.36 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.784 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.424 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 4.0 mp -97.04 -16.01 20.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.692 0.282 . . . . 0.0 110.343 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' O ' ' HD3' ' A' ' 13' ' ' ARG . . . -71.79 133.58 21.15 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.635 -175.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -135.92 143.44 44.95 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -116.23 134.02 55.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 t -79.56 -94.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 m 54.54 91.48 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.336 0.589 . . . . 0.0 110.85 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 tp -106.87 134.32 48.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.004 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.3 p -81.3 132.62 35.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.412 HD11 HD13 ' A' ' 24' ' ' ILE . 1.9 pp -129.56 161.88 38.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.663 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -108.11 155.85 19.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.005 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.17 -53.15 57.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.4 -34.39 74.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.987 0.422 . . . . 0.0 110.662 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.6 t -63.01 -34.44 77.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.038 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.663 HG13 ' O ' ' A' ' 20' ' ' ALA . 62.7 mt -59.62 -70.2 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.207 0.527 . . . . 0.0 111.269 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.495 ' CD ' ' HZ2' ' A' ' 29' ' ' LYS . 4.2 tp10 -63.71 -44.87 92.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.724 -172.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.3 m -64.66 -49.01 72.68 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.4 -45.25 18.01 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.0 t -63.32 -44.47 99.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.531 0.196 . . . . 0.0 111.531 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.495 ' HZ2' ' CD ' ' A' ' 25' ' ' GLU . 17.7 ttmm -61.32 -46.7 89.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.832 0.348 . . . . 0.0 110.735 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.9 m -61.72 -41.58 97.8 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.085 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -65.45 -42.6 92.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.984 0.421 . . . . 0.0 110.567 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.421 ' CD2' HH22 ' A' ' 73' ' ' ARG . 97.1 mt -63.81 -44.09 94.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.24 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -68.05 -37.6 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -62.79 -39.67 94.95 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.463 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.49 -44.16 98.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.822 0.344 . . . . 0.0 110.311 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.05 87.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.945 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.9 -34.11 77.07 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.833 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -59.29 -42.83 92.21 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.834 0.35 . . . . 0.0 110.483 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.1 t -85.99 -4.72 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.056 0.455 . . . . 0.0 110.16 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 62.74 27.56 16.15 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.457 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.72 5.29 10.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -64.46 -30.51 71.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.986 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.15 -23.65 68.15 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.339 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -74.83 -12.2 60.33 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.429 ' HG3' ' NE2' ' B' ' 320' ' ' GLN . 71.8 ttt-85 -91.06 103.08 15.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.58 -176.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HZ2' ' HB3' ' A' ' 46' ' ' LYS . 0.9 OUTLIER -79.13 109.6 13.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.288 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.81 67.61 2.12 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 115.949 1.139 . . . . 0.0 115.949 -170.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.62 -44.16 91.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.3 t -98.33 102.74 15.1 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HB2' ' OD1' ' A' ' 52' ' ' ASN . 13.4 Cg_endo -57.36 144.03 92.41 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.315 2.01 . . . . 0.0 111.779 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.423 ' O ' HG11 ' A' ' 54' ' ' VAL . 17.5 ttt -61.13 -38.57 86.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.244 -173.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.508 ' OD1' ' HB2' ' A' ' 50' ' ' PRO . 16.7 p-10 -62.56 -43.21 99.37 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.833 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.477 HG12 ' NH2' ' B' ' 193' ' ' ARG . 1.8 mp -68.67 -44.12 82.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.434 HG23 ' HA2' ' B' ' 323' ' ' GLY . 2.6 p -63.84 -36.85 78.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 120.63 0.252 . . . . 0.0 111.619 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.19 89.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.258 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -83.45 -32.69 25.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.371 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -63.44 -42.47 98.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.177 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -109.91 17.83 20.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.391 0.615 . . . . 0.0 111.186 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.18 145.81 49.91 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.072 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 72.66 -35.06 0.31 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.378 0.671 . . . . 0.0 112.555 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -61.23 -45.89 92.66 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -122.97 22.17 4.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.903 0.858 . . . . 0.0 110.246 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -63.87 -23.25 67.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.374 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -63.83 -45.17 90.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.847 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -75.2 -24.01 57.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.129 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.88 -42.22 94.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.0 mt -61.91 -38.41 88.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.935 175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.7 -41.06 98.85 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.658 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.439 ' OD1' ' HE2' ' B' ' 327' ' ' LYS . 20.9 t70 -60.75 -46.34 90.81 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.954 0.407 . . . . 0.0 110.434 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.18 -42.59 99.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.282 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.6 ttp -63.32 -42.87 99.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.976 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -62.83 -44.04 97.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.331 0.586 . . . . 0.0 110.997 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.421 HH22 ' CD2' ' A' ' 32' ' ' LEU . 69.7 mtp180 -64.42 -40.77 96.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.046 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -63.93 -40.24 96.0 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 120.954 0.407 . . . . 0.0 110.519 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -62.43 -48.28 80.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.874 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.445 ' O ' HG13 ' A' ' 79' ' ' ILE . 15.7 tt -68.96 -41.48 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.879 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -65.16 -37.91 88.88 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.141 0.496 . . . . 0.0 110.095 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.66 83.16 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.922 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.8 pp -65.64 -30.5 50.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.541 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.0 mt -65.44 -43.63 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.932 0.396 . . . . 0.0 111.034 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -81.24 -32.57 33.3 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.901 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -83.27 -2.94 56.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.124 0.487 . . . . 0.0 110.407 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt 64.23 38.93 7.78 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.674 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 81.3 mt -102.66 123.87 56.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.827 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -110.32 103.56 54.16 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.388 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.65 146.59 34.39 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.51 2.14 . . . . 0.0 112.295 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.14 98.23 11.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.049 0.452 . . . . 0.0 111.424 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.55 -106.48 2.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.591 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.09 129.71 24.65 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.449 ' HG2' ' CE1' ' A' ' 92' ' ' TYR . 81.0 Cg_endo -73.95 156.42 47.8 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.681 2.254 . . . . 0.0 111.928 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.0 m -76.94 119.39 20.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.017 0.437 . . . . 0.0 111.534 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.449 ' CE1' ' HG2' ' A' ' 90' ' ' PRO . 73.6 m-85 -113.82 118.81 35.3 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.01 100.57 53.84 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.443 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -90.19 145.31 4.26 Favored 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 122.555 2.17 . . . . 0.0 111.29 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.98 175.3 41.5 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.301 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.72 125.17 26.43 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -80.51 127.82 32.88 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.971 0.415 . . . . 0.0 110.563 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -117.56 115.52 25.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.595 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.4 tp -65.37 107.27 1.59 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.334 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.47 -8.71 13.43 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.383 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.93 173.39 8.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.803 0.335 . . . . 0.0 111.026 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.87 141.25 44.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.558 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -98.08 141.18 31.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.385 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.8 m -124.26 133.99 53.35 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -141.03 154.91 46.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.255 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 m -84.21 -86.44 0.12 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.0 t 68.89 111.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 122.98 0.512 . . . . 0.0 110.498 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -113.95 137.66 51.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.825 -175.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -151.34 -74.75 0.15 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -143.24 157.49 44.44 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.553 0.615 . . . . 0.0 111.297 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.424 ' CG1' ' HG ' ' A' ' 11' ' ' LEU . 28.8 m -128.78 -172.46 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -140.25 118.02 8.27 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.88 147.32 39.02 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.821 2.347 . . . . 0.0 114.623 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -135.87 143.06 44.85 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.597 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.6 t -128.37 132.17 68.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -104.7 -90.15 0.4 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.519 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.0 mt 64.1 130.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.114 0.966 . . . . 0.0 113.397 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -136.97 152.34 50.04 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.818 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.96 22.14 74.85 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.418 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.66 -28.8 68.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.808 0.337 . . . . 0.0 111.897 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -83.16 -9.02 59.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.852 0.358 . . . . 0.0 111.28 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -102.51 17.29 24.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.911 0.386 . . . . 0.0 111.342 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.2 mt -90.47 123.7 42.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.908 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -108.99 127.02 53.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.3 t -115.16 136.07 53.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.017 0.437 . . . . 0.0 112.073 -172.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -86.99 139.1 30.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.844 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -134.47 101.03 12.23 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.5 137.79 40.37 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.046 1.831 . . . . 0.0 111.527 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.98 123.13 70.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.919 0.39 . . . . 0.0 110.481 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.99 162.25 39.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.534 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -142.35 158.99 43.11 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.6 t -81.17 116.77 26.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.1 p -100.39 176.36 5.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.665 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -65.02 -30.62 71.61 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.476 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.54 97.72 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.895 0.378 . . . . 0.0 110.355 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -64.21 -44.43 91.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.949 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.478 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 90.1 t -64.47 -46.13 93.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.433 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.71 -48.4 81.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.721 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.63 -39.48 97.61 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.945 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.478 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -63.07 -44.79 94.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 0.0 110.337 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 86.6 mt -63.2 -42.26 99.28 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.74 -45.15 93.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.367 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.8 m -62.95 -42.72 99.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.614 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -60.92 -42.54 98.3 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -72.81 -20.89 61.06 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.418 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.17 -12.4 59.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.079 0.466 . . . . 0.0 110.608 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -93.61 2.99 56.19 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.498 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -117.14 75.09 0.95 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.888 0.852 . . . . 0.0 111.976 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.71 73.24 0.76 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 151' ' ' TRP . 4.1 m -144.76 173.01 12.22 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.903 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.448 ' H ' HG23 ' A' ' 150' ' ' THR . 31.5 t-105 80.72 17.52 0.57 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.395 1.078 . . . . 0.0 112.315 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.454 ' HG2' ' HB2' ' A' ' 245' ' ' LEU . 6.3 mptp? -101.89 160.01 14.85 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -94.93 4.88 53.29 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -142.23 154.37 44.73 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.986 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 78.2 -175.22 0.09 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.733 1.213 . . . . 0.0 111.304 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -138.29 99.45 0.28 Allowed Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 119.577 -1.297 . . . . 0.0 114.865 -174.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.413 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . . . -110.45 -57.0 2.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.5 t 60.89 123.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 114.592 -1.186 . . . . 0.0 113.589 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -99.95 158.14 16.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.753 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.84 86.39 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -77.12 -0.12 23.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.53 142.38 27.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.508 0.194 . . . . 0.0 110.757 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -91.61 120.09 32.08 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.95 129.98 74.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.754 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.0 m -75.91 110.32 10.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 79.9 mt -122.37 120.28 60.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.348 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -98.48 101.4 12.83 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -120.15 154.22 35.08 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.074 0.464 . . . . 0.0 111.667 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 30.8 m -123.43 129.73 51.69 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.662 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.35 125.43 7.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.903 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 25.2 m -142.38 125.83 16.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.45 -78.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.653 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -132.77 80.31 1.89 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.55 7.3 73.43 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.096 -0.574 . . . . 0.0 112.903 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -140.69 143.72 35.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.793 0.33 . . . . 0.0 110.12 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -87.27 156.73 19.52 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.193 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -122.64 174.04 7.34 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.71 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.21 -38.84 74.34 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -101.19 -178.22 28.91 Favored Glycine 0 C--N 1.318 -0.435 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.091 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.02 30.5 38.07 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.704 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -107.18 102.92 12.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -124.45 142.67 51.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 111.948 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.4 m -150.52 132.24 14.96 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.2 31.04 20.9 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.374 0.421 . . . . 0.0 110.343 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -95.84 123.42 39.41 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.99 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.2 m -91.48 116.5 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.539 0.685 . . . . 0.0 110.598 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 56.3 tp -110.13 130.51 55.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.396 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.665 ' HB2' ' NH1' ' A' ' 193' ' ' ARG . . . -121.22 135.29 55.16 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 73.9 mtm -102.19 178.21 4.66 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.149 0.5 . . . . 0.0 112.001 -172.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.61 -10.64 73.73 Favored Glycine 0 CA--C 1.505 -0.531 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.235 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -102.83 -9.23 20.11 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.618 0.247 . . . . 0.0 111.173 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.63 42.45 21.65 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.853 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.665 ' NH1' ' HB2' ' A' ' 188' ' ' ALA . 48.3 mtm180 -93.27 0.41 57.01 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.343 0.592 . . . . 0.0 110.632 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.451 ' HB2' ' HG3' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -130.17 172.95 11.23 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.445 173.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.529 HD11 ' H ' ' A' ' 195' ' ' ILE . 4.4 mp -69.07 137.47 89.56 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.98 134.75 49.94 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.984 1.789 . . . . 0.0 111.416 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.91 -38.94 2.9 Favored Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.51 ' O ' HG12 ' A' ' 202' ' ' ILE . 47.9 t80 -63.57 -49.77 72.08 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 194' ' ' MET . 88.0 mt-10 -67.11 -36.11 81.22 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.492 0.663 . . . . 0.0 109.938 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.85 -36.08 82.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.627 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.16 -8.95 77.64 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.889 -0.672 . . . . 0.0 114.095 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 198' ' ' PHE . 47.8 mm -65.14 -45.27 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 117.275 0.538 . . . . 0.0 111.194 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -58.99 130.54 47.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.167 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.9 -15.02 48.85 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.451 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -83.37 143.51 30.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 117.06 0.43 . . . . 0.0 111.724 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -96.01 160.51 14.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.274 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.47 121.44 14.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.563 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 82.51 24.13 54.59 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.393 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -105.8 113.07 26.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.374 0.607 . . . . 0.0 111.482 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -91.37 130.94 37.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.559 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.483 ' O ' ' HB ' ' A' ' 212' ' ' THR . 61.5 t80 -150.52 -29.84 0.21 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -176.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 91.1 m 79.77 143.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.839 0.455 . . . . 0.0 110.279 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.3 tp -115.75 -42.01 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 72.12 100.11 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.329 0.585 . . . . 0.0 112.03 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 63.8 t -121.89 133.96 66.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.891 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 9.4 m -93.1 -23.49 18.6 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.452 ' CE2' HG12 ' A' ' 195' ' ' ILE . 96.4 m-85 71.94 145.59 0.11 Allowed Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 122.817 0.447 . . . . 0.0 111.459 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.56 154.02 60.09 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.621 2.214 . . . . 0.0 111.846 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -65.38 -40.04 93.01 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.947 0.403 . . . . 0.0 110.775 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -88.11 32.34 0.76 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.486 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -69.25 132.71 46.91 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.728 -0.389 . . . . 0.0 109.994 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -56.67 -40.4 75.45 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.57 101.85 7.62 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -61.53 -33.26 73.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -68.36 -14.11 62.76 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.18 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.0 mt -117.48 -0.34 11.95 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -71.54 124.21 24.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.311 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.91 17.96 77.3 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.544 -0.753 . . . . 0.0 114.492 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -127.5 132.05 50.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.711 0.755 . . . . 0.0 110.663 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.21 151.71 25.54 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.73 135.89 33.6 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.501 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.92 -48.05 67.04 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 54.46 91.83 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.082 0.468 . . . . 0.0 111.067 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.88 89.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mm 69.7 90.14 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.106 0.479 . . . . 0.0 111.522 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -67.88 -47.5 68.68 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.29 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.461 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 8.0 tp 55.26 100.37 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.86 0.864 . . . . 0.0 113.034 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -95.58 -70.91 0.69 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -80.5 -86.87 0.08 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.487 HG13 ' H ' ' A' ' 242' ' ' GLU . 65.6 t 76.84 140.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.111 0.564 . . . . 0.0 111.053 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.51 ' HB3' ' NH1' ' A' ' 243' ' ' ARG . 50.8 mm-40 -64.16 -37.03 85.98 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.344 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.487 ' H ' HG13 ' A' ' 240' ' ' VAL . 36.2 mt-10 66.97 129.3 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.535 0.734 . . . . 0.0 111.881 -176.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.51 ' NH1' ' HB3' ' A' ' 241' ' ' GLU . 8.6 ptp180 173.55 114.27 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.967 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.416 ' CG ' ' H ' ' A' ' 245' ' ' LEU . 0.4 OUTLIER -142.66 -153.96 0.49 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.454 ' HB2' ' HG2' ' A' ' 152' ' ' LYS . 10.5 mp 70.18 146.09 0.11 Allowed Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.527 ' O ' ' HG2' ' A' ' 247' ' ' GLU . 95.7 Cg_endo -82.94 -159.08 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.175 2.583 . . . . 0.0 112.931 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 246' ' ' PRO . 3.4 pt-20 87.96 -176.47 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.188 1.795 . . . . 0.0 111.043 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.76 135.73 48.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.105 0.479 . . . . 0.0 111.639 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 41.2 p -88.39 -168.52 2.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.036 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.23 -51.39 66.75 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.931 0.396 . . . . 0.0 109.935 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -132.54 94.23 3.38 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -72.97 -10.22 59.56 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.297 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.25 -44.55 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.72 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.508 ' HD2' ' HB2' ' A' ' 260' ' ' ASP . 58.2 pttt -150.88 151.74 32.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.879 0.371 . . . . 0.0 111.756 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.525 ' HG3' ' H ' ' A' ' 256' ' ' PHE . 28.1 tpt180 -168.93 -175.21 2.28 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -174.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.525 ' H ' ' HG3' ' A' ' 255' ' ' ARG . 91.9 m-85 90.47 -39.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.356 1.062 . . . . 0.0 113.67 172.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 133.43 -132.13 6.37 Favored Glycine 0 C--N 1.313 -0.695 0 C-N-CA 119.326 -1.416 . . . . 0.0 113.234 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.7 m 38.18 48.26 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.933 0.893 . . . . 0.0 111.389 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 260' ' ' ASP . 33.6 tt0 66.94 -84.8 0.03 OUTLIER 'General case' 0 C--O 1.235 0.329 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.334 -174.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.508 ' HB2' ' HD2' ' A' ' 254' ' ' LYS . 4.0 p30 174.2 151.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.112 0.565 . . . . 0.0 110.434 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.39 -171.76 31.03 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.933 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.2 p -79.81 168.74 18.89 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.604 0.362 . . . . 0.0 110.911 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . 0.415 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 94.0 t -61.94 -49.56 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.785 0.326 . . . . 0.0 111.578 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -71.14 -41.33 70.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.129 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.27 95.6 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.389 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 270' ' ' VAL . 58.1 tp -61.8 -45.67 92.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.555 0.217 . . . . 0.0 111.117 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 263' ' ' VAL . 66.1 mtp180 -66.73 -41.41 87.93 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.573 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.602 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.91 -43.3 83.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.202 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -66.5 -39.81 88.89 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.705 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 266' ' ' LEU . 76.0 t -64.35 -42.35 95.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.938 176.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -57.56 -47.62 81.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.564 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 12.8 ptmt -66.99 -39.62 87.2 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -63.79 -41.03 98.01 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.987 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 98.7 mmm -64.43 -41.87 96.33 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.852 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.22 -34.92 75.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.762 0.315 . . . . 0.0 111.122 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -61.96 -43.09 99.58 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -67.07 -37.96 84.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.494 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.6 tp -61.96 -41.07 97.57 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.834 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -57.7 -46.12 84.77 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.654 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.3 m -63.65 -44.72 93.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.576 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.74 93.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.076 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.62 -43.94 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.24 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -62.53 -42.62 99.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.893 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -62.97 -41.34 99.52 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.104 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -60.26 -44.1 95.59 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.117 0.484 . . . . 0.0 110.327 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.0 t -70.02 -43.79 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.946 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.96 -47.39 86.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.299 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.9 p -62.25 -43.23 99.29 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.643 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -65.79 -42.49 90.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.842 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.615 ' O ' ' HG ' ' A' ' 294' ' ' LEU . . . -64.26 -45.62 87.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.044 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 295' ' ' VAL . 35.1 mm -63.98 -43.99 97.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.058 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.507 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 29.7 tp10 -60.52 -43.68 96.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.438 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.52 -40.3 98.6 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.278 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 290' ' ' ALA . 69.8 mt -63.38 -43.07 98.64 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.711 0.291 . . . . 0.0 111.155 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 291' ' ' ILE . 93.7 t -65.01 -44.8 95.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.941 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . 0.507 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.1 mttm -64.37 -39.8 94.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.326 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.97 95.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.921 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -137.93 102.27 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -90.02 107.38 19.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 8.7 tp -114.48 140.04 37.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.82 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -68.72 129.01 38.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.477 0.656 . . . . 0.0 110.05 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 94.0 t -99.56 135.54 20.58 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.687 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.74 132.81 53.86 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.498 2.132 . . . . 0.0 111.828 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.0 87.54 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.46 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.0 -41.74 83.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 111.537 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.2 -42.3 93.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.31 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.02 -44.58 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.817 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.09 -42.56 85.89 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.873 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.1 m -62.04 -44.64 96.27 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.055 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.487 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 74.0 mm-40 -69.37 -38.79 78.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.707 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.473 HD12 ' HG3' ' A' ' 334' ' ' ARG . 94.2 mt -62.19 -44.34 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -177.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.431 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 26.9 t70 -62.55 -43.1 99.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.037 0.446 . . . . 0.0 110.638 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.11 -43.31 95.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.293 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 95.8 mt -62.41 -41.81 98.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.037 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 85.3 mtm180 -63.72 -42.25 97.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -64.34 -41.14 96.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.554 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -63.46 -40.92 98.4 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.004 0.431 . . . . 0.0 110.603 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.42 91.76 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.223 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . . . -64.92 -37.09 86.48 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.799 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . 0.43 ' NE2' ' HG3' ' B' ' 45' ' ' ARG . 47.1 tt0 -60.64 -39.39 88.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.77 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -89.74 2.29 55.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.693 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -99.0 -2.95 36.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.342 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' B' ' 54' ' ' VAL . . . 139.98 -1.55 2.26 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.567 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 91.71 29.13 12.37 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.461 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 43.7 t-20 -72.39 124.04 24.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 0.6 OUTLIER -119.61 153.45 35.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 0.1 OUTLIER 61.37 -30.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 126.03 1.732 . . . . 0.0 114.608 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.503 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 15.9 mm100 -79.8 -5.31 55.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.301 0.572 . . . . 0.0 110.38 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.58 -18.39 63.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.38 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.92 -37.93 86.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.503 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.83 -20.13 65.13 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.853 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 81.6 mt -62.02 147.03 91.01 Favored Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.275 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.443 ' O ' ' HD1' ' A' ' 337' ' ' PHE . 32.5 Cg_exo -61.04 142.08 96.22 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.804 2.336 . . . . 0.0 112.82 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.473 ' HG3' HD12 ' A' ' 311' ' ' ILE . 21.4 ttt180 -84.49 -41.07 16.93 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.836 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -60.14 -39.48 86.48 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.05 -2.88 58.73 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.444 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.443 ' HD1' ' O ' ' A' ' 333' ' ' PRO . 60.2 m-85 -109.83 -21.33 12.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.132 0.491 . . . . 0.0 109.875 173.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.74 -29.22 67.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.08 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -60.8 -47.44 86.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 110.639 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -78.42 -22.88 47.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.598 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -62.68 -41.77 99.27 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.197 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.499 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.8 tttt -59.73 -48.29 82.26 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.551 ' O ' HG21 ' A' ' 347' ' ' VAL . 13.4 mmt85 -61.25 -45.32 95.0 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.038 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.406 HH21 ' HD3' ' A' ' 344' ' ' ARG . 67.7 mtt-85 -65.89 -38.94 90.1 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 341' ' ' ALA . 97.4 t -66.63 -43.23 90.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.031 0.444 . . . . 0.0 109.998 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 342' ' ' LYS . 59.7 t -60.24 -43.48 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.566 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 343' ' ' ARG . 71.0 t -59.51 -45.09 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.32 -43.89 98.44 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.032 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.97 -42.77 97.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.557 0.218 . . . . 0.0 111.437 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.9 mt -62.75 -45.92 90.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.94 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.12 -38.91 82.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.241 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.57 97.07 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.146 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.78 -35.05 79.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.886 0.374 . . . . 0.0 110.837 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.62 -43.69 95.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.93 -44.89 99.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.899 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -69.48 -46.28 67.0 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.0 m -63.31 -44.18 95.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -97.11 5.71 49.78 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.059 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 52.83 53.19 12.51 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.846 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.91 145.57 32.59 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.7 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.25 148.26 44.54 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.765 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.88 127.54 32.91 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.5 ' O ' HG21 ' A' ' 367' ' ' VAL . 25.2 t70 -96.9 110.68 23.14 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.784 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -59.23 -34.6 72.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.775 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.447 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 46.7 mm-40 -67.05 -40.93 87.21 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.12 0.486 . . . . 0.0 110.591 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -63.4 -38.97 93.19 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 363' ' ' ASP . 93.6 t -62.51 -41.03 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.087 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 372' ' ' GLU . 25.9 mmmt -55.34 -45.15 76.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.066 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.16 -41.31 99.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.399 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.93 -42.66 99.87 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.09 0.471 . . . . 0.0 110.38 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.79 -44.04 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.738 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 368' ' ' LYS . 47.5 mt-10 -64.87 -40.26 94.85 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.718 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.91 -38.35 86.05 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.491 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 57.6 ttm -65.49 -41.49 93.2 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.076 0.465 . . . . 0.0 110.34 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -63.23 -26.3 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.844 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.8 m -72.35 -6.77 45.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.29 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -92.09 1.25 57.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.913 0.387 . . . . 0.0 110.789 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -119.87 172.59 7.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.23 -46.2 78.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.758 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -120.97 108.82 36.21 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.958 0.409 . . . . 0.0 110.576 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.404 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 51.8 Cg_exo -56.55 -39.41 91.53 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.91 2.406 . . . . 0.0 113.233 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.84 -43.84 91.72 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.88 -37.78 88.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.451 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.45 -42.73 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.217 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.48 -44.92 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.212 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.14 -38.6 78.9 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.265 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -58.97 -46.52 87.88 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.936 0.398 . . . . 0.0 110.355 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 4.6 t80 -68.65 -44.22 74.6 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.527 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.9 p -73.45 -17.32 61.26 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -176.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.12 4.14 54.51 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.108 0.48 . . . . 0.0 111.076 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.407 ' O ' ' HG3' ' A' ' 395' ' ' MET . 16.2 t-20 -122.51 111.45 16.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.033 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -61.39 -42.08 98.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -58.56 -48.89 79.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.776 0.322 . . . . 0.0 110.636 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.27 -40.44 97.4 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.492 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.441 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 95.9 mtp -61.72 -48.86 78.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.712 0.292 . . . . 0.0 111.62 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.51 -37.65 74.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 -175.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -62.25 -44.06 97.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.203 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.477 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 51.6 tpp -66.29 -39.74 89.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.146 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 395' ' ' MET . 55.7 mtm180 -64.17 -35.96 82.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.797 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -61.74 -43.84 98.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.001 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.2 -44.48 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.912 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.72 -40.48 97.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.903 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 45.9 tp -64.47 -37.74 88.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.462 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.84 -44.27 90.92 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.165 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -65.96 -37.0 84.88 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.595 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -60.06 -42.25 94.11 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.47 82.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.926 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 85.1 t -63.55 -46.41 95.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.02 -33.06 74.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.383 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.93 96.08 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 110.569 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 93.7 t -65.16 -42.23 93.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.314 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 95.5 mt -60.49 -40.16 90.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.643 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.58 -22.61 66.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.352 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -94.39 -40.44 9.93 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.919 0.39 . . . . 0.0 111.423 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -80.36 177.99 8.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.372 0.606 . . . . 0.0 112.36 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -87.25 118.23 26.54 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.362 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.1 t -103.36 105.95 19.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.1 t -105.13 134.72 47.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.975 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.19 111.57 23.25 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.757 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -117.79 128.13 54.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.992 0.425 . . . . 0.0 110.893 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -72.06 147.43 46.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.167 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -157.13 169.64 24.32 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 120.834 0.35 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 29.6 p -91.29 165.34 13.49 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.339 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -66.35 -30.34 70.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.479 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -62.46 -38.27 89.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.862 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.57 -33.5 75.81 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.08 0.466 . . . . 0.0 110.364 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 11.2 mp -72.43 -21.34 61.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.9 mmt -73.46 -6.65 47.7 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.031 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -78.79 71.69 5.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -102.49 17.42 23.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.268 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -64.17 -39.79 94.75 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.441 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.218 178.823 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 120.95 0.405 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.14 134.67 56.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.193 0.52 . . . . 0.0 111.711 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.02 159.76 42.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.27 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 40.2 t -115.85 107.73 15.4 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.998 0.428 . . . . 0.0 110.582 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.83 139.88 21.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.137 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -122.15 154.45 37.4 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.974 0.416 . . . . 0.0 111.137 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 61.5 m -104.35 119.79 39.74 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.912 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.8 m -70.67 -66.09 0.65 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.039 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -179.46 131.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.577 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.22 -106.37 1.65 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.507 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.445 ' HG ' ' CG1' ' B' ' 111' ' ' VAL . 2.5 mp -96.99 -14.5 21.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.687 0.28 . . . . 0.0 110.364 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.1 132.62 19.35 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.552 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.9 143.83 47.16 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 122.703 0.401 . . . . 0.0 109.997 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -117.9 133.94 55.44 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 19.8 t -81.04 -93.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.1 m 55.58 90.35 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.27 0.557 . . . . 0.0 110.679 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.1 tp -106.59 133.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.075 0.464 . . . . 0.0 111.921 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 25.5 p -81.76 132.09 35.28 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.824 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.415 HD11 HD13 ' B' ' 24' ' ' ILE . 1.8 pp -128.58 164.76 29.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.653 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -111.12 156.6 21.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.14 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.25 -52.87 57.61 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -173.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -71.05 -34.14 70.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.907 0.384 . . . . 0.0 110.963 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 33.4 t -64.87 -29.1 70.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.443 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.653 HG13 ' O ' ' B' ' 20' ' ' ALA . 64.9 mt -63.25 -71.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.29 0.567 . . . . 0.0 111.302 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.483 ' CD ' ' HZ2' ' B' ' 29' ' ' LYS . 4.4 tp10 -64.35 -42.72 96.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.646 -172.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 18.1 m -63.1 -47.43 82.87 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.06 -44.3 15.33 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -174.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 81.4 t -62.44 -44.66 99.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.55 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.483 ' HZ2' ' CD ' ' B' ' 25' ' ' GLU . 17.4 ttmm -61.71 -47.16 86.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.706 0.289 . . . . 0.0 111.036 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 21.8 m -61.75 -42.42 98.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.467 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.411 ' O ' HG22 ' B' ' 35' ' ' VAL . 13.6 tp10 -65.25 -40.99 94.72 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.868 0.366 . . . . 0.0 110.562 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 96.2 mt -63.71 -44.07 94.7 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.67 -37.2 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.74 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.16 -40.49 97.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.288 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.411 HG22 ' O ' ' B' ' 31' ' ' GLU . 83.9 t -64.05 -44.07 97.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.794 0.331 . . . . 0.0 110.511 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -46.37 89.97 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.855 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.74 -33.99 76.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.088 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.83 -43.84 90.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.854 0.359 . . . . 0.0 110.448 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 t -84.84 -4.7 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.289 0.566 . . . . 0.0 110.314 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 61.98 28.53 17.33 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.499 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -105.04 5.77 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.974 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -65.06 -28.61 69.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.264 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.2 -19.26 72.03 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.273 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -76.24 -17.55 59.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.43 ' HG3' ' NE2' ' A' ' 320' ' ' GLN . 71.5 ttt-85 -87.15 93.54 9.4 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.115 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.473 ' HZ2' ' HB3' ' B' ' 46' ' ' LYS . 1.2 ptpm? -69.37 115.85 9.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 173.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.94 70.74 0.49 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 -170.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.19 -44.56 83.63 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.61 105.96 26.64 Favored Pre-proline 0 N--CA 1.439 -1.005 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.125 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.473 ' HB2' ' OD1' ' B' ' 52' ' ' ASN . 14.0 Cg_endo -58.44 145.74 93.07 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.198 1.932 . . . . 0.0 111.396 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.413 ' O ' HG11 ' B' ' 54' ' ' VAL . 19.4 ttt -63.47 -38.84 92.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.151 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . 0.473 ' OD1' ' HB2' ' B' ' 50' ' ' PRO . 21.8 p-10 -62.02 -43.25 99.23 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.899 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.474 HG12 HH21 ' A' ' 193' ' ' ARG . 1.8 mp -68.5 -44.64 82.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.416 HG23 ' HA2' ' A' ' 323' ' ' GLY . 4.3 p -63.89 -37.35 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.502 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.49 87.41 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.341 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -84.27 -33.66 23.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -62.53 -42.82 99.77 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.982 0.42 . . . . 0.0 110.946 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.6 18.21 21.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.412 0.625 . . . . 0.0 110.805 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' B' ' 61' ' ' SER . . . -64.43 145.68 49.74 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.426 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 72.75 -33.98 0.28 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.458 0.703 . . . . 0.0 112.263 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' SER . . . . . 0.408 ' H ' ' C ' ' B' ' 59' ' ' GLY . 38.7 t -61.63 -47.27 86.17 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.68 21.34 5.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 122.079 0.943 . . . . 0.0 109.899 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -63.27 -21.3 66.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.035 -177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -64.02 -47.06 81.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.774 0.321 . . . . 0.0 110.807 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.94 -23.86 55.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.268 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.74 -42.16 94.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.0 -38.47 88.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.17 -41.71 98.3 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.637 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . 0.553 ' OD1' ' HE2' ' A' ' 327' ' ' LYS . 21.1 t70 -60.23 -46.92 88.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.22 -42.91 99.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.409 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 61.0 ttp -63.03 -43.09 99.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.174 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -62.17 -43.8 98.02 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.256 0.551 . . . . 0.0 110.807 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.401 ' NH1' HG21 ' B' ' 35' ' ' VAL . 71.5 mtp180 -64.78 -40.61 95.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.314 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -63.85 -40.8 97.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.898 0.38 . . . . 0.0 110.473 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -61.09 -48.98 79.19 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.099 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.46 ' O ' HG13 ' B' ' 79' ' ' ILE . 15.5 tt -68.74 -41.25 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.39 -38.0 89.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.212 0.529 . . . . 0.0 110.072 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.66 -47.22 84.65 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.092 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.46 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.8 pp -66.69 -29.55 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.865 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.5 mt -65.46 -43.95 94.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.782 0.325 . . . . 0.0 111.07 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -81.31 -33.06 32.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -80.18 -7.91 59.17 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.064 0.459 . . . . 0.0 110.388 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt 66.93 38.08 3.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.262 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.9 mt -101.19 121.44 52.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.473 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -107.54 102.72 45.85 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.835 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.71 146.79 38.98 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 122.376 2.051 . . . . 0.0 112.085 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.35 100.63 12.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.609 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.59 -118.11 6.45 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.012 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.27 130.65 23.44 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-O 120.544 0.212 . . . . 0.0 110.883 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . 0.426 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 73.1 Cg_endo -75.25 161.6 37.78 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.982 2.455 . . . . 0.0 111.984 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -77.98 117.71 19.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.127 0.489 . . . . 0.0 111.899 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.426 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 81.6 m-85 -112.22 122.0 46.49 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 52.7 t -120.89 99.89 46.61 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-O 120.878 0.37 . . . . 0.0 110.713 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -89.66 145.24 4.72 Favored 'Trans proline' 0 N--CA 1.438 -1.791 0 C-N-CA 122.412 2.074 . . . . 0.0 111.213 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.14 174.92 40.92 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.326 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.63 126.42 29.29 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -81.27 125.19 30.03 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.023 0.44 . . . . 0.0 110.352 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -112.95 112.46 23.94 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.036 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 48.5 tp -65.43 107.11 1.56 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.047 0.451 . . . . 0.0 110.105 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.73 -16.32 8.37 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.257 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.37 -179.74 4.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.957 0.408 . . . . 0.0 111.629 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.8 138.52 37.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.744 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -96.11 143.1 27.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.473 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 45.4 m -124.92 134.67 52.57 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -140.68 155.7 46.42 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.392 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 3.0 m -84.66 -86.06 0.13 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 84.0 t 67.86 108.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.992 0.517 . . . . 0.0 110.692 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -111.51 138.69 47.71 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.639 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -152.81 -75.13 0.13 Allowed 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -142.43 157.2 45.03 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.798 -0.564 . . . . 0.0 111.32 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.445 ' CG1' ' HG ' ' B' ' 11' ' ' LEU . 27.5 m -129.94 -175.2 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 121.351 0.596 . . . . 0.0 112.342 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -138.16 119.32 10.37 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.01 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.72 148.54 32.71 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.019 2.479 . . . . 0.0 114.583 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -138.74 142.25 38.87 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.38 133.21 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -103.0 -92.25 0.34 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.451 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.4 mt 64.13 133.79 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.898 0.879 . . . . 0.0 113.337 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -141.83 152.47 43.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.469 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.2 19.42 78.47 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.465 175.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 75.3 mt -63.62 -37.2 86.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.986 0.422 . . . . 0.0 111.352 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' B' ' 121' ' ' GLU . 1.6 mp0 -72.64 -12.91 61.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.593 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.44 18.0 18.89 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.878 0.37 . . . . 0.0 111.37 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 83.6 mt -92.66 122.23 43.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -104.37 133.11 49.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.45 136.0 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 112.027 -172.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -87.21 139.21 30.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.915 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -134.3 99.88 13.07 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.8 137.18 37.68 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.968 1.779 . . . . 0.0 111.492 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.72 123.66 69.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.848 0.356 . . . . 0.0 110.349 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.14 162.86 39.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.233 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -145.24 159.16 43.44 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.815 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.46 118.0 28.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 69.9 p -101.03 174.96 5.77 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.991 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.45 -31.81 72.59 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.657 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.13 99.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.481 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -65.08 -44.61 88.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.274 0.559 . . . . 0.0 110.268 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.435 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.4 t -63.8 -46.91 93.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.723 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -64.12 -42.71 96.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.646 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.75 -39.96 95.49 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.095 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' MET . . . . . 0.554 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.0 OUTLIER -62.68 -42.97 99.91 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 94.4 mt -63.63 -41.13 98.29 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.842 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -59.23 -48.72 80.56 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.68 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.9 m -61.8 -40.55 95.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.63 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.1 mt -61.04 -41.76 97.19 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.457 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -74.02 -18.05 60.9 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.467 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.5 -8.66 59.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.256 0.551 . . . . 0.0 110.394 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -95.83 4.61 52.7 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.342 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -119.07 75.33 1.03 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.754 0.788 . . . . 0.0 112.052 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -157.31 74.66 0.78 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.424 HG23 ' H ' ' B' ' 151' ' ' TRP . 4.9 m -145.83 171.86 14.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.102 -172.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . 0.424 ' H ' HG23 ' B' ' 150' ' ' THR . 44.8 t-105 82.02 10.68 0.73 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.79 1.236 . . . . 0.0 112.393 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.507 ' HG2' ' HB2' ' B' ' 245' ' ' LEU . 6.1 mptp? -94.3 158.16 15.71 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.048 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.27 -1.56 58.1 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -141.05 156.32 46.03 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 120.444 -0.503 . . . . 0.0 112.02 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 4.6 t70 82.98 178.08 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.065 1.346 . . . . 0.0 111.136 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.0 89.62 0.26 Allowed Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 119.403 -1.379 . . . . 0.0 115.134 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . 0.458 ' HB2' ' HG3' ' B' ' 244' ' ' GLU . . . -103.38 -59.92 1.64 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 58.5 t 62.6 125.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.872 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -101.06 160.16 14.62 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.963 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.86 86.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.45 -4.38 42.19 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.79 143.48 32.82 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -96.82 121.23 38.45 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 49.5 t -119.53 129.46 75.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.773 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 25.5 m -76.42 104.28 6.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 77.1 mt -117.27 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.869 0.366 . . . . 0.0 111.582 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -99.04 91.9 5.24 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -110.78 154.17 24.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 111.462 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 38.8 m -124.72 129.54 50.68 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.646 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.35 127.38 9.17 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.84 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 27.2 m -143.26 124.61 14.67 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.93 -78.22 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.609 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -133.41 81.03 1.91 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.101 0.477 . . . . 0.0 111.423 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.3 2.72 80.25 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.247 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -140.82 149.7 42.37 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 117.043 0.422 . . . . 0.0 110.874 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -89.16 150.18 22.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.9 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -115.74 177.14 4.78 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.164 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -57.28 -40.43 77.75 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.892 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -102.2 -173.28 27.45 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.061 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.14 30.53 46.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.785 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -106.82 107.47 18.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -126.6 141.64 51.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.071 0.462 . . . . 0.0 111.957 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 50.0 m -149.34 130.44 14.45 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 57.08 31.33 19.77 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.594 0.559 . . . . 0.0 110.6 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -96.06 124.25 39.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.561 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 5.7 m -91.78 117.2 34.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.535 0.683 . . . . 0.0 110.645 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 53.2 tp -110.91 131.74 54.79 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.619 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . 0.661 ' HB2' ' NH1' ' B' ' 193' ' ' ARG . . . -121.42 137.39 54.73 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 71.1 mtm -103.65 179.14 4.36 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.153 0.501 . . . . 0.0 112.002 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.46 -20.36 44.65 Favored Glycine 0 CA--C 1.503 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.009 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -91.25 -13.69 32.29 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.767 0.317 . . . . 0.0 111.248 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.72 40.58 10.62 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.095 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.661 ' NH1' ' HB2' ' B' ' 188' ' ' ALA . 51.8 mtm180 -94.47 0.52 55.42 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.432 0.634 . . . . 0.0 110.962 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.426 ' HB2' ' HG3' ' B' ' 199' ' ' GLU . 0.0 OUTLIER -129.26 165.73 20.82 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.389 173.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.543 HD11 ' H ' ' B' ' 195' ' ' ILE . 4.5 mp -61.23 136.59 94.07 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.71 133.67 51.06 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 121.957 1.771 . . . . 0.0 111.434 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.13 -39.01 2.88 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.193 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . 0.522 ' O ' HG12 ' B' ' 202' ' ' ILE . 52.1 t80 -62.35 -48.69 78.69 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' B' ' 194' ' ' MET . 93.0 mt-10 -67.0 -36.44 82.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.283 0.563 . . . . 0.0 110.416 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.76 -35.71 81.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.218 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.38 -7.95 71.87 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.838 -0.696 . . . . 0.0 114.324 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.522 HG12 ' O ' ' B' ' 198' ' ' PHE . 48.1 mm -64.96 -44.23 96.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 117.57 0.685 . . . . 0.0 110.984 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -60.01 133.62 56.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.087 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.26 -15.04 51.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.179 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -84.24 141.18 31.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.26 0.552 . . . . 0.0 111.905 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -90.94 161.32 15.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.889 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.83 130.1 42.77 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' B' ' 237' ' ' LEU . . . 69.98 34.27 70.81 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.498 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -113.65 114.05 25.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.251 0.548 . . . . 0.0 111.59 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -91.24 137.35 32.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -156.48 -27.34 0.1 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 28.0 m 77.48 135.59 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.906 0.482 . . . . 0.0 110.988 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -106.58 -40.3 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 68.26 96.41 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.242 0.544 . . . . 0.0 112.364 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 66.4 t -119.25 135.71 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.071 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 6.5 m -93.78 -23.08 18.31 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.462 ' CE2' HG12 ' B' ' 195' ' ' ILE . 95.2 m-85 71.81 142.93 0.09 OUTLIER Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 122.892 0.477 . . . . 0.0 111.992 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.42 153.58 60.91 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.737 2.291 . . . . 0.0 111.899 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.29 -40.77 94.27 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.867 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -84.81 29.73 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.318 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -68.6 133.25 48.23 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.945 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -57.63 -40.65 79.67 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.61 101.24 8.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.34 -32.38 71.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.793 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -67.52 -14.24 62.76 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 94.7 mt -119.21 3.29 11.39 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -73.76 125.45 28.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 119.736 -0.785 . . . . 0.0 112.372 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.95 16.04 76.41 Favored Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.283 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -125.44 128.88 48.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.59 0.695 . . . . 0.0 111.244 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.94 150.53 30.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.59 137.22 35.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.614 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -68.53 -48.31 64.66 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 54.39 91.93 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.165 0.507 . . . . 0.0 111.266 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.81 92.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mm 70.38 90.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 122.869 0.468 . . . . 0.0 111.249 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.65 -48.19 67.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.322 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . 0.52 ' O ' ' HA2' ' B' ' 208' ' ' GLY . 8.1 tp 57.42 110.49 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.987 0.915 . . . . 0.0 112.917 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -105.36 -75.59 0.62 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 34.3 mmtp -77.86 -83.76 0.08 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.444 HG13 ' H ' ' B' ' 242' ' ' GLU . 86.2 t 74.51 139.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.368 0.604 . . . . 0.0 111.288 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.518 ' HB3' ' NH1' ' B' ' 243' ' ' ARG . 56.3 mm-40 -63.48 -40.15 96.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.206 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.444 ' H ' HG13 ' B' ' 240' ' ' VAL . 31.1 mt-10 66.76 129.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.303 0.641 . . . . 0.0 111.809 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.518 ' NH1' ' HB3' ' B' ' 241' ' ' GLU . 5.6 ptp180 174.44 109.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.054 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.511 ' CG ' ' H ' ' B' ' 245' ' ' LEU . 2.4 tt0 -137.03 -150.88 0.38 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.511 ' H ' ' CG ' ' B' ' 244' ' ' GLU . 10.0 mp 69.16 145.76 0.11 Allowed Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 123.538 0.735 . . . . 0.0 112.714 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . 0.553 ' O ' ' HG2' ' B' ' 247' ' ' GLU . 84.5 Cg_endo -83.28 -158.79 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.059 2.506 . . . . 0.0 112.47 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' B' ' 246' ' ' PRO . 4.0 pt-20 85.68 -176.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.934 1.694 . . . . 0.0 111.004 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.13 136.0 49.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.124 0.487 . . . . 0.0 111.824 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 20.0 p -89.78 -170.14 2.7 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.213 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.61 -52.85 62.41 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.015 0.436 . . . . 0.0 110.017 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -131.09 92.18 3.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.482 0.658 . . . . 0.0 109.241 173.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -70.63 -13.64 62.16 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.563 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 4.0 mp -63.3 -44.51 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.493 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . 0.529 ' HD2' ' HB2' ' B' ' 260' ' ' ASP . 54.9 pttt -149.84 150.84 32.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 111.459 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . 0.543 ' HG3' ' H ' ' B' ' 256' ' ' PHE . 27.5 tpt180 -166.02 -174.61 3.05 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -175.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . 0.543 ' H ' ' HG3' ' B' ' 255' ' ' ARG . 94.1 m-85 88.85 -41.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.463 1.105 . . . . 0.0 113.395 172.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 133.51 -129.86 5.5 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.304 -1.427 . . . . 0.0 113.183 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 26.8 m 37.85 49.58 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.669 0.788 . . . . 0.0 111.458 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' B' ' 260' ' ' ASP . 34.9 tt0 67.68 -85.17 0.03 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.518 -175.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . 0.529 ' HB2' ' HD2' ' B' ' 254' ' ' LYS . 2.6 p30 174.26 150.34 0.09 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.276 0.63 . . . . 0.0 109.959 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.5 -177.89 37.5 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.098 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 22.9 p -75.38 167.29 22.19 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 122.79 0.436 . . . . 0.0 110.859 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . 0.519 ' O ' ' HG3' ' B' ' 267' ' ' ARG . 99.4 t -61.93 -48.89 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -70.82 -40.3 72.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.769 0.319 . . . . 0.0 111.021 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -67.34 -40.69 91.77 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.407 ' O ' HG23 ' B' ' 270' ' ' VAL . 51.2 tp -61.78 -46.07 91.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.614 0.245 . . . . 0.0 110.961 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . 0.519 ' HG3' ' O ' ' B' ' 263' ' ' VAL . 44.8 mtp180 -66.17 -40.39 90.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.402 -177.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.54 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -68.34 -42.57 79.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.295 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -67.0 -40.15 87.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.646 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.1 t -64.35 -41.87 93.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -56.97 -47.82 79.83 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.47 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 16.2 ptmt -67.48 -38.6 84.63 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -63.67 -41.45 98.18 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.927 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.9 mmm -65.11 -42.42 93.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.973 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.19 -35.76 78.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.873 0.368 . . . . 0.0 110.973 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -63.3 -42.81 99.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -65.94 -38.64 89.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.491 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.78 -40.77 96.36 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.699 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -57.29 -48.61 78.48 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.164 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.3 m -62.9 -44.26 96.57 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.776 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.75 95.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.067 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.58 -44.25 98.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 120.969 0.414 . . . . 0.0 110.347 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -62.15 -42.53 99.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.88 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -62.9 -41.35 99.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 110.916 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -60.96 -43.92 98.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.479 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 94.9 t -69.49 -43.85 80.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.926 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . 0.406 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.1 tttt -61.12 -46.81 89.05 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.145 -176.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 75.4 p -62.04 -43.36 99.01 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -64.88 -43.73 91.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.779 0.323 . . . . 0.0 110.685 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . 0.661 ' O ' ' HG ' ' B' ' 294' ' ' LEU . . . -63.45 -46.84 84.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.076 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . 0.406 HG12 ' O ' ' B' ' 287' ' ' LYS . 38.1 mm -64.04 -44.16 97.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.646 0.26 . . . . 0.0 110.648 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . 0.492 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 32.8 tp10 -60.22 -42.61 95.53 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.352 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.91 99.16 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.382 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' B' ' 290' ' ' ALA . 65.6 mt -63.5 -42.53 98.5 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.552 0.215 . . . . 0.0 111.413 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.92 -44.57 96.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.957 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.492 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 67.8 mttm -63.78 -39.57 94.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.073 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -65.09 -40.76 95.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.125 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -137.06 100.86 4.39 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.05 98.81 11.98 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 8.6 tp -104.64 142.6 17.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.193 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.21 135.7 54.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.097 0.475 . . . . 0.0 109.799 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 90.3 t -109.88 132.91 21.14 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.37 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.58 132.27 51.1 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.421 2.081 . . . . 0.0 111.885 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.06 86.57 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.404 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.58 82.01 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.882 0.372 . . . . 0.0 111.399 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.29 -41.87 93.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.437 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . 0.405 ' O ' HG13 ' B' ' 311' ' ' ILE . 65.3 mt -65.12 -44.55 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.947 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -43.82 82.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.016 0.436 . . . . 0.0 110.958 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 31.8 m -61.56 -44.43 97.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.125 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . 0.53 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 52.0 mm-40 -68.29 -39.05 82.23 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.882 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.2 mt -62.29 -44.39 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.429 -177.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.44 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 20.3 t70 -62.38 -43.13 99.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.011 0.434 . . . . 0.0 110.872 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 91.5 t -64.88 -43.47 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.252 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 95.0 mt -62.24 -40.43 96.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 85.9 mtm180 -63.34 -40.94 98.68 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -63.83 -39.93 95.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.717 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -63.02 -40.16 96.92 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.278 0.561 . . . . 0.0 109.914 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 -42.99 81.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.29 -37.35 86.88 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.333 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . 0.429 ' NE2' ' HG3' ' A' ' 45' ' ' ARG . 48.3 tt0 -62.43 -39.6 93.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.139 0.495 . . . . 0.0 110.431 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -86.99 -0.62 56.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.59 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -97.57 -2.41 41.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.166 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . 0.434 ' HA2' HG23 ' A' ' 54' ' ' VAL . . . 140.01 -6.51 2.86 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.608 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 95.22 29.16 9.15 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.71 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 43.5 t-20 -72.38 123.33 22.83 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 0.7 OUTLIER -116.72 152.71 33.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 0.1 OUTLIER 62.06 -34.3 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.832 1.653 . . . . 0.0 114.773 177.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . 0.472 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.9 mm100 -76.72 -5.62 48.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.259 0.552 . . . . 0.0 110.454 177.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -66.23 -13.76 60.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.273 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.99 -35.97 81.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.417 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -66.86 -24.55 66.15 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.707 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.45 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 72.3 mt -58.2 142.43 80.84 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.707 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . 0.478 ' O ' ' HD1' ' B' ' 337' ' ' PHE . 36.5 Cg_exo -60.86 137.62 73.73 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.287 2.658 . . . . 0.0 113.778 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . 0.405 HH21 ' HD2' ' B' ' 334' ' ' ARG . 26.7 ttt85 -74.14 -43.42 57.52 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.143 177.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.1 -37.42 85.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -170.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 71.5 mt -87.01 -3.57 59.1 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.524 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . 0.478 ' HD1' ' O ' ' B' ' 333' ' ' PRO . 56.5 m-85 -108.48 -22.09 12.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.084 0.468 . . . . 0.0 110.34 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.55 -29.1 67.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.33 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.66 -46.93 87.64 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.826 0.346 . . . . 0.0 110.814 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -76.72 -25.43 53.53 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.33 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . 0.41 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.97 -42.09 99.73 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.469 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . 0.5 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.1 tttt -59.55 -47.09 86.9 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . 0.524 ' O ' HG21 ' B' ' 347' ' ' VAL . 13.7 mmt85 -61.87 -45.3 94.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.201 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -66.6 -37.85 85.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' 341' ' ' ALA . 96.0 t -65.2 -43.71 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.5 HG23 ' O ' ' B' ' 342' ' ' LYS . 71.1 t -60.78 -43.52 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.661 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . 0.524 HG21 ' O ' ' B' ' 343' ' ' ARG . 75.1 t -59.23 -45.31 93.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.3 -43.92 98.4 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.069 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.83 -43.0 97.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.62 0.248 . . . . 0.0 111.448 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 346' ' ' VAL . 97.0 mt -62.76 -46.26 88.87 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.895 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.39 -39.14 85.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.186 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.74 -42.15 97.85 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.357 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.26 -34.32 77.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.942 0.371 . . . . 0.0 110.923 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.2 -43.43 93.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.29 -44.51 99.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.748 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -70.64 -45.91 64.28 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 96.2 m -63.68 -45.0 92.09 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -95.23 4.17 53.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.245 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 53.48 54.19 10.46 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.95 0.5 . . . . 0.0 112.019 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.97 147.85 27.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.427 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.45 149.51 45.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.63 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.79 128.2 35.81 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . 0.5 ' O ' HG21 ' B' ' 367' ' ' VAL . 15.6 t70 -95.9 111.25 23.29 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.403 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 52.9 mm-40 -61.64 -33.26 73.63 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.814 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . 0.413 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 68.3 mm-40 -66.99 -40.26 87.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.937 0.399 . . . . 0.0 110.366 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -64.14 -38.19 90.18 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.664 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . 0.5 HG21 ' O ' ' B' ' 363' ' ' ASP . 97.8 t -61.82 -41.16 89.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.788 176.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.8 mmmt -56.56 -44.26 80.79 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.269 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.8 -41.53 99.63 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.245 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.2 -42.8 99.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.808 0.337 . . . . 0.0 110.252 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.55 -44.43 96.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.775 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.38 -42.79 98.84 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.763 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.89 -38.32 86.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.988 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 58.6 ttm -65.79 -40.91 92.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.972 0.415 . . . . 0.0 110.289 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.0 -26.59 68.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.69 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.2 m -71.89 -7.17 46.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.031 0.443 . . . . 0.0 111.229 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.0 -0.27 57.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.711 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -118.23 173.56 6.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.802 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.16 -45.89 83.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.979 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . 0.499 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 21.4 t70 -122.54 109.37 32.77 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 121.017 0.437 . . . . 0.0 110.663 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.01 -41.36 77.82 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.692 2.262 . . . . 0.0 113.132 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' B' ' 382' ' ' LYS . 32.1 mmtp -65.75 -41.99 91.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 15.9 pt-20 -62.47 -39.07 92.25 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.029 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.19 -42.64 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.784 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.17 -44.53 99.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.28 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.46 -39.26 77.85 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.826 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.95 -42.12 84.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.248 0.547 . . . . 0.0 110.018 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . 0.493 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 5.0 t80 -73.75 -41.72 62.11 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.005 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 31.3 p -80.33 -7.85 59.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.88 4.9 45.36 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.368 0.604 . . . . 0.0 110.721 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -124.47 112.65 17.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.857 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.56 -41.11 96.89 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -60.23 -48.91 79.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.631 0.253 . . . . 0.0 111.199 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.45 -40.85 98.23 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.371 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.565 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 93.5 mtp -60.94 -48.16 83.08 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.352 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.03 -38.82 72.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.264 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.98 -42.86 99.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.5 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 398' ' ' MET . . . . . 0.493 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 53.7 tpp -65.31 -39.48 92.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.668 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' B' ' 395' ' ' MET . 70.2 mtm180 -64.1 -36.48 84.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.755 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.1 -44.05 97.49 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.19 -45.45 90.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.864 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.95 -40.79 98.72 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.932 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 46.9 tp -64.16 -38.08 89.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.647 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.39 -43.13 96.94 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.441 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -65.48 -38.01 88.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.424 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -59.27 -41.34 88.66 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 120.758 0.313 . . . . 0.0 110.327 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.442 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.8 -47.36 81.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.17 -45.66 95.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.948 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -65.65 -34.54 78.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.117 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.03 -40.18 94.45 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.923 0.392 . . . . 0.0 110.638 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 407' ' ' ALA . 94.3 t -64.92 -42.29 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.338 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.67 -37.8 82.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.172 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -67.8 -14.94 63.37 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.913 0.387 . . . . 0.0 111.537 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -100.74 -37.89 8.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 110.86 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.65 175.66 9.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.156 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.47 113.98 22.16 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.094 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.9 t -99.22 107.86 21.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.039 0.447 . . . . 0.0 109.878 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -110.43 134.66 52.12 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -94.06 114.1 26.2 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.153 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -116.26 131.84 56.83 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.905 0.383 . . . . 0.0 110.598 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -76.92 147.63 36.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.229 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.0 t -157.58 165.83 34.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.61 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 26.7 p -86.73 166.51 15.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.967 0.413 . . . . 0.0 110.98 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -64.05 -28.61 69.9 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.8 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -62.41 -39.29 92.8 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.921 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.27 -33.94 76.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.029 0.442 . . . . 0.0 110.628 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.85 -31.09 69.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.686 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.5 mmt -65.6 -10.44 35.59 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.809 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -74.93 69.58 1.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.5 0.667 . . . . 0.0 109.21 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -100.77 17.88 20.88 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.519 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -63.99 -40.64 96.83 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.143 178.486 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 120.627 0.251 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -98.72 115.09 27.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.796 0.331 . . . . 0.0 110.555 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.55 135.34 62.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.044 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 p -115.63 145.84 42.34 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.799 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.9 -52.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 66.5 179.21 0.21 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.114 0.483 . . . . 0.0 110.862 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 m -136.72 128.58 29.17 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.235 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.6 m -76.59 -68.49 0.59 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.831 0.348 . . . . 0.0 110.743 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -177.42 128.62 0.15 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.085 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.45 -115.94 8.46 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.932 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.42 -7.83 57.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 106' ' ' SER . . . -68.64 126.69 21.99 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.541 -177.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -135.59 159.22 42.28 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 122.909 0.484 . . . . 0.0 110.055 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.429 ' HG3' ' CE2' ' A' ' 105' ' ' TYR . 58.7 ttp180 -131.65 149.36 52.52 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.0 -83.64 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.006 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 m 46.84 79.31 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.059 0.457 . . . . 0.0 111.184 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.4 tp -113.33 135.25 53.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.894 0.378 . . . . 0.0 111.261 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.5 m -101.9 124.24 47.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.111 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.8 pt -128.92 160.68 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.549 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -73.17 155.78 39.28 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.905 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.69 83.79 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -64.18 -39.21 93.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.205 0.526 . . . . 0.0 110.446 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -65.8 -40.33 91.8 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.69 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 20' ' ' ALA . 77.3 mt -61.24 -48.83 87.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.53 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.538 ' CD ' ' HZ3' ' A' ' 29' ' ' LYS . 4.3 tp10 -64.03 -50.87 66.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.647 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.0 m -68.68 -51.06 45.98 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.6 -49.19 22.59 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -173.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.7 t -64.21 -43.39 97.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.59 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HZ3' ' CD ' ' A' ' 25' ' ' GLU . 17.2 ttmm -58.98 -48.98 79.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.936 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -62.85 -42.14 99.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.266 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -66.62 -42.03 87.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.997 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.63 -42.86 99.83 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.89 -39.6 80.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.212 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -64.91 -42.0 95.11 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.5 m -67.05 -33.72 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.139 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.92 -41.12 95.82 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.087 0.47 . . . . 0.0 109.91 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.13 -29.57 69.33 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.37 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -58.75 -42.84 89.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.83 0.347 . . . . 0.0 110.593 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 t -92.27 -1.57 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.18 0.514 . . . . 0.0 110.241 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 61.62 29.72 18.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.844 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -101.51 5.56 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.914 0.388 . . . . 0.0 111.598 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -63.92 -31.24 72.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.601 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.68 -22.1 65.76 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.824 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -80.76 -6.11 58.04 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.584 ' HA ' ' NE2' ' B' ' 320' ' ' GLN . 22.7 ttt180 -97.46 90.57 5.1 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -92.59 76.43 5.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 169.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.69 105.65 3.12 Favored Glycine 0 N--CA 1.428 -1.841 0 CA-C-N 114.992 -1.003 . . . . 0.0 114.629 -172.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.523 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 88.4 tttt -64.46 -34.99 79.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 171.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.453 HG13 ' HB ' ' A' ' 54' ' ' VAL . 16.2 t -99.52 100.08 9.94 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.439 175.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 48' ' ' LYS . 17.2 Cg_exo -66.66 159.34 51.53 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.044 2.496 . . . . 0.0 112.495 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.508 ' HA ' HG12 ' A' ' 54' ' ' VAL . 45.7 mtt -60.05 -40.97 91.29 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.412 ' HB3' ' HZ2' ' A' ' 29' ' ' LYS . 14.1 p-10 -65.92 -21.04 66.41 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.17 -50.16 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.9 0.381 . . . . 0.0 110.928 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 51' ' ' MET . 12.6 p -67.46 -36.86 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.33 83.38 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -89.83 -1.71 58.05 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.571 -0.451 . . . . 0.0 112.212 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -101.33 -42.99 6.1 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 120.715 0.293 . . . . 0.0 111.556 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -97.49 5.1 50.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.469 0.652 . . . . 0.0 110.114 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.87 145.83 49.74 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.472 ' H ' ' HB2' ' A' ' 63' ' ' ARG . . . 72.52 -41.09 0.49 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.219 0.608 . . . . 0.0 111.699 -177.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 t -60.68 -46.62 89.65 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.856 0.462 . . . . 0.0 111.303 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 p -124.97 18.77 4.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.662 0.744 . . . . 0.0 110.045 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.472 ' HB2' ' H ' ' A' ' 60' ' ' ALA . 13.2 ttt180 -65.89 -20.24 66.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.393 -174.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.58 -48.53 77.03 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.3 -31.0 71.01 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.068 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.35 -43.34 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 99.3 mt -62.3 -39.72 93.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.77 97.7 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.446 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -62.69 -45.67 91.68 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 120.773 0.32 . . . . 0.0 110.984 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.64 -41.97 98.23 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.3 ttp -61.22 -46.06 91.97 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.965 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.2 m -63.37 -51.54 65.44 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.338 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -69.41 -38.21 77.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -65.37 -39.24 92.05 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.932 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.45 -47.17 87.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.46 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.409 ' HA ' HG12 ' A' ' 79' ' ' ILE . 15.6 tt -66.16 -38.63 82.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.25 -41.98 99.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.93 -45.33 89.74 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.435 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 76' ' ' ILE . 42.4 pt -65.74 -41.35 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.47 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.43 -42.11 95.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.472 0.653 . . . . 0.0 109.379 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -59.41 -47.85 83.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.273 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -89.82 -0.86 57.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.425 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 65.4 36.8 6.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.81 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 98.1 mt -86.64 124.62 40.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.603 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -110.15 98.18 33.89 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.576 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.94 141.75 59.68 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.531 2.154 . . . . 0.0 111.819 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.29 103.3 15.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.913 0.387 . . . . 0.0 110.538 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -127.72 8.88 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.897 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.66 128.44 25.62 Favored Pre-proline 0 C--N 1.318 -0.786 0 O-C-N 122.916 -0.167 . . . . 0.0 110.613 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.16 144.76 82.59 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.451 2.101 . . . . 0.0 111.542 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.7 m -102.46 109.04 20.56 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.6 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 94.9 m-85 -86.45 91.59 8.58 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.68 106.59 2.54 Favored Pre-proline 0 C--N 1.324 -0.532 0 O-C-N 123.546 0.529 . . . . 0.0 111.189 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 91.0 Cg_endo -97.94 166.87 0.77 Allowed 'Trans proline' 0 N--CA 1.43 -2.214 0 C-N-CA 123.026 2.484 . . . . 0.0 111.299 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.06 -136.11 6.7 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 174.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.93 130.44 51.26 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -80.8 106.37 12.75 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.246 0.546 . . . . 0.0 110.771 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -84.87 147.71 26.65 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.65 177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.6 tp -82.93 116.42 22.21 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.081 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.0 21.98 53.94 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.363 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -140.01 161.6 37.22 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.289 0.544 . . . . 0.0 109.793 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.97 142.79 54.58 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.853 0.359 . . . . 0.0 111.296 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -102.34 145.01 30.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.152 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.2 m -121.84 136.54 54.93 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.561 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 43.0 p90 -136.87 162.16 34.01 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.968 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.474 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 14.9 m -93.69 -69.9 0.73 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.2 p 49.28 101.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.179 0.99 . . . . 0.0 111.888 -173.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.32 113.98 23.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -172.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -156.27 145.8 20.84 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.858 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 65.97 143.64 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.4 m -129.4 157.44 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.842 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -165.11 100.79 0.8 Allowed Pre-proline 0 N--CA 1.466 0.372 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -88.23 158.91 6.95 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.973 2.449 . . . . 0.0 113.991 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -130.95 134.17 46.49 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -125.34 132.86 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -103.8 -78.92 0.55 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.549 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.6 mt 66.55 125.9 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.707 0.803 . . . . 0.0 112.964 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.22 155.47 47.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.4 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.11 9.56 86.5 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.04 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.22 -39.8 94.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.201 0.524 . . . . 0.0 110.885 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.2 -10.51 59.88 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.116 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.61 13.42 33.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.746 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 94.8 mt -81.76 125.49 39.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.24 0.543 . . . . 0.0 110.936 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.24 122.58 47.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.35 134.01 67.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.608 ' OE1' ' HE3' ' A' ' 420' ' ' LYS . 41.1 tt0 -82.13 146.93 29.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.499 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -135.2 91.86 18.71 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.47 113.97 3.5 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.237 1.958 . . . . 0.0 112.1 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.9 mm -97.19 112.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.74 155.91 18.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.129 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -129.93 145.31 51.62 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.304 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.12 123.46 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.882 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 64.0 p -107.81 175.59 5.43 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.583 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -67.38 -23.61 65.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.7 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.57 97.0 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.106 0.479 . . . . 0.0 109.95 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.41 -40.73 97.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.454 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.07 -45.24 99.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.703 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.24 -43.13 96.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.52 0.2 . . . . 0.0 111.068 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.33 -42.83 99.08 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.602 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.572 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.8 tpt -63.38 -46.43 86.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.641 0.258 . . . . 0.0 110.803 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.58 -41.84 98.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.483 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.38 -47.68 84.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.218 0.532 . . . . 0.0 110.399 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.8 m -63.24 -41.06 99.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.909 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 140' ' ' MET . 92.6 mt -60.48 -42.44 96.26 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -73.06 -14.59 61.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.172 0.51 . . . . 0.0 111.11 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.18 -10.23 33.8 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.802 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -99.83 -27.9 13.4 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.612 ' OE1' ' HG2' ' A' ' 255' ' ' ARG . 11.3 mm-40 -137.38 168.14 20.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -168.77 -90.18 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.429 -1.714 . . . . 0.0 108.45 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.559 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 23.7 m -162.61 159.16 24.24 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.419 ' HA ' ' CB ' ' A' ' 243' ' ' ARG . 20.5 p-90 -109.02 147.62 32.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.604 ' H ' ' HA ' ' A' ' 243' ' ' ARG . 84.0 tttt -170.41 -75.88 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.48 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -172.27 163.98 5.82 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 43.2 tttp 58.59 62.45 1.94 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.968 1.307 . . . . 0.0 114.516 174.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 244' ' ' GLU . 28.8 t70 -173.22 141.31 0.92 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.593 0.357 . . . . 0.0 110.901 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.32 53.59 0.6 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.838 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.11 -28.58 15.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.225 0.513 . . . . 0.0 110.065 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.415 ' N ' ' HD2' ' A' ' 243' ' ' ARG . 23.7 t 66.62 135.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.106 0.962 . . . . 0.0 113.227 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' A' ' 243' ' ' ARG . 6.7 mm-40 -86.8 170.22 11.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.444 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.427 ' HB1' ' OE1' ' A' ' 161' ' ' GLU . . . -71.0 -64.61 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.173 0.511 . . . . 0.0 109.901 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.427 ' OE1' ' HB1' ' A' ' 160' ' ' ALA . 1.3 pm0 -86.94 37.54 0.76 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.291 0.567 . . . . 0.0 110.551 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.61 -42.83 99.81 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.926 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 64.24 72.32 0.46 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.153 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 17.4 t -84.06 127.38 39.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.825 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.3 m -78.2 103.98 8.49 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 62.6 mt -120.62 122.51 68.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.709 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.84 89.77 5.79 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 171.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -114.77 156.73 24.32 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.307 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 29.9 m -129.79 132.2 46.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.617 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.55 131.64 10.64 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.298 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.7 m -135.85 135.74 40.03 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.822 0.344 . . . . 0.0 110.769 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 90.6 t -111.86 103.16 15.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.566 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 53.16 34.88 18.43 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.957 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.2 -11.01 47.85 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.979 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.88 138.72 50.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.901 0.85 . . . . 0.0 110.949 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -86.31 148.08 25.77 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.456 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -110.75 179.65 4.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.426 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -55.8 -52.55 63.6 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -90.44 -159.78 35.9 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.888 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.622 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . 75.29 27.7 63.35 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.827 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -116.48 102.9 9.9 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.17 141.23 51.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.812 0.339 . . . . 0.0 111.065 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.2 m -138.61 128.08 24.61 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 59.93 29.83 19.38 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.005 0.431 . . . . 0.0 110.874 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -94.94 133.66 38.46 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.429 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.3 m -97.55 122.73 49.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.421 0.629 . . . . 0.0 111.283 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 54.6 tp -109.84 125.5 52.83 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.755 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -104.66 141.46 36.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 69.8 mtm -116.62 160.42 20.72 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.228 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.88 8.04 65.55 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.741 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.413 ' HB2' ' HG2' ' A' ' 193' ' ' ARG . 98.1 mt-30 -119.7 0.36 10.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.7 29.09 55.89 Favored Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.067 -1.063 . . . . 0.0 111.128 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.413 ' HG2' ' HB2' ' A' ' 191' ' ' GLN . 32.0 mmm-85 -70.06 -30.35 67.59 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 123.248 0.619 . . . . 0.0 110.341 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.02 169.6 10.05 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.773 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.6 mm -50.76 132.66 28.23 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.987 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.68 124.39 8.23 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.669 2.246 . . . . 0.0 112.325 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.46 -37.76 3.58 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.771 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -62.21 -47.65 83.5 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -77.77 -10.14 59.39 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.805 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -88.34 -34.3 17.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.165 0.507 . . . . 0.0 109.874 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.62 -28.83 73.96 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.461 -0.791 . . . . 0.0 113.581 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.88 -26.33 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.853 0.358 . . . . 0.0 110.956 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -57.46 125.21 21.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.126 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.95 3.45 63.91 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.711 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -97.71 134.97 40.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.423 0.63 . . . . 0.0 111.883 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -90.77 160.24 15.9 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.258 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.88 138.26 57.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 110.706 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 73.53 24.04 75.7 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.898 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -118.74 101.95 8.47 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.398 0.618 . . . . 0.0 110.745 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.4 110.23 21.52 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.611 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -127.01 -10.78 5.97 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 75.3 p 57.24 164.78 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.792 0.837 . . . . 0.0 112.617 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.55 160.77 16.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -94.89 107.27 19.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.723 0.297 . . . . 0.0 110.645 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 71.3 t -121.49 122.41 67.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 6.5 m -95.55 -28.98 14.6 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -175.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 216' ' ' THR . 54.4 m-85 68.62 147.39 0.11 Allowed Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 121.009 0.433 . . . . 0.0 111.121 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.44 151.77 65.39 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.236 1.957 . . . . 0.0 111.926 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -65.12 -35.53 81.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.198 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.86 25.49 2.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.996 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -64.88 134.95 55.11 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -59.92 -15.64 23.31 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.78 105.68 17.85 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -56.61 -35.39 68.23 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.412 0.685 . . . . 0.0 111.158 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.437 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 16.0 p30 -76.91 -15.86 59.55 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.437 ' HG ' ' OD1' ' A' ' 225' ' ' ASN . 91.6 mt -115.37 5.68 14.65 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -69.53 114.53 7.84 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.434 0.635 . . . . 0.0 112.255 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.25 22.06 72.51 Favored Glycine 0 C--O 1.238 0.366 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.584 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 225' ' ' ASN . 99.1 mttt -107.7 138.77 43.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.981 0.391 . . . . 0.0 110.679 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -81.31 128.62 34.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.424 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -112.67 134.05 54.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.929 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -81.01 -44.57 17.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 212' ' ' THR . 76.0 m-85 56.58 95.73 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 121.057 0.456 . . . . 0.0 111.858 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.58 72.83 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.3 mm 61.87 92.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.109 0.564 . . . . 0.0 111.882 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -74.61 -43.48 55.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.117 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 13.2 tp 47.99 77.31 0.1 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.563 0.745 . . . . 0.0 111.567 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -71.18 -48.82 49.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -112.93 -81.17 0.59 Allowed 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.499 HG13 ' H ' ' A' ' 242' ' ' GLU . 41.2 t 81.23 150.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.713 0.805 . . . . 0.0 109.015 -173.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.79 -33.55 72.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.801 0.334 . . . . 0.0 110.466 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.499 ' H ' HG13 ' A' ' 240' ' ' VAL . 63.6 mt-10 74.62 152.75 0.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.089 0.955 . . . . 0.0 112.669 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.631 ' O ' ' HD3' ' A' ' 243' ' ' ARG . 0.0 OUTLIER -153.03 114.17 4.17 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.472 ' HG2' ' H ' ' A' ' 245' ' ' LEU . 39.1 tt0 -159.58 171.15 20.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.485 ' O ' ' HB ' ' A' ' 150' ' ' THR . 6.4 mp 70.81 108.17 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 123.59 0.756 . . . . 0.0 111.305 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.559 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 61.4 Cg_endo -81.16 101.02 1.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.026 1.817 . . . . 0.0 112.269 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.91 162.35 33.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.367 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.9 mp -84.28 88.55 7.24 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.822 0.344 . . . . 0.0 111.214 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 7.4 m -85.26 -75.89 0.34 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.724 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -177.95 -56.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.989 0.423 . . . . 0.0 110.558 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -73.71 14.64 0.35 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -78.06 -15.26 59.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.058 0.456 . . . . 0.0 110.302 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 43.0 pt -88.35 -14.23 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.098 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -138.34 94.11 2.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.628 0.728 . . . . 0.0 111.654 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.612 ' HG2' ' OE1' ' A' ' 148' ' ' GLN . 7.0 tpp180 -140.01 30.12 2.03 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.31 1.052 . . . . 0.0 108.923 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.15 15.16 9.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.201 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 77.02 15.97 81.19 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.119 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 55.9 t -99.87 141.29 17.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -54.86 -51.17 66.78 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 123.02 0.2 . . . . 0.0 111.069 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -175.61 162.44 2.77 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.265 0.353 . . . . 0.0 110.515 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -174.65 168.22 40.8 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.762 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 86.8 p -88.14 173.81 8.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.45 -48.7 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.56 -33.5 21.7 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.935 0.398 . . . . 0.0 110.322 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.4 -41.23 99.44 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.381 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.401 ' O ' HG23 ' A' ' 270' ' ' VAL . 53.4 tp -62.17 -44.45 96.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.588 0.233 . . . . 0.0 110.906 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -63.95 -42.64 97.26 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.211 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.4 -42.93 87.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.438 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -67.27 -40.14 86.15 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.906 0.384 . . . . 0.0 110.811 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 266' ' ' LEU . 78.8 t -64.85 -42.75 95.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.785 0.326 . . . . 0.0 110.15 176.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -55.76 -51.94 65.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.674 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.7 ptmt -65.63 -42.7 91.21 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.12 -39.45 94.05 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 96.5 mmm -63.9 -41.66 97.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 110.73 178.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -69.59 -31.65 69.93 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.972 0.415 . . . . 0.0 110.656 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -62.36 -42.2 99.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.98 -37.42 87.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.482 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 42.6 tp -62.39 -38.97 91.69 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.295 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -55.88 -46.92 78.16 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.209 0.528 . . . . 0.0 109.691 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.0 m -63.67 -43.92 95.27 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.65 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.56 92.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.184 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.47 -44.47 98.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.91 0.386 . . . . 0.0 110.465 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -64.64 -42.35 95.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.049 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -62.96 -41.32 99.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.155 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . 0.459 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.2 tpm_? -60.18 -44.53 95.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.938 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.14 -43.85 78.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.903 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.416 ' HZ2' ' CD ' ' A' ' 404' ' ' GLU . 88.3 tttt -61.95 -47.41 84.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.418 -176.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.1 p -62.2 -44.38 96.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -65.96 -41.51 91.15 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.134 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.61 87.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.651 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 295' ' ' VAL . 32.5 mm -64.32 -44.02 97.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.307 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.406 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 19.5 tp10 -61.08 -46.35 91.02 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.615 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.91 -40.23 95.33 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.363 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.409 HD11 HD12 ' A' ' 350' ' ' LEU . 0.7 OUTLIER -63.86 -42.61 97.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.443 0.297 . . . . 0.0 111.121 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 291' ' ' ILE . 75.1 t -64.13 -42.98 97.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 120.962 0.411 . . . . 0.0 110.687 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . 0.406 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.4 mttm -62.71 -38.77 91.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.686 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.83 -47.7 77.03 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.069 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -130.03 99.35 5.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.656 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -94.82 107.74 19.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.3 tp -110.73 143.12 21.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.725 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -73.44 121.97 21.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.236 0.541 . . . . 0.0 109.807 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 43.9 t -86.74 134.18 38.04 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.066 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.09 138.12 84.33 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.527 2.152 . . . . 0.0 112.118 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.32 -29.99 70.84 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.904 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.01 68.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.619 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.4 mt -91.34 -34.19 14.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.27 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.404 ' O ' HG13 ' A' ' 311' ' ' ILE . 71.4 mt -63.21 -51.88 65.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.723 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.36 -37.8 88.78 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 68.0 p -65.22 -46.65 79.78 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.72 0.295 . . . . 0.0 111.518 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.537 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 17.9 mm-40 -72.04 -33.21 67.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.43 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 70.7 mt -61.58 -43.74 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.516 0.198 . . . . 0.0 111.194 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.597 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 33.2 t70 -62.95 -40.93 99.15 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.687 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.54 -42.77 96.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.257 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 90.2 mt -61.64 -41.28 97.28 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.136 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 66.0 mtm180 -62.55 -39.72 94.51 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.916 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 90.8 mtt180 -63.27 -43.28 98.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.397 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -65.05 -44.67 88.26 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.03 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.53 -39.7 88.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.401 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.465 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . . . -64.62 -36.27 83.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.779 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . 0.686 ' NE2' ' HA ' ' B' ' 45' ' ' ARG . 48.1 tt0 -62.83 -43.27 99.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.549 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.49 -23.6 61.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.183 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -77.29 -4.02 42.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.77 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 140.5 -22.58 2.7 Favored Glycine 0 CA--C 1.502 -0.733 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.687 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 116.25 29.45 2.33 Favored Glycine 0 CA--C 1.497 -1.066 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.54 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 41.6 t-20 -70.72 124.0 23.24 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . 0.716 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.7 tm-20 -127.24 145.5 50.75 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.716 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 1.7 ptpp? 69.4 -37.97 0.39 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 125.574 1.55 . . . . 0.0 113.158 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.54 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 14.7 mm100 -73.63 -9.06 58.29 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.299 0.571 . . . . 0.0 110.369 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -64.02 -18.9 64.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.332 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.49 -37.63 86.73 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.22 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.88 -16.44 63.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.904 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.7 145.58 98.7 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.14 134.74 57.87 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 123.018 2.479 . . . . 0.0 112.951 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -70.7 -39.49 73.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.133 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -58.83 -33.79 70.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.06 -6.5 57.74 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.963 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -117.13 -30.78 5.55 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.608 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.55 -34.95 79.44 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -63.06 -51.06 68.16 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.995 0.426 . . . . 0.0 110.822 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.72 -28.0 65.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.48 -41.75 97.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.416 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.496 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.2 tttt -59.87 -47.14 86.96 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.533 ' O ' HG23 ' A' ' 347' ' ' VAL . 18.6 mmt85 -63.25 -45.59 90.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -66.42 -38.65 87.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.0 t -64.76 -43.34 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.645 0.259 . . . . 0.0 110.706 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 342' ' ' LYS . 77.3 t -60.31 -42.9 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.519 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 343' ' ' ARG . 87.4 t -59.53 -45.68 93.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.69 98.97 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.412 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.92 -44.44 96.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.82 0.343 . . . . 0.0 111.19 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.409 HD12 HD11 ' A' ' 294' ' ' LEU . 96.5 mt -63.92 -45.14 90.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.094 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.77 -40.99 92.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.9 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.5 98.59 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.86 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -66.3 -38.8 88.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.802 0.301 . . . . 0.0 110.723 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.96 -44.43 98.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.37 -43.83 98.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.805 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -66.54 -52.46 45.44 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.686 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.7 m -66.58 -46.17 76.86 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -87.35 -5.02 59.05 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.628 0.252 . . . . 0.0 111.377 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 59.11 70.22 0.66 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.276 0.56 . . . . 0.0 110.81 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.8 mt -101.46 124.36 47.02 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.783 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 144.15 44.06 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.082 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.04 114.96 4.48 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.487 ' O ' HG22 ' A' ' 367' ' ' VAL . 17.7 t70 -84.19 110.6 18.65 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.278 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.649 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 65.8 mm-40 -58.8 -39.1 80.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.068 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -64.65 -43.65 92.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 110.789 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -61.59 -41.25 97.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.021 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 363' ' ' ASP . 93.2 t -64.11 -35.62 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.704 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 31.0 mmmt -57.81 -45.01 86.7 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.657 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.88 -38.07 95.57 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.979 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.0 -42.68 99.91 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.068 0.461 . . . . 0.0 110.16 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.7 -43.3 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.939 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.48 -39.96 89.55 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.729 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.79 -40.72 92.23 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.702 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.8 ttm -66.59 -40.11 88.75 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 110.446 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.86 -27.14 69.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.657 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 49.3 m -74.98 4.23 6.96 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.686 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -97.62 3.94 50.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.796 0.331 . . . . 0.0 110.979 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -120.85 177.42 5.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.014 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.15 -46.14 90.29 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.642 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -128.92 120.11 20.24 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.274 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.56 -29.65 30.0 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.486 2.124 . . . . 0.0 112.896 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -65.83 -43.17 89.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -64.0 -37.39 87.25 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.349 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.35 -42.09 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.488 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.8 -44.24 98.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.093 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.86 -32.54 72.28 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -58.56 -46.72 86.29 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.128 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -68.49 -46.64 69.14 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.5 p -68.77 -17.01 63.96 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 7.91 45.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.074 0.464 . . . . 0.0 110.896 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -132.84 108.61 9.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.336 178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -62.98 -38.17 90.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -58.92 -50.76 72.82 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.827 0.346 . . . . 0.0 110.7 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.71 -39.56 94.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.399 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 90.9 mtp -61.69 -44.02 97.74 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.781 0.324 . . . . 0.0 111.278 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.57 -45.52 65.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.31 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -63.88 -42.58 97.45 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.008 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 43.6 tpp -64.9 -43.23 93.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.897 0.379 . . . . 0.0 111.132 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -66.02 -33.23 75.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.267 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.77 -44.96 93.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.26 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.52 -43.63 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.118 0.485 . . . . 0.0 110.57 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.63 -40.72 95.86 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.169 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.32 -38.46 91.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.625 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.416 ' CD ' ' HZ2' ' A' ' 287' ' ' LYS . 42.7 tt0 -59.84 -43.97 94.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.72 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -65.42 -35.15 80.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.763 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -60.99 -43.97 98.09 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.59 -45.9 84.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.165 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.1 -45.85 97.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.188 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -68.57 -27.99 66.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.018 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.54 -37.96 88.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.137 0.494 . . . . 0.0 109.84 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 89.6 t -66.19 -41.44 89.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.137 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.09 -26.44 66.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.019 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -77.39 -9.14 58.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.363 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -113.45 -31.73 6.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.82 169.23 18.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.674 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -84.59 108.61 17.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.788 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 64.4 t -84.58 128.72 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.122 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -130.38 146.8 52.01 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -121.91 123.18 41.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.705 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . 0.608 ' HE3' ' OE1' ' A' ' 126' ' ' GLU . 20.7 pttp -132.68 145.83 51.38 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.68 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -82.85 153.02 25.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -155.64 172.32 18.48 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 27.1 p -84.96 165.04 17.94 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.907 0.384 . . . . 0.0 111.161 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.78 -26.04 68.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.343 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -62.33 -40.42 96.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.608 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -65.77 -33.05 74.97 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.837 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.0 mp -74.66 -18.54 60.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.346 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.3 mmt -83.03 3.78 28.86 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -82.88 74.51 9.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.368 0.604 . . . . 0.0 109.607 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -101.28 17.75 21.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.238 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -69.93 -25.58 63.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.238 0.542 . . . . 0.0 109.685 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.729 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.69 179.392 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 120.685 0.279 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -108.68 114.85 28.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.087 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 22.4 m -123.68 135.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.092 0.472 . . . . 0.0 111.723 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 29.6 p -113.87 148.61 36.4 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.506 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.438 HG13 ' H ' ' B' ' 6' ' ' GLU . 6.4 p -151.41 -61.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.438 ' H ' HG13 ' B' ' 5' ' ' VAL . 54.2 mt-10 69.09 169.0 0.29 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.241 0.543 . . . . 0.0 111.494 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.3 m -128.78 127.76 42.62 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.171 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 23.0 m -74.51 -69.95 0.43 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.504 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -178.37 129.99 0.13 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.756 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.1 -119.03 11.0 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.697 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.66 -9.25 56.42 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' B' ' 106' ' ' SER . . . -67.49 126.62 25.19 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.283 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' B' ' 12' ' ' GLY . 0.0 OUTLIER -135.14 158.88 43.23 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 122.937 0.495 . . . . 0.0 109.898 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -129.04 151.38 49.8 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 54.1 t -102.52 -82.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.016 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m 46.51 82.38 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.184 0.516 . . . . 0.0 111.457 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 tp -116.77 135.14 58.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.985 0.421 . . . . 0.0 111.096 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.5 m -104.52 126.03 51.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.932 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 16.8 pt -129.27 160.18 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.702 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.568 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -73.2 156.02 38.99 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.573 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.07 -46.01 79.12 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -64.82 -38.66 91.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.387 . . . . 0.0 110.354 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 35.5 m -63.75 -39.73 94.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.718 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.568 HG13 ' O ' ' B' ' 20' ' ' ALA . 81.0 mt -61.23 -49.67 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.807 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.496 ' CD ' ' HZ3' ' B' ' 29' ' ' LYS . 5.3 tp10 -66.73 -48.24 69.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.729 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 20.0 m -65.83 -50.95 62.76 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.96 -49.34 18.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.21 -43.13 97.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.496 ' HZ3' ' CD ' ' B' ' 25' ' ' GLU . 18.7 ttmm -59.03 -48.67 80.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.719 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 33.3 m -63.07 -42.82 99.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.891 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -68.37 -40.08 81.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.761 0.315 . . . . 0.0 110.899 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.32 -43.1 99.62 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.68 -39.82 80.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.057 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -64.85 -42.01 95.23 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.59 -32.51 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.132 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.18 92.58 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.069 0.461 . . . . 0.0 110.033 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.88 -30.5 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.286 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -57.98 -41.52 83.12 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.038 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.8 -0.05 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.188 0.518 . . . . 0.0 110.407 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 61.09 29.1 18.71 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -101.57 4.94 10.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.143 0.497 . . . . 0.0 111.425 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.06 -33.02 74.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.598 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.14 -22.62 63.07 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.941 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -80.33 -6.56 58.17 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.63 0.252 . . . . 0.0 111.525 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.686 ' HA ' ' NE2' ' A' ' 320' ' ' GLN . 47.2 ttt85 -94.73 88.35 5.34 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 119.408 -0.917 . . . . 0.0 113.13 -177.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -89.86 86.53 6.66 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 169.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.15 102.59 2.91 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-N 115.134 -0.939 . . . . 0.0 114.84 -170.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 88.2 tttt -65.44 -34.95 79.5 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 19.3 t -101.87 100.2 14.08 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.278 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' B' ' 48' ' ' LYS . 18.6 Cg_exo -65.96 158.43 54.16 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.045 2.497 . . . . 0.0 112.607 -177.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.486 ' HA ' HG12 ' B' ' 54' ' ' VAL . 44.3 mtt -58.69 -41.69 86.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -65.99 -20.08 66.08 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.812 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -91.68 -50.33 12.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.079 0.466 . . . . 0.0 110.931 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' B' ' 51' ' ' MET . 13.0 p -67.51 -36.76 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.38 87.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -90.61 -1.64 57.88 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.281 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -100.53 -42.15 6.69 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.638 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -98.17 5.37 48.58 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.545 0.688 . . . . 0.0 109.946 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.97 146.87 49.76 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.438 ' H ' ' HB2' ' B' ' 63' ' ' ARG . . . 72.76 -41.56 0.51 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.154 0.582 . . . . 0.0 111.443 -176.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 47.0 t -60.52 -48.74 80.43 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.813 0.445 . . . . 0.0 111.428 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' B' ' 65' ' ' ASP . 7.9 p -122.03 18.64 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.771 0.796 . . . . 0.0 109.859 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.438 ' HB2' ' H ' ' B' ' 60' ' ' ALA . 12.6 ttt180 -65.58 -20.23 66.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.59 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.68 -49.53 70.6 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . 0.43 ' HB2' HG21 ' B' ' 62' ' ' VAL . 5.5 m-20 -65.78 -32.41 73.93 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.93 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.58 -43.42 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.99 -40.01 94.16 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.79 -39.32 97.31 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.728 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.96 -44.99 94.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.681 0.277 . . . . 0.0 111.072 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.65 -41.93 98.2 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.7 ttp -60.65 -45.99 92.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.86 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 55.3 m -64.2 -51.75 62.2 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.375 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -69.32 -38.06 78.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -65.06 -39.53 93.4 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.597 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -60.26 -47.21 86.96 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.54 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 17.7 tt -66.02 -38.57 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.143 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.37 -41.67 98.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.76 93.0 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.597 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -66.73 -41.25 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.46 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.69 -42.64 96.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.573 0.701 . . . . 0.0 109.419 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -60.16 -47.78 84.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.576 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -89.24 -2.03 58.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.616 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 63.24 46.64 4.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.928 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.44 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 91.4 mt -98.45 122.21 49.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.118 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -107.46 100.1 32.07 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.709 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 22.8 Cg_exo -65.17 142.74 75.1 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.434 2.089 . . . . 0.0 111.443 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.37 110.89 23.35 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.882 0.373 . . . . 0.0 110.39 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.6 -113.99 4.0 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.121 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.43 125.67 14.52 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.55 144.34 78.68 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.428 2.086 . . . . 0.0 111.586 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 46.8 m -103.47 111.91 24.57 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.056 0.455 . . . . 0.0 109.824 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.523 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.1 m-85 -87.58 89.91 8.17 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.98 108.97 3.91 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.539 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.9 Cg_endo -100.98 169.3 0.35 Allowed 'Trans proline' 0 N--CA 1.433 -2.081 0 C-N-CA 123.178 2.585 . . . . 0.0 111.256 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.82 -120.73 3.17 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -141.94 133.04 26.15 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -80.08 107.58 12.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.366 0.603 . . . . 0.0 111.066 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.79 145.68 30.32 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 38.7 tp -82.78 108.31 16.04 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.868 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.49 14.64 49.87 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.778 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -134.06 161.29 35.24 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.409 0.605 . . . . 0.0 109.923 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -66.73 143.03 57.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.011 0.434 . . . . 0.0 111.53 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -103.44 144.45 31.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.15 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.1 m -121.51 135.91 54.99 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.748 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -135.55 161.95 34.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.059 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.433 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 12.6 m -92.72 -70.44 0.7 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -175.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p 47.88 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.132 0.968 . . . . 0.0 111.811 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.55 116.61 24.79 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -172.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -157.98 147.52 19.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.562 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 65.02 143.16 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.08 157.0 42.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.75 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -165.64 97.08 0.8 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.054 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -84.56 158.58 12.46 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.972 2.448 . . . . 0.0 113.348 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -132.82 135.22 45.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 70.3 t -123.47 136.13 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -103.61 -79.74 0.53 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.537 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt 65.53 128.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.888 0.875 . . . . 0.0 113.113 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -143.39 156.51 44.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.047 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.73 8.46 87.69 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.05 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.83 -39.82 95.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.598 . . . . 0.0 110.229 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.55 -21.23 66.15 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.497 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.27 13.76 34.09 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 96.8 mt -77.65 125.41 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.223 0.535 . . . . 0.0 110.683 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -113.52 123.25 49.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.146 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.7 144.65 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.653 0.263 . . . . 0.0 111.263 -174.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . 0.561 ' OE1' ' HE3' ' B' ' 420' ' ' LYS . 38.4 tt0 -93.75 142.8 26.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.594 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -128.93 93.23 37.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.63 112.64 3.28 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.218 1.945 . . . . 0.0 111.903 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 48.6 mm -95.43 111.47 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.63 158.39 16.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.116 -178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -132.79 146.52 51.91 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.035 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 85.5 t -85.22 123.1 39.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 72.8 p -107.28 177.73 4.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.981 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -66.04 -28.42 68.84 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.8 -40.07 93.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.025 0.441 . . . . 0.0 110.361 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.01 -41.53 99.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.606 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.48 -44.94 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.016 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.38 -44.22 92.8 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.84 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.83 -42.0 98.63 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.763 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' MET . . . . . 0.556 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.8 tpt -63.02 -45.45 92.27 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.603 0.239 . . . . 0.0 110.967 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.17 -42.54 99.43 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.499 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -61.83 -45.57 93.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.422 ' O ' ' HG3' ' B' ' 147' ' ' GLN . 20.6 m -63.45 -41.21 98.64 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.833 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' B' ' 140' ' ' MET . 91.8 mt -60.43 -42.22 95.61 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -72.08 -17.34 62.01 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.066 0.46 . . . . 0.0 111.335 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.92 -9.28 40.64 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.801 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' B' ' 143' ' ' THR . 63.4 mt-30 -100.48 -27.55 13.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . 0.588 ' OE1' ' HG2' ' B' ' 255' ' ' ARG . 9.8 mm-40 -137.79 167.87 20.85 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -167.56 -90.97 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.664 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' B' ' 245' ' ' LEU . 26.8 m -163.15 155.28 18.09 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . 0.471 ' HA ' ' CB ' ' B' ' 243' ' ' ARG . 26.3 p-90 -106.28 147.66 28.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.585 ' H ' ' HA ' ' B' ' 243' ' ' ARG . 83.9 tttt -170.62 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.602 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -172.21 164.29 5.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 46.4 tttp 58.0 66.39 1.12 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.838 1.255 . . . . 0.0 114.281 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' B' ' 244' ' ' GLU . 27.8 t70 -177.96 146.48 0.42 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.182 0.593 . . . . 0.0 110.65 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.53 47.05 1.06 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.51 -0.853 . . . . 0.0 114.095 -176.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.03 -29.96 21.55 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.186 174.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' B' ' 243' ' ' ARG . 22.5 t 67.31 135.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.267 1.027 . . . . 0.0 113.172 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . 0.476 ' HG2' ' HG2' ' B' ' 243' ' ' ARG . 6.8 mm-40 -87.67 169.36 12.19 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.833 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . 0.403 ' HB1' ' OE1' ' B' ' 161' ' ' GLU . . . -70.53 -66.17 0.64 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . 0.403 ' OE1' ' HB1' ' B' ' 160' ' ' ALA . 1.7 pm0 -86.06 40.18 0.85 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.447 0.641 . . . . 0.0 110.282 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.95 -43.46 95.75 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.305 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 63.65 74.75 0.41 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.952 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 17.3 t -87.55 125.82 41.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.745 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.2 m -74.91 103.6 5.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 71.0 mt -119.52 123.27 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.044 0.45 . . . . 0.0 111.598 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . 0.488 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 23.9 m-20 -96.41 88.28 4.69 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 172.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -112.49 156.12 23.13 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.633 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 36.7 m -130.54 131.71 45.2 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.849 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.2 128.94 8.72 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.181 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 18.5 m -136.19 131.38 34.54 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.828 0.347 . . . . 0.0 110.786 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.48 105.32 18.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.823 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . 0.503 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 69.5 m-20 52.64 30.36 8.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.09 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 108.5 -12.26 36.08 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.858 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -110.7 142.48 42.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.784 0.792 . . . . 0.0 110.422 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -88.94 148.45 23.8 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.33 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -113.25 177.2 4.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.194 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -55.88 -49.37 73.56 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -89.18 -165.16 40.92 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.798 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' B' ' 169' ' ' THR . . . 77.2 24.65 65.62 Favored Glycine 0 C--O 1.22 -0.734 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.245 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -115.52 102.45 9.8 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.7 144.16 48.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.847 0.356 . . . . 0.0 110.933 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.488 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 47.2 m -139.6 132.54 29.36 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.646 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 59.97 30.55 20.04 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.684 0.615 . . . . 0.0 111.415 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -95.69 133.88 39.26 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.801 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.7 122.59 50.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.352 0.596 . . . . 0.0 111.325 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 61.4 tp -109.43 127.72 54.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.758 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -106.39 140.75 38.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 71.6 mtm -116.24 162.53 17.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.883 0.373 . . . . 0.0 111.445 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 88.21 13.8 63.31 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . 0.408 ' HB2' ' HG2' ' B' ' 193' ' ' ARG . 97.9 mt-30 -125.33 -3.16 7.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.519 0.199 . . . . 0.0 111.376 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.16 33.21 33.16 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.89 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.408 ' HG2' ' HB2' ' B' ' 191' ' ' GLN . 37.8 mmm-85 -76.33 -24.41 54.27 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.486 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.9 169.65 11.38 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.288 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 47.0 mm -51.67 133.41 36.39 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.04 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -47.18 126.33 11.47 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.526 2.151 . . . . 0.0 112.118 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.66 -38.03 3.4 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.718 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -62.5 -48.58 78.94 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.112 0.456 . . . . 0.0 112.203 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -78.08 -9.95 59.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.826 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . 0.41 ' O ' ' HD3' ' B' ' 203' ' ' LYS . 31.0 t70 -90.45 -26.35 19.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.17 0.509 . . . . 0.0 110.204 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.23 -22.78 67.26 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.285 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.92 -26.86 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.602 -0.352 . . . . 0.0 111.093 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' B' ' 200' ' ' ASP . 24.3 mtpt -55.1 126.68 25.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.038 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.48 -9.06 71.83 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.757 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -85.86 134.47 33.9 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 117.466 0.633 . . . . 0.0 111.584 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -91.6 161.38 14.95 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.354 -176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.55 139.29 58.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.723 0.297 . . . . 0.0 110.325 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 75.89 17.65 79.95 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.798 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -113.45 97.4 6.44 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.547 0.689 . . . . 0.0 111.141 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -88.91 108.06 19.34 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.947 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -129.13 -11.09 4.72 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -173.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 58.2 p 58.89 166.87 0.05 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.73 0.812 . . . . 0.0 112.655 -176.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.6 tp -146.0 153.81 13.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.465 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -88.1 105.88 17.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.771 0.319 . . . . 0.0 111.259 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 76.2 t -118.22 129.31 74.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' THR . . . . . 0.428 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 10.3 m -100.45 -34.95 9.73 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -175.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.428 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.6 m-85 70.64 144.08 0.1 Allowed Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 122.71 0.404 . . . . 0.0 110.917 -175.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 15.1 Cg_exo -69.02 152.18 73.17 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.259 1.973 . . . . 0.0 111.795 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -67.15 -33.46 75.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.411 0.624 . . . . 0.0 109.709 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -88.44 21.93 2.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.655 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -65.75 134.73 53.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.019 0.438 . . . . 0.0 110.57 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -61.53 -10.21 7.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.11 105.31 15.59 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -56.04 -36.48 68.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.41 0.684 . . . . 0.0 111.685 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.432 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 18.7 p30 -80.38 -11.81 59.65 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.404 ' HG ' ' OD1' ' B' ' 225' ' ' ASN . 93.3 mt -115.47 1.69 13.7 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -66.69 116.38 7.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.232 0.539 . . . . 0.0 111.722 -176.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.26 26.51 70.58 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.928 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.432 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 98.9 mttt -111.74 134.9 53.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.083 0.441 . . . . 0.0 110.585 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -77.29 131.82 38.34 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.897 0.38 . . . . 0.0 111.245 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.02 135.17 54.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.484 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . 0.503 ' HE2' ' OD1' ' B' ' 173' ' ' ASP . 68.9 mttm -80.8 -44.8 17.95 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' B' ' 212' ' ' THR . 76.4 m-85 56.35 95.09 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.015 0.436 . . . . 0.0 111.894 -177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.36 -50.17 74.0 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.8 mm 61.52 91.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 123.472 0.482 . . . . 0.0 111.953 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -72.69 -42.48 64.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.338 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 12.4 tp 48.21 84.83 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.821 0.848 . . . . 0.0 111.295 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.76 -59.74 2.66 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -174.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -102.55 -79.23 0.53 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.476 HG13 ' H ' ' B' ' 242' ' ' GLU . 39.3 t 77.32 150.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -172.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.97 -33.35 71.96 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.737 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.476 ' H ' HG13 ' B' ' 240' ' ' VAL . 62.5 mt-10 73.89 154.33 0.15 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.721 0.808 . . . . 0.0 112.168 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.628 ' O ' ' HD3' ' B' ' 243' ' ' ARG . 0.0 OUTLIER -156.1 110.36 2.81 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' B' ' 245' ' ' LEU . 31.9 tt0 -153.42 170.25 21.17 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.523 ' O ' ' HB ' ' B' ' 150' ' ' THR . 6.4 mp 73.64 112.23 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 123.582 0.753 . . . . 0.0 111.557 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . 0.505 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 74.5 Cg_endo -83.07 97.28 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.292 1.994 . . . . 0.0 112.711 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -132.12 163.47 28.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.733 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.2 mp -86.32 90.2 8.1 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.049 0.452 . . . . 0.0 110.797 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 5.3 m -85.88 -75.52 0.37 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.719 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 177.74 -50.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.06 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.3 3.44 3.66 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.642 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -71.49 -17.92 62.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.221 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 40.5 pt -87.15 -15.85 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.117 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -138.06 90.92 2.52 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.608 0.718 . . . . 0.0 111.986 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . 0.588 ' HG2' ' OE1' ' B' ' 148' ' ' GLN . 6.9 tpp180 -137.36 35.43 2.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.284 1.04 . . . . 0.0 108.968 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -127.87 17.65 6.76 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.825 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 72.98 23.63 77.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.545 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.12 137.21 40.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -52.7 -49.37 65.49 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.517 0.51 . . . . 0.0 111.378 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.6 p30 176.95 152.93 0.21 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.847 0.459 . . . . 0.0 111.043 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -169.39 167.32 40.4 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.983 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 26.9 p -83.38 170.93 14.01 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.597 0.199 . . . . 0.0 110.691 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 96.9 t -62.13 -51.85 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -36.38 51.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.04 0.448 . . . . 0.0 110.618 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.77 -39.79 97.81 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.48 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.405 ' O ' HG23 ' B' ' 270' ' ' VAL . 54.7 tp -61.7 -45.3 94.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.6 0.238 . . . . 0.0 110.861 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -64.72 -41.24 96.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.661 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.563 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -67.76 -43.29 80.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.556 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -67.89 -39.89 83.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.823 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.405 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.2 t -64.83 -41.72 92.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -55.43 -51.8 65.69 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.589 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.5 ptmt -66.0 -42.84 89.23 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -64.9 -38.26 90.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.0 mmm -63.67 -41.35 98.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.877 0.37 . . . . 0.0 110.164 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.3 -31.27 69.64 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.558 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -61.87 -42.77 99.46 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.4 -38.13 89.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.34 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.04 -38.2 87.84 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.272 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -56.51 -47.5 79.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.014 0.435 . . . . 0.0 109.947 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.2 m -64.61 -43.76 92.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.809 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.05 87.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.262 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.24 -44.56 99.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.968 0.413 . . . . 0.0 110.471 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -65.02 -42.01 94.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.58 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -62.82 -40.85 98.65 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.674 0.273 . . . . 0.0 110.859 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . 0.457 ' HA ' ' HE ' ' B' ' 285' ' ' ARG . 1.5 tpm_? -59.7 -44.43 93.69 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.642 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 99.4 t -70.22 -43.61 78.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.871 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.92 -47.52 84.54 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.333 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 78.0 p -61.94 -44.82 95.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.69 -41.24 92.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.62 87.9 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.539 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . 0.467 ' O ' HG23 ' B' ' 295' ' ' VAL . 33.1 mm -64.9 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.201 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . 0.468 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 34.6 tp10 -60.29 -48.19 82.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.36 -41.06 96.75 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.515 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.33 -42.07 98.94 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.467 HG23 ' O ' ' B' ' 291' ' ' ILE . 78.0 t -63.98 -42.74 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.954 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.468 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 68.4 mttm -62.53 -40.83 98.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.871 0.367 . . . . 0.0 110.544 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.6 -50.23 67.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.533 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.47 99.86 6.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.713 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -96.5 112.03 23.92 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.5 tp -116.26 144.02 24.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.6 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.54 127.14 31.92 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.33 132.83 31.07 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.464 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.45 135.59 70.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.367 2.045 . . . . 0.0 112.042 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.45 -28.96 69.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.171 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.77 79.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.817 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 99.2 mt -82.42 -36.8 26.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.628 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . 0.463 ' O ' HG13 ' B' ' 311' ' ' ILE . 73.8 mt -61.93 -50.62 79.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.689 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.59 -38.76 92.11 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 59.0 p -64.1 -44.9 90.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.952 0.406 . . . . 0.0 111.165 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . 0.518 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 52.2 mm-40 -72.86 -32.48 65.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.275 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.463 HG13 ' O ' ' B' ' 307' ' ' ILE . 85.4 mt -62.11 -43.82 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.661 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.608 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 36.3 t70 -62.59 -41.72 99.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.365 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.21 -42.9 96.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.348 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 91.0 mt -61.55 -41.24 97.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.348 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 75.2 mtm180 -62.82 -39.77 95.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.771 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 90.6 mtt180 -63.16 -43.57 97.92 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.462 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -64.71 -44.02 91.58 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.14 85.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.34 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' B' ' 325' ' ' ASN . . . -64.65 -35.81 82.22 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.034 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . 0.584 ' NE2' ' HA ' ' A' ' 45' ' ' ARG . 49.8 tt0 -63.82 -41.87 97.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.349 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -72.19 -23.92 61.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.103 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -76.32 -3.83 38.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.284 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 139.68 -29.93 2.43 Favored Glycine 0 CA--C 1.501 -0.827 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.25 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 124.31 34.38 0.72 Allowed Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . 0.527 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 39.6 t-20 -73.83 118.11 16.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . 0.725 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 3.6 tm-20 -120.91 143.31 49.02 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 2.0 ptpp? 70.33 -38.93 0.43 Allowed 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 125.581 1.552 . . . . 0.0 113.019 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . 0.527 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.4 mm100 -73.85 -8.33 55.63 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.293 0.568 . . . . 0.0 110.767 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -67.13 -14.43 62.9 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.26 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.34 -36.39 83.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.468 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -71.39 -15.42 62.37 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.956 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.57 142.43 98.46 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.71 135.47 69.53 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.11 2.54 . . . . 0.0 112.898 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 27.7 ttt85 -70.42 -40.13 74.02 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.935 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -58.61 -34.59 71.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.55 -9.25 59.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.037 0.446 . . . . 0.0 111.755 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -114.57 -30.63 6.45 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.705 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -66.48 -34.21 77.42 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.98 -52.37 64.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.051 0.453 . . . . 0.0 110.707 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -70.46 -25.63 63.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . 0.414 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.54 -42.28 99.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.329 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . 0.509 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.5 tttt -59.61 -47.12 86.84 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . 0.492 ' O ' HG23 ' B' ' 347' ' ' VAL . 17.3 mmt85 -63.57 -45.53 90.05 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -66.71 -38.88 87.6 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 341' ' ' ALA . 76.7 t -64.69 -43.0 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.655 0.264 . . . . 0.0 110.785 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.509 HG23 ' O ' ' B' ' 342' ' ' LYS . 78.1 t -60.05 -43.2 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.424 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . 0.492 HG23 ' O ' ' B' ' 343' ' ' ARG . 88.0 t -59.68 -45.57 94.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.05 -42.28 99.64 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.313 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.71 -44.02 97.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 111.005 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.14 -45.71 87.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.387 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.28 -40.66 90.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.027 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.92 -39.82 97.5 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.706 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.3 -38.74 88.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 110.836 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.28 -43.85 97.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.53 -43.78 98.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.882 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -68.54 -50.22 53.61 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.76 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 98.6 m -67.9 -47.16 69.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -85.79 -9.02 57.73 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.764 0.316 . . . . 0.0 110.964 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 59.42 73.0 0.5 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.684 0.754 . . . . 0.0 111.406 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.64 128.05 49.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 142.64 47.19 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.904 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -62.42 116.02 4.72 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . 0.441 ' O ' HG22 ' B' ' 367' ' ' VAL . 20.7 t70 -84.27 112.48 20.33 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.113 0.482 . . . . 0.0 110.846 -176.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 17.0 mm-40 -58.06 -43.21 86.78 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.376 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -66.92 -37.82 85.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.826 0.346 . . . . 0.0 111.267 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -63.31 -41.71 98.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.039 0.447 . . . . 0.0 110.078 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 363' ' ' ASP . 97.6 t -64.06 -37.61 80.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.556 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.7 mmmt -56.4 -45.04 80.81 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.806 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.86 -38.22 95.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.094 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.44 -41.43 98.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.09 0.471 . . . . 0.0 110.388 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . 0.416 HG13 ' O ' ' B' ' 367' ' ' VAL . 62.2 mt -65.47 -42.98 94.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.509 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.38 -39.47 90.79 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.457 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -61.77 -43.13 99.45 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.079 0.466 . . . . 0.0 110.282 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 57.7 ttm -67.15 -39.25 86.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.913 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.0 -33.86 75.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.721 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 66.2 m -70.82 4.7 2.36 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -97.51 2.89 50.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.061 0.458 . . . . 0.0 110.712 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -122.24 174.89 6.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.733 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -61.95 -48.8 78.8 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.825 0.345 . . . . 0.0 111.002 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 27.0 t70 -123.79 115.22 28.07 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.48 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . 0.492 ' O ' HG13 ' B' ' 385' ' ' ILE . 37.3 Cg_endo -66.61 -29.56 43.61 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 122.231 1.954 . . . . 0.0 112.928 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.47 -42.9 91.77 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 12.3 pt-20 -64.34 -36.44 84.12 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.282 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.42 -42.01 92.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.388 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . 0.492 HG13 ' O ' ' B' ' 381' ' ' PRO . 89.6 mt -61.74 -44.1 98.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.985 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.35 -33.71 74.78 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.63 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -58.14 -47.05 84.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.277 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -69.44 -46.11 67.52 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 31.0 p -68.98 -18.1 64.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.75 7.15 46.4 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.926 0.393 . . . . 0.0 111.04 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -131.47 109.62 10.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.869 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -64.25 -38.51 91.32 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -59.9 -48.31 82.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.797 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.78 -39.86 95.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.048 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 90.8 mtp -62.58 -44.26 96.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.811 0.338 . . . . 0.0 110.905 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.74 -49.28 66.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.185 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.93 -43.23 96.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.546 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 44.0 tpp -64.22 -43.16 95.85 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.805 0.336 . . . . 0.0 111.084 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -66.27 -32.91 74.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.474 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.94 -44.75 96.82 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.769 0.319 . . . . 0.0 110.295 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 85.6 t -67.18 -43.65 88.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.458 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.31 93.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.958 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.81 -38.92 92.88 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.324 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.48 -43.24 97.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.872 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.48 -35.65 81.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.73 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -61.11 -42.74 99.07 Favored 'General case' 0 C--O 1.228 -0.06 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.402 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.85 -46.78 83.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.224 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 89.9 t -62.99 -46.18 96.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -67.03 -31.18 71.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.689 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.27 93.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.111 0.481 . . . . 0.0 110.311 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 407' ' ' ALA . 99.0 t -65.36 -41.53 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.168 177.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 97.9 mt -59.87 -27.05 66.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.206 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -78.17 -6.77 55.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 111.486 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -114.83 -22.95 9.39 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.881 0.372 . . . . 0.0 110.972 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.06 169.45 12.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.057 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -83.08 116.51 22.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.619 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 60.5 t -90.24 121.72 40.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.231 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.1 t -124.04 137.79 54.54 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.1 125.2 50.91 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.576 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . 0.561 ' HE3' ' OE1' ' B' ' 126' ' ' GLU . 20.3 pttp -135.44 149.91 49.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.578 0.227 . . . . 0.0 110.653 176.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.11 159.2 20.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.8 t -158.96 172.23 18.59 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.782 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 17.0 p -85.26 164.6 17.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.015 0.436 . . . . 0.0 111.355 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -65.32 -26.21 67.95 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.543 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -61.29 -39.96 92.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.649 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.42 -36.17 82.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.419 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.51 -22.67 62.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.203 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.8 mmt -77.03 -5.75 50.01 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -76.67 78.53 3.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.34 0.591 . . . . 0.0 109.636 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -105.12 14.72 28.73 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.124 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -64.12 -37.54 87.83 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.092 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.213 178.505 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 mmt . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.29 102.68 5.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.852 0.358 . . . . 0.0 110.536 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -136.04 159.2 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.328 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.508 ' OG ' ' HA ' ' A' ' 17' ' ' ILE . 11.8 p -97.95 137.12 37.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.791 0.329 . . . . 0.0 110.736 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -153.83 138.4 9.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 69.7 mm-40 -122.4 152.56 40.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.112 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.1 m -107.35 121.5 44.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.757 0.313 . . . . 0.0 110.168 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 m -78.29 -67.36 0.74 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.461 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -170.2 110.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.629 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.65 -110.95 3.31 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.081 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.12 -39.18 93.48 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 122.655 0.382 . . . . 0.0 111.31 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -69.23 138.15 30.48 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 115.086 0.794 . . . . 0.0 115.086 -174.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 12' ' ' GLY . 7.9 mpt_? -140.85 170.31 15.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.057 0.943 . . . . 0.0 110.532 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 6.2 ttm180 -134.42 137.99 44.46 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -95.4 -84.76 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.183 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 p 43.12 91.87 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.508 ' HA ' ' OG ' ' A' ' 4' ' ' SER . 85.0 mt -113.0 131.47 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.162 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.7 m -103.01 122.89 45.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.9 pt -129.1 162.48 36.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -70.04 150.57 46.48 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.264 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.34 82.84 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -64.95 -25.34 67.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.472 . . . . 0.0 110.414 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -87.53 -32.23 19.51 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.55 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.1 mt -62.26 -50.41 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.956 0.408 . . . . 0.0 112.007 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.462 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 32.3 mm-40 -82.32 -5.02 58.3 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.7 m -100.29 -69.43 0.77 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.029 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.68 -47.58 72.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 96.3 t -63.86 -44.13 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.798 0.332 . . . . 0.0 111.349 -176.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 18.1 ttmm -61.43 -45.72 93.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.969 0.414 . . . . 0.0 110.74 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.53 ' O ' HG13 ' A' ' 33' ' ' VAL . 18.1 m -63.51 -41.29 98.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.415 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -61.23 -38.22 85.88 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.053 0.454 . . . . 0.0 110.4 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.78 -41.58 99.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.954 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 30' ' ' SER . 8.9 p -71.54 -31.65 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.569 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -62.85 -44.03 97.21 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.491 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -71.29 -31.28 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.93 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.96 -44.61 92.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.203 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.93 -33.84 76.76 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.675 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.0 -35.47 76.93 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 110.327 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.2 t -91.9 -4.88 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.321 0.581 . . . . 0.0 110.119 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 63.61 26.55 14.69 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.687 0.795 . . . . 0.0 111.435 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.17 4.55 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.851 0.358 . . . . 0.0 111.564 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.57 -33.82 76.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.936 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.65 -6.61 67.08 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.894 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -90.12 -1.0 57.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.864 0.364 . . . . 0.0 110.769 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.4 ttt-85 -94.22 82.83 4.16 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.264 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.5 94.06 6.17 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.4 101.44 2.73 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -170.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -65.36 -40.78 94.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 168.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG13 ' HB ' ' A' ' 54' ' ' VAL . 23.9 t -96.04 111.32 55.88 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.504 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.35 142.87 97.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.501 2.134 . . . . 0.0 111.65 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.559 ' HA ' HG11 ' A' ' 54' ' ' VAL . 24.1 ttt -64.43 -39.19 93.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.556 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -66.99 -20.89 65.96 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.142 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.581 HG12 HH11 ' B' ' 193' ' ' ARG . 1.7 mp -92.85 -46.56 13.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 51' ' ' MET . 9.0 p -63.79 -32.44 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 120.753 0.311 . . . . 0.0 111.358 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.43 82.15 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.66 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -93.05 -25.29 17.99 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.305 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -63.04 -43.43 98.69 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.853 0.359 . . . . 0.0 110.596 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.97 13.98 18.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.565 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.603 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -49.52 -73.07 0.39 Allowed Glycine 0 C--O 1.221 -0.703 0 CA-C-N 115.598 -0.728 . . . . 0.0 114.569 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.26 -19.3 62.37 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.862 0.331 . . . . 0.0 111.807 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 t -63.03 -45.63 91.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.032 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 66' ' ' VAL . 8.4 p -123.91 17.14 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.317 0.58 . . . . 0.0 111.121 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.603 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 37.2 ttm180 -58.92 -26.62 64.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.758 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -61.86 -52.45 64.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.304 0.574 . . . . 0.0 110.232 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.418 ' HB3' ' HG3' ' B' ' 328' ' ' GLN . 1.2 m-20 -71.85 -27.05 62.63 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.563 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 62' ' ' VAL . 88.5 t -63.78 -43.63 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.11 -39.84 93.88 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.49 -42.7 99.82 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.788 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.743 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 31.1 t70 -63.54 -43.94 95.64 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.737 0.269 . . . . 0.0 111.033 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.08 -43.85 98.26 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.476 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -67.23 -37.28 83.3 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.082 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.4 m -61.75 -43.3 99.12 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.406 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.743 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 46.2 mtp85 -64.59 -42.96 95.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.086 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -64.65 -40.44 95.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.95 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -59.81 -49.53 77.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.731 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 tt -69.03 -39.66 79.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.789 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 21.8 t0 -66.9 -41.82 86.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.258 0.551 . . . . 0.0 109.896 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.67 -41.24 92.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.727 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -65.68 -32.22 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.234 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.73 -43.55 96.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.176 0.512 . . . . 0.0 109.811 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 77' ' ' ASP . 58.7 mttm -63.83 -42.07 97.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.774 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -86.52 -4.24 59.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.895 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 64.14 36.34 9.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.367 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 98.2 mt -88.49 123.45 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.636 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -106.79 107.66 60.67 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -78.82 134.17 11.82 Favored 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 121.88 1.72 . . . . 0.0 111.406 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.94 88.28 7.26 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.165 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.72 -102.95 2.86 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.325 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.94 128.45 21.52 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 120.593 0.235 . . . . 0.0 110.924 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.07 -20.32 57.01 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.804 2.336 . . . . 0.0 112.154 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 51.3 m 68.35 95.68 0.06 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.335 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.485 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 97.4 m-85 -81.12 113.28 19.18 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.025 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.29 107.6 30.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.752 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 69.4 Cg_endo -95.65 163.71 1.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.323 2.682 . . . . 0.0 112.187 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -100.02 176.93 28.61 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.384 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.06 134.41 41.37 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -90.38 103.09 15.81 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.75 117.44 25.51 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.54 107.76 1.0 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.347 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.52 -15.71 19.72 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.988 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.93 173.79 6.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.991 0.395 . . . . 0.0 111.42 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.91 145.62 48.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.036 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -106.6 138.83 42.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.281 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.6 m -123.32 134.7 54.02 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.041 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -130.87 168.03 17.96 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.561 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.51 ' O ' HG13 ' A' ' 107' ' ' VAL . 37.7 m -87.04 -80.46 0.25 Allowed 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 106' ' ' SER . 3.7 p 56.37 121.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 C-N-CA 124.524 1.13 . . . . 0.0 111.376 -172.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -116.54 145.64 43.2 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.878 -0.513 . . . . 0.0 112.313 -172.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -155.4 -88.37 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -134.74 161.3 35.56 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -175.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.88 164.63 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.076 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -136.58 92.42 15.06 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -97.99 162.9 0.82 Allowed 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.471 2.781 . . . . 0.0 114.804 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.34 149.36 33.65 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.2 t -127.18 135.72 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -101.99 127.73 48.72 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.929 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.0 mt -118.33 134.79 54.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.603 0.239 . . . . 0.0 110.456 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -129.84 158.37 39.65 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.12 12.29 82.61 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.536 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.12 -41.24 97.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.945 0.402 . . . . 0.0 111.491 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -75.39 -8.29 56.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.051 0.453 . . . . 0.0 111.269 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.07 7.86 44.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.583 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 74.7 mt -83.89 119.0 32.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.01 0.433 . . . . 0.0 110.672 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -110.56 114.03 27.11 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.61 136.82 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.882 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -85.4 135.64 33.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.293 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -127.39 95.97 34.58 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.42 121.55 8.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.161 1.908 . . . . 0.0 112.1 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.2 mm -103.79 112.64 38.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.49 159.83 37.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.784 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.71 165.45 27.23 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.415 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -84.72 110.75 19.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.2 p -92.06 173.59 7.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.396 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -62.99 -36.67 84.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.668 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.14 -36.11 80.8 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.893 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -62.78 -39.27 93.69 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.741 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.02 -43.58 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.085 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -59.4 -44.94 92.73 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.347 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.69 -41.26 99.85 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.013 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.621 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.3 tpt -62.19 -46.78 87.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.716 0.293 . . . . 0.0 110.605 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.08 -42.17 99.59 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.266 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.45 -45.74 92.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.527 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.0 m -63.64 -43.61 96.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.669 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 140' ' ' MET . 98.5 mt -61.32 -44.64 96.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.067 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -70.48 -37.81 74.29 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.994 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.35 -36.98 85.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.428 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -84.79 33.92 0.53 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -122.78 115.64 22.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.447 0.641 . . . . 0.0 111.877 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.08 -170.44 3.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.455 ' CB ' ' H ' ' A' ' 247' ' ' GLU . 15.3 m -141.91 167.48 22.04 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 21.8 p-90 -105.1 132.5 51.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 120.678 0.275 . . . . 0.0 111.376 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -160.55 -47.19 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.335 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -154.26 -175.67 5.51 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' A' ' 240' ' ' VAL . 33.0 mmtp -52.75 154.67 2.63 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 76.22 -168.85 0.08 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.307 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 243' ' ' ARG . . . 113.5 0.74 24.78 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.504 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 74.41 -40.51 0.45 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.891 0.876 . . . . 0.0 112.407 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.3 t 73.32 -61.19 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.399 0.68 . . . . 0.0 112.447 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.492 ' HB2' ' HG2' ' A' ' 203' ' ' LYS . 10.2 pt-20 54.15 -166.18 0.09 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.905 1.282 . . . . 0.0 112.729 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.461 ' HB2' ' CA ' ' A' ' 190' ' ' GLY . . . -78.6 93.18 4.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.784 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -151.13 -65.71 0.19 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.327 0.584 . . . . 0.0 111.181 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -110.93 -168.76 1.34 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.381 -172.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 20.2 ptt180 -106.11 133.5 50.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.841 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.4 m -128.58 144.74 37.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.137 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.5 m -78.69 111.28 14.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.047 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.5 mt -123.63 122.07 64.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.02 0.438 . . . . 0.0 111.058 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.35 78.84 2.24 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -97.42 153.64 17.98 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.293 0.568 . . . . 0.0 112.183 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.3 m -119.05 128.38 54.29 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.877 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.58 126.42 9.11 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.742 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 21.1 p -137.27 134.32 36.0 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.93 -84.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.889 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -108.86 -0.04 20.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.399 0.618 . . . . 0.0 109.959 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.2 -21.82 0.97 Allowed Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.927 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -99.93 151.88 20.81 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -81.12 153.81 27.09 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.697 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -118.05 167.67 11.25 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.708 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -57.95 -32.26 67.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.57 -175.29 32.55 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.35 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.17 30.47 46.22 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.187 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.36 104.5 14.24 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -121.09 142.4 49.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.271 0.558 . . . . 0.0 112.197 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.7 m -147.1 118.4 7.84 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.252 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.83 33.68 23.5 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.596 0.56 . . . . 0.0 110.798 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -91.88 124.68 36.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.22 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 6.6 m -93.61 116.16 34.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.388 0.614 . . . . 0.0 110.992 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 163' ' ' ARG . 63.4 tp -101.88 117.57 35.12 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.804 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.555 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -91.01 108.15 19.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 76.9 mtm -89.83 149.56 22.62 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.808 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.461 ' CA ' ' HB2' ' A' ' 160' ' ' ALA . . . 98.38 12.19 45.83 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.275 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -127.21 -1.93 6.37 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.431 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 75.53 57.97 4.03 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.617 HH11 HG12 ' B' ' 53' ' ' ILE . 33.8 mmm-85 -103.72 -3.88 24.44 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.463 0.649 . . . . 0.0 109.613 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.453 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -142.66 176.29 9.15 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.997 177.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.4 mm -58.27 130.47 83.96 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.29 130.15 27.92 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.301 2.001 . . . . 0.0 111.993 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.45 -36.62 4.21 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.937 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -63.81 -47.43 80.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.175 0.487 . . . . 0.0 111.664 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.71 -8.86 59.49 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.255 0.55 . . . . 0.0 111.212 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -92.62 -31.74 15.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.605 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -65.32 -30.23 77.19 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.912 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.74 -25.97 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.912 0.387 . . . . 0.0 111.043 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.492 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 54.1 mtpt -55.95 132.71 50.53 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.397 0.679 . . . . 0.0 111.552 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.35 -12.78 66.35 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.674 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -84.71 154.73 22.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.984 0.421 . . . . 0.0 112.133 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -93.86 163.98 13.29 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.32 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.17 92.73 1.76 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.119 0.485 . . . . 0.0 110.429 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.478 ' H ' HD21 ' A' ' 237' ' ' LEU . . . 113.19 18.35 7.27 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.52 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -102.19 116.02 31.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.915 0.388 . . . . 0.0 110.795 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -95.95 119.25 34.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.611 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -138.41 -15.17 1.26 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 30.1 p 60.98 162.79 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.978 0.911 . . . . 0.0 112.292 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -149.03 133.07 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.826 0.346 . . . . 0.0 110.729 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.54 112.09 16.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.96 0.41 . . . . 0.0 111.207 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 65.1 t -113.21 129.3 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 3.2 m -95.62 -22.98 17.24 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -173.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.431 ' HD1' ' O ' ' A' ' 229' ' ' LYS . 89.1 m-85 67.74 154.47 0.14 Allowed Pre-proline 0 N--CA 1.489 1.51 0 CA-C-O 121.005 0.431 . . . . 0.0 111.452 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.66 158.11 28.31 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.309 2.006 . . . . 0.0 111.54 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -66.21 -37.55 85.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.216 0.532 . . . . 0.0 110.08 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.31 45.96 1.31 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.058 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -82.72 135.87 34.88 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -60.16 -22.25 62.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.24 105.27 17.29 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 42.2 tt0 -60.99 -24.57 66.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.22 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -73.65 -24.21 59.96 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.512 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.0 mt -113.01 3.11 16.02 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.4 ptmt -68.27 118.11 10.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.731 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.83 29.0 74.13 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.389 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.431 ' O ' ' HD1' ' A' ' 217' ' ' PHE . 99.4 mttt -124.63 140.39 52.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 117.139 0.47 . . . . 0.0 110.483 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -85.74 130.2 34.62 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.7 130.71 56.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.734 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -72.12 -39.35 68.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 59.64 105.27 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.107 0.479 . . . . 0.0 112.031 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.55 -45.82 88.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.995 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.3 mm 60.75 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.766 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -106.3 125.99 51.68 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.677 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.478 HD21 ' H ' ' A' ' 208' ' ' GLY . 4.3 mp -98.55 114.5 26.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.95 0.405 . . . . 0.0 110.867 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -94.86 -59.35 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.594 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -91.06 -88.87 0.18 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.513 ' O ' ' HE2' ' A' ' 154' ' ' LYS . 58.5 t 65.61 120.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 122.829 0.452 . . . . 0.0 110.351 -175.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -79.17 -99.96 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -166.91 155.03 9.74 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.647 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 14.2 ptp180 169.11 77.48 0.0 OUTLIER 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.668 1.187 . . . . 0.0 112.856 171.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.01 158.64 43.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.4 tp 71.95 107.53 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 123.831 0.852 . . . . 0.0 111.773 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.2 109.11 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.194 1.929 . . . . 0.0 112.368 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.455 ' H ' ' CB ' ' A' ' 150' ' ' THR . 7.8 tp10 -111.37 -21.2 11.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.053 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 42.8 tp 74.47 126.53 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.558 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.8 m -130.7 -110.68 0.26 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.904 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -175.29 -44.82 0.01 OUTLIER 'General case' 0 C--N 1.352 0.702 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.06 -29.43 65.38 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -66.55 -17.65 64.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.772 0.32 . . . . 0.0 111.711 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.09 -42.8 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 110.998 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.489 ' HD2' ' H ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -95.99 21.47 8.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.004 -177.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -69.12 -17.02 63.79 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.506 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.47 ' CE1' HD22 ' A' ' 266' ' ' LEU . 80.7 m-85 -59.02 -35.43 73.27 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.74 -28.44 15.41 Favored Glycine 0 C--N 1.322 -0.202 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.76 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.16 83.88 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 260' ' ' ASP . 13.8 tt0 55.09 -163.91 0.13 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.157 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.506 ' H ' ' HG2' ' A' ' 259' ' ' GLU . 4.0 p-10 -124.94 110.2 13.94 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.031 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -93.15 164.97 27.56 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.622 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.6 p -87.06 -173.26 4.35 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 122.465 0.306 . . . . 0.0 110.267 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.9 -47.74 92.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 120.862 0.363 . . . . 0.0 111.289 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.2 -34.25 17.86 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.768 0.318 . . . . 0.0 111.02 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.66 -40.11 98.24 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.352 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.47 HD22 ' CE1' ' A' ' 256' ' ' PHE . 53.5 tp -62.46 -42.55 99.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.505 0.193 . . . . 0.0 111.092 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -60.89 -43.83 97.93 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.953 0.406 . . . . 0.0 110.083 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -67.88 -42.25 81.52 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.236 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 24.9 tp10 -66.74 -39.98 88.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.963 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.459 ' O ' ' HG2' ' A' ' 274' ' ' MET . 75.2 t -65.03 -43.22 96.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.943 0.402 . . . . 0.0 110.054 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -58.13 -47.39 83.45 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.127 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 16.3 ptmt -67.93 -41.5 82.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.622 0.249 . . . . 0.0 111.357 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -64.12 -39.24 93.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 270' ' ' VAL . 98.8 mmm -63.5 -41.92 98.53 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.567 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -67.68 -35.04 78.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.855 0.36 . . . . 0.0 110.228 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -61.56 -43.7 98.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 109.977 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -68.88 -37.49 79.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.064 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 38.9 tp -63.17 -38.62 91.91 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.794 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -56.1 -45.62 79.37 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.151 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.5 m -61.51 -40.52 94.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.496 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.56 -45.74 92.87 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.912 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.58 -45.21 98.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 110.179 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.481 ' HD2' ' OE2' ' A' ' 405' ' ' GLU . 0.8 OUTLIER -59.77 -46.71 88.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.136 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -64.91 -41.56 95.48 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.667 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -65.32 -41.43 94.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.873 0.368 . . . . 0.0 111.404 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.92 -44.06 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.166 0.508 . . . . 0.0 109.857 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.483 ' HZ2' ' CD ' ' A' ' 404' ' ' GLU . 88.4 tttt -62.6 -47.54 83.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.629 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 55.2 p -62.41 -43.91 97.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -64.24 -42.15 96.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.768 0.318 . . . . 0.0 111.059 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.6 85.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 37.9 mm -65.42 -44.39 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.427 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.492 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 20.0 tp10 -62.56 -42.87 99.82 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.607 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.3 -43.51 98.98 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.98 -43.21 96.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.0 -44.99 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.391 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . 0.492 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 67.5 mttm -64.33 -41.42 96.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.548 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.22 -43.96 69.56 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -127.59 98.8 5.34 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.683 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -93.23 103.15 15.43 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.2 tp -107.98 139.27 30.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.975 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -67.73 131.34 45.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.213 0.53 . . . . 0.0 110.706 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.16 135.75 21.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.062 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.0 138.35 85.53 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.388 2.058 . . . . 0.0 111.987 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.37 85.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.307 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.38 -45.85 80.36 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.025 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.68 -43.3 93.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.84 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 71.4 mt -62.34 -49.98 81.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.66 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -41.63 98.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.949 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 24.6 m -61.94 -45.63 92.86 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.616 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.635 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 27.2 mm-40 -73.11 -38.05 66.48 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -176.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.499 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 82.0 mt -61.74 -43.8 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -175.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 24.9 t70 -61.45 -42.62 99.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.097 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.4 -42.55 93.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 90.3 mt -62.15 -39.67 93.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.43 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 82.5 mtm180 -62.6 -37.46 86.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.071 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 91.3 mtt180 -64.09 -38.95 92.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -63.09 -46.1 88.98 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.383 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.8 -39.53 91.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.657 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.51 94.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.409 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -65.02 -38.86 92.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.175 0.512 . . . . 0.0 110.234 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.84 -17.93 59.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.922 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -78.16 -3.57 43.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.317 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.56 -11.27 4.62 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.356 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 111.88 34.62 1.99 Allowed Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.241 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -74.75 126.6 31.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.953 0.406 . . . . 0.0 110.097 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.48 159.36 36.53 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.508 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.1 OUTLIER 69.17 -47.07 0.58 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.27 -4.9 55.13 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.18 -24.64 66.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.442 0.639 . . . . 0.0 109.807 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 38.7 tp -63.94 -33.75 76.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.705 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -80.47 -9.58 59.76 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.905 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 94.4 mt -63.83 129.03 93.57 Favored Pre-proline 0 C--O 1.24 0.572 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.476 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.84 127.24 25.39 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.848 2.365 . . . . 0.0 113.142 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -65.51 -43.97 88.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.002 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -65.25 -24.76 67.41 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.0 -10.32 55.28 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -118.1 -15.95 9.82 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.976 0.417 . . . . 0.0 111.251 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.22 -25.17 65.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.497 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.8 -50.78 67.6 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.705 0.288 . . . . 0.0 111.06 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -78.91 -20.72 48.67 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.208 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.98 -41.85 98.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -60.41 -44.24 95.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.031 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.478 ' O ' HG23 ' A' ' 347' ' ' VAL . 17.9 mmt85 -62.41 -42.78 99.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.068 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.48 ' NH2' HD22 ' A' ' 314' ' ' LEU . 73.4 mtt180 -64.81 -41.77 95.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.675 0.274 . . . . 0.0 111.061 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 89.2 t -64.89 -44.62 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.769 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 342' ' ' LYS . 72.5 t -61.13 -44.22 97.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.934 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 343' ' ' ARG . 77.4 t -60.5 -44.67 96.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.09 99.73 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.175 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 93.7 mt -63.47 -42.71 98.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.899 0.38 . . . . 0.0 110.614 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.405 ' O ' HG21 ' A' ' 354' ' ' VAL . 98.6 mt -63.13 -44.95 94.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.763 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.38 -42.02 96.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.968 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.18 -42.53 99.72 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.131 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.54 -39.24 85.02 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 117.053 0.426 . . . . 0.0 111.287 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 350' ' ' LEU . 73.0 t -60.79 -45.05 98.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.93 -44.22 97.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.687 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -65.48 -46.55 79.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 37.5 m -73.11 -44.25 60.57 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -89.27 0.63 56.63 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.777 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 56.99 67.01 1.05 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.304 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 91.0 mt -98.83 153.77 18.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.777 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -132.96 155.35 49.28 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.806 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.15 100.24 8.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 171.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.448 ' O ' HG21 ' A' ' 367' ' ' VAL . 26.8 t70 -83.16 115.96 22.14 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.127 0.489 . . . . 0.0 112.269 -173.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.605 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 68.7 mm-40 -61.35 -35.52 77.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.299 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.439 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 65.4 mm-40 -64.39 -41.71 96.53 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.093 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -63.13 -39.15 93.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.18 0.514 . . . . 0.0 109.842 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 363' ' ' ASP . 89.6 t -61.78 -39.64 84.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.332 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.5 mmmt -57.68 -44.31 85.68 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.487 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.51 -40.09 98.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.848 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.6 -43.05 99.78 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.981 0.419 . . . . 0.0 110.281 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.27 -43.92 97.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.406 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.15 -41.0 97.33 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.56 -37.25 84.55 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.351 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 48.4 ttm -66.98 -43.61 82.6 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.091 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.87 75.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.123 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.6 m -68.27 -5.29 17.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.839 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -83.45 -12.48 56.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.498 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -106.35 172.99 6.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.533 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.24 -47.31 83.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.825 0.345 . . . . 0.0 110.985 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -123.62 113.55 28.86 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.545 ' O ' HG13 ' A' ' 385' ' ' ILE . 38.1 Cg_endo -66.75 -31.19 40.12 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.229 1.953 . . . . 0.0 113.402 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -66.27 -42.96 87.71 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.28 -36.19 83.3 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.994 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.38 -42.56 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.234 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 381' ' ' PRO . 68.1 mt -61.23 -46.76 95.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.279 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 46.2 mt-10 -63.32 -44.0 96.19 Favored 'General case' 0 C--O 1.215 -0.752 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.773 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.61 -46.76 86.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -66.28 -40.84 90.34 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.429 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 51.3 p -81.58 -2.44 50.05 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 98.6 mttt -103.48 10.64 37.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.049 0.452 . . . . 0.0 110.789 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -134.42 117.51 16.39 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.259 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -63.78 -40.64 97.17 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -58.1 -49.48 76.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.674 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.55 -42.73 98.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.2 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.525 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 89.5 mtp -63.9 -48.3 77.16 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -73.58 -39.39 64.68 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -174.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -62.36 -40.72 97.35 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 44.4 tpp -64.13 -41.47 97.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.66 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 395' ' ' MET . 69.1 mtm180 -64.35 -36.44 84.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.008 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -60.95 -43.77 98.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.583 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.17 -44.09 88.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.488 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -61.65 -41.83 98.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.95 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.87 -39.5 94.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.683 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.483 ' CD ' ' HZ2' ' A' ' 287' ' ' LYS . 37.6 tt0 -59.66 -43.93 93.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.906 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.481 ' OE2' ' HD2' ' A' ' 283' ' ' ARG . 29.7 mt-10 -65.18 -37.44 87.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.541 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -60.45 -43.35 96.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.526 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.42 -44.35 91.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.968 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 86.5 t -64.73 -45.11 96.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.989 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -65.32 -33.56 76.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.32 97.49 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.865 0.364 . . . . 0.0 110.482 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.91 -42.74 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.076 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.0 mt -61.45 -41.85 97.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.183 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.04 -23.85 67.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.706 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -95.18 -8.27 36.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.32 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.53 179.43 4.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.139 0.495 . . . . 0.0 111.757 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -82.41 133.46 35.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.689 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.09 131.34 73.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -131.49 138.81 49.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.1 0.476 . . . . 0.0 110.921 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -93.58 118.82 31.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.663 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -136.33 132.93 36.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.843 0.354 . . . . 0.0 111.368 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -81.01 153.23 27.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.165 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 12.9 t -157.72 171.66 19.92 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 26.2 p -81.34 165.54 21.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.772 0.32 . . . . 0.0 110.21 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -66.04 -18.13 65.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.021 0.438 . . . . 0.0 111.26 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -62.25 -39.45 92.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.97 -38.31 90.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.19 0.519 . . . . 0.0 110.057 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.35 -36.2 83.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.488 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 5.9 mmt -65.31 -14.28 60.41 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.301 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -75.6 83.37 2.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -103.64 6.48 37.13 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.315 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -72.32 -44.83 62.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.532 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.149 -178.548 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.92 103.86 2.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 111.361 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.86 161.59 38.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.396 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.488 ' OG ' ' HA ' ' B' ' 17' ' ' ILE . 7.9 p -101.59 130.56 47.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.787 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.78 133.66 13.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 57.9 mm-40 -118.45 149.75 40.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.962 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 98.0 m -106.6 122.71 46.86 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 27.7 m -78.74 -68.54 0.64 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.363 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -166.23 110.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.582 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.81 -106.55 1.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.354 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 83.8 mt -70.34 -36.69 74.39 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.708 0.403 . . . . 0.0 112.048 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.443 ' C ' ' HD2' ' B' ' 13' ' ' ARG . . . -70.09 135.81 26.39 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 114.486 0.554 . . . . 0.0 114.486 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.443 ' HD2' ' C ' ' B' ' 12' ' ' GLY . 7.6 mpt_? -138.13 171.26 14.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.69 0.796 . . . . 0.0 110.415 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 9.8 ttm180 -135.75 138.54 42.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.77 -83.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.038 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p 42.23 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.488 ' HA ' ' OG ' ' B' ' 4' ' ' SER . 83.8 mt -110.91 130.56 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.23 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 37.6 m -103.17 123.61 47.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 20.6 pt -129.08 163.23 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.0 111.979 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.503 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -71.93 152.69 42.34 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.087 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.65 77.62 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -63.02 -32.3 73.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.241 0.544 . . . . 0.0 110.217 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 17.3 m -82.51 -32.99 28.44 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.034 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.503 HG13 ' O ' ' B' ' 20' ' ' ALA . 81.5 mt -60.59 -49.98 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 120.881 0.372 . . . . 0.0 111.834 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.479 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 28.0 mm-40 -82.99 -7.51 59.66 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 53.2 m -97.97 -69.34 0.76 Allowed 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.41 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.99 -48.3 66.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 89.7 t -64.17 -43.62 97.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.513 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.1 ttmm -61.33 -46.49 90.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 0.0 110.564 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.51 ' O ' HG13 ' B' ' 33' ' ' VAL . 21.2 m -63.53 -40.39 96.92 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.451 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -60.68 -38.93 86.59 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.021 0.438 . . . . 0.0 110.609 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.78 -41.85 99.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.839 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.51 HG13 ' O ' ' B' ' 30' ' ' SER . 9.2 p -70.93 -32.9 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 120.224 -0.591 . . . . 0.0 110.894 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -63.56 -43.84 95.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.431 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 25.7 m -70.69 -31.76 47.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.054 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.64 -42.54 98.12 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.989 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.21 -33.68 76.3 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.689 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.07 -36.63 80.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.942 0.401 . . . . 0.0 110.447 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 t -89.34 -6.39 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.3 0.571 . . . . 0.0 109.967 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 63.05 30.4 16.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.939 0.896 . . . . 0.0 111.215 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -105.72 4.11 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -64.35 -34.19 77.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.808 0.337 . . . . 0.0 110.799 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.78 -19.72 65.57 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.686 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -80.69 -3.48 50.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.677 0.275 . . . . 0.0 111.502 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 66.4 ttt-85 -91.88 83.46 5.23 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 119.946 -0.701 . . . . 0.0 112.026 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.55 95.99 6.01 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.12 98.1 2.23 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 115.319 0.888 . . . . 0.0 115.319 -171.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -64.67 -40.8 96.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 14.7 t -94.06 111.34 52.8 Favored Pre-proline 0 N--CA 1.437 -1.121 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.245 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.76 141.54 92.19 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.413 2.076 . . . . 0.0 111.665 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.478 ' HA ' HG13 ' B' ' 54' ' ' VAL . 26.1 ttt -65.63 -38.92 90.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.699 -175.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -67.47 -18.36 65.04 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.617 HG12 HH11 ' A' ' 193' ' ' ARG . 1.8 mp -96.76 -46.05 12.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.52 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' B' ' 51' ' ' MET . 8.4 p -63.85 -32.19 56.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 111.093 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.29 81.46 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.464 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -95.19 -20.84 18.9 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.34 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -63.99 -44.0 94.0 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.769 0.318 . . . . 0.0 110.513 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -113.9 12.32 18.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.242 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.644 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -50.72 -69.25 1.15 Allowed Glycine 0 C--O 1.218 -0.845 0 CA-C-N 115.488 -0.778 . . . . 0.0 114.75 -175.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.65 -18.19 61.59 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 117.0 0.4 . . . . 0.0 111.759 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 29.2 t -67.37 -52.68 37.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.969 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.476 ' O ' HG22 ' B' ' 66' ' ' VAL . 7.3 p -114.02 17.03 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.468 0.651 . . . . 0.0 111.193 -175.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 36.3 ttm180 -59.1 -33.26 70.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.986 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -59.28 -50.68 73.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.023 0.44 . . . . 0.0 110.275 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.61 -34.03 76.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.36 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 62' ' ' VAL . 81.6 t -61.16 -43.66 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.62 -39.59 91.82 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.27 -41.99 99.72 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.707 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . 0.687 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 28.4 t70 -64.22 -43.48 94.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.613 0.244 . . . . 0.0 111.076 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.37 -44.02 96.02 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.383 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -66.44 -37.24 84.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.101 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.6 m -62.25 -42.86 99.7 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.233 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.687 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 44.3 mtp85 -63.36 -43.71 96.87 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.031 0.443 . . . . 0.0 110.205 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -64.89 -40.75 95.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.092 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.8 -49.27 78.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.034 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.6 tt -68.63 -39.6 80.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.716 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.511 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 7.7 t0 -65.91 -42.51 90.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.293 0.568 . . . . 0.0 109.88 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.23 93.96 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.762 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 pt -66.53 -31.71 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.149 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.83 -43.31 96.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.112 0.482 . . . . 0.0 109.837 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' B' ' 77' ' ' ASP . 64.5 mttm -63.43 -45.2 92.01 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.849 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -81.62 -9.19 59.73 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.308 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 69.47 33.36 3.15 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.628 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 96.1 mt -84.84 128.87 38.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.955 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -112.29 101.4 52.08 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.632 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.42 143.62 53.1 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.503 2.135 . . . . 0.0 111.461 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.31 88.56 4.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.032 0.444 . . . . 0.0 110.752 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.22 -98.28 2.15 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.465 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.15 129.16 19.8 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.574 0.226 . . . . 0.0 110.948 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.78 -19.56 46.95 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.795 2.33 . . . . 0.0 112.034 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 34.1 m 71.02 95.51 0.07 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.192 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.486 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 98.5 m-85 -81.67 110.98 17.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.023 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.3 t -93.95 107.9 31.34 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.977 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 68.9 Cg_endo -96.2 159.28 1.33 Allowed 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 123.208 2.605 . . . . 0.0 111.707 177.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.94 177.6 34.19 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.089 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.48 136.16 44.14 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -88.14 106.43 18.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.659 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.65 117.09 28.27 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.68 111.35 2.71 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.006 0.432 . . . . 0.0 110.725 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.73 -10.58 35.09 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.023 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -114.44 175.68 5.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.998 0.399 . . . . 0.0 111.663 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -72.35 144.43 48.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.803 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -106.79 137.51 44.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.358 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.5 m -122.84 135.26 54.47 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.36 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -131.77 166.63 21.1 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.484 ' O ' HG13 ' B' ' 107' ' ' VAL . 32.1 m -84.16 -81.04 0.18 Allowed 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.484 HG13 ' O ' ' B' ' 106' ' ' SER . 3.6 p 55.62 117.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 C-N-CA 124.441 1.096 . . . . 0.0 111.709 -173.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -112.45 150.86 30.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -157.36 -90.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -134.42 162.32 32.56 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 33.8 m -137.32 164.97 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.89 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -138.9 94.84 9.89 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -97.57 163.43 0.89 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.52 2.814 . . . . 0.0 114.495 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -145.71 146.28 31.2 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 61.1 t -125.34 133.1 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.94 126.11 44.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.551 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 88.1 mt -115.03 136.07 53.53 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -132.31 159.44 39.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.489 0.185 . . . . 0.0 110.503 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.02 13.62 82.84 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.382 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.5 -40.18 95.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.012 0.434 . . . . 0.0 111.539 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -74.52 -4.91 39.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.321 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.33 12.75 35.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.853 0.359 . . . . 0.0 110.976 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 80.5 mt -87.3 114.7 26.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.163 0.506 . . . . 0.0 110.832 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -108.98 116.65 32.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 28.5 t -116.64 135.4 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.871 -173.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . 0.457 ' CD ' ' HZ1' ' B' ' 420' ' ' LYS . 40.6 tt0 -79.67 143.2 34.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.187 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -133.37 98.08 15.62 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -67.77 118.44 5.6 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.321 2.014 . . . . 0.0 112.259 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.7 mm -102.82 114.34 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.25 161.15 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.851 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -141.72 155.06 45.66 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.876 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.04 120.92 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.9 p -103.49 177.67 4.77 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.206 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -62.29 -36.9 83.53 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.229 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.74 84.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.484 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -63.18 -39.73 95.48 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 96.7 t -63.34 -44.69 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.812 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -58.93 -47.37 85.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.347 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.95 -41.3 99.65 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.071 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' MET . . . . . 0.67 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.1 OUTLIER -62.33 -45.67 92.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.672 0.273 . . . . 0.0 110.534 178.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.12 -42.26 99.51 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.949 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -59.07 -49.09 79.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.464 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.9 m -63.48 -43.85 96.11 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.796 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' B' ' 140' ' ' MET . 97.5 mt -61.14 -45.04 96.28 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -175.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -71.08 -37.86 72.43 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.893 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -61.78 -36.31 80.71 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.028 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -82.21 29.95 0.41 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.244 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -118.51 114.34 22.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.356 0.598 . . . . 0.0 112.179 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.92 -167.35 2.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.24 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.504 ' CB ' ' H ' ' B' ' 247' ' ' GLU . 22.8 m -144.38 165.98 26.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . 0.621 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 15.3 p-90 -102.08 131.97 48.22 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 120.723 0.297 . . . . 0.0 111.336 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 5.9 mtpp -162.48 -50.55 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.44 -175.09 4.95 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -54.26 155.29 3.83 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . 0.402 ' HB3' ' H ' ' B' ' 156' ' ' GLY . 35.3 m-20 73.98 -168.33 0.11 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.487 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' B' ' 243' ' ' ARG . . . 113.86 1.18 24.19 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.548 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . 75.11 -40.3 0.43 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.834 0.853 . . . . 0.0 112.239 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 57.7 t 71.39 -59.73 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.584 0.754 . . . . 0.0 112.768 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . 0.505 ' HB2' ' HG2' ' B' ' 203' ' ' LYS . 9.4 pt-20 53.02 -164.73 0.08 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.688 1.195 . . . . 0.0 112.787 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.75 92.8 6.09 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.699 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.97 -64.03 0.23 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.297 0.57 . . . . 0.0 110.902 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -111.0 -167.89 1.24 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.291 -173.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' B' ' 187' ' ' LEU . 24.0 ptt180 -107.79 132.17 53.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.818 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.92 140.85 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.63 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 9.5 m -76.15 109.93 10.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.217 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 84.3 mt -124.4 119.14 55.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.911 0.386 . . . . 0.0 110.794 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -95.47 75.99 3.32 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -90.59 150.64 21.64 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.349 0.595 . . . . 0.0 112.279 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 34.3 m -117.18 127.33 54.01 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.283 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.84 131.58 11.5 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.677 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 30.6 p -140.28 133.15 29.17 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 30.3 t -81.95 -84.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.954 0.407 . . . . 0.0 110.791 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -103.96 -21.3 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.505 0.669 . . . . 0.0 109.546 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.05 -16.41 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.808 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -100.34 148.53 24.59 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -82.69 149.34 27.39 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -116.37 172.18 7.36 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.35 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.31 -33.86 71.63 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.81 -178.23 32.15 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.546 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.05 29.49 41.46 Favored Glycine 0 C--O 1.224 -0.47 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.968 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.37 101.71 11.23 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -117.46 143.13 46.35 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 50.8 m -147.48 119.74 8.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.172 176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 58.07 29.97 18.6 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.429 0.456 . . . . 0.0 110.758 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -90.35 123.4 34.07 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.453 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 6.7 m -94.6 117.08 37.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.396 0.617 . . . . 0.0 110.832 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' B' ' 163' ' ' ARG . 55.2 tp -100.35 118.67 37.09 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.731 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' B' ' 193' ' ' ARG . . . -92.79 112.46 24.43 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 77.2 mtm -95.14 149.4 21.34 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.935 0.398 . . . . 0.0 111.906 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 101.55 4.28 52.63 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.396 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -119.24 -4.21 10.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.42 4.31 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.972 -1.109 . . . . 0.0 110.422 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.581 HH11 HG12 ' A' ' 53' ' ' ILE . 33.5 mmm-85 -100.89 -2.76 31.16 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.474 0.654 . . . . 0.0 109.925 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.423 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -142.63 175.07 10.09 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.981 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 45.4 mm -57.5 130.31 81.15 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.59 131.14 32.15 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.251 1.967 . . . . 0.0 111.793 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.42 -37.38 3.76 Favored Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.114 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -63.6 -47.76 80.12 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.051 0.426 . . . . 0.0 111.591 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.89 -9.42 59.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.038 0.446 . . . . 0.0 111.111 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -93.6 -30.07 15.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.247 0.546 . . . . 0.0 109.848 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.32 73.23 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.699 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.5 -26.06 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.065 0.46 . . . . 0.0 110.896 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.505 ' HG2' ' HB2' ' B' ' 159' ' ' GLU . 49.7 mtpt -54.73 130.73 41.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.571 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.55 -9.13 66.66 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.64 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -88.57 151.0 22.78 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 122.453 -0.44 . . . . 0.0 111.876 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -91.86 165.89 13.01 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.537 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.68 102.87 4.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . 0.511 ' H ' HD21 ' B' ' 237' ' ' LEU . . . 106.48 2.07 37.76 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -87.95 119.44 28.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.162 0.506 . . . . 0.0 110.973 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.52 136.32 38.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.24 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -156.18 -15.2 0.1 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 30.0 p 61.6 159.17 0.05 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.959 0.904 . . . . 0.0 112.087 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.0 tp -146.47 129.96 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.984 0.421 . . . . 0.0 110.522 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -78.58 115.63 18.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.596 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 67.2 t -113.8 132.08 63.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 7.1 m -96.05 -30.57 13.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' B' ' 216' ' ' THR . 74.6 m-85 72.7 151.06 0.14 Allowed Pre-proline 0 N--CA 1.484 1.267 0 C-N-CA 122.708 0.403 . . . . 0.0 111.084 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.67 159.2 25.07 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.284 1.99 . . . . 0.0 111.49 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -65.0 -39.05 92.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.3 0.572 . . . . 0.0 109.987 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -88.75 52.45 2.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.66 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . 0.402 ' CE2' ' HB2' ' B' ' 223' ' ' ALA . 25.7 t80 -91.26 132.94 35.81 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.402 ' HB2' ' CE2' ' B' ' 221' ' ' TYR . . . -90.87 103.61 16.3 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 45.4 tt0 -59.25 -30.42 68.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.323 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.468 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 31.2 p-10 -67.58 -24.43 65.5 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.671 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.8 mt -112.5 3.0 16.56 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.6 ptmt -66.89 112.75 4.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.129 -177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.06 23.18 76.15 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.045 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 99.1 mttt -117.98 128.85 55.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.9 0.35 . . . . 0.0 110.407 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -70.94 137.84 49.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.142 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.86 127.49 47.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.491 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -69.76 -40.24 76.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 58.95 103.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.045 0.45 . . . . 0.0 111.981 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.5 83.96 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.755 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 45.5 mm 62.58 83.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.739 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -109.0 128.08 54.64 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.564 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . 0.511 HD21 ' H ' ' B' ' 208' ' ' GLY . 3.8 mp -100.65 120.28 39.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.629 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -98.66 -56.25 2.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.439 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -94.86 -89.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 59.3 t 67.43 120.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 120.994 0.426 . . . . 0.0 110.177 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -77.46 -92.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -174.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -173.04 155.78 3.11 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.621 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 14.8 ptp180 166.92 78.12 0.0 OUTLIER 'General case' 0 C--N 1.364 1.207 0 C-N-CA 124.782 1.233 . . . . 0.0 113.129 170.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.08 160.49 40.13 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 55.4 tp 70.1 108.06 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 123.67 0.788 . . . . 0.0 111.92 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.44 111.51 2.55 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.251 1.967 . . . . 0.0 112.082 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . 0.504 ' H ' ' CB ' ' B' ' 150' ' ' THR . 6.4 tp10 -117.77 -13.09 10.16 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.438 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 41.7 tp 71.41 130.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.29 1.036 . . . . 0.0 112.848 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' THR . . . . . 0.517 HG23 ' H ' ' B' ' 250' ' ' ALA . 0.5 OUTLIER -142.96 -163.28 1.6 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.517 ' H ' HG23 ' B' ' 249' ' ' THR . . . -130.3 -21.63 2.88 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.59 -35.6 80.59 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -65.41 -17.29 64.42 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.95 -42.57 97.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.968 0.413 . . . . 0.0 111.195 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . 0.498 ' H ' ' HD2' ' B' ' 254' ' ' LYS . 0.0 OUTLIER -97.76 18.58 15.37 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -68.9 -16.83 63.86 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.007 0.432 . . . . 0.0 111.61 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . 0.424 ' CE1' HD22 ' B' ' 266' ' ' LEU . 85.3 m-85 -59.74 -30.63 68.96 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.1 -31.14 9.05 Favored Glycine 0 CA--C 1.51 -0.245 0 C-N-CA 120.196 -1.002 . . . . 0.0 114.048 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 26.2 t -81.23 85.57 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . 0.504 ' HG2' ' H ' ' B' ' 260' ' ' ASP . 12.5 tt0 53.72 -163.88 0.1 Allowed 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.681 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . 0.504 ' H ' ' HG2' ' B' ' 259' ' ' GLU . 1.4 p-10 -123.31 113.07 18.38 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.621 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -95.74 169.77 27.42 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.367 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 15.1 p -89.62 -173.75 4.07 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.9 t -60.53 -48.57 87.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.901 0.381 . . . . 0.0 111.339 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.42 -34.09 20.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.905 0.383 . . . . 0.0 110.523 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.96 -39.98 98.73 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.481 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.424 HD22 ' CE1' ' B' ' 256' ' ' PHE . 54.8 tp -62.62 -43.28 99.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.736 0.303 . . . . 0.0 110.846 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -62.4 -44.01 97.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.61 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.83 -43.83 87.38 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.053 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -66.35 -40.79 90.05 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' B' ' 274' ' ' MET . 73.6 t -64.85 -43.32 96.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.034 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . 0.423 HH21 ' HD3' ' B' ' 271' ' ' ARG . 9.8 tpt180 -57.47 -49.32 76.66 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.616 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 16.1 ptmt -67.41 -41.92 84.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.65 0.262 . . . . 0.0 111.581 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -64.58 -39.39 93.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.789 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 274' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.0 mmm -62.33 -41.61 98.7 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -68.69 -34.94 76.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.752 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -61.85 -43.91 97.9 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -69.0 -38.21 79.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.199 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 45.0 tp -62.35 -38.34 89.14 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.79 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -56.55 -44.26 80.74 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.197 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 20.4 m -62.13 -41.59 98.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.533 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.27 93.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.84 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . 0.413 ' O ' HG22 ' B' ' 286' ' ' VAL . 67.8 mt -63.04 -45.71 98.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.271 178.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . 0.496 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.9 OUTLIER -59.47 -45.84 90.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.05 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -63.91 -42.73 97.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.725 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -66.11 -39.58 90.04 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.54 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . 0.413 HG22 ' O ' ' B' ' 282' ' ' ILE . 97.9 t -65.78 -44.39 93.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.178 0.514 . . . . 0.0 110.01 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . 0.406 ' HZ2' ' CD ' ' B' ' 404' ' ' GLU . 87.9 tttt -63.28 -46.85 84.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.373 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 76.6 p -62.87 -42.78 99.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -64.05 -42.81 96.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 111.101 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.32 82.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.061 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . 0.434 ' O ' HG22 ' B' ' 295' ' ' VAL . 38.0 mm -65.28 -44.19 95.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.318 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . 0.406 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 18.1 tp10 -62.83 -43.48 98.67 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.972 0.415 . . . . 0.0 110.853 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.22 98.14 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.527 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 51.8 mt -63.25 -43.08 99.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.434 HG22 ' O ' ' B' ' 291' ' ' ILE . 84.1 t -65.34 -44.67 94.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.45 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.406 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 67.3 mttm -64.35 -41.95 96.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.332 . . . . 0.0 111.685 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.88 82.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.651 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -127.6 96.6 4.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.643 0.259 . . . . 0.0 111.538 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -91.24 93.54 9.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.319 0.58 . . . . 0.0 109.591 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.0 tp -100.95 136.9 30.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.66 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.81 135.06 50.58 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.161 0.505 . . . . 0.0 110.54 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.08 134.09 20.59 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.194 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.58 134.98 67.16 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 122.353 2.035 . . . . 0.0 112.244 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.85 78.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.151 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.86 -45.2 82.61 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.002 0.43 . . . . 0.0 111.035 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.97 -43.08 88.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.93 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . 0.422 ' O ' HG13 ' B' ' 311' ' ' ILE . 71.7 mt -62.45 -49.55 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.731 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.22 -42.98 99.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.82 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 42.7 m -62.48 -45.84 91.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.903 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . 0.633 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 65.2 mm-40 -72.01 -36.68 69.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.473 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 85.0 mt -61.82 -43.94 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.569 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 25.2 t70 -60.99 -42.75 99.03 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.718 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.25 -42.65 91.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.655 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 91.0 mt -61.94 -39.9 93.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.813 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 84.1 mtm180 -62.62 -36.77 83.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.097 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 93.0 mtt180 -63.4 -39.81 95.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.576 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -63.16 -44.74 94.65 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.455 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.59 -39.66 88.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.749 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.84 92.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.4 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.9 -40.38 94.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.287 0.565 . . . . 0.0 110.143 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -72.38 -19.72 61.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.939 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -76.09 -6.78 52.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.744 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 136.85 -12.46 3.92 Favored Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.939 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 113.21 35.61 1.6 Allowed Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.102 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -76.48 123.26 25.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.978 0.418 . . . . 0.0 110.007 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . 0.401 ' CD ' ' HZ3' ' B' ' 327' ' ' LYS . 0.1 OUTLIER -125.25 160.43 29.26 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.517 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.1 OUTLIER 69.49 -52.24 0.61 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.157 0.583 . . . . 0.0 112.534 -178.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . 0.418 ' HG3' ' HB3' ' A' ' 65' ' ' ASP . 15.4 mm100 -74.82 -4.32 37.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.96 -24.7 64.6 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.354 0.597 . . . . 0.0 109.624 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . 0.411 HD13 HH12 ' B' ' 315' ' ' ARG . 39.1 tp -63.83 -33.89 76.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.623 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -80.99 -9.97 59.77 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.034 -177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.415 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 93.9 mt -63.53 128.66 92.92 Favored Pre-proline 0 C--O 1.242 0.708 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.032 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.38 126.82 23.8 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.744 2.296 . . . . 0.0 113.025 -176.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -65.13 -44.03 89.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.062 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.89 -24.74 67.62 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.9 -8.02 57.65 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.829 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -121.21 -17.22 7.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.922 0.392 . . . . 0.0 111.506 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.05 -25.65 65.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.619 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.4 -51.53 68.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.822 0.344 . . . . 0.0 110.522 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -76.79 -23.06 52.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.124 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . 0.476 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -61.74 -40.59 95.65 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.121 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . 0.435 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.2 tttt -59.82 -45.3 92.78 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.89 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . 0.506 ' O ' HG23 ' B' ' 347' ' ' VAL . 19.0 mmt85 -62.94 -43.21 99.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.246 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . 0.478 ' NH2' HD22 ' B' ' 314' ' ' LEU . 90.8 mtt180 -64.62 -41.36 96.24 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.114 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 90.5 t -65.2 -44.16 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.588 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 342' ' ' LYS . 76.6 t -61.5 -43.62 97.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.802 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . 0.506 HG23 ' O ' ' B' ' 343' ' ' ARG . 70.4 t -60.22 -45.5 95.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.79 99.66 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.961 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 93.3 mt -63.28 -43.66 97.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.786 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.412 ' O ' HG21 ' B' ' 354' ' ' VAL . 97.6 mt -63.6 -45.64 89.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.967 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.1 -41.54 94.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.091 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.74 -42.86 99.81 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.115 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -67.48 -37.81 83.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.851 0.325 . . . . 0.0 110.948 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . 0.412 HG21 ' O ' ' B' ' 350' ' ' LEU . 70.9 t -61.0 -45.54 98.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.18 -44.68 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.915 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.6 -51.8 56.94 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 96.6 m -66.47 -45.83 78.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -86.58 -6.86 58.77 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -175.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 63.37 69.57 0.56 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.295 0.569 . . . . 0.0 111.516 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.1 mt -101.25 160.03 14.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.87 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -137.07 155.0 50.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.461 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.64 104.61 11.28 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 171.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 32.8 t70 -87.05 114.74 23.92 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -173.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 57.8 mm-40 -59.73 -36.63 76.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.059 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . 0.441 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 6.1 mm-40 -63.31 -42.51 99.03 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 111.013 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -63.24 -39.72 95.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.091 0.472 . . . . 0.0 110.072 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . 0.431 HG21 ' O ' ' B' ' 363' ' ' ASP . 70.5 t -62.81 -37.32 78.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.416 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.2 mmmt -57.4 -44.71 84.78 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.6 -38.85 96.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.082 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.76 -43.06 99.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.65 -44.19 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.095 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.51 -42.18 98.5 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.15 -37.65 81.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.894 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.4 ttm -65.83 -42.21 90.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.049 0.452 . . . . 0.0 110.719 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.28 72.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.044 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 50.6 m -71.6 -4.58 27.89 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.918 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -88.96 -4.02 58.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.877 0.37 . . . . 0.0 111.637 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -112.04 172.64 6.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.217 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.64 -48.38 72.35 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.717 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 21.4 t70 -127.82 116.4 20.78 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.041 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.48 -31.07 42.88 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.368 2.045 . . . . 0.0 113.165 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.1 -43.74 86.38 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 11.4 pt-20 -62.96 -38.86 92.8 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.891 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.91 -42.11 93.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.602 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.19 -44.19 98.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.413 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 36.7 mt-10 -64.95 -44.96 87.72 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.85 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.94 -45.77 89.62 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.16 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -66.59 -39.87 88.64 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.745 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 58.3 p -81.58 -3.36 53.1 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.3 mttt -104.13 13.34 32.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.003 0.43 . . . . 0.0 110.98 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -138.49 118.04 12.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.272 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.64 -41.52 98.24 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -56.17 -50.26 71.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.968 0.413 . . . . 0.0 110.93 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.07 -42.1 99.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.397 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.2 mtp -64.68 -53.94 39.49 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.05 -39.54 83.01 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -61.98 -40.67 96.41 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 48.6 tpp -65.26 -40.63 94.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.838 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' B' ' 395' ' ' MET . 66.8 mtm180 -64.06 -36.21 83.25 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.121 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -61.39 -42.84 99.37 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.728 0.299 . . . . 0.0 110.206 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.33 -44.85 94.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.447 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.98 -41.3 99.51 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.097 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.31 -40.09 96.39 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.649 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . 0.406 ' CD ' ' HZ2' ' B' ' 287' ' ' LYS . 38.0 tt0 -60.45 -43.44 96.85 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . 0.496 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 26.6 mt-10 -65.13 -38.17 89.79 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.616 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.73 -43.32 94.25 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 120.803 0.335 . . . . 0.0 110.38 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.95 90.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.224 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.32 -44.89 94.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.16 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 45.2 mt-10 -66.03 -33.12 75.07 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.004 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.02 96.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.386 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 95.4 t -67.45 -42.92 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.324 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.54 -41.21 97.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.002 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.83 -20.88 66.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.708 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -97.4 -6.87 33.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.301 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -111.21 179.98 3.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.267 0.556 . . . . 0.0 111.801 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.12 130.39 35.11 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.357 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 70.4 t -117.82 130.34 72.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 6.0 t -129.87 135.74 48.73 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.089 0.471 . . . . 0.0 110.674 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -93.32 123.56 36.69 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.238 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . 0.457 ' HZ1' ' CD ' ' B' ' 126' ' ' GLU . 8.9 ptmm? -138.88 133.41 31.91 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.807 0.337 . . . . 0.0 111.155 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -83.64 150.53 25.84 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.795 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -157.29 170.65 21.98 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 20.0 p -79.34 164.3 24.18 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.745 0.307 . . . . 0.0 110.284 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -64.33 -19.47 65.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.059 0.457 . . . . 0.0 111.009 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -61.31 -38.02 85.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.831 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -65.13 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.1 0.476 . . . . 0.0 110.238 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 8.2 mp -73.63 -20.47 60.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.7 mmt -78.25 -9.87 59.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -78.21 83.16 4.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.286 0.565 . . . . 0.0 109.841 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -106.09 4.02 28.72 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.532 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -67.47 -44.86 77.55 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.607 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.951 -179.536 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.792 0.329 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -84.55 95.14 8.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.081 0.467 . . . . 0.0 110.903 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.0 m -134.4 167.51 25.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.007 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.8 m -125.43 97.33 5.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.896 0.379 . . . . 0.0 111.286 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.79 140.65 23.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.742 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.598 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 41.1 tt0 -145.18 169.95 17.18 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.6 t -103.93 157.16 17.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.806 0.276 . . . . 0.0 111.204 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.4 m -123.87 -71.19 0.73 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.835 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -153.56 120.76 5.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.45 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.74 -120.38 20.05 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.733 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 6.8 mp -87.75 -5.5 58.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -71.22 130.1 18.5 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.78 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 4.7 tpp180 -119.03 -161.81 0.87 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -146.38 128.32 15.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.29 -94.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.056 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 m 52.89 87.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.12 0.486 . . . . 0.0 111.603 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 tp -108.65 139.2 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.935 0.398 . . . . 0.0 111.567 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.6 m -106.65 125.73 51.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.1 pt -127.83 157.87 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.703 0.287 . . . . 0.0 111.587 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.537 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -77.3 161.83 27.78 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.479 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.03 -49.06 76.99 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.09 -34.7 78.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.961 0.41 . . . . 0.0 110.608 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -62.21 -40.1 94.97 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.758 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.3 mt -62.13 -48.96 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.168 0.508 . . . . 0.0 110.812 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.51 ' CD ' ' HZ2' ' A' ' 29' ' ' LYS . 39.3 tp10 -67.64 -40.11 84.6 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.008 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -79.65 -67.73 0.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.37 79.28 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -172.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 98.0 t -61.81 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.688 0.28 . . . . 0.0 111.694 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HZ2' ' CD ' ' A' ' 25' ' ' GLU . 12.2 ttmm -63.4 -44.89 93.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.032 0.444 . . . . 0.0 110.306 -178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.5 m -62.79 -42.24 99.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.254 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -63.51 -36.41 83.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.776 0.322 . . . . 0.0 110.584 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.2 mt -62.48 -43.55 98.54 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.706 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.46 -35.02 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.936 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -63.49 -43.07 98.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.46 -29.32 34.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.923 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.95 -39.7 87.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.004 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.43 -21.55 58.1 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.075 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.81 -44.45 96.85 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.06 0.457 . . . . 0.0 109.876 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.4 t -91.75 -2.33 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.075 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 63.37 26.81 15.12 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.998 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -101.12 7.64 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.578 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -63.57 -33.56 75.87 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.952 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.53 -0.58 67.96 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.749 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -94.47 -3.74 49.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.764 0.316 . . . . 0.0 111.192 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -88.04 122.66 31.88 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -66.92 -7.24 20.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -173.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.55 -34.95 3.7 Favored Glycine 0 C--N 1.315 -0.62 0 C-N-CA 120.381 -0.914 . . . . 0.0 114.212 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -63.69 133.87 54.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 117.49 0.645 . . . . 0.0 109.36 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.478 HG11 HG12 ' A' ' 54' ' ' VAL . 20.0 t 64.27 72.62 0.5 Allowed Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.55 ' O ' HG11 ' A' ' 54' ' ' VAL . 58.8 Cg_endo -69.62 161.42 45.98 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.381 2.72 . . . . 0.0 113.691 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.491 ' HA ' HG21 ' A' ' 54' ' ' VAL . 49.3 mtt -62.32 -34.65 77.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -175.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.502 ' HA ' ' HZ1' ' A' ' 29' ' ' LYS . 32.8 p-10 -62.96 -25.61 68.44 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.541 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -92.73 -39.6 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.183 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 50' ' ' PRO . 8.6 m -62.59 -33.05 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 120.659 0.266 . . . . 0.0 111.118 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.43 -32.9 72.88 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.707 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -100.33 -34.35 10.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.619 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -65.54 -43.08 91.08 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -125.61 20.54 7.87 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.737 0.303 . . . . 0.0 111.117 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.649 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -57.38 -45.64 92.69 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 114.536 0.575 . . . . 0.0 114.536 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.02 -19.64 20.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 117.538 0.669 . . . . 0.0 111.369 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 t -63.13 -44.68 94.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.125 -177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.5 p -120.58 19.47 5.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.496 0.665 . . . . 0.0 110.702 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.649 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 39.5 ttm180 -58.12 -29.51 65.57 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.627 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -61.08 -50.48 73.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.538 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.99 -20.74 57.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.046 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.7 t -63.66 -44.2 98.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 99.2 mt -62.63 -40.43 96.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.173 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.2 -43.85 98.54 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.283 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.713 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 37.2 t70 -64.16 -43.23 95.81 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.983 0.391 . . . . 0.0 110.279 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 98.1 mt -61.11 -42.25 98.19 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.871 0.367 . . . . 0.0 110.265 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.3 ttp -61.4 -45.56 93.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.815 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 m -62.43 -44.62 95.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.042 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.713 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 37.6 mtp85 -65.86 -43.65 87.77 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.078 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -65.87 -40.5 91.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.061 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -61.17 -48.16 82.83 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.502 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.4 ' HA ' HG12 ' A' ' 79' ' ' ILE . 20.0 tt -68.53 -39.47 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.498 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.433 ' O ' ' HE3' ' A' ' 81' ' ' LYS . 10.6 t70 -62.35 -41.68 98.78 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.332 0.587 . . . . 0.0 109.431 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -66.05 -45.62 80.74 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.703 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.4 HG12 ' HA ' ' A' ' 76' ' ' ILE . 40.2 pt -65.46 -29.75 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.933 -176.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.26 -44.22 97.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.096 0.474 . . . . 0.0 110.766 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 77' ' ' ASP . 16.2 ptpt -81.79 -24.41 35.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.59 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -87.82 -5.96 58.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.99 0.424 . . . . 0.0 110.437 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 64.2 40.55 6.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.669 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.4 mt -101.75 118.82 49.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.408 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -107.7 102.29 44.24 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.153 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.87 141.59 65.74 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.517 2.145 . . . . 0.0 112.159 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.98 90.5 8.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.375 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.1 -109.89 3.49 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.029 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.14 127.62 24.27 Favored Pre-proline 0 C--N 1.318 -0.775 0 O-C-N 122.852 -0.205 . . . . 0.0 110.991 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.64 161.39 45.42 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.737 2.291 . . . . 0.0 111.298 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -93.61 116.09 28.58 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.316 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.441 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 93.0 m-85 -94.11 127.66 40.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.62 98.31 36.58 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 120.893 0.377 . . . . 0.0 111.334 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 90.6 Cg_endo -97.3 171.69 0.77 Allowed 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 123.471 2.78 . . . . 0.0 110.981 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.66 -175.97 22.4 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.46 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -85.07 135.07 34.15 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -90.95 125.34 35.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.391 0.615 . . . . 0.0 110.876 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -113.49 124.05 51.48 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.1 tp -69.77 123.51 21.62 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.32 -16.3 56.91 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.231 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -113.34 178.83 4.14 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -86.44 168.64 13.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.972 0.415 . . . . 0.0 111.549 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -124.0 146.88 48.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.094 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.0 m -131.54 143.21 50.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.958 0.408 . . . . 0.0 111.241 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -138.43 154.12 48.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.558 ' O ' HG13 ' A' ' 107' ' ' VAL . 21.1 m -93.79 -74.87 0.52 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -175.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 65.41 142.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 124.012 0.925 . . . . 0.0 110.119 -172.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 42.8 mt-10 -119.87 129.9 54.61 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -164.17 146.01 8.82 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 64.31 158.76 0.09 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 175.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.48 156.42 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.548 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -158.19 106.12 1.71 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -82.9 151.63 14.41 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.897 2.398 . . . . 0.0 113.983 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -123.36 145.74 48.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.44 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.75 131.04 73.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.779 0.323 . . . . 0.0 111.801 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -108.22 -85.49 0.52 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.815 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.9 mt 57.44 114.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -132.34 153.66 50.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.146 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.06 19.16 70.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.52 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.43 -41.28 98.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.135 0.493 . . . . 0.0 111.079 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -73.9 -4.72 36.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.565 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -105.41 16.27 25.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.794 0.33 . . . . 0.0 110.99 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 89.7 mt -90.86 122.48 42.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.135 0.493 . . . . 0.0 111.091 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -110.47 124.06 51.06 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.54 133.91 62.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.772 0.32 . . . . 0.0 111.425 -175.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.38 134.0 36.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.54 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -128.0 98.2 27.76 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.871 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.86 126.95 11.76 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.358 2.039 . . . . 0.0 112.386 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.2 mm -109.94 120.92 61.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.622 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.59 162.55 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.334 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -136.7 149.85 48.13 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.088 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.2 t -76.03 127.48 37.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.2 p -113.84 177.25 4.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.245 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -63.29 -34.75 78.37 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.719 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.03 90.91 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.402 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -63.47 -41.99 98.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.572 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.44 -45.5 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.403 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.93 -43.12 99.06 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.543 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.81 99.72 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.307 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.578 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 3.3 tpt -62.65 -46.93 85.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.846 0.355 . . . . 0.0 110.621 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.75 -42.04 97.9 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.598 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -62.14 -43.32 99.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.148 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.7 m -62.66 -41.55 99.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.151 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.2 mt -61.23 -42.67 99.0 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -71.26 -22.17 62.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.369 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.77 -0.55 54.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.519 0.676 . . . . 0.0 110.077 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -116.47 20.95 13.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.954 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -122.33 95.68 4.74 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.52 ' HB2' ' OE1' ' A' ' 159' ' ' GLU . . . -140.68 159.08 42.98 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 173.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.575 HG21 ' O ' ' A' ' 247' ' ' GLU . 6.9 m -122.37 142.82 50.11 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.194 -1.003 . . . . 0.0 112.055 -175.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 41.0 p-90 -74.43 132.12 41.67 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.253 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 244' ' ' GLU . 64.5 tttp -162.84 -63.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 242' ' ' GLU . 40.8 mt-10 -116.17 -96.28 0.46 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -176.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' ' 155' ' ' ASP . 23.3 tptm -92.34 -113.34 0.09 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -167.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 3.5 t70 -152.84 154.93 36.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.529 -172.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 164.22 -34.61 0.28 Allowed Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -152.76 140.2 19.65 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.9 125.98 61.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.225 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.52 ' OE1' ' HB2' ' A' ' 149' ' ' ALA . 4.4 mp0 -88.48 158.86 18.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.22 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -83.39 52.62 2.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.826 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -162.53 9.1 0.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.181 0.515 . . . . 0.0 110.665 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 163' ' ' ARG . 15.8 t70 -104.12 -172.89 2.19 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.528 -175.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.431 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 42.8 ttm180 -121.96 117.44 26.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.601 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.11 130.03 63.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.449 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 55.9 m -86.76 117.56 25.59 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 83.5 mt -126.89 123.04 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.099 0.476 . . . . 0.0 111.702 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -95.13 105.47 17.4 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -124.52 149.58 46.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.476 0.655 . . . . 0.0 112.438 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.5 m -124.52 128.37 48.85 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.423 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.63 142.98 18.95 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.887 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 m -139.53 146.25 39.69 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.54 -86.21 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.328 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -99.44 -45.65 5.76 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.026 0.441 . . . . 0.0 110.003 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.2 15.29 0.23 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.766 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -138.81 148.63 44.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.561 0.219 . . . . 0.0 110.564 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.91 161.79 30.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.468 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -131.31 177.55 7.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.033 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.86 -35.19 72.55 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -105.39 -172.59 24.01 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.863 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.68 32.54 41.01 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.502 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -113.47 114.57 26.74 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.99 146.47 49.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.947 0.404 . . . . 0.0 111.534 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -143.03 122.08 12.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.727 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 59.99 34.82 21.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.665 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -89.08 132.52 34.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.847 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 88.3 t -96.19 124.46 48.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.901 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 63.5 tp -111.5 123.96 51.31 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.019 0.438 . . . . 0.0 111.285 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -111.22 112.23 23.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 73.0 mtm -84.64 160.04 20.46 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.684 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.34 -24.83 28.99 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.411 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -91.36 -6.34 53.12 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.25 46.12 13.47 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.035 -1.079 . . . . 0.0 111.662 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -85.44 -11.75 53.62 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.22 170.51 12.92 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.425 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.2 mp -55.66 132.31 71.92 Favored Pre-proline 0 C--N 1.323 -0.559 0 O-C-N 123.385 0.428 . . . . 0.0 110.063 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -48.36 129.31 19.16 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.264 1.976 . . . . 0.0 111.681 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.68 -33.86 5.91 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.699 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -62.27 -44.7 95.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.602 0.239 . . . . 0.0 110.655 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.56 -40.55 95.76 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.93 -33.25 75.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.006 0.431 . . . . 0.0 110.847 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.03 -22.77 70.82 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.183 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.16 -43.46 97.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -52.17 115.78 1.89 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.446 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 113.78 -10.81 23.22 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.188 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.612 ' HA ' ' OE1' ' A' ' 209' ' ' GLU . 47.7 m80 -98.6 139.03 34.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.036 0.418 . . . . 0.0 111.201 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -98.26 168.94 9.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.62 132.16 48.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.5 33.13 61.35 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.118 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.612 ' OE1' ' HA ' ' A' ' 205' ' ' HIS . 41.9 tt0 -117.86 117.37 29.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.173 0.511 . . . . 0.0 110.388 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -105.1 130.81 53.2 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.815 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -153.36 -23.02 0.15 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 234' ' ' ALA . 80.4 p 60.05 167.88 0.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.776 0.831 . . . . 0.0 112.031 -175.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 19.2 tt -160.41 144.68 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.225 -0.297 . . . . 0.0 110.896 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.99 108.46 15.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.805 0.336 . . . . 0.0 111.381 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.55 122.54 64.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 16.3 p -90.36 -22.69 21.38 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -173.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 70.6 m-85 67.89 140.37 0.07 OUTLIER Pre-proline 0 N--CA 1.483 1.219 0 CA-C-O 121.068 0.461 . . . . 0.0 111.581 -176.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 14.4 Cg_exo -69.54 150.4 69.52 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.455 2.103 . . . . 0.0 112.0 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.422 ' O ' ' HE2' ' A' ' 227' ' ' LYS . 81.0 mm-40 -66.56 -38.56 87.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.992 0.425 . . . . 0.0 110.171 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -86.45 33.3 0.63 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.732 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.482 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 10.9 t80 -70.01 131.4 44.3 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -65.02 -17.23 64.26 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.482 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -98.95 99.62 10.69 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 38.9 tt0 -56.52 -33.07 65.69 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.897 -175.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -66.24 -18.41 65.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.904 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.24 -1.11 9.25 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 14.1 ptmm? -67.81 121.44 15.99 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.397 0.617 . . . . 0.0 112.301 -175.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 82.06 8.43 86.56 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.589 -0.732 . . . . 0.0 114.097 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -118.48 137.94 52.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.528 0.664 . . . . 0.0 110.879 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -91.21 155.4 18.61 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.49 144.57 32.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.733 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 3.4 mppt? -98.74 -15.82 19.19 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 56.37 -149.96 0.45 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.133 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.434 ' HA ' HG23 ' A' ' 212' ' ' THR . . . -141.0 -68.43 0.4 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.753 0.311 . . . . 0.0 110.56 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.2 mt 64.74 91.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.954 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -98.19 -27.68 14.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.291 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.0 tp 52.1 67.01 1.04 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.882 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -65.34 -43.44 90.87 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.424 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 30.7 mtpp -96.98 -80.02 0.45 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -173.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 85.4 t 77.96 139.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -171.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -91.6 -84.05 0.27 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -172.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 153' ' ' GLU . 43.0 tt0 -165.23 103.8 0.75 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 19.6 ttm-85 -166.81 113.92 0.82 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 175.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -177.92 155.24 0.97 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 42.3 tp 67.89 100.8 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.321 0 O-C-N 124.135 0.897 . . . . 0.0 111.18 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.01 111.93 2.8 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.229 1.953 . . . . 0.0 112.889 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.575 ' O ' HG21 ' A' ' 150' ' ' THR . 44.5 tt0 -137.13 147.64 46.14 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.5 mp -73.48 98.88 2.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.984 0.421 . . . . 0.0 111.108 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.9 p -95.24 -89.02 0.25 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.428 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -170.79 -51.41 0.02 OUTLIER 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.9 0.381 . . . . 0.0 111.342 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -81.14 89.39 5.99 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.994 0.426 . . . . 0.0 111.882 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.476 ' CD1' HG22 ' A' ' 253' ' ' ILE . 51.5 p90 -159.02 -13.48 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.214 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.476 HG22 ' CD1' ' A' ' 252' ' ' PHE . 19.0 pt -121.17 -41.28 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.022 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -83.36 -2.95 56.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.35 0.595 . . . . 0.0 110.327 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -124.7 98.26 5.64 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -148.72 -61.2 0.24 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -166.0 -75.64 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.54 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 68.0 t -104.25 117.74 50.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 122.832 -0.216 . . . . 0.0 111.12 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 58.1 -170.0 0.11 Allowed 'General case' 0 CA--C 1.544 0.733 0 O-C-N 123.989 0.806 . . . . 0.0 110.656 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -104.7 112.71 25.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.323 0.582 . . . . 0.0 109.789 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -98.01 167.72 23.02 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.203 -0.998 . . . . 0.0 113.774 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 56.1 p -108.63 -167.39 1.22 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.91 -54.17 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.358 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.3 -38.81 29.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.26 98.18 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.634 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.488 ' O ' HG22 ' A' ' 270' ' ' VAL . 49.0 tp -63.89 -43.21 96.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.555 0.216 . . . . 0.0 110.59 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -63.54 -40.41 96.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.391 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.23 -44.11 89.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.802 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -68.07 -38.12 82.04 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.133 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 266' ' ' LEU . 79.3 t -64.0 -43.35 97.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.656 0.265 . . . . 0.0 110.507 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -59.27 -46.37 88.71 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.993 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.5 ptmt -66.34 -44.49 83.15 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -63.95 -39.47 94.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 270' ' ' VAL . 99.3 mmm -64.47 -40.67 96.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.76 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.99 -35.3 79.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 110.795 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -62.71 -41.77 99.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.759 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -64.61 -37.49 87.75 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.734 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 46.0 tp -61.83 -38.29 87.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.876 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -57.58 -45.53 85.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.861 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.9 m -62.35 -42.39 99.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.605 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.13 82.95 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.057 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.85 -43.73 97.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.297 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.452 ' HD3' ' HG2' ' A' ' 405' ' ' GLU . 1.4 tpm_? -59.54 -46.99 87.27 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.022 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -65.61 -40.69 92.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.398 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -61.09 -43.34 99.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.26 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.43 -44.12 90.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.348 0.594 . . . . 0.0 110.19 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.439 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.5 tttt -62.05 -48.84 78.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.264 -177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.9 p -64.63 -41.38 96.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -65.86 -42.3 90.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.46 -47.23 82.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.959 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 287' ' ' LYS . 48.0 mm -64.57 -44.18 96.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.41 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.414 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 17.1 tp10 -60.16 -45.11 94.21 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 110.681 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.74 -42.7 98.51 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.246 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.48 -41.69 96.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 291' ' ' ILE . 71.3 t -63.16 -45.09 99.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.452 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . 0.414 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.7 mttm -63.83 -42.54 97.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 111.064 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.32 -42.7 62.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -118.75 92.52 3.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -98.54 99.22 10.35 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -106.1 159.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.742 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -64.13 137.5 57.99 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.22 128.52 25.54 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.242 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.439 ' O ' HG13 ' A' ' 307' ' ' ILE . 47.0 Cg_exo -56.6 128.5 30.3 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.344 2.029 . . . . 0.0 111.712 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.37 83.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.735 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.5 -41.53 90.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.9 mt -67.88 -41.65 82.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 311' ' ' ILE . 69.4 mt -61.93 -51.27 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.704 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.85 -43.81 98.1 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 41.6 m -61.6 -45.47 93.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.601 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.67 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 72.9 mm-40 -71.58 -34.1 69.64 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 307' ' ' ILE . 95.1 mt -61.4 -43.79 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.663 0.268 . . . . 0.0 110.723 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 32.7 t70 -62.3 -40.98 98.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.1 t -62.98 -44.67 99.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.275 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 46.1 mt -63.03 -39.39 94.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.956 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 83.9 mtm180 -63.08 -39.82 95.84 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.902 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 84.3 mtt180 -66.02 -38.98 89.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.786 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.58 -43.02 99.86 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.109 0.481 . . . . 0.0 109.943 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.49 -36.62 79.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.326 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.423 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . . . -62.54 -36.94 84.2 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.628 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -62.07 -42.29 99.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.434 0.635 . . . . 0.0 109.876 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -78.23 -6.96 56.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.599 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -91.37 -3.74 56.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.313 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 135.33 -21.41 3.65 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.519 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 118.15 34.11 1.17 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.455 -0.878 . . . . 0.0 111.241 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.46 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 42.0 t-20 -71.97 126.87 30.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . 0.588 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.7 tm-20 -127.8 150.57 49.77 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 6.5 ptpp? 61.94 -39.38 0.14 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.667 1.587 . . . . 0.0 114.057 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.46 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 16.0 mm100 -71.79 -11.58 60.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.271 0.558 . . . . 0.0 110.438 177.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.69 -21.23 66.28 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.987 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.443 HD11 HH12 ' A' ' 315' ' ' ARG . 63.1 tp -62.54 -37.48 86.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.131 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -80.97 -2.85 49.5 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.864 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 74.8 mt -69.42 149.08 97.26 Favored Pre-proline 0 C--O 1.239 0.541 0 O-C-N 122.265 -0.272 . . . . 0.0 110.394 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.6 143.77 99.46 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.658 2.239 . . . . 0.0 113.113 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 25.5 ttt85 -83.31 -42.17 17.44 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.808 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -57.99 -43.74 86.78 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.413 ' HB2' ' OE2' ' A' ' 224' ' ' GLU . 88.7 mt -85.74 -3.27 58.85 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.808 -176.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -104.64 -27.58 11.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.948 0.404 . . . . 0.0 110.151 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.1 -25.56 67.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.661 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -60.14 -48.04 83.38 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.845 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -80.79 -22.11 40.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.599 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.29 -41.95 99.03 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.429 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.467 ' O ' HG22 ' A' ' 346' ' ' VAL . 87.8 tttt -60.06 -46.2 90.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.16 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.537 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.0 mmt85 -62.01 -45.64 92.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.418 ' NH2' HD21 ' A' ' 314' ' ' LEU . 91.1 mtt180 -67.14 -38.09 84.94 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.451 -178.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 341' ' ' ALA . 78.7 t -64.44 -44.24 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.648 0.261 . . . . 0.0 110.599 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 342' ' ' LYS . 69.5 t -61.71 -43.34 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.572 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 343' ' ' ARG . 76.4 t -60.17 -45.2 96.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.9 -42.53 99.75 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.141 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.77 -44.75 92.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.659 0.266 . . . . 0.0 111.334 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.03 -46.71 83.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.275 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.26 -38.69 78.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.412 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.72 -42.92 96.6 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.196 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.08 -36.48 79.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.831 0.316 . . . . 0.0 110.881 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.81 -44.67 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.63 -44.23 98.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.841 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -69.87 -46.25 65.92 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.9 m -66.73 -44.98 80.12 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -90.71 4.77 50.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.967 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 53.06 47.61 24.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.109 0.48 . . . . 0.0 111.632 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.9 mt -73.37 140.26 46.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.877 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -119.86 153.63 35.53 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.851 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.13 110.04 15.16 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.459 ' O ' HG21 ' A' ' 367' ' ' VAL . 23.1 t70 -83.46 112.46 19.98 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.918 -174.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 15.7 mm-40 -59.36 -38.73 81.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.629 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.76 -42.85 90.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.431 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -62.33 -38.32 89.0 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 363' ' ' ASP . 99.0 t -64.42 -40.08 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.632 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.8 mmmt -56.65 -44.54 81.44 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.59 -40.14 98.35 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.197 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.97 -42.26 99.78 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.694 0.283 . . . . 0.0 110.639 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.13 -44.3 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.713 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.11 -39.23 89.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.45 -36.14 80.61 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.488 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 51.0 ttm -65.61 -39.8 91.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.103 0.478 . . . . 0.0 110.202 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.54 -29.79 70.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.86 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 13.2 m -72.53 -5.58 37.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.585 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.51 -8.73 52.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 0.0 110.843 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -107.36 171.09 7.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.235 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.28 -36.78 85.23 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.338 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -133.67 109.12 12.06 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 120.878 0.37 . . . . 0.0 110.736 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.96 -39.64 89.95 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.058 2.505 . . . . 0.0 113.728 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -64.36 -42.69 96.06 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.28 -37.96 87.5 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.061 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.24 -43.43 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.0 -44.94 99.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.463 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 53.9 mt-10 -68.75 -42.12 77.99 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.976 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -59.36 -46.52 88.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.828 0.347 . . . . 0.0 111.119 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.18 -41.43 94.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.664 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 32.9 p -80.23 -6.47 57.9 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 97.9 mttt -101.0 5.23 43.03 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.876 0.37 . . . . 0.0 111.0 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -126.06 119.38 27.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -62.62 -43.69 98.17 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -57.67 -49.82 75.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.762 0.315 . . . . 0.0 111.169 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.2 -42.64 99.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.545 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.2 mtp -65.44 -44.38 87.46 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.52 -42.23 71.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.459 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.99 -41.56 99.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.57 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 51.4 tpp -62.98 -41.37 99.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.843 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.444 ' HG2' HG23 ' A' ' 367' ' ' VAL . 73.4 mtm180 -65.38 -37.49 87.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.908 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.55 -44.32 96.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.41 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.65 -45.2 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.083 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.51 94.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.728 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 51.3 tp -63.08 -40.49 97.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.327 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.45 -42.56 98.95 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.598 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.452 ' HG2' ' HD3' ' A' ' 283' ' ' ARG . 29.0 mt-10 -64.96 -40.21 94.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.737 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -59.93 -41.67 92.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.554 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.33 87.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.024 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.58 -43.87 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.191 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.45 -33.58 76.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.439 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.77 98.21 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.98 0.419 . . . . 0.0 110.149 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 97.4 t -65.44 -43.07 94.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.329 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.17 -39.82 91.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -70.3 -13.02 61.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.462 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -108.83 3.04 22.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.102 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.37 173.27 6.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.337 0.589 . . . . 0.0 111.766 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -84.84 107.42 16.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.245 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.2 133.37 36.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.383 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.8 t -137.48 148.4 46.03 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.118 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -97.57 128.47 44.33 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.009 0.433 . . . . 0.0 110.965 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -134.52 127.98 32.44 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.627 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -101.16 144.12 30.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.388 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.4 t -152.4 -176.27 5.63 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.871 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.8 p -81.66 162.58 22.98 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.961 0.41 . . . . 0.0 110.836 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -67.89 -17.78 64.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.804 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -61.53 -41.67 97.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.928 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.39 -26.74 63.84 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.518 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.1 -21.35 59.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.158 0.504 . . . . 0.0 110.064 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.5 mmt -79.65 -7.11 58.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.997 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -80.48 87.39 5.69 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.503 0.668 . . . . 0.0 109.659 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -120.73 30.43 6.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.105 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -65.9 -37.14 85.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.948 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.753 179.551 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.553 0.216 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -83.77 101.29 11.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.82 160.55 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.928 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -114.42 106.59 14.48 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.858 0.361 . . . . 0.0 110.777 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -155.55 136.99 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.61 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.574 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 43.5 tt0 -142.99 169.27 17.88 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.0 t -101.02 153.8 19.24 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 117.705 0.23 . . . . 0.0 111.218 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 57.7 m -120.44 -65.76 1.12 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -162.1 123.95 2.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.465 0.174 . . . . 0.0 110.549 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.1 -120.09 18.46 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.814 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' B' ' 108' ' ' GLU . 6.8 mp -89.23 -5.86 57.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' B' ' 107' ' ' VAL . . . -70.52 132.57 22.82 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.088 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.574 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 3.5 tpp180 -121.25 -162.64 0.98 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -145.45 127.78 15.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.64 -94.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.135 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m 52.28 89.29 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.202 0.525 . . . . 0.0 111.479 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 tp -111.22 136.29 47.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.014 0.435 . . . . 0.0 111.693 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 46.1 m -101.72 126.9 48.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 17.2 pt -126.24 160.8 33.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.869 0.366 . . . . 0.0 111.794 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.566 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -81.02 161.27 24.29 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.333 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.81 77.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.322 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -65.8 -35.62 81.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.999 0.428 . . . . 0.0 110.407 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -63.01 -40.13 96.84 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.02 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.566 HG13 ' O ' ' B' ' 20' ' ' ALA . 74.8 mt -61.52 -48.65 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.328 0.585 . . . . 0.0 110.552 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.553 ' CD ' ' HZ2' ' B' ' 29' ' ' LYS . 40.7 tp10 -68.72 -44.39 73.98 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.133 -177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 12.3 m -77.69 -56.86 4.17 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.11 -46.84 55.1 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 97.6 t -63.03 -45.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.553 ' HZ2' ' CD ' ' B' ' 25' ' ' GLU . 12.7 ttmm -62.92 -45.7 91.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.993 0.425 . . . . 0.0 110.695 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 20.8 m -64.42 -36.64 84.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.287 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.4 -39.91 92.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.213 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.41 -43.24 99.3 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.714 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -70.3 -37.7 71.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.181 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.47 -41.39 96.53 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.19 -32.22 50.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.804 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.23 -40.99 94.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.021 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.03 -28.21 65.29 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.402 177.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.52 -44.35 89.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.69 -3.33 9.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.358 0.599 . . . . 0.0 109.939 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 63.67 27.48 14.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.909 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.9 pp -103.18 6.94 10.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.056 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -64.83 -29.15 70.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.951 0.405 . . . . 0.0 110.888 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.82 -2.62 82.12 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.603 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -92.98 -4.17 53.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.696 0.284 . . . . 0.0 111.533 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -87.37 128.93 35.19 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -73.78 -2.31 22.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -173.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.97 -37.23 2.84 Favored Glycine 0 C--N 1.314 -0.69 0 C-N-CA 120.473 -0.87 . . . . 0.0 114.246 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -61.26 132.48 53.75 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 117.482 0.641 . . . . 0.0 109.525 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.496 HG11 HG12 ' B' ' 54' ' ' VAL . 21.3 t 64.5 71.69 0.55 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -172.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.526 ' O ' HG11 ' B' ' 54' ' ' VAL . 59.0 Cg_endo -69.59 161.4 46.06 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.373 2.715 . . . . 0.0 113.755 -176.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.508 ' HA ' HG21 ' B' ' 54' ' ' VAL . 50.6 mtt -61.94 -33.97 75.24 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . 0.445 ' HA ' ' HZ1' ' B' ' 29' ' ' LYS . 31.7 p-10 -63.14 -24.43 67.89 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.552 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 99.1 mt -95.45 -38.9 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.465 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.526 HG11 ' O ' ' B' ' 50' ' ' PRO . 10.2 m -62.46 -33.78 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.329 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.421 ' O ' ' HA3' ' B' ' 59' ' ' GLY . . . -60.33 -32.91 71.69 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.645 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -100.64 -34.05 10.04 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.688 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -65.7 -42.82 90.73 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -126.33 19.03 7.56 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.682 0.277 . . . . 0.0 110.979 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.639 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -57.21 -47.97 83.64 Favored Glycine 0 C--O 1.222 -0.629 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.281 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.8 -23.14 22.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.283 0.541 . . . . 0.0 111.683 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -62.08 -45.65 92.57 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.149 -176.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.514 ' O ' HG23 ' B' ' 66' ' ' VAL . 10.5 p -119.11 21.45 5.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.545 0.688 . . . . 0.0 110.592 -177.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.639 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 35.1 ttm180 -59.86 -26.65 66.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.737 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -63.33 -49.59 73.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.451 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . 0.43 ' HB2' HG21 ' B' ' 62' ' ' VAL . 2.9 m-20 -75.84 -21.52 57.17 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.027 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.514 HG23 ' O ' ' B' ' 62' ' ' VAL . 79.6 t -63.24 -44.1 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.5 -40.39 96.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.345 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.53 -43.27 99.26 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.361 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . 0.756 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 37.6 t70 -64.06 -43.63 94.89 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 117.085 0.442 . . . . 0.0 110.192 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.15 -42.64 98.92 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 110.245 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.5 ttp -60.92 -45.31 95.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.862 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -62.34 -44.69 95.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.117 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.756 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 34.2 mtp85 -66.66 -43.16 85.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.046 -176.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -65.13 -40.97 95.18 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.88 0.371 . . . . 0.0 111.073 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.3 -48.25 82.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.499 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 20.1 tt -68.51 -38.75 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.36 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.91 -41.92 99.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.185 0.516 . . . . 0.0 109.81 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' B' ' 81' ' ' LYS . . . -66.08 -45.57 80.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.595 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 46.0 pt -64.95 -30.67 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.99 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.59 -44.32 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.019 0.437 . . . . 0.0 110.773 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' B' ' 78' ' ' ALA . 16.4 ptpt -81.03 -28.71 35.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.633 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -81.82 -6.88 59.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.971 0.415 . . . . 0.0 110.248 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 65.5 38.87 5.36 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.509 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.407 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 84.4 mt -100.58 118.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.678 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -106.78 100.88 33.79 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.356 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 24.0 Cg_exo -63.63 139.83 71.74 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.591 2.194 . . . . 0.0 112.208 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.64 94.13 8.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.024 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.92 -125.34 7.15 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.642 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.67 127.19 27.1 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-O 120.517 0.199 . . . . 0.0 110.935 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.77 158.11 53.88 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.618 2.212 . . . . 0.0 110.98 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 54.2 m -92.2 118.84 31.26 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.189 0.518 . . . . 0.0 110.744 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.466 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.7 m-85 -98.14 125.35 43.12 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.42 102.09 42.39 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-O 120.899 0.381 . . . . 0.0 110.971 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.8 Cg_endo -96.75 -167.81 0.12 Allowed 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 123.228 2.619 . . . . 0.0 110.854 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -130.36 -176.28 14.36 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -86.06 126.89 34.51 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -85.76 127.95 34.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.095 0.474 . . . . 0.0 110.852 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -113.63 140.99 47.74 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 38.0 tp -85.56 112.06 20.59 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.16 -177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.85 -7.68 27.62 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.688 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -120.37 172.63 7.67 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -82.16 168.44 17.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.297 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -121.28 143.68 49.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.45 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 85.6 m -125.67 136.86 53.68 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.007 0.432 . . . . 0.0 111.601 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -134.71 154.22 51.65 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.555 ' O ' HG13 ' B' ' 107' ' ' VAL . 21.4 m -95.97 -74.17 0.57 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.555 HG13 ' O ' ' B' ' 106' ' ' SER . 0.3 OUTLIER 65.36 142.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.9 0.88 . . . . 0.0 110.251 -172.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' B' ' 11' ' ' LEU . 45.2 mt-10 -119.18 130.79 55.69 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -173.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -164.62 143.67 7.1 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.759 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.66 157.19 0.06 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 m -136.04 162.29 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.75 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -161.5 106.26 1.2 Allowed Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.399 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.29 154.43 41.12 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.261 2.64 . . . . 0.0 113.923 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -127.54 142.63 51.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.078 0.951 . . . . 0.0 108.77 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 64.2 t -126.77 131.68 70.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.847 0.356 . . . . 0.0 111.746 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -110.67 -86.22 0.54 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.699 176.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 97.5 mt 59.32 121.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -137.6 157.39 46.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.147 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.48 19.63 77.85 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.909 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.91 -39.91 95.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.282 0.563 . . . . 0.0 110.672 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -74.25 -5.71 43.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.346 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -105.82 17.28 23.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.94 0.4 . . . . 0.0 110.93 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 86.9 mt -91.62 119.39 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.242 0.544 . . . . 0.0 111.199 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -108.52 122.8 47.81 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.43 135.5 57.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.625 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -78.7 138.6 38.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.568 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -133.28 97.75 16.04 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.73 121.12 6.8 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.232 1.955 . . . . 0.0 112.418 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.8 mm -105.67 116.01 48.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.859 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.82 163.49 37.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.352 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -136.51 156.77 48.12 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.96 125.84 39.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.4 p -111.89 175.08 5.57 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.458 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.02 -36.59 82.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.4 82.97 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.635 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.86 -42.09 97.63 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.367 0.604 . . . . 0.0 109.569 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.78 -45.43 98.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.517 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.3 -43.01 99.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.867 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.58 -41.94 99.75 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.449 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' MET . . . . . 0.557 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 3.5 tpt -62.55 -46.76 86.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.796 0.332 . . . . 0.0 110.452 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.52 -41.66 98.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.3 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.67 -44.19 96.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.318 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.9 m -62.83 -41.92 99.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.261 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.3 mt -60.9 -42.57 98.28 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -70.93 -20.44 62.47 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.451 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.68 1.28 54.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.375 0.607 . . . . 0.0 110.096 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.5 23.57 11.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.817 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -125.31 86.27 2.52 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . 0.504 ' HB2' ' OE1' ' B' ' 159' ' ' GLU . . . -131.54 159.42 38.22 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 172.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.558 HG21 ' O ' ' B' ' 247' ' ' GLU . 6.3 m -121.1 143.39 49.11 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.112 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . 0.553 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 44.7 p-90 -74.74 132.28 41.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.034 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.49 ' HG2' ' HG3' ' B' ' 153' ' ' GLU . 65.1 tttp -163.19 -64.71 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . 0.49 ' HG3' ' HG2' ' B' ' 152' ' ' LYS . 64.3 mt-10 -117.42 -92.6 0.52 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' B' ' 155' ' ' ASP . 22.2 tptm -94.5 -117.85 0.1 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -169.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . 0.424 ' N ' ' HG3' ' B' ' 154' ' ' LYS . 14.2 t70 -147.52 154.87 41.28 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 122.923 0.489 . . . . 0.0 110.85 -174.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 166.21 -34.56 0.23 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.238 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.35 140.44 18.4 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' B' ' 243' ' ' ARG . 59.3 t -129.35 127.5 65.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.354 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . 0.504 ' OE1' ' HB2' ' B' ' 149' ' ' ALA . 4.7 mp0 -88.38 159.2 18.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.184 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.26 49.3 1.63 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.776 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -158.49 6.39 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.78 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' B' ' 163' ' ' ARG . 13.1 t70 -102.53 -170.38 1.8 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.601 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . 0.504 ' H ' ' CG ' ' B' ' 162' ' ' ASP . 42.7 ttm180 -124.13 117.98 25.88 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.115 0.566 . . . . 0.0 110.727 -176.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.29 128.49 64.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.289 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 73.1 m -84.23 116.9 23.19 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 87.3 mt -126.27 124.52 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.126 0.489 . . . . 0.0 111.835 -176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . 0.453 ' OD2' ' HA ' ' B' ' 183' ' ' SER . 6.2 m-20 -95.24 109.35 21.48 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -127.67 150.54 49.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.444 0.64 . . . . 0.0 112.439 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.6 m -124.88 128.05 48.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.571 177.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.7 141.06 20.8 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.747 -0.74 . . . . 0.0 113.672 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 41.1 m -141.02 144.27 34.9 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 42.0 t -84.44 -83.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.94 0.4 . . . . 0.0 110.841 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -105.38 -40.58 5.77 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.18 0.514 . . . . 0.0 110.054 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.5 21.05 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.259 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -142.8 149.6 38.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 120.779 0.323 . . . . 0.0 110.404 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.41 151.49 32.73 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.976 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -120.69 -179.23 3.93 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.457 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.52 -42.54 87.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.03 -172.07 31.32 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.972 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.37 29.65 48.64 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.551 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -110.48 113.81 26.73 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -137.39 147.02 45.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.042 0.449 . . . . 0.0 111.59 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.453 ' HA ' ' OD2' ' B' ' 167' ' ' ASP . 67.8 m -146.51 129.41 16.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.313 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 58.56 31.85 21.49 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.564 0.54 . . . . 0.0 110.126 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -89.63 135.26 33.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.709 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 93.1 t -99.69 123.52 52.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.922 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.81 122.73 48.56 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.129 0.49 . . . . 0.0 111.457 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . 0.434 ' HB2' ' CZ ' ' B' ' 193' ' ' ARG . . . -111.33 111.6 22.76 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 73.9 mtm -83.86 163.69 19.93 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.303 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.54 -13.86 60.99 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.606 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -102.67 -8.22 21.09 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 79.15 48.56 6.83 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 119.928 -1.13 . . . . 0.0 111.403 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.434 ' CZ ' ' HB2' ' B' ' 188' ' ' ALA . 95.0 mtt180 -89.53 -10.35 46.5 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.51 170.32 13.87 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.06 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.468 ' H ' HD12 ' B' ' 195' ' ' ILE . 4.1 mp -54.84 133.18 66.43 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 123.347 0.404 . . . . 0.0 110.162 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -48.55 129.93 20.95 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.359 2.04 . . . . 0.0 111.776 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.04 -32.66 6.64 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.913 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -62.27 -44.38 96.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.677 0.275 . . . . 0.0 110.639 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.75 -40.63 97.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.734 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.85 -34.8 78.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.086 0.469 . . . . 0.0 110.676 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -63.52 -26.43 69.67 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.366 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.62 -43.35 98.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 109.676 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -50.86 119.59 4.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.477 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 108.2 -10.62 36.76 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.598 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.633 ' HA ' ' OE1' ' B' ' 209' ' ' GLU . 46.6 m80 -96.2 141.09 29.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.11 0.455 . . . . 0.0 111.422 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -100.46 166.69 10.81 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.8 131.98 51.63 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.02 27.55 70.19 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.701 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . 0.633 ' OE1' ' HA ' ' B' ' 205' ' ' HIS . 44.5 tt0 -112.27 111.7 22.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.273 0.559 . . . . 0.0 110.365 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.14 129.31 44.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.687 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -148.94 -26.51 0.3 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.455 HG23 ' HA ' ' B' ' 234' ' ' ALA . 50.8 p 60.67 160.33 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.935 0.894 . . . . 0.0 111.975 -176.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' B' ' 232' ' ' LYS . 18.9 tt -153.06 148.65 13.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 122.135 -0.353 . . . . 0.0 110.825 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -81.27 109.59 15.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.217 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 59.8 t -112.87 122.81 67.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 11.9 p -93.5 -21.62 19.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 68.12 137.4 0.05 OUTLIER Pre-proline 0 N--CA 1.482 1.142 0 CA-C-O 121.037 0.446 . . . . 0.0 111.75 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' B' ' 221' ' ' TYR . 16.5 Cg_exo -67.72 149.57 78.83 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.433 2.089 . . . . 0.0 112.006 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . 0.438 ' O ' ' HE2' ' B' ' 227' ' ' LYS . 75.1 mm-40 -66.71 -39.36 88.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.522 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -86.03 32.51 0.61 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.895 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 9.2 t80 -66.72 134.63 52.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -67.66 -15.32 63.59 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.448 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -101.18 105.0 16.09 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.42 ' OE1' ' HG2' ' B' ' 333' ' ' PRO . 42.1 tt0 -60.11 -33.24 71.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.672 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -66.82 -19.03 65.66 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.064 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.7 mt -121.39 0.62 10.05 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' B' ' 219' ' ' GLU . 14.9 ptmm? -68.34 119.27 12.58 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.48 0.657 . . . . 0.0 112.118 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.85 17.24 75.45 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.339 -0.846 . . . . 0.0 114.106 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -123.85 129.63 51.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.774 0.787 . . . . 0.0 111.182 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.39 153.16 29.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.005 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.96 143.55 31.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.315 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' B' ' 213' ' ' ILE . 3.9 mppt? -100.13 -14.31 18.6 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 55.45 -148.67 0.48 Allowed 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.346 0.404 . . . . 0.0 111.516 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.455 ' HA ' HG23 ' B' ' 212' ' ' THR . . . -142.75 -69.22 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.893 0.378 . . . . 0.0 110.496 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 86.2 mt 65.89 87.25 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.992 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -92.35 -27.09 17.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.19 176.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 12.3 tp 51.65 66.92 1.05 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.806 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -66.09 -43.09 88.27 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . 0.418 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 29.9 mtpp -97.14 -77.78 0.49 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -173.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' B' ' 239' ' ' LYS . 87.7 t 76.62 142.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -95.3 -86.15 0.3 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -173.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -163.53 104.13 0.94 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 119.876 -0.729 . . . . 0.0 112.79 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 19.0 ttm-85 -168.72 115.1 0.63 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.954 0.407 . . . . 0.0 111.949 175.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' B' ' 152' ' ' LYS . 0.1 OUTLIER -178.31 155.4 0.9 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 46.8 tp 67.95 100.13 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 124.041 0.838 . . . . 0.0 111.343 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.15 111.3 2.43 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.523 2.149 . . . . 0.0 112.717 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . 0.558 ' O ' HG21 ' B' ' 150' ' ' THR . 43.1 tt0 -135.18 148.74 49.78 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.39 94.54 3.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.803 0.335 . . . . 0.0 111.173 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 22.1 p -91.09 -88.22 0.19 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.599 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -172.75 -47.97 0.02 OUTLIER 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.952 0.406 . . . . 0.0 111.218 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.97 94.77 7.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.076 0.465 . . . . 0.0 111.839 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . 0.521 ' CD1' HG22 ' B' ' 253' ' ' ILE . 51.5 p90 -164.89 -22.43 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.464 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . 0.521 HG22 ' CD1' ' B' ' 252' ' ' PHE . 19.6 pt -110.93 -42.39 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -82.06 -7.59 59.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.481 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -121.22 97.61 5.6 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -149.96 -59.77 0.2 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.161 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -164.61 -84.18 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.636 -1.269 . . . . 0.0 113.54 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 66.4 t -99.0 121.25 49.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.472 0.177 . . . . 0.0 111.038 -177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 57.91 -169.41 0.12 Allowed 'General case' 0 CA--C 1.547 0.831 0 O-C-N 123.975 0.797 . . . . 0.0 110.439 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -106.1 114.63 28.88 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -100.64 164.03 18.76 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.108 -1.044 . . . . 0.0 114.057 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 33.8 p -105.85 -175.43 2.79 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.68 -49.26 85.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.06 -36.89 20.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.0 -43.36 97.49 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.731 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.473 ' O ' HG22 ' B' ' 270' ' ' VAL . 49.6 tp -63.57 -43.4 97.11 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 120.612 0.244 . . . . 0.0 110.618 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -61.71 -43.01 99.67 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.786 0.327 . . . . 0.0 111.153 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.49 -44.66 86.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.064 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -67.74 -37.21 81.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.915 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.473 HG22 ' O ' ' B' ' 266' ' ' LEU . 69.0 t -64.69 -43.08 96.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.595 0.236 . . . . 0.0 110.476 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -59.01 -46.82 87.23 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.4 ptmt -67.26 -43.66 81.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 0.0 111.62 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -64.48 -39.89 94.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.773 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.6 mmm -63.67 -42.06 98.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 110.736 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -68.97 -31.76 70.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.8 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -63.61 -41.78 98.28 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -65.8 -35.15 79.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.565 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 47.7 tp -61.95 -37.77 85.96 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.815 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -57.87 -44.98 86.97 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.805 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 19.4 m -61.86 -42.98 99.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.382 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.0 83.59 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.329 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.36 -44.12 98.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.795 0.331 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . 0.523 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.7 OUTLIER -60.14 -46.49 89.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.215 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -65.61 -40.29 92.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.523 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -60.69 -44.17 96.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.183 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.09 -44.62 91.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.177 0.513 . . . . 0.0 110.1 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . 0.467 ' HZ2' ' CD ' ' B' ' 404' ' ' GLU . 88.3 tttt -61.42 -48.17 82.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.856 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 74.8 p -65.01 -42.37 94.51 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -65.28 -42.88 92.72 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.025 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.63 -47.0 83.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.029 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . 0.459 ' O ' HG23 ' B' ' 295' ' ' VAL . 34.7 mm -64.41 -44.0 97.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.102 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -60.14 -46.19 90.49 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.925 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.24 -42.44 99.32 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.202 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.37 -41.46 96.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 291' ' ' ILE . 74.1 t -62.29 -45.33 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 O-C-N 123.114 0.259 . . . . 0.0 111.327 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -64.71 -41.95 95.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.852 0.358 . . . . 0.0 111.286 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.84 -39.65 63.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -121.7 82.92 2.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.63 94.44 9.03 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.9 tp -104.03 156.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.232 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.21 134.09 56.72 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 41.0 t -106.87 129.08 24.92 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.501 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . 0.417 ' O ' HG13 ' B' ' 307' ' ' ILE . 50.0 Cg_exo -55.92 128.3 29.67 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.427 2.085 . . . . 0.0 111.832 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.51 85.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.195 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.32 87.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.376 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.75 -41.88 95.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.786 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . 0.503 ' O ' HG13 ' B' ' 311' ' ' ILE . 69.1 mt -62.03 -49.88 82.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.502 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -42.33 99.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.55 -176.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.3 m -62.99 -45.85 90.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.97 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . 0.666 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 63.6 mm-40 -70.86 -34.02 71.22 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.503 HG13 ' O ' ' B' ' 307' ' ' ILE . 95.2 mt -61.46 -44.29 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.836 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.505 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 35.5 t70 -63.17 -39.89 95.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.985 0.421 . . . . 0.0 110.826 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.04 -43.8 97.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.458 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 56.7 mt -62.74 -39.34 93.79 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.864 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 81.5 mtm180 -63.23 -38.92 93.05 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 87.5 mtt180 -65.49 -39.55 92.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.729 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -63.25 -43.21 98.64 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.172 0.51 . . . . 0.0 110.183 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.81 80.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.237 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' B' ' 325' ' ' ASN . . . -62.5 -37.06 84.54 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.769 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -62.41 -42.41 99.41 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.567 0.699 . . . . 0.0 109.691 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.16 -6.98 56.44 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.702 -177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -89.75 -3.46 58.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.885 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.62 -33.93 2.42 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.099 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 133.27 43.21 0.15 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . 0.469 ' O ' ' HB3' ' B' ' 319' ' ' ALA . 42.5 t-20 -81.65 118.98 23.25 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.094 0.473 . . . . 0.0 109.861 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 2.4 tm-20 -120.53 151.28 39.59 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 5.7 ptpp? 61.66 -39.19 0.13 Allowed 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.774 1.63 . . . . 0.0 114.145 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . 0.465 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.3 mm100 -72.79 -11.27 60.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.349 0.595 . . . . 0.0 110.577 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -64.13 -20.91 66.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.171 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . 0.435 HD11 HH12 ' B' ' 315' ' ' ARG . 52.3 tp -62.74 -36.88 84.47 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.077 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.14 -6.43 54.71 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.582 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.436 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 77.4 mt -68.65 149.7 97.88 Favored Pre-proline 0 C--O 1.24 0.564 0 O-C-N 122.33 -0.231 . . . . 0.0 110.85 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . 0.42 ' HG2' ' OE1' ' B' ' 224' ' ' GLU . 38.7 Cg_exo -60.75 145.32 99.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.851 2.367 . . . . 0.0 113.281 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . 0.418 HH21 ' HD2' ' B' ' 334' ' ' ARG . 24.8 ttt85 -85.78 -41.62 14.91 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.417 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -57.96 -39.62 78.57 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -172.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . 0.403 ' HB2' ' OE2' ' B' ' 224' ' ' GLU . 93.6 mt -89.63 -3.88 58.06 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.757 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -105.63 -25.12 12.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.983 0.42 . . . . 0.0 110.206 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.2 -26.23 66.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.909 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.34 -51.26 70.26 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 120.931 0.396 . . . . 0.0 110.548 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -73.69 -27.28 61.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.659 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . 0.435 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -60.95 -43.6 98.48 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . 0.489 ' O ' HG22 ' B' ' 346' ' ' VAL . 87.8 tttt -59.73 -45.88 90.84 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . 0.571 ' O ' HG23 ' B' ' 347' ' ' VAL . 11.1 mmt85 -61.44 -46.25 90.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.833 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . 0.445 ' NH2' HD21 ' B' ' 314' ' ' LEU . 92.0 mtt180 -67.12 -37.63 84.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 341' ' ' ALA . 69.2 t -64.99 -44.03 96.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.708 0.289 . . . . 0.0 110.374 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.489 HG22 ' O ' ' B' ' 342' ' ' LYS . 74.3 t -61.61 -43.97 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.765 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . 0.571 HG23 ' O ' ' B' ' 343' ' ' ARG . 85.8 t -59.65 -45.0 94.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.14 99.42 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.382 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.55 -44.14 95.05 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.679 0.276 . . . . 0.0 111.225 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.416 ' O ' HG22 ' B' ' 354' ' ' VAL . 96.2 mt -64.2 -46.77 82.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.18 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.06 -39.75 82.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.385 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.65 -41.47 97.4 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.971 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -67.3 -36.7 82.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.979 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . 0.416 HG22 ' O ' ' B' ' 350' ' ' LEU . 94.3 t -61.49 -44.37 98.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.379 0.609 . . . . 0.0 109.362 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.44 -44.42 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.932 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -70.38 -46.51 63.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.927 0.394 . . . . 0.0 112.02 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 100.0 m -65.7 -42.98 90.51 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -95.14 6.24 49.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 53.02 52.13 14.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.49 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 99.2 mt -77.23 133.8 38.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.116 0.484 . . . . 0.0 111.395 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -110.71 153.33 25.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.05 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.38 109.4 14.84 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . 0.486 ' O ' HG21 ' B' ' 367' ' ' VAL . 18.3 t70 -81.75 110.86 17.46 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.201 0.524 . . . . 0.0 112.039 -173.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . 0.525 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 50.8 mm-40 -59.18 -40.73 86.6 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.237 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.51 -39.75 88.84 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.481 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -62.12 -38.81 90.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . 0.486 HG21 ' O ' ' B' ' 363' ' ' ASP . 99.1 t -63.76 -40.09 87.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.65 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 30.2 mmmt -56.49 -44.61 80.83 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.416 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.59 97.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.031 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.52 -42.47 99.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.905 0.384 . . . . 0.0 110.739 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.51 -45.1 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.28 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.81 -37.97 87.69 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -66.58 -39.45 88.45 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.524 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.7 ttm -64.54 -40.71 96.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.171 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.86 -27.01 68.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.328 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 50.6 m -75.74 -3.41 34.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.286 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -94.08 -1.25 54.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.946 0.403 . . . . 0.0 110.928 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.54 169.88 8.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.267 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.72 -40.43 87.98 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.414 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 19.6 t70 -131.69 109.64 14.54 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-O 120.914 0.388 . . . . 0.0 111.041 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.28 -40.63 83.47 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.967 2.445 . . . . 0.0 114.297 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -64.84 -43.16 93.94 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 15.7 pt-20 -62.59 -37.17 85.2 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.324 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.93 -42.84 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.339 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.23 -44.43 99.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.419 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 44.9 mt-10 -66.88 -44.35 81.13 Favored 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.997 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -59.1 -46.51 88.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.58 -41.9 92.36 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.673 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 60.2 p -79.37 -6.84 57.68 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 98.8 mttt -103.04 7.47 38.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.027 0.441 . . . . 0.0 110.922 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -125.32 118.91 26.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.77 -42.3 97.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.171 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.68 -50.72 72.26 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.878 0.37 . . . . 0.0 111.0 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.72 -42.68 97.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.867 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.429 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 90.3 mtp -65.38 -45.15 85.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.62 -39.96 66.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.221 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -62.53 -41.98 99.22 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.625 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 49.4 tpp -63.28 -40.86 98.57 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.743 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.43 ' HG2' HG23 ' B' ' 367' ' ' VAL . 71.1 mtm180 -65.11 -37.12 86.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.846 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.24 -44.39 96.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.414 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 94.3 t -66.0 -45.17 91.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.758 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.23 93.9 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.6 -40.47 97.04 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.313 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . 0.467 ' CD ' ' HZ2' ' B' ' 287' ' ' LYS . 35.7 tt0 -61.82 -43.04 99.64 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.707 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . 0.523 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 23.4 mt-10 -64.07 -40.69 96.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.467 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -60.0 -41.53 92.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.49 -46.29 86.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.128 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 95.2 t -65.94 -43.83 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.038 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.26 -34.1 77.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.0 96.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 110.198 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.25 -42.92 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.147 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.73 -39.36 91.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.952 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -68.68 -14.75 63.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.645 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -107.45 -6.59 16.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.532 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.95 170.04 9.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.169 0.509 . . . . 0.0 111.883 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -82.85 113.71 20.66 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.35 132.32 47.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.184 0.516 . . . . 0.0 111.705 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -136.1 145.28 45.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -96.38 135.03 38.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.626 0.251 . . . . 0.0 110.361 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -140.76 132.73 27.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.923 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.03 143.3 33.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.641 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.1 t -151.69 -176.84 5.78 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.633 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 50.0 p -80.48 165.51 22.1 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.099 0.476 . . . . 0.0 111.292 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -70.04 -16.7 63.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.879 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -61.74 -41.98 98.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.149 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -70.15 -27.83 64.85 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.832 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.0 -24.23 62.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.068 0.461 . . . . 0.0 109.891 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.5 mmt -79.29 -9.48 59.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.909 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -77.38 80.01 3.88 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.473 0.654 . . . . 0.0 109.928 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -115.17 29.58 7.93 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.143 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -65.91 -38.17 88.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.633 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.919 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.037 -179.33 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.828 0.346 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -104.84 151.59 23.64 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.949 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.8 m -125.58 159.74 32.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.911 0.386 . . . . 0.0 111.072 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 m -86.23 106.63 17.46 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.685 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.7 137.24 27.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 34.6 tt0 -137.77 173.31 11.78 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.409 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 9.2 t -116.08 145.66 42.84 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 117.948 0.34 . . . . 0.0 111.599 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.6 m -102.87 -68.87 0.81 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -171.29 114.87 0.4 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.918 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.41 -111.94 4.59 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.718 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.34 -31.21 65.45 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 122.505 0.322 . . . . 0.0 111.456 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.55 137.07 42.09 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 116.008 -0.542 . . . . 0.0 114.127 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.21 157.13 45.67 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.222 0.609 . . . . 0.0 110.172 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.426 ' HB3' ' HB3' ' A' ' 6' ' ' GLU . 28.8 ttm-85 -115.35 137.85 51.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.96 -86.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.456 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.2 m 49.88 84.88 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.111 0.482 . . . . 0.0 111.754 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 tp -93.32 134.4 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 120.949 0.404 . . . . 0.0 111.979 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.4 m -116.64 124.06 48.82 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.389 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.476 HG13 HG12 ' A' ' 24' ' ' ILE . 17.9 pt -135.28 169.02 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 122.558 0.343 . . . . 0.0 111.817 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.618 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.77 151.98 43.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.03 0.532 . . . . 0.0 111.871 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.79 -51.2 68.27 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.7 -36.14 83.33 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.978 0.418 . . . . 0.0 110.259 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -66.67 -35.74 80.87 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.528 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.618 HG13 ' O ' ' A' ' 20' ' ' ALA . 76.9 mt -60.33 -50.19 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 111.071 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -74.49 -42.88 58.21 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.78 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.9 m -70.44 -52.92 18.75 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.62 -44.6 66.88 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.29 -42.23 94.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.043 0.449 . . . . 0.0 110.589 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -60.78 -43.87 97.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.986 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.438 ' O ' HG11 ' A' ' 33' ' ' VAL . 25.4 m -63.03 -41.63 99.58 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.335 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.58 -40.44 96.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.236 0.541 . . . . 0.0 109.878 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.89 -41.91 99.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.024 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.438 HG11 ' O ' ' A' ' 30' ' ' SER . 12.0 p -69.16 -36.08 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.776 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -63.25 -43.48 97.87 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.13 -38.2 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.802 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.76 -47.93 81.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.61 -37.23 86.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.924 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.88 -33.81 76.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.8 t -91.43 -4.47 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-O 121.47 0.653 . . . . 0.0 109.791 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 63.5 27.2 15.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.636 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -104.41 3.95 10.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.126 0.489 . . . . 0.0 110.95 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -64.66 -34.23 77.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.426 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.63 -23.37 65.0 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.983 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -73.85 -13.57 60.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.746 0.308 . . . . 0.0 111.444 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.412 ' HG3' ' NE2' ' B' ' 320' ' ' GLN . 63.4 ttt-85 -80.75 92.18 6.01 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.268 0.556 . . . . 0.0 110.201 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.79 -43.39 98.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.005 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.99 69.98 1.25 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 115.719 1.048 . . . . 0.0 115.719 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -62.99 -41.89 99.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' A' ' 54' ' ' VAL . 11.2 t -101.42 110.53 61.86 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.692 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.63 147.41 79.66 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.83 2.353 . . . . 0.0 112.066 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.481 ' HA ' HG12 ' A' ' 54' ' ' VAL . 15.3 ttt -67.11 -22.41 65.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -172.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -81.21 -8.57 59.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.872 0.368 . . . . 0.0 110.244 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.46 HD12 ' NH2' ' B' ' 193' ' ' ARG . 87.2 mt -107.74 -49.69 7.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.267 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 51' ' ' MET . 9.6 p -62.61 -40.25 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.557 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.15 94.9 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -84.91 -19.41 32.3 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.767 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.428 ' NH1' ' SD ' ' B' ' 194' ' ' MET . 61.7 ttt180 -85.65 -45.13 11.99 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.356 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -106.65 11.9 29.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.028 0.442 . . . . 0.0 110.522 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -57.39 -63.17 5.55 Favored Glycine 0 C--O 1.216 -0.978 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.181 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.55 -27.55 67.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.053 0.427 . . . . 0.0 111.631 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -61.02 -45.05 96.39 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.156 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG23 ' HB2' ' A' ' 65' ' ' ASP . 8.3 p -131.64 21.34 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 CA-C-O 121.191 0.52 . . . . 0.0 112.098 -175.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.586 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 7.5 ttt180 -64.76 -19.98 66.1 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.628 -0.67 . . . . 0.0 111.405 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -64.77 -45.68 85.35 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.496 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.418 ' HB2' HG23 ' A' ' 62' ' ' VAL . 2.2 m-20 -73.65 -28.28 61.7 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.716 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -63.66 -44.74 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.38 -39.36 94.31 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.27 -40.77 97.83 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.043 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.751 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 29.3 t70 -62.45 -46.79 86.89 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.27 -41.88 97.69 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.911 0.386 . . . . 0.0 110.149 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 ttp -61.04 -43.96 98.11 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.6 m -62.36 -42.65 99.57 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.441 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.751 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 52.2 mtp85 -62.33 -46.49 88.49 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.751 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -65.73 -40.48 92.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.314 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.06 -48.49 81.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.668 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.4 tt -68.15 -39.1 80.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.855 0.36 . . . . 0.0 111.469 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.67 -40.36 92.3 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.234 0.54 . . . . 0.0 110.471 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.95 96.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.228 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.3 pt -67.14 -37.77 79.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.574 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.46 -44.09 98.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.082 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -75.57 -23.05 56.49 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -92.98 1.32 57.36 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.978 0.418 . . . . 0.0 110.674 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 63.38 32.79 14.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.325 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.8 mt -97.78 113.13 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -107.51 107.16 60.01 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.995 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.62 134.65 33.5 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.77 1.647 . . . . 0.0 111.315 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.52 87.17 4.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.238 0.542 . . . . 0.0 110.513 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.36 -114.8 4.54 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.804 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.29 135.2 26.73 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.25 152.17 79.81 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.705 2.27 . . . . 0.0 111.339 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.3 m -87.69 105.16 17.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.066 0.46 . . . . 0.0 111.437 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -107.65 113.78 27.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.24 96.89 48.64 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.68 145.65 26.12 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.21 1.94 . . . . 0.0 111.584 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.76 174.7 51.67 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.16 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.88 123.92 23.74 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.925 0.393 . . . . 0.0 110.23 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -86.13 133.72 33.85 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.185 0.517 . . . . 0.0 111.024 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -122.58 127.13 49.04 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.6 tp -72.42 106.53 4.57 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.132 0.492 . . . . 0.0 110.607 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.07 -8.62 14.2 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.462 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -118.37 -177.56 3.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.667 0.233 . . . . 0.0 110.73 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -76.65 160.04 29.72 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 111.269 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -126.34 138.04 53.53 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.148 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.0 m -118.08 135.71 54.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.932 0.396 . . . . 0.0 110.925 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -129.08 164.25 23.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.5 m -73.92 -83.74 0.05 OUTLIER 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.6 t 56.03 101.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.297 0.57 . . . . 0.0 111.311 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.59 126.95 34.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.28 -175.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.491 ' HB3' ' OE2' ' A' ' 110' ' ' GLU . 12.8 m-85 -127.32 -165.43 1.47 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.91 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.491 ' OE2' ' HB3' ' A' ' 109' ' ' PHE . 0.9 OUTLIER -73.12 177.97 4.7 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.048 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.2 m -124.77 164.51 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.553 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -124.9 116.48 26.16 Favored Pre-proline 0 N--CA 1.466 0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -88.56 144.43 5.57 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.895 2.396 . . . . 0.0 113.152 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -142.02 151.78 42.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.828 0.451 . . . . 0.0 109.804 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.4 t -130.44 133.06 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.896 0.379 . . . . 0.0 111.837 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -107.44 -88.24 0.47 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.746 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.0 mt 64.82 117.67 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.689 0.796 . . . . 0.0 112.481 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -137.84 150.95 47.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.492 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.14 18.65 74.04 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.944 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.77 -41.4 97.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 111.03 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.86 -3.62 23.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.252 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -106.79 17.44 23.17 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.878 0.37 . . . . 0.0 111.61 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.66 107.31 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.061 0.458 . . . . 0.0 109.952 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.32 101.73 13.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.966 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.07 133.29 36.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.935 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -87.64 124.36 33.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.456 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -122.73 96.14 45.72 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -63.92 135.61 48.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.012 1.808 . . . . 0.0 111.52 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.22 112.71 40.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.8 160.2 42.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.569 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -143.01 165.37 27.55 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.196 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.5 t -78.31 129.95 36.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.749 0.309 . . . . 0.0 110.435 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.5 p -112.38 176.86 4.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.772 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.09 -35.53 78.95 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 120.692 0.282 . . . . 0.0 111.623 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.15 84.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.256 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -63.43 -40.59 97.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.292 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 95.7 t -62.25 -49.54 83.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.652 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.85 -39.08 92.98 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.713 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.72 -40.63 99.05 Favored Glycine 0 C--O 1.237 0.331 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.743 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.565 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 5.1 tpt -63.28 -42.5 99.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.139 0.495 . . . . 0.0 109.795 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.9 mt -63.02 -40.11 96.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.573 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -56.65 -48.13 78.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.577 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.2 m -63.3 -40.75 98.23 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.366 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 140' ' ' MET . 85.3 mt -60.15 -42.23 94.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.818 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -79.79 -8.51 59.31 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.834 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -92.65 -12.59 31.17 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -90.92 -52.2 4.97 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.426 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -60.58 95.85 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.63 97.96 2.17 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 113.526 -1.67 . . . . 0.0 107.848 175.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 151' ' ' TRP . 0.2 OUTLIER -67.4 176.65 2.22 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.47 ' H ' HG23 ' A' ' 150' ' ' THR . 56.0 p-90 -99.88 161.85 13.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.453 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.553 ' H ' ' HA ' ' A' ' 243' ' ' ARG . 76.7 tttt -168.68 -79.59 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.758 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.498 ' HA ' ' HB2' ' A' ' 242' ' ' GLU . 10.0 pt-20 -165.97 80.18 0.28 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' A' ' 155' ' ' ASP . 54.8 tttt 176.65 -152.93 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.581 175.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.431 ' H ' ' HG2' ' A' ' 154' ' ' LYS . 8.9 p-10 -140.58 162.82 34.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.303 0.501 . . . . 0.0 111.054 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 119.44 -19.07 9.97 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.303 -0.951 . . . . 0.0 114.133 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -118.52 100.55 7.53 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.58 0.69 . . . . 0.0 111.947 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.8 t -132.29 136.97 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.417 ' HB3' ' H ' ' A' ' 160' ' ' ALA . 10.7 mt-10 -97.79 -169.14 1.78 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.612 ' O ' ' HA3' ' A' ' 190' ' ' GLY . . . -95.6 23.99 5.64 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.765 ' HA ' ' O ' ' A' ' 189' ' ' MET . 11.1 pt-20 -158.88 27.64 0.22 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.436 0.636 . . . . 0.0 112.292 175.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -90.32 170.11 10.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.993 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 -106.96 123.7 48.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.96 128.74 74.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.805 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.4 m -78.84 106.39 10.82 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 72.1 mt -120.03 119.33 59.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.617 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -95.5 88.66 5.14 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -109.02 147.09 32.86 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.084 0.469 . . . . 0.0 111.834 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.0 m -116.78 127.42 54.32 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.45 123.69 6.37 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.172 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.8 m -140.65 128.6 21.97 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.455 HG22 ' CD2' ' A' ' 177' ' ' PHE . 98.0 t -102.89 108.93 25.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 60.34 -50.18 0.09 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.25 1.42 . . . . 0.0 114.121 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.89 -4.37 0.05 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.066 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.44 140.86 52.55 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.092 0.472 . . . . 0.0 110.956 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -79.33 156.56 27.97 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.455 ' CD2' HG22 ' A' ' 172' ' ' VAL . 35.4 p90 -125.37 169.28 12.5 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.534 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.86 -36.12 74.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.03 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.74 -177.49 33.79 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.65 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.27 22.06 61.42 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.163 -1.017 . . . . 0.0 113.322 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -100.81 112.1 24.45 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -136.26 145.69 45.88 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.986 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.6 m -140.5 125.18 18.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.423 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 55.89 30.59 16.21 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.578 0.548 . . . . 0.0 110.635 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -83.78 122.99 29.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.018 0.437 . . . . 0.0 110.397 -176.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.3 m -87.9 106.9 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.598 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.6 tp -94.55 121.54 36.22 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.184 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.563 ' HB1' ' CZ ' ' A' ' 193' ' ' ARG . . . -91.89 119.36 31.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.765 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 83.9 mtp -84.24 153.5 23.56 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.985 -175.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 160' ' ' ALA . . . 84.0 18.31 63.41 Favored Glycine 0 CA--C 1.505 -0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.872 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -122.54 -6.39 8.67 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.155 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.88 46.36 10.92 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.656 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.563 ' CZ ' ' HB1' ' A' ' 188' ' ' ALA . 94.0 mtt180 -92.93 -6.77 47.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.461 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -131.58 167.88 18.65 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.715 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.88 134.82 92.65 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.93 129.89 18.71 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.385 2.056 . . . . 0.0 112.025 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.15 -38.97 3.04 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.358 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -65.35 -49.54 68.98 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.54 ' O ' ' HE3' ' A' ' 189' ' ' MET . 11.4 pt-20 -82.72 -9.73 59.23 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.226 0.536 . . . . 0.0 111.06 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -89.4 -32.01 17.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -74.56 -10.01 82.43 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.102 -0.953 . . . . 0.0 113.337 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 44.4 mm -64.91 -42.89 96.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -53.01 125.93 18.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.629 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 101.28 -3.59 54.71 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.066 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -103.69 148.18 26.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.721 0.761 . . . . 0.0 111.991 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.17 166.17 12.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.491 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.28 120.52 19.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 89.12 17.71 55.29 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.678 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -105.01 117.37 33.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.121 0.486 . . . . 0.0 110.256 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -99.59 123.09 43.52 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.137 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -143.7 -15.44 0.63 Allowed 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 74.4 p 59.38 164.79 0.05 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 123.886 0.874 . . . . 0.0 112.596 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -146.95 142.58 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.858 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.97 109.1 16.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.047 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 49.3 t -117.55 108.23 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.148 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 21.2 m -71.9 -44.42 63.73 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' A' ' 216' ' ' THR . 54.8 m-85 78.73 148.49 0.12 Allowed Pre-proline 0 N--CA 1.495 1.799 0 C-N-CA 123.241 0.617 . . . . 0.0 110.763 -174.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -72.0 153.79 57.85 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.708 2.272 . . . . 0.0 111.905 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.558 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 51.7 mm-40 -65.86 -39.11 90.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.419 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -95.58 39.0 1.13 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.252 0.549 . . . . 0.0 110.935 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -71.67 147.13 47.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.208 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -62.62 -19.65 63.98 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -101.6 117.04 34.09 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.52 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 2.2 tp10 -63.0 -32.7 74.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.992 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.5 -5.96 58.57 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -176.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 84.8 mt -117.81 -11.66 10.3 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.487 -0.485 . . . . 0.0 112.08 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.583 ' NZ ' HD12 ' A' ' 336' ' ' LEU . 18.4 ptmt -68.77 122.23 18.15 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.194 0.521 . . . . 0.0 112.205 -176.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.76 13.3 78.48 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.129 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.49 117.49 29.61 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.471 -0.429 . . . . 0.0 110.487 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -68.57 133.65 48.84 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.965 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -114.61 159.31 20.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.714 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -99.29 -33.11 10.86 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 53.05 99.17 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -73.85 91.88 2.01 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.143 0.497 . . . . 0.0 110.241 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.5 mm -95.18 115.4 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -112.76 -36.64 5.11 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.278 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.3 mt 67.76 152.96 0.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.265 0.626 . . . . 0.0 111.813 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -110.85 -80.64 0.58 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.665 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -111.79 -31.23 7.02 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 18.3 t 59.15 46.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 121.843 0.83 . . . . 0.0 109.528 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 60.7 -102.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.595 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . 15.2 pt-20 178.7 103.56 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.817 0.847 . . . . 0.0 108.964 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.553 ' HA ' ' H ' ' A' ' 152' ' ' LYS . 11.1 ptm180 -157.52 122.88 4.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -179.42 165.83 1.42 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.1 mt 72.64 109.02 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.028 0.531 . . . . 0.0 111.509 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.22 117.64 3.52 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.784 2.323 . . . . 0.0 114.37 -176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.38 -179.26 5.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.646 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.5 mp -91.38 128.5 37.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.081 0.467 . . . . 0.0 111.548 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 9.3 m -136.16 142.15 44.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.43 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.79 92.11 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.12 50.5 0.21 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.327 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -132.68 -58.57 0.92 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.881 0.372 . . . . 0.0 110.8 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 261' ' ' GLY . 36.9 pt -68.97 -22.13 26.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.577 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -105.55 5.72 31.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.4 0.619 . . . . 0.0 109.923 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -111.61 -1.84 15.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.531 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -98.3 116.51 30.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.15 -173.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 51.03 -109.38 0.73 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.13 136.92 55.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.057 0.543 . . . . 0.0 110.707 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 260' ' ' ASP . 2.4 tp10 66.43 -160.16 0.25 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.415 ' H ' ' HG3' ' A' ' 259' ' ' GLU . 4.9 p-10 -133.95 134.75 42.93 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.618 ' O ' ' HB ' ' A' ' 253' ' ' ILE . . . -125.65 158.25 19.92 Favored Glycine 0 C--N 1.316 -0.563 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.74 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 11.8 p -82.19 -179.43 7.4 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.665 0.386 . . . . 0.0 110.958 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.89 -47.76 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.255 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.38 -31.86 15.88 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.758 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.55 -44.24 96.87 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.042 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 270' ' ' VAL . 40.5 tp -64.78 -41.93 95.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -61.64 -43.1 99.5 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.366 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.412 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.39 -40.82 96.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.912 0.387 . . . . 0.0 110.586 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -66.63 -41.75 87.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.376 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 266' ' ' LEU . 85.7 t -63.75 -42.77 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -55.69 -47.6 76.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.301 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 0.1 OUTLIER -70.27 -40.89 74.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -64.53 -41.25 96.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.687 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 95.1 mmm -65.04 -41.63 95.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.628 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.41 -34.86 78.11 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.815 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 53.4 ttp180 -63.65 -43.64 96.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.393 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -68.32 -34.68 76.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.048 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.404 ' O ' HG13 ' A' ' 282' ' ' ILE . 50.2 tp -62.62 -37.94 88.26 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 50.7 tttm -55.98 -46.78 78.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.165 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.9 m -62.37 -40.89 97.91 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.708 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.59 -42.71 99.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.929 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 278' ' ' LEU . 64.1 mt -65.35 -43.29 94.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.828 0.347 . . . . 0.0 110.482 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.529 ' HD2' ' OE2' ' A' ' 405' ' ' GLU . 1.1 tpm_? -58.96 -44.52 91.5 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.392 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.24 -42.74 96.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.224 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -61.86 -44.47 96.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.946 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.49 -44.69 86.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.008 0.432 . . . . 0.0 110.749 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.475 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.0 tttt -61.6 -47.18 86.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.539 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.7 p -62.31 -41.08 98.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.23 -41.78 94.06 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.762 0.315 . . . . 0.0 110.791 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.37 -48.26 76.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.039 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 287' ' ' LYS . 49.4 mm -63.2 -47.91 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.513 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.509 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 26.4 tp10 -61.87 -43.02 99.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.097 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.29 -42.93 93.83 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.702 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.81 -44.49 96.03 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.54 -44.79 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.256 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . 0.509 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 64.0 mttm -61.63 -40.52 95.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.582 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.3 80.84 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.719 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -126.45 101.47 6.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -94.78 113.85 25.67 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.4 tp -119.75 153.26 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.502 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -61.75 142.68 57.12 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.952 0.406 . . . . 0.0 110.515 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 54.2 t -120.83 126.28 26.74 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.644 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.1 131.94 48.36 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.216 1.944 . . . . 0.0 111.715 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.72 -38.23 89.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.066 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.87 -44.2 82.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.023 0.439 . . . . 0.0 111.402 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.63 -41.8 95.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.446 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 311' ' ' ILE . 68.6 mt -61.75 -48.17 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.73 -46.15 84.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.159 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 48.9 m -61.03 -44.95 96.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.685 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.411 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 56.1 mm-40 -71.42 -35.35 70.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.445 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 94.3 mt -62.42 -44.42 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.69 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 13.1 t70 -64.32 -40.98 97.0 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.268 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.61 -43.94 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.978 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 96.9 mt -62.37 -41.99 99.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.684 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.465 HH12 HD12 ' A' ' 330' ' ' LEU . 79.8 mtm180 -63.59 -39.56 94.7 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.084 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 66.6 mtt180 -64.34 -40.29 95.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.261 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -64.61 -42.64 95.39 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.291 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.47 -38.43 81.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.516 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.24 -34.92 79.21 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.979 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -60.25 -37.11 79.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.408 0.623 . . . . 0.0 109.852 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -79.11 -7.56 58.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.593 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -100.8 2.29 41.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 135.4 -3.56 3.99 Favored Glycine 0 CA--C 1.509 -0.344 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.114 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 93.9 28.97 10.26 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.638 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.493 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 45.8 t-20 -70.82 130.6 42.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.975 0.417 . . . . 0.0 110.622 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.0 tm-20 -129.95 158.25 40.06 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 6.7 ptpp? 60.04 -40.06 0.09 Allowed 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 125.682 1.593 . . . . 0.0 114.473 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.493 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 15.6 mm100 -73.0 -12.7 61.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.382 0.611 . . . . 0.0 109.806 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.45 -17.55 62.81 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.762 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.465 HD12 HH12 ' A' ' 315' ' ' ARG . 56.4 tp -61.59 -32.29 72.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.252 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.88 -15.39 60.21 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.756 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.454 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 89.9 mt -66.59 138.07 95.41 Favored Pre-proline 0 C--O 1.238 0.488 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.953 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.78 119.21 6.08 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.344 2.696 . . . . 0.0 113.593 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -63.07 -45.37 92.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.356 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.14 -18.61 65.46 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.401 -173.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.583 HD12 ' NZ ' ' A' ' 227' ' ' LYS . 85.7 mt -94.2 -5.76 46.28 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -117.35 -2.32 11.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.408 0.623 . . . . 0.0 109.731 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.43 ' HG3' HD11 ' A' ' 311' ' ' ILE . 40.5 tt0 -83.34 -16.69 45.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.534 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.92 -48.74 67.73 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.045 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -74.65 -24.72 58.86 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.197 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -60.27 -44.87 94.95 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.499 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.455 ' O ' HG22 ' A' ' 346' ' ' VAL . 87.3 tttt -60.38 -46.91 88.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.427 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.507 ' O ' HG22 ' A' ' 347' ' ' VAL . 20.3 mmt85 -62.51 -44.22 96.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -66.29 -38.62 88.19 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.721 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.409 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 76.1 t -64.2 -44.1 97.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.753 0.311 . . . . 0.0 110.335 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 75.6 t -61.5 -43.29 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.644 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 343' ' ' ARG . 72.1 t -59.92 -44.44 94.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.21 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.55 -41.2 99.52 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.98 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 91.1 mt -63.1 -43.8 97.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.955 0.407 . . . . 0.0 111.095 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.0 mt -62.8 -47.36 83.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.122 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.99 -39.44 83.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.852 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.63 -43.27 96.31 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.541 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -68.18 -37.91 81.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.356 0.578 . . . . 0.0 111.042 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.06 -45.79 97.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.74 -44.2 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.018 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -66.07 -49.79 66.39 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.912 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.4 m -66.74 -44.16 82.25 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -82.19 -4.35 56.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.853 0.359 . . . . 0.0 111.063 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 60.02 38.22 20.83 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.347 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.38 152.92 39.46 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.098 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -129.29 158.96 37.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.108 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -81.48 105.6 12.78 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.499 ' O ' HG21 ' A' ' 367' ' ' VAL . 26.6 t70 -81.18 114.47 20.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.169 0.509 . . . . 0.0 112.257 -173.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 66.4 mm-40 -62.02 -37.3 84.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.255 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.421 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 63.4 mm-40 -61.92 -45.74 92.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.286 0.565 . . . . 0.0 110.179 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -63.07 -39.15 93.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.074 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 363' ' ' ASP . 93.2 t -62.96 -40.82 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.784 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.2 mmmt -57.77 -44.13 85.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.413 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.92 -38.79 97.16 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.767 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.79 -42.19 99.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.05 0.452 . . . . 0.0 110.014 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.19 -43.39 97.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.961 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.66 -44.11 97.1 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -65.63 -39.09 91.08 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.533 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 55.7 ttm -65.09 -42.87 93.66 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.096 0.474 . . . . 0.0 110.967 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 377' ' ' ALA . . . -63.31 -31.35 72.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.562 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 37.4 m -73.68 23.84 0.07 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.939 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 375' ' ' ALA . . . -123.43 0.72 8.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.737 0.303 . . . . 0.0 110.765 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.47 175.33 5.47 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.576 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -59.29 -42.22 90.77 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.835 0.35 . . . . 0.0 110.824 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -134.06 116.17 13.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.477 ' O ' HG13 ' A' ' 385' ' ' ILE . 51.4 Cg_endo -69.5 -31.99 20.55 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.272 1.982 . . . . 0.0 113.702 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -66.62 -43.76 83.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.48 -35.02 79.66 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.576 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.82 -42.66 97.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.244 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 381' ' ' PRO . 74.5 mt -61.19 -46.72 96.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.461 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 43.0 mt-10 -65.33 -43.46 90.89 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.82 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -57.0 -46.87 81.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.832 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.425 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 3.5 t80 -64.89 -42.31 94.89 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.204 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 65.4 p -76.06 -10.44 59.42 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 99.6 mttt -98.35 6.3 47.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.024 0.44 . . . . 0.0 111.005 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -130.64 111.8 12.54 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.854 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -63.38 -36.6 84.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.239 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -56.95 -53.15 61.31 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.96 0.409 . . . . 0.0 110.283 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.68 -41.21 98.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.597 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.488 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 87.8 mtp -62.07 -46.74 87.75 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 120.836 0.35 . . . . 0.0 111.708 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.61 -39.55 64.49 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.076 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -63.36 -40.6 97.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.425 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 46.7 tpp -64.68 -40.27 95.11 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.982 0.42 . . . . 0.0 110.742 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 395' ' ' MET . 70.1 mtm180 -63.38 -33.4 75.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.092 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.6 -44.28 97.3 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.17 -45.52 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.177 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.7 99.54 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.496 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 46.3 tp -64.82 -37.61 88.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.422 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.439 ' CD ' ' HZ2' ' A' ' 287' ' ' LYS . 38.8 tt0 -57.01 -46.29 82.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.716 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.529 ' OE2' ' HD2' ' A' ' 283' ' ' ARG . 26.6 mt-10 -65.26 -38.69 91.1 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.634 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -60.5 -43.35 97.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.303 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.95 -45.36 89.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 96.2 t -63.89 -46.56 93.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.274 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -68.49 -30.56 69.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.897 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.39 98.93 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.48 -43.32 96.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.033 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.5 mt -61.95 -39.0 90.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.251 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.98 -33.05 72.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.963 0.411 . . . . 0.0 110.896 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -89.08 -10.94 45.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.846 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -93.65 176.94 6.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.295 0.569 . . . . 0.0 112.348 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -93.05 112.34 24.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.291 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.42 129.45 51.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.03 0.443 . . . . 0.0 110.945 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.5 t -118.27 139.95 50.56 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.858 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -105.29 120.05 40.6 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -137.31 145.01 42.93 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.712 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.86 148.4 26.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.98 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.9 t -150.34 177.95 9.48 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.046 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 19.7 p -86.41 159.96 19.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.991 0.424 . . . . 0.0 111.474 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -66.8 -33.37 75.47 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.2 0.524 . . . . 0.0 110.742 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 428' ' ' MET . 6.6 m-20 -60.74 -37.17 80.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.514 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.25 -32.66 74.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.558 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.16 -17.7 61.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.943 0.401 . . . . 0.0 110.474 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 425' ' ' ASN . 5.7 mmt -74.95 -8.05 55.35 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.167 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -76.72 75.8 3.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -103.73 15.25 29.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.057 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -63.89 -42.02 97.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.375 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.705 -0.664 . . . . 0.0 110.757 -179.65 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 CA--C 1.513 -0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -94.74 158.08 15.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.922 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.53 158.76 43.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.692 0.282 . . . . 0.0 110.718 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 6.4 m -86.09 107.34 17.78 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.491 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.51 138.45 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.978 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.521 ' HG2' ' H ' ' B' ' 7' ' ' THR . 25.1 tt0 -137.53 177.77 7.61 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.521 ' H ' ' HG2' ' B' ' 6' ' ' GLU . 13.1 t -118.09 152.13 36.18 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.89 0.376 . . . . 0.0 111.272 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 75.3 m -110.62 -70.74 0.79 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.074 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -168.03 111.16 0.61 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.022 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.23 -108.37 2.02 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.073 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.09 -31.92 68.42 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 122.462 0.305 . . . . 0.0 111.236 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.24 139.18 39.67 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 116.005 -0.543 . . . . 0.0 114.021 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 0.0 OUTLIER -142.17 161.23 38.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.466 0.706 . . . . 0.0 110.049 -178.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.41 ' HB3' ' HB3' ' B' ' 6' ' ' GLU . 32.0 ttm-85 -119.86 138.45 53.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 39.8 t -106.03 -86.94 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.343 176.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 17.9 m 51.1 87.29 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.331 0.586 . . . . 0.0 111.458 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 tp -94.16 136.91 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.941 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 91.7 m -117.33 121.51 41.34 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.101 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.491 HG13 HG12 ' B' ' 24' ' ' ILE . 14.3 pt -135.31 165.88 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.603 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.79 151.11 47.37 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.01 -53.03 58.58 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -173.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -65.42 -36.13 83.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.091 0.472 . . . . 0.0 110.441 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.9 m -63.65 -38.23 90.34 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.561 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.603 HG13 ' O ' ' B' ' 20' ' ' ALA . 74.9 mt -59.15 -51.04 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 111.21 -177.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -73.01 -42.59 63.05 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.856 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -67.61 -52.38 39.1 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.42 -44.59 67.6 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.78 -43.06 96.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.734 0.302 . . . . 0.0 111.307 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -61.7 -44.92 96.01 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.082 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.451 ' O ' HG11 ' B' ' 33' ' ' VAL . 19.6 m -63.92 -40.83 97.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.638 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -62.6 -41.84 99.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.031 0.443 . . . . 0.0 110.454 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.48 -41.61 98.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.086 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.451 HG11 ' O ' ' B' ' 30' ' ' SER . 9.9 p -67.99 -36.5 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.316 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -63.47 -42.78 98.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.232 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.03 -36.97 77.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.335 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.77 -48.1 80.64 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.105 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.68 -36.96 85.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.906 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.48 -34.63 75.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.666 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.46 -7.52 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.368 0.604 . . . . 0.0 109.707 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 65.91 27.84 10.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.865 0.866 . . . . 0.0 111.57 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.01 3.53 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.325 0.583 . . . . 0.0 111.001 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -65.4 -32.83 74.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.072 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -7.4 58.01 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.69 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -89.04 -6.83 56.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.834 0.35 . . . . 0.0 110.35 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 65.9 ttt-85 -87.58 91.66 8.82 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.054 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -63.17 -43.58 97.85 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.61 72.66 0.7 Allowed Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 115.997 1.159 . . . . 0.0 115.997 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.92 -43.17 98.97 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 171.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.82 112.52 63.93 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.775 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -57.41 147.49 77.51 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 111.912 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.471 ' HA ' HG12 ' B' ' 54' ' ' VAL . 19.7 ttt -67.38 -24.75 65.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.543 -172.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -77.63 -10.24 59.4 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.465 HD12 ' CZ ' ' A' ' 193' ' ' ARG . 81.5 mt -108.26 -47.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.488 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' B' ' 51' ' ' MET . 12.4 p -62.89 -38.88 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.032 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.8 92.21 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -88.41 -9.22 53.35 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.052 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.44 ' NH1' ' SD ' ' A' ' 194' ' ' MET . 62.2 ttt180 -97.36 -41.47 8.22 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.238 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.61 9.87 27.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.965 0.412 . . . . 0.0 109.893 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -57.57 -63.84 4.92 Favored Glycine 0 C--O 1.211 -1.343 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.115 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.63 -27.76 66.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.978 0.389 . . . . 0.0 111.748 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.3 t -61.61 -45.09 95.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.797 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.0 21.39 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 120.996 0.427 . . . . 0.0 111.902 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.59 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 6.7 ttt180 -64.65 -21.49 66.74 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.782 -0.574 . . . . 0.0 110.914 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -62.08 -50.3 72.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.64 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.6 -25.0 60.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.1 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.93 -43.74 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.1 -39.67 95.38 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.37 -40.3 97.36 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.634 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . 0.756 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 30.6 t70 -61.29 -46.15 91.51 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.67 -42.31 98.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.495 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 60.2 ttp -61.94 -42.4 99.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -62.54 -42.85 99.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.756 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 52.3 mtp85 -63.32 -44.98 93.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.535 -176.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -65.31 -41.33 94.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.228 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -61.3 -48.05 83.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.763 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.14 -39.07 80.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.885 0.374 . . . . 0.0 111.117 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.73 -41.24 96.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.186 0.517 . . . . 0.0 110.532 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.51 -46.42 86.16 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.989 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 41.1 pt -65.35 -38.0 81.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.85 -43.62 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.126 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -76.77 -26.26 54.3 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -88.19 3.26 49.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.399 . . . . 0.0 110.793 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 63.9 28.38 14.55 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.125 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.2 mt -94.29 114.68 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -112.09 104.36 55.96 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.01 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.53 140.77 64.32 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.175 1.917 . . . . 0.0 111.695 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.54 96.32 7.3 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.857 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.29 -112.48 4.48 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.789 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.81 139.04 31.12 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.502 0.151 . . . . 0.0 110.657 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . 0.468 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 55.7 Cg_endo -68.48 155.89 67.5 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.629 2.219 . . . . 0.0 111.29 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -90.06 99.01 12.1 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.938 0.399 . . . . 0.0 111.558 -175.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.468 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 66.8 m-85 -102.95 110.96 23.07 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.4 t -115.83 98.83 51.79 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.95 145.97 25.5 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.359 2.039 . . . . 0.0 111.958 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.76 171.9 45.62 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.131 -1.033 . . . . 0.0 110.898 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.5 123.14 20.5 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.057 0.456 . . . . 0.0 110.597 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -84.44 134.19 34.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.261 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -121.78 122.11 38.77 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 46.3 tp -69.76 106.48 3.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.975 0.417 . . . . 0.0 110.716 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.98 -18.35 9.05 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.486 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -110.27 -175.33 2.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -79.7 164.42 23.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.934 0.397 . . . . 0.0 111.707 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -131.18 141.74 50.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.459 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.2 m -120.05 133.78 55.43 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.912 0.387 . . . . 0.0 111.118 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -125.28 165.28 18.6 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.139 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.9 m -75.5 -82.76 0.07 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 46.8 t 54.27 103.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 122.955 0.502 . . . . 0.0 111.315 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -88.33 123.5 32.97 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . 0.483 ' HB3' ' OE1' ' B' ' 110' ' ' GLU . 13.7 m-85 -123.36 -167.47 1.62 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.769 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . 0.483 ' OE1' ' HB3' ' B' ' 109' ' ' PHE . 1.0 OUTLIER -72.37 176.34 5.4 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -176.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 32.1 m -125.43 166.14 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.473 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -123.61 121.06 26.74 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.796 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -90.97 134.77 1.8 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 122.87 2.38 . . . . 0.0 113.136 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -135.42 144.79 46.7 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.36 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 76.5 t -126.2 134.22 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -107.52 -86.98 0.49 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.861 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 85.0 mt 62.52 120.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.197 0.999 . . . . 0.0 113.553 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -140.18 153.07 46.5 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.948 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.68 21.85 73.73 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.584 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.55 -40.67 95.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.964 0.411 . . . . 0.0 111.486 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.55 -8.73 57.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.363 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.96 8.19 44.33 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 64.7 mt -88.4 108.8 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.197 0.522 . . . . 0.0 110.089 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.36 103.95 15.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.505 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.02 133.08 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.21 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -85.57 122.96 30.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.44 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -120.78 97.08 48.59 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -69.49 130.24 19.32 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.578 1.519 . . . . 0.0 111.823 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -102.69 115.39 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 24.2 m -132.78 159.46 43.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.299 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.43 160.72 37.9 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 66.8 t -76.25 127.7 37.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 41.3 p -105.27 173.46 6.3 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.814 0.34 . . . . 0.0 110.194 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -67.56 -25.49 65.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.162 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.55 -40.36 96.79 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.122 0.487 . . . . 0.0 109.891 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -63.66 -40.8 97.75 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.026 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.0 t -61.75 -48.43 88.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.414 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.32 -38.42 90.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.901 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.7 -40.95 99.46 Favored Glycine 0 C--O 1.237 0.294 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' MET . . . . . 0.558 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 4.1 tpt -63.27 -41.84 99.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.15 0.5 . . . . 0.0 109.826 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 87.2 mt -63.16 -40.31 97.19 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.801 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -58.98 -46.88 87.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.568 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.7 m -63.39 -41.1 98.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' B' ' 140' ' ' MET . 89.5 mt -60.56 -42.86 97.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.718 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -79.07 -8.71 59.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.773 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -94.86 -5.46 44.95 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -97.73 -55.82 2.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.149 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . 0.422 ' NE2' ' HA ' ' B' ' 148' ' ' GLN . 8.1 mm-40 -58.09 96.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.07 106.55 3.64 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.901 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.532 HG23 ' H ' ' B' ' 151' ' ' TRP . 0.2 OUTLIER -73.07 175.13 6.99 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -173.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . 0.532 ' H ' HG23 ' B' ' 150' ' ' THR . 53.2 p-90 -99.43 161.21 13.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.526 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.547 ' H ' ' HA ' ' B' ' 243' ' ' ARG . 76.6 tttt -170.98 -81.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.584 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' B' ' 242' ' ' GLU . 11.8 pt-20 -164.24 76.16 0.33 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.472 ' HG2' ' H ' ' B' ' 155' ' ' ASP . 49.7 tttt 178.06 -160.79 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . 0.472 ' H ' ' HG2' ' B' ' 154' ' ' LYS . 12.2 p-10 -135.38 163.05 30.91 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 117.996 0.362 . . . . 0.0 111.153 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 119.87 -18.97 9.71 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.182 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -115.36 100.23 7.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 117.393 0.596 . . . . 0.0 112.174 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 55.0 t -130.26 136.34 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . 0.489 ' HB2' ' OD2' ' B' ' 162' ' ' ASP . 3.4 mm-40 -95.6 -170.58 2.18 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.164 0.507 . . . . 0.0 111.899 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . 0.638 ' O ' ' HA3' ' B' ' 190' ' ' GLY . . . -98.94 24.32 7.87 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . 0.787 ' HA ' ' O ' ' B' ' 189' ' ' MET . 13.4 pt-20 -158.85 25.27 0.22 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.34 0.591 . . . . 0.0 112.422 175.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' B' ' 188' ' ' ALA . 12.8 m-20 -87.81 170.7 10.97 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.398 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -108.15 121.13 44.22 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.3 t -116.74 128.26 74.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.251 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 20.7 m -76.75 104.88 7.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.97 117.99 56.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.002 0.43 . . . . 0.0 111.393 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.95 88.44 5.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -109.14 150.92 27.14 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.332 0.587 . . . . 0.0 112.182 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 46.3 m -119.97 128.28 53.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.937 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.9 114.09 3.89 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.488 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 39.2 m -131.94 124.19 28.93 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . 0.523 HG22 ' CD2' ' B' ' 177' ' ' PHE . 93.9 t -100.14 106.77 19.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 35.2 t70 67.6 -75.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.939 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -145.37 9.95 1.72 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.608 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -132.48 139.02 47.79 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.521 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.13 148.25 26.22 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . 0.523 ' CD2' HG22 ' B' ' 172' ' ' VAL . 31.9 p90 -115.84 171.41 7.79 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.442 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -59.39 -36.83 76.54 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.62 -174.45 33.82 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.04 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.73 24.31 60.53 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.991 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -103.56 106.58 17.13 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -124.73 144.78 50.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.194 0.521 . . . . 0.0 112.144 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 42.9 m -138.35 119.55 14.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.843 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 55.01 31.11 15.43 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 123.587 0.555 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -81.17 124.54 29.34 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.441 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.72 107.48 18.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.763 0.792 . . . . 0.0 110.708 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 55.1 tp -95.08 122.17 37.46 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.6 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . 0.555 ' HB1' ' CZ ' ' B' ' 193' ' ' ARG . . . -92.1 116.69 29.16 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' MET . . . . . 0.787 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 54.1 mtp -84.54 154.28 22.76 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.91 -175.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.638 ' HA3' ' O ' ' B' ' 160' ' ' ALA . . . 89.28 4.31 74.32 Favored Glycine 0 CA--C 1.501 -0.831 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.71 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -111.33 -4.33 14.96 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.312 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.27 47.65 8.91 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.018 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.555 ' CZ ' ' HB1' ' B' ' 188' ' ' ALA . 96.2 mtt180 -95.47 -3.62 46.47 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.288 0.566 . . . . 0.0 109.568 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.438 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.1 OUTLIER -134.54 168.74 18.42 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.942 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 43.7 mm -61.74 135.46 94.34 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.25 129.5 19.14 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.356 2.037 . . . . 0.0 111.85 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.44 -36.63 4.28 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.343 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -67.31 -50.95 58.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.33 0.565 . . . . 0.0 112.015 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . 0.533 ' O ' ' HE3' ' B' ' 189' ' ' MET . 10.5 pt-20 -81.48 -10.95 59.37 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.005 0.431 . . . . 0.0 111.427 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -90.72 -25.86 19.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.153 0.502 . . . . 0.0 109.705 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.21 -10.93 85.98 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.143 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.5 mm -64.27 -43.0 97.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -55.41 114.6 1.89 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.905 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 115.03 -9.11 21.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.923 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -99.4 146.64 26.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 117.319 0.56 . . . . 0.0 112.158 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.49 168.84 11.53 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.007 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.34 129.28 37.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 78.29 33.36 40.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.68 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -119.77 118.94 32.19 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.913 0.387 . . . . 0.0 110.378 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -101.67 116.62 33.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.284 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -138.29 -16.21 1.23 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 62.7 p 59.66 167.86 0.07 Allowed 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 123.712 0.805 . . . . 0.0 112.844 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -151.17 144.21 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.968 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -80.21 110.91 16.07 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.687 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 43.1 t -118.77 105.5 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' THR . . . . . 0.504 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 21.0 m -71.99 -43.54 64.93 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' B' ' 216' ' ' THR . 66.3 m-85 76.67 146.91 0.12 Allowed Pre-proline 0 N--CA 1.488 1.449 0 C-N-CA 123.044 0.538 . . . . 0.0 110.748 -174.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.7 153.82 68.74 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.788 2.325 . . . . 0.0 111.863 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . 0.497 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 65.0 mm-40 -66.7 -38.12 86.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.236 0.541 . . . . 0.0 110.069 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -94.49 40.8 1.09 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.62 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -75.15 143.88 43.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.154 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -60.96 -17.63 52.66 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.39 118.48 36.85 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.415 ' HA ' ' CD ' ' B' ' 227' ' ' LYS . 5.2 tp10 -61.86 -33.23 73.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.856 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -88.96 -5.11 58.2 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 87.7 mt -117.93 -14.72 10.02 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.029 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.644 ' NZ ' HD12 ' B' ' 336' ' ' LEU . 19.7 ptmt -63.96 122.58 16.86 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.121 0.486 . . . . 0.0 111.884 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.58 9.94 66.05 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.097 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -110.92 120.4 42.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.197 0.498 . . . . 0.0 110.485 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -72.51 134.45 45.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.871 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.56 156.52 26.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.659 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.25 -31.68 13.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 51.59 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -74.52 95.4 2.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.509 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm -96.53 114.64 33.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.57 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -108.46 -31.59 7.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.212 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.2 mt 65.5 170.41 0.21 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.407 0.683 . . . . 0.0 111.382 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -128.62 -79.61 0.57 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.122 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -115.42 -31.13 6.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 17.1 t 59.89 41.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 122.13 0.967 . . . . 0.0 109.085 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 63.67 -101.1 0.09 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.765 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' B' ' 153' ' ' GLU . 9.5 pt-20 179.9 96.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.962 0.905 . . . . 0.0 109.095 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.547 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 10.5 ptm180 -152.19 120.94 6.51 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -173.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 179.46 164.89 1.02 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 98.2 mt 70.85 112.17 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.985 0 CA-C-O 121.285 0.564 . . . . 0.0 111.617 -176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.37 118.18 2.54 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.527 2.151 . . . . 0.0 114.471 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -144.64 167.23 23.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.501 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . 0.402 HD13 ' N ' ' B' ' 248' ' ' LEU . 6.7 mp -76.82 134.68 38.99 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.045 0.45 . . . . 0.0 112.19 -175.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 8.0 m -138.07 154.91 49.23 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -79.44 -36.49 38.81 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.808 0.337 . . . . 0.0 111.642 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -75.6 56.41 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.758 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -136.09 -56.92 0.77 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.937 0.399 . . . . 0.0 110.498 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . 0.565 ' HB ' ' O ' ' B' ' 261' ' ' GLY . 36.4 pt -68.86 -22.81 26.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.163 0.506 . . . . 0.0 110.92 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -105.85 7.83 32.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.666 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -115.12 -1.06 13.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.391 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -99.66 116.75 32.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.208 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 46.59 -115.86 2.08 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 83.2 t -113.65 136.51 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.522 0.729 . . . . 0.0 110.926 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' B' ' 260' ' ' ASP . 3.0 tp10 69.18 -173.05 0.18 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . 0.453 ' H ' ' HG3' ' B' ' 259' ' ' GLU . 5.1 p-10 -125.98 117.99 24.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . 0.565 ' O ' ' HB ' ' B' ' 253' ' ' ILE . . . -103.2 162.27 16.08 Favored Glycine 0 C--N 1.316 -0.552 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.174 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 12.0 p -85.37 -178.99 6.87 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.72 -47.98 90.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.918 0.389 . . . . 0.0 111.065 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.1 -32.02 17.73 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.782 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.02 -42.35 96.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.533 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.512 ' O ' HG23 ' B' ' 270' ' ' VAL . 47.5 tp -64.33 -42.4 96.3 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.633 0.216 . . . . 0.0 110.435 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -60.86 -44.64 96.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.638 0.256 . . . . 0.0 111.155 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.16 -41.23 97.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.003 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -69.4 -38.79 78.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.1 t -63.83 -42.0 94.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -53.15 -54.83 30.09 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.498 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 12.7 ptmt -64.59 -42.61 95.48 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -63.65 -40.71 97.53 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.473 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.6 -41.41 92.82 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.195 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -66.68 -35.08 79.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.949 0.404 . . . . 0.0 110.883 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 56.3 ttp180 -62.78 -42.63 99.78 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.385 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.34 -37.29 83.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.985 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.23 -37.81 86.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.541 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 52.5 tttm -56.34 -45.94 80.17 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.37 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 42.5 m -61.83 -41.0 97.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.592 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.2 -44.91 96.53 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.158 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.35 -44.22 98.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.285 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . 0.434 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.5 OUTLIER -60.41 -44.88 95.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 178.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -64.44 -41.87 96.31 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.672 0.272 . . . . 0.0 110.927 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -61.48 -44.64 96.73 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.099 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.15 -43.27 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.988 0.423 . . . . 0.0 110.582 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.43 -47.72 84.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.806 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 73.7 p -61.94 -41.55 98.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.738 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -64.53 -44.83 89.59 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.824 0.345 . . . . 0.0 111.073 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.38 78.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.535 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . 0.439 ' O ' HG23 ' B' ' 295' ' ' VAL . 37.5 mm -64.09 -44.24 97.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.734 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . 0.465 ' HG3' ' HE2' ' B' ' 296' ' ' LYS . 30.6 tp10 -62.91 -45.11 94.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.513 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.43 95.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.7 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 1.8 tt -62.81 -43.15 99.56 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 291' ' ' ILE . 98.8 t -66.28 -43.38 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.075 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.465 ' HE2' ' HG3' ' B' ' 292' ' ' GLU . 64.3 mttm -62.21 -39.22 92.05 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.593 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.24 -37.71 66.28 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.364 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -125.45 98.53 5.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.06 115.28 27.95 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -120.28 153.64 23.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.475 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.13 142.25 58.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.151 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.85 127.42 26.0 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.207 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.5 134.0 60.56 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.568 2.179 . . . . 0.0 111.896 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.37 87.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.808 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.46 -42.75 83.14 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.474 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.65 -41.75 95.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.286 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.2 -47.45 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.114 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.12 -47.54 80.85 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.258 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 48.4 m -60.29 -44.79 95.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.897 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . 0.465 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 67.0 mm-40 -71.81 -36.69 70.33 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.551 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 92.7 mt -61.94 -44.22 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.085 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 15.0 t70 -63.34 -42.52 98.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.906 0.384 . . . . 0.0 110.322 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.34 -43.85 98.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.23 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 92.9 mt -61.91 -41.23 97.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.762 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 82.6 mtm180 -63.88 -38.64 91.83 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.141 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 62.0 mtt-85 -64.25 -40.69 96.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.926 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.1 -43.03 96.59 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.455 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.84 76.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.971 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.18 77.36 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.965 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . 0.422 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 50.7 tt0 -60.99 -34.22 74.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.332 0.587 . . . . 0.0 110.019 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -82.08 -9.22 59.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.121 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -97.09 -0.58 46.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.688 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 135.38 0.52 3.33 Favored Glycine 0 C--O 1.226 -0.403 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.85 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 90.98 29.57 12.6 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.875 -1.155 . . . . 0.0 111.822 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . 0.423 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 42.5 t-20 -71.6 125.38 26.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.126 0.489 . . . . 0.0 111.136 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -124.5 157.13 36.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? 60.12 -38.67 0.09 Allowed 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 125.882 1.673 . . . . 0.0 114.681 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . 0.423 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.2 mm100 -75.24 -10.02 59.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.19 0.519 . . . . 0.0 110.362 177.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -65.88 -12.73 56.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.353 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . 0.485 HD12 HH12 ' B' ' 315' ' ' ARG . 62.6 tp -61.62 -34.8 76.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.883 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -76.98 -11.59 59.82 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.808 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.436 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 84.3 mt -66.92 134.76 94.03 Favored Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.621 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -49.93 122.26 8.79 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.445 2.763 . . . . 0.0 113.69 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . 0.41 ' HG3' HD12 ' B' ' 311' ' ' ILE . 21.9 ttt180 -65.37 -44.56 87.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.018 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -68.38 -17.35 64.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.58 -172.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . 0.644 HD12 ' NZ ' ' B' ' 227' ' ' LYS . 92.1 mt -93.53 -5.86 48.07 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -117.36 -11.83 10.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.688 0.756 . . . . 0.0 109.767 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.98 -21.99 61.5 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.944 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -65.4 -48.64 72.14 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.907 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -75.18 -25.82 58.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.681 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . 0.438 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -59.06 -44.95 91.88 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.506 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . 0.468 ' O ' HG22 ' B' ' 346' ' ' VAL . 87.7 tttt -60.37 -45.25 94.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.255 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . 0.455 ' O ' HG22 ' B' ' 347' ' ' VAL . 18.4 mmt85 -62.68 -43.75 98.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -64.97 -38.83 92.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 121.189 -0.204 . . . . 0.0 111.059 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 341' ' ' ALA . 81.5 t -64.49 -44.14 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.436 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 70.3 t -61.8 -43.98 98.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . 0.455 HG22 ' O ' ' B' ' 343' ' ' ARG . 74.0 t -59.83 -45.21 95.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.676 0.274 . . . . 0.0 110.496 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.37 -41.25 99.76 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.805 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.5 -43.2 99.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' B' ' 346' ' ' VAL . 96.2 mt -62.91 -46.43 87.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.021 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.5 -39.31 85.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.776 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.95 -45.63 93.48 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.409 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -68.84 -37.29 79.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.218 0.509 . . . . 0.0 111.234 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.24 -46.25 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.7 -44.29 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.547 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -65.89 -50.07 65.8 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 97.3 m -65.79 -45.97 80.46 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -81.9 -7.22 59.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.694 0.283 . . . . 0.0 111.547 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 63.22 45.03 5.29 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.162 0.506 . . . . 0.0 111.317 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.01 155.95 28.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.977 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -132.22 158.65 41.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.5 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -84.85 102.48 13.12 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . 0.553 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 26.1 t70 -81.69 118.6 22.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 54.8 mm-40 -61.59 -39.07 89.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.299 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . 0.553 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 63.4 mm-40 -58.44 -48.04 82.01 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.271 0.557 . . . . 0.0 110.275 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -62.36 -40.3 95.98 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.275 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . 0.455 HG21 ' O ' ' B' ' 363' ' ' ASP . 97.1 t -63.56 -41.52 92.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.036 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 29.8 mmmt -56.97 -44.61 82.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.777 0.322 . . . . 0.0 110.135 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.38 -38.38 96.3 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.103 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.84 -42.27 99.67 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.288 0.566 . . . . 0.0 110.153 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.84 -43.31 97.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.529 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -61.33 -44.19 97.62 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -66.68 -40.0 88.37 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.937 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 55.6 ttm -64.63 -42.57 95.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.964 0.412 . . . . 0.0 110.75 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.81 -29.2 70.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.256 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 44.3 m -70.37 -7.28 41.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.955 0.407 . . . . 0.0 111.581 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.12 -2.5 58.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.441 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -108.98 174.26 5.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.053 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.62 -44.45 89.99 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.316 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -132.34 113.99 14.6 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -67.61 -30.43 35.04 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.332 2.021 . . . . 0.0 113.373 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.96 -44.35 80.76 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.69 -34.73 78.89 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.933 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.85 -43.02 97.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.438 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.37 -44.86 99.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.89 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 49.9 mt-10 -66.14 -45.0 82.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.124 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -57.1 -46.78 82.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.939 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . 0.419 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 4.4 t80 -63.52 -44.37 94.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.887 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 77.4 p -72.56 -14.12 61.56 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.1 mttt -94.46 5.82 50.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.893 0.377 . . . . 0.0 111.697 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -131.39 113.87 14.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.167 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -63.63 -37.11 86.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -56.91 -51.25 69.84 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.774 0.321 . . . . 0.0 110.533 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.83 -41.02 97.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.901 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 93.4 mtp -60.83 -51.77 67.9 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -72.69 -36.15 67.8 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.369 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.63 -41.03 98.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.988 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 398' ' ' MET . . . . . 0.419 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 50.1 tpp -63.74 -40.79 97.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.631 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -62.89 -34.3 77.13 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.745 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -61.02 -45.32 95.29 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.768 0.318 . . . . 0.0 110.452 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.49 -44.99 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.07 0.462 . . . . 0.0 110.791 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.22 97.46 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.645 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.75 -36.92 85.45 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.658 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . 0.411 ' O ' HG23 ' B' ' 408' ' ' VAL . 36.3 tt0 -58.86 -43.9 90.93 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.648 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . 0.434 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 32.2 mt-10 -65.23 -40.55 94.21 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.559 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -58.37 -44.34 88.83 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.559 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.39 -42.5 96.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 89.3 t -64.8 -46.29 92.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -67.53 -31.5 71.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.312 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.68 98.08 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.855 0.359 . . . . 0.0 110.107 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 95.9 t -66.51 -42.5 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.864 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 89.6 mt -61.56 -40.15 93.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.091 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.51 -21.79 65.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.564 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -102.06 -2.56 29.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.895 0.378 . . . . 0.0 110.952 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -101.66 173.14 6.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.147 0.499 . . . . 0.0 111.704 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -88.95 114.06 25.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.425 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.22 127.03 53.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.336 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 10.1 t -118.83 131.71 56.09 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.141 0.496 . . . . 0.0 109.92 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -98.62 113.26 25.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.662 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -129.02 146.67 50.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.846 0.355 . . . . 0.0 110.464 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -89.88 146.4 24.44 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.42 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -147.99 -175.67 4.98 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.342 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 67.6 p -94.78 159.92 14.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.33 . . . . 0.0 111.37 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.76 -34.29 77.99 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.05 0.453 . . . . 0.0 110.752 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -58.97 -39.18 80.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.409 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.0 -31.48 72.06 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 120.871 0.367 . . . . 0.0 110.854 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.21 -16.94 61.4 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.852 0.358 . . . . 0.0 110.529 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.3 mmt -75.95 -8.54 57.18 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.086 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -75.72 72.17 2.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -101.12 9.95 41.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.302 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -62.2 -46.62 88.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.917 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.623 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.104 -179.904 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.0 mtt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -66.36 120.33 13.13 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.643 0.735 . . . . 0.0 112.782 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.11 174.87 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.631 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.401 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 11.7 p -76.42 -170.71 1.57 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.958 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 4' ' ' SER . 0.6 OUTLIER 87.48 143.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.775 0.83 . . . . 0.0 111.901 177.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -140.74 156.35 46.21 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 m -88.56 129.24 35.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.9 0.381 . . . . 0.0 111.79 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.2 m -88.42 -70.59 0.63 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.069 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -166.27 122.16 1.25 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.891 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.12 -106.16 1.24 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.078 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.8 mt -92.91 -7.91 44.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.615 0.245 . . . . 0.0 110.976 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.521 ' O ' ' HD3' ' A' ' 13' ' ' ARG . . . -81.56 137.9 18.17 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.241 -0.504 . . . . 0.0 114.23 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -134.12 148.22 50.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.062 0.945 . . . . 0.0 110.84 179.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -110.81 137.96 47.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.4 t -96.73 -83.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.665 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 p 25.06 93.91 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.0 tp -123.56 139.76 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.871 0.367 . . . . 0.0 111.965 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.2 p -68.99 139.43 55.0 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.688 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.461 HD12 HG12 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -126.79 141.61 45.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -174.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.636 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -75.51 148.73 38.74 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.073 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.15 -40.22 76.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -175.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.55 -3.58 47.53 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.878 0.37 . . . . 0.0 111.449 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -105.71 -25.63 12.14 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.914 0.388 . . . . 0.0 110.624 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 20' ' ' ALA . 74.8 mt -60.56 -49.37 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.153 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 71.4 mm-40 -102.23 3.47 38.3 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -175.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.7 m -96.66 -72.14 0.65 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.265 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.84 89.0 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.1 t -62.87 -45.34 99.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.879 0.371 . . . . 0.0 111.132 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HZ2' ' HA ' ' A' ' 52' ' ' ASN . 20.2 ttmm -63.15 -45.58 91.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.7 m -62.72 -39.71 94.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.194 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 35' ' ' VAL . 8.5 tp10 -66.23 -40.55 90.34 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.53 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.28 -43.11 99.58 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.34 -39.11 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.908 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -65.48 -38.29 89.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.244 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 31' ' ' GLU . 96.0 t -62.46 -42.13 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 110.369 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.29 -41.81 94.17 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 110.223 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.87 -30.75 71.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.096 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 35' ' ' VAL . 24.5 ttmm -57.78 -41.94 83.08 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.171 0.588 . . . . 0.0 110.255 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 t -89.29 -4.48 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.005 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 64.96 33.9 9.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.646 0.778 . . . . 0.0 111.178 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.73 13.03 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.921 0.391 . . . . 0.0 111.741 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.99 -32.75 74.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.351 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.5 -3.4 58.1 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.148 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -86.47 -6.68 58.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.917 0.389 . . . . 0.0 110.834 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.9 ttt-85 -91.61 108.16 19.71 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.812 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.12 -39.49 92.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.635 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.95 29.66 22.61 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.254 -0.974 . . . . 0.0 114.757 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -60.98 -44.69 97.0 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.05 110.06 56.84 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.471 ' O ' HG13 ' A' ' 54' ' ' VAL . 53.1 Cg_exo -56.85 141.5 92.89 Favored 'Trans proline' 0 N--CA 1.477 0.557 0 C-N-CA 122.762 2.308 . . . . 0.0 112.135 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.1 ttt -68.33 -27.76 66.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -172.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.434 ' HA ' ' HZ2' ' A' ' 29' ' ' LYS . 28.7 p-10 -72.35 -17.4 61.84 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.095 0.474 . . . . 0.0 110.151 177.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.542 HD13 ' NH2' ' B' ' 193' ' ' ARG . 84.3 mt -99.75 -34.6 4.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.864 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 50' ' ' PRO . 21.4 m -60.76 -40.15 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 120.917 0.389 . . . . 0.0 111.012 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.77 -25.94 65.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -94.16 -32.5 13.7 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.066 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.401 HH12 HD12 ' B' ' 187' ' ' LEU . 15.3 tpp180 -64.68 -41.55 95.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.767 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.61 22.5 14.96 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.644 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.75 147.96 49.84 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.835 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.71 -39.69 0.45 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.468 0.707 . . . . 0.0 112.487 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 t -60.68 -47.93 84.04 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 122.678 0.391 . . . . 0.0 111.956 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.8 p -118.29 10.58 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.288 0.566 . . . . 0.0 110.733 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -60.31 -38.81 84.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.481 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 27.2 tt0 -60.08 -45.9 91.37 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.987 0.422 . . . . 0.0 110.83 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -68.1 -34.07 75.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.242 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 62' ' ' VAL . 79.2 t -60.9 -33.82 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 109.714 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 98.0 mt -61.68 -38.77 89.04 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.77 -40.27 99.0 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.498 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.91 -45.31 93.12 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.971 0.415 . . . . 0.0 110.915 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.34 -42.17 98.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.2 ttp -61.27 -46.31 90.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.316 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.3 m -64.4 -53.01 55.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.448 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -69.55 -39.44 77.42 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -65.12 -40.51 94.59 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.486 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -61.43 -48.42 81.24 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.41 ' O ' HG13 ' A' ' 79' ' ' ILE . 16.3 tt -67.78 -39.73 82.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 120.71 0.29 . . . . 0.0 111.154 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.37 -42.75 99.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.157 0.504 . . . . 0.0 110.699 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.98 87.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.309 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.7 pp -68.44 -31.13 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.12 -44.47 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.334 0.588 . . . . 0.0 110.655 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -82.93 -18.96 38.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.888 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -88.14 -7.7 56.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.325 0.583 . . . . 0.0 109.551 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 67.51 35.96 3.98 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.149 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.2 mt -100.37 116.16 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -103.35 105.44 46.65 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.455 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.92 142.89 83.84 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.403 2.069 . . . . 0.0 111.382 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.04 99.24 9.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.046 0.45 . . . . 0.0 110.836 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.08 -104.31 3.16 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.88 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.15 130.41 9.28 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.492 0.187 . . . . 0.0 110.728 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.93 154.03 37.88 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.39 2.06 . . . . 0.0 110.97 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -99.48 120.15 39.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.138 0.494 . . . . 0.0 110.49 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.453 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 97.2 m-85 -97.81 97.5 9.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.621 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.15 107.66 39.41 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.377 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 85.2 Cg_endo -89.01 157.84 5.84 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.907 2.405 . . . . 0.0 111.089 175.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.04 178.41 33.27 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.494 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.3 112.88 9.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.272 0.558 . . . . 0.0 110.038 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -79.35 127.55 32.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.522 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -107.42 119.98 40.91 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.12 117.74 9.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.015 0.436 . . . . 0.0 110.676 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.81 -5.79 54.09 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.665 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -119.97 179.59 4.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.695 0.283 . . . . 0.0 110.764 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -72.44 157.24 38.01 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 111.254 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -123.03 136.63 54.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.934 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.8 m -120.59 137.04 54.62 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.746 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -140.29 167.8 21.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.56 0.344 . . . . 0.0 111.066 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.2 m -78.31 -86.84 0.06 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.2 t 57.21 97.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.299 0.571 . . . . 0.0 110.117 -172.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -100.82 136.04 41.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -157.7 167.42 30.14 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.802 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -52.39 145.21 11.61 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -173.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.4 m -137.89 165.27 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.904 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -121.1 103.97 41.77 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -89.03 160.4 5.88 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.074 2.516 . . . . 0.0 113.531 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.08 138.85 52.71 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.28 141.62 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.636 0.255 . . . . 0.0 111.103 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -108.68 142.21 39.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.674 0.273 . . . . 0.0 110.98 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.3 mt -118.97 146.25 45.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -134.41 147.07 50.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 111.172 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.08 14.79 80.07 Favored Glycine 0 C--N 1.33 0.227 0 N-CA-C 114.273 0.469 . . . . 0.0 114.273 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.77 -38.2 90.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.177 0.513 . . . . 0.0 110.851 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.0 -8.25 54.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.807 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.39 11.07 39.83 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.917 0.389 . . . . 0.0 111.398 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.446 ' CD1' HD21 ' A' ' 294' ' ' LEU . 75.0 mt -88.95 125.64 42.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.2 119.53 38.67 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.7 t -112.19 132.6 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 111.432 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -88.57 140.66 29.23 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.538 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -130.19 106.46 16.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -68.61 118.05 5.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.059 1.839 . . . . 0.0 111.419 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -104.2 109.48 27.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.97 161.07 40.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.558 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -133.66 166.24 23.06 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.25 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.88 113.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.4 p -95.97 173.23 7.54 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.199 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.6 -32.6 73.63 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.887 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.23 -41.93 97.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.421 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.5 -39.73 95.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.831 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.79 -46.05 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.261 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -45.1 94.9 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.545 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.65 99.61 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.083 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.592 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.2 tpt -60.9 -47.41 86.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.673 0.273 . . . . 0.0 110.765 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.7 -42.0 98.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.43 -45.31 94.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.0 m -63.39 -40.75 98.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.849 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.4 mt -61.14 -40.08 92.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.162 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -74.68 -9.99 59.1 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 110.805 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.59 9.51 43.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.52 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -118.62 27.11 9.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.892 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -138.86 106.69 5.65 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.12 150.06 36.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.791 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.56 HG23 ' H ' ' A' ' 151' ' ' TRP . 0.2 OUTLIER -118.17 -176.44 3.06 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.002 -176.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.56 ' H ' HG23 ' A' ' 150' ' ' THR . 57.7 p-90 -108.66 145.04 35.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -161.67 -71.01 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.41 -127.76 0.25 Allowed 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.289 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.458 ' HE3' ' HG2' ' A' ' 242' ' ' GLU . 9.6 ptpp? -143.25 144.04 31.98 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.236 0.925 . . . . 0.0 113.426 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 156' ' ' GLY . 12.1 t70 -164.95 -151.51 0.15 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.536 ' HA3' ' HD3' ' A' ' 206' ' ' LYS . . . -104.51 59.95 0.44 Allowed Glycine 0 CA--C 1.509 -0.32 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.311 -178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.4 115.8 14.44 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.17 129.28 70.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.437 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -84.5 158.54 20.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.022 0.439 . . . . 0.0 111.962 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.4 28.7 0.24 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.74 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -170.03 21.11 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.633 0.773 . . . . 0.0 109.045 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.451 ' CG ' ' HE ' ' A' ' 243' ' ' ARG . 46.1 t0 -64.45 -42.32 96.04 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 55.7 ttp180 68.85 86.85 0.13 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.9 t -113.88 131.86 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.875 -175.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.4 m -67.93 106.8 2.43 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 86.4 mt -118.12 130.22 73.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -174.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -101.5 109.15 20.91 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.422 0.63 . . . . 0.0 109.551 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -137.29 154.43 50.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.065 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 37.3 m -127.15 131.97 50.64 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.266 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -69.46 125.22 17.17 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.983 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.3 m -138.67 131.01 28.61 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.2 t -79.78 -77.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -114.47 -60.78 1.84 Allowed 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -144.99 22.95 1.94 Allowed Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -132.57 143.91 50.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -94.1 146.61 23.85 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -111.96 173.46 6.35 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.448 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.17 -38.08 75.95 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.28 -178.45 37.2 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.045 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.38 22.63 56.27 Favored Glycine 0 C--N 1.319 -0.381 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.895 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.89 99.32 9.51 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -119.91 138.77 53.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.163 0.506 . . . . 0.0 111.743 -176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 m -142.3 122.5 13.83 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.368 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 60.06 31.68 20.7 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.459 0.475 . . . . 0.0 110.843 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -90.72 121.09 32.31 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.836 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.7 m -91.02 114.39 28.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.5 0.666 . . . . 0.0 110.464 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 163' ' ' ARG . 61.4 tp -101.74 116.05 31.87 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.391 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.688 ' HB2' ' NH1' ' A' ' 193' ' ' ARG . . . -99.96 102.64 14.07 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 50.4 mtm -75.32 171.33 14.4 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.054 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.57 5.64 71.6 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.159 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -118.03 -8.21 10.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 120.787 0.327 . . . . 0.0 111.062 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 75.4 47.47 12.57 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.215 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.688 ' NH1' ' HB2' ' A' ' 188' ' ' ALA . 49.8 mtm180 -104.79 6.29 33.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.443 0.64 . . . . 0.0 111.06 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.475 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -128.75 159.47 35.58 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.183 173.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.451 HG13 ' CE2' ' A' ' 217' ' ' PHE . 43.6 mm -54.78 131.75 65.85 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.12 123.6 5.34 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.706 2.27 . . . . 0.0 112.32 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.95 -37.33 3.88 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.36 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -62.39 -48.2 80.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.93 0.365 . . . . 0.0 111.887 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.54 -9.33 59.3 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -93.11 -27.94 16.63 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.274 0.559 . . . . 0.0 110.063 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.48 -16.43 73.73 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.629 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.52 -43.01 98.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -57.95 114.73 2.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.31 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 114.71 2.26 22.6 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.48 -0.866 . . . . 0.0 113.596 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -111.06 146.52 36.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.156 0.478 . . . . 0.0 111.593 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.536 ' HD3' ' HA3' ' A' ' 156' ' ' GLY . 75.4 mmtt -83.97 165.02 18.99 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.877 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.03 111.2 3.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.715 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 84.45 35.01 15.02 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.235 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -111.86 127.2 55.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.13 0.49 . . . . 0.0 111.641 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -92.28 142.48 27.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.58 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.431 ' O ' ' HB ' ' A' ' 212' ' ' THR . 75.4 t80 -159.48 -30.89 0.06 Allowed 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 35.5 m 78.46 142.06 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.623 0.369 . . . . 0.0 110.905 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.3 tp -138.28 127.54 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 121.062 0.458 . . . . 0.0 111.229 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -79.79 107.09 12.29 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.461 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 67.8 t -112.34 114.22 46.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.279 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 14.0 m -72.88 -41.61 64.5 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -176.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.542 ' HB2' ' O ' ' A' ' 216' ' ' THR . 68.7 m-85 80.81 143.45 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 123.539 0.736 . . . . 0.0 110.935 -174.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.68 152.44 53.35 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.437 2.091 . . . . 0.0 112.099 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -65.39 -35.68 81.68 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -87.34 23.98 1.73 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.648 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.429 ' CE2' ' HB2' ' A' ' 223' ' ' ALA . 8.3 t80 -67.94 133.71 49.56 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.044 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -67.95 -18.49 64.77 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.429 ' HB2' ' CE2' ' A' ' 221' ' ' TYR . . . -88.81 102.5 15.08 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 175.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.496 ' OE2' HD12 ' A' ' 336' ' ' LEU . 42.6 tt0 -57.05 -33.26 67.06 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.663 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -78.07 -11.39 59.91 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 90.2 mt -121.12 -4.7 9.51 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 21.8 ptmt -68.1 116.65 8.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.173 0.511 . . . . 0.0 111.71 -177.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.2 21.85 70.42 Favored Glycine 0 C--O 1.24 0.526 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.033 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.41 ' HZ2' ' HB3' ' A' ' 229' ' ' LYS . 9.9 mtpm? -121.92 112.16 17.96 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.4 142.98 57.41 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -174.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -127.94 144.08 51.1 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.782 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -100.58 -31.79 11.08 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 61.85 126.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -81.32 -40.94 22.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.769 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.2 mm 67.97 129.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.847 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.562 ' ND2' ' HZ3' ' A' ' 238' ' ' LYS . 7.6 t30 -107.08 -67.38 0.95 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.453 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 98.0 mt 62.31 94.39 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.562 ' HZ3' ' ND2' ' A' ' 236' ' ' ASN . 62.2 mttp -100.66 -37.87 8.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.136 0.493 . . . . 0.0 110.045 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -95.4 -88.43 0.26 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 92.0 t 73.39 126.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.585 0.553 . . . . 0.0 110.197 -173.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -73.8 -179.48 3.68 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.458 ' HG2' ' HE3' ' A' ' 154' ' ' LYS . 42.3 mt-10 -113.97 112.4 23.24 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -168.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.451 ' HE ' ' CG ' ' A' ' 162' ' ' ASP . 8.9 ptp180 -148.41 143.89 27.09 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.751 167.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -172.95 156.79 3.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 4.9 tt 69.77 109.26 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.199 0.6 . . . . 0.0 111.315 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -86.42 120.23 1.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.594 2.196 . . . . 0.0 112.743 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -147.18 177.57 9.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.984 0.421 . . . . 0.0 110.451 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 5.8 mp -93.06 78.1 4.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.238 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.408 ' OG1' HG21 ' A' ' 150' ' ' THR . 7.2 m -92.12 -63.16 1.27 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.882 0.372 . . . . 0.0 111.392 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -162.05 -32.1 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.045 0.45 . . . . 0.0 110.805 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -72.08 0.5 9.39 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.215 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -103.38 -26.1 13.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.173 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 44.8 pt -103.66 -8.28 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -171.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -159.61 7.22 0.1 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 119.526 -0.87 . . . . 0.0 113.089 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -120.61 135.82 54.99 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.574 0.226 . . . . 0.0 110.445 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -177.09 36.81 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 81.0 20.3 65.48 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.6 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 24.9 t -127.7 160.04 37.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -57.47 -50.9 71.56 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.033 0.444 . . . . 0.0 110.23 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -176.68 156.74 1.48 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.846 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -170.92 174.75 44.74 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.058 -1.067 . . . . 0.0 112.674 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.6 p -98.03 -173.86 2.71 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 122.716 0.406 . . . . 0.0 110.233 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 14.8 t -70.4 -71.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 111.191 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.1 pm0 -70.19 -37.02 75.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.866 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.5 -39.65 97.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.079 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 63.8 tp -63.25 -43.8 97.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.489 0.185 . . . . 0.0 110.995 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -62.62 -42.74 99.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.957 0.408 . . . . 0.0 110.282 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.54 -45.61 82.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.44 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 30.8 tp10 -66.34 -39.81 89.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.864 0.364 . . . . 0.0 110.974 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.01 -43.7 96.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.25 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -59.17 -48.56 81.14 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.03 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.8 ptmt -64.89 -44.32 90.02 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 111.198 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -65.12 -37.57 87.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.955 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 89.4 mmm -61.93 -42.85 99.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.825 0.345 . . . . 0.0 110.224 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.37 -32.14 69.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 55.3 ttp180 -63.45 -42.0 98.63 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -65.56 -35.8 81.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.855 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 44.2 tp -61.44 -36.78 81.32 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.905 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 58.1 tttm -54.81 -47.96 73.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.862 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 20.1 m -63.83 -42.44 97.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.037 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.39 -49.4 77.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.318 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 86.1 mt -64.02 -43.02 97.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.471 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -45.12 93.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.219 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -65.41 -41.37 93.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.26 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . 0.449 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.8 tpm_? -60.83 -44.13 97.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.785 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.3 t -68.88 -44.42 81.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.93 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.491 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.1 tttt -61.99 -48.44 80.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.82 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.8 p -63.62 -42.36 98.19 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.95 -39.56 90.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.204 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.03 93.95 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.851 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 287' ' ' LYS . 48.6 mm -65.11 -44.22 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.2 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.484 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 16.0 tp10 -60.02 -42.66 94.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.51 -45.82 92.03 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.709 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.446 HD21 ' CD1' ' A' ' 123' ' ' ILE . 26.5 mt -62.86 -42.17 99.65 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.8 -43.78 96.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.716 0.293 . . . . 0.0 110.849 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . 0.484 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 67.9 mttm -62.77 -41.92 99.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.037 0.446 . . . . 0.0 110.936 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.03 -46.01 65.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.917 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -123.91 100.39 6.73 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -95.86 113.7 25.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.7 tp -122.11 156.96 26.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.17 120.07 11.41 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.978 0.418 . . . . 0.0 110.057 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.86 128.12 42.75 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.449 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.45 ' O ' HG13 ' A' ' 307' ' ' ILE . 49.9 Cg_exo -55.6 129.92 37.69 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.654 2.236 . . . . 0.0 112.215 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.22 86.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.021 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.79 -45.46 82.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.011 0.434 . . . . 0.0 111.026 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.36 -41.88 93.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.988 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 311' ' ' ILE . 73.4 mt -61.54 -49.85 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.472 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.09 -42.73 99.51 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 30.1 m -62.23 -45.52 92.98 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.5 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.456 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 65.6 mm-40 -71.01 -35.0 71.88 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 307' ' ' ILE . 94.7 mt -61.94 -43.16 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.629 0.252 . . . . 0.0 111.117 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.48 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.8 t70 -59.53 -44.26 93.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.55 -42.9 96.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.127 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 84.4 mt -62.09 -40.68 96.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.48 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.8 mtm180 -61.27 -42.43 98.62 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -64.19 -38.64 91.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.916 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -62.84 -42.72 99.85 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.159 0.505 . . . . 0.0 110.116 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.1 80.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.201 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 325' ' ' ASN . . . -64.33 -37.05 86.14 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.225 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -63.62 -37.92 89.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.306 0.574 . . . . 0.0 109.646 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.94 -7.81 57.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.864 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -97.4 -0.9 45.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.246 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.06 7.61 2.25 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.168 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.18 38.84 8.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.479 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 319' ' ' ALA . 25.7 t-20 -84.6 135.23 34.28 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.874 0.369 . . . . 0.0 111.137 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.79 162.92 33.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 71.9 -54.21 0.68 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.102 0.561 . . . . 0.0 111.178 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.08 -17.78 63.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.84 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.58 -22.49 45.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.78 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.08 -34.6 76.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.546 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.88 10.19 14.61 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.672 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 77.9 mt -82.68 149.37 60.25 Favored Pre-proline 0 C--O 1.239 0.52 0 O-C-N 122.008 -0.433 . . . . 0.0 110.737 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.406 ' O ' ' HD1' ' A' ' 337' ' ' PHE . 40.4 Cg_exo -56.5 124.39 16.14 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.114 2.543 . . . . 0.0 113.111 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -70.43 -43.3 70.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.536 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -58.54 -40.59 83.41 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -170.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.496 HD12 ' OE2' ' A' ' 224' ' ' GLU . 60.7 mt -86.41 -0.32 55.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 333' ' ' PRO . 47.5 m-85 -107.45 -29.33 9.29 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -65.48 -32.49 74.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.252 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.87 -50.27 74.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -77.92 -21.86 50.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.55 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -62.45 -40.93 98.2 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.016 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.456 ' O ' HG22 ' A' ' 346' ' ' VAL . 88.2 tttt -59.79 -45.02 93.6 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.201 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.555 ' O ' HG21 ' A' ' 347' ' ' VAL . 12.3 mmt85 -61.68 -46.33 90.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.737 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -66.74 -37.51 84.79 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.466 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 341' ' ' ALA . 73.2 t -64.8 -43.64 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.607 0.241 . . . . 0.0 110.406 176.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 342' ' ' LYS . 76.1 t -61.48 -41.77 91.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.555 HG21 ' O ' ' A' ' 343' ' ' ARG . 69.1 t -58.64 -44.77 90.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.3 -40.31 98.84 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.181 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.46 -44.38 94.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 110.934 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 354' ' ' VAL . 98.2 mt -63.44 -48.5 77.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.883 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.86 -41.07 87.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.488 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.73 99.81 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.254 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.38 -35.83 78.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.643 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 350' ' ' LEU . 70.4 t -61.05 -44.9 99.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.21 -45.44 98.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -67.46 -51.72 48.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.0 m -65.33 -46.86 78.6 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -83.68 -5.97 59.32 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.351 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 61.23 55.52 2.95 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.095 0.474 . . . . 0.0 111.622 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 97.1 mt -88.85 160.19 17.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.459 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -140.88 155.61 46.28 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.901 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -75.42 104.98 6.22 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.441 ' O ' HG21 ' A' ' 367' ' ' VAL . 29.6 t70 -79.08 119.35 22.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.979 0.418 . . . . 0.0 111.341 -175.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 44.7 mm-40 -61.87 -42.74 99.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.347 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -64.89 -43.34 93.2 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.79 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 40.1 ttt85 -60.64 -42.93 97.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.238 0.542 . . . . 0.0 109.649 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 363' ' ' ASP . 87.2 t -65.96 -36.89 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.371 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.0 mmmt -56.31 -43.74 79.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.719 0.295 . . . . 0.0 110.58 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.01 95.54 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.739 -0.744 . . . . 0.0 111.935 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.2 -42.51 96.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.062 0.458 . . . . 0.0 110.2 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.96 -43.5 97.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.526 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.83 -41.4 99.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.581 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -66.46 -37.86 86.06 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.589 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.5 ttm -64.31 -43.36 94.95 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 121.027 0.442 . . . . 0.0 110.332 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.2 -29.53 70.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.392 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 44.7 m -73.0 -7.78 52.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.5 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.86 -2.37 58.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.391 0.615 . . . . 0.0 110.036 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.12 171.63 7.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.611 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -64.02 -49.09 73.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.992 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -118.79 107.63 42.14 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.779 0.323 . . . . 0.0 110.148 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.02 -34.86 99.23 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.937 2.424 . . . . 0.0 112.959 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -63.76 -45.21 90.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.45 -38.97 93.17 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.802 0.334 . . . . 0.0 110.654 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.77 -43.21 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.16 -43.78 99.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 120.826 0.346 . . . . 0.0 110.534 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.425 ' HB3' ' HE3' ' A' ' 390' ' ' LYS . 45.6 mt-10 -66.56 -38.97 88.22 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.735 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -58.07 -46.64 85.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.885 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -33.46 71.19 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 35.3 p -88.58 -5.04 58.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 386' ' ' GLU . 98.4 mttt -98.32 -0.66 43.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.941 0.401 . . . . 0.0 110.952 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -123.53 114.84 20.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.778 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -63.7 -39.77 95.13 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -58.76 -46.78 86.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.85 0.357 . . . . 0.0 110.52 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.66 -40.77 97.67 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.091 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 92.6 mtp -62.6 -44.66 95.75 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.01 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -64.57 -45.87 85.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.9 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -64.36 -44.17 92.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.537 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 46.2 tpp -63.51 -42.57 98.48 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.923 0.392 . . . . 0.0 111.323 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.432 ' HG2' HG23 ' A' ' 367' ' ' VAL . 77.2 mtm180 -65.75 -34.37 78.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.127 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -63.38 -43.02 98.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.707 0.289 . . . . 0.0 110.407 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.77 -46.1 95.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.912 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.84 88.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.38 -38.33 90.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.823 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.409 ' CD ' ' HZ2' ' A' ' 287' ' ' LYS . 40.8 tt0 -60.4 -43.99 96.14 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.341 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -66.34 -37.46 85.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.959 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -59.79 -42.66 93.89 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.45 90.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.064 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.99 -45.94 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -67.79 -30.35 69.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.558 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.16 99.35 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.69 -43.76 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.412 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.58 -38.67 88.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.237 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.25 -29.88 70.11 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.025 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.23 -22.31 18.5 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.889 0.376 . . . . 0.0 111.419 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.16 174.56 7.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.191 0.52 . . . . 0.0 111.327 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -84.28 133.27 34.56 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 66.8 t -118.14 128.88 75.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -119.3 144.25 46.91 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 120.989 0.423 . . . . 0.0 110.699 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -101.53 130.48 47.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.18 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -151.61 141.53 22.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.334 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -97.09 139.36 33.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.066 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.9 t -146.72 179.24 7.71 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.8 p -80.99 156.49 25.89 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.031 0.443 . . . . 0.0 111.372 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.3 -40.07 96.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.89 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -57.23 -34.77 68.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.177 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.04 -31.86 72.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.865 0.364 . . . . 0.0 111.237 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.6 mp -83.98 -7.81 59.31 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.026 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.7 mmt -79.28 -6.86 57.64 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.082 0.467 . . . . 0.0 110.497 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -76.15 81.4 2.96 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.453 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -106.46 13.63 28.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.824 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -66.05 -37.49 85.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.944 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.308 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.102 179.7 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.486 0.184 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -70.11 116.04 10.01 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.647 0.737 . . . . 0.0 112.172 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.17 172.47 14.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.177 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.425 ' O ' ' HB ' ' B' ' 5' ' ' VAL . 9.4 p -72.7 -175.34 1.65 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.287 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' B' ' 4' ' ' SER . 0.5 OUTLIER 89.32 141.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.908 0.883 . . . . 0.0 111.705 179.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -139.5 156.06 47.16 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 90.8 m -89.54 129.91 35.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.872 0.368 . . . . 0.0 111.766 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 75.1 m -89.11 -70.19 0.67 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -166.54 124.25 1.37 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.134 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.13 -110.6 3.47 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.648 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 85.9 mt -90.29 -6.82 54.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.519 0.199 . . . . 0.0 111.203 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.545 ' O ' ' HD3' ' B' ' 13' ' ' ARG . . . -84.27 137.54 16.02 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 114.41 0.524 . . . . 0.0 114.41 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.545 ' HD3' ' O ' ' B' ' 12' ' ' GLY . 0.0 OUTLIER -133.44 146.69 51.4 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.035 0.934 . . . . 0.0 110.619 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -108.68 138.3 45.23 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.815 0.446 . . . . 0.0 110.051 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.81 -85.91 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.684 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.4 p 27.84 94.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 tp -123.07 140.11 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.913 0.387 . . . . 0.0 111.857 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -73.01 138.15 45.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.746 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.476 HD12 HG12 ' B' ' 24' ' ' ILE . 0.9 OUTLIER -126.17 152.42 33.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -175.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.674 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -87.3 151.64 22.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.277 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.39 84.33 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -77.37 -3.14 38.63 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.187 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 15.4 t -107.56 -28.4 9.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.628 0.251 . . . . 0.0 111.075 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.674 HG13 ' O ' ' B' ' 20' ' ' ALA . 71.3 mt -60.25 -49.6 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 121.027 0.441 . . . . 0.0 112.097 -175.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.467 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 69.2 mm-40 -101.32 8.61 42.28 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -175.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 40.0 m -103.74 -70.49 0.76 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.137 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.09 -47.48 79.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.824 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 86.0 t -62.11 -45.22 99.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.467 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.7 ttmm -63.33 -45.17 92.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 60.0 m -62.8 -41.52 99.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.367 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.556 ' O ' HG22 ' B' ' 35' ' ' VAL . 10.4 tp10 -66.44 -39.05 88.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.72 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 89.3 mt -61.81 -43.02 99.67 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -66.0 -38.22 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.535 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.07 -38.65 91.84 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.556 HG22 ' O ' ' B' ' 31' ' ' GLU . 89.3 t -63.17 -43.04 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.545 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.32 97.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.432 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.02 -30.06 70.04 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.068 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' B' ' 35' ' ' VAL . 23.1 ttmm -59.51 -44.75 93.04 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.202 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.16 -2.97 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 63.52 31.39 14.83 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.329 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.82 10.8 8.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.08 -25.62 67.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.13 -4.37 78.21 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.808 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -86.67 -5.4 59.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.459 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 64.0 ttt-85 -93.21 108.26 19.92 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.841 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.18 -38.12 87.88 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.293 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.42 33.16 20.56 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.247 -0.978 . . . . 0.0 114.205 175.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -63.53 -40.98 98.44 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 t -117.18 112.47 39.76 Favored Pre-proline 0 N--CA 1.448 -0.557 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.411 ' O ' HG13 ' B' ' 54' ' ' VAL . 42.4 Cg_exo -57.53 142.77 95.53 Favored 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.687 2.258 . . . . 0.0 112.255 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 18.7 ttt -67.01 -29.38 69.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.55 -172.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . 0.427 ' HA ' ' HZ2' ' B' ' 29' ' ' LYS . 29.1 p-10 -71.85 -16.43 62.15 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.094 0.473 . . . . 0.0 110.361 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.638 HD13 ' NH2' ' A' ' 193' ' ' ARG . 78.0 mt -99.76 -36.07 5.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.789 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.411 HG13 ' O ' ' B' ' 50' ' ' PRO . 23.6 m -60.58 -40.71 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.785 0.326 . . . . 0.0 111.286 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.14 -30.0 70.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.354 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -91.79 -32.77 15.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.377 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -64.61 -41.61 96.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.869 0.366 . . . . 0.0 110.436 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -110.48 23.57 14.07 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.27 0.557 . . . . 0.0 110.509 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.94 147.5 50.34 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.781 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 71.24 -41.06 0.49 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.392 0.677 . . . . 0.0 112.296 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.3 t -58.28 -53.44 58.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.758 0.423 . . . . 0.0 111.865 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.492 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -114.76 10.61 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.296 0.57 . . . . 0.0 110.827 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -60.14 -38.95 84.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.647 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -59.44 -45.51 91.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.688 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.5 -33.2 73.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.754 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.492 HG23 ' O ' ' B' ' 62' ' ' VAL . 77.3 t -60.97 -35.19 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.47 -39.43 90.88 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.31 -39.81 98.22 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.699 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.34 -46.37 88.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.966 0.413 . . . . 0.0 110.882 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.57 -42.08 98.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.453 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 55.0 ttp -60.78 -46.5 90.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.216 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 52.0 m -64.21 -52.28 59.62 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.463 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -70.11 -39.37 75.52 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -64.98 -40.53 95.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.642 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -61.09 -47.85 84.38 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.798 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.414 ' O ' HG13 ' B' ' 79' ' ' ILE . 14.8 tt -68.13 -39.19 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.869 0.366 . . . . 0.0 111.035 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.12 -43.91 97.79 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.565 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.62 89.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.234 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.414 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.6 pp -67.12 -35.39 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.44 -43.94 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.997 0.427 . . . . 0.0 110.987 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -82.58 -19.65 38.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.006 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -88.13 -8.32 55.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.357 0.599 . . . . 0.0 109.54 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 69.56 34.4 2.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.172 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 73.6 mt -99.17 116.72 42.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -103.78 108.53 59.94 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.847 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.49 141.84 57.17 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.383 2.056 . . . . 0.0 111.394 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.45 104.45 15.39 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.058 0.456 . . . . 0.0 110.589 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.33 -109.2 3.36 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.188 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.09 124.93 13.3 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-O 120.51 0.195 . . . . 0.0 110.616 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.84 157.55 54.86 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.371 2.047 . . . . 0.0 111.023 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 20.2 m -98.16 115.67 28.78 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.029 0.442 . . . . 0.0 110.558 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -96.16 98.19 10.14 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.02 110.69 58.66 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -91.07 165.44 3.77 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.163 2.575 . . . . 0.0 111.112 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.28 179.48 25.83 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.517 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.13 114.02 10.82 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -81.69 124.81 29.92 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.202 0.525 . . . . 0.0 111.54 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.65 117.51 34.24 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.43 123.36 18.54 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.657 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.56 -17.82 56.09 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.498 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -106.32 -170.51 1.74 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.615 0.245 . . . . 0.0 111.229 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -81.12 165.45 21.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -128.83 135.99 49.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.872 0.368 . . . . 0.0 110.877 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 45.9 m -119.84 136.49 54.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.687 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -141.66 167.03 23.13 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.925 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -78.82 -84.95 0.08 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 99.1 t 56.7 93.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-O 121.171 0.51 . . . . 0.0 109.975 -172.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.48 135.44 38.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -158.65 170.45 22.14 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.971 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -50.77 145.88 6.49 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.56 165.42 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.521 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -121.67 106.6 37.11 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 120.894 0.378 . . . . 0.0 110.197 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -91.96 161.27 3.3 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.242 2.628 . . . . 0.0 113.805 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -131.56 134.39 46.02 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.996 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.87 136.3 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.657 0.265 . . . . 0.0 111.306 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.05 141.51 32.78 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.093 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 97.6 mt -119.1 141.86 48.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -129.84 145.38 51.59 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.96 18.62 78.56 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.097 -0.502 . . . . 0.0 114.127 174.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -63.51 -40.52 97.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.052 0.453 . . . . 0.0 111.339 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.97 -19.04 65.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.856 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.43 8.17 29.17 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.494 ' CD1' HD21 ' B' ' 294' ' ' LEU . 77.6 mt -86.26 127.66 40.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.064 0.459 . . . . 0.0 110.949 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -112.37 125.04 53.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.73 132.41 68.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.987 0.423 . . . . 0.0 111.635 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.28 137.14 32.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.389 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -126.37 105.76 24.43 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.67 119.41 6.42 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.088 1.859 . . . . 0.0 111.832 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.408 HG13 ' HG2' ' B' ' 419' ' ' GLU . 48.6 mm -104.63 108.24 24.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.42 159.28 40.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.51 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.24 161.07 37.2 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.194 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 46.1 t -69.68 121.25 18.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.766 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.4 p -105.92 -180.0 4.1 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.773 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.6 -34.82 77.77 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.303 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.61 94.87 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.559 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -64.95 -40.9 95.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.655 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.02 -47.43 92.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.798 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -61.81 -44.39 96.95 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.32 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.04 -41.33 99.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.18 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' MET . . . . . 0.608 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.8 tpt -60.98 -46.85 89.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.782 0.325 . . . . 0.0 110.838 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.28 -41.94 96.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.39 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.92 -43.13 99.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.828 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 18.5 m -63.24 -39.86 95.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.66 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.5 mt -60.22 -41.64 93.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.779 -176.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -72.23 -16.69 61.94 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.107 0.479 . . . . 0.0 111.11 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.31 8.11 43.04 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.568 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -117.79 24.79 10.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.74 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -138.17 106.51 5.8 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.25 147.43 31.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.594 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.548 HG23 ' H ' ' B' ' 151' ' ' TRP . 0.3 OUTLIER -111.85 -163.16 0.83 Allowed 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.104 -176.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . 0.548 ' H ' HG23 ' B' ' 150' ' ' THR . 48.4 p-90 -123.2 146.64 47.64 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.058 0.456 . . . . 0.0 112.024 -176.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -168.03 -61.81 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.01 -142.27 0.22 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.773 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.458 ' HE3' ' HG2' ' B' ' 242' ' ' GLU . 9.1 ptpp? -134.5 143.06 47.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.282 0.947 . . . . 0.0 112.874 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -164.56 -152.13 0.17 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . 0.448 ' HA3' ' HD3' ' B' ' 206' ' ' LYS . . . -99.93 63.32 0.66 Allowed Glycine 0 C--O 1.235 0.193 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.49 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.47 118.9 12.18 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.74 129.8 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -86.45 157.94 19.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.085 0.469 . . . . 0.0 112.085 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.99 26.27 0.26 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.84 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -167.55 20.17 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.414 ' CG ' ' HE ' ' B' ' 243' ' ' ARG . 45.2 t0 -64.09 -45.43 88.71 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.362 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' B' ' 187' ' ' LEU . 53.4 ttp180 72.18 88.38 0.1 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.49 132.62 64.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.077 0.465 . . . . 0.0 112.016 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 24.6 m -69.0 104.19 2.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.844 173.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 88.2 mt -116.77 128.45 74.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.906 0.384 . . . . 0.0 111.934 -175.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -102.16 110.09 21.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.47 0.652 . . . . 0.0 109.381 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -137.01 154.01 50.51 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.3 m -124.04 130.18 52.14 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.023 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -70.05 131.44 22.96 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.99 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -145.6 129.59 17.41 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 43.3 t -77.91 -76.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -113.93 -70.5 0.8 Allowed 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -135.77 23.31 3.4 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -136.09 140.55 43.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.128 -0.536 . . . . 0.0 109.647 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -91.83 146.25 23.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -106.86 174.54 5.84 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.092 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.57 -37.39 78.34 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.6 -174.68 36.95 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.786 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.84 22.91 54.49 Favored Glycine 0 C--N 1.32 -0.352 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.281 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -103.1 101.25 11.21 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -123.64 140.26 53.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.114 0.483 . . . . 0.0 111.946 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 34.6 m -141.14 121.16 13.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.539 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.81 33.17 22.9 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.55 0.531 . . . . 0.0 111.15 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -87.91 123.22 32.43 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.753 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 13.8 m -92.86 113.31 27.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.566 0.698 . . . . 0.0 110.716 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' B' ' 163' ' ' ARG . 52.1 tp -102.53 116.22 32.17 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.322 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . 0.684 ' HB2' ' NH1' ' B' ' 193' ' ' ARG . . . -99.9 105.37 17.08 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 41.9 mtm -76.17 168.88 19.25 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.129 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.9 -16.41 61.01 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.876 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -98.84 -3.46 35.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.599 -0.3 . . . . 0.0 111.455 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.16 44.6 59.76 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.176 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.684 ' NH1' ' HB2' ' B' ' 188' ' ' ALA . 47.8 mtm180 -98.32 4.63 48.68 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.417 0.627 . . . . 0.0 111.672 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.459 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -128.04 159.97 33.4 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 172.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.484 HG13 ' CE2' ' B' ' 217' ' ' PHE . 43.3 mm -54.42 133.56 62.42 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -48.09 126.22 13.01 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.359 2.039 . . . . 0.0 112.326 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.46 -34.15 6.01 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.261 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -64.32 -51.06 65.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.82 -16.65 60.69 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 121.015 0.436 . . . . 0.0 112.107 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -87.69 -21.59 25.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.173 0.511 . . . . 0.0 110.034 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.45 -10.82 85.52 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.63 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.0 mm -64.81 -42.85 96.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -55.32 124.81 18.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.762 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.5 1.59 40.56 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.793 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -111.13 148.6 32.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.313 0.557 . . . . 0.0 111.586 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . 0.448 ' HD3' ' HA3' ' B' ' 156' ' ' GLY . 75.6 mmtt -86.83 163.42 17.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.412 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.56 112.21 3.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.344 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.24 39.4 11.32 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.863 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -113.92 126.4 55.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.999 0.428 . . . . 0.0 111.035 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -92.13 136.51 33.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.619 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . 0.48 ' O ' ' HB ' ' B' ' 212' ' ' THR . 65.0 t80 -155.64 -28.26 0.1 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' B' ' 211' ' ' PHE . 91.3 m 75.92 143.83 0.08 Allowed 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 120.665 0.269 . . . . 0.0 110.749 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -138.17 128.07 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.075 0.464 . . . . 0.0 111.233 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -82.72 111.92 19.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.166 0.507 . . . . 0.0 111.522 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 73.3 t -118.19 130.92 72.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 9.9 m -94.24 -29.75 14.92 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -174.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' B' ' 216' ' ' THR . 69.1 m-85 74.3 141.35 0.08 OUTLIER Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 122.702 0.401 . . . . 0.0 111.085 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.89 151.89 51.39 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.303 2.002 . . . . 0.0 111.867 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -65.44 -34.62 78.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.73 26.87 1.05 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.28 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' B' ' 223' ' ' ALA . 7.2 t80 -70.73 133.95 47.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -67.71 -17.67 64.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.413 ' HB2' ' CE2' ' B' ' 221' ' ' TYR . . . -91.28 104.69 17.2 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 33.6 tt0 -57.79 -36.1 71.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.33 -175.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.423 ' O ' ' HD3' ' B' ' 229' ' ' LYS . 28.6 p-10 -72.92 -13.26 61.22 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.4 mt -120.13 -1.54 10.32 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.1 ptmt -69.95 114.14 7.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.301 0.572 . . . . 0.0 111.592 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.26 21.81 75.94 Favored Glycine 0 C--O 1.237 0.292 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.214 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.452 ' HZ1' ' HB3' ' B' ' 229' ' ' LYS . 9.7 mtpm? -122.28 109.91 15.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.87 145.54 55.36 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -128.44 146.23 50.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.772 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -100.97 -29.16 12.35 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -173.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 57.32 107.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -67.2 -40.23 86.44 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.832 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 48.8 mm 69.3 133.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.352 0.661 . . . . 0.0 111.338 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . 0.549 ' ND2' ' HG3' ' B' ' 238' ' ' LYS . 9.7 t30 -109.01 -65.44 1.14 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.843 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.8 mt 61.04 95.99 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . 0.549 ' HG3' ' ND2' ' B' ' 236' ' ' ASN . 64.1 mttp -102.13 -31.35 10.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.799 175.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -102.55 -87.13 0.42 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 85.4 t 72.36 121.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 123.532 0.52 . . . . 0.0 109.971 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.15 179.79 3.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.458 ' HG2' ' HE3' ' B' ' 154' ' ' LYS . 36.4 mt-10 -112.38 114.79 27.71 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -167.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.414 ' HE ' ' CG ' ' B' ' 162' ' ' ASP . 7.4 ptp180 -149.64 141.82 24.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.134 167.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.492 ' H ' ' HA ' ' B' ' 151' ' ' TRP . 1.0 OUTLIER -172.82 162.22 4.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 3.9 tt 67.57 106.45 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.229 0.611 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -85.63 118.5 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.592 2.195 . . . . 0.0 112.802 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -145.41 179.03 7.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.075 0.464 . . . . 0.0 110.733 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . 0.424 ' N ' HD12 ' B' ' 248' ' ' LEU . 4.8 mp -93.55 74.36 4.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.38 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' THR . . . . . 0.435 ' OG1' HG21 ' B' ' 150' ' ' THR . 11.6 m -85.51 -72.71 0.47 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.815 0.34 . . . . 0.0 111.258 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -154.69 -34.91 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.421 . . . . 0.0 111.12 -177.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -62.3 -35.32 78.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.672 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -64.84 -28.98 69.92 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.036 0.935 . . . . 0.0 113.505 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 43.1 pt -99.41 -4.52 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -160.23 -11.9 0.05 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 119.055 -1.058 . . . . 0.0 113.621 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -102.86 134.6 46.0 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.876 0.37 . . . . 0.0 111.255 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -172.67 36.91 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.28 20.67 69.05 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.7 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.6 161.32 35.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -52.02 -59.17 4.66 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 122.894 0.477 . . . . 0.0 109.832 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -173.78 162.46 4.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.824 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -173.31 178.42 45.27 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.583 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 93.1 p -102.56 -171.25 1.93 Allowed 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 122.263 0.225 . . . . 0.0 110.508 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.8 -57.18 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.962 0.411 . . . . 0.0 112.023 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -35.74 23.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.0 111.049 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.28 -39.14 97.51 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.391 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.86 -45.43 92.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.569 0.223 . . . . 0.0 110.631 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -64.29 -42.27 96.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.587 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.518 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.34 -45.15 89.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.314 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -67.12 -39.1 86.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.452 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.7 -44.13 96.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.606 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -60.09 -47.56 85.39 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 17.7 ptmt -64.55 -45.41 87.21 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.909 0.385 . . . . 0.0 111.077 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -65.06 -36.25 83.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 89.5 mmm -61.82 -42.67 99.31 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.031 0.443 . . . . 0.0 109.98 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -70.15 -31.43 68.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.798 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . 0.507 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 57.6 ttp180 -64.73 -42.17 95.41 Favored 'General case' 0 CA--C 1.527 0.074 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -66.85 -34.03 76.9 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.69 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.53 -38.01 85.85 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.719 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 55.4 tttm -55.84 -47.16 77.74 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.303 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 20.4 m -63.47 -42.28 98.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.907 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.02 -47.45 86.39 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.062 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.18 -43.62 97.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.234 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -44.62 96.99 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.83 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.17 -41.37 97.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.035 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . 0.493 ' HA ' ' HE ' ' B' ' 285' ' ' ARG . 4.2 tpm_? -60.42 -43.86 96.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.886 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.31 -44.12 80.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.135 0.493 . . . . 0.0 111.063 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.33 -48.58 79.19 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.938 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.6 p -65.15 -41.31 94.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.72 -40.89 92.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.642 0.258 . . . . 0.0 111.274 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.06 95.33 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.091 0.472 . . . . 0.0 110.653 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 36.7 mm -65.04 -43.49 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . 0.454 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 20.5 tp10 -61.87 -42.55 99.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.682 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.82 98.31 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.51 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' B' ' 123' ' ' ILE . 24.8 mt -63.73 -42.71 97.85 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.26 -42.16 93.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.731 0.3 . . . . 0.0 111.339 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.454 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 66.4 mttm -61.95 -40.47 95.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.698 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.3 -47.46 19.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.904 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -114.89 96.02 5.51 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -99.94 105.54 17.25 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -116.71 159.4 16.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.604 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.6 130.11 43.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 42.6 t -105.48 127.53 28.38 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.029 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.37 128.6 30.76 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.461 2.107 . . . . 0.0 111.882 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.61 80.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.754 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.66 -48.05 72.82 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.338 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 66.3 mt -67.03 -40.52 87.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.002 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . 0.498 ' O ' HG13 ' B' ' 311' ' ' ILE . 75.7 mt -61.04 -49.82 83.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.391 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.13 -43.27 99.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.566 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 38.9 m -63.11 -45.25 92.9 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.643 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . 0.411 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 70.2 mm-40 -71.22 -34.44 70.81 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.512 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 89.9 mt -61.74 -43.05 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.027 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.515 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 31.0 t70 -59.32 -44.92 92.54 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.961 0.41 . . . . 0.0 110.805 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.39 -43.93 98.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.163 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 79.3 mt -62.92 -40.38 97.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.268 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.515 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 83.1 mtm180 -61.33 -42.56 98.87 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -65.08 -37.91 89.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.703 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -62.87 -42.68 99.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.206 0.527 . . . . 0.0 109.88 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.59 -37.47 79.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.523 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' B' ' 325' ' ' ASN . . . -63.9 -37.35 87.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.929 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -63.43 -37.08 85.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.364 0.602 . . . . 0.0 109.482 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -79.51 -3.36 46.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.898 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -101.68 4.22 40.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.953 0.406 . . . . 0.0 111.13 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 128.01 7.1 4.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.936 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 87.96 46.01 4.92 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.396 -0.906 . . . . 0.0 111.776 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' B' ' 319' ' ' ALA . 26.2 t-20 -91.25 135.14 34.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 -177.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.87 160.99 38.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.1 OUTLIER 72.66 -53.57 0.7 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.05 0.54 . . . . 0.0 111.214 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.66 -16.83 63.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.849 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.86 -22.91 50.47 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.81 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.54 -35.78 78.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.912 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -79.51 -5.25 54.43 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.214 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.01 152.6 96.74 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.009 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . 0.479 ' O ' ' HD1' ' B' ' 337' ' ' PHE . 32.9 Cg_exo -59.86 140.53 93.54 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.817 2.344 . . . . 0.0 112.854 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -86.08 -43.78 12.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.898 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -59.18 -39.38 82.37 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -171.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 62.1 mt -86.21 0.31 54.0 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.826 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . 0.479 ' HD1' ' O ' ' B' ' 333' ' ' PRO . 50.8 m-85 -107.75 -29.55 9.05 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.31 -31.7 72.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.964 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -58.92 -49.08 79.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.044 0.449 . . . . 0.0 110.795 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -83.5 -21.03 32.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.012 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . 0.416 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.85 -40.48 97.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . 0.424 ' O ' HG22 ' B' ' 346' ' ' VAL . 87.7 tttt -59.35 -44.37 92.67 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.194 177.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . 0.551 ' O ' HG21 ' B' ' 347' ' ' VAL . 13.5 mmt85 -61.35 -45.22 95.32 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.772 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -67.22 -38.72 85.75 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.306 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.416 HG23 ' O ' ' B' ' 341' ' ' ALA . 74.2 t -64.53 -43.58 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.36 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.424 HG22 ' O ' ' B' ' 342' ' ' LYS . 57.7 t -61.32 -42.49 93.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.44 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . 0.551 HG21 ' O ' ' B' ' 343' ' ' ARG . 79.4 t -59.87 -44.86 95.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.51 -41.69 99.61 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.928 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.96 -44.54 95.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.748 0.308 . . . . 0.0 110.982 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.451 ' O ' HG22 ' B' ' 354' ' ' VAL . 92.7 mt -63.53 -47.2 82.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.997 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.54 -41.29 88.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.487 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.21 99.73 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.195 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.22 -35.75 78.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.061 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . 0.451 HG22 ' O ' ' B' ' 350' ' ' LEU . 76.1 t -60.61 -45.08 97.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 77.7 mt -63.4 -46.2 95.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.68 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.1 -54.26 32.7 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 47.7 m -65.21 -44.94 86.7 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -83.44 -8.47 59.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.265 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 65.43 45.39 2.83 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.271 0.558 . . . . 0.0 111.267 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 97.6 mt -78.79 156.3 28.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.768 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -139.02 153.45 48.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.516 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -75.07 105.77 6.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -80.83 116.48 20.84 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.978 0.418 . . . . 0.0 111.464 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 60.3 mm-40 -58.75 -42.61 89.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.308 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -62.42 -44.49 96.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.678 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -61.35 -42.64 99.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.207 0.527 . . . . 0.0 109.792 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . 0.413 HG23 ' HG2' ' B' ' 399' ' ' ARG . 94.7 t -65.96 -36.23 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.316 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.5 mmmt -56.31 -42.68 78.01 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.803 0.335 . . . . 0.0 110.663 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.95 -38.48 96.66 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.086 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.88 -42.04 97.6 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.1 0.476 . . . . 0.0 110.221 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 65.3 mt -65.7 -43.62 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.148 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -61.67 -40.0 93.39 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.693 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -67.28 -38.57 85.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.001 0.429 . . . . 0.0 110.412 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 58.1 ttm -64.28 -41.84 96.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.132 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . 0.418 ' HA ' HG13 ' B' ' 384' ' ' VAL . . . -64.39 -32.62 74.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.29 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 49.6 m -71.23 -8.02 50.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.454 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.85 -1.89 57.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.033 0.444 . . . . 0.0 110.507 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -117.81 173.23 6.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.123 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -65.87 -49.83 66.68 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -116.18 107.76 47.04 Favored Pre-proline 0 CA--C 1.518 -0.251 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.39 -29.21 71.81 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.106 1.871 . . . . 0.0 113.26 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -64.55 -45.12 88.47 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.89 -36.23 82.82 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.771 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . 0.418 HG13 ' HA ' ' B' ' 375' ' ' ALA . 57.9 t -65.11 -43.84 95.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.605 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.59 -43.89 98.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.983 0.421 . . . . 0.0 109.916 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -65.93 -38.13 87.86 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.928 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -58.34 -46.66 85.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.541 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.08 -42.1 76.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 41.9 p -78.27 -8.36 58.28 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.23 9.28 42.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.847 0.356 . . . . 0.0 111.259 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -134.66 111.27 9.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.061 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -61.66 -39.85 92.85 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -59.99 -45.07 93.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.771 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.89 -40.63 96.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.686 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 94.8 mtp -62.13 -45.41 93.59 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.265 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.39 -44.16 79.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.008 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -64.09 -44.91 90.9 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.27 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 40.7 tpp -63.03 -42.54 99.81 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.926 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.413 ' HG2' HG23 ' B' ' 367' ' ' VAL . 84.1 mtm180 -66.12 -34.8 78.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.616 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -63.02 -42.63 99.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.796 0.332 . . . . 0.0 110.383 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.75 -46.02 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.792 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.21 88.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.693 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.45 -38.95 93.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.529 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.12 -43.33 99.05 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.38 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -65.7 -37.52 86.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.645 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -59.54 -43.86 93.39 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.642 0.258 . . . . 0.0 110.437 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.91 89.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.25 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.21 -46.24 93.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.004 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.86 -30.8 70.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.745 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.48 -40.05 94.94 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.914 0.388 . . . . 0.0 110.139 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.15 -42.84 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.188 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.33 -39.79 91.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.305 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.47 68.42 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.549 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -96.89 -9.76 27.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.53 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.01 -170.25 1.79 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.182 0.515 . . . . 0.0 110.921 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -102.57 120.0 39.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.417 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 66.4 t -106.74 126.98 62.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 13.6 t -118.27 146.72 44.09 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.134 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . 0.408 ' HG2' HG13 ' B' ' 129' ' ' ILE . 41.4 mt-10 -107.84 123.22 48.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.298 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -144.64 147.76 33.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.751 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -97.11 147.72 23.77 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.451 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -155.46 178.48 10.19 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 22.1 p -82.21 153.38 25.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.988 0.423 . . . . 0.0 111.37 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -63.13 -34.07 76.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.835 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -60.6 -35.78 76.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.448 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.25 -32.0 73.45 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.944 0.402 . . . . 0.0 111.169 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.36 -7.95 59.49 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.86 0.362 . . . . 0.0 111.1 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.3 mmt -80.26 -6.9 58.65 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.05 0.452 . . . . 0.0 110.613 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -74.48 81.14 1.94 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.395 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -106.04 13.4 29.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.806 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -65.82 -40.53 91.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.034 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.751 -179.828 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.576 0.227 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -86.6 130.27 34.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.9 0.381 . . . . 0.0 110.349 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.56 164.95 32.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.183 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 t -111.1 102.26 10.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.859 0.361 . . . . 0.0 110.255 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.29 139.49 26.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.916 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 45.7 mt-10 -124.84 177.18 6.15 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.839 0.352 . . . . 0.0 110.808 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.4 m -124.91 131.74 53.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.909 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 45.3 m -79.86 -70.38 0.52 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 177.83 139.01 0.08 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.517 0.727 . . . . 0.0 109.569 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.85 -121.19 25.05 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.242 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 108' ' ' GLU . 81.0 mt -65.12 -39.74 93.51 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.9 0.48 . . . . 0.0 110.943 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.544 ' HA2' ' HG2' ' A' ' 108' ' ' GLU . . . -68.78 140.45 34.74 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 115.857 1.103 . . . . 0.0 115.857 -173.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -129.69 -163.57 1.32 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -160.28 116.94 2.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 117.888 0.313 . . . . 0.0 110.647 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t -95.77 -90.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.194 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m 51.1 83.79 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.224 0.535 . . . . 0.0 111.0 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 tp -113.58 145.15 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.6 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.0 p -99.64 129.78 45.81 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.557 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.447 ' CD1' HG12 ' A' ' 24' ' ' ILE . 6.5 pt -131.46 157.49 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.652 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -79.87 154.55 28.3 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.851 0.461 . . . . 0.0 112.04 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.76 -50.63 69.91 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.22 -37.33 86.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.487 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -63.24 -43.41 98.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.103 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 20' ' ' ALA . 67.0 mt -62.71 -52.34 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.232 0.539 . . . . 0.0 111.742 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.04 -38.38 72.57 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.453 -173.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -79.23 -59.29 2.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.71 -48.12 70.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -173.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.493 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 94.4 t -63.98 -43.89 97.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.48 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -61.55 -45.28 94.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.321 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 m -63.89 -41.64 97.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.726 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.431 ' O ' HG21 ' A' ' 35' ' ' VAL . 34.8 tp10 -66.55 -36.11 81.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.794 0.331 . . . . 0.0 111.102 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 91.9 mt -61.54 -42.31 98.64 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.63 -37.81 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.025 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -63.11 -41.42 99.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.817 0.342 . . . . 0.0 110.769 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 31' ' ' GLU . 91.1 t -63.74 -43.99 98.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.426 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.55 93.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.885 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.74 -33.01 74.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.231 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -59.0 -45.7 90.0 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 110.38 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.3 t -87.74 -2.68 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.265 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 64.1 27.52 14.11 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.131 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -105.38 8.67 9.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.002 0.43 . . . . 0.0 111.535 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.54 -34.08 77.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.322 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.86 -5.16 56.88 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.435 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -84.87 -10.26 57.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.907 0.353 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -88.55 110.1 20.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.338 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.71 -41.38 97.53 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.1 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.07 42.56 76.45 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 115.898 1.119 . . . . 0.0 115.898 172.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -61.81 -43.72 98.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.274 1.037 . . . . 0.0 108.717 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.24 100.81 39.04 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.441 ' HG2' HD12 ' A' ' 53' ' ' ILE . 30.9 Cg_endo -63.76 158.09 48.47 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.657 2.238 . . . . 0.0 112.543 -176.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.453 ' HA ' HG12 ' A' ' 54' ' ' VAL . 82.9 mtp -61.82 -32.63 72.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.981 -174.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -69.16 -18.74 63.97 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.208 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.635 HD11 ' NH2' ' B' ' 193' ' ' ARG . 89.5 mt -105.66 -48.26 9.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 51' ' ' MET . 14.8 p -63.09 -35.15 70.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 120.988 0.423 . . . . 0.0 111.138 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.61 81.36 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.297 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -91.54 -7.19 51.01 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.403 HH12 HD12 ' B' ' 187' ' ' LEU . 67.9 mtt180 -97.3 -30.33 13.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.177 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -111.74 12.72 21.06 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.678 0.751 . . . . 0.0 109.531 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 61' ' ' SER . . . -65.54 150.54 51.78 Favored Glycine 0 CA--C 1.493 -1.312 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.417 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.47 -41.5 0.5 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.356 0.663 . . . . 0.0 111.388 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 59' ' ' GLY . 39.1 t -60.01 -46.79 88.34 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.07 0.548 . . . . 0.0 111.151 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.4 p -124.52 14.2 4.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.456 0.646 . . . . 0.0 110.892 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -64.73 -19.11 65.59 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.985 0.422 . . . . 0.0 110.948 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -62.02 -52.32 64.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.623 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.87 -17.6 59.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.244 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 62' ' ' VAL . 77.7 t -64.64 -42.71 95.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 173.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.72 -39.61 94.61 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 71' ' ' MET . . . -60.31 -41.14 98.28 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.563 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.724 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 30.8 t70 -63.37 -43.83 96.5 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.45 -43.43 98.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.91 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 68' ' ' GLY . 24.8 ptt? -63.65 -40.74 97.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.6 m -64.17 -40.26 95.73 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.091 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.724 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 43.9 mtp85 -63.03 -43.57 98.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.165 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -64.26 -41.06 97.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.695 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.87 -48.57 79.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.914 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.442 ' O ' HG13 ' A' ' 79' ' ' ILE . 19.3 tt -67.81 -40.76 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.466 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.79 -43.01 97.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.128 0.489 . . . . 0.0 110.221 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.86 95.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.093 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.6 pp -67.01 -40.92 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.974 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.73 -44.59 96.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.537 0.684 . . . . 0.0 109.765 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -64.71 -45.35 86.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.086 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -86.69 0.66 54.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.708 0.29 . . . . 0.0 111.416 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm 63.76 52.23 2.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.751 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.11 126.29 64.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.738 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -101.27 109.66 59.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.552 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.21 117.98 4.23 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.331 2.021 . . . . 0.0 112.034 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.08 93.68 8.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.135 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.14 -159.01 17.83 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.992 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.74 123.67 59.09 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.69 112.5 2.21 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.115 1.877 . . . . 0.0 110.704 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -96.26 114.88 26.61 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.237 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.557 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 91.3 m-85 -87.66 137.39 32.37 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.99 96.91 16.0 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-O 120.873 0.368 . . . . 0.0 111.792 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 93.1 Cg_endo -103.43 -172.12 0.07 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 123.473 2.782 . . . . 0.0 111.418 175.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -118.76 -172.0 15.26 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.65 145.96 25.37 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -95.17 126.76 40.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.15 0.5 . . . . 0.0 111.044 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.66 128.5 54.23 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.6 tp -67.03 114.49 5.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.892 0.377 . . . . 0.0 110.851 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.62 1.89 55.37 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.915 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -123.17 167.76 13.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.939 0.369 . . . . 0.0 110.99 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -71.34 141.87 50.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.743 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -95.7 137.31 34.95 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.7 m -119.62 131.19 55.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.826 0.346 . . . . 0.0 111.334 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -129.94 148.11 51.77 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.077 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.494 ' O ' HG13 ' A' ' 107' ' ' VAL . 50.1 m -102.46 -65.74 0.97 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 70.65 152.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 124.12 0.968 . . . . 0.0 111.047 -175.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.544 ' HG2' ' HA2' ' A' ' 12' ' ' GLY . 25.0 mt-10 -133.26 151.23 51.91 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 122.239 -0.288 . . . . 0.0 110.47 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -154.85 -73.03 0.12 Allowed 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -112.4 162.56 15.44 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -171.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.431 HG11 HD23 ' A' ' 11' ' ' LEU . 3.9 m -136.82 143.22 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.224 177.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -145.64 98.48 4.53 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 121.083 0.468 . . . . 0.0 110.546 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.88 149.56 20.48 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.086 2.524 . . . . 0.0 114.213 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -144.36 120.15 10.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.979 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 66.5 t -123.42 135.44 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.635 0.255 . . . . 0.0 111.12 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -121.81 142.04 50.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.58 153.14 38.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.59 0.234 . . . . 0.0 110.859 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -136.94 158.15 45.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.59 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.34 17.53 68.81 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.563 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.52 -39.84 94.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.185 0.517 . . . . 0.0 111.004 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.78 -17.2 64.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.681 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.18 12.2 29.63 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.869 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.1 mt -87.81 111.89 22.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.18 0.514 . . . . 0.0 110.32 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -105.73 120.89 42.85 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.7 t -118.3 133.01 66.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.629 0.252 . . . . 0.0 110.861 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -81.09 142.64 33.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.579 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.47 93.36 40.88 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.31 113.47 3.47 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.23 1.953 . . . . 0.0 112.123 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.29 115.53 43.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.037 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.07 158.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.675 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -133.99 157.4 46.17 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.598 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -70.82 127.14 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 71.7 p -110.84 176.64 4.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.738 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -62.68 -33.92 76.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.348 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.24 -40.99 96.1 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.886 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -64.5 -47.45 78.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.116 0.484 . . . . 0.0 110.385 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.08 -45.76 95.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.757 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.93 -46.28 91.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.479 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.22 97.82 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.817 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.555 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.8 tpt -61.71 -46.51 89.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.616 0.246 . . . . 0.0 110.841 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.76 -41.66 97.95 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.972 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.85 -45.34 94.92 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.369 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 m -63.51 -42.83 98.46 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.177 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.4 mt -60.71 -43.41 97.83 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -65.85 -33.36 75.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.926 0.393 . . . . 0.0 110.964 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.7 -13.81 60.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.914 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -90.02 -54.32 4.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -56.42 125.68 23.07 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.82 -167.41 2.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.525 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 151' ' ' TRP . 4.4 m -146.43 170.74 16.21 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.48 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 6.8 p-90 -120.38 145.91 46.7 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 151' ' ' TRP . 56.3 tttp 173.55 -59.61 0.01 OUTLIER 'General case' 0 C--N 1.351 0.639 0 O-C-N 123.862 0.726 . . . . 0.0 110.531 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -109.64 177.14 4.82 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 120.692 0.282 . . . . 0.0 111.498 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -84.15 147.11 27.5 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 69.48 116.88 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.978 0.911 . . . . 0.0 113.259 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -167.9 -98.74 0.12 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.436 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.35 145.79 29.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.3 126.48 67.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -95.54 -176.7 3.84 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.765 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.81 -66.89 0.48 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.498 ' OE2' ' HA ' ' A' ' 256' ' ' PHE . 13.9 pt-20 -78.52 7.35 6.85 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 188' ' ' ALA . 31.1 t70 -72.74 147.66 45.39 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.354 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 163' ' ' ARG . 16.8 ptp180 -101.87 116.7 33.28 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.59 127.14 74.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.586 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.1 m -74.93 109.54 8.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.6 124.37 66.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.061 0.457 . . . . 0.0 111.633 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.13 91.1 6.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -111.81 149.34 31.89 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.349 0.595 . . . . 0.0 111.885 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 40.5 m -128.15 129.75 47.02 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.121 177.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.85 134.65 12.65 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.827 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.3 m -142.84 144.35 32.49 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 120.83 0.347 . . . . 0.0 110.731 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.2 t -98.76 94.12 3.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 64.75 -70.39 0.08 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.331 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -137.06 5.82 3.65 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.77 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -130.24 139.15 50.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.585 0.692 . . . . 0.0 111.169 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.37 153.1 30.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.144 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -117.62 -177.31 3.21 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -53.78 -49.57 67.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.833 0.853 . . . . 0.0 113.194 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -103.0 -164.97 25.84 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.016 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . 82.25 28.22 41.38 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.861 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -114.03 106.73 14.75 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.67 145.9 50.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.836 0.35 . . . . 0.0 111.263 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 69.1 m -139.43 130.37 26.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.713 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 55.34 32.24 18.34 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.717 0.636 . . . . 0.0 110.513 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -93.2 133.49 36.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.965 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.6 m -94.04 119.48 41.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.52 0.676 . . . . 0.0 111.376 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.439 HD12 HH12 ' B' ' 57' ' ' ARG . 29.8 tp -111.37 123.58 50.5 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.106 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.718 ' HB3' ' NH1' ' A' ' 193' ' ' ARG . . . -110.91 131.52 54.97 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 173.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.441 ' SD ' ' HB ' ' A' ' 202' ' ' ILE . 70.8 mtm -98.43 177.08 5.46 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.218 0.532 . . . . 0.0 112.032 -171.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.53 23.32 67.92 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.498 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -131.85 -15.04 3.08 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 121.096 -0.241 . . . . 0.0 111.561 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.4 42.48 9.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.063 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.718 ' NH1' ' HB3' ' A' ' 188' ' ' ALA . 70.9 mtm180 -100.69 -0.38 37.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.316 0.579 . . . . 0.0 110.754 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.439 ' HE3' ' HA ' ' A' ' 194' ' ' MET . 0.7 OUTLIER -132.01 168.7 17.48 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 175.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.422 HG12 ' CE2' ' A' ' 217' ' ' PHE . 3.4 mp -58.75 129.92 85.32 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.3 133.62 42.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.399 2.066 . . . . 0.0 111.929 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.84 -43.47 1.67 Allowed Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.089 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -63.54 -46.56 85.42 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.46 0.172 . . . . 0.0 111.053 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -86.68 14.17 7.47 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 121.184 0.516 . . . . 0.0 111.126 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.601 ' O ' ' HE2' ' A' ' 203' ' ' LYS . 17.3 t70 -113.62 -41.05 3.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.137 0.494 . . . . 0.0 109.866 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.9 -17.58 67.65 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.577 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.441 ' HB ' ' SD ' ' A' ' 189' ' ' MET . 69.9 mt -67.44 -26.31 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 122.632 -0.334 . . . . 0.0 111.316 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.601 ' HE2' ' O ' ' A' ' 200' ' ' ASP . 46.5 mtmt -57.9 132.74 54.28 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.971 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.6 -12.65 64.57 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.744 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -88.07 160.08 17.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.055 0.427 . . . . 0.0 111.679 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -88.02 176.18 7.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.943 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -91.31 53.29 2.28 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.429 0.633 . . . . 0.0 111.101 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 150.75 44.58 0.02 OUTLIER Glycine 0 C--N 1.307 -1.056 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -125.72 131.39 52.57 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.133 -0.534 . . . . 0.0 110.518 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -108.96 112.06 24.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.032 0.444 . . . . 0.0 109.931 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -132.39 -4.51 3.38 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.949 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 69.4 p 58.34 169.24 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.887 0.875 . . . . 0.0 112.473 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.5 tp -156.48 143.71 10.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.874 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.405 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 28.2 m-20 -95.28 114.89 26.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.373 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 67.9 t -117.99 129.9 73.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 8.7 m -91.31 -24.49 19.8 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -174.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 216' ' ' THR . 64.5 m-85 69.62 158.13 0.15 Allowed Pre-proline 0 N--CA 1.485 1.291 0 CA-C-O 120.849 0.357 . . . . 0.0 110.866 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -86.62 156.32 9.06 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 122.22 1.946 . . . . 0.0 112.089 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.511 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 67.5 mm-40 -66.16 -42.58 88.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.02 65.72 9.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.022 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -103.62 139.93 38.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.671 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -64.92 -18.91 65.63 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.74 110.43 22.52 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 43.2 tt0 -64.57 -35.14 80.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.019 0.437 . . . . 0.0 111.745 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -70.47 -15.7 62.84 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.554 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.1 mt -114.91 -3.95 12.65 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.5 ptmt -71.72 126.53 29.96 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.696 -176.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.08 29.2 74.23 Favored Glycine 0 C--O 1.24 0.483 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.459 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -125.62 135.48 52.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.907 0.354 . . . . 0.0 110.956 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -79.8 131.89 36.01 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.951 0.405 . . . . 0.0 110.347 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -117.12 157.99 24.98 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.559 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.405 ' HE2' ' OD1' ' A' ' 214' ' ' ASP . 34.4 mmtp -116.0 106.89 14.29 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -83.0 111.71 19.1 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.3 0.571 . . . . 0.0 110.564 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -81.74 90.9 6.39 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.486 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm -88.04 116.93 30.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -104.8 -52.61 2.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.351 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 98.9 mt 65.78 132.75 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.632 0.773 . . . . 0.0 112.557 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -111.44 -66.33 1.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.195 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -100.16 -67.86 0.83 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.387 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 17.1 t 71.08 155.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.279 0.632 . . . . 0.0 111.225 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -80.52 -179.13 7.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.982 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.33 143.79 50.99 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.301 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -175.49 104.63 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.964 0.506 . . . . 0.0 112.322 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -171.83 163.55 6.34 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 35.9 tp 75.67 111.13 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 123.933 0.893 . . . . 0.0 110.721 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.409 ' HA ' ' CG2' ' A' ' 150' ' ' THR . 92.6 Cg_endo -81.76 140.07 11.42 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.495 2.13 . . . . 0.0 114.315 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -136.16 10.44 3.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.446 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 8.5 mp 70.39 109.55 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.467 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.534 HG21 ' H ' ' A' ' 251' ' ' GLU . 30.6 m -125.93 131.9 52.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.112 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -70.84 -18.77 62.71 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . 0.534 ' H ' HG21 ' A' ' 249' ' ' THR . 47.8 mt-10 -61.89 -45.41 93.89 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -76.33 -26.14 55.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.766 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 250' ' ' ALA . 11.2 tp -73.36 -35.38 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.689 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 22.8 ptmt -92.12 -20.53 21.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -123.5 119.44 29.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.28 0.562 . . . . 0.0 111.953 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.498 ' HA ' ' OE2' ' A' ' 161' ' ' GLU . 56.1 t80 -156.43 83.54 0.98 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.03 -48.96 3.42 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -175.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.36 150.56 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 123.187 0.595 . . . . 0.0 109.877 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.27 -48.73 79.54 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.517 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.88 131.33 4.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.979 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -134.1 -142.86 4.78 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.748 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 21.6 p -142.38 -169.86 3.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.4 -66.14 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.374 0.607 . . . . 0.0 110.512 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.6 OUTLIER -70.91 -39.91 72.46 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.249 -178.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.28 -39.15 96.78 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.642 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.41 -43.92 97.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.616 0.246 . . . . 0.0 110.812 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -63.26 -42.46 99.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.171 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -67.89 -43.02 80.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.65 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -67.94 -39.06 83.52 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.991 0.424 . . . . 0.0 110.71 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.79 -41.73 92.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -55.22 -52.12 64.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.749 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.1 ptmt -65.33 -42.03 93.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.712 0.291 . . . . 0.0 111.689 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.92 -39.78 94.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.701 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 90.7 mmm -63.52 -42.66 98.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.59 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -69.45 -33.48 72.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.62 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -62.45 -43.39 98.94 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.319 0.58 . . . . 0.0 109.661 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -69.42 -33.57 73.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.053 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.64 -40.78 96.1 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.495 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -57.61 -44.4 85.46 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.058 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.2 m -62.69 -42.88 99.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.72 98.84 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.327 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.93 -43.74 97.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.983 0.421 . . . . 0.0 110.031 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -44.61 97.09 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.087 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -64.37 -41.92 96.45 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.449 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -60.92 -43.78 98.13 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.032 0.444 . . . . 0.0 110.447 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 94.0 t -68.44 -44.64 83.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.715 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.5 -46.32 88.99 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.122 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.7 p -61.87 -42.64 99.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -67.2 -41.11 86.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.997 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.81 86.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.812 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 295' ' ' VAL . 35.9 mm -64.09 -43.65 97.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.519 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.446 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 19.9 tp10 -61.23 -44.15 97.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.171 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.33 99.28 Favored Glycine 0 C--O 1.24 0.526 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.692 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.78 -42.13 95.31 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 291' ' ' ILE . 85.1 t -63.93 -44.36 97.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.914 -178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . 0.446 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.6 mttm -62.63 -37.64 87.1 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.78 0.324 . . . . 0.0 111.657 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.59 -30.03 27.3 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -128.84 92.21 3.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -91.28 98.46 11.73 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -103.25 149.11 7.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.391 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.04 135.37 57.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.907 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.64 120.54 44.81 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.068 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.99 131.52 44.07 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.592 2.195 . . . . 0.0 112.471 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.13 75.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.282 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.43 -29.18 63.94 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.681 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 90.4 mt -93.31 -31.76 14.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.826 0.346 . . . . 0.0 110.855 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 311' ' ' ILE . 95.6 mt -63.68 -46.91 93.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.759 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.12 -39.0 93.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 35.6 p -69.02 -42.38 76.46 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.724 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.645 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 24.6 mm-40 -72.69 -35.74 67.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.478 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 77.4 mt -61.7 -43.8 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.304 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.489 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 30.6 t70 -61.64 -41.94 98.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.928 0.394 . . . . 0.0 111.022 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.0 t -62.1 -43.87 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.899 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 61.7 mt -63.05 -39.28 94.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.818 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.489 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.5 mtm180 -62.04 -42.64 99.39 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -64.08 -37.86 88.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.668 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -61.5 -46.15 91.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.198 0.523 . . . . 0.0 110.043 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.29 -37.2 71.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.429 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.54 72.57 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 120.98 0.419 . . . . 0.0 111.223 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . 0.459 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 49.2 tt0 -62.33 -37.81 87.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.458 0.647 . . . . 0.0 109.956 176.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.36 -15.75 59.23 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.583 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -93.56 6.59 47.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.699 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.44 -22.69 3.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.521 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 109.6 37.53 1.89 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.337 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.413 HD22 ' HB2' ' A' ' 328' ' ' GLN . 27.3 t-20 -79.14 135.9 36.96 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.858 0.361 . . . . 0.0 110.792 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . 0.598 ' OE1' ' HG3' ' A' ' 327' ' ' LYS . 1.7 tm-20 -136.71 152.42 50.35 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.598 ' HG3' ' OE1' ' A' ' 326' ' ' GLU . 32.0 mtmm 70.89 -46.34 0.63 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.553 0.741 . . . . 0.0 112.419 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.413 ' HB2' HD22 ' A' ' 325' ' ' ASN . 17.3 mm100 -68.54 -16.69 63.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.252 0.548 . . . . 0.0 110.065 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.58 -19.05 34.95 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.859 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.476 HD11 HH12 ' A' ' 315' ' ' ARG . 52.8 tp -61.15 -38.7 87.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.774 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -75.34 -19.47 59.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.775 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 81.2 mt -55.52 136.75 70.26 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.425 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.68 127.73 23.81 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.93 2.42 . . . . 0.0 113.057 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -68.31 -42.17 79.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.263 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -59.07 -36.18 74.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.129 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.88 -39.02 93.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.456 ' CD1' ' HG2' ' A' ' 315' ' ' ARG . 96.9 m-85 -97.06 -15.78 20.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -68.84 -31.6 70.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.81 0.338 . . . . 0.0 111.197 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -61.32 -50.89 71.13 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.823 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -70.64 -28.83 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.838 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.407 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -61.06 -42.17 97.99 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.21 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.459 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.8 tttt -59.83 -47.2 86.67 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.187 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.533 ' O ' HG21 ' A' ' 347' ' ' VAL . 13.0 mmt85 -62.94 -44.89 94.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.142 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.457 ' NH2' HD23 ' A' ' 314' ' ' LEU . 93.5 mtt180 -66.58 -38.43 87.03 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 341' ' ' ALA . 71.2 t -65.31 -43.17 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.78 0.324 . . . . 0.0 110.35 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 342' ' ' LYS . 74.2 t -60.69 -42.82 93.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.482 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 343' ' ' ARG . 76.5 t -59.68 -44.72 94.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.29 99.59 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.202 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.96 -43.82 97.75 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.891 0.376 . . . . 0.0 110.841 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.31 -44.56 94.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.934 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.16 -41.67 94.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.285 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.97 -42.59 99.75 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.217 -0.516 . . . . 0.0 113.254 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . 0.408 ' CD ' HH22 ' A' ' 356' ' ' ARG . 32.1 tp10 -63.23 -44.3 95.62 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.866 0.365 . . . . 0.0 110.759 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.34 -46.26 95.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.029 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.66 -44.72 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.918 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . 0.408 HH22 ' CD ' ' A' ' 353' ' ' GLU . 7.5 tmm_? -69.68 -45.41 68.4 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.8 m -68.89 -43.24 75.68 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -86.15 -1.52 57.5 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.909 0.385 . . . . 0.0 110.663 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 57.63 44.76 20.27 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.08 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.66 149.3 34.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.399 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.77 148.41 32.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.728 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.38 126.75 29.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.55 ' O ' HG21 ' A' ' 367' ' ' VAL . 18.4 t70 -94.44 115.86 28.12 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.769 -176.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 54.3 mm-40 -60.52 -40.22 90.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.564 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.95 -40.11 91.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 110.883 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -64.02 -39.14 93.44 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.598 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 363' ' ' ASP . 90.5 t -62.68 -39.69 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.922 176.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.0 mmmt -57.11 -43.29 82.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.037 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.5 -40.68 99.42 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.035 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.04 -41.09 99.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 109.995 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.67 -42.95 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.453 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.99 -41.59 96.77 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.709 0.29 . . . . 0.0 111.046 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -65.37 -40.29 93.34 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 109.857 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 50.1 ttm -65.71 -41.64 92.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.646 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.9 -27.42 68.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.991 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.3 m -75.76 -3.08 32.89 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.548 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -96.4 4.39 52.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.836 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -125.59 -176.6 3.65 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.737 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.37 -52.83 60.05 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.404 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.577 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 21.3 t70 -125.68 125.58 24.96 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.502 ' O ' HG13 ' A' ' 385' ' ' ILE . 33.7 Cg_endo -64.64 -32.69 57.51 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 121.969 1.779 . . . . 0.0 113.102 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -68.22 -41.55 81.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 13.0 pt-20 -61.17 -38.21 85.69 Favored 'General case' 0 N--CA 1.46 0.068 0 CA-C-O 120.745 0.307 . . . . 0.0 110.177 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.99 -44.01 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.325 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 381' ' ' PRO . 74.0 mt -60.75 -46.86 95.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.4 -43.09 86.77 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.515 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -59.41 -46.82 87.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.946 0.403 . . . . 0.0 110.869 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -68.52 -41.86 79.33 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.813 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.9 p -80.18 -8.03 59.24 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.22 7.96 45.49 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.174 0.511 . . . . 0.0 110.563 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -133.38 110.96 10.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.798 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -62.33 -38.01 87.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.354 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.9 -50.68 71.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.035 0.445 . . . . 0.0 110.394 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.29 -41.98 96.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.442 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.517 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 88.9 mtp -63.33 -48.61 77.29 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.8 -39.46 66.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.612 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.91 -41.15 97.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.466 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 47.7 tpp -65.25 -40.03 93.46 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 395' ' ' MET . 79.2 mtm180 -63.09 -33.56 75.7 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.71 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.68 -41.83 98.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.127 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.15 -45.57 93.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.448 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.39 90.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.915 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 57.3 tp -62.58 -39.36 93.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.498 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -61.05 -43.75 98.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -65.78 -35.98 82.23 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.126 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -60.81 -41.52 95.84 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.207 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.36 94.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.687 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 90.6 t -64.2 -45.4 96.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.014 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.78 -35.87 82.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.535 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.28 98.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.914 0.388 . . . . 0.0 110.4 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 95.4 t -67.75 -43.45 86.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 94.5 mt -61.51 -41.5 97.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.998 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.8 -24.29 67.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.587 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -99.06 -1.99 38.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.334 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.49 172.27 6.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.982 0.42 . . . . 0.0 111.739 -177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.15 127.35 31.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.573 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.21 116.09 46.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 120.882 0.372 . . . . 0.0 110.588 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 10.0 t -115.54 128.84 56.26 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -112.88 123.57 50.63 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.1 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -145.23 150.4 36.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.795 0.331 . . . . 0.0 111.561 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -84.46 162.52 19.89 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.628 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.5 t -158.54 -176.71 6.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.798 0.332 . . . . 0.0 110.631 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 16.5 p -81.76 157.9 24.35 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.274 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -67.53 -35.63 79.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.175 0.512 . . . . 0.0 110.842 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -60.63 -35.85 77.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.109 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -66.37 -30.73 71.17 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.098 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.39 -15.99 58.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.968 0.413 . . . . 0.0 110.788 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 8.8 mmt -78.07 -6.3 54.2 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.77 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -76.18 68.51 2.61 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.509 0.671 . . . . 0.0 109.358 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -99.42 16.01 24.53 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.327 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -63.22 -39.52 94.85 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.754 0 CA-C-O 118.286 -0.864 . . . . 0.0 109.825 179.278 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.727 0.299 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.58 133.8 34.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.345 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.67 162.32 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.675 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 33.8 t -103.47 105.9 16.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.918 0.389 . . . . 0.0 110.326 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 p -146.77 139.52 19.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.728 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 61.2 mt-10 -129.06 172.83 11.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.699 0.285 . . . . 0.0 111.119 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 94.1 m -121.82 129.44 52.63 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.245 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 33.3 m -77.17 -68.8 0.58 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 175.79 139.53 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.512 0.725 . . . . 0.0 109.717 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.84 -122.62 28.26 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.379 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' B' ' 108' ' ' GLU . 78.1 mt -65.79 -39.56 91.08 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 122.868 0.467 . . . . 0.0 110.907 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.527 ' HA2' ' HG2' ' B' ' 108' ' ' GLU . . . -69.39 137.74 29.69 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 115.63 1.012 . . . . 0.0 115.63 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 1.5 tpp180 -126.04 -161.66 1.07 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -161.94 116.27 1.9 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 t -94.26 -91.86 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.138 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m 52.69 85.24 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 CA-C-O 121.28 0.562 . . . . 0.0 110.787 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 tp -114.68 144.84 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.683 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 14.4 p -100.34 126.44 46.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.971 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.438 ' CD1' HG12 ' B' ' 24' ' ' ILE . 6.6 pt -131.22 153.71 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.663 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -75.92 151.27 37.36 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.889 0.476 . . . . 0.0 112.0 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.17 -50.19 69.94 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -65.15 -37.54 87.73 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.596 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -63.71 -43.48 96.45 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.035 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.663 HG13 ' O ' ' B' ' 20' ' ' ALA . 68.8 mt -61.77 -52.58 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.242 0.544 . . . . 0.0 111.517 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -70.05 -39.22 75.84 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.16 -172.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 10.9 m -77.24 -55.7 5.19 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.38 -47.54 60.43 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 96.0 t -64.17 -43.34 97.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.194 -176.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -61.31 -45.22 95.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.39 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 40.4 m -63.07 -42.35 99.64 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.528 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.414 ' O ' HG21 ' B' ' 35' ' ' VAL . 49.0 tp10 -65.93 -36.63 83.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.369 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 91.9 mt -61.93 -42.1 98.71 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.24 -36.63 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.207 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -63.39 -41.13 98.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.621 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.414 HG21 ' O ' ' B' ' 31' ' ' GLU . 96.7 t -63.81 -44.12 98.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.437 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.74 93.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.113 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.04 -33.48 75.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.273 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -59.58 -41.73 90.91 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.642 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 10.8 t -91.08 -1.86 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.23 0.538 . . . . 0.0 110.343 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 65.14 25.13 12.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.259 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -103.93 6.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.622 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -65.84 -29.0 69.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.291 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.7 -3.86 68.78 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.281 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -86.48 -5.76 59.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.439 ' HG3' ' NE2' ' A' ' 320' ' ' GLN . 37.2 ttt85 -93.39 110.67 22.22 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.797 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.72 -42.84 99.49 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.488 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.13 46.1 67.37 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 115.906 1.122 . . . . 0.0 115.906 172.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -61.39 -44.61 96.85 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.174 0.987 . . . . 0.0 108.469 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.39 103.84 44.73 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.449 ' HG2' HD12 ' B' ' 53' ' ' ILE . 36.2 Cg_endo -64.07 156.36 59.39 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.736 2.291 . . . . 0.0 112.711 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.472 ' HA ' HG12 ' B' ' 54' ' ' VAL . 92.2 mtp -63.45 -24.99 68.07 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -174.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -79.15 -10.02 59.71 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.834 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.678 HD11 ' NH2' ' A' ' 193' ' ' ARG . 93.9 mt -114.94 -46.1 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' B' ' 51' ' ' MET . 14.6 p -63.66 -34.61 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.955 0.407 . . . . 0.0 110.797 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.0 82.89 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.168 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -88.9 -14.97 35.52 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.439 HH12 HD12 ' A' ' 187' ' ' LEU . 67.6 mtt180 -89.87 -30.62 17.77 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.41 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.62 13.3 22.56 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.653 0.739 . . . . 0.0 109.632 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' B' ' 61' ' ' SER . . . -65.46 149.45 51.63 Favored Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.447 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.59 -40.89 0.48 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.299 0.64 . . . . 0.0 111.559 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' SER . . . . . 0.429 ' H ' ' C ' ' B' ' 59' ' ' GLY . 38.7 t -60.71 -46.59 89.82 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.734 0.414 . . . . 0.0 110.973 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.459 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -123.15 13.08 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.313 0.577 . . . . 0.0 110.845 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -64.1 -19.52 65.32 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.132 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -62.9 -52.69 62.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.817 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.93 -18.38 60.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.08 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 62' ' ' VAL . 75.9 t -64.39 -42.68 96.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 173.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.58 -39.56 94.08 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' B' ' 71' ' ' MET . . . -60.37 -41.28 98.41 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.522 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . 0.743 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 30.7 t70 -63.51 -44.27 94.79 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.39 -43.62 98.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.988 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' B' ' 68' ' ' GLY . 24.8 ptt? -63.71 -40.43 96.77 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 44.6 m -64.45 -39.38 93.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.081 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.743 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 51.1 mtp85 -62.59 -43.81 97.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.996 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -64.02 -41.9 97.28 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.32 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.71 -48.39 80.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.306 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.47 ' O ' HG13 ' B' ' 79' ' ' ILE . 19.2 tt -67.52 -40.53 84.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.484 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.82 -42.27 95.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.999 0.428 . . . . 0.0 110.139 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.73 -42.28 97.93 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.057 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.47 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.6 pp -67.35 -40.95 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.642 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.95 -44.63 96.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.628 0.728 . . . . 0.0 109.798 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -65.54 -44.63 86.27 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.891 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -89.26 2.14 54.72 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 62.79 52.8 2.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.047 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.0 mt -109.13 126.6 66.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -103.2 108.38 58.68 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.512 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.29 116.26 3.86 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.199 1.933 . . . . 0.0 111.724 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.9 86.58 6.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.069 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 132.04 -168.41 22.49 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.878 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.93 123.11 74.17 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 110.526 -0.176 . . . . 0.0 110.526 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.92 113.72 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.121 1.881 . . . . 0.0 110.713 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 18.3 m -94.96 117.29 29.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.175 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.53 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.3 m-85 -92.04 134.35 34.9 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.44 97.93 25.29 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 90.1 Cg_endo -103.99 -167.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 123.668 2.912 . . . . 0.0 111.159 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -121.07 -174.09 14.85 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.17 146.89 25.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.479 0.639 . . . . 0.0 109.535 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -91.89 127.82 37.5 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.095 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -105.43 126.33 52.0 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 46.6 tp -65.94 113.57 4.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.021 0.439 . . . . 0.0 110.914 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.04 -8.72 42.45 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.12 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -112.55 177.3 4.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 117.415 0.607 . . . . 0.0 111.215 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -80.9 141.52 34.49 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.555 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -93.07 136.42 33.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.97 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 33.1 m -118.58 130.96 56.18 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.955 0.407 . . . . 0.0 111.265 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -130.41 149.06 52.27 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.287 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.493 ' O ' HG13 ' B' ' 107' ' ' VAL . 58.4 m -101.77 -66.01 0.95 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.493 HG13 ' O ' ' B' ' 106' ' ' SER . 0.3 OUTLIER 71.17 150.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 124.17 0.988 . . . . 0.0 110.964 -175.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.527 ' HG2' ' HA2' ' B' ' 12' ' ' GLY . 28.6 mt-10 -132.96 149.47 52.23 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.222 -0.299 . . . . 0.0 110.333 -175.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -155.47 -75.26 0.1 Allowed 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -108.61 162.87 13.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -171.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.424 HG11 HD23 ' B' ' 11' ' ' LEU . 3.6 m -135.68 158.83 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.125 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -161.45 104.61 1.21 Allowed Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.572 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.59 147.91 12.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.026 2.484 . . . . 0.0 114.411 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -140.32 112.54 7.76 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.428 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.4 133.92 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 111.34 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -122.37 141.36 51.65 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.333 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -120.02 150.8 39.98 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.596 0.236 . . . . 0.0 110.698 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -135.46 156.66 48.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.661 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.55 16.96 69.6 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.216 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.7 -38.96 92.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.279 0.561 . . . . 0.0 110.838 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.95 -14.73 63.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.192 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.0 21.52 13.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.878 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 76.5 mt -94.61 109.39 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.417 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -102.33 121.07 41.56 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.38 132.91 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.767 0.317 . . . . 0.0 110.844 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -83.16 139.15 33.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.406 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -123.74 94.11 46.48 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.82 113.46 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.265 1.977 . . . . 0.0 112.095 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.5 mm -102.56 118.31 49.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.048 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.87 160.61 41.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.724 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -133.7 150.27 51.52 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.943 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.71 123.37 19.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 65.2 p -106.99 176.88 5.03 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.854 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.18 -34.77 77.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.602 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.42 97.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.156 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -63.34 -45.46 91.14 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.148 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.7 -45.08 92.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.744 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -59.47 -48.71 80.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.742 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.29 -39.22 96.83 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.036 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' MET . . . . . 0.539 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 2.6 tpt -60.91 -47.43 86.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 0.0 110.65 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.66 -41.6 98.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.986 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . 0.405 ' OD1' ' HE3' ' B' ' 146' ' ' LYS . 23.0 t70 -60.95 -46.41 90.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.922 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 29.0 m -61.64 -41.74 97.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.643 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.3 mt -60.87 -41.93 96.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.758 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -71.48 -20.47 62.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.779 0.324 . . . . 0.0 111.124 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.405 ' HE3' ' OD1' ' B' ' 142' ' ' ASP . 97.3 mttt -89.05 -3.01 58.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.508 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -103.42 -48.22 4.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -62.3 124.03 19.79 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -175.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.87 -167.55 1.97 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.582 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.427 HG21 ' HA ' ' B' ' 246' ' ' PRO . 5.5 m -146.16 169.32 18.97 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . 0.491 ' O ' ' HB2' ' B' ' 152' ' ' LYS . 7.1 p-90 -117.78 145.41 44.53 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -175.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' B' ' 151' ' ' TRP . 54.2 tttp 173.41 -65.79 0.01 OUTLIER 'General case' 0 C--N 1.344 0.367 0 O-C-N 123.94 0.775 . . . . 0.0 110.36 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -102.39 175.97 5.33 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 120.861 0.362 . . . . 0.0 111.836 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -83.57 147.2 27.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.959 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 68.44 113.61 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -165.05 -95.21 0.1 Allowed Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.651 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.02 149.69 31.56 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 62.8 t -114.35 128.15 71.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -98.11 -170.86 2.04 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.081 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.99 -67.84 0.44 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -73.96 1.51 10.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' B' ' 188' ' ' ALA . 32.1 t70 -69.61 144.86 52.87 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.629 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -102.83 119.14 38.31 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.737 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 42.1 t -117.15 126.71 74.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.561 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 24.4 m -74.4 106.32 5.96 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 88.2 mt -122.26 122.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.669 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -92.9 90.35 6.95 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -112.85 149.62 32.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.325 0.583 . . . . 0.0 112.16 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 41.5 m -128.8 128.99 45.04 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.19 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.44 135.46 13.31 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.729 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 51.0 m -142.48 145.8 34.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 120.863 0.363 . . . . 0.0 110.909 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.95 94.98 3.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.03 -68.4 0.09 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.96 0.788 . . . . 0.0 112.718 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -140.86 12.09 2.88 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.797 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -136.91 138.33 40.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.491 0.646 . . . . 0.0 110.89 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -79.38 148.98 31.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.253 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -110.89 -174.55 2.5 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -57.31 -48.87 77.84 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -103.35 -162.15 25.34 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.057 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' B' ' 169' ' ' THR . . . 78.78 29.68 50.97 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.676 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -114.85 103.05 10.57 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -131.38 141.52 49.89 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.792 0.33 . . . . 0.0 111.575 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 27.7 m -136.02 133.46 37.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.651 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 55.45 33.09 20.22 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.377 0.423 . . . . 0.0 110.91 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -98.51 133.27 43.11 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.287 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.1 m -94.3 120.68 44.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-O 121.57 0.7 . . . . 0.0 111.282 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . 0.403 HD12 HH12 ' A' ' 57' ' ' ARG . 30.0 tp -111.37 125.0 53.4 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.073 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . 0.721 ' HB3' ' NH1' ' B' ' 193' ' ' ARG . . . -111.34 132.75 54.16 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 173.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' MET . . . . . 0.451 ' SD ' ' HB ' ' B' ' 202' ' ' ILE . 69.3 mtm -100.29 176.74 5.27 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.226 0.536 . . . . 0.0 112.287 -171.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 79.22 18.78 73.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.593 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -127.54 -17.94 4.5 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.68 0.276 . . . . 0.0 111.604 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.39 43.38 7.44 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.128 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.721 ' NH1' ' HB3' ' B' ' 188' ' ' ALA . 69.4 mtm180 -100.19 1.11 41.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.369 0.604 . . . . 0.0 110.934 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.432 ' HE3' ' HA ' ' B' ' 194' ' ' MET . 0.5 OUTLIER -134.19 169.16 17.59 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.637 175.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.409 HG12 ' CE2' ' B' ' 217' ' ' PHE . 3.1 mp -58.07 131.04 83.61 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.03 134.76 50.33 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.216 1.944 . . . . 0.0 111.56 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.56 -43.2 1.76 Allowed Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -63.78 -47.55 80.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 120.447 0.165 . . . . 0.0 111.174 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -86.54 14.51 6.72 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.262 0.553 . . . . 0.0 110.923 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . 0.649 ' O ' ' HE2' ' B' ' 203' ' ' LYS . 21.2 t70 -113.22 -38.76 4.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.221 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -71.13 -15.51 74.51 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.546 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.451 ' HB ' ' SD ' ' B' ' 189' ' ' MET . 69.7 mt -68.63 -25.99 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 O-C-N 122.596 -0.355 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.649 ' HE2' ' O ' ' B' ' 200' ' ' ASP . 45.0 mtmt -58.09 131.33 50.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.42 -8.09 66.51 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.731 -0.747 . . . . 0.0 114.018 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -89.73 161.08 16.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.302 0.551 . . . . 0.0 111.636 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.69 176.19 7.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.061 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -91.33 55.61 2.86 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.224 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 147.68 43.16 0.03 OUTLIER Glycine 0 C--N 1.308 -0.996 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -125.36 131.41 52.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.254 -0.473 . . . . 0.0 110.766 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -105.45 112.87 26.13 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.679 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -134.09 -3.74 2.79 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.102 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 66.3 p 58.72 169.89 0.06 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.932 0.893 . . . . 0.0 112.421 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.6 tp -157.81 143.93 8.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.59 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -97.65 113.68 25.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.515 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 61.2 t -116.43 130.1 71.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 7.3 m -92.59 -23.94 18.87 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.9 m-85 69.51 159.57 0.15 Allowed Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.885 -175.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -88.3 156.92 6.77 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.177 1.918 . . . . 0.0 111.755 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . 0.433 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 70.7 mm-40 -67.61 -39.71 84.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -84.99 72.0 10.87 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.671 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -115.52 138.11 51.37 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -63.92 -19.83 65.4 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -100.78 107.56 19.15 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.588 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 37.8 tt0 -64.0 -33.17 75.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.49 -175.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -74.71 -11.63 60.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.82 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -117.92 -4.3 11.1 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.8 ptmt -69.23 125.07 25.55 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.127 0.489 . . . . 0.0 111.743 -176.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 63.65 27.12 70.53 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.572 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.14 133.57 55.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.323 0.562 . . . . 0.0 110.974 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -75.26 134.81 41.02 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.957 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.47 154.44 37.8 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.399 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -111.33 107.19 16.37 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -83.56 109.72 17.63 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.2 0.524 . . . . 0.0 110.486 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.93 98.27 7.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.509 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.2 mm -97.11 114.55 34.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.154 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -104.18 -51.89 3.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.035 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 96.1 mt 65.75 144.02 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.549 0.739 . . . . 0.0 112.076 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.04 -63.86 1.22 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.612 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -99.64 -69.36 0.77 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.668 0.27 . . . . 0.0 111.582 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 15.5 t 70.8 154.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.412 0.685 . . . . 0.0 111.166 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.42 -179.64 7.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.905 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.36 141.04 50.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.182 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.4 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 1.4 ptp180 -174.71 105.33 0.1 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.139 0.495 . . . . 0.0 112.228 177.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -170.71 163.52 8.01 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 30.6 tp 74.75 114.95 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 123.76 0.824 . . . . 0.0 110.83 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . 0.427 ' HA ' HG21 ' B' ' 150' ' ' THR . 90.9 Cg_endo -84.0 134.65 6.22 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.477 2.118 . . . . 0.0 114.624 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -130.38 13.97 5.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.528 173.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 8.3 mp 66.26 105.68 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.876 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' THR . . . . . 0.533 HG21 ' H ' ' B' ' 251' ' ' GLU . 27.6 m -123.6 133.99 53.86 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.021 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.446 ' O ' HG23 ' B' ' 253' ' ' ILE . . . -74.6 -12.98 60.59 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.533 ' H ' HG21 ' B' ' 249' ' ' THR . 51.7 mt-10 -62.44 -43.48 98.71 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -85.08 -8.95 58.44 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . 0.446 HG23 ' O ' ' B' ' 250' ' ' ALA . 10.9 tp -91.66 -17.52 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.498 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' B' ' 260' ' ' ASP . 21.9 ptmt -106.37 -16.49 14.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.765 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -125.18 127.9 47.52 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.043 0.449 . . . . 0.0 112.095 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -168.33 82.21 0.17 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 78.25 -47.02 2.84 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.583 -175.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.49 152.23 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 122.961 0.505 . . . . 0.0 110.264 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -58.35 -51.56 69.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' B' ' 254' ' ' LYS . 2.8 p-10 -160.95 126.18 3.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.124 0.488 . . . . 0.0 109.95 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -130.98 -154.51 7.92 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.737 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 30.7 p -127.08 -164.02 1.31 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 122.53 0.332 . . . . 0.0 110.215 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.48 -63.5 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.173 0.511 . . . . 0.0 110.536 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.86 -39.59 66.37 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.934 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.25 -38.46 95.93 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.463 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.97 -43.87 97.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.679 0.276 . . . . 0.0 110.543 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -64.23 -42.02 96.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.995 0.426 . . . . 0.0 110.155 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -68.43 -41.9 79.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.6 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -68.55 -40.11 80.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 110.701 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.36 -41.32 92.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -54.44 -51.5 64.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.624 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 15.9 ptmt -67.1 -40.25 86.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.67 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.39 -39.24 93.48 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.446 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.1 mmm -63.39 -43.61 97.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.61 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.75 -33.45 72.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.924 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -60.15 -44.37 95.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.388 0.613 . . . . 0.0 109.351 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.19 -35.07 75.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.017 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.414 ' O ' HG13 ' B' ' 282' ' ' ILE . 54.2 tp -61.59 -41.26 97.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.785 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -57.78 -43.51 85.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.084 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 24.6 m -62.0 -42.66 99.4 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.511 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.46 96.13 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.435 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . 0.414 HG13 ' O ' ' B' ' 278' ' ' LEU . 63.8 mt -63.31 -44.23 99.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.465 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.93 -44.57 94.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.84 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -64.89 -42.32 94.9 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.388 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -60.71 -43.88 97.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.639 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 98.3 t -69.36 -44.44 80.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.641 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.5 -46.57 87.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.928 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 69.8 p -61.79 -43.39 98.94 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -66.46 -40.42 89.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.817 0.341 . . . . 0.0 111.156 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.14 -47.43 84.58 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.729 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . 0.44 ' O ' HG23 ' B' ' 295' ' ' VAL . 48.2 mm -64.35 -44.17 97.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.888 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -60.54 -44.08 96.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.288 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.67 99.25 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.323 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.16 -42.19 93.97 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.44 HG23 ' O ' ' B' ' 291' ' ' ILE . 76.1 t -63.82 -44.2 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.612 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.6 -41.92 99.26 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.169 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -72.25 -39.13 68.66 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -126.68 98.39 5.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -92.77 96.08 9.93 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.9 tp -100.98 148.17 7.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.828 -175.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -61.7 134.93 57.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.225 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.3 122.71 38.79 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.939 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.19 131.59 46.05 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.735 2.29 . . . . 0.0 112.555 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.98 79.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.181 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.07 67.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.443 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' B' ' 310' ' ' GLU . 92.7 mt -87.01 -33.83 19.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.413 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . 0.419 ' O ' HG13 ' B' ' 311' ' ' ILE . 97.0 mt -62.65 -48.28 88.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.787 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.05 -42.13 99.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -176.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 32.2 p -65.75 -39.98 91.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.731 0.3 . . . . 0.0 111.702 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . 0.619 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 62.3 mm-40 -72.79 -36.87 67.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.481 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 81.1 mt -62.14 -43.45 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.491 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 35.9 t70 -61.26 -41.87 97.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.869 0.366 . . . . 0.0 111.024 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.12 -43.93 99.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.991 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 64.2 mt -63.08 -38.86 92.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.894 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.491 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 74.5 mtm180 -61.36 -42.53 98.85 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -64.1 -38.54 91.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.651 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.01 -45.33 94.07 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.221 0.534 . . . . 0.0 110.31 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.8 -37.49 70.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.413 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.08 72.37 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.061 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . 0.432 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 49.2 tt0 -62.52 -39.64 94.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.337 0.589 . . . . 0.0 109.943 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -73.25 -20.38 60.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.562 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -89.95 3.87 51.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.012 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 136.42 -21.93 3.4 Favored Glycine 0 CA--C 1.508 -0.39 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.843 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 109.84 36.27 2.06 Favored Glycine 0 CA--C 1.502 -0.764 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.211 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . 0.435 HD22 ' HB2' ' B' ' 328' ' ' GLN . 26.9 t-20 -77.56 133.9 38.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.793 0.33 . . . . 0.0 110.527 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . 0.624 ' OE1' ' HG3' ' B' ' 327' ' ' LYS . 1.8 tm-20 -135.89 151.12 49.68 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.624 ' HG3' ' OE1' ' B' ' 326' ' ' GLU . 31.5 mtmm 71.39 -45.54 0.62 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.552 0.741 . . . . 0.0 112.259 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . 0.435 ' HB2' HD22 ' B' ' 325' ' ' ASN . 17.1 mm100 -70.16 -13.74 62.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.262 0.553 . . . . 0.0 110.0 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.74 -17.81 57.27 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.622 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.37 -38.02 85.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.476 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -78.03 -15.51 58.87 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.756 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 76.6 mt -57.61 137.37 82.32 Favored Pre-proline 0 C--O 1.238 0.5 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.982 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -51.3 125.62 16.97 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.051 2.501 . . . . 0.0 112.92 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -68.03 -40.78 82.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.619 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -60.39 -35.58 76.07 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.224 0.454 . . . . 0.0 112.224 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.45 -39.26 94.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.934 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -95.64 -17.13 21.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.38 -32.07 72.74 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.78 -51.04 68.65 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.686 0.279 . . . . 0.0 111.056 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -70.0 -29.32 66.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.729 0.299 . . . . 0.0 110.798 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . 0.438 ' O ' HG21 ' B' ' 345' ' ' VAL . . . -60.58 -43.99 96.73 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . 0.471 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.6 tttt -59.58 -46.55 88.6 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.469 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . 0.513 ' O ' HG21 ' B' ' 347' ' ' VAL . 13.0 mmt85 -62.03 -45.3 94.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -66.57 -38.34 86.85 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.519 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.438 HG21 ' O ' ' B' ' 341' ' ' ALA . 73.4 t -64.77 -43.46 96.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 120.724 0.297 . . . . 0.0 110.393 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 342' ' ' LYS . 79.4 t -60.7 -43.15 94.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.364 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . 0.513 HG21 ' O ' ' B' ' 343' ' ' ARG . 69.5 t -59.76 -44.8 94.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.41 -41.38 99.52 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.15 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.78 -43.48 98.68 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.732 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 97.6 mt -63.73 -44.29 94.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.891 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.5 -42.46 95.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.507 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.16 -41.69 99.63 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.431 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -64.68 -42.83 95.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.04 -45.14 97.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.82 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.42 -44.73 99.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.797 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -70.8 -45.42 64.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.958 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 98.5 m -67.48 -44.97 77.25 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -86.81 -5.25 59.17 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.604 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 57.69 74.21 0.43 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.981 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.97 144.98 31.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.13 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.63 146.99 35.07 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.205 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.84 115.31 5.19 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . 0.502 ' O ' HG21 ' B' ' 367' ' ' VAL . 16.1 t70 -84.0 117.79 23.62 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.3 -176.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 47.0 mm-40 -60.45 -39.53 87.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.313 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -65.73 -40.18 91.91 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.699 0.285 . . . . 0.0 110.759 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -62.91 -38.47 91.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.092 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . 0.502 HG21 ' O ' ' B' ' 363' ' ' ASP . 95.4 t -63.56 -40.92 90.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.636 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 29.6 mmmt -57.61 -43.43 84.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.306 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.9 -41.77 99.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.798 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.97 -41.24 99.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.398 . . . . 0.0 110.03 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.4 -43.21 98.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.375 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.44 -40.38 96.41 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.421 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.48 -39.66 88.9 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.914 0.388 . . . . 0.0 110.35 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 50.5 ttm -65.17 -40.66 94.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.562 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.59 69.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.796 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 30.5 m -79.5 16.2 1.11 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.161 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -114.18 4.49 15.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.164 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -126.63 -172.58 2.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.186 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -62.88 -62.11 1.94 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.449 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 18.9 t70 -119.03 127.24 26.62 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.075 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -66.14 -31.76 44.51 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.156 1.904 . . . . 0.0 112.818 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -67.06 -43.08 83.59 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 11.9 pt-20 -61.39 -37.86 84.97 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.56 -43.21 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.982 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.2 -44.59 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.854 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.88 -45.07 79.19 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.159 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -58.98 -46.76 87.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.856 0.36 . . . . 0.0 111.201 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -68.57 -41.9 79.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.919 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 70.3 p -78.3 -10.82 59.83 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.53 6.17 49.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.096 0.474 . . . . 0.0 110.623 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -129.27 111.9 13.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.327 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.75 -39.75 95.12 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -57.63 -51.06 71.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.899 0.381 . . . . 0.0 110.638 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.51 -41.71 98.52 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.386 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.542 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 88.6 mtp -63.36 -47.65 81.2 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -73.25 -40.52 64.57 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.825 -174.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -62.75 -41.25 99.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.211 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 46.9 tpp -64.22 -39.98 95.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.647 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' B' ' 395' ' ' MET . 77.3 mtm180 -64.15 -34.26 77.67 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.771 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.63 -42.7 99.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.823 0.344 . . . . 0.0 110.083 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.58 -44.78 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.512 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.29 -38.91 93.02 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.838 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.38 -38.89 92.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.343 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . 0.401 ' O ' HG23 ' B' ' 408' ' ' VAL . 39.8 tt0 -59.38 -43.75 92.87 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.452 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.44 -35.89 80.11 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.051 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -60.12 -41.68 93.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.921 0.391 . . . . 0.0 110.397 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.06 96.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.552 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 93.3 t -64.53 -45.61 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -65.92 -35.63 81.14 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.69 92.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.936 0.398 . . . . 0.0 110.242 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.38 -43.38 84.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.496 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 94.5 mt -61.6 -41.33 97.29 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.264 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.61 -19.53 64.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.744 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -102.83 1.47 34.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.185 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -113.09 172.31 7.02 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.111 0.482 . . . . 0.0 111.589 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -79.3 129.44 34.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.456 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 36.3 t -104.02 109.83 28.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.979 0.418 . . . . 0.0 110.943 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 6.7 t -108.2 128.52 54.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.929 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -116.59 121.17 40.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.252 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -144.82 153.06 41.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.22 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -86.79 163.62 17.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -159.0 -178.22 7.07 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 21.5 p -82.91 157.16 23.16 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.9 0.381 . . . . 0.0 111.263 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -67.8 -27.7 66.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.159 0.504 . . . . 0.0 110.311 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -61.9 -39.77 93.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.834 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.49 -31.23 71.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.104 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.56 -13.45 59.82 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.893 0.377 . . . . 0.0 111.022 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.8 mmt -80.39 -5.07 55.89 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.041 0.448 . . . . 0.0 110.589 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -76.28 69.47 2.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.57 0.7 . . . . 0.0 109.507 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -100.47 18.5 18.89 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.013 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -68.2 -33.38 74.31 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.989 0.423 . . . . 0.0 110.304 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.642 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.502 -179.693 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -97.37 136.44 37.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.87 0.367 . . . . 0.0 111.019 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.91 137.04 56.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.436 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.9 p -84.65 87.19 7.27 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.19 136.44 55.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -119.95 153.87 35.31 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.491 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 77.9 m -98.09 123.39 42.1 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.499 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 m -79.34 -56.14 4.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.138 0.494 . . . . 0.0 111.47 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -169.08 100.35 0.37 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.22 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.7 -106.21 1.21 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.863 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 109' ' ' PHE . 7.3 mp -67.36 -38.66 85.13 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 122.4 0.28 . . . . 0.0 111.081 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 106' ' ' SER . . . -57.94 137.02 50.3 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.51 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.491 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -140.69 144.3 35.56 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.532 0.206 . . . . 0.0 110.793 -177.081 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.454 ' HA ' ' HH ' ' A' ' 105' ' ' TYR . 59.5 ttp180 -115.88 129.04 56.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.5 t -89.52 -87.81 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.71 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.8 p 43.4 80.46 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 89.4 mt -109.81 132.09 58.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.5 m -97.72 123.78 41.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.8 pt -123.54 164.05 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.67 0.271 . . . . 0.0 111.474 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.48 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.24 152.18 44.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.822 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.61 -44.71 81.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.648 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.96 -36.43 84.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.203 0.525 . . . . 0.0 110.386 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 m -66.23 -34.4 77.93 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.45 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.5 mt -61.37 -48.94 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 111.624 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.503 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 55.4 mm-40 -81.47 -13.59 58.0 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -93.13 -59.83 1.94 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.099 -0.641 . . . . 0.0 111.5 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.41 -50.04 35.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 98.8 t -63.35 -43.89 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.584 0.23 . . . . 0.0 111.478 -175.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.503 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 17.1 ttmm -61.71 -45.99 91.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.54 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.8 m -66.88 -40.65 87.87 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.739 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -62.85 -41.08 99.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.731 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.4 mt -62.77 -42.64 99.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.767 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.34 -35.89 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.201 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -64.04 -42.88 96.91 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.03 -29.87 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.907 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.36 -43.19 95.31 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.52 -37.39 86.64 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.679 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -60.48 -35.57 76.23 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.471 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 t -93.02 -5.35 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 121.414 0.626 . . . . 0.0 109.939 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 62.79 28.56 16.52 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.601 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -101.83 6.1 10.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.45 0.643 . . . . 0.0 111.158 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -64.6 -29.83 70.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.71 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.6 -1.14 70.15 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.448 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -94.49 6.41 48.89 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.53 -0.394 . . . . 0.0 111.73 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.2 ttt85 -111.61 98.65 7.58 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.222 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -65.57 -43.44 89.79 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.515 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.63 70.74 1.19 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 173.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -65.63 -41.58 92.49 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 171.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.28 107.81 60.59 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.956 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HD2' HD13 ' A' ' 53' ' ' ILE . 46.1 Cg_exo -56.55 151.06 48.32 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.083 2.522 . . . . 0.0 113.114 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.417 ' O ' HG21 ' A' ' 54' ' ' VAL . 14.6 ttt -60.81 -39.39 88.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.018 -173.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -66.59 -20.74 66.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.057 0.456 . . . . 0.0 110.837 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.48 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 97.4 mt -92.22 -37.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.701 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 51' ' ' MET . 25.3 m -63.98 -36.37 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.491 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.94 -37.36 87.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.864 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.539 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.6 pt20 -80.47 -19.53 45.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.668 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.539 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 63.3 mtt180 -106.9 -27.14 10.89 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -175.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -107.74 5.31 26.56 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.519 0.675 . . . . 0.0 109.854 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 61' ' ' SER . . . -70.66 153.03 51.2 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 176.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.32 -24.84 0.16 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.211 0.604 . . . . 0.0 111.928 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 59' ' ' GLY . 36.1 t -78.2 -61.88 1.86 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.887 0.375 . . . . 0.0 110.371 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 66' ' ' VAL . 8.4 p -103.77 12.15 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.449 0.642 . . . . 0.0 110.142 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -58.96 -30.14 67.68 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.738 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -57.57 -50.28 73.64 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.063 0.459 . . . . 0.0 110.473 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.39 -23.08 54.06 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.503 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 62' ' ' VAL . 73.1 t -64.47 -43.73 96.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 174.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.06 -39.76 95.69 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.415 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.07 99.69 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.717 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 11.5 t70 -62.0 -45.6 92.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.888 0.375 . . . . 0.0 110.29 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.69 -41.87 99.33 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.458 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.9 tpt -61.57 -42.12 98.39 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -60.98 -43.04 99.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.738 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 96.9 mtt-85 -66.05 -40.61 91.1 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.333 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -63.48 -42.43 98.56 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.405 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -61.64 -51.02 70.21 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.896 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.57 -41.69 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.6 -39.97 88.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.058 0.456 . . . . 0.0 110.302 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.69 -42.85 77.19 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 pp -64.97 -32.06 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.895 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.7 -43.92 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.909 0.385 . . . . 0.0 110.886 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -78.38 -26.96 46.73 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.667 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -86.5 -5.14 59.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.892 0.377 . . . . 0.0 110.642 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 66.57 40.28 3.47 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.517 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 84.6 mt -102.23 122.22 54.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -106.73 110.76 63.9 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.48 114.55 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.288 1.992 . . . . 0.0 111.416 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.24 126.19 30.52 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.711 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.19 -116.53 7.23 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.852 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.77 114.46 6.02 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.48 156.82 60.67 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 122.635 2.223 . . . . 0.0 111.378 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.6 m -104.3 119.08 38.17 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.51 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -74.41 -21.42 59.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.234 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t 48.42 80.04 0.32 Allowed Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 123.968 0.907 . . . . 0.0 112.894 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.98 122.03 6.08 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.255 1.97 . . . . 0.0 110.725 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.84 -176.35 51.44 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.295 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.39 121.82 25.63 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.116 0.484 . . . . 0.0 110.258 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -82.6 111.9 19.0 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.488 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 98.6 mttt -91.17 129.97 37.1 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.5 tp -75.69 114.07 13.86 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.03 0.443 . . . . 0.0 110.611 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.02 4.82 59.91 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.326 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.8 mt-10 -127.38 168.32 14.99 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.717 -0.284 . . . . 0.0 110.568 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.68 142.89 54.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.074 0.464 . . . . 0.0 111.832 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -102.46 147.72 26.39 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.468 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.2 m -122.74 132.07 54.07 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.454 ' HH ' ' HA ' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -147.01 161.09 41.53 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.532 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 33.1 p -96.6 -84.48 0.36 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 106' ' ' SER . 86.9 t 75.35 112.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -173.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -103.99 122.93 46.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.08 -173.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.427 ' N ' HD23 ' A' ' 11' ' ' LEU 0.253 19.7 p90 -138.29 -95.23 0.19 Allowed 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 174.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -157.69 147.16 19.98 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.0 0.818 . . . . 0.0 111.862 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.9 m -141.28 167.81 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.078 0.551 . . . . 0.0 111.824 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -109.61 107.15 59.19 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.433 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -93.06 153.99 2.63 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.992 2.462 . . . . 0.0 112.924 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.74 143.43 17.23 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.5 t -132.23 137.8 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -175.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -84.78 141.47 30.49 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.557 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.01 143.62 50.81 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -138.38 154.33 48.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.616 0.246 . . . . 0.0 111.089 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.84 15.73 79.5 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 114.089 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.96 -40.74 97.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.974 0.416 . . . . 0.0 111.512 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -73.69 -3.68 29.76 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.704 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.59 4.99 43.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.968 0.413 . . . . 0.0 111.131 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.7 mt -87.39 126.59 41.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.53 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -107.45 116.79 32.56 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.16 133.84 47.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.136 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -85.72 144.06 28.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.478 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -132.89 101.27 14.03 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.41 138.09 58.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.251 1.967 . . . . 0.0 111.506 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 421' ' ' GLU . 48.4 mm -116.17 121.14 66.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.9 161.2 41.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.391 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -152.76 166.09 33.31 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.881 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.42 128.98 38.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.097 0.475 . . . . 0.0 111.337 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 65.8 p -109.36 173.83 6.14 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.535 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.82 -35.11 79.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.72 -37.42 81.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.374 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -63.43 -40.57 97.54 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.549 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.32 -46.04 96.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.516 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.37 -44.65 95.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.356 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.68 -41.52 99.81 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.653 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.595 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.4 tpt -61.26 -48.46 81.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.687 0.28 . . . . 0.0 110.543 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.96 -42.27 97.33 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.074 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.49 -47.64 85.25 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.945 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.6 m -62.84 -41.5 99.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.694 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 140' ' ' MET . 87.5 mt -61.34 -40.26 93.6 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -72.57 -17.09 61.74 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.978 0.418 . . . . 0.0 111.135 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.83 -0.45 55.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.901 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -116.28 30.93 7.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.662 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -134.65 79.22 1.79 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.29 121.24 37.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.322 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.605 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 35.4 m -74.72 159.93 31.41 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.398 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.411 ' N ' HG21 ' A' ' 150' ' ' THR . 36.8 t-105 -80.28 124.84 29.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.126 0.488 . . . . 0.0 110.894 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.4 ' HG3' ' OE2' ' A' ' 153' ' ' GLU . 18.5 tptm -143.53 169.13 18.28 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.4 ' OE2' ' HG3' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -82.52 -3.21 55.54 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -175.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 155' ' ' ASP . 21.8 pttp -163.78 -172.9 3.03 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.719 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 0.6 OUTLIER 91.46 122.19 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.332 1.453 . . . . 0.0 112.683 177.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -68.15 93.99 0.3 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 114.71 -1.132 . . . . 0.0 114.766 -174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -151.01 127.44 10.7 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.83 122.2 60.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -103.86 157.76 16.87 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.5 26.36 0.17 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.928 0.491 . . . . 0.0 112.22 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -139.68 -4.87 1.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.213 0.53 . . . . 0.0 109.91 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -83.58 158.17 22.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.352 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -102.72 98.46 8.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.795 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.5 t -97.86 123.01 50.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.73 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.1 m -79.49 107.49 12.31 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.1 mt -121.42 123.27 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 121.095 0.474 . . . . 0.0 111.929 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.462 ' HB2' ' HD3' ' A' ' 238' ' ' LYS . 23.5 m-20 -96.28 108.43 20.92 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -126.23 147.87 49.58 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.616 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.6 m -119.74 129.19 54.38 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.114 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.11 122.37 5.73 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.299 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.3 p -136.59 124.49 22.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.04 -85.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.787 0.327 . . . . 0.0 110.787 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -103.06 2.98 35.54 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.503 0.668 . . . . 0.0 110.006 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.26 -3.93 2.51 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.376 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -113.47 143.3 44.73 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.21 157.1 33.0 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.721 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -129.39 -177.77 4.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.246 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.19 -41.61 88.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.168 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.1 -178.59 38.85 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.312 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.05 24.99 50.73 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.449 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.0 98.89 8.52 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -130.34 143.79 50.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.095 0.474 . . . . 0.0 111.8 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.4 m -148.73 122.54 9.31 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.996 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 60.51 31.42 20.28 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.334 0.588 . . . . 0.0 109.968 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -86.18 137.68 32.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.909 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.0 m -105.01 125.33 60.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.604 0.716 . . . . 0.0 111.175 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.468 ' CD1' HH12 ' B' ' 57' ' ' ARG . 49.5 tp -114.42 118.19 33.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.212 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.431 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -93.86 110.86 22.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.616 ' HE2' ' O ' ' A' ' 199' ' ' GLU . 63.0 mtp -83.25 152.9 24.97 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.839 -175.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.9 -20.97 45.58 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.051 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -89.08 -10.91 45.63 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.92 50.95 4.97 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.15 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 188' ' ' ALA . 35.2 mmm-85 -90.49 -11.44 40.24 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.911 -0.644 . . . . 0.0 110.106 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.35 -176.74 4.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.716 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.2 mm -63.58 133.71 95.62 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.904 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.41 120.89 5.55 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.066 2.511 . . . . 0.0 112.679 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.52 -36.19 4.57 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.488 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -62.5 -48.02 81.38 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.616 ' O ' ' HE2' ' A' ' 189' ' ' MET . 12.5 pt-20 -78.85 -9.24 59.41 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.8 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -91.49 -29.26 17.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.253 0.549 . . . . 0.0 109.648 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.9 -22.63 75.78 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.881 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.21 -42.49 96.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.97 0.414 . . . . 0.0 110.171 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -53.76 131.17 38.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.118 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.67 -7.99 39.58 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.689 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -96.94 160.09 14.55 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.03 156.43 16.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.652 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.5 129.73 41.44 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.913 0.387 . . . . 0.0 110.713 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 73.63 50.99 10.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.711 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -136.02 140.96 44.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.674 0.273 . . . . 0.0 110.705 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -115.93 135.41 54.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -153.25 -13.61 0.15 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.409 -0.516 . . . . 0.0 112.276 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 30.3 p 61.71 166.87 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.97 0.908 . . . . 0.0 112.064 -175.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.6 tp -156.15 114.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.083 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.09 106.53 7.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.986 0.422 . . . . 0.0 110.873 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 78.4 t -108.95 118.91 57.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.536 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.514 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 4.8 m -69.48 -35.06 75.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' ' 216' ' ' THR . 70.5 m-85 75.69 150.99 0.13 Allowed Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 123.133 0.573 . . . . 0.0 109.498 -172.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.18 153.67 32.03 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.641 1.56 . . . . 0.0 111.474 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.546 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 64.3 mm-40 -64.02 -33.72 76.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 109.842 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -87.92 28.17 1.07 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.332 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.479 ' CE2' ' HB1' ' A' ' 223' ' ' ALA . 10.1 t80 -73.42 132.85 43.44 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -64.89 -17.42 64.3 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 221' ' ' TYR . . . -94.76 110.51 22.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 36.0 tt0 -61.56 -38.59 88.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.859 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.426 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 28.2 p30 -71.98 -9.51 58.48 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.426 ' HG ' ' OD1' ' A' ' 225' ' ' ASN . 95.5 mt -122.57 0.85 9.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.546 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.8 ptmt -70.93 110.81 5.88 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.521 0.677 . . . . 0.0 112.733 -175.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.77 12.64 83.98 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.498 -0.774 . . . . 0.0 114.097 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -118.26 127.93 54.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.357 0.578 . . . . 0.0 110.732 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -71.32 136.24 47.76 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.7 139.37 47.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.324 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -70.51 -43.37 69.8 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 212' ' ' THR . 79.5 m-85 58.39 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.078 0.551 . . . . 0.0 112.133 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.67 -50.81 72.02 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.9 mm 62.69 81.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.133 0.492 . . . . 0.0 111.235 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -66.06 -40.89 91.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.229 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.469 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 10.5 tp 50.6 82.96 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.722 0.809 . . . . 0.0 110.612 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.462 ' HD3' ' HB2' ' A' ' 167' ' ' ASP . 52.5 mtpt -93.51 -51.0 5.16 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -173.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -100.27 -92.04 0.29 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.0 t 75.43 129.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.165 0.586 . . . . 0.0 111.086 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -69.01 -35.67 76.92 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.501 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 155' ' ' ASP . 13.1 pt-20 57.86 117.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 125.34 1.456 . . . . 0.0 114.175 177.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -143.5 124.12 14.08 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.154 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 245' ' ' LEU . 0.3 OUTLIER -148.36 -175.6 4.98 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.45 ' H ' ' CD ' ' A' ' 244' ' ' GLU . 66.1 mt 73.21 105.47 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 111.099 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.605 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 64.1 Cg_endo -78.87 111.77 3.01 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.408 2.072 . . . . 0.0 113.76 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.558 ' H ' HG22 ' A' ' 150' ' ' THR . 12.6 pt-20 -135.77 17.82 3.29 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.135 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 52.7 tp 77.13 132.74 0.05 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 176.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 23.0 m -142.16 137.96 31.23 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.228 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -77.74 -9.12 58.84 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -85.26 -25.12 27.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -65.24 -22.24 66.85 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 119.779 -0.769 . . . . 0.0 113.034 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 34.8 pt -74.05 -9.57 13.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -137.67 25.67 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.919 0.39 . . . . 0.0 111.731 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -115.54 15.67 16.63 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.208 0.528 . . . . 0.0 111.63 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -94.49 14.96 19.11 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.31 -31.34 8.77 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.123 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.8 144.38 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -53.46 -47.91 69.32 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.264 0.353 . . . . 0.0 111.93 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -173.64 157.33 3.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.1 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -160.37 172.41 36.78 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.617 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 80.5 p -96.53 -134.99 0.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.711 0.255 . . . . 0.0 110.83 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 52.8 t -103.33 -68.8 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.12 0.486 . . . . 0.0 109.95 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.2 OUTLIER -70.34 -37.29 74.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.864 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.22 -37.52 94.64 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.763 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.62 -43.8 97.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.868 0.365 . . . . 0.0 110.091 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -62.73 -40.77 98.24 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.688 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.637 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.47 -47.16 85.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.146 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 272' ' ' LYS . 41.6 tp10 -65.85 -40.91 92.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.926 0.394 . . . . 0.0 111.182 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 80.2 t -64.66 -42.92 96.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.374 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -59.34 -48.82 80.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.835 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 10.0 ptmt -62.96 -44.03 97.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.756 0.312 . . . . 0.0 111.206 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -64.97 -39.25 93.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.372 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 90.5 mmm -63.8 -41.7 97.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 110.672 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.85 -35.72 80.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.417 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.5 -41.26 96.53 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.321 0.581 . . . . 0.0 109.603 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -66.59 -36.86 83.65 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.703 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 45.5 tp -62.39 -38.89 91.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.048 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -57.17 -44.14 83.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.198 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.6 m -61.7 -42.8 99.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.649 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.56 97.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.261 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.04 -44.09 97.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.175 0.512 . . . . 0.0 110.013 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -61.57 -44.47 96.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.657 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -64.04 -42.15 97.17 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.899 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . 0.459 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.4 tpm_? -61.34 -43.57 98.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.526 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 85.4 t -70.32 -44.39 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.272 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.8 -48.81 80.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.557 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 65.2 p -65.37 -42.89 92.28 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -65.81 -41.1 92.29 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.7 0.286 . . . . 0.0 111.712 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.89 80.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 295' ' ' VAL . 36.9 mm -66.05 -43.57 92.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.511 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -57.87 -44.47 86.63 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.217 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.43 -41.89 99.74 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.807 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.4 -43.31 97.92 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 291' ' ' ILE . 97.0 t -62.66 -45.74 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.35 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.37 -42.3 99.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.969 0.414 . . . . 0.0 110.987 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.74 -38.64 80.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.782 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -124.83 90.88 3.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -93.43 94.39 8.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 301' ' ' ASP . 10.9 tp -103.26 163.75 3.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.742 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.455 ' N ' HG13 ' A' ' 300' ' ' ILE . 3.8 m-20 -65.37 140.06 58.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.15 123.38 37.76 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.532 ' O ' HG13 ' A' ' 307' ' ' ILE . 46.6 Cg_exo -55.93 129.77 36.74 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.499 2.132 . . . . 0.0 111.977 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.38 -35.55 79.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.093 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.22 84.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.993 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.22 -34.5 56.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.954 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 303' ' ' PRO . 75.6 mt -61.87 -50.97 77.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.919 0.39 . . . . 0.0 111.612 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.31 -40.44 95.93 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 65.5 p -64.52 -45.94 85.08 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.509 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 43.3 mm-40 -72.01 -35.09 69.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.962 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.456 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 83.7 mt -62.08 -44.12 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.715 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.585 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 32.0 t70 -63.39 -40.85 98.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.844 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.9 t -64.05 -43.72 97.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.174 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 87.6 mt -62.53 -40.15 95.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.909 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.474 HH12 HD11 ' A' ' 330' ' ' LEU . 80.3 mtm180 -63.12 -38.91 93.06 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.266 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 90.5 mtt180 -63.73 -41.09 98.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.701 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -62.86 -44.04 97.18 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.641 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.34 -39.54 81.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.033 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.82 88.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.241 0.543 . . . . 0.0 110.435 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -62.11 -38.44 88.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.986 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.96 -37.79 79.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.07 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -74.39 39.1 0.12 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.138 0.975 . . . . 0.0 112.302 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 99.75 -2.87 57.24 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.155 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 92.94 33.58 7.28 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.159 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -71.47 132.0 44.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.721 0.296 . . . . 0.0 110.216 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.09 160.88 36.42 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.0 OUTLIER 68.77 -52.08 0.57 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.318 0.647 . . . . 0.0 112.102 -178.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.96 -3.58 29.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.12 -23.93 65.88 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.483 0.658 . . . . 0.0 109.714 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.474 HD11 HH12 ' A' ' 315' ' ' ARG . 42.2 tp -63.36 -35.15 79.44 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.266 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.94 -33.48 74.76 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.66 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 82.7 mt -47.56 133.99 10.39 Favored Pre-proline 0 N--CA 1.474 0.753 0 O-C-N 123.613 0.57 . . . . 0.0 112.458 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.24 129.62 35.48 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.962 2.441 . . . . 0.0 112.786 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -66.2 -43.42 86.85 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.303 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -63.46 -33.8 76.36 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.55 -37.18 86.35 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.643 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.54 -13.06 19.61 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.58 -30.09 67.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.675 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -62.0 -51.26 68.77 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.716 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -71.19 -27.1 63.28 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.809 0.338 . . . . 0.0 110.431 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.88 -43.06 99.61 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.781 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.408 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -59.66 -45.69 91.28 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.493 ' O ' HG23 ' A' ' 347' ' ' VAL . 8.3 mmt180 -61.43 -47.3 86.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.263 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.12 -37.73 84.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 341' ' ' ALA . 72.1 t -63.31 -44.44 99.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.255 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 70.3 t -62.0 -44.64 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.496 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 343' ' ' ARG . 70.4 t -60.53 -44.81 97.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.838 0.351 . . . . 0.0 110.137 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.79 -42.14 99.39 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.134 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.41 -43.9 96.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.734 0.302 . . . . 0.0 110.859 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.0 mt -62.81 -47.91 81.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.953 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 355' ' ' ILE . 94.3 mt -66.95 -40.43 87.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.159 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.96 -45.05 96.55 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.833 -0.622 . . . . 0.0 113.796 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -68.89 -35.12 76.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.293 0.547 . . . . 0.0 110.713 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 350' ' ' LEU . 78.5 t -60.47 -45.13 97.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 351' ' ' LEU . 80.4 mt -62.97 -46.5 96.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.916 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -67.45 -47.69 69.4 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 98.0 m -64.49 -44.83 89.75 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -87.6 -0.9 57.51 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.501 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 63.15 39.85 9.46 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.91 0.386 . . . . 0.0 111.626 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.7 mt -77.25 145.15 37.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.226 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.57 149.99 39.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.272 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.76 116.5 5.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.48 ' O ' HG21 ' A' ' 367' ' ' VAL . 27.3 t70 -86.24 116.07 24.19 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.532 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 25.7 mm-40 -59.52 -39.42 83.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.965 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -65.22 -42.52 93.34 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.018 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -63.74 -38.98 93.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.063 0.459 . . . . 0.0 109.954 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 363' ' ' ASP . 89.3 t -64.04 -38.95 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.485 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 26.8 mmmt -55.58 -45.3 77.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.428 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -64.21 -37.22 94.23 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.43 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.63 -42.11 98.18 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.337 0.589 . . . . 0.0 110.253 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.21 -43.21 97.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.792 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -60.59 -39.74 89.18 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.54 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.91 -40.14 87.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.777 0.322 . . . . 0.0 110.772 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.3 ttm -64.24 -41.73 96.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.0 0.428 . . . . 0.0 110.169 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.39 -27.22 69.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.572 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.7 m -75.27 -4.86 41.53 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.383 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -93.05 -0.54 57.1 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.204 0.526 . . . . 0.0 110.483 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -117.3 168.27 10.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.07 -50.22 72.82 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -117.95 117.62 35.28 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.837 0.351 . . . . 0.0 110.307 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.64 -28.91 25.25 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.345 2.03 . . . . 0.0 113.08 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -65.92 -43.89 86.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.22 -37.7 88.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.587 0.232 . . . . 0.0 110.911 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.86 -42.93 96.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.585 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.68 -44.53 99.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.254 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -67.25 -40.68 86.27 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 120.857 0.36 . . . . 0.0 110.197 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -58.43 -47.98 82.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 3.4 t80 -70.46 -40.25 73.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.12 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 59.4 p -77.7 -8.38 57.85 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -101.03 6.7 43.54 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.239 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -125.67 114.12 18.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.073 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -62.95 -41.45 99.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.373 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.11 -48.11 83.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 110.775 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.73 -40.63 97.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.626 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 94.1 mtp -61.96 -46.34 89.72 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.02 0.438 . . . . 0.0 110.997 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.87 -44.17 86.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.331 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -63.81 -40.92 97.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.573 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.479 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 53.1 tpp -62.95 -45.08 94.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.123 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -65.05 -29.22 70.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.567 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -62.24 -44.41 96.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.17 -44.26 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.817 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.37 94.75 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.986 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.68 -38.06 89.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.695 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.08 -44.81 91.92 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.905 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.51 -38.21 89.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.808 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -59.43 -41.66 90.08 Favored 'General case' 0 CA--C 1.526 0.032 0 CA-C-O 120.736 0.303 . . . . 0.0 110.62 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.07 79.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.39 -46.15 93.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.482 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -68.56 -30.55 69.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.498 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.33 -38.13 89.95 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.019 0.438 . . . . 0.0 109.93 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 91.5 t -64.69 -42.53 95.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.919 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.41 -40.13 93.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.82 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.65 67.48 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.495 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -99.38 -3.6 33.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.023 0.439 . . . . 0.0 110.962 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -107.85 178.87 4.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.45 107.86 19.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.559 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 97.0 t -99.9 118.66 46.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.902 -0.406 . . . . 0.0 109.902 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.5 t -120.81 158.35 27.76 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -104.82 132.78 50.64 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.077 0.465 . . . . 0.0 111.728 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -147.57 120.97 9.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.861 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 91.1 mt-10 -84.81 151.93 24.0 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.183 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.7 t -157.01 175.31 14.27 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.815 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 62.8 p -85.66 163.76 18.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.931 0.396 . . . . 0.0 111.392 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -64.56 -26.71 68.53 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.055 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -62.22 -39.7 93.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.781 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.6 -33.43 75.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.724 0.297 . . . . 0.0 111.468 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.57 -14.18 57.13 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.645 0.26 . . . . 0.0 111.262 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 2.9 mmt -76.84 -9.91 59.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.188 0.518 . . . . 0.0 110.331 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -80.68 85.65 6.03 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.387 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -105.84 29.27 6.79 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.214 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -66.52 -24.04 66.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.22 0.534 . . . . 0.0 109.912 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.377 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.451 178.389 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -78.03 134.13 37.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.185 0.517 . . . . 0.0 111.582 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 24.1 m -118.57 145.7 24.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.356 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.4 p -91.08 84.28 5.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 m -132.85 135.28 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -119.74 154.79 33.63 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.798 0.332 . . . . 0.0 111.557 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.484 ' HA ' ' HD3' ' B' ' 13' ' ' ARG . 90.3 m -99.47 118.08 35.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.522 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 14.9 m -72.66 -51.41 19.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.387 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -174.92 100.71 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.275 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.86 -107.43 1.54 Allowed Glycine 0 C--O 1.223 -0.567 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.136 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.434 HD23 ' N ' ' B' ' 109' ' ' PHE . 7.2 mp -66.77 -39.08 87.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.713 0.292 . . . . 0.0 110.919 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' B' ' 106' ' ' SER . . . -59.2 135.08 51.94 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.282 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.484 ' HD3' ' HA ' ' B' ' 7' ' ' THR . 0.0 OUTLIER -140.3 144.17 36.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.474 0.178 . . . . 0.0 110.749 -177.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.458 ' HA ' ' HH ' ' B' ' 105' ' ' TYR . 57.0 ttp180 -114.78 130.04 56.79 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.82 -89.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.729 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p 43.0 82.74 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 88.6 mt -112.88 131.38 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 60.5 m -95.47 126.85 41.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.966 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 41.6 pt -125.51 165.85 22.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.421 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.446 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.79 151.75 45.93 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.299 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.27 -43.1 82.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.63 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.75 -38.05 89.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.479 . . . . 0.0 110.194 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 23.0 m -63.3 -36.27 83.11 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.219 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.495 ' O ' ' HB ' ' B' ' 28' ' ' VAL . 75.7 mt -61.47 -50.8 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.282 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.524 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 50.2 mm-40 -75.59 -22.37 56.99 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -86.06 -68.57 0.73 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.693 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.62 -48.64 71.56 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 99.0 t -62.89 -45.33 99.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.523 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.524 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 16.4 ttmm -61.89 -44.85 95.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.503 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.6 m -65.34 -41.68 93.67 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.814 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -64.66 -38.27 90.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.701 0.286 . . . . 0.0 110.788 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 91.0 mt -62.31 -42.48 99.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.569 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -71.5 -35.26 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.991 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -64.32 -42.68 96.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.638 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -68.53 -32.45 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.129 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.66 98.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.66 -38.32 88.98 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.955 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -59.61 -37.18 77.9 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 18.0 t -87.79 -13.87 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 120.959 0.409 . . . . 0.0 110.038 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 70.83 28.63 3.3 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.756 0.823 . . . . 0.0 111.276 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.43 7.45 9.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.131 0.491 . . . . 0.0 111.598 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.3 -24.74 66.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.826 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.05 -1.83 88.12 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.955 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -94.44 7.38 45.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.712 0.291 . . . . 0.0 111.607 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 34.6 ttt85 -114.88 100.71 8.41 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.455 -0.498 . . . . 0.0 112.178 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -67.15 -46.72 73.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.675 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.86 65.92 1.62 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 116.561 1.384 . . . . 0.0 116.561 172.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -63.5 -42.68 98.49 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 t -107.34 106.06 57.42 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 114.725 -1.125 . . . . 0.0 107.997 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.435 ' HD2' HD13 ' B' ' 53' ' ' ILE . 28.0 Cg_exo -60.86 155.51 49.05 Favored 'Trans proline' 0 N--CA 1.476 0.476 0 C-N-CA 123.28 2.653 . . . . 0.0 112.969 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.492 ' HA ' HG21 ' B' ' 54' ' ' VAL . 92.3 mtp -61.18 -39.16 89.09 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' B' ' 50' ' ' PRO . 33.4 p-10 -65.7 -17.65 64.76 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.998 0.428 . . . . 0.0 110.859 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.435 HD13 ' HD2' ' B' ' 50' ' ' PRO . 89.0 mt -99.48 -36.29 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.004 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' B' ' 51' ' ' MET . 23.2 m -64.98 -37.46 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.633 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.07 83.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.227 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.445 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 7.1 pt20 -82.04 -18.67 42.42 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.468 HH12 ' CD1' ' A' ' 187' ' ' LEU . 62.9 mtt-85 -107.37 -27.51 10.43 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.7 6.63 23.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.517 0.675 . . . . 0.0 110.164 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' B' ' 61' ' ' SER . . . -70.25 157.46 53.52 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 175.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.71 -40.72 0.48 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.082 0.553 . . . . 0.0 111.499 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' SER . . . . . 0.442 ' H ' ' C ' ' B' ' 59' ' ' GLY . 42.9 t -64.99 -63.2 1.17 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.925 0.49 . . . . 0.0 111.296 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.456 ' O ' HG22 ' B' ' 66' ' ' VAL . 8.5 p -101.41 10.44 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.469 0.652 . . . . 0.0 110.206 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -59.6 -26.07 65.15 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.693 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -62.63 -49.1 76.53 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.926 0.393 . . . . 0.0 110.382 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -77.32 -21.74 53.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.813 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.456 HG22 ' O ' ' B' ' 62' ' ' VAL . 77.0 t -63.94 -43.74 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.0 -39.4 94.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.216 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.7 -42.26 99.72 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.776 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 11.5 t70 -62.31 -45.36 93.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.998 0.428 . . . . 0.0 110.378 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.42 -41.7 98.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.367 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 15.5 tpt -61.69 -42.33 98.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 51.2 m -60.98 -43.61 98.56 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.836 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 96.4 mtt-85 -65.68 -42.0 91.77 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.497 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -63.65 -41.3 98.24 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.646 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -61.67 -50.95 70.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.962 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 tt -69.93 -41.8 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.43 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 7.8 t70 -64.57 -40.52 95.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.171 0.51 . . . . 0.0 110.098 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.38 -43.1 78.08 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.66 -33.64 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.012 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.57 -44.07 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.893 0.377 . . . . 0.0 110.899 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 17.4 ptpt -77.59 -28.3 51.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.548 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -83.38 -4.56 58.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.635 0.255 . . . . 0.0 110.84 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 66.5 36.93 4.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.366 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.1 mt -99.65 120.95 49.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.832 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -107.55 112.03 62.55 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.71 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -75.14 127.24 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.059 1.84 . . . . 0.0 111.523 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.22 100.22 9.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.069 0.461 . . . . 0.0 111.016 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.98 -109.84 3.25 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.148 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.69 113.75 8.57 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.684 0.278 . . . . 0.0 111.093 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.39 160.23 45.11 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.72 2.28 . . . . 0.0 111.066 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.4 m -107.04 118.74 37.51 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.814 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -73.38 -25.07 60.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.556 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 26.0 t 49.54 79.17 0.36 Allowed Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 123.788 0.835 . . . . 0.0 112.879 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.51 126.59 8.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.301 2.0 . . . . 0.0 110.627 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.62 -172.2 48.53 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.593 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.7 121.08 26.8 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.949 0.404 . . . . 0.0 109.998 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -82.2 118.18 22.89 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.148 0.499 . . . . 0.0 110.805 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -98.7 123.69 43.07 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 tp -68.35 105.82 2.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.577 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.42 3.31 44.1 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.588 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -126.87 172.31 10.52 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.83 0.347 . . . . 0.0 111.222 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.52 141.99 57.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.733 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -105.28 144.74 31.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.948 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 34.8 m -119.98 131.2 55.09 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.011 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.458 ' HH ' ' HA ' ' B' ' 14' ' ' ARG . 0.5 OUTLIER -145.94 162.1 38.56 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' SER . . . . . 0.548 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 46.2 p -97.9 -83.78 0.4 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -174.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' B' ' 106' ' ' SER . 94.3 t 75.02 113.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -173.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -104.94 121.94 44.79 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -172.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . 0.434 ' N ' HD23 ' B' ' 11' ' ' LEU 0.255 26.3 p90 -138.71 -92.88 0.19 Allowed 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 175.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -159.43 149.15 18.61 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.018 0.826 . . . . 0.0 112.194 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.78 168.59 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.47 0.708 . . . . 0.0 111.619 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -111.28 104.42 56.13 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.425 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -91.44 154.27 3.63 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.924 2.416 . . . . 0.0 113.139 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -158.06 139.81 13.86 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 62.2 t -127.69 136.17 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.164 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -84.84 142.23 29.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.6 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.11 146.52 47.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.746 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -139.2 154.01 47.97 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.663 0.268 . . . . 0.0 111.388 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.3 20.61 76.88 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.068 -0.515 . . . . 0.0 113.857 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.73 -40.86 92.58 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.953 0.406 . . . . 0.0 111.811 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.2 -5.12 39.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.279 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.09 12.96 36.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.814 0.34 . . . . 0.0 111.057 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.49 124.02 46.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.125 0.488 . . . . 0.0 110.346 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.84 121.9 44.64 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.336 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.1 134.43 53.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.807 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -84.65 143.71 29.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.464 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -133.41 97.44 16.12 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.94 138.08 55.82 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.409 2.072 . . . . 0.0 111.427 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' B' ' 421' ' ' GLU . 48.8 mm -117.64 124.46 73.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.78 162.11 39.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.607 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -148.29 -178.77 6.49 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 80.8 t -100.02 127.6 52.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 120.875 0.369 . . . . 0.0 110.776 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 59.2 p -104.83 171.6 7.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.771 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -64.0 -34.12 77.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.608 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.6 86.05 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.498 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -62.85 -39.66 95.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.878 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.403 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.5 t -63.11 -45.57 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.179 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.76 -44.89 96.0 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.138 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.5 -40.94 99.74 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.397 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' MET . . . . . 0.602 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.1 tpt -61.77 -48.63 79.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.688 0.28 . . . . 0.0 110.5 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 91.9 mt -63.64 -42.1 98.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.224 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.46 -49.13 78.96 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.406 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.5 m -62.79 -41.61 99.35 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.763 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' B' ' 140' ' ' MET . 89.3 mt -60.63 -35.53 76.39 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -78.3 -15.11 59.07 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.54 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.3 -6.27 41.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.313 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -107.95 30.24 6.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.865 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -134.95 94.83 3.21 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -112.0 120.11 40.75 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.705 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.638 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 52.7 m -71.73 158.89 35.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.826 0.346 . . . . 0.0 111.318 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -78.89 122.56 26.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -143.53 170.07 16.5 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.29 0.29 54.19 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -165.23 -175.78 3.79 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.983 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' B' ' 242' ' ' GLU . 0.9 OUTLIER 93.2 127.76 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.829 1.651 . . . . 0.0 111.822 176.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -71.45 90.02 0.45 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 115.324 0.89 . . . . 0.0 115.324 -172.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.77 135.36 18.41 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.72 128.31 70.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -108.35 158.6 17.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.921 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.49 24.44 0.2 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.033 0.533 . . . . 0.0 112.235 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -138.11 -3.73 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.155 0.503 . . . . 0.0 109.886 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -85.3 159.54 20.02 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.49 0.662 . . . . 0.0 112.626 -172.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' B' ' 163' ' ' ARG . 12.0 ptp180 -104.6 103.11 12.72 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.663 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.54 120.17 51.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.699 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 26.6 m -77.78 105.11 8.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.75 123.59 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.547 -174.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . 0.463 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 18.1 m-20 -95.15 107.05 19.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -125.03 147.7 48.83 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.605 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 29.8 m -120.13 130.3 54.55 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.759 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.63 119.52 4.89 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.45 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 25.4 p -134.94 126.52 28.8 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 t -75.36 -90.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.499 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -98.91 -4.61 32.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.378 0.609 . . . . 0.0 109.739 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.41 -18.1 0.44 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.732 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.95 146.07 27.11 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.925 0.393 . . . . 0.0 110.205 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -81.6 156.01 25.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.987 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -125.96 -175.72 3.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.521 0.2 . . . . 0.0 111.537 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.3 -38.79 84.75 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.74 -176.89 32.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.481 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.08 26.53 36.73 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.623 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -108.01 98.25 7.84 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.27 140.04 51.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.035 0.445 . . . . 0.0 111.894 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.463 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 48.8 m -148.48 125.12 11.09 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 61.16 30.66 19.46 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.596 0.56 . . . . 0.0 110.276 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -88.82 128.82 35.66 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.027 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 16.9 m -99.34 122.69 51.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.462 0.648 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . 0.43 HD11 HH12 ' A' ' 57' ' ' ARG . 35.2 tp -111.62 120.2 41.27 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.941 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.74 112.2 24.07 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' MET . . . . . 0.614 ' HE2' ' O ' ' B' ' 199' ' ' GLU . 84.8 mtp -83.42 152.32 25.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.008 -175.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.49 -14.2 62.25 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.055 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -95.19 -11.76 27.51 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.24 48.14 6.14 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.25 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 34.8 mmm-85 -88.23 -12.39 43.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.864 -0.668 . . . . 0.0 109.796 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.18 -179.58 5.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.908 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 49.6 mm -61.05 134.04 92.8 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.85 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.81 128.4 21.43 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.837 2.358 . . . . 0.0 112.352 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.48 -39.39 2.76 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.24 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -62.54 -47.64 82.98 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . 0.614 ' O ' ' HE2' ' B' ' 189' ' ' MET . 12.1 pt-20 -79.11 -10.05 59.72 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.09 -177.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.5 -28.3 16.88 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.952 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.77 -21.86 71.47 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.659 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.92 -41.91 94.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -54.92 134.1 48.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.665 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 100.35 3.67 55.36 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.658 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -108.4 151.93 25.36 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 120.967 0.413 . . . . 0.0 110.901 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -92.81 155.61 17.53 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.053 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.12 134.99 56.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.79 50.3 25.1 Favored Glycine 0 C--O 1.236 0.222 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.944 -178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -135.65 133.54 38.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.086 0.469 . . . . 0.0 111.264 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -108.54 127.02 53.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -144.82 -12.8 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 44.1 p 60.27 166.72 0.08 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.79 0.836 . . . . 0.0 111.926 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -155.59 119.71 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.256 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.06 106.76 11.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.83 0.347 . . . . 0.0 110.829 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 97.7 t -109.23 115.57 49.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.108 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' THR . . . . . 0.524 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 8.2 m -64.09 -41.03 97.45 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.8 m-85 77.88 141.74 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 123.113 0.565 . . . . 0.0 109.809 -172.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.63 152.23 53.33 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.818 1.679 . . . . 0.0 111.878 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . 0.539 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 39.9 mm-40 -62.67 -33.52 75.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.999 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -86.77 24.78 1.39 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.113 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . 0.477 ' CE2' ' HB1' ' B' ' 223' ' ' ALA . 9.0 t80 -73.82 135.22 43.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.496 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -67.69 -14.69 63.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.477 ' HB1' ' CE2' ' B' ' 221' ' ' TYR . . . -98.65 108.71 21.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 36.5 tt0 -60.86 -36.79 80.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.42 ' OD1' ' HG ' ' B' ' 226' ' ' LEU . 25.7 p30 -72.65 -11.9 60.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.42 ' HG ' ' OD1' ' B' ' 225' ' ' ASN . 94.6 mt -120.55 -0.01 10.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.539 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.9 ptmt -70.73 108.36 4.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.573 0.701 . . . . 0.0 112.76 -175.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.33 17.1 78.55 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.799 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -121.19 123.51 42.44 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -68.02 136.16 53.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -110.96 137.04 49.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.182 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -70.08 -41.23 74.37 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -175.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' B' ' 212' ' ' THR . 74.4 m-85 57.62 100.94 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.915 0.486 . . . . 0.0 112.122 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.55 -49.77 76.21 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 61.81 77.97 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.092 0.472 . . . . 0.0 111.051 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -65.85 -39.94 91.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.886 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 12.5 tp 51.71 83.56 0.05 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.921 0.888 . . . . 0.0 111.142 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . 0.447 ' HD3' ' HB2' ' B' ' 167' ' ' ASP . 51.9 mtpt -89.98 -64.68 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -174.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -88.52 -89.75 0.14 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 42.9 t 73.42 129.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.888 0.475 . . . . 0.0 111.07 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -69.13 -35.39 76.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.962 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' B' ' 155' ' ' ASP . 12.9 pt-20 57.49 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.432 1.493 . . . . 0.0 114.061 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -139.41 125.73 20.21 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.197 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' B' ' 245' ' ' LEU . 0.9 OUTLIER -150.68 -173.85 4.6 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.537 ' H ' ' CD ' ' B' ' 244' ' ' GLU . 46.3 mt 73.6 102.37 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 123.216 0.606 . . . . 0.0 111.042 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . 0.638 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 72.2 Cg_endo -78.97 109.89 2.66 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.569 2.179 . . . . 0.0 113.857 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . 0.496 ' H ' HG22 ' B' ' 150' ' ' THR . 12.5 pt-20 -138.11 23.34 2.8 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.632 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 51.6 tp 77.0 139.08 0.07 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' THR . . . . . 0.444 HG22 ' H ' ' B' ' 251' ' ' GLU . 27.7 m -149.78 141.51 23.62 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.145 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -80.05 -9.99 59.74 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.444 ' H ' HG22 ' B' ' 249' ' ' THR . 41.4 mt-10 -84.66 -25.19 28.65 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -63.62 -28.21 69.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 41.2 pt -70.44 -9.41 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.815 0.34 . . . . 0.0 111.89 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -136.7 30.11 2.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.846 0.355 . . . . 0.0 111.55 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -118.24 12.16 13.38 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-O 121.095 0.474 . . . . 0.0 111.49 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -96.3 27.6 3.66 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.19 -40.28 2.99 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.42 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 28.0 t -68.94 137.65 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -43.63 -59.65 2.1 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.912 0.758 . . . . 0.0 111.986 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -166.81 157.84 12.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.789 0.328 . . . . 0.0 111.087 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -156.54 -171.02 22.29 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.872 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 56.8 p -111.49 -141.3 0.38 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 59.8 t -98.16 -71.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 110.025 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.2 OUTLIER -68.51 -37.07 79.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.243 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.97 93.7 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.191 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.436 ' O ' HG22 ' B' ' 270' ' ' VAL . 53.1 tp -63.08 -43.42 98.59 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -61.59 -42.11 98.39 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.459 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.566 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -62.27 -46.01 90.69 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.204 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 38.4 tp10 -66.55 -40.07 88.87 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.853 0.358 . . . . 0.0 111.176 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.436 HG22 ' O ' ' B' ' 266' ' ' LEU . 90.9 t -65.25 -43.26 95.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.413 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -60.48 -46.98 88.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 14.1 ptmt -63.19 -44.36 95.58 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.898 0.38 . . . . 0.0 111.0 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -65.21 -38.29 89.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.406 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.8 mmm -63.82 -42.4 97.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.672 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -69.02 -33.32 73.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.059 0.457 . . . . 0.0 110.585 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -63.27 -42.49 99.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.683 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -67.37 -36.39 81.27 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.002 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.455 ' O ' HG13 ' B' ' 282' ' ' ILE . 44.8 tp -62.3 -38.56 89.88 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.789 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -56.3 -45.66 80.15 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.263 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 19.4 m -61.63 -42.28 98.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.837 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.56 -42.93 99.85 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.138 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . 0.455 HG13 ' O ' ' B' ' 278' ' ' LEU . 66.5 mt -64.36 -44.36 97.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.301 178.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -60.21 -44.1 95.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.452 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -63.64 -42.79 98.11 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.166 0.291 . . . . 0.0 111.404 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -60.54 -44.74 95.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.073 0.463 . . . . 0.0 110.729 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.61 -45.2 78.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.32 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.92 -48.91 78.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.806 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -63.57 -43.4 97.1 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -65.29 -42.18 93.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.485 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.58 -47.95 81.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.994 0.426 . . . . 0.0 111.09 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . 0.403 HG22 HG21 ' B' ' 347' ' ' VAL . 51.2 mm -66.68 -43.44 90.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.92 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . 0.414 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 19.9 tp10 -57.82 -45.4 86.21 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.134 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.77 -40.62 99.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.116 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 4.8 tt -63.6 -43.9 95.56 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.32 -43.98 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.247 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.414 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 66.1 mttm -60.33 -35.18 75.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.934 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.16 -11.76 40.19 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -138.63 81.01 1.82 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -91.54 93.27 8.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -105.26 157.93 5.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.58 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.22 138.25 58.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.465 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 35.0 t -106.63 126.01 31.4 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.861 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . 0.501 ' O ' HG13 ' B' ' 307' ' ' ILE . 51.6 Cg_exo -55.99 129.19 33.58 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.428 2.086 . . . . 0.0 111.914 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.28 83.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.476 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.99 84.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.52 -38.06 83.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.507 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . 0.501 HG13 ' O ' ' B' ' 303' ' ' PRO . 73.6 mt -61.07 -50.12 81.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.248 -177.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.16 -37.53 87.67 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 63.6 p -67.6 -45.17 76.23 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.501 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . 0.544 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 66.8 mm-40 -71.81 -36.32 70.21 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 87.3 mt -62.38 -44.46 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.12 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.567 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 36.6 t70 -63.24 -41.86 99.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.823 0.344 . . . . 0.0 110.965 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.47 -43.16 98.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.298 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 84.2 mt -62.21 -39.91 94.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.693 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 79.1 mtm180 -63.37 -39.04 93.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.235 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 90.2 mtt180 -62.82 -42.23 99.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.842 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -62.95 -43.16 99.55 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.496 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.05 -39.94 82.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.964 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.44 91.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.07 0.462 . . . . 0.0 110.39 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -62.15 -37.15 84.13 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.052 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -70.56 -36.95 73.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.412 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.02 42.37 0.25 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.986 0.915 . . . . 0.0 112.172 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.77 -0.11 59.24 Favored Glycine 0 C--N 1.318 -0.465 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.033 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 89.49 30.65 13.08 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.195 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -68.6 136.35 52.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.899 0.38 . . . . 0.0 110.533 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . 0.434 ' CD ' ' HZ1' ' B' ' 327' ' ' LYS . 0.9 OUTLIER -137.98 162.29 34.47 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.549 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.0 OUTLIER 68.57 -53.43 0.55 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.298 0.639 . . . . 0.0 112.359 -178.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -73.99 -3.7 30.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.44 -24.32 65.11 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.278 0.561 . . . . 0.0 109.705 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 41.9 tp -63.23 -36.23 82.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.324 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.07 -26.02 65.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.877 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 80.0 mt -54.3 132.89 61.54 Favored Pre-proline 0 C--O 1.238 0.481 0 CA-C-O 120.706 0.288 . . . . 0.0 111.556 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.67 133.19 55.78 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.986 2.457 . . . . 0.0 113.338 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . 0.428 HH21 ' HD2' ' B' ' 334' ' ' ARG . 26.1 ttt85 -67.03 -43.81 81.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.056 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -63.85 -33.01 74.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -174.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.29 -36.57 84.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.473 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -101.36 -13.82 17.85 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -68.52 -30.4 69.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.734 0.302 . . . . 0.0 111.482 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.66 -49.85 74.87 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.792 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -72.25 -29.43 63.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 110.71 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . 0.456 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -61.72 -43.66 98.42 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.108 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . 0.438 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.6 tttt -59.47 -45.19 92.35 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . 0.526 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.7 mmt85 -62.44 -45.52 92.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -66.0 -37.89 87.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 341' ' ' ALA . 82.6 t -63.4 -44.72 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.787 0.327 . . . . 0.0 110.33 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 342' ' ' LYS . 71.7 t -61.23 -45.1 99.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.513 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 343' ' ' ARG . 85.4 t -61.24 -44.57 98.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.281 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.59 -42.32 99.15 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.15 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.04 -44.03 97.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 110.701 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.463 ' O ' HG22 ' B' ' 354' ' ' VAL . 96.2 mt -63.24 -49.45 74.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.0 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.7 -41.21 88.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.6 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.39 -42.44 98.92 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.265 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.7 -35.65 75.25 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.956 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . 0.463 HG22 ' O ' ' B' ' 350' ' ' LEU . 71.8 t -60.15 -44.73 95.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.74 -44.15 98.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.127 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -68.58 -49.03 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 39.2 m -64.48 -44.9 89.56 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -88.56 5.93 40.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.367 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 56.43 45.27 22.96 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.032 0.444 . . . . 0.0 111.528 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 98.8 mt -81.48 143.77 31.84 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.125 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.23 150.53 42.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.109 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.02 120.55 13.34 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . 0.53 ' O ' HG21 ' B' ' 367' ' ' VAL . 15.1 t70 -89.59 113.59 25.05 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.032 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 58.8 mm-40 -59.0 -38.38 79.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.449 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -65.46 -41.54 93.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.839 0.352 . . . . 0.0 110.785 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -64.92 -38.66 91.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.784 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . 0.53 HG21 ' O ' ' B' ' 363' ' ' ASP . 96.0 t -63.08 -38.77 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.389 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.4 mmmt -56.35 -44.35 80.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.53 96.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.012 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.81 -42.42 99.71 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.114 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.02 -43.22 97.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.832 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -60.83 -38.95 87.22 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.197 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -65.94 -39.0 90.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.306 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 53.8 ttm -66.39 -41.77 88.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.368 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.57 -28.24 69.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.804 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 48.7 m -75.13 -5.77 46.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.562 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -93.08 -1.34 56.59 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.946 0.403 . . . . 0.0 111.234 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -114.29 169.05 9.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.156 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -64.96 -44.09 90.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.961 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -119.65 118.88 31.79 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.798 0.332 . . . . 0.0 110.198 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.83 -30.62 21.67 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.421 2.08 . . . . 0.0 113.258 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -66.14 -43.37 87.24 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.44 -37.36 85.59 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.706 0.289 . . . . 0.0 110.851 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.44 -43.25 96.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.515 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 90.4 mt -62.33 -44.25 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.943 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 48.3 mt-10 -65.66 -44.48 86.15 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.838 178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.5 -47.82 82.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.122 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . 0.467 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 2.8 t80 -69.52 -39.88 77.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.051 -177.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 62.7 p -78.93 -8.06 58.55 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.4 mttt -99.32 1.7 44.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.967 0.413 . . . . 0.0 111.536 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . 0.444 ' OD1' HD11 ' B' ' 394' ' ' LEU . 24.6 t-20 -123.9 115.25 20.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.232 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 42.1 ttmt -63.9 -40.87 97.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.407 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.23 -49.49 76.9 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.094 0.473 . . . . 0.0 110.781 -176.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . 0.444 HD11 ' OD1' ' B' ' 391' ' ' ASN . 10.3 mp -63.61 -40.18 96.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.47 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 89.7 mtp -62.55 -45.46 92.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 111.526 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.79 -43.66 75.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.223 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -62.8 -39.81 95.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.636 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 398' ' ' MET . . . . . 0.467 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 55.5 tpp -62.82 -44.07 97.12 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.868 0.366 . . . . 0.0 110.751 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -64.65 -31.69 73.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.014 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -61.24 -45.63 93.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.78 -43.83 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.043 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.2 -41.0 96.06 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.003 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.75 -37.04 86.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.693 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.2 -45.18 91.76 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.999 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -65.74 -37.81 87.39 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.656 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -58.92 -43.12 91.03 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.868 0.366 . . . . 0.0 110.421 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.71 -47.28 78.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.599 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 94.9 t -64.12 -45.62 95.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.413 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -67.57 -32.0 72.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.555 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.69 91.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.879 0.371 . . . . 0.0 110.253 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.35 -42.64 95.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.957 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.0 -38.54 86.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.749 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.32 -23.46 66.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -99.25 -2.51 36.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.916 0.389 . . . . 0.0 110.855 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -110.15 174.46 5.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.189 0.519 . . . . 0.0 111.614 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -87.39 108.06 18.82 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.692 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 65.0 t -100.41 118.93 47.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.218 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -119.97 159.57 24.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -108.17 122.16 46.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.873 0.368 . . . . 0.0 111.504 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -134.72 123.7 24.08 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.079 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' B' ' 129' ' ' ILE . 75.3 mt-10 -84.65 154.25 22.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.908 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.0 t -158.2 176.12 12.9 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.599 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 75.0 p -85.4 165.41 17.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.895 0.379 . . . . 0.0 111.231 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -66.72 -26.5 67.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.581 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -62.58 -39.57 94.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.36 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.56 -35.77 81.03 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.361 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -78.16 -14.21 59.56 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.823 0.345 . . . . 0.0 111.461 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.4 mmt -76.69 -9.5 58.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.924 0.392 . . . . 0.0 110.703 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -80.0 87.11 5.42 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -108.82 29.61 7.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.907 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -65.6 -27.35 68.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.376 0.608 . . . . 0.0 109.584 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.478 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.52 178.265 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.429 ' HG2' ' H ' ' A' ' 2' ' ' GLN . 50.8 ttm . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.429 ' H ' ' HG2' ' A' ' 1' ' ' MET . 27.8 tt0 -57.53 108.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.159 0.504 . . . . 0.0 111.553 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 m -134.85 160.93 41.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.649 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t -135.4 131.03 35.79 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.818 0.342 . . . . 0.0 110.163 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.6 p -153.06 139.71 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.546 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -131.73 154.76 48.7 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 m -102.84 126.13 49.86 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.5 m -97.4 -58.8 1.92 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.441 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -174.3 130.42 0.37 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.571 0.224 . . . . 0.0 110.781 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.44 -112.78 5.05 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.815 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.403 ' N ' HD11 ' A' ' 11' ' ' LEU . 5.4 mp -93.61 -8.78 40.17 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.673 0.273 . . . . 0.0 110.731 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.38 122.14 5.62 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.995 -0.622 . . . . 0.0 113.646 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.05 147.5 46.63 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.432 0.693 . . . . 0.0 109.255 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -110.11 139.32 45.38 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.9 t -95.99 -89.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.9 m 68.04 100.2 0.05 Allowed 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -173.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tp -133.02 143.72 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.012 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 m -126.45 130.57 50.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.456 ' HB ' HG12 ' A' ' 24' ' ' ILE . 9.6 mt -125.79 162.11 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -177.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.554 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.7 150.09 49.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.301 0.24 . . . . 0.0 111.132 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.33 -57.08 9.87 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -174.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.11 -35.35 79.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 111.224 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 t -62.74 -41.82 99.38 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.487 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 20' ' ' ALA . 76.4 mt -60.21 -51.98 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.155 0.503 . . . . 0.0 111.354 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -70.04 -46.91 64.02 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.547 -174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.2 m -67.3 -51.33 54.01 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.93 66.5 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.87 -43.29 97.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.964 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -61.32 -45.45 94.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.16 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.2 m -62.18 -42.18 99.03 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.841 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.468 ' O ' HG21 ' A' ' 35' ' ' VAL . 10.0 tp10 -70.16 -42.03 73.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.494 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.54 -44.65 96.67 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.94 -35.43 64.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.014 0.435 . . . . 0.0 110.701 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -65.68 -41.31 92.6 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 31' ' ' GLU . 90.2 t -65.68 -41.46 90.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.398 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.34 80.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.285 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.424 ' O ' ' HD3' ' A' ' 40' ' ' ARG . 99.0 mttt -64.58 -37.58 88.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.059 177.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -61.0 -41.91 97.4 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.883 0.373 . . . . 0.0 110.598 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.87 -4.23 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.388 0.613 . . . . 0.0 110.156 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 25.6 mmt180 62.62 30.95 17.0 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.049 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -112.83 7.15 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.764 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -64.01 -35.92 82.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.081 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.23 -1.64 70.15 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.688 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -91.72 -5.19 54.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.921 0.391 . . . . 0.0 110.734 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -90.36 110.59 21.67 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.01 -39.1 91.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.615 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.83 56.45 24.76 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -62.66 -41.29 98.98 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.91 109.69 58.81 Favored Pre-proline 0 C--O 1.246 0.902 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HG2' HD13 ' A' ' 53' ' ' ILE . 47.4 Cg_exo -57.3 149.35 65.25 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.925 2.417 . . . . 0.0 112.543 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.472 ' HA ' HG13 ' A' ' 54' ' ' VAL . 15.0 ttt -60.29 -39.16 85.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.455 -173.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -69.12 -23.42 63.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.844 0.354 . . . . 0.0 110.987 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.428 HD13 ' HG2' ' A' ' 50' ' ' PRO . 96.6 mt -92.53 -41.72 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.472 HG13 ' HA ' ' A' ' 51' ' ' MET . 12.7 p -66.02 -38.78 82.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 120.936 0.398 . . . . 0.0 110.817 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.45 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -66.84 -37.37 84.36 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -72.78 -15.01 61.65 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.724 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.481 HH12 ' CD1' ' B' ' 187' ' ' LEU . 67.2 mtt180 -108.59 -52.41 2.77 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.429 ' O ' HG12 ' A' ' 62' ' ' VAL . 18.8 m-85 -108.66 -1.24 19.66 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.182 0.515 . . . . 0.0 110.646 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -63.87 -35.76 92.43 Favored Glycine 0 C--O 1.218 -0.863 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.753 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.93 -43.94 67.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.802 0.301 . . . . 0.0 111.312 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.5 m -61.19 -43.29 99.11 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.129 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -105.32 20.3 4.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.246 0.546 . . . . 0.0 110.776 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 14.1 ttm180 -63.97 -19.9 65.49 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.048 0.452 . . . . 0.0 110.147 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.37 -53.05 58.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.24 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' HB2' HG23 ' A' ' 62' ' ' VAL . 17.6 m-20 -71.02 -26.15 62.99 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.501 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 62' ' ' VAL . 91.7 t -62.05 -45.24 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.74 -40.06 95.81 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.352 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.03 99.39 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.23 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.51 -44.67 93.62 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.39 -42.76 99.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.036 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.1 ttp -60.48 -50.08 75.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.34 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.3 m -65.27 -46.38 80.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.679 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.41 ' HD3' HG12 ' A' ' 35' ' ' VAL . 58.4 ttm-85 -66.27 -46.63 76.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.792 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -66.14 -40.4 90.6 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -59.88 -48.36 81.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.908 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.508 ' O ' HG13 ' A' ' 79' ' ' ILE . 20.0 tt -68.17 -38.9 80.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.883 0.373 . . . . 0.0 111.271 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.19 -38.54 88.24 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.384 0.611 . . . . 0.0 109.767 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.69 83.73 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.766 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.7 pp -65.07 -37.33 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.076 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.32 -42.33 95.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.718 0.77 . . . . 0.0 109.156 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -59.55 -47.86 83.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.16 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -89.38 -1.43 58.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -175.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm 70.46 38.95 1.27 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.47 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 92.5 mt -93.84 121.28 44.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -110.52 101.41 48.66 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.588 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.92 131.31 6.97 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.53 2.153 . . . . 0.0 112.452 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.7 90.95 4.42 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.997 0.427 . . . . 0.0 110.4 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.46 -144.21 15.29 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.18 129.47 25.05 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 116.588 0.194 . . . . 0.0 110.678 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.21 160.2 50.4 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.827 2.352 . . . . 0.0 111.398 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.2 m -101.09 91.72 4.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.12 0.486 . . . . 0.0 112.17 -175.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -84.05 117.77 23.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.6 t -111.26 96.93 33.3 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 120.86 0.362 . . . . 0.0 111.967 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -87.99 145.14 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 122.592 2.194 . . . . 0.0 110.81 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.96 174.83 42.81 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.638 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.52 130.86 42.3 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -85.34 104.04 14.81 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.153 0.501 . . . . 0.0 110.911 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.95 111.7 19.49 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.11 112.7 2.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.118 0.485 . . . . 0.0 110.484 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.97 -14.91 19.15 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.135 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -119.0 -178.1 3.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.623 0.249 . . . . 0.0 111.035 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.52 161.18 28.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.359 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -108.8 138.81 44.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.776 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -118.31 134.54 54.95 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.198 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -136.39 162.67 32.39 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.835 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.9 m -121.8 148.78 44.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.762 0.315 . . . . 0.0 111.112 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.88 139.96 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.417 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.41 132.81 46.81 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -155.72 -159.33 0.9 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -45.96 155.22 0.2 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.557 1.543 . . . . 0.0 113.327 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.5 m -129.93 159.19 42.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.445 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -145.55 99.32 4.48 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.253 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.22 143.73 10.25 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.515 2.143 . . . . 0.0 113.124 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -159.01 125.59 4.62 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.93 162.62 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.891 0.376 . . . . 0.0 111.709 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -119.64 136.35 54.43 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.6 mt -114.23 135.3 54.2 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -128.09 133.46 49.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.626 0.251 . . . . 0.0 111.649 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.1 22.43 52.31 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.882 -0.675 . . . . 0.0 114.251 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.89 -41.42 99.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.24 0.543 . . . . 0.0 110.511 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.67 -16.77 61.88 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.619 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.05 6.98 47.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.49 127.53 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.375 0.607 . . . . 0.0 111.093 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -110.04 132.2 54.37 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.935 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.5 t -120.76 133.6 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.142 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -90.26 120.26 31.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.049 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -122.31 93.5 48.48 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.76 140.73 56.93 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.176 1.917 . . . . 0.0 112.446 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.2 mm -106.37 119.84 56.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.378 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.41 160.43 42.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.293 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.3 158.77 43.36 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.855 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.4 t -84.72 126.4 40.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.698 0.285 . . . . 0.0 110.491 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.2 p -97.74 170.02 9.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -68.57 -22.68 64.46 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.284 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.69 -38.89 92.54 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.151 0.501 . . . . 0.0 109.652 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -65.15 -36.74 85.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.336 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.45 -45.36 98.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.468 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.09 -40.48 95.99 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.438 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.81 -42.67 99.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.663 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.521 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 5.0 tpt -63.72 -45.17 91.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.922 0.391 . . . . 0.0 110.306 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.43 -41.4 98.67 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.957 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.1 -45.89 89.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.386 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.0 m -62.62 -39.55 94.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.329 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.7 mt -61.49 -41.75 97.75 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.701 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -69.43 -21.54 63.74 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.087 0.47 . . . . 0.0 110.802 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -86.56 4.13 41.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.223 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -119.8 28.54 8.06 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.664 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -138.33 95.39 3.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.57 155.99 47.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.96 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.5 HG21 ' H ' ' A' ' 151' ' ' TRP . 0.7 OUTLIER -122.29 172.35 8.37 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.766 -177.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.5 ' H ' HG21 ' A' ' 150' ' ' THR . 8.9 p-90 -55.0 136.41 47.78 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.052 0.541 . . . . 0.0 112.311 -176.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -170.32 113.87 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -73.86 85.58 1.72 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -153.0 -78.31 0.11 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.837 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -163.19 -68.21 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.434 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 243' ' ' ARG . . . 64.54 -126.92 33.59 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.198 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -146.34 -165.44 2.22 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 203' ' ' LYS . 61.2 t -119.38 126.54 75.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 57.1 mm-40 -87.88 177.93 6.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.263 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.17 -58.25 3.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.424 ' CD ' ' HE ' ' A' ' 255' ' ' ARG . 6.7 pt-20 -89.58 34.98 0.82 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.304 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.642 ' OD2' ' HD3' ' A' ' 243' ' ' ARG . 11.4 t70 -57.22 -48.7 78.14 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.412 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 65.82 88.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.607 HG23 ' OD1' ' A' ' 162' ' ' ASP . 2.9 t -109.94 132.31 58.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.694 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 m -81.15 104.62 11.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 79.7 mt -117.1 132.82 65.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -171.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -99.26 107.92 20.34 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -130.68 146.91 52.28 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.621 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 37.6 m -128.55 131.46 48.22 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.085 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.97 105.84 1.96 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.603 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.9 m -127.26 121.69 31.85 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.6 t -72.64 -76.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -109.28 -70.34 0.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.172 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -136.87 18.9 3.54 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.228 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -136.84 148.79 47.33 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -93.32 149.37 21.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.643 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -111.39 -177.8 3.29 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.24 -45.01 92.31 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.732 -176.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -93.24 -171.58 39.9 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.173 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.62 36.87 58.27 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.865 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -115.17 101.42 8.95 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.2 151.53 34.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.144 0.497 . . . . 0.0 111.54 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.8 m -139.04 126.42 21.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.471 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 56.69 38.3 29.43 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.13 0.49 . . . . 0.0 110.768 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -87.7 136.1 33.1 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.619 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.53 120.15 37.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.715 0.769 . . . . 0.0 112.15 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.437 ' CD1' HH12 ' B' ' 57' ' ' ARG . 49.0 tp -113.27 119.42 37.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.595 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.635 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -102.21 129.04 48.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 56.9 mtm -106.83 167.65 9.73 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.768 -173.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.17 14.08 61.0 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.708 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -126.62 -10.06 6.2 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.661 0.267 . . . . 0.0 111.445 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.53 40.45 9.86 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.424 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.635 ' HG3' ' O ' ' A' ' 188' ' ' ALA . 39.5 mmm-85 -79.12 -22.04 45.72 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.38 0.672 . . . . 0.0 109.939 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.424 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.1 OUTLIER -128.95 -170.0 2.19 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.185 179.494 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.439 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.2 mp -68.33 134.52 91.13 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.63 132.43 45.74 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.256 1.971 . . . . 0.0 111.918 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.47 -39.88 2.63 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.795 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -62.34 -46.31 89.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.554 0.216 . . . . 0.0 111.244 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.95 10.85 5.76 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.088 0.47 . . . . 0.0 111.894 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -114.37 -33.64 5.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.121 0.486 . . . . 0.0 110.115 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.76 -17.88 75.46 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.246 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.57 -41.97 94.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.061 0.457 . . . . 0.0 110.322 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 158' ' ' VAL . 41.5 mtpt -52.08 132.27 32.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.654 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.76 8.74 55.52 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.767 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.43 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 38.0 m80 -115.38 150.18 36.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.031 0.416 . . . . 0.0 110.72 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -87.26 163.39 16.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.169 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.95 135.49 47.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.01 15.35 79.14 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.77 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.43 ' OE2' ' HD2' ' A' ' 205' ' ' HIS . 40.7 tt0 -99.19 119.89 38.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.33 0.585 . . . . 0.0 111.362 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 235' ' ' ILE . 25.4 mt-10 -98.9 115.62 29.28 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.406 ' O ' ' HB ' ' A' ' 212' ' ' THR . 64.0 t80 -133.74 -26.09 1.6 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -173.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 77.0 m 72.42 129.96 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 120.893 0.378 . . . . 0.0 110.344 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.42 -41.07 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 70.75 97.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 122.791 0.436 . . . . 0.0 111.32 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 68.6 t -115.59 126.92 73.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.049 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.55 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 18.5 m -65.89 -41.95 90.88 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -176.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.55 ' HB2' ' O ' ' A' ' 216' ' ' THR . 27.8 m-85 77.81 134.53 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 122.957 0.503 . . . . 0.0 110.32 -173.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.16 155.7 51.84 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.369 2.046 . . . . 0.0 112.679 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -66.09 -33.78 76.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.601 0.715 . . . . 0.0 109.305 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.12 22.81 1.66 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.851 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -70.52 142.1 51.88 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.514 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -63.09 -30.37 71.54 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.67 123.62 33.3 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.419 -0.512 . . . . 0.0 109.741 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.507 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 1.5 tp10 -65.33 -31.54 72.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.381 -175.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -86.15 -5.32 59.22 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.37 -11.57 10.0 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.507 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 18.7 ptmt -71.53 119.98 16.47 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.206 0.527 . . . . 0.0 111.063 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 75.9 19.0 79.25 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.755 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -125.34 121.64 34.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.391 . . . . 0.0 110.766 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.55 138.9 45.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.615 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.54 135.47 53.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.845 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.52 -48.22 28.34 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -173.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 212' ' ' THR . 66.1 m-85 54.67 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.91 94.46 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 210' ' ' GLU . 91.6 mt 68.62 99.2 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.804 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -86.94 -51.7 5.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 32.4 tp 55.78 91.0 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.976 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -73.55 -79.33 0.08 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 54.1 mtmt -79.01 -79.11 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -170.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 92.0 t 76.9 152.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-O 120.832 0.349 . . . . 0.0 110.615 -175.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -99.12 56.53 1.04 Allowed 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -36.47 141.17 0.12 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -173.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.642 ' HD3' ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -144.6 144.83 31.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.944 177.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.401 ' HB2' ' CA ' ' A' ' 156' ' ' GLY . 38.2 tt0 -158.94 155.58 27.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.1 tt 72.09 128.03 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 123.475 0.484 . . . . 0.0 111.136 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -87.74 113.99 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.216 1.944 . . . . 0.0 113.632 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -131.37 176.24 8.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.89 111.6 23.92 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 15.6 p -104.51 -86.19 0.46 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.66 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -176.61 -49.93 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.996 0.427 . . . . 0.0 111.896 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.73 -45.11 91.39 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -62.35 -30.37 71.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 19.6 tt -85.93 -16.12 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -174.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -117.29 8.34 13.12 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.345 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.424 ' HE ' ' CD ' ' A' ' 161' ' ' GLU . 60.5 ttp180 -134.71 133.17 39.7 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.915 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -167.7 37.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 99.43 -31.54 8.2 Favored Glycine 0 C--N 1.318 -0.452 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.07 149.31 5.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.61 -47.25 80.05 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.199 0.312 . . . . 0.0 110.545 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -175.76 163.63 2.85 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.258 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -172.62 175.62 45.67 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.307 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.3 p -83.5 175.33 9.87 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.43 0.292 . . . . 0.0 110.301 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 67.4 t -61.97 -51.23 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.005 0.431 . . . . 0.0 111.054 -177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -81.06 -32.95 33.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.335 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.07 -43.24 99.42 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.19 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 270' ' ' VAL . 65.1 tp -63.14 -44.02 96.7 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.627 0.251 . . . . 0.0 110.52 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -64.12 -42.38 96.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.382 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.3 -45.02 81.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.29 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 35.5 tp10 -65.71 -38.57 89.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.998 0.427 . . . . 0.0 110.434 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 266' ' ' LEU . 75.8 t -65.49 -43.4 94.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.228 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -59.21 -46.74 87.64 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.673 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.5 ptmt -66.46 -42.62 87.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.669 0.271 . . . . 0.0 111.163 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -65.79 -37.43 86.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.5 mmm -63.52 -42.81 98.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.045 0.45 . . . . 0.0 110.111 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -70.17 -30.82 68.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.204 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -61.61 -43.79 98.19 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.39 -32.98 74.9 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.875 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.8 tp -60.8 -39.64 89.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.951 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -58.12 -46.9 84.78 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 50.4 m -62.52 -44.68 95.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.033 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.3 -51.0 69.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.83 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.45 -44.36 97.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.039 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.495 HH12 ' HG3' ' A' ' 409' ' ' GLU . 6.5 tpt180 -63.03 -45.31 92.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.79 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.43 -40.19 95.27 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.472 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -59.13 -44.4 92.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.014 0.435 . . . . 0.0 110.269 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 86.3 t -70.24 -43.11 78.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.445 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.4 tttt -59.3 -47.66 84.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.046 -177.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 74.1 p -62.88 -41.89 99.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -64.2 -42.35 96.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.583 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.432 ' O ' ' HG ' ' A' ' 294' ' ' LEU . . . -65.27 -42.6 93.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.762 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 287' ' ' LYS . 33.5 mm -64.07 -43.34 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.563 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -60.74 -43.37 98.0 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.114 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.01 -40.85 97.39 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.414 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 290' ' ' ALA . 98.5 mt -62.54 -43.13 99.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.802 0.334 . . . . 0.0 110.802 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 96.0 t -65.31 -43.78 94.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.198 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -64.23 -40.59 96.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.068 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.26 -42.74 79.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.962 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -127.21 96.34 4.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.8 105.55 17.49 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.465 HG13 ' N ' ' A' ' 301' ' ' ASP . 11.4 tp -120.1 168.68 12.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.574 -174.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.465 ' N ' HG13 ' A' ' 300' ' ' ILE . 7.3 m-20 -60.78 139.0 58.06 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.385 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.96 119.63 28.78 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.94 131.44 45.49 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.437 2.092 . . . . 0.0 111.89 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.66 84.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.102 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.55 91.1 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 111.565 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.7 mt -66.46 -40.74 89.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.833 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 311' ' ' ILE . 68.7 mt -61.66 -47.95 90.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.992 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.3 -43.04 92.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.873 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 51.0 m -62.25 -45.26 94.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.869 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.592 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 65.9 mm-40 -66.17 -39.48 89.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.234 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.54 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 95.8 mt -61.96 -43.82 98.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.548 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.6 t70 -61.62 -46.62 89.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.913 0.387 . . . . 0.0 111.306 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 91.7 t -63.35 -43.51 98.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.251 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 75.0 mt -62.49 -40.46 96.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.548 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 85.1 mtm180 -62.91 -42.15 99.69 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.132 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -64.79 -38.66 91.74 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -63.35 -44.53 94.57 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.252 0.548 . . . . 0.0 109.937 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.7 80.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.58 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.461 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -62.31 -36.29 81.7 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.944 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -63.2 -40.5 97.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.281 0.563 . . . . 0.0 109.584 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -75.06 -9.6 58.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.343 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -92.2 -7.36 48.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.845 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 136.69 -14.33 3.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.82 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 113.12 44.11 0.82 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.879 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.49 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 35.6 t-20 -87.22 127.98 35.15 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.88 0.372 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . 0.539 ' OE1' ' HG3' ' A' ' 327' ' ' LYS . 1.8 tm-20 -130.7 145.26 51.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.539 ' HG3' ' OE1' ' A' ' 326' ' ' GLU . 35.2 mtmm 72.22 -46.05 0.63 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.646 0.779 . . . . 0.0 112.422 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.49 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 12.3 mm100 -70.0 -10.98 60.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.207 0.527 . . . . 0.0 110.446 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.85 -22.54 64.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.411 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.0 tp -61.61 -33.93 74.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.679 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -79.27 -6.29 56.34 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.573 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 75.9 mt -69.24 145.63 96.17 Favored Pre-proline 0 C--O 1.241 0.623 0 O-C-N 122.186 -0.321 . . . . 0.0 110.997 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.36 127.08 23.43 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.893 2.396 . . . . 0.0 113.339 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.447 ' HG3' HD11 ' A' ' 311' ' ' ILE . 21.9 ttt180 -70.49 -41.0 73.25 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.405 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -52.16 -46.41 65.45 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -173.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.446 HD13 ' CD ' ' A' ' 224' ' ' GLU . 74.7 mt -92.27 10.13 30.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -115.72 -28.2 6.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.132 0.492 . . . . 0.0 110.228 172.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.7 -30.67 70.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.711 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -60.97 -48.24 82.75 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.471 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -78.32 -20.86 50.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.713 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.43 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.95 -40.87 97.43 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.5 ' O ' HG22 ' A' ' 346' ' ' VAL . 86.8 tttt -59.82 -45.16 93.23 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.567 ' O ' HG21 ' A' ' 347' ' ' VAL . 11.1 mmt85 -60.27 -45.8 92.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.031 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -67.46 -38.92 85.18 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.164 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 341' ' ' ALA . 82.8 t -64.27 -43.86 97.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.658 0.266 . . . . 0.0 110.351 176.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 342' ' ' LYS . 73.0 t -60.74 -43.8 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.531 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 343' ' ' ARG . 82.7 t -59.93 -45.6 94.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.45 -43.34 99.18 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.93 -43.73 94.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.59 0.233 . . . . 0.0 111.478 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.43 -44.79 93.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.924 0.393 . . . . 0.0 110.506 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 355' ' ' ILE . 95.8 mt -66.59 -39.93 88.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.816 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.84 -41.76 96.25 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.583 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -66.06 -40.46 90.92 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.889 0.344 . . . . 0.0 110.646 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.76 -45.89 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.937 178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 351' ' ' LEU . 73.6 mt -62.96 -46.98 94.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.224 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -64.07 -62.75 1.43 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.7 m -66.29 -43.86 85.14 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.3 -12.15 60.46 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.246 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 66.44 47.6 1.69 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.008 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.17 142.16 33.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.884 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.06 146.13 51.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.67 114.47 5.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.46 ' O ' HG21 ' A' ' 367' ' ' VAL . 26.8 t70 -87.01 111.48 20.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.064 0.459 . . . . 0.0 111.077 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 58.1 mm-40 -61.4 -35.04 76.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.995 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.63 -42.09 91.9 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.845 0.355 . . . . 0.0 110.764 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -63.01 -40.05 96.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.11 0.481 . . . . 0.0 110.149 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 363' ' ' ASP . 89.2 t -61.26 -39.41 82.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.335 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.0 mmmt -57.23 -43.41 82.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.508 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.65 99.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.204 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.65 -42.96 99.89 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.124 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.84 -44.85 92.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.121 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.73 -41.47 98.05 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -65.17 -42.31 93.83 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.436 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 49.6 ttp -65.25 -40.69 94.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.97 -23.45 67.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.568 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 39.6 m -73.85 -5.73 42.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.481 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -90.86 0.15 57.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.328 0.585 . . . . 0.0 110.315 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.86 170.84 8.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.542 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.06 -44.13 85.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.81 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -124.63 113.23 27.28 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.764 0.316 . . . . 0.0 110.616 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.24 -35.95 98.22 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.948 2.432 . . . . 0.0 113.221 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.28 -43.7 85.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.48 -35.8 81.67 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.884 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.93 -43.24 96.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 109.978 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.11 -43.48 98.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.88 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.45 -36.75 84.84 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.743 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -58.63 -47.43 84.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.335 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -70.66 -44.46 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 29.9 p -68.32 -15.91 63.74 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -100.77 4.74 43.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.591 0.234 . . . . 0.0 111.214 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -128.97 112.94 14.58 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 110.699 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.13 -40.56 96.43 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -56.81 -51.38 69.19 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.043 0.449 . . . . 0.0 110.794 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.37 -40.14 95.24 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.838 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 87.9 mtp -61.7 -45.63 93.17 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.638 0.256 . . . . 0.0 111.681 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.18 -44.25 63.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.367 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -63.31 -42.69 99.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.049 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 50.3 tpp -63.56 -42.07 98.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.991 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -65.59 -34.53 78.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.195 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -61.81 -42.72 99.37 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 110.106 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.99 -43.41 89.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.694 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.31 97.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.724 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.5 -36.7 84.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.489 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.22 -45.32 91.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.812 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 40.7 mt-10 -64.85 -38.46 91.06 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.419 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -60.39 -43.39 96.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.492 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.88 96.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.31 -43.51 95.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.495 ' HG3' HH12 ' A' ' 283' ' ' ARG . 80.5 mt-10 -66.02 -34.34 77.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.291 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.22 -39.12 91.74 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.15 0.5 . . . . 0.0 110.21 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.78 -42.85 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.176 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.56 -40.36 94.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.458 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.8 -27.76 68.27 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.941 0.4 . . . . 0.0 111.356 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -94.16 -8.22 40.05 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 110.821 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.35 -179.94 5.09 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.239 0.542 . . . . 0.0 111.835 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -103.41 106.39 16.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.031 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 63.9 t -92.51 132.61 36.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 120.768 0.318 . . . . 0.0 110.382 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.4 t -124.63 146.64 48.97 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.907 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.67 130.84 53.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.822 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -148.14 136.36 21.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.026 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -87.22 153.86 21.16 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.6 t -158.01 178.57 10.07 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 18.0 p -87.3 162.2 17.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.918 0.389 . . . . 0.0 111.549 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.9 -36.51 82.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.281 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -57.59 -36.94 72.39 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.893 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.2 -33.67 76.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.871 0.367 . . . . 0.0 110.939 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.5 mp -81.06 -12.45 59.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.905 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 3.2 mmt -78.49 -8.3 58.39 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -78.32 84.01 4.53 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.925 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -109.41 23.16 14.86 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.411 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -82.12 -9.0 59.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.515 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.59 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.265 -179.678 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.3 ttm . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -53.58 109.8 0.49 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.981 0.419 . . . . 0.0 111.887 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.49 161.78 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.818 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 43.7 t -136.79 130.56 32.07 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 p -152.78 137.89 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.856 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.431 ' CD ' HH11 ' B' ' 14' ' ' ARG . 41.3 mt-10 -128.17 161.06 30.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.269 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 49.9 m -110.0 125.56 53.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 16.8 m -96.66 -58.62 2.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.447 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -174.41 129.07 0.35 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.207 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.82 -114.6 6.92 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.708 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 mp -91.14 -9.84 44.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.711 0.291 . . . . 0.0 110.783 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.34 120.68 5.64 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.736 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.05 146.98 48.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.431 HH11 ' CD ' ' B' ' 6' ' ' GLU . 54.7 ttp180 -110.08 139.72 44.92 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.58 -90.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 34.9 m 68.24 99.69 0.05 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -173.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.1 tp -134.15 144.02 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.881 0.372 . . . . 0.0 111.796 -175.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.4 m -127.79 129.87 47.73 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.673 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.49 ' HB ' HG12 ' B' ' 24' ' ' ILE . 16.8 mt -123.67 162.14 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -176.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.583 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.29 148.03 52.41 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.259 0.224 . . . . 0.0 110.811 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.37 -61.54 2.12 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -66.74 -32.28 73.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.798 0.332 . . . . 0.0 110.943 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 38.6 t -63.04 -41.07 99.41 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.241 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.583 HG13 ' O ' ' B' ' 20' ' ' ALA . 76.3 mt -60.1 -52.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.124 0.488 . . . . 0.0 110.935 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -69.45 -46.11 67.48 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.594 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 21.1 m -65.46 -51.2 61.79 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.57 -47.81 62.36 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.18 -43.28 98.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.075 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -60.34 -46.51 89.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.391 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 25.4 m -62.45 -42.5 99.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.647 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.442 ' O ' HG21 ' B' ' 35' ' ' VAL . 10.0 tp10 -68.87 -42.98 76.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.571 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.96 -44.43 96.77 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -69.61 -34.51 61.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.96 0.41 . . . . 0.0 110.762 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -65.08 -42.21 94.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.56 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.443 HG12 ' HD3' ' B' ' 73' ' ' ARG . 88.2 t -65.95 -41.74 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.096 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.76 -40.76 84.84 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.377 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' B' ' 40' ' ' ARG . 98.6 mttt -65.37 -37.16 86.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.279 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.79 -44.3 96.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 110.593 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 19.7 t -78.94 -4.44 6.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.488 0.661 . . . . 0.0 109.969 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.452 ' HD3' ' O ' ' B' ' 37' ' ' LYS . 25.6 mmt180 64.53 25.85 13.28 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.44 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.7 11.39 8.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -63.46 -34.53 77.97 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.184 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.33 0.98 83.15 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.6 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -93.48 -1.67 55.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.042 0.448 . . . . 0.0 110.783 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -95.09 110.59 22.51 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -62.2 -38.49 89.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.371 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.29 56.4 25.26 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -63.52 -41.66 98.5 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.0 t -100.44 110.01 58.83 Favored Pre-proline 0 C--O 1.248 0.999 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.437 ' HG2' HD13 ' B' ' 53' ' ' ILE . 48.9 Cg_exo -57.01 149.04 64.71 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.822 2.348 . . . . 0.0 112.349 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.449 ' HA ' HG13 ' B' ' 54' ' ' VAL . 21.4 ttt -61.1 -37.19 81.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.182 -173.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -69.26 -24.82 64.03 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.929 0.395 . . . . 0.0 111.112 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.437 HD13 ' HG2' ' B' ' 50' ' ' PRO . 96.8 mt -92.69 -41.5 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' B' ' 51' ' ' MET . 13.1 p -65.16 -38.74 83.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.067 0.461 . . . . 0.0 111.019 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.448 ' O ' ' HA3' ' B' ' 59' ' ' GLY . . . -67.38 -37.37 83.05 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.413 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 9.5 pt20 -74.67 -11.73 60.25 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.38 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.437 HH12 ' CD1' ' A' ' 187' ' ' LEU . 62.8 mtt-85 -109.42 -50.17 3.02 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . 0.412 ' O ' HG12 ' B' ' 62' ' ' VAL . 20.5 m-85 -112.64 1.25 15.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.082 0.468 . . . . 0.0 110.811 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -64.99 -37.25 94.04 Favored Glycine 0 C--O 1.217 -0.941 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.074 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.86 76.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.727 0.298 . . . . 0.0 111.249 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 48.5 m -62.15 -44.55 96.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.052 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.419 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.3 p -105.09 19.99 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.352 0.596 . . . . 0.0 111.118 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 12.7 ttm180 -63.05 -20.64 65.52 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.116 0.484 . . . . 0.0 110.182 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -64.07 -53.31 51.74 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.349 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . 0.414 ' HB2' HG23 ' B' ' 62' ' ' VAL . 20.7 m-20 -69.91 -27.39 64.74 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.847 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 62' ' ' VAL . 93.6 t -61.64 -45.09 99.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -64.01 -39.87 95.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.412 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.64 -41.31 98.85 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.162 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.04 -44.69 95.18 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.33 -42.1 98.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.005 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.8 ttp -60.16 -50.77 72.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.183 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 24.4 m -65.28 -46.02 82.11 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.788 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.443 ' HD3' HG12 ' B' ' 35' ' ' VAL . 59.0 ttm-85 -66.34 -46.61 76.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.745 -175.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -66.47 -40.11 89.17 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -60.34 -48.67 80.75 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.45 ' O ' HG13 ' B' ' 79' ' ' ILE . 19.9 tt -67.45 -38.95 81.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.965 0.412 . . . . 0.0 111.259 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -66.17 -40.25 90.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.338 0.59 . . . . 0.0 109.88 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.11 85.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.828 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.7 pp -66.1 -37.2 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.37 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 -42.59 96.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.696 0.76 . . . . 0.0 109.172 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -59.95 -46.46 89.33 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.533 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -90.02 2.43 55.19 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.7 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm 65.83 41.43 3.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.69 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 87.0 mt -96.66 119.99 45.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.882 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -108.17 103.6 50.86 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -85.21 127.45 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.538 2.159 . . . . 0.0 112.328 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.46 97.94 10.51 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.069 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.64 -141.78 15.85 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.514 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.04 132.42 23.72 Favored Pre-proline 0 C--N 1.317 -0.806 0 O-C-N 122.853 -0.204 . . . . 0.0 110.695 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . 0.421 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 64.0 Cg_endo -71.78 162.02 43.32 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.826 2.351 . . . . 0.0 111.272 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 18.7 m -99.34 109.07 21.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.282 0.563 . . . . 0.0 111.17 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.421 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 87.9 m-85 -99.96 115.58 30.02 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.65 94.58 19.98 Favored Pre-proline 0 C--N 1.32 -0.717 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.931 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 90.9 Cg_endo -87.01 146.16 7.68 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.552 2.168 . . . . 0.0 110.523 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.98 172.18 39.91 Favored Glycine 0 N--CA 1.437 -1.295 0 C-N-CA 120.0 -1.095 . . . . 0.0 111.168 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.16 136.12 47.96 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -87.03 103.93 15.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.383 0.611 . . . . 0.0 111.544 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.46 111.16 18.23 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 49.3 tp -64.9 109.13 1.99 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.1 0.476 . . . . 0.0 110.408 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.06 -11.32 13.26 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.344 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.74 -177.69 3.81 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.708 0.29 . . . . 0.0 111.548 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -76.08 143.32 41.39 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.8 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -91.61 140.93 29.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.708 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 59.1 m -119.77 136.61 54.38 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.053 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -139.65 162.1 35.91 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.056 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 5.1 m -121.53 149.84 42.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.785 0.326 . . . . 0.0 111.227 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 10.8 p -133.97 142.72 40.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.307 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -105.58 128.17 53.46 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -149.68 -158.54 0.93 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -48.77 155.8 0.54 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.998 1.319 . . . . 0.0 113.318 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.18 160.81 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.114 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -144.98 97.08 4.9 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.741 0.305 . . . . 0.0 110.783 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.62 145.98 33.76 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.849 2.366 . . . . 0.0 112.801 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -164.48 123.55 1.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.5 164.86 31.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.827 0.346 . . . . 0.0 111.583 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -121.44 135.69 55.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.937 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.26 136.01 53.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -130.48 138.82 50.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.658 0.266 . . . . 0.0 111.107 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.15 19.3 61.13 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.912 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.05 -41.15 99.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.118 0.459 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.54 -5.33 32.46 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.483 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.03 13.86 27.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.903 0.382 . . . . 0.0 111.097 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 81.7 mt -102.17 128.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.152 0.501 . . . . 0.0 110.613 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -109.79 128.92 55.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.927 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 62.5 t -117.86 133.28 65.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.988 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -90.94 128.21 36.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.937 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.81 94.0 32.84 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.35 141.06 60.59 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.412 2.075 . . . . 0.0 112.503 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.7 mm -108.33 118.58 56.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.236 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.01 158.53 43.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.359 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -141.35 159.82 41.43 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.179 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -79.74 129.17 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.611 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.9 p -105.07 176.18 5.25 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.689 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -62.0 -38.09 87.3 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.35 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.95 -37.38 84.52 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.874 0.369 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -63.81 -39.03 93.26 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 89.3 t -63.65 -44.72 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.234 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.62 -42.41 92.6 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.247 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.53 98.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.959 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' MET . . . . . 0.516 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 4.6 tpt -63.11 -45.27 92.78 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.858 0.361 . . . . 0.0 110.231 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.86 -41.59 97.75 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.036 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.98 -45.46 92.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.664 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 26.5 m -61.97 -41.16 97.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.952 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.1 mt -61.21 -41.42 96.81 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.459 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -68.83 -22.5 64.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.058 0.456 . . . . 0.0 110.741 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -85.46 2.48 44.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.228 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -119.31 31.44 6.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.394 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -139.16 89.61 2.36 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.22 155.77 49.56 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.531 HG21 ' H ' ' B' ' 151' ' ' TRP . 1.2 m -124.04 172.14 9.22 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.676 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . 0.531 ' H ' HG21 ' B' ' 150' ' ' THR . 8.6 p-90 -53.18 137.11 34.95 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -172.71 119.45 0.37 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.88 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' B' ' 154' ' ' LYS . 7.5 pt-20 -77.5 89.72 3.86 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.44 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' B' ' 153' ' ' GLU . 63.5 mmtt -158.44 -72.08 0.09 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.921 0.888 . . . . 0.0 110.736 177.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -169.52 -70.91 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.318 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' B' ' 243' ' ' ARG . . . 66.45 -128.93 30.72 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.798 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -145.53 -165.76 2.27 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 50.5 t -117.43 124.73 73.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' B' ' 162' ' ' ASP . 62.0 mm-40 -87.9 174.44 8.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.068 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.3 -52.79 23.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.198 0.523 . . . . 0.0 109.821 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . 0.407 ' CD ' ' HE ' ' B' ' 255' ' ' ARG . 6.8 pt-20 -92.91 32.66 1.24 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.46 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.597 ' OD2' ' HD3' ' B' ' 243' ' ' ARG . 9.2 t70 -57.36 -48.85 77.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.378 -174.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 21.8 ttp85 66.0 88.47 0.11 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.791 0.805 . . . . 0.0 109.24 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . 0.543 HG23 ' OD1' ' B' ' 162' ' ' ASP . 3.0 t -111.49 133.0 58.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.005 -174.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.9 m -80.29 104.51 10.89 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 79.7 mt -116.83 131.0 70.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -97.86 106.21 18.48 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -128.56 146.6 50.79 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.441 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 36.1 m -129.84 131.46 46.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.208 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.38 110.75 3.23 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.562 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 14.6 m -130.67 122.37 27.24 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.47 -76.09 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -110.65 -71.91 0.74 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.817 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -134.37 16.02 4.4 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.067 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -135.17 147.59 49.45 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.916 0.389 . . . . 0.0 110.402 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -91.29 150.58 21.25 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.688 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -112.48 179.15 4.07 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.83 -42.12 88.5 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.1 -175.45 39.31 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.032 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 73.72 36.51 53.25 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.861 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -114.43 102.17 9.83 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.68 154.27 38.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.032 0.444 . . . . 0.0 111.744 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -142.56 133.4 25.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 56.27 35.22 25.42 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.377 0.423 . . . . 0.0 110.845 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -88.22 134.52 33.77 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.085 -175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 15.7 m -90.58 120.97 40.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.634 0.731 . . . . 0.0 112.01 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . 0.481 ' CD1' HH12 ' A' ' 57' ' ' ARG . 29.0 tp -114.32 121.28 43.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.502 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . 0.585 ' O ' ' HG3' ' B' ' 193' ' ' ARG . . . -101.64 132.18 47.46 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 172.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 57.5 mtm -109.91 165.78 11.45 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.084 -173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.13 0.33 65.83 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.967 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -112.94 -8.38 13.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.43 36.35 17.36 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.677 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' B' ' 188' ' ' ALA . 39.7 mmm-85 -74.49 -25.41 59.36 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.379 0.672 . . . . 0.0 110.138 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 194' ' ' MET . . . . . 0.433 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.1 OUTLIER -124.75 -171.27 2.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.522 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.407 ' N ' HD12 ' B' ' 195' ' ' ILE . 3.7 mp -68.54 136.92 90.69 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.67 132.86 47.88 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.164 1.909 . . . . 0.0 112.054 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.35 -39.79 2.69 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.05 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -62.39 -45.54 92.69 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.0 8.93 11.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -113.21 -33.67 5.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.179 0.514 . . . . 0.0 109.765 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.94 -19.26 73.44 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.396 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 98.6 mt -64.95 -33.54 64.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.262 0.554 . . . . 0.0 110.225 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -60.03 135.27 57.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.143 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.58 3.61 58.39 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.451 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.468 ' HD2' ' OE2' ' B' ' 209' ' ' GLU . 39.1 m80 -111.62 147.85 34.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 117.013 0.407 . . . . 0.0 110.934 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -85.01 163.63 18.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.073 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.62 137.0 51.91 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.29 20.55 77.03 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.968 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . 0.468 ' OE2' ' HD2' ' B' ' 205' ' ' HIS . 42.6 tt0 -101.37 121.81 42.59 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.23 0.538 . . . . 0.0 110.946 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' B' ' 235' ' ' ILE . 33.4 mt-10 -101.92 113.58 26.91 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -133.44 -27.62 1.54 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 30.8 m 74.56 130.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 120.9 0.381 . . . . 0.0 110.455 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.79 -40.53 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 70.38 97.93 0.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.199 0.523 . . . . 0.0 111.842 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 62.6 t -116.07 128.21 73.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 19.4 m -68.69 -40.78 79.88 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -176.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' B' ' 216' ' ' THR . 32.6 m-85 77.8 134.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 123.025 0.53 . . . . 0.0 110.699 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.46 156.1 50.21 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.606 2.204 . . . . 0.0 112.584 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -65.44 -34.93 79.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.525 0.678 . . . . 0.0 110.008 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -87.14 30.12 0.79 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.616 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -74.65 140.98 44.63 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -61.65 -29.13 69.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.05 121.9 33.25 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.971 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.561 ' HA ' ' CD ' ' B' ' 227' ' ' LYS . 1.4 tp10 -62.93 -33.66 75.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.562 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.463 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 30.8 p-10 -84.22 -5.9 59.32 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.61 -12.94 9.68 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.561 ' CD ' ' HA ' ' B' ' 224' ' ' GLU . 18.1 ptmt -69.19 118.72 12.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.275 0.559 . . . . 0.0 111.205 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.4 18.17 78.29 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.926 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.463 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 99.2 mttt -122.59 124.19 42.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.077 0.438 . . . . 0.0 110.698 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.5 140.57 44.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.298 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -126.86 134.45 50.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.915 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -73.2 -48.9 31.27 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -173.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' B' ' 212' ' ' THR . 61.6 m-85 55.03 98.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.657 0.383 . . . . 0.0 112.012 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.6 90.94 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 91.2 mt 67.71 98.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.167 0.587 . . . . 0.0 111.85 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . 0.426 ' HA ' ' HG2' ' B' ' 210' ' ' GLU . 28.6 t-20 -86.26 -51.0 6.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 33.4 tp 53.07 90.55 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.052 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 27.3 mttp -74.79 -78.37 0.1 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . 0.452 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 52.2 mtmt -75.46 -81.03 0.08 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.381 1.622 . . . . 0.0 115.381 -170.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.529 HG12 ' H ' ' B' ' 242' ' ' GLU . 67.7 t 75.22 139.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -174.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.645 ' O ' ' HG2' ' B' ' 242' ' ' GLU . 86.3 mt-10 -68.73 -27.82 66.27 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.082 -0.386 . . . . 0.0 111.312 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.645 ' HG2' ' O ' ' B' ' 241' ' ' GLU . 2.7 pt-20 64.51 132.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.552 1.541 . . . . 0.0 113.933 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.597 ' HD3' ' OD2' ' B' ' 162' ' ' ASP . 0.0 OUTLIER -154.35 144.1 21.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.358 178.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -159.54 153.89 23.87 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 tt 72.18 123.75 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.068 0.547 . . . . 0.0 111.352 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -84.21 115.91 2.01 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.546 2.164 . . . . 0.0 113.484 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -135.67 167.47 21.06 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.35 110.57 21.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 10.7 p -103.56 -83.55 0.48 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.92 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.4 ' O ' HG23 ' B' ' 253' ' ' ILE . . . -177.69 -53.62 0.01 OUTLIER 'General case' 0 C--N 1.343 0.319 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.65 -47.14 86.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -61.6 -26.98 68.32 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -173.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . 0.4 HG23 ' O ' ' B' ' 250' ' ' ALA . 18.9 tt -91.13 -5.89 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -127.91 6.88 6.08 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.032 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . 0.407 ' HE ' ' CD ' ' B' ' 161' ' ' GLU . 60.0 ttp180 -131.24 134.82 46.81 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.538 0.209 . . . . 0.0 110.545 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -172.87 34.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.92 -32.28 7.7 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 42.0 t -80.65 150.84 4.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.38 -51.87 65.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.375 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -175.43 163.81 3.05 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.257 173.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -172.77 177.53 45.25 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.377 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.9 p -82.12 175.8 10.03 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.33 0.252 . . . . 0.0 111.096 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.24 -49.13 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.396 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.41 -32.22 21.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.588 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.12 -43.01 99.73 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.984 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.43 ' O ' HG23 ' B' ' 270' ' ' VAL . 63.5 tp -62.86 -43.79 97.87 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.622 0.249 . . . . 0.0 110.445 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -64.25 -41.96 96.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.882 0.372 . . . . 0.0 110.367 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -66.62 -44.95 80.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.309 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 37.2 tp10 -66.3 -39.39 89.3 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.094 0.473 . . . . 0.0 110.57 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 266' ' ' LEU . 70.7 t -65.01 -42.85 95.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.089 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -59.71 -46.54 88.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.8 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 18.3 ptmt -66.09 -42.5 89.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.843 0.354 . . . . 0.0 111.007 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -66.0 -37.16 85.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.016 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.2 mmm -63.97 -43.24 96.36 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 110.496 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -70.98 -29.52 65.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.112 0.482 . . . . 0.0 110.08 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -61.86 -43.69 98.34 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -65.1 -32.33 73.97 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.823 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 57.5 tp -60.96 -39.48 89.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.017 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -58.19 -47.79 82.33 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 17.3 m -62.59 -44.04 97.3 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.866 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.26 69.21 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.795 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.22 -45.72 92.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.607 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . 0.479 HH12 ' HG3' ' B' ' 409' ' ' GLU . 8.1 tpt180 -61.7 -45.64 93.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.898 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -64.87 -39.94 94.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.46 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -59.04 -44.42 91.76 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.046 0.45 . . . . 0.0 110.382 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.13 -42.81 79.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.537 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . 0.418 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.8 tttt -59.67 -48.13 82.88 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.081 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.7 p -62.23 -41.91 98.83 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.769 0.319 . . . . 0.0 111.542 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -65.06 -41.88 94.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.813 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' B' ' 294' ' ' LEU . . . -65.61 -42.57 91.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.998 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . 0.418 HG12 ' O ' ' B' ' 287' ' ' LYS . 32.2 mm -63.8 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.573 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . 0.418 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 27.8 tp10 -59.8 -43.78 94.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.235 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.8 -40.33 97.27 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.276 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 290' ' ' ALA . 95.5 mt -62.85 -42.63 99.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.682 0.277 . . . . 0.0 110.926 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . 0.401 HG22 ' O ' ' B' ' 291' ' ' ILE . 91.4 t -65.61 -43.59 93.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.049 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . 0.418 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 68.4 mttm -63.49 -41.94 98.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.127 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.62 -41.89 78.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.055 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -126.92 94.66 4.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -93.73 106.52 18.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . 0.437 HG13 ' N ' ' B' ' 301' ' ' ASP . 11.4 tp -122.07 166.18 17.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.005 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . 0.437 ' N ' HG13 ' B' ' 300' ' ' ILE . 33.0 m-20 -61.3 135.51 57.74 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.578 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.09 122.06 30.78 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.745 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.36 131.21 43.38 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.64 2.227 . . . . 0.0 111.939 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.05 -36.43 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.975 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.02 -43.11 91.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.298 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.06 -40.54 90.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.903 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . 0.427 ' O ' HG13 ' B' ' 311' ' ' ILE . 97.0 mt -62.75 -45.99 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.754 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.17 -41.53 98.41 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.19 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 46.8 m -62.46 -45.49 92.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.316 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . 0.549 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 62.9 mm-40 -68.25 -37.99 81.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.536 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.514 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.0 mt -62.13 -43.68 98.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.625 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.51 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 17.2 t70 -60.46 -47.14 87.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.792 0.33 . . . . 0.0 111.012 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.46 -44.33 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.536 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 84.7 mt -62.76 -40.38 97.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 85.2 mtm180 -62.18 -42.4 99.24 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 32.5 mtt85 -64.91 -38.47 91.07 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -63.1 -45.16 93.35 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.074 0.464 . . . . 0.0 109.87 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.27 -36.32 79.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.745 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -61.89 -36.18 80.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.123 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -63.13 -39.43 94.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.424 0.63 . . . . 0.0 109.506 175.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -76.25 -9.91 59.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.41 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -91.21 -7.79 50.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.817 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 137.14 -12.12 3.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.809 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 112.53 42.18 0.98 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.005 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . 0.532 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 33.5 t-20 -85.27 127.04 34.17 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.876 0.369 . . . . 0.0 110.356 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . 0.464 ' OE1' ' HG3' ' B' ' 327' ' ' LYS . 2.0 tm-20 -130.2 144.49 51.39 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.464 ' HG3' ' OE1' ' B' ' 326' ' ' GLU . 35.5 mtmm 71.33 -47.92 0.66 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.627 0.771 . . . . 0.0 112.215 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . 0.532 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 14.2 mm100 -65.9 -13.06 58.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.083 0.468 . . . . 0.0 110.707 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.38 -21.81 60.44 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.643 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 57.4 tp -61.84 -33.43 74.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.638 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -79.5 -10.04 59.73 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.591 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 75.5 mt -65.14 147.41 98.57 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.61 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.23 141.18 97.58 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.574 2.183 . . . . 0.0 112.884 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . 0.423 ' HG3' HD11 ' B' ' 311' ' ' ILE . 27.2 ttt85 -85.27 -36.33 20.96 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.511 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -56.74 -46.39 81.39 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -173.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . 0.507 HD13 ' CD ' ' B' ' 224' ' ' GLU . 73.3 mt -91.86 12.08 22.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -117.96 -28.56 5.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.131 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -66.49 -31.7 72.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.714 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.61 -49.53 77.16 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.03 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -75.94 -22.47 55.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.702 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . 0.423 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.42 -41.96 98.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . 0.506 ' O ' HG22 ' B' ' 346' ' ' VAL . 87.3 tttt -60.72 -44.56 96.46 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . 0.568 ' O ' HG21 ' B' ' 347' ' ' VAL . 10.1 mmt85 -59.93 -46.18 90.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.983 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.29 -39.29 85.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.255 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 341' ' ' ALA . 87.8 t -64.78 -43.31 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.436 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.506 HG22 ' O ' ' B' ' 342' ' ' LYS . 73.8 t -60.33 -43.12 93.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.404 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . 0.568 HG21 ' O ' ' B' ' 343' ' ' ARG . 91.1 t -60.02 -45.68 95.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.34 -42.78 99.7 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.204 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.7 -44.27 94.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.43 -45.21 92.0 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.695 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.462 ' O ' HG13 ' B' ' 355' ' ' ILE . 94.4 mt -66.66 -39.62 88.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.915 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.21 -42.53 97.25 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.628 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -64.3 -39.79 94.62 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.978 0.389 . . . . 0.0 110.559 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.3 -46.36 96.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.042 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . 0.462 HG13 ' O ' ' B' ' 351' ' ' LEU . 71.0 mt -63.6 -46.29 95.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.399 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -64.6 -64.73 0.8 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 38.5 m -65.96 -43.24 88.5 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.76 -11.42 60.16 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.168 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 62.38 64.86 0.91 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.718 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.9 mt -98.02 136.97 37.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.203 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.09 150.22 45.29 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.195 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.92 120.02 13.53 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . 0.474 ' O ' HG21 ' B' ' 367' ' ' VAL . 15.5 t70 -90.17 108.34 19.68 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.939 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 66.2 mm-40 -61.68 -34.65 76.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.67 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -66.03 -41.58 90.73 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.49 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . 0.405 HH12 ' CD ' ' B' ' 409' ' ' GLU . 45.9 ttt180 -62.47 -40.79 97.79 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.001 0.429 . . . . 0.0 110.137 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . 0.474 HG21 ' O ' ' B' ' 363' ' ' ASP . 88.4 t -61.28 -39.71 83.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.236 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.2 mmmt -56.64 -44.07 80.9 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.511 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.21 -40.2 98.81 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.2 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.33 -42.88 98.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 110.239 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.64 -43.68 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.797 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -64.04 -41.96 97.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.76 -41.73 91.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.053 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 48.6 ttp -65.43 -39.7 92.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.028 0.442 . . . . 0.0 110.511 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.28 -24.67 67.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.596 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 44.9 m -73.47 -6.34 45.78 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.45 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.02 -2.09 58.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.532 0.682 . . . . 0.0 110.284 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -113.08 172.78 6.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.976 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -65.7 -47.69 74.54 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -121.76 116.24 30.44 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.803 0.335 . . . . 0.0 110.999 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . 0.459 ' O ' HG13 ' B' ' 385' ' ' ILE . 46.5 Cg_exo -58.21 -36.49 97.74 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.909 2.406 . . . . 0.0 113.116 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -64.72 -43.42 93.48 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -174.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.81 -36.81 84.4 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.933 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.44 -42.96 94.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.302 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 381' ' ' PRO . 65.7 mt -62.23 -44.83 99.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.335 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -64.93 -37.87 89.07 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.765 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -58.75 -47.06 85.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.443 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . 0.424 ' O ' ' HG3' ' B' ' 395' ' ' MET . 2.8 m-85 -69.67 -44.78 69.81 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 18.9 p -68.88 -16.26 63.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.19 4.6 48.94 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.746 0.307 . . . . 0.0 111.19 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -129.57 112.04 13.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 110.532 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -64.72 -37.5 87.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.263 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -57.23 -53.38 58.74 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.021 0.439 . . . . 0.0 110.558 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.47 -40.5 95.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.737 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.436 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 89.1 mtp -61.62 -46.18 90.92 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.89 -44.18 64.17 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.415 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -64.13 -42.13 96.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.374 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 52.3 tpp -63.1 -41.17 99.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.838 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' B' ' 395' ' ' MET . 83.0 mtm180 -65.76 -34.8 79.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.917 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.44 -42.33 99.38 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 90.4 t -66.22 -43.77 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.622 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.44 94.99 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.544 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.25 -37.14 86.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.48 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -58.29 -47.21 84.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.855 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 44.0 mt-10 -64.09 -38.14 89.98 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.564 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -61.71 -42.25 98.69 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.209 0.318 . . . . 0.0 110.672 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.53 97.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.047 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.39 -43.14 91.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.572 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . 0.479 ' HG3' HH12 ' B' ' 283' ' ' ARG . 96.6 mt-10 -63.95 -35.84 82.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.17 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.57 94.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.474 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.0 -43.06 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.474 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.21 -39.42 92.72 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.531 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.76 67.55 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.987 0.422 . . . . 0.0 111.311 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -98.08 -7.62 29.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.697 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.37 169.58 9.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.316 0.579 . . . . 0.0 112.261 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -90.78 99.41 12.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.808 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 68.4 t -86.75 131.68 34.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.697 0.284 . . . . 0.0 110.751 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.9 t -124.28 155.3 38.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.941 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -113.41 130.71 56.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.844 0.354 . . . . 0.0 110.749 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -147.48 141.25 25.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.201 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.2 150.9 19.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.335 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.1 t -158.0 174.96 14.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.361 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 17.4 p -85.63 163.67 18.16 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 111.81 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -65.01 -36.42 84.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.449 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -57.38 -38.33 74.08 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.84 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.68 -32.8 74.56 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.858 0.361 . . . . 0.0 111.166 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.25 -12.7 59.04 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.8 mmt -78.28 -8.48 58.43 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.13 0.491 . . . . 0.0 110.785 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -75.71 79.84 2.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.193 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -108.13 26.56 10.26 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.556 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -85.06 -11.79 54.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.853 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.677 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.025 -179.537 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.233 0.209 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.3 m -124.1 116.87 23.48 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.661 0.267 . . . . 0.0 110.881 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -134.93 135.87 52.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 47.8 mt-10 -111.7 175.86 5.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.102 0.477 . . . . 0.0 111.727 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 t -124.27 141.46 52.05 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.674 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.0 m -99.71 -75.91 0.56 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.917 0.389 . . . . 0.0 111.197 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -162.21 148.23 13.14 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.52 -123.02 29.75 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.037 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.547 HD11 HG12 ' A' ' 111' ' ' VAL . 1.2 mm? -100.27 4.54 44.25 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 120.974 0.416 . . . . 0.0 110.072 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -75.26 139.82 25.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.596 -0.729 . . . . 0.0 113.085 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -133.93 151.67 51.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.048 0.539 . . . . 0.0 109.895 -178.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -120.32 130.15 54.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.51 -89.95 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.276 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.5 p 40.17 81.27 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.7 tp -107.85 134.5 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.219 0.533 . . . . 0.0 111.897 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.0 p -94.37 126.51 39.67 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.771 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.494 HG13 HG12 ' A' ' 24' ' ' ILE . 14.2 pt -126.69 161.21 33.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.356 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -70.67 155.07 41.21 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.379 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.5 -39.39 83.66 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.952 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.61 -25.66 65.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.3 t -80.64 -42.2 22.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.428 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 20' ' ' ALA . 75.0 mt -59.16 -69.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.321 -176.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.508 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 77.1 mm-40 -67.37 -6.95 21.27 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.5 m -95.64 -64.19 1.08 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.988 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.21 66.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.5 t -65.01 -43.87 96.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.354 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 22.3 ttmm -61.78 -47.2 86.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.6 m -68.85 -36.59 78.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.811 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -60.93 -39.05 87.97 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.113 0.483 . . . . 0.0 110.652 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.56 -38.44 90.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.819 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.22 -44.02 99.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.171 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.76 -43.64 98.28 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.136 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.38 -35.68 74.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.24 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.24 94.9 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.068 0.461 . . . . 0.0 110.285 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.34 -34.09 77.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.013 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -61.09 -35.92 78.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.955 0.407 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 t -90.61 -5.85 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.412 0.625 . . . . 0.0 109.77 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 64.96 27.5 12.68 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.329 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.402 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.7 pp -103.67 7.98 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.069 0.461 . . . . 0.0 111.457 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.62 -34.81 79.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.514 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.02 -4.54 86.15 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.816 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -89.17 -8.2 54.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.792 0.329 . . . . 0.0 111.463 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -92.38 95.79 9.88 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.82 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -78.29 109.35 12.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.57 96.77 1.62 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 115.734 1.054 . . . . 0.0 115.734 -169.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -66.52 -43.24 85.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.457 HG12 ' HB ' ' A' ' 54' ' ' VAL . 11.6 t -104.79 115.12 63.11 Favored Pre-proline 0 N--CA 1.44 -0.929 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.265 176.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.12 139.95 86.25 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.188 1.926 . . . . 0.0 111.124 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.586 ' HA ' HG12 ' A' ' 54' ' ' VAL . 22.7 ttt -61.39 -40.08 93.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.507 -173.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -60.81 -47.77 84.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.047 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.497 HD13 HH22 ' B' ' 193' ' ' ARG . 74.9 mt -69.42 -44.97 79.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 51' ' ' MET . 14.6 p -64.11 -44.35 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.7 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.416 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -66.73 -24.06 66.18 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.381 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -85.61 -36.92 20.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.127 0.489 . . . . 0.0 110.3 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -76.54 -49.27 16.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.499 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -105.21 9.58 34.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.883 0.373 . . . . 0.0 110.483 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.628 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -59.18 -47.51 90.46 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.9 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.0 -25.49 65.43 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -61.84 -44.99 95.73 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.813 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 65' ' ' ASP . 10.7 p -126.98 24.89 2.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.564 0.697 . . . . 0.0 110.703 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.628 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 21.1 ttm180 -58.8 -33.19 70.07 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.506 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -60.49 -50.02 75.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.535 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.521 ' HB2' HG22 ' A' ' 62' ' ' VAL . 1.7 m-20 -75.24 -21.61 58.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.04 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 62' ' ' VAL . 66.7 t -63.58 -43.77 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 173.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.62 -39.01 92.43 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.107 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.97 -42.61 99.81 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.238 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.71 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 32.0 t70 -63.01 -43.91 97.43 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.197 0.498 . . . . 0.0 110.006 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.7 -41.3 97.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.299 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 49.5 ttp -60.69 -43.22 98.01 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -62.55 -44.05 97.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.284 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.71 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 32.7 mtp85 -66.08 -41.5 90.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.932 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -66.07 -41.09 91.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.388 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -60.4 -48.08 83.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.678 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.0 tt -67.41 -39.7 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.201 0.524 . . . . 0.0 111.347 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.11 -40.85 91.03 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.388 0.613 . . . . 0.0 110.185 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.68 87.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.633 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.3 pt -64.21 -39.27 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.913 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.97 -44.09 99.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 120.638 0.256 . . . . 0.0 111.275 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -29.32 60.96 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -86.54 -2.57 58.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 66.22 34.55 6.54 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.242 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.1 mt -96.06 113.43 30.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -110.48 100.84 46.65 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.908 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.14 136.34 9.01 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.076 1.85 . . . . 0.0 111.347 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.93 132.98 36.57 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.62 -125.09 7.4 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.055 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.22 130.07 18.13 Favored Pre-proline 0 C--N 1.313 -1.018 0 O-C-N 122.834 -0.215 . . . . 0.0 110.455 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.88 150.07 60.77 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.132 1.888 . . . . 0.0 110.828 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 m -94.96 116.81 29.16 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.108 0.48 . . . . 0.0 110.021 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.564 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 95.9 m-85 -91.82 114.24 26.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.94 99.56 23.27 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.138 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 58.5 Cg_endo -95.52 161.8 1.52 Allowed 'Trans proline' 0 N--CA 1.437 -1.826 0 C-N-CA 123.461 2.774 . . . . 0.0 111.65 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.82 -174.86 33.61 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.176 -1.011 . . . . 0.0 110.874 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.72 133.47 38.31 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -89.24 125.4 35.07 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.938 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -102.48 131.31 49.25 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.4 tp -81.48 102.42 10.55 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.14 -27.54 5.32 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.243 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -103.0 177.02 4.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.677 0.275 . . . . 0.0 110.707 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -81.61 168.17 18.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -125.28 139.99 53.22 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.095 0.474 . . . . 0.0 111.313 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.0 m -120.01 134.4 55.26 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.158 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -140.51 167.16 22.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.572 0.225 . . . . 0.0 111.582 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -87.05 -91.01 0.11 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.406 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 67.2 t 64.92 100.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.358 0.599 . . . . 0.0 110.564 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -99.65 146.09 26.87 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.588 -175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.409 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 10.6 p90 -159.39 -87.39 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -90.12 156.64 18.21 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.547 HG12 HD11 ' A' ' 11' ' ' LEU . 28.8 m -125.82 161.56 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.846 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -166.14 102.44 0.7 Allowed Pre-proline 0 N--CA 1.479 0.99 0 CA-C-O 120.577 0.227 . . . . 0.0 111.272 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -94.39 158.49 2.02 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 C-N-CA 123.39 2.727 . . . . 0.0 114.373 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -143.29 139.64 30.24 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.735 0.814 . . . . 0.0 109.888 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 116' ' ' GLU . 20.6 t -133.9 160.89 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 120.897 0.379 . . . . 0.0 111.78 -176.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 115' ' ' VAL . 43.5 mt-10 -140.66 153.03 45.84 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.842 0.857 . . . . 0.0 109.209 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.8 mt -112.47 130.58 55.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -141.85 154.4 45.13 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.133 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.54 22.91 74.46 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.903 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.49 -39.94 95.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.916 0.389 . . . . 0.0 111.199 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -70.24 -10.78 59.92 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.87 1.48 55.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.147 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.57 109.01 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.124 0.488 . . . . 0.0 109.957 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -104.37 119.64 39.41 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.062 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.83 127.07 59.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.883 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.7 119.04 32.19 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.571 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.556 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 78.6 tttt -111.62 106.29 56.77 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.43 128.61 12.1 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.962 1.775 . . . . 0.0 111.639 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.38 114.67 39.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.17 161.58 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -150.73 166.19 31.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.553 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.3 127.44 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.722 0.296 . . . . 0.0 110.25 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.0 p -108.15 176.41 5.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.394 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.86 -38.94 87.3 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.019 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.67 80.2 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.7 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -64.94 -43.38 92.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.327 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.49 -47.24 92.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.955 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.04 -42.61 99.36 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.003 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.26 -42.58 99.26 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.611 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.534 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -61.83 -44.92 95.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.695 0.284 . . . . 0.0 110.59 178.329 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.43 -42.44 98.69 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.272 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.87 -43.84 98.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.82 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.9 m -63.0 -41.2 99.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.553 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.6 mt -60.82 -42.23 97.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.448 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -66.14 -37.21 85.13 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.05 0.453 . . . . 0.0 110.518 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -68.46 -13.92 62.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.162 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -89.62 -6.92 55.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.432 0.634 . . . . 0.0 110.151 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -89.59 93.47 9.5 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.726 0.774 . . . . 0.0 111.952 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.81 126.17 10.07 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 247' ' ' GLU . 23.6 p -100.43 -163.76 1.05 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.505 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 4.4 p-90 -70.17 119.68 14.72 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 151' ' ' TRP . 26.5 mttp -174.52 168.34 3.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.691 1.197 . . . . 0.0 109.132 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -114.92 164.21 14.46 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -172.586 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 153' ' ' GLU . 9.9 pttp 71.28 -179.42 0.23 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.861 1.665 . . . . 0.0 113.807 175.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 13.0 t70 72.92 -90.32 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 124.966 1.306 . . . . 0.0 111.055 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 142.76 102.48 0.44 Allowed Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.954 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -132.75 64.51 1.61 Allowed 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.58 127.05 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.122 -176.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.666 ' HB3' ' HB2' ' A' ' 162' ' ' ASP . 9.2 tp10 -95.63 154.11 17.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.75 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.89 13.8 6.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 189' ' ' MET . 37.8 tt0 -155.47 26.08 0.4 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.585 0.707 . . . . 0.0 110.511 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.666 ' HB2' ' HB3' ' A' ' 159' ' ' GLU . 2.9 t70 -109.39 -170.2 1.61 Allowed 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.781 -0.575 . . . . 0.0 111.036 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -103.55 118.71 37.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.4 t -114.72 121.66 67.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.002 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.4 m -83.4 109.66 17.5 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.9 mt -115.08 128.46 72.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.106 0.479 . . . . 0.0 112.141 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.484 ' OD2' ' HB3' ' A' ' 236' ' ' ASN . 5.0 p-10 -103.03 113.33 26.72 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 172.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -142.46 162.57 35.13 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.228 0.537 . . . . 0.0 112.216 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.1 m -133.6 134.09 42.84 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.219 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.31 103.56 1.84 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.209 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 29.0 m -128.1 121.31 29.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 46.1 t -94.13 -87.13 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.833 0.349 . . . . 0.0 111.147 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -94.38 42.08 1.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.207 0.527 . . . . 0.0 109.822 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 81.33 12.45 82.09 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -123.99 139.28 54.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -92.09 137.42 32.38 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.372 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -107.26 -176.88 3.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.655 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.38 -39.74 88.38 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.402 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.21 -175.52 39.15 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.964 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 84.63 16.68 65.47 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.138 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -105.74 97.87 7.64 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.02 145.8 32.44 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.844 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 38.3 m -136.1 145.29 45.75 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.803 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 54.41 31.15 14.03 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.801 0.688 . . . . 0.0 110.543 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -85.98 127.31 34.61 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.3 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.5 115.03 39.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.49 0.662 . . . . 0.0 110.336 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 56.7 tp -103.33 126.22 50.37 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.98 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -90.65 111.88 23.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.56 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.2 mtp -81.24 150.68 28.48 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.95 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.38 -14.62 64.25 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.595 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -95.13 0.49 54.28 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.802 0.334 . . . . 0.0 111.207 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.97 55.98 6.8 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.421 HH22 HD13 ' B' ' 53' ' ' ILE . 19.3 mmt85 -100.01 -5.96 27.26 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.197 0.522 . . . . 0.0 110.55 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.5 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -135.5 178.13 7.28 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.076 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.7 mm -68.38 133.87 91.12 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.37 134.55 45.31 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.095 1.864 . . . . 0.0 111.499 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.77 -42.87 1.79 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.958 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -67.45 -52.92 33.62 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -74.2 -17.21 60.93 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.847 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.51 -30.0 22.29 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.891 0.377 . . . . 0.0 110.512 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.7 -19.05 76.31 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.008 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.4 mt -62.39 -38.07 80.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-O 120.883 0.373 . . . . 0.0 110.407 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -51.51 131.26 29.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.7 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.42 -10.66 63.23 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.353 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -95.26 159.23 15.11 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -103.21 156.41 17.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.104 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.57 134.69 51.69 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.941 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 78.86 34.56 33.91 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.637 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -124.68 130.17 51.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.879 0.371 . . . . 0.0 111.06 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' A' ' 236' ' ' ASN . 79.0 mt-10 -102.42 118.17 36.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.529 ' O ' ' HB ' ' A' ' 212' ' ' THR . 44.3 t80 -135.24 -36.84 0.79 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 99.6 m 77.65 143.94 0.08 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.339 0.256 . . . . 0.0 110.423 -176.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.2 tp -130.11 144.61 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.934 0.397 . . . . 0.0 110.909 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.79 104.68 16.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.092 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 65.7 t -119.31 128.5 75.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.5 m -98.42 -16.84 19.1 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -175.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 66.62 154.43 0.13 Allowed Pre-proline 0 N--CA 1.487 1.381 0 CA-C-O 121.117 0.484 . . . . 0.0 111.615 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.33 150.87 53.43 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.154 1.903 . . . . 0.0 111.532 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -65.82 -38.44 88.92 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.18 77.1 7.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.602 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -120.06 140.61 50.76 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -61.06 -29.86 69.98 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.76 108.1 20.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.2 tt0 -63.42 -33.59 75.88 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.427 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 30.8 p-10 -63.97 -25.16 68.01 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.737 0.303 . . . . 0.0 110.995 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 90.4 mt -109.8 -3.39 16.72 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.6 ptmt -67.85 119.12 12.02 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.951 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.8 21.91 71.56 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.94 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 225' ' ' ASN . 35.0 mmtp -100.93 135.52 42.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -86.26 110.38 19.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.004 0.43 . . . . 0.0 110.85 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -99.36 149.54 23.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.082 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -105.21 -47.17 4.04 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -175.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 58.59 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.02 0.438 . . . . 0.0 111.041 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.55 -49.2 77.15 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.0 mm 62.8 93.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 123.493 0.496 . . . . 0.0 110.842 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.484 ' HB3' ' OD2' ' A' ' 167' ' ' ASP . 9.6 t-20 -82.99 -47.29 11.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.55 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 12.6 tp 57.46 86.8 0.07 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.151 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.25 -58.06 2.67 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -101.49 -78.97 0.52 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 24.9 t 70.43 142.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 123.482 0.489 . . . . 0.0 110.512 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -75.1 -46.79 32.26 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.277 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 64.75 163.24 0.14 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -162.0 94.18 0.91 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 10.1 tp10 -123.37 157.14 33.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.379 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.1 tt 72.72 118.5 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.456 0.703 . . . . 0.0 110.932 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -87.03 115.74 1.2 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.879 2.386 . . . . 0.0 113.82 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.421 ' HG2' ' OG1' ' A' ' 150' ' ' THR . 12.5 pt-20 -130.28 -161.54 1.13 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 8.0 mp -87.02 102.91 14.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.299 0.571 . . . . 0.0 111.892 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 251' ' ' GLU . 37.9 m -134.39 132.43 39.41 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -90.15 7.28 38.75 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLU . . . . . 0.494 ' H ' HG22 ' A' ' 249' ' ' THR . 45.9 mt-10 -88.15 -15.22 36.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -73.3 -7.31 51.01 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.293 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 261' ' ' GLY . 41.8 pt -105.13 -4.3 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.629 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -136.96 11.52 3.1 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -129.92 8.25 5.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.062 0.458 . . . . 0.0 109.939 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -124.43 137.0 54.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.742 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 67.79 -129.9 27.65 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 116.13 -0.486 . . . . 0.0 114.041 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.4 t -116.98 131.69 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 122.693 0.397 . . . . 0.0 110.932 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.628 ' HG2' ' H ' ' A' ' 260' ' ' ASP . 22.1 tt0 58.28 -155.01 0.35 Allowed 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.795 0.684 . . . . 0.0 109.222 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ASP . . . . . 0.628 ' H ' ' HG2' ' A' ' 259' ' ' GLU . 1.7 p-10 -128.89 136.93 51.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 253' ' ' ILE . . . -131.82 171.74 21.2 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.238 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.0 p -82.85 177.44 8.65 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.076 0.55 . . . . 0.0 110.44 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 94.9 t -60.7 -48.24 89.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.116 0.484 . . . . 0.0 110.791 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.2 pm0 -81.4 -33.5 32.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.766 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.1 -40.3 99.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.374 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 270' ' ' VAL . 54.2 tp -62.16 -45.3 94.05 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -62.89 -44.96 94.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.577 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.573 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.27 -47.34 79.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.347 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -66.66 -38.61 87.22 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 266' ' ' LEU . 67.1 t -65.13 -42.7 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.232 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -57.94 -48.1 80.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.792 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.7 ptmt -66.33 -42.91 87.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.763 0.316 . . . . 0.0 111.413 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.31 -36.64 83.44 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.6 mmm -62.88 -42.28 99.71 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.207 0.527 . . . . 0.0 109.964 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 278' ' ' LEU . 56.9 mt-10 -69.36 -30.88 68.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.27 177.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 55.0 ttp180 -62.57 -43.42 98.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.609 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -69.93 -28.21 65.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.114 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 275' ' ' GLU . 65.3 tp -61.08 -37.72 83.71 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 60.8 tttm -58.14 -45.84 86.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.73 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -45.06 95.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.432 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.58 -50.67 72.61 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.663 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.8 -45.17 95.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.17 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.604 HH12 ' HG3' ' A' ' 409' ' ' GLU . 2.2 tpt180 -61.44 -46.37 90.39 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.897 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -64.14 -39.85 94.91 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.242 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ARG . . . . . 0.564 HH21 ' CG ' ' A' ' 285' ' ' ARG . 0.0 OUTLIER -60.27 -44.22 95.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.587 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.03 -43.55 85.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.001 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -61.12 -45.79 93.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.39 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 22.6 p -59.73 -43.64 94.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.03 -41.17 91.25 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.856 0.36 . . . . 0.0 111.189 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.55 87.03 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.8 mm -64.65 -44.46 96.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.466 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.534 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 33.1 tp10 -62.58 -40.73 97.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.95 0.405 . . . . 0.0 110.588 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.38 -43.73 97.87 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.495 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.5 -42.87 98.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.68 -46.98 93.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.227 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LYS . . . . . 0.534 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.0 mttm -65.41 -41.57 93.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.898 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.76 -41.2 79.21 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -122.64 98.43 5.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.025 0.441 . . . . 0.0 112.182 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.52 114.7 27.31 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 301' ' ' ASP . 10.7 tp -128.43 161.65 36.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.553 0.216 . . . . 0.0 110.984 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.439 ' N ' HG13 ' A' ' 300' ' ' ILE . 25.4 m-20 -65.26 140.54 58.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.846 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.7 t -115.04 123.6 31.57 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.283 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.53 124.21 14.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.211 1.941 . . . . 0.0 111.535 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.89 85.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.46 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.07 -42.34 76.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.268 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.24 -41.26 85.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.552 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.14 -46.2 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.855 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.46 -43.49 88.88 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.635 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.478 ' O ' HG23 ' A' ' 313' ' ' VAL . 49.9 m -60.89 -45.92 92.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.201 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.574 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 60.2 mm-40 -69.05 -37.44 78.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.409 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 95.8 mt -62.29 -44.14 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.115 0.483 . . . . 0.0 109.975 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.41 -39.3 93.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.647 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 309' ' ' SER . 86.2 t -65.52 -43.09 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.296 176.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 80.4 mt -61.21 -39.01 88.65 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.812 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.475 ' NH1' HD12 ' A' ' 330' ' ' LEU . 65.9 mtm180 -61.41 -37.91 85.16 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.625 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -64.63 -43.05 94.95 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.771 0.319 . . . . 0.0 111.037 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -64.74 -41.81 95.67 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.21 0.528 . . . . 0.0 110.511 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.75 -41.93 78.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.159 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.72 -35.43 80.73 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.999 0.428 . . . . 0.0 110.979 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -56.21 -44.08 79.14 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.759 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.68 -36.63 60.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.931 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -60.1 -45.05 94.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.324 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' GLY . . . . . 0.502 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . -170.61 17.64 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.096 -1.05 . . . . 0.0 112.857 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 70.79 26.65 73.66 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.209 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -97.9 154.03 17.93 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.292 0.568 . . . . 0.0 112.306 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.0 -178.49 5.47 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 70.28 -60.98 0.47 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.124 0.57 . . . . 0.0 111.592 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -69.83 -15.33 63.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.112 0.482 . . . . 0.0 110.856 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.443 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -61.66 -19.48 62.36 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.584 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.475 HD12 ' NH1' ' A' ' 315' ' ' ARG . 45.3 tp -62.19 -34.67 76.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.771 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -77.92 -0.54 27.91 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.961 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.62 144.2 85.83 Favored Pre-proline 0 C--O 1.238 0.454 0 O-C-N 122.142 -0.349 . . . . 0.0 110.715 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.431 ' HB2' HD13 ' A' ' 336' ' ' LEU . 48.1 Cg_exo -56.65 132.43 51.7 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.777 2.318 . . . . 0.0 113.114 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -67.24 -44.46 79.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.521 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.8 pm0 -64.6 -31.55 72.82 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 333' ' ' PRO . 10.9 mp -65.62 -28.62 69.25 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.584 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -107.6 -20.62 13.18 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.08 -33.26 75.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.9 -44.77 96.11 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.129 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -80.83 -24.63 38.32 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.259 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.35 -38.4 90.89 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.329 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.3 tttt -57.92 -44.92 87.15 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.733 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 347' ' ' VAL . 9.1 mmt180 -62.28 -44.21 97.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.947 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -65.51 -39.99 92.47 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.097 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.8 t -63.29 -45.96 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.101 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 342' ' ' LYS . 98.5 t -63.74 -43.64 98.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 343' ' ' ARG . 78.0 t -60.43 -45.5 96.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.543 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.6 -42.84 99.83 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.02 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.47 -44.13 95.3 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.638 0.256 . . . . 0.0 111.313 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.97 -45.59 88.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.059 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.56 -39.98 88.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.022 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.48 -40.23 97.42 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.125 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.59 -36.62 83.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 110.648 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.91 -43.57 96.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.26 -44.33 99.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.894 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -68.2 -48.92 63.93 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.8 m -64.73 -44.61 89.61 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -88.14 -7.69 56.53 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.735 0.303 . . . . 0.0 111.142 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 60.58 60.31 1.98 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.122 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.1 mt -79.29 153.61 29.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.529 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -130.43 154.15 48.03 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.968 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -78.72 105.98 10.39 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 172.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.524 ' O ' HG23 ' A' ' 367' ' ' VAL . 31.7 t70 -82.18 111.5 18.34 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.376 -0.529 . . . . 0.0 112.054 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 5.1 mm-40 -62.73 -34.33 76.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.038 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -63.64 -44.11 94.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -65.48 -38.88 91.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.193 0.521 . . . . 0.0 109.978 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 363' ' ' ASP . 84.2 t -61.64 -36.77 75.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.578 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 27.2 mmmt -54.81 -47.87 73.5 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.633 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.95 -41.26 99.93 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.521 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.94 -42.86 99.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 0.0 110.713 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.58 -43.43 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.253 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.45 -37.77 87.88 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.276 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -65.38 -41.23 93.94 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.546 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.4 ttm -64.82 -42.42 95.0 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.011 0.434 . . . . 0.0 110.548 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.68 -24.4 67.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.756 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 55.0 m -75.19 -5.13 42.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.65 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.52 5.44 49.52 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.903 0.383 . . . . 0.0 111.18 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -116.93 171.75 7.71 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.762 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -60.61 -44.69 96.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.013 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -130.04 114.41 17.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.793 0.33 . . . . 0.0 110.239 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.69 -27.27 27.02 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.499 2.133 . . . . 0.0 113.123 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -65.1 -45.72 84.04 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.8 -36.29 83.09 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.567 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.74 -42.39 94.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.473 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.77 -44.18 98.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 50.2 mt-10 -66.05 -43.21 88.15 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.56 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.34 -47.84 82.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.959 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -65.64 -45.66 82.17 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.433 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 59.1 p -73.17 -16.38 61.44 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 99.3 mttt -91.06 9.08 32.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.115 0.483 . . . . 0.0 111.291 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -131.24 113.36 13.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.489 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.37 -41.69 98.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.72 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -60.69 -45.3 94.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.041 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.1 -42.68 99.63 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.482 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.554 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 94.5 mtp -63.16 -45.47 91.71 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.051 0.453 . . . . 0.0 110.56 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.407 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 15.1 t70 -64.98 -43.98 90.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.268 -177.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -62.83 -41.76 99.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.395 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 49.0 tpp -63.98 -40.3 96.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.775 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 395' ' ' MET . 73.1 mtm180 -63.63 -35.15 79.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.837 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -62.8 -42.9 99.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.098 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.52 -43.57 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -61.4 -39.69 91.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.605 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 40.8 tp -63.79 -38.71 92.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.033 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 408' ' ' VAL . 75.2 tt0 -54.53 -50.9 66.78 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.267 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 35.2 mt-10 -66.78 -36.34 82.19 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.45 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -61.61 -44.83 96.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.833 0.349 . . . . 0.0 110.701 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -62.81 -41.85 99.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.719 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.571 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 89.1 t -65.73 -43.7 93.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.753 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.604 ' HG3' HH12 ' A' ' 283' ' ' ARG . 96.3 mt-10 -63.21 -36.79 84.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.199 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.12 -41.32 99.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.145 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 407' ' ' ALA . 97.7 t -65.38 -42.51 93.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.313 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 68.4 mt -60.3 -42.02 94.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.734 -176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.15 -23.28 67.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.771 0.32 . . . . 0.0 111.432 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -97.98 -3.97 37.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.464 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -109.51 -179.57 3.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.393 0.616 . . . . 0.0 112.399 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.69 102.24 13.95 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.215 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.8 t -94.81 128.45 46.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.373 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -120.34 128.96 53.74 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.556 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 40.1 mt-10 -100.55 118.79 37.43 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.382 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -130.03 134.51 47.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.097 0.475 . . . . 0.0 111.543 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.87 142.23 46.04 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -149.1 170.06 19.26 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.554 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 67.7 p -86.63 164.31 16.89 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.28 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -67.05 -26.11 66.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.982 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -61.88 -38.61 88.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.694 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -67.02 -30.11 70.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.778 0.323 . . . . 0.0 110.838 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.6 mp -80.92 -8.56 59.77 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 111.363 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.0 mmt -81.2 -7.3 59.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.133 0.492 . . . . 0.0 110.529 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -78.19 71.79 4.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.543 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -121.71 28.86 7.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.609 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -66.62 -38.35 86.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.52 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.765 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.465 -179.494 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.661 0.267 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -100.03 105.04 16.66 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.88 162.44 38.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.857 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 47.2 m -124.91 119.3 28.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.887 0.375 . . . . 0.0 111.23 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -136.73 137.08 47.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 49.8 mt-10 -114.3 176.35 5.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.01 0.433 . . . . 0.0 111.125 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' B' ' 13' ' ' ARG . 9.7 t -124.21 148.8 47.03 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.46 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 24.1 m -107.46 -82.12 0.55 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.868 0.366 . . . . 0.0 110.949 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -155.74 146.77 22.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.25 -123.65 28.2 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.141 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.531 HD11 HG12 ' B' ' 111' ' ' VAL . 1.2 mm? -100.08 5.84 44.96 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' B' ' 107' ' ' VAL . . . -73.48 142.6 31.52 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.376 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 0.3 OUTLIER -137.14 149.94 47.64 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.079 0.551 . . . . 0.0 109.938 -178.65 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -116.74 128.9 55.75 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.44 -92.31 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.039 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.1 p 40.75 81.66 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.031 0.532 . . . . 0.0 112.294 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 8.4 tp -108.0 136.84 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.05 0.452 . . . . 0.0 111.725 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 9.2 p -96.13 130.5 43.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.122 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.421 HG13 HG12 ' B' ' 24' ' ' ILE . 14.6 pt -131.43 162.45 39.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.501 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.539 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -74.28 157.53 35.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.304 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.61 80.4 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -65.91 -37.95 87.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.69 0.281 . . . . 0.0 110.662 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t -65.71 -43.62 88.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.933 0.397 . . . . 0.0 110.671 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.539 HG13 ' O ' ' B' ' 20' ' ' ALA . 77.0 mt -58.42 -69.04 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.26 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.523 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 76.7 mm-40 -68.53 -7.94 36.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -172.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 45.9 m -96.13 -63.98 1.1 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.946 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.2 -45.43 73.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.03 -43.42 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.925 0.393 . . . . 0.0 110.935 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.523 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.6 ttmm -61.97 -46.9 87.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.928 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.4 m -69.73 -36.39 75.83 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.468 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.85 -38.35 90.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.941 0.4 . . . . 0.0 110.725 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.33 -38.68 90.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.88 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.76 -43.46 97.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.108 0.48 . . . . 0.0 109.905 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -63.14 -42.73 99.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.49 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.07 -33.98 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.309 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.83 96.13 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.18 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' B' ' 40' ' ' ARG . 98.5 mttt -65.63 -34.25 77.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.97 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.56 -37.18 82.86 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.779 0.323 . . . . 0.0 111.001 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 t -87.97 -8.42 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.243 0.544 . . . . 0.0 109.835 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' B' ' 37' ' ' LYS . 35.1 mmt180 66.26 31.44 8.54 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.216 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.81 6.34 9.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.399 . . . . 0.0 111.51 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.23 -35.22 80.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.512 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.64 -3.52 79.07 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.942 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -91.15 -8.67 48.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.701 0.251 . . . . 0.0 111.646 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -91.81 93.25 8.76 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.742 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -76.82 106.45 8.5 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.23 99.36 2.1 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 -169.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.99 -45.89 79.98 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' B' ' 54' ' ' VAL . 15.1 t -100.27 115.22 65.68 Favored Pre-proline 0 C--O 1.249 1.044 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.311 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.0 139.76 85.26 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.428 2.085 . . . . 0.0 111.143 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.549 ' HA ' HG12 ' B' ' 54' ' ' VAL . 23.5 ttt -63.28 -38.57 91.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.596 -174.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' B' ' 29' ' ' LYS . 31.3 p-10 -64.28 -32.02 73.45 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.331 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.421 HD13 HH22 ' A' ' 193' ' ' ARG . 92.5 mt -87.51 -45.05 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.822 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' B' ' 51' ' ' MET . 12.0 p -62.55 -42.2 94.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.711 0.291 . . . . 0.0 111.382 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.87 -14.67 62.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.8 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -97.09 -41.28 8.43 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.164 0.507 . . . . 0.0 109.686 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.441 ' NH1' ' SD ' ' A' ' 194' ' ' MET . 67.9 ttt180 -70.87 -44.91 65.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.166 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -110.0 10.83 24.15 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 120.924 0.392 . . . . 0.0 110.09 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.646 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -58.75 -45.69 94.49 Favored Glycine 0 C--O 1.215 -1.054 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.147 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.06 -24.86 60.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 37.4 t -61.64 -44.17 97.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 111.511 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.51 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.1 p -123.25 21.85 4.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.312 0.577 . . . . 0.0 110.75 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.646 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 23.5 ttm180 -59.09 -33.21 70.56 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.728 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -61.18 -49.65 76.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.972 0.415 . . . . 0.0 110.515 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ASP . . . . . 0.429 ' HB2' HG22 ' B' ' 62' ' ' VAL . 1.0 OUTLIER -74.5 -22.77 58.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.538 -179.591 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.51 HG23 ' O ' ' B' ' 62' ' ' VAL . 53.8 t -63.89 -43.88 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 99.4 mt -62.77 -39.21 93.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.018 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.04 -42.7 99.88 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.202 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ASP . . . . . 0.727 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 33.8 t70 -63.66 -44.01 95.06 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.972 0.386 . . . . 0.0 109.989 177.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.35 -41.34 96.91 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.063 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 49.9 ttp -60.91 -41.88 96.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.502 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -62.97 -44.37 96.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.925 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.727 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 32.8 mtp85 -66.68 -40.95 88.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.928 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -65.31 -41.33 94.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.192 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.56 -48.86 79.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.798 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 18.7 tt -68.0 -40.15 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.873 0.368 . . . . 0.0 111.705 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -65.69 -39.79 91.64 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.284 0.564 . . . . 0.0 110.134 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.14 -47.02 75.43 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.662 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 45.5 pt -62.45 -36.75 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.05 -43.97 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 120.686 0.279 . . . . 0.0 111.139 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.52 -28.03 46.11 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.617 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.88 -4.43 58.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.655 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 62.85 42.45 7.8 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.933 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.3 mt -105.05 118.31 52.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -112.46 109.94 53.3 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.404 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -88.44 124.23 1.64 Allowed 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 122.544 2.163 . . . . 0.0 111.274 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.65 117.76 29.56 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.977 0.418 . . . . 0.0 110.505 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.7 -130.18 10.15 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.67 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.45 123.79 17.74 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-O 120.433 0.158 . . . . 0.0 110.625 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.31 131.46 19.11 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.797 1.664 . . . . 0.0 110.554 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 11.3 m -78.38 111.92 14.87 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.628 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.65 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 96.2 m-85 -83.9 105.19 14.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.14 102.73 11.51 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.47 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.4 Cg_endo -98.61 170.06 0.6 Allowed 'Trans proline' 0 N--CA 1.439 -1.723 0 C-N-CA 123.429 2.753 . . . . 0.0 111.402 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.43 -174.06 26.08 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -79.95 133.36 36.19 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -87.9 128.41 35.36 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.007 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.98 133.76 49.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 tp -86.79 88.61 7.72 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.328 0.585 . . . . 0.0 110.138 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.59 -20.9 3.65 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.174 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -108.54 178.07 4.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.496 0.189 . . . . 0.0 110.719 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -80.53 165.3 22.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.007 0.432 . . . . 0.0 111.185 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -124.1 141.92 51.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.957 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 27.7 m -122.91 135.82 54.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.041 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -142.69 165.51 27.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.366 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.8 m -85.4 -90.9 0.1 Allowed 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.442 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 85.3 t 64.94 99.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.347 0.594 . . . . 0.0 110.672 -175.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -101.11 145.6 28.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.702 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -158.11 -80.34 0.06 Allowed 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.4 ' O ' HD12 ' B' ' 11' ' ' LEU . 59.3 mt-10 -95.97 157.02 16.09 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -173.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.531 HG12 HD11 ' B' ' 11' ' ' LEU . 24.9 m -124.97 163.98 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.925 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -171.24 101.02 0.4 Allowed Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 122.252 0.221 . . . . 0.0 110.961 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -96.37 162.82 1.22 Allowed 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 123.701 2.934 . . . . 0.0 114.306 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -143.19 147.29 34.66 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.738 0.815 . . . . 0.0 110.765 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.8 156.68 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 120.675 0.274 . . . . 0.0 111.072 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.14 153.13 51.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.83 131.89 55.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -144.71 155.07 43.37 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.46 22.89 78.15 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.33 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.05 -42.1 99.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.093 0.473 . . . . 0.0 111.232 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.11 -15.7 63.88 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.201 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.33 0.41 57.26 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.427 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 81.4 mt -79.73 113.82 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.11 0.481 . . . . 0.0 109.791 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -106.42 117.53 34.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.647 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 57.7 t -103.4 126.36 57.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -93.13 119.01 31.88 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.532 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.504 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 77.3 tttt -113.39 105.86 54.85 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.26 130.11 13.75 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.967 1.778 . . . . 0.0 111.9 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -101.46 115.37 43.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.44 161.29 41.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.941 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -150.37 159.57 44.36 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.852 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.67 131.05 35.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.159 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 81.7 p -110.77 175.53 5.39 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.924 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -62.16 -35.75 79.77 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.755 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.06 89.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.601 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.18 -42.17 99.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.716 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -63.86 -46.76 93.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.793 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.78 -44.19 97.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.624 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.88 -41.58 98.7 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.085 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.483 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.0 OUTLIER -62.68 -46.0 90.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.904 0.383 . . . . 0.0 110.683 179.186 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.9 mt -63.61 -40.76 97.74 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.675 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.32 -45.96 91.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.382 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.0 m -63.13 -41.61 99.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.813 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' B' ' 140' ' ' MET . 97.7 mt -60.67 -43.56 97.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.618 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -67.18 -35.97 80.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.874 0.369 . . . . 0.0 110.936 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.19 -21.04 65.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.089 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -85.56 -4.98 59.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 110.544 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -90.27 90.55 8.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.704 0.764 . . . . 0.0 112.216 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.88 132.49 18.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.373 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 150' ' ' THR . . . . . 0.5 ' OG1' ' HG2' ' B' ' 247' ' ' GLU . 20.5 p -103.63 -165.97 1.21 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 151' ' ' TRP . . . . . 0.481 ' O ' ' HG3' ' B' ' 152' ' ' LYS . 6.0 p-90 -68.6 127.94 34.84 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.345 -174.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 152' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' B' ' 151' ' ' TRP . 21.4 mttp -178.36 -167.84 0.14 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.231 1.012 . . . . 0.0 109.896 176.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 153' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' B' ' 154' ' ' LYS . 0.0 OUTLIER -132.59 163.71 28.27 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -172.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 154' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' B' ' 153' ' ' GLU . 11.2 pttp 66.13 -178.61 0.2 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.884 1.674 . . . . 0.0 114.323 174.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 155' ' ' ASP . . . . . 0.4 ' N ' ' HG3' ' B' ' 154' ' ' LYS . 14.8 t70 71.54 -94.48 0.03 OUTLIER 'General case' 0 C--N 1.341 0.235 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.189 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 148.63 97.8 0.19 Allowed Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.551 -1.309 . . . . 0.0 113.463 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -128.21 67.41 1.36 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 23.1 t -72.0 127.67 34.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.428 -176.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 159' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 8.9 tp10 -93.53 153.54 18.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.87 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 160' ' ' ALA . . . . . 0.401 ' O ' ' HA3' ' B' ' 190' ' ' GLY . . . -89.52 23.2 2.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.622 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 161' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' B' ' 189' ' ' MET . 34.1 tt0 -163.28 25.81 0.09 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.406 0.622 . . . . 0.0 110.539 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.597 ' HB2' ' HB3' ' B' ' 159' ' ' GLU . 3.7 t70 -113.08 -172.16 2.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.316 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -99.39 124.67 44.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.6 t -120.14 126.42 75.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.337 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 10.3 m -87.58 109.8 19.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 67.6 mt -114.45 126.59 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.142 0.496 . . . . 0.0 112.264 -174.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 167' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' B' ' 236' ' ' ASN . 3.5 p-10 -101.05 110.2 22.19 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -139.53 160.29 40.21 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.385 0.612 . . . . 0.0 112.11 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.9 m -131.79 136.26 47.4 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.884 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.46 104.86 2.31 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.697 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 33.2 m -130.04 124.67 33.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.63 -89.66 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.003 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -99.62 44.74 1.01 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.197 0.522 . . . . 0.0 110.149 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.91 12.85 67.79 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.297 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -126.8 138.95 53.42 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.39 134.68 34.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.719 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 177' ' ' PHE . . . . . 0.404 ' HD1' ' H ' ' B' ' 179' ' ' GLY . 32.9 p90 -105.34 -178.28 3.61 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.776 0.322 . . . . 0.0 111.82 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.74 -39.92 82.32 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.076 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 179' ' ' GLY . . . . . 0.404 ' H ' ' HD1' ' B' ' 177' ' ' PHE . . . -95.14 -176.17 37.73 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.147 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.49 16.8 67.8 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.073 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.17 94.77 5.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.68 144.46 31.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.68 0.276 . . . . 0.0 110.976 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -135.4 146.74 48.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.085 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 56.46 30.18 16.61 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 123.589 0.556 . . . . 0.0 110.786 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -83.94 126.54 33.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.463 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 17.3 m -98.76 115.47 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.955 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 63.7 tp -106.1 127.8 53.44 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.361 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.29 106.72 18.66 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 189' ' ' MET . . . . . 0.622 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 68.1 mtp -78.95 148.38 32.66 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.758 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' B' ' 160' ' ' ALA . . . 96.3 -15.05 63.55 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.039 175.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -94.97 -1.15 53.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.799 0.333 . . . . 0.0 111.384 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.88 56.71 5.22 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.738 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.497 HH22 HD13 ' A' ' 53' ' ' ILE . 17.8 mmt85 -99.64 -6.31 27.48 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.198 0.523 . . . . 0.0 109.789 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.483 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -136.27 173.02 12.16 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.904 -178.444 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 31.2 mm -62.83 131.32 94.43 Favored Pre-proline 0 N--CA 1.437 -1.12 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.82 125.74 11.78 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.495 2.13 . . . . 0.0 111.956 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.14 -42.7 1.89 Allowed Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.288 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -63.32 -52.22 62.77 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.055 0.427 . . . . 0.0 111.866 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.79 -31.23 66.38 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.854 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.85 -39.56 76.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.888 0.375 . . . . 0.0 111.098 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -62.97 -20.34 62.28 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.688 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.5 -41.74 93.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 120.804 0.335 . . . . 0.0 110.289 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -47.5 128.39 12.39 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.8 0.84 . . . . 0.0 111.671 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.51 -19.44 45.1 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.165 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -87.53 163.68 16.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.867 0.365 . . . . 0.0 111.816 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -105.78 155.12 19.6 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.989 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.18 137.47 57.02 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 208' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' B' ' 237' ' ' LEU . . . 74.41 38.19 45.68 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.504 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -127.64 128.48 45.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.224 0.535 . . . . 0.0 111.783 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -99.23 120.17 39.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.68 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' PHE . . . . . 0.477 ' O ' ' HB ' ' B' ' 212' ' ' THR . 36.0 t80 -139.65 -35.71 0.53 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -176.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' B' ' 211' ' ' PHE . 94.8 m 75.32 142.46 0.07 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.706 0.288 . . . . 0.0 110.799 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -132.56 141.07 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 111.594 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.19 109.47 18.33 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.681 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 64.5 t -121.38 122.3 66.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 216' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 3.4 m -92.01 -21.15 20.67 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -174.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' B' ' 216' ' ' THR . 44.0 m-85 68.05 149.52 0.12 Allowed Pre-proline 0 N--CA 1.482 1.156 0 CA-C-O 120.779 0.323 . . . . 0.0 110.839 -175.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 15.6 Cg_exo -71.15 150.4 59.68 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.311 2.007 . . . . 0.0 111.767 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.43 -37.45 87.56 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.84 76.47 6.33 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.206 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -121.6 141.98 50.56 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -62.93 -29.09 70.52 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.98 110.9 22.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.609 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 43.8 tt0 -65.23 -33.54 76.25 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.728 -176.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' B' ' 229' ' ' LYS . 30.4 p-10 -66.33 -23.37 66.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.118 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.7 mt -110.69 -4.25 15.46 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.9 ptmt -69.05 119.74 13.81 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.875 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.89 34.6 90.32 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.327 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' B' ' 225' ' ' ASN . 34.7 mmtp -114.91 133.87 55.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -84.16 107.72 16.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.901 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.37 148.21 22.69 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.142 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.18 -48.99 3.71 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 58.98 102.52 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.169 0.509 . . . . 0.0 110.892 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.47 89.82 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm 61.54 102.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.175 0.59 . . . . 0.0 112.095 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 236' ' ' ASN . . . . . 0.406 ' HB3' ' OD2' ' B' ' 167' ' ' ASP . 6.4 t-20 -90.17 -51.51 5.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 237' ' ' LEU . . . . . 0.559 ' O ' ' HA2' ' B' ' 208' ' ' GLY . 13.0 tp 61.99 81.66 0.19 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.27 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -82.36 -48.58 10.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -110.18 -79.82 0.58 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t 70.18 142.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.096 0.559 . . . . 0.0 110.839 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -73.76 -47.23 40.6 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.094 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 65.58 162.18 0.14 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -158.69 91.4 1.06 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.254 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' B' ' 152' ' ' LYS . 7.8 tp10 -122.79 153.4 39.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.188 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 9.0 tt 76.24 116.07 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 C-N-CA 124.027 0.931 . . . . 0.0 110.58 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.38 113.12 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.543 2.162 . . . . 0.0 113.653 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 247' ' ' GLU . . . . . 0.5 ' HG2' ' OG1' ' B' ' 150' ' ' THR . 12.6 pt-20 -125.89 -163.57 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.0 mp -89.25 104.42 16.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.342 0.591 . . . . 0.0 111.817 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 34.2 m -132.67 133.64 43.82 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.99 15.4 13.31 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.06 -12.21 25.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -75.16 -2.51 28.07 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.821 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 253' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' B' ' 261' ' ' GLY . 43.5 pt -109.93 -3.63 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.576 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -138.76 10.56 2.66 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -131.64 13.83 4.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.041 0.448 . . . . 0.0 109.97 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -131.42 138.56 49.12 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.361 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 69.5 -129.06 22.13 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.212 -0.518 . . . . 0.0 114.073 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 75.8 t -121.03 130.02 75.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 259' ' ' GLU . . . . . 0.669 ' HG2' ' H ' ' B' ' 260' ' ' ASP . 22.0 tt0 59.5 -166.79 0.17 Allowed 'General case' 0 CA--C 1.552 1.039 0 O-C-N 123.709 0.63 . . . . 0.0 110.091 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 260' ' ' ASP . . . . . 0.669 ' H ' ' HG2' ' B' ' 259' ' ' GLU . 5.1 p-10 -110.24 144.9 38.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 261' ' ' GLY . . . . . 0.515 ' O ' ' HB ' ' B' ' 253' ' ' ILE . . . -146.43 166.19 28.19 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.138 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 12.8 p -80.32 176.89 9.36 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 122.768 0.427 . . . . 0.0 111.205 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.81 -48.0 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.749 0.309 . . . . 0.0 110.942 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' B' ' 264' ' ' GLU . 1.0 OUTLIER -82.11 -33.3 29.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 110.591 178.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.54 -41.35 99.8 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.061 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.442 ' O ' HG23 ' B' ' 270' ' ' VAL . 63.6 tp -61.58 -46.33 90.3 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 120.522 0.201 . . . . 0.0 110.595 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -65.04 -41.72 94.94 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.728 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.616 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.16 -45.92 86.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -67.88 -38.76 83.44 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 266' ' ' LEU . 58.8 t -64.38 -42.11 94.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.35 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 271' ' ' ARG . . . . . 0.405 HH21 ' HD3' ' B' ' 271' ' ' ARG . 9.4 tpt180 -58.04 -48.41 80.17 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.611 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 11.9 ptmt -66.65 -42.61 86.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.741 0.305 . . . . 0.0 111.292 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.6 -38.26 90.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.007 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.8 mmm -63.33 -42.14 98.95 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.994 0.426 . . . . 0.0 109.997 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 275' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' B' ' 278' ' ' LEU . 79.1 mt-10 -70.51 -28.77 65.21 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.738 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -64.41 -42.74 95.91 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -67.59 -27.94 67.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.711 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 278' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' B' ' 275' ' ' GLU . 63.9 tp -61.02 -38.72 87.09 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.37 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -58.21 -46.76 85.27 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.626 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 32.2 m -62.22 -44.76 95.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.895 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.71 72.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.339 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.29 -44.06 97.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.062 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 283' ' ' ARG . . . . . 0.566 HH12 ' HG3' ' B' ' 409' ' ' GLU . 1.7 tpt180 -62.25 -46.16 90.06 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.781 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -64.69 -39.88 94.43 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 285' ' ' ARG . . . . . 0.59 HH21 ' CG ' ' B' ' 285' ' ' ARG . 0.0 OUTLIER -60.85 -43.78 97.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.074 0.464 . . . . 0.0 110.588 179.03 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 76.1 t -67.75 -43.91 86.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.946 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.63 -46.47 90.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.22 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 32.2 p -60.37 -43.47 96.51 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -66.53 -41.14 89.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.363 . . . . 0.0 111.137 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.65 -48.22 78.12 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.46 -44.52 97.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.322 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -62.65 -40.28 96.55 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.61 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.34 -42.75 99.1 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.12 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.33 -42.22 98.96 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.03 -45.34 96.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 123.201 0.313 . . . . 0.0 111.196 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.87 -41.96 95.24 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.379 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -69.77 -43.13 72.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -117.89 100.83 7.83 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -96.65 113.58 25.16 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 300' ' ' ILE . . . . . 0.415 HG13 ' N ' ' B' ' 301' ' ' ASP . 10.6 tp -126.98 160.52 35.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.8 0.333 . . . . 0.0 111.117 -176.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 301' ' ' ASP . . . . . 0.415 ' N ' HG13 ' B' ' 300' ' ' ILE . 14.1 m-20 -65.71 135.95 55.63 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.629 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 16.0 t -112.64 123.07 34.7 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.533 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.66 123.96 14.08 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.141 1.894 . . . . 0.0 111.527 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.81 81.65 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.714 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.62 -45.6 73.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.113 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.79 -41.85 95.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.718 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.67 -45.74 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -43.54 86.71 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.527 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 309' ' ' SER . . . . . 0.459 ' O ' HG23 ' B' ' 313' ' ' VAL . 20.3 m -62.59 -45.39 93.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.205 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 310' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 55.3 mm-40 -66.17 -39.19 89.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.051 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.17 -44.22 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.995 0.426 . . . . 0.0 110.345 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.69 -38.02 89.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.811 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 313' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 309' ' ' SER . 96.9 t -66.6 -42.48 89.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.955 176.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 90.3 mt -61.42 -39.88 92.37 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.03 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.454 ' NH1' HD12 ' B' ' 330' ' ' LEU . 63.5 mtm180 -61.74 -37.68 85.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.316 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 -63.38 -43.89 96.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.795 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.99 -41.49 95.35 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.335 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.87 -42.5 76.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.372 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.2 -37.01 84.56 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 120.862 0.363 . . . . 0.0 111.319 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -55.4 -42.95 74.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.578 0.704 . . . . 0.0 109.539 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -74.41 -38.22 63.15 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.885 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -58.12 -46.87 84.85 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.169 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 323' ' ' GLY . . . . . 0.412 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -168.95 17.56 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.435 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 72.2 25.54 74.3 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.168 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -94.07 151.0 19.83 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -175.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -135.58 -179.7 5.8 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 68.8 -62.85 0.38 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.32 0.648 . . . . 0.0 112.084 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -67.02 -16.61 64.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.99 0.424 . . . . 0.0 111.141 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 329' ' ' ALA . . . . . 0.413 ' O ' ' HD2' ' B' ' 315' ' ' ARG . . . -60.85 -18.74 57.7 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.621 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.454 HD12 ' NH1' ' B' ' 315' ' ' ARG . 45.7 tp -61.88 -37.56 85.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.809 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -74.43 -6.17 46.72 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.976 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.6 140.6 96.54 Favored Pre-proline 0 C--O 1.241 0.606 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.934 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 333' ' ' PRO . . . . . 0.453 ' HB2' HD13 ' B' ' 336' ' ' LEU . 46.4 Cg_exo -55.08 130.62 41.74 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.951 2.434 . . . . 0.0 113.296 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -65.74 -44.01 87.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.074 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.5 pm0 -66.53 -24.48 66.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 336' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' B' ' 333' ' ' PRO . 11.0 mp -76.06 -18.94 59.0 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -116.09 -20.61 9.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -64.43 -32.22 73.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -63.49 -46.7 84.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.537 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -76.9 -26.56 54.3 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.734 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.415 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.77 -38.96 93.05 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.614 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 342' ' ' LYS . . . . . 0.428 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.8 tttt -57.76 -44.87 86.42 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.939 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 343' ' ' ARG . . . . . 0.504 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.2 mmt85 -61.64 -44.1 97.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.783 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -65.63 -39.45 91.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.597 0.237 . . . . 0.0 111.242 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 341' ' ' ALA . 77.6 t -63.58 -45.72 96.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.148 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 342' ' ' LYS . 96.9 t -63.37 -44.25 98.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 343' ' ' ARG . 78.6 t -60.54 -45.26 97.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.445 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.11 -43.08 99.87 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.368 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.09 -44.11 93.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.664 0.269 . . . . 0.0 111.359 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.85 -44.84 91.97 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.757 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.04 -39.25 89.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.05 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.53 97.83 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.015 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.29 -35.25 79.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.967 0.383 . . . . 0.0 110.851 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.18 -44.59 95.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.1 -44.13 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.704 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -68.73 -47.28 66.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 26.4 m -65.51 -45.42 83.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -88.47 -9.4 52.61 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.916 0.389 . . . . 0.0 111.069 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 60.94 61.51 1.62 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.077 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.1 mt -78.76 156.54 28.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.304 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -131.25 158.86 39.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.672 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -81.28 108.2 14.7 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 172.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 363' ' ' ASP . . . . . 0.52 ' O ' HG23 ' B' ' 367' ' ' VAL . 18.0 t70 -81.72 107.57 14.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.327 0.584 . . . . 0.0 111.825 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 364' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 5.6 mm-40 -61.39 -35.25 76.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.846 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.17 -43.28 92.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.967 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -64.27 -39.37 93.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.302 0.572 . . . . 0.0 109.836 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 367' ' ' VAL . . . . . 0.531 HG21 ' HG2' ' B' ' 399' ' ' ARG . 94.6 t -61.81 -39.54 83.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.633 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 368' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 24.9 mmmt -55.89 -46.53 78.31 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.035 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.59 -42.26 99.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.333 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 98.5 mt -63.09 -42.13 99.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.854 0.359 . . . . 0.0 110.705 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 92.1 mt -63.92 -43.09 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.286 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.27 -40.94 97.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.94 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.89 -40.02 94.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.798 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 59.9 ttm -66.65 -41.46 88.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.074 0.464 . . . . 0.0 110.796 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.75 -25.1 68.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.861 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 47.9 m -75.74 3.32 10.05 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.987 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -103.02 11.24 37.54 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.324 0.583 . . . . 0.0 110.827 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -118.18 170.8 8.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.118 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.2 -35.02 79.43 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.543 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -138.22 111.8 8.59 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.024 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.91 -30.77 32.52 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.352 2.035 . . . . 0.0 113.223 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.78 -44.27 90.54 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -65.64 -36.02 82.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.747 0.308 . . . . 0.0 110.383 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.13 -41.47 91.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.606 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.6 mt -61.43 -44.25 98.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.802 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 52.9 mt-10 -66.54 -42.32 87.36 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.559 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -58.05 -46.91 84.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.958 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -67.97 -44.07 77.52 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.656 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 41.7 p -73.75 -17.69 61.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 390' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.5 mttt -89.06 1.66 55.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.901 0.381 . . . . 0.0 111.253 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -123.11 112.61 17.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.719 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.71 -41.89 98.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.507 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -61.91 -45.18 94.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 5.8 mp -62.65 -43.06 99.77 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.675 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.539 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.8 mtp -63.2 -46.82 85.27 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.032 0.444 . . . . 0.0 110.963 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 396' ' ' ASP . . . . . 0.504 ' HA ' ' HE ' ' B' ' 399' ' ' ARG . 19.5 t70 -65.01 -43.95 90.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.784 -176.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -63.55 -40.34 96.76 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.742 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 47.4 tpp -62.78 -39.83 95.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 395' ' ' MET . 80.8 mtm180 -64.13 -35.51 81.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.695 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.11 -43.31 99.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 98.0 t -66.53 -44.04 90.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.586 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.73 95.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.943 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 47.5 tp -62.82 -38.33 90.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.03 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 404' ' ' GLU . . . . . 0.503 ' O ' HG23 ' B' ' 408' ' ' VAL . 43.8 tt0 -54.47 -51.39 65.16 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.07 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.89 -37.98 87.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.453 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -60.4 -43.54 96.58 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.576 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.442 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -64.23 -42.56 96.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.634 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 408' ' ' VAL . . . . . 0.58 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 93.0 t -65.34 -43.3 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.583 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 409' ' ' GLU . . . . . 0.566 ' HG3' HH12 ' B' ' 283' ' ' ARG . 95.2 mt-10 -63.91 -35.69 81.5 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.064 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.2 98.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.089 0.471 . . . . 0.0 110.286 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 411' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 407' ' ' ALA . 92.1 t -65.27 -42.64 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.421 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 412' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 81.4 mt -61.15 -40.68 94.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.532 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.49 -16.78 64.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.617 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -102.75 -22.76 13.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.44 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.44 179.55 5.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.257 0.551 . . . . 0.0 112.001 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.18 108.03 20.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.33 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.3 127.29 52.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.73 0.3 . . . . 0.0 110.254 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 13.6 t -119.96 130.94 55.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 419' ' ' GLU . . . . . 0.504 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 41.5 mt-10 -102.3 120.7 40.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.356 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -131.85 138.62 48.54 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.418 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.26 144.91 35.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 13.4 t -151.3 171.72 17.02 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.231 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 36.1 p -86.95 166.1 15.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.338 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -67.34 -25.95 66.25 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -62.9 -38.42 90.86 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.86 -31.67 72.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 0.0 110.672 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.24 -12.95 60.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 5.5 mmt -81.03 -7.3 59.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.001 0.429 . . . . 0.0 110.995 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -78.1 78.27 4.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.309 0.576 . . . . 0.0 110.509 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -126.06 23.63 7.09 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.63 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.39 -30.15 70.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.234 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.826 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.691 -178.673 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.232 0.167 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.7 t -117.41 113.63 22.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.935 0.398 . . . . 0.0 110.821 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 p -154.72 140.65 11.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -122.34 157.69 31.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.981 0.419 . . . . 0.0 111.204 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 m -104.44 115.56 30.59 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.857 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 9' ' ' GLN . 15.7 m -68.2 -53.42 25.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.738 0.304 . . . . 0.0 111.01 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 8' ' ' THR . 58.1 tp60 168.31 130.05 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.82 0.848 . . . . 0.0 109.586 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.22 -105.7 1.36 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.784 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 305' ' ' ALA . 4.0 mp -97.04 -16.01 20.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.692 0.282 . . . . 0.0 110.343 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 13' ' ' ARG . . . -71.79 133.58 21.15 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.635 -175.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -135.92 143.44 44.95 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -116.23 134.02 55.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 t -79.56 -94.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 m 54.54 91.48 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.336 0.589 . . . . 0.0 110.85 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 tp -106.87 134.32 48.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.004 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.3 p -81.3 132.62 35.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.515 HD13 HD11 ' A' ' 24' ' ' ILE . 1.9 pp -129.56 161.88 38.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.674 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -108.11 155.85 19.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.005 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.17 -53.15 57.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.4 -34.39 74.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.987 0.422 . . . . 0.0 110.662 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.6 t -63.01 -34.44 77.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.038 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 20' ' ' ALA . 62.7 mt -59.62 -70.2 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.207 0.527 . . . . 0.0 111.269 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.71 -44.87 92.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.724 -172.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.3 m -64.66 -49.01 72.68 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.4 -45.25 18.01 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.0 t -63.32 -44.47 99.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.531 0.196 . . . . 0.0 111.531 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -61.32 -46.7 89.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.832 0.348 . . . . 0.0 110.735 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.9 m -61.72 -41.58 97.8 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.085 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.8 tp10 -65.45 -42.6 92.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.984 0.421 . . . . 0.0 110.567 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.433 ' CD2' HH22 ' A' ' 73' ' ' ARG . 97.1 mt -63.81 -44.09 94.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.24 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -68.05 -37.6 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -62.79 -39.67 94.95 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.463 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 31' ' ' GLU . 79.1 t -63.49 -44.16 98.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.822 0.344 . . . . 0.0 110.311 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.05 87.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.945 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.9 -34.11 77.07 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.833 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -59.29 -42.83 92.21 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.834 0.35 . . . . 0.0 110.483 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.1 t -85.99 -4.72 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.056 0.455 . . . . 0.0 110.16 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 62.74 27.56 16.15 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.457 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.72 5.29 10.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -64.46 -30.51 71.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.986 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.15 -23.65 68.15 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.339 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -74.83 -12.2 60.33 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.443 ' HG3' ' NE2' ' B' ' 320' ' ' GLN . 71.8 ttt-85 -91.06 103.08 15.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.58 -176.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.13 109.6 13.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.81 67.61 2.12 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 115.949 1.139 . . . . 0.0 115.949 -170.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.62 -44.16 91.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.3 t -98.33 102.74 15.1 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HB2' ' OD1' ' A' ' 52' ' ' ASN . 13.4 Cg_endo -57.36 144.03 92.41 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.315 2.01 . . . . 0.0 111.779 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.534 ' HA ' HG12 ' A' ' 54' ' ' VAL . 17.5 ttt -61.13 -38.57 86.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.244 -173.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.518 ' OD1' ' HB2' ' A' ' 50' ' ' PRO . 16.7 p-10 -62.56 -43.21 99.37 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.833 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.536 HG21 ' HD2' ' B' ' 193' ' ' ARG . 1.8 mp -68.67 -44.12 82.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.556 HG22 ' HA2' ' B' ' 323' ' ' GLY . 2.6 p -63.84 -36.85 78.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 120.63 0.252 . . . . 0.0 111.619 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.19 89.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.258 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -83.45 -32.69 25.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.371 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -63.44 -42.47 98.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.177 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -109.91 17.83 20.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.391 0.615 . . . . 0.0 111.186 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.18 145.81 49.91 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.072 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 72.66 -35.06 0.31 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.378 0.671 . . . . 0.0 112.555 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -61.23 -45.89 92.66 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.405 HG22 ' HB2' ' A' ' 65' ' ' ASP . 7.5 p -122.97 22.17 4.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.903 0.858 . . . . 0.0 110.246 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -63.87 -23.25 67.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.374 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -63.83 -45.17 90.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.847 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' HB2' HG22 ' A' ' 62' ' ' VAL . 9.1 m-20 -75.2 -24.01 57.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.129 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.88 -42.22 94.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.0 mt -61.91 -38.41 88.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.935 175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.7 -41.06 98.85 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.658 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.459 ' OD1' ' HE2' ' B' ' 327' ' ' LYS . 20.9 t70 -60.75 -46.34 90.81 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.954 0.407 . . . . 0.0 110.434 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.18 -42.59 99.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.282 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.6 ttp -63.32 -42.87 99.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.976 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -62.83 -44.04 97.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.331 0.586 . . . . 0.0 110.997 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.433 HH22 ' CD2' ' A' ' 32' ' ' LEU . 69.7 mtp180 -64.42 -40.77 96.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.046 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -63.93 -40.24 96.0 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 120.954 0.407 . . . . 0.0 110.519 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -62.43 -48.28 80.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.874 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 79' ' ' ILE . 15.7 tt -68.96 -41.48 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.879 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -65.16 -37.91 88.88 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.141 0.496 . . . . 0.0 110.095 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.66 83.16 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.922 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.8 pp -65.64 -30.5 50.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.541 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.0 mt -65.44 -43.63 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.932 0.396 . . . . 0.0 111.034 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -81.24 -32.57 33.3 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.901 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -83.27 -2.94 56.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.124 0.487 . . . . 0.0 110.407 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt 64.23 38.93 7.78 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.674 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 81.3 mt -102.66 123.87 56.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.827 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -110.32 103.56 54.16 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.388 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.65 146.59 34.39 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.51 2.14 . . . . 0.0 112.295 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.14 98.23 11.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.049 0.452 . . . . 0.0 111.424 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.55 -106.48 2.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.591 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.09 129.71 24.65 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.468 ' HG2' ' CE1' ' A' ' 92' ' ' TYR . 81.0 Cg_endo -73.95 156.42 47.8 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.681 2.254 . . . . 0.0 111.928 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.0 m -76.94 119.39 20.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.017 0.437 . . . . 0.0 111.534 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.468 ' CE1' ' HG2' ' A' ' 90' ' ' PRO . 73.6 m-85 -113.82 118.81 35.3 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.01 100.57 53.84 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.443 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -90.19 145.31 4.26 Favored 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 122.555 2.17 . . . . 0.0 111.29 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.98 175.3 41.5 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.301 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.72 125.17 26.43 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -80.51 127.82 32.88 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.971 0.415 . . . . 0.0 110.563 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -117.56 115.52 25.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.595 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.4 tp -65.37 107.27 1.59 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.334 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.47 -8.71 13.43 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.383 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.93 173.39 8.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.803 0.335 . . . . 0.0 111.026 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.87 141.25 44.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.558 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -98.08 141.18 31.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.385 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.8 m -124.26 133.99 53.35 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -141.03 154.91 46.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.255 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 m -84.21 -86.44 0.12 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.0 t 68.89 111.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 122.98 0.512 . . . . 0.0 110.498 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -113.95 137.66 51.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.825 -175.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -151.34 -74.75 0.15 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -143.24 157.49 44.44 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.553 0.615 . . . . 0.0 111.297 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.432 ' CG1' ' HG ' ' A' ' 11' ' ' LEU . 28.8 m -128.78 -172.46 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -140.25 118.02 8.27 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.88 147.32 39.02 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.821 2.347 . . . . 0.0 114.623 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -135.87 143.06 44.85 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.597 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.6 t -128.37 132.17 68.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -104.7 -90.15 0.4 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.519 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.0 mt 64.1 130.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.114 0.966 . . . . 0.0 113.397 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -136.97 152.34 50.04 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.818 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.96 22.14 74.85 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.418 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.66 -28.8 68.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.808 0.337 . . . . 0.0 111.897 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -83.16 -9.02 59.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.852 0.358 . . . . 0.0 111.28 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -102.51 17.29 24.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.911 0.386 . . . . 0.0 111.342 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.2 mt -90.47 123.7 42.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.908 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -108.99 127.02 53.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.3 t -115.16 136.07 53.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.017 0.437 . . . . 0.0 112.073 -172.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -86.99 139.1 30.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.844 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -134.47 101.03 12.23 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.5 137.79 40.37 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.046 1.831 . . . . 0.0 111.527 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.98 123.13 70.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.919 0.39 . . . . 0.0 110.481 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.99 162.25 39.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.534 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -142.35 158.99 43.11 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.6 t -81.17 116.77 26.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.1 p -100.39 176.36 5.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.665 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -65.02 -30.62 71.61 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.476 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.54 97.72 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.895 0.378 . . . . 0.0 110.355 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -64.21 -44.43 91.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.949 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.487 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 90.1 t -64.47 -46.13 93.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.433 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.71 -48.4 81.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.721 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.63 -39.48 97.61 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.945 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.488 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -63.07 -44.79 94.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 0.0 110.337 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 86.6 mt -63.2 -42.26 99.28 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.74 -45.15 93.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.367 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.8 m -62.95 -42.72 99.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.614 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -60.92 -42.54 98.3 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -72.81 -20.89 61.06 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.418 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.17 -12.4 59.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.079 0.466 . . . . 0.0 110.608 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -93.61 2.99 56.19 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.498 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -117.14 75.09 0.95 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.888 0.852 . . . . 0.0 111.976 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.71 73.24 0.76 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 151' ' ' TRP . 4.1 m -144.76 173.01 12.22 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.903 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.503 ' H ' HG22 ' A' ' 150' ' ' THR . 31.5 t-105 80.72 17.52 0.57 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.395 1.078 . . . . 0.0 112.315 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' A' ' 245' ' ' LEU . 6.3 mptp? -101.89 160.01 14.85 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -94.93 4.88 53.29 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -142.23 154.37 44.73 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.986 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 78.2 -175.22 0.09 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.733 1.213 . . . . 0.0 111.304 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -138.29 99.45 0.28 Allowed Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 119.577 -1.297 . . . . 0.0 114.865 -174.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . . . -110.45 -57.0 2.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.5 t 60.89 123.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 114.592 -1.186 . . . . 0.0 113.589 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -99.95 158.14 16.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.753 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.84 86.39 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -77.12 -0.12 23.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.53 142.38 27.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.508 0.194 . . . . 0.0 110.757 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -91.61 120.09 32.08 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.95 129.98 74.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.754 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.0 m -75.91 110.32 10.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 79.9 mt -122.37 120.28 60.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.348 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -98.48 101.4 12.83 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -120.15 154.22 35.08 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.074 0.464 . . . . 0.0 111.667 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 30.8 m -123.43 129.73 51.69 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.662 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.35 125.43 7.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.903 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 25.2 m -142.38 125.83 16.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.45 -78.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.653 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -132.77 80.31 1.89 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.55 7.3 73.43 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.096 -0.574 . . . . 0.0 112.903 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -140.69 143.72 35.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.793 0.33 . . . . 0.0 110.12 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -87.27 156.73 19.52 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.193 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -122.64 174.04 7.34 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.71 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.21 -38.84 74.34 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -101.19 -178.22 28.91 Favored Glycine 0 C--N 1.318 -0.435 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.091 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.02 30.5 38.07 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.704 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -107.18 102.92 12.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -124.45 142.67 51.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 111.948 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.4 m -150.52 132.24 14.96 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.2 31.04 20.9 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.374 0.421 . . . . 0.0 110.343 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -95.84 123.42 39.41 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.99 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.2 m -91.48 116.5 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.539 0.685 . . . . 0.0 110.598 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 56.3 tp -110.13 130.51 55.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.396 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.687 ' HB3' ' NH1' ' A' ' 193' ' ' ARG . . . -121.22 135.29 55.16 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 73.9 mtm -102.19 178.21 4.66 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.149 0.5 . . . . 0.0 112.001 -172.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.61 -10.64 73.73 Favored Glycine 0 CA--C 1.505 -0.531 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.235 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -102.83 -9.23 20.11 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.618 0.247 . . . . 0.0 111.173 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.63 42.45 21.65 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.853 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.687 ' NH1' ' HB3' ' A' ' 188' ' ' ALA . 48.3 mtm180 -93.27 0.41 57.01 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.343 0.592 . . . . 0.0 110.632 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.502 ' HB2' ' HG3' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -130.17 172.95 11.23 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.445 173.357 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.635 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.4 mp -69.07 137.47 89.56 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.98 134.75 49.94 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.984 1.789 . . . . 0.0 111.416 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.91 -38.94 2.9 Favored Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.511 ' O ' HG12 ' A' ' 202' ' ' ILE . 47.9 t80 -63.57 -49.77 72.08 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 194' ' ' MET . 88.0 mt-10 -67.11 -36.11 81.22 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.492 0.663 . . . . 0.0 109.938 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.85 -36.08 82.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.627 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.16 -8.95 77.64 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.889 -0.672 . . . . 0.0 114.095 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 198' ' ' PHE . 47.8 mm -65.14 -45.27 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 117.275 0.538 . . . . 0.0 111.194 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -58.99 130.54 47.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.167 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.9 -15.02 48.85 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.451 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -83.37 143.51 30.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 117.06 0.43 . . . . 0.0 111.724 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -96.01 160.51 14.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.274 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.47 121.44 14.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.563 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 82.51 24.13 54.59 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.393 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -105.8 113.07 26.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.374 0.607 . . . . 0.0 111.482 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -91.37 130.94 37.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.559 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.479 ' O ' ' HB ' ' A' ' 212' ' ' THR . 61.5 t80 -150.52 -29.84 0.21 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -176.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 91.1 m 79.77 143.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.839 0.455 . . . . 0.0 110.279 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.3 tp -115.75 -42.01 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 72.12 100.11 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.329 0.585 . . . . 0.0 112.03 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 63.8 t -121.89 133.96 66.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.891 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 9.4 m -93.1 -23.49 18.6 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.45 ' CE2' HG12 ' A' ' 195' ' ' ILE . 96.4 m-85 71.94 145.59 0.11 Allowed Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 122.817 0.447 . . . . 0.0 111.459 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.56 154.02 60.09 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.621 2.214 . . . . 0.0 111.846 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -65.38 -40.04 93.01 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.947 0.403 . . . . 0.0 110.775 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -88.11 32.34 0.76 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.486 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -69.25 132.71 46.91 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.728 -0.389 . . . . 0.0 109.994 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -56.67 -40.4 75.45 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.57 101.85 7.62 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -61.53 -33.26 73.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -68.36 -14.11 62.76 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.18 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.0 mt -117.48 -0.34 11.95 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -71.54 124.21 24.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.311 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.91 17.96 77.3 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.544 -0.753 . . . . 0.0 114.492 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -127.5 132.05 50.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.711 0.755 . . . . 0.0 110.663 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.21 151.71 25.54 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.73 135.89 33.6 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.501 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.92 -48.05 67.04 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 54.46 91.83 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.082 0.468 . . . . 0.0 111.067 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.88 89.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mm 69.7 90.14 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.106 0.479 . . . . 0.0 111.522 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -67.88 -47.5 68.68 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.29 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.456 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 8.0 tp 55.26 100.37 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.86 0.864 . . . . 0.0 113.034 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -95.58 -70.91 0.69 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 34.0 mmtp -80.5 -86.87 0.08 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 242' ' ' GLU . 65.6 t 76.84 140.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.111 0.564 . . . . 0.0 111.053 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.52 ' HB3' ' NH1' ' A' ' 243' ' ' ARG . 50.8 mm-40 -64.16 -37.03 85.98 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.344 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.538 ' H ' HG12 ' A' ' 240' ' ' VAL . 36.2 mt-10 66.97 129.3 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.535 0.734 . . . . 0.0 111.881 -176.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.52 ' NH1' ' HB3' ' A' ' 241' ' ' GLU . 8.6 ptp180 173.55 114.27 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.967 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 157' ' ' ALA . 0.4 OUTLIER -142.66 -153.96 0.49 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.868 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.473 ' HB2' ' HG2' ' A' ' 152' ' ' LYS . 10.5 mp 70.18 146.09 0.11 Allowed Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.528 ' O ' ' HG2' ' A' ' 247' ' ' GLU . 95.7 Cg_endo -82.94 -159.08 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.175 2.583 . . . . 0.0 112.931 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 246' ' ' PRO . 3.4 pt-20 87.96 -176.47 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.188 1.795 . . . . 0.0 111.043 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.76 135.73 48.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.105 0.479 . . . . 0.0 111.639 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 41.2 p -88.39 -168.52 2.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.036 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.23 -51.39 66.75 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.931 0.396 . . . . 0.0 109.935 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -132.54 94.23 3.38 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -72.97 -10.22 59.56 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.297 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 253' ' ' ILE . 3.8 mp -65.25 -44.55 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.72 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.531 ' HD2' ' HB2' ' A' ' 260' ' ' ASP . 58.2 pttt -150.88 151.74 32.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.879 0.371 . . . . 0.0 111.756 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' A' ' 256' ' ' PHE . 28.1 tpt180 -168.93 -175.21 2.28 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -174.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.572 ' H ' ' HG3' ' A' ' 255' ' ' ARG . 91.9 m-85 90.47 -39.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.356 1.062 . . . . 0.0 113.67 172.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 133.43 -132.13 6.37 Favored Glycine 0 C--N 1.313 -0.695 0 C-N-CA 119.326 -1.416 . . . . 0.0 113.234 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.7 m 38.18 48.26 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.933 0.893 . . . . 0.0 111.389 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 260' ' ' ASP . 33.6 tt0 66.94 -84.8 0.03 OUTLIER 'General case' 0 C--O 1.235 0.329 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.334 -174.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ASP . . . . . 0.531 ' HB2' ' HD2' ' A' ' 254' ' ' LYS . 4.0 p30 174.2 151.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.112 0.565 . . . . 0.0 110.434 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.39 -171.76 31.03 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.933 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.2 p -79.81 168.74 18.89 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.604 0.362 . . . . 0.0 110.911 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 94.0 t -61.94 -49.56 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.785 0.326 . . . . 0.0 111.578 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.4 pm0 -71.14 -41.33 70.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.129 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.27 95.6 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.389 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 270' ' ' VAL . 58.1 tp -61.8 -45.67 92.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.555 0.217 . . . . 0.0 111.117 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 263' ' ' VAL . 66.1 mtp180 -66.73 -41.41 87.93 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.573 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.91 -43.3 83.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.202 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -66.5 -39.81 88.89 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.705 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 266' ' ' LEU . 76.0 t -64.35 -42.35 95.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.938 176.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -57.56 -47.62 81.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.564 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 12.8 ptmt -66.99 -39.62 87.2 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -63.79 -41.03 98.01 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.987 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 98.7 mmm -64.43 -41.87 96.33 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.852 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.22 -34.92 75.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.762 0.315 . . . . 0.0 111.122 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -61.96 -43.09 99.58 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -67.07 -37.96 84.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.494 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.6 tp -61.96 -41.07 97.57 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.834 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -57.7 -46.12 84.77 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.654 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.3 m -63.65 -44.72 93.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.576 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.74 93.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.076 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.62 -43.94 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.24 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -62.53 -42.62 99.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.893 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -62.97 -41.34 99.52 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.104 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -60.26 -44.1 95.59 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.117 0.484 . . . . 0.0 110.327 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.0 t -70.02 -43.79 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.946 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.96 -47.39 86.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.299 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.9 p -62.25 -43.23 99.29 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.643 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -65.79 -42.49 90.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.842 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.628 ' O ' ' HG ' ' A' ' 294' ' ' LEU . . . -64.26 -45.62 87.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.044 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 295' ' ' VAL . 35.1 mm -63.98 -43.99 97.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.058 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.511 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 29.7 tp10 -60.52 -43.68 96.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.438 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.52 -40.3 98.6 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.278 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 290' ' ' ALA . 69.8 mt -63.38 -43.07 98.64 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.711 0.291 . . . . 0.0 111.155 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 291' ' ' ILE . 93.7 t -65.01 -44.8 95.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.941 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LYS . . . . . 0.511 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.1 mttm -64.37 -39.8 94.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.326 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.97 95.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.921 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -137.93 102.27 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -90.02 107.38 19.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 8.7 tp -114.48 140.04 37.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.82 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -68.72 129.01 38.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.477 0.656 . . . . 0.0 110.05 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 94.0 t -99.56 135.54 20.58 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.687 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.74 132.81 53.86 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.498 2.132 . . . . 0.0 111.828 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.0 87.54 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.46 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' A' ' 11' ' ' LEU . . . -58.0 -41.74 83.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 111.537 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.2 -42.3 93.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.31 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.02 -44.58 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.817 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.09 -42.56 85.89 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.873 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.1 m -62.04 -44.64 96.27 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.055 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.499 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 74.0 mm-40 -69.37 -38.79 78.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.707 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.522 HD13 ' HG3' ' A' ' 334' ' ' ARG . 94.2 mt -62.19 -44.34 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -177.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.485 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 26.9 t70 -62.55 -43.1 99.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.037 0.446 . . . . 0.0 110.638 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.11 -43.31 95.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.293 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 95.8 mt -62.41 -41.81 98.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.037 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.485 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 85.3 mtm180 -63.72 -42.25 97.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -64.34 -41.14 96.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.554 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -63.46 -40.92 98.4 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.004 0.431 . . . . 0.0 110.603 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.42 91.76 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.223 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.92 -37.09 86.48 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.799 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -60.64 -39.39 88.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.77 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -89.74 2.29 55.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.693 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -99.0 -2.95 36.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.342 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' GLY . . . . . 0.546 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . 139.98 -1.55 2.26 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.567 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 91.71 29.13 12.37 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.461 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.511 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 43.7 t-20 -72.39 124.04 24.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' GLU . . . . . 0.654 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 0.6 OUTLIER -119.61 153.45 35.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 0.1 OUTLIER 61.37 -30.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 126.03 1.732 . . . . 0.0 114.608 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.511 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 15.9 mm100 -79.8 -5.31 55.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.301 0.572 . . . . 0.0 110.38 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.58 -18.39 63.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.38 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.92 -37.93 86.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.503 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.83 -20.13 65.13 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.853 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 81.6 mt -62.02 147.03 91.01 Favored Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.275 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.444 ' O ' ' HD1' ' A' ' 337' ' ' PHE . 32.5 Cg_exo -61.04 142.08 96.22 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.804 2.336 . . . . 0.0 112.82 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.522 ' HG3' HD13 ' A' ' 311' ' ' ILE . 21.4 ttt180 -84.49 -41.07 16.93 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.836 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -60.14 -39.48 86.48 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.05 -2.88 58.73 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.444 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.444 ' HD1' ' O ' ' A' ' 333' ' ' PRO . 60.2 m-85 -109.83 -21.33 12.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.132 0.491 . . . . 0.0 109.875 173.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.74 -29.22 67.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.08 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -60.8 -47.44 86.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 110.639 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -78.42 -22.88 47.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.598 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -62.68 -41.77 99.27 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.197 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.8 tttt -59.73 -48.29 82.26 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 347' ' ' VAL . 13.4 mmt85 -61.25 -45.32 95.0 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.038 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.422 HH21 ' HD3' ' A' ' 344' ' ' ARG . 67.7 mtt-85 -65.89 -38.94 90.1 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 341' ' ' ALA . 97.4 t -66.63 -43.23 90.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.031 0.444 . . . . 0.0 109.998 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 342' ' ' LYS . 59.7 t -60.24 -43.48 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.566 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 343' ' ' ARG . 71.0 t -59.51 -45.09 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.32 -43.89 98.44 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.032 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.97 -42.77 97.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.557 0.218 . . . . 0.0 111.437 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.9 mt -62.75 -45.92 90.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.94 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.12 -38.91 82.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.241 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.57 97.07 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.146 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.78 -35.05 79.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.886 0.374 . . . . 0.0 110.837 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.62 -43.69 95.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.93 -44.89 99.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.899 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -69.48 -46.28 67.0 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.0 m -63.31 -44.18 95.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -97.11 5.71 49.78 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.059 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 52.83 53.19 12.51 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.846 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.91 145.57 32.59 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.7 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.25 148.26 44.54 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.765 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.88 127.54 32.91 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 367' ' ' VAL . 25.2 t70 -96.9 110.68 23.14 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.784 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -59.23 -34.6 72.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.775 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.449 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 46.7 mm-40 -67.05 -40.93 87.21 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.12 0.486 . . . . 0.0 110.591 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -63.4 -38.97 93.19 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 363' ' ' ASP . 93.6 t -62.51 -41.03 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.087 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 372' ' ' GLU . 25.9 mmmt -55.34 -45.15 76.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.066 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.16 -41.31 99.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.399 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.93 -42.66 99.87 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.09 0.471 . . . . 0.0 110.38 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.79 -44.04 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.738 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 368' ' ' LYS . 47.5 mt-10 -64.87 -40.26 94.85 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.718 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.91 -38.35 86.05 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.491 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 57.6 ttm -65.49 -41.49 93.2 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.076 0.465 . . . . 0.0 110.34 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -63.23 -26.3 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.844 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.8 m -72.35 -6.77 45.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.29 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -92.09 1.25 57.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.913 0.387 . . . . 0.0 110.789 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -119.87 172.59 7.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.23 -46.2 78.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.758 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 26.7 t70 -120.97 108.82 36.21 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.958 0.409 . . . . 0.0 110.576 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.467 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 51.8 Cg_exo -56.55 -39.41 91.53 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.91 2.406 . . . . 0.0 113.233 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.84 -43.84 91.72 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 9.4 pt-20 -62.88 -37.78 88.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.451 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.45 -42.73 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.217 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.48 -44.92 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.212 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.14 -38.6 78.9 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.265 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -58.97 -46.52 87.88 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.936 0.398 . . . . 0.0 110.355 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.488 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 4.6 t80 -68.65 -44.22 74.6 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.527 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.9 p -73.45 -17.32 61.26 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -176.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.12 4.14 54.51 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.108 0.48 . . . . 0.0 111.076 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 395' ' ' MET . 16.2 t-20 -122.51 111.45 16.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.033 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -61.39 -42.08 98.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -58.56 -48.89 79.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.776 0.322 . . . . 0.0 110.636 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.27 -40.44 97.4 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.492 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.437 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 95.9 mtp -61.72 -48.86 78.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.712 0.292 . . . . 0.0 111.62 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.51 -37.65 74.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 -175.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -62.25 -44.06 97.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.203 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.488 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 51.6 tpp -66.29 -39.74 89.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.146 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.481 ' HG2' HG21 ' A' ' 367' ' ' VAL . 55.7 mtm180 -64.17 -35.96 82.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.797 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -61.74 -43.84 98.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.001 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.2 -44.48 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.912 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.72 -40.48 97.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.903 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 45.9 tp -64.47 -37.74 88.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.462 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.84 -44.27 90.92 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.165 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -65.96 -37.0 84.88 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.595 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -60.06 -42.25 94.11 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.47 82.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.926 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 85.1 t -63.55 -46.41 95.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.02 -33.06 74.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.383 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.93 96.08 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 110.569 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 93.7 t -65.16 -42.23 93.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.314 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 95.5 mt -60.49 -40.16 90.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.643 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.58 -22.61 66.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.352 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -94.39 -40.44 9.93 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.919 0.39 . . . . 0.0 111.423 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -80.36 177.99 8.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.372 0.606 . . . . 0.0 112.36 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -87.25 118.23 26.54 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.362 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.1 t -103.36 105.95 19.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.1 t -105.13 134.72 47.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.975 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.19 111.57 23.25 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.757 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -117.79 128.13 54.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.992 0.425 . . . . 0.0 110.893 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -72.06 147.43 46.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.167 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -157.13 169.64 24.32 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 120.834 0.35 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 29.6 p -91.29 165.34 13.49 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.339 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -66.35 -30.34 70.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.479 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -62.46 -38.27 89.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.862 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.57 -33.5 75.81 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.08 0.466 . . . . 0.0 110.364 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 11.2 mp -72.43 -21.34 61.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.9 mmt -73.46 -6.65 47.7 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.031 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -78.79 71.69 5.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -102.49 17.42 23.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.268 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -64.17 -39.79 94.75 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.441 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.218 178.823 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 120.95 0.405 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.14 134.67 56.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.193 0.52 . . . . 0.0 111.711 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.02 159.76 42.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.27 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 40.2 t -115.85 107.73 15.4 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.998 0.428 . . . . 0.0 110.582 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.83 139.88 21.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.137 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -122.15 154.45 37.4 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.974 0.416 . . . . 0.0 111.137 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 61.5 m -104.35 119.79 39.74 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.912 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.8 m -70.67 -66.09 0.65 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.039 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -179.46 131.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.577 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.22 -106.37 1.65 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.507 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.453 ' HG ' ' CG1' ' B' ' 111' ' ' VAL . 2.5 mp -96.99 -14.5 21.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.687 0.28 . . . . 0.0 110.364 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.1 132.62 19.35 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.552 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.9 143.83 47.16 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 122.703 0.401 . . . . 0.0 109.997 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -117.9 133.94 55.44 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 19.8 t -81.04 -93.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.1 m 55.58 90.35 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.27 0.557 . . . . 0.0 110.679 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.1 tp -106.59 133.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.075 0.464 . . . . 0.0 111.921 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 25.5 p -81.76 132.09 35.28 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.824 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.5 HD13 HD11 ' B' ' 24' ' ' ILE . 1.8 pp -128.58 164.76 29.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.66 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -111.12 156.6 21.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.14 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.25 -52.87 57.61 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -173.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -71.05 -34.14 70.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.907 0.384 . . . . 0.0 110.963 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 33.4 t -64.87 -29.1 70.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.443 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.66 HG13 ' O ' ' B' ' 20' ' ' ALA . 64.9 mt -63.25 -71.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.29 0.567 . . . . 0.0 111.302 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.35 -42.72 96.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.646 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 18.1 m -63.1 -47.43 82.87 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.06 -44.3 15.33 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -174.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 81.4 t -62.44 -44.66 99.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.55 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -61.71 -47.16 86.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.706 0.289 . . . . 0.0 111.036 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 21.8 m -61.75 -42.42 98.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.467 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.426 ' O ' HG23 ' B' ' 35' ' ' VAL . 13.6 tp10 -65.25 -40.99 94.72 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.868 0.366 . . . . 0.0 110.562 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 96.2 mt -63.71 -44.07 94.7 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.67 -37.2 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.74 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -63.16 -40.49 97.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.288 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 31' ' ' GLU . 83.9 t -64.05 -44.07 97.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.794 0.331 . . . . 0.0 110.511 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -46.37 89.97 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.855 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.74 -33.99 76.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.088 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.83 -43.84 90.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.854 0.359 . . . . 0.0 110.448 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 t -84.84 -4.7 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.289 0.566 . . . . 0.0 110.314 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 61.98 28.53 17.33 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.499 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.419 ' H ' HG13 ' B' ' 41' ' ' ILE . 2.8 pp -105.04 5.77 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.974 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -65.06 -28.61 69.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.264 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.2 -19.26 72.03 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.273 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -76.24 -17.55 59.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -87.15 93.54 9.4 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.115 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -69.37 115.85 9.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.94 70.74 0.49 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 -170.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.19 -44.56 83.63 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.61 105.96 26.64 Favored Pre-proline 0 N--CA 1.439 -1.005 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.125 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.484 ' HB2' ' OD1' ' B' ' 52' ' ' ASN . 14.0 Cg_endo -58.44 145.74 93.07 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.198 1.932 . . . . 0.0 111.396 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.551 ' HA ' HG12 ' B' ' 54' ' ' VAL . 19.4 ttt -63.47 -38.84 92.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.151 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ASN . . . . . 0.484 ' OD1' ' HB2' ' B' ' 50' ' ' PRO . 21.8 p-10 -62.02 -43.25 99.23 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.899 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.511 HG12 HH21 ' A' ' 193' ' ' ARG . 1.8 mp -68.5 -44.64 82.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' B' ' 51' ' ' MET . 4.3 p -63.89 -37.35 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.502 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.49 87.41 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.341 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -84.27 -33.66 23.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -62.53 -42.82 99.77 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.982 0.42 . . . . 0.0 110.946 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.6 18.21 21.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.412 0.625 . . . . 0.0 110.805 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.43 145.68 49.74 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.426 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 72.75 -33.98 0.28 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.458 0.703 . . . . 0.0 112.263 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.7 t -61.63 -47.27 86.17 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.68 21.34 5.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 122.079 0.943 . . . . 0.0 109.899 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -63.27 -21.3 66.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.035 -177.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -64.02 -47.06 81.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.774 0.321 . . . . 0.0 110.807 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.94 -23.86 55.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.268 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.74 -42.16 94.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.0 -38.47 88.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.17 -41.71 98.3 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.637 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ASP . . . . . 0.569 ' OD1' ' HE2' ' A' ' 327' ' ' LYS . 21.1 t70 -60.23 -46.92 88.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.22 -42.91 99.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.409 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 61.0 ttp -63.03 -43.09 99.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.174 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -62.17 -43.8 98.02 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.256 0.551 . . . . 0.0 110.807 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.405 ' NH1' HG21 ' B' ' 35' ' ' VAL . 71.5 mtp180 -64.78 -40.61 95.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.314 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -63.85 -40.8 97.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.898 0.38 . . . . 0.0 110.473 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -61.09 -48.98 79.19 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.099 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ILE . . . . . 0.462 ' O ' HG13 ' B' ' 79' ' ' ILE . 15.5 tt -68.74 -41.25 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.39 -38.0 89.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.212 0.529 . . . . 0.0 110.072 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.66 -47.22 84.65 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.092 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.462 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.8 pp -66.69 -29.55 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.865 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.5 mt -65.46 -43.95 94.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.782 0.325 . . . . 0.0 111.07 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -81.31 -33.06 32.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -80.18 -7.91 59.17 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.064 0.459 . . . . 0.0 110.388 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt 66.93 38.08 3.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.262 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.9 mt -101.19 121.44 52.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.473 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -107.54 102.72 45.85 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.835 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.71 146.79 38.98 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 122.376 2.051 . . . . 0.0 112.085 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.35 100.63 12.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.609 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.59 -118.11 6.45 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.012 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.27 130.65 23.44 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-O 120.544 0.212 . . . . 0.0 110.883 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' PRO . . . . . 0.436 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 73.1 Cg_endo -75.25 161.6 37.78 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.982 2.455 . . . . 0.0 111.984 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -77.98 117.71 19.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.127 0.489 . . . . 0.0 111.899 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.436 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 81.6 m-85 -112.22 122.0 46.49 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 52.7 t -120.89 99.89 46.61 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-O 120.878 0.37 . . . . 0.0 110.713 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -89.66 145.24 4.72 Favored 'Trans proline' 0 N--CA 1.438 -1.791 0 C-N-CA 122.412 2.074 . . . . 0.0 111.213 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.14 174.92 40.92 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.326 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.63 126.42 29.29 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -81.27 125.19 30.03 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.023 0.44 . . . . 0.0 110.352 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -112.95 112.46 23.94 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.036 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 48.5 tp -65.43 107.11 1.56 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.047 0.451 . . . . 0.0 110.105 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.73 -16.32 8.37 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.257 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.37 -179.74 4.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.957 0.408 . . . . 0.0 111.629 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.8 138.52 37.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.744 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -96.11 143.1 27.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.473 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 45.4 m -124.92 134.67 52.57 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -140.68 155.7 46.42 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.392 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 3.0 m -84.66 -86.06 0.13 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 84.0 t 67.86 108.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.992 0.517 . . . . 0.0 110.692 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -111.51 138.69 47.71 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.639 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -152.81 -75.13 0.13 Allowed 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -142.43 157.2 45.03 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.798 -0.564 . . . . 0.0 111.32 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.453 ' CG1' ' HG ' ' B' ' 11' ' ' LEU . 27.5 m -129.94 -175.2 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 121.351 0.596 . . . . 0.0 112.342 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -138.16 119.32 10.37 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.01 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.72 148.54 32.71 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.019 2.479 . . . . 0.0 114.583 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -138.74 142.25 38.87 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.38 133.21 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -103.0 -92.25 0.34 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.451 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.4 mt 64.13 133.79 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.898 0.879 . . . . 0.0 113.337 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -141.83 152.47 43.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.469 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.2 19.42 78.47 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.465 175.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 75.3 mt -63.62 -37.2 86.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.986 0.422 . . . . 0.0 111.352 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' B' ' 121' ' ' GLU . 1.6 mp0 -72.64 -12.91 61.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.593 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.44 18.0 18.89 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.878 0.37 . . . . 0.0 111.37 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 83.6 mt -92.66 122.23 43.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -104.37 133.11 49.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.45 136.0 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 112.027 -172.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -87.21 139.21 30.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.915 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -134.3 99.88 13.07 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.8 137.18 37.68 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.968 1.779 . . . . 0.0 111.492 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.72 123.66 69.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.848 0.356 . . . . 0.0 110.349 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.14 162.86 39.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.233 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -145.24 159.16 43.44 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.815 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.46 118.0 28.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 69.9 p -101.03 174.96 5.77 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.991 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.45 -31.81 72.59 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.657 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.13 99.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.481 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -65.08 -44.61 88.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.274 0.559 . . . . 0.0 110.268 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.4 t -63.8 -46.91 93.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.723 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -64.12 -42.71 96.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.646 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.75 -39.96 95.49 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.095 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.562 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.0 OUTLIER -62.68 -42.97 99.91 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 94.4 mt -63.63 -41.13 98.29 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.842 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -59.23 -48.72 80.56 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.68 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.9 m -61.8 -40.55 95.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.63 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 144' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.1 mt -61.04 -41.76 97.19 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.457 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -74.02 -18.05 60.9 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.467 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.5 -8.66 59.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.256 0.551 . . . . 0.0 110.394 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -95.83 4.61 52.7 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.342 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -119.07 75.33 1.03 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.754 0.788 . . . . 0.0 112.052 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -157.31 74.66 0.78 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 150' ' ' THR . . . . . 0.463 HG22 ' H ' ' B' ' 151' ' ' TRP . 4.9 m -145.83 171.86 14.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.102 -172.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' TRP . . . . . 0.463 ' H ' HG22 ' B' ' 150' ' ' THR . 44.8 t-105 82.02 10.68 0.73 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.79 1.236 . . . . 0.0 112.393 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 152' ' ' LYS . . . . . 0.535 ' HG2' ' HB2' ' B' ' 245' ' ' LEU . 6.1 mptp? -94.3 158.16 15.71 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.048 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.27 -1.56 58.1 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -141.05 156.32 46.03 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 120.444 -0.503 . . . . 0.0 112.02 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 4.6 t70 82.98 178.08 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.065 1.346 . . . . 0.0 111.136 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.0 89.62 0.26 Allowed Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 119.403 -1.379 . . . . 0.0 115.134 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 157' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' B' ' 244' ' ' GLU . . . -103.38 -59.92 1.64 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 58.5 t 62.6 125.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.872 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -101.06 160.16 14.62 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.963 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.86 86.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.45 -4.38 42.19 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.79 143.48 32.82 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -96.82 121.23 38.45 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 49.5 t -119.53 129.46 75.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.773 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 25.5 m -76.42 104.28 6.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 77.1 mt -117.27 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.869 0.366 . . . . 0.0 111.582 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 16.5 m-20 -99.04 91.9 5.24 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -110.78 154.17 24.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 111.462 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 38.8 m -124.72 129.54 50.68 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.646 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.35 127.38 9.17 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.84 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 27.2 m -143.26 124.61 14.67 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.93 -78.22 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.609 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -133.41 81.03 1.91 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.101 0.477 . . . . 0.0 111.423 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.3 2.72 80.25 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.247 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -140.82 149.7 42.37 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 117.043 0.422 . . . . 0.0 110.874 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -89.16 150.18 22.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.9 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -115.74 177.14 4.78 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.164 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -57.28 -40.43 77.75 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.892 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -102.2 -173.28 27.45 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.061 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.14 30.53 46.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.785 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -106.82 107.47 18.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -126.6 141.64 51.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.071 0.462 . . . . 0.0 111.957 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.4 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 50.0 m -149.34 130.44 14.45 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 57.08 31.33 19.77 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.594 0.559 . . . . 0.0 110.6 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -96.06 124.25 39.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.561 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 5.7 m -91.78 117.2 34.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.535 0.683 . . . . 0.0 110.645 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 53.2 tp -110.91 131.74 54.79 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.619 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 188' ' ' ALA . . . . . 0.68 ' HB3' ' NH1' ' B' ' 193' ' ' ARG . . . -121.42 137.39 54.73 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 71.1 mtm -103.65 179.14 4.36 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.153 0.501 . . . . 0.0 112.002 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.46 -20.36 44.65 Favored Glycine 0 CA--C 1.503 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.009 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -91.25 -13.69 32.29 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.767 0.317 . . . . 0.0 111.248 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.72 40.58 10.62 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.095 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.68 ' NH1' ' HB3' ' B' ' 188' ' ' ALA . 51.8 mtm180 -94.47 0.52 55.42 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.432 0.634 . . . . 0.0 110.962 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.481 ' HB2' ' HG3' ' B' ' 199' ' ' GLU . 0.0 OUTLIER -129.26 165.73 20.82 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.389 173.23 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.682 ' H ' HD12 ' B' ' 195' ' ' ILE . 4.5 mp -61.23 136.59 94.07 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.71 133.67 51.06 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 121.957 1.771 . . . . 0.0 111.434 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.13 -39.01 2.88 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.193 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 198' ' ' PHE . . . . . 0.52 ' O ' HG12 ' B' ' 202' ' ' ILE . 52.1 t80 -62.35 -48.69 78.69 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 199' ' ' GLU . . . . . 0.481 ' HG3' ' HB2' ' B' ' 194' ' ' MET . 93.0 mt-10 -67.0 -36.44 82.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.283 0.563 . . . . 0.0 110.416 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.76 -35.71 81.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.218 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.38 -7.95 71.87 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.838 -0.696 . . . . 0.0 114.324 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.52 HG12 ' O ' ' B' ' 198' ' ' PHE . 48.1 mm -64.96 -44.23 96.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 117.57 0.685 . . . . 0.0 110.984 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -60.01 133.62 56.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.087 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.26 -15.04 51.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.179 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -84.24 141.18 31.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.26 0.552 . . . . 0.0 111.905 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -90.94 161.32 15.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.889 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.83 130.1 42.77 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 208' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' B' ' 237' ' ' LEU . . . 69.98 34.27 70.81 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.498 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -113.65 114.05 25.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.251 0.548 . . . . 0.0 111.59 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -91.24 137.35 32.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -156.48 -27.34 0.1 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 28.0 m 77.48 135.59 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.906 0.482 . . . . 0.0 110.988 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -106.58 -40.3 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 68.26 96.41 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.242 0.544 . . . . 0.0 112.364 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 66.4 t -119.25 135.71 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.071 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 216' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 6.5 m -93.78 -23.08 18.31 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.462 ' CE2' HG12 ' B' ' 195' ' ' ILE . 95.2 m-85 71.81 142.93 0.09 OUTLIER Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 122.892 0.477 . . . . 0.0 111.992 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 11.6 Cg_exo -71.42 153.58 60.91 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.737 2.291 . . . . 0.0 111.899 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.29 -40.77 94.27 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.867 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -84.81 29.73 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.318 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -68.6 133.25 48.23 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.945 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -57.63 -40.65 79.67 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.61 101.24 8.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.34 -32.38 71.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.793 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -67.52 -14.24 62.76 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 94.7 mt -119.21 3.29 11.39 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -73.76 125.45 28.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 119.736 -0.785 . . . . 0.0 112.372 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.95 16.04 76.41 Favored Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.283 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -125.44 128.88 48.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.59 0.695 . . . . 0.0 111.244 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.94 150.53 30.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.59 137.22 35.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.614 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -68.53 -48.31 64.66 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 54.39 91.93 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.165 0.507 . . . . 0.0 111.266 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.81 92.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mm 70.38 90.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 122.869 0.468 . . . . 0.0 111.249 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.65 -48.19 67.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.322 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 237' ' ' LEU . . . . . 0.526 ' O ' ' HA2' ' B' ' 208' ' ' GLY . 8.1 tp 57.42 110.49 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.987 0.915 . . . . 0.0 112.917 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -105.36 -75.59 0.62 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 239' ' ' LYS . . . . . 0.411 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 34.3 mmtp -77.86 -83.76 0.08 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.5 HG12 ' H ' ' B' ' 242' ' ' GLU . 86.2 t 74.51 139.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.368 0.604 . . . . 0.0 111.288 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.522 ' HB3' ' NH1' ' B' ' 243' ' ' ARG . 56.3 mm-40 -63.48 -40.15 96.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.206 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.5 ' H ' HG12 ' B' ' 240' ' ' VAL . 31.1 mt-10 66.76 129.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.303 0.641 . . . . 0.0 111.809 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.522 ' NH1' ' HB3' ' B' ' 241' ' ' GLU . 5.6 ptp180 174.44 109.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.054 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.493 ' HG3' ' HB2' ' B' ' 157' ' ' ALA . 2.4 tt0 -137.03 -150.88 0.38 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.535 ' HB2' ' HG2' ' B' ' 152' ' ' LYS . 10.0 mp 69.16 145.76 0.11 Allowed Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 123.538 0.735 . . . . 0.0 112.714 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 246' ' ' PRO . . . . . 0.551 ' O ' ' HG2' ' B' ' 247' ' ' GLU . 84.5 Cg_endo -83.28 -158.79 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.059 2.506 . . . . 0.0 112.47 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 247' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' B' ' 246' ' ' PRO . 4.0 pt-20 85.68 -176.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.934 1.694 . . . . 0.0 111.004 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.13 136.0 49.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.124 0.487 . . . . 0.0 111.824 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 20.0 p -89.78 -170.14 2.7 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.213 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.61 -52.85 62.41 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.015 0.436 . . . . 0.0 110.017 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -131.09 92.18 3.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.482 0.658 . . . . 0.0 109.241 173.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -70.63 -13.64 62.16 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.563 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 253' ' ' ILE . . . . . 0.442 ' H ' HD12 ' B' ' 253' ' ' ILE . 4.0 mp -63.3 -44.51 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.493 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 254' ' ' LYS . . . . . 0.546 ' HD2' ' HB2' ' B' ' 260' ' ' ASP . 54.9 pttt -149.84 150.84 32.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 111.459 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 255' ' ' ARG . . . . . 0.596 ' HG3' ' H ' ' B' ' 256' ' ' PHE . 27.5 tpt180 -166.02 -174.61 3.05 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -175.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 256' ' ' PHE . . . . . 0.596 ' H ' ' HG3' ' B' ' 255' ' ' ARG . 94.1 m-85 88.85 -41.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.463 1.105 . . . . 0.0 113.395 172.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 133.51 -129.86 5.5 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.304 -1.427 . . . . 0.0 113.183 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 26.8 m 37.85 49.58 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.669 0.788 . . . . 0.0 111.458 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 259' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' B' ' 260' ' ' ASP . 34.9 tt0 67.68 -85.17 0.03 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.518 -175.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 260' ' ' ASP . . . . . 0.546 ' HB2' ' HD2' ' B' ' 254' ' ' LYS . 2.6 p30 174.26 150.34 0.09 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.276 0.63 . . . . 0.0 109.959 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.5 -177.89 37.5 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.098 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 22.9 p -75.38 167.29 22.19 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 122.79 0.436 . . . . 0.0 110.859 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 263' ' ' VAL . . . . . 0.521 ' O ' ' HG3' ' B' ' 267' ' ' ARG . 99.4 t -61.93 -48.89 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -70.82 -40.3 72.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.769 0.319 . . . . 0.0 111.021 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -67.34 -40.69 91.77 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.425 ' O ' HG23 ' B' ' 270' ' ' VAL . 51.2 tp -61.78 -46.07 91.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.614 0.245 . . . . 0.0 110.961 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 267' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' B' ' 263' ' ' VAL . 44.8 mtp180 -66.17 -40.39 90.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.402 -177.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -68.34 -42.57 79.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.295 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -67.0 -40.15 87.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.646 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.425 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.1 t -64.35 -41.87 93.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -56.97 -47.82 79.83 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.47 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 16.2 ptmt -67.48 -38.6 84.63 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -63.67 -41.45 98.18 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.927 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 274' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.9 mmm -65.11 -42.42 93.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.973 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.19 -35.76 78.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.873 0.368 . . . . 0.0 110.973 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -63.3 -42.81 99.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -65.94 -38.64 89.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.491 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.78 -40.77 96.36 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.699 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -57.29 -48.61 78.48 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.164 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.3 m -62.9 -44.26 96.57 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.776 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.75 95.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.067 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.58 -44.25 98.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 120.969 0.414 . . . . 0.0 110.347 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -62.15 -42.53 99.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.88 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -62.9 -41.35 99.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 110.916 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -60.96 -43.92 98.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.479 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 94.9 t -69.49 -43.85 80.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.926 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 287' ' ' LYS . . . . . 0.422 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.1 tttt -61.12 -46.81 89.05 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.145 -176.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 75.4 p -62.04 -43.36 99.01 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -64.88 -43.73 91.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.779 0.323 . . . . 0.0 110.685 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 290' ' ' ALA . . . . . 0.67 ' O ' ' HG ' ' B' ' 294' ' ' LEU . . . -63.45 -46.84 84.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.076 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 291' ' ' ILE . . . . . 0.422 HG12 ' O ' ' B' ' 287' ' ' LYS . 38.1 mm -64.04 -44.16 97.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.646 0.26 . . . . 0.0 110.648 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 292' ' ' GLU . . . . . 0.496 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 32.8 tp10 -60.22 -42.61 95.53 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.352 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.91 99.16 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.382 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' B' ' 290' ' ' ALA . 65.6 mt -63.5 -42.53 98.5 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.552 0.215 . . . . 0.0 111.413 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.92 -44.57 96.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.957 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 296' ' ' LYS . . . . . 0.496 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 67.8 mttm -63.78 -39.57 94.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.073 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -65.09 -40.76 95.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.125 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -137.06 100.86 4.39 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.05 98.81 11.98 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 8.6 tp -104.64 142.6 17.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.193 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.21 135.7 54.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.097 0.475 . . . . 0.0 109.799 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 90.3 t -109.88 132.91 21.14 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.37 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.58 132.27 51.1 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.421 2.081 . . . . 0.0 111.885 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.06 86.57 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.404 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.58 82.01 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.882 0.372 . . . . 0.0 111.399 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.29 -41.87 93.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.437 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 307' ' ' ILE . . . . . 0.4 ' O ' HG13 ' B' ' 311' ' ' ILE . 65.3 mt -65.12 -44.55 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.947 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -43.82 82.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.016 0.436 . . . . 0.0 110.958 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 31.8 m -61.56 -44.43 97.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.125 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 310' ' ' GLU . . . . . 0.539 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 52.0 mm-40 -68.29 -39.05 82.23 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.882 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.485 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.2 mt -62.29 -44.39 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.429 -177.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.499 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 20.3 t70 -62.38 -43.13 99.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.011 0.434 . . . . 0.0 110.872 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 91.5 t -64.88 -43.47 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.252 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 95.0 mt -62.24 -40.43 96.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.499 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 85.9 mtm180 -63.34 -40.94 98.68 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 316' ' ' ARG . . . . . 0.4 HH21 ' HD2' ' B' ' 316' ' ' ARG . 31.7 mtt180 -63.83 -39.93 95.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.717 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -63.02 -40.16 96.92 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.278 0.561 . . . . 0.0 109.914 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 -42.99 81.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 319' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -65.29 -37.35 86.88 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.333 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 320' ' ' GLN . . . . . 0.443 ' NE2' ' HG3' ' A' ' 45' ' ' ARG . 48.3 tt0 -62.43 -39.6 93.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.139 0.495 . . . . 0.0 110.431 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -86.99 -0.62 56.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.59 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -97.57 -2.41 41.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.166 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 323' ' ' GLY . . . . . 0.556 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 140.01 -6.51 2.86 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.608 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 95.22 29.16 9.15 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.71 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 325' ' ' ASN . . . . . 0.483 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 43.5 t-20 -72.38 123.33 22.83 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 326' ' ' GLU . . . . . 0.661 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 0.7 OUTLIER -116.72 152.71 33.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 0.1 OUTLIER 62.06 -34.3 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.832 1.653 . . . . 0.0 114.773 177.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 328' ' ' GLN . . . . . 0.483 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.9 mm100 -76.72 -5.62 48.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.259 0.552 . . . . 0.0 110.454 177.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -66.23 -13.76 60.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.273 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.411 HD12 HH12 ' B' ' 315' ' ' ARG . 54.2 tp -62.99 -35.97 81.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.417 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -66.86 -24.55 66.15 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.707 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 332' ' ' LEU . . . . . 0.479 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 72.3 mt -58.2 142.43 80.84 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.707 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 333' ' ' PRO . . . . . 0.477 ' O ' ' HD1' ' B' ' 337' ' ' PHE . 36.5 Cg_exo -60.86 137.62 73.73 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.287 2.658 . . . . 0.0 113.778 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 334' ' ' ARG . . . . . 0.457 ' HG3' HD13 ' B' ' 311' ' ' ILE . 26.7 ttt85 -74.14 -43.42 57.52 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.143 177.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.1 -37.42 85.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -170.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 71.5 mt -87.01 -3.57 59.1 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.524 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 337' ' ' PHE . . . . . 0.477 ' HD1' ' O ' ' B' ' 333' ' ' PRO . 56.5 m-85 -108.48 -22.09 12.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.084 0.468 . . . . 0.0 110.34 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.55 -29.1 67.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.33 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.66 -46.93 87.64 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.826 0.346 . . . . 0.0 110.814 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -76.72 -25.43 53.53 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.33 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.449 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.97 -42.09 99.73 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.469 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 342' ' ' LYS . . . . . 0.518 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.1 tttt -59.55 -47.09 86.9 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 343' ' ' ARG . . . . . 0.538 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.7 mmt85 -61.87 -45.3 94.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.201 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -66.6 -37.85 85.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 341' ' ' ALA . 96.0 t -65.2 -43.71 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 342' ' ' LYS . 71.1 t -60.78 -43.52 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.661 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.538 HG23 ' O ' ' B' ' 343' ' ' ARG . 75.1 t -59.23 -45.31 93.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.3 -43.92 98.4 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.069 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.83 -43.0 97.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.62 0.248 . . . . 0.0 111.448 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' B' ' 346' ' ' VAL . 97.0 mt -62.76 -46.26 88.87 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.895 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.39 -39.14 85.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.186 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.74 -42.15 97.85 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.357 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.26 -34.32 77.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.942 0.371 . . . . 0.0 110.923 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.2 -43.43 93.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.29 -44.51 99.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.748 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -70.64 -45.91 64.28 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 96.2 m -63.68 -45.0 92.09 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -95.23 4.17 53.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.245 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 53.48 54.19 10.46 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.95 0.5 . . . . 0.0 112.019 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.97 147.85 27.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.427 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.45 149.51 45.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.63 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.79 128.2 35.81 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 363' ' ' ASP . . . . . 0.526 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.6 t70 -95.9 111.25 23.29 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.403 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 364' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 52.9 mm-40 -61.64 -33.26 73.63 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.814 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 365' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 68.3 mm-40 -66.99 -40.26 87.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.937 0.399 . . . . 0.0 110.366 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -64.14 -38.19 90.18 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.664 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 367' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 363' ' ' ASP . 97.8 t -61.82 -41.16 89.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.788 176.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 368' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.8 mmmt -56.56 -44.26 80.79 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.269 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.8 -41.53 99.63 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.245 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.2 -42.8 99.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.808 0.337 . . . . 0.0 110.252 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.55 -44.43 96.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.775 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.38 -42.79 98.84 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.763 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.89 -38.32 86.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.988 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 58.6 ttm -65.79 -40.91 92.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.972 0.415 . . . . 0.0 110.289 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 375' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -63.0 -26.59 68.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.69 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.2 m -71.89 -7.17 46.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.031 0.443 . . . . 0.0 111.229 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.0 -0.27 57.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.711 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -118.23 173.56 6.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.802 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.16 -45.89 83.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.979 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 380' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 21.4 t70 -122.54 109.37 32.77 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 121.017 0.437 . . . . 0.0 110.663 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 381' ' ' PRO . . . . . 0.455 ' HA ' ' HB1' ' B' ' 375' ' ' ALA . 52.7 Cg_exo -56.01 -41.36 77.82 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.692 2.262 . . . . 0.0 113.132 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 382' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' B' ' 382' ' ' LYS . 32.1 mmtp -65.75 -41.99 91.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 15.9 pt-20 -62.47 -39.07 92.25 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.029 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.19 -42.64 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.784 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.17 -44.53 99.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.28 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.46 -39.26 77.85 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.826 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.95 -42.12 84.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.248 0.547 . . . . 0.0 110.018 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 388' ' ' TYR . . . . . 0.506 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 5.0 t80 -73.75 -41.72 62.11 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.005 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 31.3 p -80.33 -7.85 59.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.88 4.9 45.36 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.368 0.604 . . . . 0.0 110.721 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -124.47 112.65 17.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.857 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.56 -41.11 96.89 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -60.23 -48.91 79.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.631 0.253 . . . . 0.0 111.199 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.45 -40.85 98.23 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.371 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.569 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 93.5 mtp -60.94 -48.16 83.08 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.352 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.03 -38.82 72.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.264 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.98 -42.86 99.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.5 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 398' ' ' MET . . . . . 0.506 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 53.7 tpp -65.31 -39.48 92.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.668 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' B' ' 395' ' ' MET . 70.2 mtm180 -64.1 -36.48 84.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.755 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.1 -44.05 97.49 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.19 -45.45 90.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.864 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.95 -40.79 98.72 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.932 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 46.9 tp -64.16 -38.08 89.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.647 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.39 -43.13 96.94 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.441 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -65.48 -38.01 88.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.424 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -59.27 -41.34 88.66 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 120.758 0.313 . . . . 0.0 110.327 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.443 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.8 -47.36 81.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.17 -45.66 95.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.948 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -65.65 -34.54 78.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.117 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.03 -40.18 94.45 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.923 0.392 . . . . 0.0 110.638 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 411' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 407' ' ' ALA . 94.3 t -64.92 -42.29 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.338 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.67 -37.8 82.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.172 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -67.8 -14.94 63.37 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.913 0.387 . . . . 0.0 111.537 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -100.74 -37.89 8.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 110.86 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.65 175.66 9.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.156 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.47 113.98 22.16 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.094 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.9 t -99.22 107.86 21.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.039 0.447 . . . . 0.0 109.878 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -110.43 134.66 52.12 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -94.06 114.1 26.2 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.153 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -116.26 131.84 56.83 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.905 0.383 . . . . 0.0 110.598 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -76.92 147.63 36.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.229 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.0 t -157.58 165.83 34.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.61 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 26.7 p -86.73 166.51 15.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.967 0.413 . . . . 0.0 110.98 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -64.05 -28.61 69.9 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.8 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -62.41 -39.29 92.8 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.921 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.27 -33.94 76.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.029 0.442 . . . . 0.0 110.628 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.85 -31.09 69.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.686 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.5 mmt -65.6 -10.44 35.59 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.809 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -74.93 69.58 1.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.5 0.667 . . . . 0.0 109.21 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -100.77 17.88 20.88 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.519 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -63.99 -40.64 96.83 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.143 178.486 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.996 0.427 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 p -115.63 145.84 42.34 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.799 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.9 -52.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 66.5 179.21 0.21 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.114 0.483 . . . . 0.0 110.862 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 m -136.72 128.58 29.17 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.235 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.6 m -76.59 -68.49 0.59 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.831 0.348 . . . . 0.0 110.743 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -177.42 128.62 0.15 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.085 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.45 -115.94 8.46 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.932 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.42 -7.83 57.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 106' ' ' SER . . . -68.64 126.69 21.99 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.541 -177.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -135.59 159.22 42.28 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 122.909 0.484 . . . . 0.0 110.055 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.438 ' HG3' ' CE2' ' A' ' 105' ' ' TYR . 58.7 ttp180 -131.65 149.36 52.52 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.0 -83.64 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.006 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 m 46.84 79.31 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.059 0.457 . . . . 0.0 111.184 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.4 tp -113.33 135.25 53.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.894 0.378 . . . . 0.0 111.261 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.5 m -101.9 124.24 47.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.111 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.8 pt -128.92 160.68 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.552 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -73.17 155.78 39.28 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.905 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.69 83.79 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -64.18 -39.21 93.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.205 0.526 . . . . 0.0 110.446 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -65.8 -40.33 91.8 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.69 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 20' ' ' ALA . 77.3 mt -61.24 -48.83 87.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.53 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.03 -50.87 66.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.647 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.0 m -68.68 -51.06 45.98 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.6 -49.19 22.59 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -173.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.7 t -64.21 -43.39 97.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.59 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -58.98 -48.98 79.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.936 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -62.85 -42.14 99.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.266 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -66.62 -42.03 87.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.997 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.63 -42.86 99.83 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.89 -39.6 80.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.212 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -64.91 -42.0 95.11 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.5 m -67.05 -33.72 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.139 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.92 -41.12 95.82 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.087 0.47 . . . . 0.0 109.91 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.13 -29.57 69.33 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.37 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -58.75 -42.84 89.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.83 0.347 . . . . 0.0 110.593 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 t -92.27 -1.57 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.18 0.514 . . . . 0.0 110.241 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 61.62 29.72 18.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.844 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -101.51 5.56 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.914 0.388 . . . . 0.0 111.598 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -63.92 -31.24 72.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.601 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.68 -22.1 65.76 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.824 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -80.76 -6.11 58.04 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.44 ' HA ' ' OE1' ' B' ' 320' ' ' GLN . 22.7 ttt180 -97.46 90.57 5.1 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -92.59 76.43 5.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 169.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.69 105.65 3.12 Favored Glycine 0 N--CA 1.428 -1.841 0 CA-C-N 114.992 -1.003 . . . . 0.0 114.629 -172.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 88.4 tttt -64.46 -34.99 79.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 171.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' A' ' 54' ' ' VAL . 16.2 t -99.52 100.08 9.94 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.439 175.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 48' ' ' LYS . 17.2 Cg_exo -66.66 159.34 51.53 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.044 2.496 . . . . 0.0 112.495 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.549 ' HA ' HG12 ' A' ' 54' ' ' VAL . 45.7 mtt -60.05 -40.97 91.29 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -65.92 -21.04 66.41 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.17 -50.16 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.9 0.381 . . . . 0.0 110.928 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.612 ' HB ' HG12 ' A' ' 49' ' ' VAL . 12.6 p -67.46 -36.86 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.33 83.38 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -89.83 -1.71 58.05 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.571 -0.451 . . . . 0.0 112.212 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -101.33 -42.99 6.1 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 120.715 0.293 . . . . 0.0 111.556 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -97.49 5.1 50.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.469 0.652 . . . . 0.0 110.114 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.87 145.83 49.74 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.56 ' H ' ' HB2' ' A' ' 63' ' ' ARG . . . 72.52 -41.09 0.49 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.219 0.608 . . . . 0.0 111.699 -177.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 t -60.68 -46.62 89.65 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.856 0.462 . . . . 0.0 111.303 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 65' ' ' ASP . 8.1 p -124.97 18.77 4.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.662 0.744 . . . . 0.0 110.045 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.56 ' HB2' ' H ' ' A' ' 60' ' ' ALA . 13.2 ttt180 -65.89 -20.24 66.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.393 -174.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.58 -48.53 77.03 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.46 ' HB2' HG22 ' A' ' 62' ' ' VAL . 6.5 m-20 -67.3 -31.0 71.01 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.068 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.35 -43.34 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 99.3 mt -62.3 -39.72 93.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.77 97.7 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.446 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -62.69 -45.67 91.68 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 120.773 0.32 . . . . 0.0 110.984 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.64 -41.97 98.23 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.3 ttp -61.22 -46.06 91.97 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.965 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.2 m -63.37 -51.54 65.44 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.338 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -69.41 -38.21 77.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -65.37 -39.24 92.05 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.932 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.45 -47.17 87.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.46 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.6 tt -66.16 -38.63 82.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.25 -41.98 99.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.93 -45.33 89.74 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.435 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.4 pt -65.74 -41.35 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.47 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.43 -42.11 95.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.472 0.653 . . . . 0.0 109.379 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -59.41 -47.85 83.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.273 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -89.82 -0.86 57.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.425 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 65.4 36.8 6.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.81 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 98.1 mt -86.64 124.62 40.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.603 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -110.15 98.18 33.89 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.576 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 84' ' ' ILE . 19.7 Cg_exo -66.94 141.75 59.68 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.531 2.154 . . . . 0.0 111.819 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.29 103.3 15.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.913 0.387 . . . . 0.0 110.538 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -127.72 8.88 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.897 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.66 128.44 25.62 Favored Pre-proline 0 C--N 1.318 -0.786 0 O-C-N 122.916 -0.167 . . . . 0.0 110.613 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.16 144.76 82.59 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.451 2.101 . . . . 0.0 111.542 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.7 m -102.46 109.04 20.56 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.586 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 94.9 m-85 -86.45 91.59 8.58 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.68 106.59 2.54 Favored Pre-proline 0 C--N 1.324 -0.532 0 O-C-N 123.546 0.529 . . . . 0.0 111.189 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 91.0 Cg_endo -97.94 166.87 0.77 Allowed 'Trans proline' 0 N--CA 1.43 -2.214 0 C-N-CA 123.026 2.484 . . . . 0.0 111.299 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.06 -136.11 6.7 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 174.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.93 130.44 51.26 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -80.8 106.37 12.75 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.246 0.546 . . . . 0.0 110.771 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 97.7 mttt -84.87 147.71 26.65 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.65 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.6 tp -82.93 116.42 22.21 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.081 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.0 21.98 53.94 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.363 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . 37.0 tt0 -140.01 161.6 37.22 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.289 0.544 . . . . 0.0 109.793 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.97 142.79 54.58 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.853 0.359 . . . . 0.0 111.296 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -102.34 145.01 30.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.152 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.2 m -121.84 136.54 54.93 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.561 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 43.0 p90 -136.87 162.16 34.01 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.968 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.486 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 14.9 m -93.69 -69.9 0.73 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.2 p 49.28 101.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.179 0.99 . . . . 0.0 111.888 -173.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.32 113.98 23.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -172.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -156.27 145.8 20.84 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.858 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 65.97 143.64 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.4 m -129.4 157.44 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.842 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -165.11 100.79 0.8 Allowed Pre-proline 0 N--CA 1.466 0.372 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -88.23 158.91 6.95 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.973 2.449 . . . . 0.0 113.991 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -130.95 134.17 46.49 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -125.34 132.86 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -103.8 -78.92 0.55 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.549 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.6 mt 66.55 125.9 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.707 0.803 . . . . 0.0 112.964 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.22 155.47 47.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.4 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.11 9.56 86.5 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.04 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.22 -39.8 94.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.201 0.524 . . . . 0.0 110.885 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.4 mp0 -72.2 -10.51 59.88 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.116 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.61 13.42 33.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.746 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 94.8 mt -81.76 125.49 39.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.24 0.543 . . . . 0.0 110.936 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.24 122.58 47.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.35 134.01 67.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.621 ' OE1' ' HE3' ' A' ' 420' ' ' LYS . 41.1 tt0 -82.13 146.93 29.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.499 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -135.2 91.86 18.71 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.47 113.97 3.5 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.237 1.958 . . . . 0.0 112.1 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.9 mm -97.19 112.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.74 155.91 18.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.129 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -129.93 145.31 51.62 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.304 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.12 123.46 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.882 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 64.0 p -107.81 175.59 5.43 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.583 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -67.38 -23.61 65.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.7 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.57 97.0 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.106 0.479 . . . . 0.0 109.95 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.41 -40.73 97.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.454 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.07 -45.24 99.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.703 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.24 -43.13 96.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.52 0.2 . . . . 0.0 111.068 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.33 -42.83 99.08 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.602 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.58 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.8 tpt -63.38 -46.43 86.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.641 0.258 . . . . 0.0 110.803 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.58 -41.84 98.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.483 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.38 -47.68 84.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.218 0.532 . . . . 0.0 110.399 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.8 m -63.24 -41.06 99.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.909 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 140' ' ' MET . 92.6 mt -60.48 -42.44 96.26 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -73.06 -14.59 61.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.172 0.51 . . . . 0.0 111.11 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.18 -10.23 33.8 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.802 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -99.83 -27.9 13.4 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.626 ' OE1' ' HG2' ' A' ' 255' ' ' ARG . 11.3 mm-40 -137.38 168.14 20.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -168.77 -90.18 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.429 -1.714 . . . . 0.0 108.45 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.574 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 23.7 m -162.61 159.16 24.24 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.438 ' HA ' ' CB ' ' A' ' 243' ' ' ARG . 20.5 p-90 -109.02 147.62 32.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.632 ' H ' ' HA ' ' A' ' 243' ' ' ARG . 84.0 tttt -170.41 -75.88 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.48 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -172.27 163.98 5.82 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 43.2 tttp 58.59 62.45 1.94 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.968 1.307 . . . . 0.0 114.516 174.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 244' ' ' GLU . 28.8 t70 -173.22 141.31 0.92 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.593 0.357 . . . . 0.0 110.901 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.32 53.59 0.6 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.838 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.11 -28.58 15.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.225 0.513 . . . . 0.0 110.065 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.418 ' N ' ' HD2' ' A' ' 243' ' ' ARG . 23.7 t 66.62 135.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.106 0.962 . . . . 0.0 113.227 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.497 ' HG2' ' HG2' ' A' ' 243' ' ' ARG . 6.7 mm-40 -86.8 170.22 11.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.444 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.431 ' HB3' ' OE1' ' A' ' 161' ' ' GLU . . . -71.0 -64.61 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.173 0.511 . . . . 0.0 109.901 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.431 ' OE1' ' HB3' ' A' ' 160' ' ' ALA . 1.3 pm0 -86.94 37.54 0.76 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.291 0.567 . . . . 0.0 110.551 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.61 -42.83 99.81 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.926 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 64.24 72.32 0.46 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.153 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 17.4 t -84.06 127.38 39.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.825 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.3 m -78.2 103.98 8.49 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 62.6 mt -120.62 122.51 68.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.709 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.84 89.77 5.79 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 171.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -114.77 156.73 24.32 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.307 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 29.9 m -129.79 132.2 46.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.617 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.55 131.64 10.64 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.298 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.7 m -135.85 135.74 40.03 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.822 0.344 . . . . 0.0 110.769 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 90.6 t -111.86 103.16 15.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.566 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.405 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 78.0 m-20 53.16 34.88 18.43 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.957 177.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.2 -11.01 47.85 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.979 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.88 138.72 50.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.901 0.85 . . . . 0.0 110.949 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -86.31 148.08 25.77 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.456 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -110.75 179.65 4.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.426 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -55.8 -52.55 63.6 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -90.44 -159.78 35.9 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.888 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . 75.29 27.7 63.35 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.827 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -116.48 102.9 9.9 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.17 141.23 51.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.812 0.339 . . . . 0.0 111.065 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.2 m -138.61 128.08 24.61 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 59.93 29.83 19.38 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.005 0.431 . . . . 0.0 110.874 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -94.94 133.66 38.46 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.429 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.3 m -97.55 122.73 49.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.421 0.629 . . . . 0.0 111.283 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 54.6 tp -109.84 125.5 52.83 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.755 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -104.66 141.46 36.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 69.8 mtm -116.62 160.42 20.72 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.228 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.88 8.04 65.55 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.741 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.472 ' HB2' ' HG2' ' A' ' 193' ' ' ARG . 98.1 mt-30 -119.7 0.36 10.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.7 29.09 55.89 Favored Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.067 -1.063 . . . . 0.0 111.128 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.472 ' HG2' ' HB2' ' A' ' 191' ' ' GLN . 32.0 mmm-85 -70.06 -30.35 67.59 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 123.248 0.619 . . . . 0.0 110.341 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.433 ' HE3' ' HA ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -120.02 169.6 10.05 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.773 -178.578 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.6 mm -50.76 132.66 28.23 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.987 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.68 124.39 8.23 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.669 2.246 . . . . 0.0 112.325 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.46 -37.76 3.58 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.771 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -62.21 -47.65 83.5 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -77.77 -10.14 59.39 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.805 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 31.1 t70 -88.34 -34.3 17.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.165 0.507 . . . . 0.0 109.874 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.62 -28.83 73.96 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.461 -0.791 . . . . 0.0 113.581 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.88 -26.33 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.853 0.358 . . . . 0.0 110.956 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 200' ' ' ASP . 3.4 mtpm? -57.46 125.21 21.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.126 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.95 3.45 63.91 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.711 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -97.71 134.97 40.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.423 0.63 . . . . 0.0 111.883 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -90.77 160.24 15.9 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.258 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.88 138.26 57.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 110.706 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 73.53 24.04 75.7 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.898 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -118.74 101.95 8.47 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.398 0.618 . . . . 0.0 110.745 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.4 110.23 21.52 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.611 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -127.01 -10.78 5.97 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 75.3 p 57.24 164.78 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.792 0.837 . . . . 0.0 112.617 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 215' ' ' VAL . 10.9 tp -143.55 160.77 16.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -94.89 107.27 19.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.723 0.297 . . . . 0.0 110.645 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 71.3 t -121.49 122.41 67.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 6.5 m -95.55 -28.98 14.6 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -175.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 216' ' ' THR . 54.4 m-85 68.62 147.39 0.11 Allowed Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 121.009 0.433 . . . . 0.0 111.121 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.44 151.77 65.39 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.236 1.957 . . . . 0.0 111.926 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -65.12 -35.53 81.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.198 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.86 25.49 2.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.996 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -64.88 134.95 55.11 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -59.92 -15.64 23.31 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.78 105.68 17.85 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -56.61 -35.39 68.23 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.412 0.685 . . . . 0.0 111.158 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.445 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 16.0 p30 -76.91 -15.86 59.55 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.445 ' HG ' ' OD1' ' A' ' 225' ' ' ASN . 91.6 mt -115.37 5.68 14.65 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -69.53 114.53 7.84 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.434 0.635 . . . . 0.0 112.255 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.25 22.06 72.51 Favored Glycine 0 C--O 1.238 0.366 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.584 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 225' ' ' ASN . 99.1 mttt -107.7 138.77 43.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.981 0.391 . . . . 0.0 110.679 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -81.31 128.62 34.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.424 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -112.67 134.05 54.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.929 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.405 ' HE2' ' OD1' ' A' ' 173' ' ' ASP . 68.8 mttm -81.01 -44.57 17.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 212' ' ' THR . 76.0 m-85 56.58 95.73 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 121.057 0.456 . . . . 0.0 111.858 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.58 72.83 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.3 mm 61.87 92.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.109 0.564 . . . . 0.0 111.882 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -74.61 -43.48 55.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.117 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 13.2 tp 47.99 77.31 0.1 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.563 0.745 . . . . 0.0 111.567 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -71.18 -48.82 49.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -112.93 -81.17 0.59 Allowed 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.564 HG12 ' H ' ' A' ' 242' ' ' GLU . 41.2 t 81.23 150.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.713 0.805 . . . . 0.0 109.015 -173.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.79 -33.55 72.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.801 0.334 . . . . 0.0 110.466 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.564 ' H ' HG12 ' A' ' 240' ' ' VAL . 63.6 mt-10 74.62 152.75 0.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.089 0.955 . . . . 0.0 112.669 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.632 ' HA ' ' H ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -153.03 114.17 4.17 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.362 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 155' ' ' ASP . 39.1 tt0 -159.58 171.15 20.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 150' ' ' THR . 6.4 mp 70.81 108.17 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 123.59 0.756 . . . . 0.0 111.305 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.574 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 61.4 Cg_endo -81.16 101.02 1.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.026 1.817 . . . . 0.0 112.269 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.91 162.35 33.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.367 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.9 mp -84.28 88.55 7.24 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.822 0.344 . . . . 0.0 111.214 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 7.4 m -85.26 -75.89 0.34 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.724 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -177.95 -56.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.989 0.423 . . . . 0.0 110.558 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -73.71 14.64 0.35 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -78.06 -15.26 59.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.058 0.456 . . . . 0.0 110.302 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 43.0 pt -88.35 -14.23 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.098 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -138.34 94.11 2.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.628 0.728 . . . . 0.0 111.654 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.626 ' HG2' ' OE1' ' A' ' 148' ' ' GLN . 7.0 tpp180 -140.01 30.12 2.03 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.31 1.052 . . . . 0.0 108.923 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.15 15.16 9.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.201 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 77.02 15.97 81.19 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.119 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 55.9 t -99.87 141.29 17.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -54.86 -51.17 66.78 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 123.02 0.2 . . . . 0.0 111.069 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -175.61 162.44 2.77 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.265 0.353 . . . . 0.0 110.515 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -174.65 168.22 40.8 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.762 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 86.8 p -88.14 173.81 8.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.45 -48.7 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.56 -33.5 21.7 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.935 0.398 . . . . 0.0 110.322 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.4 -41.23 99.44 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.381 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.17 -44.45 96.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.588 0.233 . . . . 0.0 110.906 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -63.95 -42.64 97.26 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.211 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.4 -42.93 87.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.438 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -67.27 -40.14 86.15 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.906 0.384 . . . . 0.0 110.811 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 78.8 t -64.85 -42.75 95.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.785 0.326 . . . . 0.0 110.15 176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -55.76 -51.94 65.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.674 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.7 ptmt -65.63 -42.7 91.21 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.12 -39.45 94.05 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 96.5 mmm -63.9 -41.66 97.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 110.73 178.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -69.59 -31.65 69.93 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.972 0.415 . . . . 0.0 110.656 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -62.36 -42.2 99.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.98 -37.42 87.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.482 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 42.6 tp -62.39 -38.97 91.69 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.295 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -55.88 -46.92 78.16 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.209 0.528 . . . . 0.0 109.691 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.0 m -63.67 -43.92 95.27 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.65 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.56 92.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.184 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.47 -44.47 98.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.91 0.386 . . . . 0.0 110.465 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -64.64 -42.35 95.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.049 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -62.96 -41.32 99.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.155 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ARG . . . . . 0.511 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.2 tpm_? -60.18 -44.53 95.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.938 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.14 -43.85 78.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.903 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.95 -47.41 84.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.418 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.1 p -62.2 -44.38 96.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -65.96 -41.51 91.15 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.134 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.61 87.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.651 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 295' ' ' VAL . 32.5 mm -64.32 -44.02 97.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.307 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.4 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 19.5 tp10 -61.08 -46.35 91.02 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.615 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.91 -40.23 95.33 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.363 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 350' ' ' LEU . 0.7 OUTLIER -63.86 -42.61 97.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.443 0.297 . . . . 0.0 111.121 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 291' ' ' ILE . 75.1 t -64.13 -42.98 97.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 120.962 0.411 . . . . 0.0 110.687 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LYS . . . . . 0.4 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.4 mttm -62.71 -38.77 91.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.686 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.83 -47.7 77.03 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.069 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -130.03 99.35 5.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.656 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -94.82 107.74 19.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.3 tp -110.73 143.12 21.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.725 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -73.44 121.97 21.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.236 0.541 . . . . 0.0 109.807 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 43.9 t -86.74 134.18 38.04 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.066 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.09 138.12 84.33 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.527 2.152 . . . . 0.0 112.118 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.32 -29.99 70.84 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.904 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.01 68.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.619 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.4 mt -91.34 -34.19 14.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.27 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 71.4 mt -63.21 -51.88 65.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.723 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.36 -37.8 88.78 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 68.0 p -65.22 -46.65 79.78 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.72 0.295 . . . . 0.0 111.518 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.548 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 17.9 mm-40 -72.04 -33.21 67.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.431 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 70.7 mt -61.58 -43.74 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.516 0.198 . . . . 0.0 111.194 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.597 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 33.2 t70 -62.95 -40.93 99.15 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.687 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.54 -42.77 96.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.257 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 90.2 mt -61.64 -41.28 97.28 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.136 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 66.0 mtm180 -62.55 -39.72 94.51 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.916 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 90.8 mtt180 -63.27 -43.28 98.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.397 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -65.05 -44.67 88.26 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.03 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.53 -39.7 88.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.401 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.62 -36.27 83.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.779 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' GLN . . . . . 0.546 ' OE1' ' HA ' ' B' ' 45' ' ' ARG . 7.6 tt0 -62.83 -43.27 99.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.549 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.49 -23.6 61.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.183 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -77.29 -4.02 42.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.77 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 140.5 -22.58 2.7 Favored Glycine 0 CA--C 1.502 -0.733 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.687 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 116.25 29.45 2.33 Favored Glycine 0 CA--C 1.497 -1.066 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.547 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 41.6 t-20 -70.72 124.0 23.24 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' GLU . . . . . 0.721 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.7 tm-20 -127.24 145.5 50.75 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 1.7 ptpp? 69.4 -37.97 0.39 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 125.574 1.55 . . . . 0.0 113.158 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.547 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 14.7 mm100 -73.63 -9.06 58.29 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.299 0.571 . . . . 0.0 110.369 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -64.02 -18.9 64.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.332 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.49 -37.63 86.73 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.22 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.88 -16.44 63.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.904 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.7 145.58 98.7 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.14 134.74 57.87 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 123.018 2.479 . . . . 0.0 112.951 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.41 HH21 ' HD2' ' A' ' 334' ' ' ARG . 21.4 ttt180 -70.7 -39.49 73.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.133 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -58.83 -33.79 70.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.06 -6.5 57.74 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.963 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -117.13 -30.78 5.55 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.608 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.55 -34.95 79.44 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -63.06 -51.06 68.16 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.995 0.426 . . . . 0.0 110.822 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.72 -28.0 65.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.48 -41.75 97.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.416 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.2 tttt -59.87 -47.14 86.96 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.55 ' O ' HG23 ' A' ' 347' ' ' VAL . 18.6 mmt85 -63.25 -45.59 90.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -66.42 -38.65 87.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.0 t -64.76 -43.34 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.645 0.259 . . . . 0.0 110.706 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 342' ' ' LYS . 77.3 t -60.31 -42.9 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.519 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 343' ' ' ARG . 87.4 t -59.53 -45.68 93.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.69 98.97 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.412 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.92 -44.44 96.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.82 0.343 . . . . 0.0 111.19 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 294' ' ' LEU . 96.5 mt -63.92 -45.14 90.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.094 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.77 -40.99 92.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.9 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.5 98.59 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.86 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -66.3 -38.8 88.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.802 0.301 . . . . 0.0 110.723 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.96 -44.43 98.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.37 -43.83 98.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.805 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -66.54 -52.46 45.44 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.686 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.7 m -66.58 -46.17 76.86 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -87.35 -5.02 59.05 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.628 0.252 . . . . 0.0 111.377 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 59.11 70.22 0.66 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.276 0.56 . . . . 0.0 110.81 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.8 mt -101.46 124.36 47.02 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.783 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 144.15 44.06 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.082 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.04 114.96 4.48 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 367' ' ' VAL . 17.7 t70 -84.19 110.6 18.65 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.278 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 65.8 mm-40 -58.8 -39.1 80.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.068 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -64.65 -43.65 92.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 110.789 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -61.59 -41.25 97.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.021 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 363' ' ' ASP . 93.2 t -64.11 -35.62 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.704 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 31.0 mmmt -57.81 -45.01 86.7 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.657 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.88 -38.07 95.57 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.979 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.0 -42.68 99.91 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.068 0.461 . . . . 0.0 110.16 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.7 -43.3 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.939 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.48 -39.96 89.55 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.729 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.79 -40.72 92.23 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.702 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.8 ttm -66.59 -40.11 88.75 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 110.446 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.86 -27.14 69.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.657 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 49.3 m -74.98 4.23 6.96 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.686 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -97.62 3.94 50.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.796 0.331 . . . . 0.0 110.979 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -120.85 177.42 5.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.014 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.15 -46.14 90.29 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.642 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -128.92 120.11 20.24 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.274 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.56 -29.65 30.0 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.486 2.124 . . . . 0.0 112.896 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -65.83 -43.17 89.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -64.0 -37.39 87.25 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.349 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.35 -42.09 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.488 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.8 -44.24 98.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.093 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.86 -32.54 72.28 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -58.56 -46.72 86.29 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.128 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -68.49 -46.64 69.14 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.5 p -68.77 -17.01 63.96 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 7.91 45.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.074 0.464 . . . . 0.0 110.896 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -132.84 108.61 9.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.336 178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -62.98 -38.17 90.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -58.92 -50.76 72.82 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.827 0.346 . . . . 0.0 110.7 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.71 -39.56 94.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.399 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 90.9 mtp -61.69 -44.02 97.74 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.781 0.324 . . . . 0.0 111.278 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.57 -45.52 65.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.31 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -63.88 -42.58 97.45 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.008 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 43.6 tpp -64.9 -43.23 93.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.897 0.379 . . . . 0.0 111.132 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -66.02 -33.23 75.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.267 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.77 -44.96 93.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.26 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.52 -43.63 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.118 0.485 . . . . 0.0 110.57 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.63 -40.72 95.86 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.169 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.32 -38.46 91.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.625 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -59.84 -43.97 94.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.72 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -65.42 -35.15 80.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.763 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -60.99 -43.97 98.09 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.59 -45.9 84.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.165 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.1 -45.85 97.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.188 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -68.57 -27.99 66.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.018 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.54 -37.96 88.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.137 0.494 . . . . 0.0 109.84 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 89.6 t -66.19 -41.44 89.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.137 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.09 -26.44 66.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.019 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -77.39 -9.14 58.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.363 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -113.45 -31.73 6.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.82 169.23 18.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.674 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -84.59 108.61 17.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.788 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 64.4 t -84.58 128.72 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.122 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -130.38 146.8 52.01 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -121.91 123.18 41.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.705 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' LYS . . . . . 0.621 ' HE3' ' OE1' ' A' ' 126' ' ' GLU . 20.7 pttp -132.68 145.83 51.38 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.68 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -82.85 153.02 25.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -155.64 172.32 18.48 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 27.1 p -84.96 165.04 17.94 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.907 0.384 . . . . 0.0 111.161 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.78 -26.04 68.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.343 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -62.33 -40.42 96.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.608 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -65.77 -33.05 74.97 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.837 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.0 mp -74.66 -18.54 60.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.346 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.3 mmt -83.03 3.78 28.86 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -82.88 74.51 9.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.368 0.604 . . . . 0.0 109.607 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -101.28 17.75 21.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.238 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -69.93 -25.58 63.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.238 0.542 . . . . 0.0 109.685 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.729 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.69 179.392 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 120.685 0.279 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -108.68 114.85 28.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.087 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 22.4 m -123.68 135.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.092 0.472 . . . . 0.0 111.723 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 29.6 p -113.87 148.61 36.4 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.506 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.444 HG13 ' H ' ' B' ' 6' ' ' GLU . 6.4 p -151.41 -61.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.444 ' H ' HG13 ' B' ' 5' ' ' VAL . 54.2 mt-10 69.09 169.0 0.29 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.241 0.543 . . . . 0.0 111.494 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.3 m -128.78 127.76 42.62 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.171 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 23.0 m -74.51 -69.95 0.43 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.504 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -178.37 129.99 0.13 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.756 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.1 -119.03 11.0 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.697 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.66 -9.25 56.42 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' B' ' 106' ' ' SER . . . -67.49 126.62 25.19 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.283 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' B' ' 12' ' ' GLY . 0.0 OUTLIER -135.14 158.88 43.23 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 122.937 0.495 . . . . 0.0 109.898 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -129.04 151.38 49.8 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 54.1 t -102.52 -82.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.016 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m 46.51 82.38 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.184 0.516 . . . . 0.0 111.457 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 tp -116.77 135.14 58.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.985 0.421 . . . . 0.0 111.096 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.5 m -104.52 126.03 51.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.932 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 16.8 pt -129.27 160.18 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.702 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.575 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -73.2 156.02 38.99 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.573 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -56.07 -46.01 79.12 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -64.82 -38.66 91.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.387 . . . . 0.0 110.354 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 35.5 m -63.75 -39.73 94.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.718 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.575 HG13 ' O ' ' B' ' 20' ' ' ALA . 81.0 mt -61.23 -49.67 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.807 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.73 -48.24 69.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.729 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 20.0 m -65.83 -50.95 62.76 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.96 -49.34 18.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.21 -43.13 97.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -59.03 -48.67 80.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.719 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 33.3 m -63.07 -42.82 99.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.891 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -68.37 -40.08 81.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.761 0.315 . . . . 0.0 110.899 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.32 -43.1 99.62 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.68 -39.82 80.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.057 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -64.85 -42.01 95.23 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.59 -32.51 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.132 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.18 92.58 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.069 0.461 . . . . 0.0 110.033 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.88 -30.5 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.286 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -57.98 -41.52 83.12 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.038 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.8 -0.05 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.188 0.518 . . . . 0.0 110.407 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 61.09 29.1 18.71 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.405 ' H ' HG13 ' B' ' 41' ' ' ILE . 2.8 pp -101.57 4.94 10.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.143 0.497 . . . . 0.0 111.425 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.06 -33.02 74.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.598 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.14 -22.62 63.07 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.941 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -80.33 -6.56 58.17 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.63 0.252 . . . . 0.0 111.525 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.546 ' HA ' ' OE1' ' A' ' 320' ' ' GLN . 47.2 ttt85 -94.73 88.35 5.34 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 119.408 -0.917 . . . . 0.0 113.13 -177.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -89.86 86.53 6.66 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 169.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.15 102.59 2.91 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-N 115.134 -0.939 . . . . 0.0 114.84 -170.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.451 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 88.2 tttt -65.44 -34.95 79.5 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.566 HG12 ' HB ' ' B' ' 54' ' ' VAL . 19.3 t -101.87 100.2 14.08 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.278 175.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' B' ' 48' ' ' LYS . 18.6 Cg_exo -65.96 158.43 54.16 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.045 2.497 . . . . 0.0 112.607 -177.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.532 ' HA ' HG12 ' B' ' 54' ' ' VAL . 44.3 mtt -58.69 -41.69 86.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -65.99 -20.08 66.08 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.812 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -91.68 -50.33 12.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.079 0.466 . . . . 0.0 110.931 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.566 ' HB ' HG12 ' B' ' 49' ' ' VAL . 13.0 p -67.51 -36.76 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.38 87.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -90.61 -1.64 57.88 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.281 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -100.53 -42.15 6.69 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.638 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -98.17 5.37 48.58 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.545 0.688 . . . . 0.0 109.946 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.97 146.87 49.76 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.527 ' H ' ' HB2' ' B' ' 63' ' ' ARG . . . 72.76 -41.56 0.51 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.154 0.582 . . . . 0.0 111.443 -176.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 47.0 t -60.52 -48.74 80.43 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.813 0.445 . . . . 0.0 111.428 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 p -122.03 18.64 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.771 0.796 . . . . 0.0 109.859 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.527 ' HB2' ' H ' ' B' ' 60' ' ' ALA . 12.6 ttt180 -65.58 -20.23 66.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.59 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.68 -49.53 70.6 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.78 -32.41 73.93 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.93 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.58 -43.42 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.99 -40.01 94.16 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.79 -39.32 97.31 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.728 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.96 -44.99 94.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.681 0.277 . . . . 0.0 111.072 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.65 -41.93 98.2 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.7 ttp -60.65 -45.99 92.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.86 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 55.3 m -64.2 -51.75 62.2 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.375 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -69.32 -38.06 78.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -65.06 -39.53 93.4 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.597 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -60.26 -47.21 86.96 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.54 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 17.7 tt -66.02 -38.57 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.143 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.37 -41.67 98.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.76 93.0 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.597 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -66.73 -41.25 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.46 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.69 -42.64 96.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.573 0.701 . . . . 0.0 109.419 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -60.16 -47.78 84.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.576 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -89.24 -2.03 58.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.616 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 63.24 46.64 4.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.928 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.452 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 91.4 mt -98.45 122.21 49.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.118 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -107.46 100.1 32.07 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.709 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 22.8 Cg_exo -65.17 142.74 75.1 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.434 2.089 . . . . 0.0 111.443 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.37 110.89 23.35 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.882 0.373 . . . . 0.0 110.39 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.6 -113.99 4.0 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.121 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.43 125.67 14.52 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.55 144.34 78.68 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.428 2.086 . . . . 0.0 111.586 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 46.8 m -103.47 111.91 24.57 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.056 0.455 . . . . 0.0 109.824 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.503 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.1 m-85 -87.58 89.91 8.17 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.98 108.97 3.91 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.539 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.9 Cg_endo -100.98 169.3 0.35 Allowed 'Trans proline' 0 N--CA 1.433 -2.081 0 C-N-CA 123.178 2.585 . . . . 0.0 111.256 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.82 -120.73 3.17 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -141.94 133.04 26.15 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -80.08 107.58 12.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.366 0.603 . . . . 0.0 111.066 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' B' ' 101' ' ' GLU . 98.8 mttt -81.79 145.68 30.32 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 38.7 tp -82.78 108.31 16.04 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.868 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.49 14.64 49.87 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.778 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' B' ' 98' ' ' LYS . 39.7 tt0 -134.06 161.29 35.24 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.409 0.605 . . . . 0.0 109.923 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -66.73 143.03 57.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.011 0.434 . . . . 0.0 111.53 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -103.44 144.45 31.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.15 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.1 m -121.51 135.91 54.99 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.748 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -135.55 161.95 34.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.059 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.444 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 12.6 m -92.72 -70.44 0.7 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -175.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p 47.88 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.132 0.968 . . . . 0.0 111.811 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.55 116.61 24.79 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -172.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -157.98 147.52 19.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.562 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 65.02 143.16 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.08 157.0 42.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.75 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -165.64 97.08 0.8 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.054 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -84.56 158.58 12.46 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.972 2.448 . . . . 0.0 113.348 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -132.82 135.22 45.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 70.3 t -123.47 136.13 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -103.61 -79.74 0.53 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.537 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt 65.53 128.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.888 0.875 . . . . 0.0 113.113 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -143.39 156.51 44.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.047 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.73 8.46 87.69 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.05 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.83 -39.82 95.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.598 . . . . 0.0 110.229 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' B' ' 121' ' ' GLU . 1.3 mp0 -66.55 -21.23 66.15 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.497 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.27 13.76 34.09 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 96.8 mt -77.65 125.41 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.223 0.535 . . . . 0.0 110.683 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -113.52 123.25 49.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.146 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.7 144.65 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.653 0.263 . . . . 0.0 111.263 -174.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' GLU . . . . . 0.568 ' OE1' ' HE3' ' B' ' 420' ' ' LYS . 38.4 tt0 -93.75 142.8 26.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.594 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -128.93 93.23 37.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.63 112.64 3.28 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.218 1.945 . . . . 0.0 111.903 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 48.6 mm -95.43 111.47 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.63 158.39 16.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.116 -178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -132.79 146.52 51.91 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.035 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 85.5 t -85.22 123.1 39.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 72.8 p -107.28 177.73 4.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.981 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -66.04 -28.42 68.84 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.8 -40.07 93.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.025 0.441 . . . . 0.0 110.361 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.01 -41.53 99.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.606 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.48 -44.94 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.016 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.38 -44.22 92.8 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.84 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.83 -42.0 98.63 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.763 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.567 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.8 tpt -63.02 -45.45 92.27 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.603 0.239 . . . . 0.0 110.967 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.17 -42.54 99.43 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.499 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -61.83 -45.57 93.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' B' ' 147' ' ' GLN . 20.6 m -63.45 -41.21 98.64 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.833 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 144' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' B' ' 140' ' ' MET . 91.8 mt -60.43 -42.22 95.61 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -72.08 -17.34 62.01 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.066 0.46 . . . . 0.0 111.335 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.92 -9.28 40.64 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.801 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' B' ' 143' ' ' THR . 63.4 mt-30 -100.48 -27.55 13.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 148' ' ' GLN . . . . . 0.605 ' OE1' ' HG2' ' B' ' 255' ' ' ARG . 9.8 mm-40 -137.79 167.87 20.85 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -167.56 -90.97 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.664 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 150' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 26.8 m -163.15 155.28 18.09 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 151' ' ' TRP . . . . . 0.487 ' HA ' ' CB ' ' B' ' 243' ' ' ARG . 26.3 p-90 -106.28 147.66 28.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 152' ' ' LYS . . . . . 0.62 ' H ' ' HA ' ' B' ' 243' ' ' ARG . 83.9 tttt -170.62 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.602 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -172.21 164.29 5.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 46.4 tttp 58.0 66.39 1.12 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.838 1.255 . . . . 0.0 114.281 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 155' ' ' ASP . . . . . 0.522 ' HB2' ' HB2' ' B' ' 244' ' ' GLU . 27.8 t70 -177.96 146.48 0.42 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.182 0.593 . . . . 0.0 110.65 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.53 47.05 1.06 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.51 -0.853 . . . . 0.0 114.095 -176.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.03 -29.96 21.55 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.186 174.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.455 ' N ' ' HD2' ' B' ' 243' ' ' ARG . 22.5 t 67.31 135.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.267 1.027 . . . . 0.0 113.172 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 159' ' ' GLU . . . . . 0.495 ' HG2' ' HG2' ' B' ' 243' ' ' ARG . 6.8 mm-40 -87.67 169.36 12.19 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.833 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 160' ' ' ALA . . . . . 0.407 ' HB3' ' OE1' ' B' ' 161' ' ' GLU . . . -70.53 -66.17 0.64 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 161' ' ' GLU . . . . . 0.407 ' OE1' ' HB3' ' B' ' 160' ' ' ALA . 1.7 pm0 -86.06 40.18 0.85 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.447 0.641 . . . . 0.0 110.282 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.95 -43.46 95.75 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.305 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 63.65 74.75 0.41 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.952 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 17.3 t -87.55 125.82 41.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.745 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.2 m -74.91 103.6 5.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 71.0 mt -119.52 123.27 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.044 0.45 . . . . 0.0 111.598 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 167' ' ' ASP . . . . . 0.506 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 23.9 m-20 -96.41 88.28 4.69 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 172.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -112.49 156.12 23.13 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.633 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 36.7 m -130.54 131.71 45.2 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.849 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.2 128.94 8.72 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.181 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 18.5 m -136.19 131.38 34.54 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.828 0.347 . . . . 0.0 110.786 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.48 105.32 18.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.823 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 173' ' ' ASP . . . . . 0.517 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 69.5 m-20 52.64 30.36 8.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.09 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 108.5 -12.26 36.08 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.858 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -110.7 142.48 42.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.784 0.792 . . . . 0.0 110.422 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -88.94 148.45 23.8 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.33 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -113.25 177.2 4.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.194 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -55.88 -49.37 73.56 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -89.18 -165.16 40.92 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.798 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' B' ' 169' ' ' THR . . . 77.2 24.65 65.62 Favored Glycine 0 C--O 1.22 -0.734 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.245 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -115.52 102.45 9.8 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.7 144.16 48.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.847 0.356 . . . . 0.0 110.933 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.506 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 47.2 m -139.6 132.54 29.36 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.646 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 59.97 30.55 20.04 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.684 0.615 . . . . 0.0 111.415 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -95.69 133.88 39.26 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.801 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.7 122.59 50.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.352 0.596 . . . . 0.0 111.325 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 61.4 tp -109.43 127.72 54.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.758 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -106.39 140.75 38.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 71.6 mtm -116.24 162.53 17.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.883 0.373 . . . . 0.0 111.445 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 88.21 13.8 63.31 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 191' ' ' GLN . . . . . 0.459 ' HB2' ' HG2' ' B' ' 193' ' ' ARG . 97.9 mt-30 -125.33 -3.16 7.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.519 0.199 . . . . 0.0 111.376 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.16 33.21 33.16 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.89 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' B' ' 191' ' ' GLN . 37.8 mmm-85 -76.33 -24.41 54.27 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.486 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.9 169.65 11.38 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.288 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 47.0 mm -51.67 133.41 36.39 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.04 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -47.18 126.33 11.47 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.526 2.151 . . . . 0.0 112.118 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.66 -38.03 3.4 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.718 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -62.5 -48.58 78.94 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.112 0.456 . . . . 0.0 112.203 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -78.08 -9.95 59.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.826 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 200' ' ' ASP . . . . . 0.413 ' O ' ' HD3' ' B' ' 203' ' ' LYS . 31.0 t70 -90.45 -26.35 19.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.17 0.509 . . . . 0.0 110.204 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.23 -22.78 67.26 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.285 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.92 -26.86 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.602 -0.352 . . . . 0.0 111.093 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' B' ' 200' ' ' ASP . 24.3 mtpt -55.1 126.68 25.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.038 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.48 -9.06 71.83 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.757 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -85.86 134.47 33.9 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 117.466 0.633 . . . . 0.0 111.584 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' B' ' 209' ' ' GLU . 29.6 mmtp -91.6 161.38 14.95 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.354 -176.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.55 139.29 58.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.723 0.297 . . . . 0.0 110.325 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 75.89 17.65 79.95 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.798 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 209' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' B' ' 206' ' ' LYS . 42.3 tt0 -113.45 97.4 6.44 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.547 0.689 . . . . 0.0 111.141 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -88.91 108.06 19.34 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.947 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -129.13 -11.09 4.72 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -173.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 58.2 p 58.89 166.87 0.05 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.73 0.812 . . . . 0.0 112.655 -176.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.6 tp -146.0 153.81 13.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.465 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -88.1 105.88 17.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.771 0.319 . . . . 0.0 111.259 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 76.2 t -118.22 129.31 74.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 216' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 10.3 m -100.45 -34.95 9.73 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -175.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.6 m-85 70.64 144.08 0.1 Allowed Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 122.71 0.404 . . . . 0.0 110.917 -175.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 15.1 Cg_exo -69.02 152.18 73.17 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.259 1.973 . . . . 0.0 111.795 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -67.15 -33.46 75.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.411 0.624 . . . . 0.0 109.709 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -88.44 21.93 2.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.655 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -65.75 134.73 53.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.019 0.438 . . . . 0.0 110.57 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -61.53 -10.21 7.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.11 105.31 15.59 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' B' ' 227' ' ' LYS . 4.7 tp10 -56.04 -36.48 68.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.41 0.684 . . . . 0.0 111.685 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.436 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 18.7 p30 -80.38 -11.81 59.65 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.413 ' HG ' ' OD1' ' B' ' 225' ' ' ASN . 93.3 mt -115.47 1.69 13.7 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' B' ' 224' ' ' GLU . 20.4 ptmt -66.69 116.38 7.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.232 0.539 . . . . 0.0 111.722 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.26 26.51 70.58 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.928 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.436 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 98.9 mttt -111.74 134.9 53.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.083 0.441 . . . . 0.0 110.585 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -77.29 131.82 38.34 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.897 0.38 . . . . 0.0 111.245 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.02 135.17 54.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.484 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' LYS . . . . . 0.517 ' HE2' ' OD1' ' B' ' 173' ' ' ASP . 68.9 mttm -80.8 -44.8 17.95 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' B' ' 212' ' ' THR . 76.4 m-85 56.35 95.09 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.015 0.436 . . . . 0.0 111.894 -177.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.422 ' HA ' HG22 ' B' ' 212' ' ' THR . . . -61.36 -50.17 74.0 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.8 mm 61.52 91.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 123.472 0.482 . . . . 0.0 111.953 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -72.69 -42.48 64.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.338 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 12.4 tp 48.21 84.83 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.821 0.848 . . . . 0.0 111.295 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.76 -59.74 2.66 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -174.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -102.55 -79.23 0.53 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.548 HG12 ' H ' ' B' ' 242' ' ' GLU . 39.3 t 77.32 150.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -172.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.97 -33.35 71.96 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.737 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.548 ' H ' HG12 ' B' ' 240' ' ' VAL . 62.5 mt-10 73.89 154.33 0.15 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.721 0.808 . . . . 0.0 112.168 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.62 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 0.0 OUTLIER -156.1 110.36 2.81 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' B' ' 155' ' ' ASP . 31.9 tt0 -153.42 170.25 21.17 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' B' ' 150' ' ' THR . 6.4 mp 73.64 112.23 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 123.582 0.753 . . . . 0.0 111.557 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 246' ' ' PRO . . . . . 0.529 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 74.5 Cg_endo -83.07 97.28 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.292 1.994 . . . . 0.0 112.711 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 247' ' ' GLU . . . . . 0.451 ' H ' HG21 ' B' ' 150' ' ' THR . 11.2 pt-20 -132.12 163.47 28.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.733 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.2 mp -86.32 90.2 8.1 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.049 0.452 . . . . 0.0 110.797 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 5.3 m -85.88 -75.52 0.37 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.719 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 177.74 -50.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.06 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.3 3.44 3.66 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.642 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -71.49 -17.92 62.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.221 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 40.5 pt -87.15 -15.85 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.117 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -138.06 90.92 2.52 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.608 0.718 . . . . 0.0 111.986 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 255' ' ' ARG . . . . . 0.605 ' HG2' ' OE1' ' B' ' 148' ' ' GLN . 6.9 tpp180 -137.36 35.43 2.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.284 1.04 . . . . 0.0 108.968 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -127.87 17.65 6.76 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.825 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 72.98 23.63 77.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.545 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.12 137.21 40.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -52.7 -49.37 65.49 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.517 0.51 . . . . 0.0 111.378 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.6 p30 176.95 152.93 0.21 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.847 0.459 . . . . 0.0 111.043 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -169.39 167.32 40.4 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.983 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 26.9 p -83.38 170.93 14.01 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.597 0.199 . . . . 0.0 110.691 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 96.9 t -62.13 -51.85 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.0 OUTLIER -77.6 -36.38 51.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.04 0.448 . . . . 0.0 110.618 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.77 -39.79 97.81 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.48 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.42 ' O ' HG23 ' B' ' 270' ' ' VAL . 54.7 tp -61.7 -45.3 94.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.6 0.238 . . . . 0.0 110.861 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -64.72 -41.24 96.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.661 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -67.76 -43.29 80.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.556 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -67.89 -39.89 83.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.823 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.42 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.2 t -64.83 -41.72 92.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -55.43 -51.8 65.69 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.589 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.5 ptmt -66.0 -42.84 89.23 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -64.9 -38.26 90.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.0 mmm -63.67 -41.35 98.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.877 0.37 . . . . 0.0 110.164 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.3 -31.27 69.64 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.558 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -61.87 -42.77 99.46 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.4 -38.13 89.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.34 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.04 -38.2 87.84 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.272 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -56.51 -47.5 79.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.014 0.435 . . . . 0.0 109.947 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.2 m -64.61 -43.76 92.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.809 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.05 87.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.262 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.24 -44.56 99.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.968 0.413 . . . . 0.0 110.471 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -65.02 -42.01 94.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.58 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -62.82 -40.85 98.65 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.674 0.273 . . . . 0.0 110.859 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 285' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' B' ' 285' ' ' ARG . 1.5 tpm_? -59.7 -44.43 93.69 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.642 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 99.4 t -70.22 -43.61 78.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.871 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.92 -47.52 84.54 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.333 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 78.0 p -61.94 -44.82 95.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.69 -41.24 92.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.62 87.9 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.539 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 291' ' ' ILE . . . . . 0.48 ' O ' HG23 ' B' ' 295' ' ' VAL . 33.1 mm -64.9 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.201 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 292' ' ' GLU . . . . . 0.468 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 34.6 tp10 -60.29 -48.19 82.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.36 -41.06 96.75 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.515 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.52 HD13 HD13 ' B' ' 350' ' ' LEU . 4.0 tt -63.33 -42.07 98.94 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 0.48 HG23 ' O ' ' B' ' 291' ' ' ILE . 78.0 t -63.98 -42.74 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.954 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 296' ' ' LYS . . . . . 0.468 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 68.4 mttm -62.53 -40.83 98.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.871 0.367 . . . . 0.0 110.544 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.6 -50.23 67.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.533 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -125.47 99.86 6.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.713 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -96.5 112.03 23.92 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.5 tp -116.26 144.02 24.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.6 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.54 127.14 31.92 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.33 132.83 31.07 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.464 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.45 135.59 70.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.367 2.045 . . . . 0.0 112.042 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.45 -28.96 69.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.171 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.77 79.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.817 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 99.2 mt -82.42 -36.8 26.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.628 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 307' ' ' ILE . . . . . 0.454 ' O ' HG13 ' B' ' 311' ' ' ILE . 73.8 mt -61.93 -50.62 79.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.689 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.59 -38.76 92.11 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 59.0 p -64.1 -44.9 90.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.952 0.406 . . . . 0.0 111.165 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 310' ' ' GLU . . . . . 0.525 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 52.2 mm-40 -72.86 -32.48 65.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.275 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.454 HG13 ' O ' ' B' ' 307' ' ' ILE . 85.4 mt -62.11 -43.82 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.661 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.61 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 36.3 t70 -62.59 -41.72 99.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.365 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.21 -42.9 96.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.348 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 91.0 mt -61.55 -41.24 97.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.348 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.474 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 75.2 mtm180 -62.82 -39.77 95.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.771 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 316' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 90.6 mtt180 -63.16 -43.57 97.92 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.462 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -64.71 -44.02 91.58 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.14 85.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.34 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 319' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -64.65 -35.81 82.22 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.034 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 320' ' ' GLN . . . . . 0.44 ' OE1' ' HA ' ' A' ' 45' ' ' ARG . 7.9 tt0 -63.82 -41.87 97.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.349 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -72.19 -23.92 61.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.103 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -76.32 -3.83 38.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.284 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 139.68 -29.93 2.43 Favored Glycine 0 CA--C 1.501 -0.827 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.25 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 124.31 34.38 0.72 Allowed Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 325' ' ' ASN . . . . . 0.535 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 39.6 t-20 -73.83 118.11 16.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 326' ' ' GLU . . . . . 0.732 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 3.6 tm-20 -120.91 143.31 49.02 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 2.0 ptpp? 70.33 -38.93 0.43 Allowed 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 125.581 1.552 . . . . 0.0 113.019 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 328' ' ' GLN . . . . . 0.535 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.4 mm100 -73.85 -8.33 55.63 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.293 0.568 . . . . 0.0 110.767 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -67.13 -14.43 62.9 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.26 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.34 -36.39 83.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.468 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -71.39 -15.42 62.37 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.956 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.57 142.43 98.46 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.71 135.47 69.53 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.11 2.54 . . . . 0.0 112.898 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 27.7 ttt85 -70.42 -40.13 74.02 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.935 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -58.61 -34.59 71.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.55 -9.25 59.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.037 0.446 . . . . 0.0 111.755 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -114.57 -30.63 6.45 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.705 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -66.48 -34.21 77.42 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.98 -52.37 64.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.051 0.453 . . . . 0.0 110.707 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -70.46 -25.63 63.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.423 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.54 -42.28 99.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.329 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 342' ' ' LYS . . . . . 0.518 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.5 tttt -59.61 -47.12 86.84 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 343' ' ' ARG . . . . . 0.502 ' O ' HG23 ' B' ' 347' ' ' VAL . 17.3 mmt85 -63.57 -45.53 90.05 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -66.71 -38.88 87.6 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 341' ' ' ALA . 76.7 t -64.69 -43.0 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.655 0.264 . . . . 0.0 110.785 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 342' ' ' LYS . 78.1 t -60.05 -43.2 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.424 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.502 HG23 ' O ' ' B' ' 343' ' ' ARG . 88.0 t -59.68 -45.57 94.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.05 -42.28 99.64 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.313 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.71 -44.02 97.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 111.005 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.52 HD13 HD13 ' B' ' 294' ' ' LEU . 93.0 mt -64.14 -45.71 87.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.387 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.28 -40.66 90.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.027 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.92 -39.82 97.5 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.706 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.3 -38.74 88.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 110.836 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.28 -43.85 97.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.53 -43.78 98.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.882 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -68.54 -50.22 53.61 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.76 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 98.6 m -67.9 -47.16 69.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -85.79 -9.02 57.73 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.764 0.316 . . . . 0.0 110.964 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 59.42 73.0 0.5 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.684 0.754 . . . . 0.0 111.406 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.64 128.05 49.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 142.64 47.19 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.904 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -62.42 116.02 4.72 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 363' ' ' ASP . . . . . 0.471 ' O ' HG23 ' B' ' 367' ' ' VAL . 20.7 t70 -84.27 112.48 20.33 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.113 0.482 . . . . 0.0 110.846 -176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 364' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 17.0 mm-40 -58.06 -43.21 86.78 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.376 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -66.92 -37.82 85.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.826 0.346 . . . . 0.0 111.267 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -63.31 -41.71 98.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.039 0.447 . . . . 0.0 110.078 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 367' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 363' ' ' ASP . 97.6 t -64.06 -37.61 80.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.556 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 368' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.7 mmmt -56.4 -45.04 80.81 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.806 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.86 -38.22 95.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.094 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.44 -41.43 98.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.09 0.471 . . . . 0.0 110.388 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 371' ' ' ILE . . . . . 0.416 HG13 ' O ' ' B' ' 367' ' ' VAL . 62.2 mt -65.47 -42.98 94.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.509 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.38 -39.47 90.79 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.457 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -61.77 -43.13 99.45 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.079 0.466 . . . . 0.0 110.282 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 57.7 ttm -67.15 -39.25 86.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.913 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.0 -33.86 75.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.721 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 66.2 m -70.82 4.7 2.36 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -97.51 2.89 50.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.061 0.458 . . . . 0.0 110.712 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -122.24 174.89 6.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.733 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -61.95 -48.8 78.8 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.825 0.345 . . . . 0.0 111.002 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 380' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 27.0 t70 -123.79 115.22 28.07 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.48 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 381' ' ' PRO . . . . . 0.492 ' O ' HG13 ' B' ' 385' ' ' ILE . 37.3 Cg_endo -66.61 -29.56 43.61 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 122.231 1.954 . . . . 0.0 112.928 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.47 -42.9 91.77 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 12.3 pt-20 -64.34 -36.44 84.12 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.282 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.42 -42.01 92.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.388 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 385' ' ' ILE . . . . . 0.492 HG13 ' O ' ' B' ' 381' ' ' PRO . 89.6 mt -61.74 -44.1 98.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.985 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.35 -33.71 74.78 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.63 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -58.14 -47.05 84.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.277 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -69.44 -46.11 67.52 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 31.0 p -68.98 -18.1 64.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.75 7.15 46.4 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.926 0.393 . . . . 0.0 111.04 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -131.47 109.62 10.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.869 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -64.25 -38.51 91.32 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -59.9 -48.31 82.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.797 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.78 -39.86 95.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.048 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 90.8 mtp -62.58 -44.26 96.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.811 0.338 . . . . 0.0 110.905 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.74 -49.28 66.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.185 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.93 -43.23 96.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.546 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 44.0 tpp -64.22 -43.16 95.85 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.805 0.336 . . . . 0.0 111.084 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -66.27 -32.91 74.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.474 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.94 -44.75 96.82 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.769 0.319 . . . . 0.0 110.295 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 85.6 t -67.18 -43.65 88.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.458 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.31 93.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.958 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.81 -38.92 92.88 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.324 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.48 -43.24 97.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.872 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.48 -35.65 81.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.73 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -61.11 -42.74 99.07 Favored 'General case' 0 C--O 1.228 -0.06 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.402 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.85 -46.78 83.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.224 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 408' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 89.9 t -62.99 -46.18 96.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -67.03 -31.18 71.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.689 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.27 93.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.111 0.481 . . . . 0.0 110.311 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 411' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 407' ' ' ALA . 99.0 t -65.36 -41.53 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.168 177.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 412' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 97.9 mt -59.87 -27.05 66.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.206 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -78.17 -6.77 55.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 111.486 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -114.83 -22.95 9.39 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.881 0.372 . . . . 0.0 110.972 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.06 169.45 12.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.057 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -83.08 116.51 22.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.619 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 60.5 t -90.24 121.72 40.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.231 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 418' ' ' THR . . . . . 0.402 HG23 ' HG3' ' B' ' 126' ' ' GLU . 9.1 t -124.04 137.79 54.54 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.1 125.2 50.91 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.576 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 420' ' ' LYS . . . . . 0.568 ' HE3' ' OE1' ' B' ' 126' ' ' GLU . 20.3 pttp -135.44 149.91 49.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.578 0.227 . . . . 0.0 110.653 176.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.11 159.2 20.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.8 t -158.96 172.23 18.59 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.782 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 17.0 p -85.26 164.6 17.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.015 0.436 . . . . 0.0 111.355 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -65.32 -26.21 67.95 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.543 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -61.29 -39.96 92.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.649 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.42 -36.17 82.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.419 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.51 -22.67 62.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.203 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.8 mmt -77.03 -5.75 50.01 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -76.67 78.53 3.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.34 0.591 . . . . 0.0 109.636 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -105.12 14.72 28.73 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.124 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -64.12 -37.54 87.83 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.092 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.213 178.505 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.236 0.368 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 17' ' ' ILE . 11.8 p -97.95 137.12 37.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.791 0.329 . . . . 0.0 110.736 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -153.83 138.4 9.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 69.7 mm-40 -122.4 152.56 40.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.112 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.1 m -107.35 121.5 44.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.757 0.313 . . . . 0.0 110.168 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 m -78.29 -67.36 0.74 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.461 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -170.2 110.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.629 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.65 -110.95 3.31 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.081 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.401 HD23 HG13 ' A' ' 111' ' ' VAL . 90.4 mt -64.12 -39.18 93.48 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 122.655 0.382 . . . . 0.0 111.31 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -69.23 138.15 30.48 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 115.086 0.794 . . . . 0.0 115.086 -174.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 12' ' ' GLY . 7.9 mpt_? -140.85 170.31 15.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.057 0.943 . . . . 0.0 110.532 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 6.2 ttm180 -134.42 137.99 44.46 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -95.4 -84.76 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.183 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 p 43.12 91.87 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.512 ' HA ' ' OG ' ' A' ' 4' ' ' SER . 85.0 mt -113.0 131.47 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.162 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.7 m -103.01 122.89 45.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.415 HG13 HG12 ' A' ' 24' ' ' ILE . 16.9 pt -129.1 162.48 36.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.522 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -70.04 150.57 46.48 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.264 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -59.34 -39.34 82.84 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -64.95 -25.34 67.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.472 . . . . 0.0 110.414 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -87.53 -32.23 19.51 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.55 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.1 mt -62.26 -50.41 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.956 0.408 . . . . 0.0 112.007 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.477 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 32.3 mm-40 -82.32 -5.02 58.3 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.7 m -100.29 -69.43 0.77 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.029 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.68 -47.58 72.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 96.3 t -63.86 -44.13 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.798 0.332 . . . . 0.0 111.349 -176.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 18.1 ttmm -61.43 -45.72 93.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.969 0.414 . . . . 0.0 110.74 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.527 ' O ' HG12 ' A' ' 33' ' ' VAL . 18.1 m -63.51 -41.29 98.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.415 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -61.23 -38.22 85.88 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.053 0.454 . . . . 0.0 110.4 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.78 -41.58 99.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.954 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 30' ' ' SER . 8.9 p -71.54 -31.65 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.569 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -62.85 -44.03 97.21 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.491 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -71.29 -31.28 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.93 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.96 -44.61 92.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.203 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.93 -33.84 76.76 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.675 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.0 -35.47 76.93 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 110.327 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.2 t -91.9 -4.88 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.321 0.581 . . . . 0.0 110.119 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 63.61 26.55 14.69 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.687 0.795 . . . . 0.0 111.435 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.17 4.55 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.851 0.358 . . . . 0.0 111.564 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.57 -33.82 76.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.936 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.65 -6.61 67.08 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.894 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -90.12 -1.0 57.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.864 0.364 . . . . 0.0 110.769 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.4 ttt-85 -94.22 82.83 4.16 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.264 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.5 94.06 6.17 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.4 101.44 2.73 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -170.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -65.36 -40.78 94.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 168.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.505 HG12 ' HB ' ' A' ' 54' ' ' VAL . 23.9 t -96.04 111.32 55.88 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.504 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.35 142.87 97.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.501 2.134 . . . . 0.0 111.65 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.647 ' HA ' HG12 ' A' ' 54' ' ' VAL . 24.1 ttt -64.43 -39.19 93.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.556 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -66.99 -20.89 65.96 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.142 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.608 HG12 HH11 ' B' ' 193' ' ' ARG . 1.7 mp -92.85 -46.56 13.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 51' ' ' MET . 9.0 p -63.79 -32.44 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 120.753 0.311 . . . . 0.0 111.358 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.43 82.15 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.66 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -93.05 -25.29 17.99 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.305 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -63.04 -43.43 98.69 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.853 0.359 . . . . 0.0 110.596 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.97 13.98 18.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.565 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.618 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -49.52 -73.07 0.39 Allowed Glycine 0 C--O 1.221 -0.703 0 CA-C-N 115.598 -0.728 . . . . 0.0 114.569 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.26 -19.3 62.37 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.862 0.331 . . . . 0.0 111.807 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 t -63.03 -45.63 91.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.032 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.4 p -123.91 17.14 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.317 0.58 . . . . 0.0 111.121 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.618 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 37.2 ttm180 -58.92 -26.62 64.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.758 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -61.86 -52.45 64.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.304 0.574 . . . . 0.0 110.232 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' HB2' HG22 ' A' ' 62' ' ' VAL . 1.2 m-20 -71.85 -27.05 62.63 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.563 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 62' ' ' VAL . 88.5 t -63.78 -43.63 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.11 -39.84 93.88 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.49 -42.7 99.82 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.788 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.752 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 31.1 t70 -63.54 -43.94 95.64 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.737 0.269 . . . . 0.0 111.033 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.08 -43.85 98.26 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.476 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -67.23 -37.28 83.3 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.082 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.4 m -61.75 -43.3 99.12 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.406 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.752 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 46.2 mtp85 -64.59 -42.96 95.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.086 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -64.65 -40.44 95.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.95 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -59.81 -49.53 77.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.731 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 tt -69.03 -39.66 79.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.789 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 21.8 t0 -66.9 -41.82 86.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.258 0.551 . . . . 0.0 109.896 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.67 -41.24 92.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.727 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -65.68 -32.22 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.234 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.73 -43.55 96.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.176 0.512 . . . . 0.0 109.811 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 77' ' ' ASP . 58.7 mttm -63.83 -42.07 97.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.774 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -86.52 -4.24 59.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.895 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 64.14 36.34 9.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.367 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 98.2 mt -88.49 123.45 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.636 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -106.79 107.66 60.67 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -78.82 134.17 11.82 Favored 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 121.88 1.72 . . . . 0.0 111.406 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.94 88.28 7.26 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.165 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.72 -102.95 2.86 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.325 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.94 128.45 21.52 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 120.593 0.235 . . . . 0.0 110.924 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.07 -20.32 57.01 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.804 2.336 . . . . 0.0 112.154 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 51.3 m 68.35 95.68 0.06 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.335 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.491 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 97.4 m-85 -81.12 113.28 19.18 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.025 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.29 107.6 30.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.752 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 69.4 Cg_endo -95.65 163.71 1.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.323 2.682 . . . . 0.0 112.187 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -100.02 176.93 28.61 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.384 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.06 134.41 41.37 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -90.38 103.09 15.81 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.75 117.44 25.51 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.54 107.76 1.0 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.347 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.52 -15.71 19.72 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.988 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.93 173.79 6.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.991 0.395 . . . . 0.0 111.42 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.91 145.62 48.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.036 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -106.6 138.83 42.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.281 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.6 m -123.32 134.7 54.02 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.041 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -130.87 168.03 17.96 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.561 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.516 ' O ' HG12 ' A' ' 107' ' ' VAL . 37.7 m -87.04 -80.46 0.25 Allowed 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 106' ' ' SER . 3.7 p 56.37 121.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 C-N-CA 124.524 1.13 . . . . 0.0 111.376 -172.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -116.54 145.64 43.2 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.878 -0.513 . . . . 0.0 112.313 -172.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -155.4 -88.37 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -134.74 161.3 35.56 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -175.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.401 HG13 HD23 ' A' ' 11' ' ' LEU . 35.3 m -135.88 164.63 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.076 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -136.58 92.42 15.06 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -97.99 162.9 0.82 Allowed 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.471 2.781 . . . . 0.0 114.804 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.34 149.36 33.65 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.2 t -127.18 135.72 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -101.99 127.73 48.72 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.929 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.0 mt -118.33 134.79 54.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.603 0.239 . . . . 0.0 110.456 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -129.84 158.37 39.65 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.12 12.29 82.61 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.536 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.12 -41.24 97.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.945 0.402 . . . . 0.0 111.491 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -75.39 -8.29 56.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.051 0.453 . . . . 0.0 111.269 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.07 7.86 44.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.583 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 74.7 mt -83.89 119.0 32.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.01 0.433 . . . . 0.0 110.672 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -110.56 114.03 27.11 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.61 136.82 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.882 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -85.4 135.64 33.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.293 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HB3' HG13 ' A' ' 417' ' ' VAL . 83.8 tttt -127.39 95.97 34.58 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.42 121.55 8.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.161 1.908 . . . . 0.0 112.1 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.2 mm -103.79 112.64 38.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.49 159.83 37.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.784 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.71 165.45 27.23 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.415 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -84.72 110.75 19.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.2 p -92.06 173.59 7.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.396 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -62.99 -36.67 84.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.668 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.14 -36.11 80.8 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.893 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -62.78 -39.27 93.69 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.741 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.02 -43.58 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.085 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -59.4 -44.94 92.73 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.347 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.69 -41.26 99.85 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.013 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.626 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.3 tpt -62.19 -46.78 87.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.716 0.293 . . . . 0.0 110.605 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.08 -42.17 99.59 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.266 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.45 -45.74 92.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.527 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.0 m -63.64 -43.61 96.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.669 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 140' ' ' MET . 98.5 mt -61.32 -44.64 96.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.067 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -70.48 -37.81 74.29 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.994 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.35 -36.98 85.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.428 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -84.79 33.92 0.53 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -122.78 115.64 22.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.447 0.641 . . . . 0.0 111.877 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.08 -170.44 3.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.482 ' CB ' ' H ' ' A' ' 247' ' ' GLU . 15.3 m -141.91 167.48 22.04 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.695 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 21.8 p-90 -105.1 132.5 51.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 120.678 0.275 . . . . 0.0 111.376 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -160.55 -47.19 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.335 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -154.26 -175.67 5.51 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' A' ' 240' ' ' VAL . 33.0 mmtp -52.75 154.67 2.63 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 76.22 -168.85 0.08 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.307 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 243' ' ' ARG . . . 113.5 0.74 24.78 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.504 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 74.41 -40.51 0.45 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.891 0.876 . . . . 0.0 112.407 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.3 t 73.32 -61.19 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.399 0.68 . . . . 0.0 112.447 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.53 ' HB2' ' HG2' ' A' ' 203' ' ' LYS . 10.2 pt-20 54.15 -166.18 0.09 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.905 1.282 . . . . 0.0 112.729 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.467 ' HB1' ' CA ' ' A' ' 190' ' ' GLY . . . -78.6 93.18 4.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.784 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -151.13 -65.71 0.19 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.327 0.584 . . . . 0.0 111.181 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -110.93 -168.76 1.34 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.381 -172.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 20.2 ptt180 -106.11 133.5 50.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.841 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.4 m -128.58 144.74 37.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.137 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.5 m -78.69 111.28 14.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.047 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.5 mt -123.63 122.07 64.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.02 0.438 . . . . 0.0 111.058 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.35 78.84 2.24 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -97.42 153.64 17.98 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.293 0.568 . . . . 0.0 112.183 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.3 m -119.05 128.38 54.29 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.877 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.58 126.42 9.11 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.742 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 21.1 p -137.27 134.32 36.0 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.93 -84.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.889 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -108.86 -0.04 20.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.399 0.618 . . . . 0.0 109.959 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.2 -21.82 0.97 Allowed Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.927 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -99.93 151.88 20.81 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -81.12 153.81 27.09 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.697 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -118.05 167.67 11.25 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.708 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -57.95 -32.26 67.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.57 -175.29 32.55 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.35 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.17 30.47 46.22 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.187 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.36 104.5 14.24 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -121.09 142.4 49.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.271 0.558 . . . . 0.0 112.197 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.7 m -147.1 118.4 7.84 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.252 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.83 33.68 23.5 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.596 0.56 . . . . 0.0 110.798 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -91.88 124.68 36.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.22 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 6.6 m -93.61 116.16 34.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.388 0.614 . . . . 0.0 110.992 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 163' ' ' ARG . 63.4 tp -101.88 117.57 35.12 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.804 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.568 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -91.01 108.15 19.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 76.9 mtm -89.83 149.56 22.62 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.808 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.467 ' CA ' ' HB1' ' A' ' 160' ' ' ALA . . . 98.38 12.19 45.83 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.275 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -127.21 -1.93 6.37 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.431 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 75.53 57.97 4.03 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.646 HH11 HG12 ' B' ' 53' ' ' ILE . 33.8 mmm-85 -103.72 -3.88 24.44 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.463 0.649 . . . . 0.0 109.613 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.482 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -142.66 176.29 9.15 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.997 177.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.4 mm -58.27 130.47 83.96 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.29 130.15 27.92 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.301 2.001 . . . . 0.0 111.993 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.45 -36.62 4.21 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.937 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -63.81 -47.43 80.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.175 0.487 . . . . 0.0 111.664 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.71 -8.86 59.49 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.255 0.55 . . . . 0.0 111.212 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -92.62 -31.74 15.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.605 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -65.32 -30.23 77.19 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.912 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.74 -25.97 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.912 0.387 . . . . 0.0 111.043 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.53 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 54.1 mtpt -55.95 132.71 50.53 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.397 0.679 . . . . 0.0 111.552 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.35 -12.78 66.35 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.674 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -84.71 154.73 22.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.984 0.421 . . . . 0.0 112.133 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -93.86 163.98 13.29 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.32 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.17 92.73 1.76 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.119 0.485 . . . . 0.0 110.429 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.544 ' H ' HD22 ' A' ' 237' ' ' LEU . . . 113.19 18.35 7.27 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.52 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -102.19 116.02 31.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.915 0.388 . . . . 0.0 110.795 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -95.95 119.25 34.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.611 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -138.41 -15.17 1.26 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 30.1 p 60.98 162.79 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.978 0.911 . . . . 0.0 112.292 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -149.03 133.07 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.826 0.346 . . . . 0.0 110.729 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.54 112.09 16.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.96 0.41 . . . . 0.0 111.207 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 65.1 t -113.21 129.3 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 3.2 m -95.62 -22.98 17.24 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -173.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 229' ' ' LYS . 89.1 m-85 67.74 154.47 0.14 Allowed Pre-proline 0 N--CA 1.489 1.51 0 CA-C-O 121.005 0.431 . . . . 0.0 111.452 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.66 158.11 28.31 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.309 2.006 . . . . 0.0 111.54 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -66.21 -37.55 85.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.216 0.532 . . . . 0.0 110.08 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.31 45.96 1.31 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.058 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 21.5 t80 -82.72 135.87 34.88 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -60.16 -22.25 62.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.404 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -99.24 105.27 17.29 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 42.2 tt0 -60.99 -24.57 66.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.22 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -73.65 -24.21 59.96 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.512 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.0 mt -113.01 3.11 16.02 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.4 ptmt -68.27 118.11 10.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.731 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.83 29.0 74.13 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.389 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.432 ' O ' ' HD1' ' A' ' 217' ' ' PHE . 99.4 mttt -124.63 140.39 52.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 117.139 0.47 . . . . 0.0 110.483 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -85.74 130.2 34.62 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.7 130.71 56.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.734 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -72.12 -39.35 68.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 59.64 105.27 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.107 0.479 . . . . 0.0 112.031 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.55 -45.82 88.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.995 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.3 mm 60.75 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.766 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -106.3 125.99 51.68 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.677 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.544 HD22 ' H ' ' A' ' 208' ' ' GLY . 4.3 mp -98.55 114.5 26.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.95 0.405 . . . . 0.0 110.867 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -94.86 -59.35 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.594 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -91.06 -88.87 0.18 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.526 ' O ' ' HE2' ' A' ' 154' ' ' LYS . 58.5 t 65.61 120.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 122.829 0.452 . . . . 0.0 110.351 -175.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -79.17 -99.96 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -166.91 155.03 9.74 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.695 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 14.2 ptp180 169.11 77.48 0.0 OUTLIER 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.668 1.187 . . . . 0.0 112.856 171.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.01 158.64 43.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.4 tp 71.95 107.53 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 123.831 0.852 . . . . 0.0 111.773 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.2 109.11 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.194 1.929 . . . . 0.0 112.368 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.482 ' H ' ' CB ' ' A' ' 150' ' ' THR . 7.8 tp10 -111.37 -21.2 11.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.053 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 42.8 tp 74.47 126.53 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.558 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.441 ' H ' ' HE2' ' A' ' 252' ' ' PHE . 4.8 m -130.7 -110.68 0.26 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.904 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -175.29 -44.82 0.01 OUTLIER 'General case' 0 C--N 1.352 0.702 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.06 -29.43 65.38 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.441 ' HE2' ' H ' ' A' ' 249' ' ' THR . 55.4 p90 -66.55 -17.65 64.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.772 0.32 . . . . 0.0 111.711 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.09 -42.8 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 110.998 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.55 ' HD2' ' H ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -95.99 21.47 8.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.004 -177.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -69.12 -17.02 63.79 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.506 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.481 ' CE1' HD21 ' A' ' 266' ' ' LEU . 80.7 m-85 -59.02 -35.43 73.27 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.74 -28.44 15.41 Favored Glycine 0 C--N 1.322 -0.202 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.76 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.16 83.88 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.51 ' HG2' ' H ' ' A' ' 260' ' ' ASP . 13.8 tt0 55.09 -163.91 0.13 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.157 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ASP . . . . . 0.51 ' H ' ' HG2' ' A' ' 259' ' ' GLU . 4.0 p-10 -124.94 110.2 13.94 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.031 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -93.15 164.97 27.56 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.622 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.6 p -87.06 -173.26 4.35 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 122.465 0.306 . . . . 0.0 110.267 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.9 -47.74 92.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 120.862 0.363 . . . . 0.0 111.289 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.2 OUTLIER -88.2 -34.25 17.86 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.768 0.318 . . . . 0.0 111.02 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.66 -40.11 98.24 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.352 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.481 HD21 ' CE1' ' A' ' 256' ' ' PHE . 53.5 tp -62.46 -42.55 99.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.505 0.193 . . . . 0.0 111.092 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -60.89 -43.83 97.93 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.953 0.406 . . . . 0.0 110.083 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -67.88 -42.25 81.52 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.236 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 24.9 tp10 -66.74 -39.98 88.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.963 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.47 ' O ' ' HG2' ' A' ' 274' ' ' MET . 75.2 t -65.03 -43.22 96.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.943 0.402 . . . . 0.0 110.054 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -58.13 -47.39 83.45 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.127 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 16.3 ptmt -67.93 -41.5 82.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.622 0.249 . . . . 0.0 111.357 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -64.12 -39.24 93.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 270' ' ' VAL . 98.8 mmm -63.5 -41.92 98.53 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.567 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -67.68 -35.04 78.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.855 0.36 . . . . 0.0 110.228 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -61.56 -43.7 98.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 109.977 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -68.88 -37.49 79.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.064 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 38.9 tp -63.17 -38.62 91.91 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.794 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -56.1 -45.62 79.37 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.151 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.5 m -61.51 -40.52 94.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.496 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.56 -45.74 92.87 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.912 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.58 -45.21 98.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 110.179 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.496 ' HD2' ' OE2' ' A' ' 405' ' ' GLU . 0.8 OUTLIER -59.77 -46.71 88.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.136 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -64.91 -41.56 95.48 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.667 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -65.32 -41.43 94.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.873 0.368 . . . . 0.0 111.404 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.92 -44.06 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.166 0.508 . . . . 0.0 109.857 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.6 -47.54 83.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.629 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 55.2 p -62.41 -43.91 97.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -64.24 -42.15 96.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.768 0.318 . . . . 0.0 111.059 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.6 85.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 37.9 mm -65.42 -44.39 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.427 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.499 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 20.0 tp10 -62.56 -42.87 99.82 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.607 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.3 -43.51 98.98 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.98 -43.21 96.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.0 -44.99 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.391 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LYS . . . . . 0.499 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 67.5 mttm -64.33 -41.42 96.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.548 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.22 -43.96 69.56 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -127.59 98.8 5.34 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.683 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -93.23 103.15 15.43 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.2 tp -107.98 139.27 30.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.975 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -67.73 131.34 45.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.213 0.53 . . . . 0.0 110.706 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.16 135.75 21.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.062 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.0 138.35 85.53 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.388 2.058 . . . . 0.0 111.987 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.37 85.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.307 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.38 -45.85 80.36 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.025 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.68 -43.3 93.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.84 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 71.4 mt -62.34 -49.98 81.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.66 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -41.63 98.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.949 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 24.6 m -61.94 -45.63 92.86 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.616 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.644 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 27.2 mm-40 -73.11 -38.05 66.48 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -176.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.501 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 82.0 mt -61.74 -43.8 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -175.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 24.9 t70 -61.45 -42.62 99.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.097 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.4 -42.55 93.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 90.3 mt -62.15 -39.67 93.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.43 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 82.5 mtm180 -62.6 -37.46 86.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.071 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 91.3 mtt180 -64.09 -38.95 92.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -63.09 -46.1 88.98 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.383 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.8 -39.53 91.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.657 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.51 94.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.409 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -65.02 -38.86 92.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.175 0.512 . . . . 0.0 110.234 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.84 -17.93 59.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.922 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -78.16 -3.57 43.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.317 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.56 -11.27 4.62 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.356 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 111.88 34.62 1.99 Allowed Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.241 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -74.75 126.6 31.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.953 0.406 . . . . 0.0 110.097 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.48 159.36 36.53 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.538 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.1 OUTLIER 69.17 -47.07 0.58 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.27 -4.9 55.13 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.18 -24.64 66.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.442 0.639 . . . . 0.0 109.807 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.402 HD12 HH12 ' A' ' 315' ' ' ARG . 38.7 tp -63.94 -33.75 76.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.705 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -80.47 -9.58 59.76 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.905 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 94.4 mt -63.83 129.03 93.57 Favored Pre-proline 0 C--O 1.24 0.572 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.476 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 52.5 Cg_exo -54.84 127.24 25.39 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.848 2.365 . . . . 0.0 113.142 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -65.51 -43.97 88.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.002 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.4 pm0 -65.25 -24.76 67.41 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.0 -10.32 55.28 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -118.1 -15.95 9.82 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.976 0.417 . . . . 0.0 111.251 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.22 -25.17 65.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.497 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.8 -50.78 67.6 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.705 0.288 . . . . 0.0 111.06 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -78.91 -20.72 48.67 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.208 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.98 -41.85 98.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.444 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -60.41 -44.24 95.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.031 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 347' ' ' VAL . 17.9 mmt85 -62.41 -42.78 99.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.068 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.492 ' NH2' HD22 ' A' ' 314' ' ' LEU . 73.4 mtt180 -64.81 -41.77 95.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.675 0.274 . . . . 0.0 111.061 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 89.2 t -64.89 -44.62 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.769 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 342' ' ' LYS . 72.5 t -61.13 -44.22 97.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.934 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 343' ' ' ARG . 77.4 t -60.5 -44.67 96.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.09 99.73 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.175 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 93.7 mt -63.47 -42.71 98.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.899 0.38 . . . . 0.0 110.614 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.6 mt -63.13 -44.95 94.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.763 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.38 -42.02 96.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.968 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.18 -42.53 99.72 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.131 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.54 -39.24 85.02 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 117.053 0.426 . . . . 0.0 111.287 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 350' ' ' LEU . 73.0 t -60.79 -45.05 98.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.93 -44.22 97.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.687 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -65.48 -46.55 79.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 37.5 m -73.11 -44.25 60.57 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -89.27 0.63 56.63 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.777 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 56.99 67.01 1.05 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.304 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 91.0 mt -98.83 153.77 18.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.777 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -132.96 155.35 49.28 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.806 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.15 100.24 8.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 171.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 367' ' ' VAL . 26.8 t70 -83.16 115.96 22.14 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.127 0.489 . . . . 0.0 112.269 -173.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 68.7 mm-40 -61.35 -35.52 77.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.299 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.441 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 65.4 mm-40 -64.39 -41.71 96.53 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.093 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -63.13 -39.15 93.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.18 0.514 . . . . 0.0 109.842 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.539 HG21 ' HG2' ' A' ' 399' ' ' ARG . 89.6 t -61.78 -39.64 84.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.332 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.5 mmmt -57.68 -44.31 85.68 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.487 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.51 -40.09 98.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.848 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.6 -43.05 99.78 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.981 0.419 . . . . 0.0 110.281 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.27 -43.92 97.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.406 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.15 -41.0 97.33 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.56 -37.25 84.55 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.351 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 48.4 ttm -66.98 -43.61 82.6 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.091 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.87 75.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.123 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.6 m -68.27 -5.29 17.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.839 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -83.45 -12.48 56.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.498 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -106.35 172.99 6.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.533 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.24 -47.31 83.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.825 0.345 . . . . 0.0 110.985 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -123.62 113.55 28.86 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.548 ' O ' HG13 ' A' ' 385' ' ' ILE . 38.1 Cg_endo -66.75 -31.19 40.12 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.229 1.953 . . . . 0.0 113.402 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -66.27 -42.96 87.71 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.28 -36.19 83.3 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.994 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.38 -42.56 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.234 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 381' ' ' PRO . 68.1 mt -61.23 -46.76 95.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.279 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 46.2 mt-10 -63.32 -44.0 96.19 Favored 'General case' 0 C--O 1.215 -0.752 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.773 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.61 -46.76 86.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -66.28 -40.84 90.34 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.429 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 51.3 p -81.58 -2.44 50.05 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 98.6 mttt -103.48 10.64 37.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.049 0.452 . . . . 0.0 110.789 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -134.42 117.51 16.39 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.259 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -63.78 -40.64 97.17 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -58.1 -49.48 76.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.674 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.55 -42.73 98.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.2 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.526 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 89.5 mtp -63.9 -48.3 77.16 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -73.58 -39.39 64.68 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -174.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -62.36 -40.72 97.35 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 44.4 tpp -64.13 -41.47 97.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.66 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.539 ' HG2' HG21 ' A' ' 367' ' ' VAL . 69.1 mtm180 -64.35 -36.44 84.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.008 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -60.95 -43.77 98.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.583 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.17 -44.09 88.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.488 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -61.65 -41.83 98.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.95 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.87 -39.5 94.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.683 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.66 -43.93 93.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.906 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.496 ' OE2' ' HD2' ' A' ' 283' ' ' ARG . 29.7 mt-10 -65.18 -37.44 87.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.541 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -60.45 -43.35 96.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.526 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.42 -44.35 91.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.968 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 86.5 t -64.73 -45.11 96.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.989 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -65.32 -33.56 76.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.32 97.49 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.865 0.364 . . . . 0.0 110.482 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.91 -42.74 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.076 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.0 mt -61.45 -41.85 97.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.183 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.04 -23.85 67.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.706 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -95.18 -8.27 36.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.32 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.53 179.43 4.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.139 0.495 . . . . 0.0 111.757 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -82.41 133.46 35.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.689 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 127' ' ' LYS . 57.8 t -122.09 131.34 73.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -131.49 138.81 49.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.1 0.476 . . . . 0.0 110.921 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -93.58 118.82 31.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.663 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -136.33 132.93 36.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.843 0.354 . . . . 0.0 111.368 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -81.01 153.23 27.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.165 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 12.9 t -157.72 171.66 19.92 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 26.2 p -81.34 165.54 21.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.772 0.32 . . . . 0.0 110.21 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -66.04 -18.13 65.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.021 0.438 . . . . 0.0 111.26 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -62.25 -39.45 92.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.97 -38.31 90.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.19 0.519 . . . . 0.0 110.057 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.35 -36.2 83.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.488 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 5.9 mmt -65.31 -14.28 60.41 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.301 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -75.6 83.37 2.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -103.64 6.48 37.13 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.315 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -72.32 -44.83 62.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.532 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.149 -178.548 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.92 103.86 2.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 111.361 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.86 161.59 38.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.396 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.493 ' OG ' ' HA ' ' B' ' 17' ' ' ILE . 7.9 p -101.59 130.56 47.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.787 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.78 133.66 13.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.479 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 57.9 mm-40 -118.45 149.75 40.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.962 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 98.0 m -106.6 122.71 46.86 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 27.7 m -78.74 -68.54 0.64 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.363 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -166.23 110.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.582 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.81 -106.55 1.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.354 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.441 HD23 HG13 ' B' ' 111' ' ' VAL . 83.8 mt -70.34 -36.69 74.39 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.708 0.403 . . . . 0.0 112.048 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.453 ' C ' ' HD2' ' B' ' 13' ' ' ARG . . . -70.09 135.81 26.39 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 114.486 0.554 . . . . 0.0 114.486 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.453 ' HD2' ' C ' ' B' ' 12' ' ' GLY . 7.6 mpt_? -138.13 171.26 14.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.69 0.796 . . . . 0.0 110.415 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 9.8 ttm180 -135.75 138.54 42.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.77 -83.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.038 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p 42.23 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.493 ' HA ' ' OG ' ' B' ' 4' ' ' SER . 83.8 mt -110.91 130.56 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.23 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 37.6 m -103.17 123.61 47.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 20.6 pt -129.08 163.23 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.0 111.979 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.511 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -71.93 152.69 42.34 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.087 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.434 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -59.98 -36.65 77.62 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -63.02 -32.3 73.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.241 0.544 . . . . 0.0 110.217 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 17.3 m -82.51 -32.99 28.44 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.034 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.511 HG13 ' O ' ' B' ' 20' ' ' ALA . 81.5 mt -60.59 -49.98 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 120.881 0.372 . . . . 0.0 111.834 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.495 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 28.0 mm-40 -82.99 -7.51 59.66 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 53.2 m -97.97 -69.34 0.76 Allowed 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.41 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.99 -48.3 66.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 89.7 t -64.17 -43.62 97.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.513 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.495 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.1 ttmm -61.33 -46.49 90.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 0.0 110.564 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.501 ' O ' HG12 ' B' ' 33' ' ' VAL . 21.2 m -63.53 -40.39 96.92 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.451 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -60.68 -38.93 86.59 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.021 0.438 . . . . 0.0 110.609 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.78 -41.85 99.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.839 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.501 HG12 ' O ' ' B' ' 30' ' ' SER . 9.2 p -70.93 -32.9 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 120.224 -0.591 . . . . 0.0 110.894 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -63.56 -43.84 95.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.431 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 25.7 m -70.69 -31.76 47.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.054 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.64 -42.54 98.12 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.989 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.21 -33.68 76.3 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.689 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.07 -36.63 80.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.942 0.401 . . . . 0.0 110.447 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 t -89.34 -6.39 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.3 0.571 . . . . 0.0 109.967 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 63.05 30.4 16.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.939 0.896 . . . . 0.0 111.215 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -105.72 4.11 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -64.35 -34.19 77.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.808 0.337 . . . . 0.0 110.799 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.78 -19.72 65.57 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.686 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -80.69 -3.48 50.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.677 0.275 . . . . 0.0 111.502 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 66.4 ttt-85 -91.88 83.46 5.23 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 119.946 -0.701 . . . . 0.0 112.026 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.55 95.99 6.01 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.12 98.1 2.23 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 115.319 0.888 . . . . 0.0 115.319 -171.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -64.67 -40.8 96.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.486 HG12 ' HB ' ' B' ' 54' ' ' VAL . 14.7 t -94.06 111.34 52.8 Favored Pre-proline 0 N--CA 1.437 -1.121 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.245 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.76 141.54 92.19 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.413 2.076 . . . . 0.0 111.665 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.704 ' HA ' HG12 ' B' ' 54' ' ' VAL . 26.1 ttt -65.63 -38.92 90.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.699 -175.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -67.47 -18.36 65.04 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.646 HG12 HH11 ' A' ' 193' ' ' ARG . 1.8 mp -96.76 -46.05 12.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.52 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.704 HG12 ' HA ' ' B' ' 51' ' ' MET . 8.4 p -63.85 -32.19 56.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 111.093 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.29 81.46 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.464 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -95.19 -20.84 18.9 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.34 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -63.99 -44.0 94.0 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.769 0.318 . . . . 0.0 110.513 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -113.9 12.32 18.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.242 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.656 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -50.72 -69.25 1.15 Allowed Glycine 0 C--O 1.218 -0.845 0 CA-C-N 115.488 -0.778 . . . . 0.0 114.75 -175.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.65 -18.19 61.59 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 117.0 0.4 . . . . 0.0 111.759 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 29.2 t -67.37 -52.68 37.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.969 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.487 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.3 p -114.02 17.03 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.468 0.651 . . . . 0.0 111.193 -175.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.656 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 36.3 ttm180 -59.1 -33.26 70.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.986 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -59.28 -50.68 73.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.023 0.44 . . . . 0.0 110.275 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ASP . . . . . 0.46 ' HB2' HG22 ' B' ' 62' ' ' VAL . 1.8 m-20 -67.61 -34.03 76.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.36 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.487 HG23 ' O ' ' B' ' 62' ' ' VAL . 81.6 t -61.16 -43.66 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.62 -39.59 91.82 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.27 -41.99 99.72 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.707 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ASP . . . . . 0.701 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 28.4 t70 -64.22 -43.48 94.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.613 0.244 . . . . 0.0 111.076 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.37 -44.02 96.02 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.383 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -66.44 -37.24 84.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.101 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.6 m -62.25 -42.86 99.7 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.233 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.701 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 44.3 mtp85 -63.36 -43.71 96.87 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.031 0.443 . . . . 0.0 110.205 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -64.89 -40.75 95.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.092 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.8 -49.27 78.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.034 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.6 tt -68.63 -39.6 80.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.716 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.517 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 7.7 t0 -65.91 -42.51 90.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.293 0.568 . . . . 0.0 109.88 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.23 93.96 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.762 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 pt -66.53 -31.71 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.149 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.83 -43.31 96.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.112 0.482 . . . . 0.0 109.837 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' B' ' 77' ' ' ASP . 64.5 mttm -63.43 -45.2 92.01 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.849 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -81.62 -9.19 59.73 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.308 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 69.47 33.36 3.15 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.628 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 96.1 mt -84.84 128.87 38.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.955 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -112.29 101.4 52.08 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.632 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.42 143.62 53.1 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.503 2.135 . . . . 0.0 111.461 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.31 88.56 4.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.032 0.444 . . . . 0.0 110.752 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.22 -98.28 2.15 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.465 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.15 129.16 19.8 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.574 0.226 . . . . 0.0 110.948 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.78 -19.56 46.95 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.795 2.33 . . . . 0.0 112.034 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 34.1 m 71.02 95.51 0.07 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.192 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.492 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 98.5 m-85 -81.67 110.98 17.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.023 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.3 t -93.95 107.9 31.34 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.977 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 68.9 Cg_endo -96.2 159.28 1.33 Allowed 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 123.208 2.605 . . . . 0.0 111.707 177.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.94 177.6 34.19 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.089 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.48 136.16 44.14 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -88.14 106.43 18.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.659 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.65 117.09 28.27 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.68 111.35 2.71 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.006 0.432 . . . . 0.0 110.725 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.73 -10.58 35.09 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.023 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -114.44 175.68 5.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.998 0.399 . . . . 0.0 111.663 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -72.35 144.43 48.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.803 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -106.79 137.51 44.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.358 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.5 m -122.84 135.26 54.47 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.36 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -131.77 166.63 21.1 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.485 ' O ' HG12 ' B' ' 107' ' ' VAL . 32.1 m -84.16 -81.04 0.18 Allowed 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.485 HG12 ' O ' ' B' ' 106' ' ' SER . 3.6 p 55.62 117.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 C-N-CA 124.441 1.096 . . . . 0.0 111.709 -173.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -112.45 150.86 30.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -157.36 -90.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -134.42 162.32 32.56 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.441 HG13 HD23 ' B' ' 11' ' ' LEU . 33.8 m -137.32 164.97 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.89 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -138.9 94.84 9.89 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -97.57 163.43 0.89 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.52 2.814 . . . . 0.0 114.495 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -145.71 146.28 31.2 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 61.1 t -125.34 133.1 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.94 126.11 44.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.551 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 88.1 mt -115.03 136.07 53.53 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -132.31 159.44 39.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.489 0.185 . . . . 0.0 110.503 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.02 13.62 82.84 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.382 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.5 -40.18 95.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.012 0.434 . . . . 0.0 111.539 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -74.52 -4.91 39.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.321 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.33 12.75 35.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.853 0.359 . . . . 0.0 110.976 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 80.5 mt -87.3 114.7 26.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.163 0.506 . . . . 0.0 110.832 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -108.98 116.65 32.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 28.5 t -116.64 135.4 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.871 -173.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -79.67 143.2 34.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.187 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -133.37 98.08 15.62 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -67.77 118.44 5.6 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.321 2.014 . . . . 0.0 112.259 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.7 mm -102.82 114.34 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.25 161.15 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.851 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -141.72 155.06 45.66 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.876 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.04 120.92 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.9 p -103.49 177.67 4.77 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.206 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -62.29 -36.9 83.53 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.229 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.74 84.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.484 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -63.18 -39.73 95.48 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.401 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.7 t -63.34 -44.69 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.812 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -58.93 -47.37 85.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.347 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.95 -41.3 99.65 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.071 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.676 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.1 OUTLIER -62.33 -45.67 92.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.672 0.273 . . . . 0.0 110.534 178.292 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 94.4 mt -63.12 -42.26 99.51 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.949 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -59.07 -49.09 79.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.464 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.9 m -63.48 -43.85 96.11 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.796 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 144' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' B' ' 140' ' ' MET . 97.5 mt -61.14 -45.04 96.28 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -175.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -71.08 -37.86 72.43 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.893 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -61.78 -36.31 80.71 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.028 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -82.21 29.95 0.41 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.244 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -118.51 114.34 22.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.356 0.598 . . . . 0.0 112.179 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.92 -167.35 2.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.24 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 150' ' ' THR . . . . . 0.532 ' CB ' ' H ' ' B' ' 247' ' ' GLU . 22.8 m -144.38 165.98 26.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' TRP . . . . . 0.667 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 15.3 p-90 -102.08 131.97 48.22 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 120.723 0.297 . . . . 0.0 111.336 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 5.9 mtpp -162.48 -50.55 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.44 -175.09 4.95 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 154' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' B' ' 240' ' ' VAL . 34.2 mmtp -54.26 155.29 3.83 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 73.98 -168.33 0.11 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.487 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 156' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' B' ' 243' ' ' ARG . . . 113.86 1.18 24.19 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.548 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . 75.11 -40.3 0.43 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.834 0.853 . . . . 0.0 112.239 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 57.7 t 71.39 -59.73 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.584 0.754 . . . . 0.0 112.768 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 159' ' ' GLU . . . . . 0.546 ' HB2' ' HG2' ' B' ' 203' ' ' LYS . 9.4 pt-20 53.02 -164.73 0.08 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.688 1.195 . . . . 0.0 112.787 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 160' ' ' ALA . . . . . 0.407 ' HB1' ' CA ' ' B' ' 190' ' ' GLY . . . -80.75 92.8 6.09 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.699 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.97 -64.03 0.23 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.297 0.57 . . . . 0.0 110.902 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -111.0 -167.89 1.24 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.291 -173.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 163' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' B' ' 187' ' ' LEU . 24.0 ptt180 -107.79 132.17 53.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.818 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.92 140.85 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.63 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 9.5 m -76.15 109.93 10.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.217 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 84.3 mt -124.4 119.14 55.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.911 0.386 . . . . 0.0 110.794 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -95.47 75.99 3.32 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -90.59 150.64 21.64 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.349 0.595 . . . . 0.0 112.279 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 34.3 m -117.18 127.33 54.01 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.283 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.84 131.58 11.5 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.677 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 30.6 p -140.28 133.15 29.17 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 30.3 t -81.95 -84.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.954 0.407 . . . . 0.0 110.791 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -103.96 -21.3 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.505 0.669 . . . . 0.0 109.546 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.05 -16.41 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.808 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -100.34 148.53 24.59 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -82.69 149.34 27.39 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -116.37 172.18 7.36 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.35 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.31 -33.86 71.63 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.81 -178.23 32.15 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.546 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.05 29.49 41.46 Favored Glycine 0 C--O 1.224 -0.47 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.968 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.37 101.71 11.23 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -117.46 143.13 46.35 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 50.8 m -147.48 119.74 8.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.172 176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 58.07 29.97 18.6 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.429 0.456 . . . . 0.0 110.758 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -90.35 123.4 34.07 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.453 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 6.7 m -94.6 117.08 37.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.396 0.617 . . . . 0.0 110.832 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 187' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' B' ' 163' ' ' ARG . 55.2 tp -100.35 118.67 37.09 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.731 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 188' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' B' ' 193' ' ' ARG . . . -92.79 112.46 24.43 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 77.2 mtm -95.14 149.4 21.34 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.935 0.398 . . . . 0.0 111.906 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.407 ' CA ' ' HB1' ' B' ' 160' ' ' ALA . . . 101.55 4.28 52.63 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.396 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -119.24 -4.21 10.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.42 4.31 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.972 -1.109 . . . . 0.0 110.422 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.608 HH11 HG12 ' A' ' 53' ' ' ILE . 33.5 mmm-85 -100.89 -2.76 31.16 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.474 0.654 . . . . 0.0 109.925 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.452 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -142.63 175.07 10.09 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.981 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 45.4 mm -57.5 130.31 81.15 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.59 131.14 32.15 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.251 1.967 . . . . 0.0 111.793 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.42 -37.38 3.76 Favored Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.114 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -63.6 -47.76 80.12 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.051 0.426 . . . . 0.0 111.591 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.89 -9.42 59.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.038 0.446 . . . . 0.0 111.111 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -93.6 -30.07 15.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.247 0.546 . . . . 0.0 109.848 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.32 73.23 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.699 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.5 -26.06 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.065 0.46 . . . . 0.0 110.896 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.546 ' HG2' ' HB2' ' B' ' 159' ' ' GLU . 49.7 mtpt -54.73 130.73 41.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.571 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.55 -9.13 66.66 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.64 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.416 ' HA ' ' OE1' ' B' ' 209' ' ' GLU . 50.4 m80 -88.57 151.0 22.78 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 122.453 -0.44 . . . . 0.0 111.876 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -91.86 165.89 13.01 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.537 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.68 102.87 4.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 208' ' ' GLY . . . . . 0.571 ' H ' HD22 ' B' ' 237' ' ' LEU . . . 106.48 2.07 37.76 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 209' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' B' ' 205' ' ' HIS . 45.5 tt0 -87.95 119.44 28.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.162 0.506 . . . . 0.0 110.973 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.52 136.32 38.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.24 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -156.18 -15.2 0.1 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 30.0 p 61.6 159.17 0.05 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.959 0.904 . . . . 0.0 112.087 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.0 tp -146.47 129.96 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.984 0.421 . . . . 0.0 110.522 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -78.58 115.63 18.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.596 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 67.2 t -113.8 132.08 63.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 216' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 7.1 m -96.05 -30.57 13.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' B' ' 216' ' ' THR . 74.6 m-85 72.7 151.06 0.14 Allowed Pre-proline 0 N--CA 1.484 1.267 0 C-N-CA 122.708 0.403 . . . . 0.0 111.084 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.67 159.2 25.07 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.284 1.99 . . . . 0.0 111.49 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -65.0 -39.05 92.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.3 0.572 . . . . 0.0 109.987 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -88.75 52.45 2.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.66 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 25.7 t80 -91.26 132.94 35.81 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.441 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -90.87 103.61 16.3 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 45.4 tt0 -59.25 -30.42 68.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.323 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.481 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 31.2 p-10 -67.58 -24.43 65.5 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.671 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.8 mt -112.5 3.0 16.56 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.6 ptmt -66.89 112.75 4.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.129 -177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.06 23.18 76.15 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.045 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 99.1 mttt -117.98 128.85 55.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.9 0.35 . . . . 0.0 110.407 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -70.94 137.84 49.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.142 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.86 127.49 47.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.491 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -69.76 -40.24 76.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 58.95 103.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.045 0.45 . . . . 0.0 111.981 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.5 83.96 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.755 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 45.5 mm 62.58 83.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.739 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -109.0 128.08 54.64 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.564 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 237' ' ' LEU . . . . . 0.571 HD22 ' H ' ' B' ' 208' ' ' GLY . 3.8 mp -100.65 120.28 39.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.629 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -98.66 -56.25 2.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.439 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -94.86 -89.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.4 ' O ' ' HE2' ' B' ' 154' ' ' LYS . 59.3 t 67.43 120.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 120.994 0.426 . . . . 0.0 110.177 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -77.46 -92.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -174.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -173.04 155.78 3.11 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.667 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 14.8 ptp180 166.92 78.12 0.0 OUTLIER 'General case' 0 C--N 1.364 1.207 0 C-N-CA 124.782 1.233 . . . . 0.0 113.129 170.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.08 160.49 40.13 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.414 ' HA ' ' HD2' ' B' ' 246' ' ' PRO . 55.4 tp 70.1 108.06 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 123.67 0.788 . . . . 0.0 111.92 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 246' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' B' ' 245' ' ' LEU . 41.6 Cg_endo -68.44 111.51 2.55 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.251 1.967 . . . . 0.0 112.082 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 247' ' ' GLU . . . . . 0.532 ' H ' ' CB ' ' B' ' 150' ' ' THR . 6.4 tp10 -117.77 -13.09 10.16 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.438 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 41.7 tp 71.41 130.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.29 1.036 . . . . 0.0 112.848 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 249' ' ' THR . . . . . 0.526 HG22 ' H ' ' B' ' 250' ' ' ALA . 0.5 OUTLIER -142.96 -163.28 1.6 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.526 ' H ' HG22 ' B' ' 249' ' ' THR . . . -130.3 -21.63 2.88 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.59 -35.6 80.59 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 252' ' ' PHE . . . . . 0.444 ' HE2' ' H ' ' B' ' 249' ' ' THR . 55.7 p90 -65.41 -17.29 64.42 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.95 -42.57 97.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.968 0.413 . . . . 0.0 111.195 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 254' ' ' LYS . . . . . 0.572 ' H ' ' HD2' ' B' ' 254' ' ' LYS . 0.0 OUTLIER -97.76 18.58 15.37 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -68.9 -16.83 63.86 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.007 0.432 . . . . 0.0 111.61 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 256' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' B' ' 266' ' ' LEU . 85.3 m-85 -59.74 -30.63 68.96 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.1 -31.14 9.05 Favored Glycine 0 CA--C 1.51 -0.245 0 C-N-CA 120.196 -1.002 . . . . 0.0 114.048 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 26.2 t -81.23 85.57 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 259' ' ' GLU . . . . . 0.505 ' HG2' ' H ' ' B' ' 260' ' ' ASP . 12.5 tt0 53.72 -163.88 0.1 Allowed 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.681 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 260' ' ' ASP . . . . . 0.505 ' H ' ' HG2' ' B' ' 259' ' ' GLU . 1.4 p-10 -123.31 113.07 18.38 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.621 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -95.74 169.77 27.42 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.367 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 15.1 p -89.62 -173.75 4.07 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.9 t -60.53 -48.57 87.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.901 0.381 . . . . 0.0 111.339 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' B' ' 264' ' ' GLU . 0.1 OUTLIER -86.42 -34.09 20.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.905 0.383 . . . . 0.0 110.523 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.96 -39.98 98.73 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.481 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.436 HD21 ' CE1' ' B' ' 256' ' ' PHE . 54.8 tp -62.62 -43.28 99.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.736 0.303 . . . . 0.0 110.846 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -62.4 -44.01 97.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.83 -43.83 87.38 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.053 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -66.35 -40.79 90.05 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.433 ' O ' ' HG2' ' B' ' 274' ' ' MET . 73.6 t -64.85 -43.32 96.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.034 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -57.47 -49.32 76.66 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.616 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 16.1 ptmt -67.41 -41.92 84.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.65 0.262 . . . . 0.0 111.581 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -64.58 -39.39 93.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.789 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 274' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.0 mmm -62.33 -41.61 98.7 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -68.69 -34.94 76.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.752 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -61.85 -43.91 97.9 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -69.0 -38.21 79.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.199 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 45.0 tp -62.35 -38.34 89.14 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.79 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -56.55 -44.26 80.74 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.197 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 20.4 m -62.13 -41.59 98.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.533 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.27 93.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.84 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 282' ' ' ILE . . . . . 0.41 ' O ' HG23 ' B' ' 286' ' ' VAL . 67.8 mt -63.04 -45.71 98.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.271 178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 283' ' ' ARG . . . . . 0.515 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.9 OUTLIER -59.47 -45.84 90.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.05 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -63.91 -42.73 97.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.725 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -66.11 -39.58 90.04 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.54 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 286' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' 282' ' ' ILE . 97.9 t -65.78 -44.39 93.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.178 0.514 . . . . 0.0 110.01 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.28 -46.85 84.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.373 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 76.6 p -62.87 -42.78 99.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -64.05 -42.81 96.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 111.101 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.32 82.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.061 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 291' ' ' ILE . . . . . 0.442 ' O ' HG23 ' B' ' 295' ' ' VAL . 38.0 mm -65.28 -44.19 95.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.318 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 292' ' ' GLU . . . . . 0.407 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 18.1 tp10 -62.83 -43.48 98.67 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.972 0.415 . . . . 0.0 110.853 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.22 98.14 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.527 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 51.8 mt -63.25 -43.08 99.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 291' ' ' ILE . 84.1 t -65.34 -44.67 94.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.45 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 296' ' ' LYS . . . . . 0.407 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 67.3 mttm -64.35 -41.95 96.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.332 . . . . 0.0 111.685 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.88 82.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.651 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -127.6 96.6 4.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.643 0.259 . . . . 0.0 111.538 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -91.24 93.54 9.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.319 0.58 . . . . 0.0 109.591 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.0 tp -100.95 136.9 30.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.66 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.81 135.06 50.58 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.161 0.505 . . . . 0.0 110.54 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.08 134.09 20.59 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.194 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.58 134.98 67.16 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 122.353 2.035 . . . . 0.0 112.244 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.85 78.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.151 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.86 -45.2 82.61 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.002 0.43 . . . . 0.0 111.035 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.97 -43.08 88.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.93 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 307' ' ' ILE . . . . . 0.413 ' O ' HG13 ' B' ' 311' ' ' ILE . 71.7 mt -62.45 -49.55 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.731 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.22 -42.98 99.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.82 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 42.7 m -62.48 -45.84 91.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.903 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 310' ' ' GLU . . . . . 0.639 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 65.2 mm-40 -72.01 -36.68 69.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.474 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 85.0 mt -61.82 -43.94 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.568 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 25.2 t70 -60.99 -42.75 99.03 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.718 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.25 -42.65 91.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.655 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 91.0 mt -61.94 -39.9 93.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.813 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 84.1 mtm180 -62.62 -36.77 83.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.097 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 316' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 93.0 mtt180 -63.4 -39.81 95.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.576 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -63.16 -44.74 94.65 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.455 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.59 -39.66 88.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.749 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.84 92.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.4 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -64.9 -40.38 94.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.287 0.565 . . . . 0.0 110.143 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -72.38 -19.72 61.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.939 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -76.09 -6.78 52.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.744 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 136.85 -12.46 3.92 Favored Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.939 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 113.21 35.61 1.6 Allowed Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.102 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -76.48 123.26 25.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.978 0.418 . . . . 0.0 110.007 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 326' ' ' GLU . . . . . 0.402 ' CB ' HH22 ' A' ' 73' ' ' ARG . 0.1 OUTLIER -125.25 160.43 29.26 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.555 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.1 OUTLIER 69.49 -52.24 0.61 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.157 0.583 . . . . 0.0 112.534 -178.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 328' ' ' GLN . . . . . 0.435 ' HG3' ' HB3' ' A' ' 65' ' ' ASP . 15.4 mm100 -74.82 -4.32 37.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.96 -24.7 64.6 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.354 0.597 . . . . 0.0 109.624 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.45 HD12 HH12 ' B' ' 315' ' ' ARG . 39.1 tp -63.83 -33.89 76.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.623 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -80.99 -9.97 59.77 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.034 -177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 332' ' ' LEU . . . . . 0.444 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 93.9 mt -63.53 128.66 92.92 Favored Pre-proline 0 C--O 1.242 0.708 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.032 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.38 126.82 23.8 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.744 2.296 . . . . 0.0 113.025 -176.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -65.13 -44.03 89.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.062 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.89 -24.74 67.62 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.9 -8.02 57.65 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.829 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -121.21 -17.22 7.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.922 0.392 . . . . 0.0 111.506 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.05 -25.65 65.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.619 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.4 -51.53 68.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.822 0.344 . . . . 0.0 110.522 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -76.79 -23.06 52.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.124 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.469 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -61.74 -40.59 95.65 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.121 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 342' ' ' LYS . . . . . 0.445 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.2 tttt -59.82 -45.3 92.78 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.89 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 343' ' ' ARG . . . . . 0.517 ' O ' HG23 ' B' ' 347' ' ' VAL . 19.0 mmt85 -62.94 -43.21 99.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.246 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 344' ' ' ARG . . . . . 0.489 ' NH2' HD22 ' B' ' 314' ' ' LEU . 90.8 mtt180 -64.62 -41.36 96.24 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.114 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 90.5 t -65.2 -44.16 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.588 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 342' ' ' LYS . 76.6 t -61.5 -43.62 97.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.802 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 343' ' ' ARG . 70.4 t -60.22 -45.5 95.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.79 99.66 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.961 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 349' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 93.3 mt -63.28 -43.66 97.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.786 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.429 ' O ' HG23 ' B' ' 354' ' ' VAL . 97.6 mt -63.6 -45.64 89.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.967 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.1 -41.54 94.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.091 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.74 -42.86 99.81 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.115 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -67.48 -37.81 83.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.851 0.325 . . . . 0.0 110.948 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 354' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 350' ' ' LEU . 70.9 t -61.0 -45.54 98.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.18 -44.68 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.915 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.6 -51.8 56.94 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 96.6 m -66.47 -45.83 78.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -86.58 -6.86 58.77 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -175.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 63.37 69.57 0.56 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.295 0.569 . . . . 0.0 111.516 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.1 mt -101.25 160.03 14.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.87 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -137.07 155.0 50.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.461 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.64 104.61 11.28 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 171.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 363' ' ' ASP . . . . . 0.511 ' O ' HG23 ' B' ' 367' ' ' VAL . 32.8 t70 -87.05 114.74 23.92 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -173.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 364' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 57.8 mm-40 -59.73 -36.63 76.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.059 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 365' ' ' GLU . . . . . 0.442 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 6.1 mm-40 -63.31 -42.51 99.03 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 111.013 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -63.24 -39.72 95.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.091 0.472 . . . . 0.0 110.072 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 367' ' ' VAL . . . . . 0.536 HG21 ' HG2' ' B' ' 399' ' ' ARG . 70.5 t -62.81 -37.32 78.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.416 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 368' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.2 mmmt -57.4 -44.71 84.78 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.6 -38.85 96.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.082 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.76 -43.06 99.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.65 -44.19 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.095 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.51 -42.18 98.5 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.15 -37.65 81.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.894 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.4 ttm -65.83 -42.21 90.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.049 0.452 . . . . 0.0 110.719 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.28 72.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.044 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 50.6 m -71.6 -4.58 27.89 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.918 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -88.96 -4.02 58.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.877 0.37 . . . . 0.0 111.637 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -112.04 172.64 6.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.217 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.64 -48.38 72.35 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.717 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 380' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 21.4 t70 -127.82 116.4 20.78 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.041 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.48 -31.07 42.88 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.368 2.045 . . . . 0.0 113.165 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.1 -43.74 86.38 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 11.4 pt-20 -62.96 -38.86 92.8 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.891 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.91 -42.11 93.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.602 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.19 -44.19 98.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.413 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 36.7 mt-10 -64.95 -44.96 87.72 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.85 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.94 -45.77 89.62 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.16 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -66.59 -39.87 88.64 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.745 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 58.3 p -81.58 -3.36 53.1 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 390' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.3 mttt -104.13 13.34 32.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.003 0.43 . . . . 0.0 110.98 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -138.49 118.04 12.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.272 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.64 -41.52 98.24 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -56.17 -50.26 71.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.968 0.413 . . . . 0.0 110.93 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.07 -42.1 99.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.397 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.441 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.2 mtp -64.68 -53.94 39.49 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.05 -39.54 83.01 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -61.98 -40.67 96.41 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 48.6 tpp -65.26 -40.63 94.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.838 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.536 ' HG2' HG21 ' B' ' 367' ' ' VAL . 66.8 mtm180 -64.06 -36.21 83.25 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.121 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -61.39 -42.84 99.37 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.728 0.299 . . . . 0.0 110.206 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.33 -44.85 94.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.447 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.98 -41.3 99.51 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.097 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.31 -40.09 96.39 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.649 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.45 -43.44 96.85 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 405' ' ' GLU . . . . . 0.515 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 26.6 mt-10 -65.13 -38.17 89.79 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.616 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.73 -43.32 94.25 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 120.803 0.335 . . . . 0.0 110.38 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.95 90.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.224 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.32 -44.89 94.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.16 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 409' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 45.2 mt-10 -66.03 -33.12 75.07 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.004 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.02 96.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.386 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 95.4 t -67.45 -42.92 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.324 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.54 -41.21 97.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.002 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.83 -20.88 66.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.708 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -97.4 -6.87 33.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.301 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -111.21 179.98 3.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.267 0.556 . . . . 0.0 111.801 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.12 130.39 35.11 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.357 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 70.4 t -117.82 130.34 72.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 6.0 t -129.87 135.74 48.73 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.089 0.471 . . . . 0.0 110.674 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -93.32 123.56 36.69 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.238 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -138.88 133.41 31.91 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.807 0.337 . . . . 0.0 111.155 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -83.64 150.53 25.84 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.795 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -157.29 170.65 21.98 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 20.0 p -79.34 164.3 24.18 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.745 0.307 . . . . 0.0 110.284 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -64.33 -19.47 65.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.059 0.457 . . . . 0.0 111.009 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -61.31 -38.02 85.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.831 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -65.13 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.1 0.476 . . . . 0.0 110.238 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 8.2 mp -73.63 -20.47 60.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.7 mmt -78.25 -9.87 59.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -78.21 83.16 4.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.286 0.565 . . . . 0.0 109.841 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -106.09 4.02 28.72 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.532 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -67.47 -44.86 77.55 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.607 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.951 -179.536 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.235 0.295 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.8 m -125.43 97.33 5.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.896 0.379 . . . . 0.0 111.286 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.79 140.65 23.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.742 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.598 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 41.1 tt0 -145.18 169.95 17.18 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.6 t -103.93 157.16 17.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.806 0.276 . . . . 0.0 111.204 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.4 m -123.87 -71.19 0.73 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.835 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -153.56 120.76 5.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.45 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.74 -120.38 20.05 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.733 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 6.8 mp -87.75 -5.5 58.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -71.22 130.1 18.5 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.78 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 4.7 tpp180 -119.03 -161.81 0.87 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -146.38 128.32 15.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.29 -94.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.056 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 m 52.89 87.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.12 0.486 . . . . 0.0 111.603 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 tp -108.65 139.2 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.935 0.398 . . . . 0.0 111.567 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.6 m -106.65 125.73 51.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.1 pt -127.83 157.87 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.703 0.287 . . . . 0.0 111.587 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.538 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -77.3 161.83 27.78 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.479 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.03 -49.06 76.99 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.09 -34.7 78.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.961 0.41 . . . . 0.0 110.608 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -62.21 -40.1 94.97 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.758 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.3 mt -62.13 -48.96 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.168 0.508 . . . . 0.0 110.812 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -67.64 -40.11 84.6 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.008 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -79.65 -67.73 0.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.37 79.28 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -172.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.429 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 98.0 t -61.81 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.688 0.28 . . . . 0.0 111.694 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -63.4 -44.89 93.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.032 0.444 . . . . 0.0 110.306 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.5 m -62.79 -42.24 99.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.254 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -63.51 -36.41 83.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.776 0.322 . . . . 0.0 110.584 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.2 mt -62.48 -43.55 98.54 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.706 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.46 -35.02 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.936 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -63.49 -43.07 98.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.46 -29.32 34.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.923 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.95 -39.7 87.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.004 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.43 -21.55 58.1 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.075 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.81 -44.45 96.85 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.06 0.457 . . . . 0.0 109.876 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.4 t -91.75 -2.33 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.075 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 63.37 26.81 15.12 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.998 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.8 pp -101.12 7.64 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.578 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -63.57 -33.56 75.87 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.952 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.53 -0.58 67.96 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.749 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -94.47 -3.74 49.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.764 0.316 . . . . 0.0 111.192 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -88.04 122.66 31.88 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -66.92 -7.24 20.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -173.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.55 -34.95 3.7 Favored Glycine 0 C--N 1.315 -0.62 0 C-N-CA 120.381 -0.914 . . . . 0.0 114.212 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -63.69 133.87 54.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 117.49 0.645 . . . . 0.0 109.36 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.572 HG12 HG12 ' A' ' 54' ' ' VAL . 20.0 t 64.27 72.62 0.5 Allowed Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.565 ' O ' HG13 ' A' ' 54' ' ' VAL . 58.8 Cg_endo -69.62 161.42 45.98 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.381 2.72 . . . . 0.0 113.691 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.827 ' HA ' HG22 ' A' ' 54' ' ' VAL . 49.3 mtt -62.32 -34.65 77.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -175.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -62.96 -25.61 68.44 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.541 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -92.73 -39.6 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.183 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.827 HG22 ' HA ' ' A' ' 51' ' ' MET . 8.6 m -62.59 -33.05 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 120.659 0.266 . . . . 0.0 111.118 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.43 -32.9 72.88 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.707 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -100.33 -34.35 10.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.619 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -65.54 -43.08 91.08 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -125.61 20.54 7.87 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.737 0.303 . . . . 0.0 111.117 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.655 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -57.38 -45.64 92.69 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 114.536 0.575 . . . . 0.0 114.536 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.02 -19.64 20.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 117.538 0.669 . . . . 0.0 111.369 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 t -63.13 -44.68 94.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.125 -177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.5 p -120.58 19.47 5.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.496 0.665 . . . . 0.0 110.702 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 39.5 ttm180 -58.12 -29.51 65.57 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.627 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -61.08 -50.48 73.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.538 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.99 -20.74 57.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.046 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.7 t -63.66 -44.2 98.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 99.2 mt -62.63 -40.43 96.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.173 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.2 -43.85 98.54 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.283 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.713 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 37.2 t70 -64.16 -43.23 95.81 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.983 0.391 . . . . 0.0 110.279 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 98.1 mt -61.11 -42.25 98.19 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.871 0.367 . . . . 0.0 110.265 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.3 ttp -61.4 -45.56 93.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.815 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 m -62.43 -44.62 95.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.042 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.713 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 37.6 mtp85 -65.86 -43.65 87.77 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.078 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -65.87 -40.5 91.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.061 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -61.17 -48.16 82.83 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.502 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.0 tt -68.53 -39.47 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.498 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.449 ' O ' ' HE3' ' A' ' 81' ' ' LYS . 10.6 t70 -62.35 -41.68 98.78 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.332 0.587 . . . . 0.0 109.431 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -66.05 -45.62 80.74 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.703 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.2 pt -65.46 -29.75 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.933 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.26 -44.22 97.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.096 0.474 . . . . 0.0 110.766 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 16.2 ptpt -81.79 -24.41 35.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.59 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -87.82 -5.96 58.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.99 0.424 . . . . 0.0 110.437 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 64.2 40.55 6.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.669 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.4 mt -101.75 118.82 49.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.408 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -107.7 102.29 44.24 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.153 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.87 141.59 65.74 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.517 2.145 . . . . 0.0 112.159 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.98 90.5 8.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.375 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.1 -109.89 3.49 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.029 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.14 127.62 24.27 Favored Pre-proline 0 C--N 1.318 -0.775 0 O-C-N 122.852 -0.205 . . . . 0.0 110.991 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.64 161.39 45.42 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.737 2.291 . . . . 0.0 111.298 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -93.61 116.09 28.58 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.316 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.456 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 93.0 m-85 -94.11 127.66 40.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.62 98.31 36.58 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 120.893 0.377 . . . . 0.0 111.334 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 90.6 Cg_endo -97.3 171.69 0.77 Allowed 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 123.471 2.78 . . . . 0.0 110.981 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.66 -175.97 22.4 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.46 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -85.07 135.07 34.15 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -90.95 125.34 35.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.391 0.615 . . . . 0.0 110.876 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 97.8 mttt -113.49 124.05 51.48 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.1 tp -69.77 123.51 21.62 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.32 -16.3 56.91 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.231 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 50.4 mt-10 -113.34 178.83 4.14 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -86.44 168.64 13.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.972 0.415 . . . . 0.0 111.549 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -124.0 146.88 48.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.094 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.0 m -131.54 143.21 50.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.958 0.408 . . . . 0.0 111.241 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -138.43 154.12 48.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.571 ' O ' HG12 ' A' ' 107' ' ' VAL . 21.1 m -93.79 -74.87 0.52 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -175.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 65.41 142.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 124.012 0.925 . . . . 0.0 110.119 -172.256 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 42.8 mt-10 -119.87 129.9 54.61 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -164.17 146.01 8.82 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 64.31 158.76 0.09 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 175.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.48 156.42 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.548 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -158.19 106.12 1.71 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -82.9 151.63 14.41 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.897 2.398 . . . . 0.0 113.983 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -123.36 145.74 48.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.44 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.75 131.04 73.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.779 0.323 . . . . 0.0 111.801 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -108.22 -85.49 0.52 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.815 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.9 mt 57.44 114.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -132.34 153.66 50.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.146 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.06 19.16 70.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.52 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.43 -41.28 98.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.135 0.493 . . . . 0.0 111.079 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -73.9 -4.72 36.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.565 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -105.41 16.27 25.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.794 0.33 . . . . 0.0 110.99 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 89.7 mt -90.86 122.48 42.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.135 0.493 . . . . 0.0 111.091 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -110.47 124.06 51.06 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.54 133.91 62.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.772 0.32 . . . . 0.0 111.425 -175.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.38 134.0 36.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.54 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -128.0 98.2 27.76 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.871 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.86 126.95 11.76 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.358 2.039 . . . . 0.0 112.386 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.2 mm -109.94 120.92 61.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.622 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.59 162.55 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.334 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -136.7 149.85 48.13 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.088 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.2 t -76.03 127.48 37.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.2 p -113.84 177.25 4.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.245 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -63.29 -34.75 78.37 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.719 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.03 90.91 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.402 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -63.47 -41.99 98.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.572 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.44 -45.5 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.403 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.93 -43.12 99.06 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.543 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.81 99.72 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.307 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.591 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 3.3 tpt -62.65 -46.93 85.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.846 0.355 . . . . 0.0 110.621 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.75 -42.04 97.9 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.598 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -62.14 -43.32 99.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.148 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.7 m -62.66 -41.55 99.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.151 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.2 mt -61.23 -42.67 99.0 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -71.26 -22.17 62.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.369 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.77 -0.55 54.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.519 0.676 . . . . 0.0 110.077 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -116.47 20.95 13.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.954 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -122.33 95.68 4.74 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.526 ' HB3' ' OE1' ' A' ' 159' ' ' GLU . . . -140.68 159.08 42.98 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 173.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 247' ' ' GLU . 6.9 m -122.37 142.82 50.11 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.194 -1.003 . . . . 0.0 112.055 -175.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 41.0 p-90 -74.43 132.12 41.67 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.253 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 244' ' ' GLU . 64.5 tttp -162.84 -63.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 242' ' ' GLU . 40.8 mt-10 -116.17 -96.28 0.46 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -176.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 155' ' ' ASP . 23.3 tptm -92.34 -113.34 0.09 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -167.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 3.5 t70 -152.84 154.93 36.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.529 -172.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 164.22 -34.61 0.28 Allowed Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -152.76 140.2 19.65 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.437 ' HA ' ' HD2' ' A' ' 243' ' ' ARG . 58.1 t -129.9 125.98 61.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.225 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.526 ' OE1' ' HB3' ' A' ' 149' ' ' ALA . 4.4 mp0 -88.48 158.86 18.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.22 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -83.39 52.62 2.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.826 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.402 ' CD ' HH11 ' A' ' 255' ' ' ARG . 1.2 pp20? -162.53 9.1 0.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.181 0.515 . . . . 0.0 110.665 177.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 163' ' ' ARG . 15.8 t70 -104.12 -172.89 2.19 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.528 -175.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.402 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 42.8 ttm180 -121.96 117.44 26.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.601 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.11 130.03 63.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.449 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 55.9 m -86.76 117.56 25.59 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 83.5 mt -126.89 123.04 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.099 0.476 . . . . 0.0 111.702 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -95.13 105.47 17.4 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -124.52 149.58 46.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.476 0.655 . . . . 0.0 112.438 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.5 m -124.52 128.37 48.85 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.423 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.63 142.98 18.95 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.887 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 m -139.53 146.25 39.69 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.54 -86.21 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.328 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -99.44 -45.65 5.76 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.026 0.441 . . . . 0.0 110.003 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.2 15.29 0.23 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.766 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -138.81 148.63 44.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.561 0.219 . . . . 0.0 110.564 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.91 161.79 30.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.468 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -131.31 177.55 7.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.033 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.86 -35.19 72.55 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -105.39 -172.59 24.01 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.863 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.68 32.54 41.01 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.502 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -113.47 114.57 26.74 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.99 146.47 49.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.947 0.404 . . . . 0.0 111.534 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -143.03 122.08 12.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.727 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 59.99 34.82 21.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.665 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -89.08 132.52 34.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.847 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 88.3 t -96.19 124.46 48.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.901 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 63.5 tp -111.5 123.96 51.31 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.019 0.438 . . . . 0.0 111.285 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -111.22 112.23 23.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 73.0 mtm -84.64 160.04 20.46 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.684 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.34 -24.83 28.99 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.411 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -91.36 -6.34 53.12 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.25 46.12 13.47 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.035 -1.079 . . . . 0.0 111.662 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -85.44 -11.75 53.62 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.22 170.51 12.92 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.425 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.641 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.2 mp -55.66 132.31 71.92 Favored Pre-proline 0 C--N 1.323 -0.559 0 O-C-N 123.385 0.428 . . . . 0.0 110.063 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -48.36 129.31 19.16 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.264 1.976 . . . . 0.0 111.681 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.68 -33.86 5.91 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.699 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -62.27 -44.7 95.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.602 0.239 . . . . 0.0 110.655 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.56 -40.55 95.76 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.93 -33.25 75.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.006 0.431 . . . . 0.0 110.847 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.03 -22.77 70.82 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.183 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.16 -43.46 97.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -52.17 115.78 1.89 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.446 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 113.78 -10.81 23.22 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.188 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.625 ' HA ' ' OE1' ' A' ' 209' ' ' GLU . 47.7 m80 -98.6 139.03 34.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.036 0.418 . . . . 0.0 111.201 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -98.26 168.94 9.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.62 132.16 48.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.5 33.13 61.35 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.118 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.625 ' OE1' ' HA ' ' A' ' 205' ' ' HIS . 41.9 tt0 -117.86 117.37 29.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.173 0.511 . . . . 0.0 110.388 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -105.1 130.81 53.2 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.815 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -153.36 -23.02 0.15 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.463 HG22 ' HA ' ' A' ' 234' ' ' ALA . 80.4 p 60.05 167.88 0.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.776 0.831 . . . . 0.0 112.031 -175.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 19.2 tt -160.41 144.68 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.225 -0.297 . . . . 0.0 110.896 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.99 108.46 15.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.805 0.336 . . . . 0.0 111.381 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.55 122.54 64.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 16.3 p -90.36 -22.69 21.38 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -173.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 70.6 m-85 67.89 140.37 0.07 OUTLIER Pre-proline 0 N--CA 1.483 1.219 0 CA-C-O 121.068 0.461 . . . . 0.0 111.581 -176.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 14.4 Cg_exo -69.54 150.4 69.52 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.455 2.103 . . . . 0.0 112.0 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.436 ' O ' ' HE2' ' A' ' 227' ' ' LYS . 81.0 mm-40 -66.56 -38.56 87.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.992 0.425 . . . . 0.0 110.171 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -86.45 33.3 0.63 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.732 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.515 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 10.9 t80 -70.01 131.4 44.3 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -65.02 -17.23 64.26 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.515 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -98.95 99.62 10.69 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 38.9 tt0 -56.52 -33.07 65.69 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.897 -175.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -66.24 -18.41 65.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.904 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.24 -1.11 9.25 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 14.1 ptmm? -67.81 121.44 15.99 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.397 0.617 . . . . 0.0 112.301 -175.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 82.06 8.43 86.56 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.589 -0.732 . . . . 0.0 114.097 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -118.48 137.94 52.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.528 0.664 . . . . 0.0 110.879 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -91.21 155.4 18.61 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.49 144.57 32.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.733 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 3.4 mppt? -98.74 -15.82 19.19 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 56.37 -149.96 0.45 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.133 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.463 ' HA ' HG22 ' A' ' 212' ' ' THR . . . -141.0 -68.43 0.4 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.753 0.311 . . . . 0.0 110.56 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.2 mt 64.74 91.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.954 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -98.19 -27.68 14.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.291 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.0 tp 52.1 67.01 1.04 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.882 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -65.34 -43.44 90.87 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.433 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 30.7 mtpp -96.98 -80.02 0.45 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -173.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 85.4 t 77.96 139.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -171.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -91.6 -84.05 0.27 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -172.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 153' ' ' GLU . 43.0 tt0 -165.23 103.8 0.75 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 19.6 ttm-85 -166.81 113.92 0.82 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 175.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -177.92 155.24 0.97 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 42.3 tp 67.89 100.8 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.321 0 O-C-N 124.135 0.897 . . . . 0.0 111.18 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 42.1 Cg_endo -69.01 111.93 2.8 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.229 1.953 . . . . 0.0 112.889 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.582 ' O ' HG21 ' A' ' 150' ' ' THR . 44.5 tt0 -137.13 147.64 46.14 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.5 mp -73.48 98.88 2.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.984 0.421 . . . . 0.0 111.108 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.9 p -95.24 -89.02 0.25 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.428 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -170.79 -51.41 0.02 OUTLIER 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.9 0.381 . . . . 0.0 111.342 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -81.14 89.39 5.99 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.994 0.426 . . . . 0.0 111.882 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.486 ' CD1' HG23 ' A' ' 253' ' ' ILE . 51.5 p90 -159.02 -13.48 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.214 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.486 HG23 ' CD1' ' A' ' 252' ' ' PHE . 19.0 pt -121.17 -41.28 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.022 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -83.36 -2.95 56.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.35 0.595 . . . . 0.0 110.327 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.402 HH11 ' CD ' ' A' ' 161' ' ' GLU . 54.2 ttp180 -124.7 98.26 5.64 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -148.72 -61.2 0.24 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -166.0 -75.64 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.54 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 68.0 t -104.25 117.74 50.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 122.832 -0.216 . . . . 0.0 111.12 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 58.1 -170.0 0.11 Allowed 'General case' 0 CA--C 1.544 0.733 0 O-C-N 123.989 0.806 . . . . 0.0 110.656 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -104.7 112.71 25.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.323 0.582 . . . . 0.0 109.789 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -98.01 167.72 23.02 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.203 -0.998 . . . . 0.0 113.774 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 56.1 p -108.63 -167.39 1.22 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.91 -54.17 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.358 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.2 OUTLIER -80.3 -38.81 29.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 -178.514 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.26 98.18 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.634 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 270' ' ' VAL . 49.0 tp -63.89 -43.21 96.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.555 0.216 . . . . 0.0 110.59 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -63.54 -40.41 96.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.391 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.23 -44.11 89.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.802 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -68.07 -38.12 82.04 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.133 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 266' ' ' LEU . 79.3 t -64.0 -43.35 97.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.656 0.265 . . . . 0.0 110.507 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -59.27 -46.37 88.71 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.993 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.5 ptmt -66.34 -44.49 83.15 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -63.95 -39.47 94.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 270' ' ' VAL . 99.3 mmm -64.47 -40.67 96.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.76 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.99 -35.3 79.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 110.795 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -62.71 -41.77 99.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.759 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -64.61 -37.49 87.75 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.734 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 46.0 tp -61.83 -38.29 87.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.876 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -57.58 -45.53 85.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.861 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.9 m -62.35 -42.39 99.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.605 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.13 82.95 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.057 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.85 -43.73 97.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.297 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.496 ' HD3' ' HG2' ' A' ' 405' ' ' GLU . 1.4 tpm_? -59.54 -46.99 87.27 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.022 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -65.61 -40.69 92.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.398 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -61.09 -43.34 99.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.26 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.43 -44.12 90.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.348 0.594 . . . . 0.0 110.19 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.46 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.5 tttt -62.05 -48.84 78.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.264 -177.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.9 p -64.63 -41.38 96.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -65.86 -42.3 90.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.46 -47.23 82.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.959 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 287' ' ' LYS . 48.0 mm -64.57 -44.18 96.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.41 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.445 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 17.1 tp10 -60.16 -45.11 94.21 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 110.681 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.74 -42.7 98.51 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.246 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.48 -41.69 96.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 291' ' ' ILE . 71.3 t -63.16 -45.09 99.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.452 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LYS . . . . . 0.445 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.7 mttm -63.83 -42.54 97.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 111.064 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.32 -42.7 62.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -118.75 92.52 3.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -98.54 99.22 10.35 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -106.1 159.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.742 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -64.13 137.5 57.99 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.22 128.52 25.54 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.242 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.437 ' O ' HG13 ' A' ' 307' ' ' ILE . 47.0 Cg_exo -56.6 128.5 30.3 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.344 2.029 . . . . 0.0 111.712 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.37 83.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.735 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.5 -41.53 90.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.9 mt -67.88 -41.65 82.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.501 ' O ' HG13 ' A' ' 311' ' ' ILE . 69.4 mt -61.93 -51.27 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.704 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.85 -43.81 98.1 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 41.6 m -61.6 -45.47 93.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.601 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.68 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 72.9 mm-40 -71.58 -34.1 69.64 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 307' ' ' ILE . 95.1 mt -61.4 -43.79 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.663 0.268 . . . . 0.0 110.723 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.504 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.7 t70 -62.3 -40.98 98.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.1 t -62.98 -44.67 99.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.275 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 46.1 mt -63.03 -39.39 94.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.956 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.504 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 83.9 mtm180 -63.08 -39.82 95.84 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.902 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 84.3 mtt180 -66.02 -38.98 89.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.786 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.58 -43.02 99.86 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.109 0.481 . . . . 0.0 109.943 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.49 -36.62 79.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.326 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -62.54 -36.94 84.2 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.628 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -62.07 -42.29 99.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.434 0.635 . . . . 0.0 109.876 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -78.23 -6.96 56.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.599 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -91.37 -3.74 56.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.313 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 135.33 -21.41 3.65 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.519 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 118.15 34.11 1.17 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.455 -0.878 . . . . 0.0 111.241 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.471 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 42.0 t-20 -71.97 126.87 30.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.7 tm-20 -127.8 150.57 49.77 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 6.5 ptpp? 61.94 -39.38 0.14 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.667 1.587 . . . . 0.0 114.057 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.471 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 16.0 mm100 -71.79 -11.58 60.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.271 0.558 . . . . 0.0 110.438 177.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.69 -21.23 66.28 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.987 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.47 HD12 HH12 ' A' ' 315' ' ' ARG . 63.1 tp -62.54 -37.48 86.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.131 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -80.97 -2.85 49.5 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.864 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 74.8 mt -69.42 149.08 97.26 Favored Pre-proline 0 C--O 1.239 0.541 0 O-C-N 122.265 -0.272 . . . . 0.0 110.394 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.6 143.77 99.46 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.658 2.239 . . . . 0.0 113.113 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 25.5 ttt85 -83.31 -42.17 17.44 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.808 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -57.99 -43.74 86.78 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.424 ' HB2' ' OE2' ' A' ' 224' ' ' GLU . 88.7 mt -85.74 -3.27 58.85 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.808 -176.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -104.64 -27.58 11.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.948 0.404 . . . . 0.0 110.151 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.1 -25.56 67.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.661 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -60.14 -48.04 83.38 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.845 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -80.79 -22.11 40.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.599 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.29 -41.95 99.03 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.429 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.8 tttt -60.06 -46.2 90.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.16 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.549 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.0 mmt85 -62.01 -45.64 92.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.428 ' NH2' HD22 ' A' ' 314' ' ' LEU . 91.1 mtt180 -67.14 -38.09 84.94 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.451 -178.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 341' ' ' ALA . 78.7 t -64.44 -44.24 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.648 0.261 . . . . 0.0 110.599 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 342' ' ' LYS . 69.5 t -61.71 -43.34 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.572 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 343' ' ' ARG . 76.4 t -60.17 -45.2 96.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.9 -42.53 99.75 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.141 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.77 -44.75 92.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.659 0.266 . . . . 0.0 111.334 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 354' ' ' VAL . 96.2 mt -64.03 -46.71 83.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.275 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.26 -38.69 78.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.412 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.72 -42.92 96.6 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.196 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.08 -36.48 79.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.831 0.316 . . . . 0.0 110.881 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 350' ' ' LEU . 86.6 t -60.81 -44.67 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.63 -44.23 98.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.841 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -69.87 -46.25 65.92 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.9 m -66.73 -44.98 80.12 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -90.71 4.77 50.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.967 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 53.06 47.61 24.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.109 0.48 . . . . 0.0 111.632 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.9 mt -73.37 140.26 46.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.877 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -119.86 153.63 35.53 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.851 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.13 110.04 15.16 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.498 ' O ' HG23 ' A' ' 367' ' ' VAL . 23.1 t70 -83.46 112.46 19.98 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.918 -174.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.57 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 15.7 mm-40 -59.36 -38.73 81.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.629 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.76 -42.85 90.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.431 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -62.33 -38.32 89.0 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.517 HG21 ' HG2' ' A' ' 399' ' ' ARG . 99.0 t -64.42 -40.08 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.632 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.8 mmmt -56.65 -44.54 81.44 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.59 -40.14 98.35 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.197 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.97 -42.26 99.78 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.694 0.283 . . . . 0.0 110.639 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.13 -44.3 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.713 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.11 -39.23 89.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.45 -36.14 80.61 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.488 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 51.0 ttm -65.61 -39.8 91.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.103 0.478 . . . . 0.0 110.202 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -61.54 -29.79 70.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.86 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 13.2 m -72.53 -5.58 37.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.585 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.51 -8.73 52.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 0.0 110.843 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -107.36 171.09 7.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.235 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.28 -36.78 85.23 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.338 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -133.67 109.12 12.06 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 120.878 0.37 . . . . 0.0 110.736 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.425 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 53.0 Cg_exo -56.96 -39.64 89.95 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.058 2.505 . . . . 0.0 113.728 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -64.36 -42.69 96.06 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.28 -37.96 87.5 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.061 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.24 -43.43 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.0 -44.94 99.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.463 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 53.9 mt-10 -68.75 -42.12 77.99 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.976 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -59.36 -46.52 88.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.828 0.347 . . . . 0.0 111.119 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.18 -41.43 94.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.664 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 32.9 p -80.23 -6.47 57.9 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 97.9 mttt -101.0 5.23 43.03 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.876 0.37 . . . . 0.0 111.0 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -126.06 119.38 27.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -62.62 -43.69 98.17 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -57.67 -49.82 75.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.762 0.315 . . . . 0.0 111.169 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.2 -42.64 99.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.545 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.435 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.2 mtp -65.44 -44.38 87.46 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.52 -42.23 71.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.459 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.99 -41.56 99.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.57 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 51.4 tpp -62.98 -41.37 99.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.843 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.517 ' HG2' HG21 ' A' ' 367' ' ' VAL . 73.4 mtm180 -65.38 -37.49 87.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.908 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.55 -44.32 96.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.41 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.65 -45.2 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.083 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.51 94.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.728 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 51.3 tp -63.08 -40.49 97.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.327 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.45 -42.56 98.95 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.598 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.496 ' HG2' ' HD3' ' A' ' 283' ' ' ARG . 29.0 mt-10 -64.96 -40.21 94.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.737 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -59.93 -41.67 92.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.554 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.33 87.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.024 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.58 -43.87 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.191 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.45 -33.58 76.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.439 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.77 98.21 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.98 0.419 . . . . 0.0 110.149 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 97.4 t -65.44 -43.07 94.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.329 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.17 -39.82 91.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -70.3 -13.02 61.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.462 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -108.83 3.04 22.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.102 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.37 173.27 6.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.337 0.589 . . . . 0.0 111.766 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -84.84 107.42 16.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.245 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.2 133.37 36.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.383 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.8 t -137.48 148.4 46.03 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.118 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -97.57 128.47 44.33 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.009 0.433 . . . . 0.0 110.965 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -134.52 127.98 32.44 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.627 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -101.16 144.12 30.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.388 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.4 t -152.4 -176.27 5.63 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.871 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.8 p -81.66 162.58 22.98 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.961 0.41 . . . . 0.0 110.836 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -67.89 -17.78 64.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.804 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -61.53 -41.67 97.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.928 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.39 -26.74 63.84 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.518 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.1 -21.35 59.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.158 0.504 . . . . 0.0 110.064 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.5 mmt -79.65 -7.11 58.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.997 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -80.48 87.39 5.69 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.503 0.668 . . . . 0.0 109.659 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -120.73 30.43 6.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.105 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -65.9 -37.14 85.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.948 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.753 179.551 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.553 0.216 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -83.77 101.29 11.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.82 160.55 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.928 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -114.42 106.59 14.48 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.858 0.361 . . . . 0.0 110.777 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -155.55 136.99 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.61 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.569 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 43.5 tt0 -142.99 169.27 17.88 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.0 t -101.02 153.8 19.24 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 117.705 0.23 . . . . 0.0 111.218 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 57.7 m -120.44 -65.76 1.12 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -162.1 123.95 2.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.465 0.174 . . . . 0.0 110.549 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.1 -120.09 18.46 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.814 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' B' ' 108' ' ' GLU . 6.8 mp -89.23 -5.86 57.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' B' ' 107' ' ' VAL . . . -70.52 132.57 22.82 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.088 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 3.5 tpp180 -121.25 -162.64 0.98 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -145.45 127.78 15.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.64 -94.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.135 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m 52.28 89.29 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.202 0.525 . . . . 0.0 111.479 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 tp -111.22 136.29 47.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.014 0.435 . . . . 0.0 111.693 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 46.1 m -101.72 126.9 48.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 17.2 pt -126.24 160.8 33.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.869 0.366 . . . . 0.0 111.794 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.573 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -81.02 161.27 24.29 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.333 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.81 77.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.322 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -65.8 -35.62 81.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.999 0.428 . . . . 0.0 110.407 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -63.01 -40.13 96.84 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.02 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.573 HG13 ' O ' ' B' ' 20' ' ' ALA . 74.8 mt -61.52 -48.65 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.328 0.585 . . . . 0.0 110.552 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -68.72 -44.39 73.98 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.133 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 12.3 m -77.69 -56.86 4.17 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.11 -46.84 55.1 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 97.6 t -63.03 -45.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -62.92 -45.7 91.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.993 0.425 . . . . 0.0 110.695 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 20.8 m -64.42 -36.64 84.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.287 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.4 -39.91 92.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.213 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 95.1 mt -62.41 -43.24 99.3 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.714 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -70.3 -37.7 71.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.181 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.47 -41.39 96.53 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.19 -32.22 50.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.804 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.23 -40.99 94.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.021 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.03 -28.21 65.29 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.402 177.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.52 -44.35 89.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.69 -3.33 9.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.358 0.599 . . . . 0.0 109.939 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 63.67 27.48 14.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.909 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.9 pp -103.18 6.94 10.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.056 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -64.83 -29.15 70.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.951 0.405 . . . . 0.0 110.888 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.82 -2.62 82.12 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.603 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -92.98 -4.17 53.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.696 0.284 . . . . 0.0 111.533 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -87.37 128.93 35.19 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -73.78 -2.31 22.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -173.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.97 -37.23 2.84 Favored Glycine 0 C--N 1.314 -0.69 0 C-N-CA 120.473 -0.87 . . . . 0.0 114.246 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -61.26 132.48 53.75 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 117.482 0.641 . . . . 0.0 109.525 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.573 HG12 HG12 ' B' ' 54' ' ' VAL . 21.3 t 64.5 71.69 0.55 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -172.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.548 ' O ' HG13 ' B' ' 54' ' ' VAL . 59.0 Cg_endo -69.59 161.4 46.06 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.373 2.715 . . . . 0.0 113.755 -176.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.76 ' HA ' HG22 ' B' ' 54' ' ' VAL . 50.6 mtt -61.94 -33.97 75.24 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -63.14 -24.43 67.89 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.552 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 99.1 mt -95.45 -38.9 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.465 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.76 HG22 ' HA ' ' B' ' 51' ' ' MET . 10.2 m -62.46 -33.78 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.329 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.427 ' O ' ' HA3' ' B' ' 59' ' ' GLY . . . -60.33 -32.91 71.69 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.645 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -100.64 -34.05 10.04 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.688 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -65.7 -42.82 90.73 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -126.33 19.03 7.56 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.682 0.277 . . . . 0.0 110.979 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.649 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -57.21 -47.97 83.64 Favored Glycine 0 C--O 1.222 -0.629 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.281 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.8 -23.14 22.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.283 0.541 . . . . 0.0 111.683 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -62.08 -45.65 92.57 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.149 -176.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.521 ' O ' HG23 ' B' ' 66' ' ' VAL . 10.5 p -119.11 21.45 5.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.545 0.688 . . . . 0.0 110.592 -177.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.649 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 35.1 ttm180 -59.86 -26.65 66.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.737 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -63.33 -49.59 73.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.451 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ASP . . . . . 0.462 ' HB2' HG22 ' B' ' 62' ' ' VAL . 2.9 m-20 -75.84 -21.52 57.17 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.027 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.521 HG23 ' O ' ' B' ' 62' ' ' VAL . 79.6 t -63.24 -44.1 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.5 -40.39 96.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.345 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.53 -43.27 99.26 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.361 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ASP . . . . . 0.76 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 37.6 t70 -64.06 -43.63 94.89 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 117.085 0.442 . . . . 0.0 110.192 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.15 -42.64 98.92 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 110.245 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.5 ttp -60.92 -45.31 95.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.862 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -62.34 -44.69 95.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.117 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.76 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 34.2 mtp85 -66.66 -43.16 85.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.046 -176.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -65.13 -40.97 95.18 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.88 0.371 . . . . 0.0 111.073 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.3 -48.25 82.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.499 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 20.1 tt -68.51 -38.75 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.36 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.411 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 11.2 t70 -62.91 -41.92 99.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.185 0.516 . . . . 0.0 109.81 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' B' ' 81' ' ' LYS . . . -66.08 -45.57 80.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.595 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 46.0 pt -64.95 -30.67 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.99 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.59 -44.32 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.019 0.437 . . . . 0.0 110.773 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' B' ' 78' ' ' ALA . 16.4 ptpt -81.03 -28.71 35.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.633 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -81.82 -6.88 59.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.971 0.415 . . . . 0.0 110.248 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 65.5 38.87 5.36 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.509 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.421 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 84.4 mt -100.58 118.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.678 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -106.78 100.88 33.79 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.356 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 24.0 Cg_exo -63.63 139.83 71.74 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.591 2.194 . . . . 0.0 112.208 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.64 94.13 8.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.024 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.92 -125.34 7.15 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.642 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.67 127.19 27.1 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-O 120.517 0.199 . . . . 0.0 110.935 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.77 158.11 53.88 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.618 2.212 . . . . 0.0 110.98 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 54.2 m -92.2 118.84 31.26 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.189 0.518 . . . . 0.0 110.744 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.481 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.7 m-85 -98.14 125.35 43.12 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.42 102.09 42.39 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-O 120.899 0.381 . . . . 0.0 110.971 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.8 Cg_endo -96.75 -167.81 0.12 Allowed 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 123.228 2.619 . . . . 0.0 110.854 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -130.36 -176.28 14.36 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -86.06 126.89 34.51 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -85.76 127.95 34.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.095 0.474 . . . . 0.0 110.852 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 98.6 mttt -113.63 140.99 47.74 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 38.0 tp -85.56 112.06 20.59 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.16 -177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.85 -7.68 27.62 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.688 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 48.9 mt-10 -120.37 172.63 7.67 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -82.16 168.44 17.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.297 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -121.28 143.68 49.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.45 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 85.6 m -125.67 136.86 53.68 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.007 0.432 . . . . 0.0 111.601 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -134.71 154.22 51.65 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.569 ' O ' HG12 ' B' ' 107' ' ' VAL . 21.4 m -95.97 -74.17 0.57 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.569 HG12 ' O ' ' B' ' 106' ' ' SER . 0.3 OUTLIER 65.36 142.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.9 0.88 . . . . 0.0 110.251 -172.364 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 11' ' ' LEU . 45.2 mt-10 -119.18 130.79 55.69 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -173.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -164.62 143.67 7.1 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.759 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.66 157.19 0.06 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 m -136.04 162.29 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.75 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -161.5 106.26 1.2 Allowed Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.399 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.29 154.43 41.12 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.261 2.64 . . . . 0.0 113.923 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -127.54 142.63 51.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.078 0.951 . . . . 0.0 108.77 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 64.2 t -126.77 131.68 70.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.847 0.356 . . . . 0.0 111.746 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -110.67 -86.22 0.54 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.699 176.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 97.5 mt 59.32 121.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -137.6 157.39 46.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.147 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.48 19.63 77.85 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.909 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.91 -39.91 95.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.282 0.563 . . . . 0.0 110.672 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -74.25 -5.71 43.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.346 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -105.82 17.28 23.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.94 0.4 . . . . 0.0 110.93 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 86.9 mt -91.62 119.39 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.242 0.544 . . . . 0.0 111.199 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -108.52 122.8 47.81 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.43 135.5 57.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.625 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -78.7 138.6 38.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.568 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -133.28 97.75 16.04 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.73 121.12 6.8 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.232 1.955 . . . . 0.0 112.418 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.8 mm -105.67 116.01 48.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.859 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.405 HG21 HD21 ' B' ' 427' ' ' LEU . 27.5 m -131.82 163.49 37.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.352 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -136.51 156.77 48.12 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.96 125.84 39.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.4 p -111.89 175.08 5.57 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.458 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.02 -36.59 82.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.4 82.97 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.635 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.86 -42.09 97.63 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.367 0.604 . . . . 0.0 109.569 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.78 -45.43 98.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.517 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.3 -43.01 99.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.867 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.58 -41.94 99.75 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.449 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.567 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 3.5 tpt -62.55 -46.76 86.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.796 0.332 . . . . 0.0 110.452 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.52 -41.66 98.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.3 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.67 -44.19 96.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.318 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.9 m -62.83 -41.92 99.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.261 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 144' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.3 mt -60.9 -42.57 98.28 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -70.93 -20.44 62.47 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.451 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.68 1.28 54.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.375 0.607 . . . . 0.0 110.096 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.5 23.57 11.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.817 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -125.31 86.27 2.52 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 149' ' ' ALA . . . . . 0.52 ' HB3' ' OE1' ' B' ' 159' ' ' GLU . . . -131.54 159.42 38.22 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 172.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 150' ' ' THR . . . . . 0.568 HG21 ' O ' ' B' ' 247' ' ' GLU . 6.3 m -121.1 143.39 49.11 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.112 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' TRP . . . . . 0.604 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 44.7 p-90 -74.74 132.28 41.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.034 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 152' ' ' LYS . . . . . 0.525 ' HG2' ' HG3' ' B' ' 153' ' ' GLU . 65.1 tttp -163.19 -64.71 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 153' ' ' GLU . . . . . 0.525 ' HG3' ' HG2' ' B' ' 152' ' ' LYS . 64.3 mt-10 -117.42 -92.6 0.52 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 154' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' B' ' 155' ' ' ASP . 22.2 tptm -94.5 -117.85 0.1 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -169.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 155' ' ' ASP . . . . . 0.419 ' N ' ' HG3' ' B' ' 154' ' ' LYS . 14.2 t70 -147.52 154.87 41.28 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 122.923 0.489 . . . . 0.0 110.85 -174.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 166.21 -34.56 0.23 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.238 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.35 140.44 18.4 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.459 ' HA ' ' HD2' ' B' ' 243' ' ' ARG . 59.3 t -129.35 127.5 65.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.354 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 159' ' ' GLU . . . . . 0.52 ' OE1' ' HB3' ' B' ' 149' ' ' ALA . 4.7 mp0 -88.38 159.2 18.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.184 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.26 49.3 1.63 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.776 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -158.49 6.39 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.78 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.46 ' CG ' ' H ' ' B' ' 163' ' ' ARG . 13.1 t70 -102.53 -170.38 1.8 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.601 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 163' ' ' ARG . . . . . 0.46 ' H ' ' CG ' ' B' ' 162' ' ' ASP . 42.7 ttm180 -124.13 117.98 25.88 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.115 0.566 . . . . 0.0 110.727 -176.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.29 128.49 64.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.289 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 73.1 m -84.23 116.9 23.19 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 87.3 mt -126.27 124.52 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.126 0.489 . . . . 0.0 111.835 -176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' ASP . . . . . 0.471 ' OD2' ' HA ' ' B' ' 183' ' ' SER . 6.2 m-20 -95.24 109.35 21.48 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -127.67 150.54 49.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.444 0.64 . . . . 0.0 112.439 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.6 m -124.88 128.05 48.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.571 177.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.7 141.06 20.8 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.747 -0.74 . . . . 0.0 113.672 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 41.1 m -141.02 144.27 34.9 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 42.0 t -84.44 -83.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.94 0.4 . . . . 0.0 110.841 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -105.38 -40.58 5.77 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.18 0.514 . . . . 0.0 110.054 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.5 21.05 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.259 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -142.8 149.6 38.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 120.779 0.323 . . . . 0.0 110.404 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.41 151.49 32.73 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.976 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -120.69 -179.23 3.93 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.457 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.52 -42.54 87.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.03 -172.07 31.32 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.972 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.37 29.65 48.64 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.551 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -110.48 113.81 26.73 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -137.39 147.02 45.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.042 0.449 . . . . 0.0 111.59 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.471 ' HA ' ' OD2' ' B' ' 167' ' ' ASP . 67.8 m -146.51 129.41 16.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.313 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 58.56 31.85 21.49 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.564 0.54 . . . . 0.0 110.126 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -89.63 135.26 33.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.709 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 93.1 t -99.69 123.52 52.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.922 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.81 122.73 48.56 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.129 0.49 . . . . 0.0 111.457 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 188' ' ' ALA . . . . . 0.443 ' HB3' ' CZ ' ' B' ' 193' ' ' ARG . . . -111.33 111.6 22.76 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 73.9 mtm -83.86 163.69 19.93 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.303 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.54 -13.86 60.99 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.606 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -102.67 -8.22 21.09 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 79.15 48.56 6.83 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 119.928 -1.13 . . . . 0.0 111.403 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.443 ' CZ ' ' HB3' ' B' ' 188' ' ' ALA . 95.0 mtt180 -89.53 -10.35 46.5 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.405 ' CE ' ' HA ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -129.51 170.32 13.87 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.06 178.606 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.622 ' H ' HD12 ' B' ' 195' ' ' ILE . 4.1 mp -54.84 133.18 66.43 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 123.347 0.404 . . . . 0.0 110.162 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -48.55 129.93 20.95 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.359 2.04 . . . . 0.0 111.776 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.04 -32.66 6.64 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.913 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -62.27 -44.38 96.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.677 0.275 . . . . 0.0 110.639 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.75 -40.63 97.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.734 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.85 -34.8 78.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.086 0.469 . . . . 0.0 110.676 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -63.52 -26.43 69.67 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.366 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.62 -43.35 98.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 109.676 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -50.86 119.59 4.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.477 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 108.2 -10.62 36.76 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.598 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.649 ' HA ' ' OE1' ' B' ' 209' ' ' GLU . 46.6 m80 -96.2 141.09 29.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.11 0.455 . . . . 0.0 111.422 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.407 ' HG2' ' OE2' ' B' ' 209' ' ' GLU . 17.1 mmtm -100.46 166.69 10.81 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 207' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' B' ' 240' ' ' VAL . . . -61.8 131.98 51.63 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.02 27.55 70.19 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.701 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 209' ' ' GLU . . . . . 0.649 ' OE1' ' HA ' ' B' ' 205' ' ' HIS . 44.5 tt0 -112.27 111.7 22.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.273 0.559 . . . . 0.0 110.365 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.14 129.31 44.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.687 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -148.94 -26.51 0.3 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.492 HG22 ' HA ' ' B' ' 234' ' ' ALA . 50.8 p 60.67 160.33 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.935 0.894 . . . . 0.0 111.975 -176.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' B' ' 232' ' ' LYS . 18.9 tt -153.06 148.65 13.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 122.135 -0.353 . . . . 0.0 110.825 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -81.27 109.59 15.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.217 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 59.8 t -112.87 122.81 67.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 11.9 p -93.5 -21.62 19.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 68.12 137.4 0.05 OUTLIER Pre-proline 0 N--CA 1.482 1.142 0 CA-C-O 121.037 0.446 . . . . 0.0 111.75 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' B' ' 221' ' ' TYR . 16.5 Cg_exo -67.72 149.57 78.83 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.433 2.089 . . . . 0.0 112.006 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 219' ' ' GLU . . . . . 0.445 ' O ' ' HE2' ' B' ' 227' ' ' LYS . 75.1 mm-40 -66.71 -39.36 88.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.522 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -86.03 32.51 0.61 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.895 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 9.2 t80 -66.72 134.63 52.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -67.66 -15.32 63.59 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.459 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -101.18 105.0 16.09 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.43 ' OE1' ' HG2' ' B' ' 333' ' ' PRO . 42.1 tt0 -60.11 -33.24 71.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.672 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -66.82 -19.03 65.66 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.064 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.7 mt -121.39 0.62 10.05 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' B' ' 219' ' ' GLU . 14.9 ptmm? -68.34 119.27 12.58 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.48 0.657 . . . . 0.0 112.118 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.85 17.24 75.45 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.339 -0.846 . . . . 0.0 114.106 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -123.85 129.63 51.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.774 0.787 . . . . 0.0 111.182 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.39 153.16 29.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.005 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.96 143.55 31.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.315 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 232' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' B' ' 213' ' ' ILE . 3.9 mppt? -100.13 -14.31 18.6 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.401 ' HB3' ' H ' ' B' ' 234' ' ' ALA . 95.8 m-85 55.45 -148.67 0.48 Allowed 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.346 0.404 . . . . 0.0 111.516 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' B' ' 212' ' ' THR . . . -142.75 -69.22 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.893 0.378 . . . . 0.0 110.496 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 86.2 mt 65.89 87.25 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.992 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -92.35 -27.09 17.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.19 176.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 12.3 tp 51.65 66.92 1.05 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.806 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -66.09 -43.09 88.27 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 239' ' ' LYS . . . . . 0.427 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 29.9 mtpp -97.14 -77.78 0.49 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -173.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' B' ' 239' ' ' LYS . 87.7 t 76.62 142.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -95.3 -86.15 0.3 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -173.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -163.53 104.13 0.94 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 119.876 -0.729 . . . . 0.0 112.79 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 19.0 ttm-85 -168.72 115.1 0.63 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.954 0.407 . . . . 0.0 111.949 175.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' B' ' 152' ' ' LYS . 0.1 OUTLIER -178.31 155.4 0.9 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.688 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 46.8 tp 67.95 100.13 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 124.041 0.838 . . . . 0.0 111.343 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 246' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' B' ' 150' ' ' THR . 41.0 Cg_endo -68.15 111.3 2.43 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.523 2.149 . . . . 0.0 112.717 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 247' ' ' GLU . . . . . 0.568 ' O ' HG21 ' B' ' 150' ' ' THR . 43.1 tt0 -135.18 148.74 49.78 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.39 94.54 3.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.803 0.335 . . . . 0.0 111.173 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 22.1 p -91.09 -88.22 0.19 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.599 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -172.75 -47.97 0.02 OUTLIER 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.952 0.406 . . . . 0.0 111.218 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.97 94.77 7.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.076 0.465 . . . . 0.0 111.839 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 252' ' ' PHE . . . . . 0.531 ' CD1' HG23 ' B' ' 253' ' ' ILE . 51.5 p90 -164.89 -22.43 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.464 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 253' ' ' ILE . . . . . 0.531 HG23 ' CD1' ' B' ' 252' ' ' PHE . 19.6 pt -110.93 -42.39 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -82.06 -7.59 59.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.481 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -121.22 97.61 5.6 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -149.96 -59.77 0.2 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.161 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -164.61 -84.18 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.636 -1.269 . . . . 0.0 113.54 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 66.4 t -99.0 121.25 49.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.472 0.177 . . . . 0.0 111.038 -177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 57.91 -169.41 0.12 Allowed 'General case' 0 CA--C 1.547 0.831 0 O-C-N 123.975 0.797 . . . . 0.0 110.439 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -106.1 114.63 28.88 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -100.64 164.03 18.76 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.108 -1.044 . . . . 0.0 114.057 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 33.8 p -105.85 -175.43 2.79 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.68 -49.26 85.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.2 OUTLIER -85.06 -36.89 20.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 -178.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.0 -43.36 97.49 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.731 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.503 ' O ' HG23 ' B' ' 270' ' ' VAL . 49.6 tp -63.57 -43.4 97.11 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 120.612 0.244 . . . . 0.0 110.618 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -61.71 -43.01 99.67 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.786 0.327 . . . . 0.0 111.153 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.532 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.49 -44.66 86.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.064 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -67.74 -37.21 81.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.915 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.503 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.0 t -64.69 -43.08 96.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.595 0.236 . . . . 0.0 110.476 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -59.01 -46.82 87.23 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.4 ptmt -67.26 -43.66 81.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 0.0 111.62 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -64.48 -39.89 94.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.773 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.6 mmm -63.67 -42.06 98.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 110.736 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -68.97 -31.76 70.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.8 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 276' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 60.8 ttp180 -63.61 -41.78 98.28 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -65.8 -35.15 79.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.565 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 47.7 tp -61.95 -37.77 85.96 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.815 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 279' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 62.9 tttm -57.87 -44.98 86.97 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.805 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 19.4 m -61.86 -42.98 99.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.382 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.0 83.59 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.329 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.36 -44.12 98.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.795 0.331 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 283' ' ' ARG . . . . . 0.541 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.7 OUTLIER -60.14 -46.49 89.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.215 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -65.61 -40.29 92.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.523 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -60.69 -44.17 96.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.183 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.09 -44.62 91.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.177 0.513 . . . . 0.0 110.1 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.42 -48.17 82.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.856 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 74.8 p -65.01 -42.37 94.51 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -65.28 -42.88 92.72 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.025 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.63 -47.0 83.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.029 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 291' ' ' ILE . . . . . 0.459 ' O ' HG23 ' B' ' 295' ' ' VAL . 34.7 mm -64.41 -44.0 97.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.102 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -60.14 -46.19 90.49 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.925 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.24 -42.44 99.32 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.202 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.37 -41.46 96.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 291' ' ' ILE . 74.1 t -62.29 -45.33 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 O-C-N 123.114 0.259 . . . . 0.0 111.327 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -64.71 -41.95 95.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.852 0.358 . . . . 0.0 111.286 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.84 -39.65 63.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -121.7 82.92 2.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.63 94.44 9.03 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.9 tp -104.03 156.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.232 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.21 134.09 56.72 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 41.0 t -106.87 129.08 24.92 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.501 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.417 ' O ' HG13 ' B' ' 307' ' ' ILE . 50.0 Cg_exo -55.92 128.3 29.67 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.427 2.085 . . . . 0.0 111.832 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.51 85.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.195 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.32 87.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.376 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.75 -41.88 95.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.786 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 307' ' ' ILE . . . . . 0.498 ' O ' HG13 ' B' ' 311' ' ' ILE . 69.1 mt -62.03 -49.88 82.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.502 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -42.33 99.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.55 -176.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.3 m -62.99 -45.85 90.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.97 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 310' ' ' GLU . . . . . 0.677 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 63.6 mm-40 -70.86 -34.02 71.22 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.498 HG13 ' O ' ' B' ' 307' ' ' ILE . 95.2 mt -61.46 -44.29 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.836 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 35.5 t70 -63.17 -39.89 95.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.985 0.421 . . . . 0.0 110.826 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.04 -43.8 97.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.458 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 56.7 mt -62.74 -39.34 93.79 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.864 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 81.5 mtm180 -63.23 -38.92 93.05 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 316' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 87.5 mtt180 -65.49 -39.55 92.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.729 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -63.25 -43.21 98.64 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.172 0.51 . . . . 0.0 110.183 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.81 80.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.237 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 319' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -62.5 -37.06 84.54 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.769 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -62.41 -42.41 99.41 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.567 0.699 . . . . 0.0 109.691 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.16 -6.98 56.44 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.702 -177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -89.75 -3.46 58.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.885 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.62 -33.93 2.42 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.099 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 133.27 43.21 0.15 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 325' ' ' ASN . . . . . 0.476 ' HB3' ' HB1' ' B' ' 319' ' ' ALA . 42.5 t-20 -81.65 118.98 23.25 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.094 0.473 . . . . 0.0 109.861 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 326' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 2.4 tm-20 -120.53 151.28 39.59 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 5.7 ptpp? 61.66 -39.19 0.13 Allowed 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.774 1.63 . . . . 0.0 114.145 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 328' ' ' GLN . . . . . 0.472 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.3 mm100 -72.79 -11.27 60.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.349 0.595 . . . . 0.0 110.577 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -64.13 -20.91 66.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.171 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.464 HD12 HH12 ' B' ' 315' ' ' ARG . 52.3 tp -62.74 -36.88 84.47 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.077 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.14 -6.43 54.71 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.582 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 332' ' ' LEU . . . . . 0.469 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 77.4 mt -68.65 149.7 97.88 Favored Pre-proline 0 C--O 1.24 0.564 0 O-C-N 122.33 -0.231 . . . . 0.0 110.85 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 333' ' ' PRO . . . . . 0.43 ' HG2' ' OE1' ' B' ' 224' ' ' GLU . 38.7 Cg_exo -60.75 145.32 99.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.851 2.367 . . . . 0.0 113.281 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 334' ' ' ARG . . . . . 0.448 HH21 ' HD2' ' B' ' 334' ' ' ARG . 24.8 ttt85 -85.78 -41.62 14.91 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.417 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -57.96 -39.62 78.57 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -172.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 336' ' ' LEU . . . . . 0.415 ' HB2' ' OE2' ' B' ' 224' ' ' GLU . 93.6 mt -89.63 -3.88 58.06 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.757 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -105.63 -25.12 12.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.983 0.42 . . . . 0.0 110.206 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.2 -26.23 66.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.909 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.34 -51.26 70.26 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 120.931 0.396 . . . . 0.0 110.548 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -73.69 -27.28 61.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.659 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.463 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -60.95 -43.6 98.48 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 342' ' ' LYS . . . . . 0.488 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.8 tttt -59.73 -45.88 90.84 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 343' ' ' ARG . . . . . 0.578 ' O ' HG23 ' B' ' 347' ' ' VAL . 11.1 mmt85 -61.44 -46.25 90.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.833 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 344' ' ' ARG . . . . . 0.48 ' NH2' HD22 ' B' ' 314' ' ' LEU . 92.0 mtt180 -67.12 -37.63 84.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 341' ' ' ALA . 69.2 t -64.99 -44.03 96.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.708 0.289 . . . . 0.0 110.374 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 342' ' ' LYS . 74.3 t -61.61 -43.97 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.765 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.578 HG23 ' O ' ' B' ' 343' ' ' ARG . 85.8 t -59.65 -45.0 94.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.14 99.42 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.382 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.55 -44.14 95.05 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.679 0.276 . . . . 0.0 111.225 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.42 ' O ' HG23 ' B' ' 354' ' ' VAL . 96.2 mt -64.2 -46.77 82.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.18 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.06 -39.75 82.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.385 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.65 -41.47 97.4 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.971 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -67.3 -36.7 82.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.979 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 354' ' ' VAL . . . . . 0.42 HG23 ' O ' ' B' ' 350' ' ' LEU . 94.3 t -61.49 -44.37 98.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.379 0.609 . . . . 0.0 109.362 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.44 -44.42 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.932 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -70.38 -46.51 63.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.927 0.394 . . . . 0.0 112.02 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 100.0 m -65.7 -42.98 90.51 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -95.14 6.24 49.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 53.02 52.13 14.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.49 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 99.2 mt -77.23 133.8 38.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.116 0.484 . . . . 0.0 111.395 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -110.71 153.33 25.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.05 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.38 109.4 14.84 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 363' ' ' ASP . . . . . 0.505 ' O ' HG23 ' B' ' 367' ' ' VAL . 18.3 t70 -81.75 110.86 17.46 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.201 0.524 . . . . 0.0 112.039 -173.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 364' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 50.8 mm-40 -59.18 -40.73 86.6 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.237 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.51 -39.75 88.84 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.481 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -62.12 -38.81 90.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 367' ' ' VAL . . . . . 0.505 HG23 ' O ' ' B' ' 363' ' ' ASP . 99.1 t -63.76 -40.09 87.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.65 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 368' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 30.2 mmmt -56.49 -44.61 80.83 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.416 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.59 97.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.031 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.52 -42.47 99.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.905 0.384 . . . . 0.0 110.739 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.51 -45.1 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.28 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.81 -37.97 87.69 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -66.58 -39.45 88.45 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.524 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.7 ttm -64.54 -40.71 96.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.171 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 375' ' ' ALA . . . . . 0.438 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -61.86 -27.01 68.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.328 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 50.6 m -75.74 -3.41 34.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.286 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -94.08 -1.25 54.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.946 0.403 . . . . 0.0 110.928 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.54 169.88 8.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.267 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.72 -40.43 87.98 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.414 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 380' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 19.6 t70 -131.69 109.64 14.54 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-O 120.914 0.388 . . . . 0.0 111.041 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 381' ' ' PRO . . . . . 0.438 ' HA ' ' HB1' ' B' ' 375' ' ' ALA . 52.0 Cg_exo -56.28 -40.63 83.47 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.967 2.445 . . . . 0.0 114.297 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -64.84 -43.16 93.94 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 15.7 pt-20 -62.59 -37.17 85.2 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.324 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.93 -42.84 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.339 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.23 -44.43 99.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.419 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 44.9 mt-10 -66.88 -44.35 81.13 Favored 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.997 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -59.1 -46.51 88.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.58 -41.9 92.36 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.673 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 60.2 p -79.37 -6.84 57.68 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 390' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 98.8 mttt -103.04 7.47 38.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.027 0.441 . . . . 0.0 110.922 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -125.32 118.91 26.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.77 -42.3 97.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.171 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.68 -50.72 72.26 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.878 0.37 . . . . 0.0 111.0 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.72 -42.68 97.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.867 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.428 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 90.3 mtp -65.38 -45.15 85.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.62 -39.96 66.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.221 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -62.53 -41.98 99.22 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.625 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 49.4 tpp -63.28 -40.86 98.57 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.743 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.485 ' HG2' HG21 ' B' ' 367' ' ' VAL . 71.1 mtm180 -65.11 -37.12 86.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.846 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.24 -44.39 96.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.414 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 94.3 t -66.0 -45.17 91.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.758 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.23 93.9 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.6 -40.47 97.04 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.313 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.82 -43.04 99.64 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.707 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 405' ' ' GLU . . . . . 0.541 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 23.4 mt-10 -64.07 -40.69 96.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.467 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -60.0 -41.53 92.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.49 -46.29 86.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.128 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 95.2 t -65.94 -43.83 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.038 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.26 -34.1 77.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.0 96.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 110.198 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.25 -42.92 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.147 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.73 -39.36 91.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.952 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -68.68 -14.75 63.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.645 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -107.45 -6.59 16.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.532 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.95 170.04 9.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.169 0.509 . . . . 0.0 111.883 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -82.85 113.71 20.66 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.35 132.32 47.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.184 0.516 . . . . 0.0 111.705 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -136.1 145.28 45.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -96.38 135.03 38.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.626 0.251 . . . . 0.0 110.361 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -140.76 132.73 27.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.923 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.03 143.3 33.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.641 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.1 t -151.69 -176.84 5.78 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.633 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 50.0 p -80.48 165.51 22.1 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.099 0.476 . . . . 0.0 111.292 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -70.04 -16.7 63.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.879 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -61.74 -41.98 98.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.149 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -70.15 -27.83 64.85 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.832 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 427' ' ' LEU . . . . . 0.405 HD21 HG21 ' B' ' 130' ' ' VAL . 10.3 mp -71.0 -24.23 62.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.068 0.461 . . . . 0.0 109.891 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.5 mmt -79.29 -9.48 59.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.909 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -77.38 80.01 3.88 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.473 0.654 . . . . 0.0 109.928 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -115.17 29.58 7.93 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.143 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -65.91 -38.17 88.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.633 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.919 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.037 -179.33 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.452 -0.372 0 CA-C-O 120.911 0.386 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 m -86.23 106.63 17.46 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.685 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.7 137.24 27.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 34.6 tt0 -137.77 173.31 11.78 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.4 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 9.2 t -116.08 145.66 42.84 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 117.948 0.34 . . . . 0.0 111.599 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.6 m -102.87 -68.87 0.81 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -171.29 114.87 0.4 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.918 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.41 -111.94 4.59 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.718 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.34 -31.21 65.45 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 122.505 0.322 . . . . 0.0 111.456 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.55 137.07 42.09 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 116.008 -0.542 . . . . 0.0 114.127 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -141.21 157.13 45.67 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.222 0.609 . . . . 0.0 110.172 -178.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' A' ' 6' ' ' GLU . 28.8 ttm-85 -115.35 137.85 51.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.96 -86.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.456 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.2 m 49.88 84.88 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.111 0.482 . . . . 0.0 111.754 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 tp -93.32 134.4 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 120.949 0.404 . . . . 0.0 111.979 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.4 m -116.64 124.06 48.82 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.389 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 HG12 ' A' ' 24' ' ' ILE . 17.9 pt -135.28 169.02 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 122.558 0.343 . . . . 0.0 111.817 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.626 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.77 151.98 43.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.03 0.532 . . . . 0.0 111.871 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -55.79 -51.2 68.27 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.7 -36.14 83.33 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.978 0.418 . . . . 0.0 110.259 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -66.67 -35.74 80.87 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.528 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.626 HG13 ' O ' ' A' ' 20' ' ' ALA . 76.9 mt -60.33 -50.19 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 111.071 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -74.49 -42.88 58.21 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.78 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.9 m -70.44 -52.92 18.75 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.62 -44.6 66.88 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.29 -42.23 94.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.043 0.449 . . . . 0.0 110.589 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -60.78 -43.87 97.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.986 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 33' ' ' VAL . 25.4 m -63.03 -41.63 99.58 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.335 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.58 -40.44 96.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.236 0.541 . . . . 0.0 109.878 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.89 -41.91 99.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.024 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 30' ' ' SER . 12.0 p -69.16 -36.08 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.776 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -63.25 -43.48 97.87 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.13 -38.2 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.802 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.76 -47.93 81.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.61 -37.23 86.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.924 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.88 -33.81 76.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.8 t -91.43 -4.47 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-O 121.47 0.653 . . . . 0.0 109.791 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 63.5 27.2 15.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.636 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -104.41 3.95 10.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.126 0.489 . . . . 0.0 110.95 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -64.66 -34.23 77.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.426 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.63 -23.37 65.0 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.983 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -73.85 -13.57 60.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.746 0.308 . . . . 0.0 111.444 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 63.4 ttt-85 -80.75 92.18 6.01 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.268 0.556 . . . . 0.0 110.201 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.79 -43.39 98.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.005 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.99 69.98 1.25 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 115.719 1.048 . . . . 0.0 115.719 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -62.99 -41.89 99.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 54' ' ' VAL . 11.2 t -101.42 110.53 61.86 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.692 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.63 147.41 79.66 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.83 2.353 . . . . 0.0 112.066 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.522 ' HA ' HG12 ' A' ' 54' ' ' VAL . 15.3 ttt -67.11 -22.41 65.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -172.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -81.21 -8.57 59.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.872 0.368 . . . . 0.0 110.244 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.449 HD13 ' NH2' ' B' ' 193' ' ' ARG . 87.2 mt -107.74 -49.69 7.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.267 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 51' ' ' MET . 9.6 p -62.61 -40.25 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.557 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.15 94.9 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -84.91 -19.41 32.3 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.767 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.455 ' NH1' ' SD ' ' B' ' 194' ' ' MET . 61.7 ttt180 -85.65 -45.13 11.99 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.356 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -106.65 11.9 29.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.028 0.442 . . . . 0.0 110.522 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.581 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -57.39 -63.17 5.55 Favored Glycine 0 C--O 1.216 -0.978 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.181 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.55 -27.55 67.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.053 0.427 . . . . 0.0 111.631 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -61.02 -45.05 96.39 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.156 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 65' ' ' ASP . 8.3 p -131.64 21.34 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 CA-C-O 121.191 0.52 . . . . 0.0 112.098 -175.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.581 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 7.5 ttt180 -64.76 -19.98 66.1 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.628 -0.67 . . . . 0.0 111.405 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -64.77 -45.68 85.35 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.496 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.458 ' HB2' HG22 ' A' ' 62' ' ' VAL . 2.2 m-20 -73.65 -28.28 61.7 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.716 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -63.66 -44.74 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.38 -39.36 94.31 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.27 -40.77 97.83 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.043 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.76 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 29.3 t70 -62.45 -46.79 86.89 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.27 -41.88 97.69 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.911 0.386 . . . . 0.0 110.149 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 ttp -61.04 -43.96 98.11 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.6 m -62.36 -42.65 99.57 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.441 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.76 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 52.2 mtp85 -62.33 -46.49 88.49 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.751 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -65.73 -40.48 92.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.314 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.06 -48.49 81.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.668 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.4 tt -68.15 -39.1 80.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.855 0.36 . . . . 0.0 111.469 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.67 -40.36 92.3 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.234 0.54 . . . . 0.0 110.471 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.95 96.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.228 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.3 pt -67.14 -37.77 79.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.574 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.46 -44.09 98.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.082 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -75.57 -23.05 56.49 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -92.98 1.32 57.36 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.978 0.418 . . . . 0.0 110.674 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 63.38 32.79 14.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.325 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.8 mt -97.78 113.13 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -107.51 107.16 60.01 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.995 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.62 134.65 33.5 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.77 1.647 . . . . 0.0 111.315 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.52 87.17 4.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.238 0.542 . . . . 0.0 110.513 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.36 -114.8 4.54 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.804 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.29 135.2 26.73 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.25 152.17 79.81 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.705 2.27 . . . . 0.0 111.339 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.3 m -87.69 105.16 17.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.066 0.46 . . . . 0.0 111.437 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -107.65 113.78 27.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.24 96.89 48.64 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.68 145.65 26.12 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.21 1.94 . . . . 0.0 111.584 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.76 174.7 51.67 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.16 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.88 123.92 23.74 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.925 0.393 . . . . 0.0 110.23 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -86.13 133.72 33.85 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.185 0.517 . . . . 0.0 111.024 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -122.58 127.13 49.04 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.6 tp -72.42 106.53 4.57 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.132 0.492 . . . . 0.0 110.607 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.07 -8.62 14.2 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.462 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -118.37 -177.56 3.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.667 0.233 . . . . 0.0 110.73 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -76.65 160.04 29.72 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 111.269 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -126.34 138.04 53.53 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.148 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.0 m -118.08 135.71 54.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.932 0.396 . . . . 0.0 110.925 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -129.08 164.25 23.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.5 m -73.92 -83.74 0.05 OUTLIER 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.6 t 56.03 101.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.297 0.57 . . . . 0.0 111.311 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.59 126.95 34.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.28 -175.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.499 ' HB3' ' OE2' ' A' ' 110' ' ' GLU . 12.8 m-85 -127.32 -165.43 1.47 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.91 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.499 ' OE2' ' HB3' ' A' ' 109' ' ' PHE . 0.9 OUTLIER -73.12 177.97 4.7 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.048 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 305' ' ' ALA . 35.2 m -124.77 164.51 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.553 -176.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -124.9 116.48 26.16 Favored Pre-proline 0 N--CA 1.466 0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -88.56 144.43 5.57 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.895 2.396 . . . . 0.0 113.152 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -142.02 151.78 42.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.828 0.451 . . . . 0.0 109.804 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.4 t -130.44 133.06 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.896 0.379 . . . . 0.0 111.837 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -107.44 -88.24 0.47 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.746 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.0 mt 64.82 117.67 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.689 0.796 . . . . 0.0 112.481 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -137.84 150.95 47.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.492 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.14 18.65 74.04 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.944 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.77 -41.4 97.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 111.03 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.86 -3.62 23.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.252 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -106.79 17.44 23.17 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.878 0.37 . . . . 0.0 111.61 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.66 107.31 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.061 0.458 . . . . 0.0 109.952 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.32 101.73 13.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.966 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.07 133.29 36.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.935 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -87.64 124.36 33.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.456 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -122.73 96.14 45.72 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -63.92 135.61 48.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.012 1.808 . . . . 0.0 111.52 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.22 112.71 40.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.8 160.2 42.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.569 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -143.01 165.37 27.55 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.196 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.408 HG11 HH12 ' A' ' 271' ' ' ARG . 64.5 t -78.31 129.95 36.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.749 0.309 . . . . 0.0 110.435 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.5 p -112.38 176.86 4.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.772 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.09 -35.53 78.95 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 120.692 0.282 . . . . 0.0 111.623 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.15 84.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.256 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -63.43 -40.59 97.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.292 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 95.7 t -62.25 -49.54 83.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.652 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.85 -39.08 92.98 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.713 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.72 -40.63 99.05 Favored Glycine 0 C--O 1.237 0.331 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.743 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.575 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 5.1 tpt -63.28 -42.5 99.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.139 0.495 . . . . 0.0 109.795 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.9 mt -63.02 -40.11 96.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.573 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -56.65 -48.13 78.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.577 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.2 m -63.3 -40.75 98.23 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.366 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 140' ' ' MET . 85.3 mt -60.15 -42.23 94.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.818 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -79.79 -8.51 59.31 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.834 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -92.65 -12.59 31.17 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -90.92 -52.2 4.97 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.426 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -60.58 95.85 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.63 97.96 2.17 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 113.526 -1.67 . . . . 0.0 107.848 175.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 151' ' ' TRP . 0.2 OUTLIER -67.4 176.65 2.22 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.456 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.484 ' H ' HG22 ' A' ' 150' ' ' THR . 56.0 p-90 -99.88 161.85 13.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.453 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.587 ' H ' ' HA ' ' A' ' 243' ' ' ARG . 76.7 tttt -168.68 -79.59 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.758 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 242' ' ' GLU . 10.0 pt-20 -165.97 80.18 0.28 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 155' ' ' ASP . 54.8 tttt 176.65 -152.93 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.581 175.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.421 ' H ' ' HG2' ' A' ' 154' ' ' LYS . 8.9 p-10 -140.58 162.82 34.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.303 0.501 . . . . 0.0 111.054 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 119.44 -19.07 9.97 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.303 -0.951 . . . . 0.0 114.133 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -118.52 100.55 7.53 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.58 0.69 . . . . 0.0 111.947 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.8 t -132.29 136.97 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -97.79 -169.14 1.78 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.619 ' O ' ' HA3' ' A' ' 190' ' ' GLY . . . -95.6 23.99 5.64 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.775 ' HA ' ' O ' ' A' ' 189' ' ' MET . 11.1 pt-20 -158.88 27.64 0.22 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.436 0.636 . . . . 0.0 112.292 175.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 188' ' ' ALA . 13.0 m-20 -90.32 170.11 10.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.993 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 -106.96 123.7 48.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.96 128.74 74.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.805 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.4 m -78.84 106.39 10.82 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 72.1 mt -120.03 119.33 59.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.617 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -95.5 88.66 5.14 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -109.02 147.09 32.86 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.084 0.469 . . . . 0.0 111.834 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.0 m -116.78 127.42 54.32 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.45 123.69 6.37 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.172 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.8 m -140.65 128.6 21.97 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.469 HG23 ' CD2' ' A' ' 177' ' ' PHE . 98.0 t -102.89 108.93 25.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 60.34 -50.18 0.09 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.25 1.42 . . . . 0.0 114.121 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.89 -4.37 0.05 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.066 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.44 140.86 52.55 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.092 0.472 . . . . 0.0 110.956 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -79.33 156.56 27.97 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.469 ' CD2' HG23 ' A' ' 172' ' ' VAL . 35.4 p90 -125.37 169.28 12.5 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.534 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.86 -36.12 74.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.03 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.74 -177.49 33.79 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.65 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.27 22.06 61.42 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.163 -1.017 . . . . 0.0 113.322 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -100.81 112.1 24.45 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -136.26 145.69 45.88 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.986 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.6 m -140.5 125.18 18.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.423 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 55.89 30.59 16.21 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.578 0.548 . . . . 0.0 110.635 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -83.78 122.99 29.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.018 0.437 . . . . 0.0 110.397 -176.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.3 m -87.9 106.9 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.598 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.6 tp -94.55 121.54 36.22 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.184 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 193' ' ' ARG . . . -91.89 119.36 31.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.775 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 83.9 mtp -84.24 153.5 23.56 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.985 -175.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 160' ' ' ALA . . . 84.0 18.31 63.41 Favored Glycine 0 CA--C 1.505 -0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.872 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -122.54 -6.39 8.67 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.155 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.88 46.36 10.92 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.656 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 94.0 mtt180 -92.93 -6.77 47.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.475 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -131.58 167.88 18.65 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.715 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.88 134.82 92.65 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.93 129.89 18.71 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.385 2.056 . . . . 0.0 112.025 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.15 -38.97 3.04 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.358 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -65.35 -49.54 68.98 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.409 ' O ' ' HE3' ' A' ' 189' ' ' MET . 11.4 pt-20 -82.72 -9.73 59.23 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.226 0.536 . . . . 0.0 111.06 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -89.4 -32.01 17.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -74.56 -10.01 82.43 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.102 -0.953 . . . . 0.0 113.337 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.464 ' HB ' ' HE1' ' A' ' 189' ' ' MET . 44.4 mm -64.91 -42.89 96.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -53.01 125.93 18.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.629 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 101.28 -3.59 54.71 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.066 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -103.69 148.18 26.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.721 0.761 . . . . 0.0 111.991 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.17 166.17 12.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.491 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.28 120.52 19.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 89.12 17.71 55.29 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.678 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -105.01 117.37 33.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.121 0.486 . . . . 0.0 110.256 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -99.59 123.09 43.52 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.137 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -143.7 -15.44 0.63 Allowed 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 74.4 p 59.38 164.79 0.05 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 123.886 0.874 . . . . 0.0 112.596 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -146.95 142.58 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.858 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.97 109.1 16.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.047 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 49.3 t -117.55 108.23 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.148 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 21.2 m -71.9 -44.42 63.73 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 216' ' ' THR . 54.8 m-85 78.73 148.49 0.12 Allowed Pre-proline 0 N--CA 1.495 1.799 0 C-N-CA 123.241 0.617 . . . . 0.0 110.763 -174.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -72.0 153.79 57.85 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.708 2.272 . . . . 0.0 111.905 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.585 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 51.7 mm-40 -65.86 -39.11 90.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.419 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -95.58 39.0 1.13 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.252 0.549 . . . . 0.0 110.935 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -71.67 147.13 47.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.208 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -62.62 -19.65 63.98 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -101.6 117.04 34.09 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.545 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 2.2 tp10 -63.0 -32.7 74.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.992 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.5 -5.96 58.57 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -176.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 84.8 mt -117.81 -11.66 10.3 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.487 -0.485 . . . . 0.0 112.08 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.598 ' NZ ' HD13 ' A' ' 336' ' ' LEU . 18.4 ptmt -68.77 122.23 18.15 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.194 0.521 . . . . 0.0 112.205 -176.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.76 13.3 78.48 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.129 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.49 117.49 29.61 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.471 -0.429 . . . . 0.0 110.487 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -68.57 133.65 48.84 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.965 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -114.61 159.31 20.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.714 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -99.29 -33.11 10.86 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 53.05 99.17 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -73.85 91.88 2.01 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.143 0.497 . . . . 0.0 110.241 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.5 mm -95.18 115.4 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -112.76 -36.64 5.11 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.278 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.3 mt 67.76 152.96 0.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.265 0.626 . . . . 0.0 111.813 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -110.85 -80.64 0.58 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.665 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -111.79 -31.23 7.02 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 18.3 t 59.15 46.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 121.843 0.83 . . . . 0.0 109.528 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 60.7 -102.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.595 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . 15.2 pt-20 178.7 103.56 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.817 0.847 . . . . 0.0 108.964 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.587 ' HA ' ' H ' ' A' ' 152' ' ' LYS . 11.1 ptm180 -157.52 122.88 4.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -179.42 165.83 1.42 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.1 mt 72.64 109.02 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.028 0.531 . . . . 0.0 111.509 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.22 117.64 3.52 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.784 2.323 . . . . 0.0 114.37 -176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.38 -179.26 5.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.646 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.5 mp -91.38 128.5 37.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.081 0.467 . . . . 0.0 111.548 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 9.3 m -136.16 142.15 44.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.43 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.79 92.11 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.12 50.5 0.21 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.327 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -132.68 -58.57 0.92 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.881 0.372 . . . . 0.0 110.8 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 261' ' ' GLY . 36.9 pt -68.97 -22.13 26.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.577 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -105.55 5.72 31.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.4 0.619 . . . . 0.0 109.923 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -111.61 -1.84 15.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.531 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -98.3 116.51 30.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.15 -173.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 51.03 -109.38 0.73 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 175.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.13 136.92 55.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.057 0.543 . . . . 0.0 110.707 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 260' ' ' ASP . 2.4 tp10 66.43 -160.16 0.25 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ASP . . . . . 0.42 ' H ' ' HG3' ' A' ' 259' ' ' GLU . 4.9 p-10 -133.95 134.75 42.93 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.627 ' O ' ' HB ' ' A' ' 253' ' ' ILE . . . -125.65 158.25 19.92 Favored Glycine 0 C--N 1.316 -0.563 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.74 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 11.8 p -82.19 -179.43 7.4 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.665 0.386 . . . . 0.0 110.958 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.89 -47.76 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.255 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.38 -31.86 15.88 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.758 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.55 -44.24 96.87 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.042 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 270' ' ' VAL . 40.5 tp -64.78 -41.93 95.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -61.64 -43.1 99.5 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.366 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.39 -40.82 96.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.912 0.387 . . . . 0.0 110.586 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -66.63 -41.75 87.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.376 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 266' ' ' LEU . 85.7 t -63.75 -42.77 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.408 HH12 HG11 ' A' ' 132' ' ' VAL . 9.4 tpt180 -55.69 -47.6 76.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.301 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 0.1 OUTLIER -70.27 -40.89 74.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -64.53 -41.25 96.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.687 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 95.1 mmm -65.04 -41.63 95.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.628 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.41 -34.86 78.11 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.815 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.56 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 53.4 ttp180 -63.65 -43.64 96.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.393 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -68.32 -34.68 76.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.048 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.413 ' O ' HG13 ' A' ' 282' ' ' ILE . 50.2 tp -62.62 -37.94 88.26 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.56 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 50.7 tttm -55.98 -46.78 78.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.165 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.9 m -62.37 -40.89 97.91 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.708 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.59 -42.71 99.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.929 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 278' ' ' LEU . 64.1 mt -65.35 -43.29 94.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.828 0.347 . . . . 0.0 110.482 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.549 ' HD2' ' OE2' ' A' ' 405' ' ' GLU . 1.1 tpm_? -58.96 -44.52 91.5 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.392 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.24 -42.74 96.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.224 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -61.86 -44.47 96.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.946 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.49 -44.69 86.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.008 0.432 . . . . 0.0 110.749 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.0 tttt -61.6 -47.18 86.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.539 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.7 p -62.31 -41.08 98.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.23 -41.78 94.06 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.762 0.315 . . . . 0.0 110.791 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.37 -48.26 76.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.039 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 287' ' ' LYS . 49.4 mm -63.2 -47.91 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.513 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.548 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 26.4 tp10 -61.87 -43.02 99.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.097 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.29 -42.93 93.83 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.702 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.81 -44.49 96.03 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.54 -44.79 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.256 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LYS . . . . . 0.548 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 64.0 mttm -61.63 -40.52 95.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.582 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.3 80.84 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.719 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -126.45 101.47 6.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -94.78 113.85 25.67 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.4 tp -119.75 153.26 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.502 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -61.75 142.68 57.12 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.952 0.406 . . . . 0.0 110.515 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 54.2 t -120.83 126.28 26.74 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.644 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.1 131.94 48.36 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.216 1.944 . . . . 0.0 111.715 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.72 -38.23 89.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.066 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ALA . . . . . 0.406 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -56.87 -44.2 82.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.023 0.439 . . . . 0.0 111.402 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.63 -41.8 95.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.446 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 311' ' ' ILE . 68.6 mt -61.75 -48.17 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.73 -46.15 84.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.159 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 48.9 m -61.03 -44.95 96.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.685 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.424 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 56.1 mm-40 -71.42 -35.35 70.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.45 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 94.3 mt -62.42 -44.42 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.69 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 13.1 t70 -64.32 -40.98 97.0 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.268 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.61 -43.94 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.978 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 96.9 mt -62.37 -41.99 99.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.684 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.495 HH12 HD12 ' A' ' 330' ' ' LEU . 79.8 mtm180 -63.59 -39.56 94.7 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.084 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 66.6 mtt180 -64.34 -40.29 95.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.261 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -64.61 -42.64 95.39 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.291 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.47 -38.43 81.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.516 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.24 -34.92 79.21 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.979 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' GLN . . . . . 0.412 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 52.3 tt0 -60.25 -37.11 79.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.408 0.623 . . . . 0.0 109.852 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -79.11 -7.56 58.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.593 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -100.8 2.29 41.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 135.4 -3.56 3.99 Favored Glycine 0 CA--C 1.509 -0.344 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.114 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 93.9 28.97 10.26 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.638 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.505 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 45.8 t-20 -70.82 130.6 42.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.975 0.417 . . . . 0.0 110.622 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.0 tm-20 -129.95 158.25 40.06 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 6.7 ptpp? 60.04 -40.06 0.09 Allowed 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 125.682 1.593 . . . . 0.0 114.473 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.505 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 15.6 mm100 -73.0 -12.7 61.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.382 0.611 . . . . 0.0 109.806 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.45 -17.55 62.81 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.762 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.495 HD12 HH12 ' A' ' 315' ' ' ARG . 56.4 tp -61.59 -32.29 72.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.252 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.88 -15.39 60.21 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.756 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.485 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 89.9 mt -66.59 138.07 95.41 Favored Pre-proline 0 C--O 1.238 0.488 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.953 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.78 119.21 6.08 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.344 2.696 . . . . 0.0 113.593 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.446 ' HG3' HD13 ' A' ' 311' ' ' ILE . 21.5 ttt180 -63.07 -45.37 92.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.356 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 0.9 OUTLIER -66.14 -18.61 65.46 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.401 -173.138 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.598 HD13 ' NZ ' ' A' ' 227' ' ' LYS . 85.7 mt -94.2 -5.76 46.28 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -117.35 -2.32 11.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.408 0.623 . . . . 0.0 109.731 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.444 ' HG3' HD11 ' A' ' 311' ' ' ILE . 40.5 tt0 -83.34 -16.69 45.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.534 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.92 -48.74 67.73 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.045 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -74.65 -24.72 58.86 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.197 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -60.27 -44.87 94.95 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.499 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.3 tttt -60.38 -46.91 88.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.427 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.52 ' O ' HG23 ' A' ' 347' ' ' VAL . 20.3 mmt85 -62.51 -44.22 96.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -66.29 -38.62 88.19 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.721 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 76.1 t -64.2 -44.1 97.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.753 0.311 . . . . 0.0 110.335 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.52 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 75.6 t -61.5 -43.29 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.644 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 343' ' ' ARG . 72.1 t -59.92 -44.44 94.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.21 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.55 -41.2 99.52 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.98 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 91.1 mt -63.1 -43.8 97.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.955 0.407 . . . . 0.0 111.095 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.0 mt -62.8 -47.36 83.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.122 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.99 -39.44 83.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.852 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.63 -43.27 96.31 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.541 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -68.18 -37.91 81.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.356 0.578 . . . . 0.0 111.042 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.06 -45.79 97.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.74 -44.2 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.018 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -66.07 -49.79 66.39 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.912 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.4 m -66.74 -44.16 82.25 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -82.19 -4.35 56.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.853 0.359 . . . . 0.0 111.063 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 60.02 38.22 20.83 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.347 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.38 152.92 39.46 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.098 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -129.29 158.96 37.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.108 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -81.48 105.6 12.78 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 367' ' ' VAL . 26.6 t70 -81.18 114.47 20.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.169 0.509 . . . . 0.0 112.257 -173.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.543 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 66.4 mm-40 -62.02 -37.3 84.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.255 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 63.4 mm-40 -61.92 -45.74 92.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.286 0.565 . . . . 0.0 110.179 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -63.07 -39.15 93.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.074 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 363' ' ' ASP . 93.2 t -62.96 -40.82 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.784 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.2 mmmt -57.77 -44.13 85.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.413 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.92 -38.79 97.16 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.767 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.79 -42.19 99.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.05 0.452 . . . . 0.0 110.014 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.19 -43.39 97.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.961 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.66 -44.11 97.1 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -65.63 -39.09 91.08 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.533 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 55.7 ttm -65.09 -42.87 93.66 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.096 0.474 . . . . 0.0 110.967 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 377' ' ' ALA . . . -63.31 -31.35 72.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.562 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 37.4 m -73.68 23.84 0.07 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.939 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' A' ' 375' ' ' ALA . . . -123.43 0.72 8.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.737 0.303 . . . . 0.0 110.765 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.47 175.33 5.47 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.576 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -59.29 -42.22 90.77 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.835 0.35 . . . . 0.0 110.824 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -134.06 116.17 13.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.476 ' O ' HG13 ' A' ' 385' ' ' ILE . 51.4 Cg_endo -69.5 -31.99 20.55 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.272 1.982 . . . . 0.0 113.702 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -66.62 -43.76 83.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.48 -35.02 79.66 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.576 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.82 -42.66 97.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.244 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 381' ' ' PRO . 74.5 mt -61.19 -46.72 96.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.461 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 43.0 mt-10 -65.33 -43.46 90.89 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.82 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -57.0 -46.87 81.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.832 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.439 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 3.5 t80 -64.89 -42.31 94.89 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.204 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 65.4 p -76.06 -10.44 59.42 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 99.6 mttt -98.35 6.3 47.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.024 0.44 . . . . 0.0 111.005 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 24.2 t-20 -130.64 111.8 12.54 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.854 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -63.38 -36.6 84.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.239 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' GLU . . . . . 0.407 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 25.7 tp10 -56.95 -53.15 61.31 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.96 0.409 . . . . 0.0 110.283 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.68 -41.21 98.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.597 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.489 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 87.8 mtp -62.07 -46.74 87.75 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 120.836 0.35 . . . . 0.0 111.708 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.61 -39.55 64.49 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.076 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -63.36 -40.6 97.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.439 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 46.7 tpp -64.68 -40.27 95.11 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.982 0.42 . . . . 0.0 110.742 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 395' ' ' MET . 70.1 mtm180 -63.38 -33.4 75.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.092 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.6 -44.28 97.3 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.17 -45.52 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.177 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.7 99.54 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.496 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 46.3 tp -64.82 -37.61 88.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.422 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.01 -46.29 82.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.716 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.549 ' OE2' ' HD2' ' A' ' 283' ' ' ARG . 26.6 mt-10 -65.26 -38.69 91.1 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.634 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -60.5 -43.35 97.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.303 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.95 -45.36 89.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.433 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 96.2 t -63.89 -46.56 93.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.274 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -68.49 -30.56 69.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.897 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.39 98.93 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.48 -43.32 96.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.033 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.5 mt -61.95 -39.0 90.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.251 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.98 -33.05 72.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.963 0.411 . . . . 0.0 110.896 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -89.08 -10.94 45.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.846 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -93.65 176.94 6.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.295 0.569 . . . . 0.0 112.348 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -93.05 112.34 24.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.291 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.42 129.45 51.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.03 0.443 . . . . 0.0 110.945 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.5 t -118.27 139.95 50.56 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.858 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -105.29 120.05 40.6 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -137.31 145.01 42.93 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.712 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.86 148.4 26.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.98 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.9 t -150.34 177.95 9.48 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.046 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 19.7 p -86.41 159.96 19.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.991 0.424 . . . . 0.0 111.474 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -66.8 -33.37 75.47 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.2 0.524 . . . . 0.0 110.742 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 428' ' ' MET . 6.6 m-20 -60.74 -37.17 80.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.514 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.25 -32.66 74.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.558 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.16 -17.7 61.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.943 0.401 . . . . 0.0 110.474 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 425' ' ' ASN . 5.7 mmt -74.95 -8.05 55.35 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.167 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -76.72 75.8 3.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -103.73 15.25 29.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.057 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -63.89 -42.02 97.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.375 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.705 -0.664 . . . . 0.0 110.757 -179.65 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 CA--C 1.513 -0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -94.74 158.08 15.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.922 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.53 158.76 43.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.692 0.282 . . . . 0.0 110.718 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 6.4 m -86.09 107.34 17.78 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.491 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.51 138.45 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.978 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.535 ' HG2' ' H ' ' B' ' 7' ' ' THR . 25.1 tt0 -137.53 177.77 7.61 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.535 ' H ' ' HG2' ' B' ' 6' ' ' GLU . 13.1 t -118.09 152.13 36.18 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.89 0.376 . . . . 0.0 111.272 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 75.3 m -110.62 -70.74 0.79 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.074 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -168.03 111.16 0.61 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.022 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.23 -108.37 2.02 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.073 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.09 -31.92 68.42 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 122.462 0.305 . . . . 0.0 111.236 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.24 139.18 39.67 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 116.005 -0.543 . . . . 0.0 114.021 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 0.0 OUTLIER -142.17 161.23 38.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.466 0.706 . . . . 0.0 110.049 -178.157 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' B' ' 6' ' ' GLU . 32.0 ttm-85 -119.86 138.45 53.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 39.8 t -106.03 -86.94 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.343 176.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 17.9 m 51.1 87.29 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.331 0.586 . . . . 0.0 111.458 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 tp -94.16 136.91 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.941 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 91.7 m -117.33 121.51 41.34 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.101 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.536 HG13 HG12 ' B' ' 24' ' ' ILE . 14.3 pt -135.31 165.88 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.611 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.79 151.11 47.37 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.456 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -54.01 -53.03 58.58 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -173.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -65.42 -36.13 83.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.091 0.472 . . . . 0.0 110.441 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.9 m -63.65 -38.23 90.34 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.561 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.611 HG13 ' O ' ' B' ' 20' ' ' ALA . 74.9 mt -59.15 -51.04 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 111.21 -177.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -73.01 -42.59 63.05 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.856 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -67.61 -52.38 39.1 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.42 -44.59 67.6 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.78 -43.06 96.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.734 0.302 . . . . 0.0 111.307 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -61.7 -44.92 96.01 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.082 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.449 ' O ' HG12 ' B' ' 33' ' ' VAL . 19.6 m -63.92 -40.83 97.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.638 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -62.6 -41.84 99.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.031 0.443 . . . . 0.0 110.454 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.48 -41.61 98.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.086 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.449 HG12 ' O ' ' B' ' 30' ' ' SER . 9.9 p -67.99 -36.5 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.316 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -63.47 -42.78 98.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.232 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.03 -36.97 77.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.335 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.77 -48.1 80.64 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.105 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.68 -36.96 85.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.906 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.48 -34.63 75.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.666 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.46 -7.52 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.368 0.604 . . . . 0.0 109.707 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 65.91 27.84 10.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.865 0.866 . . . . 0.0 111.57 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.01 3.53 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.325 0.583 . . . . 0.0 111.001 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -65.4 -32.83 74.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.072 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -7.4 58.01 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.69 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -89.04 -6.83 56.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.834 0.35 . . . . 0.0 110.35 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 65.9 ttt-85 -87.58 91.66 8.82 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.054 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -63.17 -43.58 97.85 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.61 72.66 0.7 Allowed Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 115.997 1.159 . . . . 0.0 115.997 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.92 -43.17 98.97 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 171.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.82 112.52 63.93 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.775 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -57.41 147.49 77.51 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 111.912 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.551 ' HA ' HG12 ' B' ' 54' ' ' VAL . 19.7 ttt -67.38 -24.75 65.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.543 -172.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -77.63 -10.24 59.4 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.447 HD13 ' CZ ' ' A' ' 193' ' ' ARG . 81.5 mt -108.26 -47.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.488 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' B' ' 51' ' ' MET . 12.4 p -62.89 -38.88 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.032 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.8 92.21 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -88.41 -9.22 53.35 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.052 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.44 ' NH1' ' SD ' ' A' ' 194' ' ' MET . 62.2 ttt180 -97.36 -41.47 8.22 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.238 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.61 9.87 27.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.965 0.412 . . . . 0.0 109.893 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -57.57 -63.84 4.92 Favored Glycine 0 C--O 1.211 -1.343 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.115 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.63 -27.76 66.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.978 0.389 . . . . 0.0 111.748 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.3 t -61.61 -45.09 95.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.797 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.428 HG22 ' O ' ' B' ' 62' ' ' VAL . 7.6 p -131.0 21.39 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 120.996 0.427 . . . . 0.0 111.902 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.59 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 6.7 ttt180 -64.65 -21.49 66.74 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.782 -0.574 . . . . 0.0 110.914 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -62.08 -50.3 72.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.64 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' B' ' 62' ' ' VAL . 1.1 m-20 -73.6 -25.0 60.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.1 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.93 -43.74 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.1 -39.67 95.38 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.37 -40.3 97.36 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.634 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ASP . . . . . 0.764 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 30.6 t70 -61.29 -46.15 91.51 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.67 -42.31 98.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.495 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 60.2 ttp -61.94 -42.4 99.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -62.54 -42.85 99.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.764 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 52.3 mtp85 -63.32 -44.98 93.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.535 -176.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -65.31 -41.33 94.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.228 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -61.3 -48.05 83.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.763 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.14 -39.07 80.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.885 0.374 . . . . 0.0 111.117 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.73 -41.24 96.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.186 0.517 . . . . 0.0 110.532 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.51 -46.42 86.16 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.989 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 41.1 pt -65.35 -38.0 81.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.85 -43.62 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.126 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -76.77 -26.26 54.3 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -88.19 3.26 49.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.399 . . . . 0.0 110.793 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 63.9 28.38 14.55 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.125 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.2 mt -94.29 114.68 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -112.09 104.36 55.96 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.01 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.53 140.77 64.32 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.175 1.917 . . . . 0.0 111.695 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.54 96.32 7.3 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.857 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.29 -112.48 4.48 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.789 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.81 139.04 31.12 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.502 0.151 . . . . 0.0 110.657 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' PRO . . . . . 0.491 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 55.7 Cg_endo -68.48 155.89 67.5 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.629 2.219 . . . . 0.0 111.29 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -90.06 99.01 12.1 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.938 0.399 . . . . 0.0 111.558 -175.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.491 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 66.8 m-85 -102.95 110.96 23.07 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.4 t -115.83 98.83 51.79 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.95 145.97 25.5 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.359 2.039 . . . . 0.0 111.958 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.76 171.9 45.62 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.131 -1.033 . . . . 0.0 110.898 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.5 123.14 20.5 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.057 0.456 . . . . 0.0 110.597 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -84.44 134.19 34.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.261 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -121.78 122.11 38.77 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 46.3 tp -69.76 106.48 3.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.975 0.417 . . . . 0.0 110.716 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.98 -18.35 9.05 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.486 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -110.27 -175.33 2.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -79.7 164.42 23.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.934 0.397 . . . . 0.0 111.707 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -131.18 141.74 50.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.459 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.2 m -120.05 133.78 55.43 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.912 0.387 . . . . 0.0 111.118 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -125.28 165.28 18.6 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.139 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.9 m -75.5 -82.76 0.07 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 46.8 t 54.27 103.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 122.955 0.502 . . . . 0.0 111.315 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -88.33 123.5 32.97 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' PHE . . . . . 0.494 ' HB3' ' OE1' ' B' ' 110' ' ' GLU . 13.7 m-85 -123.36 -167.47 1.62 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.769 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.494 ' OE1' ' HB3' ' B' ' 109' ' ' PHE . 1.0 OUTLIER -72.37 176.34 5.4 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -176.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' B' ' 305' ' ' ALA . 32.1 m -125.43 166.14 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.473 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' B' ' 113' ' ' PRO . 69.9 m-85 -123.61 121.06 26.74 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.796 -178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 112' ' ' TYR . 73.8 Cg_endo -90.97 134.77 1.8 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 122.87 2.38 . . . . 0.0 113.136 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -135.42 144.79 46.7 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.36 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 76.5 t -126.2 134.22 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -107.52 -86.98 0.49 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.861 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 85.0 mt 62.52 120.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.197 0.999 . . . . 0.0 113.553 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -140.18 153.07 46.5 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.948 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.68 21.85 73.73 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.584 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.55 -40.67 95.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.964 0.411 . . . . 0.0 111.486 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.55 -8.73 57.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.363 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.96 8.19 44.33 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 64.7 mt -88.4 108.8 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.197 0.522 . . . . 0.0 110.089 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.36 103.95 15.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.505 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.02 133.08 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.21 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -85.57 122.96 30.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.44 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -120.78 97.08 48.59 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -69.49 130.24 19.32 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.578 1.519 . . . . 0.0 111.823 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -102.69 115.39 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 24.2 m -132.78 159.46 43.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.299 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.43 160.72 37.9 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 66.8 t -76.25 127.7 37.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 41.3 p -105.27 173.46 6.3 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.814 0.34 . . . . 0.0 110.194 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -67.56 -25.49 65.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.162 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.55 -40.36 96.79 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.122 0.487 . . . . 0.0 109.891 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -63.66 -40.8 97.75 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.026 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.0 t -61.75 -48.43 88.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.414 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.32 -38.42 90.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.901 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.7 -40.95 99.46 Favored Glycine 0 C--O 1.237 0.294 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.565 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 4.1 tpt -63.27 -41.84 99.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.15 0.5 . . . . 0.0 109.826 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 87.2 mt -63.16 -40.31 97.19 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.801 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -58.98 -46.88 87.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.568 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.7 m -63.39 -41.1 98.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 144' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' B' ' 140' ' ' MET . 89.5 mt -60.56 -42.86 97.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.718 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -79.07 -8.71 59.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.773 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -94.86 -5.46 44.95 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -97.73 -55.82 2.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.149 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 148' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' B' ' 148' ' ' GLN . 8.1 mm-40 -58.09 96.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.07 106.55 3.64 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.901 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 150' ' ' THR . . . . . 0.608 HG22 ' H ' ' B' ' 151' ' ' TRP . 0.2 OUTLIER -73.07 175.13 6.99 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -173.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 151' ' ' TRP . . . . . 0.608 ' H ' HG22 ' B' ' 150' ' ' THR . 53.2 p-90 -99.43 161.21 13.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.526 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 152' ' ' LYS . . . . . 0.588 ' H ' ' HA ' ' B' ' 243' ' ' ARG . 76.6 tttt -170.98 -81.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.584 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 153' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' B' ' 242' ' ' GLU . 11.8 pt-20 -164.24 76.16 0.33 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 154' ' ' LYS . . . . . 0.462 ' HG2' ' H ' ' B' ' 155' ' ' ASP . 49.7 tttt 178.06 -160.79 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 155' ' ' ASP . . . . . 0.462 ' H ' ' HG2' ' B' ' 154' ' ' LYS . 12.2 p-10 -135.38 163.05 30.91 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 117.996 0.362 . . . . 0.0 111.153 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 119.87 -18.97 9.71 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.182 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -115.36 100.23 7.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 117.393 0.596 . . . . 0.0 112.174 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 55.0 t -130.26 136.34 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 159' ' ' GLU . . . . . 0.5 ' HB2' ' OD2' ' B' ' 162' ' ' ASP . 3.4 mm-40 -95.6 -170.58 2.18 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.164 0.507 . . . . 0.0 111.899 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 160' ' ' ALA . . . . . 0.648 ' O ' ' HA3' ' B' ' 190' ' ' GLY . . . -98.94 24.32 7.87 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 161' ' ' GLU . . . . . 0.791 ' HA ' ' O ' ' B' ' 189' ' ' MET . 13.4 pt-20 -158.85 25.27 0.22 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.34 0.591 . . . . 0.0 112.422 175.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' B' ' 188' ' ' ALA . 12.8 m-20 -87.81 170.7 10.97 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.398 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -108.15 121.13 44.22 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.3 t -116.74 128.26 74.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.251 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 20.7 m -76.75 104.88 7.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.97 117.99 56.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.002 0.43 . . . . 0.0 111.393 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.95 88.44 5.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -109.14 150.92 27.14 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.332 0.587 . . . . 0.0 112.182 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 46.3 m -119.97 128.28 53.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.937 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.9 114.09 3.89 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.488 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 39.2 m -131.94 124.19 28.93 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' VAL . . . . . 0.537 HG23 ' CD2' ' B' ' 177' ' ' PHE . 93.9 t -100.14 106.77 19.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 35.2 t70 67.6 -75.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.939 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -145.37 9.95 1.72 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.608 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -132.48 139.02 47.79 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.521 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.13 148.25 26.22 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 177' ' ' PHE . . . . . 0.537 ' CD2' HG23 ' B' ' 172' ' ' VAL . 31.9 p90 -115.84 171.41 7.79 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.442 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -59.39 -36.83 76.54 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.62 -174.45 33.82 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.04 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.73 24.31 60.53 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.991 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -103.56 106.58 17.13 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -124.73 144.78 50.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.194 0.521 . . . . 0.0 112.144 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 42.9 m -138.35 119.55 14.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.843 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 55.01 31.11 15.43 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 123.587 0.555 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -81.17 124.54 29.34 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.441 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.72 107.48 18.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.763 0.792 . . . . 0.0 110.708 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 55.1 tp -95.08 122.17 37.46 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.6 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 188' ' ' ALA . . . . . 0.578 ' HB3' ' CZ ' ' B' ' 193' ' ' ARG . . . -92.1 116.69 29.16 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 189' ' ' MET . . . . . 0.791 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 54.1 mtp -84.54 154.28 22.76 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.91 -175.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.648 ' HA3' ' O ' ' B' ' 160' ' ' ALA . . . 89.28 4.31 74.32 Favored Glycine 0 CA--C 1.501 -0.831 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.71 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -111.33 -4.33 14.96 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.312 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.27 47.65 8.91 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.018 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.578 ' CZ ' ' HB3' ' B' ' 188' ' ' ALA . 96.2 mtt180 -95.47 -3.62 46.47 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.288 0.566 . . . . 0.0 109.568 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.455 ' SD ' ' NH1' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -134.54 168.74 18.42 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.942 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 43.7 mm -61.74 135.46 94.34 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.25 129.5 19.14 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.356 2.037 . . . . 0.0 111.85 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.44 -36.63 4.28 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.343 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -67.31 -50.95 58.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.33 0.565 . . . . 0.0 112.015 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 199' ' ' GLU . . . . . 0.456 ' O ' ' HE3' ' B' ' 189' ' ' MET . 10.5 pt-20 -81.48 -10.95 59.37 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.005 0.431 . . . . 0.0 111.427 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -90.72 -25.86 19.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.153 0.502 . . . . 0.0 109.705 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.21 -10.93 85.98 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.143 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.5 mm -64.27 -43.0 97.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -55.41 114.6 1.89 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.905 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 115.03 -9.11 21.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.923 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -99.4 146.64 26.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 117.319 0.56 . . . . 0.0 112.158 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.49 168.84 11.53 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.007 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.34 129.28 37.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 78.29 33.36 40.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.68 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -119.77 118.94 32.19 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.913 0.387 . . . . 0.0 110.378 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -101.67 116.62 33.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.284 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -138.29 -16.21 1.23 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 62.7 p 59.66 167.86 0.07 Allowed 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 123.712 0.805 . . . . 0.0 112.844 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -151.17 144.21 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.968 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -80.21 110.91 16.07 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.687 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 43.1 t -118.77 105.5 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 216' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 21.0 m -71.99 -43.54 64.93 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' B' ' 216' ' ' THR . 66.3 m-85 76.67 146.91 0.12 Allowed Pre-proline 0 N--CA 1.488 1.449 0 C-N-CA 123.044 0.538 . . . . 0.0 110.748 -174.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.7 153.82 68.74 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.788 2.325 . . . . 0.0 111.863 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 219' ' ' GLU . . . . . 0.515 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 65.0 mm-40 -66.7 -38.12 86.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.236 0.541 . . . . 0.0 110.069 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -94.49 40.8 1.09 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.62 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -75.15 143.88 43.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.154 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -60.96 -17.63 52.66 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.39 118.48 36.85 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.441 ' HA ' ' CD ' ' B' ' 227' ' ' LYS . 5.2 tp10 -61.86 -33.23 73.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.856 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -88.96 -5.11 58.2 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 87.7 mt -117.93 -14.72 10.02 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.029 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.668 ' NZ ' HD13 ' B' ' 336' ' ' LEU . 19.7 ptmt -63.96 122.58 16.86 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.121 0.486 . . . . 0.0 111.884 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.58 9.94 66.05 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.097 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -110.92 120.4 42.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.197 0.498 . . . . 0.0 110.485 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -72.51 134.45 45.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.871 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.56 156.52 26.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.659 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.25 -31.68 13.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 51.59 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -74.52 95.4 2.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.509 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm -96.53 114.64 33.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.57 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -108.46 -31.59 7.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.212 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.2 mt 65.5 170.41 0.21 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.407 0.683 . . . . 0.0 111.382 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -128.62 -79.61 0.57 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.122 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -115.42 -31.13 6.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.4 ' O ' HG12 ' B' ' 240' ' ' VAL . 17.1 t 59.89 41.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 122.13 0.967 . . . . 0.0 109.085 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 63.67 -101.1 0.09 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.765 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.538 ' HB2' ' HA ' ' B' ' 153' ' ' GLU . 9.5 pt-20 179.9 96.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.962 0.905 . . . . 0.0 109.095 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.588 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 10.5 ptm180 -152.19 120.94 6.51 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -173.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 179.46 164.89 1.02 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 98.2 mt 70.85 112.17 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.985 0 CA-C-O 121.285 0.564 . . . . 0.0 111.617 -176.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.37 118.18 2.54 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.527 2.151 . . . . 0.0 114.471 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -144.64 167.23 23.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.501 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.82 134.68 38.99 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.045 0.45 . . . . 0.0 112.19 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 8.0 m -138.07 154.91 49.23 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -79.44 -36.49 38.81 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.808 0.337 . . . . 0.0 111.642 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -75.6 56.41 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.758 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -136.09 -56.92 0.77 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.937 0.399 . . . . 0.0 110.498 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 253' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' B' ' 261' ' ' GLY . 36.4 pt -68.86 -22.81 26.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.163 0.506 . . . . 0.0 110.92 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -105.85 7.83 32.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.666 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -115.12 -1.06 13.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.391 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -99.66 116.75 32.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.208 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 46.59 -115.86 2.08 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 83.2 t -113.65 136.51 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.522 0.729 . . . . 0.0 110.926 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 259' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' B' ' 260' ' ' ASP . 3.0 tp10 69.18 -173.05 0.18 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 260' ' ' ASP . . . . . 0.449 ' H ' ' HG3' ' B' ' 259' ' ' GLU . 5.1 p-10 -125.98 117.99 24.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 261' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' B' ' 253' ' ' ILE . . . -103.2 162.27 16.08 Favored Glycine 0 C--N 1.316 -0.552 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.174 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 12.0 p -85.37 -178.99 6.87 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.72 -47.98 90.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.918 0.389 . . . . 0.0 111.065 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.1 -32.02 17.73 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.782 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.02 -42.35 96.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.533 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.507 ' O ' HG23 ' B' ' 270' ' ' VAL . 47.5 tp -64.33 -42.4 96.3 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.633 0.216 . . . . 0.0 110.435 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -60.86 -44.64 96.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.638 0.256 . . . . 0.0 111.155 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.16 -41.23 97.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.003 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -69.4 -38.79 78.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.507 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.1 t -63.83 -42.0 94.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -53.15 -54.83 30.09 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.498 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 12.7 ptmt -64.59 -42.61 95.48 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -63.65 -40.71 97.53 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.473 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.6 -41.41 92.82 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.195 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -66.68 -35.08 79.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.949 0.404 . . . . 0.0 110.883 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 276' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 56.3 ttp180 -62.78 -42.63 99.78 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.385 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.34 -37.29 83.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.985 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.23 -37.81 86.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.541 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 279' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 52.5 tttm -56.34 -45.94 80.17 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.37 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 42.5 m -61.83 -41.0 97.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.592 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.2 -44.91 96.53 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.158 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.35 -44.22 98.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.285 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 283' ' ' ARG . . . . . 0.453 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.5 OUTLIER -60.41 -44.88 95.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 178.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -64.44 -41.87 96.31 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.672 0.272 . . . . 0.0 110.927 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -61.48 -44.64 96.73 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.099 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.15 -43.27 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.988 0.423 . . . . 0.0 110.582 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.43 -47.72 84.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.806 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 73.7 p -61.94 -41.55 98.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.738 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -64.53 -44.83 89.59 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.824 0.345 . . . . 0.0 111.073 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.38 78.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.535 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 291' ' ' ILE . . . . . 0.428 ' O ' HG23 ' B' ' 295' ' ' VAL . 37.5 mm -64.09 -44.24 97.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.734 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 292' ' ' GLU . . . . . 0.512 ' HG3' ' HE2' ' B' ' 296' ' ' LYS . 30.6 tp10 -62.91 -45.11 94.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.513 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.43 95.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.7 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.404 HD13 HD13 ' B' ' 350' ' ' LEU . 1.8 tt -62.81 -43.15 99.56 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 291' ' ' ILE . 98.8 t -66.28 -43.38 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.075 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 296' ' ' LYS . . . . . 0.512 ' HE2' ' HG3' ' B' ' 292' ' ' GLU . 64.3 mttm -62.21 -39.22 92.05 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.593 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.24 -37.71 66.28 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.364 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -125.45 98.53 5.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.06 115.28 27.95 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -120.28 153.64 23.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.475 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.13 142.25 58.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.151 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.85 127.42 26.0 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.207 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.5 134.0 60.56 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.568 2.179 . . . . 0.0 111.896 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.37 87.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.808 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 305' ' ' ALA . . . . . 0.433 ' HB2' HG11 ' B' ' 111' ' ' VAL . . . -57.46 -42.75 83.14 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.474 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.65 -41.75 95.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.286 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.2 -47.45 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.114 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.12 -47.54 80.85 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.258 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 48.4 m -60.29 -44.79 95.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.897 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 310' ' ' GLU . . . . . 0.474 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 67.0 mm-40 -71.81 -36.69 70.33 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.552 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 92.7 mt -61.94 -44.22 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.085 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.498 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 15.0 t70 -63.34 -42.52 98.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.906 0.384 . . . . 0.0 110.322 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.34 -43.85 98.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.23 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 92.9 mt -61.91 -41.23 97.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.762 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 82.6 mtm180 -63.88 -38.64 91.83 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.141 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 316' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 62.0 mtt-85 -64.25 -40.69 96.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.926 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.1 -43.03 96.59 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.455 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.84 76.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.971 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.18 77.36 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.965 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 320' ' ' GLN . . . . . 0.436 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 8.1 tt0 -60.99 -34.22 74.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.332 0.587 . . . . 0.0 110.019 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -82.08 -9.22 59.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.121 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -97.09 -0.58 46.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.688 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 323' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 135.38 0.52 3.33 Favored Glycine 0 C--O 1.226 -0.403 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.85 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 324' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 90.98 29.57 12.6 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.875 -1.155 . . . . 0.0 111.822 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 325' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 42.5 t-20 -71.6 125.38 26.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.126 0.489 . . . . 0.0 111.136 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 326' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 3.0 tm-20 -124.5 157.13 36.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 6.6 ptpp? 60.12 -38.67 0.09 Allowed 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 125.882 1.673 . . . . 0.0 114.681 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 328' ' ' GLN . . . . . 0.435 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.2 mm100 -75.24 -10.02 59.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.19 0.519 . . . . 0.0 110.362 177.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -65.88 -12.73 56.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.353 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.519 HD12 HH12 ' B' ' 315' ' ' ARG . 62.6 tp -61.62 -34.8 76.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.883 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -76.98 -11.59 59.82 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.808 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 332' ' ' LEU . . . . . 0.464 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 84.3 mt -66.92 134.76 94.03 Favored Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.621 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -49.93 122.26 8.79 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.445 2.763 . . . . 0.0 113.69 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 334' ' ' ARG . . . . . 0.482 ' HG3' HD13 ' B' ' 311' ' ' ILE . 21.9 ttt180 -65.37 -44.56 87.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.018 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -68.38 -17.35 64.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.58 -172.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 336' ' ' LEU . . . . . 0.668 HD13 ' NZ ' ' B' ' 227' ' ' LYS . 92.1 mt -93.53 -5.86 48.07 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -117.36 -11.83 10.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.688 0.756 . . . . 0.0 109.767 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.98 -21.99 61.5 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.944 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -65.4 -48.64 72.14 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.907 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -75.18 -25.82 58.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.681 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.433 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -59.06 -44.95 91.88 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.506 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 342' ' ' LYS . . . . . 0.472 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.7 tttt -60.37 -45.25 94.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.255 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 343' ' ' ARG . . . . . 0.467 ' O ' HG23 ' B' ' 347' ' ' VAL . 18.4 mmt85 -62.68 -43.75 98.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -64.97 -38.83 92.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 121.189 -0.204 . . . . 0.0 111.059 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 341' ' ' ALA . 81.5 t -64.49 -44.14 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.436 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.512 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 70.3 t -61.8 -43.98 98.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.467 HG23 ' O ' ' B' ' 343' ' ' ARG . 74.0 t -59.83 -45.21 95.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.676 0.274 . . . . 0.0 110.496 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.37 -41.25 99.76 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.805 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.5 -43.2 99.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' B' ' 346' ' ' VAL . 96.2 mt -62.91 -46.43 87.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.021 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.5 -39.31 85.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.776 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.95 -45.63 93.48 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.409 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -68.84 -37.29 79.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.218 0.509 . . . . 0.0 111.234 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.24 -46.25 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.7 -44.29 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.547 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -65.89 -50.07 65.8 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 97.3 m -65.79 -45.97 80.46 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -81.9 -7.22 59.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.694 0.283 . . . . 0.0 111.547 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 63.22 45.03 5.29 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.162 0.506 . . . . 0.0 111.317 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.01 155.95 28.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.977 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -132.22 158.65 41.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.5 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -84.85 102.48 13.12 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 363' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 26.1 t70 -81.69 118.6 22.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 364' ' ' GLU . . . . . 0.594 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 54.8 mm-40 -61.59 -39.07 89.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.299 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 365' ' ' GLU . . . . . 0.552 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 63.4 mm-40 -58.44 -48.04 82.01 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.271 0.557 . . . . 0.0 110.275 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -62.36 -40.3 95.98 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.275 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 367' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 363' ' ' ASP . 97.1 t -63.56 -41.52 92.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.036 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 368' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 29.8 mmmt -56.97 -44.61 82.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.777 0.322 . . . . 0.0 110.135 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.38 -38.38 96.3 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.103 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.84 -42.27 99.67 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.288 0.566 . . . . 0.0 110.153 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.84 -43.31 97.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.529 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -61.33 -44.19 97.62 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -66.68 -40.0 88.37 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.937 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 55.6 ttm -64.63 -42.57 95.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.964 0.412 . . . . 0.0 110.75 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.81 -29.2 70.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.256 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 44.3 m -70.37 -7.28 41.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.955 0.407 . . . . 0.0 111.581 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.12 -2.5 58.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.441 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -108.98 174.26 5.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.053 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.62 -44.45 89.99 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.316 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -132.34 113.99 14.6 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -67.61 -30.43 35.04 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.332 2.021 . . . . 0.0 113.373 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.96 -44.35 80.76 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.69 -34.73 78.89 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.933 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.85 -43.02 97.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.438 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.37 -44.86 99.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.89 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 49.9 mt-10 -66.14 -45.0 82.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.124 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -57.1 -46.78 82.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.939 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 388' ' ' TYR . . . . . 0.433 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 4.4 t80 -63.52 -44.37 94.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.887 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 77.4 p -72.56 -14.12 61.56 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 390' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.1 mttt -94.46 5.82 50.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.893 0.377 . . . . 0.0 111.697 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -131.39 113.87 14.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.167 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -63.63 -37.11 86.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -56.91 -51.25 69.84 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.774 0.321 . . . . 0.0 110.533 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.83 -41.02 97.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.901 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 93.4 mtp -60.83 -51.77 67.9 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -72.69 -36.15 67.8 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.369 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.63 -41.03 98.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.988 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 398' ' ' MET . . . . . 0.433 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 50.1 tpp -63.74 -40.79 97.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.631 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.442 ' HG2' HG21 ' B' ' 367' ' ' VAL . 25.8 mtm180 -62.89 -34.3 77.13 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.745 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -61.02 -45.32 95.29 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.768 0.318 . . . . 0.0 110.452 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.49 -44.99 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.07 0.462 . . . . 0.0 110.791 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.22 97.46 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.645 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.75 -36.92 85.45 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.658 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 404' ' ' GLU . . . . . 0.419 ' O ' HG23 ' B' ' 408' ' ' VAL . 36.3 tt0 -58.86 -43.9 90.93 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.648 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 405' ' ' GLU . . . . . 0.453 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 32.2 mt-10 -65.23 -40.55 94.21 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.559 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -58.37 -44.34 88.83 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.559 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.39 -42.5 96.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 408' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 89.3 t -64.8 -46.29 92.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -67.53 -31.5 71.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.312 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.68 98.08 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.855 0.359 . . . . 0.0 110.107 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 95.9 t -66.51 -42.5 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.864 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 412' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 89.6 mt -61.56 -40.15 93.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.091 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.51 -21.79 65.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.564 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -102.06 -2.56 29.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.895 0.378 . . . . 0.0 110.952 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -101.66 173.14 6.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.147 0.499 . . . . 0.0 111.704 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -88.95 114.06 25.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.425 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.22 127.03 53.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.336 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 10.1 t -118.83 131.71 56.09 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.141 0.496 . . . . 0.0 109.92 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -98.62 113.26 25.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.662 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -129.02 146.67 50.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.846 0.355 . . . . 0.0 110.464 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -89.88 146.4 24.44 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.42 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -147.99 -175.67 4.98 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.342 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 67.6 p -94.78 159.92 14.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.33 . . . . 0.0 111.37 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.76 -34.29 77.99 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.05 0.453 . . . . 0.0 110.752 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -58.97 -39.18 80.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.409 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.0 -31.48 72.06 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 120.871 0.367 . . . . 0.0 110.854 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.21 -16.94 61.4 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.852 0.358 . . . . 0.0 110.529 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.3 mmt -75.95 -8.54 57.18 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.086 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -75.72 72.17 2.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -101.12 9.95 41.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.302 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -62.2 -46.62 88.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.917 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.623 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.104 -179.904 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 11.7 p -76.42 -170.71 1.57 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.958 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 4' ' ' SER . 0.6 OUTLIER 87.48 143.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.775 0.83 . . . . 0.0 111.901 177.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -140.74 156.35 46.21 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 m -88.56 129.24 35.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.9 0.381 . . . . 0.0 111.79 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.2 m -88.42 -70.59 0.63 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.069 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -166.27 122.16 1.25 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.891 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.12 -106.16 1.24 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.078 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.8 mt -92.91 -7.91 44.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.615 0.245 . . . . 0.0 110.976 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.524 ' O ' ' HD3' ' A' ' 13' ' ' ARG . . . -81.56 137.9 18.17 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.241 -0.504 . . . . 0.0 114.23 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.524 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -134.12 148.22 50.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.062 0.945 . . . . 0.0 110.84 179.347 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -110.81 137.96 47.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.4 t -96.73 -83.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.665 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 p 25.06 93.91 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.0 tp -123.56 139.76 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.871 0.367 . . . . 0.0 111.965 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.2 p -68.99 139.43 55.0 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.688 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.472 HD13 HG12 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -126.79 141.61 45.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -174.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.641 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -75.51 148.73 38.74 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.073 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -57.15 -40.22 76.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -175.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.55 -3.58 47.53 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.878 0.37 . . . . 0.0 111.449 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -105.71 -25.63 12.14 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.914 0.388 . . . . 0.0 110.624 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.641 HG13 ' O ' ' A' ' 20' ' ' ALA . 74.8 mt -60.56 -49.37 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.153 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.411 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 71.4 mm-40 -102.23 3.47 38.3 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -175.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.7 m -96.66 -72.14 0.65 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.265 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.84 89.0 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.403 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 99.1 t -62.87 -45.34 99.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.879 0.371 . . . . 0.0 111.132 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 20.2 ttmm -63.15 -45.58 91.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.7 m -62.72 -39.71 94.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.194 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.5 tp10 -66.23 -40.55 90.34 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.53 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.8 mt -62.28 -43.11 99.58 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.34 -39.11 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.908 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -65.48 -38.29 89.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.244 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 31' ' ' GLU . 96.0 t -62.46 -42.13 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 110.369 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.29 -41.81 94.17 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 110.223 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.87 -30.75 71.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.096 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 35' ' ' VAL . 24.5 ttmm -57.78 -41.94 83.08 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.171 0.588 . . . . 0.0 110.255 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 t -89.29 -4.48 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.005 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 64.96 33.9 9.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.646 0.778 . . . . 0.0 111.178 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.73 13.03 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.921 0.391 . . . . 0.0 111.741 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.99 -32.75 74.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.351 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.5 -3.4 58.1 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.148 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -86.47 -6.68 58.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.917 0.389 . . . . 0.0 110.834 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.9 ttt-85 -91.61 108.16 19.71 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.812 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.12 -39.49 92.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.635 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.95 29.66 22.61 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.254 -0.974 . . . . 0.0 114.757 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -60.98 -44.69 97.0 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.05 110.06 56.84 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.476 ' O ' HG13 ' A' ' 54' ' ' VAL . 53.1 Cg_exo -56.85 141.5 92.89 Favored 'Trans proline' 0 N--CA 1.477 0.557 0 C-N-CA 122.762 2.308 . . . . 0.0 112.135 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.503 ' HA ' HG22 ' A' ' 54' ' ' VAL . 16.1 ttt -68.33 -27.76 66.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -172.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -72.35 -17.4 61.84 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.095 0.474 . . . . 0.0 110.151 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.524 HD13 ' NH2' ' B' ' 193' ' ' ARG . 84.3 mt -99.75 -34.6 4.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.864 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' A' ' 51' ' ' MET . 21.4 m -60.76 -40.15 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 120.917 0.389 . . . . 0.0 111.012 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.77 -25.94 65.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -94.16 -32.5 13.7 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.066 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.425 HH12 HD13 ' B' ' 187' ' ' LEU . 15.3 tpp180 -64.68 -41.55 95.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.767 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.61 22.5 14.96 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.644 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.75 147.96 49.84 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.835 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.71 -39.69 0.45 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.468 0.707 . . . . 0.0 112.487 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 t -60.68 -47.93 84.04 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 122.678 0.391 . . . . 0.0 111.956 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.8 p -118.29 10.58 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.288 0.566 . . . . 0.0 110.733 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -60.31 -38.81 84.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.481 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 27.2 tt0 -60.08 -45.9 91.37 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.987 0.422 . . . . 0.0 110.83 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -68.1 -34.07 75.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.242 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 62' ' ' VAL . 79.2 t -60.9 -33.82 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 109.714 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 98.0 mt -61.68 -38.77 89.04 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.77 -40.27 99.0 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.498 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.91 -45.31 93.12 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.971 0.415 . . . . 0.0 110.915 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.34 -42.17 98.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.2 ttp -61.27 -46.31 90.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.316 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.3 m -64.4 -53.01 55.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.448 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -69.55 -39.44 77.42 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -65.12 -40.51 94.59 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.486 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -61.43 -48.42 81.24 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.406 ' O ' HG13 ' A' ' 79' ' ' ILE . 16.3 tt -67.78 -39.73 82.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 120.71 0.29 . . . . 0.0 111.154 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.37 -42.75 99.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.157 0.504 . . . . 0.0 110.699 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.98 87.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.309 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.7 pp -68.44 -31.13 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.12 -44.47 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.334 0.588 . . . . 0.0 110.655 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -82.93 -18.96 38.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.888 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -88.14 -7.7 56.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.325 0.583 . . . . 0.0 109.551 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 67.51 35.96 3.98 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.149 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.2 mt -100.37 116.16 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -103.35 105.44 46.65 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.455 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.92 142.89 83.84 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.403 2.069 . . . . 0.0 111.382 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.04 99.24 9.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.046 0.45 . . . . 0.0 110.836 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.08 -104.31 3.16 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.88 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.15 130.41 9.28 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.492 0.187 . . . . 0.0 110.728 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.93 154.03 37.88 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.39 2.06 . . . . 0.0 110.97 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -99.48 120.15 39.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.138 0.494 . . . . 0.0 110.49 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.464 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 97.2 m-85 -97.81 97.5 9.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.621 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.15 107.66 39.41 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.377 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 85.2 Cg_endo -89.01 157.84 5.84 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.907 2.405 . . . . 0.0 111.089 175.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.04 178.41 33.27 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.494 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.3 112.88 9.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.272 0.558 . . . . 0.0 110.038 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -79.35 127.55 32.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.522 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -107.42 119.98 40.91 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.12 117.74 9.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.015 0.436 . . . . 0.0 110.676 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.81 -5.79 54.09 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.665 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -119.97 179.59 4.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.695 0.283 . . . . 0.0 110.764 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -72.44 157.24 38.01 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 111.254 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -123.03 136.63 54.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.934 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.8 m -120.59 137.04 54.62 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.746 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -140.29 167.8 21.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.56 0.344 . . . . 0.0 111.066 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.2 m -78.31 -86.84 0.06 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.2 t 57.21 97.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.299 0.571 . . . . 0.0 110.117 -172.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -100.82 136.04 41.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -157.7 167.42 30.14 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.802 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -52.39 145.21 11.61 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -173.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.4 m -137.89 165.27 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.904 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -121.1 103.97 41.77 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -89.03 160.4 5.88 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.074 2.516 . . . . 0.0 113.531 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.08 138.85 52.71 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.28 141.62 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.636 0.255 . . . . 0.0 111.103 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -108.68 142.21 39.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.674 0.273 . . . . 0.0 110.98 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.3 mt -118.97 146.25 45.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -134.41 147.07 50.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 111.172 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.08 14.79 80.07 Favored Glycine 0 C--N 1.33 0.227 0 N-CA-C 114.273 0.469 . . . . 0.0 114.273 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.77 -38.2 90.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.177 0.513 . . . . 0.0 110.851 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.3 mp0 -73.0 -8.25 54.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.807 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.39 11.07 39.83 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.917 0.389 . . . . 0.0 111.398 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.449 ' CD1' HD21 ' A' ' 294' ' ' LEU . 75.0 mt -88.95 125.64 42.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.2 119.53 38.67 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.7 t -112.19 132.6 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 111.432 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -88.57 140.66 29.23 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.538 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -130.19 106.46 16.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -68.61 118.05 5.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.059 1.839 . . . . 0.0 111.419 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -104.2 109.48 27.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.97 161.07 40.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.558 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -133.66 166.24 23.06 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.25 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.88 113.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.4 p -95.97 173.23 7.54 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.199 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.6 -32.6 73.63 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.887 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.23 -41.93 97.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.421 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.5 -39.73 95.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.831 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.79 -46.05 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.261 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -45.1 94.9 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.545 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.65 99.61 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.083 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.601 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.2 tpt -60.9 -47.41 86.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.673 0.273 . . . . 0.0 110.765 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.7 -42.0 98.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.43 -45.31 94.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.0 m -63.39 -40.75 98.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.849 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.4 mt -61.14 -40.08 92.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.162 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -74.68 -9.99 59.1 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 110.805 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.59 9.51 43.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.52 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -118.62 27.11 9.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.892 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -138.86 106.69 5.65 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.12 150.06 36.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.791 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 151' ' ' TRP . 0.2 OUTLIER -118.17 -176.44 3.06 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.002 -176.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.572 ' H ' HG22 ' A' ' 150' ' ' THR . 57.7 p-90 -108.66 145.04 35.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -161.67 -71.01 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.41 -127.76 0.25 Allowed 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.289 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.486 ' HE3' ' HG2' ' A' ' 242' ' ' GLU . 9.6 ptpp? -143.25 144.04 31.98 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.236 0.925 . . . . 0.0 113.426 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 156' ' ' GLY . 12.1 t70 -164.95 -151.51 0.15 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.573 ' HA3' ' HD3' ' A' ' 206' ' ' LYS . . . -104.51 59.95 0.44 Allowed Glycine 0 CA--C 1.509 -0.32 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.311 -178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.4 115.8 14.44 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.17 129.28 70.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.437 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -84.5 158.54 20.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.022 0.439 . . . . 0.0 111.962 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.4 28.7 0.24 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.74 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -170.03 21.11 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.633 0.773 . . . . 0.0 109.045 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.474 ' CG ' ' HE ' ' A' ' 243' ' ' ARG . 46.1 t0 -64.45 -42.32 96.04 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 55.7 ttp180 68.85 86.85 0.13 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.445 HG13 ' H ' ' A' ' 241' ' ' GLU . 48.9 t -113.88 131.86 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.875 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.4 m -67.93 106.8 2.43 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 86.4 mt -118.12 130.22 73.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -174.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -101.5 109.15 20.91 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.422 0.63 . . . . 0.0 109.551 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -137.29 154.43 50.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.065 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 37.3 m -127.15 131.97 50.64 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.266 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -69.46 125.22 17.17 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.983 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.3 m -138.67 131.01 28.61 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.2 t -79.78 -77.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -114.47 -60.78 1.84 Allowed 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -144.99 22.95 1.94 Allowed Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -132.57 143.91 50.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -94.1 146.61 23.85 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -111.96 173.46 6.35 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.448 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.17 -38.08 75.95 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.28 -178.45 37.2 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.045 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.38 22.63 56.27 Favored Glycine 0 C--N 1.319 -0.381 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.895 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.89 99.32 9.51 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -119.91 138.77 53.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.163 0.506 . . . . 0.0 111.743 -176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 m -142.3 122.5 13.83 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.368 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 60.06 31.68 20.7 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.459 0.475 . . . . 0.0 110.843 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -90.72 121.09 32.31 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.836 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.7 m -91.02 114.39 28.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.5 0.666 . . . . 0.0 110.464 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.44 HD13 HH12 ' B' ' 57' ' ' ARG . 61.4 tp -101.74 116.05 31.87 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.391 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.71 ' HB3' ' NH1' ' A' ' 193' ' ' ARG . . . -99.96 102.64 14.07 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 50.4 mtm -75.32 171.33 14.4 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.054 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.57 5.64 71.6 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.159 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -118.03 -8.21 10.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 120.787 0.327 . . . . 0.0 111.062 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 75.4 47.47 12.57 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.215 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.71 ' NH1' ' HB3' ' A' ' 188' ' ' ALA . 49.8 mtm180 -104.79 6.29 33.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.443 0.64 . . . . 0.0 111.06 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.518 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -128.75 159.47 35.58 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.183 173.062 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.456 HG13 ' CE2' ' A' ' 217' ' ' PHE . 43.6 mm -54.78 131.75 65.85 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.12 123.6 5.34 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.706 2.27 . . . . 0.0 112.32 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.95 -37.33 3.88 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.36 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -62.39 -48.2 80.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.93 0.365 . . . . 0.0 111.887 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.54 -9.33 59.3 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -93.11 -27.94 16.63 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.274 0.559 . . . . 0.0 110.063 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.48 -16.43 73.73 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.629 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.52 -43.01 98.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -57.95 114.73 2.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.31 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 114.71 2.26 22.6 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.48 -0.866 . . . . 0.0 113.596 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -111.06 146.52 36.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.156 0.478 . . . . 0.0 111.593 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.573 ' HD3' ' HA3' ' A' ' 156' ' ' GLY . 75.4 mmtt -83.97 165.02 18.99 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.877 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.03 111.2 3.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.715 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 84.45 35.01 15.02 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.235 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -111.86 127.2 55.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.13 0.49 . . . . 0.0 111.641 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -92.28 142.48 27.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.58 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.434 ' O ' ' HB ' ' A' ' 212' ' ' THR . 75.4 t80 -159.48 -30.89 0.06 Allowed 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 35.5 m 78.46 142.06 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.623 0.369 . . . . 0.0 110.905 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.3 tp -138.28 127.54 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 121.062 0.458 . . . . 0.0 111.229 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -79.79 107.09 12.29 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.461 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 67.8 t -112.34 114.22 46.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.279 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 14.0 m -72.88 -41.61 64.5 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -176.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.544 ' HB2' ' O ' ' A' ' 216' ' ' THR . 68.7 m-85 80.81 143.45 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 123.539 0.736 . . . . 0.0 110.935 -174.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.68 152.44 53.35 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.437 2.091 . . . . 0.0 112.099 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -65.39 -35.68 81.68 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -87.34 23.98 1.73 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.648 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 8.3 t80 -67.94 133.71 49.56 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.044 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -67.95 -18.49 64.77 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.462 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -88.81 102.5 15.08 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 175.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.504 ' OE2' HD12 ' A' ' 336' ' ' LEU . 42.6 tt0 -57.05 -33.26 67.06 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.663 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -78.07 -11.39 59.91 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 90.2 mt -121.12 -4.7 9.51 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 21.8 ptmt -68.1 116.65 8.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.173 0.511 . . . . 0.0 111.71 -177.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.2 21.85 70.42 Favored Glycine 0 C--O 1.24 0.526 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.033 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -121.92 112.16 17.96 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.4 142.98 57.41 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -174.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -127.94 144.08 51.1 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.782 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -100.58 -31.79 11.08 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 61.85 126.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -81.32 -40.94 22.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.769 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.2 mm 67.97 129.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.847 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -107.08 -67.38 0.95 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.453 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 98.0 mt 62.31 94.39 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -100.66 -37.87 8.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.136 0.493 . . . . 0.0 110.045 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 24.0 mmtm -95.4 -88.43 0.26 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 92.0 t 73.39 126.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.585 0.553 . . . . 0.0 110.197 -173.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.445 ' H ' HG13 ' A' ' 164' ' ' VAL . 42.9 mt-10 -73.8 -179.48 3.68 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.486 ' HG2' ' HE3' ' A' ' 154' ' ' LYS . 42.3 mt-10 -113.97 112.4 23.24 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -168.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 8.9 ptp180 -148.41 143.89 27.09 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.751 167.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -172.95 156.79 3.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 4.9 tt 69.77 109.26 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.199 0.6 . . . . 0.0 111.315 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -86.42 120.23 1.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.594 2.196 . . . . 0.0 112.743 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -147.18 177.57 9.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.984 0.421 . . . . 0.0 110.451 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 248' ' ' LEU . 5.8 mp -93.06 78.1 4.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.238 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.419 ' OG1' HG21 ' A' ' 150' ' ' THR . 7.2 m -92.12 -63.16 1.27 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.882 0.372 . . . . 0.0 111.392 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -162.05 -32.1 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.045 0.45 . . . . 0.0 110.805 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -72.08 0.5 9.39 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.215 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -103.38 -26.1 13.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.173 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 44.8 pt -103.66 -8.28 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -171.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -159.61 7.22 0.1 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 119.526 -0.87 . . . . 0.0 113.089 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -120.61 135.82 54.99 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.574 0.226 . . . . 0.0 110.445 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -177.09 36.81 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 81.0 20.3 65.48 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.6 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 24.9 t -127.7 160.04 37.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -57.47 -50.9 71.56 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.033 0.444 . . . . 0.0 110.23 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -176.68 156.74 1.48 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.846 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -170.92 174.75 44.74 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.058 -1.067 . . . . 0.0 112.674 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.6 p -98.03 -173.86 2.71 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 122.716 0.406 . . . . 0.0 110.233 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 14.8 t -70.4 -71.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 111.191 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.518 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.1 pm0 -70.19 -37.02 75.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.866 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.5 -39.65 97.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.079 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 63.8 tp -63.25 -43.8 97.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.489 0.185 . . . . 0.0 110.995 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -62.62 -42.74 99.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.957 0.408 . . . . 0.0 110.282 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.54 -45.61 82.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.44 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 30.8 tp10 -66.34 -39.81 89.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.864 0.364 . . . . 0.0 110.974 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.01 -43.7 96.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.25 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.405 HH21 ' HD3' ' A' ' 271' ' ' ARG . 9.0 tpt180 -59.17 -48.56 81.14 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.03 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.8 ptmt -64.89 -44.32 90.02 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 111.198 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -65.12 -37.57 87.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.955 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 89.4 mmm -61.93 -42.85 99.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.825 0.345 . . . . 0.0 110.224 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.37 -32.14 69.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 55.3 ttp180 -63.45 -42.0 98.63 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -65.56 -35.8 81.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.855 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 44.2 tp -61.44 -36.78 81.32 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.905 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 58.1 tttm -54.81 -47.96 73.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.862 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 20.1 m -63.83 -42.44 97.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.037 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.39 -49.4 77.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.318 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 86.1 mt -64.02 -43.02 97.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.471 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -45.12 93.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.219 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -65.41 -41.37 93.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.26 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ARG . . . . . 0.492 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.8 tpm_? -60.83 -44.13 97.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.785 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.3 t -68.88 -44.42 81.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.93 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.509 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.1 tttt -61.99 -48.44 80.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.82 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.8 p -63.62 -42.36 98.19 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.95 -39.56 90.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.204 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.03 93.95 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.851 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 287' ' ' LYS . 48.6 mm -65.11 -44.22 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.2 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.487 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 16.0 tp10 -60.02 -42.66 94.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.51 -45.82 92.03 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.709 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.449 HD21 ' CD1' ' A' ' 123' ' ' ILE . 26.5 mt -62.86 -42.17 99.65 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.8 -43.78 96.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.716 0.293 . . . . 0.0 110.849 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LYS . . . . . 0.487 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 67.9 mttm -62.77 -41.92 99.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.037 0.446 . . . . 0.0 110.936 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.03 -46.01 65.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.917 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -123.91 100.39 6.73 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -95.86 113.7 25.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.7 tp -122.11 156.96 26.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.17 120.07 11.41 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.978 0.418 . . . . 0.0 110.057 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.86 128.12 42.75 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.449 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.448 ' O ' HG13 ' A' ' 307' ' ' ILE . 49.9 Cg_exo -55.6 129.92 37.69 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.654 2.236 . . . . 0.0 112.215 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.22 86.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.021 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.79 -45.46 82.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.011 0.434 . . . . 0.0 111.026 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.36 -41.88 93.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.988 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.505 ' O ' HG13 ' A' ' 311' ' ' ILE . 73.4 mt -61.54 -49.85 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.472 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.09 -42.73 99.51 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 30.1 m -62.23 -45.52 92.98 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.5 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.466 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 65.6 mm-40 -71.01 -35.0 71.88 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 307' ' ' ILE . 94.7 mt -61.94 -43.16 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.629 0.252 . . . . 0.0 111.117 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.541 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.8 t70 -59.53 -44.26 93.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.55 -42.9 96.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.127 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 84.4 mt -62.09 -40.68 96.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.541 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.8 mtm180 -61.27 -42.43 98.62 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -64.19 -38.64 91.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.916 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -62.84 -42.72 99.85 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.159 0.505 . . . . 0.0 110.116 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.1 80.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.201 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.33 -37.05 86.14 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.225 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -63.62 -37.92 89.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.306 0.574 . . . . 0.0 109.646 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.94 -7.81 57.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.864 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -97.4 -0.9 45.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.246 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.06 7.61 2.25 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.168 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.18 38.84 8.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.479 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.433 ' HB3' ' HB1' ' A' ' 319' ' ' ALA . 25.7 t-20 -84.6 135.23 34.28 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.874 0.369 . . . . 0.0 111.137 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.79 162.92 33.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.401 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.1 OUTLIER 71.9 -54.21 0.68 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.102 0.561 . . . . 0.0 111.178 -178.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.08 -17.78 63.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.84 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.58 -22.49 45.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.78 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.08 -34.6 76.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.546 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 331' ' ' GLU . 36.3 tt0 -85.88 10.19 14.61 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.672 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 77.9 mt -82.68 149.37 60.25 Favored Pre-proline 0 C--O 1.239 0.52 0 O-C-N 122.008 -0.433 . . . . 0.0 110.737 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.406 ' O ' ' HD1' ' A' ' 337' ' ' PHE . 40.4 Cg_exo -56.5 124.39 16.14 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.114 2.543 . . . . 0.0 113.111 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -70.43 -43.3 70.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.536 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -58.54 -40.59 83.41 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -170.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.504 HD12 ' OE2' ' A' ' 224' ' ' GLU . 60.7 mt -86.41 -0.32 55.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 333' ' ' PRO . 47.5 m-85 -107.45 -29.33 9.29 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -65.48 -32.49 74.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.252 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.87 -50.27 74.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -77.92 -21.86 50.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.55 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -62.45 -40.93 98.2 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.016 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.464 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.2 tttt -59.79 -45.02 93.6 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.201 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.3 mmt85 -61.68 -46.33 90.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.737 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -66.74 -37.51 84.79 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.466 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 341' ' ' ALA . 73.2 t -64.8 -43.64 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.607 0.241 . . . . 0.0 110.406 176.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 342' ' ' LYS . 76.1 t -61.48 -41.77 91.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 343' ' ' ARG . 69.1 t -58.64 -44.77 90.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.3 -40.31 98.84 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.181 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.46 -44.38 94.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 110.934 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.2 mt -63.44 -48.5 77.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.883 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.86 -41.07 87.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.488 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.73 99.81 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.254 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.38 -35.83 78.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.643 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 350' ' ' LEU . 70.4 t -61.05 -44.9 99.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.21 -45.44 98.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -67.46 -51.72 48.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.0 m -65.33 -46.86 78.6 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -83.68 -5.97 59.32 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.351 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 61.23 55.52 2.95 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.095 0.474 . . . . 0.0 111.622 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 97.1 mt -88.85 160.19 17.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.459 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -140.88 155.61 46.28 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.901 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -75.42 104.98 6.22 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 367' ' ' VAL . 29.6 t70 -79.08 119.35 22.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.979 0.418 . . . . 0.0 111.341 -175.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 44.7 mm-40 -61.87 -42.74 99.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.347 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -64.89 -43.34 93.2 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.79 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 40.1 ttt85 -60.64 -42.93 97.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.238 0.542 . . . . 0.0 109.649 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.456 HG21 ' HG2' ' A' ' 399' ' ' ARG . 87.2 t -65.96 -36.89 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.371 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.0 mmmt -56.31 -43.74 79.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.719 0.295 . . . . 0.0 110.58 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.01 95.54 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.739 -0.744 . . . . 0.0 111.935 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.2 -42.51 96.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.062 0.458 . . . . 0.0 110.2 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.96 -43.5 97.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.526 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.83 -41.4 99.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.581 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -66.46 -37.86 86.06 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.589 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.5 ttm -64.31 -43.36 94.95 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 121.027 0.442 . . . . 0.0 110.332 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.2 -29.53 70.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.392 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 44.7 m -73.0 -7.78 52.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.5 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.86 -2.37 58.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.391 0.615 . . . . 0.0 110.036 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.12 171.63 7.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.611 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -64.02 -49.09 73.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.992 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 32.9 t70 -118.79 107.63 42.14 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.779 0.323 . . . . 0.0 110.148 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.02 -34.86 99.23 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.937 2.424 . . . . 0.0 112.959 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -63.76 -45.21 90.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 10.7 pt-20 -63.45 -38.97 93.17 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.802 0.334 . . . . 0.0 110.654 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.77 -43.21 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.16 -43.78 99.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 120.826 0.346 . . . . 0.0 110.534 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.435 ' HB3' ' HE3' ' A' ' 390' ' ' LYS . 45.6 mt-10 -66.56 -38.97 88.22 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.735 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -58.07 -46.64 85.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.885 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -33.46 71.19 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 35.3 p -88.58 -5.04 58.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 386' ' ' GLU . 98.4 mttt -98.32 -0.66 43.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.941 0.401 . . . . 0.0 110.952 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -123.53 114.84 20.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.778 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -63.7 -39.77 95.13 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -58.76 -46.78 86.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.85 0.357 . . . . 0.0 110.52 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.66 -40.77 97.67 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.091 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 92.6 mtp -62.6 -44.66 95.75 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.01 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -64.57 -45.87 85.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.9 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -64.36 -44.17 92.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.537 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 46.2 tpp -63.51 -42.57 98.48 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.923 0.392 . . . . 0.0 111.323 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.456 ' HG2' HG21 ' A' ' 367' ' ' VAL . 77.2 mtm180 -65.75 -34.37 78.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.127 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -63.38 -43.02 98.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.707 0.289 . . . . 0.0 110.407 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.77 -46.1 95.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.912 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.84 88.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.38 -38.33 90.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.823 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.4 -43.99 96.14 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.341 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -66.34 -37.46 85.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.959 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -59.79 -42.66 93.89 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.45 90.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.064 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.99 -45.94 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -67.79 -30.35 69.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.558 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.16 99.35 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.69 -43.76 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.412 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.58 -38.67 88.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.237 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.25 -29.88 70.11 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.025 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.23 -22.31 18.5 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.889 0.376 . . . . 0.0 111.419 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.16 174.56 7.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.191 0.52 . . . . 0.0 111.327 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -84.28 133.27 34.56 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 66.8 t -118.14 128.88 75.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -119.3 144.25 46.91 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 120.989 0.423 . . . . 0.0 110.699 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -101.53 130.48 47.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.18 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -151.61 141.53 22.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.334 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -97.09 139.36 33.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.066 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.9 t -146.72 179.24 7.71 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.8 p -80.99 156.49 25.89 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.031 0.443 . . . . 0.0 111.372 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.3 -40.07 96.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.89 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -57.23 -34.77 68.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.177 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.04 -31.86 72.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.865 0.364 . . . . 0.0 111.237 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.6 mp -83.98 -7.81 59.31 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.026 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.7 mmt -79.28 -6.86 57.64 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.082 0.467 . . . . 0.0 110.497 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -76.15 81.4 2.96 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.453 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -106.46 13.63 28.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.824 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -66.05 -37.49 85.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.944 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.308 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.102 179.7 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.486 0.184 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -70.11 116.04 10.01 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.647 0.737 . . . . 0.0 112.172 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.17 172.47 14.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.177 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.441 ' O ' ' HB ' ' B' ' 5' ' ' VAL . 9.4 p -72.7 -175.34 1.65 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.287 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' B' ' 4' ' ' SER . 0.5 OUTLIER 89.32 141.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.908 0.883 . . . . 0.0 111.705 179.527 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -139.5 156.06 47.16 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 90.8 m -89.54 129.91 35.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.872 0.368 . . . . 0.0 111.766 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 75.1 m -89.11 -70.19 0.67 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -166.54 124.25 1.37 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.134 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.13 -110.6 3.47 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.648 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 85.9 mt -90.29 -6.82 54.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.519 0.199 . . . . 0.0 111.203 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.548 ' O ' ' HD3' ' B' ' 13' ' ' ARG . . . -84.27 137.54 16.02 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 114.41 0.524 . . . . 0.0 114.41 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.548 ' HD3' ' O ' ' B' ' 12' ' ' GLY . 0.0 OUTLIER -133.44 146.69 51.4 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.035 0.934 . . . . 0.0 110.619 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.42 HH21 ' HD2' ' B' ' 14' ' ' ARG . 30.5 ttm180 -108.68 138.3 45.23 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.815 0.446 . . . . 0.0 110.051 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.81 -85.91 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.684 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.4 p 27.84 94.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 tp -123.07 140.11 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.913 0.387 . . . . 0.0 111.857 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -73.01 138.15 45.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.746 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.476 HD13 HG12 ' B' ' 24' ' ' ILE . 0.9 OUTLIER -126.17 152.42 33.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -175.171 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.681 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -87.3 151.64 22.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.277 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.39 84.33 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -77.37 -3.14 38.63 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.187 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 15.4 t -107.56 -28.4 9.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.628 0.251 . . . . 0.0 111.075 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.681 HG13 ' O ' ' B' ' 20' ' ' ALA . 71.3 mt -60.25 -49.6 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 121.027 0.441 . . . . 0.0 112.097 -175.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.474 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 69.2 mm-40 -101.32 8.61 42.28 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -175.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 40.0 m -103.74 -70.49 0.76 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.137 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.09 -47.48 79.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.824 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.455 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 86.0 t -62.11 -45.22 99.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.7 ttmm -63.33 -45.17 92.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 60.0 m -62.8 -41.52 99.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.367 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.572 ' O ' HG23 ' B' ' 35' ' ' VAL . 10.4 tp10 -66.44 -39.05 88.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.72 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 89.3 mt -61.81 -43.02 99.67 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -66.0 -38.22 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.535 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -64.07 -38.65 91.84 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 31' ' ' GLU . 89.3 t -63.17 -43.04 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.545 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.32 97.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.432 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.02 -30.06 70.04 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.068 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' B' ' 35' ' ' VAL . 23.1 ttmm -59.51 -44.75 93.04 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.202 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.16 -2.97 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 63.52 31.39 14.83 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.329 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.82 10.8 8.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.08 -25.62 67.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.13 -4.37 78.21 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.808 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -86.67 -5.4 59.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.459 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 64.0 ttt-85 -93.21 108.26 19.92 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.841 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.18 -38.12 87.88 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.293 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.42 33.16 20.56 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.247 -0.978 . . . . 0.0 114.205 175.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -63.53 -40.98 98.44 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 t -117.18 112.47 39.76 Favored Pre-proline 0 N--CA 1.448 -0.557 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.44 ' HG2' HD12 ' B' ' 53' ' ' ILE . 42.4 Cg_exo -57.53 142.77 95.53 Favored 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.687 2.258 . . . . 0.0 112.255 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.493 ' HA ' HG22 ' B' ' 54' ' ' VAL . 18.7 ttt -67.01 -29.38 69.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.55 -172.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ASN . . . . . 0.422 ' OD1' HG13 ' B' ' 53' ' ' ILE . 29.1 p-10 -71.85 -16.43 62.15 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.094 0.473 . . . . 0.0 110.361 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.617 HD13 ' NH2' ' A' ' 193' ' ' ARG . 78.0 mt -99.76 -36.07 5.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.789 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' B' ' 51' ' ' MET . 23.6 m -60.58 -40.71 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.785 0.326 . . . . 0.0 111.286 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.14 -30.0 70.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.354 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -91.79 -32.77 15.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.377 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.44 HH12 HD13 ' A' ' 187' ' ' LEU . 15.1 tpp180 -64.61 -41.61 96.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.869 0.366 . . . . 0.0 110.436 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -110.48 23.57 14.07 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.27 0.557 . . . . 0.0 110.509 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.94 147.5 50.34 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.781 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 71.24 -41.06 0.49 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.392 0.677 . . . . 0.0 112.296 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.3 t -58.28 -53.44 58.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.758 0.423 . . . . 0.0 111.865 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.501 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -114.76 10.61 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.296 0.57 . . . . 0.0 110.827 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -60.14 -38.95 84.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.647 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -59.44 -45.51 91.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.688 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.5 -33.2 73.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.754 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 62' ' ' VAL . 77.3 t -60.97 -35.19 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.47 -39.43 90.88 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.31 -39.81 98.22 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.699 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.34 -46.37 88.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.966 0.413 . . . . 0.0 110.882 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.57 -42.08 98.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.453 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 55.0 ttp -60.78 -46.5 90.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.216 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 52.0 m -64.21 -52.28 59.62 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.463 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -70.11 -39.37 75.52 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -64.98 -40.53 95.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.642 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -61.09 -47.85 84.38 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.798 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ILE . . . . . 0.419 ' O ' HG13 ' B' ' 79' ' ' ILE . 14.8 tt -68.13 -39.19 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.869 0.366 . . . . 0.0 111.035 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.12 -43.91 97.79 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.565 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.62 89.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.234 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.419 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.6 pp -67.12 -35.39 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.44 -43.94 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.997 0.427 . . . . 0.0 110.987 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -82.58 -19.65 38.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.006 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -88.13 -8.32 55.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.357 0.599 . . . . 0.0 109.54 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 69.56 34.4 2.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.172 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 73.6 mt -99.17 116.72 42.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -103.78 108.53 59.94 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.847 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.49 141.84 57.17 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.383 2.056 . . . . 0.0 111.394 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.45 104.45 15.39 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.058 0.456 . . . . 0.0 110.589 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.33 -109.2 3.36 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.188 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.09 124.93 13.3 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-O 120.51 0.195 . . . . 0.0 110.616 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.84 157.55 54.86 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.371 2.047 . . . . 0.0 111.023 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 20.2 m -98.16 115.67 28.78 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.029 0.442 . . . . 0.0 110.558 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -96.16 98.19 10.14 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.02 110.69 58.66 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -91.07 165.44 3.77 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.163 2.575 . . . . 0.0 111.112 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.28 179.48 25.83 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.517 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.13 114.02 10.82 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -81.69 124.81 29.92 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.202 0.525 . . . . 0.0 111.54 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.65 117.51 34.24 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.43 123.36 18.54 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.657 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.56 -17.82 56.09 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.498 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -106.32 -170.51 1.74 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.615 0.245 . . . . 0.0 111.229 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -81.12 165.45 21.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -128.83 135.99 49.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.872 0.368 . . . . 0.0 110.877 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 45.9 m -119.84 136.49 54.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.687 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -141.66 167.03 23.13 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.925 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -78.82 -84.95 0.08 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 99.1 t 56.7 93.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-O 121.171 0.51 . . . . 0.0 109.975 -172.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.48 135.44 38.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -158.65 170.45 22.14 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.971 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -50.77 145.88 6.49 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.56 165.42 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.521 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -121.67 106.6 37.11 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 120.894 0.378 . . . . 0.0 110.197 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -91.96 161.27 3.3 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.242 2.628 . . . . 0.0 113.805 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -131.56 134.39 46.02 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.996 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.87 136.3 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.657 0.265 . . . . 0.0 111.306 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.05 141.51 32.78 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.093 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 97.6 mt -119.1 141.86 48.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -129.84 145.38 51.59 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.96 18.62 78.56 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.097 -0.502 . . . . 0.0 114.127 174.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -63.51 -40.52 97.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.052 0.453 . . . . 0.0 111.339 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.97 -19.04 65.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.856 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.43 8.17 29.17 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.503 ' CD1' HD21 ' B' ' 294' ' ' LEU . 77.6 mt -86.26 127.66 40.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.064 0.459 . . . . 0.0 110.949 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -112.37 125.04 53.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.73 132.41 68.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.987 0.423 . . . . 0.0 111.635 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.28 137.14 32.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.389 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -126.37 105.76 24.43 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.67 119.41 6.42 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.088 1.859 . . . . 0.0 111.832 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.438 HG13 ' HG2' ' B' ' 419' ' ' GLU . 48.6 mm -104.63 108.24 24.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.42 159.28 40.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.51 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.24 161.07 37.2 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.194 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 46.1 t -69.68 121.25 18.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.766 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.4 p -105.92 -180.0 4.1 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.773 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.6 -34.82 77.77 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.303 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.61 94.87 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.559 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -64.95 -40.9 95.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.655 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.02 -47.43 92.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.798 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -61.81 -44.39 96.95 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.32 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.04 -41.33 99.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.18 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.617 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.8 tpt -60.98 -46.85 89.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.782 0.325 . . . . 0.0 110.838 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.28 -41.94 96.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.39 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.92 -43.13 99.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.828 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 18.5 m -63.24 -39.86 95.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.66 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 144' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.5 mt -60.22 -41.64 93.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.779 -176.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -72.23 -16.69 61.94 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.107 0.479 . . . . 0.0 111.11 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.31 8.11 43.04 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.568 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -117.79 24.79 10.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.74 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -138.17 106.51 5.8 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.25 147.43 31.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.594 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 150' ' ' THR . . . . . 0.574 HG22 ' H ' ' B' ' 151' ' ' TRP . 0.3 OUTLIER -111.85 -163.16 0.83 Allowed 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.104 -176.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 151' ' ' TRP . . . . . 0.574 ' H ' HG22 ' B' ' 150' ' ' THR . 48.4 p-90 -123.2 146.64 47.64 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.058 0.456 . . . . 0.0 112.024 -176.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -168.03 -61.81 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.01 -142.27 0.22 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.773 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 154' ' ' LYS . . . . . 0.489 ' HE3' ' HG2' ' B' ' 242' ' ' GLU . 9.1 ptpp? -134.5 143.06 47.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.282 0.947 . . . . 0.0 112.874 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -164.56 -152.13 0.17 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 156' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' B' ' 206' ' ' LYS . . . -99.93 63.32 0.66 Allowed Glycine 0 C--O 1.235 0.193 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.49 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.47 118.9 12.18 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.74 129.8 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -86.45 157.94 19.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.085 0.469 . . . . 0.0 112.085 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.99 26.27 0.26 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.84 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -167.55 20.17 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.422 ' CG ' ' HE ' ' B' ' 243' ' ' ARG . 45.2 t0 -64.09 -45.43 88.71 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.362 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 163' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' B' ' 187' ' ' LEU . 53.4 ttp180 72.18 88.38 0.1 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.49 132.62 64.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.077 0.465 . . . . 0.0 112.016 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 24.6 m -69.0 104.19 2.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.844 173.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 88.2 mt -116.77 128.45 74.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.906 0.384 . . . . 0.0 111.934 -175.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -102.16 110.09 21.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.47 0.652 . . . . 0.0 109.381 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -137.01 154.01 50.51 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.3 m -124.04 130.18 52.14 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.023 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -70.05 131.44 22.96 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.99 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -145.6 129.59 17.41 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 43.3 t -77.91 -76.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -113.93 -70.5 0.8 Allowed 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -135.77 23.31 3.4 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -136.09 140.55 43.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.128 -0.536 . . . . 0.0 109.647 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -91.83 146.25 23.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -106.86 174.54 5.84 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.092 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.57 -37.39 78.34 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.6 -174.68 36.95 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.786 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.84 22.91 54.49 Favored Glycine 0 C--N 1.32 -0.352 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.281 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -103.1 101.25 11.21 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -123.64 140.26 53.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.114 0.483 . . . . 0.0 111.946 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 34.6 m -141.14 121.16 13.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.539 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.81 33.17 22.9 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.55 0.531 . . . . 0.0 111.15 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -87.91 123.22 32.43 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.753 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 13.8 m -92.86 113.31 27.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.566 0.698 . . . . 0.0 110.716 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 187' ' ' LEU . . . . . 0.425 HD13 HH12 ' A' ' 57' ' ' ARG . 52.1 tp -102.53 116.22 32.17 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.322 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 188' ' ' ALA . . . . . 0.713 ' HB3' ' NH1' ' B' ' 193' ' ' ARG . . . -99.9 105.37 17.08 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 41.9 mtm -76.17 168.88 19.25 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.129 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.9 -16.41 61.01 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.876 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -98.84 -3.46 35.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.599 -0.3 . . . . 0.0 111.455 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.16 44.6 59.76 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.176 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.713 ' NH1' ' HB3' ' B' ' 188' ' ' ALA . 47.8 mtm180 -98.32 4.63 48.68 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.417 0.627 . . . . 0.0 111.672 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.506 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -128.04 159.97 33.4 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 172.378 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.487 HG13 ' CE2' ' B' ' 217' ' ' PHE . 43.3 mm -54.42 133.56 62.42 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -48.09 126.22 13.01 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.359 2.039 . . . . 0.0 112.326 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.46 -34.15 6.01 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.261 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -64.32 -51.06 65.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.82 -16.65 60.69 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 121.015 0.436 . . . . 0.0 112.107 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -87.69 -21.59 25.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.173 0.511 . . . . 0.0 110.034 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.45 -10.82 85.52 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.63 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.0 mm -64.81 -42.85 96.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -55.32 124.81 18.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.762 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.5 1.59 40.56 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.793 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -111.13 148.6 32.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.313 0.557 . . . . 0.0 111.586 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.472 ' HD3' ' HA3' ' B' ' 156' ' ' GLY . 75.6 mmtt -86.83 163.42 17.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.412 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.56 112.21 3.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.344 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.24 39.4 11.32 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.863 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -113.92 126.4 55.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.999 0.428 . . . . 0.0 111.035 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -92.13 136.51 33.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.619 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 211' ' ' PHE . . . . . 0.48 ' O ' ' HB ' ' B' ' 212' ' ' THR . 65.0 t80 -155.64 -28.26 0.1 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' B' ' 211' ' ' PHE . 91.3 m 75.92 143.83 0.08 Allowed 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 120.665 0.269 . . . . 0.0 110.749 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -138.17 128.07 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.075 0.464 . . . . 0.0 111.233 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -82.72 111.92 19.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.166 0.507 . . . . 0.0 111.522 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 73.3 t -118.19 130.92 72.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 9.9 m -94.24 -29.75 14.92 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -174.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' B' ' 216' ' ' THR . 69.1 m-85 74.3 141.35 0.08 OUTLIER Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 122.702 0.401 . . . . 0.0 111.085 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.89 151.89 51.39 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.303 2.002 . . . . 0.0 111.867 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -65.44 -34.62 78.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.73 26.87 1.05 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.28 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 7.2 t80 -70.73 133.95 47.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -67.71 -17.67 64.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.439 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -91.28 104.69 17.2 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 33.6 tt0 -57.79 -36.1 71.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.33 -175.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.431 ' O ' ' HD3' ' B' ' 229' ' ' LYS . 28.6 p-10 -72.92 -13.26 61.22 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.4 mt -120.13 -1.54 10.32 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.1 ptmt -69.95 114.14 7.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.301 0.572 . . . . 0.0 111.592 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.26 21.81 75.94 Favored Glycine 0 C--O 1.237 0.292 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.214 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' B' ' 225' ' ' ASN . 9.7 mtpm? -122.28 109.91 15.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.87 145.54 55.36 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -128.44 146.23 50.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.772 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -100.97 -29.16 12.35 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -173.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 57.32 107.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -67.2 -40.23 86.44 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.832 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 48.8 mm 69.3 133.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.352 0.661 . . . . 0.0 111.338 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 236' ' ' ASN . . . . . 0.423 ' OD1' ' HG3' ' B' ' 238' ' ' LYS . 26.5 t-20 -109.01 -65.44 1.14 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.843 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.8 mt 61.04 95.99 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 238' ' ' LYS . . . . . 0.423 ' HG3' ' OD1' ' B' ' 236' ' ' ASN . 64.1 mttp -102.13 -31.35 10.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.799 175.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -102.55 -87.13 0.42 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 85.4 t 72.36 121.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 123.532 0.52 . . . . 0.0 109.971 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.15 179.79 3.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.489 ' HG2' ' HE3' ' B' ' 154' ' ' LYS . 36.4 mt-10 -112.38 114.79 27.71 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -167.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 7.4 ptp180 -149.64 141.82 24.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.134 167.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.501 ' H ' ' HA ' ' B' ' 151' ' ' TRP . 1.0 OUTLIER -172.82 162.22 4.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.636 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 3.9 tt 67.57 106.45 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.229 0.611 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -85.63 118.5 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.592 2.195 . . . . 0.0 112.802 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -145.41 179.03 7.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.075 0.464 . . . . 0.0 110.733 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' LEU . . . . . 0.439 ' N ' HD12 ' B' ' 248' ' ' LEU . 4.8 mp -93.55 74.36 4.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.38 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 249' ' ' THR . . . . . 0.441 ' OG1' HG21 ' B' ' 150' ' ' THR . 11.6 m -85.51 -72.71 0.47 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.815 0.34 . . . . 0.0 111.258 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -154.69 -34.91 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.421 . . . . 0.0 111.12 -177.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -62.3 -35.32 78.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.672 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -64.84 -28.98 69.92 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.036 0.935 . . . . 0.0 113.505 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 43.1 pt -99.41 -4.52 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -160.23 -11.9 0.05 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 119.055 -1.058 . . . . 0.0 113.621 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -102.86 134.6 46.0 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.876 0.37 . . . . 0.0 111.255 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -172.67 36.91 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.28 20.67 69.05 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.7 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.6 161.32 35.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -52.02 -59.17 4.66 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 122.894 0.477 . . . . 0.0 109.832 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -173.78 162.46 4.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.824 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -173.31 178.42 45.27 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.583 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 93.1 p -102.56 -171.25 1.93 Allowed 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 122.263 0.225 . . . . 0.0 110.508 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.8 -57.18 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.962 0.411 . . . . 0.0 112.023 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -35.74 23.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.0 111.049 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.28 -39.14 97.51 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.391 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.402 ' O ' HG23 ' B' ' 270' ' ' VAL . 54.0 tp -62.86 -45.43 92.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.569 0.223 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -64.29 -42.27 96.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.587 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.518 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.34 -45.15 89.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.314 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -67.12 -39.1 86.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.452 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 266' ' ' LEU . 66.3 t -64.7 -44.13 96.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.606 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -60.09 -47.56 85.39 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 17.7 ptmt -64.55 -45.41 87.21 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.909 0.385 . . . . 0.0 111.077 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -65.06 -36.25 83.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 89.5 mmm -61.82 -42.67 99.31 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.031 0.443 . . . . 0.0 109.98 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -70.15 -31.43 68.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.798 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 276' ' ' ARG . . . . . 0.519 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 57.6 ttp180 -64.73 -42.17 95.41 Favored 'General case' 0 CA--C 1.527 0.074 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -66.85 -34.03 76.9 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.69 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.53 -38.01 85.85 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.719 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 279' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 55.4 tttm -55.84 -47.16 77.74 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.303 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 20.4 m -63.47 -42.28 98.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.907 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.02 -47.45 86.39 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.062 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.18 -43.62 97.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.234 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -44.62 96.99 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.83 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.17 -41.37 97.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.035 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 285' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' B' ' 285' ' ' ARG . 4.2 tpm_? -60.42 -43.86 96.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.886 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.31 -44.12 80.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.135 0.493 . . . . 0.0 111.063 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.33 -48.58 79.19 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.938 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.6 p -65.15 -41.31 94.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.72 -40.89 92.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.642 0.258 . . . . 0.0 111.274 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.06 95.33 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.091 0.472 . . . . 0.0 110.653 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 36.7 mm -65.04 -43.49 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 292' ' ' GLU . . . . . 0.46 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 20.5 tp10 -61.87 -42.55 99.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.682 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.82 98.31 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.51 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.503 HD21 ' CD1' ' B' ' 123' ' ' ILE . 24.8 mt -63.73 -42.71 97.85 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.26 -42.16 93.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.731 0.3 . . . . 0.0 111.339 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 296' ' ' LYS . . . . . 0.46 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 66.4 mttm -61.95 -40.47 95.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.698 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.3 -47.46 19.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.904 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -114.89 96.02 5.51 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -99.94 105.54 17.25 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -116.71 159.4 16.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.604 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.6 130.11 43.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 42.6 t -105.48 127.53 28.38 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.029 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.37 128.6 30.76 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.461 2.107 . . . . 0.0 111.882 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.61 80.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.754 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.66 -48.05 72.82 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.338 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 66.3 mt -67.03 -40.52 87.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.002 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 307' ' ' ILE . . . . . 0.487 ' O ' HG13 ' B' ' 311' ' ' ILE . 75.7 mt -61.04 -49.82 83.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.391 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.13 -43.27 99.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.566 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 38.9 m -63.11 -45.25 92.9 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.643 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 310' ' ' GLU . . . . . 0.419 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 70.2 mm-40 -71.22 -34.44 70.81 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.51 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 89.9 mt -61.74 -43.05 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.027 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.586 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 31.0 t70 -59.32 -44.92 92.54 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.961 0.41 . . . . 0.0 110.805 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.39 -43.93 98.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.163 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 79.3 mt -62.92 -40.38 97.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.268 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.586 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 83.1 mtm180 -61.33 -42.56 98.87 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -65.08 -37.91 89.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.703 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -62.87 -42.68 99.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.206 0.527 . . . . 0.0 109.88 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.59 -37.47 79.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.523 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 319' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -63.9 -37.35 87.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.929 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -63.43 -37.08 85.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.364 0.602 . . . . 0.0 109.482 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -79.51 -3.36 46.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.898 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -101.68 4.22 40.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.953 0.406 . . . . 0.0 111.13 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 128.01 7.1 4.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.936 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 87.96 46.01 4.92 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.396 -0.906 . . . . 0.0 111.776 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 325' ' ' ASN . . . . . 0.474 ' HB3' ' HB1' ' B' ' 319' ' ' ALA . 26.2 t-20 -91.25 135.14 34.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 -177.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.87 160.99 38.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.44 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.1 OUTLIER 72.66 -53.57 0.7 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.05 0.54 . . . . 0.0 111.214 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.66 -16.83 63.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.849 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.86 -22.91 50.47 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.81 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.54 -35.78 78.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.912 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -79.51 -5.25 54.43 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.214 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.01 152.6 96.74 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.009 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 333' ' ' PRO . . . . . 0.479 ' O ' ' HD1' ' B' ' 337' ' ' PHE . 32.9 Cg_exo -59.86 140.53 93.54 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.817 2.344 . . . . 0.0 112.854 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -86.08 -43.78 12.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.898 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.6 pm0 -59.18 -39.38 82.37 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 62.1 mt -86.21 0.31 54.0 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.826 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 337' ' ' PHE . . . . . 0.479 ' HD1' ' O ' ' B' ' 333' ' ' PRO . 50.8 m-85 -107.75 -29.55 9.05 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.31 -31.7 72.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.964 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -58.92 -49.08 79.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.044 0.449 . . . . 0.0 110.795 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -83.5 -21.03 32.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.012 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.445 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.85 -40.48 97.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 342' ' ' LYS . . . . . 0.43 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.7 tttt -59.35 -44.37 92.67 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.194 177.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 343' ' ' ARG . . . . . 0.562 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.5 mmt85 -61.35 -45.22 95.32 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.772 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -67.22 -38.72 85.75 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.306 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 341' ' ' ALA . 74.2 t -64.53 -43.58 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.36 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 342' ' ' LYS . 57.7 t -61.32 -42.49 93.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.44 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 343' ' ' ARG . 79.4 t -59.87 -44.86 95.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.51 -41.69 99.61 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.928 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.96 -44.54 95.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.748 0.308 . . . . 0.0 110.982 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.457 ' O ' HG23 ' B' ' 354' ' ' VAL . 92.7 mt -63.53 -47.2 82.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.997 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.54 -41.29 88.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.487 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.21 99.73 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.195 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.22 -35.75 78.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.061 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 354' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 350' ' ' LEU . 76.1 t -60.61 -45.08 97.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 77.7 mt -63.4 -46.2 95.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.68 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.1 -54.26 32.7 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 47.7 m -65.21 -44.94 86.7 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -83.44 -8.47 59.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.265 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 65.43 45.39 2.83 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.271 0.558 . . . . 0.0 111.267 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 97.6 mt -78.79 156.3 28.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.768 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -139.02 153.45 48.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.516 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -75.07 105.77 6.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -80.83 116.48 20.84 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.978 0.418 . . . . 0.0 111.464 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 364' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 60.3 mm-40 -58.75 -42.61 89.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.308 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -62.42 -44.49 96.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.678 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -61.35 -42.64 99.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.207 0.527 . . . . 0.0 109.792 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 367' ' ' VAL . . . . . 0.435 HG21 ' HG2' ' B' ' 399' ' ' ARG . 94.7 t -65.96 -36.23 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.316 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 368' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.5 mmmt -56.31 -42.68 78.01 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.803 0.335 . . . . 0.0 110.663 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.95 -38.48 96.66 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.086 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.88 -42.04 97.6 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.1 0.476 . . . . 0.0 110.221 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 65.3 mt -65.7 -43.62 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.148 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -61.67 -40.0 93.39 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.693 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -67.28 -38.57 85.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.001 0.429 . . . . 0.0 110.412 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 58.1 ttm -64.28 -41.84 96.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.132 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 375' ' ' ALA . . . . . 0.433 ' HA ' HG11 ' B' ' 384' ' ' VAL . . . -64.39 -32.62 74.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.29 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 49.6 m -71.23 -8.02 50.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.454 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.85 -1.89 57.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.033 0.444 . . . . 0.0 110.507 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -117.81 173.23 6.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.123 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -65.87 -49.83 66.68 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -116.18 107.76 47.04 Favored Pre-proline 0 CA--C 1.518 -0.251 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.39 -29.21 71.81 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.106 1.871 . . . . 0.0 113.26 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -64.55 -45.12 88.47 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.89 -36.23 82.82 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.771 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 384' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' B' ' 375' ' ' ALA . 57.9 t -65.11 -43.84 95.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.605 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.59 -43.89 98.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.983 0.421 . . . . 0.0 109.916 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -65.93 -38.13 87.86 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.928 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -58.34 -46.66 85.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.541 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.08 -42.1 76.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 41.9 p -78.27 -8.36 58.28 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.23 9.28 42.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.847 0.356 . . . . 0.0 111.259 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -134.66 111.27 9.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.061 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -61.66 -39.85 92.85 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -59.99 -45.07 93.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.771 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.89 -40.63 96.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.686 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 94.8 mtp -62.13 -45.41 93.59 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.265 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.39 -44.16 79.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.008 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -64.09 -44.91 90.9 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.27 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 40.7 tpp -63.03 -42.54 99.81 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.926 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.435 ' HG2' HG21 ' B' ' 367' ' ' VAL . 84.1 mtm180 -66.12 -34.8 78.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.616 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -63.02 -42.63 99.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.796 0.332 . . . . 0.0 110.383 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.75 -46.02 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.792 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.21 88.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.693 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.45 -38.95 93.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.529 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.12 -43.33 99.05 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.38 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -65.7 -37.52 86.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.645 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -59.54 -43.86 93.39 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.642 0.258 . . . . 0.0 110.437 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.91 89.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.25 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.21 -46.24 93.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.004 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.86 -30.8 70.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.745 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.48 -40.05 94.94 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.914 0.388 . . . . 0.0 110.139 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.15 -42.84 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.188 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.33 -39.79 91.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.305 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.47 68.42 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.549 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -96.89 -9.76 27.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.53 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.01 -170.25 1.79 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.182 0.515 . . . . 0.0 110.921 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -102.57 120.0 39.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.417 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 66.4 t -106.74 126.98 62.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 13.6 t -118.27 146.72 44.09 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.134 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 419' ' ' GLU . . . . . 0.438 ' HG2' HG13 ' B' ' 129' ' ' ILE . 41.4 mt-10 -107.84 123.22 48.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.298 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -144.64 147.76 33.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.751 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -97.11 147.72 23.77 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.451 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -155.46 178.48 10.19 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 22.1 p -82.21 153.38 25.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.988 0.423 . . . . 0.0 111.37 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -63.13 -34.07 76.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.835 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -60.6 -35.78 76.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.448 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.25 -32.0 73.45 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.944 0.402 . . . . 0.0 111.169 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.36 -7.95 59.49 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.86 0.362 . . . . 0.0 111.1 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.3 mmt -80.26 -6.9 58.65 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.05 0.452 . . . . 0.0 110.613 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -74.48 81.14 1.94 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.395 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -106.04 13.4 29.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.806 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -65.82 -40.53 91.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.034 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.751 -179.828 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.233 0.23 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 t -111.1 102.26 10.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.859 0.361 . . . . 0.0 110.255 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.29 139.49 26.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.916 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 45.7 mt-10 -124.84 177.18 6.15 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.839 0.352 . . . . 0.0 110.808 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 94.4 m -124.91 131.74 53.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.909 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 45.3 m -79.86 -70.38 0.52 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 177.83 139.01 0.08 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.517 0.727 . . . . 0.0 109.569 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.85 -121.19 25.05 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.242 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.579 HD23 HG13 ' A' ' 111' ' ' VAL . 81.0 mt -65.12 -39.74 93.51 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.9 0.48 . . . . 0.0 110.943 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.6 ' HA2' ' HG2' ' A' ' 108' ' ' GLU . . . -68.78 140.45 34.74 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 115.857 1.103 . . . . 0.0 115.857 -173.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -129.69 -163.57 1.32 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -160.28 116.94 2.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 117.888 0.313 . . . . 0.0 110.647 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t -95.77 -90.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.194 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m 51.1 83.79 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.224 0.535 . . . . 0.0 111.0 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 tp -113.58 145.15 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.6 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.0 p -99.64 129.78 45.81 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.557 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 24' ' ' ILE . 6.5 pt -131.46 157.49 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -79.87 154.55 28.3 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.851 0.461 . . . . 0.0 112.04 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.76 -50.63 69.91 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.22 -37.33 86.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.487 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -63.24 -43.41 98.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.103 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 20' ' ' ALA . 67.0 mt -62.71 -52.34 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.232 0.539 . . . . 0.0 111.742 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.04 -38.38 72.57 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.453 -173.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -79.23 -59.29 2.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.71 -48.12 70.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -173.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.5 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 94.4 t -63.98 -43.89 97.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.48 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -61.55 -45.28 94.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.321 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 m -63.89 -41.64 97.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.726 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 35' ' ' VAL . 34.8 tp10 -66.55 -36.11 81.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.794 0.331 . . . . 0.0 111.102 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 91.9 mt -61.54 -42.31 98.64 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.63 -37.81 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.025 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -63.11 -41.42 99.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.817 0.342 . . . . 0.0 110.769 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 31' ' ' GLU . 91.1 t -63.74 -43.99 98.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.426 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.55 93.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.885 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.74 -33.01 74.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.231 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -59.0 -45.7 90.0 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 110.38 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.3 t -87.74 -2.68 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.265 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 64.1 27.52 14.11 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.131 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.416 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.8 pp -105.38 8.67 9.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.002 0.43 . . . . 0.0 111.535 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.54 -34.08 77.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.322 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.86 -5.16 56.88 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.435 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -84.87 -10.26 57.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.907 0.353 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -88.55 110.1 20.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.338 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.71 -41.38 97.53 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.1 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.07 42.56 76.45 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 115.898 1.119 . . . . 0.0 115.898 172.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -61.81 -43.72 98.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.274 1.037 . . . . 0.0 108.717 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.476 HG12 ' HB ' ' A' ' 54' ' ' VAL . 3.5 t -108.24 100.81 39.04 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 173.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.543 ' HG2' HD12 ' A' ' 53' ' ' ILE . 30.9 Cg_endo -63.76 158.09 48.47 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.657 2.238 . . . . 0.0 112.543 -176.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.488 ' HA ' HG12 ' A' ' 54' ' ' VAL . 82.9 mtp -61.82 -32.63 72.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.981 -174.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -69.16 -18.74 63.97 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.208 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.584 HD13 ' NH2' ' B' ' 193' ' ' ARG . 89.5 mt -105.66 -48.26 9.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 51' ' ' MET . 14.8 p -63.09 -35.15 70.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 120.988 0.423 . . . . 0.0 111.138 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.61 81.36 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.297 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -91.54 -7.19 51.01 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.464 HH12 HD12 ' B' ' 187' ' ' LEU . 67.9 mtt180 -97.3 -30.33 13.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.177 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -111.74 12.72 21.06 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.678 0.751 . . . . 0.0 109.531 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 61' ' ' SER . . . -65.54 150.54 51.78 Favored Glycine 0 CA--C 1.493 -1.312 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.417 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.47 -41.5 0.5 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.356 0.663 . . . . 0.0 111.388 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 59' ' ' GLY . 39.1 t -60.01 -46.79 88.34 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.07 0.548 . . . . 0.0 111.151 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.4 p -124.52 14.2 4.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.456 0.646 . . . . 0.0 110.892 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -64.73 -19.11 65.59 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.985 0.422 . . . . 0.0 110.948 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -62.02 -52.32 64.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.623 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.87 -17.6 59.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.244 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 62' ' ' VAL . 77.7 t -64.64 -42.71 95.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 173.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.72 -39.61 94.61 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' ' 71' ' ' MET . . . -60.31 -41.14 98.28 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.563 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.731 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 30.8 t70 -63.37 -43.83 96.5 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.45 -43.43 98.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.91 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' A' ' 68' ' ' GLY . 24.8 ptt? -63.65 -40.74 97.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.6 m -64.17 -40.26 95.73 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.091 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 43.9 mtp85 -63.03 -43.57 98.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.165 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -64.26 -41.06 97.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.695 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.87 -48.57 79.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.914 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 79' ' ' ILE . 19.3 tt -67.81 -40.76 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.466 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.79 -43.01 97.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.128 0.489 . . . . 0.0 110.221 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.86 95.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.093 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.6 pp -67.01 -40.92 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.974 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.73 -44.59 96.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.537 0.684 . . . . 0.0 109.765 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -64.71 -45.35 86.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.086 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -86.69 0.66 54.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.708 0.29 . . . . 0.0 111.416 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm 63.76 52.23 2.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.751 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.11 126.29 64.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.738 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -101.27 109.66 59.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.552 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.21 117.98 4.23 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.331 2.021 . . . . 0.0 112.034 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.08 93.68 8.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.135 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.14 -159.01 17.83 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.992 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.74 123.67 59.09 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.69 112.5 2.21 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.115 1.877 . . . . 0.0 110.704 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -96.26 114.88 26.61 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.237 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.579 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 91.3 m-85 -87.66 137.39 32.37 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.99 96.91 16.0 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-O 120.873 0.368 . . . . 0.0 111.792 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 93.1 Cg_endo -103.43 -172.12 0.07 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 123.473 2.782 . . . . 0.0 111.418 175.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -118.76 -172.0 15.26 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.65 145.96 25.37 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -95.17 126.76 40.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.15 0.5 . . . . 0.0 111.044 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.66 128.5 54.23 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.6 tp -67.03 114.49 5.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.892 0.377 . . . . 0.0 110.851 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.62 1.89 55.37 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.915 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -123.17 167.76 13.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.939 0.369 . . . . 0.0 110.99 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -71.34 141.87 50.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.743 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -95.7 137.31 34.95 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.7 m -119.62 131.19 55.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.826 0.346 . . . . 0.0 111.334 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -129.94 148.11 51.77 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.077 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 107' ' ' VAL . 50.1 m -102.46 -65.74 0.97 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 70.65 152.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 124.12 0.968 . . . . 0.0 111.047 -175.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.6 ' HG2' ' HA2' ' A' ' 12' ' ' GLY . 25.0 mt-10 -133.26 151.23 51.91 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 122.239 -0.288 . . . . 0.0 110.47 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -154.85 -73.03 0.12 Allowed 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -112.4 162.56 15.44 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -171.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.579 HG13 HD23 ' A' ' 11' ' ' LEU . 3.9 m -136.82 143.22 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.224 177.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -145.64 98.48 4.53 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 121.083 0.468 . . . . 0.0 110.546 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.88 149.56 20.48 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.086 2.524 . . . . 0.0 114.213 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -144.36 120.15 10.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.979 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 66.5 t -123.42 135.44 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.635 0.255 . . . . 0.0 111.12 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -121.81 142.04 50.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.58 153.14 38.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.59 0.234 . . . . 0.0 110.859 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -136.94 158.15 45.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.59 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.34 17.53 68.81 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.563 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.52 -39.84 94.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.185 0.517 . . . . 0.0 111.004 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.78 -17.2 64.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.681 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.18 12.2 29.63 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.869 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.1 mt -87.81 111.89 22.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.18 0.514 . . . . 0.0 110.32 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -105.73 120.89 42.85 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.7 t -118.3 133.01 66.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.629 0.252 . . . . 0.0 110.861 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -81.09 142.64 33.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.579 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.47 93.36 40.88 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.31 113.47 3.47 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.23 1.953 . . . . 0.0 112.123 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.29 115.53 43.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.037 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.07 158.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.675 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -133.99 157.4 46.17 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.598 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -70.82 127.14 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 71.7 p -110.84 176.64 4.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.738 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -62.68 -33.92 76.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.348 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.24 -40.99 96.1 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.886 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -64.5 -47.45 78.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.116 0.484 . . . . 0.0 110.385 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.08 -45.76 95.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.757 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.93 -46.28 91.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.479 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.22 97.82 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.817 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.563 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.8 tpt -61.71 -46.51 89.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.616 0.246 . . . . 0.0 110.841 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.76 -41.66 97.95 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.972 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.85 -45.34 94.92 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.369 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 m -63.51 -42.83 98.46 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.177 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.4 mt -60.71 -43.41 97.83 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -65.85 -33.36 75.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.926 0.393 . . . . 0.0 110.964 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.7 -13.81 60.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.914 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -90.02 -54.32 4.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -56.42 125.68 23.07 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.82 -167.41 2.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.525 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 151' ' ' TRP . 4.4 m -146.43 170.74 16.21 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.543 ' H ' HG22 ' A' ' 150' ' ' THR . 6.8 p-90 -120.38 145.91 46.7 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 151' ' ' TRP . 56.3 tttp 173.55 -59.61 0.01 OUTLIER 'General case' 0 C--N 1.351 0.639 0 O-C-N 123.862 0.726 . . . . 0.0 110.531 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -109.64 177.14 4.82 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 120.692 0.282 . . . . 0.0 111.498 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -84.15 147.11 27.5 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 69.48 116.88 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.978 0.911 . . . . 0.0 113.259 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -167.9 -98.74 0.12 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.436 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.35 145.79 29.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.3 126.48 67.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -95.54 -176.7 3.84 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.765 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.81 -66.89 0.48 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.492 ' OE2' ' HA ' ' A' ' 256' ' ' PHE . 13.9 pt-20 -78.52 7.35 6.85 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 188' ' ' ALA . 31.1 t70 -72.74 147.66 45.39 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.354 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 163' ' ' ARG . 16.8 ptp180 -101.87 116.7 33.28 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.59 127.14 74.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.586 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.1 m -74.93 109.54 8.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.6 124.37 66.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.061 0.457 . . . . 0.0 111.633 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.13 91.1 6.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -111.81 149.34 31.89 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.349 0.595 . . . . 0.0 111.885 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 40.5 m -128.15 129.75 47.02 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.121 177.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.85 134.65 12.65 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.827 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.3 m -142.84 144.35 32.49 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 120.83 0.347 . . . . 0.0 110.731 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.2 t -98.76 94.12 3.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 64.75 -70.39 0.08 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.331 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -137.06 5.82 3.65 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.77 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -130.24 139.15 50.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.585 0.692 . . . . 0.0 111.169 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.37 153.1 30.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.144 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -117.62 -177.31 3.21 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -53.78 -49.57 67.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.833 0.853 . . . . 0.0 113.194 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -103.0 -164.97 25.84 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.016 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . 82.25 28.22 41.38 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.861 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -114.03 106.73 14.75 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.67 145.9 50.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.836 0.35 . . . . 0.0 111.263 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 69.1 m -139.43 130.37 26.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.713 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 55.34 32.24 18.34 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.717 0.636 . . . . 0.0 110.513 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -93.2 133.49 36.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.965 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.6 m -94.04 119.48 41.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.52 0.676 . . . . 0.0 111.376 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.5 HD12 HH12 ' B' ' 57' ' ' ARG . 29.8 tp -111.37 123.58 50.5 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.106 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.73 ' HB3' ' NH1' ' A' ' 193' ' ' ARG . . . -110.91 131.52 54.97 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 173.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.449 ' SD ' ' HB ' ' A' ' 202' ' ' ILE . 70.8 mtm -98.43 177.08 5.46 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.218 0.532 . . . . 0.0 112.032 -171.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.53 23.32 67.92 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.498 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -131.85 -15.04 3.08 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 121.096 -0.241 . . . . 0.0 111.561 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.4 42.48 9.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.063 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.73 ' NH1' ' HB3' ' A' ' 188' ' ' ALA . 70.9 mtm180 -100.69 -0.38 37.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.316 0.579 . . . . 0.0 110.754 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.479 ' HE2' ' HA ' ' A' ' 194' ' ' MET . 0.7 OUTLIER -132.01 168.7 17.48 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 175.069 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 195' ' ' ILE . 3.4 mp -58.75 129.92 85.32 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.3 133.62 42.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.399 2.066 . . . . 0.0 111.929 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.84 -43.47 1.67 Allowed Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.089 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -63.54 -46.56 85.42 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.46 0.172 . . . . 0.0 111.053 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -86.68 14.17 7.47 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 121.184 0.516 . . . . 0.0 111.126 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.614 ' O ' ' HE2' ' A' ' 203' ' ' LYS . 17.3 t70 -113.62 -41.05 3.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.137 0.494 . . . . 0.0 109.866 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.9 -17.58 67.65 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.577 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.449 ' HB ' ' SD ' ' A' ' 189' ' ' MET . 69.9 mt -67.44 -26.31 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 122.632 -0.334 . . . . 0.0 111.316 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.614 ' HE2' ' O ' ' A' ' 200' ' ' ASP . 46.5 mtmt -57.9 132.74 54.28 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.971 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.6 -12.65 64.57 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.744 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -88.07 160.08 17.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.055 0.427 . . . . 0.0 111.679 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -88.02 176.18 7.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.943 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -91.31 53.29 2.28 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.429 0.633 . . . . 0.0 111.101 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 150.75 44.58 0.02 OUTLIER Glycine 0 C--N 1.307 -1.056 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -125.72 131.39 52.57 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.133 -0.534 . . . . 0.0 110.518 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -108.96 112.06 24.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.032 0.444 . . . . 0.0 109.931 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -132.39 -4.51 3.38 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.949 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 69.4 p 58.34 169.24 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.887 0.875 . . . . 0.0 112.473 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.5 tp -156.48 143.71 10.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.874 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.413 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 28.2 m-20 -95.28 114.89 26.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.373 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 67.9 t -117.99 129.9 73.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 8.7 m -91.31 -24.49 19.8 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -174.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 216' ' ' THR . 64.5 m-85 69.62 158.13 0.15 Allowed Pre-proline 0 N--CA 1.485 1.291 0 CA-C-O 120.849 0.357 . . . . 0.0 110.866 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -86.62 156.32 9.06 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 122.22 1.946 . . . . 0.0 112.089 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.52 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 67.5 mm-40 -66.16 -42.58 88.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.02 65.72 9.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.022 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -103.62 139.93 38.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.671 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -64.92 -18.91 65.63 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.74 110.43 22.52 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.563 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 43.2 tt0 -64.57 -35.14 80.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.019 0.437 . . . . 0.0 111.745 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -70.47 -15.7 62.84 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.554 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.1 mt -114.91 -3.95 12.65 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.5 ptmt -71.72 126.53 29.96 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.696 -176.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.08 29.2 74.23 Favored Glycine 0 C--O 1.24 0.483 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.459 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -125.62 135.48 52.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.907 0.354 . . . . 0.0 110.956 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -79.8 131.89 36.01 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.951 0.405 . . . . 0.0 110.347 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -117.12 157.99 24.98 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.559 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.413 ' HE2' ' OD1' ' A' ' 214' ' ' ASP . 34.4 mmtp -116.0 106.89 14.29 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -83.0 111.71 19.1 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.3 0.571 . . . . 0.0 110.564 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -81.74 90.9 6.39 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.486 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm -88.04 116.93 30.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -104.8 -52.61 2.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.351 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 98.9 mt 65.78 132.75 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.632 0.773 . . . . 0.0 112.557 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -111.44 -66.33 1.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.195 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -100.16 -67.86 0.83 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.387 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 17.1 t 71.08 155.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.279 0.632 . . . . 0.0 111.225 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -80.52 -179.13 7.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.982 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.33 143.79 50.99 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.301 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -175.49 104.63 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.964 0.506 . . . . 0.0 112.322 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -171.83 163.55 6.34 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.431 HD12 ' HD2' ' A' ' 246' ' ' PRO . 35.9 tp 75.67 111.13 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 123.933 0.893 . . . . 0.0 110.721 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.541 ' HA ' HG21 ' A' ' 150' ' ' THR . 92.6 Cg_endo -81.76 140.07 11.42 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.495 2.13 . . . . 0.0 114.315 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -136.16 10.44 3.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.446 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 8.5 mp 70.39 109.55 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.467 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 251' ' ' GLU . 30.6 m -125.93 131.9 52.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.112 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -70.84 -18.77 62.71 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 249' ' ' THR . 47.8 mt-10 -61.89 -45.41 93.89 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -76.33 -26.14 55.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.766 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 250' ' ' ALA . 11.2 tp -73.36 -35.38 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.689 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 22.8 ptmt -92.12 -20.53 21.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -123.5 119.44 29.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.28 0.562 . . . . 0.0 111.953 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.492 ' HA ' ' OE2' ' A' ' 161' ' ' GLU . 56.1 t80 -156.43 83.54 0.98 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.03 -48.96 3.42 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -175.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.36 150.56 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 123.187 0.595 . . . . 0.0 109.877 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.27 -48.73 79.54 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.517 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.88 131.33 4.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.979 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -134.1 -142.86 4.78 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.748 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 21.6 p -142.38 -169.86 3.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.4 -66.14 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.374 0.607 . . . . 0.0 110.512 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.53 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.6 OUTLIER -70.91 -39.91 72.46 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.249 -178.567 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.28 -39.15 96.78 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.642 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.407 ' O ' HG23 ' A' ' 270' ' ' VAL . 52.2 tp -62.41 -43.92 97.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.616 0.246 . . . . 0.0 110.812 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -63.26 -42.46 99.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.171 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -67.89 -43.02 80.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.65 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -67.94 -39.06 83.52 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.991 0.424 . . . . 0.0 110.71 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 266' ' ' LEU . 75.1 t -64.79 -41.73 92.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -55.22 -52.12 64.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.749 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.1 ptmt -65.33 -42.03 93.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.712 0.291 . . . . 0.0 111.689 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.92 -39.78 94.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.701 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 90.7 mmm -63.52 -42.66 98.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.59 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -69.45 -33.48 72.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.62 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -62.45 -43.39 98.94 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.319 0.58 . . . . 0.0 109.661 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -69.42 -33.57 73.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.053 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.64 -40.78 96.1 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.495 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -57.61 -44.4 85.46 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.058 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.2 m -62.69 -42.88 99.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.72 98.84 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.327 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.93 -43.74 97.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.983 0.421 . . . . 0.0 110.031 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -44.61 97.09 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.087 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -64.37 -41.92 96.45 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.449 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ARG . . . . . 0.442 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 2.0 tpm_? -60.92 -43.78 98.13 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.032 0.444 . . . . 0.0 110.447 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 94.0 t -68.44 -44.64 83.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.715 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.5 -46.32 88.99 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.122 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.7 p -61.87 -42.64 99.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -67.2 -41.11 86.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.997 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.81 86.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.812 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 295' ' ' VAL . 35.9 mm -64.09 -43.65 97.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.519 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.479 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 19.9 tp10 -61.23 -44.15 97.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.171 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.33 99.28 Favored Glycine 0 C--O 1.24 0.526 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.692 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.78 -42.13 95.31 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 291' ' ' ILE . 85.1 t -63.93 -44.36 97.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.914 -178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LYS . . . . . 0.479 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.6 mttm -62.63 -37.64 87.1 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.78 0.324 . . . . 0.0 111.657 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.59 -30.03 27.3 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -128.84 92.21 3.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -91.28 98.46 11.73 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -103.25 149.11 7.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.391 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.04 135.37 57.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.907 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.64 120.54 44.81 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.068 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.99 131.52 44.07 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.592 2.195 . . . . 0.0 112.471 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.13 75.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.282 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.43 -29.18 63.94 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.681 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.592 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 90.4 mt -93.31 -31.76 14.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.826 0.346 . . . . 0.0 110.855 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 311' ' ' ILE . 95.6 mt -63.68 -46.91 93.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.759 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.12 -39.0 93.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 35.6 p -69.02 -42.38 76.46 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.724 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.655 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 24.6 mm-40 -72.69 -35.74 67.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.48 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 77.4 mt -61.7 -43.8 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.304 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.557 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 30.6 t70 -61.64 -41.94 98.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.928 0.394 . . . . 0.0 111.022 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.0 t -62.1 -43.87 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.899 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 61.7 mt -63.05 -39.28 94.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.818 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.557 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.5 mtm180 -62.04 -42.64 99.39 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -64.08 -37.86 88.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.668 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -61.5 -46.15 91.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.198 0.523 . . . . 0.0 110.043 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.29 -37.2 71.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.429 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.54 72.57 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 120.98 0.419 . . . . 0.0 111.223 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' GLN . . . . . 0.479 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 7.9 tt0 -62.33 -37.81 87.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.458 0.647 . . . . 0.0 109.956 176.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.36 -15.75 59.23 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.583 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -93.56 6.59 47.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.699 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' GLY . . . . . 0.454 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . 134.44 -22.69 3.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.521 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 109.6 37.53 1.89 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.337 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.431 HD21 ' HB2' ' A' ' 328' ' ' GLN . 27.3 t-20 -79.14 135.9 36.96 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.858 0.361 . . . . 0.0 110.792 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' GLU . . . . . 0.608 ' OE1' ' HG3' ' A' ' 327' ' ' LYS . 1.7 tm-20 -136.71 152.42 50.35 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.608 ' HG3' ' OE1' ' A' ' 326' ' ' GLU . 32.0 mtmm 70.89 -46.34 0.63 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.553 0.741 . . . . 0.0 112.419 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.431 ' HB2' HD21 ' A' ' 325' ' ' ASN . 17.3 mm100 -68.54 -16.69 63.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.252 0.548 . . . . 0.0 110.065 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.58 -19.05 34.95 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.859 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.522 HD12 HH12 ' A' ' 315' ' ' ARG . 52.8 tp -61.15 -38.7 87.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.774 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -75.34 -19.47 59.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.775 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 81.2 mt -55.52 136.75 70.26 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.425 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.68 127.73 23.81 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.93 2.42 . . . . 0.0 113.057 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.402 HH21 ' HD2' ' A' ' 334' ' ' ARG . 24.8 ttt180 -68.31 -42.17 79.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.263 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -59.07 -36.18 74.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.129 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.88 -39.02 93.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.471 ' CD1' ' HG2' ' A' ' 315' ' ' ARG . 96.9 m-85 -97.06 -15.78 20.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -68.84 -31.6 70.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.81 0.338 . . . . 0.0 111.197 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -61.32 -50.89 71.13 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.823 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -70.64 -28.83 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.838 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.06 -42.17 97.99 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.21 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.8 tttt -59.83 -47.2 86.67 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.187 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.547 ' O ' HG23 ' A' ' 347' ' ' VAL . 13.0 mmt85 -62.94 -44.89 94.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.142 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.468 ' NH2' HD22 ' A' ' 314' ' ' LEU . 93.5 mtt180 -66.58 -38.43 87.03 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.2 t -65.31 -43.17 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.78 0.324 . . . . 0.0 110.35 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 342' ' ' LYS . 74.2 t -60.69 -42.82 93.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.482 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 343' ' ' ARG . 76.5 t -59.68 -44.72 94.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.29 99.59 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.202 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.96 -43.82 97.75 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.891 0.376 . . . . 0.0 110.841 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.31 -44.56 94.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.934 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.16 -41.67 94.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.285 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.97 -42.59 99.75 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.217 -0.516 . . . . 0.0 113.254 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 356' ' ' ARG . 32.1 tp10 -63.23 -44.3 95.62 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.866 0.365 . . . . 0.0 110.759 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.34 -46.26 95.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.029 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.66 -44.72 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.918 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ARG . . . . . 0.403 HH22 ' CD ' ' A' ' 353' ' ' GLU . 7.5 tmm_? -69.68 -45.41 68.4 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.8 m -68.89 -43.24 75.68 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -86.15 -1.52 57.5 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.909 0.385 . . . . 0.0 110.663 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 57.63 44.76 20.27 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.08 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.66 149.3 34.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.399 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.77 148.41 32.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.728 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.38 126.75 29.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 367' ' ' VAL . 18.4 t70 -94.44 115.86 28.12 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.769 -176.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 54.3 mm-40 -60.52 -40.22 90.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.564 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.95 -40.11 91.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 110.883 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -64.02 -39.14 93.44 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.598 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 363' ' ' ASP . 90.5 t -62.68 -39.69 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.922 176.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.0 mmmt -57.11 -43.29 82.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.037 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.5 -40.68 99.42 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.035 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.04 -41.09 99.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 109.995 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.67 -42.95 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.453 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.99 -41.59 96.77 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.709 0.29 . . . . 0.0 111.046 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -65.37 -40.29 93.34 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 109.857 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 50.1 ttm -65.71 -41.64 92.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.646 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.9 -27.42 68.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.991 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.3 m -75.76 -3.08 32.89 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.548 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -96.4 4.39 52.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.836 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -125.59 -176.6 3.65 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.737 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.37 -52.83 60.05 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.404 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.596 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 21.3 t70 -125.68 125.58 24.96 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.501 ' O ' HG13 ' A' ' 385' ' ' ILE . 33.7 Cg_endo -64.64 -32.69 57.51 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 121.969 1.779 . . . . 0.0 113.102 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -68.22 -41.55 81.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 13.0 pt-20 -61.17 -38.21 85.69 Favored 'General case' 0 N--CA 1.46 0.068 0 CA-C-O 120.745 0.307 . . . . 0.0 110.177 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.99 -44.01 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.325 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 381' ' ' PRO . 74.0 mt -60.75 -46.86 95.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.4 -43.09 86.77 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.515 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -59.41 -46.82 87.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.946 0.403 . . . . 0.0 110.869 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -68.52 -41.86 79.33 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.813 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.9 p -80.18 -8.03 59.24 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.22 7.96 45.49 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.174 0.511 . . . . 0.0 110.563 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -133.38 110.96 10.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.798 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -62.33 -38.01 87.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.354 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.9 -50.68 71.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.035 0.445 . . . . 0.0 110.394 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.29 -41.98 96.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.442 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.515 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 88.9 mtp -63.33 -48.61 77.29 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.8 -39.46 66.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.612 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.91 -41.15 97.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.466 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 47.7 tpp -65.25 -40.03 93.46 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 395' ' ' MET . 79.2 mtm180 -63.09 -33.56 75.7 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.71 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.68 -41.83 98.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.127 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.15 -45.57 93.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.448 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.39 90.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.915 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 57.3 tp -62.58 -39.36 93.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.498 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 408' ' ' VAL . 38.4 tt0 -61.05 -43.75 98.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -65.78 -35.98 82.23 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.126 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -60.81 -41.52 95.84 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.207 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.36 94.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.687 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.428 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 90.6 t -64.2 -45.4 96.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.014 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.78 -35.87 82.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.535 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.28 98.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.914 0.388 . . . . 0.0 110.4 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 95.4 t -67.75 -43.45 86.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 94.5 mt -61.51 -41.5 97.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.998 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.8 -24.29 67.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.587 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -99.06 -1.99 38.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.334 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.49 172.27 6.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.982 0.42 . . . . 0.0 111.739 -177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.15 127.35 31.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.573 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.21 116.09 46.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 120.882 0.372 . . . . 0.0 110.588 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 10.0 t -115.54 128.84 56.26 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -112.88 123.57 50.63 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.1 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -145.23 150.4 36.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.795 0.331 . . . . 0.0 111.561 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -84.46 162.52 19.89 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.628 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.5 t -158.54 -176.71 6.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.798 0.332 . . . . 0.0 110.631 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 16.5 p -81.76 157.9 24.35 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.274 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -67.53 -35.63 79.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.175 0.512 . . . . 0.0 110.842 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -60.63 -35.85 77.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.109 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -66.37 -30.73 71.17 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.098 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.39 -15.99 58.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.968 0.413 . . . . 0.0 110.788 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 8.8 mmt -78.07 -6.3 54.2 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.77 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -76.18 68.51 2.61 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.509 0.671 . . . . 0.0 109.358 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -99.42 16.01 24.53 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.327 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -63.22 -39.52 94.85 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.754 0 CA-C-O 118.286 -0.864 . . . . 0.0 109.825 179.278 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.727 0.299 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.58 133.8 34.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.345 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.67 162.32 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.675 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 33.8 t -103.47 105.9 16.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.918 0.389 . . . . 0.0 110.326 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 p -146.77 139.52 19.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.728 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 61.2 mt-10 -129.06 172.83 11.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.699 0.285 . . . . 0.0 111.119 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 94.1 m -121.82 129.44 52.63 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.245 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 33.3 m -77.17 -68.8 0.58 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 175.79 139.53 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.512 0.725 . . . . 0.0 109.717 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.84 -122.62 28.26 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.379 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.59 HD23 HG13 ' B' ' 111' ' ' VAL . 78.1 mt -65.79 -39.56 91.08 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 122.868 0.467 . . . . 0.0 110.907 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.582 ' HA2' ' HG2' ' B' ' 108' ' ' GLU . . . -69.39 137.74 29.69 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 115.63 1.012 . . . . 0.0 115.63 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 1.5 tpp180 -126.04 -161.66 1.07 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -161.94 116.27 1.9 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 t -94.26 -91.86 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.138 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m 52.69 85.24 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 CA-C-O 121.28 0.562 . . . . 0.0 110.787 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 tp -114.68 144.84 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.683 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 14.4 p -100.34 126.44 46.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.971 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.45 ' CD1' HG12 ' B' ' 24' ' ' ILE . 6.6 pt -131.22 153.71 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.663 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -75.92 151.27 37.36 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.889 0.476 . . . . 0.0 112.0 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.17 -50.19 69.94 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -65.15 -37.54 87.73 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.596 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -63.71 -43.48 96.45 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.035 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.663 HG13 ' O ' ' B' ' 20' ' ' ALA . 68.8 mt -61.77 -52.58 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.242 0.544 . . . . 0.0 111.517 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -70.05 -39.22 75.84 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.16 -172.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 10.9 m -77.24 -55.7 5.19 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.38 -47.54 60.43 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 96.0 t -64.17 -43.34 97.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.194 -176.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -61.31 -45.22 95.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.39 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 40.4 m -63.07 -42.35 99.64 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.528 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.424 ' O ' HG23 ' B' ' 35' ' ' VAL . 49.0 tp10 -65.93 -36.63 83.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.369 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 91.9 mt -61.93 -42.1 98.71 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.24 -36.63 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.207 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -63.39 -41.13 98.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.621 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 31' ' ' GLU . 96.7 t -63.81 -44.12 98.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.437 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.74 93.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.113 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.04 -33.48 75.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.273 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -59.58 -41.73 90.91 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.642 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 10.8 t -91.08 -1.86 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.23 0.538 . . . . 0.0 110.343 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 65.14 25.13 12.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.259 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -103.93 6.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.622 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -65.84 -29.0 69.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.291 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.7 -3.86 68.78 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.281 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -86.48 -5.76 59.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -93.39 110.67 22.22 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.797 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.72 -42.84 99.49 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.488 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.13 46.1 67.37 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 115.906 1.122 . . . . 0.0 115.906 172.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -61.39 -44.61 96.85 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.174 0.987 . . . . 0.0 108.469 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.451 HG12 ' HB ' ' B' ' 54' ' ' VAL . 3.4 t -105.39 103.84 44.73 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 174.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' B' ' 53' ' ' ILE . 36.2 Cg_endo -64.07 156.36 59.39 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.736 2.291 . . . . 0.0 112.711 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.511 ' HA ' HG12 ' B' ' 54' ' ' VAL . 92.2 mtp -63.45 -24.99 68.07 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -174.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -79.15 -10.02 59.71 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.834 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.637 HD13 ' NH2' ' A' ' 193' ' ' ARG . 93.9 mt -114.94 -46.1 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' B' ' 51' ' ' MET . 14.6 p -63.66 -34.61 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.955 0.407 . . . . 0.0 110.797 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.0 82.89 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.168 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -88.9 -14.97 35.52 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.5 HH12 HD12 ' A' ' 187' ' ' LEU . 67.6 mtt180 -89.87 -30.62 17.77 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.41 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.62 13.3 22.56 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.653 0.739 . . . . 0.0 109.632 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.46 149.45 51.63 Favored Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.447 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.59 -40.89 0.48 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.299 0.64 . . . . 0.0 111.559 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.7 t -60.71 -46.59 89.82 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.734 0.414 . . . . 0.0 110.973 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -123.15 13.08 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.313 0.577 . . . . 0.0 110.845 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -64.1 -19.52 65.32 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.132 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -62.9 -52.69 62.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.817 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.93 -18.38 60.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.08 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 62' ' ' VAL . 75.9 t -64.39 -42.68 96.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 173.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.58 -39.56 94.08 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' B' ' 71' ' ' MET . . . -60.37 -41.28 98.41 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.522 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ASP . . . . . 0.748 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 30.7 t70 -63.51 -44.27 94.79 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.39 -43.62 98.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.988 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' B' ' 68' ' ' GLY . 24.8 ptt? -63.71 -40.43 96.77 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 44.6 m -64.45 -39.38 93.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.081 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.748 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 51.1 mtp85 -62.59 -43.81 97.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.996 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -64.02 -41.9 97.28 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.32 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.71 -48.39 80.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.306 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ILE . . . . . 0.476 ' O ' HG13 ' B' ' 79' ' ' ILE . 19.2 tt -67.52 -40.53 84.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.484 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.82 -42.27 95.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.999 0.428 . . . . 0.0 110.139 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.73 -42.28 97.93 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.057 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.476 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.6 pp -67.35 -40.95 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.642 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.95 -44.63 96.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.628 0.728 . . . . 0.0 109.798 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -65.54 -44.63 86.27 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.891 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -89.26 2.14 54.72 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 62.79 52.8 2.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.047 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.0 mt -109.13 126.6 66.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -103.2 108.38 58.68 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.512 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.29 116.26 3.86 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.199 1.933 . . . . 0.0 111.724 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.9 86.58 6.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.069 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 132.04 -168.41 22.49 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.878 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.93 123.11 74.17 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 110.526 -0.176 . . . . 0.0 110.526 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.92 113.72 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.121 1.881 . . . . 0.0 110.713 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 18.3 m -94.96 117.29 29.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.175 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.548 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.3 m-85 -92.04 134.35 34.9 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.44 97.93 25.29 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 90.1 Cg_endo -103.99 -167.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 123.668 2.912 . . . . 0.0 111.159 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -121.07 -174.09 14.85 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.17 146.89 25.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.479 0.639 . . . . 0.0 109.535 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -91.89 127.82 37.5 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.095 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -105.43 126.33 52.0 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 46.6 tp -65.94 113.57 4.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.021 0.439 . . . . 0.0 110.914 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.04 -8.72 42.45 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.12 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -112.55 177.3 4.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 117.415 0.607 . . . . 0.0 111.215 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -80.9 141.52 34.49 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.555 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -93.07 136.42 33.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.97 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 33.1 m -118.58 130.96 56.18 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.955 0.407 . . . . 0.0 111.265 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -130.41 149.06 52.27 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.287 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.5 ' O ' HG12 ' B' ' 107' ' ' VAL . 58.4 m -101.77 -66.01 0.95 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.5 HG12 ' O ' ' B' ' 106' ' ' SER . 0.3 OUTLIER 71.17 150.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 124.17 0.988 . . . . 0.0 110.964 -175.358 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.582 ' HG2' ' HA2' ' B' ' 12' ' ' GLY . 28.6 mt-10 -132.96 149.47 52.23 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.222 -0.299 . . . . 0.0 110.333 -175.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -155.47 -75.26 0.1 Allowed 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -108.61 162.87 13.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -171.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.59 HG13 HD23 ' B' ' 11' ' ' LEU . 3.6 m -135.68 158.83 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.125 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -161.45 104.61 1.21 Allowed Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.572 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.59 147.91 12.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.026 2.484 . . . . 0.0 114.411 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -140.32 112.54 7.76 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.428 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.4 133.92 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 111.34 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -122.37 141.36 51.65 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.333 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -120.02 150.8 39.98 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.596 0.236 . . . . 0.0 110.698 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -135.46 156.66 48.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.661 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.55 16.96 69.6 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.216 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.7 -38.96 92.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.279 0.561 . . . . 0.0 110.838 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.95 -14.73 63.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.192 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.0 21.52 13.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.878 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 76.5 mt -94.61 109.39 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.417 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -102.33 121.07 41.56 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.38 132.91 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.767 0.317 . . . . 0.0 110.844 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -83.16 139.15 33.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.406 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -123.74 94.11 46.48 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.82 113.46 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.265 1.977 . . . . 0.0 112.095 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.5 mm -102.56 118.31 49.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.048 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.87 160.61 41.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.724 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -133.7 150.27 51.52 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.943 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.71 123.37 19.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 65.2 p -106.99 176.88 5.03 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.854 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.18 -34.77 77.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.602 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.42 97.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.156 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -63.34 -45.46 91.14 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.148 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.7 -45.08 92.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.744 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -59.47 -48.71 80.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.742 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.29 -39.22 96.83 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.036 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.55 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 2.6 tpt -60.91 -47.43 86.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 0.0 110.65 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.66 -41.6 98.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.986 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -60.95 -46.41 90.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.922 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 29.0 m -61.64 -41.74 97.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.643 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 144' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.3 mt -60.87 -41.93 96.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.758 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -71.48 -20.47 62.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.779 0.324 . . . . 0.0 111.124 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -89.05 -3.01 58.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.508 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -103.42 -48.22 4.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -62.3 124.03 19.79 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -175.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.87 -167.55 1.97 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.582 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 150' ' ' THR . . . . . 0.558 HG21 ' HA ' ' B' ' 246' ' ' PRO . 5.5 m -146.16 169.32 18.97 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 151' ' ' TRP . . . . . 0.53 ' H ' HG22 ' B' ' 150' ' ' THR . 7.1 p-90 -117.78 145.41 44.53 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -175.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 152' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' B' ' 151' ' ' TRP . 54.2 tttp 173.41 -65.79 0.01 OUTLIER 'General case' 0 C--N 1.344 0.367 0 O-C-N 123.94 0.775 . . . . 0.0 110.36 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -102.39 175.97 5.33 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 120.861 0.362 . . . . 0.0 111.836 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -83.57 147.2 27.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.959 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 68.44 113.61 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -165.05 -95.21 0.1 Allowed Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.651 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.02 149.69 31.56 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 62.8 t -114.35 128.15 71.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -98.11 -170.86 2.04 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.081 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.99 -67.84 0.44 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -73.96 1.51 10.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' B' ' 188' ' ' ALA . 32.1 t70 -69.61 144.86 52.87 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.629 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -102.83 119.14 38.31 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.737 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 42.1 t -117.15 126.71 74.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.561 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 24.4 m -74.4 106.32 5.96 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 88.2 mt -122.26 122.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.669 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -92.9 90.35 6.95 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -112.85 149.62 32.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.325 0.583 . . . . 0.0 112.16 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 41.5 m -128.8 128.99 45.04 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.19 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.44 135.46 13.31 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.729 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 51.0 m -142.48 145.8 34.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 120.863 0.363 . . . . 0.0 110.909 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.95 94.98 3.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.03 -68.4 0.09 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.96 0.788 . . . . 0.0 112.718 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -140.86 12.09 2.88 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.797 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -136.91 138.33 40.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.491 0.646 . . . . 0.0 110.89 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -79.38 148.98 31.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.253 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -110.89 -174.55 2.5 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -57.31 -48.87 77.84 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -103.35 -162.15 25.34 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.057 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' B' ' 169' ' ' THR . . . 78.78 29.68 50.97 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.676 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -114.85 103.05 10.57 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -131.38 141.52 49.89 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.792 0.33 . . . . 0.0 111.575 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 27.7 m -136.02 133.46 37.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.651 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 55.45 33.09 20.22 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.377 0.423 . . . . 0.0 110.91 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -98.51 133.27 43.11 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.287 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.1 m -94.3 120.68 44.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-O 121.57 0.7 . . . . 0.0 111.282 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 187' ' ' LEU . . . . . 0.464 HD12 HH12 ' A' ' 57' ' ' ARG . 30.0 tp -111.37 125.0 53.4 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.073 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 188' ' ' ALA . . . . . 0.73 ' HB3' ' NH1' ' B' ' 193' ' ' ARG . . . -111.34 132.75 54.16 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 173.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 189' ' ' MET . . . . . 0.461 ' SD ' ' HB ' ' B' ' 202' ' ' ILE . 69.3 mtm -100.29 176.74 5.27 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.226 0.536 . . . . 0.0 112.287 -171.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 79.22 18.78 73.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.593 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -127.54 -17.94 4.5 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.68 0.276 . . . . 0.0 111.604 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.39 43.38 7.44 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.128 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.73 ' NH1' ' HB3' ' B' ' 188' ' ' ALA . 69.4 mtm180 -100.19 1.11 41.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.369 0.604 . . . . 0.0 110.934 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.469 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.5 OUTLIER -134.19 169.16 17.59 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.637 175.164 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.461 ' H ' HD12 ' B' ' 195' ' ' ILE . 3.1 mp -58.07 131.04 83.61 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.03 134.76 50.33 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.216 1.944 . . . . 0.0 111.56 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.56 -43.2 1.76 Allowed Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -63.78 -47.55 80.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 120.447 0.165 . . . . 0.0 111.174 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -86.54 14.51 6.72 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.262 0.553 . . . . 0.0 110.923 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 200' ' ' ASP . . . . . 0.665 ' O ' ' HE2' ' B' ' 203' ' ' LYS . 21.2 t70 -113.22 -38.76 4.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.221 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -71.13 -15.51 74.51 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.546 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.461 ' HB ' ' SD ' ' B' ' 189' ' ' MET . 69.7 mt -68.63 -25.99 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 O-C-N 122.596 -0.355 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.665 ' HE2' ' O ' ' B' ' 200' ' ' ASP . 45.0 mtmt -58.09 131.33 50.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.42 -8.09 66.51 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.731 -0.747 . . . . 0.0 114.018 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -89.73 161.08 16.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.302 0.551 . . . . 0.0 111.636 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.69 176.19 7.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.061 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -91.33 55.61 2.86 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.224 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 147.68 43.16 0.03 OUTLIER Glycine 0 C--N 1.308 -0.996 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -125.36 131.41 52.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.254 -0.473 . . . . 0.0 110.766 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -105.45 112.87 26.13 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.679 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -134.09 -3.74 2.79 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.102 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 66.3 p 58.72 169.89 0.06 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.932 0.893 . . . . 0.0 112.421 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.6 tp -157.81 143.93 8.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.59 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -97.65 113.68 25.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.515 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 61.2 t -116.43 130.1 71.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 216' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 7.3 m -92.59 -23.94 18.87 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.9 m-85 69.51 159.57 0.15 Allowed Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.885 -175.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -88.3 156.92 6.77 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.177 1.918 . . . . 0.0 111.755 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 219' ' ' GLU . . . . . 0.451 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 70.7 mm-40 -67.61 -39.71 84.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -84.99 72.0 10.87 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.671 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -115.52 138.11 51.37 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -63.92 -19.83 65.4 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -100.78 107.56 19.15 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 37.8 tt0 -64.0 -33.17 75.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.49 -175.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -74.71 -11.63 60.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.82 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -117.92 -4.3 11.1 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.8 ptmt -69.23 125.07 25.55 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.127 0.489 . . . . 0.0 111.743 -176.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 63.65 27.12 70.53 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.572 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.14 133.57 55.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.323 0.562 . . . . 0.0 110.974 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -75.26 134.81 41.02 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.957 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.47 154.44 37.8 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.399 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -111.33 107.19 16.37 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -83.56 109.72 17.63 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.2 0.524 . . . . 0.0 110.486 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.93 98.27 7.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.509 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.2 mm -97.11 114.55 34.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.154 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -104.18 -51.89 3.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.035 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 96.1 mt 65.75 144.02 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.549 0.739 . . . . 0.0 112.076 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.04 -63.86 1.22 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.612 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -99.64 -69.36 0.77 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.668 0.27 . . . . 0.0 111.582 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 15.5 t 70.8 154.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.412 0.685 . . . . 0.0 111.166 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.42 -179.64 7.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.905 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.36 141.04 50.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.182 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.433 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 1.4 ptp180 -174.71 105.33 0.1 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.139 0.495 . . . . 0.0 112.228 177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -170.71 163.52 8.01 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 30.6 tp 74.75 114.95 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 123.76 0.824 . . . . 0.0 110.83 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 246' ' ' PRO . . . . . 0.558 ' HA ' HG21 ' B' ' 150' ' ' THR . 90.9 Cg_endo -84.0 134.65 6.22 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.477 2.118 . . . . 0.0 114.624 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -130.38 13.97 5.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.528 173.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 8.3 mp 66.26 105.68 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.876 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 249' ' ' THR . . . . . 0.605 HG22 ' H ' ' B' ' 251' ' ' GLU . 27.6 m -123.6 133.99 53.86 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.021 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.425 ' O ' HG22 ' B' ' 253' ' ' ILE . . . -74.6 -12.98 60.59 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.605 ' H ' HG22 ' B' ' 249' ' ' THR . 51.7 mt-10 -62.44 -43.48 98.71 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -85.08 -8.95 58.44 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 253' ' ' ILE . . . . . 0.425 HG22 ' O ' ' B' ' 250' ' ' ALA . 10.9 tp -91.66 -17.52 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.498 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 254' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' B' ' 260' ' ' ASP . 21.9 ptmt -106.37 -16.49 14.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.765 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -125.18 127.9 47.52 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.043 0.449 . . . . 0.0 112.095 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -168.33 82.21 0.17 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 78.25 -47.02 2.84 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.583 -175.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.49 152.23 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 122.961 0.505 . . . . 0.0 110.264 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -58.35 -51.56 69.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 260' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' B' ' 254' ' ' LYS . 2.8 p-10 -160.95 126.18 3.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.124 0.488 . . . . 0.0 109.95 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -130.98 -154.51 7.92 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.737 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 30.7 p -127.08 -164.02 1.31 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 122.53 0.332 . . . . 0.0 110.215 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.48 -63.5 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.173 0.511 . . . . 0.0 110.536 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.2 OUTLIER -72.86 -39.59 66.37 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.934 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.25 -38.46 95.93 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.463 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.97 -43.87 97.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.679 0.276 . . . . 0.0 110.543 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -64.23 -42.02 96.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.995 0.426 . . . . 0.0 110.155 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -68.43 -41.9 79.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.6 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -68.55 -40.11 80.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 110.701 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.36 -41.32 92.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -54.44 -51.5 64.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.624 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 15.9 ptmt -67.1 -40.25 86.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.67 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.39 -39.24 93.48 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.446 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.1 mmm -63.39 -43.61 97.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.61 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.75 -33.45 72.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.924 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -60.15 -44.37 95.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.388 0.613 . . . . 0.0 109.351 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.19 -35.07 75.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.017 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 278' ' ' LEU . . . . . 0.422 ' O ' HG13 ' B' ' 282' ' ' ILE . 54.2 tp -61.59 -41.26 97.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.785 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -57.78 -43.51 85.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.084 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 24.6 m -62.0 -42.66 99.4 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.511 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.46 96.13 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.435 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 282' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 278' ' ' LEU . 63.8 mt -63.31 -44.23 99.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.465 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.93 -44.57 94.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.84 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -64.89 -42.32 94.9 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.388 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -60.71 -43.88 97.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.639 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 98.3 t -69.36 -44.44 80.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.641 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 287' ' ' LYS . . . . . 0.416 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.0 tttt -62.5 -46.57 87.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.928 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 69.8 p -61.79 -43.39 98.94 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -66.46 -40.42 89.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.817 0.341 . . . . 0.0 111.156 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.14 -47.43 84.58 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.729 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 291' ' ' ILE . . . . . 0.447 ' O ' HG23 ' B' ' 295' ' ' VAL . 48.2 mm -64.35 -44.17 97.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.888 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -60.54 -44.08 96.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.288 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.67 99.25 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.323 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.16 -42.19 93.97 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 291' ' ' ILE . 76.1 t -63.82 -44.2 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.612 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.6 -41.92 99.26 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.169 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -72.25 -39.13 68.66 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -126.68 98.39 5.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -92.77 96.08 9.93 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.9 tp -100.98 148.17 7.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.828 -175.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -61.7 134.93 57.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.225 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.3 122.71 38.79 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.939 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.19 131.59 46.05 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.735 2.29 . . . . 0.0 112.555 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.98 79.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.181 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.07 67.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.443 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 306' ' ' LEU . . . . . 0.435 ' O ' ' HG2' ' B' ' 310' ' ' GLU . 92.7 mt -87.01 -33.83 19.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.413 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 307' ' ' ILE . . . . . 0.417 ' O ' HG13 ' B' ' 311' ' ' ILE . 97.0 mt -62.65 -48.28 88.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.787 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.05 -42.13 99.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -176.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 32.2 p -65.75 -39.98 91.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.731 0.3 . . . . 0.0 111.702 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 310' ' ' GLU . . . . . 0.627 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 62.3 mm-40 -72.79 -36.87 67.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 81.1 mt -62.14 -43.45 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.556 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 35.9 t70 -61.26 -41.87 97.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.869 0.366 . . . . 0.0 111.024 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.12 -43.93 99.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.991 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 64.2 mt -63.08 -38.86 92.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.894 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.556 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 74.5 mtm180 -61.36 -42.53 98.85 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -64.1 -38.54 91.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.651 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.01 -45.33 94.07 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.221 0.534 . . . . 0.0 110.31 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.8 -37.49 70.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.413 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.08 72.37 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.061 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 320' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 7.9 tt0 -62.52 -39.64 94.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.337 0.589 . . . . 0.0 109.943 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -73.25 -20.38 60.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.562 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -89.95 3.87 51.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.012 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 323' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 136.42 -21.93 3.4 Favored Glycine 0 CA--C 1.508 -0.39 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.843 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 324' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 109.84 36.27 2.06 Favored Glycine 0 CA--C 1.502 -0.764 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.211 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 325' ' ' ASN . . . . . 0.454 HD21 ' HB2' ' B' ' 328' ' ' GLN . 26.9 t-20 -77.56 133.9 38.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.793 0.33 . . . . 0.0 110.527 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 326' ' ' GLU . . . . . 0.633 ' OE1' ' HG3' ' B' ' 327' ' ' LYS . 1.8 tm-20 -135.89 151.12 49.68 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.633 ' HG3' ' OE1' ' B' ' 326' ' ' GLU . 31.5 mtmm 71.39 -45.54 0.62 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.552 0.741 . . . . 0.0 112.259 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 328' ' ' GLN . . . . . 0.454 ' HB2' HD21 ' B' ' 325' ' ' ASN . 17.1 mm100 -70.16 -13.74 62.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.262 0.553 . . . . 0.0 110.0 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.74 -17.81 57.27 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.622 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.37 -38.02 85.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.476 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -78.03 -15.51 58.87 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.756 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 76.6 mt -57.61 137.37 82.32 Favored Pre-proline 0 C--O 1.238 0.5 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.982 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -51.3 125.62 16.97 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.051 2.501 . . . . 0.0 112.92 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -68.03 -40.78 82.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.619 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.7 pm0 -60.39 -35.58 76.07 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.224 0.454 . . . . 0.0 112.224 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.45 -39.26 94.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.934 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -95.64 -17.13 21.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.38 -32.07 72.74 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.78 -51.04 68.65 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.686 0.279 . . . . 0.0 111.056 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -70.0 -29.32 66.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.729 0.299 . . . . 0.0 110.798 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.442 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -60.58 -43.99 96.73 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 342' ' ' LYS . . . . . 0.476 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.6 tttt -59.58 -46.55 88.6 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.469 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 343' ' ' ARG . . . . . 0.528 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.0 mmt85 -62.03 -45.3 94.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 344' ' ' ARG . . . . . 0.413 ' NH2' HD22 ' B' ' 314' ' ' LEU . 94.9 mtt180 -66.57 -38.34 86.85 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.519 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 341' ' ' ALA . 73.4 t -64.77 -43.46 96.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 120.724 0.297 . . . . 0.0 110.393 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 342' ' ' LYS . 79.4 t -60.7 -43.15 94.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.364 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.528 HG23 ' O ' ' B' ' 343' ' ' ARG . 69.5 t -59.76 -44.8 94.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.41 -41.38 99.52 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.15 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.78 -43.48 98.68 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.732 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 97.6 mt -63.73 -44.29 94.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.891 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.5 -42.46 95.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.507 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.16 -41.69 99.63 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.431 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -64.68 -42.83 95.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.04 -45.14 97.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.82 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.42 -44.73 99.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.797 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -70.8 -45.42 64.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.958 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 98.5 m -67.48 -44.97 77.25 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -86.81 -5.25 59.17 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.604 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 57.69 74.21 0.43 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.981 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.97 144.98 31.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.13 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.63 146.99 35.07 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.205 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.84 115.31 5.19 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 363' ' ' ASP . . . . . 0.539 ' O ' HG23 ' B' ' 367' ' ' VAL . 16.1 t70 -84.0 117.79 23.62 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.3 -176.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 364' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 47.0 mm-40 -60.45 -39.53 87.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.313 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -65.73 -40.18 91.91 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.699 0.285 . . . . 0.0 110.759 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -62.91 -38.47 91.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.092 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 367' ' ' VAL . . . . . 0.539 HG23 ' O ' ' B' ' 363' ' ' ASP . 95.4 t -63.56 -40.92 90.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.636 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 368' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 29.6 mmmt -57.61 -43.43 84.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.306 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.9 -41.77 99.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.798 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.97 -41.24 99.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.398 . . . . 0.0 110.03 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.4 -43.21 98.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.375 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.44 -40.38 96.41 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.421 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.48 -39.66 88.9 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.914 0.388 . . . . 0.0 110.35 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 50.5 ttm -65.17 -40.66 94.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.562 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 375' ' ' ALA . . . . . 0.41 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -62.1 -28.59 69.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.796 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 30.5 m -79.5 16.2 1.11 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.161 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -114.18 4.49 15.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.164 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -126.63 -172.58 2.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.186 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -62.88 -62.11 1.94 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.449 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 380' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 18.9 t70 -119.03 127.24 26.62 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.075 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 381' ' ' PRO . . . . . 0.41 ' HA ' ' HB1' ' B' ' 375' ' ' ALA . 35.5 Cg_endo -66.14 -31.76 44.51 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.156 1.904 . . . . 0.0 112.818 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -67.06 -43.08 83.59 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 11.9 pt-20 -61.39 -37.86 84.97 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.56 -43.21 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.982 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.2 -44.59 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.854 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.88 -45.07 79.19 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.159 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -58.98 -46.76 87.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.856 0.36 . . . . 0.0 111.201 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -68.57 -41.9 79.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.919 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 70.3 p -78.3 -10.82 59.83 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.53 6.17 49.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.096 0.474 . . . . 0.0 110.623 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -129.27 111.9 13.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.327 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.75 -39.75 95.12 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -57.63 -51.06 71.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.899 0.381 . . . . 0.0 110.638 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.51 -41.71 98.52 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.386 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.545 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 88.6 mtp -63.36 -47.65 81.2 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -73.25 -40.52 64.57 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.825 -174.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -62.75 -41.25 99.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.211 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 46.9 tpp -64.22 -39.98 95.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.647 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' B' ' 395' ' ' MET . 77.3 mtm180 -64.15 -34.26 77.67 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.771 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.63 -42.7 99.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.823 0.344 . . . . 0.0 110.083 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.58 -44.78 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.512 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.29 -38.91 93.02 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.838 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.38 -38.89 92.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.343 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 404' ' ' GLU . . . . . 0.402 ' O ' HG23 ' B' ' 408' ' ' VAL . 39.8 tt0 -59.38 -43.75 92.87 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.452 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.44 -35.89 80.11 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.051 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -60.12 -41.68 93.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.921 0.391 . . . . 0.0 110.397 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.06 96.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.552 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 408' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 93.3 t -64.53 -45.61 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -65.92 -35.63 81.14 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.69 92.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.936 0.398 . . . . 0.0 110.242 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.38 -43.38 84.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.496 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 412' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 94.5 mt -61.6 -41.33 97.29 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.264 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.61 -19.53 64.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.744 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -102.83 1.47 34.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.185 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -113.09 172.31 7.02 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.111 0.482 . . . . 0.0 111.589 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -79.3 129.44 34.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.456 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 36.3 t -104.02 109.83 28.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.979 0.418 . . . . 0.0 110.943 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 6.7 t -108.2 128.52 54.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.929 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -116.59 121.17 40.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.252 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -144.82 153.06 41.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.22 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -86.79 163.62 17.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -159.0 -178.22 7.07 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 21.5 p -82.91 157.16 23.16 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.9 0.381 . . . . 0.0 111.263 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -67.8 -27.7 66.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.159 0.504 . . . . 0.0 110.311 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -61.9 -39.77 93.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.834 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.49 -31.23 71.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.104 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.56 -13.45 59.82 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.893 0.377 . . . . 0.0 111.022 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.8 mmt -80.39 -5.07 55.89 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.041 0.448 . . . . 0.0 110.589 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -76.28 69.47 2.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.57 0.7 . . . . 0.0 109.507 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -100.47 18.5 18.89 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.013 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -68.2 -33.38 74.31 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.989 0.423 . . . . 0.0 110.304 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.642 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.502 -179.693 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.24 0.581 0 CA-C-O 120.611 0.243 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.9 p -84.65 87.19 7.27 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.19 136.44 55.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -119.95 153.87 35.31 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.523 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 77.9 m -98.09 123.39 42.1 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.499 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 m -79.34 -56.14 4.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.138 0.494 . . . . 0.0 111.47 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -169.08 100.35 0.37 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.22 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.7 -106.21 1.21 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.863 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 109' ' ' PHE . 7.3 mp -67.36 -38.66 85.13 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 122.4 0.28 . . . . 0.0 111.081 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 106' ' ' SER . . . -57.94 137.02 50.3 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.51 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -140.69 144.3 35.56 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.532 0.206 . . . . 0.0 110.793 -177.081 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -115.88 129.04 56.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.5 t -89.52 -87.81 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.71 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.8 p 43.4 80.46 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 89.4 mt -109.81 132.09 58.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.5 m -97.72 123.78 41.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.8 pt -123.54 164.05 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.67 0.271 . . . . 0.0 111.474 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.487 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.24 152.18 44.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.822 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.61 -44.71 81.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.648 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.96 -36.43 84.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.203 0.525 . . . . 0.0 110.386 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 m -66.23 -34.4 77.93 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.45 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.5 mt -61.37 -48.94 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 111.624 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.513 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 55.4 mm-40 -81.47 -13.59 58.0 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -93.13 -59.83 1.94 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.099 -0.641 . . . . 0.0 111.5 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.41 -50.04 35.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 98.8 t -63.35 -43.89 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.584 0.23 . . . . 0.0 111.478 -175.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 17.1 ttmm -61.71 -45.99 91.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.54 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.8 m -66.88 -40.65 87.87 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.739 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -62.85 -41.08 99.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.731 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.4 mt -62.77 -42.64 99.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.767 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.34 -35.89 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.201 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -64.04 -42.88 96.91 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.03 -29.87 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.907 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.36 -43.19 95.31 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.52 -37.39 86.64 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.679 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -60.48 -35.57 76.23 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.471 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 t -93.02 -5.35 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 121.414 0.626 . . . . 0.0 109.939 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 62.79 28.56 16.52 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.601 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.8 pp -101.83 6.1 10.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.45 0.643 . . . . 0.0 111.158 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -64.6 -29.83 70.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.71 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.6 -1.14 70.15 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.448 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -94.49 6.41 48.89 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.53 -0.394 . . . . 0.0 111.73 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.2 ttt85 -111.61 98.65 7.58 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.222 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -65.57 -43.44 89.79 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.515 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.63 70.74 1.19 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 173.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -65.63 -41.58 92.49 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 171.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.28 107.81 60.59 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.956 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD2' HD12 ' A' ' 53' ' ' ILE . 46.1 Cg_exo -56.55 151.06 48.32 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.083 2.522 . . . . 0.0 113.114 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.524 ' HA ' HG22 ' A' ' 54' ' ' VAL . 14.6 ttt -60.81 -39.39 88.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.018 -173.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -66.59 -20.74 66.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.057 0.456 . . . . 0.0 110.837 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.492 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 97.4 mt -92.22 -37.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.701 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.524 HG22 ' HA ' ' A' ' 51' ' ' MET . 25.3 m -63.98 -36.37 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.491 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.94 -37.36 87.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.864 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.604 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.6 pt20 -80.47 -19.53 45.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.668 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.604 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 63.3 mtt180 -106.9 -27.14 10.89 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -175.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -107.74 5.31 26.56 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.519 0.675 . . . . 0.0 109.854 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 61' ' ' SER . . . -70.66 153.03 51.2 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 176.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.411 ' H ' ' HB2' ' A' ' 63' ' ' ARG . . . 70.32 -24.84 0.16 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.211 0.604 . . . . 0.0 111.928 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 59' ' ' GLY . 36.1 t -78.2 -61.88 1.86 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.887 0.375 . . . . 0.0 110.371 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.4 p -103.77 12.15 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.449 0.642 . . . . 0.0 110.142 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HB2' ' H ' ' A' ' 60' ' ' ALA . 41.3 ttm180 -58.96 -30.14 67.68 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.738 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -57.57 -50.28 73.64 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.063 0.459 . . . . 0.0 110.473 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.39 -23.08 54.06 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.503 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 62' ' ' VAL . 73.1 t -64.47 -43.73 96.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 174.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.06 -39.76 95.69 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.415 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.07 99.69 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.717 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 11.5 t70 -62.0 -45.6 92.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.888 0.375 . . . . 0.0 110.29 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.69 -41.87 99.33 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.458 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.9 tpt -61.57 -42.12 98.39 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -60.98 -43.04 99.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.738 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 96.9 mtt-85 -66.05 -40.61 91.1 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.333 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -63.48 -42.43 98.56 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.405 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -61.64 -51.02 70.21 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.896 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.57 -41.69 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.6 -39.97 88.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.058 0.456 . . . . 0.0 110.302 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -68.69 -42.85 77.19 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 pp -64.97 -32.06 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.895 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.7 -43.92 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.909 0.385 . . . . 0.0 110.886 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 17.8 ptpt -78.38 -26.96 46.73 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.667 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -86.5 -5.14 59.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.892 0.377 . . . . 0.0 110.642 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 66.57 40.28 3.47 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.517 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 84.6 mt -102.23 122.22 54.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -106.73 110.76 63.9 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.48 114.55 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.288 1.992 . . . . 0.0 111.416 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.24 126.19 30.52 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.711 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.19 -116.53 7.23 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.852 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.77 114.46 6.02 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.48 156.82 60.67 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 122.635 2.223 . . . . 0.0 111.378 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.6 m -104.3 119.08 38.17 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.51 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -74.41 -21.42 59.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.234 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t 48.42 80.04 0.32 Allowed Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 123.968 0.907 . . . . 0.0 112.894 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.98 122.03 6.08 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.255 1.97 . . . . 0.0 110.725 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.84 -176.35 51.44 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.295 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.39 121.82 25.63 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.116 0.484 . . . . 0.0 110.258 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -82.6 111.9 19.0 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.488 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 98.6 mttt -91.17 129.97 37.1 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.5 tp -75.69 114.07 13.86 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.03 0.443 . . . . 0.0 110.611 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.02 4.82 59.91 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.326 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.8 mt-10 -127.38 168.32 14.99 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.717 -0.284 . . . . 0.0 110.568 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.68 142.89 54.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.074 0.464 . . . . 0.0 111.832 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -102.46 147.72 26.39 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.468 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.2 m -122.74 132.07 54.07 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -147.01 161.09 41.53 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.544 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 33.1 p -96.6 -84.48 0.36 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 106' ' ' SER . 86.9 t 75.35 112.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -173.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -103.99 122.93 46.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.08 -173.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.438 ' N ' HD23 ' A' ' 11' ' ' LEU 0.253 19.7 p90 -138.29 -95.23 0.19 Allowed 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 174.675 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -157.69 147.16 19.98 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.0 0.818 . . . . 0.0 111.862 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.9 m -141.28 167.81 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.078 0.551 . . . . 0.0 111.824 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -109.61 107.15 59.19 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.433 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -93.06 153.99 2.63 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.992 2.462 . . . . 0.0 112.924 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.74 143.43 17.23 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.5 t -132.23 137.8 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -175.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -84.78 141.47 30.49 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.557 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.01 143.62 50.81 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -138.38 154.33 48.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.616 0.246 . . . . 0.0 111.089 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.84 15.73 79.5 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 114.089 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.96 -40.74 97.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.974 0.416 . . . . 0.0 111.512 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -73.69 -3.68 29.76 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.704 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.59 4.99 43.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.968 0.413 . . . . 0.0 111.131 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.7 mt -87.39 126.59 41.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.53 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -107.45 116.79 32.56 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.16 133.84 47.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.136 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -85.72 144.06 28.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.478 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -132.89 101.27 14.03 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.41 138.09 58.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.251 1.967 . . . . 0.0 111.506 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 421' ' ' GLU . 48.4 mm -116.17 121.14 66.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.9 161.2 41.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.391 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -152.76 166.09 33.31 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.881 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.42 128.98 38.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.097 0.475 . . . . 0.0 111.337 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 65.8 p -109.36 173.83 6.14 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.535 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.82 -35.11 79.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.72 -37.42 81.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.374 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -63.43 -40.57 97.54 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.549 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.32 -46.04 96.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.516 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.37 -44.65 95.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.356 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.68 -41.52 99.81 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.653 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.606 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.4 tpt -61.26 -48.46 81.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.687 0.28 . . . . 0.0 110.543 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.96 -42.27 97.33 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.074 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.49 -47.64 85.25 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.945 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.6 m -62.84 -41.5 99.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.694 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 140' ' ' MET . 87.5 mt -61.34 -40.26 93.6 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -72.57 -17.09 61.74 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.978 0.418 . . . . 0.0 111.135 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.83 -0.45 55.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.901 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -116.28 30.93 7.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.662 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -134.65 79.22 1.79 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.29 121.24 37.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.322 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.626 HG21 ' H ' ' A' ' 247' ' ' GLU . 35.4 m -74.72 159.93 31.41 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.398 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 36.8 t-105 -80.28 124.84 29.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.126 0.488 . . . . 0.0 110.894 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.409 ' HG3' ' OE2' ' A' ' 153' ' ' GLU . 18.5 tptm -143.53 169.13 18.28 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.409 ' OE2' ' HG3' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -82.52 -3.21 55.54 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -175.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 155' ' ' ASP . 21.8 pttp -163.78 -172.9 3.03 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.719 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 0.6 OUTLIER 91.46 122.19 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.332 1.453 . . . . 0.0 112.683 177.496 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -68.15 93.99 0.3 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 114.71 -1.132 . . . . 0.0 114.766 -174.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -151.01 127.44 10.7 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.83 122.2 60.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -103.86 157.76 16.87 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.5 26.36 0.17 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.928 0.491 . . . . 0.0 112.22 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -139.68 -4.87 1.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.213 0.53 . . . . 0.0 109.91 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -83.58 158.17 22.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.352 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -102.72 98.46 8.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.795 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.5 t -97.86 123.01 50.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.73 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.1 m -79.49 107.49 12.31 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.1 mt -121.42 123.27 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 121.095 0.474 . . . . 0.0 111.929 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.495 ' HB2' ' HD3' ' A' ' 238' ' ' LYS . 23.5 m-20 -96.28 108.43 20.92 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -126.23 147.87 49.58 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.616 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.6 m -119.74 129.19 54.38 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.114 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.11 122.37 5.73 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.299 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.3 p -136.59 124.49 22.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.04 -85.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.787 0.327 . . . . 0.0 110.787 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -103.06 2.98 35.54 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.503 0.668 . . . . 0.0 110.006 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.26 -3.93 2.51 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.376 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -113.47 143.3 44.73 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.21 157.1 33.0 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.721 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -129.39 -177.77 4.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.246 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.19 -41.61 88.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.168 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.1 -178.59 38.85 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.312 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.05 24.99 50.73 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.449 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.0 98.89 8.52 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -130.34 143.79 50.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.095 0.474 . . . . 0.0 111.8 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.4 m -148.73 122.54 9.31 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.996 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 60.51 31.42 20.28 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.334 0.588 . . . . 0.0 109.968 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -86.18 137.68 32.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.909 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.0 m -105.01 125.33 60.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.604 0.716 . . . . 0.0 111.175 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.49 ' CD1' HH12 ' B' ' 57' ' ' ARG . 49.5 tp -114.42 118.19 33.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.212 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -93.86 110.86 22.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 63.0 mtp -83.25 152.9 24.97 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.839 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.9 -20.97 45.58 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.051 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -89.08 -10.91 45.63 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.92 50.95 4.97 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.15 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 188' ' ' ALA . 35.2 mmm-85 -90.49 -11.44 40.24 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.911 -0.644 . . . . 0.0 110.106 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.35 -176.74 4.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.716 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.2 mm -63.58 133.71 95.62 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.904 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.41 120.89 5.55 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.066 2.511 . . . . 0.0 112.679 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.52 -36.19 4.57 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.488 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -62.5 -48.02 81.38 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -78.85 -9.24 59.41 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.8 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -91.49 -29.26 17.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.253 0.549 . . . . 0.0 109.648 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.9 -22.63 75.78 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.881 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.21 -42.49 96.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.97 0.414 . . . . 0.0 110.171 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -53.76 131.17 38.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.118 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.67 -7.99 39.58 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.689 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -96.94 160.09 14.55 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.03 156.43 16.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.652 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.5 129.73 41.44 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.913 0.387 . . . . 0.0 110.713 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 73.63 50.99 10.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.711 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -136.02 140.96 44.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.674 0.273 . . . . 0.0 110.705 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -115.93 135.41 54.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -153.25 -13.61 0.15 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.409 -0.516 . . . . 0.0 112.276 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 30.3 p 61.71 166.87 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.97 0.908 . . . . 0.0 112.064 -175.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.6 tp -156.15 114.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.083 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.09 106.53 7.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.986 0.422 . . . . 0.0 110.873 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 78.4 t -108.95 118.91 57.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.536 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 4.8 m -69.48 -35.06 75.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 216' ' ' THR . 70.5 m-85 75.69 150.99 0.13 Allowed Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 123.133 0.573 . . . . 0.0 109.498 -172.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.18 153.67 32.03 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.641 1.56 . . . . 0.0 111.474 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.561 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 64.3 mm-40 -64.02 -33.72 76.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 109.842 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -87.92 28.17 1.07 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.332 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 10.1 t80 -73.42 132.85 43.44 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -64.89 -17.42 64.3 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.503 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -94.76 110.51 22.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 36.0 tt0 -61.56 -38.59 88.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.859 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.434 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 28.2 p30 -71.98 -9.51 58.48 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.434 ' HG ' ' OD1' ' A' ' 225' ' ' ASN . 95.5 mt -122.57 0.85 9.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.561 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.8 ptmt -70.93 110.81 5.88 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.521 0.677 . . . . 0.0 112.733 -175.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.77 12.64 83.98 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.498 -0.774 . . . . 0.0 114.097 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -118.26 127.93 54.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.357 0.578 . . . . 0.0 110.732 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -71.32 136.24 47.76 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.7 139.37 47.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.324 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -70.51 -43.37 69.8 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 212' ' ' THR . 79.5 m-85 58.39 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.078 0.551 . . . . 0.0 112.133 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.67 -50.81 72.02 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.9 mm 62.69 81.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.133 0.492 . . . . 0.0 111.235 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -66.06 -40.89 91.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.229 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.472 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 10.5 tp 50.6 82.96 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.722 0.809 . . . . 0.0 110.612 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.495 ' HD3' ' HB2' ' A' ' 167' ' ' ASP . 52.5 mtpt -93.51 -51.0 5.16 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -173.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -100.27 -92.04 0.29 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.0 t 75.43 129.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.165 0.586 . . . . 0.0 111.086 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -69.01 -35.67 76.92 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.501 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 155' ' ' ASP . 13.1 pt-20 57.86 117.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 125.34 1.456 . . . . 0.0 114.175 177.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -143.5 124.12 14.08 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.154 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 245' ' ' LEU . 0.3 OUTLIER -148.36 -175.6 4.98 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.46 ' H ' ' CD ' ' A' ' 244' ' ' GLU . 66.1 mt 73.21 105.47 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 111.099 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.597 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 64.1 Cg_endo -78.87 111.77 3.01 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.408 2.072 . . . . 0.0 113.76 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.626 ' H ' HG21 ' A' ' 150' ' ' THR . 12.6 pt-20 -135.77 17.82 3.29 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.135 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 52.7 tp 77.13 132.74 0.05 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 176.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 251' ' ' GLU . 23.0 m -142.16 137.96 31.23 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.228 176.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -77.74 -9.12 58.84 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLU . . . . . 0.428 ' H ' HG22 ' A' ' 249' ' ' THR . 39.6 mt-10 -85.26 -25.12 27.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -176.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -65.24 -22.24 66.85 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 119.779 -0.769 . . . . 0.0 113.034 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 34.8 pt -74.05 -9.57 13.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -137.67 25.67 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.919 0.39 . . . . 0.0 111.731 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -115.54 15.67 16.63 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.208 0.528 . . . . 0.0 111.63 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -94.49 14.96 19.11 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.31 -31.34 8.77 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.123 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.8 144.38 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -53.46 -47.91 69.32 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.264 0.353 . . . . 0.0 111.93 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -173.64 157.33 3.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.1 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -160.37 172.41 36.78 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.617 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 80.5 p -96.53 -134.99 0.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.711 0.255 . . . . 0.0 110.83 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 52.8 t -103.33 -68.8 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.12 0.486 . . . . 0.0 109.95 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.2 OUTLIER -70.34 -37.29 74.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.864 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.22 -37.52 94.64 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.763 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.62 -43.8 97.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.868 0.365 . . . . 0.0 110.091 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -62.73 -40.77 98.24 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.688 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.65 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.47 -47.16 85.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.146 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 272' ' ' LYS . 41.6 tp10 -65.85 -40.91 92.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.926 0.394 . . . . 0.0 111.182 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 80.2 t -64.66 -42.92 96.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.374 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -59.34 -48.82 80.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.835 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 10.0 ptmt -62.96 -44.03 97.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.756 0.312 . . . . 0.0 111.206 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -64.97 -39.25 93.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.372 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 90.5 mmm -63.8 -41.7 97.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 110.672 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.85 -35.72 80.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.417 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.5 -41.26 96.53 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.321 0.581 . . . . 0.0 109.603 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -66.59 -36.86 83.65 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.703 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 45.5 tp -62.39 -38.89 91.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.048 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -57.17 -44.14 83.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.198 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.6 m -61.7 -42.8 99.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.649 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.56 97.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.261 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.04 -44.09 97.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.175 0.512 . . . . 0.0 110.013 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -61.57 -44.47 96.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.657 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -64.04 -42.15 97.17 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.899 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ARG . . . . . 0.508 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.4 tpm_? -61.34 -43.57 98.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.526 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 85.4 t -70.32 -44.39 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.272 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.8 -48.81 80.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.557 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 65.2 p -65.37 -42.89 92.28 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -65.81 -41.1 92.29 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.7 0.286 . . . . 0.0 111.712 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.89 80.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 295' ' ' VAL . 36.9 mm -66.05 -43.57 92.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.511 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -57.87 -44.47 86.63 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.217 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.43 -41.89 99.74 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.807 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.4 -43.31 97.92 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 291' ' ' ILE . 97.0 t -62.66 -45.74 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.35 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.37 -42.3 99.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.969 0.414 . . . . 0.0 110.987 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.74 -38.64 80.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.782 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -124.83 90.88 3.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -93.43 94.39 8.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 301' ' ' ASP . 10.9 tp -103.26 163.75 3.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.742 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.448 ' N ' HG13 ' A' ' 300' ' ' ILE . 3.8 m-20 -65.37 140.06 58.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.15 123.38 37.76 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.539 ' O ' HG13 ' A' ' 307' ' ' ILE . 46.6 Cg_exo -55.93 129.77 36.74 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.499 2.132 . . . . 0.0 111.977 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.38 -35.55 79.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.093 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.22 84.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.993 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.22 -34.5 56.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.954 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 303' ' ' PRO . 75.6 mt -61.87 -50.97 77.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.919 0.39 . . . . 0.0 111.612 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.31 -40.44 95.93 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 65.5 p -64.52 -45.94 85.08 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.519 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 43.3 mm-40 -72.01 -35.09 69.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.962 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 83.7 mt -62.08 -44.12 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.715 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.591 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 32.0 t70 -63.39 -40.85 98.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.844 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.9 t -64.05 -43.72 97.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.174 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 87.6 mt -62.53 -40.15 95.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.909 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.509 HH12 HD12 ' A' ' 330' ' ' LEU . 80.3 mtm180 -63.12 -38.91 93.06 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.266 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 90.5 mtt180 -63.73 -41.09 98.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.701 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -62.86 -44.04 97.18 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.641 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.34 -39.54 81.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.033 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.82 88.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.241 0.543 . . . . 0.0 110.435 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -62.11 -38.44 88.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.986 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.96 -37.79 79.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.07 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -74.39 39.1 0.12 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.138 0.975 . . . . 0.0 112.302 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' GLY . . . . . 0.407 ' HA2' ' HB ' ' B' ' 54' ' ' VAL . . . 99.75 -2.87 57.24 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.155 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 92.94 33.58 7.28 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.159 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -71.47 132.0 44.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.721 0.296 . . . . 0.0 110.216 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.09 160.88 36.42 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.0 OUTLIER 68.77 -52.08 0.57 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.318 0.647 . . . . 0.0 112.102 -178.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.96 -3.58 29.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.12 -23.93 65.88 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.483 0.658 . . . . 0.0 109.714 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.509 HD12 HH12 ' A' ' 315' ' ' ARG . 42.2 tp -63.36 -35.15 79.44 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.266 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.94 -33.48 74.76 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.66 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 82.7 mt -47.56 133.99 10.39 Favored Pre-proline 0 N--CA 1.474 0.753 0 O-C-N 123.613 0.57 . . . . 0.0 112.458 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.441 ' HB2' HD13 ' A' ' 336' ' ' LEU . 50.7 Cg_exo -54.24 129.62 35.48 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.962 2.441 . . . . 0.0 112.786 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -66.2 -43.42 86.85 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.303 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -63.46 -33.8 76.36 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.441 HD13 ' HB2' ' A' ' 333' ' ' PRO . 10.8 mp -63.55 -37.18 86.35 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.643 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.54 -13.06 19.61 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.58 -30.09 67.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.675 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -62.0 -51.26 68.77 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.716 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -71.19 -27.1 63.28 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.809 0.338 . . . . 0.0 110.431 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.436 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.88 -43.06 99.61 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.781 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.415 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -59.66 -45.69 91.28 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 347' ' ' VAL . 8.3 mmt180 -61.43 -47.3 86.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.263 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.12 -37.73 84.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 341' ' ' ALA . 72.1 t -63.31 -44.44 99.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.255 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.48 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 70.3 t -62.0 -44.64 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.496 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 343' ' ' ARG . 70.4 t -60.53 -44.81 97.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.838 0.351 . . . . 0.0 110.137 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.79 -42.14 99.39 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.134 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.41 -43.9 96.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.734 0.302 . . . . 0.0 110.859 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.0 mt -62.81 -47.91 81.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.953 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.404 ' O ' HG13 ' A' ' 355' ' ' ILE . 94.3 mt -66.95 -40.43 87.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.159 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.96 -45.05 96.55 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.833 -0.622 . . . . 0.0 113.796 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -68.89 -35.12 76.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.293 0.547 . . . . 0.0 110.713 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 350' ' ' LEU . 78.5 t -60.47 -45.13 97.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 351' ' ' LEU . 80.4 mt -62.97 -46.5 96.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.916 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -67.45 -47.69 69.4 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 98.0 m -64.49 -44.83 89.75 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -87.6 -0.9 57.51 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.501 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 63.15 39.85 9.46 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.91 0.386 . . . . 0.0 111.626 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.7 mt -77.25 145.15 37.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.226 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.57 149.99 39.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.272 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.76 116.5 5.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 367' ' ' VAL . 27.3 t70 -86.24 116.07 24.19 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.532 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 25.7 mm-40 -59.52 -39.42 83.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.965 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -65.22 -42.52 93.34 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.018 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -63.74 -38.98 93.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.063 0.459 . . . . 0.0 109.954 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 363' ' ' ASP . 89.3 t -64.04 -38.95 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.485 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 26.8 mmmt -55.58 -45.3 77.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.428 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -64.21 -37.22 94.23 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.43 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.63 -42.11 98.18 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.337 0.589 . . . . 0.0 110.253 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.21 -43.21 97.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.792 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -60.59 -39.74 89.18 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.54 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.91 -40.14 87.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.777 0.322 . . . . 0.0 110.772 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.3 ttm -64.24 -41.73 96.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.0 0.428 . . . . 0.0 110.169 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.39 -27.22 69.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.572 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.7 m -75.27 -4.86 41.53 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.383 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -93.05 -0.54 57.1 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.204 0.526 . . . . 0.0 110.483 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -117.3 168.27 10.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.07 -50.22 72.82 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -117.95 117.62 35.28 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.837 0.351 . . . . 0.0 110.307 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.64 -28.91 25.25 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.345 2.03 . . . . 0.0 113.08 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -65.92 -43.89 86.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.22 -37.7 88.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.587 0.232 . . . . 0.0 110.911 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.86 -42.93 96.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.585 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.68 -44.53 99.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.254 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -67.25 -40.68 86.27 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 120.857 0.36 . . . . 0.0 110.197 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -58.43 -47.98 82.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.49 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 3.4 t80 -70.46 -40.25 73.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.12 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 59.4 p -77.7 -8.38 57.85 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -101.03 6.7 43.54 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.239 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -125.67 114.12 18.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.073 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -62.95 -41.45 99.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.373 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.11 -48.11 83.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 110.775 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.73 -40.63 97.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.626 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 94.1 mtp -61.96 -46.34 89.72 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.02 0.438 . . . . 0.0 110.997 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.87 -44.17 86.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.331 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -63.81 -40.92 97.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.573 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.49 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 53.1 tpp -62.95 -45.08 94.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.123 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.441 ' HG2' HG21 ' A' ' 367' ' ' VAL . 47.4 mtm180 -65.05 -29.22 70.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.567 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -62.24 -44.41 96.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.17 -44.26 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.817 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.37 94.75 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.986 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.68 -38.06 89.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.695 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.08 -44.81 91.92 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.905 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.51 -38.21 89.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.808 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -59.43 -41.66 90.08 Favored 'General case' 0 CA--C 1.526 0.032 0 CA-C-O 120.736 0.303 . . . . 0.0 110.62 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.07 79.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.39 -46.15 93.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.482 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -68.56 -30.55 69.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.498 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.33 -38.13 89.95 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.019 0.438 . . . . 0.0 109.93 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 91.5 t -64.69 -42.53 95.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.919 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.41 -40.13 93.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.82 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.65 67.48 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.495 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -99.38 -3.6 33.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.023 0.439 . . . . 0.0 110.962 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -107.85 178.87 4.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.45 107.86 19.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.559 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 97.0 t -99.9 118.66 46.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.902 -0.406 . . . . 0.0 109.902 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.5 t -120.81 158.35 27.76 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -104.82 132.78 50.64 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.077 0.465 . . . . 0.0 111.728 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -147.57 120.97 9.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.861 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 91.1 mt-10 -84.81 151.93 24.0 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.183 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.7 t -157.01 175.31 14.27 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.815 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 62.8 p -85.66 163.76 18.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.931 0.396 . . . . 0.0 111.392 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -64.56 -26.71 68.53 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.055 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -62.22 -39.7 93.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.781 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.6 -33.43 75.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.724 0.297 . . . . 0.0 111.468 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.57 -14.18 57.13 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.645 0.26 . . . . 0.0 111.262 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 2.9 mmt -76.84 -9.91 59.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.188 0.518 . . . . 0.0 110.331 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -80.68 85.65 6.03 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.387 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -105.84 29.27 6.79 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.214 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -66.52 -24.04 66.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.22 0.534 . . . . 0.0 109.912 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.377 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.451 178.389 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -78.03 134.13 37.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.185 0.517 . . . . 0.0 111.582 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 24.1 m -118.57 145.7 24.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.356 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.4 p -91.08 84.28 5.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 m -132.85 135.28 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -119.74 154.79 33.63 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.798 0.332 . . . . 0.0 111.557 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.512 ' HA ' ' HD3' ' B' ' 13' ' ' ARG . 90.3 m -99.47 118.08 35.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.522 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 14.9 m -72.66 -51.41 19.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.387 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -174.92 100.71 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.275 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.86 -107.43 1.54 Allowed Glycine 0 C--O 1.223 -0.567 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.136 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.449 HD23 ' N ' ' B' ' 109' ' ' PHE . 7.2 mp -66.77 -39.08 87.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.713 0.292 . . . . 0.0 110.919 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' B' ' 106' ' ' SER . . . -59.2 135.08 51.94 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.282 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.512 ' HD3' ' HA ' ' B' ' 7' ' ' THR . 0.0 OUTLIER -140.3 144.17 36.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.474 0.178 . . . . 0.0 110.749 -177.014 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -114.78 130.04 56.79 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.82 -89.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.729 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p 43.0 82.74 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 88.6 mt -112.88 131.38 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 60.5 m -95.47 126.85 41.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.966 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 41.6 pt -125.51 165.85 22.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.421 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.453 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.79 151.75 45.93 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.299 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.416 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -57.27 -43.1 82.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.63 -176.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.75 -38.05 89.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.479 . . . . 0.0 110.194 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 23.0 m -63.3 -36.27 83.11 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.219 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.5 ' O ' ' HB ' ' B' ' 28' ' ' VAL . 75.7 mt -61.47 -50.8 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.282 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.536 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 50.2 mm-40 -75.59 -22.37 56.99 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -86.06 -68.57 0.73 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.693 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.62 -48.64 71.56 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 99.0 t -62.89 -45.33 99.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.523 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.536 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 16.4 ttmm -61.89 -44.85 95.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.503 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.6 m -65.34 -41.68 93.67 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.814 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -64.66 -38.27 90.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.701 0.286 . . . . 0.0 110.788 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 91.0 mt -62.31 -42.48 99.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.569 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -71.5 -35.26 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.991 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -64.32 -42.68 96.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.638 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -68.53 -32.45 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.129 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.66 98.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.66 -38.32 88.98 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.955 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -59.61 -37.18 77.9 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 18.0 t -87.79 -13.87 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 120.959 0.409 . . . . 0.0 110.038 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 70.83 28.63 3.3 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.756 0.823 . . . . 0.0 111.276 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.43 7.45 9.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.131 0.491 . . . . 0.0 111.598 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.3 -24.74 66.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.826 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.05 -1.83 88.12 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.955 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -94.44 7.38 45.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.712 0.291 . . . . 0.0 111.607 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 34.6 ttt85 -114.88 100.71 8.41 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.455 -0.498 . . . . 0.0 112.178 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -67.15 -46.72 73.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.675 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.86 65.92 1.62 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 116.561 1.384 . . . . 0.0 116.561 172.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -63.5 -42.68 98.49 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 t -107.34 106.06 57.42 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 114.725 -1.125 . . . . 0.0 107.997 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.442 ' HB2' ' OD1' ' B' ' 52' ' ' ASN . 28.0 Cg_exo -60.86 155.51 49.05 Favored 'Trans proline' 0 N--CA 1.476 0.476 0 C-N-CA 123.28 2.653 . . . . 0.0 112.969 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.656 ' HA ' HG22 ' B' ' 54' ' ' VAL . 92.3 mtp -61.18 -39.16 89.09 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ASN . . . . . 0.442 ' OD1' ' HB2' ' B' ' 50' ' ' PRO . 33.4 p-10 -65.7 -17.65 64.76 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.998 0.428 . . . . 0.0 110.859 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.433 HD12 ' HD2' ' B' ' 50' ' ' PRO . 89.0 mt -99.48 -36.29 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.004 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.656 HG22 ' HA ' ' B' ' 51' ' ' MET . 23.2 m -64.98 -37.46 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.633 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.07 83.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.227 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLN . . . . . 0.457 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 7.1 pt20 -82.04 -18.67 42.42 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.49 HH12 ' CD1' ' A' ' 187' ' ' LEU . 62.9 mtt-85 -107.37 -27.51 10.43 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.7 6.63 23.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.517 0.675 . . . . 0.0 110.164 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' B' ' 61' ' ' SER . . . -70.25 157.46 53.52 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 175.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.402 ' H ' ' HB2' ' B' ' 63' ' ' ARG . . . 70.71 -40.72 0.48 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.082 0.553 . . . . 0.0 111.499 -177.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 59' ' ' GLY . 42.9 t -64.99 -63.2 1.17 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.925 0.49 . . . . 0.0 111.296 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.469 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.5 p -101.41 10.44 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.469 0.652 . . . . 0.0 110.206 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.402 ' HB2' ' H ' ' B' ' 60' ' ' ALA . 41.8 ttm180 -59.6 -26.07 65.15 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.693 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -62.63 -49.1 76.53 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.926 0.393 . . . . 0.0 110.382 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -77.32 -21.74 53.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.813 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.469 HG23 ' O ' ' B' ' 62' ' ' VAL . 77.0 t -63.94 -43.74 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.0 -39.4 94.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.216 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.7 -42.26 99.72 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.776 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ASP . . . . . 0.434 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 11.5 t70 -62.31 -45.36 93.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.998 0.428 . . . . 0.0 110.378 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.42 -41.7 98.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.367 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 15.5 tpt -61.69 -42.33 98.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 51.2 m -60.98 -43.61 98.56 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.836 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 96.4 mtt-85 -65.68 -42.0 91.77 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.497 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -63.65 -41.3 98.24 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.646 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -61.67 -50.95 70.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.962 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 tt -69.93 -41.8 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.441 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 7.8 t70 -64.57 -40.52 95.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.171 0.51 . . . . 0.0 110.098 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.38 -43.1 78.08 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.66 -33.64 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.012 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.57 -44.07 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.893 0.377 . . . . 0.0 110.899 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 17.4 ptpt -77.59 -28.3 51.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.548 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -83.38 -4.56 58.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.635 0.255 . . . . 0.0 110.84 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 66.5 36.93 4.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.366 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.1 mt -99.65 120.95 49.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.832 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -107.55 112.03 62.55 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.71 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -75.14 127.24 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.059 1.84 . . . . 0.0 111.523 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.22 100.22 9.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.069 0.461 . . . . 0.0 111.016 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.98 -109.84 3.25 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.148 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.69 113.75 8.57 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.684 0.278 . . . . 0.0 111.093 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.39 160.23 45.11 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.72 2.28 . . . . 0.0 111.066 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.4 m -107.04 118.74 37.51 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.814 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -73.38 -25.07 60.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.556 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 26.0 t 49.54 79.17 0.36 Allowed Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 123.788 0.835 . . . . 0.0 112.879 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.51 126.59 8.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.301 2.0 . . . . 0.0 110.627 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.62 -172.2 48.53 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.593 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.7 121.08 26.8 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.949 0.404 . . . . 0.0 109.998 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -82.2 118.18 22.89 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.148 0.499 . . . . 0.0 110.805 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -98.7 123.69 43.07 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 tp -68.35 105.82 2.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.577 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.42 3.31 44.1 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.588 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -126.87 172.31 10.52 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.83 0.347 . . . . 0.0 111.222 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.52 141.99 57.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.733 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -105.28 144.74 31.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.948 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 34.8 m -119.98 131.2 55.09 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.011 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.94 162.1 38.56 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.564 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 46.2 p -97.9 -83.78 0.4 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -174.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' B' ' 106' ' ' SER . 94.3 t 75.02 113.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -173.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -104.94 121.94 44.79 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -172.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' PHE . . . . . 0.449 ' N ' HD23 ' B' ' 11' ' ' LEU 0.255 26.3 p90 -138.71 -92.88 0.19 Allowed 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 175.207 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -159.43 149.15 18.61 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.018 0.826 . . . . 0.0 112.194 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.78 168.59 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.47 0.708 . . . . 0.0 111.619 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -111.28 104.42 56.13 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.425 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -91.44 154.27 3.63 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.924 2.416 . . . . 0.0 113.139 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -158.06 139.81 13.86 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 62.2 t -127.69 136.17 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.164 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -84.84 142.23 29.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.6 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.11 146.52 47.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.746 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -139.2 154.01 47.97 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.663 0.268 . . . . 0.0 111.388 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.3 20.61 76.88 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.068 -0.515 . . . . 0.0 113.857 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.73 -40.86 92.58 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.953 0.406 . . . . 0.0 111.811 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.2 -5.12 39.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.279 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.09 12.96 36.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.814 0.34 . . . . 0.0 111.057 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.49 124.02 46.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.125 0.488 . . . . 0.0 110.346 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.84 121.9 44.64 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.336 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.1 134.43 53.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.807 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -84.65 143.71 29.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.464 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -133.41 97.44 16.12 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.94 138.08 55.82 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.409 2.072 . . . . 0.0 111.427 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' B' ' 421' ' ' GLU . 48.8 mm -117.64 124.46 73.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.78 162.11 39.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.607 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -148.29 -178.77 6.49 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 80.8 t -100.02 127.6 52.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 120.875 0.369 . . . . 0.0 110.776 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 59.2 p -104.83 171.6 7.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.771 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -64.0 -34.12 77.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.608 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.6 86.05 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.498 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -62.85 -39.66 95.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.878 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.41 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.5 t -63.11 -45.57 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.179 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.76 -44.89 96.0 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.138 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.5 -40.94 99.74 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.397 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.612 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.1 tpt -61.77 -48.63 79.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.688 0.28 . . . . 0.0 110.5 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 91.9 mt -63.64 -42.1 98.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.224 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.46 -49.13 78.96 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.406 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.5 m -62.79 -41.61 99.35 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.763 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' B' ' 140' ' ' MET . 89.3 mt -60.63 -35.53 76.39 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -78.3 -15.11 59.07 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.54 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.3 -6.27 41.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.313 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -107.95 30.24 6.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.865 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -134.95 94.83 3.21 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -112.0 120.11 40.75 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.705 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' THR . . . . . 0.642 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 52.7 m -71.73 158.89 35.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.826 0.346 . . . . 0.0 111.318 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -78.89 122.56 26.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 152' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' B' ' 152' ' ' LYS . 17.1 tptm -143.53 170.07 16.5 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 153' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' B' ' 153' ' ' GLU . 0.6 OUTLIER -86.29 0.29 54.19 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -165.23 -175.78 3.79 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.983 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 155' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' B' ' 242' ' ' GLU . 0.9 OUTLIER 93.2 127.76 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.829 1.651 . . . . 0.0 111.822 176.107 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -71.45 90.02 0.45 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 115.324 0.89 . . . . 0.0 115.324 -172.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.77 135.36 18.41 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.72 128.31 70.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -108.35 158.6 17.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.921 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.49 24.44 0.2 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.033 0.533 . . . . 0.0 112.235 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -138.11 -3.73 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.155 0.503 . . . . 0.0 109.886 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -85.3 159.54 20.02 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.49 0.662 . . . . 0.0 112.626 -172.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 163' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' B' ' 163' ' ' ARG . 12.0 ptp180 -104.6 103.11 12.72 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.663 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.54 120.17 51.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.699 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 26.6 m -77.78 105.11 8.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.75 123.59 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.547 -174.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' ASP . . . . . 0.479 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 18.1 m-20 -95.15 107.05 19.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -125.03 147.7 48.83 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.605 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 29.8 m -120.13 130.3 54.55 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.759 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.63 119.52 4.89 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.45 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 25.4 p -134.94 126.52 28.8 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 t -75.36 -90.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.499 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -98.91 -4.61 32.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.378 0.609 . . . . 0.0 109.739 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.41 -18.1 0.44 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.732 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.95 146.07 27.11 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.925 0.393 . . . . 0.0 110.205 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -81.6 156.01 25.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.987 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -125.96 -175.72 3.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.521 0.2 . . . . 0.0 111.537 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.3 -38.79 84.75 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.74 -176.89 32.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.481 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.08 26.53 36.73 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.623 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -108.01 98.25 7.84 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.27 140.04 51.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.035 0.445 . . . . 0.0 111.894 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.479 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 48.8 m -148.48 125.12 11.09 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 61.16 30.66 19.46 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.596 0.56 . . . . 0.0 110.276 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -88.82 128.82 35.66 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.027 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 16.9 m -99.34 122.69 51.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.462 0.648 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 187' ' ' LEU . . . . . 0.519 HD12 HH12 ' A' ' 57' ' ' ARG . 35.2 tp -111.62 120.2 41.27 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.941 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.74 112.2 24.07 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 189' ' ' MET . . . . . 0.615 ' HE3' ' O ' ' B' ' 199' ' ' GLU . 84.8 mtp -83.42 152.32 25.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.008 -175.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.49 -14.2 62.25 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.055 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 191' ' ' GLN . . . . . 0.418 ' HB2' ' HG2' ' B' ' 193' ' ' ARG . 97.8 mt-30 -95.19 -11.76 27.51 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -176.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.24 48.14 6.14 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.25 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.418 ' HG2' ' HB2' ' B' ' 191' ' ' GLN . 34.8 mmm-85 -88.23 -12.39 43.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.864 -0.668 . . . . 0.0 109.796 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.18 -179.58 5.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.908 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 49.6 mm -61.05 134.04 92.8 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.85 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.81 128.4 21.43 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.837 2.358 . . . . 0.0 112.352 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.48 -39.39 2.76 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.24 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -62.54 -47.64 82.98 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 199' ' ' GLU . . . . . 0.615 ' O ' ' HE3' ' B' ' 189' ' ' MET . 12.1 pt-20 -79.11 -10.05 59.72 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.09 -177.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.5 -28.3 16.88 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.952 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.77 -21.86 71.47 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.659 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.92 -41.91 94.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -54.92 134.1 48.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.665 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 100.35 3.67 55.36 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.658 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -108.4 151.93 25.36 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 120.967 0.413 . . . . 0.0 110.901 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -92.81 155.61 17.53 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.053 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.12 134.99 56.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.79 50.3 25.1 Favored Glycine 0 C--O 1.236 0.222 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.944 -178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 209' ' ' GLU . . . . . 0.402 ' H ' HD23 ' B' ' 237' ' ' LEU . 44.3 tt0 -135.65 133.54 38.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.086 0.469 . . . . 0.0 111.264 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -108.54 127.02 53.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -144.82 -12.8 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 44.1 p 60.27 166.72 0.08 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.79 0.836 . . . . 0.0 111.926 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -155.59 119.71 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.256 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.06 106.76 11.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.83 0.347 . . . . 0.0 110.829 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 215' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 97.7 t -109.23 115.57 49.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.108 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 216' ' ' THR . . . . . 0.526 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 8.2 m -64.09 -41.03 97.45 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.526 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.8 m-85 77.88 141.74 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 123.113 0.565 . . . . 0.0 109.809 -172.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.63 152.23 53.33 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.818 1.679 . . . . 0.0 111.878 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 219' ' ' GLU . . . . . 0.555 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 39.9 mm-40 -62.67 -33.52 75.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.999 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -86.77 24.78 1.39 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.113 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' TYR . . . . . 0.509 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 9.0 t80 -73.82 135.22 43.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.496 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -67.69 -14.69 63.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.509 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -98.65 108.71 21.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 36.5 tt0 -60.86 -36.79 80.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.428 ' OD1' ' HG ' ' B' ' 226' ' ' LEU . 25.7 p30 -72.65 -11.9 60.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.428 ' HG ' ' OD1' ' B' ' 225' ' ' ASN . 94.6 mt -120.55 -0.01 10.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.555 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.9 ptmt -70.73 108.36 4.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.573 0.701 . . . . 0.0 112.76 -175.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.33 17.1 78.55 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.799 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -121.19 123.51 42.44 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -68.02 136.16 53.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -110.96 137.04 49.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.182 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -70.08 -41.23 74.37 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -175.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' B' ' 212' ' ' THR . 74.4 m-85 57.62 100.94 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.915 0.486 . . . . 0.0 112.122 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.411 ' HA ' HG22 ' B' ' 212' ' ' THR . . . -58.55 -49.77 76.21 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 61.81 77.97 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.092 0.472 . . . . 0.0 111.051 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -65.85 -39.94 91.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.886 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 237' ' ' LEU . . . . . 0.402 HD23 ' H ' ' B' ' 209' ' ' GLU . 12.5 tp 51.71 83.56 0.05 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.921 0.888 . . . . 0.0 111.142 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 238' ' ' LYS . . . . . 0.472 ' HD3' ' HB2' ' B' ' 167' ' ' ASP . 51.9 mtpt -89.98 -64.68 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -174.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -88.52 -89.75 0.14 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 42.9 t 73.42 129.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.888 0.475 . . . . 0.0 111.07 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -69.13 -35.39 76.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.962 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' B' ' 155' ' ' ASP . 12.9 pt-20 57.49 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.432 1.493 . . . . 0.0 114.061 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -139.41 125.73 20.21 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.197 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' B' ' 245' ' ' LEU . 0.9 OUTLIER -150.68 -173.85 4.6 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.549 ' H ' ' CD ' ' B' ' 244' ' ' GLU . 46.3 mt 73.6 102.37 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 123.216 0.606 . . . . 0.0 111.042 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 246' ' ' PRO . . . . . 0.642 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 72.2 Cg_endo -78.97 109.89 2.66 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.569 2.179 . . . . 0.0 113.857 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 247' ' ' GLU . . . . . 0.581 ' H ' HG21 ' B' ' 150' ' ' THR . 12.5 pt-20 -138.11 23.34 2.8 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.632 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 51.6 tp 77.0 139.08 0.07 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 249' ' ' THR . . . . . 0.504 HG22 ' H ' ' B' ' 251' ' ' GLU . 27.7 m -149.78 141.51 23.62 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.145 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -80.05 -9.99 59.74 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.504 ' H ' HG22 ' B' ' 249' ' ' THR . 41.4 mt-10 -84.66 -25.19 28.65 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -63.62 -28.21 69.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 41.2 pt -70.44 -9.41 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.815 0.34 . . . . 0.0 111.89 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -136.7 30.11 2.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.846 0.355 . . . . 0.0 111.55 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -118.24 12.16 13.38 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-O 121.095 0.474 . . . . 0.0 111.49 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -96.3 27.6 3.66 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.19 -40.28 2.99 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.42 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 28.0 t -68.94 137.65 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -43.63 -59.65 2.1 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.912 0.758 . . . . 0.0 111.986 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -166.81 157.84 12.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.789 0.328 . . . . 0.0 111.087 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -156.54 -171.02 22.29 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.872 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 56.8 p -111.49 -141.3 0.38 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 59.8 t -98.16 -71.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 110.025 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.2 OUTLIER -68.51 -37.07 79.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.243 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.97 93.7 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.191 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 270' ' ' VAL . 53.1 tp -63.08 -43.42 98.59 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -61.59 -42.11 98.39 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.459 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -62.27 -46.01 90.69 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.204 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 269' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 38.4 tp10 -66.55 -40.07 88.87 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.853 0.358 . . . . 0.0 111.176 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 266' ' ' LEU . 90.9 t -65.25 -43.26 95.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.413 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -60.48 -46.98 88.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 14.1 ptmt -63.19 -44.36 95.58 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.898 0.38 . . . . 0.0 111.0 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -65.21 -38.29 89.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.406 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.8 mmm -63.82 -42.4 97.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.672 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -69.02 -33.32 73.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.059 0.457 . . . . 0.0 110.585 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -63.27 -42.49 99.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.683 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -67.37 -36.39 81.27 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.002 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 278' ' ' LEU . . . . . 0.459 ' O ' HG13 ' B' ' 282' ' ' ILE . 44.8 tp -62.3 -38.56 89.88 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.789 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -56.3 -45.66 80.15 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.263 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 19.4 m -61.63 -42.28 98.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.837 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.56 -42.93 99.85 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.138 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 282' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 278' ' ' LEU . 66.5 mt -64.36 -44.36 97.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.301 178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -60.21 -44.1 95.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.452 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -63.64 -42.79 98.11 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.166 0.291 . . . . 0.0 111.404 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -60.54 -44.74 95.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.073 0.463 . . . . 0.0 110.729 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.61 -45.2 78.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.32 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.92 -48.91 78.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.806 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -63.57 -43.4 97.1 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -65.29 -42.18 93.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.485 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.58 -47.95 81.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.994 0.426 . . . . 0.0 111.09 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 291' ' ' ILE . . . . . 0.499 HG21 HG22 ' B' ' 347' ' ' VAL . 51.2 mm -66.68 -43.44 90.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.92 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 292' ' ' GLU . . . . . 0.414 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 19.9 tp10 -57.82 -45.4 86.21 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.134 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.77 -40.62 99.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.116 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.447 HD13 HD13 ' B' ' 350' ' ' LEU . 4.8 tt -63.6 -43.9 95.56 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.32 -43.98 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.247 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 296' ' ' LYS . . . . . 0.414 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 66.1 mttm -60.33 -35.18 75.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.934 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.16 -11.76 40.19 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -138.63 81.01 1.82 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -91.54 93.27 8.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -105.26 157.93 5.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.58 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.22 138.25 58.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.465 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 35.0 t -106.63 126.01 31.4 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.861 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.503 ' O ' HG13 ' B' ' 307' ' ' ILE . 51.6 Cg_exo -55.99 129.19 33.58 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.428 2.086 . . . . 0.0 111.914 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.28 83.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.476 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.99 84.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.52 -38.06 83.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.507 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 307' ' ' ILE . . . . . 0.503 HG13 ' O ' ' B' ' 303' ' ' PRO . 73.6 mt -61.07 -50.12 81.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.248 -177.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.16 -37.53 87.67 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 63.6 p -67.6 -45.17 76.23 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.501 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 310' ' ' GLU . . . . . 0.554 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 66.8 mm-40 -71.81 -36.32 70.21 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.494 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 87.3 mt -62.38 -44.46 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.12 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.569 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 36.6 t70 -63.24 -41.86 99.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.823 0.344 . . . . 0.0 110.965 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.47 -43.16 98.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.298 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 84.2 mt -62.21 -39.91 94.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.693 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 79.1 mtm180 -63.37 -39.04 93.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.235 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 316' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 90.2 mtt180 -62.82 -42.23 99.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.842 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -62.95 -43.16 99.55 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.496 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.05 -39.94 82.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.964 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.44 91.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.07 0.462 . . . . 0.0 110.39 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -62.15 -37.15 84.13 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.052 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -70.56 -36.95 73.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.412 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.02 42.37 0.25 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.986 0.915 . . . . 0.0 112.172 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.77 -0.11 59.24 Favored Glycine 0 C--N 1.318 -0.465 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.033 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 89.49 30.65 13.08 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.195 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -68.6 136.35 52.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.899 0.38 . . . . 0.0 110.533 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 326' ' ' GLU . . . . . 0.423 ' HB3' HH11 ' A' ' 73' ' ' ARG . 0.9 OUTLIER -137.98 162.29 34.47 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.574 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.0 OUTLIER 68.57 -53.43 0.55 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.298 0.639 . . . . 0.0 112.359 -178.156 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -73.99 -3.7 30.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.44 -24.32 65.11 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.278 0.561 . . . . 0.0 109.705 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.427 HD12 HH12 ' B' ' 315' ' ' ARG . 41.9 tp -63.23 -36.23 82.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.324 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.07 -26.02 65.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.877 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 332' ' ' LEU . . . . . 0.424 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 80.0 mt -54.3 132.89 61.54 Favored Pre-proline 0 C--O 1.238 0.481 0 CA-C-O 120.706 0.288 . . . . 0.0 111.556 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 333' ' ' PRO . . . . . 0.449 ' HB2' HD13 ' B' ' 336' ' ' LEU . 50.5 Cg_exo -54.67 133.19 55.78 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.986 2.457 . . . . 0.0 113.338 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 334' ' ' ARG . . . . . 0.42 HH21 ' HD2' ' B' ' 334' ' ' ARG . 26.1 ttt85 -67.03 -43.81 81.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.056 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -63.85 -33.01 74.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -174.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 336' ' ' LEU . . . . . 0.449 HD13 ' HB2' ' B' ' 333' ' ' PRO . 10.8 mp -64.29 -36.57 84.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.473 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -101.36 -13.82 17.85 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 338' ' ' GLU . . . . . 0.402 ' HG3' HD11 ' B' ' 311' ' ' ILE . 39.9 tt0 -68.52 -30.4 69.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.734 0.302 . . . . 0.0 111.482 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.66 -49.85 74.87 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.792 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -72.25 -29.43 63.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 110.71 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.466 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -61.72 -43.66 98.42 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.108 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 342' ' ' LYS . . . . . 0.443 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.6 tttt -59.47 -45.19 92.35 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 343' ' ' ARG . . . . . 0.53 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.7 mmt85 -62.44 -45.52 92.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -66.0 -37.89 87.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 341' ' ' ALA . 82.6 t -63.4 -44.72 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.787 0.327 . . . . 0.0 110.33 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 342' ' ' LYS . 71.7 t -61.23 -45.1 99.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.513 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 343' ' ' ARG . 85.4 t -61.24 -44.57 98.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.281 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.59 -42.32 99.15 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.15 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.04 -44.03 97.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 110.701 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.473 ' O ' HG23 ' B' ' 354' ' ' VAL . 96.2 mt -63.24 -49.45 74.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.0 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.7 -41.21 88.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.6 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.39 -42.44 98.92 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.265 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.7 -35.65 75.25 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.956 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 354' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 350' ' ' LEU . 71.8 t -60.15 -44.73 95.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.74 -44.15 98.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.127 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -68.58 -49.03 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 39.2 m -64.48 -44.9 89.56 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -88.56 5.93 40.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.367 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 56.43 45.27 22.96 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.032 0.444 . . . . 0.0 111.528 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 98.8 mt -81.48 143.77 31.84 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.125 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.23 150.53 42.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.109 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.02 120.55 13.34 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 363' ' ' ASP . . . . . 0.554 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.1 t70 -89.59 113.59 25.05 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.032 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 364' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 58.8 mm-40 -59.0 -38.38 79.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.449 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -65.46 -41.54 93.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.839 0.352 . . . . 0.0 110.785 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -64.92 -38.66 91.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.784 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 367' ' ' VAL . . . . . 0.554 HG23 ' O ' ' B' ' 363' ' ' ASP . 96.0 t -63.08 -38.77 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.389 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 368' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.4 mmmt -56.35 -44.35 80.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.53 96.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.012 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.81 -42.42 99.71 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.114 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.02 -43.22 97.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.832 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -60.83 -38.95 87.22 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.197 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -65.94 -39.0 90.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.306 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 53.8 ttm -66.39 -41.77 88.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.368 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.57 -28.24 69.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.804 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 48.7 m -75.13 -5.77 46.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.562 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -93.08 -1.34 56.59 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.946 0.403 . . . . 0.0 111.234 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -114.29 169.05 9.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.156 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -64.96 -44.09 90.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.961 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -119.65 118.88 31.79 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.798 0.332 . . . . 0.0 110.198 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.83 -30.62 21.67 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.421 2.08 . . . . 0.0 113.258 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -66.14 -43.37 87.24 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.44 -37.36 85.59 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.706 0.289 . . . . 0.0 110.851 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.44 -43.25 96.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.515 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 90.4 mt -62.33 -44.25 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.943 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 48.3 mt-10 -65.66 -44.48 86.15 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.838 178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.5 -47.82 82.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.122 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 388' ' ' TYR . . . . . 0.48 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 2.8 t80 -69.52 -39.88 77.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.051 -177.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 62.7 p -78.93 -8.06 58.55 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 390' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.4 mttt -99.32 1.7 44.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.967 0.413 . . . . 0.0 111.536 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 391' ' ' ASN . . . . . 0.434 ' OD1' HD13 ' B' ' 394' ' ' LEU . 24.6 t-20 -123.9 115.25 20.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.232 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 42.1 ttmt -63.9 -40.87 97.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.407 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.23 -49.49 76.9 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.094 0.473 . . . . 0.0 110.781 -176.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 394' ' ' LEU . . . . . 0.434 HD13 ' OD1' ' B' ' 391' ' ' ASN . 10.3 mp -63.61 -40.18 96.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.47 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 89.7 mtp -62.55 -45.46 92.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 111.526 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.79 -43.66 75.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.223 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -62.8 -39.81 95.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.636 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 398' ' ' MET . . . . . 0.48 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 55.5 tpp -62.82 -44.07 97.12 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.868 0.366 . . . . 0.0 110.751 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.406 ' HG2' HG21 ' B' ' 367' ' ' VAL . 56.1 mtm180 -64.65 -31.69 73.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.014 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -61.24 -45.63 93.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.78 -43.83 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.043 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.2 -41.0 96.06 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.003 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.75 -37.04 86.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.693 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.2 -45.18 91.76 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.999 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -65.74 -37.81 87.39 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.656 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -58.92 -43.12 91.03 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.868 0.366 . . . . 0.0 110.421 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.407 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -64.71 -47.28 78.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.599 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 94.9 t -64.12 -45.62 95.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.413 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -67.57 -32.0 72.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.555 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.69 91.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.879 0.371 . . . . 0.0 110.253 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 411' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 407' ' ' ALA . 93.6 t -64.35 -42.64 95.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.957 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.0 -38.54 86.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.749 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.32 -23.46 66.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -99.25 -2.51 36.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.916 0.389 . . . . 0.0 110.855 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -110.15 174.46 5.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.189 0.519 . . . . 0.0 111.614 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -87.39 108.06 18.82 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.692 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 65.0 t -100.41 118.93 47.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.218 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -119.97 159.57 24.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -108.17 122.16 46.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.873 0.368 . . . . 0.0 111.504 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -134.72 123.7 24.08 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.079 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 421' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' B' ' 129' ' ' ILE . 75.3 mt-10 -84.65 154.25 22.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.908 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.0 t -158.2 176.12 12.9 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.599 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 75.0 p -85.4 165.41 17.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.895 0.379 . . . . 0.0 111.231 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -66.72 -26.5 67.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.581 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -62.58 -39.57 94.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.36 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.56 -35.77 81.03 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.361 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -78.16 -14.21 59.56 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.823 0.345 . . . . 0.0 111.461 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.4 mmt -76.69 -9.5 58.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.924 0.392 . . . . 0.0 110.703 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -80.0 87.11 5.42 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -108.82 29.61 7.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.907 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -65.6 -27.35 68.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.376 0.608 . . . . 0.0 109.584 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.478 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.52 178.265 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t -135.4 131.03 35.79 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.818 0.342 . . . . 0.0 110.163 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.6 p -153.06 139.71 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.546 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -131.73 154.76 48.7 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 m -102.84 126.13 49.86 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.5 m -97.4 -58.8 1.92 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.441 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -174.3 130.42 0.37 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.571 0.224 . . . . 0.0 110.781 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.44 -112.78 5.05 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.815 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 11' ' ' LEU . 5.4 mp -93.61 -8.78 40.17 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.673 0.273 . . . . 0.0 110.731 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.38 122.14 5.62 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.995 -0.622 . . . . 0.0 113.646 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.05 147.5 46.63 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.432 0.693 . . . . 0.0 109.255 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -110.11 139.32 45.38 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.9 t -95.99 -89.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.9 m 68.04 100.2 0.05 Allowed 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -173.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tp -133.02 143.72 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.012 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 m -126.45 130.57 50.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.506 ' HB ' HG12 ' A' ' 24' ' ' ILE . 9.6 mt -125.79 162.11 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -177.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.557 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.7 150.09 49.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.301 0.24 . . . . 0.0 111.132 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.33 -57.08 9.87 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -174.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.11 -35.35 79.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 111.224 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 t -62.74 -41.82 99.38 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.487 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 20' ' ' ALA . 76.4 mt -60.21 -51.98 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.155 0.503 . . . . 0.0 111.354 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -70.04 -46.91 64.02 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.547 -174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.2 m -67.3 -51.33 54.01 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.93 66.5 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.87 -43.29 97.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.964 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -61.32 -45.45 94.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.16 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.2 m -62.18 -42.18 99.03 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.841 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.0 tp10 -70.16 -42.03 73.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.494 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.54 -44.65 96.67 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.94 -35.43 64.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.014 0.435 . . . . 0.0 110.701 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -65.68 -41.31 92.6 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.54 HG11 ' HD3' ' A' ' 73' ' ' ARG . 90.2 t -65.68 -41.46 90.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.398 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.34 80.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.285 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.421 ' O ' ' HD3' ' A' ' 40' ' ' ARG . 99.0 mttt -64.58 -37.58 88.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.059 177.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -61.0 -41.91 97.4 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.883 0.373 . . . . 0.0 110.598 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.87 -4.23 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.388 0.613 . . . . 0.0 110.156 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 25.6 mmt180 62.62 30.95 17.0 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.049 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -112.83 7.15 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.764 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -64.01 -35.92 82.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.081 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.23 -1.64 70.15 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.688 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -91.72 -5.19 54.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.921 0.391 . . . . 0.0 110.734 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -90.36 110.59 21.67 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.01 -39.1 91.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.615 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.83 56.45 24.76 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 173.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -62.66 -41.29 98.98 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.91 109.69 58.81 Favored Pre-proline 0 C--O 1.246 0.902 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.462 ' HG2' HD12 ' A' ' 53' ' ' ILE . 47.4 Cg_exo -57.3 149.35 65.25 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.925 2.417 . . . . 0.0 112.543 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.555 ' HA ' HG12 ' A' ' 54' ' ' VAL . 15.0 ttt -60.29 -39.16 85.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.455 -173.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -69.12 -23.42 63.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.844 0.354 . . . . 0.0 110.987 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.462 HD12 ' HG2' ' A' ' 50' ' ' PRO . 96.6 mt -92.53 -41.72 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 51' ' ' MET . 12.7 p -66.02 -38.78 82.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 120.936 0.398 . . . . 0.0 110.817 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.444 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -66.84 -37.37 84.36 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.43 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 9.7 pt20 -72.78 -15.01 61.65 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.724 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.501 HH12 ' CD1' ' B' ' 187' ' ' LEU . 67.2 mtt180 -108.59 -52.41 2.77 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.437 ' O ' HG12 ' A' ' 62' ' ' VAL . 18.8 m-85 -108.66 -1.24 19.66 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.182 0.515 . . . . 0.0 110.646 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -63.87 -35.76 92.43 Favored Glycine 0 C--O 1.218 -0.863 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.753 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.93 -43.94 67.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.802 0.301 . . . . 0.0 111.312 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.5 m -61.19 -43.29 99.11 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.129 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 65' ' ' ASP . 8.0 p -105.32 20.3 4.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.246 0.546 . . . . 0.0 110.776 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 14.1 ttm180 -63.97 -19.9 65.49 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.048 0.452 . . . . 0.0 110.147 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.37 -53.05 58.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.24 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.528 ' HB2' HG22 ' A' ' 62' ' ' VAL . 17.6 m-20 -71.02 -26.15 62.99 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.501 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 62' ' ' VAL . 91.7 t -62.05 -45.24 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.74 -40.06 95.81 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.352 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.03 99.39 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.23 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.51 -44.67 93.62 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.39 -42.76 99.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.036 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.1 ttp -60.48 -50.08 75.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.34 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.3 m -65.27 -46.38 80.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.679 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.54 ' HD3' HG11 ' A' ' 35' ' ' VAL . 58.4 ttm-85 -66.27 -46.63 76.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.792 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -66.14 -40.4 90.6 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -59.88 -48.36 81.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.908 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 79' ' ' ILE . 20.0 tt -68.17 -38.9 80.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.883 0.373 . . . . 0.0 111.271 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.19 -38.54 88.24 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.384 0.611 . . . . 0.0 109.767 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.69 83.73 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.766 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.7 pp -65.07 -37.33 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.076 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.32 -42.33 95.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.718 0.77 . . . . 0.0 109.156 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -59.55 -47.86 83.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.16 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -89.38 -1.43 58.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -175.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm 70.46 38.95 1.27 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.47 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 92.5 mt -93.84 121.28 44.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -110.52 101.41 48.66 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.588 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.92 131.31 6.97 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.53 2.153 . . . . 0.0 112.452 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.7 90.95 4.42 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.997 0.427 . . . . 0.0 110.4 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.46 -144.21 15.29 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.18 129.47 25.05 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 116.588 0.194 . . . . 0.0 110.678 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HG2' ' CE1' ' A' ' 92' ' ' TYR . 60.5 Cg_endo -70.21 160.2 50.4 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.827 2.352 . . . . 0.0 111.398 178.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.2 m -101.09 91.72 4.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.12 0.486 . . . . 0.0 112.17 -175.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.42 ' CE1' ' HG2' ' A' ' 90' ' ' PRO . 87.5 m-85 -84.05 117.77 23.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.6 t -111.26 96.93 33.3 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 120.86 0.362 . . . . 0.0 111.967 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -87.99 145.14 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 122.592 2.194 . . . . 0.0 110.81 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.96 174.83 42.81 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.638 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.52 130.86 42.3 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -85.34 104.04 14.81 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.153 0.501 . . . . 0.0 110.911 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.95 111.7 19.49 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.11 112.7 2.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.118 0.485 . . . . 0.0 110.484 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.97 -14.91 19.15 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.135 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -119.0 -178.1 3.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.623 0.249 . . . . 0.0 111.035 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.52 161.18 28.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.359 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -108.8 138.81 44.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.776 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -118.31 134.54 54.95 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.198 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -136.39 162.67 32.39 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.835 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.9 m -121.8 148.78 44.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.762 0.315 . . . . 0.0 111.112 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.88 139.96 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.417 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.41 132.81 46.81 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -155.72 -159.33 0.9 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -45.96 155.22 0.2 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.557 1.543 . . . . 0.0 113.327 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.5 m -129.93 159.19 42.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.445 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -145.55 99.32 4.48 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.253 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.22 143.73 10.25 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.515 2.143 . . . . 0.0 113.124 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -159.01 125.59 4.62 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.93 162.62 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.891 0.376 . . . . 0.0 111.709 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -119.64 136.35 54.43 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.6 mt -114.23 135.3 54.2 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -128.09 133.46 49.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.626 0.251 . . . . 0.0 111.649 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.1 22.43 52.31 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.882 -0.675 . . . . 0.0 114.251 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.89 -41.42 99.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.24 0.543 . . . . 0.0 110.511 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.67 -16.77 61.88 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.619 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.05 6.98 47.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.49 127.53 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.375 0.607 . . . . 0.0 111.093 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -110.04 132.2 54.37 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.935 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.5 t -120.76 133.6 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.142 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -90.26 120.26 31.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.049 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -122.31 93.5 48.48 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.76 140.73 56.93 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.176 1.917 . . . . 0.0 112.446 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.2 mm -106.37 119.84 56.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.378 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.41 160.43 42.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.293 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.3 158.77 43.36 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.855 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.4 t -84.72 126.4 40.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.698 0.285 . . . . 0.0 110.491 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.2 p -97.74 170.02 9.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -68.57 -22.68 64.46 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.284 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.69 -38.89 92.54 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.151 0.501 . . . . 0.0 109.652 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -65.15 -36.74 85.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.336 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.45 -45.36 98.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.468 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.09 -40.48 95.99 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.438 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.81 -42.67 99.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.663 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.532 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 5.0 tpt -63.72 -45.17 91.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.922 0.391 . . . . 0.0 110.306 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.43 -41.4 98.67 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.957 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.1 -45.89 89.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.386 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.0 m -62.62 -39.55 94.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.329 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.7 mt -61.49 -41.75 97.75 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.701 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -69.43 -21.54 63.74 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.087 0.47 . . . . 0.0 110.802 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -86.56 4.13 41.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.223 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -119.8 28.54 8.06 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.664 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -138.33 95.39 3.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.57 155.99 47.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.96 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 243' ' ' ARG . 0.7 OUTLIER -122.29 172.35 8.37 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.766 -177.391 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.468 ' H ' HG22 ' A' ' 150' ' ' THR . 8.9 p-90 -55.0 136.41 47.78 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.052 0.541 . . . . 0.0 112.311 -176.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -170.32 113.87 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -73.86 85.58 1.72 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -153.0 -78.31 0.11 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.837 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -163.19 -68.21 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.434 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 243' ' ' ARG . . . 64.54 -126.92 33.59 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.198 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -146.34 -165.44 2.22 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 203' ' ' LYS . 61.2 t -119.38 126.54 75.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 57.1 mm-40 -87.88 177.93 6.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.263 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.17 -58.25 3.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 255' ' ' ARG . 6.7 pt-20 -89.58 34.98 0.82 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.304 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.656 ' OD2' ' HD3' ' A' ' 243' ' ' ARG . 11.4 t70 -57.22 -48.7 78.14 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.412 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 65.82 88.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.617 HG22 ' OD1' ' A' ' 162' ' ' ASP . 2.9 t -109.94 132.31 58.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.694 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 m -81.15 104.62 11.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 79.7 mt -117.1 132.82 65.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -171.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -99.26 107.92 20.34 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -130.68 146.91 52.28 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.621 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 37.6 m -128.55 131.46 48.22 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.085 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.97 105.84 1.96 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.603 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.9 m -127.26 121.69 31.85 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.6 t -72.64 -76.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -109.28 -70.34 0.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.172 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -136.87 18.9 3.54 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.228 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -136.84 148.79 47.33 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -93.32 149.37 21.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.643 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -111.39 -177.8 3.29 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.24 -45.01 92.31 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.732 -176.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -93.24 -171.58 39.9 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.173 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.62 36.87 58.27 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.865 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -115.17 101.42 8.95 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.2 151.53 34.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.144 0.497 . . . . 0.0 111.54 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.8 m -139.04 126.42 21.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.471 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 56.69 38.3 29.43 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.13 0.49 . . . . 0.0 110.768 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -87.7 136.1 33.1 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.619 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.53 120.15 37.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.715 0.769 . . . . 0.0 112.15 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.461 ' CD1' HH12 ' B' ' 57' ' ' ARG . 49.0 tp -113.27 119.42 37.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.595 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.648 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -102.21 129.04 48.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 56.9 mtm -106.83 167.65 9.73 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.768 -173.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.17 14.08 61.0 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.708 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.432 ' HB2' ' HG2' ' A' ' 193' ' ' ARG . 98.2 mt-30 -126.62 -10.06 6.2 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.661 0.267 . . . . 0.0 111.445 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.53 40.45 9.86 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.424 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 188' ' ' ALA . 39.5 mmm-85 -79.12 -22.04 45.72 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.38 0.672 . . . . 0.0 109.939 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.436 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.1 OUTLIER -128.95 -170.0 2.19 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.185 179.494 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.2 mp -68.33 134.52 91.13 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.63 132.43 45.74 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.256 1.971 . . . . 0.0 111.918 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.47 -39.88 2.63 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.795 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -62.34 -46.31 89.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.554 0.216 . . . . 0.0 111.244 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.95 10.85 5.76 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.088 0.47 . . . . 0.0 111.894 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -114.37 -33.64 5.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.121 0.486 . . . . 0.0 110.115 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.76 -17.88 75.46 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.246 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.57 -41.97 94.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.061 0.457 . . . . 0.0 110.322 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.436 ' HA ' ' HB ' ' A' ' 158' ' ' VAL . 41.5 mtpt -52.08 132.27 32.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.654 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.76 8.74 55.52 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.767 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -115.38 150.18 36.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.031 0.416 . . . . 0.0 110.72 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -87.26 163.39 16.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.169 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.95 135.49 47.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.01 15.35 79.14 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.77 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.19 119.89 38.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.33 0.585 . . . . 0.0 111.362 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 235' ' ' ILE . 25.4 mt-10 -98.9 115.62 29.28 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.408 ' O ' ' HB ' ' A' ' 212' ' ' THR . 64.0 t80 -133.74 -26.09 1.6 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -173.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 77.0 m 72.42 129.96 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 120.893 0.378 . . . . 0.0 110.344 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.42 -41.07 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 70.75 97.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 122.791 0.436 . . . . 0.0 111.32 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 68.6 t -115.59 126.92 73.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.049 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.56 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 18.5 m -65.89 -41.95 90.88 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -176.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.56 ' HB2' ' O ' ' A' ' 216' ' ' THR . 27.8 m-85 77.81 134.53 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 122.957 0.503 . . . . 0.0 110.32 -173.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.16 155.7 51.84 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.369 2.046 . . . . 0.0 112.679 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -66.09 -33.78 76.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.601 0.715 . . . . 0.0 109.305 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.12 22.81 1.66 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.851 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -70.52 142.1 51.88 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.514 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -63.09 -30.37 71.54 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.67 123.62 33.3 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.419 -0.512 . . . . 0.0 109.741 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.526 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 1.5 tp10 -65.33 -31.54 72.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.381 -175.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -86.15 -5.32 59.22 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.37 -11.57 10.0 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.526 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 18.7 ptmt -71.53 119.98 16.47 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.206 0.527 . . . . 0.0 111.063 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 75.9 19.0 79.25 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.755 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -125.34 121.64 34.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.391 . . . . 0.0 110.766 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.55 138.9 45.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.615 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.54 135.47 53.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.845 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.52 -48.22 28.34 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -173.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 212' ' ' THR . 66.1 m-85 54.67 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.91 94.46 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 210' ' ' GLU . 91.6 mt 68.62 99.2 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.804 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -86.94 -51.7 5.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 32.4 tp 55.78 91.0 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.976 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -73.55 -79.33 0.08 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 54.1 mtmt -79.01 -79.11 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -170.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 92.0 t 76.9 152.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-O 120.832 0.349 . . . . 0.0 110.615 -175.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -99.12 56.53 1.04 Allowed 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -36.47 141.17 0.12 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -173.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.656 ' HD3' ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -144.6 144.83 31.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.944 177.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.404 ' HB2' ' CA ' ' A' ' 156' ' ' GLY . 38.2 tt0 -158.94 155.58 27.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 9.1 tt 72.09 128.03 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 123.475 0.484 . . . . 0.0 111.136 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 245' ' ' LEU . 61.2 Cg_endo -87.74 113.99 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.216 1.944 . . . . 0.0 113.632 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -131.37 176.24 8.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.89 111.6 23.92 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 15.6 p -104.51 -86.19 0.46 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.66 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -176.61 -49.93 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.996 0.427 . . . . 0.0 111.896 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.73 -45.11 91.39 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -62.35 -30.37 71.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 263' ' ' VAL . 19.6 tt -85.93 -16.12 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -117.29 8.34 13.12 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.345 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 161' ' ' GLU . 60.5 ttp180 -134.71 133.17 39.7 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.915 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -167.7 37.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 99.43 -31.54 8.2 Favored Glycine 0 C--N 1.318 -0.452 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.07 149.31 5.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.61 -47.25 80.05 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.199 0.312 . . . . 0.0 110.545 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -175.76 163.63 2.85 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.258 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -172.62 175.62 45.67 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.307 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.3 p -83.5 175.33 9.87 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.43 0.292 . . . . 0.0 110.301 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' VAL . . . . . 0.433 HG22 HD11 ' A' ' 253' ' ' ILE . 67.4 t -61.97 -51.23 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.005 0.431 . . . . 0.0 111.054 -177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -81.06 -32.95 33.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.335 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.07 -43.24 99.42 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.19 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 270' ' ' VAL . 65.1 tp -63.14 -44.02 96.7 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.627 0.251 . . . . 0.0 110.52 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -64.12 -42.38 96.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.382 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.536 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.3 -45.02 81.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.29 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 35.5 tp10 -65.71 -38.57 89.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.998 0.427 . . . . 0.0 110.434 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 266' ' ' LEU . 75.8 t -65.49 -43.4 94.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.228 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -59.21 -46.74 87.64 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.673 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.5 ptmt -66.46 -42.62 87.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.669 0.271 . . . . 0.0 111.163 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -65.79 -37.43 86.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.5 mmm -63.52 -42.81 98.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.045 0.45 . . . . 0.0 110.111 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -70.17 -30.82 68.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.204 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -61.61 -43.79 98.19 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.39 -32.98 74.9 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.875 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.8 tp -60.8 -39.64 89.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.951 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -58.12 -46.9 84.78 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 50.4 m -62.52 -44.68 95.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.033 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.3 -51.0 69.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.83 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.45 -44.36 97.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.039 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.544 HH12 ' HG3' ' A' ' 409' ' ' GLU . 6.5 tpt180 -63.03 -45.31 92.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.79 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.43 -40.19 95.27 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.472 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -59.13 -44.4 92.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.014 0.435 . . . . 0.0 110.269 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 86.3 t -70.24 -43.11 78.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.4 tttt -59.3 -47.66 84.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.046 -177.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 74.1 p -62.88 -41.89 99.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -64.2 -42.35 96.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.583 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 294' ' ' LEU . . . -65.27 -42.6 93.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.762 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 287' ' ' LYS . 33.5 mm -64.07 -43.34 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.563 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -60.74 -43.37 98.0 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.114 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.01 -40.85 97.39 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.414 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 290' ' ' ALA . 98.5 mt -62.54 -43.13 99.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.802 0.334 . . . . 0.0 110.802 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 291' ' ' ILE . 96.0 t -65.31 -43.78 94.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.198 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -64.23 -40.59 96.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.068 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.26 -42.74 79.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.962 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -127.21 96.34 4.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.8 105.55 17.49 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 301' ' ' ASP . 11.4 tp -120.1 168.68 12.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.574 -174.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 300' ' ' ILE . 7.3 m-20 -60.78 139.0 58.06 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.385 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.96 119.63 28.78 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.94 131.44 45.49 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.437 2.092 . . . . 0.0 111.89 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.66 84.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.102 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.55 91.1 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 111.565 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.7 mt -66.46 -40.74 89.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.833 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.417 ' O ' HG13 ' A' ' 311' ' ' ILE . 68.7 mt -61.66 -47.95 90.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.992 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.3 -43.04 92.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.873 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 51.0 m -62.25 -45.26 94.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.869 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.6 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 65.9 mm-40 -66.17 -39.48 89.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.234 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.54 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 95.8 mt -61.96 -43.82 98.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.621 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.6 t70 -61.62 -46.62 89.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.913 0.387 . . . . 0.0 111.306 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 91.7 t -63.35 -43.51 98.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.251 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 75.0 mt -62.49 -40.46 96.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.621 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 85.1 mtm180 -62.91 -42.15 99.69 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.132 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -64.79 -38.66 91.74 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -63.35 -44.53 94.57 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.252 0.548 . . . . 0.0 109.937 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.7 80.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.58 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -62.31 -36.29 81.7 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.944 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -63.2 -40.5 97.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.281 0.563 . . . . 0.0 109.584 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -75.06 -9.6 58.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.343 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -92.2 -7.36 48.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.845 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . 136.69 -14.33 3.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.82 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 113.12 44.11 0.82 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.879 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 35.6 t-20 -87.22 127.98 35.15 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.88 0.372 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' GLU . . . . . 0.549 ' OE1' ' HG3' ' A' ' 327' ' ' LYS . 1.8 tm-20 -130.7 145.26 51.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.549 ' HG3' ' OE1' ' A' ' 326' ' ' GLU . 35.2 mtmm 72.22 -46.05 0.63 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.646 0.779 . . . . 0.0 112.422 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.503 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 12.3 mm100 -70.0 -10.98 60.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.207 0.527 . . . . 0.0 110.446 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.85 -22.54 64.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.411 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.432 HD12 HH12 ' A' ' 315' ' ' ARG . 60.0 tp -61.61 -33.93 74.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.679 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -79.27 -6.29 56.34 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.573 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 75.9 mt -69.24 145.63 96.17 Favored Pre-proline 0 C--O 1.241 0.623 0 O-C-N 122.186 -0.321 . . . . 0.0 110.997 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.36 127.08 23.43 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.893 2.396 . . . . 0.0 113.339 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.484 ' HG3' HD13 ' A' ' 311' ' ' ILE . 21.9 ttt180 -70.49 -41.0 73.25 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.405 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -52.16 -46.41 65.45 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -173.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.469 HD12 ' CD ' ' A' ' 224' ' ' GLU . 74.7 mt -92.27 10.13 30.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -115.72 -28.2 6.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.132 0.492 . . . . 0.0 110.228 172.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.7 -30.67 70.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.711 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -60.97 -48.24 82.75 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.471 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -78.32 -20.86 50.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.713 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.95 -40.87 97.43 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.505 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.8 tttt -59.82 -45.16 93.23 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.567 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.1 mmt85 -60.27 -45.8 92.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.031 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -67.46 -38.92 85.18 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.164 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 341' ' ' ALA . 82.8 t -64.27 -43.86 97.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.658 0.266 . . . . 0.0 110.351 176.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 342' ' ' LYS . 73.0 t -60.74 -43.8 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.531 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 343' ' ' ARG . 82.7 t -59.93 -45.6 94.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.45 -43.34 99.18 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.93 -43.73 94.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.59 0.233 . . . . 0.0 111.478 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.43 -44.79 93.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.924 0.393 . . . . 0.0 110.506 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 355' ' ' ILE . 95.8 mt -66.59 -39.93 88.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.816 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.84 -41.76 96.25 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.583 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -66.06 -40.46 90.92 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.889 0.344 . . . . 0.0 110.646 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.76 -45.89 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.937 178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 351' ' ' LEU . 73.6 mt -62.96 -46.98 94.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.224 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -64.07 -62.75 1.43 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.7 m -66.29 -43.86 85.14 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.3 -12.15 60.46 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.246 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 66.44 47.6 1.69 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.008 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.17 142.16 33.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.884 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.06 146.13 51.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.67 114.47 5.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.487 ' O ' HG23 ' A' ' 367' ' ' VAL . 26.8 t70 -87.01 111.48 20.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.064 0.459 . . . . 0.0 111.077 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 58.1 mm-40 -61.4 -35.04 76.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.995 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.63 -42.09 91.9 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.845 0.355 . . . . 0.0 110.764 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -63.01 -40.05 96.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.11 0.481 . . . . 0.0 110.149 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 363' ' ' ASP . 89.2 t -61.26 -39.41 82.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.335 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.0 mmmt -57.23 -43.41 82.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.508 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.65 99.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.204 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.65 -42.96 99.89 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.124 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.84 -44.85 92.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.121 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.73 -41.47 98.05 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -65.17 -42.31 93.83 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.436 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 49.6 ttp -65.25 -40.69 94.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -62.97 -23.45 67.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.568 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 39.6 m -73.85 -5.73 42.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.481 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -90.86 0.15 57.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.328 0.585 . . . . 0.0 110.315 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.86 170.84 8.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.542 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.06 -44.13 85.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.81 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -124.63 113.23 27.28 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.764 0.316 . . . . 0.0 110.616 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.428 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 40.1 Cg_exo -58.24 -35.95 98.22 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.948 2.432 . . . . 0.0 113.221 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.28 -43.7 85.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.48 -35.8 81.67 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.884 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.93 -43.24 96.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 109.978 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.11 -43.48 98.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.88 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.45 -36.75 84.84 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.743 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -58.63 -47.43 84.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.335 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' A' ' 395' ' ' MET . 5.7 m-85 -70.66 -44.46 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 29.9 p -68.32 -15.91 63.74 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -100.77 4.74 43.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.591 0.234 . . . . 0.0 111.214 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -128.97 112.94 14.58 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 110.699 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.13 -40.56 96.43 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -56.81 -51.38 69.19 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.043 0.449 . . . . 0.0 110.794 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.37 -40.14 95.24 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.838 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 388' ' ' TYR . 87.9 mtp -61.7 -45.63 93.17 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.638 0.256 . . . . 0.0 111.681 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.18 -44.25 63.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.367 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -63.31 -42.69 99.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.049 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 50.3 tpp -63.56 -42.07 98.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.991 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.463 ' HG2' HG21 ' A' ' 367' ' ' VAL . 83.2 mtm180 -65.59 -34.53 78.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.195 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -61.81 -42.72 99.37 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 110.106 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.99 -43.41 89.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.694 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.31 97.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.724 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.5 -36.7 84.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.489 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.22 -45.32 91.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.812 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 40.7 mt-10 -64.85 -38.46 91.06 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.419 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -60.39 -43.39 96.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.492 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.88 96.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.31 -43.51 95.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.544 ' HG3' HH12 ' A' ' 283' ' ' ARG . 80.5 mt-10 -66.02 -34.34 77.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.291 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.22 -39.12 91.74 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.15 0.5 . . . . 0.0 110.21 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.78 -42.85 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.176 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.56 -40.36 94.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.458 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.8 -27.76 68.27 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.941 0.4 . . . . 0.0 111.356 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -94.16 -8.22 40.05 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 110.821 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.35 -179.94 5.09 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.239 0.542 . . . . 0.0 111.835 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -103.41 106.39 16.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.031 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 63.9 t -92.51 132.61 36.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 120.768 0.318 . . . . 0.0 110.382 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.4 t -124.63 146.64 48.97 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.907 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.67 130.84 53.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.822 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -148.14 136.36 21.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.026 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -87.22 153.86 21.16 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.6 t -158.01 178.57 10.07 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 18.0 p -87.3 162.2 17.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.918 0.389 . . . . 0.0 111.549 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.9 -36.51 82.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.281 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -57.59 -36.94 72.39 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.893 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.2 -33.67 76.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.871 0.367 . . . . 0.0 110.939 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.5 mp -81.06 -12.45 59.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.905 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 3.2 mmt -78.49 -8.3 58.39 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -78.32 84.01 4.53 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.925 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -109.41 23.16 14.86 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.411 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -82.12 -9.0 59.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.515 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.59 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.265 -179.678 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.403 ' HG2' ' H ' ' B' ' 2' ' ' GLN . 53.3 ttm . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' GLN . . . . . 0.403 ' H ' ' HG2' ' B' ' 1' ' ' MET . 26.0 tt0 -53.58 109.8 0.49 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.981 0.419 . . . . 0.0 111.887 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.49 161.78 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.818 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 43.7 t -136.79 130.56 32.07 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 p -152.78 137.89 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.856 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 41.3 mt-10 -128.17 161.06 30.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.269 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 49.9 m -110.0 125.56 53.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 16.8 m -96.66 -58.62 2.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.447 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -174.41 129.07 0.35 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.207 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.82 -114.6 6.92 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.708 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 mp -91.14 -9.84 44.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.711 0.291 . . . . 0.0 110.783 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.34 120.68 5.64 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.736 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.05 146.98 48.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 54.7 ttp180 -110.08 139.72 44.92 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.58 -90.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' THR . . . . . 0.402 ' OG1' HG23 ' B' ' 104' ' ' THR . 34.9 m 68.24 99.69 0.05 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.1 tp -134.15 144.02 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.881 0.372 . . . . 0.0 111.796 -175.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.4 m -127.79 129.87 47.73 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.673 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.55 ' HB ' HG12 ' B' ' 24' ' ' ILE . 16.8 mt -123.67 162.14 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -176.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.592 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.29 148.03 52.41 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.259 0.224 . . . . 0.0 110.811 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.37 -61.54 2.12 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -66.74 -32.28 73.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.798 0.332 . . . . 0.0 110.943 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 38.6 t -63.04 -41.07 99.41 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.241 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.592 HG13 ' O ' ' B' ' 20' ' ' ALA . 76.3 mt -60.1 -52.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.124 0.488 . . . . 0.0 110.935 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -69.45 -46.11 67.48 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.594 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 21.1 m -65.46 -51.2 61.79 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.57 -47.81 62.36 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.18 -43.28 98.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.075 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -60.34 -46.51 89.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.391 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 25.4 m -62.45 -42.5 99.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.647 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.45 ' O ' HG23 ' B' ' 35' ' ' VAL . 10.0 tp10 -68.87 -42.98 76.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.571 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.96 -44.43 96.77 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -69.61 -34.51 61.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.96 0.41 . . . . 0.0 110.762 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -65.08 -42.21 94.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.56 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.565 HG11 ' HD3' ' B' ' 73' ' ' ARG . 88.2 t -65.95 -41.74 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.096 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.76 -40.76 84.84 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.377 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.455 ' O ' ' HD3' ' B' ' 40' ' ' ARG . 98.6 mttt -65.37 -37.16 86.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.279 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.79 -44.3 96.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 110.593 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 19.7 t -78.94 -4.44 6.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.488 0.661 . . . . 0.0 109.969 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' B' ' 37' ' ' LYS . 25.6 mmt180 64.53 25.85 13.28 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.44 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.7 11.39 8.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -63.46 -34.53 77.97 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.184 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.33 0.98 83.15 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.6 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -93.48 -1.67 55.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.042 0.448 . . . . 0.0 110.783 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -95.09 110.59 22.51 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -62.2 -38.49 89.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.371 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.29 56.4 25.26 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -63.52 -41.66 98.5 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.0 t -100.44 110.01 58.83 Favored Pre-proline 0 C--O 1.248 0.999 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.46 ' HG2' HD12 ' B' ' 53' ' ' ILE . 48.9 Cg_exo -57.01 149.04 64.71 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.822 2.348 . . . . 0.0 112.349 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.538 ' HA ' HG12 ' B' ' 54' ' ' VAL . 21.4 ttt -61.1 -37.19 81.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.182 -173.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -69.26 -24.82 64.03 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.929 0.395 . . . . 0.0 111.112 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.46 HD12 ' HG2' ' B' ' 50' ' ' PRO . 96.8 mt -92.69 -41.5 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' B' ' 51' ' ' MET . 13.1 p -65.16 -38.74 83.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.067 0.461 . . . . 0.0 111.019 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.442 ' O ' ' HA3' ' B' ' 59' ' ' GLY . . . -67.38 -37.37 83.05 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 9.5 pt20 -74.67 -11.73 60.25 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.38 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.461 HH12 ' CD1' ' A' ' 187' ' ' LEU . 62.8 mtt-85 -109.42 -50.17 3.02 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' TYR . . . . . 0.42 ' O ' HG12 ' B' ' 62' ' ' VAL . 20.5 m-85 -112.64 1.25 15.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.082 0.468 . . . . 0.0 110.811 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -64.99 -37.25 94.04 Favored Glycine 0 C--O 1.217 -0.941 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.074 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.86 76.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.727 0.298 . . . . 0.0 111.249 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 48.5 m -62.15 -44.55 96.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.052 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' B' ' 65' ' ' ASP . 8.3 p -105.09 19.99 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.352 0.596 . . . . 0.0 111.118 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 12.7 ttm180 -63.05 -20.64 65.52 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.116 0.484 . . . . 0.0 110.182 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -64.07 -53.31 51.74 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.349 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ASP . . . . . 0.524 ' HB2' HG22 ' B' ' 62' ' ' VAL . 20.7 m-20 -69.91 -27.39 64.74 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.847 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 62' ' ' VAL . 93.6 t -61.64 -45.09 99.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -64.01 -39.87 95.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.412 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.64 -41.31 98.85 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.162 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.04 -44.69 95.18 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.33 -42.1 98.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.005 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.8 ttp -60.16 -50.77 72.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.183 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 24.4 m -65.28 -46.02 82.11 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.788 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.565 ' HD3' HG11 ' B' ' 35' ' ' VAL . 59.0 ttm-85 -66.34 -46.61 76.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.745 -175.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -66.47 -40.11 89.17 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -60.34 -48.67 80.75 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ILE . . . . . 0.453 ' O ' HG13 ' B' ' 79' ' ' ILE . 19.9 tt -67.45 -38.95 81.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.965 0.412 . . . . 0.0 111.259 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -66.17 -40.25 90.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.338 0.59 . . . . 0.0 109.88 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.11 85.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.828 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.453 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.7 pp -66.1 -37.2 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.37 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 -42.59 96.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.696 0.76 . . . . 0.0 109.172 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -59.95 -46.46 89.33 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.533 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -90.02 2.43 55.19 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.7 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm 65.83 41.43 3.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.69 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 87.0 mt -96.66 119.99 45.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.882 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -108.17 103.6 50.86 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -85.21 127.45 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.538 2.159 . . . . 0.0 112.328 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.46 97.94 10.51 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.069 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.64 -141.78 15.85 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.514 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.04 132.42 23.72 Favored Pre-proline 0 C--N 1.317 -0.806 0 O-C-N 122.853 -0.204 . . . . 0.0 110.695 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' PRO . . . . . 0.442 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 64.0 Cg_endo -71.78 162.02 43.32 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.826 2.351 . . . . 0.0 111.272 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 18.7 m -99.34 109.07 21.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.282 0.563 . . . . 0.0 111.17 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.442 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 87.9 m-85 -99.96 115.58 30.02 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.65 94.58 19.98 Favored Pre-proline 0 C--N 1.32 -0.717 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.931 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 90.9 Cg_endo -87.01 146.16 7.68 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.552 2.168 . . . . 0.0 110.523 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.98 172.18 39.91 Favored Glycine 0 N--CA 1.437 -1.295 0 C-N-CA 120.0 -1.095 . . . . 0.0 111.168 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.16 136.12 47.96 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -87.03 103.93 15.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.383 0.611 . . . . 0.0 111.544 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.46 111.16 18.23 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 49.3 tp -64.9 109.13 1.99 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.1 0.476 . . . . 0.0 110.408 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.06 -11.32 13.26 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.344 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.74 -177.69 3.81 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.708 0.29 . . . . 0.0 111.548 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -76.08 143.32 41.39 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.8 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -91.61 140.93 29.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.708 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.405 HG21 ' HD2' ' B' ' 14' ' ' ARG . 59.1 m -119.77 136.61 54.38 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.053 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -139.65 162.1 35.91 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.056 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 5.1 m -121.53 149.84 42.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.785 0.326 . . . . 0.0 111.227 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 10.8 p -133.97 142.72 40.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.307 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -105.58 128.17 53.46 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -149.68 -158.54 0.93 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -48.77 155.8 0.54 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.998 1.319 . . . . 0.0 113.318 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.18 160.81 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.114 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -144.98 97.08 4.9 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.741 0.305 . . . . 0.0 110.783 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.62 145.98 33.76 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.849 2.366 . . . . 0.0 112.801 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -164.48 123.55 1.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.5 164.86 31.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.827 0.346 . . . . 0.0 111.583 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -121.44 135.69 55.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.937 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.26 136.01 53.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -130.48 138.82 50.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.658 0.266 . . . . 0.0 111.107 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.15 19.3 61.13 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.912 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.05 -41.15 99.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.118 0.459 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.54 -5.33 32.46 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.483 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.03 13.86 27.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.903 0.382 . . . . 0.0 111.097 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 81.7 mt -102.17 128.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.152 0.501 . . . . 0.0 110.613 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -109.79 128.92 55.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.927 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 62.5 t -117.86 133.28 65.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.988 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -90.94 128.21 36.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.937 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.81 94.0 32.84 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.35 141.06 60.59 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.412 2.075 . . . . 0.0 112.503 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.7 mm -108.33 118.58 56.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.236 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.01 158.53 43.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.359 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -141.35 159.82 41.43 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.179 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -79.74 129.17 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.611 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.9 p -105.07 176.18 5.25 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.689 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -62.0 -38.09 87.3 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.35 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.95 -37.38 84.52 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.874 0.369 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -63.81 -39.03 93.26 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 89.3 t -63.65 -44.72 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.234 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.62 -42.41 92.6 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.247 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.53 98.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.959 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.525 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 4.6 tpt -63.11 -45.27 92.78 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.858 0.361 . . . . 0.0 110.231 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.86 -41.59 97.75 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.036 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.98 -45.46 92.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.664 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 26.5 m -61.97 -41.16 97.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.952 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 144' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.1 mt -61.21 -41.42 96.81 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.459 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -68.83 -22.5 64.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.058 0.456 . . . . 0.0 110.741 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -85.46 2.48 44.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.228 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -119.31 31.44 6.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.394 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -139.16 89.61 2.36 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.22 155.77 49.56 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 150' ' ' THR . . . . . 0.499 HG22 ' H ' ' B' ' 151' ' ' TRP . 1.2 m -124.04 172.14 9.22 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.676 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 151' ' ' TRP . . . . . 0.499 ' H ' HG22 ' B' ' 150' ' ' THR . 8.6 p-90 -53.18 137.11 34.95 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -172.71 119.45 0.37 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.88 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 153' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' B' ' 154' ' ' LYS . 7.5 pt-20 -77.5 89.72 3.86 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.44 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 154' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' B' ' 153' ' ' GLU . 63.5 mmtt -158.44 -72.08 0.09 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.921 0.888 . . . . 0.0 110.736 177.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -169.52 -70.91 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.318 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 156' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' B' ' 243' ' ' ARG . . . 66.45 -128.93 30.72 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.798 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -145.53 -165.76 2.27 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' B' ' 203' ' ' LYS . 50.5 t -117.43 124.73 73.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 159' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' B' ' 162' ' ' ASP . 62.0 mm-40 -87.9 174.44 8.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.068 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.3 -52.79 23.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.198 0.523 . . . . 0.0 109.821 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 161' ' ' GLU . . . . . 0.435 ' CD ' ' HE ' ' B' ' 255' ' ' ARG . 6.8 pt-20 -92.91 32.66 1.24 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.46 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.61 ' OD2' ' HD3' ' B' ' 243' ' ' ARG . 9.2 t70 -57.36 -48.85 77.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.378 -174.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 21.8 ttp85 66.0 88.47 0.11 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.791 0.805 . . . . 0.0 109.24 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.554 HG22 ' OD1' ' B' ' 162' ' ' ASP . 3.0 t -111.49 133.0 58.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.005 -174.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.9 m -80.29 104.51 10.89 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 79.7 mt -116.83 131.0 70.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -97.86 106.21 18.48 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -128.56 146.6 50.79 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.441 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 36.1 m -129.84 131.46 46.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.208 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.38 110.75 3.23 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.562 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 14.6 m -130.67 122.37 27.24 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.47 -76.09 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -110.65 -71.91 0.74 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.817 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -134.37 16.02 4.4 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.067 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -135.17 147.59 49.45 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.916 0.389 . . . . 0.0 110.402 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -91.29 150.58 21.25 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.688 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -112.48 179.15 4.07 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.83 -42.12 88.5 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.1 -175.45 39.31 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.032 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 73.72 36.51 53.25 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.861 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -114.43 102.17 9.83 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.68 154.27 38.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.032 0.444 . . . . 0.0 111.744 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -142.56 133.4 25.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 56.27 35.22 25.42 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.377 0.423 . . . . 0.0 110.845 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 185' ' ' PHE . . . . . 0.41 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 42.4 t80 -88.22 134.52 33.77 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.085 -175.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 15.7 m -90.58 120.97 40.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.634 0.731 . . . . 0.0 112.01 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 187' ' ' LEU . . . . . 0.501 ' CD1' HH12 ' A' ' 57' ' ' ARG . 29.0 tp -114.32 121.28 43.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.502 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 188' ' ' ALA . . . . . 0.598 ' O ' ' HG3' ' B' ' 193' ' ' ARG . . . -101.64 132.18 47.46 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 172.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 57.5 mtm -109.91 165.78 11.45 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.084 -173.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.13 0.33 65.83 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.967 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 191' ' ' GLN . . . . . 0.436 ' HB2' ' HG2' ' B' ' 193' ' ' ARG . 97.7 mt-30 -112.94 -8.38 13.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.43 36.35 17.36 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.677 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' B' ' 188' ' ' ALA . 39.7 mmm-85 -74.49 -25.41 59.36 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.379 0.672 . . . . 0.0 110.138 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 194' ' ' MET . . . . . 0.439 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.1 OUTLIER -124.75 -171.27 2.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.522 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.444 ' H ' HD12 ' B' ' 195' ' ' ILE . 3.7 mp -68.54 136.92 90.69 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.67 132.86 47.88 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.164 1.909 . . . . 0.0 112.054 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.35 -39.79 2.69 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.05 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -62.39 -45.54 92.69 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.0 8.93 11.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -113.21 -33.67 5.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.179 0.514 . . . . 0.0 109.765 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.94 -19.26 73.44 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.396 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 98.6 mt -64.95 -33.54 64.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.262 0.554 . . . . 0.0 110.225 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.404 ' HA ' ' HB ' ' B' ' 158' ' ' VAL . 44.6 mtpt -60.03 135.27 57.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.143 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.58 3.61 58.39 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.451 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -111.62 147.85 34.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 117.013 0.407 . . . . 0.0 110.934 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -85.01 163.63 18.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.073 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.62 137.0 51.91 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.29 20.55 77.03 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.968 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -101.37 121.81 42.59 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.23 0.538 . . . . 0.0 110.946 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 210' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' B' ' 236' ' ' ASN . 33.4 mt-10 -101.92 113.58 26.91 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -133.44 -27.62 1.54 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 30.8 m 74.56 130.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 120.9 0.381 . . . . 0.0 110.455 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.79 -40.53 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 70.38 97.93 0.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.199 0.523 . . . . 0.0 111.842 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 62.6 t -116.07 128.21 73.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 216' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 19.4 m -68.69 -40.78 79.88 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -176.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.542 ' HB2' ' O ' ' B' ' 216' ' ' THR . 32.6 m-85 77.8 134.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 123.025 0.53 . . . . 0.0 110.699 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.46 156.1 50.21 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.606 2.204 . . . . 0.0 112.584 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -65.44 -34.93 79.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.525 0.678 . . . . 0.0 110.008 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -87.14 30.12 0.79 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.616 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -74.65 140.98 44.63 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -61.65 -29.13 69.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.05 121.9 33.25 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.971 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.582 ' HA ' ' CD ' ' B' ' 227' ' ' LYS . 1.4 tp10 -62.93 -33.66 75.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.562 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.476 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 30.8 p-10 -84.22 -5.9 59.32 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.61 -12.94 9.68 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.582 ' CD ' ' HA ' ' B' ' 224' ' ' GLU . 18.1 ptmt -69.19 118.72 12.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.275 0.559 . . . . 0.0 111.205 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.4 18.17 78.29 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.926 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 99.2 mttt -122.59 124.19 42.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.077 0.438 . . . . 0.0 110.698 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.5 140.57 44.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.298 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -126.86 134.45 50.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.915 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -73.2 -48.9 31.27 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -173.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' B' ' 212' ' ' THR . 61.6 m-85 55.03 98.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.657 0.383 . . . . 0.0 112.012 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.6 90.94 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 91.2 mt 67.71 98.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.167 0.587 . . . . 0.0 111.85 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 236' ' ' ASN . . . . . 0.469 ' HA ' ' HG2' ' B' ' 210' ' ' GLU . 28.6 t-20 -86.26 -51.0 6.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 33.4 tp 53.07 90.55 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.052 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 27.3 mttp -74.79 -78.37 0.1 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 239' ' ' LYS . . . . . 0.457 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 52.2 mtmt -75.46 -81.03 0.08 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.381 1.622 . . . . 0.0 115.381 -170.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.632 HG12 ' H ' ' B' ' 242' ' ' GLU . 67.7 t 75.22 139.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -174.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' B' ' 242' ' ' GLU . 86.3 mt-10 -68.73 -27.82 66.27 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.082 -0.386 . . . . 0.0 111.312 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' B' ' 241' ' ' GLU . 2.7 pt-20 64.51 132.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.552 1.541 . . . . 0.0 113.933 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.61 ' HD3' ' OD2' ' B' ' 162' ' ' ASP . 0.0 OUTLIER -154.35 144.1 21.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.358 178.399 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -159.54 153.89 23.87 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 tt 72.18 123.75 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.068 0.547 . . . . 0.0 111.352 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -84.21 115.91 2.01 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.546 2.164 . . . . 0.0 113.484 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -135.67 167.47 21.06 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.35 110.57 21.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 10.7 p -103.56 -83.55 0.48 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.92 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 250' ' ' ALA . . . . . 0.404 ' O ' HG22 ' B' ' 253' ' ' ILE . . . -177.69 -53.62 0.01 OUTLIER 'General case' 0 C--N 1.343 0.319 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.65 -47.14 86.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -61.6 -26.98 68.32 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -173.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 253' ' ' ILE . . . . . 0.404 HG22 ' O ' ' B' ' 250' ' ' ALA . 18.9 tt -91.13 -5.89 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -127.91 6.88 6.08 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.032 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 255' ' ' ARG . . . . . 0.435 ' HE ' ' CD ' ' B' ' 161' ' ' GLU . 60.0 ttp180 -131.24 134.82 46.81 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.538 0.209 . . . . 0.0 110.545 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -172.87 34.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.92 -32.28 7.7 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 42.0 t -80.65 150.84 4.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.38 -51.87 65.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.375 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -175.43 163.81 3.05 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.257 173.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -172.77 177.53 45.25 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.377 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.9 p -82.12 175.8 10.03 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.33 0.252 . . . . 0.0 111.096 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.24 -49.13 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.396 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.41 -32.22 21.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.588 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.12 -43.01 99.73 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.984 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 270' ' ' VAL . 63.5 tp -62.86 -43.79 97.87 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.622 0.249 . . . . 0.0 110.445 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -64.25 -41.96 96.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.882 0.372 . . . . 0.0 110.367 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -66.62 -44.95 80.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.309 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 269' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 37.2 tp10 -66.3 -39.39 89.3 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.094 0.473 . . . . 0.0 110.57 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 266' ' ' LEU . 70.7 t -65.01 -42.85 95.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.089 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -59.71 -46.54 88.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.8 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 18.3 ptmt -66.09 -42.5 89.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.843 0.354 . . . . 0.0 111.007 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -66.0 -37.16 85.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.016 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.2 mmm -63.97 -43.24 96.36 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 110.496 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -70.98 -29.52 65.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.112 0.482 . . . . 0.0 110.08 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -61.86 -43.69 98.34 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -65.1 -32.33 73.97 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.823 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 57.5 tp -60.96 -39.48 89.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.017 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -58.19 -47.79 82.33 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 177.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 17.3 m -62.59 -44.04 97.3 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.866 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.26 69.21 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.795 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.22 -45.72 92.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.607 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 283' ' ' ARG . . . . . 0.519 HH12 ' HG3' ' B' ' 409' ' ' GLU . 8.1 tpt180 -61.7 -45.64 93.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.898 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -64.87 -39.94 94.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.46 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -59.04 -44.42 91.76 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.046 0.45 . . . . 0.0 110.382 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.13 -42.81 79.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.537 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 287' ' ' LYS . . . . . 0.435 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.8 tttt -59.67 -48.13 82.88 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.081 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.7 p -62.23 -41.91 98.83 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.769 0.319 . . . . 0.0 111.542 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -65.06 -41.88 94.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.813 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 290' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' B' ' 294' ' ' LEU . . . -65.61 -42.57 91.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.998 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 291' ' ' ILE . . . . . 0.435 HG12 ' O ' ' B' ' 287' ' ' LYS . 32.2 mm -63.8 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.573 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 292' ' ' GLU . . . . . 0.416 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 27.8 tp10 -59.8 -43.78 94.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.235 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.8 -40.33 97.27 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.276 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' B' ' 290' ' ' ALA . 95.5 mt -62.85 -42.63 99.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.682 0.277 . . . . 0.0 110.926 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 295' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 291' ' ' ILE . 91.4 t -65.61 -43.59 93.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.049 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 296' ' ' LYS . . . . . 0.416 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 68.4 mttm -63.49 -41.94 98.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.127 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.62 -41.89 78.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.055 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -126.92 94.66 4.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -93.73 106.52 18.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 300' ' ' ILE . . . . . 0.437 HG13 ' N ' ' B' ' 301' ' ' ASP . 11.4 tp -122.07 166.18 17.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.005 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 301' ' ' ASP . . . . . 0.437 ' N ' HG13 ' B' ' 300' ' ' ILE . 33.0 m-20 -61.3 135.51 57.74 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.578 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.09 122.06 30.78 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.745 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.36 131.21 43.38 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.64 2.227 . . . . 0.0 111.939 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.05 -36.43 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.975 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.02 -43.11 91.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.298 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.06 -40.54 90.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.903 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 307' ' ' ILE . . . . . 0.418 ' O ' HG13 ' B' ' 311' ' ' ILE . 97.0 mt -62.75 -45.99 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.754 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.17 -41.53 98.41 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.19 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 46.8 m -62.46 -45.49 92.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.316 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 310' ' ' GLU . . . . . 0.555 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 62.9 mm-40 -68.25 -37.99 81.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.536 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.0 mt -62.13 -43.68 98.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.625 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.578 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 17.2 t70 -60.46 -47.14 87.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.792 0.33 . . . . 0.0 111.012 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.46 -44.33 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.536 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 84.7 mt -62.76 -40.38 97.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.578 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 85.2 mtm180 -62.18 -42.4 99.24 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 32.5 mtt85 -64.91 -38.47 91.07 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -63.1 -45.16 93.35 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.074 0.464 . . . . 0.0 109.87 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.27 -36.32 79.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.745 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 319' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -61.89 -36.18 80.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.123 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -63.13 -39.43 94.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.424 0.63 . . . . 0.0 109.506 175.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -76.25 -9.91 59.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.41 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -91.21 -7.79 50.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.817 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 323' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 137.14 -12.12 3.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.809 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 112.53 42.18 0.98 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.005 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 325' ' ' ASN . . . . . 0.546 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 33.5 t-20 -85.27 127.04 34.17 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.876 0.369 . . . . 0.0 110.356 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 326' ' ' GLU . . . . . 0.47 ' OE1' ' HG3' ' B' ' 327' ' ' LYS . 2.0 tm-20 -130.2 144.49 51.39 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.47 ' HG3' ' OE1' ' B' ' 326' ' ' GLU . 35.5 mtmm 71.33 -47.92 0.66 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.627 0.771 . . . . 0.0 112.215 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 328' ' ' GLN . . . . . 0.546 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 14.2 mm100 -65.9 -13.06 58.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.083 0.468 . . . . 0.0 110.707 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.38 -21.81 60.44 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.643 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.42 HD12 HH12 ' B' ' 315' ' ' ARG . 57.4 tp -61.84 -33.43 74.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.638 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -79.5 -10.04 59.73 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.591 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 75.5 mt -65.14 147.41 98.57 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.61 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.23 141.18 97.58 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.574 2.183 . . . . 0.0 112.884 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 334' ' ' ARG . . . . . 0.472 ' HG3' HD13 ' B' ' 311' ' ' ILE . 27.2 ttt85 -85.27 -36.33 20.96 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.511 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -56.74 -46.39 81.39 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 336' ' ' LEU . . . . . 0.523 HD12 ' CD ' ' B' ' 224' ' ' GLU . 73.3 mt -91.86 12.08 22.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -117.96 -28.56 5.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.131 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -66.49 -31.7 72.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.714 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.61 -49.53 77.16 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.03 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -75.94 -22.47 55.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.702 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.435 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.42 -41.96 98.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 342' ' ' LYS . . . . . 0.51 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.3 tttt -60.72 -44.56 96.46 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 343' ' ' ARG . . . . . 0.574 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.1 mmt85 -59.93 -46.18 90.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.983 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.29 -39.29 85.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.255 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 341' ' ' ALA . 87.8 t -64.78 -43.31 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.436 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.51 HG23 ' O ' ' B' ' 342' ' ' LYS . 73.8 t -60.33 -43.12 93.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.404 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 343' ' ' ARG . 91.1 t -60.02 -45.68 95.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.34 -42.78 99.7 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.204 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.7 -44.27 94.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.43 -45.21 92.0 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.695 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.461 ' O ' HG13 ' B' ' 355' ' ' ILE . 94.4 mt -66.66 -39.62 88.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.915 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.21 -42.53 97.25 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.628 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -64.3 -39.79 94.62 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.978 0.389 . . . . 0.0 110.559 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.3 -46.36 96.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.042 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 355' ' ' ILE . . . . . 0.461 HG13 ' O ' ' B' ' 351' ' ' LEU . 71.0 mt -63.6 -46.29 95.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.399 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -64.6 -64.73 0.8 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 38.5 m -65.96 -43.24 88.5 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.76 -11.42 60.16 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.168 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 62.38 64.86 0.91 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.718 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.9 mt -98.02 136.97 37.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.203 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.09 150.22 45.29 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.195 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.92 120.02 13.53 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 363' ' ' ASP . . . . . 0.496 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.5 t70 -90.17 108.34 19.68 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.939 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 364' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 66.2 mm-40 -61.68 -34.65 76.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.67 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -66.03 -41.58 90.73 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.49 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 366' ' ' ARG . . . . . 0.416 HH12 ' CD ' ' B' ' 409' ' ' GLU . 45.9 ttt180 -62.47 -40.79 97.79 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.001 0.429 . . . . 0.0 110.137 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 367' ' ' VAL . . . . . 0.496 HG23 ' O ' ' B' ' 363' ' ' ASP . 88.4 t -61.28 -39.71 83.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.236 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 368' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.2 mmmt -56.64 -44.07 80.9 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.511 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.21 -40.2 98.81 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.2 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.33 -42.88 98.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 110.239 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.64 -43.68 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.797 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -64.04 -41.96 97.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.76 -41.73 91.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.053 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 48.6 ttp -65.43 -39.7 92.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.028 0.442 . . . . 0.0 110.511 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 375' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -63.28 -24.67 67.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.596 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 44.9 m -73.47 -6.34 45.78 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.45 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.02 -2.09 58.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.532 0.682 . . . . 0.0 110.284 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -113.08 172.78 6.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.976 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -65.7 -47.69 74.54 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -121.76 116.24 30.44 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.803 0.335 . . . . 0.0 110.999 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 381' ' ' PRO . . . . . 0.461 ' O ' HG13 ' B' ' 385' ' ' ILE . 46.5 Cg_exo -58.21 -36.49 97.74 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.909 2.406 . . . . 0.0 113.116 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -64.72 -43.42 93.48 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -174.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.81 -36.81 84.4 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.933 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.44 -42.96 94.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.302 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 385' ' ' ILE . . . . . 0.461 HG13 ' O ' ' B' ' 381' ' ' PRO . 65.7 mt -62.23 -44.83 99.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.335 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -64.93 -37.87 89.07 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.765 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -58.75 -47.06 85.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.443 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 388' ' ' TYR . . . . . 0.44 ' O ' ' HG3' ' B' ' 395' ' ' MET . 2.8 m-85 -69.67 -44.78 69.81 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 18.9 p -68.88 -16.26 63.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.19 4.6 48.94 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.746 0.307 . . . . 0.0 111.19 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -129.57 112.04 13.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 110.532 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -64.72 -37.5 87.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.263 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -57.23 -53.38 58.74 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.021 0.439 . . . . 0.0 110.558 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.47 -40.5 95.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.737 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' B' ' 388' ' ' TYR . 89.1 mtp -61.62 -46.18 90.92 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.89 -44.18 64.17 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.415 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -64.13 -42.13 96.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.374 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 52.3 tpp -63.1 -41.17 99.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.838 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' B' ' 395' ' ' MET . 83.0 mtm180 -65.76 -34.8 79.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.917 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.44 -42.33 99.38 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 90.4 t -66.22 -43.77 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.622 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.44 94.99 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.544 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.25 -37.14 86.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.48 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -58.29 -47.21 84.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.855 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.09 -38.14 89.98 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.564 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -61.71 -42.25 98.69 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.209 0.318 . . . . 0.0 110.672 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.53 97.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.047 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.39 -43.14 91.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.572 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 409' ' ' GLU . . . . . 0.519 ' HG3' HH12 ' B' ' 283' ' ' ARG . 96.6 mt-10 -63.95 -35.84 82.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.17 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.57 94.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.474 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.0 -43.06 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.474 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.21 -39.42 92.72 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.531 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.76 67.55 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.987 0.422 . . . . 0.0 111.311 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -98.08 -7.62 29.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.697 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.37 169.58 9.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.316 0.579 . . . . 0.0 112.261 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -90.78 99.41 12.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.808 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 68.4 t -86.75 131.68 34.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.697 0.284 . . . . 0.0 110.751 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.9 t -124.28 155.3 38.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.941 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -113.41 130.71 56.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.844 0.354 . . . . 0.0 110.749 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -147.48 141.25 25.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.201 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.2 150.9 19.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.335 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.1 t -158.0 174.96 14.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.361 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 17.4 p -85.63 163.67 18.16 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 111.81 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -65.01 -36.42 84.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.449 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -57.38 -38.33 74.08 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.84 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.68 -32.8 74.56 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.858 0.361 . . . . 0.0 111.166 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.25 -12.7 59.04 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.8 mmt -78.28 -8.48 58.43 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.13 0.491 . . . . 0.0 110.785 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -75.71 79.84 2.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.193 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -108.13 26.56 10.26 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.556 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -85.06 -11.79 54.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.853 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.677 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.025 -179.537 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ptp . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 120.534 0.207 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.2 tm0? -95.24 105.45 17.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.61 159.81 34.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.322 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.3 m -124.1 116.87 23.48 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.661 0.267 . . . . 0.0 110.881 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -134.93 135.87 52.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 47.8 mt-10 -111.7 175.86 5.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.102 0.477 . . . . 0.0 111.727 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 t -124.27 141.46 52.05 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.674 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.0 m -99.71 -75.91 0.56 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.917 0.389 . . . . 0.0 111.197 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -162.21 148.23 13.14 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.52 -123.02 29.75 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.037 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.547 HD11 HG12 ' A' ' 111' ' ' VAL . 1.2 mm? -100.27 4.54 44.25 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 120.974 0.416 . . . . 0.0 110.072 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -75.26 139.82 25.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.596 -0.729 . . . . 0.0 113.085 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -133.93 151.67 51.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.048 0.539 . . . . 0.0 109.895 -178.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -120.32 130.15 54.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.51 -89.95 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.276 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.5 p 40.17 81.27 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.7 tp -107.85 134.5 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.219 0.533 . . . . 0.0 111.897 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.0 p -94.37 126.51 39.67 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.771 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.494 HG13 HG12 ' A' ' 24' ' ' ILE . 14.2 pt -126.69 161.21 33.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.356 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -70.67 155.07 41.21 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.379 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.5 -39.39 83.66 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.952 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.61 -25.66 65.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.3 t -80.64 -42.2 22.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.428 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 20' ' ' ALA . 75.0 mt -59.16 -69.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.321 -176.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.508 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 77.1 mm-40 -67.37 -6.95 21.27 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.5 m -95.64 -64.19 1.08 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.988 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.21 66.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.5 t -65.01 -43.87 96.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.354 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 22.3 ttmm -61.78 -47.2 86.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.6 m -68.85 -36.59 78.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.811 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -60.93 -39.05 87.97 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.113 0.483 . . . . 0.0 110.652 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.56 -38.44 90.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.819 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.22 -44.02 99.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.171 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.76 -43.64 98.28 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.136 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.38 -35.68 74.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.24 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.24 94.9 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.068 0.461 . . . . 0.0 110.285 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.34 -34.09 77.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.013 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -61.09 -35.92 78.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.955 0.407 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 t -90.61 -5.85 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.412 0.625 . . . . 0.0 109.77 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 64.96 27.5 12.68 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.329 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.402 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.7 pp -103.67 7.98 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.069 0.461 . . . . 0.0 111.457 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.62 -34.81 79.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.514 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.02 -4.54 86.15 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.816 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -89.17 -8.2 54.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.792 0.329 . . . . 0.0 111.463 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -92.38 95.79 9.88 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.82 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -78.29 109.35 12.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.57 96.77 1.62 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 115.734 1.054 . . . . 0.0 115.734 -169.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -66.52 -43.24 85.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.457 HG12 ' HB ' ' A' ' 54' ' ' VAL . 11.6 t -104.79 115.12 63.11 Favored Pre-proline 0 N--CA 1.44 -0.929 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.265 176.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.12 139.95 86.25 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.188 1.926 . . . . 0.0 111.124 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.586 ' HA ' HG12 ' A' ' 54' ' ' VAL . 22.7 ttt -61.39 -40.08 93.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.507 -173.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -60.81 -47.77 84.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.047 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.497 HD13 HH22 ' B' ' 193' ' ' ARG . 74.9 mt -69.42 -44.97 79.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 51' ' ' MET . 14.6 p -64.11 -44.35 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.7 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.416 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -66.73 -24.06 66.18 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.381 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -85.61 -36.92 20.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.127 0.489 . . . . 0.0 110.3 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -76.54 -49.27 16.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.499 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -105.21 9.58 34.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.883 0.373 . . . . 0.0 110.483 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.628 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -59.18 -47.51 90.46 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.9 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.0 -25.49 65.43 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -61.84 -44.99 95.73 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.813 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 65' ' ' ASP . 10.7 p -126.98 24.89 2.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.564 0.697 . . . . 0.0 110.703 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.628 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 21.1 ttm180 -58.8 -33.19 70.07 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.506 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -60.49 -50.02 75.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.535 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.521 ' HB2' HG22 ' A' ' 62' ' ' VAL . 1.7 m-20 -75.24 -21.61 58.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.04 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 62' ' ' VAL . 66.7 t -63.58 -43.77 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 173.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.62 -39.01 92.43 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.107 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.97 -42.61 99.81 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.238 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.71 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 32.0 t70 -63.01 -43.91 97.43 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.197 0.498 . . . . 0.0 110.006 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.7 -41.3 97.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.299 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 49.5 ttp -60.69 -43.22 98.01 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -62.55 -44.05 97.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.284 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.71 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 32.7 mtp85 -66.08 -41.5 90.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.932 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -66.07 -41.09 91.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.388 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -60.4 -48.08 83.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.678 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.0 tt -67.41 -39.7 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.201 0.524 . . . . 0.0 111.347 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.11 -40.85 91.03 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.388 0.613 . . . . 0.0 110.185 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.68 87.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.633 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.3 pt -64.21 -39.27 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.913 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.97 -44.09 99.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 120.638 0.256 . . . . 0.0 111.275 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -29.32 60.96 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -86.54 -2.57 58.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 66.22 34.55 6.54 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.242 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.1 mt -96.06 113.43 30.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -110.48 100.84 46.65 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.908 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.14 136.34 9.01 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.076 1.85 . . . . 0.0 111.347 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.93 132.98 36.57 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.62 -125.09 7.4 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.055 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.22 130.07 18.13 Favored Pre-proline 0 C--N 1.313 -1.018 0 O-C-N 122.834 -0.215 . . . . 0.0 110.455 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.88 150.07 60.77 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.132 1.888 . . . . 0.0 110.828 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 m -94.96 116.81 29.16 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.108 0.48 . . . . 0.0 110.021 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.564 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 95.9 m-85 -91.82 114.24 26.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.94 99.56 23.27 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.138 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 58.5 Cg_endo -95.52 161.8 1.52 Allowed 'Trans proline' 0 N--CA 1.437 -1.826 0 C-N-CA 123.461 2.774 . . . . 0.0 111.65 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.82 -174.86 33.61 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.176 -1.011 . . . . 0.0 110.874 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.72 133.47 38.31 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -89.24 125.4 35.07 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.938 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -102.48 131.31 49.25 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.4 tp -81.48 102.42 10.55 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.14 -27.54 5.32 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.243 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -103.0 177.02 4.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.677 0.275 . . . . 0.0 110.707 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -81.61 168.17 18.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -125.28 139.99 53.22 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.095 0.474 . . . . 0.0 111.313 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.0 m -120.01 134.4 55.26 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.158 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -140.51 167.16 22.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.572 0.225 . . . . 0.0 111.582 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -87.05 -91.01 0.11 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.406 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 67.2 t 64.92 100.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.358 0.599 . . . . 0.0 110.564 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -99.65 146.09 26.87 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.588 -175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.409 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 10.6 p90 -159.39 -87.39 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -90.12 156.64 18.21 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.547 HG12 HD11 ' A' ' 11' ' ' LEU . 28.8 m -125.82 161.56 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.846 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -166.14 102.44 0.7 Allowed Pre-proline 0 N--CA 1.479 0.99 0 CA-C-O 120.577 0.227 . . . . 0.0 111.272 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -94.39 158.49 2.02 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 C-N-CA 123.39 2.727 . . . . 0.0 114.373 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -143.29 139.64 30.24 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.735 0.814 . . . . 0.0 109.888 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 116' ' ' GLU . 20.6 t -133.9 160.89 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 120.897 0.379 . . . . 0.0 111.78 -176.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 115' ' ' VAL . 43.5 mt-10 -140.66 153.03 45.84 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.842 0.857 . . . . 0.0 109.209 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.8 mt -112.47 130.58 55.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -141.85 154.4 45.13 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.133 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.54 22.91 74.46 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.903 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.49 -39.94 95.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.916 0.389 . . . . 0.0 111.199 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -70.24 -10.78 59.92 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.87 1.48 55.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.147 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.57 109.01 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.124 0.488 . . . . 0.0 109.957 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -104.37 119.64 39.41 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.062 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.83 127.07 59.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.883 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.7 119.04 32.19 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.571 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.556 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 78.6 tttt -111.62 106.29 56.77 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.43 128.61 12.1 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.962 1.775 . . . . 0.0 111.639 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.38 114.67 39.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.17 161.58 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -150.73 166.19 31.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.553 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.3 127.44 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.722 0.296 . . . . 0.0 110.25 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.0 p -108.15 176.41 5.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.394 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.86 -38.94 87.3 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.019 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.67 80.2 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.7 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -64.94 -43.38 92.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.327 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.49 -47.24 92.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.955 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.04 -42.61 99.36 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.003 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.26 -42.58 99.26 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.611 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.534 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -61.83 -44.92 95.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.695 0.284 . . . . 0.0 110.59 178.329 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.43 -42.44 98.69 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.272 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.87 -43.84 98.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.82 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.9 m -63.0 -41.2 99.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.553 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.6 mt -60.82 -42.23 97.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.448 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -66.14 -37.21 85.13 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.05 0.453 . . . . 0.0 110.518 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -68.46 -13.92 62.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.162 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -89.62 -6.92 55.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.432 0.634 . . . . 0.0 110.151 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -89.59 93.47 9.5 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.726 0.774 . . . . 0.0 111.952 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.81 126.17 10.07 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 247' ' ' GLU . 23.6 p -100.43 -163.76 1.05 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.505 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 4.4 p-90 -70.17 119.68 14.72 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 151' ' ' TRP . 26.5 mttp -174.52 168.34 3.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.691 1.197 . . . . 0.0 109.132 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -114.92 164.21 14.46 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -172.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 153' ' ' GLU . 9.9 pttp 71.28 -179.42 0.23 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.861 1.665 . . . . 0.0 113.807 175.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 13.0 t70 72.92 -90.32 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 124.966 1.306 . . . . 0.0 111.055 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 142.76 102.48 0.44 Allowed Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.954 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -132.75 64.51 1.61 Allowed 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.58 127.05 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.122 -176.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.666 ' HB3' ' HB2' ' A' ' 162' ' ' ASP . 9.2 tp10 -95.63 154.11 17.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.75 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.89 13.8 6.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 189' ' ' MET . 37.8 tt0 -155.47 26.08 0.4 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.585 0.707 . . . . 0.0 110.511 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.666 ' HB2' ' HB3' ' A' ' 159' ' ' GLU . 2.9 t70 -109.39 -170.2 1.61 Allowed 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.781 -0.575 . . . . 0.0 111.036 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -103.55 118.71 37.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.4 t -114.72 121.66 67.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.002 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.4 m -83.4 109.66 17.5 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.9 mt -115.08 128.46 72.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.106 0.479 . . . . 0.0 112.141 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.484 ' OD2' ' HB3' ' A' ' 236' ' ' ASN . 5.0 p-10 -103.03 113.33 26.72 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 172.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -142.46 162.57 35.13 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.228 0.537 . . . . 0.0 112.216 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.1 m -133.6 134.09 42.84 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.219 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.31 103.56 1.84 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.209 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 29.0 m -128.1 121.31 29.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 46.1 t -94.13 -87.13 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.833 0.349 . . . . 0.0 111.147 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -94.38 42.08 1.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.207 0.527 . . . . 0.0 109.822 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 81.33 12.45 82.09 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -123.99 139.28 54.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -92.09 137.42 32.38 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.372 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -107.26 -176.88 3.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.655 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.38 -39.74 88.38 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.402 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.21 -175.52 39.15 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.964 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 84.63 16.68 65.47 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.138 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -105.74 97.87 7.64 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.02 145.8 32.44 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.844 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 38.3 m -136.1 145.29 45.75 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.803 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 54.41 31.15 14.03 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.801 0.688 . . . . 0.0 110.543 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -85.98 127.31 34.61 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.3 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.5 115.03 39.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.49 0.662 . . . . 0.0 110.336 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 56.7 tp -103.33 126.22 50.37 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.98 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -90.65 111.88 23.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.56 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.2 mtp -81.24 150.68 28.48 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.95 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.38 -14.62 64.25 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.595 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -95.13 0.49 54.28 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.802 0.334 . . . . 0.0 111.207 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.97 55.98 6.8 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.421 HH22 HD13 ' B' ' 53' ' ' ILE . 19.3 mmt85 -100.01 -5.96 27.26 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.197 0.522 . . . . 0.0 110.55 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.5 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -135.5 178.13 7.28 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.076 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.7 mm -68.38 133.87 91.12 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.37 134.55 45.31 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.095 1.864 . . . . 0.0 111.499 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.77 -42.87 1.79 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.958 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -67.45 -52.92 33.62 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -74.2 -17.21 60.93 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.847 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.51 -30.0 22.29 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.891 0.377 . . . . 0.0 110.512 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.7 -19.05 76.31 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.008 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.4 mt -62.39 -38.07 80.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-O 120.883 0.373 . . . . 0.0 110.407 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -51.51 131.26 29.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.7 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.42 -10.66 63.23 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.353 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -95.26 159.23 15.11 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -103.21 156.41 17.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.104 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.57 134.69 51.69 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.941 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 78.86 34.56 33.91 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.637 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -124.68 130.17 51.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.879 0.371 . . . . 0.0 111.06 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' A' ' 236' ' ' ASN . 79.0 mt-10 -102.42 118.17 36.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.529 ' O ' ' HB ' ' A' ' 212' ' ' THR . 44.3 t80 -135.24 -36.84 0.79 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 99.6 m 77.65 143.94 0.08 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.339 0.256 . . . . 0.0 110.423 -176.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.2 tp -130.11 144.61 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.934 0.397 . . . . 0.0 110.909 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.79 104.68 16.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.092 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 65.7 t -119.31 128.5 75.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.5 m -98.42 -16.84 19.1 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -175.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 66.62 154.43 0.13 Allowed Pre-proline 0 N--CA 1.487 1.381 0 CA-C-O 121.117 0.484 . . . . 0.0 111.615 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.33 150.87 53.43 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.154 1.903 . . . . 0.0 111.532 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -65.82 -38.44 88.92 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.18 77.1 7.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.602 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -120.06 140.61 50.76 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -61.06 -29.86 69.98 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.76 108.1 20.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.2 tt0 -63.42 -33.59 75.88 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.427 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 30.8 p-10 -63.97 -25.16 68.01 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.737 0.303 . . . . 0.0 110.995 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 90.4 mt -109.8 -3.39 16.72 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.6 ptmt -67.85 119.12 12.02 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.951 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.8 21.91 71.56 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.94 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 225' ' ' ASN . 35.0 mmtp -100.93 135.52 42.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -86.26 110.38 19.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.004 0.43 . . . . 0.0 110.85 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -99.36 149.54 23.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.082 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -105.21 -47.17 4.04 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -175.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 58.59 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.02 0.438 . . . . 0.0 111.041 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.55 -49.2 77.15 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.0 mm 62.8 93.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 123.493 0.496 . . . . 0.0 110.842 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.484 ' HB3' ' OD2' ' A' ' 167' ' ' ASP . 9.6 t-20 -82.99 -47.29 11.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.55 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 12.6 tp 57.46 86.8 0.07 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.151 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.25 -58.06 2.67 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -101.49 -78.97 0.52 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 24.9 t 70.43 142.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 123.482 0.489 . . . . 0.0 110.512 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -75.1 -46.79 32.26 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.277 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 64.75 163.24 0.14 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -162.0 94.18 0.91 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 10.1 tp10 -123.37 157.14 33.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.379 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.1 tt 72.72 118.5 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.456 0.703 . . . . 0.0 110.932 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -87.03 115.74 1.2 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.879 2.386 . . . . 0.0 113.82 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.421 ' HG2' ' OG1' ' A' ' 150' ' ' THR . 12.5 pt-20 -130.28 -161.54 1.13 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 8.0 mp -87.02 102.91 14.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.299 0.571 . . . . 0.0 111.892 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 251' ' ' GLU . 37.9 m -134.39 132.43 39.41 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -90.15 7.28 38.75 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLU . . . . . 0.494 ' H ' HG22 ' A' ' 249' ' ' THR . 45.9 mt-10 -88.15 -15.22 36.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -73.3 -7.31 51.01 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.293 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 261' ' ' GLY . 41.8 pt -105.13 -4.3 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.629 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -136.96 11.52 3.1 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -129.92 8.25 5.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.062 0.458 . . . . 0.0 109.939 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -124.43 137.0 54.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.742 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 67.79 -129.9 27.65 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 116.13 -0.486 . . . . 0.0 114.041 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.4 t -116.98 131.69 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 122.693 0.397 . . . . 0.0 110.932 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.628 ' HG2' ' H ' ' A' ' 260' ' ' ASP . 22.1 tt0 58.28 -155.01 0.35 Allowed 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.795 0.684 . . . . 0.0 109.222 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ASP . . . . . 0.628 ' H ' ' HG2' ' A' ' 259' ' ' GLU . 1.7 p-10 -128.89 136.93 51.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 253' ' ' ILE . . . -131.82 171.74 21.2 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.238 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.0 p -82.85 177.44 8.65 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.076 0.55 . . . . 0.0 110.44 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 94.9 t -60.7 -48.24 89.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.116 0.484 . . . . 0.0 110.791 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.2 pm0 -81.4 -33.5 32.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.766 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.1 -40.3 99.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.374 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 270' ' ' VAL . 54.2 tp -62.16 -45.3 94.05 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -62.89 -44.96 94.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.577 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.573 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.27 -47.34 79.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.347 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -66.66 -38.61 87.22 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 266' ' ' LEU . 67.1 t -65.13 -42.7 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.232 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -57.94 -48.1 80.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.792 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.7 ptmt -66.33 -42.91 87.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.763 0.316 . . . . 0.0 111.413 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.31 -36.64 83.44 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.6 mmm -62.88 -42.28 99.71 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.207 0.527 . . . . 0.0 109.964 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 278' ' ' LEU . 56.9 mt-10 -69.36 -30.88 68.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.27 177.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 55.0 ttp180 -62.57 -43.42 98.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.609 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -69.93 -28.21 65.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.114 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 275' ' ' GLU . 65.3 tp -61.08 -37.72 83.71 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 60.8 tttm -58.14 -45.84 86.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.73 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -45.06 95.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.432 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.58 -50.67 72.61 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.663 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.8 -45.17 95.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.17 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.604 HH12 ' HG3' ' A' ' 409' ' ' GLU . 2.2 tpt180 -61.44 -46.37 90.39 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.897 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -64.14 -39.85 94.91 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.242 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.564 HH21 ' CG ' ' A' ' 285' ' ' ARG . 0.0 OUTLIER -60.27 -44.22 95.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.587 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.03 -43.55 85.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.001 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -61.12 -45.79 93.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.39 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 22.6 p -59.73 -43.64 94.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.03 -41.17 91.25 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.856 0.36 . . . . 0.0 111.189 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.55 87.03 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.8 mm -64.65 -44.46 96.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.466 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.534 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 33.1 tp10 -62.58 -40.73 97.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.95 0.405 . . . . 0.0 110.588 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.38 -43.73 97.87 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.495 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.5 -42.87 98.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.68 -46.98 93.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.227 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LYS . . . . . 0.534 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.0 mttm -65.41 -41.57 93.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.898 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.76 -41.2 79.21 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -122.64 98.43 5.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.025 0.441 . . . . 0.0 112.182 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.52 114.7 27.31 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 301' ' ' ASP . 10.7 tp -128.43 161.65 36.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.553 0.216 . . . . 0.0 110.984 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.439 ' N ' HG13 ' A' ' 300' ' ' ILE . 25.4 m-20 -65.26 140.54 58.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.846 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.7 t -115.04 123.6 31.57 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.283 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.53 124.21 14.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.211 1.941 . . . . 0.0 111.535 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.89 85.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.46 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.07 -42.34 76.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.268 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.24 -41.26 85.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.552 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.14 -46.2 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.855 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.46 -43.49 88.88 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.635 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.478 ' O ' HG23 ' A' ' 313' ' ' VAL . 49.9 m -60.89 -45.92 92.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.201 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.574 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 60.2 mm-40 -69.05 -37.44 78.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.409 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 95.8 mt -62.29 -44.14 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.115 0.483 . . . . 0.0 109.975 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.41 -39.3 93.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.647 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 309' ' ' SER . 86.2 t -65.52 -43.09 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.296 176.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 80.4 mt -61.21 -39.01 88.65 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.812 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.475 ' NH1' HD12 ' A' ' 330' ' ' LEU . 65.9 mtm180 -61.41 -37.91 85.16 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.625 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -64.63 -43.05 94.95 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.771 0.319 . . . . 0.0 111.037 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -64.74 -41.81 95.67 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.21 0.528 . . . . 0.0 110.511 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.75 -41.93 78.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.159 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.72 -35.43 80.73 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.999 0.428 . . . . 0.0 110.979 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -56.21 -44.08 79.14 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.759 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.68 -36.63 60.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.931 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -60.1 -45.05 94.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.324 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLY . . . . . 0.502 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . -170.61 17.64 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.096 -1.05 . . . . 0.0 112.857 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 70.79 26.65 73.66 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.209 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -97.9 154.03 17.93 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.292 0.568 . . . . 0.0 112.306 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.0 -178.49 5.47 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 70.28 -60.98 0.47 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.124 0.57 . . . . 0.0 111.592 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -69.83 -15.33 63.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.112 0.482 . . . . 0.0 110.856 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.443 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -61.66 -19.48 62.36 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.584 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.475 HD12 ' NH1' ' A' ' 315' ' ' ARG . 45.3 tp -62.19 -34.67 76.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.771 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -77.92 -0.54 27.91 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.961 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.62 144.2 85.83 Favored Pre-proline 0 C--O 1.238 0.454 0 O-C-N 122.142 -0.349 . . . . 0.0 110.715 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.431 ' HB2' HD13 ' A' ' 336' ' ' LEU . 48.1 Cg_exo -56.65 132.43 51.7 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.777 2.318 . . . . 0.0 113.114 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -67.24 -44.46 79.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.521 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.8 pm0 -64.6 -31.55 72.82 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 333' ' ' PRO . 10.9 mp -65.62 -28.62 69.25 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.584 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -107.6 -20.62 13.18 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.08 -33.26 75.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.9 -44.77 96.11 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.129 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -80.83 -24.63 38.32 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.259 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.35 -38.4 90.89 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.329 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.3 tttt -57.92 -44.92 87.15 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.733 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 347' ' ' VAL . 9.1 mmt180 -62.28 -44.21 97.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.947 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -65.51 -39.99 92.47 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.097 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.8 t -63.29 -45.96 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.101 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 342' ' ' LYS . 98.5 t -63.74 -43.64 98.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 343' ' ' ARG . 78.0 t -60.43 -45.5 96.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.543 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.6 -42.84 99.83 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.02 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.47 -44.13 95.3 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.638 0.256 . . . . 0.0 111.313 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.97 -45.59 88.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.059 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.56 -39.98 88.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.022 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.48 -40.23 97.42 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.125 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.59 -36.62 83.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 110.648 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.91 -43.57 96.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.26 -44.33 99.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.894 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -68.2 -48.92 63.93 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.8 m -64.73 -44.61 89.61 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -88.14 -7.69 56.53 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.735 0.303 . . . . 0.0 111.142 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 60.58 60.31 1.98 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.122 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.1 mt -79.29 153.61 29.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.529 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -130.43 154.15 48.03 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.968 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -78.72 105.98 10.39 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 172.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.524 ' O ' HG23 ' A' ' 367' ' ' VAL . 31.7 t70 -82.18 111.5 18.34 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.376 -0.529 . . . . 0.0 112.054 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 5.1 mm-40 -62.73 -34.33 76.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.038 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -63.64 -44.11 94.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -65.48 -38.88 91.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.193 0.521 . . . . 0.0 109.978 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 363' ' ' ASP . 84.2 t -61.64 -36.77 75.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.578 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 27.2 mmmt -54.81 -47.87 73.5 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.633 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.95 -41.26 99.93 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.521 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.94 -42.86 99.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 0.0 110.713 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.58 -43.43 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.253 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.45 -37.77 87.88 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.276 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -65.38 -41.23 93.94 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.546 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.4 ttm -64.82 -42.42 95.0 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.011 0.434 . . . . 0.0 110.548 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.68 -24.4 67.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.756 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 55.0 m -75.19 -5.13 42.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.65 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.52 5.44 49.52 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.903 0.383 . . . . 0.0 111.18 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -116.93 171.75 7.71 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.762 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -60.61 -44.69 96.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.013 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -130.04 114.41 17.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.793 0.33 . . . . 0.0 110.239 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.69 -27.27 27.02 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.499 2.133 . . . . 0.0 113.123 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -65.1 -45.72 84.04 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.8 -36.29 83.09 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.567 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.74 -42.39 94.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.473 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.77 -44.18 98.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 50.2 mt-10 -66.05 -43.21 88.15 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.56 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.34 -47.84 82.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.959 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -65.64 -45.66 82.17 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.433 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 59.1 p -73.17 -16.38 61.44 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 99.3 mttt -91.06 9.08 32.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.115 0.483 . . . . 0.0 111.291 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -131.24 113.36 13.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.489 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.37 -41.69 98.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.72 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -60.69 -45.3 94.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.041 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.1 -42.68 99.63 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.482 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.554 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 94.5 mtp -63.16 -45.47 91.71 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.051 0.453 . . . . 0.0 110.56 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.407 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 15.1 t70 -64.98 -43.98 90.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.268 -177.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -62.83 -41.76 99.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.395 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 49.0 tpp -63.98 -40.3 96.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.775 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 395' ' ' MET . 73.1 mtm180 -63.63 -35.15 79.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.837 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -62.8 -42.9 99.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.098 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.52 -43.57 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -61.4 -39.69 91.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.605 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 40.8 tp -63.79 -38.71 92.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.033 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 408' ' ' VAL . 75.2 tt0 -54.53 -50.9 66.78 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.267 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 35.2 mt-10 -66.78 -36.34 82.19 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.45 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -61.61 -44.83 96.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.833 0.349 . . . . 0.0 110.701 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -62.81 -41.85 99.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.719 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.571 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 89.1 t -65.73 -43.7 93.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.753 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.604 ' HG3' HH12 ' A' ' 283' ' ' ARG . 96.3 mt-10 -63.21 -36.79 84.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.199 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.12 -41.32 99.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.145 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 407' ' ' ALA . 97.7 t -65.38 -42.51 93.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.313 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 68.4 mt -60.3 -42.02 94.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.734 -176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.15 -23.28 67.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.771 0.32 . . . . 0.0 111.432 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -97.98 -3.97 37.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.464 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -109.51 -179.57 3.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.393 0.616 . . . . 0.0 112.399 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.69 102.24 13.95 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.215 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.8 t -94.81 128.45 46.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.373 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -120.34 128.96 53.74 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.556 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 40.1 mt-10 -100.55 118.79 37.43 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.382 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -130.03 134.51 47.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.097 0.475 . . . . 0.0 111.543 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.87 142.23 46.04 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -149.1 170.06 19.26 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.554 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 67.7 p -86.63 164.31 16.89 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.28 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -67.05 -26.11 66.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.982 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -61.88 -38.61 88.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.694 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -67.02 -30.11 70.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.778 0.323 . . . . 0.0 110.838 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.6 mp -80.92 -8.56 59.77 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 111.363 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.0 mmt -81.2 -7.3 59.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.133 0.492 . . . . 0.0 110.529 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -78.19 71.79 4.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.543 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -121.71 28.86 7.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.609 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -66.62 -38.35 86.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.52 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.765 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.465 -179.494 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.661 0.267 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -100.03 105.04 16.66 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.88 162.44 38.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.857 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 47.2 m -124.91 119.3 28.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.887 0.375 . . . . 0.0 111.23 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -136.73 137.08 47.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 49.8 mt-10 -114.3 176.35 5.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.01 0.433 . . . . 0.0 111.125 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' B' ' 13' ' ' ARG . 9.7 t -124.21 148.8 47.03 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.46 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 24.1 m -107.46 -82.12 0.55 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.868 0.366 . . . . 0.0 110.949 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -155.74 146.77 22.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.25 -123.65 28.2 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.141 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.531 HD11 HG12 ' B' ' 111' ' ' VAL . 1.2 mm? -100.08 5.84 44.96 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' B' ' 107' ' ' VAL . . . -73.48 142.6 31.52 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.376 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 0.3 OUTLIER -137.14 149.94 47.64 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.079 0.551 . . . . 0.0 109.938 -178.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -116.74 128.9 55.75 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.44 -92.31 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.039 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.1 p 40.75 81.66 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.031 0.532 . . . . 0.0 112.294 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 8.4 tp -108.0 136.84 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.05 0.452 . . . . 0.0 111.725 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 9.2 p -96.13 130.5 43.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.122 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.421 HG13 HG12 ' B' ' 24' ' ' ILE . 14.6 pt -131.43 162.45 39.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.501 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.539 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -74.28 157.53 35.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.304 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.61 80.4 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -65.91 -37.95 87.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.69 0.281 . . . . 0.0 110.662 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t -65.71 -43.62 88.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.933 0.397 . . . . 0.0 110.671 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.539 HG13 ' O ' ' B' ' 20' ' ' ALA . 77.0 mt -58.42 -69.04 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.26 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.523 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 76.7 mm-40 -68.53 -7.94 36.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -172.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 45.9 m -96.13 -63.98 1.1 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.946 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.2 -45.43 73.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.03 -43.42 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.925 0.393 . . . . 0.0 110.935 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.523 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.6 ttmm -61.97 -46.9 87.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.928 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.4 m -69.73 -36.39 75.83 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.468 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.85 -38.35 90.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.941 0.4 . . . . 0.0 110.725 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.33 -38.68 90.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.88 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.76 -43.46 97.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.108 0.48 . . . . 0.0 109.905 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -63.14 -42.73 99.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.49 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.07 -33.98 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.309 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.83 96.13 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.18 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' B' ' 40' ' ' ARG . 98.5 mttt -65.63 -34.25 77.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.97 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.56 -37.18 82.86 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.779 0.323 . . . . 0.0 111.001 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 t -87.97 -8.42 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.243 0.544 . . . . 0.0 109.835 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' B' ' 37' ' ' LYS . 35.1 mmt180 66.26 31.44 8.54 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.216 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.81 6.34 9.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.399 . . . . 0.0 111.51 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.23 -35.22 80.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.512 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.64 -3.52 79.07 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.942 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -91.15 -8.67 48.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.701 0.251 . . . . 0.0 111.646 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -91.81 93.25 8.76 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.742 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -76.82 106.45 8.5 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.23 99.36 2.1 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 -169.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.99 -45.89 79.98 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' B' ' 54' ' ' VAL . 15.1 t -100.27 115.22 65.68 Favored Pre-proline 0 C--O 1.249 1.044 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.311 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.0 139.76 85.26 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.428 2.085 . . . . 0.0 111.143 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.549 ' HA ' HG12 ' B' ' 54' ' ' VAL . 23.5 ttt -63.28 -38.57 91.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.596 -174.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' B' ' 29' ' ' LYS . 31.3 p-10 -64.28 -32.02 73.45 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.331 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.421 HD13 HH22 ' A' ' 193' ' ' ARG . 92.5 mt -87.51 -45.05 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.822 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' B' ' 51' ' ' MET . 12.0 p -62.55 -42.2 94.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.711 0.291 . . . . 0.0 111.382 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.87 -14.67 62.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.8 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -97.09 -41.28 8.43 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.164 0.507 . . . . 0.0 109.686 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.441 ' NH1' ' SD ' ' A' ' 194' ' ' MET . 67.9 ttt180 -70.87 -44.91 65.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.166 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -110.0 10.83 24.15 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 120.924 0.392 . . . . 0.0 110.09 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.646 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -58.75 -45.69 94.49 Favored Glycine 0 C--O 1.215 -1.054 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.147 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.06 -24.86 60.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 37.4 t -61.64 -44.17 97.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 111.511 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.51 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.1 p -123.25 21.85 4.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.312 0.577 . . . . 0.0 110.75 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.646 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 23.5 ttm180 -59.09 -33.21 70.56 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.728 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -61.18 -49.65 76.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.972 0.415 . . . . 0.0 110.515 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ASP . . . . . 0.429 ' HB2' HG22 ' B' ' 62' ' ' VAL . 1.0 OUTLIER -74.5 -22.77 58.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.538 -179.591 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.51 HG23 ' O ' ' B' ' 62' ' ' VAL . 53.8 t -63.89 -43.88 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 99.4 mt -62.77 -39.21 93.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.018 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.04 -42.7 99.88 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.202 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ASP . . . . . 0.727 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 33.8 t70 -63.66 -44.01 95.06 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.972 0.386 . . . . 0.0 109.989 177.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.35 -41.34 96.91 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.063 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 49.9 ttp -60.91 -41.88 96.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.502 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -62.97 -44.37 96.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.925 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.727 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 32.8 mtp85 -66.68 -40.95 88.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.928 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -65.31 -41.33 94.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.192 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.56 -48.86 79.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.798 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 18.7 tt -68.0 -40.15 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.873 0.368 . . . . 0.0 111.705 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -65.69 -39.79 91.64 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.284 0.564 . . . . 0.0 110.134 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.14 -47.02 75.43 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.662 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 45.5 pt -62.45 -36.75 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.05 -43.97 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 120.686 0.279 . . . . 0.0 111.139 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.52 -28.03 46.11 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.617 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.88 -4.43 58.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.655 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 62.85 42.45 7.8 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.933 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.3 mt -105.05 118.31 52.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -112.46 109.94 53.3 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.404 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -88.44 124.23 1.64 Allowed 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 122.544 2.163 . . . . 0.0 111.274 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.65 117.76 29.56 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.977 0.418 . . . . 0.0 110.505 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.7 -130.18 10.15 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.67 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.45 123.79 17.74 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-O 120.433 0.158 . . . . 0.0 110.625 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.31 131.46 19.11 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.797 1.664 . . . . 0.0 110.554 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 11.3 m -78.38 111.92 14.87 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.628 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.65 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 96.2 m-85 -83.9 105.19 14.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.14 102.73 11.51 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.47 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.4 Cg_endo -98.61 170.06 0.6 Allowed 'Trans proline' 0 N--CA 1.439 -1.723 0 C-N-CA 123.429 2.753 . . . . 0.0 111.402 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.43 -174.06 26.08 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -79.95 133.36 36.19 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -87.9 128.41 35.36 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.007 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.98 133.76 49.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 tp -86.79 88.61 7.72 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.328 0.585 . . . . 0.0 110.138 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.59 -20.9 3.65 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.174 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -108.54 178.07 4.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.496 0.189 . . . . 0.0 110.719 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -80.53 165.3 22.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.007 0.432 . . . . 0.0 111.185 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -124.1 141.92 51.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.957 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 27.7 m -122.91 135.82 54.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.041 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -142.69 165.51 27.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.366 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.8 m -85.4 -90.9 0.1 Allowed 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.442 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 85.3 t 64.94 99.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.347 0.594 . . . . 0.0 110.672 -175.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -101.11 145.6 28.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.702 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -158.11 -80.34 0.06 Allowed 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.4 ' O ' HD12 ' B' ' 11' ' ' LEU . 59.3 mt-10 -95.97 157.02 16.09 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -173.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.531 HG12 HD11 ' B' ' 11' ' ' LEU . 24.9 m -124.97 163.98 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.925 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -171.24 101.02 0.4 Allowed Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 122.252 0.221 . . . . 0.0 110.961 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -96.37 162.82 1.22 Allowed 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 123.701 2.934 . . . . 0.0 114.306 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -143.19 147.29 34.66 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.738 0.815 . . . . 0.0 110.765 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.8 156.68 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 120.675 0.274 . . . . 0.0 111.072 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.14 153.13 51.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.83 131.89 55.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -144.71 155.07 43.37 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.46 22.89 78.15 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.33 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.05 -42.1 99.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.093 0.473 . . . . 0.0 111.232 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.11 -15.7 63.88 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.201 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.33 0.41 57.26 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.427 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 81.4 mt -79.73 113.82 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.11 0.481 . . . . 0.0 109.791 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -106.42 117.53 34.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.647 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 57.7 t -103.4 126.36 57.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -93.13 119.01 31.88 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.532 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.504 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 77.3 tttt -113.39 105.86 54.85 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.26 130.11 13.75 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.967 1.778 . . . . 0.0 111.9 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -101.46 115.37 43.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.44 161.29 41.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.941 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -150.37 159.57 44.36 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.852 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.67 131.05 35.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.159 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 81.7 p -110.77 175.53 5.39 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.924 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -62.16 -35.75 79.77 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.755 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.06 89.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.601 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.18 -42.17 99.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.716 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -63.86 -46.76 93.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.793 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.78 -44.19 97.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.624 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.88 -41.58 98.7 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.085 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.483 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.0 OUTLIER -62.68 -46.0 90.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.904 0.383 . . . . 0.0 110.683 179.186 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.9 mt -63.61 -40.76 97.74 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.675 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.32 -45.96 91.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.382 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.0 m -63.13 -41.61 99.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.813 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' B' ' 140' ' ' MET . 97.7 mt -60.67 -43.56 97.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.618 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -67.18 -35.97 80.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.874 0.369 . . . . 0.0 110.936 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.19 -21.04 65.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.089 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -85.56 -4.98 59.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 110.544 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -90.27 90.55 8.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.704 0.764 . . . . 0.0 112.216 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.88 132.49 18.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.373 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.5 ' OG1' ' HG2' ' B' ' 247' ' ' GLU . 20.5 p -103.63 -165.97 1.21 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' TRP . . . . . 0.481 ' O ' ' HG3' ' B' ' 152' ' ' LYS . 6.0 p-90 -68.6 127.94 34.84 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.345 -174.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' B' ' 151' ' ' TRP . 21.4 mttp -178.36 -167.84 0.14 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.231 1.012 . . . . 0.0 109.896 176.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' B' ' 154' ' ' LYS . 0.0 OUTLIER -132.59 163.71 28.27 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -172.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' B' ' 153' ' ' GLU . 11.2 pttp 66.13 -178.61 0.2 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.884 1.674 . . . . 0.0 114.323 174.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ASP . . . . . 0.4 ' N ' ' HG3' ' B' ' 154' ' ' LYS . 14.8 t70 71.54 -94.48 0.03 OUTLIER 'General case' 0 C--N 1.341 0.235 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.189 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 148.63 97.8 0.19 Allowed Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.551 -1.309 . . . . 0.0 113.463 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -128.21 67.41 1.36 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 23.1 t -72.0 127.67 34.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.428 -176.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 8.9 tp10 -93.53 153.54 18.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.87 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 160' ' ' ALA . . . . . 0.401 ' O ' ' HA3' ' B' ' 190' ' ' GLY . . . -89.52 23.2 2.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.622 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 161' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' B' ' 189' ' ' MET . 34.1 tt0 -163.28 25.81 0.09 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.406 0.622 . . . . 0.0 110.539 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.597 ' HB2' ' HB3' ' B' ' 159' ' ' GLU . 3.7 t70 -113.08 -172.16 2.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.316 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -99.39 124.67 44.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.6 t -120.14 126.42 75.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.337 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 10.3 m -87.58 109.8 19.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 67.6 mt -114.45 126.59 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.142 0.496 . . . . 0.0 112.264 -174.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' B' ' 236' ' ' ASN . 3.5 p-10 -101.05 110.2 22.19 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -139.53 160.29 40.21 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.385 0.612 . . . . 0.0 112.11 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.9 m -131.79 136.26 47.4 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.884 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.46 104.86 2.31 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.697 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 33.2 m -130.04 124.67 33.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.63 -89.66 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.003 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -99.62 44.74 1.01 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.197 0.522 . . . . 0.0 110.149 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.91 12.85 67.79 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.297 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -126.8 138.95 53.42 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.39 134.68 34.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.719 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' PHE . . . . . 0.404 ' HD1' ' H ' ' B' ' 179' ' ' GLY . 32.9 p90 -105.34 -178.28 3.61 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.776 0.322 . . . . 0.0 111.82 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.74 -39.92 82.32 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.076 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' GLY . . . . . 0.404 ' H ' ' HD1' ' B' ' 177' ' ' PHE . . . -95.14 -176.17 37.73 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.147 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.49 16.8 67.8 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.073 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.17 94.77 5.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.68 144.46 31.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.68 0.276 . . . . 0.0 110.976 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -135.4 146.74 48.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.085 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 56.46 30.18 16.61 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 123.589 0.556 . . . . 0.0 110.786 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -83.94 126.54 33.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.463 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 17.3 m -98.76 115.47 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.955 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 63.7 tp -106.1 127.8 53.44 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.361 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.29 106.72 18.66 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 189' ' ' MET . . . . . 0.622 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 68.1 mtp -78.95 148.38 32.66 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.758 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' B' ' 160' ' ' ALA . . . 96.3 -15.05 63.55 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.039 175.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -94.97 -1.15 53.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.799 0.333 . . . . 0.0 111.384 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.88 56.71 5.22 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.738 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.497 HH22 HD13 ' A' ' 53' ' ' ILE . 17.8 mmt85 -99.64 -6.31 27.48 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.198 0.523 . . . . 0.0 109.789 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.483 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -136.27 173.02 12.16 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.904 -178.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 31.2 mm -62.83 131.32 94.43 Favored Pre-proline 0 N--CA 1.437 -1.12 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.82 125.74 11.78 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.495 2.13 . . . . 0.0 111.956 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.14 -42.7 1.89 Allowed Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.288 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -63.32 -52.22 62.77 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.055 0.427 . . . . 0.0 111.866 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.79 -31.23 66.38 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.854 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.85 -39.56 76.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.888 0.375 . . . . 0.0 111.098 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -62.97 -20.34 62.28 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.688 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.5 -41.74 93.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 120.804 0.335 . . . . 0.0 110.289 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -47.5 128.39 12.39 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.8 0.84 . . . . 0.0 111.671 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.51 -19.44 45.1 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.165 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -87.53 163.68 16.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.867 0.365 . . . . 0.0 111.816 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -105.78 155.12 19.6 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.989 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.18 137.47 57.02 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' B' ' 237' ' ' LEU . . . 74.41 38.19 45.68 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.504 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -127.64 128.48 45.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.224 0.535 . . . . 0.0 111.783 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -99.23 120.17 39.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.68 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' PHE . . . . . 0.477 ' O ' ' HB ' ' B' ' 212' ' ' THR . 36.0 t80 -139.65 -35.71 0.53 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -176.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' B' ' 211' ' ' PHE . 94.8 m 75.32 142.46 0.07 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.706 0.288 . . . . 0.0 110.799 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -132.56 141.07 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 111.594 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.19 109.47 18.33 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.681 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 64.5 t -121.38 122.3 66.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 3.4 m -92.01 -21.15 20.67 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -174.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' B' ' 216' ' ' THR . 44.0 m-85 68.05 149.52 0.12 Allowed Pre-proline 0 N--CA 1.482 1.156 0 CA-C-O 120.779 0.323 . . . . 0.0 110.839 -175.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 15.6 Cg_exo -71.15 150.4 59.68 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.311 2.007 . . . . 0.0 111.767 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.43 -37.45 87.56 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.84 76.47 6.33 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.206 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -121.6 141.98 50.56 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -62.93 -29.09 70.52 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.98 110.9 22.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.609 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 43.8 tt0 -65.23 -33.54 76.25 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.728 -176.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' B' ' 229' ' ' LYS . 30.4 p-10 -66.33 -23.37 66.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.118 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.7 mt -110.69 -4.25 15.46 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.9 ptmt -69.05 119.74 13.81 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.875 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.89 34.6 90.32 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.327 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' B' ' 225' ' ' ASN . 34.7 mmtp -114.91 133.87 55.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -84.16 107.72 16.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.901 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.37 148.21 22.69 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.142 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.18 -48.99 3.71 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 58.98 102.52 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.169 0.509 . . . . 0.0 110.892 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.47 89.82 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm 61.54 102.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.175 0.59 . . . . 0.0 112.095 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' ASN . . . . . 0.406 ' HB3' ' OD2' ' B' ' 167' ' ' ASP . 6.4 t-20 -90.17 -51.51 5.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 237' ' ' LEU . . . . . 0.559 ' O ' ' HA2' ' B' ' 208' ' ' GLY . 13.0 tp 61.99 81.66 0.19 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.27 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -82.36 -48.58 10.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -110.18 -79.82 0.58 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t 70.18 142.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.096 0.559 . . . . 0.0 110.839 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -73.76 -47.23 40.6 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.094 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 65.58 162.18 0.14 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -158.69 91.4 1.06 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.254 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' B' ' 152' ' ' LYS . 7.8 tp10 -122.79 153.4 39.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.188 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 9.0 tt 76.24 116.07 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 C-N-CA 124.027 0.931 . . . . 0.0 110.58 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.38 113.12 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.543 2.162 . . . . 0.0 113.653 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' GLU . . . . . 0.5 ' HG2' ' OG1' ' B' ' 150' ' ' THR . 12.6 pt-20 -125.89 -163.57 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.0 mp -89.25 104.42 16.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.342 0.591 . . . . 0.0 111.817 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 34.2 m -132.67 133.64 43.82 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.99 15.4 13.31 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.06 -12.21 25.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -75.16 -2.51 28.07 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.821 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' B' ' 261' ' ' GLY . 43.5 pt -109.93 -3.63 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.576 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -138.76 10.56 2.66 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -131.64 13.83 4.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.041 0.448 . . . . 0.0 109.97 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -131.42 138.56 49.12 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.361 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 69.5 -129.06 22.13 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.212 -0.518 . . . . 0.0 114.073 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 75.8 t -121.03 130.02 75.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 259' ' ' GLU . . . . . 0.669 ' HG2' ' H ' ' B' ' 260' ' ' ASP . 22.0 tt0 59.5 -166.79 0.17 Allowed 'General case' 0 CA--C 1.552 1.039 0 O-C-N 123.709 0.63 . . . . 0.0 110.091 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 260' ' ' ASP . . . . . 0.669 ' H ' ' HG2' ' B' ' 259' ' ' GLU . 5.1 p-10 -110.24 144.9 38.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 261' ' ' GLY . . . . . 0.515 ' O ' ' HB ' ' B' ' 253' ' ' ILE . . . -146.43 166.19 28.19 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.138 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 12.8 p -80.32 176.89 9.36 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 122.768 0.427 . . . . 0.0 111.205 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.81 -48.0 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.749 0.309 . . . . 0.0 110.942 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' B' ' 264' ' ' GLU . 1.0 OUTLIER -82.11 -33.3 29.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 110.591 178.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.54 -41.35 99.8 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.061 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.442 ' O ' HG23 ' B' ' 270' ' ' VAL . 63.6 tp -61.58 -46.33 90.3 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 120.522 0.201 . . . . 0.0 110.595 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -65.04 -41.72 94.94 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.728 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.616 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.16 -45.92 86.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -67.88 -38.76 83.44 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 266' ' ' LEU . 58.8 t -64.38 -42.11 94.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.35 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 271' ' ' ARG . . . . . 0.405 HH21 ' HD3' ' B' ' 271' ' ' ARG . 9.4 tpt180 -58.04 -48.41 80.17 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.611 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 11.9 ptmt -66.65 -42.61 86.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.741 0.305 . . . . 0.0 111.292 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.6 -38.26 90.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.007 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.8 mmm -63.33 -42.14 98.95 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.994 0.426 . . . . 0.0 109.997 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 275' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' B' ' 278' ' ' LEU . 79.1 mt-10 -70.51 -28.77 65.21 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.738 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -64.41 -42.74 95.91 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -67.59 -27.94 67.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.711 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' B' ' 275' ' ' GLU . 63.9 tp -61.02 -38.72 87.09 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.37 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -58.21 -46.76 85.27 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.626 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 32.2 m -62.22 -44.76 95.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.895 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.71 72.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.339 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.29 -44.06 97.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.062 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 283' ' ' ARG . . . . . 0.566 HH12 ' HG3' ' B' ' 409' ' ' GLU . 1.7 tpt180 -62.25 -46.16 90.06 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.781 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -64.69 -39.88 94.43 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 285' ' ' ARG . . . . . 0.59 HH21 ' CG ' ' B' ' 285' ' ' ARG . 0.0 OUTLIER -60.85 -43.78 97.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.074 0.464 . . . . 0.0 110.588 179.03 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 76.1 t -67.75 -43.91 86.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.946 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.63 -46.47 90.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.22 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 32.2 p -60.37 -43.47 96.51 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -66.53 -41.14 89.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.363 . . . . 0.0 111.137 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.65 -48.22 78.12 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.46 -44.52 97.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.322 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -62.65 -40.28 96.55 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.61 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.34 -42.75 99.1 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.12 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.33 -42.22 98.96 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.03 -45.34 96.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 123.201 0.313 . . . . 0.0 111.196 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.87 -41.96 95.24 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.379 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -69.77 -43.13 72.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -117.89 100.83 7.83 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -96.65 113.58 25.16 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 300' ' ' ILE . . . . . 0.415 HG13 ' N ' ' B' ' 301' ' ' ASP . 10.6 tp -126.98 160.52 35.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.8 0.333 . . . . 0.0 111.117 -176.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 301' ' ' ASP . . . . . 0.415 ' N ' HG13 ' B' ' 300' ' ' ILE . 14.1 m-20 -65.71 135.95 55.63 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.629 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 16.0 t -112.64 123.07 34.7 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.533 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.66 123.96 14.08 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.141 1.894 . . . . 0.0 111.527 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.81 81.65 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.714 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.62 -45.6 73.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.113 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.79 -41.85 95.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.718 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.67 -45.74 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -43.54 86.71 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.527 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 309' ' ' SER . . . . . 0.459 ' O ' HG23 ' B' ' 313' ' ' VAL . 20.3 m -62.59 -45.39 93.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.205 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 310' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 55.3 mm-40 -66.17 -39.19 89.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.051 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.17 -44.22 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.995 0.426 . . . . 0.0 110.345 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.69 -38.02 89.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.811 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 313' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 309' ' ' SER . 96.9 t -66.6 -42.48 89.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.955 176.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 90.3 mt -61.42 -39.88 92.37 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.03 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.454 ' NH1' HD12 ' B' ' 330' ' ' LEU . 63.5 mtm180 -61.74 -37.68 85.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.316 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 -63.38 -43.89 96.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.795 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.99 -41.49 95.35 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.335 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.87 -42.5 76.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.372 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.2 -37.01 84.56 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 120.862 0.363 . . . . 0.0 111.319 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -55.4 -42.95 74.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.578 0.704 . . . . 0.0 109.539 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -74.41 -38.22 63.15 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.885 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -58.12 -46.87 84.85 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.169 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 323' ' ' GLY . . . . . 0.412 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -168.95 17.56 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.435 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 72.2 25.54 74.3 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.168 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -94.07 151.0 19.83 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -175.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -135.58 -179.7 5.8 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 68.8 -62.85 0.38 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.32 0.648 . . . . 0.0 112.084 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -67.02 -16.61 64.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.99 0.424 . . . . 0.0 111.141 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 329' ' ' ALA . . . . . 0.413 ' O ' ' HD2' ' B' ' 315' ' ' ARG . . . -60.85 -18.74 57.7 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.621 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.454 HD12 ' NH1' ' B' ' 315' ' ' ARG . 45.7 tp -61.88 -37.56 85.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.809 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -74.43 -6.17 46.72 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.976 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.6 140.6 96.54 Favored Pre-proline 0 C--O 1.241 0.606 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.934 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 333' ' ' PRO . . . . . 0.453 ' HB2' HD13 ' B' ' 336' ' ' LEU . 46.4 Cg_exo -55.08 130.62 41.74 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.951 2.434 . . . . 0.0 113.296 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -65.74 -44.01 87.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.074 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.5 pm0 -66.53 -24.48 66.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 336' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' B' ' 333' ' ' PRO . 11.0 mp -76.06 -18.94 59.0 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -116.09 -20.61 9.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -64.43 -32.22 73.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -63.49 -46.7 84.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.537 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -76.9 -26.56 54.3 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.734 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.415 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.77 -38.96 93.05 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.614 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 342' ' ' LYS . . . . . 0.428 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.8 tttt -57.76 -44.87 86.42 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.939 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 343' ' ' ARG . . . . . 0.504 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.2 mmt85 -61.64 -44.1 97.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.783 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -65.63 -39.45 91.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.597 0.237 . . . . 0.0 111.242 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 341' ' ' ALA . 77.6 t -63.58 -45.72 96.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.148 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 342' ' ' LYS . 96.9 t -63.37 -44.25 98.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 343' ' ' ARG . 78.6 t -60.54 -45.26 97.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.445 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.11 -43.08 99.87 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.368 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.09 -44.11 93.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.664 0.269 . . . . 0.0 111.359 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.85 -44.84 91.97 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.757 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.04 -39.25 89.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.05 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.53 97.83 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.015 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.29 -35.25 79.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.967 0.383 . . . . 0.0 110.851 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.18 -44.59 95.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.1 -44.13 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.704 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -68.73 -47.28 66.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 26.4 m -65.51 -45.42 83.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -88.47 -9.4 52.61 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.916 0.389 . . . . 0.0 111.069 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 60.94 61.51 1.62 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.077 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.1 mt -78.76 156.54 28.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.304 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -131.25 158.86 39.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.672 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -81.28 108.2 14.7 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 172.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 363' ' ' ASP . . . . . 0.52 ' O ' HG23 ' B' ' 367' ' ' VAL . 18.0 t70 -81.72 107.57 14.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.327 0.584 . . . . 0.0 111.825 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 364' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 5.6 mm-40 -61.39 -35.25 76.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.846 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.17 -43.28 92.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.967 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -64.27 -39.37 93.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.302 0.572 . . . . 0.0 109.836 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 367' ' ' VAL . . . . . 0.531 HG21 ' HG2' ' B' ' 399' ' ' ARG . 94.6 t -61.81 -39.54 83.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.633 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 368' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 24.9 mmmt -55.89 -46.53 78.31 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.035 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.59 -42.26 99.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.333 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 98.5 mt -63.09 -42.13 99.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.854 0.359 . . . . 0.0 110.705 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 92.1 mt -63.92 -43.09 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.286 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.27 -40.94 97.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.94 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.89 -40.02 94.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.798 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 59.9 ttm -66.65 -41.46 88.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.074 0.464 . . . . 0.0 110.796 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.75 -25.1 68.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.861 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 47.9 m -75.74 3.32 10.05 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.987 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -103.02 11.24 37.54 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.324 0.583 . . . . 0.0 110.827 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -118.18 170.8 8.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.118 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.2 -35.02 79.43 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.543 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -138.22 111.8 8.59 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.024 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.91 -30.77 32.52 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.352 2.035 . . . . 0.0 113.223 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.78 -44.27 90.54 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -65.64 -36.02 82.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.747 0.308 . . . . 0.0 110.383 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.13 -41.47 91.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.606 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.6 mt -61.43 -44.25 98.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.802 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 52.9 mt-10 -66.54 -42.32 87.36 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.559 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -58.05 -46.91 84.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.958 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -67.97 -44.07 77.52 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.656 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 41.7 p -73.75 -17.69 61.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 390' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.5 mttt -89.06 1.66 55.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.901 0.381 . . . . 0.0 111.253 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -123.11 112.61 17.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.719 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.71 -41.89 98.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.507 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -61.91 -45.18 94.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 5.8 mp -62.65 -43.06 99.77 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.675 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.539 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.8 mtp -63.2 -46.82 85.27 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.032 0.444 . . . . 0.0 110.963 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 396' ' ' ASP . . . . . 0.504 ' HA ' ' HE ' ' B' ' 399' ' ' ARG . 19.5 t70 -65.01 -43.95 90.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.784 -176.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -63.55 -40.34 96.76 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.742 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 47.4 tpp -62.78 -39.83 95.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 395' ' ' MET . 80.8 mtm180 -64.13 -35.51 81.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.695 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.11 -43.31 99.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 98.0 t -66.53 -44.04 90.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.586 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.73 95.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.943 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 47.5 tp -62.82 -38.33 90.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.03 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 404' ' ' GLU . . . . . 0.503 ' O ' HG23 ' B' ' 408' ' ' VAL . 43.8 tt0 -54.47 -51.39 65.16 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.07 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.89 -37.98 87.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.453 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -60.4 -43.54 96.58 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.576 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.442 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -64.23 -42.56 96.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.634 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 408' ' ' VAL . . . . . 0.58 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 93.0 t -65.34 -43.3 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.583 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 409' ' ' GLU . . . . . 0.566 ' HG3' HH12 ' B' ' 283' ' ' ARG . 95.2 mt-10 -63.91 -35.69 81.5 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.064 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.2 98.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.089 0.471 . . . . 0.0 110.286 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 411' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 407' ' ' ALA . 92.1 t -65.27 -42.64 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.421 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 81.4 mt -61.15 -40.68 94.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.532 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.49 -16.78 64.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.617 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -102.75 -22.76 13.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.44 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.44 179.55 5.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.257 0.551 . . . . 0.0 112.001 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.18 108.03 20.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.33 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.3 127.29 52.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.73 0.3 . . . . 0.0 110.254 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 13.6 t -119.96 130.94 55.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 419' ' ' GLU . . . . . 0.504 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 41.5 mt-10 -102.3 120.7 40.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.356 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -131.85 138.62 48.54 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.418 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.26 144.91 35.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 13.4 t -151.3 171.72 17.02 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.231 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 36.1 p -86.95 166.1 15.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.338 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -67.34 -25.95 66.25 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -62.9 -38.42 90.86 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.86 -31.67 72.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 0.0 110.672 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.24 -12.95 60.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 5.5 mmt -81.03 -7.3 59.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.001 0.429 . . . . 0.0 110.995 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -78.1 78.27 4.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.309 0.576 . . . . 0.0 110.509 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -126.06 23.63 7.09 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.63 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.39 -30.15 70.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.234 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.826 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.691 -178.673 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 CA--C 1.545 0.752 0 CA-C-O 120.695 0.283 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -65.5 137.7 57.6 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.858 0.361 . . . . 0.0 111.183 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.33 158.31 41.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.504 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.7 t -117.41 113.63 22.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.935 0.398 . . . . 0.0 110.821 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 p -154.72 140.65 11.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -122.34 157.69 31.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.981 0.419 . . . . 0.0 111.204 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 m -104.44 115.56 30.59 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.857 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 9' ' ' GLN . 15.7 m -68.2 -53.42 25.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.738 0.304 . . . . 0.0 111.01 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 8' ' ' THR . 58.1 tp60 168.31 130.05 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.82 0.848 . . . . 0.0 109.586 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.22 -105.7 1.36 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.784 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 305' ' ' ALA . 4.0 mp -97.04 -16.01 20.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.692 0.282 . . . . 0.0 110.343 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 13' ' ' ARG . . . -71.79 133.58 21.15 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.635 -175.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -135.92 143.44 44.95 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -116.23 134.02 55.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 t -79.56 -94.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 m 54.54 91.48 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.336 0.589 . . . . 0.0 110.85 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 tp -106.87 134.32 48.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.004 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.3 p -81.3 132.62 35.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.515 HD13 HD11 ' A' ' 24' ' ' ILE . 1.9 pp -129.56 161.88 38.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.674 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -108.11 155.85 19.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.005 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.17 -53.15 57.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.4 -34.39 74.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.987 0.422 . . . . 0.0 110.662 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.6 t -63.01 -34.44 77.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.038 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 20' ' ' ALA . 62.7 mt -59.62 -70.2 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.207 0.527 . . . . 0.0 111.269 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.71 -44.87 92.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.724 -172.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.3 m -64.66 -49.01 72.68 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.4 -45.25 18.01 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.0 t -63.32 -44.47 99.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.531 0.196 . . . . 0.0 111.531 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -61.32 -46.7 89.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.832 0.348 . . . . 0.0 110.735 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.9 m -61.72 -41.58 97.8 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.085 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.8 tp10 -65.45 -42.6 92.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.984 0.421 . . . . 0.0 110.567 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.433 ' CD2' HH22 ' A' ' 73' ' ' ARG . 97.1 mt -63.81 -44.09 94.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.24 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -68.05 -37.6 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -62.79 -39.67 94.95 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.463 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 31' ' ' GLU . 79.1 t -63.49 -44.16 98.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.822 0.344 . . . . 0.0 110.311 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.05 87.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.945 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.9 -34.11 77.07 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.833 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -59.29 -42.83 92.21 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.834 0.35 . . . . 0.0 110.483 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.1 t -85.99 -4.72 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.056 0.455 . . . . 0.0 110.16 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 62.74 27.56 16.15 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.457 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.72 5.29 10.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -64.46 -30.51 71.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.986 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.15 -23.65 68.15 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.339 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -74.83 -12.2 60.33 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.443 ' HG3' ' NE2' ' B' ' 320' ' ' GLN . 71.8 ttt-85 -91.06 103.08 15.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.58 -176.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.13 109.6 13.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.81 67.61 2.12 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 115.949 1.139 . . . . 0.0 115.949 -170.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.62 -44.16 91.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.3 t -98.33 102.74 15.1 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HB2' ' OD1' ' A' ' 52' ' ' ASN . 13.4 Cg_endo -57.36 144.03 92.41 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.315 2.01 . . . . 0.0 111.779 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.534 ' HA ' HG12 ' A' ' 54' ' ' VAL . 17.5 ttt -61.13 -38.57 86.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.244 -173.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.518 ' OD1' ' HB2' ' A' ' 50' ' ' PRO . 16.7 p-10 -62.56 -43.21 99.37 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.833 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.536 HG21 ' HD2' ' B' ' 193' ' ' ARG . 1.8 mp -68.67 -44.12 82.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.556 HG22 ' HA2' ' B' ' 323' ' ' GLY . 2.6 p -63.84 -36.85 78.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 120.63 0.252 . . . . 0.0 111.619 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.19 89.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.258 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -83.45 -32.69 25.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.371 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -63.44 -42.47 98.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.177 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -109.91 17.83 20.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.391 0.615 . . . . 0.0 111.186 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.18 145.81 49.91 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.072 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 72.66 -35.06 0.31 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.378 0.671 . . . . 0.0 112.555 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -61.23 -45.89 92.66 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.405 HG22 ' HB2' ' A' ' 65' ' ' ASP . 7.5 p -122.97 22.17 4.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.903 0.858 . . . . 0.0 110.246 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -63.87 -23.25 67.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.374 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -63.83 -45.17 90.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.847 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' HB2' HG22 ' A' ' 62' ' ' VAL . 9.1 m-20 -75.2 -24.01 57.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.129 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.88 -42.22 94.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.0 mt -61.91 -38.41 88.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.935 175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.7 -41.06 98.85 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.658 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.459 ' OD1' ' HE2' ' B' ' 327' ' ' LYS . 20.9 t70 -60.75 -46.34 90.81 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.954 0.407 . . . . 0.0 110.434 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.18 -42.59 99.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.282 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.6 ttp -63.32 -42.87 99.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.976 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -62.83 -44.04 97.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.331 0.586 . . . . 0.0 110.997 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.433 HH22 ' CD2' ' A' ' 32' ' ' LEU . 69.7 mtp180 -64.42 -40.77 96.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.046 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -63.93 -40.24 96.0 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 120.954 0.407 . . . . 0.0 110.519 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -62.43 -48.28 80.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.874 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 79' ' ' ILE . 15.7 tt -68.96 -41.48 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.879 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -65.16 -37.91 88.88 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.141 0.496 . . . . 0.0 110.095 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.66 83.16 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.922 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.8 pp -65.64 -30.5 50.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.541 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.0 mt -65.44 -43.63 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.932 0.396 . . . . 0.0 111.034 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -81.24 -32.57 33.3 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.901 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -83.27 -2.94 56.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.124 0.487 . . . . 0.0 110.407 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt 64.23 38.93 7.78 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.674 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 81.3 mt -102.66 123.87 56.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.827 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -110.32 103.56 54.16 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.388 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.65 146.59 34.39 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.51 2.14 . . . . 0.0 112.295 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.14 98.23 11.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.049 0.452 . . . . 0.0 111.424 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.55 -106.48 2.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.591 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.09 129.71 24.65 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.468 ' HG2' ' CE1' ' A' ' 92' ' ' TYR . 81.0 Cg_endo -73.95 156.42 47.8 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.681 2.254 . . . . 0.0 111.928 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.0 m -76.94 119.39 20.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.017 0.437 . . . . 0.0 111.534 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.468 ' CE1' ' HG2' ' A' ' 90' ' ' PRO . 73.6 m-85 -113.82 118.81 35.3 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.01 100.57 53.84 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.443 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -90.19 145.31 4.26 Favored 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 122.555 2.17 . . . . 0.0 111.29 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.98 175.3 41.5 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.301 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.72 125.17 26.43 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -80.51 127.82 32.88 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.971 0.415 . . . . 0.0 110.563 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -117.56 115.52 25.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.595 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.4 tp -65.37 107.27 1.59 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.334 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.47 -8.71 13.43 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.383 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.93 173.39 8.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.803 0.335 . . . . 0.0 111.026 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.87 141.25 44.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.558 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -98.08 141.18 31.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.385 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.8 m -124.26 133.99 53.35 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -141.03 154.91 46.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.255 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 m -84.21 -86.44 0.12 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.0 t 68.89 111.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 122.98 0.512 . . . . 0.0 110.498 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -113.95 137.66 51.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.825 -175.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -151.34 -74.75 0.15 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -143.24 157.49 44.44 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.553 0.615 . . . . 0.0 111.297 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.432 ' CG1' ' HG ' ' A' ' 11' ' ' LEU . 28.8 m -128.78 -172.46 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -140.25 118.02 8.27 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.88 147.32 39.02 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.821 2.347 . . . . 0.0 114.623 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -135.87 143.06 44.85 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.597 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.6 t -128.37 132.17 68.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -104.7 -90.15 0.4 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.519 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.0 mt 64.1 130.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.114 0.966 . . . . 0.0 113.397 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -136.97 152.34 50.04 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.818 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.96 22.14 74.85 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.418 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.66 -28.8 68.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.808 0.337 . . . . 0.0 111.897 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -83.16 -9.02 59.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.852 0.358 . . . . 0.0 111.28 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -102.51 17.29 24.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.911 0.386 . . . . 0.0 111.342 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.2 mt -90.47 123.7 42.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.908 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -108.99 127.02 53.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.3 t -115.16 136.07 53.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.017 0.437 . . . . 0.0 112.073 -172.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -86.99 139.1 30.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.844 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -134.47 101.03 12.23 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.5 137.79 40.37 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.046 1.831 . . . . 0.0 111.527 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.98 123.13 70.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.919 0.39 . . . . 0.0 110.481 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.99 162.25 39.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.534 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -142.35 158.99 43.11 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.6 t -81.17 116.77 26.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.1 p -100.39 176.36 5.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.665 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -65.02 -30.62 71.61 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.476 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.54 97.72 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.895 0.378 . . . . 0.0 110.355 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -64.21 -44.43 91.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.949 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.487 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 90.1 t -64.47 -46.13 93.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.433 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.71 -48.4 81.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.721 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.63 -39.48 97.61 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.945 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.488 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -63.07 -44.79 94.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 0.0 110.337 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 86.6 mt -63.2 -42.26 99.28 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.74 -45.15 93.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.367 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.8 m -62.95 -42.72 99.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.614 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -60.92 -42.54 98.3 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -72.81 -20.89 61.06 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.418 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.17 -12.4 59.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.079 0.466 . . . . 0.0 110.608 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -93.61 2.99 56.19 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.498 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -117.14 75.09 0.95 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.888 0.852 . . . . 0.0 111.976 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.71 73.24 0.76 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 151' ' ' TRP . 4.1 m -144.76 173.01 12.22 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.903 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.503 ' H ' HG22 ' A' ' 150' ' ' THR . 31.5 t-105 80.72 17.52 0.57 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.395 1.078 . . . . 0.0 112.315 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' A' ' 245' ' ' LEU . 6.3 mptp? -101.89 160.01 14.85 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -94.93 4.88 53.29 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -142.23 154.37 44.73 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.986 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 78.2 -175.22 0.09 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.733 1.213 . . . . 0.0 111.304 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -138.29 99.45 0.28 Allowed Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 119.577 -1.297 . . . . 0.0 114.865 -174.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . . . -110.45 -57.0 2.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.5 t 60.89 123.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 114.592 -1.186 . . . . 0.0 113.589 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -99.95 158.14 16.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.753 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.84 86.39 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -77.12 -0.12 23.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.53 142.38 27.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.508 0.194 . . . . 0.0 110.757 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -91.61 120.09 32.08 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.95 129.98 74.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.754 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.0 m -75.91 110.32 10.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 79.9 mt -122.37 120.28 60.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.348 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -98.48 101.4 12.83 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -120.15 154.22 35.08 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.074 0.464 . . . . 0.0 111.667 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 30.8 m -123.43 129.73 51.69 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.662 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.35 125.43 7.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.903 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 25.2 m -142.38 125.83 16.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.45 -78.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.653 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -132.77 80.31 1.89 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.55 7.3 73.43 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.096 -0.574 . . . . 0.0 112.903 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -140.69 143.72 35.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.793 0.33 . . . . 0.0 110.12 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -87.27 156.73 19.52 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.193 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -122.64 174.04 7.34 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.71 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.21 -38.84 74.34 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -101.19 -178.22 28.91 Favored Glycine 0 C--N 1.318 -0.435 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.091 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.02 30.5 38.07 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.704 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -107.18 102.92 12.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -124.45 142.67 51.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 111.948 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.4 m -150.52 132.24 14.96 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.2 31.04 20.9 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.374 0.421 . . . . 0.0 110.343 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -95.84 123.42 39.41 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.99 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.2 m -91.48 116.5 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.539 0.685 . . . . 0.0 110.598 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 56.3 tp -110.13 130.51 55.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.396 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.687 ' HB3' ' NH1' ' A' ' 193' ' ' ARG . . . -121.22 135.29 55.16 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 73.9 mtm -102.19 178.21 4.66 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.149 0.5 . . . . 0.0 112.001 -172.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.61 -10.64 73.73 Favored Glycine 0 CA--C 1.505 -0.531 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.235 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -102.83 -9.23 20.11 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.618 0.247 . . . . 0.0 111.173 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.63 42.45 21.65 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.853 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.687 ' NH1' ' HB3' ' A' ' 188' ' ' ALA . 48.3 mtm180 -93.27 0.41 57.01 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.343 0.592 . . . . 0.0 110.632 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.502 ' HB2' ' HG3' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -130.17 172.95 11.23 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.445 173.357 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.635 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.4 mp -69.07 137.47 89.56 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.98 134.75 49.94 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.984 1.789 . . . . 0.0 111.416 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.91 -38.94 2.9 Favored Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.511 ' O ' HG12 ' A' ' 202' ' ' ILE . 47.9 t80 -63.57 -49.77 72.08 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 194' ' ' MET . 88.0 mt-10 -67.11 -36.11 81.22 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.492 0.663 . . . . 0.0 109.938 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.85 -36.08 82.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.627 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.16 -8.95 77.64 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.889 -0.672 . . . . 0.0 114.095 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 198' ' ' PHE . 47.8 mm -65.14 -45.27 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 117.275 0.538 . . . . 0.0 111.194 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -58.99 130.54 47.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.167 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.9 -15.02 48.85 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.451 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -83.37 143.51 30.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 117.06 0.43 . . . . 0.0 111.724 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -96.01 160.51 14.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.274 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.47 121.44 14.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.563 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 82.51 24.13 54.59 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.393 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -105.8 113.07 26.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.374 0.607 . . . . 0.0 111.482 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -91.37 130.94 37.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.559 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.479 ' O ' ' HB ' ' A' ' 212' ' ' THR . 61.5 t80 -150.52 -29.84 0.21 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -176.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 91.1 m 79.77 143.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.839 0.455 . . . . 0.0 110.279 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.3 tp -115.75 -42.01 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 72.12 100.11 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.329 0.585 . . . . 0.0 112.03 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 63.8 t -121.89 133.96 66.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.891 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 9.4 m -93.1 -23.49 18.6 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.45 ' CE2' HG12 ' A' ' 195' ' ' ILE . 96.4 m-85 71.94 145.59 0.11 Allowed Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 122.817 0.447 . . . . 0.0 111.459 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.56 154.02 60.09 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.621 2.214 . . . . 0.0 111.846 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -65.38 -40.04 93.01 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.947 0.403 . . . . 0.0 110.775 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -88.11 32.34 0.76 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.486 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -69.25 132.71 46.91 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.728 -0.389 . . . . 0.0 109.994 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -56.67 -40.4 75.45 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.57 101.85 7.62 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -61.53 -33.26 73.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -68.36 -14.11 62.76 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.18 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.0 mt -117.48 -0.34 11.95 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -71.54 124.21 24.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.311 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.91 17.96 77.3 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.544 -0.753 . . . . 0.0 114.492 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -127.5 132.05 50.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.711 0.755 . . . . 0.0 110.663 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.21 151.71 25.54 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.73 135.89 33.6 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.501 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.92 -48.05 67.04 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 54.46 91.83 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.082 0.468 . . . . 0.0 111.067 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.88 89.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mm 69.7 90.14 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.106 0.479 . . . . 0.0 111.522 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -67.88 -47.5 68.68 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.29 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.456 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 8.0 tp 55.26 100.37 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.86 0.864 . . . . 0.0 113.034 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -95.58 -70.91 0.69 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 34.0 mmtp -80.5 -86.87 0.08 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 242' ' ' GLU . 65.6 t 76.84 140.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.111 0.564 . . . . 0.0 111.053 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.52 ' HB3' ' NH1' ' A' ' 243' ' ' ARG . 50.8 mm-40 -64.16 -37.03 85.98 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.344 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.538 ' H ' HG12 ' A' ' 240' ' ' VAL . 36.2 mt-10 66.97 129.3 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.535 0.734 . . . . 0.0 111.881 -176.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.52 ' NH1' ' HB3' ' A' ' 241' ' ' GLU . 8.6 ptp180 173.55 114.27 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.967 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 157' ' ' ALA . 0.4 OUTLIER -142.66 -153.96 0.49 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.473 ' HB2' ' HG2' ' A' ' 152' ' ' LYS . 10.5 mp 70.18 146.09 0.11 Allowed Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.528 ' O ' ' HG2' ' A' ' 247' ' ' GLU . 95.7 Cg_endo -82.94 -159.08 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.175 2.583 . . . . 0.0 112.931 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 246' ' ' PRO . 3.4 pt-20 87.96 -176.47 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.188 1.795 . . . . 0.0 111.043 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.76 135.73 48.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.105 0.479 . . . . 0.0 111.639 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 41.2 p -88.39 -168.52 2.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.036 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.23 -51.39 66.75 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.931 0.396 . . . . 0.0 109.935 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -132.54 94.23 3.38 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -72.97 -10.22 59.56 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.297 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 253' ' ' ILE . 3.8 mp -65.25 -44.55 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.72 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.531 ' HD2' ' HB2' ' A' ' 260' ' ' ASP . 58.2 pttt -150.88 151.74 32.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.879 0.371 . . . . 0.0 111.756 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' A' ' 256' ' ' PHE . 28.1 tpt180 -168.93 -175.21 2.28 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -174.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.572 ' H ' ' HG3' ' A' ' 255' ' ' ARG . 91.9 m-85 90.47 -39.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.356 1.062 . . . . 0.0 113.67 172.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 133.43 -132.13 6.37 Favored Glycine 0 C--N 1.313 -0.695 0 C-N-CA 119.326 -1.416 . . . . 0.0 113.234 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.7 m 38.18 48.26 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.933 0.893 . . . . 0.0 111.389 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 260' ' ' ASP . 33.6 tt0 66.94 -84.8 0.03 OUTLIER 'General case' 0 C--O 1.235 0.329 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.334 -174.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ASP . . . . . 0.531 ' HB2' ' HD2' ' A' ' 254' ' ' LYS . 4.0 p30 174.2 151.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.112 0.565 . . . . 0.0 110.434 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.39 -171.76 31.03 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.933 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.2 p -79.81 168.74 18.89 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.604 0.362 . . . . 0.0 110.911 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 94.0 t -61.94 -49.56 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.785 0.326 . . . . 0.0 111.578 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.4 pm0 -71.14 -41.33 70.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.129 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.27 95.6 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.389 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 270' ' ' VAL . 58.1 tp -61.8 -45.67 92.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.555 0.217 . . . . 0.0 111.117 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 263' ' ' VAL . 66.1 mtp180 -66.73 -41.41 87.93 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.573 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.91 -43.3 83.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.202 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -66.5 -39.81 88.89 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.705 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 266' ' ' LEU . 76.0 t -64.35 -42.35 95.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.938 176.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -57.56 -47.62 81.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.564 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 12.8 ptmt -66.99 -39.62 87.2 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -63.79 -41.03 98.01 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.987 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 98.7 mmm -64.43 -41.87 96.33 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.852 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.22 -34.92 75.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.762 0.315 . . . . 0.0 111.122 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -61.96 -43.09 99.58 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -67.07 -37.96 84.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.494 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.6 tp -61.96 -41.07 97.57 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.834 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -57.7 -46.12 84.77 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.654 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.3 m -63.65 -44.72 93.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.576 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.74 93.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.076 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.62 -43.94 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.24 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -62.53 -42.62 99.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.893 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -62.97 -41.34 99.52 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.104 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -60.26 -44.1 95.59 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.117 0.484 . . . . 0.0 110.327 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.0 t -70.02 -43.79 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.946 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.96 -47.39 86.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.299 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.9 p -62.25 -43.23 99.29 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.643 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -65.79 -42.49 90.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.842 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.628 ' O ' ' HG ' ' A' ' 294' ' ' LEU . . . -64.26 -45.62 87.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.044 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 295' ' ' VAL . 35.1 mm -63.98 -43.99 97.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.058 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.511 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 29.7 tp10 -60.52 -43.68 96.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.438 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.52 -40.3 98.6 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.278 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 290' ' ' ALA . 69.8 mt -63.38 -43.07 98.64 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.711 0.291 . . . . 0.0 111.155 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 291' ' ' ILE . 93.7 t -65.01 -44.8 95.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.941 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LYS . . . . . 0.511 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.1 mttm -64.37 -39.8 94.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.326 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.97 95.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.921 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -137.93 102.27 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -90.02 107.38 19.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 8.7 tp -114.48 140.04 37.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.82 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -68.72 129.01 38.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.477 0.656 . . . . 0.0 110.05 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 94.0 t -99.56 135.54 20.58 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.687 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.74 132.81 53.86 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.498 2.132 . . . . 0.0 111.828 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.0 87.54 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.46 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' A' ' 11' ' ' LEU . . . -58.0 -41.74 83.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 111.537 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.2 -42.3 93.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.31 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.02 -44.58 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.817 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.09 -42.56 85.89 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.873 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.1 m -62.04 -44.64 96.27 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.055 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.499 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 74.0 mm-40 -69.37 -38.79 78.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.707 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.522 HD13 ' HG3' ' A' ' 334' ' ' ARG . 94.2 mt -62.19 -44.34 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -177.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.485 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 26.9 t70 -62.55 -43.1 99.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.037 0.446 . . . . 0.0 110.638 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.11 -43.31 95.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.293 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 95.8 mt -62.41 -41.81 98.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.037 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.485 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 85.3 mtm180 -63.72 -42.25 97.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -64.34 -41.14 96.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.554 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -63.46 -40.92 98.4 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.004 0.431 . . . . 0.0 110.603 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.42 91.76 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.223 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.92 -37.09 86.48 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.799 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -60.64 -39.39 88.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.77 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -89.74 2.29 55.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.693 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -99.0 -2.95 36.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.342 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLY . . . . . 0.546 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . 139.98 -1.55 2.26 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.567 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 91.71 29.13 12.37 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.461 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.511 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 43.7 t-20 -72.39 124.04 24.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.654 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 0.6 OUTLIER -119.61 153.45 35.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 0.1 OUTLIER 61.37 -30.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 126.03 1.732 . . . . 0.0 114.608 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.511 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 15.9 mm100 -79.8 -5.31 55.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.301 0.572 . . . . 0.0 110.38 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.58 -18.39 63.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.38 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.92 -37.93 86.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.503 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.83 -20.13 65.13 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.853 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 81.6 mt -62.02 147.03 91.01 Favored Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.275 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.444 ' O ' ' HD1' ' A' ' 337' ' ' PHE . 32.5 Cg_exo -61.04 142.08 96.22 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.804 2.336 . . . . 0.0 112.82 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.522 ' HG3' HD13 ' A' ' 311' ' ' ILE . 21.4 ttt180 -84.49 -41.07 16.93 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.836 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -60.14 -39.48 86.48 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.05 -2.88 58.73 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.444 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.444 ' HD1' ' O ' ' A' ' 333' ' ' PRO . 60.2 m-85 -109.83 -21.33 12.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.132 0.491 . . . . 0.0 109.875 173.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.74 -29.22 67.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.08 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -60.8 -47.44 86.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 110.639 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -78.42 -22.88 47.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.598 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -62.68 -41.77 99.27 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.197 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.8 tttt -59.73 -48.29 82.26 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 347' ' ' VAL . 13.4 mmt85 -61.25 -45.32 95.0 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.038 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.422 HH21 ' HD3' ' A' ' 344' ' ' ARG . 67.7 mtt-85 -65.89 -38.94 90.1 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 341' ' ' ALA . 97.4 t -66.63 -43.23 90.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.031 0.444 . . . . 0.0 109.998 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 342' ' ' LYS . 59.7 t -60.24 -43.48 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.566 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 343' ' ' ARG . 71.0 t -59.51 -45.09 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.32 -43.89 98.44 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.032 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.97 -42.77 97.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.557 0.218 . . . . 0.0 111.437 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.9 mt -62.75 -45.92 90.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.94 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.12 -38.91 82.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.241 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.57 97.07 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.146 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.78 -35.05 79.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.886 0.374 . . . . 0.0 110.837 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.62 -43.69 95.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.93 -44.89 99.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.899 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -69.48 -46.28 67.0 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.0 m -63.31 -44.18 95.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -97.11 5.71 49.78 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.059 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 52.83 53.19 12.51 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.846 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.91 145.57 32.59 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.7 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.25 148.26 44.54 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.765 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.88 127.54 32.91 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 367' ' ' VAL . 25.2 t70 -96.9 110.68 23.14 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.784 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -59.23 -34.6 72.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.775 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.449 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 46.7 mm-40 -67.05 -40.93 87.21 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.12 0.486 . . . . 0.0 110.591 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -63.4 -38.97 93.19 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 363' ' ' ASP . 93.6 t -62.51 -41.03 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.087 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 372' ' ' GLU . 25.9 mmmt -55.34 -45.15 76.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.066 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.16 -41.31 99.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.399 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.93 -42.66 99.87 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.09 0.471 . . . . 0.0 110.38 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.79 -44.04 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.738 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 368' ' ' LYS . 47.5 mt-10 -64.87 -40.26 94.85 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.718 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.91 -38.35 86.05 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.491 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 57.6 ttm -65.49 -41.49 93.2 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.076 0.465 . . . . 0.0 110.34 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -63.23 -26.3 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.844 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.8 m -72.35 -6.77 45.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.29 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -92.09 1.25 57.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.913 0.387 . . . . 0.0 110.789 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -119.87 172.59 7.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.23 -46.2 78.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.758 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 26.7 t70 -120.97 108.82 36.21 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.958 0.409 . . . . 0.0 110.576 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.467 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 51.8 Cg_exo -56.55 -39.41 91.53 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.91 2.406 . . . . 0.0 113.233 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.84 -43.84 91.72 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 9.4 pt-20 -62.88 -37.78 88.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.451 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.45 -42.73 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.217 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.48 -44.92 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.212 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.14 -38.6 78.9 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.265 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -58.97 -46.52 87.88 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.936 0.398 . . . . 0.0 110.355 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.488 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 4.6 t80 -68.65 -44.22 74.6 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.527 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.9 p -73.45 -17.32 61.26 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -176.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.12 4.14 54.51 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.108 0.48 . . . . 0.0 111.076 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 395' ' ' MET . 16.2 t-20 -122.51 111.45 16.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.033 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -61.39 -42.08 98.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -58.56 -48.89 79.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.776 0.322 . . . . 0.0 110.636 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.27 -40.44 97.4 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.492 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.437 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 95.9 mtp -61.72 -48.86 78.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.712 0.292 . . . . 0.0 111.62 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.51 -37.65 74.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 -175.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -62.25 -44.06 97.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.203 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.488 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 51.6 tpp -66.29 -39.74 89.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.146 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.481 ' HG2' HG21 ' A' ' 367' ' ' VAL . 55.7 mtm180 -64.17 -35.96 82.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.797 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -61.74 -43.84 98.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.001 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.2 -44.48 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.912 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.72 -40.48 97.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.903 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 45.9 tp -64.47 -37.74 88.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.462 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.84 -44.27 90.92 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.165 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -65.96 -37.0 84.88 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.595 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -60.06 -42.25 94.11 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.47 82.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.926 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 85.1 t -63.55 -46.41 95.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.02 -33.06 74.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.383 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.93 96.08 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 110.569 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 93.7 t -65.16 -42.23 93.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.314 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 95.5 mt -60.49 -40.16 90.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.643 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.58 -22.61 66.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.352 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -94.39 -40.44 9.93 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.919 0.39 . . . . 0.0 111.423 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -80.36 177.99 8.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.372 0.606 . . . . 0.0 112.36 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -87.25 118.23 26.54 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.362 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.1 t -103.36 105.95 19.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.1 t -105.13 134.72 47.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.975 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.19 111.57 23.25 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.757 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -117.79 128.13 54.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.992 0.425 . . . . 0.0 110.893 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -72.06 147.43 46.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.167 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -157.13 169.64 24.32 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 120.834 0.35 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 29.6 p -91.29 165.34 13.49 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.339 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -66.35 -30.34 70.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.479 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -62.46 -38.27 89.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.862 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.57 -33.5 75.81 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.08 0.466 . . . . 0.0 110.364 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 11.2 mp -72.43 -21.34 61.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.9 mmt -73.46 -6.65 47.7 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.031 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -78.79 71.69 5.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -102.49 17.42 23.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.268 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -64.17 -39.79 94.75 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.441 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.218 178.823 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 120.95 0.405 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.14 134.67 56.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.193 0.52 . . . . 0.0 111.711 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.02 159.76 42.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.27 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 40.2 t -115.85 107.73 15.4 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.998 0.428 . . . . 0.0 110.582 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.83 139.88 21.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.137 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -122.15 154.45 37.4 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.974 0.416 . . . . 0.0 111.137 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 61.5 m -104.35 119.79 39.74 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.912 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.8 m -70.67 -66.09 0.65 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.039 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -179.46 131.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.577 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.22 -106.37 1.65 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.507 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.453 ' HG ' ' CG1' ' B' ' 111' ' ' VAL . 2.5 mp -96.99 -14.5 21.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.687 0.28 . . . . 0.0 110.364 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.1 132.62 19.35 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.552 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.9 143.83 47.16 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 122.703 0.401 . . . . 0.0 109.997 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -117.9 133.94 55.44 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 19.8 t -81.04 -93.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.1 m 55.58 90.35 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.27 0.557 . . . . 0.0 110.679 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.1 tp -106.59 133.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.075 0.464 . . . . 0.0 111.921 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 25.5 p -81.76 132.09 35.28 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.824 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.5 HD13 HD11 ' B' ' 24' ' ' ILE . 1.8 pp -128.58 164.76 29.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.66 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -111.12 156.6 21.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.14 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.25 -52.87 57.61 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -173.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -71.05 -34.14 70.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.907 0.384 . . . . 0.0 110.963 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 33.4 t -64.87 -29.1 70.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.443 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.66 HG13 ' O ' ' B' ' 20' ' ' ALA . 64.9 mt -63.25 -71.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.29 0.567 . . . . 0.0 111.302 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.35 -42.72 96.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.646 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 18.1 m -63.1 -47.43 82.87 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.06 -44.3 15.33 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -174.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 81.4 t -62.44 -44.66 99.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.55 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -61.71 -47.16 86.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.706 0.289 . . . . 0.0 111.036 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 21.8 m -61.75 -42.42 98.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.467 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.426 ' O ' HG23 ' B' ' 35' ' ' VAL . 13.6 tp10 -65.25 -40.99 94.72 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.868 0.366 . . . . 0.0 110.562 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 96.2 mt -63.71 -44.07 94.7 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.67 -37.2 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.74 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -63.16 -40.49 97.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.288 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 31' ' ' GLU . 83.9 t -64.05 -44.07 97.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.794 0.331 . . . . 0.0 110.511 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -46.37 89.97 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.855 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.74 -33.99 76.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.088 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.83 -43.84 90.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.854 0.359 . . . . 0.0 110.448 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 t -84.84 -4.7 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.289 0.566 . . . . 0.0 110.314 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 61.98 28.53 17.33 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.499 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.419 ' H ' HG13 ' B' ' 41' ' ' ILE . 2.8 pp -105.04 5.77 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.974 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -65.06 -28.61 69.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.264 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.2 -19.26 72.03 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.273 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -76.24 -17.55 59.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -87.15 93.54 9.4 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.115 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -69.37 115.85 9.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.94 70.74 0.49 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 -170.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.19 -44.56 83.63 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.61 105.96 26.64 Favored Pre-proline 0 N--CA 1.439 -1.005 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.125 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.484 ' HB2' ' OD1' ' B' ' 52' ' ' ASN . 14.0 Cg_endo -58.44 145.74 93.07 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.198 1.932 . . . . 0.0 111.396 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.551 ' HA ' HG12 ' B' ' 54' ' ' VAL . 19.4 ttt -63.47 -38.84 92.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.151 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ASN . . . . . 0.484 ' OD1' ' HB2' ' B' ' 50' ' ' PRO . 21.8 p-10 -62.02 -43.25 99.23 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.899 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.511 HG12 HH21 ' A' ' 193' ' ' ARG . 1.8 mp -68.5 -44.64 82.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' B' ' 51' ' ' MET . 4.3 p -63.89 -37.35 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.502 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.49 87.41 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.341 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -84.27 -33.66 23.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -62.53 -42.82 99.77 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.982 0.42 . . . . 0.0 110.946 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.6 18.21 21.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.412 0.625 . . . . 0.0 110.805 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.43 145.68 49.74 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.426 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 72.75 -33.98 0.28 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.458 0.703 . . . . 0.0 112.263 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.7 t -61.63 -47.27 86.17 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.68 21.34 5.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 122.079 0.943 . . . . 0.0 109.899 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -63.27 -21.3 66.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.035 -177.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -64.02 -47.06 81.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.774 0.321 . . . . 0.0 110.807 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.94 -23.86 55.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.268 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.74 -42.16 94.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.0 -38.47 88.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.17 -41.71 98.3 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.637 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ASP . . . . . 0.569 ' OD1' ' HE2' ' A' ' 327' ' ' LYS . 21.1 t70 -60.23 -46.92 88.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.22 -42.91 99.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.409 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 61.0 ttp -63.03 -43.09 99.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.174 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -62.17 -43.8 98.02 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.256 0.551 . . . . 0.0 110.807 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.405 ' NH1' HG21 ' B' ' 35' ' ' VAL . 71.5 mtp180 -64.78 -40.61 95.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.314 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -63.85 -40.8 97.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.898 0.38 . . . . 0.0 110.473 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -61.09 -48.98 79.19 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.099 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.462 ' O ' HG13 ' B' ' 79' ' ' ILE . 15.5 tt -68.74 -41.25 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.39 -38.0 89.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.212 0.529 . . . . 0.0 110.072 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.66 -47.22 84.65 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.092 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.462 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.8 pp -66.69 -29.55 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.865 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.5 mt -65.46 -43.95 94.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.782 0.325 . . . . 0.0 111.07 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -81.31 -33.06 32.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -80.18 -7.91 59.17 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.064 0.459 . . . . 0.0 110.388 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt 66.93 38.08 3.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.262 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.9 mt -101.19 121.44 52.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.473 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -107.54 102.72 45.85 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.835 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.71 146.79 38.98 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 122.376 2.051 . . . . 0.0 112.085 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.35 100.63 12.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.609 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.59 -118.11 6.45 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.012 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.27 130.65 23.44 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-O 120.544 0.212 . . . . 0.0 110.883 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' PRO . . . . . 0.436 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 73.1 Cg_endo -75.25 161.6 37.78 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.982 2.455 . . . . 0.0 111.984 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -77.98 117.71 19.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.127 0.489 . . . . 0.0 111.899 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.436 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 81.6 m-85 -112.22 122.0 46.49 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 52.7 t -120.89 99.89 46.61 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-O 120.878 0.37 . . . . 0.0 110.713 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -89.66 145.24 4.72 Favored 'Trans proline' 0 N--CA 1.438 -1.791 0 C-N-CA 122.412 2.074 . . . . 0.0 111.213 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.14 174.92 40.92 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.326 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.63 126.42 29.29 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -81.27 125.19 30.03 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.023 0.44 . . . . 0.0 110.352 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -112.95 112.46 23.94 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.036 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 48.5 tp -65.43 107.11 1.56 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.047 0.451 . . . . 0.0 110.105 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.73 -16.32 8.37 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.257 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.37 -179.74 4.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.957 0.408 . . . . 0.0 111.629 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.8 138.52 37.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.744 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -96.11 143.1 27.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.473 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 45.4 m -124.92 134.67 52.57 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -140.68 155.7 46.42 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.392 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 3.0 m -84.66 -86.06 0.13 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 84.0 t 67.86 108.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.992 0.517 . . . . 0.0 110.692 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -111.51 138.69 47.71 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.639 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -152.81 -75.13 0.13 Allowed 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -142.43 157.2 45.03 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.798 -0.564 . . . . 0.0 111.32 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.453 ' CG1' ' HG ' ' B' ' 11' ' ' LEU . 27.5 m -129.94 -175.2 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 121.351 0.596 . . . . 0.0 112.342 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -138.16 119.32 10.37 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.01 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.72 148.54 32.71 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.019 2.479 . . . . 0.0 114.583 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -138.74 142.25 38.87 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.38 133.21 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -103.0 -92.25 0.34 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.451 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.4 mt 64.13 133.79 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.898 0.879 . . . . 0.0 113.337 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -141.83 152.47 43.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.469 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.2 19.42 78.47 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.465 175.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 75.3 mt -63.62 -37.2 86.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.986 0.422 . . . . 0.0 111.352 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' B' ' 121' ' ' GLU . 1.6 mp0 -72.64 -12.91 61.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.593 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.44 18.0 18.89 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.878 0.37 . . . . 0.0 111.37 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 83.6 mt -92.66 122.23 43.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -104.37 133.11 49.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.45 136.0 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 112.027 -172.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -87.21 139.21 30.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.915 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -134.3 99.88 13.07 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.8 137.18 37.68 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.968 1.779 . . . . 0.0 111.492 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.72 123.66 69.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.848 0.356 . . . . 0.0 110.349 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.14 162.86 39.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.233 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -145.24 159.16 43.44 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.815 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.46 118.0 28.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 69.9 p -101.03 174.96 5.77 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.991 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.45 -31.81 72.59 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.657 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.13 99.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.481 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -65.08 -44.61 88.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.274 0.559 . . . . 0.0 110.268 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.4 t -63.8 -46.91 93.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.723 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -64.12 -42.71 96.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.646 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.75 -39.96 95.49 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.095 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.562 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.0 OUTLIER -62.68 -42.97 99.91 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 94.4 mt -63.63 -41.13 98.29 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.842 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -59.23 -48.72 80.56 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.68 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.9 m -61.8 -40.55 95.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.63 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.1 mt -61.04 -41.76 97.19 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.457 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -74.02 -18.05 60.9 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.467 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.5 -8.66 59.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.256 0.551 . . . . 0.0 110.394 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -95.83 4.61 52.7 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.342 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -119.07 75.33 1.03 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.754 0.788 . . . . 0.0 112.052 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -157.31 74.66 0.78 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.463 HG22 ' H ' ' B' ' 151' ' ' TRP . 4.9 m -145.83 171.86 14.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.102 -172.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' TRP . . . . . 0.463 ' H ' HG22 ' B' ' 150' ' ' THR . 44.8 t-105 82.02 10.68 0.73 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.79 1.236 . . . . 0.0 112.393 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.535 ' HG2' ' HB2' ' B' ' 245' ' ' LEU . 6.1 mptp? -94.3 158.16 15.71 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.048 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.27 -1.56 58.1 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -141.05 156.32 46.03 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 120.444 -0.503 . . . . 0.0 112.02 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 4.6 t70 82.98 178.08 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.065 1.346 . . . . 0.0 111.136 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.0 89.62 0.26 Allowed Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 119.403 -1.379 . . . . 0.0 115.134 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' B' ' 244' ' ' GLU . . . -103.38 -59.92 1.64 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 58.5 t 62.6 125.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.872 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -101.06 160.16 14.62 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.963 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.86 86.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.45 -4.38 42.19 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.79 143.48 32.82 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -96.82 121.23 38.45 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 49.5 t -119.53 129.46 75.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.773 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 25.5 m -76.42 104.28 6.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 77.1 mt -117.27 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.869 0.366 . . . . 0.0 111.582 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 16.5 m-20 -99.04 91.9 5.24 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -110.78 154.17 24.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 111.462 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 38.8 m -124.72 129.54 50.68 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.646 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.35 127.38 9.17 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.84 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 27.2 m -143.26 124.61 14.67 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.93 -78.22 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.609 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -133.41 81.03 1.91 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.101 0.477 . . . . 0.0 111.423 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.3 2.72 80.25 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.247 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -140.82 149.7 42.37 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 117.043 0.422 . . . . 0.0 110.874 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -89.16 150.18 22.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.9 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -115.74 177.14 4.78 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.164 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -57.28 -40.43 77.75 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.892 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -102.2 -173.28 27.45 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.061 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.14 30.53 46.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.785 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -106.82 107.47 18.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -126.6 141.64 51.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.071 0.462 . . . . 0.0 111.957 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.4 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 50.0 m -149.34 130.44 14.45 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 57.08 31.33 19.77 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.594 0.559 . . . . 0.0 110.6 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -96.06 124.25 39.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.561 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 5.7 m -91.78 117.2 34.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.535 0.683 . . . . 0.0 110.645 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 53.2 tp -110.91 131.74 54.79 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.619 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 188' ' ' ALA . . . . . 0.68 ' HB3' ' NH1' ' B' ' 193' ' ' ARG . . . -121.42 137.39 54.73 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 71.1 mtm -103.65 179.14 4.36 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.153 0.501 . . . . 0.0 112.002 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.46 -20.36 44.65 Favored Glycine 0 CA--C 1.503 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.009 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -91.25 -13.69 32.29 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.767 0.317 . . . . 0.0 111.248 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.72 40.58 10.62 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.095 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.68 ' NH1' ' HB3' ' B' ' 188' ' ' ALA . 51.8 mtm180 -94.47 0.52 55.42 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.432 0.634 . . . . 0.0 110.962 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.481 ' HB2' ' HG3' ' B' ' 199' ' ' GLU . 0.0 OUTLIER -129.26 165.73 20.82 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.389 173.23 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.682 ' H ' HD12 ' B' ' 195' ' ' ILE . 4.5 mp -61.23 136.59 94.07 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.71 133.67 51.06 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 121.957 1.771 . . . . 0.0 111.434 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.13 -39.01 2.88 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.193 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 198' ' ' PHE . . . . . 0.52 ' O ' HG12 ' B' ' 202' ' ' ILE . 52.1 t80 -62.35 -48.69 78.69 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 199' ' ' GLU . . . . . 0.481 ' HG3' ' HB2' ' B' ' 194' ' ' MET . 93.0 mt-10 -67.0 -36.44 82.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.283 0.563 . . . . 0.0 110.416 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.76 -35.71 81.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.218 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.38 -7.95 71.87 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.838 -0.696 . . . . 0.0 114.324 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.52 HG12 ' O ' ' B' ' 198' ' ' PHE . 48.1 mm -64.96 -44.23 96.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 117.57 0.685 . . . . 0.0 110.984 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -60.01 133.62 56.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.087 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.26 -15.04 51.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.179 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -84.24 141.18 31.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.26 0.552 . . . . 0.0 111.905 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -90.94 161.32 15.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.889 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.83 130.1 42.77 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 208' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' B' ' 237' ' ' LEU . . . 69.98 34.27 70.81 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.498 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -113.65 114.05 25.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.251 0.548 . . . . 0.0 111.59 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -91.24 137.35 32.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -156.48 -27.34 0.1 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 28.0 m 77.48 135.59 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.906 0.482 . . . . 0.0 110.988 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -106.58 -40.3 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 68.26 96.41 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.242 0.544 . . . . 0.0 112.364 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 66.4 t -119.25 135.71 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.071 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 216' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 6.5 m -93.78 -23.08 18.31 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.462 ' CE2' HG12 ' B' ' 195' ' ' ILE . 95.2 m-85 71.81 142.93 0.09 OUTLIER Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 122.892 0.477 . . . . 0.0 111.992 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 11.6 Cg_exo -71.42 153.58 60.91 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.737 2.291 . . . . 0.0 111.899 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.29 -40.77 94.27 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.867 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -84.81 29.73 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.318 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -68.6 133.25 48.23 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.945 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -57.63 -40.65 79.67 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.61 101.24 8.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.34 -32.38 71.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.793 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -67.52 -14.24 62.76 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 94.7 mt -119.21 3.29 11.39 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -73.76 125.45 28.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 119.736 -0.785 . . . . 0.0 112.372 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.95 16.04 76.41 Favored Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.283 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -125.44 128.88 48.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.59 0.695 . . . . 0.0 111.244 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.94 150.53 30.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.59 137.22 35.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.614 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -68.53 -48.31 64.66 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 54.39 91.93 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.165 0.507 . . . . 0.0 111.266 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.81 92.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mm 70.38 90.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 122.869 0.468 . . . . 0.0 111.249 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.65 -48.19 67.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.322 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' LEU . . . . . 0.526 ' O ' ' HA2' ' B' ' 208' ' ' GLY . 8.1 tp 57.42 110.49 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.987 0.915 . . . . 0.0 112.917 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -105.36 -75.59 0.62 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 239' ' ' LYS . . . . . 0.411 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 34.3 mmtp -77.86 -83.76 0.08 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.5 HG12 ' H ' ' B' ' 242' ' ' GLU . 86.2 t 74.51 139.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.368 0.604 . . . . 0.0 111.288 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.522 ' HB3' ' NH1' ' B' ' 243' ' ' ARG . 56.3 mm-40 -63.48 -40.15 96.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.206 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.5 ' H ' HG12 ' B' ' 240' ' ' VAL . 31.1 mt-10 66.76 129.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.303 0.641 . . . . 0.0 111.809 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.522 ' NH1' ' HB3' ' B' ' 241' ' ' GLU . 5.6 ptp180 174.44 109.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.054 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.493 ' HG3' ' HB2' ' B' ' 157' ' ' ALA . 2.4 tt0 -137.03 -150.88 0.38 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.535 ' HB2' ' HG2' ' B' ' 152' ' ' LYS . 10.0 mp 69.16 145.76 0.11 Allowed Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 123.538 0.735 . . . . 0.0 112.714 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 246' ' ' PRO . . . . . 0.551 ' O ' ' HG2' ' B' ' 247' ' ' GLU . 84.5 Cg_endo -83.28 -158.79 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.059 2.506 . . . . 0.0 112.47 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 247' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' B' ' 246' ' ' PRO . 4.0 pt-20 85.68 -176.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.934 1.694 . . . . 0.0 111.004 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.13 136.0 49.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.124 0.487 . . . . 0.0 111.824 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 20.0 p -89.78 -170.14 2.7 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.213 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.61 -52.85 62.41 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.015 0.436 . . . . 0.0 110.017 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -131.09 92.18 3.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.482 0.658 . . . . 0.0 109.241 173.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -70.63 -13.64 62.16 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.563 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' ILE . . . . . 0.442 ' H ' HD12 ' B' ' 253' ' ' ILE . 4.0 mp -63.3 -44.51 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.493 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 254' ' ' LYS . . . . . 0.546 ' HD2' ' HB2' ' B' ' 260' ' ' ASP . 54.9 pttt -149.84 150.84 32.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 111.459 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.596 ' HG3' ' H ' ' B' ' 256' ' ' PHE . 27.5 tpt180 -166.02 -174.61 3.05 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -175.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 256' ' ' PHE . . . . . 0.596 ' H ' ' HG3' ' B' ' 255' ' ' ARG . 94.1 m-85 88.85 -41.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.463 1.105 . . . . 0.0 113.395 172.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 133.51 -129.86 5.5 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.304 -1.427 . . . . 0.0 113.183 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 26.8 m 37.85 49.58 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.669 0.788 . . . . 0.0 111.458 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 259' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' B' ' 260' ' ' ASP . 34.9 tt0 67.68 -85.17 0.03 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.518 -175.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 260' ' ' ASP . . . . . 0.546 ' HB2' ' HD2' ' B' ' 254' ' ' LYS . 2.6 p30 174.26 150.34 0.09 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.276 0.63 . . . . 0.0 109.959 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.5 -177.89 37.5 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.098 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 22.9 p -75.38 167.29 22.19 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 122.79 0.436 . . . . 0.0 110.859 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 263' ' ' VAL . . . . . 0.521 ' O ' ' HG3' ' B' ' 267' ' ' ARG . 99.4 t -61.93 -48.89 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -70.82 -40.3 72.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.769 0.319 . . . . 0.0 111.021 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -67.34 -40.69 91.77 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.425 ' O ' HG23 ' B' ' 270' ' ' VAL . 51.2 tp -61.78 -46.07 91.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.614 0.245 . . . . 0.0 110.961 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 267' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' B' ' 263' ' ' VAL . 44.8 mtp180 -66.17 -40.39 90.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.402 -177.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -68.34 -42.57 79.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.295 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -67.0 -40.15 87.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.646 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.425 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.1 t -64.35 -41.87 93.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -56.97 -47.82 79.83 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.47 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 16.2 ptmt -67.48 -38.6 84.63 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -63.67 -41.45 98.18 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.927 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 274' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.9 mmm -65.11 -42.42 93.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.973 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.19 -35.76 78.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.873 0.368 . . . . 0.0 110.973 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -63.3 -42.81 99.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -65.94 -38.64 89.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.491 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.78 -40.77 96.36 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.699 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -57.29 -48.61 78.48 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.164 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.3 m -62.9 -44.26 96.57 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.776 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.75 95.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.067 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.58 -44.25 98.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 120.969 0.414 . . . . 0.0 110.347 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -62.15 -42.53 99.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.88 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -62.9 -41.35 99.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 110.916 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -60.96 -43.92 98.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.479 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 94.9 t -69.49 -43.85 80.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.926 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 287' ' ' LYS . . . . . 0.422 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.1 tttt -61.12 -46.81 89.05 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.145 -176.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 75.4 p -62.04 -43.36 99.01 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -64.88 -43.73 91.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.779 0.323 . . . . 0.0 110.685 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 290' ' ' ALA . . . . . 0.67 ' O ' ' HG ' ' B' ' 294' ' ' LEU . . . -63.45 -46.84 84.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.076 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 291' ' ' ILE . . . . . 0.422 HG12 ' O ' ' B' ' 287' ' ' LYS . 38.1 mm -64.04 -44.16 97.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.646 0.26 . . . . 0.0 110.648 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 292' ' ' GLU . . . . . 0.496 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 32.8 tp10 -60.22 -42.61 95.53 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.352 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.91 99.16 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.382 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' B' ' 290' ' ' ALA . 65.6 mt -63.5 -42.53 98.5 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.552 0.215 . . . . 0.0 111.413 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.92 -44.57 96.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.957 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.496 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 67.8 mttm -63.78 -39.57 94.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.073 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -65.09 -40.76 95.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.125 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -137.06 100.86 4.39 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.05 98.81 11.98 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 8.6 tp -104.64 142.6 17.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.193 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.21 135.7 54.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.097 0.475 . . . . 0.0 109.799 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 90.3 t -109.88 132.91 21.14 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.37 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.58 132.27 51.1 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.421 2.081 . . . . 0.0 111.885 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.06 86.57 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.404 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.58 82.01 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.882 0.372 . . . . 0.0 111.399 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.29 -41.87 93.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.437 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 307' ' ' ILE . . . . . 0.4 ' O ' HG13 ' B' ' 311' ' ' ILE . 65.3 mt -65.12 -44.55 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.947 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -43.82 82.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.016 0.436 . . . . 0.0 110.958 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 31.8 m -61.56 -44.43 97.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.125 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 310' ' ' GLU . . . . . 0.539 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 52.0 mm-40 -68.29 -39.05 82.23 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.882 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.485 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.2 mt -62.29 -44.39 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.429 -177.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.499 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 20.3 t70 -62.38 -43.13 99.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.011 0.434 . . . . 0.0 110.872 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 91.5 t -64.88 -43.47 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.252 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 95.0 mt -62.24 -40.43 96.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.499 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 85.9 mtm180 -63.34 -40.94 98.68 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 316' ' ' ARG . . . . . 0.4 HH21 ' HD2' ' B' ' 316' ' ' ARG . 31.7 mtt180 -63.83 -39.93 95.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.717 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -63.02 -40.16 96.92 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.278 0.561 . . . . 0.0 109.914 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 -42.99 81.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 319' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -65.29 -37.35 86.88 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.333 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 320' ' ' GLN . . . . . 0.443 ' NE2' ' HG3' ' A' ' 45' ' ' ARG . 48.3 tt0 -62.43 -39.6 93.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.139 0.495 . . . . 0.0 110.431 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -86.99 -0.62 56.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.59 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -97.57 -2.41 41.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.166 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 323' ' ' GLY . . . . . 0.556 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 140.01 -6.51 2.86 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.608 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 95.22 29.16 9.15 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.71 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 325' ' ' ASN . . . . . 0.483 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 43.5 t-20 -72.38 123.33 22.83 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 326' ' ' GLU . . . . . 0.661 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 0.7 OUTLIER -116.72 152.71 33.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 0.1 OUTLIER 62.06 -34.3 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.832 1.653 . . . . 0.0 114.773 177.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 328' ' ' GLN . . . . . 0.483 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.9 mm100 -76.72 -5.62 48.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.259 0.552 . . . . 0.0 110.454 177.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -66.23 -13.76 60.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.273 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.411 HD12 HH12 ' B' ' 315' ' ' ARG . 54.2 tp -62.99 -35.97 81.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.417 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -66.86 -24.55 66.15 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.707 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.479 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 72.3 mt -58.2 142.43 80.84 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.707 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 333' ' ' PRO . . . . . 0.477 ' O ' ' HD1' ' B' ' 337' ' ' PHE . 36.5 Cg_exo -60.86 137.62 73.73 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.287 2.658 . . . . 0.0 113.778 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 334' ' ' ARG . . . . . 0.457 ' HG3' HD13 ' B' ' 311' ' ' ILE . 26.7 ttt85 -74.14 -43.42 57.52 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.143 177.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.1 -37.42 85.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -170.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 71.5 mt -87.01 -3.57 59.1 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.524 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 337' ' ' PHE . . . . . 0.477 ' HD1' ' O ' ' B' ' 333' ' ' PRO . 56.5 m-85 -108.48 -22.09 12.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.084 0.468 . . . . 0.0 110.34 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.55 -29.1 67.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.33 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.66 -46.93 87.64 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.826 0.346 . . . . 0.0 110.814 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -76.72 -25.43 53.53 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.33 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.449 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.97 -42.09 99.73 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.469 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 342' ' ' LYS . . . . . 0.518 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.1 tttt -59.55 -47.09 86.9 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 343' ' ' ARG . . . . . 0.538 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.7 mmt85 -61.87 -45.3 94.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.201 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -66.6 -37.85 85.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 341' ' ' ALA . 96.0 t -65.2 -43.71 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 342' ' ' LYS . 71.1 t -60.78 -43.52 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.661 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.538 HG23 ' O ' ' B' ' 343' ' ' ARG . 75.1 t -59.23 -45.31 93.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.3 -43.92 98.4 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.069 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.83 -43.0 97.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.62 0.248 . . . . 0.0 111.448 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' B' ' 346' ' ' VAL . 97.0 mt -62.76 -46.26 88.87 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.895 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.39 -39.14 85.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.186 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.74 -42.15 97.85 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.357 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.26 -34.32 77.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.942 0.371 . . . . 0.0 110.923 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.2 -43.43 93.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.29 -44.51 99.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.748 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -70.64 -45.91 64.28 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 96.2 m -63.68 -45.0 92.09 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -95.23 4.17 53.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.245 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 53.48 54.19 10.46 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.95 0.5 . . . . 0.0 112.019 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.97 147.85 27.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.427 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.45 149.51 45.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.63 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.79 128.2 35.81 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 363' ' ' ASP . . . . . 0.526 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.6 t70 -95.9 111.25 23.29 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.403 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 364' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 52.9 mm-40 -61.64 -33.26 73.63 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.814 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 365' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 68.3 mm-40 -66.99 -40.26 87.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.937 0.399 . . . . 0.0 110.366 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -64.14 -38.19 90.18 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.664 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 367' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 363' ' ' ASP . 97.8 t -61.82 -41.16 89.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.788 176.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 368' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.8 mmmt -56.56 -44.26 80.79 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.269 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.8 -41.53 99.63 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.245 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.2 -42.8 99.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.808 0.337 . . . . 0.0 110.252 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.55 -44.43 96.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.775 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.38 -42.79 98.84 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.763 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.89 -38.32 86.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.988 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 58.6 ttm -65.79 -40.91 92.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.972 0.415 . . . . 0.0 110.289 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 375' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -63.0 -26.59 68.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.69 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.2 m -71.89 -7.17 46.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.031 0.443 . . . . 0.0 111.229 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.0 -0.27 57.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.711 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -118.23 173.56 6.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.802 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.16 -45.89 83.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.979 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 380' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 21.4 t70 -122.54 109.37 32.77 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 121.017 0.437 . . . . 0.0 110.663 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 381' ' ' PRO . . . . . 0.455 ' HA ' ' HB1' ' B' ' 375' ' ' ALA . 52.7 Cg_exo -56.01 -41.36 77.82 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.692 2.262 . . . . 0.0 113.132 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 382' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' B' ' 382' ' ' LYS . 32.1 mmtp -65.75 -41.99 91.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 15.9 pt-20 -62.47 -39.07 92.25 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.029 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.19 -42.64 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.784 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.17 -44.53 99.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.28 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.46 -39.26 77.85 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.826 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.95 -42.12 84.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.248 0.547 . . . . 0.0 110.018 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 388' ' ' TYR . . . . . 0.506 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 5.0 t80 -73.75 -41.72 62.11 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.005 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 31.3 p -80.33 -7.85 59.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.88 4.9 45.36 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.368 0.604 . . . . 0.0 110.721 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -124.47 112.65 17.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.857 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.56 -41.11 96.89 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -60.23 -48.91 79.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.631 0.253 . . . . 0.0 111.199 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.45 -40.85 98.23 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.371 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.569 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 93.5 mtp -60.94 -48.16 83.08 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.352 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.03 -38.82 72.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.264 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.98 -42.86 99.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.5 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 398' ' ' MET . . . . . 0.506 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 53.7 tpp -65.31 -39.48 92.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.668 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' B' ' 395' ' ' MET . 70.2 mtm180 -64.1 -36.48 84.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.755 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.1 -44.05 97.49 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.19 -45.45 90.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.864 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.95 -40.79 98.72 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.932 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 46.9 tp -64.16 -38.08 89.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.647 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.39 -43.13 96.94 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.441 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -65.48 -38.01 88.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.424 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -59.27 -41.34 88.66 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 120.758 0.313 . . . . 0.0 110.327 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.443 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.8 -47.36 81.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 178.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.17 -45.66 95.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.948 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -65.65 -34.54 78.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.117 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.03 -40.18 94.45 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.923 0.392 . . . . 0.0 110.638 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 411' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 407' ' ' ALA . 94.3 t -64.92 -42.29 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.338 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.67 -37.8 82.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.172 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -67.8 -14.94 63.37 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.913 0.387 . . . . 0.0 111.537 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -100.74 -37.89 8.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 110.86 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.65 175.66 9.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.156 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.47 113.98 22.16 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.094 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.9 t -99.22 107.86 21.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.039 0.447 . . . . 0.0 109.878 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -110.43 134.66 52.12 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -94.06 114.1 26.2 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.153 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -116.26 131.84 56.83 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.905 0.383 . . . . 0.0 110.598 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -76.92 147.63 36.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.229 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.0 t -157.58 165.83 34.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.61 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 26.7 p -86.73 166.51 15.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.967 0.413 . . . . 0.0 110.98 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -64.05 -28.61 69.9 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.8 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -62.41 -39.29 92.8 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.921 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.27 -33.94 76.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.029 0.442 . . . . 0.0 110.628 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.85 -31.09 69.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.686 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.5 mmt -65.6 -10.44 35.59 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.809 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -74.93 69.58 1.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.5 0.667 . . . . 0.0 109.21 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -100.77 17.88 20.88 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.519 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -63.99 -40.64 96.83 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.143 178.486 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 120.627 0.251 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -98.72 115.09 27.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.796 0.331 . . . . 0.0 110.555 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.55 135.34 62.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.044 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 p -115.63 145.84 42.34 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.799 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.9 -52.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 66.5 179.21 0.21 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.114 0.483 . . . . 0.0 110.862 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 m -136.72 128.58 29.17 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.235 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.6 m -76.59 -68.49 0.59 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.831 0.348 . . . . 0.0 110.743 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -177.42 128.62 0.15 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.085 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.45 -115.94 8.46 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.932 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.42 -7.83 57.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 106' ' ' SER . . . -68.64 126.69 21.99 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.541 -177.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -135.59 159.22 42.28 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 122.909 0.484 . . . . 0.0 110.055 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.438 ' HG3' ' CE2' ' A' ' 105' ' ' TYR . 58.7 ttp180 -131.65 149.36 52.52 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.0 -83.64 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.006 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 m 46.84 79.31 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.059 0.457 . . . . 0.0 111.184 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.4 tp -113.33 135.25 53.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.894 0.378 . . . . 0.0 111.261 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.5 m -101.9 124.24 47.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.111 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.8 pt -128.92 160.68 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.552 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -73.17 155.78 39.28 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.905 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.69 83.79 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -64.18 -39.21 93.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.205 0.526 . . . . 0.0 110.446 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -65.8 -40.33 91.8 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.69 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 20' ' ' ALA . 77.3 mt -61.24 -48.83 87.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.53 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.03 -50.87 66.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.647 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.0 m -68.68 -51.06 45.98 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.6 -49.19 22.59 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -173.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.7 t -64.21 -43.39 97.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.59 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -58.98 -48.98 79.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.936 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -62.85 -42.14 99.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.266 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -66.62 -42.03 87.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.997 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.63 -42.86 99.83 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.89 -39.6 80.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.212 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -64.91 -42.0 95.11 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.5 m -67.05 -33.72 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.139 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.92 -41.12 95.82 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.087 0.47 . . . . 0.0 109.91 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.13 -29.57 69.33 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.37 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -58.75 -42.84 89.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.83 0.347 . . . . 0.0 110.593 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 t -92.27 -1.57 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.18 0.514 . . . . 0.0 110.241 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 61.62 29.72 18.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.844 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -101.51 5.56 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.914 0.388 . . . . 0.0 111.598 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -63.92 -31.24 72.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.601 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.68 -22.1 65.76 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.824 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -80.76 -6.11 58.04 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.44 ' HA ' ' OE1' ' B' ' 320' ' ' GLN . 22.7 ttt180 -97.46 90.57 5.1 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -92.59 76.43 5.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 169.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.69 105.65 3.12 Favored Glycine 0 N--CA 1.428 -1.841 0 CA-C-N 114.992 -1.003 . . . . 0.0 114.629 -172.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 88.4 tttt -64.46 -34.99 79.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 171.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' A' ' 54' ' ' VAL . 16.2 t -99.52 100.08 9.94 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.439 175.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 48' ' ' LYS . 17.2 Cg_exo -66.66 159.34 51.53 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.044 2.496 . . . . 0.0 112.495 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.549 ' HA ' HG12 ' A' ' 54' ' ' VAL . 45.7 mtt -60.05 -40.97 91.29 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -65.92 -21.04 66.41 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.17 -50.16 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.9 0.381 . . . . 0.0 110.928 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.612 ' HB ' HG12 ' A' ' 49' ' ' VAL . 12.6 p -67.46 -36.86 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.33 83.38 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -89.83 -1.71 58.05 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.571 -0.451 . . . . 0.0 112.212 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -101.33 -42.99 6.1 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 120.715 0.293 . . . . 0.0 111.556 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -97.49 5.1 50.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.469 0.652 . . . . 0.0 110.114 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.87 145.83 49.74 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.56 ' H ' ' HB2' ' A' ' 63' ' ' ARG . . . 72.52 -41.09 0.49 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.219 0.608 . . . . 0.0 111.699 -177.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 t -60.68 -46.62 89.65 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.856 0.462 . . . . 0.0 111.303 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 65' ' ' ASP . 8.1 p -124.97 18.77 4.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.662 0.744 . . . . 0.0 110.045 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.56 ' HB2' ' H ' ' A' ' 60' ' ' ALA . 13.2 ttt180 -65.89 -20.24 66.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.393 -174.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.58 -48.53 77.03 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.46 ' HB2' HG22 ' A' ' 62' ' ' VAL . 6.5 m-20 -67.3 -31.0 71.01 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.068 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.35 -43.34 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 99.3 mt -62.3 -39.72 93.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.77 97.7 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.446 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -62.69 -45.67 91.68 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 120.773 0.32 . . . . 0.0 110.984 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.64 -41.97 98.23 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.3 ttp -61.22 -46.06 91.97 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.965 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.2 m -63.37 -51.54 65.44 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.338 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -69.41 -38.21 77.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -65.37 -39.24 92.05 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.932 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.45 -47.17 87.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.46 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.6 tt -66.16 -38.63 82.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.25 -41.98 99.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.93 -45.33 89.74 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.435 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.4 pt -65.74 -41.35 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.47 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.43 -42.11 95.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.472 0.653 . . . . 0.0 109.379 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -59.41 -47.85 83.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.273 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -89.82 -0.86 57.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.425 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 65.4 36.8 6.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.81 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 98.1 mt -86.64 124.62 40.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.603 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -110.15 98.18 33.89 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.576 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 84' ' ' ILE . 19.7 Cg_exo -66.94 141.75 59.68 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.531 2.154 . . . . 0.0 111.819 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.29 103.3 15.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.913 0.387 . . . . 0.0 110.538 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -127.72 8.88 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.897 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.66 128.44 25.62 Favored Pre-proline 0 C--N 1.318 -0.786 0 O-C-N 122.916 -0.167 . . . . 0.0 110.613 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.16 144.76 82.59 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.451 2.101 . . . . 0.0 111.542 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.7 m -102.46 109.04 20.56 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.586 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 94.9 m-85 -86.45 91.59 8.58 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.68 106.59 2.54 Favored Pre-proline 0 C--N 1.324 -0.532 0 O-C-N 123.546 0.529 . . . . 0.0 111.189 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 91.0 Cg_endo -97.94 166.87 0.77 Allowed 'Trans proline' 0 N--CA 1.43 -2.214 0 C-N-CA 123.026 2.484 . . . . 0.0 111.299 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.06 -136.11 6.7 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 174.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.93 130.44 51.26 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -80.8 106.37 12.75 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.246 0.546 . . . . 0.0 110.771 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 97.7 mttt -84.87 147.71 26.65 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.65 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.6 tp -82.93 116.42 22.21 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.081 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.0 21.98 53.94 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.363 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . 37.0 tt0 -140.01 161.6 37.22 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.289 0.544 . . . . 0.0 109.793 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.97 142.79 54.58 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.853 0.359 . . . . 0.0 111.296 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -102.34 145.01 30.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.152 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.2 m -121.84 136.54 54.93 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.561 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 43.0 p90 -136.87 162.16 34.01 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.968 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.486 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 14.9 m -93.69 -69.9 0.73 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.2 p 49.28 101.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.179 0.99 . . . . 0.0 111.888 -173.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.32 113.98 23.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -172.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -156.27 145.8 20.84 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.858 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 65.97 143.64 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.4 m -129.4 157.44 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.842 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -165.11 100.79 0.8 Allowed Pre-proline 0 N--CA 1.466 0.372 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -88.23 158.91 6.95 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.973 2.449 . . . . 0.0 113.991 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -130.95 134.17 46.49 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -125.34 132.86 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -103.8 -78.92 0.55 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.549 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.6 mt 66.55 125.9 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.707 0.803 . . . . 0.0 112.964 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.22 155.47 47.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.4 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.11 9.56 86.5 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.04 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.22 -39.8 94.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.201 0.524 . . . . 0.0 110.885 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.4 mp0 -72.2 -10.51 59.88 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.116 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.61 13.42 33.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.746 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 94.8 mt -81.76 125.49 39.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.24 0.543 . . . . 0.0 110.936 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.24 122.58 47.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.35 134.01 67.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.621 ' OE1' ' HE3' ' A' ' 420' ' ' LYS . 41.1 tt0 -82.13 146.93 29.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.499 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -135.2 91.86 18.71 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.47 113.97 3.5 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.237 1.958 . . . . 0.0 112.1 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.9 mm -97.19 112.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.74 155.91 18.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.129 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -129.93 145.31 51.62 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.304 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.12 123.46 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.882 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 64.0 p -107.81 175.59 5.43 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.583 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -67.38 -23.61 65.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.7 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.57 97.0 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.106 0.479 . . . . 0.0 109.95 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.41 -40.73 97.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.454 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.07 -45.24 99.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.703 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.24 -43.13 96.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.52 0.2 . . . . 0.0 111.068 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.33 -42.83 99.08 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.602 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.58 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.8 tpt -63.38 -46.43 86.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.641 0.258 . . . . 0.0 110.803 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.58 -41.84 98.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.483 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.38 -47.68 84.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.218 0.532 . . . . 0.0 110.399 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.8 m -63.24 -41.06 99.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.909 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 140' ' ' MET . 92.6 mt -60.48 -42.44 96.26 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -73.06 -14.59 61.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.172 0.51 . . . . 0.0 111.11 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.18 -10.23 33.8 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.802 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -99.83 -27.9 13.4 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.626 ' OE1' ' HG2' ' A' ' 255' ' ' ARG . 11.3 mm-40 -137.38 168.14 20.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -168.77 -90.18 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.429 -1.714 . . . . 0.0 108.45 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.574 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 23.7 m -162.61 159.16 24.24 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.438 ' HA ' ' CB ' ' A' ' 243' ' ' ARG . 20.5 p-90 -109.02 147.62 32.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.632 ' H ' ' HA ' ' A' ' 243' ' ' ARG . 84.0 tttt -170.41 -75.88 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.48 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -172.27 163.98 5.82 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 43.2 tttp 58.59 62.45 1.94 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.968 1.307 . . . . 0.0 114.516 174.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 244' ' ' GLU . 28.8 t70 -173.22 141.31 0.92 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.593 0.357 . . . . 0.0 110.901 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.32 53.59 0.6 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.838 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.11 -28.58 15.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.225 0.513 . . . . 0.0 110.065 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.418 ' N ' ' HD2' ' A' ' 243' ' ' ARG . 23.7 t 66.62 135.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.106 0.962 . . . . 0.0 113.227 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.497 ' HG2' ' HG2' ' A' ' 243' ' ' ARG . 6.7 mm-40 -86.8 170.22 11.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.444 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.431 ' HB3' ' OE1' ' A' ' 161' ' ' GLU . . . -71.0 -64.61 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.173 0.511 . . . . 0.0 109.901 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.431 ' OE1' ' HB3' ' A' ' 160' ' ' ALA . 1.3 pm0 -86.94 37.54 0.76 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.291 0.567 . . . . 0.0 110.551 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.61 -42.83 99.81 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.926 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 64.24 72.32 0.46 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.153 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 17.4 t -84.06 127.38 39.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.825 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.3 m -78.2 103.98 8.49 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 62.6 mt -120.62 122.51 68.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.709 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.84 89.77 5.79 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 171.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -114.77 156.73 24.32 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.307 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 29.9 m -129.79 132.2 46.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.617 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.55 131.64 10.64 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.298 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.7 m -135.85 135.74 40.03 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.822 0.344 . . . . 0.0 110.769 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 90.6 t -111.86 103.16 15.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.566 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.405 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 78.0 m-20 53.16 34.88 18.43 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.957 177.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.2 -11.01 47.85 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.979 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.88 138.72 50.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.901 0.85 . . . . 0.0 110.949 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -86.31 148.08 25.77 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.456 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -110.75 179.65 4.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.426 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -55.8 -52.55 63.6 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -90.44 -159.78 35.9 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.888 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . 75.29 27.7 63.35 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.827 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -116.48 102.9 9.9 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.17 141.23 51.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.812 0.339 . . . . 0.0 111.065 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.2 m -138.61 128.08 24.61 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 59.93 29.83 19.38 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.005 0.431 . . . . 0.0 110.874 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -94.94 133.66 38.46 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.429 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.3 m -97.55 122.73 49.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.421 0.629 . . . . 0.0 111.283 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 54.6 tp -109.84 125.5 52.83 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.755 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -104.66 141.46 36.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 69.8 mtm -116.62 160.42 20.72 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.228 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.88 8.04 65.55 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.741 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.472 ' HB2' ' HG2' ' A' ' 193' ' ' ARG . 98.1 mt-30 -119.7 0.36 10.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.7 29.09 55.89 Favored Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.067 -1.063 . . . . 0.0 111.128 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.472 ' HG2' ' HB2' ' A' ' 191' ' ' GLN . 32.0 mmm-85 -70.06 -30.35 67.59 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 123.248 0.619 . . . . 0.0 110.341 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.433 ' HE3' ' HA ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -120.02 169.6 10.05 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.773 -178.578 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.6 mm -50.76 132.66 28.23 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.987 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.68 124.39 8.23 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.669 2.246 . . . . 0.0 112.325 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.46 -37.76 3.58 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.771 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -62.21 -47.65 83.5 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -77.77 -10.14 59.39 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.805 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 31.1 t70 -88.34 -34.3 17.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.165 0.507 . . . . 0.0 109.874 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.62 -28.83 73.96 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.461 -0.791 . . . . 0.0 113.581 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.88 -26.33 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.853 0.358 . . . . 0.0 110.956 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 200' ' ' ASP . 3.4 mtpm? -57.46 125.21 21.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.126 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.95 3.45 63.91 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.711 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -97.71 134.97 40.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.423 0.63 . . . . 0.0 111.883 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -90.77 160.24 15.9 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.258 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.88 138.26 57.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 110.706 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 73.53 24.04 75.7 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.898 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -118.74 101.95 8.47 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.398 0.618 . . . . 0.0 110.745 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.4 110.23 21.52 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.611 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -127.01 -10.78 5.97 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 75.3 p 57.24 164.78 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.792 0.837 . . . . 0.0 112.617 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 215' ' ' VAL . 10.9 tp -143.55 160.77 16.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -94.89 107.27 19.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.723 0.297 . . . . 0.0 110.645 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 71.3 t -121.49 122.41 67.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 6.5 m -95.55 -28.98 14.6 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -175.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 216' ' ' THR . 54.4 m-85 68.62 147.39 0.11 Allowed Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 121.009 0.433 . . . . 0.0 111.121 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.44 151.77 65.39 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.236 1.957 . . . . 0.0 111.926 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -65.12 -35.53 81.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.198 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.86 25.49 2.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.996 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -64.88 134.95 55.11 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -59.92 -15.64 23.31 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.78 105.68 17.85 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -56.61 -35.39 68.23 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.412 0.685 . . . . 0.0 111.158 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.445 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 16.0 p30 -76.91 -15.86 59.55 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.445 ' HG ' ' OD1' ' A' ' 225' ' ' ASN . 91.6 mt -115.37 5.68 14.65 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -69.53 114.53 7.84 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.434 0.635 . . . . 0.0 112.255 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.25 22.06 72.51 Favored Glycine 0 C--O 1.238 0.366 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.584 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 225' ' ' ASN . 99.1 mttt -107.7 138.77 43.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.981 0.391 . . . . 0.0 110.679 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -81.31 128.62 34.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.424 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -112.67 134.05 54.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.929 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.405 ' HE2' ' OD1' ' A' ' 173' ' ' ASP . 68.8 mttm -81.01 -44.57 17.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 212' ' ' THR . 76.0 m-85 56.58 95.73 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 121.057 0.456 . . . . 0.0 111.858 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.58 72.83 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.3 mm 61.87 92.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.109 0.564 . . . . 0.0 111.882 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -74.61 -43.48 55.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.117 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 13.2 tp 47.99 77.31 0.1 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.563 0.745 . . . . 0.0 111.567 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -71.18 -48.82 49.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -112.93 -81.17 0.59 Allowed 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.564 HG12 ' H ' ' A' ' 242' ' ' GLU . 41.2 t 81.23 150.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.713 0.805 . . . . 0.0 109.015 -173.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.79 -33.55 72.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.801 0.334 . . . . 0.0 110.466 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.564 ' H ' HG12 ' A' ' 240' ' ' VAL . 63.6 mt-10 74.62 152.75 0.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.089 0.955 . . . . 0.0 112.669 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.632 ' HA ' ' H ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -153.03 114.17 4.17 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.362 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 155' ' ' ASP . 39.1 tt0 -159.58 171.15 20.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 150' ' ' THR . 6.4 mp 70.81 108.17 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 123.59 0.756 . . . . 0.0 111.305 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.574 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 61.4 Cg_endo -81.16 101.02 1.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.026 1.817 . . . . 0.0 112.269 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.91 162.35 33.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.367 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.9 mp -84.28 88.55 7.24 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.822 0.344 . . . . 0.0 111.214 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 7.4 m -85.26 -75.89 0.34 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.724 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -177.95 -56.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.989 0.423 . . . . 0.0 110.558 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -73.71 14.64 0.35 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -78.06 -15.26 59.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.058 0.456 . . . . 0.0 110.302 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 43.0 pt -88.35 -14.23 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.098 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -138.34 94.11 2.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.628 0.728 . . . . 0.0 111.654 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.626 ' HG2' ' OE1' ' A' ' 148' ' ' GLN . 7.0 tpp180 -140.01 30.12 2.03 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.31 1.052 . . . . 0.0 108.923 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.15 15.16 9.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.201 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 77.02 15.97 81.19 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.119 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 55.9 t -99.87 141.29 17.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -54.86 -51.17 66.78 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 123.02 0.2 . . . . 0.0 111.069 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -175.61 162.44 2.77 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.265 0.353 . . . . 0.0 110.515 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -174.65 168.22 40.8 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.762 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 86.8 p -88.14 173.81 8.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.45 -48.7 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.56 -33.5 21.7 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.935 0.398 . . . . 0.0 110.322 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.4 -41.23 99.44 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.381 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.17 -44.45 96.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.588 0.233 . . . . 0.0 110.906 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -63.95 -42.64 97.26 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.211 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.4 -42.93 87.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.438 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -67.27 -40.14 86.15 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.906 0.384 . . . . 0.0 110.811 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 78.8 t -64.85 -42.75 95.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.785 0.326 . . . . 0.0 110.15 176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -55.76 -51.94 65.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.674 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.7 ptmt -65.63 -42.7 91.21 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.12 -39.45 94.05 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 96.5 mmm -63.9 -41.66 97.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 110.73 178.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -69.59 -31.65 69.93 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.972 0.415 . . . . 0.0 110.656 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -62.36 -42.2 99.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.98 -37.42 87.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.482 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 42.6 tp -62.39 -38.97 91.69 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.295 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -55.88 -46.92 78.16 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.209 0.528 . . . . 0.0 109.691 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.0 m -63.67 -43.92 95.27 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.65 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.56 92.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.184 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.47 -44.47 98.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.91 0.386 . . . . 0.0 110.465 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -64.64 -42.35 95.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.049 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -62.96 -41.32 99.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.155 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.511 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.2 tpm_? -60.18 -44.53 95.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.938 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.14 -43.85 78.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.903 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.95 -47.41 84.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.418 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.1 p -62.2 -44.38 96.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -65.96 -41.51 91.15 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.134 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.61 87.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.651 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 295' ' ' VAL . 32.5 mm -64.32 -44.02 97.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.307 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.4 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 19.5 tp10 -61.08 -46.35 91.02 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.615 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.91 -40.23 95.33 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.363 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 350' ' ' LEU . 0.7 OUTLIER -63.86 -42.61 97.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.443 0.297 . . . . 0.0 111.121 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 291' ' ' ILE . 75.1 t -64.13 -42.98 97.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 120.962 0.411 . . . . 0.0 110.687 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LYS . . . . . 0.4 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.4 mttm -62.71 -38.77 91.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.686 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.83 -47.7 77.03 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.069 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -130.03 99.35 5.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.656 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -94.82 107.74 19.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.3 tp -110.73 143.12 21.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.725 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -73.44 121.97 21.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.236 0.541 . . . . 0.0 109.807 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 43.9 t -86.74 134.18 38.04 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.066 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.09 138.12 84.33 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.527 2.152 . . . . 0.0 112.118 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.32 -29.99 70.84 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.904 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.01 68.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.619 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.4 mt -91.34 -34.19 14.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.27 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 71.4 mt -63.21 -51.88 65.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.723 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.36 -37.8 88.78 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 68.0 p -65.22 -46.65 79.78 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.72 0.295 . . . . 0.0 111.518 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.548 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 17.9 mm-40 -72.04 -33.21 67.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.431 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 70.7 mt -61.58 -43.74 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.516 0.198 . . . . 0.0 111.194 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.597 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 33.2 t70 -62.95 -40.93 99.15 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.687 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.54 -42.77 96.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.257 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 90.2 mt -61.64 -41.28 97.28 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.136 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 66.0 mtm180 -62.55 -39.72 94.51 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.916 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 90.8 mtt180 -63.27 -43.28 98.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.397 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -65.05 -44.67 88.26 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.03 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.53 -39.7 88.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.401 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.62 -36.27 83.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.779 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' GLN . . . . . 0.546 ' OE1' ' HA ' ' B' ' 45' ' ' ARG . 7.6 tt0 -62.83 -43.27 99.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.549 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.49 -23.6 61.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.183 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -77.29 -4.02 42.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.77 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 140.5 -22.58 2.7 Favored Glycine 0 CA--C 1.502 -0.733 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.687 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 116.25 29.45 2.33 Favored Glycine 0 CA--C 1.497 -1.066 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.547 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 41.6 t-20 -70.72 124.0 23.24 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.721 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.7 tm-20 -127.24 145.5 50.75 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 1.7 ptpp? 69.4 -37.97 0.39 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 125.574 1.55 . . . . 0.0 113.158 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.547 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 14.7 mm100 -73.63 -9.06 58.29 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.299 0.571 . . . . 0.0 110.369 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -64.02 -18.9 64.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.332 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.49 -37.63 86.73 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.22 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.88 -16.44 63.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.904 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.7 145.58 98.7 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.14 134.74 57.87 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 123.018 2.479 . . . . 0.0 112.951 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.41 HH21 ' HD2' ' A' ' 334' ' ' ARG . 21.4 ttt180 -70.7 -39.49 73.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.133 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -58.83 -33.79 70.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.06 -6.5 57.74 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.963 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -117.13 -30.78 5.55 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.608 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.55 -34.95 79.44 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -63.06 -51.06 68.16 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.995 0.426 . . . . 0.0 110.822 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.72 -28.0 65.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.48 -41.75 97.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.416 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.2 tttt -59.87 -47.14 86.96 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.55 ' O ' HG23 ' A' ' 347' ' ' VAL . 18.6 mmt85 -63.25 -45.59 90.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -66.42 -38.65 87.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.0 t -64.76 -43.34 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.645 0.259 . . . . 0.0 110.706 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 342' ' ' LYS . 77.3 t -60.31 -42.9 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.519 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 343' ' ' ARG . 87.4 t -59.53 -45.68 93.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.69 98.97 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.412 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.92 -44.44 96.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.82 0.343 . . . . 0.0 111.19 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 294' ' ' LEU . 96.5 mt -63.92 -45.14 90.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.094 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.77 -40.99 92.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.9 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.5 98.59 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.86 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -66.3 -38.8 88.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.802 0.301 . . . . 0.0 110.723 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.96 -44.43 98.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.37 -43.83 98.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.805 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -66.54 -52.46 45.44 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.686 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.7 m -66.58 -46.17 76.86 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -87.35 -5.02 59.05 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.628 0.252 . . . . 0.0 111.377 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 59.11 70.22 0.66 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.276 0.56 . . . . 0.0 110.81 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.8 mt -101.46 124.36 47.02 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.783 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 144.15 44.06 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.082 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.04 114.96 4.48 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 367' ' ' VAL . 17.7 t70 -84.19 110.6 18.65 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.278 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 65.8 mm-40 -58.8 -39.1 80.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.068 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -64.65 -43.65 92.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 110.789 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -61.59 -41.25 97.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.021 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 363' ' ' ASP . 93.2 t -64.11 -35.62 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.704 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 31.0 mmmt -57.81 -45.01 86.7 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.657 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.88 -38.07 95.57 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.979 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.0 -42.68 99.91 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.068 0.461 . . . . 0.0 110.16 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.7 -43.3 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.939 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.48 -39.96 89.55 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.729 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.79 -40.72 92.23 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.702 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.8 ttm -66.59 -40.11 88.75 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 110.446 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.86 -27.14 69.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.657 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 49.3 m -74.98 4.23 6.96 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.686 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -97.62 3.94 50.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.796 0.331 . . . . 0.0 110.979 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -120.85 177.42 5.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.014 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.15 -46.14 90.29 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.642 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -128.92 120.11 20.24 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.274 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.56 -29.65 30.0 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.486 2.124 . . . . 0.0 112.896 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -65.83 -43.17 89.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -64.0 -37.39 87.25 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.349 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.35 -42.09 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.488 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.8 -44.24 98.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.093 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.86 -32.54 72.28 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -58.56 -46.72 86.29 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.128 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -68.49 -46.64 69.14 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.5 p -68.77 -17.01 63.96 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 7.91 45.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.074 0.464 . . . . 0.0 110.896 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -132.84 108.61 9.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.336 178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -62.98 -38.17 90.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -58.92 -50.76 72.82 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.827 0.346 . . . . 0.0 110.7 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.71 -39.56 94.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.399 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 90.9 mtp -61.69 -44.02 97.74 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.781 0.324 . . . . 0.0 111.278 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.57 -45.52 65.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.31 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -63.88 -42.58 97.45 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.008 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 43.6 tpp -64.9 -43.23 93.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.897 0.379 . . . . 0.0 111.132 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -66.02 -33.23 75.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.267 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.77 -44.96 93.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.26 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.52 -43.63 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.118 0.485 . . . . 0.0 110.57 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.63 -40.72 95.86 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.169 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.32 -38.46 91.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.625 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -59.84 -43.97 94.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.72 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -65.42 -35.15 80.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.763 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -60.99 -43.97 98.09 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.59 -45.9 84.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.165 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.1 -45.85 97.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.188 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -68.57 -27.99 66.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.018 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.54 -37.96 88.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.137 0.494 . . . . 0.0 109.84 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 89.6 t -66.19 -41.44 89.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.137 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.09 -26.44 66.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.019 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -77.39 -9.14 58.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.363 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -113.45 -31.73 6.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.82 169.23 18.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.674 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -84.59 108.61 17.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.788 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 64.4 t -84.58 128.72 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.122 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -130.38 146.8 52.01 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -121.91 123.18 41.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.705 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' LYS . . . . . 0.621 ' HE3' ' OE1' ' A' ' 126' ' ' GLU . 20.7 pttp -132.68 145.83 51.38 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.68 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -82.85 153.02 25.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -155.64 172.32 18.48 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 27.1 p -84.96 165.04 17.94 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.907 0.384 . . . . 0.0 111.161 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.78 -26.04 68.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.343 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -62.33 -40.42 96.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.608 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -65.77 -33.05 74.97 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.837 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.0 mp -74.66 -18.54 60.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.346 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.3 mmt -83.03 3.78 28.86 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -82.88 74.51 9.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.368 0.604 . . . . 0.0 109.607 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -101.28 17.75 21.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.238 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -69.93 -25.58 63.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.238 0.542 . . . . 0.0 109.685 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.729 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.69 179.392 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 120.685 0.279 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -108.68 114.85 28.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.087 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 22.4 m -123.68 135.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.092 0.472 . . . . 0.0 111.723 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 29.6 p -113.87 148.61 36.4 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.506 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.444 HG13 ' H ' ' B' ' 6' ' ' GLU . 6.4 p -151.41 -61.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.444 ' H ' HG13 ' B' ' 5' ' ' VAL . 54.2 mt-10 69.09 169.0 0.29 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.241 0.543 . . . . 0.0 111.494 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.3 m -128.78 127.76 42.62 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.171 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 23.0 m -74.51 -69.95 0.43 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.504 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -178.37 129.99 0.13 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.756 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.1 -119.03 11.0 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.697 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.66 -9.25 56.42 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' B' ' 106' ' ' SER . . . -67.49 126.62 25.19 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.283 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' B' ' 12' ' ' GLY . 0.0 OUTLIER -135.14 158.88 43.23 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 122.937 0.495 . . . . 0.0 109.898 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -129.04 151.38 49.8 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 54.1 t -102.52 -82.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.016 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m 46.51 82.38 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.184 0.516 . . . . 0.0 111.457 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 tp -116.77 135.14 58.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.985 0.421 . . . . 0.0 111.096 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.5 m -104.52 126.03 51.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.932 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 16.8 pt -129.27 160.18 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.702 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.575 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -73.2 156.02 38.99 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.573 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -56.07 -46.01 79.12 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -64.82 -38.66 91.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.387 . . . . 0.0 110.354 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 35.5 m -63.75 -39.73 94.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.718 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.575 HG13 ' O ' ' B' ' 20' ' ' ALA . 81.0 mt -61.23 -49.67 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.807 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.73 -48.24 69.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.729 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 20.0 m -65.83 -50.95 62.76 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.96 -49.34 18.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.21 -43.13 97.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -59.03 -48.67 80.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.719 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 33.3 m -63.07 -42.82 99.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.891 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -68.37 -40.08 81.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.761 0.315 . . . . 0.0 110.899 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.32 -43.1 99.62 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.68 -39.82 80.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.057 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -64.85 -42.01 95.23 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.59 -32.51 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.132 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.18 92.58 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.069 0.461 . . . . 0.0 110.033 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.88 -30.5 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.286 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -57.98 -41.52 83.12 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.038 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.8 -0.05 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.188 0.518 . . . . 0.0 110.407 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 61.09 29.1 18.71 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.405 ' H ' HG13 ' B' ' 41' ' ' ILE . 2.8 pp -101.57 4.94 10.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.143 0.497 . . . . 0.0 111.425 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.06 -33.02 74.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.598 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.14 -22.62 63.07 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.941 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -80.33 -6.56 58.17 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.63 0.252 . . . . 0.0 111.525 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.546 ' HA ' ' OE1' ' A' ' 320' ' ' GLN . 47.2 ttt85 -94.73 88.35 5.34 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 119.408 -0.917 . . . . 0.0 113.13 -177.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -89.86 86.53 6.66 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 169.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.15 102.59 2.91 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-N 115.134 -0.939 . . . . 0.0 114.84 -170.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.451 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 88.2 tttt -65.44 -34.95 79.5 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.566 HG12 ' HB ' ' B' ' 54' ' ' VAL . 19.3 t -101.87 100.2 14.08 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.278 175.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' B' ' 48' ' ' LYS . 18.6 Cg_exo -65.96 158.43 54.16 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.045 2.497 . . . . 0.0 112.607 -177.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.532 ' HA ' HG12 ' B' ' 54' ' ' VAL . 44.3 mtt -58.69 -41.69 86.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -65.99 -20.08 66.08 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.812 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -91.68 -50.33 12.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.079 0.466 . . . . 0.0 110.931 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.566 ' HB ' HG12 ' B' ' 49' ' ' VAL . 13.0 p -67.51 -36.76 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.38 87.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -90.61 -1.64 57.88 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.281 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -100.53 -42.15 6.69 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.638 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -98.17 5.37 48.58 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.545 0.688 . . . . 0.0 109.946 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.97 146.87 49.76 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.527 ' H ' ' HB2' ' B' ' 63' ' ' ARG . . . 72.76 -41.56 0.51 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.154 0.582 . . . . 0.0 111.443 -176.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 47.0 t -60.52 -48.74 80.43 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.813 0.445 . . . . 0.0 111.428 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 p -122.03 18.64 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.771 0.796 . . . . 0.0 109.859 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.527 ' HB2' ' H ' ' B' ' 60' ' ' ALA . 12.6 ttt180 -65.58 -20.23 66.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.59 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.68 -49.53 70.6 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.78 -32.41 73.93 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.93 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.58 -43.42 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.99 -40.01 94.16 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.79 -39.32 97.31 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.728 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.96 -44.99 94.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.681 0.277 . . . . 0.0 111.072 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.65 -41.93 98.2 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.7 ttp -60.65 -45.99 92.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.86 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 55.3 m -64.2 -51.75 62.2 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.375 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -69.32 -38.06 78.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -65.06 -39.53 93.4 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.597 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -60.26 -47.21 86.96 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.54 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 17.7 tt -66.02 -38.57 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.143 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.37 -41.67 98.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.76 93.0 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.597 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -66.73 -41.25 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.46 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.69 -42.64 96.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.573 0.701 . . . . 0.0 109.419 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -60.16 -47.78 84.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.576 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -89.24 -2.03 58.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.616 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 63.24 46.64 4.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.928 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.452 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 91.4 mt -98.45 122.21 49.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.118 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -107.46 100.1 32.07 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.709 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 22.8 Cg_exo -65.17 142.74 75.1 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.434 2.089 . . . . 0.0 111.443 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.37 110.89 23.35 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.882 0.373 . . . . 0.0 110.39 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.6 -113.99 4.0 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.121 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.43 125.67 14.52 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.55 144.34 78.68 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.428 2.086 . . . . 0.0 111.586 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 46.8 m -103.47 111.91 24.57 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.056 0.455 . . . . 0.0 109.824 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.503 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.1 m-85 -87.58 89.91 8.17 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.98 108.97 3.91 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.539 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.9 Cg_endo -100.98 169.3 0.35 Allowed 'Trans proline' 0 N--CA 1.433 -2.081 0 C-N-CA 123.178 2.585 . . . . 0.0 111.256 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.82 -120.73 3.17 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -141.94 133.04 26.15 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -80.08 107.58 12.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.366 0.603 . . . . 0.0 111.066 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' B' ' 101' ' ' GLU . 98.8 mttt -81.79 145.68 30.32 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 38.7 tp -82.78 108.31 16.04 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.868 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.49 14.64 49.87 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.778 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' B' ' 98' ' ' LYS . 39.7 tt0 -134.06 161.29 35.24 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.409 0.605 . . . . 0.0 109.923 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -66.73 143.03 57.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.011 0.434 . . . . 0.0 111.53 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -103.44 144.45 31.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.15 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.1 m -121.51 135.91 54.99 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.748 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -135.55 161.95 34.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.059 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.444 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 12.6 m -92.72 -70.44 0.7 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -175.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p 47.88 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.132 0.968 . . . . 0.0 111.811 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.55 116.61 24.79 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -172.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -157.98 147.52 19.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.562 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 65.02 143.16 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.08 157.0 42.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.75 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -165.64 97.08 0.8 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.054 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -84.56 158.58 12.46 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.972 2.448 . . . . 0.0 113.348 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -132.82 135.22 45.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 70.3 t -123.47 136.13 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -103.61 -79.74 0.53 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.537 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt 65.53 128.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.888 0.875 . . . . 0.0 113.113 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -143.39 156.51 44.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.047 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.73 8.46 87.69 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.05 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.83 -39.82 95.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.598 . . . . 0.0 110.229 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' B' ' 121' ' ' GLU . 1.3 mp0 -66.55 -21.23 66.15 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.497 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.27 13.76 34.09 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 96.8 mt -77.65 125.41 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.223 0.535 . . . . 0.0 110.683 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -113.52 123.25 49.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.146 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.7 144.65 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.653 0.263 . . . . 0.0 111.263 -174.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' GLU . . . . . 0.568 ' OE1' ' HE3' ' B' ' 420' ' ' LYS . 38.4 tt0 -93.75 142.8 26.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.594 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -128.93 93.23 37.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.63 112.64 3.28 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.218 1.945 . . . . 0.0 111.903 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 48.6 mm -95.43 111.47 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.63 158.39 16.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.116 -178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -132.79 146.52 51.91 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.035 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 85.5 t -85.22 123.1 39.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 72.8 p -107.28 177.73 4.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.981 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -66.04 -28.42 68.84 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.8 -40.07 93.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.025 0.441 . . . . 0.0 110.361 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.01 -41.53 99.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.606 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.48 -44.94 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.016 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.38 -44.22 92.8 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.84 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.83 -42.0 98.63 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.763 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.567 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.8 tpt -63.02 -45.45 92.27 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.603 0.239 . . . . 0.0 110.967 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.17 -42.54 99.43 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.499 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -61.83 -45.57 93.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' B' ' 147' ' ' GLN . 20.6 m -63.45 -41.21 98.64 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.833 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 144' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' B' ' 140' ' ' MET . 91.8 mt -60.43 -42.22 95.61 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -72.08 -17.34 62.01 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.066 0.46 . . . . 0.0 111.335 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.92 -9.28 40.64 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.801 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' B' ' 143' ' ' THR . 63.4 mt-30 -100.48 -27.55 13.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLN . . . . . 0.605 ' OE1' ' HG2' ' B' ' 255' ' ' ARG . 9.8 mm-40 -137.79 167.87 20.85 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -167.56 -90.97 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.664 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 26.8 m -163.15 155.28 18.09 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' TRP . . . . . 0.487 ' HA ' ' CB ' ' B' ' 243' ' ' ARG . 26.3 p-90 -106.28 147.66 28.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.62 ' H ' ' HA ' ' B' ' 243' ' ' ARG . 83.9 tttt -170.62 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.602 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -172.21 164.29 5.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 46.4 tttp 58.0 66.39 1.12 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.838 1.255 . . . . 0.0 114.281 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ASP . . . . . 0.522 ' HB2' ' HB2' ' B' ' 244' ' ' GLU . 27.8 t70 -177.96 146.48 0.42 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.182 0.593 . . . . 0.0 110.65 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.53 47.05 1.06 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.51 -0.853 . . . . 0.0 114.095 -176.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.03 -29.96 21.55 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.186 174.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.455 ' N ' ' HD2' ' B' ' 243' ' ' ARG . 22.5 t 67.31 135.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.267 1.027 . . . . 0.0 113.172 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' GLU . . . . . 0.495 ' HG2' ' HG2' ' B' ' 243' ' ' ARG . 6.8 mm-40 -87.67 169.36 12.19 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.833 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' ALA . . . . . 0.407 ' HB3' ' OE1' ' B' ' 161' ' ' GLU . . . -70.53 -66.17 0.64 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 161' ' ' GLU . . . . . 0.407 ' OE1' ' HB3' ' B' ' 160' ' ' ALA . 1.7 pm0 -86.06 40.18 0.85 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.447 0.641 . . . . 0.0 110.282 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.95 -43.46 95.75 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.305 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 63.65 74.75 0.41 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.952 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 17.3 t -87.55 125.82 41.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.745 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.2 m -74.91 103.6 5.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 71.0 mt -119.52 123.27 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.044 0.45 . . . . 0.0 111.598 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' ASP . . . . . 0.506 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 23.9 m-20 -96.41 88.28 4.69 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 172.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -112.49 156.12 23.13 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.633 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 36.7 m -130.54 131.71 45.2 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.849 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.2 128.94 8.72 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.181 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 18.5 m -136.19 131.38 34.54 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.828 0.347 . . . . 0.0 110.786 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.48 105.32 18.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.823 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' ASP . . . . . 0.517 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 69.5 m-20 52.64 30.36 8.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.09 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 108.5 -12.26 36.08 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.858 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -110.7 142.48 42.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.784 0.792 . . . . 0.0 110.422 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -88.94 148.45 23.8 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.33 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -113.25 177.2 4.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.194 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -55.88 -49.37 73.56 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -89.18 -165.16 40.92 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.798 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' B' ' 169' ' ' THR . . . 77.2 24.65 65.62 Favored Glycine 0 C--O 1.22 -0.734 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.245 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -115.52 102.45 9.8 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.7 144.16 48.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.847 0.356 . . . . 0.0 110.933 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.506 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 47.2 m -139.6 132.54 29.36 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.646 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 59.97 30.55 20.04 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.684 0.615 . . . . 0.0 111.415 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -95.69 133.88 39.26 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.801 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.7 122.59 50.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.352 0.596 . . . . 0.0 111.325 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 61.4 tp -109.43 127.72 54.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.758 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -106.39 140.75 38.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 71.6 mtm -116.24 162.53 17.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.883 0.373 . . . . 0.0 111.445 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 88.21 13.8 63.31 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 191' ' ' GLN . . . . . 0.459 ' HB2' ' HG2' ' B' ' 193' ' ' ARG . 97.9 mt-30 -125.33 -3.16 7.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.519 0.199 . . . . 0.0 111.376 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.16 33.21 33.16 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.89 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' B' ' 191' ' ' GLN . 37.8 mmm-85 -76.33 -24.41 54.27 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.486 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.9 169.65 11.38 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.288 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 47.0 mm -51.67 133.41 36.39 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.04 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -47.18 126.33 11.47 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.526 2.151 . . . . 0.0 112.118 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.66 -38.03 3.4 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.718 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -62.5 -48.58 78.94 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.112 0.456 . . . . 0.0 112.203 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -78.08 -9.95 59.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.826 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 200' ' ' ASP . . . . . 0.413 ' O ' ' HD3' ' B' ' 203' ' ' LYS . 31.0 t70 -90.45 -26.35 19.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.17 0.509 . . . . 0.0 110.204 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.23 -22.78 67.26 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.285 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.92 -26.86 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.602 -0.352 . . . . 0.0 111.093 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' B' ' 200' ' ' ASP . 24.3 mtpt -55.1 126.68 25.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.038 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.48 -9.06 71.83 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.757 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -85.86 134.47 33.9 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 117.466 0.633 . . . . 0.0 111.584 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' B' ' 209' ' ' GLU . 29.6 mmtp -91.6 161.38 14.95 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.354 -176.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.55 139.29 58.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.723 0.297 . . . . 0.0 110.325 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 75.89 17.65 79.95 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.798 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' B' ' 206' ' ' LYS . 42.3 tt0 -113.45 97.4 6.44 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.547 0.689 . . . . 0.0 111.141 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -88.91 108.06 19.34 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.947 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -129.13 -11.09 4.72 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -173.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 58.2 p 58.89 166.87 0.05 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.73 0.812 . . . . 0.0 112.655 -176.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.6 tp -146.0 153.81 13.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.465 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -88.1 105.88 17.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.771 0.319 . . . . 0.0 111.259 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 76.2 t -118.22 129.31 74.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 10.3 m -100.45 -34.95 9.73 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -175.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.6 m-85 70.64 144.08 0.1 Allowed Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 122.71 0.404 . . . . 0.0 110.917 -175.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 15.1 Cg_exo -69.02 152.18 73.17 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.259 1.973 . . . . 0.0 111.795 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -67.15 -33.46 75.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.411 0.624 . . . . 0.0 109.709 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -88.44 21.93 2.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.655 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -65.75 134.73 53.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.019 0.438 . . . . 0.0 110.57 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -61.53 -10.21 7.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.11 105.31 15.59 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' B' ' 227' ' ' LYS . 4.7 tp10 -56.04 -36.48 68.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.41 0.684 . . . . 0.0 111.685 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.436 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 18.7 p30 -80.38 -11.81 59.65 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.413 ' HG ' ' OD1' ' B' ' 225' ' ' ASN . 93.3 mt -115.47 1.69 13.7 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' B' ' 224' ' ' GLU . 20.4 ptmt -66.69 116.38 7.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.232 0.539 . . . . 0.0 111.722 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.26 26.51 70.58 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.928 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.436 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 98.9 mttt -111.74 134.9 53.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.083 0.441 . . . . 0.0 110.585 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -77.29 131.82 38.34 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.897 0.38 . . . . 0.0 111.245 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.02 135.17 54.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.484 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' LYS . . . . . 0.517 ' HE2' ' OD1' ' B' ' 173' ' ' ASP . 68.9 mttm -80.8 -44.8 17.95 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' B' ' 212' ' ' THR . 76.4 m-85 56.35 95.09 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.015 0.436 . . . . 0.0 111.894 -177.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.422 ' HA ' HG22 ' B' ' 212' ' ' THR . . . -61.36 -50.17 74.0 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.8 mm 61.52 91.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 123.472 0.482 . . . . 0.0 111.953 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -72.69 -42.48 64.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.338 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 12.4 tp 48.21 84.83 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.821 0.848 . . . . 0.0 111.295 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.76 -59.74 2.66 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -174.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -102.55 -79.23 0.53 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.548 HG12 ' H ' ' B' ' 242' ' ' GLU . 39.3 t 77.32 150.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -172.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.97 -33.35 71.96 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.737 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.548 ' H ' HG12 ' B' ' 240' ' ' VAL . 62.5 mt-10 73.89 154.33 0.15 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.721 0.808 . . . . 0.0 112.168 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.62 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 0.0 OUTLIER -156.1 110.36 2.81 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' B' ' 155' ' ' ASP . 31.9 tt0 -153.42 170.25 21.17 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' B' ' 150' ' ' THR . 6.4 mp 73.64 112.23 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 123.582 0.753 . . . . 0.0 111.557 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 246' ' ' PRO . . . . . 0.529 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 74.5 Cg_endo -83.07 97.28 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.292 1.994 . . . . 0.0 112.711 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 247' ' ' GLU . . . . . 0.451 ' H ' HG21 ' B' ' 150' ' ' THR . 11.2 pt-20 -132.12 163.47 28.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.733 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.2 mp -86.32 90.2 8.1 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.049 0.452 . . . . 0.0 110.797 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 5.3 m -85.88 -75.52 0.37 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.719 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 177.74 -50.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.06 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.3 3.44 3.66 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.642 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -71.49 -17.92 62.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.221 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 40.5 pt -87.15 -15.85 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.117 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -138.06 90.92 2.52 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.608 0.718 . . . . 0.0 111.986 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.605 ' HG2' ' OE1' ' B' ' 148' ' ' GLN . 6.9 tpp180 -137.36 35.43 2.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.284 1.04 . . . . 0.0 108.968 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -127.87 17.65 6.76 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.825 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 72.98 23.63 77.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.545 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.12 137.21 40.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -52.7 -49.37 65.49 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.517 0.51 . . . . 0.0 111.378 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.6 p30 176.95 152.93 0.21 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.847 0.459 . . . . 0.0 111.043 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -169.39 167.32 40.4 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.983 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 26.9 p -83.38 170.93 14.01 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.597 0.199 . . . . 0.0 110.691 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 96.9 t -62.13 -51.85 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.0 OUTLIER -77.6 -36.38 51.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.04 0.448 . . . . 0.0 110.618 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.77 -39.79 97.81 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.48 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.42 ' O ' HG23 ' B' ' 270' ' ' VAL . 54.7 tp -61.7 -45.3 94.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.6 0.238 . . . . 0.0 110.861 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -64.72 -41.24 96.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.661 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -67.76 -43.29 80.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.556 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -67.89 -39.89 83.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.823 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.42 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.2 t -64.83 -41.72 92.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -55.43 -51.8 65.69 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.589 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.5 ptmt -66.0 -42.84 89.23 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -64.9 -38.26 90.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.0 mmm -63.67 -41.35 98.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.877 0.37 . . . . 0.0 110.164 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.3 -31.27 69.64 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.558 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -61.87 -42.77 99.46 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.4 -38.13 89.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.34 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.04 -38.2 87.84 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.272 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -56.51 -47.5 79.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.014 0.435 . . . . 0.0 109.947 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.2 m -64.61 -43.76 92.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.809 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.05 87.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.262 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.24 -44.56 99.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.968 0.413 . . . . 0.0 110.471 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -65.02 -42.01 94.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.58 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -62.82 -40.85 98.65 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.674 0.273 . . . . 0.0 110.859 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 285' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' B' ' 285' ' ' ARG . 1.5 tpm_? -59.7 -44.43 93.69 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.642 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 99.4 t -70.22 -43.61 78.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.871 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.92 -47.52 84.54 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.333 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 78.0 p -61.94 -44.82 95.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.69 -41.24 92.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.62 87.9 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.539 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 291' ' ' ILE . . . . . 0.48 ' O ' HG23 ' B' ' 295' ' ' VAL . 33.1 mm -64.9 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.201 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 292' ' ' GLU . . . . . 0.468 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 34.6 tp10 -60.29 -48.19 82.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.36 -41.06 96.75 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.515 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.52 HD13 HD13 ' B' ' 350' ' ' LEU . 4.0 tt -63.33 -42.07 98.94 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 0.48 HG23 ' O ' ' B' ' 291' ' ' ILE . 78.0 t -63.98 -42.74 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.954 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.468 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 68.4 mttm -62.53 -40.83 98.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.871 0.367 . . . . 0.0 110.544 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.6 -50.23 67.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.533 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -125.47 99.86 6.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.713 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -96.5 112.03 23.92 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.5 tp -116.26 144.02 24.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.6 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.54 127.14 31.92 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.33 132.83 31.07 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.464 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.45 135.59 70.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.367 2.045 . . . . 0.0 112.042 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.45 -28.96 69.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.171 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.77 79.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.817 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 99.2 mt -82.42 -36.8 26.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.628 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 307' ' ' ILE . . . . . 0.454 ' O ' HG13 ' B' ' 311' ' ' ILE . 73.8 mt -61.93 -50.62 79.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.689 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.59 -38.76 92.11 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 59.0 p -64.1 -44.9 90.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.952 0.406 . . . . 0.0 111.165 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 310' ' ' GLU . . . . . 0.525 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 52.2 mm-40 -72.86 -32.48 65.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.275 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.454 HG13 ' O ' ' B' ' 307' ' ' ILE . 85.4 mt -62.11 -43.82 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.661 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.61 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 36.3 t70 -62.59 -41.72 99.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.365 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.21 -42.9 96.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.348 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 91.0 mt -61.55 -41.24 97.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.348 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.474 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 75.2 mtm180 -62.82 -39.77 95.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.771 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 316' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 90.6 mtt180 -63.16 -43.57 97.92 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.462 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -64.71 -44.02 91.58 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.14 85.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.34 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 319' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -64.65 -35.81 82.22 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.034 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 320' ' ' GLN . . . . . 0.44 ' OE1' ' HA ' ' A' ' 45' ' ' ARG . 7.9 tt0 -63.82 -41.87 97.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.349 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -72.19 -23.92 61.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.103 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -76.32 -3.83 38.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.284 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 139.68 -29.93 2.43 Favored Glycine 0 CA--C 1.501 -0.827 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.25 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 124.31 34.38 0.72 Allowed Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 325' ' ' ASN . . . . . 0.535 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 39.6 t-20 -73.83 118.11 16.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 326' ' ' GLU . . . . . 0.732 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 3.6 tm-20 -120.91 143.31 49.02 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 2.0 ptpp? 70.33 -38.93 0.43 Allowed 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 125.581 1.552 . . . . 0.0 113.019 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 328' ' ' GLN . . . . . 0.535 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.4 mm100 -73.85 -8.33 55.63 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.293 0.568 . . . . 0.0 110.767 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -67.13 -14.43 62.9 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.26 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.34 -36.39 83.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.468 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -71.39 -15.42 62.37 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.956 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.57 142.43 98.46 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.71 135.47 69.53 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.11 2.54 . . . . 0.0 112.898 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 27.7 ttt85 -70.42 -40.13 74.02 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.935 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -58.61 -34.59 71.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.55 -9.25 59.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.037 0.446 . . . . 0.0 111.755 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -114.57 -30.63 6.45 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.705 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -66.48 -34.21 77.42 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.98 -52.37 64.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.051 0.453 . . . . 0.0 110.707 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -70.46 -25.63 63.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.423 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.54 -42.28 99.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.329 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 342' ' ' LYS . . . . . 0.518 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.5 tttt -59.61 -47.12 86.84 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 343' ' ' ARG . . . . . 0.502 ' O ' HG23 ' B' ' 347' ' ' VAL . 17.3 mmt85 -63.57 -45.53 90.05 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -66.71 -38.88 87.6 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 341' ' ' ALA . 76.7 t -64.69 -43.0 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.655 0.264 . . . . 0.0 110.785 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 342' ' ' LYS . 78.1 t -60.05 -43.2 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.424 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.502 HG23 ' O ' ' B' ' 343' ' ' ARG . 88.0 t -59.68 -45.57 94.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.05 -42.28 99.64 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.313 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.71 -44.02 97.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 111.005 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.52 HD13 HD13 ' B' ' 294' ' ' LEU . 93.0 mt -64.14 -45.71 87.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.387 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.28 -40.66 90.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.027 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.92 -39.82 97.5 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.706 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.3 -38.74 88.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 110.836 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.28 -43.85 97.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.53 -43.78 98.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.882 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -68.54 -50.22 53.61 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.76 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 98.6 m -67.9 -47.16 69.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -85.79 -9.02 57.73 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.764 0.316 . . . . 0.0 110.964 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 59.42 73.0 0.5 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.684 0.754 . . . . 0.0 111.406 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.64 128.05 49.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 142.64 47.19 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.904 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -62.42 116.02 4.72 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 363' ' ' ASP . . . . . 0.471 ' O ' HG23 ' B' ' 367' ' ' VAL . 20.7 t70 -84.27 112.48 20.33 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.113 0.482 . . . . 0.0 110.846 -176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 364' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 17.0 mm-40 -58.06 -43.21 86.78 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.376 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -66.92 -37.82 85.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.826 0.346 . . . . 0.0 111.267 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -63.31 -41.71 98.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.039 0.447 . . . . 0.0 110.078 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 367' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 363' ' ' ASP . 97.6 t -64.06 -37.61 80.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.556 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 368' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.7 mmmt -56.4 -45.04 80.81 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.806 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.86 -38.22 95.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.094 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.44 -41.43 98.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.09 0.471 . . . . 0.0 110.388 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 371' ' ' ILE . . . . . 0.416 HG13 ' O ' ' B' ' 367' ' ' VAL . 62.2 mt -65.47 -42.98 94.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.509 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.38 -39.47 90.79 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.457 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -61.77 -43.13 99.45 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.079 0.466 . . . . 0.0 110.282 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 57.7 ttm -67.15 -39.25 86.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.913 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.0 -33.86 75.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.721 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 66.2 m -70.82 4.7 2.36 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -97.51 2.89 50.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.061 0.458 . . . . 0.0 110.712 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -122.24 174.89 6.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.733 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -61.95 -48.8 78.8 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.825 0.345 . . . . 0.0 111.002 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 380' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 27.0 t70 -123.79 115.22 28.07 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.48 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 381' ' ' PRO . . . . . 0.492 ' O ' HG13 ' B' ' 385' ' ' ILE . 37.3 Cg_endo -66.61 -29.56 43.61 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 122.231 1.954 . . . . 0.0 112.928 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.47 -42.9 91.77 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 12.3 pt-20 -64.34 -36.44 84.12 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.282 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.42 -42.01 92.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.388 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 385' ' ' ILE . . . . . 0.492 HG13 ' O ' ' B' ' 381' ' ' PRO . 89.6 mt -61.74 -44.1 98.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.985 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.35 -33.71 74.78 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.63 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -58.14 -47.05 84.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.277 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -69.44 -46.11 67.52 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 31.0 p -68.98 -18.1 64.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.75 7.15 46.4 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.926 0.393 . . . . 0.0 111.04 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -131.47 109.62 10.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.869 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -64.25 -38.51 91.32 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -59.9 -48.31 82.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.797 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.78 -39.86 95.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.048 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 90.8 mtp -62.58 -44.26 96.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.811 0.338 . . . . 0.0 110.905 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.74 -49.28 66.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.185 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.93 -43.23 96.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.546 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 44.0 tpp -64.22 -43.16 95.85 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.805 0.336 . . . . 0.0 111.084 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -66.27 -32.91 74.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.474 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.94 -44.75 96.82 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.769 0.319 . . . . 0.0 110.295 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 85.6 t -67.18 -43.65 88.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.458 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.31 93.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.958 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.81 -38.92 92.88 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.324 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.48 -43.24 97.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.872 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.48 -35.65 81.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.73 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -61.11 -42.74 99.07 Favored 'General case' 0 C--O 1.228 -0.06 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.402 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.85 -46.78 83.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.224 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 408' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 89.9 t -62.99 -46.18 96.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -67.03 -31.18 71.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.689 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.27 93.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.111 0.481 . . . . 0.0 110.311 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 411' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 407' ' ' ALA . 99.0 t -65.36 -41.53 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.168 177.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 97.9 mt -59.87 -27.05 66.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.206 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -78.17 -6.77 55.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 111.486 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -114.83 -22.95 9.39 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.881 0.372 . . . . 0.0 110.972 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.06 169.45 12.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.057 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -83.08 116.51 22.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.619 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 60.5 t -90.24 121.72 40.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.231 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 418' ' ' THR . . . . . 0.402 HG23 ' HG3' ' B' ' 126' ' ' GLU . 9.1 t -124.04 137.79 54.54 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.1 125.2 50.91 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.576 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 420' ' ' LYS . . . . . 0.568 ' HE3' ' OE1' ' B' ' 126' ' ' GLU . 20.3 pttp -135.44 149.91 49.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.578 0.227 . . . . 0.0 110.653 176.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.11 159.2 20.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.8 t -158.96 172.23 18.59 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.782 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 17.0 p -85.26 164.6 17.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.015 0.436 . . . . 0.0 111.355 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -65.32 -26.21 67.95 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.543 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -61.29 -39.96 92.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.649 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.42 -36.17 82.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.419 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.51 -22.67 62.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.203 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.8 mmt -77.03 -5.75 50.01 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -76.67 78.53 3.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.34 0.591 . . . . 0.0 109.636 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -105.12 14.72 28.73 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.124 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -64.12 -37.54 87.83 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.092 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.213 178.505 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 mmt . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.29 102.68 5.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.852 0.358 . . . . 0.0 110.536 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -136.04 159.2 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.328 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 17' ' ' ILE . 11.8 p -97.95 137.12 37.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.791 0.329 . . . . 0.0 110.736 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -153.83 138.4 9.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 69.7 mm-40 -122.4 152.56 40.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.112 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.1 m -107.35 121.5 44.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.757 0.313 . . . . 0.0 110.168 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 m -78.29 -67.36 0.74 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.461 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -170.2 110.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.629 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.65 -110.95 3.31 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.081 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.401 HD23 HG13 ' A' ' 111' ' ' VAL . 90.4 mt -64.12 -39.18 93.48 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 122.655 0.382 . . . . 0.0 111.31 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -69.23 138.15 30.48 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 115.086 0.794 . . . . 0.0 115.086 -174.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 12' ' ' GLY . 7.9 mpt_? -140.85 170.31 15.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.057 0.943 . . . . 0.0 110.532 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 6.2 ttm180 -134.42 137.99 44.46 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -95.4 -84.76 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.183 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 p 43.12 91.87 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.512 ' HA ' ' OG ' ' A' ' 4' ' ' SER . 85.0 mt -113.0 131.47 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.162 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.7 m -103.01 122.89 45.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.415 HG13 HG12 ' A' ' 24' ' ' ILE . 16.9 pt -129.1 162.48 36.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.522 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -70.04 150.57 46.48 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.264 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -59.34 -39.34 82.84 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -64.95 -25.34 67.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.472 . . . . 0.0 110.414 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -87.53 -32.23 19.51 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.55 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.1 mt -62.26 -50.41 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.956 0.408 . . . . 0.0 112.007 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.477 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 32.3 mm-40 -82.32 -5.02 58.3 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.7 m -100.29 -69.43 0.77 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.029 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.68 -47.58 72.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 96.3 t -63.86 -44.13 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.798 0.332 . . . . 0.0 111.349 -176.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 18.1 ttmm -61.43 -45.72 93.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.969 0.414 . . . . 0.0 110.74 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.527 ' O ' HG12 ' A' ' 33' ' ' VAL . 18.1 m -63.51 -41.29 98.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.415 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -61.23 -38.22 85.88 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.053 0.454 . . . . 0.0 110.4 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.78 -41.58 99.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.954 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 30' ' ' SER . 8.9 p -71.54 -31.65 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.569 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -62.85 -44.03 97.21 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.491 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -71.29 -31.28 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.93 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.96 -44.61 92.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.203 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.93 -33.84 76.76 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.675 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.0 -35.47 76.93 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 110.327 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.2 t -91.9 -4.88 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.321 0.581 . . . . 0.0 110.119 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 63.61 26.55 14.69 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.687 0.795 . . . . 0.0 111.435 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.17 4.55 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.851 0.358 . . . . 0.0 111.564 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.57 -33.82 76.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.936 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.65 -6.61 67.08 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.894 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -90.12 -1.0 57.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.864 0.364 . . . . 0.0 110.769 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.4 ttt-85 -94.22 82.83 4.16 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.264 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.5 94.06 6.17 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.4 101.44 2.73 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -170.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -65.36 -40.78 94.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 168.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.505 HG12 ' HB ' ' A' ' 54' ' ' VAL . 23.9 t -96.04 111.32 55.88 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.504 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.35 142.87 97.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.501 2.134 . . . . 0.0 111.65 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.647 ' HA ' HG12 ' A' ' 54' ' ' VAL . 24.1 ttt -64.43 -39.19 93.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.556 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -66.99 -20.89 65.96 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.142 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.608 HG12 HH11 ' B' ' 193' ' ' ARG . 1.7 mp -92.85 -46.56 13.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 51' ' ' MET . 9.0 p -63.79 -32.44 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 120.753 0.311 . . . . 0.0 111.358 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.43 82.15 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.66 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -93.05 -25.29 17.99 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.305 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -63.04 -43.43 98.69 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.853 0.359 . . . . 0.0 110.596 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.97 13.98 18.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.565 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.618 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -49.52 -73.07 0.39 Allowed Glycine 0 C--O 1.221 -0.703 0 CA-C-N 115.598 -0.728 . . . . 0.0 114.569 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.26 -19.3 62.37 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.862 0.331 . . . . 0.0 111.807 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 t -63.03 -45.63 91.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.032 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.4 p -123.91 17.14 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.317 0.58 . . . . 0.0 111.121 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.618 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 37.2 ttm180 -58.92 -26.62 64.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.758 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -61.86 -52.45 64.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.304 0.574 . . . . 0.0 110.232 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' HB2' HG22 ' A' ' 62' ' ' VAL . 1.2 m-20 -71.85 -27.05 62.63 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.563 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 62' ' ' VAL . 88.5 t -63.78 -43.63 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.11 -39.84 93.88 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.49 -42.7 99.82 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.788 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.752 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 31.1 t70 -63.54 -43.94 95.64 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.737 0.269 . . . . 0.0 111.033 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.08 -43.85 98.26 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.476 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -67.23 -37.28 83.3 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.082 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.4 m -61.75 -43.3 99.12 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.406 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.752 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 46.2 mtp85 -64.59 -42.96 95.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.086 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -64.65 -40.44 95.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.95 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -59.81 -49.53 77.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.731 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 tt -69.03 -39.66 79.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.789 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 21.8 t0 -66.9 -41.82 86.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.258 0.551 . . . . 0.0 109.896 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.67 -41.24 92.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.727 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -65.68 -32.22 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.234 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.73 -43.55 96.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.176 0.512 . . . . 0.0 109.811 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 77' ' ' ASP . 58.7 mttm -63.83 -42.07 97.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.774 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -86.52 -4.24 59.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.895 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 64.14 36.34 9.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.367 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 98.2 mt -88.49 123.45 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.636 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -106.79 107.66 60.67 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -78.82 134.17 11.82 Favored 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 121.88 1.72 . . . . 0.0 111.406 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.94 88.28 7.26 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.165 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.72 -102.95 2.86 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.325 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.94 128.45 21.52 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 120.593 0.235 . . . . 0.0 110.924 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.07 -20.32 57.01 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.804 2.336 . . . . 0.0 112.154 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 51.3 m 68.35 95.68 0.06 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.335 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.491 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 97.4 m-85 -81.12 113.28 19.18 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.025 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.29 107.6 30.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.752 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 69.4 Cg_endo -95.65 163.71 1.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.323 2.682 . . . . 0.0 112.187 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -100.02 176.93 28.61 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.384 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.06 134.41 41.37 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -90.38 103.09 15.81 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.75 117.44 25.51 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.54 107.76 1.0 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.347 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.52 -15.71 19.72 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.988 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.93 173.79 6.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.991 0.395 . . . . 0.0 111.42 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.91 145.62 48.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.036 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -106.6 138.83 42.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.281 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.6 m -123.32 134.7 54.02 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.041 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -130.87 168.03 17.96 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.561 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.516 ' O ' HG12 ' A' ' 107' ' ' VAL . 37.7 m -87.04 -80.46 0.25 Allowed 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 106' ' ' SER . 3.7 p 56.37 121.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 C-N-CA 124.524 1.13 . . . . 0.0 111.376 -172.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -116.54 145.64 43.2 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.878 -0.513 . . . . 0.0 112.313 -172.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -155.4 -88.37 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -134.74 161.3 35.56 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -175.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.401 HG13 HD23 ' A' ' 11' ' ' LEU . 35.3 m -135.88 164.63 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.076 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -136.58 92.42 15.06 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -97.99 162.9 0.82 Allowed 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.471 2.781 . . . . 0.0 114.804 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.34 149.36 33.65 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.2 t -127.18 135.72 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -101.99 127.73 48.72 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.929 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.0 mt -118.33 134.79 54.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.603 0.239 . . . . 0.0 110.456 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -129.84 158.37 39.65 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.12 12.29 82.61 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.536 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.12 -41.24 97.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.945 0.402 . . . . 0.0 111.491 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -75.39 -8.29 56.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.051 0.453 . . . . 0.0 111.269 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.07 7.86 44.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.583 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 74.7 mt -83.89 119.0 32.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.01 0.433 . . . . 0.0 110.672 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -110.56 114.03 27.11 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.61 136.82 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.882 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -85.4 135.64 33.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.293 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HB3' HG13 ' A' ' 417' ' ' VAL . 83.8 tttt -127.39 95.97 34.58 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.42 121.55 8.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.161 1.908 . . . . 0.0 112.1 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.2 mm -103.79 112.64 38.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.49 159.83 37.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.784 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.71 165.45 27.23 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.415 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -84.72 110.75 19.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.2 p -92.06 173.59 7.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.396 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -62.99 -36.67 84.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.668 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.14 -36.11 80.8 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.893 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -62.78 -39.27 93.69 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.741 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.02 -43.58 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.085 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -59.4 -44.94 92.73 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.347 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.69 -41.26 99.85 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.013 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.626 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.3 tpt -62.19 -46.78 87.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.716 0.293 . . . . 0.0 110.605 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.08 -42.17 99.59 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.266 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.45 -45.74 92.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.527 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.0 m -63.64 -43.61 96.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.669 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 140' ' ' MET . 98.5 mt -61.32 -44.64 96.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.067 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -70.48 -37.81 74.29 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.994 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.35 -36.98 85.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.428 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -84.79 33.92 0.53 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -122.78 115.64 22.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.447 0.641 . . . . 0.0 111.877 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.08 -170.44 3.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.482 ' CB ' ' H ' ' A' ' 247' ' ' GLU . 15.3 m -141.91 167.48 22.04 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.695 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 21.8 p-90 -105.1 132.5 51.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 120.678 0.275 . . . . 0.0 111.376 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -160.55 -47.19 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.335 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -154.26 -175.67 5.51 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' A' ' 240' ' ' VAL . 33.0 mmtp -52.75 154.67 2.63 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 76.22 -168.85 0.08 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.307 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 243' ' ' ARG . . . 113.5 0.74 24.78 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.504 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 74.41 -40.51 0.45 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.891 0.876 . . . . 0.0 112.407 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.3 t 73.32 -61.19 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.399 0.68 . . . . 0.0 112.447 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.53 ' HB2' ' HG2' ' A' ' 203' ' ' LYS . 10.2 pt-20 54.15 -166.18 0.09 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.905 1.282 . . . . 0.0 112.729 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.467 ' HB1' ' CA ' ' A' ' 190' ' ' GLY . . . -78.6 93.18 4.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.784 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -151.13 -65.71 0.19 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.327 0.584 . . . . 0.0 111.181 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -110.93 -168.76 1.34 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.381 -172.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 20.2 ptt180 -106.11 133.5 50.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.841 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.4 m -128.58 144.74 37.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.137 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.5 m -78.69 111.28 14.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.047 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.5 mt -123.63 122.07 64.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.02 0.438 . . . . 0.0 111.058 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.35 78.84 2.24 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -97.42 153.64 17.98 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.293 0.568 . . . . 0.0 112.183 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.3 m -119.05 128.38 54.29 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.877 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.58 126.42 9.11 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.742 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 21.1 p -137.27 134.32 36.0 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.93 -84.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.889 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -108.86 -0.04 20.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.399 0.618 . . . . 0.0 109.959 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.2 -21.82 0.97 Allowed Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.927 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -99.93 151.88 20.81 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -81.12 153.81 27.09 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.697 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -118.05 167.67 11.25 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.708 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -57.95 -32.26 67.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.57 -175.29 32.55 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.35 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.17 30.47 46.22 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.187 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.36 104.5 14.24 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -121.09 142.4 49.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.271 0.558 . . . . 0.0 112.197 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.7 m -147.1 118.4 7.84 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.252 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.83 33.68 23.5 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.596 0.56 . . . . 0.0 110.798 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -91.88 124.68 36.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.22 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 6.6 m -93.61 116.16 34.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.388 0.614 . . . . 0.0 110.992 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 163' ' ' ARG . 63.4 tp -101.88 117.57 35.12 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.804 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.568 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -91.01 108.15 19.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 76.9 mtm -89.83 149.56 22.62 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.808 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.467 ' CA ' ' HB1' ' A' ' 160' ' ' ALA . . . 98.38 12.19 45.83 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.275 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -127.21 -1.93 6.37 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.431 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 75.53 57.97 4.03 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.646 HH11 HG12 ' B' ' 53' ' ' ILE . 33.8 mmm-85 -103.72 -3.88 24.44 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.463 0.649 . . . . 0.0 109.613 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.482 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -142.66 176.29 9.15 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.997 177.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.4 mm -58.27 130.47 83.96 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.29 130.15 27.92 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.301 2.001 . . . . 0.0 111.993 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.45 -36.62 4.21 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.937 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -63.81 -47.43 80.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.175 0.487 . . . . 0.0 111.664 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.71 -8.86 59.49 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.255 0.55 . . . . 0.0 111.212 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -92.62 -31.74 15.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.605 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -65.32 -30.23 77.19 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.912 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.74 -25.97 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.912 0.387 . . . . 0.0 111.043 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.53 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 54.1 mtpt -55.95 132.71 50.53 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.397 0.679 . . . . 0.0 111.552 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.35 -12.78 66.35 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.674 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -84.71 154.73 22.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.984 0.421 . . . . 0.0 112.133 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -93.86 163.98 13.29 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.32 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.17 92.73 1.76 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.119 0.485 . . . . 0.0 110.429 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.544 ' H ' HD22 ' A' ' 237' ' ' LEU . . . 113.19 18.35 7.27 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.52 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -102.19 116.02 31.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.915 0.388 . . . . 0.0 110.795 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -95.95 119.25 34.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.611 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -138.41 -15.17 1.26 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 30.1 p 60.98 162.79 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.978 0.911 . . . . 0.0 112.292 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -149.03 133.07 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.826 0.346 . . . . 0.0 110.729 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.54 112.09 16.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.96 0.41 . . . . 0.0 111.207 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 65.1 t -113.21 129.3 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 3.2 m -95.62 -22.98 17.24 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -173.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 229' ' ' LYS . 89.1 m-85 67.74 154.47 0.14 Allowed Pre-proline 0 N--CA 1.489 1.51 0 CA-C-O 121.005 0.431 . . . . 0.0 111.452 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.66 158.11 28.31 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.309 2.006 . . . . 0.0 111.54 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -66.21 -37.55 85.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.216 0.532 . . . . 0.0 110.08 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.31 45.96 1.31 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.058 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 21.5 t80 -82.72 135.87 34.88 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -60.16 -22.25 62.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.404 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -99.24 105.27 17.29 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 42.2 tt0 -60.99 -24.57 66.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.22 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -73.65 -24.21 59.96 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.512 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.0 mt -113.01 3.11 16.02 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.4 ptmt -68.27 118.11 10.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.731 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.83 29.0 74.13 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.389 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.432 ' O ' ' HD1' ' A' ' 217' ' ' PHE . 99.4 mttt -124.63 140.39 52.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 117.139 0.47 . . . . 0.0 110.483 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -85.74 130.2 34.62 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.7 130.71 56.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.734 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -72.12 -39.35 68.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 59.64 105.27 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.107 0.479 . . . . 0.0 112.031 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.55 -45.82 88.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.995 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.3 mm 60.75 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.766 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -106.3 125.99 51.68 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.677 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.544 HD22 ' H ' ' A' ' 208' ' ' GLY . 4.3 mp -98.55 114.5 26.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.95 0.405 . . . . 0.0 110.867 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -94.86 -59.35 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.594 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -91.06 -88.87 0.18 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.526 ' O ' ' HE2' ' A' ' 154' ' ' LYS . 58.5 t 65.61 120.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 122.829 0.452 . . . . 0.0 110.351 -175.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -79.17 -99.96 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -166.91 155.03 9.74 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.695 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 14.2 ptp180 169.11 77.48 0.0 OUTLIER 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.668 1.187 . . . . 0.0 112.856 171.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.01 158.64 43.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.4 tp 71.95 107.53 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 123.831 0.852 . . . . 0.0 111.773 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.2 109.11 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.194 1.929 . . . . 0.0 112.368 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.482 ' H ' ' CB ' ' A' ' 150' ' ' THR . 7.8 tp10 -111.37 -21.2 11.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.053 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 42.8 tp 74.47 126.53 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.558 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.441 ' H ' ' HE2' ' A' ' 252' ' ' PHE . 4.8 m -130.7 -110.68 0.26 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.904 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -175.29 -44.82 0.01 OUTLIER 'General case' 0 C--N 1.352 0.702 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.06 -29.43 65.38 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.441 ' HE2' ' H ' ' A' ' 249' ' ' THR . 55.4 p90 -66.55 -17.65 64.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.772 0.32 . . . . 0.0 111.711 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.09 -42.8 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 110.998 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.55 ' HD2' ' H ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -95.99 21.47 8.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.004 -177.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -69.12 -17.02 63.79 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.506 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.481 ' CE1' HD21 ' A' ' 266' ' ' LEU . 80.7 m-85 -59.02 -35.43 73.27 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.74 -28.44 15.41 Favored Glycine 0 C--N 1.322 -0.202 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.76 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.16 83.88 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.51 ' HG2' ' H ' ' A' ' 260' ' ' ASP . 13.8 tt0 55.09 -163.91 0.13 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.157 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ASP . . . . . 0.51 ' H ' ' HG2' ' A' ' 259' ' ' GLU . 4.0 p-10 -124.94 110.2 13.94 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.031 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -93.15 164.97 27.56 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.622 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.6 p -87.06 -173.26 4.35 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 122.465 0.306 . . . . 0.0 110.267 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.9 -47.74 92.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 120.862 0.363 . . . . 0.0 111.289 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.2 OUTLIER -88.2 -34.25 17.86 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.768 0.318 . . . . 0.0 111.02 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.66 -40.11 98.24 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.352 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.481 HD21 ' CE1' ' A' ' 256' ' ' PHE . 53.5 tp -62.46 -42.55 99.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.505 0.193 . . . . 0.0 111.092 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -60.89 -43.83 97.93 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.953 0.406 . . . . 0.0 110.083 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -67.88 -42.25 81.52 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.236 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 24.9 tp10 -66.74 -39.98 88.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.963 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.47 ' O ' ' HG2' ' A' ' 274' ' ' MET . 75.2 t -65.03 -43.22 96.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.943 0.402 . . . . 0.0 110.054 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -58.13 -47.39 83.45 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.127 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 16.3 ptmt -67.93 -41.5 82.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.622 0.249 . . . . 0.0 111.357 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -64.12 -39.24 93.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 270' ' ' VAL . 98.8 mmm -63.5 -41.92 98.53 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.567 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -67.68 -35.04 78.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.855 0.36 . . . . 0.0 110.228 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -61.56 -43.7 98.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 109.977 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -68.88 -37.49 79.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.064 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 38.9 tp -63.17 -38.62 91.91 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.794 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -56.1 -45.62 79.37 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.151 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.5 m -61.51 -40.52 94.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.496 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.56 -45.74 92.87 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.912 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.58 -45.21 98.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 110.179 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.496 ' HD2' ' OE2' ' A' ' 405' ' ' GLU . 0.8 OUTLIER -59.77 -46.71 88.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.136 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -64.91 -41.56 95.48 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.667 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -65.32 -41.43 94.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.873 0.368 . . . . 0.0 111.404 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.92 -44.06 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.166 0.508 . . . . 0.0 109.857 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.6 -47.54 83.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.629 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 55.2 p -62.41 -43.91 97.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -64.24 -42.15 96.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.768 0.318 . . . . 0.0 111.059 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.6 85.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 37.9 mm -65.42 -44.39 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.427 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.499 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 20.0 tp10 -62.56 -42.87 99.82 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.607 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.3 -43.51 98.98 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.98 -43.21 96.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.0 -44.99 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.391 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LYS . . . . . 0.499 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 67.5 mttm -64.33 -41.42 96.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.548 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.22 -43.96 69.56 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -127.59 98.8 5.34 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.683 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -93.23 103.15 15.43 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.2 tp -107.98 139.27 30.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.975 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -67.73 131.34 45.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.213 0.53 . . . . 0.0 110.706 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.16 135.75 21.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.062 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.0 138.35 85.53 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.388 2.058 . . . . 0.0 111.987 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.37 85.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.307 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.38 -45.85 80.36 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.025 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.68 -43.3 93.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.84 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 71.4 mt -62.34 -49.98 81.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.66 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -41.63 98.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.949 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 24.6 m -61.94 -45.63 92.86 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.616 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.644 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 27.2 mm-40 -73.11 -38.05 66.48 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -176.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.501 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 82.0 mt -61.74 -43.8 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -175.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 24.9 t70 -61.45 -42.62 99.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.097 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.4 -42.55 93.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 90.3 mt -62.15 -39.67 93.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.43 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 82.5 mtm180 -62.6 -37.46 86.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.071 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 91.3 mtt180 -64.09 -38.95 92.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -63.09 -46.1 88.98 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.383 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.8 -39.53 91.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.657 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.51 94.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.409 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -65.02 -38.86 92.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.175 0.512 . . . . 0.0 110.234 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.84 -17.93 59.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.922 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -78.16 -3.57 43.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.317 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.56 -11.27 4.62 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.356 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 111.88 34.62 1.99 Allowed Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.241 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -74.75 126.6 31.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.953 0.406 . . . . 0.0 110.097 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.48 159.36 36.53 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.538 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.1 OUTLIER 69.17 -47.07 0.58 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.27 -4.9 55.13 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.18 -24.64 66.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.442 0.639 . . . . 0.0 109.807 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.402 HD12 HH12 ' A' ' 315' ' ' ARG . 38.7 tp -63.94 -33.75 76.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.705 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -80.47 -9.58 59.76 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.905 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 94.4 mt -63.83 129.03 93.57 Favored Pre-proline 0 C--O 1.24 0.572 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.476 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 52.5 Cg_exo -54.84 127.24 25.39 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.848 2.365 . . . . 0.0 113.142 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -65.51 -43.97 88.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.002 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.4 pm0 -65.25 -24.76 67.41 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.0 -10.32 55.28 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -118.1 -15.95 9.82 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.976 0.417 . . . . 0.0 111.251 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.22 -25.17 65.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.497 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.8 -50.78 67.6 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.705 0.288 . . . . 0.0 111.06 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -78.91 -20.72 48.67 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.208 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.98 -41.85 98.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.444 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -60.41 -44.24 95.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.031 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 347' ' ' VAL . 17.9 mmt85 -62.41 -42.78 99.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.068 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.492 ' NH2' HD22 ' A' ' 314' ' ' LEU . 73.4 mtt180 -64.81 -41.77 95.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.675 0.274 . . . . 0.0 111.061 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 89.2 t -64.89 -44.62 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.769 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 342' ' ' LYS . 72.5 t -61.13 -44.22 97.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.934 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 343' ' ' ARG . 77.4 t -60.5 -44.67 96.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.09 99.73 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.175 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 93.7 mt -63.47 -42.71 98.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.899 0.38 . . . . 0.0 110.614 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.6 mt -63.13 -44.95 94.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.763 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.38 -42.02 96.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.968 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.18 -42.53 99.72 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.131 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.54 -39.24 85.02 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 117.053 0.426 . . . . 0.0 111.287 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 350' ' ' LEU . 73.0 t -60.79 -45.05 98.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.93 -44.22 97.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.687 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -65.48 -46.55 79.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 37.5 m -73.11 -44.25 60.57 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -89.27 0.63 56.63 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.777 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 56.99 67.01 1.05 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.304 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 91.0 mt -98.83 153.77 18.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.777 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -132.96 155.35 49.28 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.806 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.15 100.24 8.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 171.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 367' ' ' VAL . 26.8 t70 -83.16 115.96 22.14 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.127 0.489 . . . . 0.0 112.269 -173.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 68.7 mm-40 -61.35 -35.52 77.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.299 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.441 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 65.4 mm-40 -64.39 -41.71 96.53 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.093 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -63.13 -39.15 93.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.18 0.514 . . . . 0.0 109.842 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.539 HG21 ' HG2' ' A' ' 399' ' ' ARG . 89.6 t -61.78 -39.64 84.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.332 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.5 mmmt -57.68 -44.31 85.68 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.487 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.51 -40.09 98.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.848 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.6 -43.05 99.78 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.981 0.419 . . . . 0.0 110.281 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.27 -43.92 97.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.406 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.15 -41.0 97.33 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.56 -37.25 84.55 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.351 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 48.4 ttm -66.98 -43.61 82.6 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.091 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.87 75.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.123 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.6 m -68.27 -5.29 17.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.839 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -83.45 -12.48 56.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.498 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -106.35 172.99 6.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.533 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.24 -47.31 83.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.825 0.345 . . . . 0.0 110.985 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -123.62 113.55 28.86 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.548 ' O ' HG13 ' A' ' 385' ' ' ILE . 38.1 Cg_endo -66.75 -31.19 40.12 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.229 1.953 . . . . 0.0 113.402 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -66.27 -42.96 87.71 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.28 -36.19 83.3 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.994 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.38 -42.56 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.234 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 381' ' ' PRO . 68.1 mt -61.23 -46.76 95.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.279 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 46.2 mt-10 -63.32 -44.0 96.19 Favored 'General case' 0 C--O 1.215 -0.752 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.773 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.61 -46.76 86.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -66.28 -40.84 90.34 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.429 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 51.3 p -81.58 -2.44 50.05 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 98.6 mttt -103.48 10.64 37.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.049 0.452 . . . . 0.0 110.789 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -134.42 117.51 16.39 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.259 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -63.78 -40.64 97.17 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -58.1 -49.48 76.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.674 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.55 -42.73 98.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.2 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.526 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 89.5 mtp -63.9 -48.3 77.16 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -73.58 -39.39 64.68 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -174.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -62.36 -40.72 97.35 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 44.4 tpp -64.13 -41.47 97.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.66 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.539 ' HG2' HG21 ' A' ' 367' ' ' VAL . 69.1 mtm180 -64.35 -36.44 84.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.008 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -60.95 -43.77 98.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.583 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.17 -44.09 88.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.488 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -61.65 -41.83 98.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.95 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.87 -39.5 94.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.683 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.66 -43.93 93.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.906 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.496 ' OE2' ' HD2' ' A' ' 283' ' ' ARG . 29.7 mt-10 -65.18 -37.44 87.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.541 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -60.45 -43.35 96.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.526 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.42 -44.35 91.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.968 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 86.5 t -64.73 -45.11 96.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.989 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -65.32 -33.56 76.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.32 97.49 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.865 0.364 . . . . 0.0 110.482 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.91 -42.74 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.076 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.0 mt -61.45 -41.85 97.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.183 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.04 -23.85 67.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.706 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -95.18 -8.27 36.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.32 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.53 179.43 4.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.139 0.495 . . . . 0.0 111.757 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -82.41 133.46 35.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.689 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 127' ' ' LYS . 57.8 t -122.09 131.34 73.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -131.49 138.81 49.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.1 0.476 . . . . 0.0 110.921 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -93.58 118.82 31.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.663 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -136.33 132.93 36.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.843 0.354 . . . . 0.0 111.368 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -81.01 153.23 27.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.165 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 12.9 t -157.72 171.66 19.92 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 26.2 p -81.34 165.54 21.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.772 0.32 . . . . 0.0 110.21 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -66.04 -18.13 65.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.021 0.438 . . . . 0.0 111.26 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -62.25 -39.45 92.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.97 -38.31 90.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.19 0.519 . . . . 0.0 110.057 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.35 -36.2 83.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.488 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 5.9 mmt -65.31 -14.28 60.41 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.301 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -75.6 83.37 2.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -103.64 6.48 37.13 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.315 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -72.32 -44.83 62.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.532 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.149 -178.548 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.92 103.86 2.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 111.361 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.86 161.59 38.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.396 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.493 ' OG ' ' HA ' ' B' ' 17' ' ' ILE . 7.9 p -101.59 130.56 47.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.787 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.78 133.66 13.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.479 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 57.9 mm-40 -118.45 149.75 40.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.962 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 98.0 m -106.6 122.71 46.86 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 27.7 m -78.74 -68.54 0.64 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.363 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -166.23 110.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.582 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.81 -106.55 1.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.354 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.441 HD23 HG13 ' B' ' 111' ' ' VAL . 83.8 mt -70.34 -36.69 74.39 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.708 0.403 . . . . 0.0 112.048 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.453 ' C ' ' HD2' ' B' ' 13' ' ' ARG . . . -70.09 135.81 26.39 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 114.486 0.554 . . . . 0.0 114.486 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.453 ' HD2' ' C ' ' B' ' 12' ' ' GLY . 7.6 mpt_? -138.13 171.26 14.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.69 0.796 . . . . 0.0 110.415 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 9.8 ttm180 -135.75 138.54 42.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.77 -83.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.038 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p 42.23 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.493 ' HA ' ' OG ' ' B' ' 4' ' ' SER . 83.8 mt -110.91 130.56 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.23 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 37.6 m -103.17 123.61 47.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 20.6 pt -129.08 163.23 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.0 111.979 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.511 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -71.93 152.69 42.34 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.087 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.434 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -59.98 -36.65 77.62 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -63.02 -32.3 73.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.241 0.544 . . . . 0.0 110.217 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 17.3 m -82.51 -32.99 28.44 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.034 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.511 HG13 ' O ' ' B' ' 20' ' ' ALA . 81.5 mt -60.59 -49.98 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 120.881 0.372 . . . . 0.0 111.834 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.495 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 28.0 mm-40 -82.99 -7.51 59.66 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 53.2 m -97.97 -69.34 0.76 Allowed 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.41 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.99 -48.3 66.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 89.7 t -64.17 -43.62 97.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.513 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.495 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.1 ttmm -61.33 -46.49 90.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 0.0 110.564 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.501 ' O ' HG12 ' B' ' 33' ' ' VAL . 21.2 m -63.53 -40.39 96.92 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.451 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -60.68 -38.93 86.59 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.021 0.438 . . . . 0.0 110.609 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.78 -41.85 99.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.839 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.501 HG12 ' O ' ' B' ' 30' ' ' SER . 9.2 p -70.93 -32.9 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 120.224 -0.591 . . . . 0.0 110.894 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -63.56 -43.84 95.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.431 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 25.7 m -70.69 -31.76 47.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.054 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.64 -42.54 98.12 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.989 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.21 -33.68 76.3 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.689 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.07 -36.63 80.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.942 0.401 . . . . 0.0 110.447 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 t -89.34 -6.39 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.3 0.571 . . . . 0.0 109.967 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 63.05 30.4 16.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.939 0.896 . . . . 0.0 111.215 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -105.72 4.11 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -64.35 -34.19 77.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.808 0.337 . . . . 0.0 110.799 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.78 -19.72 65.57 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.686 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -80.69 -3.48 50.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.677 0.275 . . . . 0.0 111.502 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 66.4 ttt-85 -91.88 83.46 5.23 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 119.946 -0.701 . . . . 0.0 112.026 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.55 95.99 6.01 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.12 98.1 2.23 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 115.319 0.888 . . . . 0.0 115.319 -171.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -64.67 -40.8 96.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.486 HG12 ' HB ' ' B' ' 54' ' ' VAL . 14.7 t -94.06 111.34 52.8 Favored Pre-proline 0 N--CA 1.437 -1.121 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.245 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.76 141.54 92.19 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.413 2.076 . . . . 0.0 111.665 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.704 ' HA ' HG12 ' B' ' 54' ' ' VAL . 26.1 ttt -65.63 -38.92 90.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.699 -175.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -67.47 -18.36 65.04 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.646 HG12 HH11 ' A' ' 193' ' ' ARG . 1.8 mp -96.76 -46.05 12.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.52 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.704 HG12 ' HA ' ' B' ' 51' ' ' MET . 8.4 p -63.85 -32.19 56.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 111.093 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.29 81.46 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.464 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -95.19 -20.84 18.9 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.34 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -63.99 -44.0 94.0 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.769 0.318 . . . . 0.0 110.513 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -113.9 12.32 18.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.242 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.656 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -50.72 -69.25 1.15 Allowed Glycine 0 C--O 1.218 -0.845 0 CA-C-N 115.488 -0.778 . . . . 0.0 114.75 -175.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.65 -18.19 61.59 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 117.0 0.4 . . . . 0.0 111.759 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 29.2 t -67.37 -52.68 37.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.969 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.487 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.3 p -114.02 17.03 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.468 0.651 . . . . 0.0 111.193 -175.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.656 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 36.3 ttm180 -59.1 -33.26 70.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.986 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -59.28 -50.68 73.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.023 0.44 . . . . 0.0 110.275 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ASP . . . . . 0.46 ' HB2' HG22 ' B' ' 62' ' ' VAL . 1.8 m-20 -67.61 -34.03 76.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.36 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.487 HG23 ' O ' ' B' ' 62' ' ' VAL . 81.6 t -61.16 -43.66 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.62 -39.59 91.82 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.27 -41.99 99.72 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.707 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ASP . . . . . 0.701 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 28.4 t70 -64.22 -43.48 94.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.613 0.244 . . . . 0.0 111.076 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.37 -44.02 96.02 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.383 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -66.44 -37.24 84.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.101 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.6 m -62.25 -42.86 99.7 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.233 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.701 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 44.3 mtp85 -63.36 -43.71 96.87 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.031 0.443 . . . . 0.0 110.205 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -64.89 -40.75 95.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.092 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.8 -49.27 78.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.034 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.6 tt -68.63 -39.6 80.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.716 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.517 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 7.7 t0 -65.91 -42.51 90.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.293 0.568 . . . . 0.0 109.88 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.23 93.96 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.762 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 pt -66.53 -31.71 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.149 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.83 -43.31 96.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.112 0.482 . . . . 0.0 109.837 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' B' ' 77' ' ' ASP . 64.5 mttm -63.43 -45.2 92.01 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.849 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -81.62 -9.19 59.73 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.308 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 69.47 33.36 3.15 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.628 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 96.1 mt -84.84 128.87 38.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.955 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -112.29 101.4 52.08 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.632 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.42 143.62 53.1 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.503 2.135 . . . . 0.0 111.461 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.31 88.56 4.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.032 0.444 . . . . 0.0 110.752 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.22 -98.28 2.15 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.465 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.15 129.16 19.8 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.574 0.226 . . . . 0.0 110.948 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.78 -19.56 46.95 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.795 2.33 . . . . 0.0 112.034 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 34.1 m 71.02 95.51 0.07 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.192 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.492 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 98.5 m-85 -81.67 110.98 17.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.023 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.3 t -93.95 107.9 31.34 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.977 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 68.9 Cg_endo -96.2 159.28 1.33 Allowed 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 123.208 2.605 . . . . 0.0 111.707 177.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.94 177.6 34.19 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.089 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.48 136.16 44.14 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -88.14 106.43 18.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.659 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.65 117.09 28.27 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.68 111.35 2.71 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.006 0.432 . . . . 0.0 110.725 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.73 -10.58 35.09 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.023 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -114.44 175.68 5.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.998 0.399 . . . . 0.0 111.663 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -72.35 144.43 48.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.803 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -106.79 137.51 44.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.358 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.5 m -122.84 135.26 54.47 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.36 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -131.77 166.63 21.1 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.485 ' O ' HG12 ' B' ' 107' ' ' VAL . 32.1 m -84.16 -81.04 0.18 Allowed 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.485 HG12 ' O ' ' B' ' 106' ' ' SER . 3.6 p 55.62 117.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 C-N-CA 124.441 1.096 . . . . 0.0 111.709 -173.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -112.45 150.86 30.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -157.36 -90.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -134.42 162.32 32.56 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.441 HG13 HD23 ' B' ' 11' ' ' LEU . 33.8 m -137.32 164.97 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.89 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -138.9 94.84 9.89 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -97.57 163.43 0.89 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.52 2.814 . . . . 0.0 114.495 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -145.71 146.28 31.2 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 61.1 t -125.34 133.1 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.94 126.11 44.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.551 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 88.1 mt -115.03 136.07 53.53 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -132.31 159.44 39.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.489 0.185 . . . . 0.0 110.503 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.02 13.62 82.84 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.382 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.5 -40.18 95.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.012 0.434 . . . . 0.0 111.539 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -74.52 -4.91 39.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.321 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.33 12.75 35.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.853 0.359 . . . . 0.0 110.976 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 80.5 mt -87.3 114.7 26.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.163 0.506 . . . . 0.0 110.832 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -108.98 116.65 32.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 28.5 t -116.64 135.4 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.871 -173.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -79.67 143.2 34.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.187 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -133.37 98.08 15.62 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -67.77 118.44 5.6 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.321 2.014 . . . . 0.0 112.259 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.7 mm -102.82 114.34 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.25 161.15 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.851 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -141.72 155.06 45.66 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.876 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.04 120.92 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.9 p -103.49 177.67 4.77 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.206 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -62.29 -36.9 83.53 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.229 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.74 84.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.484 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -63.18 -39.73 95.48 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.401 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.7 t -63.34 -44.69 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.812 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -58.93 -47.37 85.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.347 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.95 -41.3 99.65 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.071 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.676 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.1 OUTLIER -62.33 -45.67 92.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.672 0.273 . . . . 0.0 110.534 178.292 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 94.4 mt -63.12 -42.26 99.51 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.949 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -59.07 -49.09 79.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.464 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.9 m -63.48 -43.85 96.11 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.796 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' B' ' 140' ' ' MET . 97.5 mt -61.14 -45.04 96.28 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -175.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -71.08 -37.86 72.43 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.893 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -61.78 -36.31 80.71 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.028 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -82.21 29.95 0.41 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.244 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -118.51 114.34 22.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.356 0.598 . . . . 0.0 112.179 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.92 -167.35 2.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.24 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.532 ' CB ' ' H ' ' B' ' 247' ' ' GLU . 22.8 m -144.38 165.98 26.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' TRP . . . . . 0.667 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 15.3 p-90 -102.08 131.97 48.22 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 120.723 0.297 . . . . 0.0 111.336 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 5.9 mtpp -162.48 -50.55 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.44 -175.09 4.95 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' B' ' 240' ' ' VAL . 34.2 mmtp -54.26 155.29 3.83 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 73.98 -168.33 0.11 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.487 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' B' ' 243' ' ' ARG . . . 113.86 1.18 24.19 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.548 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . 75.11 -40.3 0.43 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.834 0.853 . . . . 0.0 112.239 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 57.7 t 71.39 -59.73 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.584 0.754 . . . . 0.0 112.768 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' GLU . . . . . 0.546 ' HB2' ' HG2' ' B' ' 203' ' ' LYS . 9.4 pt-20 53.02 -164.73 0.08 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.688 1.195 . . . . 0.0 112.787 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' ALA . . . . . 0.407 ' HB1' ' CA ' ' B' ' 190' ' ' GLY . . . -80.75 92.8 6.09 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.699 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.97 -64.03 0.23 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.297 0.57 . . . . 0.0 110.902 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -111.0 -167.89 1.24 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.291 -173.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' B' ' 187' ' ' LEU . 24.0 ptt180 -107.79 132.17 53.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.818 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.92 140.85 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.63 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 9.5 m -76.15 109.93 10.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.217 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 84.3 mt -124.4 119.14 55.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.911 0.386 . . . . 0.0 110.794 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -95.47 75.99 3.32 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -90.59 150.64 21.64 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.349 0.595 . . . . 0.0 112.279 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 34.3 m -117.18 127.33 54.01 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.283 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.84 131.58 11.5 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.677 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 30.6 p -140.28 133.15 29.17 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 30.3 t -81.95 -84.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.954 0.407 . . . . 0.0 110.791 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -103.96 -21.3 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.505 0.669 . . . . 0.0 109.546 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.05 -16.41 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.808 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -100.34 148.53 24.59 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -82.69 149.34 27.39 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -116.37 172.18 7.36 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.35 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.31 -33.86 71.63 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.81 -178.23 32.15 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.546 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.05 29.49 41.46 Favored Glycine 0 C--O 1.224 -0.47 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.968 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.37 101.71 11.23 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -117.46 143.13 46.35 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 50.8 m -147.48 119.74 8.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.172 176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 58.07 29.97 18.6 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.429 0.456 . . . . 0.0 110.758 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -90.35 123.4 34.07 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.453 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 6.7 m -94.6 117.08 37.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.396 0.617 . . . . 0.0 110.832 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' B' ' 163' ' ' ARG . 55.2 tp -100.35 118.67 37.09 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.731 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 188' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' B' ' 193' ' ' ARG . . . -92.79 112.46 24.43 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 77.2 mtm -95.14 149.4 21.34 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.935 0.398 . . . . 0.0 111.906 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.407 ' CA ' ' HB1' ' B' ' 160' ' ' ALA . . . 101.55 4.28 52.63 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.396 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -119.24 -4.21 10.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.42 4.31 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.972 -1.109 . . . . 0.0 110.422 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.608 HH11 HG12 ' A' ' 53' ' ' ILE . 33.5 mmm-85 -100.89 -2.76 31.16 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.474 0.654 . . . . 0.0 109.925 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.452 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -142.63 175.07 10.09 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.981 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 45.4 mm -57.5 130.31 81.15 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.59 131.14 32.15 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.251 1.967 . . . . 0.0 111.793 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.42 -37.38 3.76 Favored Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.114 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -63.6 -47.76 80.12 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.051 0.426 . . . . 0.0 111.591 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.89 -9.42 59.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.038 0.446 . . . . 0.0 111.111 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -93.6 -30.07 15.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.247 0.546 . . . . 0.0 109.848 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.32 73.23 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.699 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.5 -26.06 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.065 0.46 . . . . 0.0 110.896 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.546 ' HG2' ' HB2' ' B' ' 159' ' ' GLU . 49.7 mtpt -54.73 130.73 41.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.571 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.55 -9.13 66.66 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.64 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.416 ' HA ' ' OE1' ' B' ' 209' ' ' GLU . 50.4 m80 -88.57 151.0 22.78 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 122.453 -0.44 . . . . 0.0 111.876 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -91.86 165.89 13.01 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.537 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.68 102.87 4.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' GLY . . . . . 0.571 ' H ' HD22 ' B' ' 237' ' ' LEU . . . 106.48 2.07 37.76 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 209' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' B' ' 205' ' ' HIS . 45.5 tt0 -87.95 119.44 28.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.162 0.506 . . . . 0.0 110.973 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.52 136.32 38.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.24 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -156.18 -15.2 0.1 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 30.0 p 61.6 159.17 0.05 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.959 0.904 . . . . 0.0 112.087 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.0 tp -146.47 129.96 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.984 0.421 . . . . 0.0 110.522 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -78.58 115.63 18.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.596 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 67.2 t -113.8 132.08 63.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 7.1 m -96.05 -30.57 13.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' B' ' 216' ' ' THR . 74.6 m-85 72.7 151.06 0.14 Allowed Pre-proline 0 N--CA 1.484 1.267 0 C-N-CA 122.708 0.403 . . . . 0.0 111.084 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.67 159.2 25.07 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.284 1.99 . . . . 0.0 111.49 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -65.0 -39.05 92.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.3 0.572 . . . . 0.0 109.987 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -88.75 52.45 2.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.66 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 25.7 t80 -91.26 132.94 35.81 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.441 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -90.87 103.61 16.3 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 45.4 tt0 -59.25 -30.42 68.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.323 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.481 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 31.2 p-10 -67.58 -24.43 65.5 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.671 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.8 mt -112.5 3.0 16.56 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.6 ptmt -66.89 112.75 4.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.129 -177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.06 23.18 76.15 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.045 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 99.1 mttt -117.98 128.85 55.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.9 0.35 . . . . 0.0 110.407 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -70.94 137.84 49.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.142 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.86 127.49 47.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.491 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -69.76 -40.24 76.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 58.95 103.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.045 0.45 . . . . 0.0 111.981 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.5 83.96 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.755 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 45.5 mm 62.58 83.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.739 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -109.0 128.08 54.64 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.564 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' LEU . . . . . 0.571 HD22 ' H ' ' B' ' 208' ' ' GLY . 3.8 mp -100.65 120.28 39.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.629 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -98.66 -56.25 2.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.439 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -94.86 -89.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.4 ' O ' ' HE2' ' B' ' 154' ' ' LYS . 59.3 t 67.43 120.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 120.994 0.426 . . . . 0.0 110.177 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -77.46 -92.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -174.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -173.04 155.78 3.11 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.667 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 14.8 ptp180 166.92 78.12 0.0 OUTLIER 'General case' 0 C--N 1.364 1.207 0 C-N-CA 124.782 1.233 . . . . 0.0 113.129 170.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.08 160.49 40.13 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.414 ' HA ' ' HD2' ' B' ' 246' ' ' PRO . 55.4 tp 70.1 108.06 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 123.67 0.788 . . . . 0.0 111.92 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 246' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' B' ' 245' ' ' LEU . 41.6 Cg_endo -68.44 111.51 2.55 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.251 1.967 . . . . 0.0 112.082 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 247' ' ' GLU . . . . . 0.532 ' H ' ' CB ' ' B' ' 150' ' ' THR . 6.4 tp10 -117.77 -13.09 10.16 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.438 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 41.7 tp 71.41 130.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.29 1.036 . . . . 0.0 112.848 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' THR . . . . . 0.526 HG22 ' H ' ' B' ' 250' ' ' ALA . 0.5 OUTLIER -142.96 -163.28 1.6 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.526 ' H ' HG22 ' B' ' 249' ' ' THR . . . -130.3 -21.63 2.88 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.59 -35.6 80.59 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' PHE . . . . . 0.444 ' HE2' ' H ' ' B' ' 249' ' ' THR . 55.7 p90 -65.41 -17.29 64.42 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.95 -42.57 97.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.968 0.413 . . . . 0.0 111.195 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' LYS . . . . . 0.572 ' H ' ' HD2' ' B' ' 254' ' ' LYS . 0.0 OUTLIER -97.76 18.58 15.37 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -68.9 -16.83 63.86 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.007 0.432 . . . . 0.0 111.61 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 256' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' B' ' 266' ' ' LEU . 85.3 m-85 -59.74 -30.63 68.96 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.1 -31.14 9.05 Favored Glycine 0 CA--C 1.51 -0.245 0 C-N-CA 120.196 -1.002 . . . . 0.0 114.048 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 26.2 t -81.23 85.57 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 259' ' ' GLU . . . . . 0.505 ' HG2' ' H ' ' B' ' 260' ' ' ASP . 12.5 tt0 53.72 -163.88 0.1 Allowed 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.681 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 260' ' ' ASP . . . . . 0.505 ' H ' ' HG2' ' B' ' 259' ' ' GLU . 1.4 p-10 -123.31 113.07 18.38 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.621 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -95.74 169.77 27.42 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.367 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 15.1 p -89.62 -173.75 4.07 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.9 t -60.53 -48.57 87.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.901 0.381 . . . . 0.0 111.339 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' B' ' 264' ' ' GLU . 0.1 OUTLIER -86.42 -34.09 20.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.905 0.383 . . . . 0.0 110.523 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.96 -39.98 98.73 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.481 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.436 HD21 ' CE1' ' B' ' 256' ' ' PHE . 54.8 tp -62.62 -43.28 99.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.736 0.303 . . . . 0.0 110.846 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -62.4 -44.01 97.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.83 -43.83 87.38 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.053 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -66.35 -40.79 90.05 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.433 ' O ' ' HG2' ' B' ' 274' ' ' MET . 73.6 t -64.85 -43.32 96.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.034 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -57.47 -49.32 76.66 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.616 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 16.1 ptmt -67.41 -41.92 84.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.65 0.262 . . . . 0.0 111.581 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -64.58 -39.39 93.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.789 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 274' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.0 mmm -62.33 -41.61 98.7 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -68.69 -34.94 76.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.752 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -61.85 -43.91 97.9 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -69.0 -38.21 79.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.199 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 45.0 tp -62.35 -38.34 89.14 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.79 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -56.55 -44.26 80.74 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.197 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 20.4 m -62.13 -41.59 98.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.533 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.27 93.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.84 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 282' ' ' ILE . . . . . 0.41 ' O ' HG23 ' B' ' 286' ' ' VAL . 67.8 mt -63.04 -45.71 98.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.271 178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 283' ' ' ARG . . . . . 0.515 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.9 OUTLIER -59.47 -45.84 90.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.05 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -63.91 -42.73 97.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.725 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -66.11 -39.58 90.04 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.54 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 286' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' 282' ' ' ILE . 97.9 t -65.78 -44.39 93.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.178 0.514 . . . . 0.0 110.01 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.28 -46.85 84.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.373 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 76.6 p -62.87 -42.78 99.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -64.05 -42.81 96.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 111.101 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.32 82.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.061 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 291' ' ' ILE . . . . . 0.442 ' O ' HG23 ' B' ' 295' ' ' VAL . 38.0 mm -65.28 -44.19 95.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.318 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 292' ' ' GLU . . . . . 0.407 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 18.1 tp10 -62.83 -43.48 98.67 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.972 0.415 . . . . 0.0 110.853 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.22 98.14 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.527 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 51.8 mt -63.25 -43.08 99.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 291' ' ' ILE . 84.1 t -65.34 -44.67 94.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.45 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.407 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 67.3 mttm -64.35 -41.95 96.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.332 . . . . 0.0 111.685 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.88 82.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.651 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -127.6 96.6 4.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.643 0.259 . . . . 0.0 111.538 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -91.24 93.54 9.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.319 0.58 . . . . 0.0 109.591 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.0 tp -100.95 136.9 30.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.66 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.81 135.06 50.58 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.161 0.505 . . . . 0.0 110.54 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.08 134.09 20.59 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.194 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.58 134.98 67.16 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 122.353 2.035 . . . . 0.0 112.244 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.85 78.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.151 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.86 -45.2 82.61 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.002 0.43 . . . . 0.0 111.035 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.97 -43.08 88.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.93 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 307' ' ' ILE . . . . . 0.413 ' O ' HG13 ' B' ' 311' ' ' ILE . 71.7 mt -62.45 -49.55 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.731 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.22 -42.98 99.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.82 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 42.7 m -62.48 -45.84 91.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.903 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 310' ' ' GLU . . . . . 0.639 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 65.2 mm-40 -72.01 -36.68 69.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.474 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 85.0 mt -61.82 -43.94 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.568 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 25.2 t70 -60.99 -42.75 99.03 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.718 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.25 -42.65 91.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.655 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 91.0 mt -61.94 -39.9 93.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.813 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 84.1 mtm180 -62.62 -36.77 83.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.097 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 316' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 93.0 mtt180 -63.4 -39.81 95.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.576 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -63.16 -44.74 94.65 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.455 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.59 -39.66 88.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.749 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.84 92.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.4 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -64.9 -40.38 94.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.287 0.565 . . . . 0.0 110.143 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -72.38 -19.72 61.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.939 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -76.09 -6.78 52.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.744 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 136.85 -12.46 3.92 Favored Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.939 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 113.21 35.61 1.6 Allowed Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.102 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -76.48 123.26 25.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.978 0.418 . . . . 0.0 110.007 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 326' ' ' GLU . . . . . 0.402 ' CB ' HH22 ' A' ' 73' ' ' ARG . 0.1 OUTLIER -125.25 160.43 29.26 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.555 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.1 OUTLIER 69.49 -52.24 0.61 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.157 0.583 . . . . 0.0 112.534 -178.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 328' ' ' GLN . . . . . 0.435 ' HG3' ' HB3' ' A' ' 65' ' ' ASP . 15.4 mm100 -74.82 -4.32 37.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.96 -24.7 64.6 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.354 0.597 . . . . 0.0 109.624 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.45 HD12 HH12 ' B' ' 315' ' ' ARG . 39.1 tp -63.83 -33.89 76.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.623 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -80.99 -9.97 59.77 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.034 -177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.444 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 93.9 mt -63.53 128.66 92.92 Favored Pre-proline 0 C--O 1.242 0.708 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.032 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.38 126.82 23.8 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.744 2.296 . . . . 0.0 113.025 -176.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -65.13 -44.03 89.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.062 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.89 -24.74 67.62 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.9 -8.02 57.65 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.829 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -121.21 -17.22 7.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.922 0.392 . . . . 0.0 111.506 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.05 -25.65 65.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.619 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.4 -51.53 68.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.822 0.344 . . . . 0.0 110.522 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -76.79 -23.06 52.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.124 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.469 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -61.74 -40.59 95.65 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.121 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 342' ' ' LYS . . . . . 0.445 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.2 tttt -59.82 -45.3 92.78 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.89 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 343' ' ' ARG . . . . . 0.517 ' O ' HG23 ' B' ' 347' ' ' VAL . 19.0 mmt85 -62.94 -43.21 99.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.246 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 344' ' ' ARG . . . . . 0.489 ' NH2' HD22 ' B' ' 314' ' ' LEU . 90.8 mtt180 -64.62 -41.36 96.24 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.114 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 90.5 t -65.2 -44.16 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.588 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 342' ' ' LYS . 76.6 t -61.5 -43.62 97.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.802 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 343' ' ' ARG . 70.4 t -60.22 -45.5 95.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.79 99.66 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.961 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 349' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 93.3 mt -63.28 -43.66 97.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.786 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.429 ' O ' HG23 ' B' ' 354' ' ' VAL . 97.6 mt -63.6 -45.64 89.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.967 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.1 -41.54 94.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.091 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.74 -42.86 99.81 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.115 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -67.48 -37.81 83.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.851 0.325 . . . . 0.0 110.948 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 354' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 350' ' ' LEU . 70.9 t -61.0 -45.54 98.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.18 -44.68 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.915 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.6 -51.8 56.94 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 96.6 m -66.47 -45.83 78.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -86.58 -6.86 58.77 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -175.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 63.37 69.57 0.56 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.295 0.569 . . . . 0.0 111.516 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.1 mt -101.25 160.03 14.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.87 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -137.07 155.0 50.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.461 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.64 104.61 11.28 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 171.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 363' ' ' ASP . . . . . 0.511 ' O ' HG23 ' B' ' 367' ' ' VAL . 32.8 t70 -87.05 114.74 23.92 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -173.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 364' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 57.8 mm-40 -59.73 -36.63 76.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.059 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 365' ' ' GLU . . . . . 0.442 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 6.1 mm-40 -63.31 -42.51 99.03 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 111.013 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -63.24 -39.72 95.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.091 0.472 . . . . 0.0 110.072 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 367' ' ' VAL . . . . . 0.536 HG21 ' HG2' ' B' ' 399' ' ' ARG . 70.5 t -62.81 -37.32 78.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.416 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 368' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.2 mmmt -57.4 -44.71 84.78 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.6 -38.85 96.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.082 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.76 -43.06 99.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.65 -44.19 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.095 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.51 -42.18 98.5 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.15 -37.65 81.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.894 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.4 ttm -65.83 -42.21 90.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.049 0.452 . . . . 0.0 110.719 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.28 72.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.044 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 50.6 m -71.6 -4.58 27.89 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.918 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -88.96 -4.02 58.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.877 0.37 . . . . 0.0 111.637 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -112.04 172.64 6.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.217 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.64 -48.38 72.35 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.717 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 380' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 21.4 t70 -127.82 116.4 20.78 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.041 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.48 -31.07 42.88 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.368 2.045 . . . . 0.0 113.165 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.1 -43.74 86.38 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 11.4 pt-20 -62.96 -38.86 92.8 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.891 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.91 -42.11 93.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.602 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.19 -44.19 98.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.413 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 36.7 mt-10 -64.95 -44.96 87.72 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.85 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.94 -45.77 89.62 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.16 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -66.59 -39.87 88.64 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.745 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 58.3 p -81.58 -3.36 53.1 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 390' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.3 mttt -104.13 13.34 32.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.003 0.43 . . . . 0.0 110.98 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -138.49 118.04 12.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.272 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.64 -41.52 98.24 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -56.17 -50.26 71.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.968 0.413 . . . . 0.0 110.93 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.07 -42.1 99.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.397 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.441 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.2 mtp -64.68 -53.94 39.49 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.05 -39.54 83.01 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -61.98 -40.67 96.41 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 48.6 tpp -65.26 -40.63 94.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.838 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.536 ' HG2' HG21 ' B' ' 367' ' ' VAL . 66.8 mtm180 -64.06 -36.21 83.25 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.121 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -61.39 -42.84 99.37 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.728 0.299 . . . . 0.0 110.206 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.33 -44.85 94.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.447 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.98 -41.3 99.51 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.097 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.31 -40.09 96.39 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.649 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.45 -43.44 96.85 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 405' ' ' GLU . . . . . 0.515 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 26.6 mt-10 -65.13 -38.17 89.79 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.616 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.73 -43.32 94.25 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 120.803 0.335 . . . . 0.0 110.38 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.95 90.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.224 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.32 -44.89 94.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.16 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 409' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 45.2 mt-10 -66.03 -33.12 75.07 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.004 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.02 96.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.386 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 95.4 t -67.45 -42.92 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.324 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.54 -41.21 97.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.002 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.83 -20.88 66.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.708 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -97.4 -6.87 33.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.301 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -111.21 179.98 3.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.267 0.556 . . . . 0.0 111.801 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.12 130.39 35.11 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.357 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 70.4 t -117.82 130.34 72.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 6.0 t -129.87 135.74 48.73 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.089 0.471 . . . . 0.0 110.674 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -93.32 123.56 36.69 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.238 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -138.88 133.41 31.91 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.807 0.337 . . . . 0.0 111.155 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -83.64 150.53 25.84 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.795 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -157.29 170.65 21.98 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 20.0 p -79.34 164.3 24.18 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.745 0.307 . . . . 0.0 110.284 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -64.33 -19.47 65.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.059 0.457 . . . . 0.0 111.009 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -61.31 -38.02 85.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.831 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -65.13 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.1 0.476 . . . . 0.0 110.238 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 8.2 mp -73.63 -20.47 60.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.7 mmt -78.25 -9.87 59.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -78.21 83.16 4.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.286 0.565 . . . . 0.0 109.841 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -106.09 4.02 28.72 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.532 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -67.47 -44.86 77.55 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.607 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.951 -179.536 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.792 0.329 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -84.55 95.14 8.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.081 0.467 . . . . 0.0 110.903 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.0 m -134.4 167.51 25.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.007 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.8 m -125.43 97.33 5.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.896 0.379 . . . . 0.0 111.286 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.79 140.65 23.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.742 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.598 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 41.1 tt0 -145.18 169.95 17.18 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.6 t -103.93 157.16 17.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.806 0.276 . . . . 0.0 111.204 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.4 m -123.87 -71.19 0.73 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.835 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -153.56 120.76 5.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.45 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.74 -120.38 20.05 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.733 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 6.8 mp -87.75 -5.5 58.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -71.22 130.1 18.5 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.78 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 4.7 tpp180 -119.03 -161.81 0.87 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -146.38 128.32 15.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.29 -94.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.056 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 m 52.89 87.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.12 0.486 . . . . 0.0 111.603 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 tp -108.65 139.2 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.935 0.398 . . . . 0.0 111.567 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.6 m -106.65 125.73 51.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.1 pt -127.83 157.87 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.703 0.287 . . . . 0.0 111.587 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.538 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -77.3 161.83 27.78 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.479 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.03 -49.06 76.99 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.09 -34.7 78.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.961 0.41 . . . . 0.0 110.608 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -62.21 -40.1 94.97 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.758 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.3 mt -62.13 -48.96 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.168 0.508 . . . . 0.0 110.812 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -67.64 -40.11 84.6 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.008 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -79.65 -67.73 0.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.37 79.28 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -172.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.429 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 98.0 t -61.81 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.688 0.28 . . . . 0.0 111.694 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -63.4 -44.89 93.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.032 0.444 . . . . 0.0 110.306 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.5 m -62.79 -42.24 99.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.254 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -63.51 -36.41 83.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.776 0.322 . . . . 0.0 110.584 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.2 mt -62.48 -43.55 98.54 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.706 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.46 -35.02 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.936 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -63.49 -43.07 98.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.46 -29.32 34.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.923 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.95 -39.7 87.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.004 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.43 -21.55 58.1 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.075 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.81 -44.45 96.85 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.06 0.457 . . . . 0.0 109.876 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.4 t -91.75 -2.33 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.075 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 63.37 26.81 15.12 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.998 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.8 pp -101.12 7.64 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.578 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -63.57 -33.56 75.87 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.952 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.53 -0.58 67.96 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.749 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -94.47 -3.74 49.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.764 0.316 . . . . 0.0 111.192 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -88.04 122.66 31.88 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -66.92 -7.24 20.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -173.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.55 -34.95 3.7 Favored Glycine 0 C--N 1.315 -0.62 0 C-N-CA 120.381 -0.914 . . . . 0.0 114.212 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -63.69 133.87 54.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 117.49 0.645 . . . . 0.0 109.36 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.572 HG12 HG12 ' A' ' 54' ' ' VAL . 20.0 t 64.27 72.62 0.5 Allowed Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.565 ' O ' HG13 ' A' ' 54' ' ' VAL . 58.8 Cg_endo -69.62 161.42 45.98 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.381 2.72 . . . . 0.0 113.691 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.827 ' HA ' HG22 ' A' ' 54' ' ' VAL . 49.3 mtt -62.32 -34.65 77.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -175.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -62.96 -25.61 68.44 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.541 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -92.73 -39.6 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.183 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.827 HG22 ' HA ' ' A' ' 51' ' ' MET . 8.6 m -62.59 -33.05 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 120.659 0.266 . . . . 0.0 111.118 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.43 -32.9 72.88 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.707 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -100.33 -34.35 10.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.619 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -65.54 -43.08 91.08 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -125.61 20.54 7.87 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.737 0.303 . . . . 0.0 111.117 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.655 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -57.38 -45.64 92.69 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 114.536 0.575 . . . . 0.0 114.536 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.02 -19.64 20.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 117.538 0.669 . . . . 0.0 111.369 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 t -63.13 -44.68 94.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.125 -177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.5 p -120.58 19.47 5.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.496 0.665 . . . . 0.0 110.702 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 39.5 ttm180 -58.12 -29.51 65.57 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.627 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -61.08 -50.48 73.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.538 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.99 -20.74 57.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.046 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.7 t -63.66 -44.2 98.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 99.2 mt -62.63 -40.43 96.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.173 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.2 -43.85 98.54 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.283 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.713 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 37.2 t70 -64.16 -43.23 95.81 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.983 0.391 . . . . 0.0 110.279 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 98.1 mt -61.11 -42.25 98.19 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.871 0.367 . . . . 0.0 110.265 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.3 ttp -61.4 -45.56 93.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.815 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 m -62.43 -44.62 95.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.042 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.713 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 37.6 mtp85 -65.86 -43.65 87.77 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.078 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -65.87 -40.5 91.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.061 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -61.17 -48.16 82.83 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.502 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.0 tt -68.53 -39.47 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.498 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.449 ' O ' ' HE3' ' A' ' 81' ' ' LYS . 10.6 t70 -62.35 -41.68 98.78 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.332 0.587 . . . . 0.0 109.431 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -66.05 -45.62 80.74 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.703 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.2 pt -65.46 -29.75 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.933 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.26 -44.22 97.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.096 0.474 . . . . 0.0 110.766 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 16.2 ptpt -81.79 -24.41 35.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.59 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -87.82 -5.96 58.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.99 0.424 . . . . 0.0 110.437 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 64.2 40.55 6.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.669 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.4 mt -101.75 118.82 49.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.408 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -107.7 102.29 44.24 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.153 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.87 141.59 65.74 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.517 2.145 . . . . 0.0 112.159 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.98 90.5 8.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.375 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.1 -109.89 3.49 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.029 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.14 127.62 24.27 Favored Pre-proline 0 C--N 1.318 -0.775 0 O-C-N 122.852 -0.205 . . . . 0.0 110.991 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.64 161.39 45.42 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.737 2.291 . . . . 0.0 111.298 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -93.61 116.09 28.58 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.316 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.456 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 93.0 m-85 -94.11 127.66 40.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.62 98.31 36.58 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 120.893 0.377 . . . . 0.0 111.334 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 90.6 Cg_endo -97.3 171.69 0.77 Allowed 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 123.471 2.78 . . . . 0.0 110.981 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.66 -175.97 22.4 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.46 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -85.07 135.07 34.15 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -90.95 125.34 35.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.391 0.615 . . . . 0.0 110.876 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 97.8 mttt -113.49 124.05 51.48 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.1 tp -69.77 123.51 21.62 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.32 -16.3 56.91 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.231 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 50.4 mt-10 -113.34 178.83 4.14 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -86.44 168.64 13.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.972 0.415 . . . . 0.0 111.549 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -124.0 146.88 48.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.094 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.0 m -131.54 143.21 50.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.958 0.408 . . . . 0.0 111.241 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -138.43 154.12 48.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.571 ' O ' HG12 ' A' ' 107' ' ' VAL . 21.1 m -93.79 -74.87 0.52 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -175.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 65.41 142.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 124.012 0.925 . . . . 0.0 110.119 -172.256 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 42.8 mt-10 -119.87 129.9 54.61 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -164.17 146.01 8.82 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 64.31 158.76 0.09 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 175.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.48 156.42 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.548 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -158.19 106.12 1.71 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -82.9 151.63 14.41 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.897 2.398 . . . . 0.0 113.983 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -123.36 145.74 48.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.44 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.75 131.04 73.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.779 0.323 . . . . 0.0 111.801 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -108.22 -85.49 0.52 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.815 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.9 mt 57.44 114.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -132.34 153.66 50.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.146 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.06 19.16 70.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.52 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.43 -41.28 98.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.135 0.493 . . . . 0.0 111.079 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -73.9 -4.72 36.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.565 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -105.41 16.27 25.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.794 0.33 . . . . 0.0 110.99 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 89.7 mt -90.86 122.48 42.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.135 0.493 . . . . 0.0 111.091 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -110.47 124.06 51.06 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.54 133.91 62.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.772 0.32 . . . . 0.0 111.425 -175.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.38 134.0 36.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.54 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -128.0 98.2 27.76 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.871 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.86 126.95 11.76 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.358 2.039 . . . . 0.0 112.386 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.2 mm -109.94 120.92 61.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.622 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.59 162.55 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.334 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -136.7 149.85 48.13 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.088 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.2 t -76.03 127.48 37.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.2 p -113.84 177.25 4.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.245 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -63.29 -34.75 78.37 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.719 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.03 90.91 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.402 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -63.47 -41.99 98.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.572 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.44 -45.5 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.403 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.93 -43.12 99.06 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.543 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.81 99.72 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.307 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.591 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 3.3 tpt -62.65 -46.93 85.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.846 0.355 . . . . 0.0 110.621 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.75 -42.04 97.9 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.598 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -62.14 -43.32 99.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.148 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.7 m -62.66 -41.55 99.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.151 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.2 mt -61.23 -42.67 99.0 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -71.26 -22.17 62.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.369 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.77 -0.55 54.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.519 0.676 . . . . 0.0 110.077 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -116.47 20.95 13.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.954 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -122.33 95.68 4.74 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.526 ' HB3' ' OE1' ' A' ' 159' ' ' GLU . . . -140.68 159.08 42.98 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 173.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 247' ' ' GLU . 6.9 m -122.37 142.82 50.11 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.194 -1.003 . . . . 0.0 112.055 -175.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 41.0 p-90 -74.43 132.12 41.67 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.253 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 244' ' ' GLU . 64.5 tttp -162.84 -63.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 242' ' ' GLU . 40.8 mt-10 -116.17 -96.28 0.46 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -176.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 155' ' ' ASP . 23.3 tptm -92.34 -113.34 0.09 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -167.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 3.5 t70 -152.84 154.93 36.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.529 -172.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 164.22 -34.61 0.28 Allowed Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -152.76 140.2 19.65 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.437 ' HA ' ' HD2' ' A' ' 243' ' ' ARG . 58.1 t -129.9 125.98 61.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.225 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.526 ' OE1' ' HB3' ' A' ' 149' ' ' ALA . 4.4 mp0 -88.48 158.86 18.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.22 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -83.39 52.62 2.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.826 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.402 ' CD ' HH11 ' A' ' 255' ' ' ARG . 1.2 pp20? -162.53 9.1 0.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.181 0.515 . . . . 0.0 110.665 177.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 163' ' ' ARG . 15.8 t70 -104.12 -172.89 2.19 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.528 -175.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.402 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 42.8 ttm180 -121.96 117.44 26.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.601 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.11 130.03 63.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.449 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 55.9 m -86.76 117.56 25.59 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 83.5 mt -126.89 123.04 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.099 0.476 . . . . 0.0 111.702 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -95.13 105.47 17.4 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -124.52 149.58 46.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.476 0.655 . . . . 0.0 112.438 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.5 m -124.52 128.37 48.85 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.423 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.63 142.98 18.95 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.887 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 m -139.53 146.25 39.69 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.54 -86.21 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.328 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -99.44 -45.65 5.76 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.026 0.441 . . . . 0.0 110.003 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.2 15.29 0.23 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.766 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -138.81 148.63 44.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.561 0.219 . . . . 0.0 110.564 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.91 161.79 30.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.468 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -131.31 177.55 7.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.033 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.86 -35.19 72.55 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -105.39 -172.59 24.01 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.863 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.68 32.54 41.01 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.502 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -113.47 114.57 26.74 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.99 146.47 49.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.947 0.404 . . . . 0.0 111.534 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -143.03 122.08 12.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.727 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 59.99 34.82 21.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.665 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -89.08 132.52 34.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.847 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 88.3 t -96.19 124.46 48.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.901 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 63.5 tp -111.5 123.96 51.31 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.019 0.438 . . . . 0.0 111.285 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -111.22 112.23 23.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 73.0 mtm -84.64 160.04 20.46 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.684 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.34 -24.83 28.99 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.411 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -91.36 -6.34 53.12 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.25 46.12 13.47 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.035 -1.079 . . . . 0.0 111.662 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -85.44 -11.75 53.62 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.22 170.51 12.92 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.425 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.641 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.2 mp -55.66 132.31 71.92 Favored Pre-proline 0 C--N 1.323 -0.559 0 O-C-N 123.385 0.428 . . . . 0.0 110.063 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -48.36 129.31 19.16 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.264 1.976 . . . . 0.0 111.681 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.68 -33.86 5.91 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.699 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -62.27 -44.7 95.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.602 0.239 . . . . 0.0 110.655 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.56 -40.55 95.76 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.93 -33.25 75.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.006 0.431 . . . . 0.0 110.847 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.03 -22.77 70.82 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.183 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.16 -43.46 97.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -52.17 115.78 1.89 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.446 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 113.78 -10.81 23.22 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.188 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.625 ' HA ' ' OE1' ' A' ' 209' ' ' GLU . 47.7 m80 -98.6 139.03 34.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.036 0.418 . . . . 0.0 111.201 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -98.26 168.94 9.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.62 132.16 48.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.5 33.13 61.35 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.118 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.625 ' OE1' ' HA ' ' A' ' 205' ' ' HIS . 41.9 tt0 -117.86 117.37 29.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.173 0.511 . . . . 0.0 110.388 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -105.1 130.81 53.2 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.815 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -153.36 -23.02 0.15 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.463 HG22 ' HA ' ' A' ' 234' ' ' ALA . 80.4 p 60.05 167.88 0.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.776 0.831 . . . . 0.0 112.031 -175.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 19.2 tt -160.41 144.68 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.225 -0.297 . . . . 0.0 110.896 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.99 108.46 15.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.805 0.336 . . . . 0.0 111.381 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.55 122.54 64.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 16.3 p -90.36 -22.69 21.38 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -173.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 70.6 m-85 67.89 140.37 0.07 OUTLIER Pre-proline 0 N--CA 1.483 1.219 0 CA-C-O 121.068 0.461 . . . . 0.0 111.581 -176.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 14.4 Cg_exo -69.54 150.4 69.52 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.455 2.103 . . . . 0.0 112.0 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.436 ' O ' ' HE2' ' A' ' 227' ' ' LYS . 81.0 mm-40 -66.56 -38.56 87.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.992 0.425 . . . . 0.0 110.171 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -86.45 33.3 0.63 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.732 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.515 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 10.9 t80 -70.01 131.4 44.3 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -65.02 -17.23 64.26 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.515 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -98.95 99.62 10.69 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 38.9 tt0 -56.52 -33.07 65.69 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.897 -175.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -66.24 -18.41 65.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.904 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.24 -1.11 9.25 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 14.1 ptmm? -67.81 121.44 15.99 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.397 0.617 . . . . 0.0 112.301 -175.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 82.06 8.43 86.56 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.589 -0.732 . . . . 0.0 114.097 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -118.48 137.94 52.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.528 0.664 . . . . 0.0 110.879 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -91.21 155.4 18.61 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.49 144.57 32.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.733 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 3.4 mppt? -98.74 -15.82 19.19 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 56.37 -149.96 0.45 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.133 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.463 ' HA ' HG22 ' A' ' 212' ' ' THR . . . -141.0 -68.43 0.4 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.753 0.311 . . . . 0.0 110.56 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.2 mt 64.74 91.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.954 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -98.19 -27.68 14.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.291 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.0 tp 52.1 67.01 1.04 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.882 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -65.34 -43.44 90.87 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.433 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 30.7 mtpp -96.98 -80.02 0.45 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -173.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 85.4 t 77.96 139.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -171.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -91.6 -84.05 0.27 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -172.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 153' ' ' GLU . 43.0 tt0 -165.23 103.8 0.75 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 19.6 ttm-85 -166.81 113.92 0.82 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 175.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -177.92 155.24 0.97 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 42.3 tp 67.89 100.8 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.321 0 O-C-N 124.135 0.897 . . . . 0.0 111.18 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 42.1 Cg_endo -69.01 111.93 2.8 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.229 1.953 . . . . 0.0 112.889 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.582 ' O ' HG21 ' A' ' 150' ' ' THR . 44.5 tt0 -137.13 147.64 46.14 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.5 mp -73.48 98.88 2.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.984 0.421 . . . . 0.0 111.108 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.9 p -95.24 -89.02 0.25 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.428 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -170.79 -51.41 0.02 OUTLIER 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.9 0.381 . . . . 0.0 111.342 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -81.14 89.39 5.99 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.994 0.426 . . . . 0.0 111.882 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.486 ' CD1' HG23 ' A' ' 253' ' ' ILE . 51.5 p90 -159.02 -13.48 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.214 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.486 HG23 ' CD1' ' A' ' 252' ' ' PHE . 19.0 pt -121.17 -41.28 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.022 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -83.36 -2.95 56.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.35 0.595 . . . . 0.0 110.327 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.402 HH11 ' CD ' ' A' ' 161' ' ' GLU . 54.2 ttp180 -124.7 98.26 5.64 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -148.72 -61.2 0.24 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -166.0 -75.64 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.54 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 68.0 t -104.25 117.74 50.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 122.832 -0.216 . . . . 0.0 111.12 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 58.1 -170.0 0.11 Allowed 'General case' 0 CA--C 1.544 0.733 0 O-C-N 123.989 0.806 . . . . 0.0 110.656 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -104.7 112.71 25.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.323 0.582 . . . . 0.0 109.789 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -98.01 167.72 23.02 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.203 -0.998 . . . . 0.0 113.774 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 56.1 p -108.63 -167.39 1.22 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.91 -54.17 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.358 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.2 OUTLIER -80.3 -38.81 29.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 -178.514 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.26 98.18 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.634 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 270' ' ' VAL . 49.0 tp -63.89 -43.21 96.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.555 0.216 . . . . 0.0 110.59 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -63.54 -40.41 96.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.391 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.23 -44.11 89.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.802 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -68.07 -38.12 82.04 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.133 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 266' ' ' LEU . 79.3 t -64.0 -43.35 97.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.656 0.265 . . . . 0.0 110.507 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -59.27 -46.37 88.71 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.993 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.5 ptmt -66.34 -44.49 83.15 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -63.95 -39.47 94.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 270' ' ' VAL . 99.3 mmm -64.47 -40.67 96.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.76 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.99 -35.3 79.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 110.795 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -62.71 -41.77 99.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.759 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -64.61 -37.49 87.75 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.734 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 46.0 tp -61.83 -38.29 87.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.876 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -57.58 -45.53 85.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.861 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.9 m -62.35 -42.39 99.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.605 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.13 82.95 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.057 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.85 -43.73 97.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.297 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.496 ' HD3' ' HG2' ' A' ' 405' ' ' GLU . 1.4 tpm_? -59.54 -46.99 87.27 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.022 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -65.61 -40.69 92.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.398 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -61.09 -43.34 99.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.26 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.43 -44.12 90.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.348 0.594 . . . . 0.0 110.19 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.46 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.5 tttt -62.05 -48.84 78.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.264 -177.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.9 p -64.63 -41.38 96.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -65.86 -42.3 90.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.46 -47.23 82.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.959 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 287' ' ' LYS . 48.0 mm -64.57 -44.18 96.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.41 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.445 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 17.1 tp10 -60.16 -45.11 94.21 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 110.681 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.74 -42.7 98.51 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.246 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.48 -41.69 96.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 291' ' ' ILE . 71.3 t -63.16 -45.09 99.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.452 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LYS . . . . . 0.445 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.7 mttm -63.83 -42.54 97.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 111.064 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.32 -42.7 62.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -118.75 92.52 3.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -98.54 99.22 10.35 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -106.1 159.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.742 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -64.13 137.5 57.99 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.22 128.52 25.54 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.242 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.437 ' O ' HG13 ' A' ' 307' ' ' ILE . 47.0 Cg_exo -56.6 128.5 30.3 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.344 2.029 . . . . 0.0 111.712 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.37 83.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.735 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.5 -41.53 90.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.9 mt -67.88 -41.65 82.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.501 ' O ' HG13 ' A' ' 311' ' ' ILE . 69.4 mt -61.93 -51.27 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.704 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.85 -43.81 98.1 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 41.6 m -61.6 -45.47 93.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.601 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.68 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 72.9 mm-40 -71.58 -34.1 69.64 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 307' ' ' ILE . 95.1 mt -61.4 -43.79 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.663 0.268 . . . . 0.0 110.723 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.504 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.7 t70 -62.3 -40.98 98.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.1 t -62.98 -44.67 99.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.275 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 46.1 mt -63.03 -39.39 94.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.956 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.504 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 83.9 mtm180 -63.08 -39.82 95.84 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.902 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 84.3 mtt180 -66.02 -38.98 89.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.786 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.58 -43.02 99.86 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.109 0.481 . . . . 0.0 109.943 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.49 -36.62 79.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.326 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -62.54 -36.94 84.2 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.628 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -62.07 -42.29 99.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.434 0.635 . . . . 0.0 109.876 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -78.23 -6.96 56.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.599 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -91.37 -3.74 56.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.313 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 135.33 -21.41 3.65 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.519 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 118.15 34.11 1.17 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.455 -0.878 . . . . 0.0 111.241 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.471 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 42.0 t-20 -71.97 126.87 30.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.7 tm-20 -127.8 150.57 49.77 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 6.5 ptpp? 61.94 -39.38 0.14 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.667 1.587 . . . . 0.0 114.057 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.471 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 16.0 mm100 -71.79 -11.58 60.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.271 0.558 . . . . 0.0 110.438 177.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.69 -21.23 66.28 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.987 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.47 HD12 HH12 ' A' ' 315' ' ' ARG . 63.1 tp -62.54 -37.48 86.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.131 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -80.97 -2.85 49.5 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.864 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 74.8 mt -69.42 149.08 97.26 Favored Pre-proline 0 C--O 1.239 0.541 0 O-C-N 122.265 -0.272 . . . . 0.0 110.394 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.6 143.77 99.46 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.658 2.239 . . . . 0.0 113.113 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 25.5 ttt85 -83.31 -42.17 17.44 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.808 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -57.99 -43.74 86.78 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.424 ' HB2' ' OE2' ' A' ' 224' ' ' GLU . 88.7 mt -85.74 -3.27 58.85 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.808 -176.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -104.64 -27.58 11.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.948 0.404 . . . . 0.0 110.151 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.1 -25.56 67.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.661 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -60.14 -48.04 83.38 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.845 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -80.79 -22.11 40.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.599 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.29 -41.95 99.03 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.429 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.8 tttt -60.06 -46.2 90.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.16 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.549 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.0 mmt85 -62.01 -45.64 92.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.428 ' NH2' HD22 ' A' ' 314' ' ' LEU . 91.1 mtt180 -67.14 -38.09 84.94 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.451 -178.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 341' ' ' ALA . 78.7 t -64.44 -44.24 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.648 0.261 . . . . 0.0 110.599 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 342' ' ' LYS . 69.5 t -61.71 -43.34 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.572 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 343' ' ' ARG . 76.4 t -60.17 -45.2 96.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.9 -42.53 99.75 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.141 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.77 -44.75 92.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.659 0.266 . . . . 0.0 111.334 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 354' ' ' VAL . 96.2 mt -64.03 -46.71 83.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.275 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.26 -38.69 78.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.412 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.72 -42.92 96.6 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.196 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.08 -36.48 79.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.831 0.316 . . . . 0.0 110.881 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 350' ' ' LEU . 86.6 t -60.81 -44.67 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.63 -44.23 98.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.841 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -69.87 -46.25 65.92 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.9 m -66.73 -44.98 80.12 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -90.71 4.77 50.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.967 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 53.06 47.61 24.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.109 0.48 . . . . 0.0 111.632 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.9 mt -73.37 140.26 46.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.877 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -119.86 153.63 35.53 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.851 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.13 110.04 15.16 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.498 ' O ' HG23 ' A' ' 367' ' ' VAL . 23.1 t70 -83.46 112.46 19.98 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.918 -174.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.57 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 15.7 mm-40 -59.36 -38.73 81.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.629 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.76 -42.85 90.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.431 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -62.33 -38.32 89.0 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.517 HG21 ' HG2' ' A' ' 399' ' ' ARG . 99.0 t -64.42 -40.08 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.632 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.8 mmmt -56.65 -44.54 81.44 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.59 -40.14 98.35 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.197 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.97 -42.26 99.78 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.694 0.283 . . . . 0.0 110.639 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.13 -44.3 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.713 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.11 -39.23 89.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.45 -36.14 80.61 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.488 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 51.0 ttm -65.61 -39.8 91.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.103 0.478 . . . . 0.0 110.202 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -61.54 -29.79 70.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.86 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 13.2 m -72.53 -5.58 37.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.585 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.51 -8.73 52.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 0.0 110.843 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -107.36 171.09 7.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.235 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.28 -36.78 85.23 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.338 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -133.67 109.12 12.06 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 120.878 0.37 . . . . 0.0 110.736 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.425 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 53.0 Cg_exo -56.96 -39.64 89.95 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.058 2.505 . . . . 0.0 113.728 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -64.36 -42.69 96.06 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.28 -37.96 87.5 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.061 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.24 -43.43 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.0 -44.94 99.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.463 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 53.9 mt-10 -68.75 -42.12 77.99 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.976 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -59.36 -46.52 88.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.828 0.347 . . . . 0.0 111.119 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.18 -41.43 94.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.664 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 32.9 p -80.23 -6.47 57.9 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 97.9 mttt -101.0 5.23 43.03 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.876 0.37 . . . . 0.0 111.0 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -126.06 119.38 27.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -62.62 -43.69 98.17 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -57.67 -49.82 75.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.762 0.315 . . . . 0.0 111.169 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.2 -42.64 99.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.545 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.435 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.2 mtp -65.44 -44.38 87.46 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.52 -42.23 71.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.459 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.99 -41.56 99.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.57 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 51.4 tpp -62.98 -41.37 99.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.843 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.517 ' HG2' HG21 ' A' ' 367' ' ' VAL . 73.4 mtm180 -65.38 -37.49 87.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.908 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.55 -44.32 96.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.41 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.65 -45.2 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.083 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.51 94.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.728 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 51.3 tp -63.08 -40.49 97.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.327 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.45 -42.56 98.95 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.598 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.496 ' HG2' ' HD3' ' A' ' 283' ' ' ARG . 29.0 mt-10 -64.96 -40.21 94.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.737 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -59.93 -41.67 92.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.554 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.33 87.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.024 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.58 -43.87 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.191 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.45 -33.58 76.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.439 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.77 98.21 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.98 0.419 . . . . 0.0 110.149 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 97.4 t -65.44 -43.07 94.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.329 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.17 -39.82 91.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -70.3 -13.02 61.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.462 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -108.83 3.04 22.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.102 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.37 173.27 6.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.337 0.589 . . . . 0.0 111.766 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -84.84 107.42 16.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.245 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.2 133.37 36.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.383 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.8 t -137.48 148.4 46.03 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.118 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -97.57 128.47 44.33 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.009 0.433 . . . . 0.0 110.965 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -134.52 127.98 32.44 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.627 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -101.16 144.12 30.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.388 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.4 t -152.4 -176.27 5.63 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.871 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.8 p -81.66 162.58 22.98 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.961 0.41 . . . . 0.0 110.836 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -67.89 -17.78 64.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.804 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -61.53 -41.67 97.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.928 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.39 -26.74 63.84 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.518 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.1 -21.35 59.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.158 0.504 . . . . 0.0 110.064 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.5 mmt -79.65 -7.11 58.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.997 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -80.48 87.39 5.69 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.503 0.668 . . . . 0.0 109.659 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -120.73 30.43 6.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.105 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -65.9 -37.14 85.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.948 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.753 179.551 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.553 0.216 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -83.77 101.29 11.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.82 160.55 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.928 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -114.42 106.59 14.48 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.858 0.361 . . . . 0.0 110.777 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -155.55 136.99 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.61 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.569 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 43.5 tt0 -142.99 169.27 17.88 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.0 t -101.02 153.8 19.24 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 117.705 0.23 . . . . 0.0 111.218 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 57.7 m -120.44 -65.76 1.12 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -162.1 123.95 2.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.465 0.174 . . . . 0.0 110.549 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.1 -120.09 18.46 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.814 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' B' ' 108' ' ' GLU . 6.8 mp -89.23 -5.86 57.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' B' ' 107' ' ' VAL . . . -70.52 132.57 22.82 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.088 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 3.5 tpp180 -121.25 -162.64 0.98 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -145.45 127.78 15.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.64 -94.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.135 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m 52.28 89.29 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.202 0.525 . . . . 0.0 111.479 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 tp -111.22 136.29 47.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.014 0.435 . . . . 0.0 111.693 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 46.1 m -101.72 126.9 48.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 17.2 pt -126.24 160.8 33.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.869 0.366 . . . . 0.0 111.794 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.573 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -81.02 161.27 24.29 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.333 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.81 77.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.322 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -65.8 -35.62 81.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.999 0.428 . . . . 0.0 110.407 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -63.01 -40.13 96.84 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.02 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.573 HG13 ' O ' ' B' ' 20' ' ' ALA . 74.8 mt -61.52 -48.65 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.328 0.585 . . . . 0.0 110.552 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -68.72 -44.39 73.98 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.133 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 12.3 m -77.69 -56.86 4.17 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.11 -46.84 55.1 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 97.6 t -63.03 -45.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -62.92 -45.7 91.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.993 0.425 . . . . 0.0 110.695 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 20.8 m -64.42 -36.64 84.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.287 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.4 -39.91 92.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.213 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 95.1 mt -62.41 -43.24 99.3 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.714 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -70.3 -37.7 71.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.181 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.47 -41.39 96.53 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.19 -32.22 50.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.804 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.23 -40.99 94.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.021 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.03 -28.21 65.29 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.402 177.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.52 -44.35 89.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.69 -3.33 9.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.358 0.599 . . . . 0.0 109.939 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 63.67 27.48 14.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.909 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.9 pp -103.18 6.94 10.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.056 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -64.83 -29.15 70.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.951 0.405 . . . . 0.0 110.888 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.82 -2.62 82.12 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.603 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -92.98 -4.17 53.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.696 0.284 . . . . 0.0 111.533 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -87.37 128.93 35.19 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -73.78 -2.31 22.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -173.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.97 -37.23 2.84 Favored Glycine 0 C--N 1.314 -0.69 0 C-N-CA 120.473 -0.87 . . . . 0.0 114.246 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -61.26 132.48 53.75 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 117.482 0.641 . . . . 0.0 109.525 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.573 HG12 HG12 ' B' ' 54' ' ' VAL . 21.3 t 64.5 71.69 0.55 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -172.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.548 ' O ' HG13 ' B' ' 54' ' ' VAL . 59.0 Cg_endo -69.59 161.4 46.06 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.373 2.715 . . . . 0.0 113.755 -176.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.76 ' HA ' HG22 ' B' ' 54' ' ' VAL . 50.6 mtt -61.94 -33.97 75.24 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -63.14 -24.43 67.89 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.552 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 99.1 mt -95.45 -38.9 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.465 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.76 HG22 ' HA ' ' B' ' 51' ' ' MET . 10.2 m -62.46 -33.78 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.329 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.427 ' O ' ' HA3' ' B' ' 59' ' ' GLY . . . -60.33 -32.91 71.69 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.645 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -100.64 -34.05 10.04 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.688 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -65.7 -42.82 90.73 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -126.33 19.03 7.56 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.682 0.277 . . . . 0.0 110.979 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.649 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -57.21 -47.97 83.64 Favored Glycine 0 C--O 1.222 -0.629 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.281 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.8 -23.14 22.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.283 0.541 . . . . 0.0 111.683 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -62.08 -45.65 92.57 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.149 -176.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.521 ' O ' HG23 ' B' ' 66' ' ' VAL . 10.5 p -119.11 21.45 5.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.545 0.688 . . . . 0.0 110.592 -177.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.649 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 35.1 ttm180 -59.86 -26.65 66.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.737 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -63.33 -49.59 73.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.451 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ASP . . . . . 0.462 ' HB2' HG22 ' B' ' 62' ' ' VAL . 2.9 m-20 -75.84 -21.52 57.17 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.027 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.521 HG23 ' O ' ' B' ' 62' ' ' VAL . 79.6 t -63.24 -44.1 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.5 -40.39 96.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.345 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.53 -43.27 99.26 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.361 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ASP . . . . . 0.76 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 37.6 t70 -64.06 -43.63 94.89 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 117.085 0.442 . . . . 0.0 110.192 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.15 -42.64 98.92 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 110.245 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.5 ttp -60.92 -45.31 95.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.862 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -62.34 -44.69 95.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.117 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.76 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 34.2 mtp85 -66.66 -43.16 85.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.046 -176.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -65.13 -40.97 95.18 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.88 0.371 . . . . 0.0 111.073 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.3 -48.25 82.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.499 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 20.1 tt -68.51 -38.75 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.36 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.411 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 11.2 t70 -62.91 -41.92 99.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.185 0.516 . . . . 0.0 109.81 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' B' ' 81' ' ' LYS . . . -66.08 -45.57 80.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.595 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 46.0 pt -64.95 -30.67 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.99 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.59 -44.32 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.019 0.437 . . . . 0.0 110.773 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' B' ' 78' ' ' ALA . 16.4 ptpt -81.03 -28.71 35.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.633 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -81.82 -6.88 59.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.971 0.415 . . . . 0.0 110.248 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 65.5 38.87 5.36 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.509 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.421 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 84.4 mt -100.58 118.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.678 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -106.78 100.88 33.79 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.356 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 24.0 Cg_exo -63.63 139.83 71.74 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.591 2.194 . . . . 0.0 112.208 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.64 94.13 8.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.024 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.92 -125.34 7.15 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.642 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.67 127.19 27.1 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-O 120.517 0.199 . . . . 0.0 110.935 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.77 158.11 53.88 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.618 2.212 . . . . 0.0 110.98 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 54.2 m -92.2 118.84 31.26 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.189 0.518 . . . . 0.0 110.744 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.481 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.7 m-85 -98.14 125.35 43.12 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.42 102.09 42.39 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-O 120.899 0.381 . . . . 0.0 110.971 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.8 Cg_endo -96.75 -167.81 0.12 Allowed 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 123.228 2.619 . . . . 0.0 110.854 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -130.36 -176.28 14.36 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -86.06 126.89 34.51 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -85.76 127.95 34.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.095 0.474 . . . . 0.0 110.852 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 98.6 mttt -113.63 140.99 47.74 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 38.0 tp -85.56 112.06 20.59 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.16 -177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.85 -7.68 27.62 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.688 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 48.9 mt-10 -120.37 172.63 7.67 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -82.16 168.44 17.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.297 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -121.28 143.68 49.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.45 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 85.6 m -125.67 136.86 53.68 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.007 0.432 . . . . 0.0 111.601 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -134.71 154.22 51.65 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.569 ' O ' HG12 ' B' ' 107' ' ' VAL . 21.4 m -95.97 -74.17 0.57 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.569 HG12 ' O ' ' B' ' 106' ' ' SER . 0.3 OUTLIER 65.36 142.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.9 0.88 . . . . 0.0 110.251 -172.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 11' ' ' LEU . 45.2 mt-10 -119.18 130.79 55.69 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -173.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -164.62 143.67 7.1 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.759 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.66 157.19 0.06 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 m -136.04 162.29 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.75 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -161.5 106.26 1.2 Allowed Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.399 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.29 154.43 41.12 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.261 2.64 . . . . 0.0 113.923 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -127.54 142.63 51.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.078 0.951 . . . . 0.0 108.77 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 64.2 t -126.77 131.68 70.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.847 0.356 . . . . 0.0 111.746 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -110.67 -86.22 0.54 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.699 176.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 97.5 mt 59.32 121.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -137.6 157.39 46.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.147 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.48 19.63 77.85 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.909 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.91 -39.91 95.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.282 0.563 . . . . 0.0 110.672 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -74.25 -5.71 43.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.346 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -105.82 17.28 23.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.94 0.4 . . . . 0.0 110.93 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 86.9 mt -91.62 119.39 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.242 0.544 . . . . 0.0 111.199 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -108.52 122.8 47.81 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.43 135.5 57.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.625 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -78.7 138.6 38.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.568 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -133.28 97.75 16.04 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.73 121.12 6.8 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.232 1.955 . . . . 0.0 112.418 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.8 mm -105.67 116.01 48.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.859 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.405 HG21 HD21 ' B' ' 427' ' ' LEU . 27.5 m -131.82 163.49 37.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.352 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -136.51 156.77 48.12 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.96 125.84 39.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.4 p -111.89 175.08 5.57 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.458 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.02 -36.59 82.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.4 82.97 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.635 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.86 -42.09 97.63 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.367 0.604 . . . . 0.0 109.569 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.78 -45.43 98.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.517 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.3 -43.01 99.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.867 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.58 -41.94 99.75 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.449 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.567 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 3.5 tpt -62.55 -46.76 86.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.796 0.332 . . . . 0.0 110.452 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.52 -41.66 98.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.3 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.67 -44.19 96.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.318 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.9 m -62.83 -41.92 99.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.261 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.3 mt -60.9 -42.57 98.28 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -70.93 -20.44 62.47 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.451 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.68 1.28 54.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.375 0.607 . . . . 0.0 110.096 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.5 23.57 11.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.817 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -125.31 86.27 2.52 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' ALA . . . . . 0.52 ' HB3' ' OE1' ' B' ' 159' ' ' GLU . . . -131.54 159.42 38.22 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 172.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.568 HG21 ' O ' ' B' ' 247' ' ' GLU . 6.3 m -121.1 143.39 49.11 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.112 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' TRP . . . . . 0.604 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 44.7 p-90 -74.74 132.28 41.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.034 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.525 ' HG2' ' HG3' ' B' ' 153' ' ' GLU . 65.1 tttp -163.19 -64.71 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLU . . . . . 0.525 ' HG3' ' HG2' ' B' ' 152' ' ' LYS . 64.3 mt-10 -117.42 -92.6 0.52 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' B' ' 155' ' ' ASP . 22.2 tptm -94.5 -117.85 0.1 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -169.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ASP . . . . . 0.419 ' N ' ' HG3' ' B' ' 154' ' ' LYS . 14.2 t70 -147.52 154.87 41.28 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 122.923 0.489 . . . . 0.0 110.85 -174.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 166.21 -34.56 0.23 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.238 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.35 140.44 18.4 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.459 ' HA ' ' HD2' ' B' ' 243' ' ' ARG . 59.3 t -129.35 127.5 65.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.354 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 159' ' ' GLU . . . . . 0.52 ' OE1' ' HB3' ' B' ' 149' ' ' ALA . 4.7 mp0 -88.38 159.2 18.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.184 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.26 49.3 1.63 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.776 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -158.49 6.39 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.78 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.46 ' CG ' ' H ' ' B' ' 163' ' ' ARG . 13.1 t70 -102.53 -170.38 1.8 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.601 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' ARG . . . . . 0.46 ' H ' ' CG ' ' B' ' 162' ' ' ASP . 42.7 ttm180 -124.13 117.98 25.88 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.115 0.566 . . . . 0.0 110.727 -176.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.29 128.49 64.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.289 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 73.1 m -84.23 116.9 23.19 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 87.3 mt -126.27 124.52 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.126 0.489 . . . . 0.0 111.835 -176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' ASP . . . . . 0.471 ' OD2' ' HA ' ' B' ' 183' ' ' SER . 6.2 m-20 -95.24 109.35 21.48 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -127.67 150.54 49.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.444 0.64 . . . . 0.0 112.439 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.6 m -124.88 128.05 48.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.571 177.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.7 141.06 20.8 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.747 -0.74 . . . . 0.0 113.672 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 41.1 m -141.02 144.27 34.9 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 42.0 t -84.44 -83.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.94 0.4 . . . . 0.0 110.841 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -105.38 -40.58 5.77 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.18 0.514 . . . . 0.0 110.054 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.5 21.05 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.259 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -142.8 149.6 38.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 120.779 0.323 . . . . 0.0 110.404 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.41 151.49 32.73 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.976 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -120.69 -179.23 3.93 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.457 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.52 -42.54 87.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.03 -172.07 31.32 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.972 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.37 29.65 48.64 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.551 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -110.48 113.81 26.73 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -137.39 147.02 45.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.042 0.449 . . . . 0.0 111.59 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.471 ' HA ' ' OD2' ' B' ' 167' ' ' ASP . 67.8 m -146.51 129.41 16.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.313 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 58.56 31.85 21.49 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.564 0.54 . . . . 0.0 110.126 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -89.63 135.26 33.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.709 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 93.1 t -99.69 123.52 52.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.922 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.81 122.73 48.56 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.129 0.49 . . . . 0.0 111.457 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' ALA . . . . . 0.443 ' HB3' ' CZ ' ' B' ' 193' ' ' ARG . . . -111.33 111.6 22.76 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 73.9 mtm -83.86 163.69 19.93 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.303 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.54 -13.86 60.99 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.606 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -102.67 -8.22 21.09 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 79.15 48.56 6.83 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 119.928 -1.13 . . . . 0.0 111.403 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.443 ' CZ ' ' HB3' ' B' ' 188' ' ' ALA . 95.0 mtt180 -89.53 -10.35 46.5 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.405 ' CE ' ' HA ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -129.51 170.32 13.87 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.06 178.606 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.622 ' H ' HD12 ' B' ' 195' ' ' ILE . 4.1 mp -54.84 133.18 66.43 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 123.347 0.404 . . . . 0.0 110.162 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -48.55 129.93 20.95 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.359 2.04 . . . . 0.0 111.776 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.04 -32.66 6.64 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.913 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -62.27 -44.38 96.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.677 0.275 . . . . 0.0 110.639 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.75 -40.63 97.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.734 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.85 -34.8 78.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.086 0.469 . . . . 0.0 110.676 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -63.52 -26.43 69.67 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.366 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.62 -43.35 98.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 109.676 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -50.86 119.59 4.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.477 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 108.2 -10.62 36.76 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.598 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.649 ' HA ' ' OE1' ' B' ' 209' ' ' GLU . 46.6 m80 -96.2 141.09 29.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.11 0.455 . . . . 0.0 111.422 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.407 ' HG2' ' OE2' ' B' ' 209' ' ' GLU . 17.1 mmtm -100.46 166.69 10.81 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 207' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' B' ' 240' ' ' VAL . . . -61.8 131.98 51.63 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.02 27.55 70.19 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.701 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' GLU . . . . . 0.649 ' OE1' ' HA ' ' B' ' 205' ' ' HIS . 44.5 tt0 -112.27 111.7 22.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.273 0.559 . . . . 0.0 110.365 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.14 129.31 44.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.687 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -148.94 -26.51 0.3 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.492 HG22 ' HA ' ' B' ' 234' ' ' ALA . 50.8 p 60.67 160.33 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.935 0.894 . . . . 0.0 111.975 -176.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' B' ' 232' ' ' LYS . 18.9 tt -153.06 148.65 13.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 122.135 -0.353 . . . . 0.0 110.825 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -81.27 109.59 15.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.217 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 59.8 t -112.87 122.81 67.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 11.9 p -93.5 -21.62 19.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 68.12 137.4 0.05 OUTLIER Pre-proline 0 N--CA 1.482 1.142 0 CA-C-O 121.037 0.446 . . . . 0.0 111.75 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' B' ' 221' ' ' TYR . 16.5 Cg_exo -67.72 149.57 78.83 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.433 2.089 . . . . 0.0 112.006 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 219' ' ' GLU . . . . . 0.445 ' O ' ' HE2' ' B' ' 227' ' ' LYS . 75.1 mm-40 -66.71 -39.36 88.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.522 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -86.03 32.51 0.61 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.895 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 9.2 t80 -66.72 134.63 52.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -67.66 -15.32 63.59 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.459 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -101.18 105.0 16.09 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.43 ' OE1' ' HG2' ' B' ' 333' ' ' PRO . 42.1 tt0 -60.11 -33.24 71.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.672 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -66.82 -19.03 65.66 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.064 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.7 mt -121.39 0.62 10.05 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' B' ' 219' ' ' GLU . 14.9 ptmm? -68.34 119.27 12.58 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.48 0.657 . . . . 0.0 112.118 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.85 17.24 75.45 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.339 -0.846 . . . . 0.0 114.106 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -123.85 129.63 51.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.774 0.787 . . . . 0.0 111.182 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.39 153.16 29.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.005 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.96 143.55 31.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.315 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 232' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' B' ' 213' ' ' ILE . 3.9 mppt? -100.13 -14.31 18.6 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.401 ' HB3' ' H ' ' B' ' 234' ' ' ALA . 95.8 m-85 55.45 -148.67 0.48 Allowed 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.346 0.404 . . . . 0.0 111.516 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' B' ' 212' ' ' THR . . . -142.75 -69.22 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.893 0.378 . . . . 0.0 110.496 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 86.2 mt 65.89 87.25 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.992 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -92.35 -27.09 17.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.19 176.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 12.3 tp 51.65 66.92 1.05 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.806 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -66.09 -43.09 88.27 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 239' ' ' LYS . . . . . 0.427 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 29.9 mtpp -97.14 -77.78 0.49 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -173.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' B' ' 239' ' ' LYS . 87.7 t 76.62 142.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -95.3 -86.15 0.3 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -173.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -163.53 104.13 0.94 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 119.876 -0.729 . . . . 0.0 112.79 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 19.0 ttm-85 -168.72 115.1 0.63 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.954 0.407 . . . . 0.0 111.949 175.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' B' ' 152' ' ' LYS . 0.1 OUTLIER -178.31 155.4 0.9 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.688 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 46.8 tp 67.95 100.13 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 124.041 0.838 . . . . 0.0 111.343 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 246' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' B' ' 150' ' ' THR . 41.0 Cg_endo -68.15 111.3 2.43 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.523 2.149 . . . . 0.0 112.717 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 247' ' ' GLU . . . . . 0.568 ' O ' HG21 ' B' ' 150' ' ' THR . 43.1 tt0 -135.18 148.74 49.78 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.39 94.54 3.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.803 0.335 . . . . 0.0 111.173 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 22.1 p -91.09 -88.22 0.19 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.599 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -172.75 -47.97 0.02 OUTLIER 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.952 0.406 . . . . 0.0 111.218 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.97 94.77 7.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.076 0.465 . . . . 0.0 111.839 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' PHE . . . . . 0.531 ' CD1' HG23 ' B' ' 253' ' ' ILE . 51.5 p90 -164.89 -22.43 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.464 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 253' ' ' ILE . . . . . 0.531 HG23 ' CD1' ' B' ' 252' ' ' PHE . 19.6 pt -110.93 -42.39 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -82.06 -7.59 59.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.481 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -121.22 97.61 5.6 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -149.96 -59.77 0.2 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.161 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -164.61 -84.18 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.636 -1.269 . . . . 0.0 113.54 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 66.4 t -99.0 121.25 49.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.472 0.177 . . . . 0.0 111.038 -177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 57.91 -169.41 0.12 Allowed 'General case' 0 CA--C 1.547 0.831 0 O-C-N 123.975 0.797 . . . . 0.0 110.439 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -106.1 114.63 28.88 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -100.64 164.03 18.76 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.108 -1.044 . . . . 0.0 114.057 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 33.8 p -105.85 -175.43 2.79 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.68 -49.26 85.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.2 OUTLIER -85.06 -36.89 20.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 -178.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.0 -43.36 97.49 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.731 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.503 ' O ' HG23 ' B' ' 270' ' ' VAL . 49.6 tp -63.57 -43.4 97.11 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 120.612 0.244 . . . . 0.0 110.618 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -61.71 -43.01 99.67 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.786 0.327 . . . . 0.0 111.153 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.532 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.49 -44.66 86.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.064 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -67.74 -37.21 81.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.915 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.503 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.0 t -64.69 -43.08 96.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.595 0.236 . . . . 0.0 110.476 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -59.01 -46.82 87.23 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.4 ptmt -67.26 -43.66 81.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 0.0 111.62 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -64.48 -39.89 94.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.773 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.6 mmm -63.67 -42.06 98.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 110.736 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -68.97 -31.76 70.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.8 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 276' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 60.8 ttp180 -63.61 -41.78 98.28 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -65.8 -35.15 79.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.565 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 47.7 tp -61.95 -37.77 85.96 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.815 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 279' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 62.9 tttm -57.87 -44.98 86.97 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.805 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 19.4 m -61.86 -42.98 99.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.382 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.0 83.59 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.329 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.36 -44.12 98.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.795 0.331 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 283' ' ' ARG . . . . . 0.541 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.7 OUTLIER -60.14 -46.49 89.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.215 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -65.61 -40.29 92.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.523 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -60.69 -44.17 96.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.183 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.09 -44.62 91.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.177 0.513 . . . . 0.0 110.1 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.42 -48.17 82.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.856 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 74.8 p -65.01 -42.37 94.51 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -65.28 -42.88 92.72 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.025 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.63 -47.0 83.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.029 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 291' ' ' ILE . . . . . 0.459 ' O ' HG23 ' B' ' 295' ' ' VAL . 34.7 mm -64.41 -44.0 97.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.102 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -60.14 -46.19 90.49 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.925 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.24 -42.44 99.32 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.202 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.37 -41.46 96.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 291' ' ' ILE . 74.1 t -62.29 -45.33 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 O-C-N 123.114 0.259 . . . . 0.0 111.327 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -64.71 -41.95 95.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.852 0.358 . . . . 0.0 111.286 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.84 -39.65 63.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -121.7 82.92 2.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.63 94.44 9.03 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.9 tp -104.03 156.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.232 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.21 134.09 56.72 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 41.0 t -106.87 129.08 24.92 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.501 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.417 ' O ' HG13 ' B' ' 307' ' ' ILE . 50.0 Cg_exo -55.92 128.3 29.67 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.427 2.085 . . . . 0.0 111.832 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.51 85.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.195 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.32 87.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.376 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.75 -41.88 95.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.786 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 307' ' ' ILE . . . . . 0.498 ' O ' HG13 ' B' ' 311' ' ' ILE . 69.1 mt -62.03 -49.88 82.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.502 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -42.33 99.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.55 -176.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.3 m -62.99 -45.85 90.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.97 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 310' ' ' GLU . . . . . 0.677 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 63.6 mm-40 -70.86 -34.02 71.22 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.498 HG13 ' O ' ' B' ' 307' ' ' ILE . 95.2 mt -61.46 -44.29 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.836 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 35.5 t70 -63.17 -39.89 95.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.985 0.421 . . . . 0.0 110.826 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.04 -43.8 97.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.458 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 56.7 mt -62.74 -39.34 93.79 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.864 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 81.5 mtm180 -63.23 -38.92 93.05 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 316' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 87.5 mtt180 -65.49 -39.55 92.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.729 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -63.25 -43.21 98.64 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.172 0.51 . . . . 0.0 110.183 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.81 80.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.237 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 319' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -62.5 -37.06 84.54 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.769 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -62.41 -42.41 99.41 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.567 0.699 . . . . 0.0 109.691 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.16 -6.98 56.44 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.702 -177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -89.75 -3.46 58.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.885 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.62 -33.93 2.42 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.099 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 133.27 43.21 0.15 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 325' ' ' ASN . . . . . 0.476 ' HB3' ' HB1' ' B' ' 319' ' ' ALA . 42.5 t-20 -81.65 118.98 23.25 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.094 0.473 . . . . 0.0 109.861 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 326' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 2.4 tm-20 -120.53 151.28 39.59 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 5.7 ptpp? 61.66 -39.19 0.13 Allowed 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.774 1.63 . . . . 0.0 114.145 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 328' ' ' GLN . . . . . 0.472 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.3 mm100 -72.79 -11.27 60.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.349 0.595 . . . . 0.0 110.577 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -64.13 -20.91 66.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.171 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.464 HD12 HH12 ' B' ' 315' ' ' ARG . 52.3 tp -62.74 -36.88 84.47 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.077 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.14 -6.43 54.71 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.582 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.469 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 77.4 mt -68.65 149.7 97.88 Favored Pre-proline 0 C--O 1.24 0.564 0 O-C-N 122.33 -0.231 . . . . 0.0 110.85 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 333' ' ' PRO . . . . . 0.43 ' HG2' ' OE1' ' B' ' 224' ' ' GLU . 38.7 Cg_exo -60.75 145.32 99.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.851 2.367 . . . . 0.0 113.281 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 334' ' ' ARG . . . . . 0.448 HH21 ' HD2' ' B' ' 334' ' ' ARG . 24.8 ttt85 -85.78 -41.62 14.91 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.417 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -57.96 -39.62 78.57 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -172.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 336' ' ' LEU . . . . . 0.415 ' HB2' ' OE2' ' B' ' 224' ' ' GLU . 93.6 mt -89.63 -3.88 58.06 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.757 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -105.63 -25.12 12.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.983 0.42 . . . . 0.0 110.206 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.2 -26.23 66.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.909 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.34 -51.26 70.26 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 120.931 0.396 . . . . 0.0 110.548 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -73.69 -27.28 61.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.659 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.463 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -60.95 -43.6 98.48 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 342' ' ' LYS . . . . . 0.488 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.8 tttt -59.73 -45.88 90.84 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 343' ' ' ARG . . . . . 0.578 ' O ' HG23 ' B' ' 347' ' ' VAL . 11.1 mmt85 -61.44 -46.25 90.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.833 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 344' ' ' ARG . . . . . 0.48 ' NH2' HD22 ' B' ' 314' ' ' LEU . 92.0 mtt180 -67.12 -37.63 84.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 341' ' ' ALA . 69.2 t -64.99 -44.03 96.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.708 0.289 . . . . 0.0 110.374 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 342' ' ' LYS . 74.3 t -61.61 -43.97 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.765 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.578 HG23 ' O ' ' B' ' 343' ' ' ARG . 85.8 t -59.65 -45.0 94.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.14 99.42 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.382 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.55 -44.14 95.05 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.679 0.276 . . . . 0.0 111.225 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.42 ' O ' HG23 ' B' ' 354' ' ' VAL . 96.2 mt -64.2 -46.77 82.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.18 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.06 -39.75 82.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.385 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.65 -41.47 97.4 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.971 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -67.3 -36.7 82.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.979 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 354' ' ' VAL . . . . . 0.42 HG23 ' O ' ' B' ' 350' ' ' LEU . 94.3 t -61.49 -44.37 98.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.379 0.609 . . . . 0.0 109.362 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.44 -44.42 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.932 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -70.38 -46.51 63.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.927 0.394 . . . . 0.0 112.02 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 100.0 m -65.7 -42.98 90.51 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -95.14 6.24 49.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 53.02 52.13 14.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.49 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 99.2 mt -77.23 133.8 38.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.116 0.484 . . . . 0.0 111.395 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -110.71 153.33 25.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.05 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.38 109.4 14.84 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 363' ' ' ASP . . . . . 0.505 ' O ' HG23 ' B' ' 367' ' ' VAL . 18.3 t70 -81.75 110.86 17.46 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.201 0.524 . . . . 0.0 112.039 -173.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 364' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 50.8 mm-40 -59.18 -40.73 86.6 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.237 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.51 -39.75 88.84 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.481 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -62.12 -38.81 90.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 367' ' ' VAL . . . . . 0.505 HG23 ' O ' ' B' ' 363' ' ' ASP . 99.1 t -63.76 -40.09 87.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.65 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 368' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 30.2 mmmt -56.49 -44.61 80.83 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.416 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.59 97.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.031 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.52 -42.47 99.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.905 0.384 . . . . 0.0 110.739 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.51 -45.1 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.28 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.81 -37.97 87.69 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -66.58 -39.45 88.45 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.524 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.7 ttm -64.54 -40.71 96.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.171 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 375' ' ' ALA . . . . . 0.438 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -61.86 -27.01 68.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.328 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 50.6 m -75.74 -3.41 34.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.286 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -94.08 -1.25 54.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.946 0.403 . . . . 0.0 110.928 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.54 169.88 8.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.267 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.72 -40.43 87.98 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.414 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 380' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 19.6 t70 -131.69 109.64 14.54 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-O 120.914 0.388 . . . . 0.0 111.041 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 381' ' ' PRO . . . . . 0.438 ' HA ' ' HB1' ' B' ' 375' ' ' ALA . 52.0 Cg_exo -56.28 -40.63 83.47 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.967 2.445 . . . . 0.0 114.297 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -64.84 -43.16 93.94 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 15.7 pt-20 -62.59 -37.17 85.2 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.324 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.93 -42.84 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.339 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.23 -44.43 99.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.419 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 44.9 mt-10 -66.88 -44.35 81.13 Favored 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.997 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -59.1 -46.51 88.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.58 -41.9 92.36 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.673 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 60.2 p -79.37 -6.84 57.68 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 390' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 98.8 mttt -103.04 7.47 38.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.027 0.441 . . . . 0.0 110.922 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -125.32 118.91 26.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.77 -42.3 97.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.171 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.68 -50.72 72.26 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.878 0.37 . . . . 0.0 111.0 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.72 -42.68 97.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.867 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.428 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 90.3 mtp -65.38 -45.15 85.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.62 -39.96 66.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.221 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -62.53 -41.98 99.22 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.625 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 49.4 tpp -63.28 -40.86 98.57 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.743 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.485 ' HG2' HG21 ' B' ' 367' ' ' VAL . 71.1 mtm180 -65.11 -37.12 86.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.846 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.24 -44.39 96.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.414 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 94.3 t -66.0 -45.17 91.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.758 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.23 93.9 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.6 -40.47 97.04 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.313 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.82 -43.04 99.64 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.707 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 405' ' ' GLU . . . . . 0.541 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 23.4 mt-10 -64.07 -40.69 96.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.467 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -60.0 -41.53 92.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.49 -46.29 86.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.128 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 95.2 t -65.94 -43.83 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.038 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.26 -34.1 77.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.0 96.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 110.198 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.25 -42.92 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.147 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.73 -39.36 91.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.952 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -68.68 -14.75 63.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.645 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -107.45 -6.59 16.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.532 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.95 170.04 9.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.169 0.509 . . . . 0.0 111.883 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -82.85 113.71 20.66 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.35 132.32 47.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.184 0.516 . . . . 0.0 111.705 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -136.1 145.28 45.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -96.38 135.03 38.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.626 0.251 . . . . 0.0 110.361 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -140.76 132.73 27.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.923 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.03 143.3 33.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.641 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.1 t -151.69 -176.84 5.78 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.633 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 50.0 p -80.48 165.51 22.1 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.099 0.476 . . . . 0.0 111.292 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -70.04 -16.7 63.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.879 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -61.74 -41.98 98.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.149 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -70.15 -27.83 64.85 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.832 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 427' ' ' LEU . . . . . 0.405 HD21 HG21 ' B' ' 130' ' ' VAL . 10.3 mp -71.0 -24.23 62.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.068 0.461 . . . . 0.0 109.891 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.5 mmt -79.29 -9.48 59.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.909 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -77.38 80.01 3.88 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.473 0.654 . . . . 0.0 109.928 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -115.17 29.58 7.93 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.143 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -65.91 -38.17 88.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.633 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.919 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.037 -179.33 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.828 0.346 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -104.84 151.59 23.64 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.949 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.8 m -125.58 159.74 32.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.911 0.386 . . . . 0.0 111.072 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 m -86.23 106.63 17.46 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.685 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.7 137.24 27.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 34.6 tt0 -137.77 173.31 11.78 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.4 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 9.2 t -116.08 145.66 42.84 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 117.948 0.34 . . . . 0.0 111.599 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.6 m -102.87 -68.87 0.81 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -171.29 114.87 0.4 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.918 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.41 -111.94 4.59 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.718 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.34 -31.21 65.45 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 122.505 0.322 . . . . 0.0 111.456 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.55 137.07 42.09 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 116.008 -0.542 . . . . 0.0 114.127 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -141.21 157.13 45.67 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.222 0.609 . . . . 0.0 110.172 -178.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' A' ' 6' ' ' GLU . 28.8 ttm-85 -115.35 137.85 51.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.96 -86.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.456 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.2 m 49.88 84.88 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.111 0.482 . . . . 0.0 111.754 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 tp -93.32 134.4 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 120.949 0.404 . . . . 0.0 111.979 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.4 m -116.64 124.06 48.82 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.389 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 HG12 ' A' ' 24' ' ' ILE . 17.9 pt -135.28 169.02 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 122.558 0.343 . . . . 0.0 111.817 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.626 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.77 151.98 43.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.03 0.532 . . . . 0.0 111.871 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -55.79 -51.2 68.27 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.7 -36.14 83.33 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.978 0.418 . . . . 0.0 110.259 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -66.67 -35.74 80.87 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.528 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.626 HG13 ' O ' ' A' ' 20' ' ' ALA . 76.9 mt -60.33 -50.19 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 111.071 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -74.49 -42.88 58.21 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.78 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.9 m -70.44 -52.92 18.75 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.62 -44.6 66.88 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.29 -42.23 94.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.043 0.449 . . . . 0.0 110.589 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -60.78 -43.87 97.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.986 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 33' ' ' VAL . 25.4 m -63.03 -41.63 99.58 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.335 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.58 -40.44 96.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.236 0.541 . . . . 0.0 109.878 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.89 -41.91 99.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.024 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 30' ' ' SER . 12.0 p -69.16 -36.08 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.776 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -63.25 -43.48 97.87 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.13 -38.2 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.802 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.76 -47.93 81.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.61 -37.23 86.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.924 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.88 -33.81 76.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.8 t -91.43 -4.47 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-O 121.47 0.653 . . . . 0.0 109.791 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 63.5 27.2 15.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.636 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -104.41 3.95 10.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.126 0.489 . . . . 0.0 110.95 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -64.66 -34.23 77.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.426 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.63 -23.37 65.0 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.983 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -73.85 -13.57 60.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.746 0.308 . . . . 0.0 111.444 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 63.4 ttt-85 -80.75 92.18 6.01 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.268 0.556 . . . . 0.0 110.201 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.79 -43.39 98.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.005 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.99 69.98 1.25 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 115.719 1.048 . . . . 0.0 115.719 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -62.99 -41.89 99.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 54' ' ' VAL . 11.2 t -101.42 110.53 61.86 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.692 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.63 147.41 79.66 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.83 2.353 . . . . 0.0 112.066 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.522 ' HA ' HG12 ' A' ' 54' ' ' VAL . 15.3 ttt -67.11 -22.41 65.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -172.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -81.21 -8.57 59.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.872 0.368 . . . . 0.0 110.244 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.449 HD13 ' NH2' ' B' ' 193' ' ' ARG . 87.2 mt -107.74 -49.69 7.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.267 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 51' ' ' MET . 9.6 p -62.61 -40.25 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.557 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.15 94.9 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -84.91 -19.41 32.3 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.767 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' NH1' ' SD ' ' B' ' 194' ' ' MET . 61.7 ttt180 -85.65 -45.13 11.99 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.356 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -106.65 11.9 29.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.028 0.442 . . . . 0.0 110.522 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.581 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -57.39 -63.17 5.55 Favored Glycine 0 C--O 1.216 -0.978 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.181 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.55 -27.55 67.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.053 0.427 . . . . 0.0 111.631 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -61.02 -45.05 96.39 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.156 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 65' ' ' ASP . 8.3 p -131.64 21.34 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 CA-C-O 121.191 0.52 . . . . 0.0 112.098 -175.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.581 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 7.5 ttt180 -64.76 -19.98 66.1 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.628 -0.67 . . . . 0.0 111.405 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -64.77 -45.68 85.35 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.496 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.458 ' HB2' HG22 ' A' ' 62' ' ' VAL . 2.2 m-20 -73.65 -28.28 61.7 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.716 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -63.66 -44.74 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.38 -39.36 94.31 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.27 -40.77 97.83 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.043 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.76 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 29.3 t70 -62.45 -46.79 86.89 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.27 -41.88 97.69 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.911 0.386 . . . . 0.0 110.149 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 ttp -61.04 -43.96 98.11 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.6 m -62.36 -42.65 99.57 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.441 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.76 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 52.2 mtp85 -62.33 -46.49 88.49 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.751 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -65.73 -40.48 92.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.314 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.06 -48.49 81.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.668 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.4 tt -68.15 -39.1 80.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.855 0.36 . . . . 0.0 111.469 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.67 -40.36 92.3 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.234 0.54 . . . . 0.0 110.471 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.95 96.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.228 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.3 pt -67.14 -37.77 79.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.574 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.46 -44.09 98.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.082 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -75.57 -23.05 56.49 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -92.98 1.32 57.36 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.978 0.418 . . . . 0.0 110.674 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 63.38 32.79 14.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.325 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.8 mt -97.78 113.13 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -107.51 107.16 60.01 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.995 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.62 134.65 33.5 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.77 1.647 . . . . 0.0 111.315 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.52 87.17 4.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.238 0.542 . . . . 0.0 110.513 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.36 -114.8 4.54 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.804 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.29 135.2 26.73 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.25 152.17 79.81 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.705 2.27 . . . . 0.0 111.339 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.3 m -87.69 105.16 17.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.066 0.46 . . . . 0.0 111.437 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -107.65 113.78 27.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.24 96.89 48.64 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.68 145.65 26.12 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.21 1.94 . . . . 0.0 111.584 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.76 174.7 51.67 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.16 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.88 123.92 23.74 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.925 0.393 . . . . 0.0 110.23 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -86.13 133.72 33.85 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.185 0.517 . . . . 0.0 111.024 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -122.58 127.13 49.04 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.6 tp -72.42 106.53 4.57 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.132 0.492 . . . . 0.0 110.607 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.07 -8.62 14.2 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.462 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -118.37 -177.56 3.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.667 0.233 . . . . 0.0 110.73 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -76.65 160.04 29.72 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 111.269 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -126.34 138.04 53.53 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.148 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.0 m -118.08 135.71 54.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.932 0.396 . . . . 0.0 110.925 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -129.08 164.25 23.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.5 m -73.92 -83.74 0.05 OUTLIER 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.6 t 56.03 101.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.297 0.57 . . . . 0.0 111.311 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.59 126.95 34.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.28 -175.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.499 ' HB3' ' OE2' ' A' ' 110' ' ' GLU . 12.8 m-85 -127.32 -165.43 1.47 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.91 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.499 ' OE2' ' HB3' ' A' ' 109' ' ' PHE . 0.9 OUTLIER -73.12 177.97 4.7 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.048 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 305' ' ' ALA . 35.2 m -124.77 164.51 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.553 -176.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -124.9 116.48 26.16 Favored Pre-proline 0 N--CA 1.466 0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -88.56 144.43 5.57 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.895 2.396 . . . . 0.0 113.152 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -142.02 151.78 42.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.828 0.451 . . . . 0.0 109.804 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.4 t -130.44 133.06 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.896 0.379 . . . . 0.0 111.837 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -107.44 -88.24 0.47 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.746 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.0 mt 64.82 117.67 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.689 0.796 . . . . 0.0 112.481 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -137.84 150.95 47.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.492 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.14 18.65 74.04 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.944 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.77 -41.4 97.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 111.03 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.86 -3.62 23.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.252 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -106.79 17.44 23.17 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.878 0.37 . . . . 0.0 111.61 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.66 107.31 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.061 0.458 . . . . 0.0 109.952 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.32 101.73 13.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.966 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.07 133.29 36.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.935 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -87.64 124.36 33.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.456 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -122.73 96.14 45.72 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -63.92 135.61 48.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.012 1.808 . . . . 0.0 111.52 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.22 112.71 40.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.8 160.2 42.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.569 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -143.01 165.37 27.55 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.196 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.408 HG11 HH12 ' A' ' 271' ' ' ARG . 64.5 t -78.31 129.95 36.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.749 0.309 . . . . 0.0 110.435 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.5 p -112.38 176.86 4.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.772 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.09 -35.53 78.95 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 120.692 0.282 . . . . 0.0 111.623 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.15 84.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.256 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -63.43 -40.59 97.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.292 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 95.7 t -62.25 -49.54 83.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.652 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.85 -39.08 92.98 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.713 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.72 -40.63 99.05 Favored Glycine 0 C--O 1.237 0.331 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.743 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.575 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 5.1 tpt -63.28 -42.5 99.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.139 0.495 . . . . 0.0 109.795 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.9 mt -63.02 -40.11 96.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.573 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -56.65 -48.13 78.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.577 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.2 m -63.3 -40.75 98.23 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.366 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 140' ' ' MET . 85.3 mt -60.15 -42.23 94.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.818 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -79.79 -8.51 59.31 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.834 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -92.65 -12.59 31.17 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -90.92 -52.2 4.97 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.426 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -60.58 95.85 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.63 97.96 2.17 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 113.526 -1.67 . . . . 0.0 107.848 175.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 151' ' ' TRP . 0.2 OUTLIER -67.4 176.65 2.22 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.484 ' H ' HG22 ' A' ' 150' ' ' THR . 56.0 p-90 -99.88 161.85 13.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.453 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.587 ' H ' ' HA ' ' A' ' 243' ' ' ARG . 76.7 tttt -168.68 -79.59 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.758 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 242' ' ' GLU . 10.0 pt-20 -165.97 80.18 0.28 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 155' ' ' ASP . 54.8 tttt 176.65 -152.93 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.581 175.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.421 ' H ' ' HG2' ' A' ' 154' ' ' LYS . 8.9 p-10 -140.58 162.82 34.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.303 0.501 . . . . 0.0 111.054 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 119.44 -19.07 9.97 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.303 -0.951 . . . . 0.0 114.133 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -118.52 100.55 7.53 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.58 0.69 . . . . 0.0 111.947 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.8 t -132.29 136.97 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -97.79 -169.14 1.78 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.619 ' O ' ' HA3' ' A' ' 190' ' ' GLY . . . -95.6 23.99 5.64 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.775 ' HA ' ' O ' ' A' ' 189' ' ' MET . 11.1 pt-20 -158.88 27.64 0.22 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.436 0.636 . . . . 0.0 112.292 175.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 188' ' ' ALA . 13.0 m-20 -90.32 170.11 10.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.993 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 -106.96 123.7 48.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.96 128.74 74.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.805 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.4 m -78.84 106.39 10.82 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 72.1 mt -120.03 119.33 59.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.617 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -95.5 88.66 5.14 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -109.02 147.09 32.86 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.084 0.469 . . . . 0.0 111.834 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.0 m -116.78 127.42 54.32 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.45 123.69 6.37 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.172 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.8 m -140.65 128.6 21.97 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.469 HG23 ' CD2' ' A' ' 177' ' ' PHE . 98.0 t -102.89 108.93 25.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 60.34 -50.18 0.09 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.25 1.42 . . . . 0.0 114.121 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.89 -4.37 0.05 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.066 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.44 140.86 52.55 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.092 0.472 . . . . 0.0 110.956 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -79.33 156.56 27.97 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.469 ' CD2' HG23 ' A' ' 172' ' ' VAL . 35.4 p90 -125.37 169.28 12.5 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.534 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.86 -36.12 74.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.03 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.74 -177.49 33.79 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.65 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.27 22.06 61.42 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.163 -1.017 . . . . 0.0 113.322 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -100.81 112.1 24.45 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -136.26 145.69 45.88 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.986 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.6 m -140.5 125.18 18.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.423 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 55.89 30.59 16.21 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.578 0.548 . . . . 0.0 110.635 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -83.78 122.99 29.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.018 0.437 . . . . 0.0 110.397 -176.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.3 m -87.9 106.9 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.598 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.6 tp -94.55 121.54 36.22 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.184 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 193' ' ' ARG . . . -91.89 119.36 31.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.775 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 83.9 mtp -84.24 153.5 23.56 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.985 -175.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 160' ' ' ALA . . . 84.0 18.31 63.41 Favored Glycine 0 CA--C 1.505 -0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.872 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -122.54 -6.39 8.67 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.155 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.88 46.36 10.92 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.656 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 94.0 mtt180 -92.93 -6.77 47.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.475 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -131.58 167.88 18.65 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.715 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.88 134.82 92.65 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.93 129.89 18.71 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.385 2.056 . . . . 0.0 112.025 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.15 -38.97 3.04 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.358 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -65.35 -49.54 68.98 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.409 ' O ' ' HE3' ' A' ' 189' ' ' MET . 11.4 pt-20 -82.72 -9.73 59.23 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.226 0.536 . . . . 0.0 111.06 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -89.4 -32.01 17.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -74.56 -10.01 82.43 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.102 -0.953 . . . . 0.0 113.337 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.464 ' HB ' ' HE1' ' A' ' 189' ' ' MET . 44.4 mm -64.91 -42.89 96.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -53.01 125.93 18.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.629 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 101.28 -3.59 54.71 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.066 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -103.69 148.18 26.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.721 0.761 . . . . 0.0 111.991 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.17 166.17 12.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.491 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.28 120.52 19.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 89.12 17.71 55.29 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.678 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -105.01 117.37 33.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.121 0.486 . . . . 0.0 110.256 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -99.59 123.09 43.52 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.137 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -143.7 -15.44 0.63 Allowed 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 74.4 p 59.38 164.79 0.05 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 123.886 0.874 . . . . 0.0 112.596 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -146.95 142.58 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.858 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.97 109.1 16.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.047 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 49.3 t -117.55 108.23 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.148 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 21.2 m -71.9 -44.42 63.73 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 216' ' ' THR . 54.8 m-85 78.73 148.49 0.12 Allowed Pre-proline 0 N--CA 1.495 1.799 0 C-N-CA 123.241 0.617 . . . . 0.0 110.763 -174.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -72.0 153.79 57.85 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.708 2.272 . . . . 0.0 111.905 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.585 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 51.7 mm-40 -65.86 -39.11 90.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.419 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -95.58 39.0 1.13 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.252 0.549 . . . . 0.0 110.935 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -71.67 147.13 47.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.208 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -62.62 -19.65 63.98 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -101.6 117.04 34.09 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.545 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 2.2 tp10 -63.0 -32.7 74.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.992 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.5 -5.96 58.57 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -176.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 84.8 mt -117.81 -11.66 10.3 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.487 -0.485 . . . . 0.0 112.08 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.598 ' NZ ' HD13 ' A' ' 336' ' ' LEU . 18.4 ptmt -68.77 122.23 18.15 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.194 0.521 . . . . 0.0 112.205 -176.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.76 13.3 78.48 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.129 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.49 117.49 29.61 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.471 -0.429 . . . . 0.0 110.487 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -68.57 133.65 48.84 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.965 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -114.61 159.31 20.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.714 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -99.29 -33.11 10.86 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 53.05 99.17 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -73.85 91.88 2.01 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.143 0.497 . . . . 0.0 110.241 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.5 mm -95.18 115.4 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -112.76 -36.64 5.11 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.278 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.3 mt 67.76 152.96 0.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.265 0.626 . . . . 0.0 111.813 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -110.85 -80.64 0.58 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.665 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -111.79 -31.23 7.02 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 18.3 t 59.15 46.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 121.843 0.83 . . . . 0.0 109.528 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 60.7 -102.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.595 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . 15.2 pt-20 178.7 103.56 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.817 0.847 . . . . 0.0 108.964 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.587 ' HA ' ' H ' ' A' ' 152' ' ' LYS . 11.1 ptm180 -157.52 122.88 4.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -179.42 165.83 1.42 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.1 mt 72.64 109.02 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.028 0.531 . . . . 0.0 111.509 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.22 117.64 3.52 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.784 2.323 . . . . 0.0 114.37 -176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.38 -179.26 5.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.646 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.5 mp -91.38 128.5 37.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.081 0.467 . . . . 0.0 111.548 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 9.3 m -136.16 142.15 44.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.43 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.79 92.11 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.12 50.5 0.21 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.327 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -132.68 -58.57 0.92 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.881 0.372 . . . . 0.0 110.8 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 261' ' ' GLY . 36.9 pt -68.97 -22.13 26.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.577 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -105.55 5.72 31.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.4 0.619 . . . . 0.0 109.923 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -111.61 -1.84 15.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.531 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -98.3 116.51 30.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.15 -173.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 51.03 -109.38 0.73 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 175.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.13 136.92 55.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.057 0.543 . . . . 0.0 110.707 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 260' ' ' ASP . 2.4 tp10 66.43 -160.16 0.25 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ASP . . . . . 0.42 ' H ' ' HG3' ' A' ' 259' ' ' GLU . 4.9 p-10 -133.95 134.75 42.93 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.627 ' O ' ' HB ' ' A' ' 253' ' ' ILE . . . -125.65 158.25 19.92 Favored Glycine 0 C--N 1.316 -0.563 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.74 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 11.8 p -82.19 -179.43 7.4 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.665 0.386 . . . . 0.0 110.958 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.89 -47.76 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.255 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.38 -31.86 15.88 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.758 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.55 -44.24 96.87 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.042 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 270' ' ' VAL . 40.5 tp -64.78 -41.93 95.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -61.64 -43.1 99.5 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.366 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.39 -40.82 96.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.912 0.387 . . . . 0.0 110.586 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -66.63 -41.75 87.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.376 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 266' ' ' LEU . 85.7 t -63.75 -42.77 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.408 HH12 HG11 ' A' ' 132' ' ' VAL . 9.4 tpt180 -55.69 -47.6 76.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.301 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 0.1 OUTLIER -70.27 -40.89 74.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -64.53 -41.25 96.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.687 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 95.1 mmm -65.04 -41.63 95.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.628 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.41 -34.86 78.11 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.815 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.56 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 53.4 ttp180 -63.65 -43.64 96.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.393 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -68.32 -34.68 76.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.048 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.413 ' O ' HG13 ' A' ' 282' ' ' ILE . 50.2 tp -62.62 -37.94 88.26 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.56 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 50.7 tttm -55.98 -46.78 78.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.165 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.9 m -62.37 -40.89 97.91 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.708 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.59 -42.71 99.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.929 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 278' ' ' LEU . 64.1 mt -65.35 -43.29 94.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.828 0.347 . . . . 0.0 110.482 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.549 ' HD2' ' OE2' ' A' ' 405' ' ' GLU . 1.1 tpm_? -58.96 -44.52 91.5 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.392 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.24 -42.74 96.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.224 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -61.86 -44.47 96.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.946 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.49 -44.69 86.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.008 0.432 . . . . 0.0 110.749 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.0 tttt -61.6 -47.18 86.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.539 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.7 p -62.31 -41.08 98.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.23 -41.78 94.06 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.762 0.315 . . . . 0.0 110.791 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.37 -48.26 76.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.039 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 287' ' ' LYS . 49.4 mm -63.2 -47.91 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.513 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.548 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 26.4 tp10 -61.87 -43.02 99.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.097 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.29 -42.93 93.83 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.702 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.81 -44.49 96.03 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.54 -44.79 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.256 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LYS . . . . . 0.548 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 64.0 mttm -61.63 -40.52 95.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.582 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.3 80.84 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.719 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -126.45 101.47 6.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -94.78 113.85 25.67 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.4 tp -119.75 153.26 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.502 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -61.75 142.68 57.12 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.952 0.406 . . . . 0.0 110.515 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 54.2 t -120.83 126.28 26.74 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.644 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.1 131.94 48.36 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.216 1.944 . . . . 0.0 111.715 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.72 -38.23 89.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.066 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ALA . . . . . 0.406 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -56.87 -44.2 82.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.023 0.439 . . . . 0.0 111.402 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.63 -41.8 95.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.446 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 311' ' ' ILE . 68.6 mt -61.75 -48.17 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.73 -46.15 84.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.159 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 48.9 m -61.03 -44.95 96.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.685 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.424 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 56.1 mm-40 -71.42 -35.35 70.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.45 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 94.3 mt -62.42 -44.42 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.69 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 13.1 t70 -64.32 -40.98 97.0 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.268 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.61 -43.94 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.978 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 96.9 mt -62.37 -41.99 99.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.684 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.495 HH12 HD12 ' A' ' 330' ' ' LEU . 79.8 mtm180 -63.59 -39.56 94.7 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.084 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 66.6 mtt180 -64.34 -40.29 95.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.261 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -64.61 -42.64 95.39 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.291 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.47 -38.43 81.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.516 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.24 -34.92 79.21 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.979 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' GLN . . . . . 0.412 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 52.3 tt0 -60.25 -37.11 79.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.408 0.623 . . . . 0.0 109.852 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -79.11 -7.56 58.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.593 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -100.8 2.29 41.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 135.4 -3.56 3.99 Favored Glycine 0 CA--C 1.509 -0.344 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.114 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 93.9 28.97 10.26 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.638 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.505 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 45.8 t-20 -70.82 130.6 42.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.975 0.417 . . . . 0.0 110.622 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.0 tm-20 -129.95 158.25 40.06 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 6.7 ptpp? 60.04 -40.06 0.09 Allowed 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 125.682 1.593 . . . . 0.0 114.473 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.505 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 15.6 mm100 -73.0 -12.7 61.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.382 0.611 . . . . 0.0 109.806 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.45 -17.55 62.81 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.762 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.495 HD12 HH12 ' A' ' 315' ' ' ARG . 56.4 tp -61.59 -32.29 72.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.252 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.88 -15.39 60.21 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.756 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.485 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 89.9 mt -66.59 138.07 95.41 Favored Pre-proline 0 C--O 1.238 0.488 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.953 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.78 119.21 6.08 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.344 2.696 . . . . 0.0 113.593 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.446 ' HG3' HD13 ' A' ' 311' ' ' ILE . 21.5 ttt180 -63.07 -45.37 92.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.356 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 0.9 OUTLIER -66.14 -18.61 65.46 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.401 -173.138 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.598 HD13 ' NZ ' ' A' ' 227' ' ' LYS . 85.7 mt -94.2 -5.76 46.28 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -117.35 -2.32 11.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.408 0.623 . . . . 0.0 109.731 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.444 ' HG3' HD11 ' A' ' 311' ' ' ILE . 40.5 tt0 -83.34 -16.69 45.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.534 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.92 -48.74 67.73 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.045 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -74.65 -24.72 58.86 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.197 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -60.27 -44.87 94.95 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.499 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.3 tttt -60.38 -46.91 88.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.427 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.52 ' O ' HG23 ' A' ' 347' ' ' VAL . 20.3 mmt85 -62.51 -44.22 96.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -66.29 -38.62 88.19 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.721 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 76.1 t -64.2 -44.1 97.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.753 0.311 . . . . 0.0 110.335 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.52 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 75.6 t -61.5 -43.29 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.644 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 343' ' ' ARG . 72.1 t -59.92 -44.44 94.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.21 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.55 -41.2 99.52 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.98 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 91.1 mt -63.1 -43.8 97.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.955 0.407 . . . . 0.0 111.095 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.0 mt -62.8 -47.36 83.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.122 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.99 -39.44 83.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.852 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.63 -43.27 96.31 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.541 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -68.18 -37.91 81.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.356 0.578 . . . . 0.0 111.042 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.06 -45.79 97.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.74 -44.2 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.018 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -66.07 -49.79 66.39 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.912 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.4 m -66.74 -44.16 82.25 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -82.19 -4.35 56.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.853 0.359 . . . . 0.0 111.063 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 60.02 38.22 20.83 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.347 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.38 152.92 39.46 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.098 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -129.29 158.96 37.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.108 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -81.48 105.6 12.78 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 367' ' ' VAL . 26.6 t70 -81.18 114.47 20.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.169 0.509 . . . . 0.0 112.257 -173.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.543 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 66.4 mm-40 -62.02 -37.3 84.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.255 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 63.4 mm-40 -61.92 -45.74 92.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.286 0.565 . . . . 0.0 110.179 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -63.07 -39.15 93.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.074 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 363' ' ' ASP . 93.2 t -62.96 -40.82 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.784 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.2 mmmt -57.77 -44.13 85.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.413 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.92 -38.79 97.16 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.767 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.79 -42.19 99.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.05 0.452 . . . . 0.0 110.014 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.19 -43.39 97.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.961 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.66 -44.11 97.1 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -65.63 -39.09 91.08 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.533 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 55.7 ttm -65.09 -42.87 93.66 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.096 0.474 . . . . 0.0 110.967 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 377' ' ' ALA . . . -63.31 -31.35 72.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.562 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 37.4 m -73.68 23.84 0.07 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.939 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' A' ' 375' ' ' ALA . . . -123.43 0.72 8.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.737 0.303 . . . . 0.0 110.765 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.47 175.33 5.47 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.576 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -59.29 -42.22 90.77 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.835 0.35 . . . . 0.0 110.824 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -134.06 116.17 13.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.476 ' O ' HG13 ' A' ' 385' ' ' ILE . 51.4 Cg_endo -69.5 -31.99 20.55 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.272 1.982 . . . . 0.0 113.702 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -66.62 -43.76 83.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.48 -35.02 79.66 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.576 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.82 -42.66 97.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.244 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 381' ' ' PRO . 74.5 mt -61.19 -46.72 96.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.461 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 43.0 mt-10 -65.33 -43.46 90.89 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.82 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -57.0 -46.87 81.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.832 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.439 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 3.5 t80 -64.89 -42.31 94.89 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.204 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 65.4 p -76.06 -10.44 59.42 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 99.6 mttt -98.35 6.3 47.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.024 0.44 . . . . 0.0 111.005 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 24.2 t-20 -130.64 111.8 12.54 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.854 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -63.38 -36.6 84.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.239 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' GLU . . . . . 0.407 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 25.7 tp10 -56.95 -53.15 61.31 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.96 0.409 . . . . 0.0 110.283 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.68 -41.21 98.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.597 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.489 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 87.8 mtp -62.07 -46.74 87.75 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 120.836 0.35 . . . . 0.0 111.708 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.61 -39.55 64.49 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.076 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -63.36 -40.6 97.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.439 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 46.7 tpp -64.68 -40.27 95.11 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.982 0.42 . . . . 0.0 110.742 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 395' ' ' MET . 70.1 mtm180 -63.38 -33.4 75.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.092 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.6 -44.28 97.3 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.17 -45.52 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.177 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.7 99.54 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.496 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 46.3 tp -64.82 -37.61 88.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.422 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.01 -46.29 82.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.716 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.549 ' OE2' ' HD2' ' A' ' 283' ' ' ARG . 26.6 mt-10 -65.26 -38.69 91.1 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.634 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -60.5 -43.35 97.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.303 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.95 -45.36 89.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.433 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 96.2 t -63.89 -46.56 93.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.274 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -68.49 -30.56 69.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.897 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.39 98.93 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.48 -43.32 96.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.033 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.5 mt -61.95 -39.0 90.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.251 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.98 -33.05 72.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.963 0.411 . . . . 0.0 110.896 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -89.08 -10.94 45.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.846 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -93.65 176.94 6.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.295 0.569 . . . . 0.0 112.348 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -93.05 112.34 24.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.291 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.42 129.45 51.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.03 0.443 . . . . 0.0 110.945 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.5 t -118.27 139.95 50.56 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.858 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -105.29 120.05 40.6 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -137.31 145.01 42.93 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.712 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.86 148.4 26.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.98 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.9 t -150.34 177.95 9.48 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.046 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 19.7 p -86.41 159.96 19.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.991 0.424 . . . . 0.0 111.474 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -66.8 -33.37 75.47 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.2 0.524 . . . . 0.0 110.742 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 428' ' ' MET . 6.6 m-20 -60.74 -37.17 80.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.514 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.25 -32.66 74.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.558 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.16 -17.7 61.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.943 0.401 . . . . 0.0 110.474 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 425' ' ' ASN . 5.7 mmt -74.95 -8.05 55.35 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.167 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -76.72 75.8 3.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -103.73 15.25 29.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.057 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -63.89 -42.02 97.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.375 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.705 -0.664 . . . . 0.0 110.757 -179.65 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 CA--C 1.513 -0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -94.74 158.08 15.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.922 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.53 158.76 43.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.692 0.282 . . . . 0.0 110.718 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 6.4 m -86.09 107.34 17.78 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.491 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.51 138.45 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.978 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.535 ' HG2' ' H ' ' B' ' 7' ' ' THR . 25.1 tt0 -137.53 177.77 7.61 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.535 ' H ' ' HG2' ' B' ' 6' ' ' GLU . 13.1 t -118.09 152.13 36.18 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.89 0.376 . . . . 0.0 111.272 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 75.3 m -110.62 -70.74 0.79 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.074 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -168.03 111.16 0.61 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.022 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.23 -108.37 2.02 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.073 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.09 -31.92 68.42 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 122.462 0.305 . . . . 0.0 111.236 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.24 139.18 39.67 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 116.005 -0.543 . . . . 0.0 114.021 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 0.0 OUTLIER -142.17 161.23 38.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.466 0.706 . . . . 0.0 110.049 -178.157 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' B' ' 6' ' ' GLU . 32.0 ttm-85 -119.86 138.45 53.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 39.8 t -106.03 -86.94 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.343 176.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 17.9 m 51.1 87.29 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.331 0.586 . . . . 0.0 111.458 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 tp -94.16 136.91 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.941 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 91.7 m -117.33 121.51 41.34 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.101 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.536 HG13 HG12 ' B' ' 24' ' ' ILE . 14.3 pt -135.31 165.88 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.611 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.79 151.11 47.37 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.456 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -54.01 -53.03 58.58 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -173.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -65.42 -36.13 83.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.091 0.472 . . . . 0.0 110.441 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.9 m -63.65 -38.23 90.34 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.561 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.611 HG13 ' O ' ' B' ' 20' ' ' ALA . 74.9 mt -59.15 -51.04 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 111.21 -177.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -73.01 -42.59 63.05 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.856 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -67.61 -52.38 39.1 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.42 -44.59 67.6 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.78 -43.06 96.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.734 0.302 . . . . 0.0 111.307 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -61.7 -44.92 96.01 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.082 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.449 ' O ' HG12 ' B' ' 33' ' ' VAL . 19.6 m -63.92 -40.83 97.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.638 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -62.6 -41.84 99.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.031 0.443 . . . . 0.0 110.454 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.48 -41.61 98.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.086 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.449 HG12 ' O ' ' B' ' 30' ' ' SER . 9.9 p -67.99 -36.5 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.316 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -63.47 -42.78 98.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.232 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.03 -36.97 77.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.335 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.77 -48.1 80.64 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.105 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.68 -36.96 85.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.906 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.48 -34.63 75.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.666 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.46 -7.52 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.368 0.604 . . . . 0.0 109.707 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 65.91 27.84 10.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.865 0.866 . . . . 0.0 111.57 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.01 3.53 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.325 0.583 . . . . 0.0 111.001 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -65.4 -32.83 74.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.072 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -7.4 58.01 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.69 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -89.04 -6.83 56.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.834 0.35 . . . . 0.0 110.35 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 65.9 ttt-85 -87.58 91.66 8.82 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.054 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -63.17 -43.58 97.85 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.61 72.66 0.7 Allowed Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 115.997 1.159 . . . . 0.0 115.997 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.92 -43.17 98.97 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 171.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.82 112.52 63.93 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.775 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -57.41 147.49 77.51 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 111.912 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.551 ' HA ' HG12 ' B' ' 54' ' ' VAL . 19.7 ttt -67.38 -24.75 65.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.543 -172.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -77.63 -10.24 59.4 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.447 HD13 ' CZ ' ' A' ' 193' ' ' ARG . 81.5 mt -108.26 -47.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.488 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' B' ' 51' ' ' MET . 12.4 p -62.89 -38.88 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.032 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.8 92.21 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -88.41 -9.22 53.35 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.052 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.44 ' NH1' ' SD ' ' A' ' 194' ' ' MET . 62.2 ttt180 -97.36 -41.47 8.22 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.238 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.61 9.87 27.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.965 0.412 . . . . 0.0 109.893 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -57.57 -63.84 4.92 Favored Glycine 0 C--O 1.211 -1.343 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.115 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.63 -27.76 66.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.978 0.389 . . . . 0.0 111.748 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.3 t -61.61 -45.09 95.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.797 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.428 HG22 ' O ' ' B' ' 62' ' ' VAL . 7.6 p -131.0 21.39 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 120.996 0.427 . . . . 0.0 111.902 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.59 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 6.7 ttt180 -64.65 -21.49 66.74 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.782 -0.574 . . . . 0.0 110.914 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -62.08 -50.3 72.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.64 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' B' ' 62' ' ' VAL . 1.1 m-20 -73.6 -25.0 60.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.1 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.93 -43.74 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.1 -39.67 95.38 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.37 -40.3 97.36 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.634 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ASP . . . . . 0.764 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 30.6 t70 -61.29 -46.15 91.51 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.67 -42.31 98.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.495 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 60.2 ttp -61.94 -42.4 99.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -62.54 -42.85 99.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.764 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 52.3 mtp85 -63.32 -44.98 93.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.535 -176.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -65.31 -41.33 94.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.228 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -61.3 -48.05 83.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.763 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.14 -39.07 80.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.885 0.374 . . . . 0.0 111.117 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.73 -41.24 96.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.186 0.517 . . . . 0.0 110.532 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.51 -46.42 86.16 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.989 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 41.1 pt -65.35 -38.0 81.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.85 -43.62 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.126 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -76.77 -26.26 54.3 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -88.19 3.26 49.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.399 . . . . 0.0 110.793 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 63.9 28.38 14.55 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.125 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.2 mt -94.29 114.68 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -112.09 104.36 55.96 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.01 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.53 140.77 64.32 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.175 1.917 . . . . 0.0 111.695 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.54 96.32 7.3 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.857 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.29 -112.48 4.48 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.789 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.81 139.04 31.12 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.502 0.151 . . . . 0.0 110.657 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' PRO . . . . . 0.491 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 55.7 Cg_endo -68.48 155.89 67.5 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.629 2.219 . . . . 0.0 111.29 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -90.06 99.01 12.1 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.938 0.399 . . . . 0.0 111.558 -175.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.491 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 66.8 m-85 -102.95 110.96 23.07 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.4 t -115.83 98.83 51.79 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.95 145.97 25.5 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.359 2.039 . . . . 0.0 111.958 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.76 171.9 45.62 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.131 -1.033 . . . . 0.0 110.898 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.5 123.14 20.5 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.057 0.456 . . . . 0.0 110.597 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -84.44 134.19 34.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.261 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -121.78 122.11 38.77 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 46.3 tp -69.76 106.48 3.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.975 0.417 . . . . 0.0 110.716 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.98 -18.35 9.05 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.486 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -110.27 -175.33 2.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -79.7 164.42 23.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.934 0.397 . . . . 0.0 111.707 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -131.18 141.74 50.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.459 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.2 m -120.05 133.78 55.43 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.912 0.387 . . . . 0.0 111.118 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -125.28 165.28 18.6 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.139 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.9 m -75.5 -82.76 0.07 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 46.8 t 54.27 103.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 122.955 0.502 . . . . 0.0 111.315 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -88.33 123.5 32.97 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' PHE . . . . . 0.494 ' HB3' ' OE1' ' B' ' 110' ' ' GLU . 13.7 m-85 -123.36 -167.47 1.62 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.769 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.494 ' OE1' ' HB3' ' B' ' 109' ' ' PHE . 1.0 OUTLIER -72.37 176.34 5.4 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -176.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' B' ' 305' ' ' ALA . 32.1 m -125.43 166.14 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.473 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' B' ' 113' ' ' PRO . 69.9 m-85 -123.61 121.06 26.74 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.796 -178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 112' ' ' TYR . 73.8 Cg_endo -90.97 134.77 1.8 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 122.87 2.38 . . . . 0.0 113.136 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -135.42 144.79 46.7 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.36 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 76.5 t -126.2 134.22 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -107.52 -86.98 0.49 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.861 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 85.0 mt 62.52 120.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.197 0.999 . . . . 0.0 113.553 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -140.18 153.07 46.5 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.948 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.68 21.85 73.73 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.584 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.55 -40.67 95.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.964 0.411 . . . . 0.0 111.486 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.55 -8.73 57.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.363 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.96 8.19 44.33 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 64.7 mt -88.4 108.8 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.197 0.522 . . . . 0.0 110.089 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.36 103.95 15.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.505 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.02 133.08 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.21 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -85.57 122.96 30.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.44 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -120.78 97.08 48.59 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -69.49 130.24 19.32 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.578 1.519 . . . . 0.0 111.823 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -102.69 115.39 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 24.2 m -132.78 159.46 43.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.299 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.43 160.72 37.9 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 66.8 t -76.25 127.7 37.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 41.3 p -105.27 173.46 6.3 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.814 0.34 . . . . 0.0 110.194 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -67.56 -25.49 65.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.162 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.55 -40.36 96.79 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.122 0.487 . . . . 0.0 109.891 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -63.66 -40.8 97.75 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.026 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.0 t -61.75 -48.43 88.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.414 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.32 -38.42 90.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.901 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.7 -40.95 99.46 Favored Glycine 0 C--O 1.237 0.294 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.565 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 4.1 tpt -63.27 -41.84 99.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.15 0.5 . . . . 0.0 109.826 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 87.2 mt -63.16 -40.31 97.19 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.801 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -58.98 -46.88 87.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.568 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.7 m -63.39 -41.1 98.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' B' ' 140' ' ' MET . 89.5 mt -60.56 -42.86 97.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.718 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -79.07 -8.71 59.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.773 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -94.86 -5.46 44.95 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -97.73 -55.82 2.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.149 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' B' ' 148' ' ' GLN . 8.1 mm-40 -58.09 96.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.07 106.55 3.64 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.901 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.608 HG22 ' H ' ' B' ' 151' ' ' TRP . 0.2 OUTLIER -73.07 175.13 6.99 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -173.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 151' ' ' TRP . . . . . 0.608 ' H ' HG22 ' B' ' 150' ' ' THR . 53.2 p-90 -99.43 161.21 13.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.526 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.588 ' H ' ' HA ' ' B' ' 243' ' ' ARG . 76.6 tttt -170.98 -81.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.584 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' B' ' 242' ' ' GLU . 11.8 pt-20 -164.24 76.16 0.33 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.462 ' HG2' ' H ' ' B' ' 155' ' ' ASP . 49.7 tttt 178.06 -160.79 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ASP . . . . . 0.462 ' H ' ' HG2' ' B' ' 154' ' ' LYS . 12.2 p-10 -135.38 163.05 30.91 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 117.996 0.362 . . . . 0.0 111.153 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 119.87 -18.97 9.71 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.182 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -115.36 100.23 7.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 117.393 0.596 . . . . 0.0 112.174 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 55.0 t -130.26 136.34 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' GLU . . . . . 0.5 ' HB2' ' OD2' ' B' ' 162' ' ' ASP . 3.4 mm-40 -95.6 -170.58 2.18 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.164 0.507 . . . . 0.0 111.899 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' ALA . . . . . 0.648 ' O ' ' HA3' ' B' ' 190' ' ' GLY . . . -98.94 24.32 7.87 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 161' ' ' GLU . . . . . 0.791 ' HA ' ' O ' ' B' ' 189' ' ' MET . 13.4 pt-20 -158.85 25.27 0.22 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.34 0.591 . . . . 0.0 112.422 175.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' B' ' 188' ' ' ALA . 12.8 m-20 -87.81 170.7 10.97 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.398 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -108.15 121.13 44.22 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.3 t -116.74 128.26 74.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.251 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 20.7 m -76.75 104.88 7.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.97 117.99 56.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.002 0.43 . . . . 0.0 111.393 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.95 88.44 5.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -109.14 150.92 27.14 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.332 0.587 . . . . 0.0 112.182 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 46.3 m -119.97 128.28 53.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.937 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.9 114.09 3.89 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.488 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 39.2 m -131.94 124.19 28.93 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' VAL . . . . . 0.537 HG23 ' CD2' ' B' ' 177' ' ' PHE . 93.9 t -100.14 106.77 19.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 35.2 t70 67.6 -75.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.939 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -145.37 9.95 1.72 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.608 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -132.48 139.02 47.79 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.521 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.13 148.25 26.22 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' PHE . . . . . 0.537 ' CD2' HG23 ' B' ' 172' ' ' VAL . 31.9 p90 -115.84 171.41 7.79 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.442 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -59.39 -36.83 76.54 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.62 -174.45 33.82 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.04 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.73 24.31 60.53 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.991 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -103.56 106.58 17.13 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -124.73 144.78 50.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.194 0.521 . . . . 0.0 112.144 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 42.9 m -138.35 119.55 14.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.843 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 55.01 31.11 15.43 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 123.587 0.555 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -81.17 124.54 29.34 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.441 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.72 107.48 18.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.763 0.792 . . . . 0.0 110.708 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 55.1 tp -95.08 122.17 37.46 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.6 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 188' ' ' ALA . . . . . 0.578 ' HB3' ' CZ ' ' B' ' 193' ' ' ARG . . . -92.1 116.69 29.16 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 189' ' ' MET . . . . . 0.791 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 54.1 mtp -84.54 154.28 22.76 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.91 -175.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.648 ' HA3' ' O ' ' B' ' 160' ' ' ALA . . . 89.28 4.31 74.32 Favored Glycine 0 CA--C 1.501 -0.831 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.71 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -111.33 -4.33 14.96 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.312 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.27 47.65 8.91 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.018 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.578 ' CZ ' ' HB3' ' B' ' 188' ' ' ALA . 96.2 mtt180 -95.47 -3.62 46.47 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.288 0.566 . . . . 0.0 109.568 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.455 ' SD ' ' NH1' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -134.54 168.74 18.42 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.942 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 43.7 mm -61.74 135.46 94.34 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.25 129.5 19.14 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.356 2.037 . . . . 0.0 111.85 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.44 -36.63 4.28 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.343 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -67.31 -50.95 58.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.33 0.565 . . . . 0.0 112.015 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 199' ' ' GLU . . . . . 0.456 ' O ' ' HE3' ' B' ' 189' ' ' MET . 10.5 pt-20 -81.48 -10.95 59.37 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.005 0.431 . . . . 0.0 111.427 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -90.72 -25.86 19.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.153 0.502 . . . . 0.0 109.705 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.21 -10.93 85.98 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.143 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.5 mm -64.27 -43.0 97.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -55.41 114.6 1.89 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.905 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 115.03 -9.11 21.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.923 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -99.4 146.64 26.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 117.319 0.56 . . . . 0.0 112.158 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.49 168.84 11.53 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.007 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.34 129.28 37.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 78.29 33.36 40.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.68 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -119.77 118.94 32.19 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.913 0.387 . . . . 0.0 110.378 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -101.67 116.62 33.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.284 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -138.29 -16.21 1.23 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 62.7 p 59.66 167.86 0.07 Allowed 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 123.712 0.805 . . . . 0.0 112.844 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -151.17 144.21 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.968 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -80.21 110.91 16.07 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.687 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 43.1 t -118.77 105.5 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 21.0 m -71.99 -43.54 64.93 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' B' ' 216' ' ' THR . 66.3 m-85 76.67 146.91 0.12 Allowed Pre-proline 0 N--CA 1.488 1.449 0 C-N-CA 123.044 0.538 . . . . 0.0 110.748 -174.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.7 153.82 68.74 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.788 2.325 . . . . 0.0 111.863 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 219' ' ' GLU . . . . . 0.515 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 65.0 mm-40 -66.7 -38.12 86.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.236 0.541 . . . . 0.0 110.069 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -94.49 40.8 1.09 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.62 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -75.15 143.88 43.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.154 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -60.96 -17.63 52.66 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.39 118.48 36.85 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.441 ' HA ' ' CD ' ' B' ' 227' ' ' LYS . 5.2 tp10 -61.86 -33.23 73.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.856 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -88.96 -5.11 58.2 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 87.7 mt -117.93 -14.72 10.02 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.029 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.668 ' NZ ' HD13 ' B' ' 336' ' ' LEU . 19.7 ptmt -63.96 122.58 16.86 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.121 0.486 . . . . 0.0 111.884 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.58 9.94 66.05 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.097 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -110.92 120.4 42.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.197 0.498 . . . . 0.0 110.485 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -72.51 134.45 45.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.871 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.56 156.52 26.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.659 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.25 -31.68 13.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 51.59 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -74.52 95.4 2.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.509 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm -96.53 114.64 33.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.57 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -108.46 -31.59 7.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.212 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.2 mt 65.5 170.41 0.21 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.407 0.683 . . . . 0.0 111.382 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -128.62 -79.61 0.57 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.122 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -115.42 -31.13 6.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.4 ' O ' HG12 ' B' ' 240' ' ' VAL . 17.1 t 59.89 41.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 122.13 0.967 . . . . 0.0 109.085 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 63.67 -101.1 0.09 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.765 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.538 ' HB2' ' HA ' ' B' ' 153' ' ' GLU . 9.5 pt-20 179.9 96.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.962 0.905 . . . . 0.0 109.095 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.588 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 10.5 ptm180 -152.19 120.94 6.51 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -173.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 179.46 164.89 1.02 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 98.2 mt 70.85 112.17 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.985 0 CA-C-O 121.285 0.564 . . . . 0.0 111.617 -176.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.37 118.18 2.54 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.527 2.151 . . . . 0.0 114.471 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -144.64 167.23 23.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.501 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.82 134.68 38.99 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.045 0.45 . . . . 0.0 112.19 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 8.0 m -138.07 154.91 49.23 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -79.44 -36.49 38.81 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.808 0.337 . . . . 0.0 111.642 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -75.6 56.41 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.758 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -136.09 -56.92 0.77 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.937 0.399 . . . . 0.0 110.498 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 253' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' B' ' 261' ' ' GLY . 36.4 pt -68.86 -22.81 26.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.163 0.506 . . . . 0.0 110.92 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -105.85 7.83 32.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.666 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -115.12 -1.06 13.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.391 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -99.66 116.75 32.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.208 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 46.59 -115.86 2.08 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 83.2 t -113.65 136.51 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.522 0.729 . . . . 0.0 110.926 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 259' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' B' ' 260' ' ' ASP . 3.0 tp10 69.18 -173.05 0.18 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 260' ' ' ASP . . . . . 0.449 ' H ' ' HG3' ' B' ' 259' ' ' GLU . 5.1 p-10 -125.98 117.99 24.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 261' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' B' ' 253' ' ' ILE . . . -103.2 162.27 16.08 Favored Glycine 0 C--N 1.316 -0.552 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.174 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 12.0 p -85.37 -178.99 6.87 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.72 -47.98 90.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.918 0.389 . . . . 0.0 111.065 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.1 -32.02 17.73 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.782 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.02 -42.35 96.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.533 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.507 ' O ' HG23 ' B' ' 270' ' ' VAL . 47.5 tp -64.33 -42.4 96.3 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.633 0.216 . . . . 0.0 110.435 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -60.86 -44.64 96.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.638 0.256 . . . . 0.0 111.155 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.16 -41.23 97.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.003 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -69.4 -38.79 78.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.507 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.1 t -63.83 -42.0 94.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -53.15 -54.83 30.09 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.498 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 12.7 ptmt -64.59 -42.61 95.48 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -63.65 -40.71 97.53 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.473 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.6 -41.41 92.82 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.195 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -66.68 -35.08 79.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.949 0.404 . . . . 0.0 110.883 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 276' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 56.3 ttp180 -62.78 -42.63 99.78 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.385 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.34 -37.29 83.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.985 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.23 -37.81 86.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.541 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 279' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 52.5 tttm -56.34 -45.94 80.17 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.37 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 42.5 m -61.83 -41.0 97.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.592 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.2 -44.91 96.53 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.158 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.35 -44.22 98.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.285 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 283' ' ' ARG . . . . . 0.453 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.5 OUTLIER -60.41 -44.88 95.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 178.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -64.44 -41.87 96.31 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.672 0.272 . . . . 0.0 110.927 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -61.48 -44.64 96.73 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.099 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.15 -43.27 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.988 0.423 . . . . 0.0 110.582 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.43 -47.72 84.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.806 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 73.7 p -61.94 -41.55 98.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.738 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -64.53 -44.83 89.59 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.824 0.345 . . . . 0.0 111.073 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.38 78.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.535 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 291' ' ' ILE . . . . . 0.428 ' O ' HG23 ' B' ' 295' ' ' VAL . 37.5 mm -64.09 -44.24 97.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.734 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 292' ' ' GLU . . . . . 0.512 ' HG3' ' HE2' ' B' ' 296' ' ' LYS . 30.6 tp10 -62.91 -45.11 94.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.513 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.43 95.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.7 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.404 HD13 HD13 ' B' ' 350' ' ' LEU . 1.8 tt -62.81 -43.15 99.56 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 291' ' ' ILE . 98.8 t -66.28 -43.38 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.075 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.512 ' HE2' ' HG3' ' B' ' 292' ' ' GLU . 64.3 mttm -62.21 -39.22 92.05 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.593 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.24 -37.71 66.28 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.364 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -125.45 98.53 5.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.06 115.28 27.95 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -120.28 153.64 23.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.475 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.13 142.25 58.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.151 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.85 127.42 26.0 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.207 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.5 134.0 60.56 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.568 2.179 . . . . 0.0 111.896 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.37 87.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.808 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 305' ' ' ALA . . . . . 0.433 ' HB2' HG11 ' B' ' 111' ' ' VAL . . . -57.46 -42.75 83.14 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.474 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.65 -41.75 95.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.286 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.2 -47.45 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.114 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.12 -47.54 80.85 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.258 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 48.4 m -60.29 -44.79 95.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.897 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 310' ' ' GLU . . . . . 0.474 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 67.0 mm-40 -71.81 -36.69 70.33 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.552 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 92.7 mt -61.94 -44.22 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.085 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.498 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 15.0 t70 -63.34 -42.52 98.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.906 0.384 . . . . 0.0 110.322 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.34 -43.85 98.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.23 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 92.9 mt -61.91 -41.23 97.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.762 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 82.6 mtm180 -63.88 -38.64 91.83 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.141 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 316' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 62.0 mtt-85 -64.25 -40.69 96.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.926 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.1 -43.03 96.59 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.455 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.84 76.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.971 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.18 77.36 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.965 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 320' ' ' GLN . . . . . 0.436 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 8.1 tt0 -60.99 -34.22 74.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.332 0.587 . . . . 0.0 110.019 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -82.08 -9.22 59.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.121 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -97.09 -0.58 46.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.688 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 323' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 135.38 0.52 3.33 Favored Glycine 0 C--O 1.226 -0.403 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.85 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 324' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 90.98 29.57 12.6 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.875 -1.155 . . . . 0.0 111.822 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 325' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 42.5 t-20 -71.6 125.38 26.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.126 0.489 . . . . 0.0 111.136 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 326' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 3.0 tm-20 -124.5 157.13 36.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 6.6 ptpp? 60.12 -38.67 0.09 Allowed 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 125.882 1.673 . . . . 0.0 114.681 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 328' ' ' GLN . . . . . 0.435 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.2 mm100 -75.24 -10.02 59.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.19 0.519 . . . . 0.0 110.362 177.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -65.88 -12.73 56.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.353 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.519 HD12 HH12 ' B' ' 315' ' ' ARG . 62.6 tp -61.62 -34.8 76.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.883 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -76.98 -11.59 59.82 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.808 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.464 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 84.3 mt -66.92 134.76 94.03 Favored Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.621 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -49.93 122.26 8.79 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.445 2.763 . . . . 0.0 113.69 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 334' ' ' ARG . . . . . 0.482 ' HG3' HD13 ' B' ' 311' ' ' ILE . 21.9 ttt180 -65.37 -44.56 87.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.018 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -68.38 -17.35 64.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.58 -172.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 336' ' ' LEU . . . . . 0.668 HD13 ' NZ ' ' B' ' 227' ' ' LYS . 92.1 mt -93.53 -5.86 48.07 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -117.36 -11.83 10.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.688 0.756 . . . . 0.0 109.767 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.98 -21.99 61.5 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.944 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -65.4 -48.64 72.14 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.907 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -75.18 -25.82 58.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.681 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.433 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -59.06 -44.95 91.88 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.506 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 342' ' ' LYS . . . . . 0.472 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.7 tttt -60.37 -45.25 94.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.255 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 343' ' ' ARG . . . . . 0.467 ' O ' HG23 ' B' ' 347' ' ' VAL . 18.4 mmt85 -62.68 -43.75 98.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -64.97 -38.83 92.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 121.189 -0.204 . . . . 0.0 111.059 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 341' ' ' ALA . 81.5 t -64.49 -44.14 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.436 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.512 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 70.3 t -61.8 -43.98 98.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.467 HG23 ' O ' ' B' ' 343' ' ' ARG . 74.0 t -59.83 -45.21 95.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.676 0.274 . . . . 0.0 110.496 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.37 -41.25 99.76 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.805 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.5 -43.2 99.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' B' ' 346' ' ' VAL . 96.2 mt -62.91 -46.43 87.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.021 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.5 -39.31 85.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.776 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.95 -45.63 93.48 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.409 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -68.84 -37.29 79.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.218 0.509 . . . . 0.0 111.234 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.24 -46.25 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.7 -44.29 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.547 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -65.89 -50.07 65.8 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 97.3 m -65.79 -45.97 80.46 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -81.9 -7.22 59.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.694 0.283 . . . . 0.0 111.547 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 63.22 45.03 5.29 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.162 0.506 . . . . 0.0 111.317 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.01 155.95 28.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.977 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -132.22 158.65 41.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.5 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -84.85 102.48 13.12 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 363' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 26.1 t70 -81.69 118.6 22.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 364' ' ' GLU . . . . . 0.594 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 54.8 mm-40 -61.59 -39.07 89.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.299 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 365' ' ' GLU . . . . . 0.552 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 63.4 mm-40 -58.44 -48.04 82.01 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.271 0.557 . . . . 0.0 110.275 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -62.36 -40.3 95.98 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.275 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 367' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 363' ' ' ASP . 97.1 t -63.56 -41.52 92.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.036 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 368' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 29.8 mmmt -56.97 -44.61 82.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.777 0.322 . . . . 0.0 110.135 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.38 -38.38 96.3 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.103 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.84 -42.27 99.67 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.288 0.566 . . . . 0.0 110.153 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.84 -43.31 97.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.529 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -61.33 -44.19 97.62 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -66.68 -40.0 88.37 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.937 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 55.6 ttm -64.63 -42.57 95.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.964 0.412 . . . . 0.0 110.75 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.81 -29.2 70.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.256 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 44.3 m -70.37 -7.28 41.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.955 0.407 . . . . 0.0 111.581 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.12 -2.5 58.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.441 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -108.98 174.26 5.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.053 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.62 -44.45 89.99 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.316 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -132.34 113.99 14.6 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -67.61 -30.43 35.04 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.332 2.021 . . . . 0.0 113.373 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.96 -44.35 80.76 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.69 -34.73 78.89 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.933 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.85 -43.02 97.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.438 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.37 -44.86 99.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.89 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 49.9 mt-10 -66.14 -45.0 82.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.124 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -57.1 -46.78 82.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.939 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 388' ' ' TYR . . . . . 0.433 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 4.4 t80 -63.52 -44.37 94.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.887 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 77.4 p -72.56 -14.12 61.56 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 390' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.1 mttt -94.46 5.82 50.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.893 0.377 . . . . 0.0 111.697 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -131.39 113.87 14.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.167 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -63.63 -37.11 86.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -56.91 -51.25 69.84 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.774 0.321 . . . . 0.0 110.533 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.83 -41.02 97.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.901 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 93.4 mtp -60.83 -51.77 67.9 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -72.69 -36.15 67.8 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.369 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.63 -41.03 98.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.988 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 398' ' ' MET . . . . . 0.433 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 50.1 tpp -63.74 -40.79 97.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.631 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.442 ' HG2' HG21 ' B' ' 367' ' ' VAL . 25.8 mtm180 -62.89 -34.3 77.13 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.745 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -61.02 -45.32 95.29 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.768 0.318 . . . . 0.0 110.452 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.49 -44.99 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.07 0.462 . . . . 0.0 110.791 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.22 97.46 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.645 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.75 -36.92 85.45 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.658 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 404' ' ' GLU . . . . . 0.419 ' O ' HG23 ' B' ' 408' ' ' VAL . 36.3 tt0 -58.86 -43.9 90.93 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.648 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 405' ' ' GLU . . . . . 0.453 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 32.2 mt-10 -65.23 -40.55 94.21 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.559 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -58.37 -44.34 88.83 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.559 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.39 -42.5 96.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 408' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 89.3 t -64.8 -46.29 92.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -67.53 -31.5 71.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.312 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.68 98.08 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.855 0.359 . . . . 0.0 110.107 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 95.9 t -66.51 -42.5 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.864 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 89.6 mt -61.56 -40.15 93.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.091 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.51 -21.79 65.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.564 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -102.06 -2.56 29.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.895 0.378 . . . . 0.0 110.952 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -101.66 173.14 6.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.147 0.499 . . . . 0.0 111.704 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -88.95 114.06 25.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.425 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.22 127.03 53.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.336 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 10.1 t -118.83 131.71 56.09 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.141 0.496 . . . . 0.0 109.92 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -98.62 113.26 25.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.662 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -129.02 146.67 50.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.846 0.355 . . . . 0.0 110.464 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -89.88 146.4 24.44 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.42 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -147.99 -175.67 4.98 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.342 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 67.6 p -94.78 159.92 14.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.33 . . . . 0.0 111.37 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.76 -34.29 77.99 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.05 0.453 . . . . 0.0 110.752 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -58.97 -39.18 80.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.409 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.0 -31.48 72.06 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 120.871 0.367 . . . . 0.0 110.854 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.21 -16.94 61.4 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.852 0.358 . . . . 0.0 110.529 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.3 mmt -75.95 -8.54 57.18 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.086 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -75.72 72.17 2.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -101.12 9.95 41.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.302 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -62.2 -46.62 88.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.917 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.623 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.104 -179.904 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.0 mtt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -66.36 120.33 13.13 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.643 0.735 . . . . 0.0 112.782 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.11 174.87 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.631 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 11.7 p -76.42 -170.71 1.57 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.958 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 4' ' ' SER . 0.6 OUTLIER 87.48 143.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.775 0.83 . . . . 0.0 111.901 177.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -140.74 156.35 46.21 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 m -88.56 129.24 35.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.9 0.381 . . . . 0.0 111.79 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.2 m -88.42 -70.59 0.63 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.069 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -166.27 122.16 1.25 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.891 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.12 -106.16 1.24 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.078 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.8 mt -92.91 -7.91 44.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.615 0.245 . . . . 0.0 110.976 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.524 ' O ' ' HD3' ' A' ' 13' ' ' ARG . . . -81.56 137.9 18.17 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.241 -0.504 . . . . 0.0 114.23 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.524 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -134.12 148.22 50.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.062 0.945 . . . . 0.0 110.84 179.347 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -110.81 137.96 47.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.4 t -96.73 -83.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.665 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 p 25.06 93.91 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.0 tp -123.56 139.76 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.871 0.367 . . . . 0.0 111.965 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.2 p -68.99 139.43 55.0 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.688 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.472 HD13 HG12 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -126.79 141.61 45.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -174.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.641 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -75.51 148.73 38.74 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.073 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -57.15 -40.22 76.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -175.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.55 -3.58 47.53 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.878 0.37 . . . . 0.0 111.449 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -105.71 -25.63 12.14 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.914 0.388 . . . . 0.0 110.624 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.641 HG13 ' O ' ' A' ' 20' ' ' ALA . 74.8 mt -60.56 -49.37 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.153 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.411 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 71.4 mm-40 -102.23 3.47 38.3 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -175.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.7 m -96.66 -72.14 0.65 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.265 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.84 89.0 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.403 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 99.1 t -62.87 -45.34 99.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.879 0.371 . . . . 0.0 111.132 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 20.2 ttmm -63.15 -45.58 91.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.7 m -62.72 -39.71 94.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.194 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.5 tp10 -66.23 -40.55 90.34 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.53 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.8 mt -62.28 -43.11 99.58 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.34 -39.11 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.908 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -65.48 -38.29 89.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.244 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 31' ' ' GLU . 96.0 t -62.46 -42.13 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 110.369 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.29 -41.81 94.17 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 110.223 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.87 -30.75 71.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.096 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 35' ' ' VAL . 24.5 ttmm -57.78 -41.94 83.08 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.171 0.588 . . . . 0.0 110.255 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 t -89.29 -4.48 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.005 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 64.96 33.9 9.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.646 0.778 . . . . 0.0 111.178 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.73 13.03 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.921 0.391 . . . . 0.0 111.741 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.99 -32.75 74.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.351 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.5 -3.4 58.1 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.148 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -86.47 -6.68 58.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.917 0.389 . . . . 0.0 110.834 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.9 ttt-85 -91.61 108.16 19.71 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.812 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.12 -39.49 92.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.635 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.95 29.66 22.61 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.254 -0.974 . . . . 0.0 114.757 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -60.98 -44.69 97.0 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.05 110.06 56.84 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.476 ' O ' HG13 ' A' ' 54' ' ' VAL . 53.1 Cg_exo -56.85 141.5 92.89 Favored 'Trans proline' 0 N--CA 1.477 0.557 0 C-N-CA 122.762 2.308 . . . . 0.0 112.135 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.503 ' HA ' HG22 ' A' ' 54' ' ' VAL . 16.1 ttt -68.33 -27.76 66.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -172.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -72.35 -17.4 61.84 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.095 0.474 . . . . 0.0 110.151 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.524 HD13 ' NH2' ' B' ' 193' ' ' ARG . 84.3 mt -99.75 -34.6 4.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.864 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' A' ' 51' ' ' MET . 21.4 m -60.76 -40.15 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 120.917 0.389 . . . . 0.0 111.012 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.77 -25.94 65.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -94.16 -32.5 13.7 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.066 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.425 HH12 HD13 ' B' ' 187' ' ' LEU . 15.3 tpp180 -64.68 -41.55 95.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.767 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.61 22.5 14.96 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.644 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.75 147.96 49.84 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.835 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.71 -39.69 0.45 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.468 0.707 . . . . 0.0 112.487 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 t -60.68 -47.93 84.04 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 122.678 0.391 . . . . 0.0 111.956 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.8 p -118.29 10.58 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.288 0.566 . . . . 0.0 110.733 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -60.31 -38.81 84.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.481 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 27.2 tt0 -60.08 -45.9 91.37 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.987 0.422 . . . . 0.0 110.83 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -68.1 -34.07 75.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.242 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 62' ' ' VAL . 79.2 t -60.9 -33.82 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 109.714 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 98.0 mt -61.68 -38.77 89.04 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.77 -40.27 99.0 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.498 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.91 -45.31 93.12 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.971 0.415 . . . . 0.0 110.915 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.34 -42.17 98.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.2 ttp -61.27 -46.31 90.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.316 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.3 m -64.4 -53.01 55.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.448 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -69.55 -39.44 77.42 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -65.12 -40.51 94.59 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.486 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -61.43 -48.42 81.24 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.406 ' O ' HG13 ' A' ' 79' ' ' ILE . 16.3 tt -67.78 -39.73 82.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 120.71 0.29 . . . . 0.0 111.154 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.37 -42.75 99.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.157 0.504 . . . . 0.0 110.699 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.98 87.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.309 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.7 pp -68.44 -31.13 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.12 -44.47 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.334 0.588 . . . . 0.0 110.655 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -82.93 -18.96 38.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.888 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -88.14 -7.7 56.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.325 0.583 . . . . 0.0 109.551 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 67.51 35.96 3.98 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.149 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.2 mt -100.37 116.16 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -103.35 105.44 46.65 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.455 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.92 142.89 83.84 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.403 2.069 . . . . 0.0 111.382 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.04 99.24 9.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.046 0.45 . . . . 0.0 110.836 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.08 -104.31 3.16 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.88 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.15 130.41 9.28 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.492 0.187 . . . . 0.0 110.728 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.93 154.03 37.88 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.39 2.06 . . . . 0.0 110.97 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -99.48 120.15 39.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.138 0.494 . . . . 0.0 110.49 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.464 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 97.2 m-85 -97.81 97.5 9.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.621 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.15 107.66 39.41 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.377 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 85.2 Cg_endo -89.01 157.84 5.84 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.907 2.405 . . . . 0.0 111.089 175.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.04 178.41 33.27 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.494 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.3 112.88 9.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.272 0.558 . . . . 0.0 110.038 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -79.35 127.55 32.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.522 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -107.42 119.98 40.91 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.12 117.74 9.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.015 0.436 . . . . 0.0 110.676 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.81 -5.79 54.09 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.665 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -119.97 179.59 4.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.695 0.283 . . . . 0.0 110.764 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -72.44 157.24 38.01 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 111.254 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -123.03 136.63 54.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.934 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.8 m -120.59 137.04 54.62 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.746 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -140.29 167.8 21.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.56 0.344 . . . . 0.0 111.066 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.2 m -78.31 -86.84 0.06 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.2 t 57.21 97.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.299 0.571 . . . . 0.0 110.117 -172.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -100.82 136.04 41.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -157.7 167.42 30.14 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.802 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -52.39 145.21 11.61 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -173.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.4 m -137.89 165.27 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.904 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -121.1 103.97 41.77 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -89.03 160.4 5.88 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.074 2.516 . . . . 0.0 113.531 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.08 138.85 52.71 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.28 141.62 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.636 0.255 . . . . 0.0 111.103 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -108.68 142.21 39.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.674 0.273 . . . . 0.0 110.98 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.3 mt -118.97 146.25 45.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -134.41 147.07 50.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 111.172 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.08 14.79 80.07 Favored Glycine 0 C--N 1.33 0.227 0 N-CA-C 114.273 0.469 . . . . 0.0 114.273 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.77 -38.2 90.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.177 0.513 . . . . 0.0 110.851 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.3 mp0 -73.0 -8.25 54.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.807 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.39 11.07 39.83 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.917 0.389 . . . . 0.0 111.398 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.449 ' CD1' HD21 ' A' ' 294' ' ' LEU . 75.0 mt -88.95 125.64 42.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.2 119.53 38.67 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.7 t -112.19 132.6 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 111.432 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -88.57 140.66 29.23 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.538 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -130.19 106.46 16.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -68.61 118.05 5.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.059 1.839 . . . . 0.0 111.419 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -104.2 109.48 27.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.97 161.07 40.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.558 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -133.66 166.24 23.06 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.25 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.88 113.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.4 p -95.97 173.23 7.54 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.199 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.6 -32.6 73.63 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.887 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.23 -41.93 97.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.421 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.5 -39.73 95.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.831 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.79 -46.05 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.261 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -45.1 94.9 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.545 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.65 99.61 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.083 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.601 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.2 tpt -60.9 -47.41 86.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.673 0.273 . . . . 0.0 110.765 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.7 -42.0 98.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.43 -45.31 94.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.0 m -63.39 -40.75 98.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.849 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.4 mt -61.14 -40.08 92.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.162 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -74.68 -9.99 59.1 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 110.805 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.59 9.51 43.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.52 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -118.62 27.11 9.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.892 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -138.86 106.69 5.65 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.12 150.06 36.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.791 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 151' ' ' TRP . 0.2 OUTLIER -118.17 -176.44 3.06 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.002 -176.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.572 ' H ' HG22 ' A' ' 150' ' ' THR . 57.7 p-90 -108.66 145.04 35.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -161.67 -71.01 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.41 -127.76 0.25 Allowed 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.289 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.486 ' HE3' ' HG2' ' A' ' 242' ' ' GLU . 9.6 ptpp? -143.25 144.04 31.98 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.236 0.925 . . . . 0.0 113.426 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 156' ' ' GLY . 12.1 t70 -164.95 -151.51 0.15 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.573 ' HA3' ' HD3' ' A' ' 206' ' ' LYS . . . -104.51 59.95 0.44 Allowed Glycine 0 CA--C 1.509 -0.32 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.311 -178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.4 115.8 14.44 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.17 129.28 70.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.437 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -84.5 158.54 20.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.022 0.439 . . . . 0.0 111.962 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.4 28.7 0.24 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.74 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -170.03 21.11 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.633 0.773 . . . . 0.0 109.045 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.474 ' CG ' ' HE ' ' A' ' 243' ' ' ARG . 46.1 t0 -64.45 -42.32 96.04 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 55.7 ttp180 68.85 86.85 0.13 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.445 HG13 ' H ' ' A' ' 241' ' ' GLU . 48.9 t -113.88 131.86 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.875 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.4 m -67.93 106.8 2.43 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 86.4 mt -118.12 130.22 73.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -174.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -101.5 109.15 20.91 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.422 0.63 . . . . 0.0 109.551 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -137.29 154.43 50.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.065 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 37.3 m -127.15 131.97 50.64 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.266 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -69.46 125.22 17.17 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.983 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.3 m -138.67 131.01 28.61 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.2 t -79.78 -77.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -114.47 -60.78 1.84 Allowed 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -144.99 22.95 1.94 Allowed Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -132.57 143.91 50.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -94.1 146.61 23.85 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -111.96 173.46 6.35 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.448 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.17 -38.08 75.95 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.28 -178.45 37.2 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.045 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.38 22.63 56.27 Favored Glycine 0 C--N 1.319 -0.381 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.895 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.89 99.32 9.51 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -119.91 138.77 53.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.163 0.506 . . . . 0.0 111.743 -176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 m -142.3 122.5 13.83 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.368 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 60.06 31.68 20.7 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.459 0.475 . . . . 0.0 110.843 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -90.72 121.09 32.31 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.836 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.7 m -91.02 114.39 28.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.5 0.666 . . . . 0.0 110.464 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.44 HD13 HH12 ' B' ' 57' ' ' ARG . 61.4 tp -101.74 116.05 31.87 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.391 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.71 ' HB3' ' NH1' ' A' ' 193' ' ' ARG . . . -99.96 102.64 14.07 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 50.4 mtm -75.32 171.33 14.4 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.054 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.57 5.64 71.6 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.159 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -118.03 -8.21 10.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 120.787 0.327 . . . . 0.0 111.062 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 75.4 47.47 12.57 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.215 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.71 ' NH1' ' HB3' ' A' ' 188' ' ' ALA . 49.8 mtm180 -104.79 6.29 33.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.443 0.64 . . . . 0.0 111.06 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.518 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -128.75 159.47 35.58 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.183 173.062 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.456 HG13 ' CE2' ' A' ' 217' ' ' PHE . 43.6 mm -54.78 131.75 65.85 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.12 123.6 5.34 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.706 2.27 . . . . 0.0 112.32 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.95 -37.33 3.88 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.36 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -62.39 -48.2 80.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.93 0.365 . . . . 0.0 111.887 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.54 -9.33 59.3 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -93.11 -27.94 16.63 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.274 0.559 . . . . 0.0 110.063 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.48 -16.43 73.73 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.629 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.52 -43.01 98.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -57.95 114.73 2.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.31 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 114.71 2.26 22.6 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.48 -0.866 . . . . 0.0 113.596 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -111.06 146.52 36.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.156 0.478 . . . . 0.0 111.593 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.573 ' HD3' ' HA3' ' A' ' 156' ' ' GLY . 75.4 mmtt -83.97 165.02 18.99 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.877 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.03 111.2 3.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.715 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 84.45 35.01 15.02 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.235 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -111.86 127.2 55.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.13 0.49 . . . . 0.0 111.641 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -92.28 142.48 27.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.58 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.434 ' O ' ' HB ' ' A' ' 212' ' ' THR . 75.4 t80 -159.48 -30.89 0.06 Allowed 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 35.5 m 78.46 142.06 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.623 0.369 . . . . 0.0 110.905 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.3 tp -138.28 127.54 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 121.062 0.458 . . . . 0.0 111.229 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -79.79 107.09 12.29 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.461 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 67.8 t -112.34 114.22 46.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.279 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 14.0 m -72.88 -41.61 64.5 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -176.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.544 ' HB2' ' O ' ' A' ' 216' ' ' THR . 68.7 m-85 80.81 143.45 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 123.539 0.736 . . . . 0.0 110.935 -174.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.68 152.44 53.35 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.437 2.091 . . . . 0.0 112.099 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -65.39 -35.68 81.68 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -87.34 23.98 1.73 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.648 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 8.3 t80 -67.94 133.71 49.56 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.044 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -67.95 -18.49 64.77 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.462 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -88.81 102.5 15.08 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 175.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.504 ' OE2' HD12 ' A' ' 336' ' ' LEU . 42.6 tt0 -57.05 -33.26 67.06 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.663 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -78.07 -11.39 59.91 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 90.2 mt -121.12 -4.7 9.51 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 21.8 ptmt -68.1 116.65 8.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.173 0.511 . . . . 0.0 111.71 -177.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.2 21.85 70.42 Favored Glycine 0 C--O 1.24 0.526 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.033 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -121.92 112.16 17.96 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.4 142.98 57.41 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -174.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -127.94 144.08 51.1 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.782 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -100.58 -31.79 11.08 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 61.85 126.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -81.32 -40.94 22.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.769 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.2 mm 67.97 129.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.847 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -107.08 -67.38 0.95 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.453 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 98.0 mt 62.31 94.39 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -100.66 -37.87 8.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.136 0.493 . . . . 0.0 110.045 174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 24.0 mmtm -95.4 -88.43 0.26 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 92.0 t 73.39 126.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.585 0.553 . . . . 0.0 110.197 -173.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.445 ' H ' HG13 ' A' ' 164' ' ' VAL . 42.9 mt-10 -73.8 -179.48 3.68 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.486 ' HG2' ' HE3' ' A' ' 154' ' ' LYS . 42.3 mt-10 -113.97 112.4 23.24 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -168.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 8.9 ptp180 -148.41 143.89 27.09 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.751 167.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -172.95 156.79 3.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 4.9 tt 69.77 109.26 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.199 0.6 . . . . 0.0 111.315 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -86.42 120.23 1.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.594 2.196 . . . . 0.0 112.743 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -147.18 177.57 9.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.984 0.421 . . . . 0.0 110.451 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 248' ' ' LEU . 5.8 mp -93.06 78.1 4.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.238 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.419 ' OG1' HG21 ' A' ' 150' ' ' THR . 7.2 m -92.12 -63.16 1.27 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.882 0.372 . . . . 0.0 111.392 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -162.05 -32.1 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.045 0.45 . . . . 0.0 110.805 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -72.08 0.5 9.39 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.215 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -103.38 -26.1 13.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.173 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 44.8 pt -103.66 -8.28 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -171.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -159.61 7.22 0.1 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 119.526 -0.87 . . . . 0.0 113.089 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -120.61 135.82 54.99 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.574 0.226 . . . . 0.0 110.445 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -177.09 36.81 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 81.0 20.3 65.48 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.6 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 24.9 t -127.7 160.04 37.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -57.47 -50.9 71.56 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.033 0.444 . . . . 0.0 110.23 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -176.68 156.74 1.48 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.846 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -170.92 174.75 44.74 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.058 -1.067 . . . . 0.0 112.674 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.6 p -98.03 -173.86 2.71 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 122.716 0.406 . . . . 0.0 110.233 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 14.8 t -70.4 -71.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 111.191 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.518 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.1 pm0 -70.19 -37.02 75.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.866 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.5 -39.65 97.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.079 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 63.8 tp -63.25 -43.8 97.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.489 0.185 . . . . 0.0 110.995 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -62.62 -42.74 99.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.957 0.408 . . . . 0.0 110.282 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.54 -45.61 82.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.44 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 30.8 tp10 -66.34 -39.81 89.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.864 0.364 . . . . 0.0 110.974 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.01 -43.7 96.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.25 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.405 HH21 ' HD3' ' A' ' 271' ' ' ARG . 9.0 tpt180 -59.17 -48.56 81.14 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.03 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.8 ptmt -64.89 -44.32 90.02 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 111.198 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -65.12 -37.57 87.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.955 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 89.4 mmm -61.93 -42.85 99.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.825 0.345 . . . . 0.0 110.224 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.37 -32.14 69.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 55.3 ttp180 -63.45 -42.0 98.63 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -65.56 -35.8 81.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.855 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 44.2 tp -61.44 -36.78 81.32 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.905 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 58.1 tttm -54.81 -47.96 73.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.862 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 20.1 m -63.83 -42.44 97.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.037 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.39 -49.4 77.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.318 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 86.1 mt -64.02 -43.02 97.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.471 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -45.12 93.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.219 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -65.41 -41.37 93.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.26 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.492 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.8 tpm_? -60.83 -44.13 97.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.785 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.3 t -68.88 -44.42 81.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.93 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.509 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.1 tttt -61.99 -48.44 80.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.82 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.8 p -63.62 -42.36 98.19 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.95 -39.56 90.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.204 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.03 93.95 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.851 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 287' ' ' LYS . 48.6 mm -65.11 -44.22 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.2 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.487 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 16.0 tp10 -60.02 -42.66 94.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.51 -45.82 92.03 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.709 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.449 HD21 ' CD1' ' A' ' 123' ' ' ILE . 26.5 mt -62.86 -42.17 99.65 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.8 -43.78 96.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.716 0.293 . . . . 0.0 110.849 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LYS . . . . . 0.487 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 67.9 mttm -62.77 -41.92 99.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.037 0.446 . . . . 0.0 110.936 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.03 -46.01 65.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.917 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -123.91 100.39 6.73 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -95.86 113.7 25.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.7 tp -122.11 156.96 26.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.17 120.07 11.41 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.978 0.418 . . . . 0.0 110.057 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.86 128.12 42.75 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.449 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.448 ' O ' HG13 ' A' ' 307' ' ' ILE . 49.9 Cg_exo -55.6 129.92 37.69 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.654 2.236 . . . . 0.0 112.215 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.22 86.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.021 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.79 -45.46 82.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.011 0.434 . . . . 0.0 111.026 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.36 -41.88 93.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.988 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.505 ' O ' HG13 ' A' ' 311' ' ' ILE . 73.4 mt -61.54 -49.85 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.472 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.09 -42.73 99.51 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 30.1 m -62.23 -45.52 92.98 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.5 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.466 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 65.6 mm-40 -71.01 -35.0 71.88 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 307' ' ' ILE . 94.7 mt -61.94 -43.16 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.629 0.252 . . . . 0.0 111.117 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.541 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.8 t70 -59.53 -44.26 93.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.55 -42.9 96.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.127 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 84.4 mt -62.09 -40.68 96.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.541 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.8 mtm180 -61.27 -42.43 98.62 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -64.19 -38.64 91.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.916 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -62.84 -42.72 99.85 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.159 0.505 . . . . 0.0 110.116 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.1 80.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.201 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.33 -37.05 86.14 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.225 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -63.62 -37.92 89.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.306 0.574 . . . . 0.0 109.646 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.94 -7.81 57.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.864 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -97.4 -0.9 45.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.246 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.06 7.61 2.25 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.168 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.18 38.84 8.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.479 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.433 ' HB3' ' HB1' ' A' ' 319' ' ' ALA . 25.7 t-20 -84.6 135.23 34.28 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.874 0.369 . . . . 0.0 111.137 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.79 162.92 33.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.401 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.1 OUTLIER 71.9 -54.21 0.68 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.102 0.561 . . . . 0.0 111.178 -178.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.08 -17.78 63.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.84 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.58 -22.49 45.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.78 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.08 -34.6 76.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.546 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 331' ' ' GLU . 36.3 tt0 -85.88 10.19 14.61 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.672 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 77.9 mt -82.68 149.37 60.25 Favored Pre-proline 0 C--O 1.239 0.52 0 O-C-N 122.008 -0.433 . . . . 0.0 110.737 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.406 ' O ' ' HD1' ' A' ' 337' ' ' PHE . 40.4 Cg_exo -56.5 124.39 16.14 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.114 2.543 . . . . 0.0 113.111 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -70.43 -43.3 70.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.536 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -58.54 -40.59 83.41 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -170.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.504 HD12 ' OE2' ' A' ' 224' ' ' GLU . 60.7 mt -86.41 -0.32 55.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 333' ' ' PRO . 47.5 m-85 -107.45 -29.33 9.29 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -65.48 -32.49 74.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.252 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.87 -50.27 74.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -77.92 -21.86 50.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.55 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -62.45 -40.93 98.2 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.016 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.464 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.2 tttt -59.79 -45.02 93.6 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.201 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.3 mmt85 -61.68 -46.33 90.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.737 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -66.74 -37.51 84.79 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.466 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 341' ' ' ALA . 73.2 t -64.8 -43.64 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.607 0.241 . . . . 0.0 110.406 176.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 342' ' ' LYS . 76.1 t -61.48 -41.77 91.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 343' ' ' ARG . 69.1 t -58.64 -44.77 90.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.3 -40.31 98.84 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.181 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.46 -44.38 94.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 110.934 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.2 mt -63.44 -48.5 77.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.883 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.86 -41.07 87.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.488 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.73 99.81 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.254 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.38 -35.83 78.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.643 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 350' ' ' LEU . 70.4 t -61.05 -44.9 99.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.21 -45.44 98.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -67.46 -51.72 48.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.0 m -65.33 -46.86 78.6 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -83.68 -5.97 59.32 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.351 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 61.23 55.52 2.95 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.095 0.474 . . . . 0.0 111.622 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 97.1 mt -88.85 160.19 17.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.459 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -140.88 155.61 46.28 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.901 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -75.42 104.98 6.22 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 367' ' ' VAL . 29.6 t70 -79.08 119.35 22.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.979 0.418 . . . . 0.0 111.341 -175.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 44.7 mm-40 -61.87 -42.74 99.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.347 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -64.89 -43.34 93.2 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.79 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 40.1 ttt85 -60.64 -42.93 97.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.238 0.542 . . . . 0.0 109.649 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.456 HG21 ' HG2' ' A' ' 399' ' ' ARG . 87.2 t -65.96 -36.89 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.371 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.0 mmmt -56.31 -43.74 79.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.719 0.295 . . . . 0.0 110.58 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.01 95.54 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.739 -0.744 . . . . 0.0 111.935 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.2 -42.51 96.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.062 0.458 . . . . 0.0 110.2 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.96 -43.5 97.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.526 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.83 -41.4 99.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.581 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -66.46 -37.86 86.06 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.589 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.5 ttm -64.31 -43.36 94.95 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 121.027 0.442 . . . . 0.0 110.332 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.2 -29.53 70.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.392 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 44.7 m -73.0 -7.78 52.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.5 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.86 -2.37 58.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.391 0.615 . . . . 0.0 110.036 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.12 171.63 7.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.611 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -64.02 -49.09 73.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.992 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 32.9 t70 -118.79 107.63 42.14 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.779 0.323 . . . . 0.0 110.148 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.02 -34.86 99.23 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.937 2.424 . . . . 0.0 112.959 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -63.76 -45.21 90.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 10.7 pt-20 -63.45 -38.97 93.17 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.802 0.334 . . . . 0.0 110.654 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.77 -43.21 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.16 -43.78 99.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 120.826 0.346 . . . . 0.0 110.534 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.435 ' HB3' ' HE3' ' A' ' 390' ' ' LYS . 45.6 mt-10 -66.56 -38.97 88.22 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.735 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -58.07 -46.64 85.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.885 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -33.46 71.19 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 35.3 p -88.58 -5.04 58.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 386' ' ' GLU . 98.4 mttt -98.32 -0.66 43.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.941 0.401 . . . . 0.0 110.952 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -123.53 114.84 20.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.778 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -63.7 -39.77 95.13 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -58.76 -46.78 86.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.85 0.357 . . . . 0.0 110.52 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.66 -40.77 97.67 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.091 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 92.6 mtp -62.6 -44.66 95.75 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.01 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -64.57 -45.87 85.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.9 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -64.36 -44.17 92.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.537 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 46.2 tpp -63.51 -42.57 98.48 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.923 0.392 . . . . 0.0 111.323 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.456 ' HG2' HG21 ' A' ' 367' ' ' VAL . 77.2 mtm180 -65.75 -34.37 78.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.127 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -63.38 -43.02 98.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.707 0.289 . . . . 0.0 110.407 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.77 -46.1 95.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.912 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.84 88.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.38 -38.33 90.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.823 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.4 -43.99 96.14 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.341 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -66.34 -37.46 85.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.959 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -59.79 -42.66 93.89 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.45 90.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.064 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.99 -45.94 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -67.79 -30.35 69.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.558 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.16 99.35 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.69 -43.76 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.412 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.58 -38.67 88.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.237 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.25 -29.88 70.11 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.025 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.23 -22.31 18.5 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.889 0.376 . . . . 0.0 111.419 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.16 174.56 7.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.191 0.52 . . . . 0.0 111.327 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -84.28 133.27 34.56 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 66.8 t -118.14 128.88 75.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -119.3 144.25 46.91 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 120.989 0.423 . . . . 0.0 110.699 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -101.53 130.48 47.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.18 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -151.61 141.53 22.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.334 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -97.09 139.36 33.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.066 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.9 t -146.72 179.24 7.71 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.8 p -80.99 156.49 25.89 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.031 0.443 . . . . 0.0 111.372 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.3 -40.07 96.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.89 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -57.23 -34.77 68.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.177 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.04 -31.86 72.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.865 0.364 . . . . 0.0 111.237 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.6 mp -83.98 -7.81 59.31 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.026 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.7 mmt -79.28 -6.86 57.64 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.082 0.467 . . . . 0.0 110.497 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -76.15 81.4 2.96 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.453 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -106.46 13.63 28.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.824 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -66.05 -37.49 85.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.944 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.308 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.102 179.7 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.486 0.184 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -70.11 116.04 10.01 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.647 0.737 . . . . 0.0 112.172 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.17 172.47 14.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.177 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.441 ' O ' ' HB ' ' B' ' 5' ' ' VAL . 9.4 p -72.7 -175.34 1.65 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.287 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' B' ' 4' ' ' SER . 0.5 OUTLIER 89.32 141.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.908 0.883 . . . . 0.0 111.705 179.527 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -139.5 156.06 47.16 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 90.8 m -89.54 129.91 35.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.872 0.368 . . . . 0.0 111.766 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 75.1 m -89.11 -70.19 0.67 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -166.54 124.25 1.37 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.134 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.13 -110.6 3.47 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.648 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 85.9 mt -90.29 -6.82 54.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.519 0.199 . . . . 0.0 111.203 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.548 ' O ' ' HD3' ' B' ' 13' ' ' ARG . . . -84.27 137.54 16.02 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 114.41 0.524 . . . . 0.0 114.41 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.548 ' HD3' ' O ' ' B' ' 12' ' ' GLY . 0.0 OUTLIER -133.44 146.69 51.4 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.035 0.934 . . . . 0.0 110.619 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.42 HH21 ' HD2' ' B' ' 14' ' ' ARG . 30.5 ttm180 -108.68 138.3 45.23 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.815 0.446 . . . . 0.0 110.051 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.81 -85.91 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.684 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.4 p 27.84 94.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 tp -123.07 140.11 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.913 0.387 . . . . 0.0 111.857 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -73.01 138.15 45.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.746 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.476 HD13 HG12 ' B' ' 24' ' ' ILE . 0.9 OUTLIER -126.17 152.42 33.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -175.171 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.681 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -87.3 151.64 22.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.277 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.39 84.33 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -77.37 -3.14 38.63 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.187 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 15.4 t -107.56 -28.4 9.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.628 0.251 . . . . 0.0 111.075 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.681 HG13 ' O ' ' B' ' 20' ' ' ALA . 71.3 mt -60.25 -49.6 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 121.027 0.441 . . . . 0.0 112.097 -175.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.474 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 69.2 mm-40 -101.32 8.61 42.28 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -175.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 40.0 m -103.74 -70.49 0.76 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.137 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.09 -47.48 79.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.824 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.455 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 86.0 t -62.11 -45.22 99.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.7 ttmm -63.33 -45.17 92.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 60.0 m -62.8 -41.52 99.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.367 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.572 ' O ' HG23 ' B' ' 35' ' ' VAL . 10.4 tp10 -66.44 -39.05 88.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.72 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 89.3 mt -61.81 -43.02 99.67 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -66.0 -38.22 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.535 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -64.07 -38.65 91.84 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 31' ' ' GLU . 89.3 t -63.17 -43.04 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.545 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.32 97.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.432 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.02 -30.06 70.04 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.068 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' B' ' 35' ' ' VAL . 23.1 ttmm -59.51 -44.75 93.04 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.202 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.16 -2.97 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 63.52 31.39 14.83 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.329 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.82 10.8 8.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.08 -25.62 67.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.13 -4.37 78.21 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.808 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -86.67 -5.4 59.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.459 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 64.0 ttt-85 -93.21 108.26 19.92 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.841 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.18 -38.12 87.88 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.293 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.42 33.16 20.56 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.247 -0.978 . . . . 0.0 114.205 175.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -63.53 -40.98 98.44 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 t -117.18 112.47 39.76 Favored Pre-proline 0 N--CA 1.448 -0.557 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.44 ' HG2' HD12 ' B' ' 53' ' ' ILE . 42.4 Cg_exo -57.53 142.77 95.53 Favored 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.687 2.258 . . . . 0.0 112.255 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.493 ' HA ' HG22 ' B' ' 54' ' ' VAL . 18.7 ttt -67.01 -29.38 69.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.55 -172.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ASN . . . . . 0.422 ' OD1' HG13 ' B' ' 53' ' ' ILE . 29.1 p-10 -71.85 -16.43 62.15 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.094 0.473 . . . . 0.0 110.361 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.617 HD13 ' NH2' ' A' ' 193' ' ' ARG . 78.0 mt -99.76 -36.07 5.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.789 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' B' ' 51' ' ' MET . 23.6 m -60.58 -40.71 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.785 0.326 . . . . 0.0 111.286 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.14 -30.0 70.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.354 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -91.79 -32.77 15.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.377 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.44 HH12 HD13 ' A' ' 187' ' ' LEU . 15.1 tpp180 -64.61 -41.61 96.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.869 0.366 . . . . 0.0 110.436 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -110.48 23.57 14.07 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.27 0.557 . . . . 0.0 110.509 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.94 147.5 50.34 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.781 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 71.24 -41.06 0.49 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.392 0.677 . . . . 0.0 112.296 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.3 t -58.28 -53.44 58.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.758 0.423 . . . . 0.0 111.865 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.501 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -114.76 10.61 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.296 0.57 . . . . 0.0 110.827 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -60.14 -38.95 84.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.647 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -59.44 -45.51 91.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.688 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.5 -33.2 73.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.754 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 62' ' ' VAL . 77.3 t -60.97 -35.19 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.47 -39.43 90.88 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.31 -39.81 98.22 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.699 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.34 -46.37 88.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.966 0.413 . . . . 0.0 110.882 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.57 -42.08 98.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.453 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 55.0 ttp -60.78 -46.5 90.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.216 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 52.0 m -64.21 -52.28 59.62 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.463 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -70.11 -39.37 75.52 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -64.98 -40.53 95.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.642 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -61.09 -47.85 84.38 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.798 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.419 ' O ' HG13 ' B' ' 79' ' ' ILE . 14.8 tt -68.13 -39.19 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.869 0.366 . . . . 0.0 111.035 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.12 -43.91 97.79 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.565 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.62 89.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.234 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.419 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.6 pp -67.12 -35.39 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.44 -43.94 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.997 0.427 . . . . 0.0 110.987 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -82.58 -19.65 38.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.006 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -88.13 -8.32 55.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.357 0.599 . . . . 0.0 109.54 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 69.56 34.4 2.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.172 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 73.6 mt -99.17 116.72 42.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -103.78 108.53 59.94 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.847 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.49 141.84 57.17 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.383 2.056 . . . . 0.0 111.394 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.45 104.45 15.39 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.058 0.456 . . . . 0.0 110.589 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.33 -109.2 3.36 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.188 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.09 124.93 13.3 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-O 120.51 0.195 . . . . 0.0 110.616 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.84 157.55 54.86 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.371 2.047 . . . . 0.0 111.023 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 20.2 m -98.16 115.67 28.78 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.029 0.442 . . . . 0.0 110.558 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -96.16 98.19 10.14 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.02 110.69 58.66 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -91.07 165.44 3.77 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.163 2.575 . . . . 0.0 111.112 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.28 179.48 25.83 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.517 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.13 114.02 10.82 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -81.69 124.81 29.92 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.202 0.525 . . . . 0.0 111.54 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.65 117.51 34.24 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.43 123.36 18.54 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.657 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.56 -17.82 56.09 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.498 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -106.32 -170.51 1.74 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.615 0.245 . . . . 0.0 111.229 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -81.12 165.45 21.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -128.83 135.99 49.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.872 0.368 . . . . 0.0 110.877 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 45.9 m -119.84 136.49 54.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.687 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -141.66 167.03 23.13 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.925 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -78.82 -84.95 0.08 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 99.1 t 56.7 93.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-O 121.171 0.51 . . . . 0.0 109.975 -172.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.48 135.44 38.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -158.65 170.45 22.14 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.971 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -50.77 145.88 6.49 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.56 165.42 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.521 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -121.67 106.6 37.11 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 120.894 0.378 . . . . 0.0 110.197 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -91.96 161.27 3.3 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.242 2.628 . . . . 0.0 113.805 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -131.56 134.39 46.02 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.996 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.87 136.3 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.657 0.265 . . . . 0.0 111.306 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.05 141.51 32.78 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.093 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 97.6 mt -119.1 141.86 48.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -129.84 145.38 51.59 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.96 18.62 78.56 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.097 -0.502 . . . . 0.0 114.127 174.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -63.51 -40.52 97.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.052 0.453 . . . . 0.0 111.339 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.97 -19.04 65.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.856 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.43 8.17 29.17 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.503 ' CD1' HD21 ' B' ' 294' ' ' LEU . 77.6 mt -86.26 127.66 40.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.064 0.459 . . . . 0.0 110.949 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -112.37 125.04 53.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.73 132.41 68.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.987 0.423 . . . . 0.0 111.635 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.28 137.14 32.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.389 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -126.37 105.76 24.43 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.67 119.41 6.42 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.088 1.859 . . . . 0.0 111.832 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.438 HG13 ' HG2' ' B' ' 419' ' ' GLU . 48.6 mm -104.63 108.24 24.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.42 159.28 40.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.51 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.24 161.07 37.2 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.194 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 46.1 t -69.68 121.25 18.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.766 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.4 p -105.92 -180.0 4.1 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.773 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.6 -34.82 77.77 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.303 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.61 94.87 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.559 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -64.95 -40.9 95.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.655 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.02 -47.43 92.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.798 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -61.81 -44.39 96.95 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.32 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.04 -41.33 99.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.18 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.617 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.8 tpt -60.98 -46.85 89.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.782 0.325 . . . . 0.0 110.838 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.28 -41.94 96.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.39 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.92 -43.13 99.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.828 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 18.5 m -63.24 -39.86 95.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.66 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.5 mt -60.22 -41.64 93.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.779 -176.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -72.23 -16.69 61.94 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.107 0.479 . . . . 0.0 111.11 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.31 8.11 43.04 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.568 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -117.79 24.79 10.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.74 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -138.17 106.51 5.8 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.25 147.43 31.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.594 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.574 HG22 ' H ' ' B' ' 151' ' ' TRP . 0.3 OUTLIER -111.85 -163.16 0.83 Allowed 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.104 -176.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 151' ' ' TRP . . . . . 0.574 ' H ' HG22 ' B' ' 150' ' ' THR . 48.4 p-90 -123.2 146.64 47.64 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.058 0.456 . . . . 0.0 112.024 -176.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -168.03 -61.81 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.01 -142.27 0.22 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.773 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.489 ' HE3' ' HG2' ' B' ' 242' ' ' GLU . 9.1 ptpp? -134.5 143.06 47.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.282 0.947 . . . . 0.0 112.874 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -164.56 -152.13 0.17 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' B' ' 206' ' ' LYS . . . -99.93 63.32 0.66 Allowed Glycine 0 C--O 1.235 0.193 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.49 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.47 118.9 12.18 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.74 129.8 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -86.45 157.94 19.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.085 0.469 . . . . 0.0 112.085 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.99 26.27 0.26 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.84 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -167.55 20.17 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.422 ' CG ' ' HE ' ' B' ' 243' ' ' ARG . 45.2 t0 -64.09 -45.43 88.71 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.362 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' B' ' 187' ' ' LEU . 53.4 ttp180 72.18 88.38 0.1 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.49 132.62 64.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.077 0.465 . . . . 0.0 112.016 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 24.6 m -69.0 104.19 2.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.844 173.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 88.2 mt -116.77 128.45 74.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.906 0.384 . . . . 0.0 111.934 -175.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -102.16 110.09 21.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.47 0.652 . . . . 0.0 109.381 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -137.01 154.01 50.51 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.3 m -124.04 130.18 52.14 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.023 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -70.05 131.44 22.96 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.99 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -145.6 129.59 17.41 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 43.3 t -77.91 -76.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -113.93 -70.5 0.8 Allowed 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -135.77 23.31 3.4 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -136.09 140.55 43.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.128 -0.536 . . . . 0.0 109.647 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -91.83 146.25 23.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -106.86 174.54 5.84 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.092 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.57 -37.39 78.34 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.6 -174.68 36.95 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.786 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.84 22.91 54.49 Favored Glycine 0 C--N 1.32 -0.352 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.281 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -103.1 101.25 11.21 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -123.64 140.26 53.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.114 0.483 . . . . 0.0 111.946 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 34.6 m -141.14 121.16 13.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.539 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.81 33.17 22.9 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.55 0.531 . . . . 0.0 111.15 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -87.91 123.22 32.43 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.753 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 13.8 m -92.86 113.31 27.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.566 0.698 . . . . 0.0 110.716 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.425 HD13 HH12 ' A' ' 57' ' ' ARG . 52.1 tp -102.53 116.22 32.17 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.322 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 188' ' ' ALA . . . . . 0.713 ' HB3' ' NH1' ' B' ' 193' ' ' ARG . . . -99.9 105.37 17.08 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 41.9 mtm -76.17 168.88 19.25 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.129 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.9 -16.41 61.01 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.876 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -98.84 -3.46 35.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.599 -0.3 . . . . 0.0 111.455 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.16 44.6 59.76 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.176 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.713 ' NH1' ' HB3' ' B' ' 188' ' ' ALA . 47.8 mtm180 -98.32 4.63 48.68 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.417 0.627 . . . . 0.0 111.672 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.506 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -128.04 159.97 33.4 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 172.378 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.487 HG13 ' CE2' ' B' ' 217' ' ' PHE . 43.3 mm -54.42 133.56 62.42 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -48.09 126.22 13.01 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.359 2.039 . . . . 0.0 112.326 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.46 -34.15 6.01 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.261 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -64.32 -51.06 65.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.82 -16.65 60.69 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 121.015 0.436 . . . . 0.0 112.107 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -87.69 -21.59 25.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.173 0.511 . . . . 0.0 110.034 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.45 -10.82 85.52 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.63 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.0 mm -64.81 -42.85 96.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -55.32 124.81 18.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.762 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.5 1.59 40.56 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.793 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -111.13 148.6 32.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.313 0.557 . . . . 0.0 111.586 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.472 ' HD3' ' HA3' ' B' ' 156' ' ' GLY . 75.6 mmtt -86.83 163.42 17.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.412 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.56 112.21 3.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.344 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.24 39.4 11.32 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.863 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -113.92 126.4 55.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.999 0.428 . . . . 0.0 111.035 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -92.13 136.51 33.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.619 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' PHE . . . . . 0.48 ' O ' ' HB ' ' B' ' 212' ' ' THR . 65.0 t80 -155.64 -28.26 0.1 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' B' ' 211' ' ' PHE . 91.3 m 75.92 143.83 0.08 Allowed 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 120.665 0.269 . . . . 0.0 110.749 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -138.17 128.07 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.075 0.464 . . . . 0.0 111.233 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -82.72 111.92 19.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.166 0.507 . . . . 0.0 111.522 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 73.3 t -118.19 130.92 72.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 9.9 m -94.24 -29.75 14.92 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -174.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' B' ' 216' ' ' THR . 69.1 m-85 74.3 141.35 0.08 OUTLIER Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 122.702 0.401 . . . . 0.0 111.085 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.89 151.89 51.39 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.303 2.002 . . . . 0.0 111.867 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -65.44 -34.62 78.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.73 26.87 1.05 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.28 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 7.2 t80 -70.73 133.95 47.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -67.71 -17.67 64.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.439 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -91.28 104.69 17.2 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 33.6 tt0 -57.79 -36.1 71.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.33 -175.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.431 ' O ' ' HD3' ' B' ' 229' ' ' LYS . 28.6 p-10 -72.92 -13.26 61.22 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.4 mt -120.13 -1.54 10.32 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.1 ptmt -69.95 114.14 7.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.301 0.572 . . . . 0.0 111.592 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.26 21.81 75.94 Favored Glycine 0 C--O 1.237 0.292 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.214 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' B' ' 225' ' ' ASN . 9.7 mtpm? -122.28 109.91 15.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.87 145.54 55.36 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -128.44 146.23 50.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.772 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -100.97 -29.16 12.35 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -173.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 57.32 107.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -67.2 -40.23 86.44 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.832 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 48.8 mm 69.3 133.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.352 0.661 . . . . 0.0 111.338 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' ASN . . . . . 0.423 ' OD1' ' HG3' ' B' ' 238' ' ' LYS . 26.5 t-20 -109.01 -65.44 1.14 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.843 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.8 mt 61.04 95.99 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' LYS . . . . . 0.423 ' HG3' ' OD1' ' B' ' 236' ' ' ASN . 64.1 mttp -102.13 -31.35 10.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.799 175.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -102.55 -87.13 0.42 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 85.4 t 72.36 121.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 123.532 0.52 . . . . 0.0 109.971 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.15 179.79 3.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.489 ' HG2' ' HE3' ' B' ' 154' ' ' LYS . 36.4 mt-10 -112.38 114.79 27.71 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -167.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 7.4 ptp180 -149.64 141.82 24.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.134 167.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.501 ' H ' ' HA ' ' B' ' 151' ' ' TRP . 1.0 OUTLIER -172.82 162.22 4.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.636 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 3.9 tt 67.57 106.45 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.229 0.611 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -85.63 118.5 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.592 2.195 . . . . 0.0 112.802 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -145.41 179.03 7.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.075 0.464 . . . . 0.0 110.733 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' LEU . . . . . 0.439 ' N ' HD12 ' B' ' 248' ' ' LEU . 4.8 mp -93.55 74.36 4.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.38 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 249' ' ' THR . . . . . 0.441 ' OG1' HG21 ' B' ' 150' ' ' THR . 11.6 m -85.51 -72.71 0.47 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.815 0.34 . . . . 0.0 111.258 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -154.69 -34.91 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.421 . . . . 0.0 111.12 -177.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -62.3 -35.32 78.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.672 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -64.84 -28.98 69.92 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.036 0.935 . . . . 0.0 113.505 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 43.1 pt -99.41 -4.52 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -160.23 -11.9 0.05 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 119.055 -1.058 . . . . 0.0 113.621 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -102.86 134.6 46.0 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.876 0.37 . . . . 0.0 111.255 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -172.67 36.91 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.28 20.67 69.05 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.7 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.6 161.32 35.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -52.02 -59.17 4.66 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 122.894 0.477 . . . . 0.0 109.832 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -173.78 162.46 4.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.824 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -173.31 178.42 45.27 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.583 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 93.1 p -102.56 -171.25 1.93 Allowed 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 122.263 0.225 . . . . 0.0 110.508 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.8 -57.18 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.962 0.411 . . . . 0.0 112.023 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -35.74 23.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.0 111.049 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.28 -39.14 97.51 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.391 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.402 ' O ' HG23 ' B' ' 270' ' ' VAL . 54.0 tp -62.86 -45.43 92.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.569 0.223 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -64.29 -42.27 96.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.587 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.518 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.34 -45.15 89.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.314 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -67.12 -39.1 86.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.452 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 266' ' ' LEU . 66.3 t -64.7 -44.13 96.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.606 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -60.09 -47.56 85.39 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 17.7 ptmt -64.55 -45.41 87.21 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.909 0.385 . . . . 0.0 111.077 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -65.06 -36.25 83.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 89.5 mmm -61.82 -42.67 99.31 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.031 0.443 . . . . 0.0 109.98 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -70.15 -31.43 68.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.798 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 276' ' ' ARG . . . . . 0.519 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 57.6 ttp180 -64.73 -42.17 95.41 Favored 'General case' 0 CA--C 1.527 0.074 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -66.85 -34.03 76.9 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.69 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.53 -38.01 85.85 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.719 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 279' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 55.4 tttm -55.84 -47.16 77.74 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.303 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 20.4 m -63.47 -42.28 98.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.907 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.02 -47.45 86.39 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.062 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.18 -43.62 97.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.234 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -44.62 96.99 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.83 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.17 -41.37 97.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.035 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 285' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' B' ' 285' ' ' ARG . 4.2 tpm_? -60.42 -43.86 96.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.886 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.31 -44.12 80.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.135 0.493 . . . . 0.0 111.063 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.33 -48.58 79.19 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.938 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.6 p -65.15 -41.31 94.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.72 -40.89 92.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.642 0.258 . . . . 0.0 111.274 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.06 95.33 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.091 0.472 . . . . 0.0 110.653 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 36.7 mm -65.04 -43.49 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 292' ' ' GLU . . . . . 0.46 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 20.5 tp10 -61.87 -42.55 99.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.682 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.82 98.31 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.51 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.503 HD21 ' CD1' ' B' ' 123' ' ' ILE . 24.8 mt -63.73 -42.71 97.85 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.26 -42.16 93.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.731 0.3 . . . . 0.0 111.339 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.46 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 66.4 mttm -61.95 -40.47 95.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.698 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.3 -47.46 19.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.904 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -114.89 96.02 5.51 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -99.94 105.54 17.25 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -116.71 159.4 16.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.604 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.6 130.11 43.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 42.6 t -105.48 127.53 28.38 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.029 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.37 128.6 30.76 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.461 2.107 . . . . 0.0 111.882 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.61 80.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.754 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.66 -48.05 72.82 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.338 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 66.3 mt -67.03 -40.52 87.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.002 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 307' ' ' ILE . . . . . 0.487 ' O ' HG13 ' B' ' 311' ' ' ILE . 75.7 mt -61.04 -49.82 83.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.391 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.13 -43.27 99.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.566 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 38.9 m -63.11 -45.25 92.9 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.643 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 310' ' ' GLU . . . . . 0.419 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 70.2 mm-40 -71.22 -34.44 70.81 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.51 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 89.9 mt -61.74 -43.05 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.027 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.586 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 31.0 t70 -59.32 -44.92 92.54 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.961 0.41 . . . . 0.0 110.805 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.39 -43.93 98.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.163 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 79.3 mt -62.92 -40.38 97.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.268 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.586 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 83.1 mtm180 -61.33 -42.56 98.87 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -65.08 -37.91 89.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.703 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -62.87 -42.68 99.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.206 0.527 . . . . 0.0 109.88 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.59 -37.47 79.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.523 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 319' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -63.9 -37.35 87.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.929 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -63.43 -37.08 85.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.364 0.602 . . . . 0.0 109.482 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -79.51 -3.36 46.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.898 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -101.68 4.22 40.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.953 0.406 . . . . 0.0 111.13 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 128.01 7.1 4.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.936 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 87.96 46.01 4.92 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.396 -0.906 . . . . 0.0 111.776 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 325' ' ' ASN . . . . . 0.474 ' HB3' ' HB1' ' B' ' 319' ' ' ALA . 26.2 t-20 -91.25 135.14 34.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 -177.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.87 160.99 38.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.44 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.1 OUTLIER 72.66 -53.57 0.7 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.05 0.54 . . . . 0.0 111.214 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.66 -16.83 63.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.849 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.86 -22.91 50.47 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.81 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.54 -35.78 78.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.912 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -79.51 -5.25 54.43 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.214 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.01 152.6 96.74 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.009 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 333' ' ' PRO . . . . . 0.479 ' O ' ' HD1' ' B' ' 337' ' ' PHE . 32.9 Cg_exo -59.86 140.53 93.54 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.817 2.344 . . . . 0.0 112.854 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -86.08 -43.78 12.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.898 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.6 pm0 -59.18 -39.38 82.37 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 62.1 mt -86.21 0.31 54.0 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.826 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 337' ' ' PHE . . . . . 0.479 ' HD1' ' O ' ' B' ' 333' ' ' PRO . 50.8 m-85 -107.75 -29.55 9.05 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.31 -31.7 72.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.964 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -58.92 -49.08 79.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.044 0.449 . . . . 0.0 110.795 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -83.5 -21.03 32.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.012 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.445 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.85 -40.48 97.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 342' ' ' LYS . . . . . 0.43 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.7 tttt -59.35 -44.37 92.67 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.194 177.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 343' ' ' ARG . . . . . 0.562 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.5 mmt85 -61.35 -45.22 95.32 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.772 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -67.22 -38.72 85.75 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.306 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 341' ' ' ALA . 74.2 t -64.53 -43.58 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.36 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 342' ' ' LYS . 57.7 t -61.32 -42.49 93.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.44 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 343' ' ' ARG . 79.4 t -59.87 -44.86 95.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.51 -41.69 99.61 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.928 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.96 -44.54 95.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.748 0.308 . . . . 0.0 110.982 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.457 ' O ' HG23 ' B' ' 354' ' ' VAL . 92.7 mt -63.53 -47.2 82.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.997 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.54 -41.29 88.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.487 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.21 99.73 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.195 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.22 -35.75 78.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.061 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 354' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 350' ' ' LEU . 76.1 t -60.61 -45.08 97.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 77.7 mt -63.4 -46.2 95.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.68 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.1 -54.26 32.7 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 47.7 m -65.21 -44.94 86.7 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -83.44 -8.47 59.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.265 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 65.43 45.39 2.83 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.271 0.558 . . . . 0.0 111.267 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 97.6 mt -78.79 156.3 28.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.768 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -139.02 153.45 48.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.516 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -75.07 105.77 6.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -80.83 116.48 20.84 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.978 0.418 . . . . 0.0 111.464 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 364' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 60.3 mm-40 -58.75 -42.61 89.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.308 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -62.42 -44.49 96.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.678 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -61.35 -42.64 99.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.207 0.527 . . . . 0.0 109.792 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 367' ' ' VAL . . . . . 0.435 HG21 ' HG2' ' B' ' 399' ' ' ARG . 94.7 t -65.96 -36.23 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.316 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 368' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.5 mmmt -56.31 -42.68 78.01 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.803 0.335 . . . . 0.0 110.663 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.95 -38.48 96.66 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.086 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.88 -42.04 97.6 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.1 0.476 . . . . 0.0 110.221 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 65.3 mt -65.7 -43.62 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.148 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -61.67 -40.0 93.39 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.693 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -67.28 -38.57 85.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.001 0.429 . . . . 0.0 110.412 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 58.1 ttm -64.28 -41.84 96.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.132 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 375' ' ' ALA . . . . . 0.433 ' HA ' HG11 ' B' ' 384' ' ' VAL . . . -64.39 -32.62 74.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.29 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 49.6 m -71.23 -8.02 50.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.454 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.85 -1.89 57.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.033 0.444 . . . . 0.0 110.507 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -117.81 173.23 6.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.123 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -65.87 -49.83 66.68 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -116.18 107.76 47.04 Favored Pre-proline 0 CA--C 1.518 -0.251 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.39 -29.21 71.81 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.106 1.871 . . . . 0.0 113.26 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -64.55 -45.12 88.47 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.89 -36.23 82.82 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.771 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 384' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' B' ' 375' ' ' ALA . 57.9 t -65.11 -43.84 95.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.605 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.59 -43.89 98.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.983 0.421 . . . . 0.0 109.916 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -65.93 -38.13 87.86 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.928 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -58.34 -46.66 85.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.541 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.08 -42.1 76.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 41.9 p -78.27 -8.36 58.28 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.23 9.28 42.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.847 0.356 . . . . 0.0 111.259 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -134.66 111.27 9.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.061 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -61.66 -39.85 92.85 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -59.99 -45.07 93.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.771 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.89 -40.63 96.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.686 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 94.8 mtp -62.13 -45.41 93.59 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.265 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.39 -44.16 79.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.008 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -64.09 -44.91 90.9 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.27 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 40.7 tpp -63.03 -42.54 99.81 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.926 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.435 ' HG2' HG21 ' B' ' 367' ' ' VAL . 84.1 mtm180 -66.12 -34.8 78.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.616 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -63.02 -42.63 99.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.796 0.332 . . . . 0.0 110.383 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.75 -46.02 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.792 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.21 88.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.693 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.45 -38.95 93.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.529 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.12 -43.33 99.05 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.38 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -65.7 -37.52 86.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.645 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -59.54 -43.86 93.39 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.642 0.258 . . . . 0.0 110.437 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.91 89.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.25 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.21 -46.24 93.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.004 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.86 -30.8 70.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.745 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.48 -40.05 94.94 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.914 0.388 . . . . 0.0 110.139 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.15 -42.84 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.188 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.33 -39.79 91.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.305 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.47 68.42 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.549 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -96.89 -9.76 27.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.53 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.01 -170.25 1.79 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.182 0.515 . . . . 0.0 110.921 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -102.57 120.0 39.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.417 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 66.4 t -106.74 126.98 62.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 13.6 t -118.27 146.72 44.09 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.134 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 419' ' ' GLU . . . . . 0.438 ' HG2' HG13 ' B' ' 129' ' ' ILE . 41.4 mt-10 -107.84 123.22 48.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.298 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -144.64 147.76 33.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.751 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -97.11 147.72 23.77 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.451 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -155.46 178.48 10.19 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 22.1 p -82.21 153.38 25.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.988 0.423 . . . . 0.0 111.37 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -63.13 -34.07 76.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.835 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -60.6 -35.78 76.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.448 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.25 -32.0 73.45 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.944 0.402 . . . . 0.0 111.169 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.36 -7.95 59.49 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.86 0.362 . . . . 0.0 111.1 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.3 mmt -80.26 -6.9 58.65 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.05 0.452 . . . . 0.0 110.613 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -74.48 81.14 1.94 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.395 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -106.04 13.4 29.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.806 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -65.82 -40.53 91.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.034 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.751 -179.828 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.576 0.227 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -86.6 130.27 34.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.9 0.381 . . . . 0.0 110.349 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.56 164.95 32.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.183 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 t -111.1 102.26 10.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.859 0.361 . . . . 0.0 110.255 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.29 139.49 26.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.916 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 45.7 mt-10 -124.84 177.18 6.15 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.839 0.352 . . . . 0.0 110.808 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 94.4 m -124.91 131.74 53.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.909 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 45.3 m -79.86 -70.38 0.52 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 177.83 139.01 0.08 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.517 0.727 . . . . 0.0 109.569 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.85 -121.19 25.05 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.242 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.579 HD23 HG13 ' A' ' 111' ' ' VAL . 81.0 mt -65.12 -39.74 93.51 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.9 0.48 . . . . 0.0 110.943 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.6 ' HA2' ' HG2' ' A' ' 108' ' ' GLU . . . -68.78 140.45 34.74 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 115.857 1.103 . . . . 0.0 115.857 -173.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -129.69 -163.57 1.32 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -160.28 116.94 2.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 117.888 0.313 . . . . 0.0 110.647 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t -95.77 -90.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.194 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m 51.1 83.79 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.224 0.535 . . . . 0.0 111.0 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 tp -113.58 145.15 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.6 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.0 p -99.64 129.78 45.81 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.557 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 24' ' ' ILE . 6.5 pt -131.46 157.49 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -79.87 154.55 28.3 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.851 0.461 . . . . 0.0 112.04 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.76 -50.63 69.91 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.22 -37.33 86.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.487 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -63.24 -43.41 98.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.103 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 20' ' ' ALA . 67.0 mt -62.71 -52.34 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.232 0.539 . . . . 0.0 111.742 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.04 -38.38 72.57 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.453 -173.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -79.23 -59.29 2.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.71 -48.12 70.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -173.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.5 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 94.4 t -63.98 -43.89 97.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.48 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -61.55 -45.28 94.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.321 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 m -63.89 -41.64 97.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.726 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 35' ' ' VAL . 34.8 tp10 -66.55 -36.11 81.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.794 0.331 . . . . 0.0 111.102 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 91.9 mt -61.54 -42.31 98.64 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.63 -37.81 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.025 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -63.11 -41.42 99.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.817 0.342 . . . . 0.0 110.769 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 31' ' ' GLU . 91.1 t -63.74 -43.99 98.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.426 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.55 93.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.885 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.74 -33.01 74.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.231 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -59.0 -45.7 90.0 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 110.38 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.3 t -87.74 -2.68 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.265 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 64.1 27.52 14.11 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.131 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.416 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.8 pp -105.38 8.67 9.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.002 0.43 . . . . 0.0 111.535 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.54 -34.08 77.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.322 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.86 -5.16 56.88 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.435 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -84.87 -10.26 57.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.907 0.353 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -88.55 110.1 20.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.338 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.71 -41.38 97.53 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.1 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.07 42.56 76.45 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 115.898 1.119 . . . . 0.0 115.898 172.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -61.81 -43.72 98.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.274 1.037 . . . . 0.0 108.717 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.476 HG12 ' HB ' ' A' ' 54' ' ' VAL . 3.5 t -108.24 100.81 39.04 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 173.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.543 ' HG2' HD12 ' A' ' 53' ' ' ILE . 30.9 Cg_endo -63.76 158.09 48.47 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.657 2.238 . . . . 0.0 112.543 -176.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.488 ' HA ' HG12 ' A' ' 54' ' ' VAL . 82.9 mtp -61.82 -32.63 72.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.981 -174.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -69.16 -18.74 63.97 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.208 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.584 HD13 ' NH2' ' B' ' 193' ' ' ARG . 89.5 mt -105.66 -48.26 9.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 51' ' ' MET . 14.8 p -63.09 -35.15 70.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 120.988 0.423 . . . . 0.0 111.138 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.61 81.36 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.297 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -91.54 -7.19 51.01 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.464 HH12 HD12 ' B' ' 187' ' ' LEU . 67.9 mtt180 -97.3 -30.33 13.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.177 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -111.74 12.72 21.06 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.678 0.751 . . . . 0.0 109.531 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 61' ' ' SER . . . -65.54 150.54 51.78 Favored Glycine 0 CA--C 1.493 -1.312 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.417 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.47 -41.5 0.5 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.356 0.663 . . . . 0.0 111.388 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 59' ' ' GLY . 39.1 t -60.01 -46.79 88.34 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.07 0.548 . . . . 0.0 111.151 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.4 p -124.52 14.2 4.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.456 0.646 . . . . 0.0 110.892 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -64.73 -19.11 65.59 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.985 0.422 . . . . 0.0 110.948 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -62.02 -52.32 64.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.623 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.87 -17.6 59.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.244 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 62' ' ' VAL . 77.7 t -64.64 -42.71 95.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 173.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.72 -39.61 94.61 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' ' 71' ' ' MET . . . -60.31 -41.14 98.28 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.563 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.731 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 30.8 t70 -63.37 -43.83 96.5 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.45 -43.43 98.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.91 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' A' ' 68' ' ' GLY . 24.8 ptt? -63.65 -40.74 97.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.6 m -64.17 -40.26 95.73 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.091 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 43.9 mtp85 -63.03 -43.57 98.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.165 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -64.26 -41.06 97.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.695 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.87 -48.57 79.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.914 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 79' ' ' ILE . 19.3 tt -67.81 -40.76 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.466 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.79 -43.01 97.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.128 0.489 . . . . 0.0 110.221 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.86 95.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.093 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.6 pp -67.01 -40.92 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.974 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.73 -44.59 96.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.537 0.684 . . . . 0.0 109.765 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -64.71 -45.35 86.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.086 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -86.69 0.66 54.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.708 0.29 . . . . 0.0 111.416 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm 63.76 52.23 2.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.751 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.11 126.29 64.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.738 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -101.27 109.66 59.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.552 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.21 117.98 4.23 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.331 2.021 . . . . 0.0 112.034 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.08 93.68 8.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.135 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.14 -159.01 17.83 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.992 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.74 123.67 59.09 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.69 112.5 2.21 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.115 1.877 . . . . 0.0 110.704 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -96.26 114.88 26.61 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.237 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.579 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 91.3 m-85 -87.66 137.39 32.37 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.99 96.91 16.0 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-O 120.873 0.368 . . . . 0.0 111.792 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 93.1 Cg_endo -103.43 -172.12 0.07 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 123.473 2.782 . . . . 0.0 111.418 175.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -118.76 -172.0 15.26 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.65 145.96 25.37 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -95.17 126.76 40.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.15 0.5 . . . . 0.0 111.044 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.66 128.5 54.23 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.6 tp -67.03 114.49 5.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.892 0.377 . . . . 0.0 110.851 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.62 1.89 55.37 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.915 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -123.17 167.76 13.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.939 0.369 . . . . 0.0 110.99 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -71.34 141.87 50.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.743 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -95.7 137.31 34.95 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.7 m -119.62 131.19 55.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.826 0.346 . . . . 0.0 111.334 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -129.94 148.11 51.77 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.077 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 107' ' ' VAL . 50.1 m -102.46 -65.74 0.97 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 70.65 152.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 124.12 0.968 . . . . 0.0 111.047 -175.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.6 ' HG2' ' HA2' ' A' ' 12' ' ' GLY . 25.0 mt-10 -133.26 151.23 51.91 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 122.239 -0.288 . . . . 0.0 110.47 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -154.85 -73.03 0.12 Allowed 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -112.4 162.56 15.44 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -171.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.579 HG13 HD23 ' A' ' 11' ' ' LEU . 3.9 m -136.82 143.22 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.224 177.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -145.64 98.48 4.53 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 121.083 0.468 . . . . 0.0 110.546 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.88 149.56 20.48 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.086 2.524 . . . . 0.0 114.213 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -144.36 120.15 10.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.979 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 66.5 t -123.42 135.44 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.635 0.255 . . . . 0.0 111.12 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -121.81 142.04 50.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.58 153.14 38.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.59 0.234 . . . . 0.0 110.859 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -136.94 158.15 45.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.59 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.34 17.53 68.81 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.563 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.52 -39.84 94.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.185 0.517 . . . . 0.0 111.004 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.78 -17.2 64.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.681 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.18 12.2 29.63 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.869 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.1 mt -87.81 111.89 22.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.18 0.514 . . . . 0.0 110.32 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -105.73 120.89 42.85 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.7 t -118.3 133.01 66.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.629 0.252 . . . . 0.0 110.861 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -81.09 142.64 33.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.579 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.47 93.36 40.88 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.31 113.47 3.47 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.23 1.953 . . . . 0.0 112.123 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.29 115.53 43.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.037 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.07 158.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.675 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -133.99 157.4 46.17 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.598 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -70.82 127.14 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 71.7 p -110.84 176.64 4.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.738 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -62.68 -33.92 76.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.348 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.24 -40.99 96.1 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.886 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -64.5 -47.45 78.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.116 0.484 . . . . 0.0 110.385 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.08 -45.76 95.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.757 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.93 -46.28 91.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.479 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.22 97.82 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.817 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.563 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.8 tpt -61.71 -46.51 89.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.616 0.246 . . . . 0.0 110.841 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.76 -41.66 97.95 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.972 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.85 -45.34 94.92 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.369 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 m -63.51 -42.83 98.46 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.177 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.4 mt -60.71 -43.41 97.83 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -65.85 -33.36 75.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.926 0.393 . . . . 0.0 110.964 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.7 -13.81 60.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.914 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -90.02 -54.32 4.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -56.42 125.68 23.07 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.82 -167.41 2.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.525 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 151' ' ' TRP . 4.4 m -146.43 170.74 16.21 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.543 ' H ' HG22 ' A' ' 150' ' ' THR . 6.8 p-90 -120.38 145.91 46.7 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 151' ' ' TRP . 56.3 tttp 173.55 -59.61 0.01 OUTLIER 'General case' 0 C--N 1.351 0.639 0 O-C-N 123.862 0.726 . . . . 0.0 110.531 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -109.64 177.14 4.82 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 120.692 0.282 . . . . 0.0 111.498 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -84.15 147.11 27.5 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 69.48 116.88 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.978 0.911 . . . . 0.0 113.259 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -167.9 -98.74 0.12 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.436 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.35 145.79 29.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.3 126.48 67.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -95.54 -176.7 3.84 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.765 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.81 -66.89 0.48 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.492 ' OE2' ' HA ' ' A' ' 256' ' ' PHE . 13.9 pt-20 -78.52 7.35 6.85 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 188' ' ' ALA . 31.1 t70 -72.74 147.66 45.39 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.354 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 163' ' ' ARG . 16.8 ptp180 -101.87 116.7 33.28 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.59 127.14 74.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.586 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.1 m -74.93 109.54 8.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.6 124.37 66.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.061 0.457 . . . . 0.0 111.633 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.13 91.1 6.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -111.81 149.34 31.89 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.349 0.595 . . . . 0.0 111.885 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 40.5 m -128.15 129.75 47.02 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.121 177.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.85 134.65 12.65 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.827 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.3 m -142.84 144.35 32.49 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 120.83 0.347 . . . . 0.0 110.731 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.2 t -98.76 94.12 3.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 64.75 -70.39 0.08 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.331 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -137.06 5.82 3.65 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.77 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -130.24 139.15 50.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.585 0.692 . . . . 0.0 111.169 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.37 153.1 30.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.144 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -117.62 -177.31 3.21 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -53.78 -49.57 67.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.833 0.853 . . . . 0.0 113.194 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -103.0 -164.97 25.84 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.016 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . 82.25 28.22 41.38 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.861 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -114.03 106.73 14.75 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.67 145.9 50.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.836 0.35 . . . . 0.0 111.263 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 69.1 m -139.43 130.37 26.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.713 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 55.34 32.24 18.34 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.717 0.636 . . . . 0.0 110.513 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -93.2 133.49 36.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.965 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.6 m -94.04 119.48 41.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.52 0.676 . . . . 0.0 111.376 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.5 HD12 HH12 ' B' ' 57' ' ' ARG . 29.8 tp -111.37 123.58 50.5 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.106 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.73 ' HB3' ' NH1' ' A' ' 193' ' ' ARG . . . -110.91 131.52 54.97 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 173.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.449 ' SD ' ' HB ' ' A' ' 202' ' ' ILE . 70.8 mtm -98.43 177.08 5.46 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.218 0.532 . . . . 0.0 112.032 -171.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.53 23.32 67.92 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.498 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -131.85 -15.04 3.08 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 121.096 -0.241 . . . . 0.0 111.561 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.4 42.48 9.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.063 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.73 ' NH1' ' HB3' ' A' ' 188' ' ' ALA . 70.9 mtm180 -100.69 -0.38 37.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.316 0.579 . . . . 0.0 110.754 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.479 ' HE2' ' HA ' ' A' ' 194' ' ' MET . 0.7 OUTLIER -132.01 168.7 17.48 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 175.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 195' ' ' ILE . 3.4 mp -58.75 129.92 85.32 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.3 133.62 42.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.399 2.066 . . . . 0.0 111.929 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.84 -43.47 1.67 Allowed Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.089 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -63.54 -46.56 85.42 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.46 0.172 . . . . 0.0 111.053 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -86.68 14.17 7.47 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 121.184 0.516 . . . . 0.0 111.126 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.614 ' O ' ' HE2' ' A' ' 203' ' ' LYS . 17.3 t70 -113.62 -41.05 3.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.137 0.494 . . . . 0.0 109.866 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.9 -17.58 67.65 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.577 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.449 ' HB ' ' SD ' ' A' ' 189' ' ' MET . 69.9 mt -67.44 -26.31 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 122.632 -0.334 . . . . 0.0 111.316 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.614 ' HE2' ' O ' ' A' ' 200' ' ' ASP . 46.5 mtmt -57.9 132.74 54.28 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.971 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.6 -12.65 64.57 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.744 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -88.07 160.08 17.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.055 0.427 . . . . 0.0 111.679 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -88.02 176.18 7.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.943 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -91.31 53.29 2.28 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.429 0.633 . . . . 0.0 111.101 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 150.75 44.58 0.02 OUTLIER Glycine 0 C--N 1.307 -1.056 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -125.72 131.39 52.57 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.133 -0.534 . . . . 0.0 110.518 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -108.96 112.06 24.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.032 0.444 . . . . 0.0 109.931 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -132.39 -4.51 3.38 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.949 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 69.4 p 58.34 169.24 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.887 0.875 . . . . 0.0 112.473 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.5 tp -156.48 143.71 10.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.874 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.413 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 28.2 m-20 -95.28 114.89 26.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.373 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 67.9 t -117.99 129.9 73.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 8.7 m -91.31 -24.49 19.8 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -174.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 216' ' ' THR . 64.5 m-85 69.62 158.13 0.15 Allowed Pre-proline 0 N--CA 1.485 1.291 0 CA-C-O 120.849 0.357 . . . . 0.0 110.866 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -86.62 156.32 9.06 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 122.22 1.946 . . . . 0.0 112.089 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.52 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 67.5 mm-40 -66.16 -42.58 88.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.02 65.72 9.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.022 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -103.62 139.93 38.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.671 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -64.92 -18.91 65.63 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.74 110.43 22.52 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.563 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 43.2 tt0 -64.57 -35.14 80.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.019 0.437 . . . . 0.0 111.745 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -70.47 -15.7 62.84 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.554 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.1 mt -114.91 -3.95 12.65 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.5 ptmt -71.72 126.53 29.96 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.696 -176.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.08 29.2 74.23 Favored Glycine 0 C--O 1.24 0.483 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.459 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -125.62 135.48 52.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.907 0.354 . . . . 0.0 110.956 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -79.8 131.89 36.01 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.951 0.405 . . . . 0.0 110.347 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -117.12 157.99 24.98 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.559 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.413 ' HE2' ' OD1' ' A' ' 214' ' ' ASP . 34.4 mmtp -116.0 106.89 14.29 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -83.0 111.71 19.1 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.3 0.571 . . . . 0.0 110.564 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -81.74 90.9 6.39 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.486 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm -88.04 116.93 30.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -104.8 -52.61 2.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.351 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 98.9 mt 65.78 132.75 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.632 0.773 . . . . 0.0 112.557 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -111.44 -66.33 1.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.195 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -100.16 -67.86 0.83 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.387 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 17.1 t 71.08 155.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.279 0.632 . . . . 0.0 111.225 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -80.52 -179.13 7.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.982 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.33 143.79 50.99 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.301 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -175.49 104.63 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.964 0.506 . . . . 0.0 112.322 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -171.83 163.55 6.34 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.431 HD12 ' HD2' ' A' ' 246' ' ' PRO . 35.9 tp 75.67 111.13 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 123.933 0.893 . . . . 0.0 110.721 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.541 ' HA ' HG21 ' A' ' 150' ' ' THR . 92.6 Cg_endo -81.76 140.07 11.42 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.495 2.13 . . . . 0.0 114.315 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -136.16 10.44 3.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.446 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 8.5 mp 70.39 109.55 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.467 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 251' ' ' GLU . 30.6 m -125.93 131.9 52.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.112 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -70.84 -18.77 62.71 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 249' ' ' THR . 47.8 mt-10 -61.89 -45.41 93.89 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -76.33 -26.14 55.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.766 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 250' ' ' ALA . 11.2 tp -73.36 -35.38 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.689 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 22.8 ptmt -92.12 -20.53 21.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -123.5 119.44 29.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.28 0.562 . . . . 0.0 111.953 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.492 ' HA ' ' OE2' ' A' ' 161' ' ' GLU . 56.1 t80 -156.43 83.54 0.98 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.03 -48.96 3.42 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -175.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.36 150.56 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 123.187 0.595 . . . . 0.0 109.877 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.27 -48.73 79.54 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.517 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.88 131.33 4.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.979 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -134.1 -142.86 4.78 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.748 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 21.6 p -142.38 -169.86 3.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.4 -66.14 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.374 0.607 . . . . 0.0 110.512 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.53 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.6 OUTLIER -70.91 -39.91 72.46 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.249 -178.567 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.28 -39.15 96.78 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.642 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.407 ' O ' HG23 ' A' ' 270' ' ' VAL . 52.2 tp -62.41 -43.92 97.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.616 0.246 . . . . 0.0 110.812 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -63.26 -42.46 99.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.171 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -67.89 -43.02 80.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.65 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -67.94 -39.06 83.52 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.991 0.424 . . . . 0.0 110.71 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 266' ' ' LEU . 75.1 t -64.79 -41.73 92.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -55.22 -52.12 64.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.749 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.1 ptmt -65.33 -42.03 93.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.712 0.291 . . . . 0.0 111.689 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.92 -39.78 94.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.701 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 90.7 mmm -63.52 -42.66 98.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.59 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -69.45 -33.48 72.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.62 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -62.45 -43.39 98.94 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.319 0.58 . . . . 0.0 109.661 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -69.42 -33.57 73.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.053 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.64 -40.78 96.1 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.495 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -57.61 -44.4 85.46 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.058 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.2 m -62.69 -42.88 99.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.72 98.84 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.327 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.93 -43.74 97.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.983 0.421 . . . . 0.0 110.031 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -44.61 97.09 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.087 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -64.37 -41.92 96.45 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.449 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.442 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 2.0 tpm_? -60.92 -43.78 98.13 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.032 0.444 . . . . 0.0 110.447 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 94.0 t -68.44 -44.64 83.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.715 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.5 -46.32 88.99 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.122 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.7 p -61.87 -42.64 99.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -67.2 -41.11 86.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.997 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.81 86.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.812 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 295' ' ' VAL . 35.9 mm -64.09 -43.65 97.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.519 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.479 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 19.9 tp10 -61.23 -44.15 97.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.171 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.33 99.28 Favored Glycine 0 C--O 1.24 0.526 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.692 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.78 -42.13 95.31 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 291' ' ' ILE . 85.1 t -63.93 -44.36 97.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.914 -178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LYS . . . . . 0.479 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.6 mttm -62.63 -37.64 87.1 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.78 0.324 . . . . 0.0 111.657 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.59 -30.03 27.3 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -128.84 92.21 3.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -91.28 98.46 11.73 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -103.25 149.11 7.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.391 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.04 135.37 57.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.907 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.64 120.54 44.81 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.068 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.99 131.52 44.07 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.592 2.195 . . . . 0.0 112.471 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.13 75.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.282 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.43 -29.18 63.94 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.681 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.592 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 90.4 mt -93.31 -31.76 14.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.826 0.346 . . . . 0.0 110.855 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 311' ' ' ILE . 95.6 mt -63.68 -46.91 93.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.759 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.12 -39.0 93.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 35.6 p -69.02 -42.38 76.46 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.724 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.655 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 24.6 mm-40 -72.69 -35.74 67.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.48 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 77.4 mt -61.7 -43.8 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.304 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.557 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 30.6 t70 -61.64 -41.94 98.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.928 0.394 . . . . 0.0 111.022 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.0 t -62.1 -43.87 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.899 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 61.7 mt -63.05 -39.28 94.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.818 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.557 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.5 mtm180 -62.04 -42.64 99.39 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -64.08 -37.86 88.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.668 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -61.5 -46.15 91.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.198 0.523 . . . . 0.0 110.043 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.29 -37.2 71.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.429 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.54 72.57 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 120.98 0.419 . . . . 0.0 111.223 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' GLN . . . . . 0.479 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 7.9 tt0 -62.33 -37.81 87.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.458 0.647 . . . . 0.0 109.956 176.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.36 -15.75 59.23 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.583 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -93.56 6.59 47.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.699 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLY . . . . . 0.454 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . 134.44 -22.69 3.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.521 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 109.6 37.53 1.89 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.337 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.431 HD21 ' HB2' ' A' ' 328' ' ' GLN . 27.3 t-20 -79.14 135.9 36.96 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.858 0.361 . . . . 0.0 110.792 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.608 ' OE1' ' HG3' ' A' ' 327' ' ' LYS . 1.7 tm-20 -136.71 152.42 50.35 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.608 ' HG3' ' OE1' ' A' ' 326' ' ' GLU . 32.0 mtmm 70.89 -46.34 0.63 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.553 0.741 . . . . 0.0 112.419 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.431 ' HB2' HD21 ' A' ' 325' ' ' ASN . 17.3 mm100 -68.54 -16.69 63.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.252 0.548 . . . . 0.0 110.065 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.58 -19.05 34.95 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.859 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.522 HD12 HH12 ' A' ' 315' ' ' ARG . 52.8 tp -61.15 -38.7 87.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.774 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -75.34 -19.47 59.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.775 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 81.2 mt -55.52 136.75 70.26 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.425 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.68 127.73 23.81 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.93 2.42 . . . . 0.0 113.057 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.402 HH21 ' HD2' ' A' ' 334' ' ' ARG . 24.8 ttt180 -68.31 -42.17 79.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.263 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -59.07 -36.18 74.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.129 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.88 -39.02 93.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.471 ' CD1' ' HG2' ' A' ' 315' ' ' ARG . 96.9 m-85 -97.06 -15.78 20.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -68.84 -31.6 70.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.81 0.338 . . . . 0.0 111.197 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -61.32 -50.89 71.13 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.823 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -70.64 -28.83 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.838 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.06 -42.17 97.99 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.21 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.8 tttt -59.83 -47.2 86.67 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.187 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.547 ' O ' HG23 ' A' ' 347' ' ' VAL . 13.0 mmt85 -62.94 -44.89 94.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.142 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.468 ' NH2' HD22 ' A' ' 314' ' ' LEU . 93.5 mtt180 -66.58 -38.43 87.03 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.2 t -65.31 -43.17 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.78 0.324 . . . . 0.0 110.35 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 342' ' ' LYS . 74.2 t -60.69 -42.82 93.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.482 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 343' ' ' ARG . 76.5 t -59.68 -44.72 94.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.29 99.59 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.202 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.96 -43.82 97.75 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.891 0.376 . . . . 0.0 110.841 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.31 -44.56 94.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.934 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.16 -41.67 94.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.285 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.97 -42.59 99.75 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.217 -0.516 . . . . 0.0 113.254 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 356' ' ' ARG . 32.1 tp10 -63.23 -44.3 95.62 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.866 0.365 . . . . 0.0 110.759 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.34 -46.26 95.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.029 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.66 -44.72 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.918 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.403 HH22 ' CD ' ' A' ' 353' ' ' GLU . 7.5 tmm_? -69.68 -45.41 68.4 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.8 m -68.89 -43.24 75.68 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -86.15 -1.52 57.5 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.909 0.385 . . . . 0.0 110.663 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 57.63 44.76 20.27 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.08 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.66 149.3 34.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.399 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.77 148.41 32.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.728 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.38 126.75 29.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 367' ' ' VAL . 18.4 t70 -94.44 115.86 28.12 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.769 -176.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 54.3 mm-40 -60.52 -40.22 90.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.564 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.95 -40.11 91.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 110.883 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -64.02 -39.14 93.44 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.598 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 363' ' ' ASP . 90.5 t -62.68 -39.69 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.922 176.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.0 mmmt -57.11 -43.29 82.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.037 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.5 -40.68 99.42 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.035 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.04 -41.09 99.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 109.995 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.67 -42.95 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.453 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.99 -41.59 96.77 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.709 0.29 . . . . 0.0 111.046 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -65.37 -40.29 93.34 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 109.857 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 50.1 ttm -65.71 -41.64 92.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.646 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.9 -27.42 68.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.991 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.3 m -75.76 -3.08 32.89 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.548 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -96.4 4.39 52.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.836 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -125.59 -176.6 3.65 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.737 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.37 -52.83 60.05 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.404 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.596 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 21.3 t70 -125.68 125.58 24.96 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.501 ' O ' HG13 ' A' ' 385' ' ' ILE . 33.7 Cg_endo -64.64 -32.69 57.51 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 121.969 1.779 . . . . 0.0 113.102 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -68.22 -41.55 81.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 13.0 pt-20 -61.17 -38.21 85.69 Favored 'General case' 0 N--CA 1.46 0.068 0 CA-C-O 120.745 0.307 . . . . 0.0 110.177 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.99 -44.01 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.325 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 381' ' ' PRO . 74.0 mt -60.75 -46.86 95.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.4 -43.09 86.77 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.515 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -59.41 -46.82 87.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.946 0.403 . . . . 0.0 110.869 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -68.52 -41.86 79.33 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.813 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.9 p -80.18 -8.03 59.24 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.22 7.96 45.49 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.174 0.511 . . . . 0.0 110.563 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -133.38 110.96 10.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.798 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -62.33 -38.01 87.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.354 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.9 -50.68 71.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.035 0.445 . . . . 0.0 110.394 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.29 -41.98 96.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.442 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.515 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 88.9 mtp -63.33 -48.61 77.29 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.8 -39.46 66.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.612 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.91 -41.15 97.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.466 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 47.7 tpp -65.25 -40.03 93.46 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 395' ' ' MET . 79.2 mtm180 -63.09 -33.56 75.7 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.71 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.68 -41.83 98.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.127 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.15 -45.57 93.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.448 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.39 90.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.915 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 57.3 tp -62.58 -39.36 93.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.498 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 408' ' ' VAL . 38.4 tt0 -61.05 -43.75 98.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -65.78 -35.98 82.23 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.126 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -60.81 -41.52 95.84 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.207 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.36 94.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.687 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.428 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 90.6 t -64.2 -45.4 96.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.014 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.78 -35.87 82.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.535 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.28 98.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.914 0.388 . . . . 0.0 110.4 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 95.4 t -67.75 -43.45 86.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 94.5 mt -61.51 -41.5 97.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.998 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.8 -24.29 67.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.587 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -99.06 -1.99 38.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.334 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.49 172.27 6.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.982 0.42 . . . . 0.0 111.739 -177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.15 127.35 31.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.573 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.21 116.09 46.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 120.882 0.372 . . . . 0.0 110.588 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 10.0 t -115.54 128.84 56.26 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -112.88 123.57 50.63 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.1 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -145.23 150.4 36.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.795 0.331 . . . . 0.0 111.561 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -84.46 162.52 19.89 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.628 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.5 t -158.54 -176.71 6.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.798 0.332 . . . . 0.0 110.631 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 16.5 p -81.76 157.9 24.35 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.274 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -67.53 -35.63 79.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.175 0.512 . . . . 0.0 110.842 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -60.63 -35.85 77.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.109 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -66.37 -30.73 71.17 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.098 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.39 -15.99 58.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.968 0.413 . . . . 0.0 110.788 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 8.8 mmt -78.07 -6.3 54.2 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.77 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -76.18 68.51 2.61 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.509 0.671 . . . . 0.0 109.358 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -99.42 16.01 24.53 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.327 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -63.22 -39.52 94.85 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.754 0 CA-C-O 118.286 -0.864 . . . . 0.0 109.825 179.278 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.727 0.299 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.58 133.8 34.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.345 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.67 162.32 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.675 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 33.8 t -103.47 105.9 16.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.918 0.389 . . . . 0.0 110.326 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 p -146.77 139.52 19.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.728 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 61.2 mt-10 -129.06 172.83 11.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.699 0.285 . . . . 0.0 111.119 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 94.1 m -121.82 129.44 52.63 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.245 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 33.3 m -77.17 -68.8 0.58 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 175.79 139.53 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.512 0.725 . . . . 0.0 109.717 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.84 -122.62 28.26 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.379 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.59 HD23 HG13 ' B' ' 111' ' ' VAL . 78.1 mt -65.79 -39.56 91.08 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 122.868 0.467 . . . . 0.0 110.907 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.582 ' HA2' ' HG2' ' B' ' 108' ' ' GLU . . . -69.39 137.74 29.69 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 115.63 1.012 . . . . 0.0 115.63 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 1.5 tpp180 -126.04 -161.66 1.07 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -161.94 116.27 1.9 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 t -94.26 -91.86 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.138 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m 52.69 85.24 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 CA-C-O 121.28 0.562 . . . . 0.0 110.787 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 tp -114.68 144.84 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.683 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 14.4 p -100.34 126.44 46.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.971 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.45 ' CD1' HG12 ' B' ' 24' ' ' ILE . 6.6 pt -131.22 153.71 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.663 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -75.92 151.27 37.36 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.889 0.476 . . . . 0.0 112.0 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.17 -50.19 69.94 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -65.15 -37.54 87.73 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.596 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -63.71 -43.48 96.45 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.035 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.663 HG13 ' O ' ' B' ' 20' ' ' ALA . 68.8 mt -61.77 -52.58 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.242 0.544 . . . . 0.0 111.517 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -70.05 -39.22 75.84 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.16 -172.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 10.9 m -77.24 -55.7 5.19 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.38 -47.54 60.43 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 96.0 t -64.17 -43.34 97.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.194 -176.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -61.31 -45.22 95.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.39 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 40.4 m -63.07 -42.35 99.64 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.528 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.424 ' O ' HG23 ' B' ' 35' ' ' VAL . 49.0 tp10 -65.93 -36.63 83.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.369 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 91.9 mt -61.93 -42.1 98.71 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.24 -36.63 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.207 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -63.39 -41.13 98.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.621 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 31' ' ' GLU . 96.7 t -63.81 -44.12 98.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.437 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.74 93.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.113 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.04 -33.48 75.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.273 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -59.58 -41.73 90.91 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.642 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 10.8 t -91.08 -1.86 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.23 0.538 . . . . 0.0 110.343 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 65.14 25.13 12.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.259 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -103.93 6.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.622 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -65.84 -29.0 69.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.291 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.7 -3.86 68.78 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.281 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -86.48 -5.76 59.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -93.39 110.67 22.22 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.797 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.72 -42.84 99.49 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.488 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.13 46.1 67.37 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 115.906 1.122 . . . . 0.0 115.906 172.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -61.39 -44.61 96.85 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.174 0.987 . . . . 0.0 108.469 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.451 HG12 ' HB ' ' B' ' 54' ' ' VAL . 3.4 t -105.39 103.84 44.73 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 174.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' B' ' 53' ' ' ILE . 36.2 Cg_endo -64.07 156.36 59.39 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.736 2.291 . . . . 0.0 112.711 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.511 ' HA ' HG12 ' B' ' 54' ' ' VAL . 92.2 mtp -63.45 -24.99 68.07 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -174.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -79.15 -10.02 59.71 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.834 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.637 HD13 ' NH2' ' A' ' 193' ' ' ARG . 93.9 mt -114.94 -46.1 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' B' ' 51' ' ' MET . 14.6 p -63.66 -34.61 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.955 0.407 . . . . 0.0 110.797 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.0 82.89 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.168 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -88.9 -14.97 35.52 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.5 HH12 HD12 ' A' ' 187' ' ' LEU . 67.6 mtt180 -89.87 -30.62 17.77 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.41 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.62 13.3 22.56 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.653 0.739 . . . . 0.0 109.632 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.46 149.45 51.63 Favored Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.447 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.59 -40.89 0.48 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.299 0.64 . . . . 0.0 111.559 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.7 t -60.71 -46.59 89.82 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.734 0.414 . . . . 0.0 110.973 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -123.15 13.08 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.313 0.577 . . . . 0.0 110.845 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -64.1 -19.52 65.32 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.132 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -62.9 -52.69 62.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.817 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.93 -18.38 60.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.08 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 62' ' ' VAL . 75.9 t -64.39 -42.68 96.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 173.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.58 -39.56 94.08 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' B' ' 71' ' ' MET . . . -60.37 -41.28 98.41 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.522 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ASP . . . . . 0.748 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 30.7 t70 -63.51 -44.27 94.79 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.39 -43.62 98.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.988 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' B' ' 68' ' ' GLY . 24.8 ptt? -63.71 -40.43 96.77 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 44.6 m -64.45 -39.38 93.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.081 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.748 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 51.1 mtp85 -62.59 -43.81 97.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.996 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -64.02 -41.9 97.28 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.32 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.71 -48.39 80.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.306 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.476 ' O ' HG13 ' B' ' 79' ' ' ILE . 19.2 tt -67.52 -40.53 84.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.484 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.82 -42.27 95.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.999 0.428 . . . . 0.0 110.139 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.73 -42.28 97.93 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.057 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.476 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.6 pp -67.35 -40.95 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.642 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.95 -44.63 96.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.628 0.728 . . . . 0.0 109.798 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -65.54 -44.63 86.27 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.891 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -89.26 2.14 54.72 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 62.79 52.8 2.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.047 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.0 mt -109.13 126.6 66.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -103.2 108.38 58.68 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.512 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.29 116.26 3.86 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.199 1.933 . . . . 0.0 111.724 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.9 86.58 6.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.069 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 132.04 -168.41 22.49 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.878 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.93 123.11 74.17 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 110.526 -0.176 . . . . 0.0 110.526 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.92 113.72 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.121 1.881 . . . . 0.0 110.713 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 18.3 m -94.96 117.29 29.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.175 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.548 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.3 m-85 -92.04 134.35 34.9 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.44 97.93 25.29 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 90.1 Cg_endo -103.99 -167.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 123.668 2.912 . . . . 0.0 111.159 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -121.07 -174.09 14.85 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.17 146.89 25.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.479 0.639 . . . . 0.0 109.535 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -91.89 127.82 37.5 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.095 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -105.43 126.33 52.0 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 46.6 tp -65.94 113.57 4.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.021 0.439 . . . . 0.0 110.914 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.04 -8.72 42.45 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.12 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -112.55 177.3 4.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 117.415 0.607 . . . . 0.0 111.215 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -80.9 141.52 34.49 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.555 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -93.07 136.42 33.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.97 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 33.1 m -118.58 130.96 56.18 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.955 0.407 . . . . 0.0 111.265 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -130.41 149.06 52.27 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.287 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.5 ' O ' HG12 ' B' ' 107' ' ' VAL . 58.4 m -101.77 -66.01 0.95 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.5 HG12 ' O ' ' B' ' 106' ' ' SER . 0.3 OUTLIER 71.17 150.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 124.17 0.988 . . . . 0.0 110.964 -175.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.582 ' HG2' ' HA2' ' B' ' 12' ' ' GLY . 28.6 mt-10 -132.96 149.47 52.23 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.222 -0.299 . . . . 0.0 110.333 -175.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -155.47 -75.26 0.1 Allowed 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -108.61 162.87 13.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -171.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.59 HG13 HD23 ' B' ' 11' ' ' LEU . 3.6 m -135.68 158.83 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.125 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -161.45 104.61 1.21 Allowed Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.572 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.59 147.91 12.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.026 2.484 . . . . 0.0 114.411 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -140.32 112.54 7.76 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.428 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.4 133.92 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 111.34 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -122.37 141.36 51.65 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.333 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -120.02 150.8 39.98 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.596 0.236 . . . . 0.0 110.698 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -135.46 156.66 48.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.661 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.55 16.96 69.6 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.216 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.7 -38.96 92.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.279 0.561 . . . . 0.0 110.838 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.95 -14.73 63.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.192 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.0 21.52 13.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.878 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 76.5 mt -94.61 109.39 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.417 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -102.33 121.07 41.56 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.38 132.91 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.767 0.317 . . . . 0.0 110.844 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -83.16 139.15 33.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.406 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -123.74 94.11 46.48 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.82 113.46 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.265 1.977 . . . . 0.0 112.095 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.5 mm -102.56 118.31 49.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.048 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.87 160.61 41.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.724 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -133.7 150.27 51.52 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.943 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.71 123.37 19.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 65.2 p -106.99 176.88 5.03 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.854 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.18 -34.77 77.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.602 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.42 97.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.156 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -63.34 -45.46 91.14 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.148 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.7 -45.08 92.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.744 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -59.47 -48.71 80.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.742 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.29 -39.22 96.83 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.036 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.55 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 2.6 tpt -60.91 -47.43 86.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 0.0 110.65 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.66 -41.6 98.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.986 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -60.95 -46.41 90.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.922 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 29.0 m -61.64 -41.74 97.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.643 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.3 mt -60.87 -41.93 96.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.758 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -71.48 -20.47 62.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.779 0.324 . . . . 0.0 111.124 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -89.05 -3.01 58.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.508 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -103.42 -48.22 4.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -62.3 124.03 19.79 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -175.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.87 -167.55 1.97 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.582 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.558 HG21 ' HA ' ' B' ' 246' ' ' PRO . 5.5 m -146.16 169.32 18.97 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' TRP . . . . . 0.53 ' H ' HG22 ' B' ' 150' ' ' THR . 7.1 p-90 -117.78 145.41 44.53 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -175.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' B' ' 151' ' ' TRP . 54.2 tttp 173.41 -65.79 0.01 OUTLIER 'General case' 0 C--N 1.344 0.367 0 O-C-N 123.94 0.775 . . . . 0.0 110.36 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -102.39 175.97 5.33 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 120.861 0.362 . . . . 0.0 111.836 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -83.57 147.2 27.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.959 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 68.44 113.61 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -165.05 -95.21 0.1 Allowed Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.651 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.02 149.69 31.56 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 62.8 t -114.35 128.15 71.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -98.11 -170.86 2.04 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.081 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.99 -67.84 0.44 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -73.96 1.51 10.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' B' ' 188' ' ' ALA . 32.1 t70 -69.61 144.86 52.87 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.629 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -102.83 119.14 38.31 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.737 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 42.1 t -117.15 126.71 74.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.561 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 24.4 m -74.4 106.32 5.96 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 88.2 mt -122.26 122.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.669 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -92.9 90.35 6.95 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -112.85 149.62 32.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.325 0.583 . . . . 0.0 112.16 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 41.5 m -128.8 128.99 45.04 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.19 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.44 135.46 13.31 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.729 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 51.0 m -142.48 145.8 34.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 120.863 0.363 . . . . 0.0 110.909 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.95 94.98 3.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.03 -68.4 0.09 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.96 0.788 . . . . 0.0 112.718 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -140.86 12.09 2.88 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.797 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -136.91 138.33 40.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.491 0.646 . . . . 0.0 110.89 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -79.38 148.98 31.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.253 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -110.89 -174.55 2.5 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -57.31 -48.87 77.84 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -103.35 -162.15 25.34 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.057 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' B' ' 169' ' ' THR . . . 78.78 29.68 50.97 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.676 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -114.85 103.05 10.57 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -131.38 141.52 49.89 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.792 0.33 . . . . 0.0 111.575 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 27.7 m -136.02 133.46 37.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.651 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 55.45 33.09 20.22 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.377 0.423 . . . . 0.0 110.91 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -98.51 133.27 43.11 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.287 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.1 m -94.3 120.68 44.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-O 121.57 0.7 . . . . 0.0 111.282 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.464 HD12 HH12 ' A' ' 57' ' ' ARG . 30.0 tp -111.37 125.0 53.4 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.073 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 188' ' ' ALA . . . . . 0.73 ' HB3' ' NH1' ' B' ' 193' ' ' ARG . . . -111.34 132.75 54.16 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 173.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 189' ' ' MET . . . . . 0.461 ' SD ' ' HB ' ' B' ' 202' ' ' ILE . 69.3 mtm -100.29 176.74 5.27 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.226 0.536 . . . . 0.0 112.287 -171.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 79.22 18.78 73.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.593 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -127.54 -17.94 4.5 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.68 0.276 . . . . 0.0 111.604 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.39 43.38 7.44 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.128 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.73 ' NH1' ' HB3' ' B' ' 188' ' ' ALA . 69.4 mtm180 -100.19 1.11 41.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.369 0.604 . . . . 0.0 110.934 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.469 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.5 OUTLIER -134.19 169.16 17.59 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.637 175.164 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.461 ' H ' HD12 ' B' ' 195' ' ' ILE . 3.1 mp -58.07 131.04 83.61 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.03 134.76 50.33 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.216 1.944 . . . . 0.0 111.56 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.56 -43.2 1.76 Allowed Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -63.78 -47.55 80.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 120.447 0.165 . . . . 0.0 111.174 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -86.54 14.51 6.72 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.262 0.553 . . . . 0.0 110.923 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 200' ' ' ASP . . . . . 0.665 ' O ' ' HE2' ' B' ' 203' ' ' LYS . 21.2 t70 -113.22 -38.76 4.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.221 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -71.13 -15.51 74.51 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.546 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.461 ' HB ' ' SD ' ' B' ' 189' ' ' MET . 69.7 mt -68.63 -25.99 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 O-C-N 122.596 -0.355 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.665 ' HE2' ' O ' ' B' ' 200' ' ' ASP . 45.0 mtmt -58.09 131.33 50.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.42 -8.09 66.51 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.731 -0.747 . . . . 0.0 114.018 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -89.73 161.08 16.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.302 0.551 . . . . 0.0 111.636 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.69 176.19 7.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.061 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -91.33 55.61 2.86 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.224 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 147.68 43.16 0.03 OUTLIER Glycine 0 C--N 1.308 -0.996 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -125.36 131.41 52.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.254 -0.473 . . . . 0.0 110.766 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -105.45 112.87 26.13 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.679 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -134.09 -3.74 2.79 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.102 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 66.3 p 58.72 169.89 0.06 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.932 0.893 . . . . 0.0 112.421 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.6 tp -157.81 143.93 8.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.59 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -97.65 113.68 25.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.515 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 61.2 t -116.43 130.1 71.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 7.3 m -92.59 -23.94 18.87 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.9 m-85 69.51 159.57 0.15 Allowed Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.885 -175.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -88.3 156.92 6.77 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.177 1.918 . . . . 0.0 111.755 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' GLU . . . . . 0.451 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 70.7 mm-40 -67.61 -39.71 84.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -84.99 72.0 10.87 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.671 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -115.52 138.11 51.37 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -63.92 -19.83 65.4 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -100.78 107.56 19.15 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 37.8 tt0 -64.0 -33.17 75.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.49 -175.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -74.71 -11.63 60.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.82 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -117.92 -4.3 11.1 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.8 ptmt -69.23 125.07 25.55 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.127 0.489 . . . . 0.0 111.743 -176.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 63.65 27.12 70.53 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.572 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.14 133.57 55.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.323 0.562 . . . . 0.0 110.974 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -75.26 134.81 41.02 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.957 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.47 154.44 37.8 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.399 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -111.33 107.19 16.37 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -83.56 109.72 17.63 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.2 0.524 . . . . 0.0 110.486 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.93 98.27 7.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.509 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.2 mm -97.11 114.55 34.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.154 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -104.18 -51.89 3.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.035 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 96.1 mt 65.75 144.02 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.549 0.739 . . . . 0.0 112.076 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.04 -63.86 1.22 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.612 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -99.64 -69.36 0.77 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.668 0.27 . . . . 0.0 111.582 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 15.5 t 70.8 154.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.412 0.685 . . . . 0.0 111.166 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.42 -179.64 7.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.905 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.36 141.04 50.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.182 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.433 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 1.4 ptp180 -174.71 105.33 0.1 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.139 0.495 . . . . 0.0 112.228 177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -170.71 163.52 8.01 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 30.6 tp 74.75 114.95 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 123.76 0.824 . . . . 0.0 110.83 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 246' ' ' PRO . . . . . 0.558 ' HA ' HG21 ' B' ' 150' ' ' THR . 90.9 Cg_endo -84.0 134.65 6.22 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.477 2.118 . . . . 0.0 114.624 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -130.38 13.97 5.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.528 173.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 8.3 mp 66.26 105.68 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.876 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 249' ' ' THR . . . . . 0.605 HG22 ' H ' ' B' ' 251' ' ' GLU . 27.6 m -123.6 133.99 53.86 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.021 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.425 ' O ' HG22 ' B' ' 253' ' ' ILE . . . -74.6 -12.98 60.59 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.605 ' H ' HG22 ' B' ' 249' ' ' THR . 51.7 mt-10 -62.44 -43.48 98.71 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -85.08 -8.95 58.44 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' ILE . . . . . 0.425 HG22 ' O ' ' B' ' 250' ' ' ALA . 10.9 tp -91.66 -17.52 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.498 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 254' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' B' ' 260' ' ' ASP . 21.9 ptmt -106.37 -16.49 14.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.765 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -125.18 127.9 47.52 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.043 0.449 . . . . 0.0 112.095 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -168.33 82.21 0.17 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 78.25 -47.02 2.84 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.583 -175.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.49 152.23 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 122.961 0.505 . . . . 0.0 110.264 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -58.35 -51.56 69.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 260' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' B' ' 254' ' ' LYS . 2.8 p-10 -160.95 126.18 3.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.124 0.488 . . . . 0.0 109.95 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -130.98 -154.51 7.92 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.737 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 30.7 p -127.08 -164.02 1.31 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 122.53 0.332 . . . . 0.0 110.215 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.48 -63.5 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.173 0.511 . . . . 0.0 110.536 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.2 OUTLIER -72.86 -39.59 66.37 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.934 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.25 -38.46 95.93 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.463 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.97 -43.87 97.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.679 0.276 . . . . 0.0 110.543 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -64.23 -42.02 96.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.995 0.426 . . . . 0.0 110.155 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -68.43 -41.9 79.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.6 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -68.55 -40.11 80.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 110.701 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.36 -41.32 92.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -54.44 -51.5 64.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.624 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 15.9 ptmt -67.1 -40.25 86.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.67 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.39 -39.24 93.48 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.446 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.1 mmm -63.39 -43.61 97.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.61 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.75 -33.45 72.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.924 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -60.15 -44.37 95.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.388 0.613 . . . . 0.0 109.351 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.19 -35.07 75.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.017 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.422 ' O ' HG13 ' B' ' 282' ' ' ILE . 54.2 tp -61.59 -41.26 97.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.785 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -57.78 -43.51 85.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.084 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 24.6 m -62.0 -42.66 99.4 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.511 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.46 96.13 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.435 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 282' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 278' ' ' LEU . 63.8 mt -63.31 -44.23 99.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.465 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.93 -44.57 94.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.84 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -64.89 -42.32 94.9 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.388 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -60.71 -43.88 97.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.639 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 98.3 t -69.36 -44.44 80.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.641 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 287' ' ' LYS . . . . . 0.416 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.0 tttt -62.5 -46.57 87.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.928 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 69.8 p -61.79 -43.39 98.94 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -66.46 -40.42 89.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.817 0.341 . . . . 0.0 111.156 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.14 -47.43 84.58 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.729 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 291' ' ' ILE . . . . . 0.447 ' O ' HG23 ' B' ' 295' ' ' VAL . 48.2 mm -64.35 -44.17 97.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.888 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -60.54 -44.08 96.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.288 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.67 99.25 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.323 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.16 -42.19 93.97 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 291' ' ' ILE . 76.1 t -63.82 -44.2 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.612 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.6 -41.92 99.26 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.169 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -72.25 -39.13 68.66 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -126.68 98.39 5.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -92.77 96.08 9.93 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.9 tp -100.98 148.17 7.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.828 -175.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -61.7 134.93 57.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.225 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.3 122.71 38.79 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.939 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.19 131.59 46.05 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.735 2.29 . . . . 0.0 112.555 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.98 79.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.181 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.07 67.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.443 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 306' ' ' LEU . . . . . 0.435 ' O ' ' HG2' ' B' ' 310' ' ' GLU . 92.7 mt -87.01 -33.83 19.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.413 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 307' ' ' ILE . . . . . 0.417 ' O ' HG13 ' B' ' 311' ' ' ILE . 97.0 mt -62.65 -48.28 88.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.787 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.05 -42.13 99.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -176.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 32.2 p -65.75 -39.98 91.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.731 0.3 . . . . 0.0 111.702 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 310' ' ' GLU . . . . . 0.627 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 62.3 mm-40 -72.79 -36.87 67.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 81.1 mt -62.14 -43.45 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.556 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 35.9 t70 -61.26 -41.87 97.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.869 0.366 . . . . 0.0 111.024 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.12 -43.93 99.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.991 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 64.2 mt -63.08 -38.86 92.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.894 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.556 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 74.5 mtm180 -61.36 -42.53 98.85 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -64.1 -38.54 91.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.651 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.01 -45.33 94.07 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.221 0.534 . . . . 0.0 110.31 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.8 -37.49 70.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.413 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.08 72.37 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.061 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 320' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 7.9 tt0 -62.52 -39.64 94.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.337 0.589 . . . . 0.0 109.943 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -73.25 -20.38 60.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.562 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -89.95 3.87 51.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.012 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 323' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 136.42 -21.93 3.4 Favored Glycine 0 CA--C 1.508 -0.39 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.843 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 324' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 109.84 36.27 2.06 Favored Glycine 0 CA--C 1.502 -0.764 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.211 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 325' ' ' ASN . . . . . 0.454 HD21 ' HB2' ' B' ' 328' ' ' GLN . 26.9 t-20 -77.56 133.9 38.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.793 0.33 . . . . 0.0 110.527 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 326' ' ' GLU . . . . . 0.633 ' OE1' ' HG3' ' B' ' 327' ' ' LYS . 1.8 tm-20 -135.89 151.12 49.68 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.633 ' HG3' ' OE1' ' B' ' 326' ' ' GLU . 31.5 mtmm 71.39 -45.54 0.62 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.552 0.741 . . . . 0.0 112.259 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 328' ' ' GLN . . . . . 0.454 ' HB2' HD21 ' B' ' 325' ' ' ASN . 17.1 mm100 -70.16 -13.74 62.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.262 0.553 . . . . 0.0 110.0 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.74 -17.81 57.27 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.622 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.37 -38.02 85.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.476 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -78.03 -15.51 58.87 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.756 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 76.6 mt -57.61 137.37 82.32 Favored Pre-proline 0 C--O 1.238 0.5 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.982 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -51.3 125.62 16.97 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.051 2.501 . . . . 0.0 112.92 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -68.03 -40.78 82.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.619 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.7 pm0 -60.39 -35.58 76.07 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.224 0.454 . . . . 0.0 112.224 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.45 -39.26 94.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.934 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -95.64 -17.13 21.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.38 -32.07 72.74 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.78 -51.04 68.65 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.686 0.279 . . . . 0.0 111.056 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -70.0 -29.32 66.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.729 0.299 . . . . 0.0 110.798 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.442 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -60.58 -43.99 96.73 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 342' ' ' LYS . . . . . 0.476 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.6 tttt -59.58 -46.55 88.6 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.469 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 343' ' ' ARG . . . . . 0.528 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.0 mmt85 -62.03 -45.3 94.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 344' ' ' ARG . . . . . 0.413 ' NH2' HD22 ' B' ' 314' ' ' LEU . 94.9 mtt180 -66.57 -38.34 86.85 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.519 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 341' ' ' ALA . 73.4 t -64.77 -43.46 96.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 120.724 0.297 . . . . 0.0 110.393 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 342' ' ' LYS . 79.4 t -60.7 -43.15 94.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.364 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.528 HG23 ' O ' ' B' ' 343' ' ' ARG . 69.5 t -59.76 -44.8 94.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.41 -41.38 99.52 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.15 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.78 -43.48 98.68 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.732 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 97.6 mt -63.73 -44.29 94.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.891 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.5 -42.46 95.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.507 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.16 -41.69 99.63 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.431 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -64.68 -42.83 95.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.04 -45.14 97.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.82 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.42 -44.73 99.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.797 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -70.8 -45.42 64.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.958 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 98.5 m -67.48 -44.97 77.25 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -86.81 -5.25 59.17 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.604 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 57.69 74.21 0.43 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.981 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.97 144.98 31.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.13 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.63 146.99 35.07 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.205 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.84 115.31 5.19 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 363' ' ' ASP . . . . . 0.539 ' O ' HG23 ' B' ' 367' ' ' VAL . 16.1 t70 -84.0 117.79 23.62 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.3 -176.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 364' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 47.0 mm-40 -60.45 -39.53 87.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.313 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -65.73 -40.18 91.91 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.699 0.285 . . . . 0.0 110.759 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -62.91 -38.47 91.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.092 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 367' ' ' VAL . . . . . 0.539 HG23 ' O ' ' B' ' 363' ' ' ASP . 95.4 t -63.56 -40.92 90.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.636 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 368' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 29.6 mmmt -57.61 -43.43 84.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.306 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.9 -41.77 99.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.798 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.97 -41.24 99.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.398 . . . . 0.0 110.03 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.4 -43.21 98.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.375 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.44 -40.38 96.41 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.421 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.48 -39.66 88.9 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.914 0.388 . . . . 0.0 110.35 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 50.5 ttm -65.17 -40.66 94.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.562 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 375' ' ' ALA . . . . . 0.41 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -62.1 -28.59 69.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.796 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 30.5 m -79.5 16.2 1.11 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.161 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -114.18 4.49 15.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.164 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -126.63 -172.58 2.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.186 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -62.88 -62.11 1.94 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.449 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 380' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 18.9 t70 -119.03 127.24 26.62 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.075 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 381' ' ' PRO . . . . . 0.41 ' HA ' ' HB1' ' B' ' 375' ' ' ALA . 35.5 Cg_endo -66.14 -31.76 44.51 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.156 1.904 . . . . 0.0 112.818 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -67.06 -43.08 83.59 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 11.9 pt-20 -61.39 -37.86 84.97 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.56 -43.21 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.982 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.2 -44.59 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.854 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.88 -45.07 79.19 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.159 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -58.98 -46.76 87.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.856 0.36 . . . . 0.0 111.201 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -68.57 -41.9 79.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.919 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 70.3 p -78.3 -10.82 59.83 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.53 6.17 49.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.096 0.474 . . . . 0.0 110.623 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -129.27 111.9 13.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.327 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.75 -39.75 95.12 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -57.63 -51.06 71.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.899 0.381 . . . . 0.0 110.638 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.51 -41.71 98.52 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.386 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.545 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 88.6 mtp -63.36 -47.65 81.2 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -73.25 -40.52 64.57 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.825 -174.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -62.75 -41.25 99.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.211 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 46.9 tpp -64.22 -39.98 95.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.647 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' B' ' 395' ' ' MET . 77.3 mtm180 -64.15 -34.26 77.67 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.771 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.63 -42.7 99.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.823 0.344 . . . . 0.0 110.083 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.58 -44.78 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.512 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.29 -38.91 93.02 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.838 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.38 -38.89 92.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.343 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 404' ' ' GLU . . . . . 0.402 ' O ' HG23 ' B' ' 408' ' ' VAL . 39.8 tt0 -59.38 -43.75 92.87 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.452 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.44 -35.89 80.11 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.051 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -60.12 -41.68 93.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.921 0.391 . . . . 0.0 110.397 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.06 96.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.552 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 408' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 93.3 t -64.53 -45.61 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -65.92 -35.63 81.14 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.69 92.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.936 0.398 . . . . 0.0 110.242 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.38 -43.38 84.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.496 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 94.5 mt -61.6 -41.33 97.29 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.264 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.61 -19.53 64.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.744 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -102.83 1.47 34.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.185 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -113.09 172.31 7.02 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.111 0.482 . . . . 0.0 111.589 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -79.3 129.44 34.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.456 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 36.3 t -104.02 109.83 28.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.979 0.418 . . . . 0.0 110.943 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 6.7 t -108.2 128.52 54.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.929 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -116.59 121.17 40.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.252 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -144.82 153.06 41.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.22 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -86.79 163.62 17.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -159.0 -178.22 7.07 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 21.5 p -82.91 157.16 23.16 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.9 0.381 . . . . 0.0 111.263 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -67.8 -27.7 66.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.159 0.504 . . . . 0.0 110.311 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -61.9 -39.77 93.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.834 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.49 -31.23 71.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.104 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.56 -13.45 59.82 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.893 0.377 . . . . 0.0 111.022 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.8 mmt -80.39 -5.07 55.89 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.041 0.448 . . . . 0.0 110.589 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -76.28 69.47 2.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.57 0.7 . . . . 0.0 109.507 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -100.47 18.5 18.89 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.013 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -68.2 -33.38 74.31 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.989 0.423 . . . . 0.0 110.304 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.642 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.502 -179.693 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -97.37 136.44 37.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.87 0.367 . . . . 0.0 111.019 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.91 137.04 56.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.436 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.9 p -84.65 87.19 7.27 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.19 136.44 55.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -119.95 153.87 35.31 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.523 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 77.9 m -98.09 123.39 42.1 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.499 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 m -79.34 -56.14 4.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.138 0.494 . . . . 0.0 111.47 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -169.08 100.35 0.37 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.22 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.7 -106.21 1.21 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.863 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 109' ' ' PHE . 7.3 mp -67.36 -38.66 85.13 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 122.4 0.28 . . . . 0.0 111.081 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 106' ' ' SER . . . -57.94 137.02 50.3 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.51 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -140.69 144.3 35.56 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.532 0.206 . . . . 0.0 110.793 -177.081 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -115.88 129.04 56.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.5 t -89.52 -87.81 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.71 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.8 p 43.4 80.46 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 89.4 mt -109.81 132.09 58.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.5 m -97.72 123.78 41.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.8 pt -123.54 164.05 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.67 0.271 . . . . 0.0 111.474 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.487 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.24 152.18 44.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.822 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.61 -44.71 81.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.648 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.96 -36.43 84.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.203 0.525 . . . . 0.0 110.386 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 m -66.23 -34.4 77.93 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.45 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.5 mt -61.37 -48.94 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 111.624 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.513 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 55.4 mm-40 -81.47 -13.59 58.0 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -93.13 -59.83 1.94 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.099 -0.641 . . . . 0.0 111.5 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.41 -50.04 35.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 98.8 t -63.35 -43.89 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.584 0.23 . . . . 0.0 111.478 -175.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 17.1 ttmm -61.71 -45.99 91.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.54 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.8 m -66.88 -40.65 87.87 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.739 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -62.85 -41.08 99.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.731 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.4 mt -62.77 -42.64 99.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.767 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.34 -35.89 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.201 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -64.04 -42.88 96.91 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.03 -29.87 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.907 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.36 -43.19 95.31 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.52 -37.39 86.64 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.679 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -60.48 -35.57 76.23 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.471 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 t -93.02 -5.35 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 121.414 0.626 . . . . 0.0 109.939 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 62.79 28.56 16.52 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.601 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.8 pp -101.83 6.1 10.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.45 0.643 . . . . 0.0 111.158 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -64.6 -29.83 70.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.71 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.6 -1.14 70.15 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.448 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -94.49 6.41 48.89 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.53 -0.394 . . . . 0.0 111.73 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.2 ttt85 -111.61 98.65 7.58 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.222 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -65.57 -43.44 89.79 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.515 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.63 70.74 1.19 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 173.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -65.63 -41.58 92.49 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 171.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.28 107.81 60.59 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.956 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD2' HD12 ' A' ' 53' ' ' ILE . 46.1 Cg_exo -56.55 151.06 48.32 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.083 2.522 . . . . 0.0 113.114 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.524 ' HA ' HG22 ' A' ' 54' ' ' VAL . 14.6 ttt -60.81 -39.39 88.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.018 -173.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -66.59 -20.74 66.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.057 0.456 . . . . 0.0 110.837 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.492 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 97.4 mt -92.22 -37.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.701 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.524 HG22 ' HA ' ' A' ' 51' ' ' MET . 25.3 m -63.98 -36.37 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.491 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.94 -37.36 87.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.864 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.604 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.6 pt20 -80.47 -19.53 45.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.668 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.604 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 63.3 mtt180 -106.9 -27.14 10.89 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -175.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -107.74 5.31 26.56 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.519 0.675 . . . . 0.0 109.854 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 61' ' ' SER . . . -70.66 153.03 51.2 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 176.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.411 ' H ' ' HB2' ' A' ' 63' ' ' ARG . . . 70.32 -24.84 0.16 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.211 0.604 . . . . 0.0 111.928 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 59' ' ' GLY . 36.1 t -78.2 -61.88 1.86 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.887 0.375 . . . . 0.0 110.371 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.4 p -103.77 12.15 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.449 0.642 . . . . 0.0 110.142 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HB2' ' H ' ' A' ' 60' ' ' ALA . 41.3 ttm180 -58.96 -30.14 67.68 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.738 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -57.57 -50.28 73.64 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.063 0.459 . . . . 0.0 110.473 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.39 -23.08 54.06 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.503 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 62' ' ' VAL . 73.1 t -64.47 -43.73 96.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 174.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.06 -39.76 95.69 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.415 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.07 99.69 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.717 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 11.5 t70 -62.0 -45.6 92.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.888 0.375 . . . . 0.0 110.29 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.69 -41.87 99.33 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.458 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.9 tpt -61.57 -42.12 98.39 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -60.98 -43.04 99.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.738 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 96.9 mtt-85 -66.05 -40.61 91.1 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.333 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -63.48 -42.43 98.56 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.405 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -61.64 -51.02 70.21 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.896 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.57 -41.69 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.6 -39.97 88.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.058 0.456 . . . . 0.0 110.302 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -68.69 -42.85 77.19 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 pp -64.97 -32.06 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.895 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.7 -43.92 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.909 0.385 . . . . 0.0 110.886 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 17.8 ptpt -78.38 -26.96 46.73 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.667 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -86.5 -5.14 59.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.892 0.377 . . . . 0.0 110.642 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 66.57 40.28 3.47 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.517 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 84.6 mt -102.23 122.22 54.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -106.73 110.76 63.9 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.48 114.55 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.288 1.992 . . . . 0.0 111.416 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.24 126.19 30.52 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.711 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.19 -116.53 7.23 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.852 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.77 114.46 6.02 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.48 156.82 60.67 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 122.635 2.223 . . . . 0.0 111.378 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.6 m -104.3 119.08 38.17 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.51 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -74.41 -21.42 59.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.234 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t 48.42 80.04 0.32 Allowed Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 123.968 0.907 . . . . 0.0 112.894 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.98 122.03 6.08 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.255 1.97 . . . . 0.0 110.725 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.84 -176.35 51.44 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.295 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.39 121.82 25.63 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.116 0.484 . . . . 0.0 110.258 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -82.6 111.9 19.0 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.488 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 98.6 mttt -91.17 129.97 37.1 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.5 tp -75.69 114.07 13.86 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.03 0.443 . . . . 0.0 110.611 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.02 4.82 59.91 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.326 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.8 mt-10 -127.38 168.32 14.99 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.717 -0.284 . . . . 0.0 110.568 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.68 142.89 54.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.074 0.464 . . . . 0.0 111.832 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -102.46 147.72 26.39 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.468 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.2 m -122.74 132.07 54.07 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -147.01 161.09 41.53 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.544 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 33.1 p -96.6 -84.48 0.36 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 106' ' ' SER . 86.9 t 75.35 112.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -173.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -103.99 122.93 46.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.08 -173.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.438 ' N ' HD23 ' A' ' 11' ' ' LEU 0.253 19.7 p90 -138.29 -95.23 0.19 Allowed 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 174.675 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -157.69 147.16 19.98 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.0 0.818 . . . . 0.0 111.862 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.9 m -141.28 167.81 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.078 0.551 . . . . 0.0 111.824 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -109.61 107.15 59.19 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.433 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -93.06 153.99 2.63 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.992 2.462 . . . . 0.0 112.924 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.74 143.43 17.23 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.5 t -132.23 137.8 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -175.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -84.78 141.47 30.49 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.557 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.01 143.62 50.81 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -138.38 154.33 48.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.616 0.246 . . . . 0.0 111.089 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.84 15.73 79.5 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 114.089 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.96 -40.74 97.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.974 0.416 . . . . 0.0 111.512 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -73.69 -3.68 29.76 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.704 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.59 4.99 43.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.968 0.413 . . . . 0.0 111.131 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.7 mt -87.39 126.59 41.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.53 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -107.45 116.79 32.56 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.16 133.84 47.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.136 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -85.72 144.06 28.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.478 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -132.89 101.27 14.03 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.41 138.09 58.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.251 1.967 . . . . 0.0 111.506 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 421' ' ' GLU . 48.4 mm -116.17 121.14 66.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.9 161.2 41.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.391 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -152.76 166.09 33.31 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.881 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.42 128.98 38.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.097 0.475 . . . . 0.0 111.337 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 65.8 p -109.36 173.83 6.14 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.535 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.82 -35.11 79.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.72 -37.42 81.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.374 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -63.43 -40.57 97.54 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.549 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.32 -46.04 96.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.516 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.37 -44.65 95.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.356 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.68 -41.52 99.81 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.653 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.606 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.4 tpt -61.26 -48.46 81.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.687 0.28 . . . . 0.0 110.543 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.96 -42.27 97.33 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.074 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.49 -47.64 85.25 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.945 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.6 m -62.84 -41.5 99.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.694 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 140' ' ' MET . 87.5 mt -61.34 -40.26 93.6 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -72.57 -17.09 61.74 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.978 0.418 . . . . 0.0 111.135 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.83 -0.45 55.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.901 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -116.28 30.93 7.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.662 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -134.65 79.22 1.79 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.29 121.24 37.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.322 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.626 HG21 ' H ' ' A' ' 247' ' ' GLU . 35.4 m -74.72 159.93 31.41 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.398 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 36.8 t-105 -80.28 124.84 29.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.126 0.488 . . . . 0.0 110.894 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.409 ' HG3' ' OE2' ' A' ' 153' ' ' GLU . 18.5 tptm -143.53 169.13 18.28 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.409 ' OE2' ' HG3' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -82.52 -3.21 55.54 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -175.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 155' ' ' ASP . 21.8 pttp -163.78 -172.9 3.03 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.719 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 0.6 OUTLIER 91.46 122.19 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.332 1.453 . . . . 0.0 112.683 177.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -68.15 93.99 0.3 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 114.71 -1.132 . . . . 0.0 114.766 -174.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -151.01 127.44 10.7 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.83 122.2 60.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -103.86 157.76 16.87 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.5 26.36 0.17 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.928 0.491 . . . . 0.0 112.22 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -139.68 -4.87 1.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.213 0.53 . . . . 0.0 109.91 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -83.58 158.17 22.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.352 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -102.72 98.46 8.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.795 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.5 t -97.86 123.01 50.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.73 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.1 m -79.49 107.49 12.31 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.1 mt -121.42 123.27 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 121.095 0.474 . . . . 0.0 111.929 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.495 ' HB2' ' HD3' ' A' ' 238' ' ' LYS . 23.5 m-20 -96.28 108.43 20.92 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -126.23 147.87 49.58 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.616 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.6 m -119.74 129.19 54.38 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.114 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.11 122.37 5.73 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.299 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.3 p -136.59 124.49 22.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.04 -85.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.787 0.327 . . . . 0.0 110.787 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -103.06 2.98 35.54 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.503 0.668 . . . . 0.0 110.006 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.26 -3.93 2.51 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.376 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -113.47 143.3 44.73 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.21 157.1 33.0 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.721 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -129.39 -177.77 4.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.246 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.19 -41.61 88.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.168 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.1 -178.59 38.85 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.312 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.05 24.99 50.73 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.449 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.0 98.89 8.52 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -130.34 143.79 50.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.095 0.474 . . . . 0.0 111.8 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.4 m -148.73 122.54 9.31 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.996 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 60.51 31.42 20.28 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.334 0.588 . . . . 0.0 109.968 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -86.18 137.68 32.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.909 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.0 m -105.01 125.33 60.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.604 0.716 . . . . 0.0 111.175 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.49 ' CD1' HH12 ' B' ' 57' ' ' ARG . 49.5 tp -114.42 118.19 33.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.212 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -93.86 110.86 22.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 63.0 mtp -83.25 152.9 24.97 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.839 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.9 -20.97 45.58 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.051 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -89.08 -10.91 45.63 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.92 50.95 4.97 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.15 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 188' ' ' ALA . 35.2 mmm-85 -90.49 -11.44 40.24 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.911 -0.644 . . . . 0.0 110.106 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.35 -176.74 4.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.716 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.2 mm -63.58 133.71 95.62 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.904 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.41 120.89 5.55 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.066 2.511 . . . . 0.0 112.679 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.52 -36.19 4.57 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.488 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -62.5 -48.02 81.38 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -78.85 -9.24 59.41 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.8 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -91.49 -29.26 17.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.253 0.549 . . . . 0.0 109.648 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.9 -22.63 75.78 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.881 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.21 -42.49 96.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.97 0.414 . . . . 0.0 110.171 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -53.76 131.17 38.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.118 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.67 -7.99 39.58 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.689 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -96.94 160.09 14.55 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.03 156.43 16.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.652 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.5 129.73 41.44 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.913 0.387 . . . . 0.0 110.713 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 73.63 50.99 10.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.711 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -136.02 140.96 44.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.674 0.273 . . . . 0.0 110.705 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -115.93 135.41 54.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -153.25 -13.61 0.15 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.409 -0.516 . . . . 0.0 112.276 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 30.3 p 61.71 166.87 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.97 0.908 . . . . 0.0 112.064 -175.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.6 tp -156.15 114.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.083 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.09 106.53 7.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.986 0.422 . . . . 0.0 110.873 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 78.4 t -108.95 118.91 57.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.536 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 4.8 m -69.48 -35.06 75.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 216' ' ' THR . 70.5 m-85 75.69 150.99 0.13 Allowed Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 123.133 0.573 . . . . 0.0 109.498 -172.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.18 153.67 32.03 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.641 1.56 . . . . 0.0 111.474 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.561 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 64.3 mm-40 -64.02 -33.72 76.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 109.842 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -87.92 28.17 1.07 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.332 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 10.1 t80 -73.42 132.85 43.44 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -64.89 -17.42 64.3 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.503 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -94.76 110.51 22.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 36.0 tt0 -61.56 -38.59 88.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.859 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.434 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 28.2 p30 -71.98 -9.51 58.48 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.434 ' HG ' ' OD1' ' A' ' 225' ' ' ASN . 95.5 mt -122.57 0.85 9.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.561 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.8 ptmt -70.93 110.81 5.88 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.521 0.677 . . . . 0.0 112.733 -175.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.77 12.64 83.98 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.498 -0.774 . . . . 0.0 114.097 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -118.26 127.93 54.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.357 0.578 . . . . 0.0 110.732 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -71.32 136.24 47.76 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.7 139.37 47.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.324 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -70.51 -43.37 69.8 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 212' ' ' THR . 79.5 m-85 58.39 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.078 0.551 . . . . 0.0 112.133 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.67 -50.81 72.02 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.9 mm 62.69 81.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.133 0.492 . . . . 0.0 111.235 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -66.06 -40.89 91.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.229 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.472 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 10.5 tp 50.6 82.96 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.722 0.809 . . . . 0.0 110.612 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.495 ' HD3' ' HB2' ' A' ' 167' ' ' ASP . 52.5 mtpt -93.51 -51.0 5.16 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -173.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -100.27 -92.04 0.29 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.0 t 75.43 129.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.165 0.586 . . . . 0.0 111.086 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -69.01 -35.67 76.92 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.501 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 155' ' ' ASP . 13.1 pt-20 57.86 117.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 125.34 1.456 . . . . 0.0 114.175 177.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -143.5 124.12 14.08 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.154 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 245' ' ' LEU . 0.3 OUTLIER -148.36 -175.6 4.98 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.46 ' H ' ' CD ' ' A' ' 244' ' ' GLU . 66.1 mt 73.21 105.47 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 111.099 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.597 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 64.1 Cg_endo -78.87 111.77 3.01 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.408 2.072 . . . . 0.0 113.76 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.626 ' H ' HG21 ' A' ' 150' ' ' THR . 12.6 pt-20 -135.77 17.82 3.29 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.135 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 52.7 tp 77.13 132.74 0.05 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 176.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 251' ' ' GLU . 23.0 m -142.16 137.96 31.23 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.228 176.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -77.74 -9.12 58.84 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLU . . . . . 0.428 ' H ' HG22 ' A' ' 249' ' ' THR . 39.6 mt-10 -85.26 -25.12 27.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -176.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -65.24 -22.24 66.85 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 119.779 -0.769 . . . . 0.0 113.034 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 34.8 pt -74.05 -9.57 13.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -137.67 25.67 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.919 0.39 . . . . 0.0 111.731 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -115.54 15.67 16.63 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.208 0.528 . . . . 0.0 111.63 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -94.49 14.96 19.11 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.31 -31.34 8.77 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.123 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.8 144.38 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -53.46 -47.91 69.32 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.264 0.353 . . . . 0.0 111.93 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -173.64 157.33 3.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.1 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -160.37 172.41 36.78 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.617 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 80.5 p -96.53 -134.99 0.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.711 0.255 . . . . 0.0 110.83 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 52.8 t -103.33 -68.8 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.12 0.486 . . . . 0.0 109.95 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.2 OUTLIER -70.34 -37.29 74.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.864 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.22 -37.52 94.64 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.763 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.62 -43.8 97.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.868 0.365 . . . . 0.0 110.091 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -62.73 -40.77 98.24 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.688 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.65 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.47 -47.16 85.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.146 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 272' ' ' LYS . 41.6 tp10 -65.85 -40.91 92.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.926 0.394 . . . . 0.0 111.182 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 80.2 t -64.66 -42.92 96.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.374 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -59.34 -48.82 80.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.835 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 10.0 ptmt -62.96 -44.03 97.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.756 0.312 . . . . 0.0 111.206 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -64.97 -39.25 93.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.372 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 90.5 mmm -63.8 -41.7 97.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 110.672 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.85 -35.72 80.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.417 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.5 -41.26 96.53 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.321 0.581 . . . . 0.0 109.603 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -66.59 -36.86 83.65 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.703 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 45.5 tp -62.39 -38.89 91.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.048 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -57.17 -44.14 83.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.198 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.6 m -61.7 -42.8 99.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.649 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.56 97.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.261 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.04 -44.09 97.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.175 0.512 . . . . 0.0 110.013 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -61.57 -44.47 96.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.657 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -64.04 -42.15 97.17 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.899 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.508 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.4 tpm_? -61.34 -43.57 98.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.526 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 85.4 t -70.32 -44.39 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.272 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.8 -48.81 80.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.557 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 65.2 p -65.37 -42.89 92.28 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -65.81 -41.1 92.29 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.7 0.286 . . . . 0.0 111.712 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.89 80.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 295' ' ' VAL . 36.9 mm -66.05 -43.57 92.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.511 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -57.87 -44.47 86.63 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.217 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.43 -41.89 99.74 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.807 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.4 -43.31 97.92 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 291' ' ' ILE . 97.0 t -62.66 -45.74 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.35 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.37 -42.3 99.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.969 0.414 . . . . 0.0 110.987 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.74 -38.64 80.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.782 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -124.83 90.88 3.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -93.43 94.39 8.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 301' ' ' ASP . 10.9 tp -103.26 163.75 3.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.742 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.448 ' N ' HG13 ' A' ' 300' ' ' ILE . 3.8 m-20 -65.37 140.06 58.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.15 123.38 37.76 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.539 ' O ' HG13 ' A' ' 307' ' ' ILE . 46.6 Cg_exo -55.93 129.77 36.74 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.499 2.132 . . . . 0.0 111.977 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.38 -35.55 79.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.093 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.22 84.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.993 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.22 -34.5 56.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.954 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 303' ' ' PRO . 75.6 mt -61.87 -50.97 77.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.919 0.39 . . . . 0.0 111.612 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.31 -40.44 95.93 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 65.5 p -64.52 -45.94 85.08 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.519 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 43.3 mm-40 -72.01 -35.09 69.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.962 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 83.7 mt -62.08 -44.12 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.715 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.591 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 32.0 t70 -63.39 -40.85 98.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.844 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.9 t -64.05 -43.72 97.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.174 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 87.6 mt -62.53 -40.15 95.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.909 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.509 HH12 HD12 ' A' ' 330' ' ' LEU . 80.3 mtm180 -63.12 -38.91 93.06 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.266 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 90.5 mtt180 -63.73 -41.09 98.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.701 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -62.86 -44.04 97.18 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.641 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.34 -39.54 81.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.033 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.82 88.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.241 0.543 . . . . 0.0 110.435 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -62.11 -38.44 88.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.986 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.96 -37.79 79.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.07 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -74.39 39.1 0.12 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.138 0.975 . . . . 0.0 112.302 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLY . . . . . 0.407 ' HA2' ' HB ' ' B' ' 54' ' ' VAL . . . 99.75 -2.87 57.24 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.155 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 92.94 33.58 7.28 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.159 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -71.47 132.0 44.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.721 0.296 . . . . 0.0 110.216 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.09 160.88 36.42 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.0 OUTLIER 68.77 -52.08 0.57 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.318 0.647 . . . . 0.0 112.102 -178.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.96 -3.58 29.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.12 -23.93 65.88 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.483 0.658 . . . . 0.0 109.714 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.509 HD12 HH12 ' A' ' 315' ' ' ARG . 42.2 tp -63.36 -35.15 79.44 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.266 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.94 -33.48 74.76 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.66 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 82.7 mt -47.56 133.99 10.39 Favored Pre-proline 0 N--CA 1.474 0.753 0 O-C-N 123.613 0.57 . . . . 0.0 112.458 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.441 ' HB2' HD13 ' A' ' 336' ' ' LEU . 50.7 Cg_exo -54.24 129.62 35.48 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.962 2.441 . . . . 0.0 112.786 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -66.2 -43.42 86.85 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.303 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -63.46 -33.8 76.36 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.441 HD13 ' HB2' ' A' ' 333' ' ' PRO . 10.8 mp -63.55 -37.18 86.35 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.643 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.54 -13.06 19.61 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.58 -30.09 67.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.675 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -62.0 -51.26 68.77 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.716 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -71.19 -27.1 63.28 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.809 0.338 . . . . 0.0 110.431 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.436 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.88 -43.06 99.61 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.781 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.415 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -59.66 -45.69 91.28 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 347' ' ' VAL . 8.3 mmt180 -61.43 -47.3 86.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.263 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.12 -37.73 84.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 341' ' ' ALA . 72.1 t -63.31 -44.44 99.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.255 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.48 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 70.3 t -62.0 -44.64 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.496 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 343' ' ' ARG . 70.4 t -60.53 -44.81 97.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.838 0.351 . . . . 0.0 110.137 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.79 -42.14 99.39 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.134 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.41 -43.9 96.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.734 0.302 . . . . 0.0 110.859 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.0 mt -62.81 -47.91 81.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.953 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.404 ' O ' HG13 ' A' ' 355' ' ' ILE . 94.3 mt -66.95 -40.43 87.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.159 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.96 -45.05 96.55 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.833 -0.622 . . . . 0.0 113.796 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -68.89 -35.12 76.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.293 0.547 . . . . 0.0 110.713 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 350' ' ' LEU . 78.5 t -60.47 -45.13 97.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 351' ' ' LEU . 80.4 mt -62.97 -46.5 96.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.916 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -67.45 -47.69 69.4 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 98.0 m -64.49 -44.83 89.75 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -87.6 -0.9 57.51 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.501 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 63.15 39.85 9.46 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.91 0.386 . . . . 0.0 111.626 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.7 mt -77.25 145.15 37.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.226 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.57 149.99 39.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.272 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.76 116.5 5.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 367' ' ' VAL . 27.3 t70 -86.24 116.07 24.19 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.532 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 25.7 mm-40 -59.52 -39.42 83.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.965 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -65.22 -42.52 93.34 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.018 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -63.74 -38.98 93.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.063 0.459 . . . . 0.0 109.954 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 363' ' ' ASP . 89.3 t -64.04 -38.95 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.485 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 26.8 mmmt -55.58 -45.3 77.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.428 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -64.21 -37.22 94.23 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.43 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.63 -42.11 98.18 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.337 0.589 . . . . 0.0 110.253 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.21 -43.21 97.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.792 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -60.59 -39.74 89.18 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.54 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.91 -40.14 87.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.777 0.322 . . . . 0.0 110.772 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.3 ttm -64.24 -41.73 96.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.0 0.428 . . . . 0.0 110.169 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.39 -27.22 69.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.572 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.7 m -75.27 -4.86 41.53 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.383 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -93.05 -0.54 57.1 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.204 0.526 . . . . 0.0 110.483 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -117.3 168.27 10.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.07 -50.22 72.82 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -117.95 117.62 35.28 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.837 0.351 . . . . 0.0 110.307 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.64 -28.91 25.25 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.345 2.03 . . . . 0.0 113.08 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -65.92 -43.89 86.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.22 -37.7 88.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.587 0.232 . . . . 0.0 110.911 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.86 -42.93 96.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.585 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.68 -44.53 99.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.254 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -67.25 -40.68 86.27 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 120.857 0.36 . . . . 0.0 110.197 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -58.43 -47.98 82.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.49 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 3.4 t80 -70.46 -40.25 73.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.12 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 59.4 p -77.7 -8.38 57.85 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -101.03 6.7 43.54 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.239 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -125.67 114.12 18.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.073 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -62.95 -41.45 99.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.373 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.11 -48.11 83.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 110.775 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.73 -40.63 97.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.626 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 94.1 mtp -61.96 -46.34 89.72 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.02 0.438 . . . . 0.0 110.997 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.87 -44.17 86.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.331 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -63.81 -40.92 97.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.573 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.49 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 53.1 tpp -62.95 -45.08 94.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.123 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.441 ' HG2' HG21 ' A' ' 367' ' ' VAL . 47.4 mtm180 -65.05 -29.22 70.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.567 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -62.24 -44.41 96.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.17 -44.26 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.817 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.37 94.75 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.986 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.68 -38.06 89.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.695 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.08 -44.81 91.92 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.905 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.51 -38.21 89.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.808 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -59.43 -41.66 90.08 Favored 'General case' 0 CA--C 1.526 0.032 0 CA-C-O 120.736 0.303 . . . . 0.0 110.62 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.07 79.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.39 -46.15 93.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.482 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -68.56 -30.55 69.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.498 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.33 -38.13 89.95 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.019 0.438 . . . . 0.0 109.93 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 91.5 t -64.69 -42.53 95.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.919 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.41 -40.13 93.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.82 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.65 67.48 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.495 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -99.38 -3.6 33.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.023 0.439 . . . . 0.0 110.962 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -107.85 178.87 4.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.45 107.86 19.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.559 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 97.0 t -99.9 118.66 46.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.902 -0.406 . . . . 0.0 109.902 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.5 t -120.81 158.35 27.76 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -104.82 132.78 50.64 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.077 0.465 . . . . 0.0 111.728 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -147.57 120.97 9.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.861 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 91.1 mt-10 -84.81 151.93 24.0 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.183 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.7 t -157.01 175.31 14.27 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.815 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 62.8 p -85.66 163.76 18.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.931 0.396 . . . . 0.0 111.392 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -64.56 -26.71 68.53 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.055 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -62.22 -39.7 93.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.781 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.6 -33.43 75.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.724 0.297 . . . . 0.0 111.468 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.57 -14.18 57.13 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.645 0.26 . . . . 0.0 111.262 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 2.9 mmt -76.84 -9.91 59.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.188 0.518 . . . . 0.0 110.331 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -80.68 85.65 6.03 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.387 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -105.84 29.27 6.79 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.214 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -66.52 -24.04 66.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.22 0.534 . . . . 0.0 109.912 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.377 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.451 178.389 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -78.03 134.13 37.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.185 0.517 . . . . 0.0 111.582 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 24.1 m -118.57 145.7 24.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.356 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.4 p -91.08 84.28 5.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 m -132.85 135.28 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -119.74 154.79 33.63 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.798 0.332 . . . . 0.0 111.557 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.512 ' HA ' ' HD3' ' B' ' 13' ' ' ARG . 90.3 m -99.47 118.08 35.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.522 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 14.9 m -72.66 -51.41 19.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.387 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -174.92 100.71 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.275 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.86 -107.43 1.54 Allowed Glycine 0 C--O 1.223 -0.567 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.136 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.449 HD23 ' N ' ' B' ' 109' ' ' PHE . 7.2 mp -66.77 -39.08 87.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.713 0.292 . . . . 0.0 110.919 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' B' ' 106' ' ' SER . . . -59.2 135.08 51.94 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.282 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.512 ' HD3' ' HA ' ' B' ' 7' ' ' THR . 0.0 OUTLIER -140.3 144.17 36.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.474 0.178 . . . . 0.0 110.749 -177.014 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -114.78 130.04 56.79 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.82 -89.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.729 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p 43.0 82.74 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 88.6 mt -112.88 131.38 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 60.5 m -95.47 126.85 41.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.966 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 41.6 pt -125.51 165.85 22.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.421 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.453 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.79 151.75 45.93 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.299 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.416 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -57.27 -43.1 82.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.63 -176.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.75 -38.05 89.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.479 . . . . 0.0 110.194 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 23.0 m -63.3 -36.27 83.11 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.219 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.5 ' O ' ' HB ' ' B' ' 28' ' ' VAL . 75.7 mt -61.47 -50.8 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.282 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.536 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 50.2 mm-40 -75.59 -22.37 56.99 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -86.06 -68.57 0.73 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.693 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.62 -48.64 71.56 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 99.0 t -62.89 -45.33 99.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.523 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.536 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 16.4 ttmm -61.89 -44.85 95.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.503 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.6 m -65.34 -41.68 93.67 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.814 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -64.66 -38.27 90.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.701 0.286 . . . . 0.0 110.788 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 91.0 mt -62.31 -42.48 99.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.569 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -71.5 -35.26 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.991 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -64.32 -42.68 96.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.638 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -68.53 -32.45 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.129 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.66 98.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.66 -38.32 88.98 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.955 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -59.61 -37.18 77.9 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 18.0 t -87.79 -13.87 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 120.959 0.409 . . . . 0.0 110.038 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 70.83 28.63 3.3 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.756 0.823 . . . . 0.0 111.276 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.43 7.45 9.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.131 0.491 . . . . 0.0 111.598 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.3 -24.74 66.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.826 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.05 -1.83 88.12 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.955 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -94.44 7.38 45.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.712 0.291 . . . . 0.0 111.607 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 34.6 ttt85 -114.88 100.71 8.41 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.455 -0.498 . . . . 0.0 112.178 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -67.15 -46.72 73.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.675 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.86 65.92 1.62 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 116.561 1.384 . . . . 0.0 116.561 172.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -63.5 -42.68 98.49 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 t -107.34 106.06 57.42 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 114.725 -1.125 . . . . 0.0 107.997 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.442 ' HB2' ' OD1' ' B' ' 52' ' ' ASN . 28.0 Cg_exo -60.86 155.51 49.05 Favored 'Trans proline' 0 N--CA 1.476 0.476 0 C-N-CA 123.28 2.653 . . . . 0.0 112.969 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.656 ' HA ' HG22 ' B' ' 54' ' ' VAL . 92.3 mtp -61.18 -39.16 89.09 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ASN . . . . . 0.442 ' OD1' ' HB2' ' B' ' 50' ' ' PRO . 33.4 p-10 -65.7 -17.65 64.76 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.998 0.428 . . . . 0.0 110.859 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.433 HD12 ' HD2' ' B' ' 50' ' ' PRO . 89.0 mt -99.48 -36.29 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.004 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.656 HG22 ' HA ' ' B' ' 51' ' ' MET . 23.2 m -64.98 -37.46 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.633 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.07 83.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.227 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.457 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 7.1 pt20 -82.04 -18.67 42.42 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.49 HH12 ' CD1' ' A' ' 187' ' ' LEU . 62.9 mtt-85 -107.37 -27.51 10.43 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.7 6.63 23.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.517 0.675 . . . . 0.0 110.164 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' B' ' 61' ' ' SER . . . -70.25 157.46 53.52 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 175.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.402 ' H ' ' HB2' ' B' ' 63' ' ' ARG . . . 70.71 -40.72 0.48 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.082 0.553 . . . . 0.0 111.499 -177.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 59' ' ' GLY . 42.9 t -64.99 -63.2 1.17 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.925 0.49 . . . . 0.0 111.296 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.469 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.5 p -101.41 10.44 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.469 0.652 . . . . 0.0 110.206 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.402 ' HB2' ' H ' ' B' ' 60' ' ' ALA . 41.8 ttm180 -59.6 -26.07 65.15 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.693 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -62.63 -49.1 76.53 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.926 0.393 . . . . 0.0 110.382 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -77.32 -21.74 53.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.813 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.469 HG23 ' O ' ' B' ' 62' ' ' VAL . 77.0 t -63.94 -43.74 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.0 -39.4 94.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.216 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.7 -42.26 99.72 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.776 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ASP . . . . . 0.434 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 11.5 t70 -62.31 -45.36 93.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.998 0.428 . . . . 0.0 110.378 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.42 -41.7 98.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.367 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 15.5 tpt -61.69 -42.33 98.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 51.2 m -60.98 -43.61 98.56 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.836 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 96.4 mtt-85 -65.68 -42.0 91.77 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.497 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -63.65 -41.3 98.24 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.646 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -61.67 -50.95 70.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.962 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 tt -69.93 -41.8 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.441 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 7.8 t70 -64.57 -40.52 95.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.171 0.51 . . . . 0.0 110.098 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.38 -43.1 78.08 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.66 -33.64 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.012 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.57 -44.07 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.893 0.377 . . . . 0.0 110.899 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 17.4 ptpt -77.59 -28.3 51.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.548 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -83.38 -4.56 58.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.635 0.255 . . . . 0.0 110.84 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 66.5 36.93 4.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.366 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.1 mt -99.65 120.95 49.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.832 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -107.55 112.03 62.55 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.71 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -75.14 127.24 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.059 1.84 . . . . 0.0 111.523 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.22 100.22 9.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.069 0.461 . . . . 0.0 111.016 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.98 -109.84 3.25 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.148 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.69 113.75 8.57 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.684 0.278 . . . . 0.0 111.093 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.39 160.23 45.11 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.72 2.28 . . . . 0.0 111.066 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.4 m -107.04 118.74 37.51 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.814 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -73.38 -25.07 60.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.556 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 26.0 t 49.54 79.17 0.36 Allowed Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 123.788 0.835 . . . . 0.0 112.879 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.51 126.59 8.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.301 2.0 . . . . 0.0 110.627 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.62 -172.2 48.53 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.593 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.7 121.08 26.8 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.949 0.404 . . . . 0.0 109.998 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -82.2 118.18 22.89 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.148 0.499 . . . . 0.0 110.805 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -98.7 123.69 43.07 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 tp -68.35 105.82 2.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.577 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.42 3.31 44.1 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.588 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -126.87 172.31 10.52 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.83 0.347 . . . . 0.0 111.222 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.52 141.99 57.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.733 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -105.28 144.74 31.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.948 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 34.8 m -119.98 131.2 55.09 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.011 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.94 162.1 38.56 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.564 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 46.2 p -97.9 -83.78 0.4 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -174.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' B' ' 106' ' ' SER . 94.3 t 75.02 113.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -173.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -104.94 121.94 44.79 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -172.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' PHE . . . . . 0.449 ' N ' HD23 ' B' ' 11' ' ' LEU 0.255 26.3 p90 -138.71 -92.88 0.19 Allowed 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 175.207 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -159.43 149.15 18.61 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.018 0.826 . . . . 0.0 112.194 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.78 168.59 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.47 0.708 . . . . 0.0 111.619 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -111.28 104.42 56.13 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.425 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -91.44 154.27 3.63 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.924 2.416 . . . . 0.0 113.139 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -158.06 139.81 13.86 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 62.2 t -127.69 136.17 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.164 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -84.84 142.23 29.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.6 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.11 146.52 47.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.746 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -139.2 154.01 47.97 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.663 0.268 . . . . 0.0 111.388 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.3 20.61 76.88 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.068 -0.515 . . . . 0.0 113.857 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.73 -40.86 92.58 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.953 0.406 . . . . 0.0 111.811 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.2 -5.12 39.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.279 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.09 12.96 36.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.814 0.34 . . . . 0.0 111.057 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.49 124.02 46.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.125 0.488 . . . . 0.0 110.346 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.84 121.9 44.64 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.336 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.1 134.43 53.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.807 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -84.65 143.71 29.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.464 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -133.41 97.44 16.12 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.94 138.08 55.82 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.409 2.072 . . . . 0.0 111.427 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' B' ' 421' ' ' GLU . 48.8 mm -117.64 124.46 73.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.78 162.11 39.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.607 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -148.29 -178.77 6.49 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 80.8 t -100.02 127.6 52.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 120.875 0.369 . . . . 0.0 110.776 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 59.2 p -104.83 171.6 7.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.771 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -64.0 -34.12 77.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.608 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.6 86.05 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.498 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -62.85 -39.66 95.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.878 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.41 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.5 t -63.11 -45.57 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.179 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.76 -44.89 96.0 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.138 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.5 -40.94 99.74 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.397 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.612 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.1 tpt -61.77 -48.63 79.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.688 0.28 . . . . 0.0 110.5 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 91.9 mt -63.64 -42.1 98.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.224 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.46 -49.13 78.96 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.406 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.5 m -62.79 -41.61 99.35 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.763 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' B' ' 140' ' ' MET . 89.3 mt -60.63 -35.53 76.39 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -78.3 -15.11 59.07 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.54 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.3 -6.27 41.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.313 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -107.95 30.24 6.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.865 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -134.95 94.83 3.21 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -112.0 120.11 40.75 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.705 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.642 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 52.7 m -71.73 158.89 35.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.826 0.346 . . . . 0.0 111.318 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -78.89 122.56 26.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' B' ' 152' ' ' LYS . 17.1 tptm -143.53 170.07 16.5 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' B' ' 153' ' ' GLU . 0.6 OUTLIER -86.29 0.29 54.19 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -165.23 -175.78 3.79 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.983 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' B' ' 242' ' ' GLU . 0.9 OUTLIER 93.2 127.76 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.829 1.651 . . . . 0.0 111.822 176.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -71.45 90.02 0.45 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 115.324 0.89 . . . . 0.0 115.324 -172.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.77 135.36 18.41 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.72 128.31 70.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -108.35 158.6 17.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.921 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.49 24.44 0.2 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.033 0.533 . . . . 0.0 112.235 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -138.11 -3.73 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.155 0.503 . . . . 0.0 109.886 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -85.3 159.54 20.02 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.49 0.662 . . . . 0.0 112.626 -172.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' B' ' 163' ' ' ARG . 12.0 ptp180 -104.6 103.11 12.72 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.663 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.54 120.17 51.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.699 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 26.6 m -77.78 105.11 8.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.75 123.59 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.547 -174.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' ASP . . . . . 0.479 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 18.1 m-20 -95.15 107.05 19.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -125.03 147.7 48.83 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.605 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 29.8 m -120.13 130.3 54.55 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.759 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.63 119.52 4.89 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.45 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 25.4 p -134.94 126.52 28.8 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 t -75.36 -90.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.499 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -98.91 -4.61 32.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.378 0.609 . . . . 0.0 109.739 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.41 -18.1 0.44 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.732 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.95 146.07 27.11 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.925 0.393 . . . . 0.0 110.205 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -81.6 156.01 25.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.987 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -125.96 -175.72 3.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.521 0.2 . . . . 0.0 111.537 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.3 -38.79 84.75 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.74 -176.89 32.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.481 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.08 26.53 36.73 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.623 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -108.01 98.25 7.84 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.27 140.04 51.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.035 0.445 . . . . 0.0 111.894 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.479 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 48.8 m -148.48 125.12 11.09 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 61.16 30.66 19.46 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.596 0.56 . . . . 0.0 110.276 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -88.82 128.82 35.66 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.027 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 16.9 m -99.34 122.69 51.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.462 0.648 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.519 HD12 HH12 ' A' ' 57' ' ' ARG . 35.2 tp -111.62 120.2 41.27 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.941 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.74 112.2 24.07 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 189' ' ' MET . . . . . 0.615 ' HE3' ' O ' ' B' ' 199' ' ' GLU . 84.8 mtp -83.42 152.32 25.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.008 -175.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.49 -14.2 62.25 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.055 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 191' ' ' GLN . . . . . 0.418 ' HB2' ' HG2' ' B' ' 193' ' ' ARG . 97.8 mt-30 -95.19 -11.76 27.51 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -176.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.24 48.14 6.14 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.25 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.418 ' HG2' ' HB2' ' B' ' 191' ' ' GLN . 34.8 mmm-85 -88.23 -12.39 43.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.864 -0.668 . . . . 0.0 109.796 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.18 -179.58 5.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.908 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 49.6 mm -61.05 134.04 92.8 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.85 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.81 128.4 21.43 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.837 2.358 . . . . 0.0 112.352 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.48 -39.39 2.76 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.24 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -62.54 -47.64 82.98 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 199' ' ' GLU . . . . . 0.615 ' O ' ' HE3' ' B' ' 189' ' ' MET . 12.1 pt-20 -79.11 -10.05 59.72 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.09 -177.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.5 -28.3 16.88 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.952 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.77 -21.86 71.47 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.659 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.92 -41.91 94.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -54.92 134.1 48.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.665 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 100.35 3.67 55.36 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.658 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -108.4 151.93 25.36 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 120.967 0.413 . . . . 0.0 110.901 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -92.81 155.61 17.53 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.053 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.12 134.99 56.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.79 50.3 25.1 Favored Glycine 0 C--O 1.236 0.222 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.944 -178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' GLU . . . . . 0.402 ' H ' HD23 ' B' ' 237' ' ' LEU . 44.3 tt0 -135.65 133.54 38.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.086 0.469 . . . . 0.0 111.264 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -108.54 127.02 53.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -144.82 -12.8 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 44.1 p 60.27 166.72 0.08 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.79 0.836 . . . . 0.0 111.926 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -155.59 119.71 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.256 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.06 106.76 11.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.83 0.347 . . . . 0.0 110.829 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 97.7 t -109.23 115.57 49.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.108 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 216' ' ' THR . . . . . 0.526 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 8.2 m -64.09 -41.03 97.45 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.526 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.8 m-85 77.88 141.74 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 123.113 0.565 . . . . 0.0 109.809 -172.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.63 152.23 53.33 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.818 1.679 . . . . 0.0 111.878 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 219' ' ' GLU . . . . . 0.555 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 39.9 mm-40 -62.67 -33.52 75.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.999 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -86.77 24.78 1.39 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.113 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' TYR . . . . . 0.509 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 9.0 t80 -73.82 135.22 43.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.496 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -67.69 -14.69 63.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.509 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -98.65 108.71 21.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 36.5 tt0 -60.86 -36.79 80.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.428 ' OD1' ' HG ' ' B' ' 226' ' ' LEU . 25.7 p30 -72.65 -11.9 60.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.428 ' HG ' ' OD1' ' B' ' 225' ' ' ASN . 94.6 mt -120.55 -0.01 10.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.555 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.9 ptmt -70.73 108.36 4.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.573 0.701 . . . . 0.0 112.76 -175.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.33 17.1 78.55 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.799 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -121.19 123.51 42.44 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -68.02 136.16 53.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -110.96 137.04 49.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.182 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -70.08 -41.23 74.37 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -175.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' B' ' 212' ' ' THR . 74.4 m-85 57.62 100.94 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.915 0.486 . . . . 0.0 112.122 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.411 ' HA ' HG22 ' B' ' 212' ' ' THR . . . -58.55 -49.77 76.21 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 61.81 77.97 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.092 0.472 . . . . 0.0 111.051 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -65.85 -39.94 91.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.886 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' LEU . . . . . 0.402 HD23 ' H ' ' B' ' 209' ' ' GLU . 12.5 tp 51.71 83.56 0.05 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.921 0.888 . . . . 0.0 111.142 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 238' ' ' LYS . . . . . 0.472 ' HD3' ' HB2' ' B' ' 167' ' ' ASP . 51.9 mtpt -89.98 -64.68 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -174.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -88.52 -89.75 0.14 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 42.9 t 73.42 129.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.888 0.475 . . . . 0.0 111.07 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -69.13 -35.39 76.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.962 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' B' ' 155' ' ' ASP . 12.9 pt-20 57.49 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.432 1.493 . . . . 0.0 114.061 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -139.41 125.73 20.21 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.197 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' B' ' 245' ' ' LEU . 0.9 OUTLIER -150.68 -173.85 4.6 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.549 ' H ' ' CD ' ' B' ' 244' ' ' GLU . 46.3 mt 73.6 102.37 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 123.216 0.606 . . . . 0.0 111.042 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 246' ' ' PRO . . . . . 0.642 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 72.2 Cg_endo -78.97 109.89 2.66 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.569 2.179 . . . . 0.0 113.857 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 247' ' ' GLU . . . . . 0.581 ' H ' HG21 ' B' ' 150' ' ' THR . 12.5 pt-20 -138.11 23.34 2.8 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.632 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 51.6 tp 77.0 139.08 0.07 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 249' ' ' THR . . . . . 0.504 HG22 ' H ' ' B' ' 251' ' ' GLU . 27.7 m -149.78 141.51 23.62 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.145 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -80.05 -9.99 59.74 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.504 ' H ' HG22 ' B' ' 249' ' ' THR . 41.4 mt-10 -84.66 -25.19 28.65 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -63.62 -28.21 69.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 41.2 pt -70.44 -9.41 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.815 0.34 . . . . 0.0 111.89 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -136.7 30.11 2.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.846 0.355 . . . . 0.0 111.55 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -118.24 12.16 13.38 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-O 121.095 0.474 . . . . 0.0 111.49 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -96.3 27.6 3.66 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.19 -40.28 2.99 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.42 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 28.0 t -68.94 137.65 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -43.63 -59.65 2.1 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.912 0.758 . . . . 0.0 111.986 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -166.81 157.84 12.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.789 0.328 . . . . 0.0 111.087 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -156.54 -171.02 22.29 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.872 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 56.8 p -111.49 -141.3 0.38 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 59.8 t -98.16 -71.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 110.025 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.2 OUTLIER -68.51 -37.07 79.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.243 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.97 93.7 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.191 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 270' ' ' VAL . 53.1 tp -63.08 -43.42 98.59 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -61.59 -42.11 98.39 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.459 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -62.27 -46.01 90.69 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.204 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 269' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 38.4 tp10 -66.55 -40.07 88.87 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.853 0.358 . . . . 0.0 111.176 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 266' ' ' LEU . 90.9 t -65.25 -43.26 95.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.413 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -60.48 -46.98 88.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 14.1 ptmt -63.19 -44.36 95.58 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.898 0.38 . . . . 0.0 111.0 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -65.21 -38.29 89.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.406 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.8 mmm -63.82 -42.4 97.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.672 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -69.02 -33.32 73.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.059 0.457 . . . . 0.0 110.585 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -63.27 -42.49 99.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.683 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -67.37 -36.39 81.27 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.002 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.459 ' O ' HG13 ' B' ' 282' ' ' ILE . 44.8 tp -62.3 -38.56 89.88 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.789 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -56.3 -45.66 80.15 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.263 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 19.4 m -61.63 -42.28 98.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.837 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.56 -42.93 99.85 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.138 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 282' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 278' ' ' LEU . 66.5 mt -64.36 -44.36 97.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.301 178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -60.21 -44.1 95.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.452 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -63.64 -42.79 98.11 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.166 0.291 . . . . 0.0 111.404 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -60.54 -44.74 95.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.073 0.463 . . . . 0.0 110.729 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.61 -45.2 78.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.32 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.92 -48.91 78.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.806 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -63.57 -43.4 97.1 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -65.29 -42.18 93.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.485 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.58 -47.95 81.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.994 0.426 . . . . 0.0 111.09 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 291' ' ' ILE . . . . . 0.499 HG21 HG22 ' B' ' 347' ' ' VAL . 51.2 mm -66.68 -43.44 90.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.92 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 292' ' ' GLU . . . . . 0.414 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 19.9 tp10 -57.82 -45.4 86.21 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.134 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.77 -40.62 99.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.116 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.447 HD13 HD13 ' B' ' 350' ' ' LEU . 4.8 tt -63.6 -43.9 95.56 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.32 -43.98 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.247 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.414 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 66.1 mttm -60.33 -35.18 75.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.934 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.16 -11.76 40.19 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -138.63 81.01 1.82 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -91.54 93.27 8.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -105.26 157.93 5.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.58 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.22 138.25 58.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.465 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 35.0 t -106.63 126.01 31.4 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.861 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.503 ' O ' HG13 ' B' ' 307' ' ' ILE . 51.6 Cg_exo -55.99 129.19 33.58 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.428 2.086 . . . . 0.0 111.914 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.28 83.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.476 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.99 84.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.52 -38.06 83.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.507 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 307' ' ' ILE . . . . . 0.503 HG13 ' O ' ' B' ' 303' ' ' PRO . 73.6 mt -61.07 -50.12 81.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.248 -177.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.16 -37.53 87.67 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 63.6 p -67.6 -45.17 76.23 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.501 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 310' ' ' GLU . . . . . 0.554 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 66.8 mm-40 -71.81 -36.32 70.21 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.494 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 87.3 mt -62.38 -44.46 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.12 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.569 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 36.6 t70 -63.24 -41.86 99.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.823 0.344 . . . . 0.0 110.965 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.47 -43.16 98.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.298 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 84.2 mt -62.21 -39.91 94.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.693 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 79.1 mtm180 -63.37 -39.04 93.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.235 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 316' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 90.2 mtt180 -62.82 -42.23 99.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.842 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -62.95 -43.16 99.55 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.496 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.05 -39.94 82.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.964 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.44 91.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.07 0.462 . . . . 0.0 110.39 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -62.15 -37.15 84.13 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.052 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -70.56 -36.95 73.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.412 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.02 42.37 0.25 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.986 0.915 . . . . 0.0 112.172 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.77 -0.11 59.24 Favored Glycine 0 C--N 1.318 -0.465 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.033 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 89.49 30.65 13.08 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.195 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -68.6 136.35 52.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.899 0.38 . . . . 0.0 110.533 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 326' ' ' GLU . . . . . 0.423 ' HB3' HH11 ' A' ' 73' ' ' ARG . 0.9 OUTLIER -137.98 162.29 34.47 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.574 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.0 OUTLIER 68.57 -53.43 0.55 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.298 0.639 . . . . 0.0 112.359 -178.156 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -73.99 -3.7 30.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.44 -24.32 65.11 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.278 0.561 . . . . 0.0 109.705 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.427 HD12 HH12 ' B' ' 315' ' ' ARG . 41.9 tp -63.23 -36.23 82.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.324 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.07 -26.02 65.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.877 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.424 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 80.0 mt -54.3 132.89 61.54 Favored Pre-proline 0 C--O 1.238 0.481 0 CA-C-O 120.706 0.288 . . . . 0.0 111.556 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 333' ' ' PRO . . . . . 0.449 ' HB2' HD13 ' B' ' 336' ' ' LEU . 50.5 Cg_exo -54.67 133.19 55.78 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.986 2.457 . . . . 0.0 113.338 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 334' ' ' ARG . . . . . 0.42 HH21 ' HD2' ' B' ' 334' ' ' ARG . 26.1 ttt85 -67.03 -43.81 81.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.056 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -63.85 -33.01 74.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -174.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 336' ' ' LEU . . . . . 0.449 HD13 ' HB2' ' B' ' 333' ' ' PRO . 10.8 mp -64.29 -36.57 84.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.473 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -101.36 -13.82 17.85 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 338' ' ' GLU . . . . . 0.402 ' HG3' HD11 ' B' ' 311' ' ' ILE . 39.9 tt0 -68.52 -30.4 69.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.734 0.302 . . . . 0.0 111.482 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.66 -49.85 74.87 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.792 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -72.25 -29.43 63.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 110.71 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.466 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -61.72 -43.66 98.42 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.108 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 342' ' ' LYS . . . . . 0.443 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.6 tttt -59.47 -45.19 92.35 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 343' ' ' ARG . . . . . 0.53 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.7 mmt85 -62.44 -45.52 92.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -66.0 -37.89 87.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 341' ' ' ALA . 82.6 t -63.4 -44.72 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.787 0.327 . . . . 0.0 110.33 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 342' ' ' LYS . 71.7 t -61.23 -45.1 99.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.513 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 343' ' ' ARG . 85.4 t -61.24 -44.57 98.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.281 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.59 -42.32 99.15 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.15 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.04 -44.03 97.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 110.701 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.473 ' O ' HG23 ' B' ' 354' ' ' VAL . 96.2 mt -63.24 -49.45 74.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.0 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.7 -41.21 88.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.6 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.39 -42.44 98.92 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.265 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.7 -35.65 75.25 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.956 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 354' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 350' ' ' LEU . 71.8 t -60.15 -44.73 95.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.74 -44.15 98.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.127 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -68.58 -49.03 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 39.2 m -64.48 -44.9 89.56 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -88.56 5.93 40.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.367 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 56.43 45.27 22.96 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.032 0.444 . . . . 0.0 111.528 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 98.8 mt -81.48 143.77 31.84 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.125 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.23 150.53 42.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.109 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.02 120.55 13.34 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 363' ' ' ASP . . . . . 0.554 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.1 t70 -89.59 113.59 25.05 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.032 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 364' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 58.8 mm-40 -59.0 -38.38 79.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.449 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -65.46 -41.54 93.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.839 0.352 . . . . 0.0 110.785 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -64.92 -38.66 91.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.784 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 367' ' ' VAL . . . . . 0.554 HG23 ' O ' ' B' ' 363' ' ' ASP . 96.0 t -63.08 -38.77 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.389 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 368' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.4 mmmt -56.35 -44.35 80.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.53 96.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.012 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.81 -42.42 99.71 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.114 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.02 -43.22 97.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.832 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -60.83 -38.95 87.22 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.197 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -65.94 -39.0 90.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.306 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 53.8 ttm -66.39 -41.77 88.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.368 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.57 -28.24 69.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.804 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 48.7 m -75.13 -5.77 46.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.562 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -93.08 -1.34 56.59 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.946 0.403 . . . . 0.0 111.234 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -114.29 169.05 9.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.156 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -64.96 -44.09 90.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.961 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -119.65 118.88 31.79 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.798 0.332 . . . . 0.0 110.198 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.83 -30.62 21.67 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.421 2.08 . . . . 0.0 113.258 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -66.14 -43.37 87.24 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.44 -37.36 85.59 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.706 0.289 . . . . 0.0 110.851 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.44 -43.25 96.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.515 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 90.4 mt -62.33 -44.25 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.943 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 48.3 mt-10 -65.66 -44.48 86.15 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.838 178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.5 -47.82 82.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.122 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 388' ' ' TYR . . . . . 0.48 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 2.8 t80 -69.52 -39.88 77.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.051 -177.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 62.7 p -78.93 -8.06 58.55 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 390' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.4 mttt -99.32 1.7 44.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.967 0.413 . . . . 0.0 111.536 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 391' ' ' ASN . . . . . 0.434 ' OD1' HD13 ' B' ' 394' ' ' LEU . 24.6 t-20 -123.9 115.25 20.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.232 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 42.1 ttmt -63.9 -40.87 97.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.407 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.23 -49.49 76.9 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.094 0.473 . . . . 0.0 110.781 -176.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 394' ' ' LEU . . . . . 0.434 HD13 ' OD1' ' B' ' 391' ' ' ASN . 10.3 mp -63.61 -40.18 96.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.47 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 89.7 mtp -62.55 -45.46 92.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 111.526 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.79 -43.66 75.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.223 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -62.8 -39.81 95.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.636 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 398' ' ' MET . . . . . 0.48 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 55.5 tpp -62.82 -44.07 97.12 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.868 0.366 . . . . 0.0 110.751 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.406 ' HG2' HG21 ' B' ' 367' ' ' VAL . 56.1 mtm180 -64.65 -31.69 73.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.014 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -61.24 -45.63 93.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.78 -43.83 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.043 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.2 -41.0 96.06 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.003 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.75 -37.04 86.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.693 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.2 -45.18 91.76 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.999 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -65.74 -37.81 87.39 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.656 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -58.92 -43.12 91.03 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.868 0.366 . . . . 0.0 110.421 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.407 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -64.71 -47.28 78.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.599 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 94.9 t -64.12 -45.62 95.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.413 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -67.57 -32.0 72.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.555 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.69 91.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.879 0.371 . . . . 0.0 110.253 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 411' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 407' ' ' ALA . 93.6 t -64.35 -42.64 95.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.957 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.0 -38.54 86.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.749 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.32 -23.46 66.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -99.25 -2.51 36.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.916 0.389 . . . . 0.0 110.855 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -110.15 174.46 5.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.189 0.519 . . . . 0.0 111.614 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -87.39 108.06 18.82 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.692 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 65.0 t -100.41 118.93 47.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.218 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -119.97 159.57 24.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -108.17 122.16 46.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.873 0.368 . . . . 0.0 111.504 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -134.72 123.7 24.08 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.079 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 421' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' B' ' 129' ' ' ILE . 75.3 mt-10 -84.65 154.25 22.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.908 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.0 t -158.2 176.12 12.9 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.599 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 75.0 p -85.4 165.41 17.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.895 0.379 . . . . 0.0 111.231 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -66.72 -26.5 67.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.581 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -62.58 -39.57 94.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.36 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.56 -35.77 81.03 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.361 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -78.16 -14.21 59.56 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.823 0.345 . . . . 0.0 111.461 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.4 mmt -76.69 -9.5 58.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.924 0.392 . . . . 0.0 110.703 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -80.0 87.11 5.42 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -108.82 29.61 7.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.907 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -65.6 -27.35 68.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.376 0.608 . . . . 0.0 109.584 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.478 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.52 178.265 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HG2' ' H ' ' A' ' 2' ' ' GLN . 50.8 ttm . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.453 ' H ' ' HG2' ' A' ' 1' ' ' MET . 27.8 tt0 -57.53 108.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.159 0.504 . . . . 0.0 111.553 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 m -134.85 160.93 41.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.649 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t -135.4 131.03 35.79 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.818 0.342 . . . . 0.0 110.163 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.6 p -153.06 139.71 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.546 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -131.73 154.76 48.7 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 m -102.84 126.13 49.86 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.5 m -97.4 -58.8 1.92 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.441 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -174.3 130.42 0.37 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.571 0.224 . . . . 0.0 110.781 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.44 -112.78 5.05 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.815 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 11' ' ' LEU . 5.4 mp -93.61 -8.78 40.17 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.673 0.273 . . . . 0.0 110.731 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.38 122.14 5.62 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.995 -0.622 . . . . 0.0 113.646 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.05 147.5 46.63 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.432 0.693 . . . . 0.0 109.255 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -110.11 139.32 45.38 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.9 t -95.99 -89.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.9 m 68.04 100.2 0.05 Allowed 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -173.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tp -133.02 143.72 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.012 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 m -126.45 130.57 50.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.506 ' HB ' HG12 ' A' ' 24' ' ' ILE . 9.6 mt -125.79 162.11 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -177.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.557 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.7 150.09 49.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.301 0.24 . . . . 0.0 111.132 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.33 -57.08 9.87 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -174.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.11 -35.35 79.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 111.224 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 t -62.74 -41.82 99.38 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.487 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 20' ' ' ALA . 76.4 mt -60.21 -51.98 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.155 0.503 . . . . 0.0 111.354 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -70.04 -46.91 64.02 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.547 -174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.2 m -67.3 -51.33 54.01 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.93 66.5 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.87 -43.29 97.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.964 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -61.32 -45.45 94.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.16 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.2 m -62.18 -42.18 99.03 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.841 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.0 tp10 -70.16 -42.03 73.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.494 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.54 -44.65 96.67 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.94 -35.43 64.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.014 0.435 . . . . 0.0 110.701 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -65.68 -41.31 92.6 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.54 HG11 ' HD3' ' A' ' 73' ' ' ARG . 90.2 t -65.68 -41.46 90.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.398 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.34 80.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.285 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.421 ' O ' ' HD3' ' A' ' 40' ' ' ARG . 99.0 mttt -64.58 -37.58 88.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.059 177.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -61.0 -41.91 97.4 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.883 0.373 . . . . 0.0 110.598 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.87 -4.23 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.388 0.613 . . . . 0.0 110.156 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 25.6 mmt180 62.62 30.95 17.0 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.049 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -112.83 7.15 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.764 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -64.01 -35.92 82.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.081 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.23 -1.64 70.15 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.688 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -91.72 -5.19 54.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.921 0.391 . . . . 0.0 110.734 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -90.36 110.59 21.67 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.01 -39.1 91.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.615 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.83 56.45 24.76 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 173.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -62.66 -41.29 98.98 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.91 109.69 58.81 Favored Pre-proline 0 C--O 1.246 0.902 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.462 ' HG2' HD12 ' A' ' 53' ' ' ILE . 47.4 Cg_exo -57.3 149.35 65.25 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.925 2.417 . . . . 0.0 112.543 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.555 ' HA ' HG12 ' A' ' 54' ' ' VAL . 15.0 ttt -60.29 -39.16 85.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.455 -173.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -69.12 -23.42 63.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.844 0.354 . . . . 0.0 110.987 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.462 HD12 ' HG2' ' A' ' 50' ' ' PRO . 96.6 mt -92.53 -41.72 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 51' ' ' MET . 12.7 p -66.02 -38.78 82.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 120.936 0.398 . . . . 0.0 110.817 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.444 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -66.84 -37.37 84.36 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.43 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 9.7 pt20 -72.78 -15.01 61.65 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.724 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.501 HH12 ' CD1' ' B' ' 187' ' ' LEU . 67.2 mtt180 -108.59 -52.41 2.77 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.437 ' O ' HG12 ' A' ' 62' ' ' VAL . 18.8 m-85 -108.66 -1.24 19.66 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.182 0.515 . . . . 0.0 110.646 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -63.87 -35.76 92.43 Favored Glycine 0 C--O 1.218 -0.863 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.753 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.93 -43.94 67.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.802 0.301 . . . . 0.0 111.312 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.5 m -61.19 -43.29 99.11 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.129 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 65' ' ' ASP . 8.0 p -105.32 20.3 4.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.246 0.546 . . . . 0.0 110.776 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 14.1 ttm180 -63.97 -19.9 65.49 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.048 0.452 . . . . 0.0 110.147 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.37 -53.05 58.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.24 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.528 ' HB2' HG22 ' A' ' 62' ' ' VAL . 17.6 m-20 -71.02 -26.15 62.99 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.501 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 62' ' ' VAL . 91.7 t -62.05 -45.24 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.74 -40.06 95.81 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.352 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.03 99.39 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.23 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.51 -44.67 93.62 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.39 -42.76 99.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.036 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.1 ttp -60.48 -50.08 75.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.34 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.3 m -65.27 -46.38 80.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.679 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.54 ' HD3' HG11 ' A' ' 35' ' ' VAL . 58.4 ttm-85 -66.27 -46.63 76.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.792 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -66.14 -40.4 90.6 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -59.88 -48.36 81.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.908 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 79' ' ' ILE . 20.0 tt -68.17 -38.9 80.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.883 0.373 . . . . 0.0 111.271 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.19 -38.54 88.24 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.384 0.611 . . . . 0.0 109.767 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.69 83.73 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.766 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.7 pp -65.07 -37.33 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.076 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.32 -42.33 95.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.718 0.77 . . . . 0.0 109.156 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -59.55 -47.86 83.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.16 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -89.38 -1.43 58.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -175.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm 70.46 38.95 1.27 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.47 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 92.5 mt -93.84 121.28 44.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -110.52 101.41 48.66 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.588 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.92 131.31 6.97 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.53 2.153 . . . . 0.0 112.452 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.7 90.95 4.42 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.997 0.427 . . . . 0.0 110.4 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.46 -144.21 15.29 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.18 129.47 25.05 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 116.588 0.194 . . . . 0.0 110.678 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HG2' ' CE1' ' A' ' 92' ' ' TYR . 60.5 Cg_endo -70.21 160.2 50.4 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.827 2.352 . . . . 0.0 111.398 178.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.2 m -101.09 91.72 4.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.12 0.486 . . . . 0.0 112.17 -175.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.42 ' CE1' ' HG2' ' A' ' 90' ' ' PRO . 87.5 m-85 -84.05 117.77 23.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.6 t -111.26 96.93 33.3 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 120.86 0.362 . . . . 0.0 111.967 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -87.99 145.14 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 122.592 2.194 . . . . 0.0 110.81 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.96 174.83 42.81 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.638 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.52 130.86 42.3 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -85.34 104.04 14.81 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.153 0.501 . . . . 0.0 110.911 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.95 111.7 19.49 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.11 112.7 2.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.118 0.485 . . . . 0.0 110.484 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.97 -14.91 19.15 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.135 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -119.0 -178.1 3.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.623 0.249 . . . . 0.0 111.035 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.52 161.18 28.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.359 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -108.8 138.81 44.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.776 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -118.31 134.54 54.95 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.198 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -136.39 162.67 32.39 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.835 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.9 m -121.8 148.78 44.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.762 0.315 . . . . 0.0 111.112 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.88 139.96 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.417 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.41 132.81 46.81 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -155.72 -159.33 0.9 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -45.96 155.22 0.2 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.557 1.543 . . . . 0.0 113.327 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.5 m -129.93 159.19 42.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.445 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -145.55 99.32 4.48 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.253 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.22 143.73 10.25 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.515 2.143 . . . . 0.0 113.124 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -159.01 125.59 4.62 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.93 162.62 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.891 0.376 . . . . 0.0 111.709 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -119.64 136.35 54.43 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.6 mt -114.23 135.3 54.2 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -128.09 133.46 49.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.626 0.251 . . . . 0.0 111.649 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.1 22.43 52.31 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.882 -0.675 . . . . 0.0 114.251 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.89 -41.42 99.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.24 0.543 . . . . 0.0 110.511 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.67 -16.77 61.88 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.619 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.05 6.98 47.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.49 127.53 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.375 0.607 . . . . 0.0 111.093 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -110.04 132.2 54.37 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.935 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.5 t -120.76 133.6 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.142 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -90.26 120.26 31.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.049 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -122.31 93.5 48.48 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.76 140.73 56.93 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.176 1.917 . . . . 0.0 112.446 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.2 mm -106.37 119.84 56.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.378 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.41 160.43 42.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.293 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.3 158.77 43.36 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.855 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.4 t -84.72 126.4 40.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.698 0.285 . . . . 0.0 110.491 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.2 p -97.74 170.02 9.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -68.57 -22.68 64.46 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.284 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.69 -38.89 92.54 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.151 0.501 . . . . 0.0 109.652 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -65.15 -36.74 85.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.336 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.45 -45.36 98.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.468 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.09 -40.48 95.99 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.438 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.81 -42.67 99.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.663 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.532 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 5.0 tpt -63.72 -45.17 91.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.922 0.391 . . . . 0.0 110.306 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.43 -41.4 98.67 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.957 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.1 -45.89 89.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.386 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.0 m -62.62 -39.55 94.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.329 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.7 mt -61.49 -41.75 97.75 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.701 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -69.43 -21.54 63.74 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.087 0.47 . . . . 0.0 110.802 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -86.56 4.13 41.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.223 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -119.8 28.54 8.06 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.664 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -138.33 95.39 3.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.57 155.99 47.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.96 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 243' ' ' ARG . 0.7 OUTLIER -122.29 172.35 8.37 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.766 -177.391 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.468 ' H ' HG22 ' A' ' 150' ' ' THR . 8.9 p-90 -55.0 136.41 47.78 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.052 0.541 . . . . 0.0 112.311 -176.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -170.32 113.87 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -73.86 85.58 1.72 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -153.0 -78.31 0.11 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.837 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -163.19 -68.21 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.434 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 243' ' ' ARG . . . 64.54 -126.92 33.59 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.198 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -146.34 -165.44 2.22 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 203' ' ' LYS . 61.2 t -119.38 126.54 75.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 57.1 mm-40 -87.88 177.93 6.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.263 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.17 -58.25 3.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 255' ' ' ARG . 6.7 pt-20 -89.58 34.98 0.82 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.304 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.656 ' OD2' ' HD3' ' A' ' 243' ' ' ARG . 11.4 t70 -57.22 -48.7 78.14 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.412 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 65.82 88.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.617 HG22 ' OD1' ' A' ' 162' ' ' ASP . 2.9 t -109.94 132.31 58.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.694 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 m -81.15 104.62 11.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 79.7 mt -117.1 132.82 65.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -171.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -99.26 107.92 20.34 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -130.68 146.91 52.28 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.621 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 37.6 m -128.55 131.46 48.22 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.085 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.97 105.84 1.96 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.603 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.9 m -127.26 121.69 31.85 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.6 t -72.64 -76.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -109.28 -70.34 0.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.172 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -136.87 18.9 3.54 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.228 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -136.84 148.79 47.33 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -93.32 149.37 21.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.643 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -111.39 -177.8 3.29 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.24 -45.01 92.31 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.732 -176.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -93.24 -171.58 39.9 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.173 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.62 36.87 58.27 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.865 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -115.17 101.42 8.95 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.2 151.53 34.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.144 0.497 . . . . 0.0 111.54 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.8 m -139.04 126.42 21.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.471 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 56.69 38.3 29.43 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.13 0.49 . . . . 0.0 110.768 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -87.7 136.1 33.1 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.619 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.53 120.15 37.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.715 0.769 . . . . 0.0 112.15 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.461 ' CD1' HH12 ' B' ' 57' ' ' ARG . 49.0 tp -113.27 119.42 37.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.595 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.648 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -102.21 129.04 48.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 56.9 mtm -106.83 167.65 9.73 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.768 -173.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.17 14.08 61.0 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.708 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.432 ' HB2' ' HG2' ' A' ' 193' ' ' ARG . 98.2 mt-30 -126.62 -10.06 6.2 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.661 0.267 . . . . 0.0 111.445 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.53 40.45 9.86 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.424 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 188' ' ' ALA . 39.5 mmm-85 -79.12 -22.04 45.72 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.38 0.672 . . . . 0.0 109.939 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.436 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.1 OUTLIER -128.95 -170.0 2.19 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.185 179.494 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.2 mp -68.33 134.52 91.13 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.63 132.43 45.74 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.256 1.971 . . . . 0.0 111.918 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.47 -39.88 2.63 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.795 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -62.34 -46.31 89.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.554 0.216 . . . . 0.0 111.244 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.95 10.85 5.76 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.088 0.47 . . . . 0.0 111.894 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -114.37 -33.64 5.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.121 0.486 . . . . 0.0 110.115 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.76 -17.88 75.46 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.246 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.57 -41.97 94.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.061 0.457 . . . . 0.0 110.322 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.436 ' HA ' ' HB ' ' A' ' 158' ' ' VAL . 41.5 mtpt -52.08 132.27 32.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.654 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.76 8.74 55.52 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.767 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -115.38 150.18 36.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.031 0.416 . . . . 0.0 110.72 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -87.26 163.39 16.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.169 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.95 135.49 47.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.01 15.35 79.14 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.77 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.19 119.89 38.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.33 0.585 . . . . 0.0 111.362 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 235' ' ' ILE . 25.4 mt-10 -98.9 115.62 29.28 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.408 ' O ' ' HB ' ' A' ' 212' ' ' THR . 64.0 t80 -133.74 -26.09 1.6 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -173.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 77.0 m 72.42 129.96 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 120.893 0.378 . . . . 0.0 110.344 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.42 -41.07 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 70.75 97.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 122.791 0.436 . . . . 0.0 111.32 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 68.6 t -115.59 126.92 73.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.049 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.56 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 18.5 m -65.89 -41.95 90.88 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -176.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.56 ' HB2' ' O ' ' A' ' 216' ' ' THR . 27.8 m-85 77.81 134.53 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 122.957 0.503 . . . . 0.0 110.32 -173.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.16 155.7 51.84 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.369 2.046 . . . . 0.0 112.679 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -66.09 -33.78 76.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.601 0.715 . . . . 0.0 109.305 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.12 22.81 1.66 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.851 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -70.52 142.1 51.88 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.514 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -63.09 -30.37 71.54 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.67 123.62 33.3 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.419 -0.512 . . . . 0.0 109.741 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.526 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 1.5 tp10 -65.33 -31.54 72.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.381 -175.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -86.15 -5.32 59.22 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.37 -11.57 10.0 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.526 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 18.7 ptmt -71.53 119.98 16.47 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.206 0.527 . . . . 0.0 111.063 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 75.9 19.0 79.25 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.755 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -125.34 121.64 34.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.391 . . . . 0.0 110.766 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.55 138.9 45.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.615 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.54 135.47 53.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.845 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.52 -48.22 28.34 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -173.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 212' ' ' THR . 66.1 m-85 54.67 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.91 94.46 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 210' ' ' GLU . 91.6 mt 68.62 99.2 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.804 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -86.94 -51.7 5.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 32.4 tp 55.78 91.0 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.976 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -73.55 -79.33 0.08 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 54.1 mtmt -79.01 -79.11 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -170.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 92.0 t 76.9 152.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-O 120.832 0.349 . . . . 0.0 110.615 -175.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -99.12 56.53 1.04 Allowed 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -36.47 141.17 0.12 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -173.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.656 ' HD3' ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -144.6 144.83 31.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.944 177.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.404 ' HB2' ' CA ' ' A' ' 156' ' ' GLY . 38.2 tt0 -158.94 155.58 27.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 9.1 tt 72.09 128.03 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 123.475 0.484 . . . . 0.0 111.136 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 245' ' ' LEU . 61.2 Cg_endo -87.74 113.99 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.216 1.944 . . . . 0.0 113.632 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -131.37 176.24 8.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.89 111.6 23.92 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 15.6 p -104.51 -86.19 0.46 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.66 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -176.61 -49.93 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.996 0.427 . . . . 0.0 111.896 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.73 -45.11 91.39 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -62.35 -30.37 71.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 263' ' ' VAL . 19.6 tt -85.93 -16.12 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -117.29 8.34 13.12 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.345 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 161' ' ' GLU . 60.5 ttp180 -134.71 133.17 39.7 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.915 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -167.7 37.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 99.43 -31.54 8.2 Favored Glycine 0 C--N 1.318 -0.452 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.07 149.31 5.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.61 -47.25 80.05 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.199 0.312 . . . . 0.0 110.545 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -175.76 163.63 2.85 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.258 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -172.62 175.62 45.67 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.307 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.3 p -83.5 175.33 9.87 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.43 0.292 . . . . 0.0 110.301 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' VAL . . . . . 0.433 HG22 HD11 ' A' ' 253' ' ' ILE . 67.4 t -61.97 -51.23 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.005 0.431 . . . . 0.0 111.054 -177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -81.06 -32.95 33.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.335 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.07 -43.24 99.42 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.19 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 270' ' ' VAL . 65.1 tp -63.14 -44.02 96.7 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.627 0.251 . . . . 0.0 110.52 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -64.12 -42.38 96.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.382 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.536 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.3 -45.02 81.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.29 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 35.5 tp10 -65.71 -38.57 89.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.998 0.427 . . . . 0.0 110.434 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 266' ' ' LEU . 75.8 t -65.49 -43.4 94.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.228 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -59.21 -46.74 87.64 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.673 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.5 ptmt -66.46 -42.62 87.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.669 0.271 . . . . 0.0 111.163 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -65.79 -37.43 86.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.5 mmm -63.52 -42.81 98.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.045 0.45 . . . . 0.0 110.111 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -70.17 -30.82 68.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.204 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -61.61 -43.79 98.19 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.39 -32.98 74.9 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.875 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.8 tp -60.8 -39.64 89.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.951 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -58.12 -46.9 84.78 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 50.4 m -62.52 -44.68 95.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.033 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.3 -51.0 69.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.83 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.45 -44.36 97.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.039 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.544 HH12 ' HG3' ' A' ' 409' ' ' GLU . 6.5 tpt180 -63.03 -45.31 92.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.79 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.43 -40.19 95.27 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.472 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -59.13 -44.4 92.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.014 0.435 . . . . 0.0 110.269 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 86.3 t -70.24 -43.11 78.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.4 tttt -59.3 -47.66 84.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.046 -177.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 74.1 p -62.88 -41.89 99.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -64.2 -42.35 96.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.583 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 294' ' ' LEU . . . -65.27 -42.6 93.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.762 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 287' ' ' LYS . 33.5 mm -64.07 -43.34 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.563 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -60.74 -43.37 98.0 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.114 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.01 -40.85 97.39 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.414 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 290' ' ' ALA . 98.5 mt -62.54 -43.13 99.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.802 0.334 . . . . 0.0 110.802 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 291' ' ' ILE . 96.0 t -65.31 -43.78 94.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.198 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -64.23 -40.59 96.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.068 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.26 -42.74 79.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.962 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -127.21 96.34 4.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.8 105.55 17.49 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 301' ' ' ASP . 11.4 tp -120.1 168.68 12.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.574 -174.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 300' ' ' ILE . 7.3 m-20 -60.78 139.0 58.06 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.385 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.96 119.63 28.78 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.94 131.44 45.49 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.437 2.092 . . . . 0.0 111.89 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.66 84.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.102 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.55 91.1 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 111.565 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.7 mt -66.46 -40.74 89.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.833 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.417 ' O ' HG13 ' A' ' 311' ' ' ILE . 68.7 mt -61.66 -47.95 90.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.992 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.3 -43.04 92.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.873 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 51.0 m -62.25 -45.26 94.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.869 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.6 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 65.9 mm-40 -66.17 -39.48 89.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.234 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.54 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 95.8 mt -61.96 -43.82 98.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.621 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.6 t70 -61.62 -46.62 89.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.913 0.387 . . . . 0.0 111.306 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 91.7 t -63.35 -43.51 98.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.251 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 75.0 mt -62.49 -40.46 96.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.621 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 85.1 mtm180 -62.91 -42.15 99.69 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.132 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -64.79 -38.66 91.74 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -63.35 -44.53 94.57 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.252 0.548 . . . . 0.0 109.937 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.7 80.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.58 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -62.31 -36.29 81.7 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.944 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -63.2 -40.5 97.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.281 0.563 . . . . 0.0 109.584 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -75.06 -9.6 58.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.343 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -92.2 -7.36 48.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.845 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . 136.69 -14.33 3.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.82 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 113.12 44.11 0.82 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.879 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 35.6 t-20 -87.22 127.98 35.15 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.88 0.372 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.549 ' OE1' ' HG3' ' A' ' 327' ' ' LYS . 1.8 tm-20 -130.7 145.26 51.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.549 ' HG3' ' OE1' ' A' ' 326' ' ' GLU . 35.2 mtmm 72.22 -46.05 0.63 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.646 0.779 . . . . 0.0 112.422 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.503 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 12.3 mm100 -70.0 -10.98 60.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.207 0.527 . . . . 0.0 110.446 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.85 -22.54 64.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.411 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.432 HD12 HH12 ' A' ' 315' ' ' ARG . 60.0 tp -61.61 -33.93 74.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.679 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -79.27 -6.29 56.34 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.573 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 75.9 mt -69.24 145.63 96.17 Favored Pre-proline 0 C--O 1.241 0.623 0 O-C-N 122.186 -0.321 . . . . 0.0 110.997 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.36 127.08 23.43 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.893 2.396 . . . . 0.0 113.339 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.484 ' HG3' HD13 ' A' ' 311' ' ' ILE . 21.9 ttt180 -70.49 -41.0 73.25 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.405 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -52.16 -46.41 65.45 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -173.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.469 HD12 ' CD ' ' A' ' 224' ' ' GLU . 74.7 mt -92.27 10.13 30.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -115.72 -28.2 6.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.132 0.492 . . . . 0.0 110.228 172.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.7 -30.67 70.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.711 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -60.97 -48.24 82.75 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.471 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -78.32 -20.86 50.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.713 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.95 -40.87 97.43 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.505 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.8 tttt -59.82 -45.16 93.23 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.567 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.1 mmt85 -60.27 -45.8 92.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.031 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -67.46 -38.92 85.18 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.164 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 341' ' ' ALA . 82.8 t -64.27 -43.86 97.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.658 0.266 . . . . 0.0 110.351 176.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 342' ' ' LYS . 73.0 t -60.74 -43.8 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.531 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 343' ' ' ARG . 82.7 t -59.93 -45.6 94.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.45 -43.34 99.18 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.93 -43.73 94.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.59 0.233 . . . . 0.0 111.478 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.43 -44.79 93.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.924 0.393 . . . . 0.0 110.506 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 355' ' ' ILE . 95.8 mt -66.59 -39.93 88.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.816 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.84 -41.76 96.25 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.583 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -66.06 -40.46 90.92 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.889 0.344 . . . . 0.0 110.646 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.76 -45.89 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.937 178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 351' ' ' LEU . 73.6 mt -62.96 -46.98 94.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.224 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -64.07 -62.75 1.43 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.7 m -66.29 -43.86 85.14 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.3 -12.15 60.46 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.246 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 66.44 47.6 1.69 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.008 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.17 142.16 33.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.884 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.06 146.13 51.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.67 114.47 5.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.487 ' O ' HG23 ' A' ' 367' ' ' VAL . 26.8 t70 -87.01 111.48 20.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.064 0.459 . . . . 0.0 111.077 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 58.1 mm-40 -61.4 -35.04 76.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.995 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.63 -42.09 91.9 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.845 0.355 . . . . 0.0 110.764 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -63.01 -40.05 96.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.11 0.481 . . . . 0.0 110.149 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 363' ' ' ASP . 89.2 t -61.26 -39.41 82.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.335 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.0 mmmt -57.23 -43.41 82.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.508 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.65 99.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.204 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.65 -42.96 99.89 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.124 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.84 -44.85 92.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.121 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.73 -41.47 98.05 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -65.17 -42.31 93.83 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.436 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 49.6 ttp -65.25 -40.69 94.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -62.97 -23.45 67.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.568 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 39.6 m -73.85 -5.73 42.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.481 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -90.86 0.15 57.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.328 0.585 . . . . 0.0 110.315 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.86 170.84 8.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.542 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.06 -44.13 85.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.81 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -124.63 113.23 27.28 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.764 0.316 . . . . 0.0 110.616 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.428 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 40.1 Cg_exo -58.24 -35.95 98.22 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.948 2.432 . . . . 0.0 113.221 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.28 -43.7 85.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.48 -35.8 81.67 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.884 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.93 -43.24 96.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 109.978 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.11 -43.48 98.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.88 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.45 -36.75 84.84 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.743 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -58.63 -47.43 84.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.335 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' A' ' 395' ' ' MET . 5.7 m-85 -70.66 -44.46 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 29.9 p -68.32 -15.91 63.74 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -100.77 4.74 43.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.591 0.234 . . . . 0.0 111.214 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -128.97 112.94 14.58 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 110.699 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.13 -40.56 96.43 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -56.81 -51.38 69.19 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.043 0.449 . . . . 0.0 110.794 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.37 -40.14 95.24 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.838 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 388' ' ' TYR . 87.9 mtp -61.7 -45.63 93.17 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.638 0.256 . . . . 0.0 111.681 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.18 -44.25 63.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.367 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -63.31 -42.69 99.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.049 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 50.3 tpp -63.56 -42.07 98.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.991 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.463 ' HG2' HG21 ' A' ' 367' ' ' VAL . 83.2 mtm180 -65.59 -34.53 78.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.195 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -61.81 -42.72 99.37 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 110.106 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.99 -43.41 89.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.694 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.31 97.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.724 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.5 -36.7 84.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.489 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.22 -45.32 91.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.812 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 40.7 mt-10 -64.85 -38.46 91.06 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.419 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -60.39 -43.39 96.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.492 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.88 96.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.31 -43.51 95.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.544 ' HG3' HH12 ' A' ' 283' ' ' ARG . 80.5 mt-10 -66.02 -34.34 77.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.291 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.22 -39.12 91.74 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.15 0.5 . . . . 0.0 110.21 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.78 -42.85 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.176 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.56 -40.36 94.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.458 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.8 -27.76 68.27 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.941 0.4 . . . . 0.0 111.356 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -94.16 -8.22 40.05 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 110.821 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.35 -179.94 5.09 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.239 0.542 . . . . 0.0 111.835 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -103.41 106.39 16.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.031 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 63.9 t -92.51 132.61 36.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 120.768 0.318 . . . . 0.0 110.382 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.4 t -124.63 146.64 48.97 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.907 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.67 130.84 53.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.822 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -148.14 136.36 21.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.026 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -87.22 153.86 21.16 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.6 t -158.01 178.57 10.07 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 18.0 p -87.3 162.2 17.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.918 0.389 . . . . 0.0 111.549 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.9 -36.51 82.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.281 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -57.59 -36.94 72.39 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.893 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.2 -33.67 76.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.871 0.367 . . . . 0.0 110.939 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.5 mp -81.06 -12.45 59.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.905 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 3.2 mmt -78.49 -8.3 58.39 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -78.32 84.01 4.53 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.925 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -109.41 23.16 14.86 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.411 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -82.12 -9.0 59.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.515 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.59 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.265 -179.678 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.403 ' HG2' ' H ' ' B' ' 2' ' ' GLN . 53.3 ttm . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.403 ' H ' ' HG2' ' B' ' 1' ' ' MET . 26.0 tt0 -53.58 109.8 0.49 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.981 0.419 . . . . 0.0 111.887 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.49 161.78 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.818 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 43.7 t -136.79 130.56 32.07 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 p -152.78 137.89 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.856 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 41.3 mt-10 -128.17 161.06 30.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.269 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 49.9 m -110.0 125.56 53.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 16.8 m -96.66 -58.62 2.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.447 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -174.41 129.07 0.35 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.207 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.82 -114.6 6.92 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.708 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 mp -91.14 -9.84 44.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.711 0.291 . . . . 0.0 110.783 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.34 120.68 5.64 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.736 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.05 146.98 48.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 54.7 ttp180 -110.08 139.72 44.92 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.58 -90.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.402 ' OG1' HG23 ' B' ' 104' ' ' THR . 34.9 m 68.24 99.69 0.05 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.1 tp -134.15 144.02 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.881 0.372 . . . . 0.0 111.796 -175.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.4 m -127.79 129.87 47.73 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.673 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.55 ' HB ' HG12 ' B' ' 24' ' ' ILE . 16.8 mt -123.67 162.14 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -176.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.592 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.29 148.03 52.41 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.259 0.224 . . . . 0.0 110.811 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.37 -61.54 2.12 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -66.74 -32.28 73.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.798 0.332 . . . . 0.0 110.943 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 38.6 t -63.04 -41.07 99.41 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.241 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.592 HG13 ' O ' ' B' ' 20' ' ' ALA . 76.3 mt -60.1 -52.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.124 0.488 . . . . 0.0 110.935 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -69.45 -46.11 67.48 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.594 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 21.1 m -65.46 -51.2 61.79 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.57 -47.81 62.36 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.18 -43.28 98.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.075 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -60.34 -46.51 89.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.391 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 25.4 m -62.45 -42.5 99.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.647 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.45 ' O ' HG23 ' B' ' 35' ' ' VAL . 10.0 tp10 -68.87 -42.98 76.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.571 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.96 -44.43 96.77 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -69.61 -34.51 61.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.96 0.41 . . . . 0.0 110.762 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -65.08 -42.21 94.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.56 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.565 HG11 ' HD3' ' B' ' 73' ' ' ARG . 88.2 t -65.95 -41.74 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.096 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.76 -40.76 84.84 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.377 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.455 ' O ' ' HD3' ' B' ' 40' ' ' ARG . 98.6 mttt -65.37 -37.16 86.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.279 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.79 -44.3 96.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 110.593 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 19.7 t -78.94 -4.44 6.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.488 0.661 . . . . 0.0 109.969 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' B' ' 37' ' ' LYS . 25.6 mmt180 64.53 25.85 13.28 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.44 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.7 11.39 8.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -63.46 -34.53 77.97 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.184 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.33 0.98 83.15 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.6 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -93.48 -1.67 55.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.042 0.448 . . . . 0.0 110.783 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -95.09 110.59 22.51 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -62.2 -38.49 89.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.371 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.29 56.4 25.26 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -63.52 -41.66 98.5 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.0 t -100.44 110.01 58.83 Favored Pre-proline 0 C--O 1.248 0.999 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.46 ' HG2' HD12 ' B' ' 53' ' ' ILE . 48.9 Cg_exo -57.01 149.04 64.71 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.822 2.348 . . . . 0.0 112.349 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.538 ' HA ' HG12 ' B' ' 54' ' ' VAL . 21.4 ttt -61.1 -37.19 81.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.182 -173.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -69.26 -24.82 64.03 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.929 0.395 . . . . 0.0 111.112 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.46 HD12 ' HG2' ' B' ' 50' ' ' PRO . 96.8 mt -92.69 -41.5 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' B' ' 51' ' ' MET . 13.1 p -65.16 -38.74 83.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.067 0.461 . . . . 0.0 111.019 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.442 ' O ' ' HA3' ' B' ' 59' ' ' GLY . . . -67.38 -37.37 83.05 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 9.5 pt20 -74.67 -11.73 60.25 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.38 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.461 HH12 ' CD1' ' A' ' 187' ' ' LEU . 62.8 mtt-85 -109.42 -50.17 3.02 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' TYR . . . . . 0.42 ' O ' HG12 ' B' ' 62' ' ' VAL . 20.5 m-85 -112.64 1.25 15.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.082 0.468 . . . . 0.0 110.811 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -64.99 -37.25 94.04 Favored Glycine 0 C--O 1.217 -0.941 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.074 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.86 76.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.727 0.298 . . . . 0.0 111.249 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 48.5 m -62.15 -44.55 96.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.052 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' B' ' 65' ' ' ASP . 8.3 p -105.09 19.99 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.352 0.596 . . . . 0.0 111.118 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 12.7 ttm180 -63.05 -20.64 65.52 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.116 0.484 . . . . 0.0 110.182 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -64.07 -53.31 51.74 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.349 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ASP . . . . . 0.524 ' HB2' HG22 ' B' ' 62' ' ' VAL . 20.7 m-20 -69.91 -27.39 64.74 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.847 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 62' ' ' VAL . 93.6 t -61.64 -45.09 99.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -64.01 -39.87 95.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.412 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.64 -41.31 98.85 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.162 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.04 -44.69 95.18 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.33 -42.1 98.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.005 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.8 ttp -60.16 -50.77 72.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.183 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 24.4 m -65.28 -46.02 82.11 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.788 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.565 ' HD3' HG11 ' B' ' 35' ' ' VAL . 59.0 ttm-85 -66.34 -46.61 76.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.745 -175.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -66.47 -40.11 89.17 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -60.34 -48.67 80.75 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.453 ' O ' HG13 ' B' ' 79' ' ' ILE . 19.9 tt -67.45 -38.95 81.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.965 0.412 . . . . 0.0 111.259 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -66.17 -40.25 90.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.338 0.59 . . . . 0.0 109.88 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.11 85.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.828 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.453 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.7 pp -66.1 -37.2 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.37 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 -42.59 96.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.696 0.76 . . . . 0.0 109.172 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -59.95 -46.46 89.33 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.533 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -90.02 2.43 55.19 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.7 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm 65.83 41.43 3.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.69 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 87.0 mt -96.66 119.99 45.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.882 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -108.17 103.6 50.86 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -85.21 127.45 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.538 2.159 . . . . 0.0 112.328 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.46 97.94 10.51 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.069 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.64 -141.78 15.85 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.514 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.04 132.42 23.72 Favored Pre-proline 0 C--N 1.317 -0.806 0 O-C-N 122.853 -0.204 . . . . 0.0 110.695 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' PRO . . . . . 0.442 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 64.0 Cg_endo -71.78 162.02 43.32 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.826 2.351 . . . . 0.0 111.272 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 18.7 m -99.34 109.07 21.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.282 0.563 . . . . 0.0 111.17 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.442 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 87.9 m-85 -99.96 115.58 30.02 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.65 94.58 19.98 Favored Pre-proline 0 C--N 1.32 -0.717 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.931 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 90.9 Cg_endo -87.01 146.16 7.68 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.552 2.168 . . . . 0.0 110.523 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.98 172.18 39.91 Favored Glycine 0 N--CA 1.437 -1.295 0 C-N-CA 120.0 -1.095 . . . . 0.0 111.168 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.16 136.12 47.96 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -87.03 103.93 15.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.383 0.611 . . . . 0.0 111.544 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.46 111.16 18.23 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 49.3 tp -64.9 109.13 1.99 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.1 0.476 . . . . 0.0 110.408 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.06 -11.32 13.26 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.344 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.74 -177.69 3.81 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.708 0.29 . . . . 0.0 111.548 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -76.08 143.32 41.39 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.8 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -91.61 140.93 29.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.708 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.405 HG21 ' HD2' ' B' ' 14' ' ' ARG . 59.1 m -119.77 136.61 54.38 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.053 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -139.65 162.1 35.91 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.056 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 5.1 m -121.53 149.84 42.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.785 0.326 . . . . 0.0 111.227 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 10.8 p -133.97 142.72 40.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.307 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -105.58 128.17 53.46 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -149.68 -158.54 0.93 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -48.77 155.8 0.54 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.998 1.319 . . . . 0.0 113.318 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.18 160.81 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.114 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -144.98 97.08 4.9 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.741 0.305 . . . . 0.0 110.783 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.62 145.98 33.76 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.849 2.366 . . . . 0.0 112.801 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -164.48 123.55 1.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.5 164.86 31.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.827 0.346 . . . . 0.0 111.583 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -121.44 135.69 55.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.937 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.26 136.01 53.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -130.48 138.82 50.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.658 0.266 . . . . 0.0 111.107 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.15 19.3 61.13 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.912 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.05 -41.15 99.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.118 0.459 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.54 -5.33 32.46 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.483 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.03 13.86 27.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.903 0.382 . . . . 0.0 111.097 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 81.7 mt -102.17 128.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.152 0.501 . . . . 0.0 110.613 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -109.79 128.92 55.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.927 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 62.5 t -117.86 133.28 65.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.988 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -90.94 128.21 36.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.937 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.81 94.0 32.84 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.35 141.06 60.59 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.412 2.075 . . . . 0.0 112.503 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.7 mm -108.33 118.58 56.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.236 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.01 158.53 43.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.359 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -141.35 159.82 41.43 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.179 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -79.74 129.17 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.611 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.9 p -105.07 176.18 5.25 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.689 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -62.0 -38.09 87.3 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.35 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.95 -37.38 84.52 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.874 0.369 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -63.81 -39.03 93.26 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 89.3 t -63.65 -44.72 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.234 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.62 -42.41 92.6 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.247 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.53 98.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.959 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.525 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 4.6 tpt -63.11 -45.27 92.78 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.858 0.361 . . . . 0.0 110.231 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.86 -41.59 97.75 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.036 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.98 -45.46 92.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.664 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 26.5 m -61.97 -41.16 97.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.952 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.1 mt -61.21 -41.42 96.81 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.459 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -68.83 -22.5 64.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.058 0.456 . . . . 0.0 110.741 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -85.46 2.48 44.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.228 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -119.31 31.44 6.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.394 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -139.16 89.61 2.36 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.22 155.77 49.56 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.499 HG22 ' H ' ' B' ' 151' ' ' TRP . 1.2 m -124.04 172.14 9.22 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.676 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' TRP . . . . . 0.499 ' H ' HG22 ' B' ' 150' ' ' THR . 8.6 p-90 -53.18 137.11 34.95 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -172.71 119.45 0.37 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.88 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' B' ' 154' ' ' LYS . 7.5 pt-20 -77.5 89.72 3.86 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.44 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' B' ' 153' ' ' GLU . 63.5 mmtt -158.44 -72.08 0.09 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.921 0.888 . . . . 0.0 110.736 177.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -169.52 -70.91 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.318 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' B' ' 243' ' ' ARG . . . 66.45 -128.93 30.72 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.798 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -145.53 -165.76 2.27 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' B' ' 203' ' ' LYS . 50.5 t -117.43 124.73 73.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' B' ' 162' ' ' ASP . 62.0 mm-40 -87.9 174.44 8.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.068 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.3 -52.79 23.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.198 0.523 . . . . 0.0 109.821 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' GLU . . . . . 0.435 ' CD ' ' HE ' ' B' ' 255' ' ' ARG . 6.8 pt-20 -92.91 32.66 1.24 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.46 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.61 ' OD2' ' HD3' ' B' ' 243' ' ' ARG . 9.2 t70 -57.36 -48.85 77.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.378 -174.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 21.8 ttp85 66.0 88.47 0.11 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.791 0.805 . . . . 0.0 109.24 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.554 HG22 ' OD1' ' B' ' 162' ' ' ASP . 3.0 t -111.49 133.0 58.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.005 -174.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.9 m -80.29 104.51 10.89 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 79.7 mt -116.83 131.0 70.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -97.86 106.21 18.48 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -128.56 146.6 50.79 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.441 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 36.1 m -129.84 131.46 46.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.208 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.38 110.75 3.23 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.562 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 14.6 m -130.67 122.37 27.24 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.47 -76.09 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -110.65 -71.91 0.74 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.817 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -134.37 16.02 4.4 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.067 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -135.17 147.59 49.45 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.916 0.389 . . . . 0.0 110.402 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -91.29 150.58 21.25 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.688 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -112.48 179.15 4.07 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.83 -42.12 88.5 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.1 -175.45 39.31 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.032 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 73.72 36.51 53.25 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.861 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -114.43 102.17 9.83 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.68 154.27 38.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.032 0.444 . . . . 0.0 111.744 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -142.56 133.4 25.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 56.27 35.22 25.42 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.377 0.423 . . . . 0.0 110.845 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 185' ' ' PHE . . . . . 0.41 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 42.4 t80 -88.22 134.52 33.77 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.085 -175.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 15.7 m -90.58 120.97 40.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.634 0.731 . . . . 0.0 112.01 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 187' ' ' LEU . . . . . 0.501 ' CD1' HH12 ' A' ' 57' ' ' ARG . 29.0 tp -114.32 121.28 43.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.502 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 188' ' ' ALA . . . . . 0.598 ' O ' ' HG3' ' B' ' 193' ' ' ARG . . . -101.64 132.18 47.46 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 172.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 57.5 mtm -109.91 165.78 11.45 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.084 -173.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.13 0.33 65.83 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.967 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 191' ' ' GLN . . . . . 0.436 ' HB2' ' HG2' ' B' ' 193' ' ' ARG . 97.7 mt-30 -112.94 -8.38 13.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.43 36.35 17.36 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.677 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' B' ' 188' ' ' ALA . 39.7 mmm-85 -74.49 -25.41 59.36 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.379 0.672 . . . . 0.0 110.138 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 194' ' ' MET . . . . . 0.439 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.1 OUTLIER -124.75 -171.27 2.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.522 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.444 ' H ' HD12 ' B' ' 195' ' ' ILE . 3.7 mp -68.54 136.92 90.69 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.67 132.86 47.88 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.164 1.909 . . . . 0.0 112.054 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.35 -39.79 2.69 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.05 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -62.39 -45.54 92.69 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.0 8.93 11.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -113.21 -33.67 5.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.179 0.514 . . . . 0.0 109.765 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.94 -19.26 73.44 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.396 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 98.6 mt -64.95 -33.54 64.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.262 0.554 . . . . 0.0 110.225 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.404 ' HA ' ' HB ' ' B' ' 158' ' ' VAL . 44.6 mtpt -60.03 135.27 57.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.143 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.58 3.61 58.39 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.451 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -111.62 147.85 34.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 117.013 0.407 . . . . 0.0 110.934 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -85.01 163.63 18.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.073 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.62 137.0 51.91 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.29 20.55 77.03 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.968 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -101.37 121.81 42.59 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.23 0.538 . . . . 0.0 110.946 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 210' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' B' ' 236' ' ' ASN . 33.4 mt-10 -101.92 113.58 26.91 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -133.44 -27.62 1.54 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 30.8 m 74.56 130.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 120.9 0.381 . . . . 0.0 110.455 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.79 -40.53 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 70.38 97.93 0.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.199 0.523 . . . . 0.0 111.842 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 62.6 t -116.07 128.21 73.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 216' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 19.4 m -68.69 -40.78 79.88 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -176.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.542 ' HB2' ' O ' ' B' ' 216' ' ' THR . 32.6 m-85 77.8 134.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 123.025 0.53 . . . . 0.0 110.699 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.46 156.1 50.21 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.606 2.204 . . . . 0.0 112.584 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -65.44 -34.93 79.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.525 0.678 . . . . 0.0 110.008 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -87.14 30.12 0.79 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.616 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -74.65 140.98 44.63 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -61.65 -29.13 69.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.05 121.9 33.25 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.971 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.582 ' HA ' ' CD ' ' B' ' 227' ' ' LYS . 1.4 tp10 -62.93 -33.66 75.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.562 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.476 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 30.8 p-10 -84.22 -5.9 59.32 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.61 -12.94 9.68 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.582 ' CD ' ' HA ' ' B' ' 224' ' ' GLU . 18.1 ptmt -69.19 118.72 12.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.275 0.559 . . . . 0.0 111.205 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.4 18.17 78.29 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.926 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 99.2 mttt -122.59 124.19 42.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.077 0.438 . . . . 0.0 110.698 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.5 140.57 44.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.298 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -126.86 134.45 50.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.915 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -73.2 -48.9 31.27 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -173.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' B' ' 212' ' ' THR . 61.6 m-85 55.03 98.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.657 0.383 . . . . 0.0 112.012 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.6 90.94 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 91.2 mt 67.71 98.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.167 0.587 . . . . 0.0 111.85 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 236' ' ' ASN . . . . . 0.469 ' HA ' ' HG2' ' B' ' 210' ' ' GLU . 28.6 t-20 -86.26 -51.0 6.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 33.4 tp 53.07 90.55 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.052 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 27.3 mttp -74.79 -78.37 0.1 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 239' ' ' LYS . . . . . 0.457 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 52.2 mtmt -75.46 -81.03 0.08 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.381 1.622 . . . . 0.0 115.381 -170.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.632 HG12 ' H ' ' B' ' 242' ' ' GLU . 67.7 t 75.22 139.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -174.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' B' ' 242' ' ' GLU . 86.3 mt-10 -68.73 -27.82 66.27 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.082 -0.386 . . . . 0.0 111.312 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' B' ' 241' ' ' GLU . 2.7 pt-20 64.51 132.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.552 1.541 . . . . 0.0 113.933 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.61 ' HD3' ' OD2' ' B' ' 162' ' ' ASP . 0.0 OUTLIER -154.35 144.1 21.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.358 178.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -159.54 153.89 23.87 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 tt 72.18 123.75 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.068 0.547 . . . . 0.0 111.352 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -84.21 115.91 2.01 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.546 2.164 . . . . 0.0 113.484 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -135.67 167.47 21.06 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.35 110.57 21.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 10.7 p -103.56 -83.55 0.48 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.92 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.404 ' O ' HG22 ' B' ' 253' ' ' ILE . . . -177.69 -53.62 0.01 OUTLIER 'General case' 0 C--N 1.343 0.319 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.65 -47.14 86.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -61.6 -26.98 68.32 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -173.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 253' ' ' ILE . . . . . 0.404 HG22 ' O ' ' B' ' 250' ' ' ALA . 18.9 tt -91.13 -5.89 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -127.91 6.88 6.08 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.032 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.435 ' HE ' ' CD ' ' B' ' 161' ' ' GLU . 60.0 ttp180 -131.24 134.82 46.81 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.538 0.209 . . . . 0.0 110.545 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -172.87 34.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.92 -32.28 7.7 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 42.0 t -80.65 150.84 4.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.38 -51.87 65.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.375 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -175.43 163.81 3.05 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.257 173.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -172.77 177.53 45.25 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.377 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.9 p -82.12 175.8 10.03 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.33 0.252 . . . . 0.0 111.096 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.24 -49.13 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.396 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.41 -32.22 21.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.588 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.12 -43.01 99.73 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.984 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 270' ' ' VAL . 63.5 tp -62.86 -43.79 97.87 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.622 0.249 . . . . 0.0 110.445 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -64.25 -41.96 96.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.882 0.372 . . . . 0.0 110.367 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -66.62 -44.95 80.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.309 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 269' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 37.2 tp10 -66.3 -39.39 89.3 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.094 0.473 . . . . 0.0 110.57 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 266' ' ' LEU . 70.7 t -65.01 -42.85 95.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.089 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -59.71 -46.54 88.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.8 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 18.3 ptmt -66.09 -42.5 89.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.843 0.354 . . . . 0.0 111.007 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -66.0 -37.16 85.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.016 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.2 mmm -63.97 -43.24 96.36 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 110.496 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -70.98 -29.52 65.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.112 0.482 . . . . 0.0 110.08 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -61.86 -43.69 98.34 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -65.1 -32.33 73.97 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.823 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 57.5 tp -60.96 -39.48 89.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.017 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -58.19 -47.79 82.33 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 177.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 17.3 m -62.59 -44.04 97.3 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.866 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.26 69.21 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.795 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.22 -45.72 92.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.607 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 283' ' ' ARG . . . . . 0.519 HH12 ' HG3' ' B' ' 409' ' ' GLU . 8.1 tpt180 -61.7 -45.64 93.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.898 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -64.87 -39.94 94.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.46 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -59.04 -44.42 91.76 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.046 0.45 . . . . 0.0 110.382 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.13 -42.81 79.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.537 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 287' ' ' LYS . . . . . 0.435 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.8 tttt -59.67 -48.13 82.88 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.081 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.7 p -62.23 -41.91 98.83 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.769 0.319 . . . . 0.0 111.542 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -65.06 -41.88 94.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.813 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 290' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' B' ' 294' ' ' LEU . . . -65.61 -42.57 91.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.998 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 291' ' ' ILE . . . . . 0.435 HG12 ' O ' ' B' ' 287' ' ' LYS . 32.2 mm -63.8 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.573 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 292' ' ' GLU . . . . . 0.416 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 27.8 tp10 -59.8 -43.78 94.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.235 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.8 -40.33 97.27 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.276 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' B' ' 290' ' ' ALA . 95.5 mt -62.85 -42.63 99.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.682 0.277 . . . . 0.0 110.926 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 295' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 291' ' ' ILE . 91.4 t -65.61 -43.59 93.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.049 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 296' ' ' LYS . . . . . 0.416 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 68.4 mttm -63.49 -41.94 98.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.127 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.62 -41.89 78.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.055 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -126.92 94.66 4.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -93.73 106.52 18.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 300' ' ' ILE . . . . . 0.437 HG13 ' N ' ' B' ' 301' ' ' ASP . 11.4 tp -122.07 166.18 17.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.005 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 301' ' ' ASP . . . . . 0.437 ' N ' HG13 ' B' ' 300' ' ' ILE . 33.0 m-20 -61.3 135.51 57.74 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.578 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.09 122.06 30.78 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.745 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.36 131.21 43.38 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.64 2.227 . . . . 0.0 111.939 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.05 -36.43 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.975 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.02 -43.11 91.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.298 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.06 -40.54 90.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.903 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 307' ' ' ILE . . . . . 0.418 ' O ' HG13 ' B' ' 311' ' ' ILE . 97.0 mt -62.75 -45.99 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.754 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.17 -41.53 98.41 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.19 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 46.8 m -62.46 -45.49 92.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.316 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 310' ' ' GLU . . . . . 0.555 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 62.9 mm-40 -68.25 -37.99 81.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.536 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.0 mt -62.13 -43.68 98.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.625 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.578 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 17.2 t70 -60.46 -47.14 87.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.792 0.33 . . . . 0.0 111.012 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.46 -44.33 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.536 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 84.7 mt -62.76 -40.38 97.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.578 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 85.2 mtm180 -62.18 -42.4 99.24 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 32.5 mtt85 -64.91 -38.47 91.07 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -63.1 -45.16 93.35 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.074 0.464 . . . . 0.0 109.87 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.27 -36.32 79.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.745 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 319' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -61.89 -36.18 80.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.123 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -63.13 -39.43 94.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.424 0.63 . . . . 0.0 109.506 175.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -76.25 -9.91 59.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.41 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -91.21 -7.79 50.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.817 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 323' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 137.14 -12.12 3.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.809 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 112.53 42.18 0.98 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.005 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 325' ' ' ASN . . . . . 0.546 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 33.5 t-20 -85.27 127.04 34.17 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.876 0.369 . . . . 0.0 110.356 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 326' ' ' GLU . . . . . 0.47 ' OE1' ' HG3' ' B' ' 327' ' ' LYS . 2.0 tm-20 -130.2 144.49 51.39 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.47 ' HG3' ' OE1' ' B' ' 326' ' ' GLU . 35.5 mtmm 71.33 -47.92 0.66 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.627 0.771 . . . . 0.0 112.215 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 328' ' ' GLN . . . . . 0.546 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 14.2 mm100 -65.9 -13.06 58.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.083 0.468 . . . . 0.0 110.707 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.38 -21.81 60.44 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.643 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.42 HD12 HH12 ' B' ' 315' ' ' ARG . 57.4 tp -61.84 -33.43 74.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.638 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -79.5 -10.04 59.73 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.591 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 75.5 mt -65.14 147.41 98.57 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.61 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.23 141.18 97.58 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.574 2.183 . . . . 0.0 112.884 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 334' ' ' ARG . . . . . 0.472 ' HG3' HD13 ' B' ' 311' ' ' ILE . 27.2 ttt85 -85.27 -36.33 20.96 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.511 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -56.74 -46.39 81.39 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 336' ' ' LEU . . . . . 0.523 HD12 ' CD ' ' B' ' 224' ' ' GLU . 73.3 mt -91.86 12.08 22.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -117.96 -28.56 5.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.131 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -66.49 -31.7 72.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.714 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.61 -49.53 77.16 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.03 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -75.94 -22.47 55.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.702 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.435 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.42 -41.96 98.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 342' ' ' LYS . . . . . 0.51 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.3 tttt -60.72 -44.56 96.46 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 343' ' ' ARG . . . . . 0.574 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.1 mmt85 -59.93 -46.18 90.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.983 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.29 -39.29 85.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.255 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 341' ' ' ALA . 87.8 t -64.78 -43.31 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.436 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.51 HG23 ' O ' ' B' ' 342' ' ' LYS . 73.8 t -60.33 -43.12 93.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.404 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 343' ' ' ARG . 91.1 t -60.02 -45.68 95.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.34 -42.78 99.7 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.204 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.7 -44.27 94.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.43 -45.21 92.0 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.695 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.461 ' O ' HG13 ' B' ' 355' ' ' ILE . 94.4 mt -66.66 -39.62 88.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.915 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.21 -42.53 97.25 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.628 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -64.3 -39.79 94.62 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.978 0.389 . . . . 0.0 110.559 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.3 -46.36 96.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.042 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 355' ' ' ILE . . . . . 0.461 HG13 ' O ' ' B' ' 351' ' ' LEU . 71.0 mt -63.6 -46.29 95.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.399 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -64.6 -64.73 0.8 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 38.5 m -65.96 -43.24 88.5 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.76 -11.42 60.16 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.168 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 62.38 64.86 0.91 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.718 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.9 mt -98.02 136.97 37.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.203 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.09 150.22 45.29 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.195 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.92 120.02 13.53 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 363' ' ' ASP . . . . . 0.496 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.5 t70 -90.17 108.34 19.68 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.939 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 364' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 66.2 mm-40 -61.68 -34.65 76.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.67 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -66.03 -41.58 90.73 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.49 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 366' ' ' ARG . . . . . 0.416 HH12 ' CD ' ' B' ' 409' ' ' GLU . 45.9 ttt180 -62.47 -40.79 97.79 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.001 0.429 . . . . 0.0 110.137 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 367' ' ' VAL . . . . . 0.496 HG23 ' O ' ' B' ' 363' ' ' ASP . 88.4 t -61.28 -39.71 83.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.236 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 368' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.2 mmmt -56.64 -44.07 80.9 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.511 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.21 -40.2 98.81 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.2 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.33 -42.88 98.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 110.239 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.64 -43.68 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.797 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -64.04 -41.96 97.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.76 -41.73 91.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.053 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 48.6 ttp -65.43 -39.7 92.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.028 0.442 . . . . 0.0 110.511 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 375' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -63.28 -24.67 67.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.596 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 44.9 m -73.47 -6.34 45.78 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.45 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.02 -2.09 58.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.532 0.682 . . . . 0.0 110.284 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -113.08 172.78 6.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.976 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -65.7 -47.69 74.54 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -121.76 116.24 30.44 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.803 0.335 . . . . 0.0 110.999 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 381' ' ' PRO . . . . . 0.461 ' O ' HG13 ' B' ' 385' ' ' ILE . 46.5 Cg_exo -58.21 -36.49 97.74 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.909 2.406 . . . . 0.0 113.116 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -64.72 -43.42 93.48 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -174.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.81 -36.81 84.4 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.933 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.44 -42.96 94.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.302 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 385' ' ' ILE . . . . . 0.461 HG13 ' O ' ' B' ' 381' ' ' PRO . 65.7 mt -62.23 -44.83 99.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.335 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -64.93 -37.87 89.07 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.765 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -58.75 -47.06 85.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.443 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 388' ' ' TYR . . . . . 0.44 ' O ' ' HG3' ' B' ' 395' ' ' MET . 2.8 m-85 -69.67 -44.78 69.81 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 18.9 p -68.88 -16.26 63.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.19 4.6 48.94 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.746 0.307 . . . . 0.0 111.19 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -129.57 112.04 13.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 110.532 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -64.72 -37.5 87.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.263 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -57.23 -53.38 58.74 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.021 0.439 . . . . 0.0 110.558 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.47 -40.5 95.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.737 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' B' ' 388' ' ' TYR . 89.1 mtp -61.62 -46.18 90.92 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.89 -44.18 64.17 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.415 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -64.13 -42.13 96.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.374 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 52.3 tpp -63.1 -41.17 99.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.838 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' B' ' 395' ' ' MET . 83.0 mtm180 -65.76 -34.8 79.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.917 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.44 -42.33 99.38 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 90.4 t -66.22 -43.77 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.622 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.44 94.99 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.544 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.25 -37.14 86.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.48 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -58.29 -47.21 84.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.855 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.09 -38.14 89.98 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.564 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -61.71 -42.25 98.69 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.209 0.318 . . . . 0.0 110.672 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.53 97.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.047 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.39 -43.14 91.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.572 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 409' ' ' GLU . . . . . 0.519 ' HG3' HH12 ' B' ' 283' ' ' ARG . 96.6 mt-10 -63.95 -35.84 82.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.17 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.57 94.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.474 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.0 -43.06 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.474 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.21 -39.42 92.72 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.531 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.76 67.55 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.987 0.422 . . . . 0.0 111.311 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -98.08 -7.62 29.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.697 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.37 169.58 9.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.316 0.579 . . . . 0.0 112.261 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -90.78 99.41 12.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.808 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 68.4 t -86.75 131.68 34.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.697 0.284 . . . . 0.0 110.751 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.9 t -124.28 155.3 38.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.941 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -113.41 130.71 56.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.844 0.354 . . . . 0.0 110.749 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -147.48 141.25 25.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.201 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.2 150.9 19.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.335 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.1 t -158.0 174.96 14.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.361 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 17.4 p -85.63 163.67 18.16 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 111.81 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -65.01 -36.42 84.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.449 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -57.38 -38.33 74.08 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.84 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.68 -32.8 74.56 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.858 0.361 . . . . 0.0 111.166 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.25 -12.7 59.04 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.8 mmt -78.28 -8.48 58.43 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.13 0.491 . . . . 0.0 110.785 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -75.71 79.84 2.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.193 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -108.13 26.56 10.26 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.556 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -85.06 -11.79 54.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.853 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.677 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.025 -179.537 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.233 0.209 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.3 m -124.1 116.87 23.48 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.661 0.267 . . . . 0.0 110.881 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -134.93 135.87 52.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 47.8 mt-10 -111.7 175.86 5.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.102 0.477 . . . . 0.0 111.727 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 t -124.27 141.46 52.05 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.674 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.0 m -99.71 -75.91 0.56 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.917 0.389 . . . . 0.0 111.197 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -162.21 148.23 13.14 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.52 -123.02 29.75 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.037 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.547 HD11 HG12 ' A' ' 111' ' ' VAL . 1.2 mm? -100.27 4.54 44.25 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 120.974 0.416 . . . . 0.0 110.072 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -75.26 139.82 25.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.596 -0.729 . . . . 0.0 113.085 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -133.93 151.67 51.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.048 0.539 . . . . 0.0 109.895 -178.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -120.32 130.15 54.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.51 -89.95 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.276 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.5 p 40.17 81.27 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.7 tp -107.85 134.5 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.219 0.533 . . . . 0.0 111.897 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.0 p -94.37 126.51 39.67 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.771 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.494 HG13 HG12 ' A' ' 24' ' ' ILE . 14.2 pt -126.69 161.21 33.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.356 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -70.67 155.07 41.21 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.379 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.5 -39.39 83.66 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.952 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.61 -25.66 65.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.3 t -80.64 -42.2 22.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.428 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 20' ' ' ALA . 75.0 mt -59.16 -69.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.321 -176.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.508 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 77.1 mm-40 -67.37 -6.95 21.27 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.5 m -95.64 -64.19 1.08 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.988 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.21 66.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.5 t -65.01 -43.87 96.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.354 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 22.3 ttmm -61.78 -47.2 86.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.6 m -68.85 -36.59 78.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.811 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -60.93 -39.05 87.97 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.113 0.483 . . . . 0.0 110.652 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.56 -38.44 90.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.819 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.22 -44.02 99.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.171 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.76 -43.64 98.28 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.136 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.38 -35.68 74.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.24 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.24 94.9 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.068 0.461 . . . . 0.0 110.285 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.34 -34.09 77.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.013 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -61.09 -35.92 78.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.955 0.407 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 t -90.61 -5.85 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.412 0.625 . . . . 0.0 109.77 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 64.96 27.5 12.68 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.329 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.402 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.7 pp -103.67 7.98 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.069 0.461 . . . . 0.0 111.457 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.62 -34.81 79.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.514 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.02 -4.54 86.15 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.816 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -89.17 -8.2 54.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.792 0.329 . . . . 0.0 111.463 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -92.38 95.79 9.88 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.82 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -78.29 109.35 12.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.57 96.77 1.62 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 115.734 1.054 . . . . 0.0 115.734 -169.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -66.52 -43.24 85.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.457 HG12 ' HB ' ' A' ' 54' ' ' VAL . 11.6 t -104.79 115.12 63.11 Favored Pre-proline 0 N--CA 1.44 -0.929 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.265 176.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.12 139.95 86.25 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.188 1.926 . . . . 0.0 111.124 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.586 ' HA ' HG12 ' A' ' 54' ' ' VAL . 22.7 ttt -61.39 -40.08 93.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.507 -173.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -60.81 -47.77 84.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.047 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.497 HD13 HH22 ' B' ' 193' ' ' ARG . 74.9 mt -69.42 -44.97 79.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 51' ' ' MET . 14.6 p -64.11 -44.35 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.7 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.416 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -66.73 -24.06 66.18 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.381 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -85.61 -36.92 20.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.127 0.489 . . . . 0.0 110.3 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -76.54 -49.27 16.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.499 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -105.21 9.58 34.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.883 0.373 . . . . 0.0 110.483 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.628 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -59.18 -47.51 90.46 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.9 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.0 -25.49 65.43 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -61.84 -44.99 95.73 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.813 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 65' ' ' ASP . 10.7 p -126.98 24.89 2.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.564 0.697 . . . . 0.0 110.703 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.628 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 21.1 ttm180 -58.8 -33.19 70.07 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.506 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -60.49 -50.02 75.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.535 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.521 ' HB2' HG22 ' A' ' 62' ' ' VAL . 1.7 m-20 -75.24 -21.61 58.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.04 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 62' ' ' VAL . 66.7 t -63.58 -43.77 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 173.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.62 -39.01 92.43 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.107 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.97 -42.61 99.81 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.238 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.71 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 32.0 t70 -63.01 -43.91 97.43 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.197 0.498 . . . . 0.0 110.006 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.7 -41.3 97.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.299 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 49.5 ttp -60.69 -43.22 98.01 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -62.55 -44.05 97.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.284 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.71 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 32.7 mtp85 -66.08 -41.5 90.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.932 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -66.07 -41.09 91.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.388 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -60.4 -48.08 83.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.678 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.0 tt -67.41 -39.7 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.201 0.524 . . . . 0.0 111.347 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.11 -40.85 91.03 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.388 0.613 . . . . 0.0 110.185 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.68 87.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.633 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.3 pt -64.21 -39.27 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.913 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.97 -44.09 99.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 120.638 0.256 . . . . 0.0 111.275 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -29.32 60.96 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -86.54 -2.57 58.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 66.22 34.55 6.54 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.242 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.1 mt -96.06 113.43 30.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -110.48 100.84 46.65 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.908 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.14 136.34 9.01 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.076 1.85 . . . . 0.0 111.347 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.93 132.98 36.57 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.62 -125.09 7.4 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.055 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.22 130.07 18.13 Favored Pre-proline 0 C--N 1.313 -1.018 0 O-C-N 122.834 -0.215 . . . . 0.0 110.455 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.88 150.07 60.77 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.132 1.888 . . . . 0.0 110.828 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 m -94.96 116.81 29.16 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.108 0.48 . . . . 0.0 110.021 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.564 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 95.9 m-85 -91.82 114.24 26.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.94 99.56 23.27 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.138 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 58.5 Cg_endo -95.52 161.8 1.52 Allowed 'Trans proline' 0 N--CA 1.437 -1.826 0 C-N-CA 123.461 2.774 . . . . 0.0 111.65 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.82 -174.86 33.61 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.176 -1.011 . . . . 0.0 110.874 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.72 133.47 38.31 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -89.24 125.4 35.07 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.938 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -102.48 131.31 49.25 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.4 tp -81.48 102.42 10.55 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.14 -27.54 5.32 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.243 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -103.0 177.02 4.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.677 0.275 . . . . 0.0 110.707 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -81.61 168.17 18.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -125.28 139.99 53.22 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.095 0.474 . . . . 0.0 111.313 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.0 m -120.01 134.4 55.26 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.158 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -140.51 167.16 22.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.572 0.225 . . . . 0.0 111.582 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -87.05 -91.01 0.11 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.406 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 67.2 t 64.92 100.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.358 0.599 . . . . 0.0 110.564 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -99.65 146.09 26.87 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.588 -175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.409 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 10.6 p90 -159.39 -87.39 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -90.12 156.64 18.21 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.547 HG12 HD11 ' A' ' 11' ' ' LEU . 28.8 m -125.82 161.56 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.846 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -166.14 102.44 0.7 Allowed Pre-proline 0 N--CA 1.479 0.99 0 CA-C-O 120.577 0.227 . . . . 0.0 111.272 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -94.39 158.49 2.02 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 C-N-CA 123.39 2.727 . . . . 0.0 114.373 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -143.29 139.64 30.24 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.735 0.814 . . . . 0.0 109.888 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 116' ' ' GLU . 20.6 t -133.9 160.89 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 120.897 0.379 . . . . 0.0 111.78 -176.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 115' ' ' VAL . 43.5 mt-10 -140.66 153.03 45.84 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.842 0.857 . . . . 0.0 109.209 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.8 mt -112.47 130.58 55.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -141.85 154.4 45.13 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.133 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.54 22.91 74.46 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.903 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.49 -39.94 95.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.916 0.389 . . . . 0.0 111.199 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -70.24 -10.78 59.92 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.87 1.48 55.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.147 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.57 109.01 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.124 0.488 . . . . 0.0 109.957 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -104.37 119.64 39.41 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.062 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.83 127.07 59.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.883 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.7 119.04 32.19 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.571 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.556 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 78.6 tttt -111.62 106.29 56.77 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.43 128.61 12.1 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.962 1.775 . . . . 0.0 111.639 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.38 114.67 39.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.17 161.58 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -150.73 166.19 31.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.553 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.3 127.44 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.722 0.296 . . . . 0.0 110.25 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.0 p -108.15 176.41 5.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.394 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.86 -38.94 87.3 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.019 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.67 80.2 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.7 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -64.94 -43.38 92.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.327 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.49 -47.24 92.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.955 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.04 -42.61 99.36 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.003 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.26 -42.58 99.26 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.611 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.534 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -61.83 -44.92 95.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.695 0.284 . . . . 0.0 110.59 178.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.43 -42.44 98.69 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.272 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.87 -43.84 98.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.82 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.9 m -63.0 -41.2 99.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.553 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.6 mt -60.82 -42.23 97.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.448 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -66.14 -37.21 85.13 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.05 0.453 . . . . 0.0 110.518 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -68.46 -13.92 62.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.162 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -89.62 -6.92 55.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.432 0.634 . . . . 0.0 110.151 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -89.59 93.47 9.5 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.726 0.774 . . . . 0.0 111.952 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.81 126.17 10.07 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 247' ' ' GLU . 23.6 p -100.43 -163.76 1.05 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.505 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 4.4 p-90 -70.17 119.68 14.72 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 151' ' ' TRP . 26.5 mttp -174.52 168.34 3.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.691 1.197 . . . . 0.0 109.132 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -114.92 164.21 14.46 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -172.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 153' ' ' GLU . 9.9 pttp 71.28 -179.42 0.23 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.861 1.665 . . . . 0.0 113.807 175.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 13.0 t70 72.92 -90.32 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 124.966 1.306 . . . . 0.0 111.055 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 142.76 102.48 0.44 Allowed Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.954 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -132.75 64.51 1.61 Allowed 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.58 127.05 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.122 -176.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.666 ' HB3' ' HB2' ' A' ' 162' ' ' ASP . 9.2 tp10 -95.63 154.11 17.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.75 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.89 13.8 6.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 189' ' ' MET . 37.8 tt0 -155.47 26.08 0.4 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.585 0.707 . . . . 0.0 110.511 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.666 ' HB2' ' HB3' ' A' ' 159' ' ' GLU . 2.9 t70 -109.39 -170.2 1.61 Allowed 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.781 -0.575 . . . . 0.0 111.036 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -103.55 118.71 37.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.4 t -114.72 121.66 67.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.002 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.4 m -83.4 109.66 17.5 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.9 mt -115.08 128.46 72.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.106 0.479 . . . . 0.0 112.141 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.484 ' OD2' ' HB3' ' A' ' 236' ' ' ASN . 5.0 p-10 -103.03 113.33 26.72 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 172.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -142.46 162.57 35.13 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.228 0.537 . . . . 0.0 112.216 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.1 m -133.6 134.09 42.84 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.219 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.31 103.56 1.84 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.209 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 29.0 m -128.1 121.31 29.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 46.1 t -94.13 -87.13 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.833 0.349 . . . . 0.0 111.147 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -94.38 42.08 1.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.207 0.527 . . . . 0.0 109.822 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 81.33 12.45 82.09 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -123.99 139.28 54.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -92.09 137.42 32.38 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.372 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -107.26 -176.88 3.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.655 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.38 -39.74 88.38 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.402 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.21 -175.52 39.15 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.964 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 84.63 16.68 65.47 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.138 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -105.74 97.87 7.64 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.02 145.8 32.44 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.844 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 38.3 m -136.1 145.29 45.75 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.803 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 54.41 31.15 14.03 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.801 0.688 . . . . 0.0 110.543 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -85.98 127.31 34.61 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.3 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.5 115.03 39.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.49 0.662 . . . . 0.0 110.336 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 56.7 tp -103.33 126.22 50.37 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.98 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -90.65 111.88 23.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.56 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.2 mtp -81.24 150.68 28.48 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.95 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.38 -14.62 64.25 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.595 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -95.13 0.49 54.28 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.802 0.334 . . . . 0.0 111.207 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.97 55.98 6.8 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.421 HH22 HD13 ' B' ' 53' ' ' ILE . 19.3 mmt85 -100.01 -5.96 27.26 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.197 0.522 . . . . 0.0 110.55 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.5 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -135.5 178.13 7.28 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.076 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.7 mm -68.38 133.87 91.12 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.37 134.55 45.31 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.095 1.864 . . . . 0.0 111.499 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.77 -42.87 1.79 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.958 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -67.45 -52.92 33.62 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -74.2 -17.21 60.93 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.847 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.51 -30.0 22.29 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.891 0.377 . . . . 0.0 110.512 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.7 -19.05 76.31 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.008 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.4 mt -62.39 -38.07 80.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-O 120.883 0.373 . . . . 0.0 110.407 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -51.51 131.26 29.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.7 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.42 -10.66 63.23 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.353 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -95.26 159.23 15.11 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -103.21 156.41 17.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.104 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.57 134.69 51.69 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.941 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 78.86 34.56 33.91 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.637 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -124.68 130.17 51.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.879 0.371 . . . . 0.0 111.06 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' A' ' 236' ' ' ASN . 79.0 mt-10 -102.42 118.17 36.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.529 ' O ' ' HB ' ' A' ' 212' ' ' THR . 44.3 t80 -135.24 -36.84 0.79 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 99.6 m 77.65 143.94 0.08 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.339 0.256 . . . . 0.0 110.423 -176.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.2 tp -130.11 144.61 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.934 0.397 . . . . 0.0 110.909 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.79 104.68 16.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.092 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 65.7 t -119.31 128.5 75.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.5 m -98.42 -16.84 19.1 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -175.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 66.62 154.43 0.13 Allowed Pre-proline 0 N--CA 1.487 1.381 0 CA-C-O 121.117 0.484 . . . . 0.0 111.615 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.33 150.87 53.43 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.154 1.903 . . . . 0.0 111.532 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -65.82 -38.44 88.92 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.18 77.1 7.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.602 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -120.06 140.61 50.76 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -61.06 -29.86 69.98 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.76 108.1 20.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.2 tt0 -63.42 -33.59 75.88 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.427 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 30.8 p-10 -63.97 -25.16 68.01 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.737 0.303 . . . . 0.0 110.995 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 90.4 mt -109.8 -3.39 16.72 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.6 ptmt -67.85 119.12 12.02 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.951 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.8 21.91 71.56 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.94 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 225' ' ' ASN . 35.0 mmtp -100.93 135.52 42.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -86.26 110.38 19.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.004 0.43 . . . . 0.0 110.85 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -99.36 149.54 23.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.082 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -105.21 -47.17 4.04 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -175.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 58.59 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.02 0.438 . . . . 0.0 111.041 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.55 -49.2 77.15 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.0 mm 62.8 93.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 123.493 0.496 . . . . 0.0 110.842 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.484 ' HB3' ' OD2' ' A' ' 167' ' ' ASP . 9.6 t-20 -82.99 -47.29 11.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.55 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 12.6 tp 57.46 86.8 0.07 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.151 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.25 -58.06 2.67 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -101.49 -78.97 0.52 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 24.9 t 70.43 142.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 123.482 0.489 . . . . 0.0 110.512 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -75.1 -46.79 32.26 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.277 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 64.75 163.24 0.14 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -162.0 94.18 0.91 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 10.1 tp10 -123.37 157.14 33.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.379 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.1 tt 72.72 118.5 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.456 0.703 . . . . 0.0 110.932 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -87.03 115.74 1.2 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.879 2.386 . . . . 0.0 113.82 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.421 ' HG2' ' OG1' ' A' ' 150' ' ' THR . 12.5 pt-20 -130.28 -161.54 1.13 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 8.0 mp -87.02 102.91 14.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.299 0.571 . . . . 0.0 111.892 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 251' ' ' GLU . 37.9 m -134.39 132.43 39.41 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -90.15 7.28 38.75 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . 0.494 ' H ' HG22 ' A' ' 249' ' ' THR . 45.9 mt-10 -88.15 -15.22 36.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -73.3 -7.31 51.01 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.293 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 261' ' ' GLY . 41.8 pt -105.13 -4.3 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.629 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -136.96 11.52 3.1 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -129.92 8.25 5.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.062 0.458 . . . . 0.0 109.939 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -124.43 137.0 54.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.742 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 67.79 -129.9 27.65 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 116.13 -0.486 . . . . 0.0 114.041 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.4 t -116.98 131.69 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 122.693 0.397 . . . . 0.0 110.932 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.628 ' HG2' ' H ' ' A' ' 260' ' ' ASP . 22.1 tt0 58.28 -155.01 0.35 Allowed 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.795 0.684 . . . . 0.0 109.222 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . 0.628 ' H ' ' HG2' ' A' ' 259' ' ' GLU . 1.7 p-10 -128.89 136.93 51.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 253' ' ' ILE . . . -131.82 171.74 21.2 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.238 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.0 p -82.85 177.44 8.65 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.076 0.55 . . . . 0.0 110.44 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 94.9 t -60.7 -48.24 89.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.116 0.484 . . . . 0.0 110.791 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.2 pm0 -81.4 -33.5 32.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.766 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.1 -40.3 99.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.374 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 270' ' ' VAL . 54.2 tp -62.16 -45.3 94.05 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -62.89 -44.96 94.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.577 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.573 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.27 -47.34 79.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.347 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -66.66 -38.61 87.22 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 266' ' ' LEU . 67.1 t -65.13 -42.7 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.232 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -57.94 -48.1 80.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.792 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.7 ptmt -66.33 -42.91 87.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.763 0.316 . . . . 0.0 111.413 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.31 -36.64 83.44 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.6 mmm -62.88 -42.28 99.71 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.207 0.527 . . . . 0.0 109.964 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 278' ' ' LEU . 56.9 mt-10 -69.36 -30.88 68.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.27 177.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 55.0 ttp180 -62.57 -43.42 98.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.609 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -69.93 -28.21 65.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.114 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 275' ' ' GLU . 65.3 tp -61.08 -37.72 83.71 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 60.8 tttm -58.14 -45.84 86.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.73 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -45.06 95.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.432 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.58 -50.67 72.61 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.663 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.8 -45.17 95.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.17 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.604 HH12 ' HG3' ' A' ' 409' ' ' GLU . 2.2 tpt180 -61.44 -46.37 90.39 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.897 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -64.14 -39.85 94.91 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.242 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . 0.564 HH21 ' CG ' ' A' ' 285' ' ' ARG . 0.0 OUTLIER -60.27 -44.22 95.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.587 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.03 -43.55 85.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.001 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -61.12 -45.79 93.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.39 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 22.6 p -59.73 -43.64 94.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.03 -41.17 91.25 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.856 0.36 . . . . 0.0 111.189 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.55 87.03 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.8 mm -64.65 -44.46 96.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.466 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.534 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 33.1 tp10 -62.58 -40.73 97.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.95 0.405 . . . . 0.0 110.588 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.38 -43.73 97.87 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.495 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.5 -42.87 98.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.68 -46.98 93.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.227 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . 0.534 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.0 mttm -65.41 -41.57 93.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.898 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.76 -41.2 79.21 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -122.64 98.43 5.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.025 0.441 . . . . 0.0 112.182 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.52 114.7 27.31 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 301' ' ' ASP . 10.7 tp -128.43 161.65 36.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.553 0.216 . . . . 0.0 110.984 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.439 ' N ' HG13 ' A' ' 300' ' ' ILE . 25.4 m-20 -65.26 140.54 58.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.846 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.7 t -115.04 123.6 31.57 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.283 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.53 124.21 14.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.211 1.941 . . . . 0.0 111.535 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.89 85.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.46 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.07 -42.34 76.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.268 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.24 -41.26 85.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.552 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.14 -46.2 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.855 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.46 -43.49 88.88 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.635 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.478 ' O ' HG23 ' A' ' 313' ' ' VAL . 49.9 m -60.89 -45.92 92.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.201 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.574 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 60.2 mm-40 -69.05 -37.44 78.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.409 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 95.8 mt -62.29 -44.14 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.115 0.483 . . . . 0.0 109.975 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.41 -39.3 93.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.647 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 309' ' ' SER . 86.2 t -65.52 -43.09 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.296 176.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 80.4 mt -61.21 -39.01 88.65 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.812 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.475 ' NH1' HD12 ' A' ' 330' ' ' LEU . 65.9 mtm180 -61.41 -37.91 85.16 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.625 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -64.63 -43.05 94.95 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.771 0.319 . . . . 0.0 111.037 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -64.74 -41.81 95.67 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.21 0.528 . . . . 0.0 110.511 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.75 -41.93 78.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.159 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.72 -35.43 80.73 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.999 0.428 . . . . 0.0 110.979 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -56.21 -44.08 79.14 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.759 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.68 -36.63 60.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.931 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -60.1 -45.05 94.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.324 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . 0.502 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . -170.61 17.64 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.096 -1.05 . . . . 0.0 112.857 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 70.79 26.65 73.66 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.209 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -97.9 154.03 17.93 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.292 0.568 . . . . 0.0 112.306 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.0 -178.49 5.47 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 70.28 -60.98 0.47 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.124 0.57 . . . . 0.0 111.592 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -69.83 -15.33 63.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.112 0.482 . . . . 0.0 110.856 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.443 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -61.66 -19.48 62.36 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.584 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.475 HD12 ' NH1' ' A' ' 315' ' ' ARG . 45.3 tp -62.19 -34.67 76.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.771 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -77.92 -0.54 27.91 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.961 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.62 144.2 85.83 Favored Pre-proline 0 C--O 1.238 0.454 0 O-C-N 122.142 -0.349 . . . . 0.0 110.715 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.431 ' HB2' HD13 ' A' ' 336' ' ' LEU . 48.1 Cg_exo -56.65 132.43 51.7 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.777 2.318 . . . . 0.0 113.114 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -67.24 -44.46 79.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.521 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.8 pm0 -64.6 -31.55 72.82 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 333' ' ' PRO . 10.9 mp -65.62 -28.62 69.25 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.584 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -107.6 -20.62 13.18 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.08 -33.26 75.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.9 -44.77 96.11 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.129 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -80.83 -24.63 38.32 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.259 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.35 -38.4 90.89 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.329 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.3 tttt -57.92 -44.92 87.15 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.733 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 347' ' ' VAL . 9.1 mmt180 -62.28 -44.21 97.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.947 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -65.51 -39.99 92.47 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.097 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.8 t -63.29 -45.96 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.101 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 342' ' ' LYS . 98.5 t -63.74 -43.64 98.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 343' ' ' ARG . 78.0 t -60.43 -45.5 96.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.543 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.6 -42.84 99.83 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.02 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.47 -44.13 95.3 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.638 0.256 . . . . 0.0 111.313 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.97 -45.59 88.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.059 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.56 -39.98 88.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.022 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.48 -40.23 97.42 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.125 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.59 -36.62 83.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 110.648 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.91 -43.57 96.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.26 -44.33 99.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.894 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -68.2 -48.92 63.93 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.8 m -64.73 -44.61 89.61 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -88.14 -7.69 56.53 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.735 0.303 . . . . 0.0 111.142 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 60.58 60.31 1.98 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.122 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.1 mt -79.29 153.61 29.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.529 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -130.43 154.15 48.03 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.968 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -78.72 105.98 10.39 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 172.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.524 ' O ' HG23 ' A' ' 367' ' ' VAL . 31.7 t70 -82.18 111.5 18.34 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.376 -0.529 . . . . 0.0 112.054 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 5.1 mm-40 -62.73 -34.33 76.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.038 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -63.64 -44.11 94.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -65.48 -38.88 91.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.193 0.521 . . . . 0.0 109.978 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 363' ' ' ASP . 84.2 t -61.64 -36.77 75.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.578 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 27.2 mmmt -54.81 -47.87 73.5 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.633 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.95 -41.26 99.93 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.521 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.94 -42.86 99.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 0.0 110.713 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.58 -43.43 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.253 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.45 -37.77 87.88 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.276 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -65.38 -41.23 93.94 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.546 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.4 ttm -64.82 -42.42 95.0 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.011 0.434 . . . . 0.0 110.548 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.68 -24.4 67.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.756 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 55.0 m -75.19 -5.13 42.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.65 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.52 5.44 49.52 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.903 0.383 . . . . 0.0 111.18 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -116.93 171.75 7.71 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.762 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -60.61 -44.69 96.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.013 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -130.04 114.41 17.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.793 0.33 . . . . 0.0 110.239 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.69 -27.27 27.02 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.499 2.133 . . . . 0.0 113.123 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -65.1 -45.72 84.04 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.8 -36.29 83.09 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.567 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.74 -42.39 94.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.473 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.77 -44.18 98.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 50.2 mt-10 -66.05 -43.21 88.15 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.56 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.34 -47.84 82.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.959 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -65.64 -45.66 82.17 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.433 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 59.1 p -73.17 -16.38 61.44 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 99.3 mttt -91.06 9.08 32.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.115 0.483 . . . . 0.0 111.291 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -131.24 113.36 13.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.489 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.37 -41.69 98.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.72 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -60.69 -45.3 94.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.041 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.1 -42.68 99.63 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.482 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.554 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 94.5 mtp -63.16 -45.47 91.71 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.051 0.453 . . . . 0.0 110.56 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.407 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 15.1 t70 -64.98 -43.98 90.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.268 -177.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -62.83 -41.76 99.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.395 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 49.0 tpp -63.98 -40.3 96.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.775 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 395' ' ' MET . 73.1 mtm180 -63.63 -35.15 79.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.837 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -62.8 -42.9 99.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.098 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.52 -43.57 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -61.4 -39.69 91.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.605 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 40.8 tp -63.79 -38.71 92.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.033 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 408' ' ' VAL . 75.2 tt0 -54.53 -50.9 66.78 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.267 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 35.2 mt-10 -66.78 -36.34 82.19 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.45 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -61.61 -44.83 96.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.833 0.349 . . . . 0.0 110.701 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -62.81 -41.85 99.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.719 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.571 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 89.1 t -65.73 -43.7 93.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.753 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.604 ' HG3' HH12 ' A' ' 283' ' ' ARG . 96.3 mt-10 -63.21 -36.79 84.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.199 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.12 -41.32 99.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.145 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 407' ' ' ALA . 97.7 t -65.38 -42.51 93.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.313 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 68.4 mt -60.3 -42.02 94.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.734 -176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.15 -23.28 67.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.771 0.32 . . . . 0.0 111.432 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -97.98 -3.97 37.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.464 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -109.51 -179.57 3.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.393 0.616 . . . . 0.0 112.399 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.69 102.24 13.95 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.215 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.8 t -94.81 128.45 46.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.373 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -120.34 128.96 53.74 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.556 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 40.1 mt-10 -100.55 118.79 37.43 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.382 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -130.03 134.51 47.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.097 0.475 . . . . 0.0 111.543 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.87 142.23 46.04 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -149.1 170.06 19.26 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.554 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 67.7 p -86.63 164.31 16.89 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.28 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -67.05 -26.11 66.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.982 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -61.88 -38.61 88.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.694 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -67.02 -30.11 70.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.778 0.323 . . . . 0.0 110.838 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.6 mp -80.92 -8.56 59.77 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 111.363 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.0 mmt -81.2 -7.3 59.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.133 0.492 . . . . 0.0 110.529 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -78.19 71.79 4.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.543 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -121.71 28.86 7.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.609 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -66.62 -38.35 86.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.52 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.765 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.465 -179.494 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.661 0.267 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -100.03 105.04 16.66 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.88 162.44 38.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.857 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 47.2 m -124.91 119.3 28.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.887 0.375 . . . . 0.0 111.23 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -136.73 137.08 47.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 49.8 mt-10 -114.3 176.35 5.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.01 0.433 . . . . 0.0 111.125 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' B' ' 13' ' ' ARG . 9.7 t -124.21 148.8 47.03 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.46 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 24.1 m -107.46 -82.12 0.55 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.868 0.366 . . . . 0.0 110.949 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -155.74 146.77 22.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.25 -123.65 28.2 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.141 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.531 HD11 HG12 ' B' ' 111' ' ' VAL . 1.2 mm? -100.08 5.84 44.96 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' B' ' 107' ' ' VAL . . . -73.48 142.6 31.52 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.376 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 0.3 OUTLIER -137.14 149.94 47.64 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.079 0.551 . . . . 0.0 109.938 -178.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -116.74 128.9 55.75 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.44 -92.31 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.039 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.1 p 40.75 81.66 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.031 0.532 . . . . 0.0 112.294 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 8.4 tp -108.0 136.84 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.05 0.452 . . . . 0.0 111.725 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 9.2 p -96.13 130.5 43.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.122 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.421 HG13 HG12 ' B' ' 24' ' ' ILE . 14.6 pt -131.43 162.45 39.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.501 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.539 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -74.28 157.53 35.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.304 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.61 80.4 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -65.91 -37.95 87.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.69 0.281 . . . . 0.0 110.662 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t -65.71 -43.62 88.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.933 0.397 . . . . 0.0 110.671 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.539 HG13 ' O ' ' B' ' 20' ' ' ALA . 77.0 mt -58.42 -69.04 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.26 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.523 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 76.7 mm-40 -68.53 -7.94 36.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -172.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 45.9 m -96.13 -63.98 1.1 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.946 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.2 -45.43 73.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.03 -43.42 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.925 0.393 . . . . 0.0 110.935 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.523 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.6 ttmm -61.97 -46.9 87.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.928 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.4 m -69.73 -36.39 75.83 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.468 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.85 -38.35 90.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.941 0.4 . . . . 0.0 110.725 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.33 -38.68 90.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.88 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.76 -43.46 97.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.108 0.48 . . . . 0.0 109.905 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -63.14 -42.73 99.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.49 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.07 -33.98 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.309 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.83 96.13 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.18 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' B' ' 40' ' ' ARG . 98.5 mttt -65.63 -34.25 77.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.97 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.56 -37.18 82.86 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.779 0.323 . . . . 0.0 111.001 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 t -87.97 -8.42 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.243 0.544 . . . . 0.0 109.835 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' B' ' 37' ' ' LYS . 35.1 mmt180 66.26 31.44 8.54 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.216 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.81 6.34 9.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.399 . . . . 0.0 111.51 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.23 -35.22 80.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.512 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.64 -3.52 79.07 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.942 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -91.15 -8.67 48.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.701 0.251 . . . . 0.0 111.646 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -91.81 93.25 8.76 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.742 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -76.82 106.45 8.5 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.23 99.36 2.1 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 -169.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.99 -45.89 79.98 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' B' ' 54' ' ' VAL . 15.1 t -100.27 115.22 65.68 Favored Pre-proline 0 C--O 1.249 1.044 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.311 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.0 139.76 85.26 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.428 2.085 . . . . 0.0 111.143 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.549 ' HA ' HG12 ' B' ' 54' ' ' VAL . 23.5 ttt -63.28 -38.57 91.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.596 -174.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' B' ' 29' ' ' LYS . 31.3 p-10 -64.28 -32.02 73.45 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.331 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.421 HD13 HH22 ' A' ' 193' ' ' ARG . 92.5 mt -87.51 -45.05 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.822 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' B' ' 51' ' ' MET . 12.0 p -62.55 -42.2 94.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.711 0.291 . . . . 0.0 111.382 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.87 -14.67 62.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.8 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -97.09 -41.28 8.43 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.164 0.507 . . . . 0.0 109.686 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.441 ' NH1' ' SD ' ' A' ' 194' ' ' MET . 67.9 ttt180 -70.87 -44.91 65.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.166 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -110.0 10.83 24.15 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 120.924 0.392 . . . . 0.0 110.09 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.646 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -58.75 -45.69 94.49 Favored Glycine 0 C--O 1.215 -1.054 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.147 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.06 -24.86 60.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 37.4 t -61.64 -44.17 97.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 111.511 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.51 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.1 p -123.25 21.85 4.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.312 0.577 . . . . 0.0 110.75 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.646 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 23.5 ttm180 -59.09 -33.21 70.56 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.728 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -61.18 -49.65 76.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.972 0.415 . . . . 0.0 110.515 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . 0.429 ' HB2' HG22 ' B' ' 62' ' ' VAL . 1.0 OUTLIER -74.5 -22.77 58.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.538 -179.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.51 HG23 ' O ' ' B' ' 62' ' ' VAL . 53.8 t -63.89 -43.88 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 99.4 mt -62.77 -39.21 93.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.018 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.04 -42.7 99.88 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.202 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . 0.727 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 33.8 t70 -63.66 -44.01 95.06 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.972 0.386 . . . . 0.0 109.989 177.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.35 -41.34 96.91 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.063 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 49.9 ttp -60.91 -41.88 96.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.502 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -62.97 -44.37 96.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.925 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.727 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 32.8 mtp85 -66.68 -40.95 88.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.928 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -65.31 -41.33 94.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.192 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.56 -48.86 79.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.798 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 18.7 tt -68.0 -40.15 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.873 0.368 . . . . 0.0 111.705 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -65.69 -39.79 91.64 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.284 0.564 . . . . 0.0 110.134 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.14 -47.02 75.43 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.662 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 45.5 pt -62.45 -36.75 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.05 -43.97 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 120.686 0.279 . . . . 0.0 111.139 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.52 -28.03 46.11 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.617 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.88 -4.43 58.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.655 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 62.85 42.45 7.8 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.933 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.3 mt -105.05 118.31 52.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -112.46 109.94 53.3 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.404 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -88.44 124.23 1.64 Allowed 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 122.544 2.163 . . . . 0.0 111.274 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.65 117.76 29.56 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.977 0.418 . . . . 0.0 110.505 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.7 -130.18 10.15 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.67 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.45 123.79 17.74 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-O 120.433 0.158 . . . . 0.0 110.625 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.31 131.46 19.11 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.797 1.664 . . . . 0.0 110.554 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 11.3 m -78.38 111.92 14.87 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.628 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.65 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 96.2 m-85 -83.9 105.19 14.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.14 102.73 11.51 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.47 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.4 Cg_endo -98.61 170.06 0.6 Allowed 'Trans proline' 0 N--CA 1.439 -1.723 0 C-N-CA 123.429 2.753 . . . . 0.0 111.402 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.43 -174.06 26.08 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -79.95 133.36 36.19 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -87.9 128.41 35.36 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.007 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.98 133.76 49.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 tp -86.79 88.61 7.72 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.328 0.585 . . . . 0.0 110.138 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.59 -20.9 3.65 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.174 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -108.54 178.07 4.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.496 0.189 . . . . 0.0 110.719 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -80.53 165.3 22.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.007 0.432 . . . . 0.0 111.185 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -124.1 141.92 51.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.957 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 27.7 m -122.91 135.82 54.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.041 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -142.69 165.51 27.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.366 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.8 m -85.4 -90.9 0.1 Allowed 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.442 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 85.3 t 64.94 99.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.347 0.594 . . . . 0.0 110.672 -175.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -101.11 145.6 28.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.702 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -158.11 -80.34 0.06 Allowed 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.4 ' O ' HD12 ' B' ' 11' ' ' LEU . 59.3 mt-10 -95.97 157.02 16.09 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -173.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.531 HG12 HD11 ' B' ' 11' ' ' LEU . 24.9 m -124.97 163.98 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.925 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -171.24 101.02 0.4 Allowed Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 122.252 0.221 . . . . 0.0 110.961 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -96.37 162.82 1.22 Allowed 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 123.701 2.934 . . . . 0.0 114.306 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -143.19 147.29 34.66 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.738 0.815 . . . . 0.0 110.765 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.8 156.68 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 120.675 0.274 . . . . 0.0 111.072 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.14 153.13 51.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.83 131.89 55.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -144.71 155.07 43.37 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.46 22.89 78.15 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.33 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.05 -42.1 99.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.093 0.473 . . . . 0.0 111.232 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.11 -15.7 63.88 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.201 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.33 0.41 57.26 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.427 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 81.4 mt -79.73 113.82 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.11 0.481 . . . . 0.0 109.791 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -106.42 117.53 34.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.647 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 57.7 t -103.4 126.36 57.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -93.13 119.01 31.88 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.532 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.504 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 77.3 tttt -113.39 105.86 54.85 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.26 130.11 13.75 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.967 1.778 . . . . 0.0 111.9 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -101.46 115.37 43.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.44 161.29 41.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.941 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -150.37 159.57 44.36 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.852 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.67 131.05 35.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.159 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 81.7 p -110.77 175.53 5.39 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.924 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -62.16 -35.75 79.77 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.755 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.06 89.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.601 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.18 -42.17 99.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.716 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -63.86 -46.76 93.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.793 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.78 -44.19 97.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.624 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.88 -41.58 98.7 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.085 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.483 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.0 OUTLIER -62.68 -46.0 90.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.904 0.383 . . . . 0.0 110.683 179.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.9 mt -63.61 -40.76 97.74 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.675 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.32 -45.96 91.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.382 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.0 m -63.13 -41.61 99.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.813 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' B' ' 140' ' ' MET . 97.7 mt -60.67 -43.56 97.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.618 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -67.18 -35.97 80.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.874 0.369 . . . . 0.0 110.936 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.19 -21.04 65.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.089 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -85.56 -4.98 59.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 110.544 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -90.27 90.55 8.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.704 0.764 . . . . 0.0 112.216 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.88 132.49 18.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.373 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . 0.5 ' OG1' ' HG2' ' B' ' 247' ' ' GLU . 20.5 p -103.63 -165.97 1.21 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . 0.481 ' O ' ' HG3' ' B' ' 152' ' ' LYS . 6.0 p-90 -68.6 127.94 34.84 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.345 -174.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' B' ' 151' ' ' TRP . 21.4 mttp -178.36 -167.84 0.14 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.231 1.012 . . . . 0.0 109.896 176.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' B' ' 154' ' ' LYS . 0.0 OUTLIER -132.59 163.71 28.27 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -172.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' B' ' 153' ' ' GLU . 11.2 pttp 66.13 -178.61 0.2 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.884 1.674 . . . . 0.0 114.323 174.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . 0.4 ' N ' ' HG3' ' B' ' 154' ' ' LYS . 14.8 t70 71.54 -94.48 0.03 OUTLIER 'General case' 0 C--N 1.341 0.235 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.189 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 148.63 97.8 0.19 Allowed Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.551 -1.309 . . . . 0.0 113.463 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -128.21 67.41 1.36 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 23.1 t -72.0 127.67 34.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.428 -176.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 8.9 tp10 -93.53 153.54 18.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.87 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . 0.401 ' O ' ' HA3' ' B' ' 190' ' ' GLY . . . -89.52 23.2 2.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.622 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' B' ' 189' ' ' MET . 34.1 tt0 -163.28 25.81 0.09 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.406 0.622 . . . . 0.0 110.539 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.597 ' HB2' ' HB3' ' B' ' 159' ' ' GLU . 3.7 t70 -113.08 -172.16 2.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.316 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -99.39 124.67 44.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.6 t -120.14 126.42 75.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.337 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 10.3 m -87.58 109.8 19.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 67.6 mt -114.45 126.59 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.142 0.496 . . . . 0.0 112.264 -174.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' B' ' 236' ' ' ASN . 3.5 p-10 -101.05 110.2 22.19 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -139.53 160.29 40.21 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.385 0.612 . . . . 0.0 112.11 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.9 m -131.79 136.26 47.4 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.884 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.46 104.86 2.31 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.697 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 33.2 m -130.04 124.67 33.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.63 -89.66 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.003 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -99.62 44.74 1.01 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.197 0.522 . . . . 0.0 110.149 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.91 12.85 67.79 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.297 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -126.8 138.95 53.42 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.39 134.68 34.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.719 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . 0.404 ' HD1' ' H ' ' B' ' 179' ' ' GLY . 32.9 p90 -105.34 -178.28 3.61 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.776 0.322 . . . . 0.0 111.82 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.74 -39.92 82.32 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.076 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . 0.404 ' H ' ' HD1' ' B' ' 177' ' ' PHE . . . -95.14 -176.17 37.73 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.147 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.49 16.8 67.8 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.073 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.17 94.77 5.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.68 144.46 31.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.68 0.276 . . . . 0.0 110.976 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -135.4 146.74 48.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.085 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 56.46 30.18 16.61 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 123.589 0.556 . . . . 0.0 110.786 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -83.94 126.54 33.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.463 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 17.3 m -98.76 115.47 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.955 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 63.7 tp -106.1 127.8 53.44 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.361 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.29 106.72 18.66 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . 0.622 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 68.1 mtp -78.95 148.38 32.66 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.758 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' B' ' 160' ' ' ALA . . . 96.3 -15.05 63.55 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.039 175.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -94.97 -1.15 53.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.799 0.333 . . . . 0.0 111.384 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.88 56.71 5.22 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.738 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.497 HH22 HD13 ' A' ' 53' ' ' ILE . 17.8 mmt85 -99.64 -6.31 27.48 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.198 0.523 . . . . 0.0 109.789 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.483 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -136.27 173.02 12.16 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.904 -178.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 31.2 mm -62.83 131.32 94.43 Favored Pre-proline 0 N--CA 1.437 -1.12 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.82 125.74 11.78 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.495 2.13 . . . . 0.0 111.956 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.14 -42.7 1.89 Allowed Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.288 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -63.32 -52.22 62.77 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.055 0.427 . . . . 0.0 111.866 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.79 -31.23 66.38 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.854 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.85 -39.56 76.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.888 0.375 . . . . 0.0 111.098 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -62.97 -20.34 62.28 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.688 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.5 -41.74 93.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 120.804 0.335 . . . . 0.0 110.289 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -47.5 128.39 12.39 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.8 0.84 . . . . 0.0 111.671 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.51 -19.44 45.1 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.165 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -87.53 163.68 16.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.867 0.365 . . . . 0.0 111.816 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -105.78 155.12 19.6 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.989 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.18 137.47 57.02 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' B' ' 237' ' ' LEU . . . 74.41 38.19 45.68 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.504 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -127.64 128.48 45.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.224 0.535 . . . . 0.0 111.783 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -99.23 120.17 39.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.68 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . 0.477 ' O ' ' HB ' ' B' ' 212' ' ' THR . 36.0 t80 -139.65 -35.71 0.53 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -176.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' B' ' 211' ' ' PHE . 94.8 m 75.32 142.46 0.07 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.706 0.288 . . . . 0.0 110.799 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -132.56 141.07 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 111.594 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.19 109.47 18.33 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.681 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 64.5 t -121.38 122.3 66.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 3.4 m -92.01 -21.15 20.67 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -174.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' B' ' 216' ' ' THR . 44.0 m-85 68.05 149.52 0.12 Allowed Pre-proline 0 N--CA 1.482 1.156 0 CA-C-O 120.779 0.323 . . . . 0.0 110.839 -175.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 15.6 Cg_exo -71.15 150.4 59.68 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.311 2.007 . . . . 0.0 111.767 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.43 -37.45 87.56 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.84 76.47 6.33 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.206 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -121.6 141.98 50.56 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -62.93 -29.09 70.52 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.98 110.9 22.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.609 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 43.8 tt0 -65.23 -33.54 76.25 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.728 -176.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' B' ' 229' ' ' LYS . 30.4 p-10 -66.33 -23.37 66.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.118 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.7 mt -110.69 -4.25 15.46 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.9 ptmt -69.05 119.74 13.81 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.875 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.89 34.6 90.32 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.327 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' B' ' 225' ' ' ASN . 34.7 mmtp -114.91 133.87 55.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -84.16 107.72 16.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.901 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.37 148.21 22.69 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.142 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.18 -48.99 3.71 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 58.98 102.52 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.169 0.509 . . . . 0.0 110.892 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.47 89.82 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm 61.54 102.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.175 0.59 . . . . 0.0 112.095 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . 0.406 ' HB3' ' OD2' ' B' ' 167' ' ' ASP . 6.4 t-20 -90.17 -51.51 5.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . 0.559 ' O ' ' HA2' ' B' ' 208' ' ' GLY . 13.0 tp 61.99 81.66 0.19 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.27 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -82.36 -48.58 10.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -110.18 -79.82 0.58 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t 70.18 142.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.096 0.559 . . . . 0.0 110.839 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -73.76 -47.23 40.6 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.094 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 65.58 162.18 0.14 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -158.69 91.4 1.06 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.254 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' B' ' 152' ' ' LYS . 7.8 tp10 -122.79 153.4 39.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.188 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 9.0 tt 76.24 116.07 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 C-N-CA 124.027 0.931 . . . . 0.0 110.58 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.38 113.12 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.543 2.162 . . . . 0.0 113.653 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . 0.5 ' HG2' ' OG1' ' B' ' 150' ' ' THR . 12.6 pt-20 -125.89 -163.57 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.0 mp -89.25 104.42 16.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.342 0.591 . . . . 0.0 111.817 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 34.2 m -132.67 133.64 43.82 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.99 15.4 13.31 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.06 -12.21 25.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -75.16 -2.51 28.07 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.821 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' B' ' 261' ' ' GLY . 43.5 pt -109.93 -3.63 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.576 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -138.76 10.56 2.66 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -131.64 13.83 4.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.041 0.448 . . . . 0.0 109.97 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -131.42 138.56 49.12 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.361 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 69.5 -129.06 22.13 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.212 -0.518 . . . . 0.0 114.073 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 75.8 t -121.03 130.02 75.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . 0.669 ' HG2' ' H ' ' B' ' 260' ' ' ASP . 22.0 tt0 59.5 -166.79 0.17 Allowed 'General case' 0 CA--C 1.552 1.039 0 O-C-N 123.709 0.63 . . . . 0.0 110.091 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . 0.669 ' H ' ' HG2' ' B' ' 259' ' ' GLU . 5.1 p-10 -110.24 144.9 38.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . 0.515 ' O ' ' HB ' ' B' ' 253' ' ' ILE . . . -146.43 166.19 28.19 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.138 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 12.8 p -80.32 176.89 9.36 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 122.768 0.427 . . . . 0.0 111.205 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.81 -48.0 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.749 0.309 . . . . 0.0 110.942 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' B' ' 264' ' ' GLU . 1.0 OUTLIER -82.11 -33.3 29.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 110.591 178.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.54 -41.35 99.8 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.061 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.442 ' O ' HG23 ' B' ' 270' ' ' VAL . 63.6 tp -61.58 -46.33 90.3 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 120.522 0.201 . . . . 0.0 110.595 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -65.04 -41.72 94.94 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.728 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.616 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.16 -45.92 86.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -67.88 -38.76 83.44 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 266' ' ' LEU . 58.8 t -64.38 -42.11 94.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.35 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . 0.405 HH21 ' HD3' ' B' ' 271' ' ' ARG . 9.4 tpt180 -58.04 -48.41 80.17 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.611 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 11.9 ptmt -66.65 -42.61 86.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.741 0.305 . . . . 0.0 111.292 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.6 -38.26 90.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.007 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.8 mmm -63.33 -42.14 98.95 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.994 0.426 . . . . 0.0 109.997 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' B' ' 278' ' ' LEU . 79.1 mt-10 -70.51 -28.77 65.21 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.738 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -64.41 -42.74 95.91 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -67.59 -27.94 67.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.711 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' B' ' 275' ' ' GLU . 63.9 tp -61.02 -38.72 87.09 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.37 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -58.21 -46.76 85.27 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.626 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 32.2 m -62.22 -44.76 95.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.895 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.71 72.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.339 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.29 -44.06 97.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.062 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . 0.566 HH12 ' HG3' ' B' ' 409' ' ' GLU . 1.7 tpt180 -62.25 -46.16 90.06 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.781 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -64.69 -39.88 94.43 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . 0.59 HH21 ' CG ' ' B' ' 285' ' ' ARG . 0.0 OUTLIER -60.85 -43.78 97.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.074 0.464 . . . . 0.0 110.588 179.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 76.1 t -67.75 -43.91 86.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.946 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.63 -46.47 90.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.22 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 32.2 p -60.37 -43.47 96.51 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -66.53 -41.14 89.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.363 . . . . 0.0 111.137 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.65 -48.22 78.12 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.46 -44.52 97.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.322 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -62.65 -40.28 96.55 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.61 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.34 -42.75 99.1 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.12 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.33 -42.22 98.96 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.03 -45.34 96.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 123.201 0.313 . . . . 0.0 111.196 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.87 -41.96 95.24 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.379 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -69.77 -43.13 72.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -117.89 100.83 7.83 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -96.65 113.58 25.16 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . 0.415 HG13 ' N ' ' B' ' 301' ' ' ASP . 10.6 tp -126.98 160.52 35.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.8 0.333 . . . . 0.0 111.117 -176.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . 0.415 ' N ' HG13 ' B' ' 300' ' ' ILE . 14.1 m-20 -65.71 135.95 55.63 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.629 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 16.0 t -112.64 123.07 34.7 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.533 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.66 123.96 14.08 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.141 1.894 . . . . 0.0 111.527 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.81 81.65 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.714 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.62 -45.6 73.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.113 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.79 -41.85 95.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.718 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.67 -45.74 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -43.54 86.71 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.527 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . 0.459 ' O ' HG23 ' B' ' 313' ' ' VAL . 20.3 m -62.59 -45.39 93.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.205 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 55.3 mm-40 -66.17 -39.19 89.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.051 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.17 -44.22 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.995 0.426 . . . . 0.0 110.345 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.69 -38.02 89.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.811 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 309' ' ' SER . 96.9 t -66.6 -42.48 89.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.955 176.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 90.3 mt -61.42 -39.88 92.37 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.03 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.454 ' NH1' HD12 ' B' ' 330' ' ' LEU . 63.5 mtm180 -61.74 -37.68 85.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.316 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 -63.38 -43.89 96.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.795 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.99 -41.49 95.35 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.335 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.87 -42.5 76.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.372 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.2 -37.01 84.56 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 120.862 0.363 . . . . 0.0 111.319 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -55.4 -42.95 74.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.578 0.704 . . . . 0.0 109.539 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -74.41 -38.22 63.15 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.885 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -58.12 -46.87 84.85 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.169 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . 0.412 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -168.95 17.56 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.435 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 72.2 25.54 74.3 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.168 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -94.07 151.0 19.83 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -175.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -135.58 -179.7 5.8 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 68.8 -62.85 0.38 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.32 0.648 . . . . 0.0 112.084 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -67.02 -16.61 64.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.99 0.424 . . . . 0.0 111.141 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . 0.413 ' O ' ' HD2' ' B' ' 315' ' ' ARG . . . -60.85 -18.74 57.7 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.621 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.454 HD12 ' NH1' ' B' ' 315' ' ' ARG . 45.7 tp -61.88 -37.56 85.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.809 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -74.43 -6.17 46.72 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.976 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.6 140.6 96.54 Favored Pre-proline 0 C--O 1.241 0.606 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.934 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . 0.453 ' HB2' HD13 ' B' ' 336' ' ' LEU . 46.4 Cg_exo -55.08 130.62 41.74 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.951 2.434 . . . . 0.0 113.296 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -65.74 -44.01 87.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.074 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.5 pm0 -66.53 -24.48 66.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' B' ' 333' ' ' PRO . 11.0 mp -76.06 -18.94 59.0 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -116.09 -20.61 9.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -64.43 -32.22 73.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -63.49 -46.7 84.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.537 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -76.9 -26.56 54.3 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.734 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.415 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.77 -38.96 93.05 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.614 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . 0.428 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.8 tttt -57.76 -44.87 86.42 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.939 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . 0.504 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.2 mmt85 -61.64 -44.1 97.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.783 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -65.63 -39.45 91.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.597 0.237 . . . . 0.0 111.242 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 341' ' ' ALA . 77.6 t -63.58 -45.72 96.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.148 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 342' ' ' LYS . 96.9 t -63.37 -44.25 98.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 343' ' ' ARG . 78.6 t -60.54 -45.26 97.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.445 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.11 -43.08 99.87 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.368 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.09 -44.11 93.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.664 0.269 . . . . 0.0 111.359 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.85 -44.84 91.97 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.757 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.04 -39.25 89.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.05 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.53 97.83 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.015 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.29 -35.25 79.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.967 0.383 . . . . 0.0 110.851 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.18 -44.59 95.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.1 -44.13 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.704 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -68.73 -47.28 66.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 26.4 m -65.51 -45.42 83.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -88.47 -9.4 52.61 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.916 0.389 . . . . 0.0 111.069 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 60.94 61.51 1.62 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.077 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.1 mt -78.76 156.54 28.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.304 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -131.25 158.86 39.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.672 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -81.28 108.2 14.7 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 172.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . 0.52 ' O ' HG23 ' B' ' 367' ' ' VAL . 18.0 t70 -81.72 107.57 14.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.327 0.584 . . . . 0.0 111.825 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 5.6 mm-40 -61.39 -35.25 76.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.846 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.17 -43.28 92.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.967 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -64.27 -39.37 93.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.302 0.572 . . . . 0.0 109.836 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . 0.531 HG21 ' HG2' ' B' ' 399' ' ' ARG . 94.6 t -61.81 -39.54 83.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.633 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 24.9 mmmt -55.89 -46.53 78.31 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.035 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.59 -42.26 99.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.333 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 98.5 mt -63.09 -42.13 99.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.854 0.359 . . . . 0.0 110.705 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 92.1 mt -63.92 -43.09 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.286 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.27 -40.94 97.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.94 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.89 -40.02 94.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.798 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 59.9 ttm -66.65 -41.46 88.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.074 0.464 . . . . 0.0 110.796 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.75 -25.1 68.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.861 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 47.9 m -75.74 3.32 10.05 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.987 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -103.02 11.24 37.54 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.324 0.583 . . . . 0.0 110.827 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -118.18 170.8 8.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.118 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.2 -35.02 79.43 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.543 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -138.22 111.8 8.59 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.024 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.91 -30.77 32.52 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.352 2.035 . . . . 0.0 113.223 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.78 -44.27 90.54 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -65.64 -36.02 82.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.747 0.308 . . . . 0.0 110.383 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.13 -41.47 91.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.606 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.6 mt -61.43 -44.25 98.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.802 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 52.9 mt-10 -66.54 -42.32 87.36 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.559 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -58.05 -46.91 84.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.958 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -67.97 -44.07 77.52 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.656 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 41.7 p -73.75 -17.69 61.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.5 mttt -89.06 1.66 55.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.901 0.381 . . . . 0.0 111.253 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -123.11 112.61 17.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.719 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.71 -41.89 98.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.507 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -61.91 -45.18 94.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 5.8 mp -62.65 -43.06 99.77 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.675 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.539 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.8 mtp -63.2 -46.82 85.27 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.032 0.444 . . . . 0.0 110.963 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . 0.504 ' HA ' ' HE ' ' B' ' 399' ' ' ARG . 19.5 t70 -65.01 -43.95 90.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.784 -176.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -63.55 -40.34 96.76 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.742 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 47.4 tpp -62.78 -39.83 95.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 395' ' ' MET . 80.8 mtm180 -64.13 -35.51 81.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.695 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.11 -43.31 99.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 98.0 t -66.53 -44.04 90.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.586 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.73 95.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.943 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 47.5 tp -62.82 -38.33 90.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.03 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . 0.503 ' O ' HG23 ' B' ' 408' ' ' VAL . 43.8 tt0 -54.47 -51.39 65.16 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.07 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.89 -37.98 87.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.453 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -60.4 -43.54 96.58 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.576 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.442 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -64.23 -42.56 96.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.634 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . 0.58 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 93.0 t -65.34 -43.3 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.583 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . 0.566 ' HG3' HH12 ' B' ' 283' ' ' ARG . 95.2 mt-10 -63.91 -35.69 81.5 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.064 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.2 98.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.089 0.471 . . . . 0.0 110.286 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 407' ' ' ALA . 92.1 t -65.27 -42.64 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.421 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 81.4 mt -61.15 -40.68 94.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.532 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.49 -16.78 64.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.617 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -102.75 -22.76 13.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.44 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.44 179.55 5.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.257 0.551 . . . . 0.0 112.001 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.18 108.03 20.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.33 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.3 127.29 52.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.73 0.3 . . . . 0.0 110.254 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 13.6 t -119.96 130.94 55.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . 0.504 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 41.5 mt-10 -102.3 120.7 40.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.356 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -131.85 138.62 48.54 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.418 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.26 144.91 35.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 13.4 t -151.3 171.72 17.02 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.231 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 36.1 p -86.95 166.1 15.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.338 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -67.34 -25.95 66.25 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -62.9 -38.42 90.86 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.86 -31.67 72.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 0.0 110.672 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.24 -12.95 60.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 5.5 mmt -81.03 -7.3 59.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.001 0.429 . . . . 0.0 110.995 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -78.1 78.27 4.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.309 0.576 . . . . 0.0 110.509 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -126.06 23.63 7.09 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.63 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.39 -30.15 70.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.234 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.826 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.691 -178.673 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.232 0.167 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.7 t -117.41 113.63 22.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.935 0.398 . . . . 0.0 110.821 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 p -154.72 140.65 11.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -122.34 157.69 31.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.981 0.419 . . . . 0.0 111.204 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 m -104.44 115.56 30.59 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.857 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 9' ' ' GLN . 15.7 m -68.2 -53.42 25.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.738 0.304 . . . . 0.0 111.01 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 8' ' ' THR . 58.1 tp60 168.31 130.05 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.82 0.848 . . . . 0.0 109.586 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.22 -105.7 1.36 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.784 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 305' ' ' ALA . 4.0 mp -97.04 -16.01 20.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.692 0.282 . . . . 0.0 110.343 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 13' ' ' ARG . . . -71.79 133.58 21.15 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.635 -175.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -135.92 143.44 44.95 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -116.23 134.02 55.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 t -79.56 -94.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 m 54.54 91.48 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.336 0.589 . . . . 0.0 110.85 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 tp -106.87 134.32 48.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.004 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.3 p -81.3 132.62 35.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.515 HD13 HD11 ' A' ' 24' ' ' ILE . 1.9 pp -129.56 161.88 38.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.674 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -108.11 155.85 19.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.005 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.17 -53.15 57.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.4 -34.39 74.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.987 0.422 . . . . 0.0 110.662 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.6 t -63.01 -34.44 77.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.038 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 20' ' ' ALA . 62.7 mt -59.62 -70.2 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.207 0.527 . . . . 0.0 111.269 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.71 -44.87 92.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.724 -172.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.3 m -64.66 -49.01 72.68 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.4 -45.25 18.01 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.0 t -63.32 -44.47 99.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.531 0.196 . . . . 0.0 111.531 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -61.32 -46.7 89.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.832 0.348 . . . . 0.0 110.735 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.9 m -61.72 -41.58 97.8 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.085 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.8 tp10 -65.45 -42.6 92.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.984 0.421 . . . . 0.0 110.567 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.433 ' CD2' HH22 ' A' ' 73' ' ' ARG . 97.1 mt -63.81 -44.09 94.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.24 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -68.05 -37.6 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -62.79 -39.67 94.95 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.463 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 31' ' ' GLU . 79.1 t -63.49 -44.16 98.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.822 0.344 . . . . 0.0 110.311 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.05 87.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.945 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.9 -34.11 77.07 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.833 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -59.29 -42.83 92.21 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.834 0.35 . . . . 0.0 110.483 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.1 t -85.99 -4.72 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.056 0.455 . . . . 0.0 110.16 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 62.74 27.56 16.15 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.457 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.72 5.29 10.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -64.46 -30.51 71.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.986 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.15 -23.65 68.15 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.339 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -74.83 -12.2 60.33 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.443 ' HG3' ' NE2' ' B' ' 320' ' ' GLN . 71.8 ttt-85 -91.06 103.08 15.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.58 -176.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.13 109.6 13.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.81 67.61 2.12 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 115.949 1.139 . . . . 0.0 115.949 -170.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.62 -44.16 91.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.3 t -98.33 102.74 15.1 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HB2' ' OD1' ' A' ' 52' ' ' ASN . 13.4 Cg_endo -57.36 144.03 92.41 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.315 2.01 . . . . 0.0 111.779 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.534 ' HA ' HG12 ' A' ' 54' ' ' VAL . 17.5 ttt -61.13 -38.57 86.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.244 -173.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.518 ' OD1' ' HB2' ' A' ' 50' ' ' PRO . 16.7 p-10 -62.56 -43.21 99.37 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.833 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.536 HG21 ' HD2' ' B' ' 193' ' ' ARG . 1.8 mp -68.67 -44.12 82.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.556 HG22 ' HA2' ' B' ' 323' ' ' GLY . 2.6 p -63.84 -36.85 78.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 120.63 0.252 . . . . 0.0 111.619 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.19 89.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.258 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -83.45 -32.69 25.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.371 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -63.44 -42.47 98.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.177 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -109.91 17.83 20.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.391 0.615 . . . . 0.0 111.186 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.18 145.81 49.91 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.072 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 72.66 -35.06 0.31 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.378 0.671 . . . . 0.0 112.555 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -61.23 -45.89 92.66 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.405 HG22 ' HB2' ' A' ' 65' ' ' ASP . 7.5 p -122.97 22.17 4.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.903 0.858 . . . . 0.0 110.246 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -63.87 -23.25 67.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.374 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -63.83 -45.17 90.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.847 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' HB2' HG22 ' A' ' 62' ' ' VAL . 9.1 m-20 -75.2 -24.01 57.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.129 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.88 -42.22 94.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.0 mt -61.91 -38.41 88.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.935 175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.7 -41.06 98.85 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.658 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.459 ' OD1' ' HE2' ' B' ' 327' ' ' LYS . 20.9 t70 -60.75 -46.34 90.81 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.954 0.407 . . . . 0.0 110.434 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.18 -42.59 99.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.282 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.6 ttp -63.32 -42.87 99.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.976 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -62.83 -44.04 97.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.331 0.586 . . . . 0.0 110.997 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.433 HH22 ' CD2' ' A' ' 32' ' ' LEU . 69.7 mtp180 -64.42 -40.77 96.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.046 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -63.93 -40.24 96.0 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 120.954 0.407 . . . . 0.0 110.519 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -62.43 -48.28 80.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.874 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 79' ' ' ILE . 15.7 tt -68.96 -41.48 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.879 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -65.16 -37.91 88.88 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.141 0.496 . . . . 0.0 110.095 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.66 83.16 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.922 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.8 pp -65.64 -30.5 50.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.541 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.0 mt -65.44 -43.63 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.932 0.396 . . . . 0.0 111.034 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -81.24 -32.57 33.3 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.901 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -83.27 -2.94 56.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.124 0.487 . . . . 0.0 110.407 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt 64.23 38.93 7.78 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.674 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 81.3 mt -102.66 123.87 56.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.827 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -110.32 103.56 54.16 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.388 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.65 146.59 34.39 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.51 2.14 . . . . 0.0 112.295 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.14 98.23 11.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.049 0.452 . . . . 0.0 111.424 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.55 -106.48 2.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.591 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.09 129.71 24.65 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.468 ' HG2' ' CE1' ' A' ' 92' ' ' TYR . 81.0 Cg_endo -73.95 156.42 47.8 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.681 2.254 . . . . 0.0 111.928 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.0 m -76.94 119.39 20.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.017 0.437 . . . . 0.0 111.534 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.468 ' CE1' ' HG2' ' A' ' 90' ' ' PRO . 73.6 m-85 -113.82 118.81 35.3 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.01 100.57 53.84 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.443 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -90.19 145.31 4.26 Favored 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 122.555 2.17 . . . . 0.0 111.29 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.98 175.3 41.5 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.301 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.72 125.17 26.43 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -80.51 127.82 32.88 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.971 0.415 . . . . 0.0 110.563 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -117.56 115.52 25.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.595 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.4 tp -65.37 107.27 1.59 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.334 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.47 -8.71 13.43 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.383 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.93 173.39 8.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.803 0.335 . . . . 0.0 111.026 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.87 141.25 44.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.558 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -98.08 141.18 31.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.385 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.8 m -124.26 133.99 53.35 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -141.03 154.91 46.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.255 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 m -84.21 -86.44 0.12 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.0 t 68.89 111.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 122.98 0.512 . . . . 0.0 110.498 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -113.95 137.66 51.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.825 -175.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -151.34 -74.75 0.15 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -143.24 157.49 44.44 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.553 0.615 . . . . 0.0 111.297 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.432 ' CG1' ' HG ' ' A' ' 11' ' ' LEU . 28.8 m -128.78 -172.46 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -140.25 118.02 8.27 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.88 147.32 39.02 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.821 2.347 . . . . 0.0 114.623 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -135.87 143.06 44.85 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.597 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.6 t -128.37 132.17 68.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -104.7 -90.15 0.4 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.519 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.0 mt 64.1 130.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.114 0.966 . . . . 0.0 113.397 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -136.97 152.34 50.04 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.818 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.96 22.14 74.85 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.418 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.66 -28.8 68.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.808 0.337 . . . . 0.0 111.897 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -83.16 -9.02 59.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.852 0.358 . . . . 0.0 111.28 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -102.51 17.29 24.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.911 0.386 . . . . 0.0 111.342 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.2 mt -90.47 123.7 42.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.908 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -108.99 127.02 53.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.3 t -115.16 136.07 53.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.017 0.437 . . . . 0.0 112.073 -172.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -86.99 139.1 30.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.844 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -134.47 101.03 12.23 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.5 137.79 40.37 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.046 1.831 . . . . 0.0 111.527 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.98 123.13 70.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.919 0.39 . . . . 0.0 110.481 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.99 162.25 39.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.534 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -142.35 158.99 43.11 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.6 t -81.17 116.77 26.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.1 p -100.39 176.36 5.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.665 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -65.02 -30.62 71.61 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.476 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.54 97.72 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.895 0.378 . . . . 0.0 110.355 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -64.21 -44.43 91.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.949 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.487 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 90.1 t -64.47 -46.13 93.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.433 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.71 -48.4 81.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.721 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.63 -39.48 97.61 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.945 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.488 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -63.07 -44.79 94.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 0.0 110.337 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 86.6 mt -63.2 -42.26 99.28 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.74 -45.15 93.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.367 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.8 m -62.95 -42.72 99.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.614 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -60.92 -42.54 98.3 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -72.81 -20.89 61.06 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.418 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.17 -12.4 59.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.079 0.466 . . . . 0.0 110.608 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -93.61 2.99 56.19 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.498 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -117.14 75.09 0.95 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.888 0.852 . . . . 0.0 111.976 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.71 73.24 0.76 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 151' ' ' TRP . 4.1 m -144.76 173.01 12.22 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.903 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.503 ' H ' HG22 ' A' ' 150' ' ' THR . 31.5 t-105 80.72 17.52 0.57 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.395 1.078 . . . . 0.0 112.315 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' A' ' 245' ' ' LEU . 6.3 mptp? -101.89 160.01 14.85 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -94.93 4.88 53.29 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -142.23 154.37 44.73 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.986 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 78.2 -175.22 0.09 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.733 1.213 . . . . 0.0 111.304 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -138.29 99.45 0.28 Allowed Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 119.577 -1.297 . . . . 0.0 114.865 -174.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . . . -110.45 -57.0 2.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.5 t 60.89 123.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 114.592 -1.186 . . . . 0.0 113.589 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -99.95 158.14 16.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.753 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.84 86.39 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -77.12 -0.12 23.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.53 142.38 27.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.508 0.194 . . . . 0.0 110.757 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -91.61 120.09 32.08 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.95 129.98 74.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.754 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.0 m -75.91 110.32 10.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 79.9 mt -122.37 120.28 60.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.348 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -98.48 101.4 12.83 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -120.15 154.22 35.08 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.074 0.464 . . . . 0.0 111.667 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 30.8 m -123.43 129.73 51.69 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.662 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.35 125.43 7.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.903 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 25.2 m -142.38 125.83 16.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.45 -78.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.653 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -132.77 80.31 1.89 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.55 7.3 73.43 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.096 -0.574 . . . . 0.0 112.903 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -140.69 143.72 35.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.793 0.33 . . . . 0.0 110.12 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -87.27 156.73 19.52 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.193 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -122.64 174.04 7.34 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.71 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.21 -38.84 74.34 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -101.19 -178.22 28.91 Favored Glycine 0 C--N 1.318 -0.435 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.091 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.02 30.5 38.07 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.704 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -107.18 102.92 12.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -124.45 142.67 51.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 111.948 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.4 m -150.52 132.24 14.96 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.2 31.04 20.9 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.374 0.421 . . . . 0.0 110.343 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -95.84 123.42 39.41 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.99 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.2 m -91.48 116.5 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.539 0.685 . . . . 0.0 110.598 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 56.3 tp -110.13 130.51 55.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.396 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.687 ' HB3' ' NH1' ' A' ' 193' ' ' ARG . . . -121.22 135.29 55.16 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 73.9 mtm -102.19 178.21 4.66 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.149 0.5 . . . . 0.0 112.001 -172.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.61 -10.64 73.73 Favored Glycine 0 CA--C 1.505 -0.531 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.235 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -102.83 -9.23 20.11 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.618 0.247 . . . . 0.0 111.173 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.63 42.45 21.65 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.853 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.687 ' NH1' ' HB3' ' A' ' 188' ' ' ALA . 48.3 mtm180 -93.27 0.41 57.01 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.343 0.592 . . . . 0.0 110.632 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.502 ' HB2' ' HG3' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -130.17 172.95 11.23 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.445 173.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.635 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.4 mp -69.07 137.47 89.56 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.98 134.75 49.94 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.984 1.789 . . . . 0.0 111.416 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.91 -38.94 2.9 Favored Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.511 ' O ' HG12 ' A' ' 202' ' ' ILE . 47.9 t80 -63.57 -49.77 72.08 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 194' ' ' MET . 88.0 mt-10 -67.11 -36.11 81.22 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.492 0.663 . . . . 0.0 109.938 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.85 -36.08 82.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.627 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.16 -8.95 77.64 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.889 -0.672 . . . . 0.0 114.095 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 198' ' ' PHE . 47.8 mm -65.14 -45.27 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 117.275 0.538 . . . . 0.0 111.194 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -58.99 130.54 47.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.167 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.9 -15.02 48.85 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.451 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -83.37 143.51 30.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 117.06 0.43 . . . . 0.0 111.724 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -96.01 160.51 14.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.274 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.47 121.44 14.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.563 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 82.51 24.13 54.59 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.393 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -105.8 113.07 26.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.374 0.607 . . . . 0.0 111.482 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -91.37 130.94 37.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.559 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.479 ' O ' ' HB ' ' A' ' 212' ' ' THR . 61.5 t80 -150.52 -29.84 0.21 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -176.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 91.1 m 79.77 143.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.839 0.455 . . . . 0.0 110.279 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.3 tp -115.75 -42.01 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 72.12 100.11 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.329 0.585 . . . . 0.0 112.03 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 63.8 t -121.89 133.96 66.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.891 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 9.4 m -93.1 -23.49 18.6 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.45 ' CE2' HG12 ' A' ' 195' ' ' ILE . 96.4 m-85 71.94 145.59 0.11 Allowed Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 122.817 0.447 . . . . 0.0 111.459 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.56 154.02 60.09 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.621 2.214 . . . . 0.0 111.846 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -65.38 -40.04 93.01 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.947 0.403 . . . . 0.0 110.775 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -88.11 32.34 0.76 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.486 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -69.25 132.71 46.91 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.728 -0.389 . . . . 0.0 109.994 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -56.67 -40.4 75.45 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.57 101.85 7.62 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -61.53 -33.26 73.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -68.36 -14.11 62.76 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.18 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.0 mt -117.48 -0.34 11.95 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -71.54 124.21 24.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.311 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.91 17.96 77.3 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.544 -0.753 . . . . 0.0 114.492 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -127.5 132.05 50.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.711 0.755 . . . . 0.0 110.663 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.21 151.71 25.54 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.73 135.89 33.6 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.501 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.92 -48.05 67.04 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 54.46 91.83 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.082 0.468 . . . . 0.0 111.067 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.88 89.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mm 69.7 90.14 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.106 0.479 . . . . 0.0 111.522 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -67.88 -47.5 68.68 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.29 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.456 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 8.0 tp 55.26 100.37 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.86 0.864 . . . . 0.0 113.034 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -95.58 -70.91 0.69 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 34.0 mmtp -80.5 -86.87 0.08 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 242' ' ' GLU . 65.6 t 76.84 140.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.111 0.564 . . . . 0.0 111.053 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.52 ' HB3' ' NH1' ' A' ' 243' ' ' ARG . 50.8 mm-40 -64.16 -37.03 85.98 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.344 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.538 ' H ' HG12 ' A' ' 240' ' ' VAL . 36.2 mt-10 66.97 129.3 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.535 0.734 . . . . 0.0 111.881 -176.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.52 ' NH1' ' HB3' ' A' ' 241' ' ' GLU . 8.6 ptp180 173.55 114.27 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.967 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 157' ' ' ALA . 0.4 OUTLIER -142.66 -153.96 0.49 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.473 ' HB2' ' HG2' ' A' ' 152' ' ' LYS . 10.5 mp 70.18 146.09 0.11 Allowed Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.528 ' O ' ' HG2' ' A' ' 247' ' ' GLU . 95.7 Cg_endo -82.94 -159.08 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.175 2.583 . . . . 0.0 112.931 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 246' ' ' PRO . 3.4 pt-20 87.96 -176.47 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.188 1.795 . . . . 0.0 111.043 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.76 135.73 48.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.105 0.479 . . . . 0.0 111.639 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 41.2 p -88.39 -168.52 2.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.036 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.23 -51.39 66.75 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.931 0.396 . . . . 0.0 109.935 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -132.54 94.23 3.38 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -72.97 -10.22 59.56 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.297 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 253' ' ' ILE . 3.8 mp -65.25 -44.55 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.72 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.531 ' HD2' ' HB2' ' A' ' 260' ' ' ASP . 58.2 pttt -150.88 151.74 32.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.879 0.371 . . . . 0.0 111.756 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' A' ' 256' ' ' PHE . 28.1 tpt180 -168.93 -175.21 2.28 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -174.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.572 ' H ' ' HG3' ' A' ' 255' ' ' ARG . 91.9 m-85 90.47 -39.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.356 1.062 . . . . 0.0 113.67 172.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 133.43 -132.13 6.37 Favored Glycine 0 C--N 1.313 -0.695 0 C-N-CA 119.326 -1.416 . . . . 0.0 113.234 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.7 m 38.18 48.26 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.933 0.893 . . . . 0.0 111.389 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 260' ' ' ASP . 33.6 tt0 66.94 -84.8 0.03 OUTLIER 'General case' 0 C--O 1.235 0.329 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.334 -174.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . 0.531 ' HB2' ' HD2' ' A' ' 254' ' ' LYS . 4.0 p30 174.2 151.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.112 0.565 . . . . 0.0 110.434 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.39 -171.76 31.03 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.933 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.2 p -79.81 168.74 18.89 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.604 0.362 . . . . 0.0 110.911 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 94.0 t -61.94 -49.56 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.785 0.326 . . . . 0.0 111.578 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.4 pm0 -71.14 -41.33 70.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.129 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.27 95.6 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.389 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 270' ' ' VAL . 58.1 tp -61.8 -45.67 92.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.555 0.217 . . . . 0.0 111.117 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 263' ' ' VAL . 66.1 mtp180 -66.73 -41.41 87.93 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.573 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.91 -43.3 83.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.202 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -66.5 -39.81 88.89 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.705 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 266' ' ' LEU . 76.0 t -64.35 -42.35 95.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.938 176.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -57.56 -47.62 81.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.564 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 12.8 ptmt -66.99 -39.62 87.2 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -63.79 -41.03 98.01 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.987 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 98.7 mmm -64.43 -41.87 96.33 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.852 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.22 -34.92 75.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.762 0.315 . . . . 0.0 111.122 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -61.96 -43.09 99.58 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -67.07 -37.96 84.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.494 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.6 tp -61.96 -41.07 97.57 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.834 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -57.7 -46.12 84.77 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.654 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.3 m -63.65 -44.72 93.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.576 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.74 93.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.076 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.62 -43.94 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.24 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -62.53 -42.62 99.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.893 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -62.97 -41.34 99.52 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.104 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -60.26 -44.1 95.59 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.117 0.484 . . . . 0.0 110.327 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.0 t -70.02 -43.79 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.946 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.96 -47.39 86.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.299 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.9 p -62.25 -43.23 99.29 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.643 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -65.79 -42.49 90.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.842 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.628 ' O ' ' HG ' ' A' ' 294' ' ' LEU . . . -64.26 -45.62 87.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.044 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 295' ' ' VAL . 35.1 mm -63.98 -43.99 97.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.058 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.511 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 29.7 tp10 -60.52 -43.68 96.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.438 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.52 -40.3 98.6 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.278 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 290' ' ' ALA . 69.8 mt -63.38 -43.07 98.64 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.711 0.291 . . . . 0.0 111.155 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 291' ' ' ILE . 93.7 t -65.01 -44.8 95.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.941 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . 0.511 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.1 mttm -64.37 -39.8 94.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.326 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.97 95.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.921 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -137.93 102.27 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -90.02 107.38 19.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 8.7 tp -114.48 140.04 37.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.82 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -68.72 129.01 38.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.477 0.656 . . . . 0.0 110.05 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 94.0 t -99.56 135.54 20.58 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.687 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.74 132.81 53.86 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.498 2.132 . . . . 0.0 111.828 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.0 87.54 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.46 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' A' ' 11' ' ' LEU . . . -58.0 -41.74 83.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 111.537 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.2 -42.3 93.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.31 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.02 -44.58 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.817 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.09 -42.56 85.89 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.873 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.1 m -62.04 -44.64 96.27 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.055 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.499 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 74.0 mm-40 -69.37 -38.79 78.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.707 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.522 HD13 ' HG3' ' A' ' 334' ' ' ARG . 94.2 mt -62.19 -44.34 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -177.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.485 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 26.9 t70 -62.55 -43.1 99.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.037 0.446 . . . . 0.0 110.638 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.11 -43.31 95.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.293 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 95.8 mt -62.41 -41.81 98.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.037 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.485 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 85.3 mtm180 -63.72 -42.25 97.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -64.34 -41.14 96.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.554 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -63.46 -40.92 98.4 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.004 0.431 . . . . 0.0 110.603 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.42 91.76 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.223 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.92 -37.09 86.48 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.799 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . 0.44 ' NE2' ' HG3' ' B' ' 45' ' ' ARG . 47.1 tt0 -60.64 -39.39 88.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.77 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -89.74 2.29 55.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.693 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -99.0 -2.95 36.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.342 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . 0.546 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . 139.98 -1.55 2.26 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.567 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 91.71 29.13 12.37 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.461 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.511 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 43.7 t-20 -72.39 124.04 24.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . 0.654 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 0.6 OUTLIER -119.61 153.45 35.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 0.1 OUTLIER 61.37 -30.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 126.03 1.732 . . . . 0.0 114.608 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.511 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 15.9 mm100 -79.8 -5.31 55.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.301 0.572 . . . . 0.0 110.38 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.58 -18.39 63.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.38 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.92 -37.93 86.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.503 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.83 -20.13 65.13 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.853 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 81.6 mt -62.02 147.03 91.01 Favored Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.275 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.444 ' O ' ' HD1' ' A' ' 337' ' ' PHE . 32.5 Cg_exo -61.04 142.08 96.22 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.804 2.336 . . . . 0.0 112.82 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.522 ' HG3' HD13 ' A' ' 311' ' ' ILE . 21.4 ttt180 -84.49 -41.07 16.93 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.836 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -60.14 -39.48 86.48 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.05 -2.88 58.73 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.444 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.444 ' HD1' ' O ' ' A' ' 333' ' ' PRO . 60.2 m-85 -109.83 -21.33 12.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.132 0.491 . . . . 0.0 109.875 173.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.74 -29.22 67.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.08 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -60.8 -47.44 86.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 110.639 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -78.42 -22.88 47.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.598 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -62.68 -41.77 99.27 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.197 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.8 tttt -59.73 -48.29 82.26 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 347' ' ' VAL . 13.4 mmt85 -61.25 -45.32 95.0 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.038 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.422 HH21 ' HD3' ' A' ' 344' ' ' ARG . 67.7 mtt-85 -65.89 -38.94 90.1 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 341' ' ' ALA . 97.4 t -66.63 -43.23 90.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.031 0.444 . . . . 0.0 109.998 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 342' ' ' LYS . 59.7 t -60.24 -43.48 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.566 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 343' ' ' ARG . 71.0 t -59.51 -45.09 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.32 -43.89 98.44 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.032 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.97 -42.77 97.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.557 0.218 . . . . 0.0 111.437 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.9 mt -62.75 -45.92 90.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.94 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.12 -38.91 82.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.241 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.57 97.07 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.146 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.78 -35.05 79.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.886 0.374 . . . . 0.0 110.837 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.62 -43.69 95.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.93 -44.89 99.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.899 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -69.48 -46.28 67.0 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.0 m -63.31 -44.18 95.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -97.11 5.71 49.78 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.059 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 52.83 53.19 12.51 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.846 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.91 145.57 32.59 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.7 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.25 148.26 44.54 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.765 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.88 127.54 32.91 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 367' ' ' VAL . 25.2 t70 -96.9 110.68 23.14 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.784 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -59.23 -34.6 72.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.775 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.449 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 46.7 mm-40 -67.05 -40.93 87.21 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.12 0.486 . . . . 0.0 110.591 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -63.4 -38.97 93.19 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 363' ' ' ASP . 93.6 t -62.51 -41.03 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.087 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 372' ' ' GLU . 25.9 mmmt -55.34 -45.15 76.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.066 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.16 -41.31 99.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.399 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.93 -42.66 99.87 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.09 0.471 . . . . 0.0 110.38 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.79 -44.04 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.738 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 368' ' ' LYS . 47.5 mt-10 -64.87 -40.26 94.85 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.718 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.91 -38.35 86.05 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.491 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 57.6 ttm -65.49 -41.49 93.2 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.076 0.465 . . . . 0.0 110.34 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -63.23 -26.3 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.844 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.8 m -72.35 -6.77 45.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.29 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -92.09 1.25 57.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.913 0.387 . . . . 0.0 110.789 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -119.87 172.59 7.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.23 -46.2 78.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.758 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 26.7 t70 -120.97 108.82 36.21 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.958 0.409 . . . . 0.0 110.576 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.467 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 51.8 Cg_exo -56.55 -39.41 91.53 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.91 2.406 . . . . 0.0 113.233 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.84 -43.84 91.72 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 9.4 pt-20 -62.88 -37.78 88.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.451 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.45 -42.73 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.217 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.48 -44.92 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.212 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.14 -38.6 78.9 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.265 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -58.97 -46.52 87.88 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.936 0.398 . . . . 0.0 110.355 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.488 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 4.6 t80 -68.65 -44.22 74.6 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.527 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.9 p -73.45 -17.32 61.26 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -176.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.12 4.14 54.51 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.108 0.48 . . . . 0.0 111.076 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 395' ' ' MET . 16.2 t-20 -122.51 111.45 16.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.033 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -61.39 -42.08 98.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -58.56 -48.89 79.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.776 0.322 . . . . 0.0 110.636 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.27 -40.44 97.4 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.492 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.437 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 95.9 mtp -61.72 -48.86 78.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.712 0.292 . . . . 0.0 111.62 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.51 -37.65 74.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 -175.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -62.25 -44.06 97.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.203 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.488 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 51.6 tpp -66.29 -39.74 89.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.146 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.481 ' HG2' HG21 ' A' ' 367' ' ' VAL . 55.7 mtm180 -64.17 -35.96 82.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.797 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -61.74 -43.84 98.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.001 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.2 -44.48 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.912 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.72 -40.48 97.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.903 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 45.9 tp -64.47 -37.74 88.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.462 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.84 -44.27 90.92 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.165 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -65.96 -37.0 84.88 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.595 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -60.06 -42.25 94.11 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.47 82.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.926 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 85.1 t -63.55 -46.41 95.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.02 -33.06 74.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.383 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.93 96.08 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 110.569 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 93.7 t -65.16 -42.23 93.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.314 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 95.5 mt -60.49 -40.16 90.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.643 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.58 -22.61 66.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.352 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -94.39 -40.44 9.93 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.919 0.39 . . . . 0.0 111.423 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -80.36 177.99 8.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.372 0.606 . . . . 0.0 112.36 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -87.25 118.23 26.54 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.362 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.1 t -103.36 105.95 19.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.1 t -105.13 134.72 47.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.975 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.19 111.57 23.25 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.757 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -117.79 128.13 54.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.992 0.425 . . . . 0.0 110.893 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -72.06 147.43 46.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.167 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -157.13 169.64 24.32 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 120.834 0.35 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 29.6 p -91.29 165.34 13.49 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.339 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -66.35 -30.34 70.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.479 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -62.46 -38.27 89.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.862 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.57 -33.5 75.81 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.08 0.466 . . . . 0.0 110.364 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 11.2 mp -72.43 -21.34 61.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.9 mmt -73.46 -6.65 47.7 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.031 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -78.79 71.69 5.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -102.49 17.42 23.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.268 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -64.17 -39.79 94.75 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.441 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.218 178.823 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 120.95 0.405 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.14 134.67 56.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.193 0.52 . . . . 0.0 111.711 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.02 159.76 42.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.27 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 40.2 t -115.85 107.73 15.4 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.998 0.428 . . . . 0.0 110.582 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.83 139.88 21.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.137 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -122.15 154.45 37.4 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.974 0.416 . . . . 0.0 111.137 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 61.5 m -104.35 119.79 39.74 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.912 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.8 m -70.67 -66.09 0.65 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.039 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -179.46 131.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.577 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.22 -106.37 1.65 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.507 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.453 ' HG ' ' CG1' ' B' ' 111' ' ' VAL . 2.5 mp -96.99 -14.5 21.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.687 0.28 . . . . 0.0 110.364 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.1 132.62 19.35 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.552 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.9 143.83 47.16 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 122.703 0.401 . . . . 0.0 109.997 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -117.9 133.94 55.44 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 19.8 t -81.04 -93.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.1 m 55.58 90.35 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.27 0.557 . . . . 0.0 110.679 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.1 tp -106.59 133.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.075 0.464 . . . . 0.0 111.921 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 25.5 p -81.76 132.09 35.28 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.824 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.5 HD13 HD11 ' B' ' 24' ' ' ILE . 1.8 pp -128.58 164.76 29.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.66 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -111.12 156.6 21.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.14 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.25 -52.87 57.61 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -173.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -71.05 -34.14 70.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.907 0.384 . . . . 0.0 110.963 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 33.4 t -64.87 -29.1 70.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.443 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.66 HG13 ' O ' ' B' ' 20' ' ' ALA . 64.9 mt -63.25 -71.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.29 0.567 . . . . 0.0 111.302 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.35 -42.72 96.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.646 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 18.1 m -63.1 -47.43 82.87 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.06 -44.3 15.33 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -174.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 81.4 t -62.44 -44.66 99.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.55 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -61.71 -47.16 86.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.706 0.289 . . . . 0.0 111.036 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 21.8 m -61.75 -42.42 98.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.467 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.426 ' O ' HG23 ' B' ' 35' ' ' VAL . 13.6 tp10 -65.25 -40.99 94.72 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.868 0.366 . . . . 0.0 110.562 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 96.2 mt -63.71 -44.07 94.7 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.67 -37.2 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.74 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.16 -40.49 97.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.288 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 31' ' ' GLU . 83.9 t -64.05 -44.07 97.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.794 0.331 . . . . 0.0 110.511 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -46.37 89.97 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.855 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.74 -33.99 76.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.088 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.83 -43.84 90.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.854 0.359 . . . . 0.0 110.448 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 t -84.84 -4.7 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.289 0.566 . . . . 0.0 110.314 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 61.98 28.53 17.33 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.499 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.419 ' H ' HG13 ' B' ' 41' ' ' ILE . 2.8 pp -105.04 5.77 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.974 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -65.06 -28.61 69.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.264 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.2 -19.26 72.03 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.273 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -76.24 -17.55 59.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.44 ' HG3' ' NE2' ' A' ' 320' ' ' GLN . 71.5 ttt-85 -87.15 93.54 9.4 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.115 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -69.37 115.85 9.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.94 70.74 0.49 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 -170.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.19 -44.56 83.63 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.61 105.96 26.64 Favored Pre-proline 0 N--CA 1.439 -1.005 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.125 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.484 ' HB2' ' OD1' ' B' ' 52' ' ' ASN . 14.0 Cg_endo -58.44 145.74 93.07 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.198 1.932 . . . . 0.0 111.396 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.551 ' HA ' HG12 ' B' ' 54' ' ' VAL . 19.4 ttt -63.47 -38.84 92.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.151 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . 0.484 ' OD1' ' HB2' ' B' ' 50' ' ' PRO . 21.8 p-10 -62.02 -43.25 99.23 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.899 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.511 HG12 HH21 ' A' ' 193' ' ' ARG . 1.8 mp -68.5 -44.64 82.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' B' ' 51' ' ' MET . 4.3 p -63.89 -37.35 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.502 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.49 87.41 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.341 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -84.27 -33.66 23.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -62.53 -42.82 99.77 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.982 0.42 . . . . 0.0 110.946 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.6 18.21 21.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.412 0.625 . . . . 0.0 110.805 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.43 145.68 49.74 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.426 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 72.75 -33.98 0.28 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.458 0.703 . . . . 0.0 112.263 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.7 t -61.63 -47.27 86.17 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.68 21.34 5.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 122.079 0.943 . . . . 0.0 109.899 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -63.27 -21.3 66.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.035 -177.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -64.02 -47.06 81.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.774 0.321 . . . . 0.0 110.807 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.94 -23.86 55.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.268 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.74 -42.16 94.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.0 -38.47 88.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.17 -41.71 98.3 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.637 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . 0.569 ' OD1' ' HE2' ' A' ' 327' ' ' LYS . 21.1 t70 -60.23 -46.92 88.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.22 -42.91 99.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.409 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 61.0 ttp -63.03 -43.09 99.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.174 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -62.17 -43.8 98.02 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.256 0.551 . . . . 0.0 110.807 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.405 ' NH1' HG21 ' B' ' 35' ' ' VAL . 71.5 mtp180 -64.78 -40.61 95.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.314 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -63.85 -40.8 97.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.898 0.38 . . . . 0.0 110.473 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -61.09 -48.98 79.19 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.099 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . 0.462 ' O ' HG13 ' B' ' 79' ' ' ILE . 15.5 tt -68.74 -41.25 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.39 -38.0 89.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.212 0.529 . . . . 0.0 110.072 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.66 -47.22 84.65 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.092 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.462 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.8 pp -66.69 -29.55 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.865 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.5 mt -65.46 -43.95 94.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.782 0.325 . . . . 0.0 111.07 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -81.31 -33.06 32.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -80.18 -7.91 59.17 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.064 0.459 . . . . 0.0 110.388 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt 66.93 38.08 3.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.262 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.9 mt -101.19 121.44 52.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.473 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -107.54 102.72 45.85 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.835 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.71 146.79 38.98 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 122.376 2.051 . . . . 0.0 112.085 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.35 100.63 12.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.609 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.59 -118.11 6.45 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.012 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.27 130.65 23.44 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-O 120.544 0.212 . . . . 0.0 110.883 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . 0.436 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 73.1 Cg_endo -75.25 161.6 37.78 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.982 2.455 . . . . 0.0 111.984 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -77.98 117.71 19.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.127 0.489 . . . . 0.0 111.899 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.436 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 81.6 m-85 -112.22 122.0 46.49 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 52.7 t -120.89 99.89 46.61 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-O 120.878 0.37 . . . . 0.0 110.713 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -89.66 145.24 4.72 Favored 'Trans proline' 0 N--CA 1.438 -1.791 0 C-N-CA 122.412 2.074 . . . . 0.0 111.213 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.14 174.92 40.92 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.326 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.63 126.42 29.29 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -81.27 125.19 30.03 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.023 0.44 . . . . 0.0 110.352 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -112.95 112.46 23.94 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.036 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 48.5 tp -65.43 107.11 1.56 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.047 0.451 . . . . 0.0 110.105 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.73 -16.32 8.37 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.257 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.37 -179.74 4.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.957 0.408 . . . . 0.0 111.629 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.8 138.52 37.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.744 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -96.11 143.1 27.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.473 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 45.4 m -124.92 134.67 52.57 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -140.68 155.7 46.42 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.392 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 3.0 m -84.66 -86.06 0.13 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 84.0 t 67.86 108.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.992 0.517 . . . . 0.0 110.692 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -111.51 138.69 47.71 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.639 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -152.81 -75.13 0.13 Allowed 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -142.43 157.2 45.03 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.798 -0.564 . . . . 0.0 111.32 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.453 ' CG1' ' HG ' ' B' ' 11' ' ' LEU . 27.5 m -129.94 -175.2 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 121.351 0.596 . . . . 0.0 112.342 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -138.16 119.32 10.37 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.01 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.72 148.54 32.71 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.019 2.479 . . . . 0.0 114.583 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -138.74 142.25 38.87 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.38 133.21 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -103.0 -92.25 0.34 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.451 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.4 mt 64.13 133.79 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.898 0.879 . . . . 0.0 113.337 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -141.83 152.47 43.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.469 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.2 19.42 78.47 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.465 175.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 75.3 mt -63.62 -37.2 86.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.986 0.422 . . . . 0.0 111.352 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' B' ' 121' ' ' GLU . 1.6 mp0 -72.64 -12.91 61.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.593 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.44 18.0 18.89 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.878 0.37 . . . . 0.0 111.37 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 83.6 mt -92.66 122.23 43.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -104.37 133.11 49.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.45 136.0 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 112.027 -172.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -87.21 139.21 30.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.915 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -134.3 99.88 13.07 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.8 137.18 37.68 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.968 1.779 . . . . 0.0 111.492 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.72 123.66 69.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.848 0.356 . . . . 0.0 110.349 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.14 162.86 39.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.233 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -145.24 159.16 43.44 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.815 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.46 118.0 28.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 69.9 p -101.03 174.96 5.77 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.991 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.45 -31.81 72.59 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.657 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.13 99.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.481 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -65.08 -44.61 88.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.274 0.559 . . . . 0.0 110.268 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.4 t -63.8 -46.91 93.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.723 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -64.12 -42.71 96.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.646 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.75 -39.96 95.49 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.095 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.562 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.0 OUTLIER -62.68 -42.97 99.91 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 94.4 mt -63.63 -41.13 98.29 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.842 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -59.23 -48.72 80.56 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.68 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.9 m -61.8 -40.55 95.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.63 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.1 mt -61.04 -41.76 97.19 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.457 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -74.02 -18.05 60.9 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.467 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.5 -8.66 59.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.256 0.551 . . . . 0.0 110.394 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -95.83 4.61 52.7 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.342 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -119.07 75.33 1.03 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.754 0.788 . . . . 0.0 112.052 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -157.31 74.66 0.78 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . 0.463 HG22 ' H ' ' B' ' 151' ' ' TRP . 4.9 m -145.83 171.86 14.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.102 -172.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . 0.463 ' H ' HG22 ' B' ' 150' ' ' THR . 44.8 t-105 82.02 10.68 0.73 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.79 1.236 . . . . 0.0 112.393 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . 0.535 ' HG2' ' HB2' ' B' ' 245' ' ' LEU . 6.1 mptp? -94.3 158.16 15.71 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.048 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.27 -1.56 58.1 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -141.05 156.32 46.03 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 120.444 -0.503 . . . . 0.0 112.02 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 4.6 t70 82.98 178.08 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.065 1.346 . . . . 0.0 111.136 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.0 89.62 0.26 Allowed Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 119.403 -1.379 . . . . 0.0 115.134 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' B' ' 244' ' ' GLU . . . -103.38 -59.92 1.64 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 58.5 t 62.6 125.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.872 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -101.06 160.16 14.62 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.963 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.86 86.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.45 -4.38 42.19 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.79 143.48 32.82 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -96.82 121.23 38.45 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 49.5 t -119.53 129.46 75.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.773 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 25.5 m -76.42 104.28 6.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 77.1 mt -117.27 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.869 0.366 . . . . 0.0 111.582 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 16.5 m-20 -99.04 91.9 5.24 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -110.78 154.17 24.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 111.462 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 38.8 m -124.72 129.54 50.68 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.646 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.35 127.38 9.17 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.84 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 27.2 m -143.26 124.61 14.67 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.93 -78.22 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.609 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -133.41 81.03 1.91 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.101 0.477 . . . . 0.0 111.423 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.3 2.72 80.25 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.247 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -140.82 149.7 42.37 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 117.043 0.422 . . . . 0.0 110.874 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -89.16 150.18 22.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.9 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -115.74 177.14 4.78 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.164 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -57.28 -40.43 77.75 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.892 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -102.2 -173.28 27.45 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.061 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.14 30.53 46.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.785 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -106.82 107.47 18.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -126.6 141.64 51.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.071 0.462 . . . . 0.0 111.957 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.4 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 50.0 m -149.34 130.44 14.45 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 57.08 31.33 19.77 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.594 0.559 . . . . 0.0 110.6 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -96.06 124.25 39.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.561 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 5.7 m -91.78 117.2 34.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.535 0.683 . . . . 0.0 110.645 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 53.2 tp -110.91 131.74 54.79 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.619 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . 0.68 ' HB3' ' NH1' ' B' ' 193' ' ' ARG . . . -121.42 137.39 54.73 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 71.1 mtm -103.65 179.14 4.36 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.153 0.501 . . . . 0.0 112.002 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.46 -20.36 44.65 Favored Glycine 0 CA--C 1.503 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.009 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -91.25 -13.69 32.29 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.767 0.317 . . . . 0.0 111.248 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.72 40.58 10.62 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.095 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.68 ' NH1' ' HB3' ' B' ' 188' ' ' ALA . 51.8 mtm180 -94.47 0.52 55.42 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.432 0.634 . . . . 0.0 110.962 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.481 ' HB2' ' HG3' ' B' ' 199' ' ' GLU . 0.0 OUTLIER -129.26 165.73 20.82 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.389 173.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.682 ' H ' HD12 ' B' ' 195' ' ' ILE . 4.5 mp -61.23 136.59 94.07 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.71 133.67 51.06 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 121.957 1.771 . . . . 0.0 111.434 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.13 -39.01 2.88 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.193 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . 0.52 ' O ' HG12 ' B' ' 202' ' ' ILE . 52.1 t80 -62.35 -48.69 78.69 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . 0.481 ' HG3' ' HB2' ' B' ' 194' ' ' MET . 93.0 mt-10 -67.0 -36.44 82.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.283 0.563 . . . . 0.0 110.416 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.76 -35.71 81.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.218 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.38 -7.95 71.87 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.838 -0.696 . . . . 0.0 114.324 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.52 HG12 ' O ' ' B' ' 198' ' ' PHE . 48.1 mm -64.96 -44.23 96.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 117.57 0.685 . . . . 0.0 110.984 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -60.01 133.62 56.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.087 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.26 -15.04 51.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.179 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -84.24 141.18 31.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.26 0.552 . . . . 0.0 111.905 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -90.94 161.32 15.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.889 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.83 130.1 42.77 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' B' ' 237' ' ' LEU . . . 69.98 34.27 70.81 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.498 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -113.65 114.05 25.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.251 0.548 . . . . 0.0 111.59 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -91.24 137.35 32.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -156.48 -27.34 0.1 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 28.0 m 77.48 135.59 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.906 0.482 . . . . 0.0 110.988 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -106.58 -40.3 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 68.26 96.41 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.242 0.544 . . . . 0.0 112.364 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 66.4 t -119.25 135.71 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.071 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 6.5 m -93.78 -23.08 18.31 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.462 ' CE2' HG12 ' B' ' 195' ' ' ILE . 95.2 m-85 71.81 142.93 0.09 OUTLIER Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 122.892 0.477 . . . . 0.0 111.992 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 11.6 Cg_exo -71.42 153.58 60.91 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.737 2.291 . . . . 0.0 111.899 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.29 -40.77 94.27 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.867 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -84.81 29.73 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.318 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -68.6 133.25 48.23 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.945 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -57.63 -40.65 79.67 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.61 101.24 8.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.34 -32.38 71.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.793 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -67.52 -14.24 62.76 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 94.7 mt -119.21 3.29 11.39 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -73.76 125.45 28.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 119.736 -0.785 . . . . 0.0 112.372 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.95 16.04 76.41 Favored Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.283 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -125.44 128.88 48.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.59 0.695 . . . . 0.0 111.244 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.94 150.53 30.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.59 137.22 35.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.614 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -68.53 -48.31 64.66 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 54.39 91.93 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.165 0.507 . . . . 0.0 111.266 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.81 92.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mm 70.38 90.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 122.869 0.468 . . . . 0.0 111.249 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.65 -48.19 67.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.322 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . 0.526 ' O ' ' HA2' ' B' ' 208' ' ' GLY . 8.1 tp 57.42 110.49 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.987 0.915 . . . . 0.0 112.917 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -105.36 -75.59 0.62 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . 0.411 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 34.3 mmtp -77.86 -83.76 0.08 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.5 HG12 ' H ' ' B' ' 242' ' ' GLU . 86.2 t 74.51 139.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.368 0.604 . . . . 0.0 111.288 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.522 ' HB3' ' NH1' ' B' ' 243' ' ' ARG . 56.3 mm-40 -63.48 -40.15 96.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.206 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.5 ' H ' HG12 ' B' ' 240' ' ' VAL . 31.1 mt-10 66.76 129.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.303 0.641 . . . . 0.0 111.809 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.522 ' NH1' ' HB3' ' B' ' 241' ' ' GLU . 5.6 ptp180 174.44 109.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.054 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.493 ' HG3' ' HB2' ' B' ' 157' ' ' ALA . 2.4 tt0 -137.03 -150.88 0.38 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.535 ' HB2' ' HG2' ' B' ' 152' ' ' LYS . 10.0 mp 69.16 145.76 0.11 Allowed Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 123.538 0.735 . . . . 0.0 112.714 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . 0.551 ' O ' ' HG2' ' B' ' 247' ' ' GLU . 84.5 Cg_endo -83.28 -158.79 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.059 2.506 . . . . 0.0 112.47 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' B' ' 246' ' ' PRO . 4.0 pt-20 85.68 -176.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.934 1.694 . . . . 0.0 111.004 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.13 136.0 49.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.124 0.487 . . . . 0.0 111.824 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 20.0 p -89.78 -170.14 2.7 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.213 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.61 -52.85 62.41 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.015 0.436 . . . . 0.0 110.017 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -131.09 92.18 3.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.482 0.658 . . . . 0.0 109.241 173.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -70.63 -13.64 62.16 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.563 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' ILE . . . . . 0.442 ' H ' HD12 ' B' ' 253' ' ' ILE . 4.0 mp -63.3 -44.51 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.493 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' LYS . . . . . 0.546 ' HD2' ' HB2' ' B' ' 260' ' ' ASP . 54.9 pttt -149.84 150.84 32.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 111.459 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . 0.596 ' HG3' ' H ' ' B' ' 256' ' ' PHE . 27.5 tpt180 -166.02 -174.61 3.05 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -175.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 256' ' ' PHE . . . . . 0.596 ' H ' ' HG3' ' B' ' 255' ' ' ARG . 94.1 m-85 88.85 -41.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.463 1.105 . . . . 0.0 113.395 172.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 133.51 -129.86 5.5 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.304 -1.427 . . . . 0.0 113.183 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 26.8 m 37.85 49.58 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.669 0.788 . . . . 0.0 111.458 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' B' ' 260' ' ' ASP . 34.9 tt0 67.68 -85.17 0.03 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.518 -175.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . 0.546 ' HB2' ' HD2' ' B' ' 254' ' ' LYS . 2.6 p30 174.26 150.34 0.09 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.276 0.63 . . . . 0.0 109.959 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.5 -177.89 37.5 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.098 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 22.9 p -75.38 167.29 22.19 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 122.79 0.436 . . . . 0.0 110.859 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . 0.521 ' O ' ' HG3' ' B' ' 267' ' ' ARG . 99.4 t -61.93 -48.89 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -70.82 -40.3 72.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.769 0.319 . . . . 0.0 111.021 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -67.34 -40.69 91.77 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.425 ' O ' HG23 ' B' ' 270' ' ' VAL . 51.2 tp -61.78 -46.07 91.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.614 0.245 . . . . 0.0 110.961 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' B' ' 263' ' ' VAL . 44.8 mtp180 -66.17 -40.39 90.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.402 -177.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -68.34 -42.57 79.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.295 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -67.0 -40.15 87.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.646 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.425 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.1 t -64.35 -41.87 93.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -56.97 -47.82 79.83 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.47 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 16.2 ptmt -67.48 -38.6 84.63 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -63.67 -41.45 98.18 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.927 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.9 mmm -65.11 -42.42 93.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.973 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.19 -35.76 78.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.873 0.368 . . . . 0.0 110.973 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -63.3 -42.81 99.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -65.94 -38.64 89.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.491 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.78 -40.77 96.36 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.699 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -57.29 -48.61 78.48 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.164 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.3 m -62.9 -44.26 96.57 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.776 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.75 95.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.067 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.58 -44.25 98.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 120.969 0.414 . . . . 0.0 110.347 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -62.15 -42.53 99.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.88 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -62.9 -41.35 99.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 110.916 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -60.96 -43.92 98.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.479 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 94.9 t -69.49 -43.85 80.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.926 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . 0.422 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.1 tttt -61.12 -46.81 89.05 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.145 -176.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 75.4 p -62.04 -43.36 99.01 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -64.88 -43.73 91.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.779 0.323 . . . . 0.0 110.685 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . 0.67 ' O ' ' HG ' ' B' ' 294' ' ' LEU . . . -63.45 -46.84 84.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.076 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . 0.422 HG12 ' O ' ' B' ' 287' ' ' LYS . 38.1 mm -64.04 -44.16 97.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.646 0.26 . . . . 0.0 110.648 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . 0.496 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 32.8 tp10 -60.22 -42.61 95.53 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.352 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.91 99.16 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.382 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' B' ' 290' ' ' ALA . 65.6 mt -63.5 -42.53 98.5 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.552 0.215 . . . . 0.0 111.413 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.92 -44.57 96.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.957 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . 0.496 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 67.8 mttm -63.78 -39.57 94.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.073 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -65.09 -40.76 95.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.125 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -137.06 100.86 4.39 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.05 98.81 11.98 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 8.6 tp -104.64 142.6 17.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.193 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.21 135.7 54.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.097 0.475 . . . . 0.0 109.799 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 90.3 t -109.88 132.91 21.14 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.37 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.58 132.27 51.1 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.421 2.081 . . . . 0.0 111.885 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.06 86.57 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.404 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.58 82.01 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.882 0.372 . . . . 0.0 111.399 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.29 -41.87 93.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.437 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . 0.4 ' O ' HG13 ' B' ' 311' ' ' ILE . 65.3 mt -65.12 -44.55 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.947 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -43.82 82.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.016 0.436 . . . . 0.0 110.958 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 31.8 m -61.56 -44.43 97.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.125 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . 0.539 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 52.0 mm-40 -68.29 -39.05 82.23 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.882 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.485 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.2 mt -62.29 -44.39 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.429 -177.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.499 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 20.3 t70 -62.38 -43.13 99.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.011 0.434 . . . . 0.0 110.872 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 91.5 t -64.88 -43.47 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.252 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 95.0 mt -62.24 -40.43 96.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.499 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 85.9 mtm180 -63.34 -40.94 98.68 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . 0.4 HH21 ' HD2' ' B' ' 316' ' ' ARG . 31.7 mtt180 -63.83 -39.93 95.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.717 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -63.02 -40.16 96.92 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.278 0.561 . . . . 0.0 109.914 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 -42.99 81.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -65.29 -37.35 86.88 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.333 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . 0.443 ' NE2' ' HG3' ' A' ' 45' ' ' ARG . 48.3 tt0 -62.43 -39.6 93.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.139 0.495 . . . . 0.0 110.431 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -86.99 -0.62 56.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.59 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -97.57 -2.41 41.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.166 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . 0.556 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 140.01 -6.51 2.86 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.608 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 95.22 29.16 9.15 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.71 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . 0.483 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 43.5 t-20 -72.38 123.33 22.83 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . 0.661 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 0.7 OUTLIER -116.72 152.71 33.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 0.1 OUTLIER 62.06 -34.3 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.832 1.653 . . . . 0.0 114.773 177.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . 0.483 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.9 mm100 -76.72 -5.62 48.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.259 0.552 . . . . 0.0 110.454 177.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -66.23 -13.76 60.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.273 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.411 HD12 HH12 ' B' ' 315' ' ' ARG . 54.2 tp -62.99 -35.97 81.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.417 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -66.86 -24.55 66.15 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.707 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . 0.479 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 72.3 mt -58.2 142.43 80.84 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.707 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . 0.477 ' O ' ' HD1' ' B' ' 337' ' ' PHE . 36.5 Cg_exo -60.86 137.62 73.73 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.287 2.658 . . . . 0.0 113.778 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . 0.457 ' HG3' HD13 ' B' ' 311' ' ' ILE . 26.7 ttt85 -74.14 -43.42 57.52 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.143 177.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.1 -37.42 85.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -170.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 71.5 mt -87.01 -3.57 59.1 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.524 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . 0.477 ' HD1' ' O ' ' B' ' 333' ' ' PRO . 56.5 m-85 -108.48 -22.09 12.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.084 0.468 . . . . 0.0 110.34 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.55 -29.1 67.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.33 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.66 -46.93 87.64 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.826 0.346 . . . . 0.0 110.814 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -76.72 -25.43 53.53 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.33 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.449 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.97 -42.09 99.73 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.469 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . 0.518 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.1 tttt -59.55 -47.09 86.9 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . 0.538 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.7 mmt85 -61.87 -45.3 94.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.201 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -66.6 -37.85 85.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 341' ' ' ALA . 96.0 t -65.2 -43.71 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 342' ' ' LYS . 71.1 t -60.78 -43.52 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.661 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.538 HG23 ' O ' ' B' ' 343' ' ' ARG . 75.1 t -59.23 -45.31 93.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.3 -43.92 98.4 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.069 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.83 -43.0 97.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.62 0.248 . . . . 0.0 111.448 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' B' ' 346' ' ' VAL . 97.0 mt -62.76 -46.26 88.87 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.895 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.39 -39.14 85.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.186 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.74 -42.15 97.85 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.357 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.26 -34.32 77.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.942 0.371 . . . . 0.0 110.923 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.2 -43.43 93.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.29 -44.51 99.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.748 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -70.64 -45.91 64.28 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 96.2 m -63.68 -45.0 92.09 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -95.23 4.17 53.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.245 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 53.48 54.19 10.46 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.95 0.5 . . . . 0.0 112.019 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.97 147.85 27.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.427 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.45 149.51 45.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.63 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.79 128.2 35.81 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . 0.526 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.6 t70 -95.9 111.25 23.29 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.403 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 52.9 mm-40 -61.64 -33.26 73.63 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.814 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 68.3 mm-40 -66.99 -40.26 87.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.937 0.399 . . . . 0.0 110.366 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -64.14 -38.19 90.18 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.664 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 363' ' ' ASP . 97.8 t -61.82 -41.16 89.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.788 176.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.8 mmmt -56.56 -44.26 80.79 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.269 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.8 -41.53 99.63 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.245 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.2 -42.8 99.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.808 0.337 . . . . 0.0 110.252 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.55 -44.43 96.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.775 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.38 -42.79 98.84 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.763 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.89 -38.32 86.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.988 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 58.6 ttm -65.79 -40.91 92.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.972 0.415 . . . . 0.0 110.289 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -63.0 -26.59 68.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.69 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.2 m -71.89 -7.17 46.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.031 0.443 . . . . 0.0 111.229 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.0 -0.27 57.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.711 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -118.23 173.56 6.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.802 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.16 -45.89 83.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.979 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 21.4 t70 -122.54 109.37 32.77 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 121.017 0.437 . . . . 0.0 110.663 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . 0.455 ' HA ' ' HB1' ' B' ' 375' ' ' ALA . 52.7 Cg_exo -56.01 -41.36 77.82 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.692 2.262 . . . . 0.0 113.132 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' B' ' 382' ' ' LYS . 32.1 mmtp -65.75 -41.99 91.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 15.9 pt-20 -62.47 -39.07 92.25 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.029 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.19 -42.64 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.784 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.17 -44.53 99.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.28 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.46 -39.26 77.85 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.826 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.95 -42.12 84.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.248 0.547 . . . . 0.0 110.018 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . 0.506 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 5.0 t80 -73.75 -41.72 62.11 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.005 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 31.3 p -80.33 -7.85 59.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.88 4.9 45.36 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.368 0.604 . . . . 0.0 110.721 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -124.47 112.65 17.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.857 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.56 -41.11 96.89 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -60.23 -48.91 79.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.631 0.253 . . . . 0.0 111.199 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.45 -40.85 98.23 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.371 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.569 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 93.5 mtp -60.94 -48.16 83.08 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.352 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.03 -38.82 72.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.264 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.98 -42.86 99.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.5 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . 0.506 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 53.7 tpp -65.31 -39.48 92.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.668 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' B' ' 395' ' ' MET . 70.2 mtm180 -64.1 -36.48 84.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.755 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.1 -44.05 97.49 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.19 -45.45 90.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.864 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.95 -40.79 98.72 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.932 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 46.9 tp -64.16 -38.08 89.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.647 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.39 -43.13 96.94 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.441 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -65.48 -38.01 88.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.424 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -59.27 -41.34 88.66 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 120.758 0.313 . . . . 0.0 110.327 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.443 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.8 -47.36 81.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.17 -45.66 95.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.948 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -65.65 -34.54 78.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.117 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.03 -40.18 94.45 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.923 0.392 . . . . 0.0 110.638 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 407' ' ' ALA . 94.3 t -64.92 -42.29 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.338 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.67 -37.8 82.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.172 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -67.8 -14.94 63.37 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.913 0.387 . . . . 0.0 111.537 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -100.74 -37.89 8.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 110.86 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.65 175.66 9.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.156 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.47 113.98 22.16 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.094 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.9 t -99.22 107.86 21.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.039 0.447 . . . . 0.0 109.878 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -110.43 134.66 52.12 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -94.06 114.1 26.2 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.153 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -116.26 131.84 56.83 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.905 0.383 . . . . 0.0 110.598 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -76.92 147.63 36.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.229 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.0 t -157.58 165.83 34.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.61 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 26.7 p -86.73 166.51 15.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.967 0.413 . . . . 0.0 110.98 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -64.05 -28.61 69.9 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.8 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -62.41 -39.29 92.8 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.921 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.27 -33.94 76.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.029 0.442 . . . . 0.0 110.628 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.85 -31.09 69.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.686 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.5 mmt -65.6 -10.44 35.59 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.809 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -74.93 69.58 1.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.5 0.667 . . . . 0.0 109.21 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -100.77 17.88 20.88 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.519 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -63.99 -40.64 96.83 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.143 178.486 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.996 0.427 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 p -115.63 145.84 42.34 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.799 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.9 -52.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 66.5 179.21 0.21 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.114 0.483 . . . . 0.0 110.862 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 m -136.72 128.58 29.17 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.235 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.6 m -76.59 -68.49 0.59 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.831 0.348 . . . . 0.0 110.743 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -177.42 128.62 0.15 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.085 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.45 -115.94 8.46 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.932 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.42 -7.83 57.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 106' ' ' SER . . . -68.64 126.69 21.99 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.541 -177.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -135.59 159.22 42.28 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 122.909 0.484 . . . . 0.0 110.055 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.438 ' HG3' ' CE2' ' A' ' 105' ' ' TYR . 58.7 ttp180 -131.65 149.36 52.52 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.0 -83.64 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.006 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 m 46.84 79.31 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.059 0.457 . . . . 0.0 111.184 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.4 tp -113.33 135.25 53.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.894 0.378 . . . . 0.0 111.261 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.5 m -101.9 124.24 47.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.111 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.8 pt -128.92 160.68 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.552 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -73.17 155.78 39.28 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.905 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.69 83.79 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -64.18 -39.21 93.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.205 0.526 . . . . 0.0 110.446 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -65.8 -40.33 91.8 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.69 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 20' ' ' ALA . 77.3 mt -61.24 -48.83 87.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.53 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.03 -50.87 66.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.647 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.0 m -68.68 -51.06 45.98 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.6 -49.19 22.59 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -173.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.7 t -64.21 -43.39 97.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.59 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -58.98 -48.98 79.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.936 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -62.85 -42.14 99.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.266 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -66.62 -42.03 87.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.997 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.63 -42.86 99.83 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.89 -39.6 80.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.212 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -64.91 -42.0 95.11 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.5 m -67.05 -33.72 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.139 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.92 -41.12 95.82 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.087 0.47 . . . . 0.0 109.91 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.13 -29.57 69.33 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.37 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -58.75 -42.84 89.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.83 0.347 . . . . 0.0 110.593 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 t -92.27 -1.57 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.18 0.514 . . . . 0.0 110.241 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 61.62 29.72 18.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.844 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -101.51 5.56 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.914 0.388 . . . . 0.0 111.598 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -63.92 -31.24 72.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.601 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.68 -22.1 65.76 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.824 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -80.76 -6.11 58.04 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.59 ' HA ' ' NE2' ' B' ' 320' ' ' GLN . 22.7 ttt180 -97.46 90.57 5.1 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -92.59 76.43 5.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 169.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.69 105.65 3.12 Favored Glycine 0 N--CA 1.428 -1.841 0 CA-C-N 114.992 -1.003 . . . . 0.0 114.629 -172.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 88.4 tttt -64.46 -34.99 79.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 171.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' A' ' 54' ' ' VAL . 16.2 t -99.52 100.08 9.94 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.439 175.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 48' ' ' LYS . 17.2 Cg_exo -66.66 159.34 51.53 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.044 2.496 . . . . 0.0 112.495 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.549 ' HA ' HG12 ' A' ' 54' ' ' VAL . 45.7 mtt -60.05 -40.97 91.29 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -65.92 -21.04 66.41 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.17 -50.16 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.9 0.381 . . . . 0.0 110.928 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.612 ' HB ' HG12 ' A' ' 49' ' ' VAL . 12.6 p -67.46 -36.86 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.33 83.38 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -89.83 -1.71 58.05 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.571 -0.451 . . . . 0.0 112.212 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -101.33 -42.99 6.1 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 120.715 0.293 . . . . 0.0 111.556 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -97.49 5.1 50.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.469 0.652 . . . . 0.0 110.114 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.87 145.83 49.74 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.56 ' H ' ' HB2' ' A' ' 63' ' ' ARG . . . 72.52 -41.09 0.49 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.219 0.608 . . . . 0.0 111.699 -177.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 t -60.68 -46.62 89.65 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.856 0.462 . . . . 0.0 111.303 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 65' ' ' ASP . 8.1 p -124.97 18.77 4.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.662 0.744 . . . . 0.0 110.045 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.56 ' HB2' ' H ' ' A' ' 60' ' ' ALA . 13.2 ttt180 -65.89 -20.24 66.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.393 -174.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.58 -48.53 77.03 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.46 ' HB2' HG22 ' A' ' 62' ' ' VAL . 6.5 m-20 -67.3 -31.0 71.01 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.068 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.35 -43.34 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 99.3 mt -62.3 -39.72 93.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.77 97.7 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.446 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -62.69 -45.67 91.68 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 120.773 0.32 . . . . 0.0 110.984 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.64 -41.97 98.23 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.3 ttp -61.22 -46.06 91.97 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.965 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.2 m -63.37 -51.54 65.44 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.338 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -69.41 -38.21 77.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -65.37 -39.24 92.05 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.932 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.45 -47.17 87.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.46 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.6 tt -66.16 -38.63 82.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.25 -41.98 99.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.93 -45.33 89.74 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.435 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.4 pt -65.74 -41.35 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.47 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.43 -42.11 95.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.472 0.653 . . . . 0.0 109.379 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -59.41 -47.85 83.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.273 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -89.82 -0.86 57.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.425 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 65.4 36.8 6.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.81 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 98.1 mt -86.64 124.62 40.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.603 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -110.15 98.18 33.89 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.576 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 84' ' ' ILE . 19.7 Cg_exo -66.94 141.75 59.68 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.531 2.154 . . . . 0.0 111.819 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.29 103.3 15.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.913 0.387 . . . . 0.0 110.538 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -127.72 8.88 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.897 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.66 128.44 25.62 Favored Pre-proline 0 C--N 1.318 -0.786 0 O-C-N 122.916 -0.167 . . . . 0.0 110.613 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.16 144.76 82.59 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.451 2.101 . . . . 0.0 111.542 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.7 m -102.46 109.04 20.56 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.586 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 94.9 m-85 -86.45 91.59 8.58 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.68 106.59 2.54 Favored Pre-proline 0 C--N 1.324 -0.532 0 O-C-N 123.546 0.529 . . . . 0.0 111.189 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 91.0 Cg_endo -97.94 166.87 0.77 Allowed 'Trans proline' 0 N--CA 1.43 -2.214 0 C-N-CA 123.026 2.484 . . . . 0.0 111.299 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.06 -136.11 6.7 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 174.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.93 130.44 51.26 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -80.8 106.37 12.75 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.246 0.546 . . . . 0.0 110.771 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 97.7 mttt -84.87 147.71 26.65 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.65 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.6 tp -82.93 116.42 22.21 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.081 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.0 21.98 53.94 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.363 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . 37.0 tt0 -140.01 161.6 37.22 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.289 0.544 . . . . 0.0 109.793 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.97 142.79 54.58 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.853 0.359 . . . . 0.0 111.296 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -102.34 145.01 30.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.152 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.2 m -121.84 136.54 54.93 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.561 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 43.0 p90 -136.87 162.16 34.01 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.968 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.486 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 14.9 m -93.69 -69.9 0.73 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.2 p 49.28 101.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.179 0.99 . . . . 0.0 111.888 -173.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.32 113.98 23.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -172.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -156.27 145.8 20.84 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.858 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 65.97 143.64 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.4 m -129.4 157.44 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.842 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -165.11 100.79 0.8 Allowed Pre-proline 0 N--CA 1.466 0.372 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -88.23 158.91 6.95 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.973 2.449 . . . . 0.0 113.991 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -130.95 134.17 46.49 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -125.34 132.86 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -103.8 -78.92 0.55 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.549 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.6 mt 66.55 125.9 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.707 0.803 . . . . 0.0 112.964 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.22 155.47 47.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.4 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.11 9.56 86.5 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.04 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.22 -39.8 94.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.201 0.524 . . . . 0.0 110.885 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.4 mp0 -72.2 -10.51 59.88 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.116 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.61 13.42 33.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.746 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 94.8 mt -81.76 125.49 39.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.24 0.543 . . . . 0.0 110.936 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.24 122.58 47.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.35 134.01 67.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.621 ' OE1' ' HE3' ' A' ' 420' ' ' LYS . 41.1 tt0 -82.13 146.93 29.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.499 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -135.2 91.86 18.71 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.47 113.97 3.5 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.237 1.958 . . . . 0.0 112.1 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.9 mm -97.19 112.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.74 155.91 18.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.129 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -129.93 145.31 51.62 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.304 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.12 123.46 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.882 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 64.0 p -107.81 175.59 5.43 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.583 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -67.38 -23.61 65.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.7 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.57 97.0 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.106 0.479 . . . . 0.0 109.95 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.41 -40.73 97.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.454 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.07 -45.24 99.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.703 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.24 -43.13 96.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.52 0.2 . . . . 0.0 111.068 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.33 -42.83 99.08 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.602 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.58 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.8 tpt -63.38 -46.43 86.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.641 0.258 . . . . 0.0 110.803 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.58 -41.84 98.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.483 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.38 -47.68 84.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.218 0.532 . . . . 0.0 110.399 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.8 m -63.24 -41.06 99.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.909 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 140' ' ' MET . 92.6 mt -60.48 -42.44 96.26 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -73.06 -14.59 61.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.172 0.51 . . . . 0.0 111.11 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.18 -10.23 33.8 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.802 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -99.83 -27.9 13.4 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.626 ' OE1' ' HG2' ' A' ' 255' ' ' ARG . 11.3 mm-40 -137.38 168.14 20.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -168.77 -90.18 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.429 -1.714 . . . . 0.0 108.45 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.574 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 23.7 m -162.61 159.16 24.24 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.438 ' HA ' ' CB ' ' A' ' 243' ' ' ARG . 20.5 p-90 -109.02 147.62 32.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.632 ' H ' ' HA ' ' A' ' 243' ' ' ARG . 84.0 tttt -170.41 -75.88 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.48 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -172.27 163.98 5.82 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 43.2 tttp 58.59 62.45 1.94 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.968 1.307 . . . . 0.0 114.516 174.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 244' ' ' GLU . 28.8 t70 -173.22 141.31 0.92 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.593 0.357 . . . . 0.0 110.901 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.32 53.59 0.6 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.838 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.11 -28.58 15.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.225 0.513 . . . . 0.0 110.065 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.418 ' N ' ' HD2' ' A' ' 243' ' ' ARG . 23.7 t 66.62 135.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.106 0.962 . . . . 0.0 113.227 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.497 ' HG2' ' HG2' ' A' ' 243' ' ' ARG . 6.7 mm-40 -86.8 170.22 11.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.444 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.431 ' HB3' ' OE1' ' A' ' 161' ' ' GLU . . . -71.0 -64.61 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.173 0.511 . . . . 0.0 109.901 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.431 ' OE1' ' HB3' ' A' ' 160' ' ' ALA . 1.3 pm0 -86.94 37.54 0.76 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.291 0.567 . . . . 0.0 110.551 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.61 -42.83 99.81 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.926 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 64.24 72.32 0.46 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.153 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 17.4 t -84.06 127.38 39.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.825 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.3 m -78.2 103.98 8.49 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 62.6 mt -120.62 122.51 68.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.709 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.84 89.77 5.79 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 171.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -114.77 156.73 24.32 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.307 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 29.9 m -129.79 132.2 46.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.617 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.55 131.64 10.64 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.298 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.7 m -135.85 135.74 40.03 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.822 0.344 . . . . 0.0 110.769 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 90.6 t -111.86 103.16 15.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.566 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.405 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 78.0 m-20 53.16 34.88 18.43 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.957 177.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.2 -11.01 47.85 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.979 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.88 138.72 50.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.901 0.85 . . . . 0.0 110.949 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -86.31 148.08 25.77 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.456 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -110.75 179.65 4.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.426 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -55.8 -52.55 63.6 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -90.44 -159.78 35.9 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.888 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . 75.29 27.7 63.35 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.827 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -116.48 102.9 9.9 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.17 141.23 51.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.812 0.339 . . . . 0.0 111.065 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.2 m -138.61 128.08 24.61 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 59.93 29.83 19.38 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.005 0.431 . . . . 0.0 110.874 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -94.94 133.66 38.46 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.429 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.3 m -97.55 122.73 49.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.421 0.629 . . . . 0.0 111.283 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 54.6 tp -109.84 125.5 52.83 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.755 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -104.66 141.46 36.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 69.8 mtm -116.62 160.42 20.72 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.228 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.88 8.04 65.55 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.741 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.472 ' HB2' ' HG2' ' A' ' 193' ' ' ARG . 98.1 mt-30 -119.7 0.36 10.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.7 29.09 55.89 Favored Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.067 -1.063 . . . . 0.0 111.128 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.472 ' HG2' ' HB2' ' A' ' 191' ' ' GLN . 32.0 mmm-85 -70.06 -30.35 67.59 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 123.248 0.619 . . . . 0.0 110.341 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.433 ' HE3' ' HA ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -120.02 169.6 10.05 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.773 -178.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.6 mm -50.76 132.66 28.23 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.987 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.68 124.39 8.23 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.669 2.246 . . . . 0.0 112.325 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.46 -37.76 3.58 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.771 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -62.21 -47.65 83.5 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -77.77 -10.14 59.39 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.805 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 31.1 t70 -88.34 -34.3 17.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.165 0.507 . . . . 0.0 109.874 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.62 -28.83 73.96 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.461 -0.791 . . . . 0.0 113.581 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.88 -26.33 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.853 0.358 . . . . 0.0 110.956 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 200' ' ' ASP . 3.4 mtpm? -57.46 125.21 21.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.126 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.95 3.45 63.91 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.711 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -97.71 134.97 40.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.423 0.63 . . . . 0.0 111.883 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -90.77 160.24 15.9 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.258 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.88 138.26 57.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 110.706 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 73.53 24.04 75.7 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.898 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -118.74 101.95 8.47 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.398 0.618 . . . . 0.0 110.745 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.4 110.23 21.52 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.611 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -127.01 -10.78 5.97 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 75.3 p 57.24 164.78 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.792 0.837 . . . . 0.0 112.617 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 215' ' ' VAL . 10.9 tp -143.55 160.77 16.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -94.89 107.27 19.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.723 0.297 . . . . 0.0 110.645 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 71.3 t -121.49 122.41 67.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 6.5 m -95.55 -28.98 14.6 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -175.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 216' ' ' THR . 54.4 m-85 68.62 147.39 0.11 Allowed Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 121.009 0.433 . . . . 0.0 111.121 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.44 151.77 65.39 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.236 1.957 . . . . 0.0 111.926 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -65.12 -35.53 81.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.198 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.86 25.49 2.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.996 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -64.88 134.95 55.11 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -59.92 -15.64 23.31 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.78 105.68 17.85 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -56.61 -35.39 68.23 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.412 0.685 . . . . 0.0 111.158 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.445 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 16.0 p30 -76.91 -15.86 59.55 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.445 ' HG ' ' OD1' ' A' ' 225' ' ' ASN . 91.6 mt -115.37 5.68 14.65 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -69.53 114.53 7.84 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.434 0.635 . . . . 0.0 112.255 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.25 22.06 72.51 Favored Glycine 0 C--O 1.238 0.366 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.584 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 225' ' ' ASN . 99.1 mttt -107.7 138.77 43.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.981 0.391 . . . . 0.0 110.679 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -81.31 128.62 34.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.424 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -112.67 134.05 54.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.929 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.405 ' HE2' ' OD1' ' A' ' 173' ' ' ASP . 68.8 mttm -81.01 -44.57 17.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 212' ' ' THR . 76.0 m-85 56.58 95.73 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 121.057 0.456 . . . . 0.0 111.858 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.58 72.83 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.3 mm 61.87 92.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.109 0.564 . . . . 0.0 111.882 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -74.61 -43.48 55.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.117 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 13.2 tp 47.99 77.31 0.1 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.563 0.745 . . . . 0.0 111.567 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -71.18 -48.82 49.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -112.93 -81.17 0.59 Allowed 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.564 HG12 ' H ' ' A' ' 242' ' ' GLU . 41.2 t 81.23 150.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.713 0.805 . . . . 0.0 109.015 -173.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.79 -33.55 72.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.801 0.334 . . . . 0.0 110.466 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.564 ' H ' HG12 ' A' ' 240' ' ' VAL . 63.6 mt-10 74.62 152.75 0.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.089 0.955 . . . . 0.0 112.669 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.632 ' HA ' ' H ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -153.03 114.17 4.17 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 155' ' ' ASP . 39.1 tt0 -159.58 171.15 20.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 150' ' ' THR . 6.4 mp 70.81 108.17 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 123.59 0.756 . . . . 0.0 111.305 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.574 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 61.4 Cg_endo -81.16 101.02 1.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.026 1.817 . . . . 0.0 112.269 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.91 162.35 33.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.367 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.9 mp -84.28 88.55 7.24 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.822 0.344 . . . . 0.0 111.214 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 7.4 m -85.26 -75.89 0.34 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.724 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -177.95 -56.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.989 0.423 . . . . 0.0 110.558 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -73.71 14.64 0.35 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -78.06 -15.26 59.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.058 0.456 . . . . 0.0 110.302 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 43.0 pt -88.35 -14.23 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.098 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -138.34 94.11 2.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.628 0.728 . . . . 0.0 111.654 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.626 ' HG2' ' OE1' ' A' ' 148' ' ' GLN . 7.0 tpp180 -140.01 30.12 2.03 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.31 1.052 . . . . 0.0 108.923 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.15 15.16 9.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.201 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 77.02 15.97 81.19 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.119 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 55.9 t -99.87 141.29 17.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -54.86 -51.17 66.78 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 123.02 0.2 . . . . 0.0 111.069 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -175.61 162.44 2.77 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.265 0.353 . . . . 0.0 110.515 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -174.65 168.22 40.8 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.762 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 86.8 p -88.14 173.81 8.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.45 -48.7 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.56 -33.5 21.7 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.935 0.398 . . . . 0.0 110.322 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.4 -41.23 99.44 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.381 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.17 -44.45 96.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.588 0.233 . . . . 0.0 110.906 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -63.95 -42.64 97.26 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.211 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.4 -42.93 87.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.438 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -67.27 -40.14 86.15 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.906 0.384 . . . . 0.0 110.811 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 78.8 t -64.85 -42.75 95.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.785 0.326 . . . . 0.0 110.15 176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -55.76 -51.94 65.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.674 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.7 ptmt -65.63 -42.7 91.21 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.12 -39.45 94.05 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 96.5 mmm -63.9 -41.66 97.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 110.73 178.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -69.59 -31.65 69.93 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.972 0.415 . . . . 0.0 110.656 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -62.36 -42.2 99.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.98 -37.42 87.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.482 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 42.6 tp -62.39 -38.97 91.69 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.295 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -55.88 -46.92 78.16 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.209 0.528 . . . . 0.0 109.691 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.0 m -63.67 -43.92 95.27 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.65 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.56 92.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.184 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.47 -44.47 98.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.91 0.386 . . . . 0.0 110.465 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -64.64 -42.35 95.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.049 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -62.96 -41.32 99.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.155 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . 0.511 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.2 tpm_? -60.18 -44.53 95.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.938 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.14 -43.85 78.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.903 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.95 -47.41 84.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.418 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.1 p -62.2 -44.38 96.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -65.96 -41.51 91.15 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.134 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.61 87.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.651 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 295' ' ' VAL . 32.5 mm -64.32 -44.02 97.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.307 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.4 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 19.5 tp10 -61.08 -46.35 91.02 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.615 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.91 -40.23 95.33 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.363 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 350' ' ' LEU . 0.7 OUTLIER -63.86 -42.61 97.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.443 0.297 . . . . 0.0 111.121 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 291' ' ' ILE . 75.1 t -64.13 -42.98 97.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 120.962 0.411 . . . . 0.0 110.687 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . 0.4 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.4 mttm -62.71 -38.77 91.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.686 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.83 -47.7 77.03 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.069 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -130.03 99.35 5.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.656 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -94.82 107.74 19.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.3 tp -110.73 143.12 21.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.725 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -73.44 121.97 21.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.236 0.541 . . . . 0.0 109.807 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 43.9 t -86.74 134.18 38.04 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.066 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.09 138.12 84.33 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.527 2.152 . . . . 0.0 112.118 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.32 -29.99 70.84 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.904 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.01 68.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.619 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.4 mt -91.34 -34.19 14.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.27 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 71.4 mt -63.21 -51.88 65.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.723 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.36 -37.8 88.78 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 68.0 p -65.22 -46.65 79.78 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.72 0.295 . . . . 0.0 111.518 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.548 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 17.9 mm-40 -72.04 -33.21 67.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.431 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 70.7 mt -61.58 -43.74 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.516 0.198 . . . . 0.0 111.194 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.597 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 33.2 t70 -62.95 -40.93 99.15 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.687 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.54 -42.77 96.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.257 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 90.2 mt -61.64 -41.28 97.28 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.136 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 66.0 mtm180 -62.55 -39.72 94.51 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.916 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 90.8 mtt180 -63.27 -43.28 98.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.397 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -65.05 -44.67 88.26 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.03 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.53 -39.7 88.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.401 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.62 -36.27 83.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.779 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . 0.696 ' NE2' ' HA ' ' B' ' 45' ' ' ARG . 48.1 tt0 -62.83 -43.27 99.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.549 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.49 -23.6 61.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.183 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -77.29 -4.02 42.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.77 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 140.5 -22.58 2.7 Favored Glycine 0 CA--C 1.502 -0.733 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.687 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 116.25 29.45 2.33 Favored Glycine 0 CA--C 1.497 -1.066 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.547 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 41.6 t-20 -70.72 124.0 23.24 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . 0.721 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.7 tm-20 -127.24 145.5 50.75 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 1.7 ptpp? 69.4 -37.97 0.39 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 125.574 1.55 . . . . 0.0 113.158 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.547 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 14.7 mm100 -73.63 -9.06 58.29 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.299 0.571 . . . . 0.0 110.369 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -64.02 -18.9 64.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.332 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.49 -37.63 86.73 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.22 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.88 -16.44 63.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.904 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.7 145.58 98.7 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.14 134.74 57.87 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 123.018 2.479 . . . . 0.0 112.951 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.41 HH21 ' HD2' ' A' ' 334' ' ' ARG . 21.4 ttt180 -70.7 -39.49 73.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.133 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -58.83 -33.79 70.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.06 -6.5 57.74 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.963 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -117.13 -30.78 5.55 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.608 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.55 -34.95 79.44 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -63.06 -51.06 68.16 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.995 0.426 . . . . 0.0 110.822 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.72 -28.0 65.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.48 -41.75 97.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.416 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.2 tttt -59.87 -47.14 86.96 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.55 ' O ' HG23 ' A' ' 347' ' ' VAL . 18.6 mmt85 -63.25 -45.59 90.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -66.42 -38.65 87.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.0 t -64.76 -43.34 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.645 0.259 . . . . 0.0 110.706 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 342' ' ' LYS . 77.3 t -60.31 -42.9 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.519 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 343' ' ' ARG . 87.4 t -59.53 -45.68 93.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.69 98.97 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.412 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.92 -44.44 96.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.82 0.343 . . . . 0.0 111.19 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 294' ' ' LEU . 96.5 mt -63.92 -45.14 90.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.094 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.77 -40.99 92.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.9 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.5 98.59 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.86 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -66.3 -38.8 88.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.802 0.301 . . . . 0.0 110.723 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.96 -44.43 98.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.37 -43.83 98.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.805 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -66.54 -52.46 45.44 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.686 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.7 m -66.58 -46.17 76.86 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -87.35 -5.02 59.05 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.628 0.252 . . . . 0.0 111.377 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 59.11 70.22 0.66 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.276 0.56 . . . . 0.0 110.81 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.8 mt -101.46 124.36 47.02 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.783 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 144.15 44.06 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.082 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.04 114.96 4.48 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 367' ' ' VAL . 17.7 t70 -84.19 110.6 18.65 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.278 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 65.8 mm-40 -58.8 -39.1 80.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.068 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -64.65 -43.65 92.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 110.789 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -61.59 -41.25 97.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.021 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 363' ' ' ASP . 93.2 t -64.11 -35.62 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.704 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 31.0 mmmt -57.81 -45.01 86.7 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.657 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.88 -38.07 95.57 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.979 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.0 -42.68 99.91 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.068 0.461 . . . . 0.0 110.16 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.7 -43.3 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.939 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.48 -39.96 89.55 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.729 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.79 -40.72 92.23 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.702 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.8 ttm -66.59 -40.11 88.75 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 110.446 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.86 -27.14 69.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.657 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 49.3 m -74.98 4.23 6.96 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.686 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -97.62 3.94 50.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.796 0.331 . . . . 0.0 110.979 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -120.85 177.42 5.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.014 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.15 -46.14 90.29 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.642 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -128.92 120.11 20.24 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.274 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.56 -29.65 30.0 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.486 2.124 . . . . 0.0 112.896 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -65.83 -43.17 89.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -64.0 -37.39 87.25 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.349 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.35 -42.09 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.488 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.8 -44.24 98.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.093 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.86 -32.54 72.28 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -58.56 -46.72 86.29 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.128 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -68.49 -46.64 69.14 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.5 p -68.77 -17.01 63.96 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 7.91 45.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.074 0.464 . . . . 0.0 110.896 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -132.84 108.61 9.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.336 178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -62.98 -38.17 90.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -58.92 -50.76 72.82 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.827 0.346 . . . . 0.0 110.7 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.71 -39.56 94.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.399 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 90.9 mtp -61.69 -44.02 97.74 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.781 0.324 . . . . 0.0 111.278 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.57 -45.52 65.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.31 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -63.88 -42.58 97.45 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.008 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 43.6 tpp -64.9 -43.23 93.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.897 0.379 . . . . 0.0 111.132 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -66.02 -33.23 75.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.267 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.77 -44.96 93.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.26 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.52 -43.63 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.118 0.485 . . . . 0.0 110.57 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.63 -40.72 95.86 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.169 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.32 -38.46 91.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.625 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -59.84 -43.97 94.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.72 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -65.42 -35.15 80.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.763 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -60.99 -43.97 98.09 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.59 -45.9 84.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.165 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.1 -45.85 97.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.188 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -68.57 -27.99 66.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.018 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.54 -37.96 88.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.137 0.494 . . . . 0.0 109.84 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 89.6 t -66.19 -41.44 89.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.137 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.09 -26.44 66.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.019 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -77.39 -9.14 58.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.363 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -113.45 -31.73 6.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.82 169.23 18.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.674 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -84.59 108.61 17.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.788 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 64.4 t -84.58 128.72 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.122 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -130.38 146.8 52.01 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -121.91 123.18 41.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.705 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . 0.621 ' HE3' ' OE1' ' A' ' 126' ' ' GLU . 20.7 pttp -132.68 145.83 51.38 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.68 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -82.85 153.02 25.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -155.64 172.32 18.48 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 27.1 p -84.96 165.04 17.94 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.907 0.384 . . . . 0.0 111.161 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.78 -26.04 68.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.343 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -62.33 -40.42 96.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.608 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -65.77 -33.05 74.97 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.837 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.0 mp -74.66 -18.54 60.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.346 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.3 mmt -83.03 3.78 28.86 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -82.88 74.51 9.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.368 0.604 . . . . 0.0 109.607 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -101.28 17.75 21.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.238 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -69.93 -25.58 63.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.238 0.542 . . . . 0.0 109.685 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.729 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.69 179.392 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 120.685 0.279 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -108.68 114.85 28.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.087 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 22.4 m -123.68 135.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.092 0.472 . . . . 0.0 111.723 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 29.6 p -113.87 148.61 36.4 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.506 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.444 HG13 ' H ' ' B' ' 6' ' ' GLU . 6.4 p -151.41 -61.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.444 ' H ' HG13 ' B' ' 5' ' ' VAL . 54.2 mt-10 69.09 169.0 0.29 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.241 0.543 . . . . 0.0 111.494 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.3 m -128.78 127.76 42.62 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.171 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 23.0 m -74.51 -69.95 0.43 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.504 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -178.37 129.99 0.13 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.756 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.1 -119.03 11.0 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.697 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.66 -9.25 56.42 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' B' ' 106' ' ' SER . . . -67.49 126.62 25.19 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.283 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' B' ' 12' ' ' GLY . 0.0 OUTLIER -135.14 158.88 43.23 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 122.937 0.495 . . . . 0.0 109.898 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -129.04 151.38 49.8 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 54.1 t -102.52 -82.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.016 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m 46.51 82.38 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.184 0.516 . . . . 0.0 111.457 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 tp -116.77 135.14 58.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.985 0.421 . . . . 0.0 111.096 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.5 m -104.52 126.03 51.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.932 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 16.8 pt -129.27 160.18 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.702 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.575 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -73.2 156.02 38.99 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.573 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -56.07 -46.01 79.12 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -64.82 -38.66 91.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.387 . . . . 0.0 110.354 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 35.5 m -63.75 -39.73 94.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.718 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.575 HG13 ' O ' ' B' ' 20' ' ' ALA . 81.0 mt -61.23 -49.67 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.807 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.73 -48.24 69.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.729 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 20.0 m -65.83 -50.95 62.76 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.96 -49.34 18.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.21 -43.13 97.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -59.03 -48.67 80.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.719 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 33.3 m -63.07 -42.82 99.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.891 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -68.37 -40.08 81.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.761 0.315 . . . . 0.0 110.899 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.32 -43.1 99.62 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.68 -39.82 80.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.057 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -64.85 -42.01 95.23 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.59 -32.51 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.132 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.18 92.58 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.069 0.461 . . . . 0.0 110.033 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.88 -30.5 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.286 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -57.98 -41.52 83.12 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.038 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.8 -0.05 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.188 0.518 . . . . 0.0 110.407 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 61.09 29.1 18.71 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.405 ' H ' HG13 ' B' ' 41' ' ' ILE . 2.8 pp -101.57 4.94 10.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.143 0.497 . . . . 0.0 111.425 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.06 -33.02 74.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.598 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.14 -22.62 63.07 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.941 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -80.33 -6.56 58.17 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.63 0.252 . . . . 0.0 111.525 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.696 ' HA ' ' NE2' ' A' ' 320' ' ' GLN . 47.2 ttt85 -94.73 88.35 5.34 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 119.408 -0.917 . . . . 0.0 113.13 -177.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -89.86 86.53 6.66 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 169.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.15 102.59 2.91 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-N 115.134 -0.939 . . . . 0.0 114.84 -170.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.451 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 88.2 tttt -65.44 -34.95 79.5 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.566 HG12 ' HB ' ' B' ' 54' ' ' VAL . 19.3 t -101.87 100.2 14.08 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.278 175.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' B' ' 48' ' ' LYS . 18.6 Cg_exo -65.96 158.43 54.16 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.045 2.497 . . . . 0.0 112.607 -177.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.532 ' HA ' HG12 ' B' ' 54' ' ' VAL . 44.3 mtt -58.69 -41.69 86.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -65.99 -20.08 66.08 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.812 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -91.68 -50.33 12.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.079 0.466 . . . . 0.0 110.931 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.566 ' HB ' HG12 ' B' ' 49' ' ' VAL . 13.0 p -67.51 -36.76 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.38 87.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -90.61 -1.64 57.88 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.281 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -100.53 -42.15 6.69 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.638 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -98.17 5.37 48.58 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.545 0.688 . . . . 0.0 109.946 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.97 146.87 49.76 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.527 ' H ' ' HB2' ' B' ' 63' ' ' ARG . . . 72.76 -41.56 0.51 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.154 0.582 . . . . 0.0 111.443 -176.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 47.0 t -60.52 -48.74 80.43 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.813 0.445 . . . . 0.0 111.428 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 p -122.03 18.64 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.771 0.796 . . . . 0.0 109.859 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.527 ' HB2' ' H ' ' B' ' 60' ' ' ALA . 12.6 ttt180 -65.58 -20.23 66.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.59 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.68 -49.53 70.6 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.78 -32.41 73.93 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.93 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.58 -43.42 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.99 -40.01 94.16 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.79 -39.32 97.31 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.728 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.96 -44.99 94.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.681 0.277 . . . . 0.0 111.072 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.65 -41.93 98.2 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.7 ttp -60.65 -45.99 92.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.86 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 55.3 m -64.2 -51.75 62.2 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.375 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -69.32 -38.06 78.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -65.06 -39.53 93.4 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.597 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -60.26 -47.21 86.96 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.54 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 17.7 tt -66.02 -38.57 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.143 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.37 -41.67 98.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.76 93.0 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.597 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -66.73 -41.25 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.46 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.69 -42.64 96.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.573 0.701 . . . . 0.0 109.419 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -60.16 -47.78 84.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.576 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -89.24 -2.03 58.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.616 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 63.24 46.64 4.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.928 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.452 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 91.4 mt -98.45 122.21 49.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.118 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -107.46 100.1 32.07 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.709 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 22.8 Cg_exo -65.17 142.74 75.1 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.434 2.089 . . . . 0.0 111.443 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.37 110.89 23.35 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.882 0.373 . . . . 0.0 110.39 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.6 -113.99 4.0 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.121 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.43 125.67 14.52 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.55 144.34 78.68 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.428 2.086 . . . . 0.0 111.586 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 46.8 m -103.47 111.91 24.57 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.056 0.455 . . . . 0.0 109.824 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.503 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.1 m-85 -87.58 89.91 8.17 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.98 108.97 3.91 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.539 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.9 Cg_endo -100.98 169.3 0.35 Allowed 'Trans proline' 0 N--CA 1.433 -2.081 0 C-N-CA 123.178 2.585 . . . . 0.0 111.256 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.82 -120.73 3.17 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -141.94 133.04 26.15 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -80.08 107.58 12.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.366 0.603 . . . . 0.0 111.066 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' B' ' 101' ' ' GLU . 98.8 mttt -81.79 145.68 30.32 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 38.7 tp -82.78 108.31 16.04 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.868 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.49 14.64 49.87 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.778 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' B' ' 98' ' ' LYS . 39.7 tt0 -134.06 161.29 35.24 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.409 0.605 . . . . 0.0 109.923 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -66.73 143.03 57.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.011 0.434 . . . . 0.0 111.53 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -103.44 144.45 31.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.15 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.1 m -121.51 135.91 54.99 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.748 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -135.55 161.95 34.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.059 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.444 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 12.6 m -92.72 -70.44 0.7 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -175.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p 47.88 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.132 0.968 . . . . 0.0 111.811 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.55 116.61 24.79 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -172.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -157.98 147.52 19.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.562 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 65.02 143.16 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.08 157.0 42.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.75 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -165.64 97.08 0.8 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.054 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -84.56 158.58 12.46 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.972 2.448 . . . . 0.0 113.348 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -132.82 135.22 45.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 70.3 t -123.47 136.13 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -103.61 -79.74 0.53 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.537 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt 65.53 128.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.888 0.875 . . . . 0.0 113.113 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -143.39 156.51 44.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.047 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.73 8.46 87.69 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.05 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.83 -39.82 95.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.598 . . . . 0.0 110.229 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' B' ' 121' ' ' GLU . 1.3 mp0 -66.55 -21.23 66.15 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.497 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.27 13.76 34.09 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 96.8 mt -77.65 125.41 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.223 0.535 . . . . 0.0 110.683 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -113.52 123.25 49.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.146 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.7 144.65 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.653 0.263 . . . . 0.0 111.263 -174.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . 0.568 ' OE1' ' HE3' ' B' ' 420' ' ' LYS . 38.4 tt0 -93.75 142.8 26.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.594 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -128.93 93.23 37.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.63 112.64 3.28 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.218 1.945 . . . . 0.0 111.903 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 48.6 mm -95.43 111.47 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.63 158.39 16.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.116 -178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -132.79 146.52 51.91 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.035 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 85.5 t -85.22 123.1 39.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 72.8 p -107.28 177.73 4.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.981 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -66.04 -28.42 68.84 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.8 -40.07 93.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.025 0.441 . . . . 0.0 110.361 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.01 -41.53 99.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.606 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.48 -44.94 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.016 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.38 -44.22 92.8 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.84 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.83 -42.0 98.63 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.763 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.567 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.8 tpt -63.02 -45.45 92.27 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.603 0.239 . . . . 0.0 110.967 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.17 -42.54 99.43 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.499 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -61.83 -45.57 93.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' B' ' 147' ' ' GLN . 20.6 m -63.45 -41.21 98.64 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.833 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' B' ' 140' ' ' MET . 91.8 mt -60.43 -42.22 95.61 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -72.08 -17.34 62.01 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.066 0.46 . . . . 0.0 111.335 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.92 -9.28 40.64 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.801 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' B' ' 143' ' ' THR . 63.4 mt-30 -100.48 -27.55 13.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . 0.605 ' OE1' ' HG2' ' B' ' 255' ' ' ARG . 9.8 mm-40 -137.79 167.87 20.85 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -167.56 -90.97 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.664 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 26.8 m -163.15 155.28 18.09 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . 0.487 ' HA ' ' CB ' ' B' ' 243' ' ' ARG . 26.3 p-90 -106.28 147.66 28.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . 0.62 ' H ' ' HA ' ' B' ' 243' ' ' ARG . 83.9 tttt -170.62 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.602 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -172.21 164.29 5.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 46.4 tttp 58.0 66.39 1.12 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.838 1.255 . . . . 0.0 114.281 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . 0.522 ' HB2' ' HB2' ' B' ' 244' ' ' GLU . 27.8 t70 -177.96 146.48 0.42 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.182 0.593 . . . . 0.0 110.65 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.53 47.05 1.06 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.51 -0.853 . . . . 0.0 114.095 -176.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.03 -29.96 21.55 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.186 174.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.455 ' N ' ' HD2' ' B' ' 243' ' ' ARG . 22.5 t 67.31 135.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.267 1.027 . . . . 0.0 113.172 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . 0.495 ' HG2' ' HG2' ' B' ' 243' ' ' ARG . 6.8 mm-40 -87.67 169.36 12.19 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.833 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . 0.407 ' HB3' ' OE1' ' B' ' 161' ' ' GLU . . . -70.53 -66.17 0.64 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . 0.407 ' OE1' ' HB3' ' B' ' 160' ' ' ALA . 1.7 pm0 -86.06 40.18 0.85 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.447 0.641 . . . . 0.0 110.282 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.95 -43.46 95.75 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.305 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 63.65 74.75 0.41 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.952 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 17.3 t -87.55 125.82 41.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.745 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.2 m -74.91 103.6 5.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 71.0 mt -119.52 123.27 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.044 0.45 . . . . 0.0 111.598 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . 0.506 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 23.9 m-20 -96.41 88.28 4.69 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 172.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -112.49 156.12 23.13 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.633 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 36.7 m -130.54 131.71 45.2 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.849 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.2 128.94 8.72 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.181 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 18.5 m -136.19 131.38 34.54 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.828 0.347 . . . . 0.0 110.786 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.48 105.32 18.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.823 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . 0.517 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 69.5 m-20 52.64 30.36 8.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.09 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 108.5 -12.26 36.08 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.858 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -110.7 142.48 42.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.784 0.792 . . . . 0.0 110.422 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -88.94 148.45 23.8 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.33 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -113.25 177.2 4.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.194 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -55.88 -49.37 73.56 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -89.18 -165.16 40.92 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.798 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' B' ' 169' ' ' THR . . . 77.2 24.65 65.62 Favored Glycine 0 C--O 1.22 -0.734 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.245 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -115.52 102.45 9.8 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.7 144.16 48.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.847 0.356 . . . . 0.0 110.933 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.506 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 47.2 m -139.6 132.54 29.36 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.646 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 59.97 30.55 20.04 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.684 0.615 . . . . 0.0 111.415 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -95.69 133.88 39.26 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.801 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.7 122.59 50.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.352 0.596 . . . . 0.0 111.325 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 61.4 tp -109.43 127.72 54.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.758 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -106.39 140.75 38.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 71.6 mtm -116.24 162.53 17.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.883 0.373 . . . . 0.0 111.445 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 88.21 13.8 63.31 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . 0.459 ' HB2' ' HG2' ' B' ' 193' ' ' ARG . 97.9 mt-30 -125.33 -3.16 7.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.519 0.199 . . . . 0.0 111.376 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.16 33.21 33.16 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.89 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' B' ' 191' ' ' GLN . 37.8 mmm-85 -76.33 -24.41 54.27 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.486 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.9 169.65 11.38 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.288 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 47.0 mm -51.67 133.41 36.39 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.04 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -47.18 126.33 11.47 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.526 2.151 . . . . 0.0 112.118 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.66 -38.03 3.4 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.718 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -62.5 -48.58 78.94 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.112 0.456 . . . . 0.0 112.203 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -78.08 -9.95 59.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.826 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . 0.413 ' O ' ' HD3' ' B' ' 203' ' ' LYS . 31.0 t70 -90.45 -26.35 19.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.17 0.509 . . . . 0.0 110.204 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.23 -22.78 67.26 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.285 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.92 -26.86 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.602 -0.352 . . . . 0.0 111.093 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' B' ' 200' ' ' ASP . 24.3 mtpt -55.1 126.68 25.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.038 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.48 -9.06 71.83 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.757 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -85.86 134.47 33.9 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 117.466 0.633 . . . . 0.0 111.584 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' B' ' 209' ' ' GLU . 29.6 mmtp -91.6 161.38 14.95 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.354 -176.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.55 139.29 58.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.723 0.297 . . . . 0.0 110.325 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 75.89 17.65 79.95 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.798 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' B' ' 206' ' ' LYS . 42.3 tt0 -113.45 97.4 6.44 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.547 0.689 . . . . 0.0 111.141 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -88.91 108.06 19.34 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.947 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -129.13 -11.09 4.72 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -173.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 58.2 p 58.89 166.87 0.05 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.73 0.812 . . . . 0.0 112.655 -176.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.6 tp -146.0 153.81 13.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.465 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -88.1 105.88 17.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.771 0.319 . . . . 0.0 111.259 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 76.2 t -118.22 129.31 74.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 10.3 m -100.45 -34.95 9.73 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -175.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.6 m-85 70.64 144.08 0.1 Allowed Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 122.71 0.404 . . . . 0.0 110.917 -175.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 15.1 Cg_exo -69.02 152.18 73.17 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.259 1.973 . . . . 0.0 111.795 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -67.15 -33.46 75.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.411 0.624 . . . . 0.0 109.709 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -88.44 21.93 2.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.655 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -65.75 134.73 53.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.019 0.438 . . . . 0.0 110.57 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -61.53 -10.21 7.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.11 105.31 15.59 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' B' ' 227' ' ' LYS . 4.7 tp10 -56.04 -36.48 68.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.41 0.684 . . . . 0.0 111.685 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.436 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 18.7 p30 -80.38 -11.81 59.65 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.413 ' HG ' ' OD1' ' B' ' 225' ' ' ASN . 93.3 mt -115.47 1.69 13.7 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' B' ' 224' ' ' GLU . 20.4 ptmt -66.69 116.38 7.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.232 0.539 . . . . 0.0 111.722 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.26 26.51 70.58 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.928 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.436 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 98.9 mttt -111.74 134.9 53.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.083 0.441 . . . . 0.0 110.585 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -77.29 131.82 38.34 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.897 0.38 . . . . 0.0 111.245 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.02 135.17 54.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.484 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . 0.517 ' HE2' ' OD1' ' B' ' 173' ' ' ASP . 68.9 mttm -80.8 -44.8 17.95 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' B' ' 212' ' ' THR . 76.4 m-85 56.35 95.09 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.015 0.436 . . . . 0.0 111.894 -177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.422 ' HA ' HG22 ' B' ' 212' ' ' THR . . . -61.36 -50.17 74.0 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.8 mm 61.52 91.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 123.472 0.482 . . . . 0.0 111.953 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -72.69 -42.48 64.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.338 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 12.4 tp 48.21 84.83 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.821 0.848 . . . . 0.0 111.295 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.76 -59.74 2.66 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -174.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -102.55 -79.23 0.53 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.548 HG12 ' H ' ' B' ' 242' ' ' GLU . 39.3 t 77.32 150.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -172.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.97 -33.35 71.96 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.737 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.548 ' H ' HG12 ' B' ' 240' ' ' VAL . 62.5 mt-10 73.89 154.33 0.15 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.721 0.808 . . . . 0.0 112.168 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.62 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 0.0 OUTLIER -156.1 110.36 2.81 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' B' ' 155' ' ' ASP . 31.9 tt0 -153.42 170.25 21.17 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' B' ' 150' ' ' THR . 6.4 mp 73.64 112.23 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 123.582 0.753 . . . . 0.0 111.557 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . 0.529 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 74.5 Cg_endo -83.07 97.28 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.292 1.994 . . . . 0.0 112.711 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . 0.451 ' H ' HG21 ' B' ' 150' ' ' THR . 11.2 pt-20 -132.12 163.47 28.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.733 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.2 mp -86.32 90.2 8.1 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.049 0.452 . . . . 0.0 110.797 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 5.3 m -85.88 -75.52 0.37 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.719 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 177.74 -50.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.06 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.3 3.44 3.66 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.642 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -71.49 -17.92 62.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.221 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 40.5 pt -87.15 -15.85 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.117 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -138.06 90.92 2.52 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.608 0.718 . . . . 0.0 111.986 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . 0.605 ' HG2' ' OE1' ' B' ' 148' ' ' GLN . 6.9 tpp180 -137.36 35.43 2.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.284 1.04 . . . . 0.0 108.968 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -127.87 17.65 6.76 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.825 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 72.98 23.63 77.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.545 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.12 137.21 40.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -52.7 -49.37 65.49 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.517 0.51 . . . . 0.0 111.378 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.6 p30 176.95 152.93 0.21 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.847 0.459 . . . . 0.0 111.043 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -169.39 167.32 40.4 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.983 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 26.9 p -83.38 170.93 14.01 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.597 0.199 . . . . 0.0 110.691 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 96.9 t -62.13 -51.85 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.0 OUTLIER -77.6 -36.38 51.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.04 0.448 . . . . 0.0 110.618 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.77 -39.79 97.81 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.48 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.42 ' O ' HG23 ' B' ' 270' ' ' VAL . 54.7 tp -61.7 -45.3 94.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.6 0.238 . . . . 0.0 110.861 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -64.72 -41.24 96.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.661 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -67.76 -43.29 80.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.556 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -67.89 -39.89 83.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.823 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.42 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.2 t -64.83 -41.72 92.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -55.43 -51.8 65.69 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.589 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.5 ptmt -66.0 -42.84 89.23 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -64.9 -38.26 90.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.0 mmm -63.67 -41.35 98.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.877 0.37 . . . . 0.0 110.164 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.3 -31.27 69.64 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.558 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -61.87 -42.77 99.46 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.4 -38.13 89.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.34 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.04 -38.2 87.84 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.272 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -56.51 -47.5 79.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.014 0.435 . . . . 0.0 109.947 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.2 m -64.61 -43.76 92.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.809 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.05 87.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.262 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.24 -44.56 99.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.968 0.413 . . . . 0.0 110.471 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -65.02 -42.01 94.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.58 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -62.82 -40.85 98.65 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.674 0.273 . . . . 0.0 110.859 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' B' ' 285' ' ' ARG . 1.5 tpm_? -59.7 -44.43 93.69 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.642 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 99.4 t -70.22 -43.61 78.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.871 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.92 -47.52 84.54 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.333 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 78.0 p -61.94 -44.82 95.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.69 -41.24 92.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.62 87.9 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.539 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . 0.48 ' O ' HG23 ' B' ' 295' ' ' VAL . 33.1 mm -64.9 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.201 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . 0.468 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 34.6 tp10 -60.29 -48.19 82.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.36 -41.06 96.75 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.515 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.52 HD13 HD13 ' B' ' 350' ' ' LEU . 4.0 tt -63.33 -42.07 98.94 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 0.48 HG23 ' O ' ' B' ' 291' ' ' ILE . 78.0 t -63.98 -42.74 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.954 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . 0.468 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 68.4 mttm -62.53 -40.83 98.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.871 0.367 . . . . 0.0 110.544 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.6 -50.23 67.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.533 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.47 99.86 6.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.713 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -96.5 112.03 23.92 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.5 tp -116.26 144.02 24.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.6 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.54 127.14 31.92 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.33 132.83 31.07 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.464 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.45 135.59 70.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.367 2.045 . . . . 0.0 112.042 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.45 -28.96 69.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.171 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.77 79.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.817 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 99.2 mt -82.42 -36.8 26.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.628 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . 0.454 ' O ' HG13 ' B' ' 311' ' ' ILE . 73.8 mt -61.93 -50.62 79.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.689 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.59 -38.76 92.11 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 59.0 p -64.1 -44.9 90.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.952 0.406 . . . . 0.0 111.165 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . 0.525 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 52.2 mm-40 -72.86 -32.48 65.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.275 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.454 HG13 ' O ' ' B' ' 307' ' ' ILE . 85.4 mt -62.11 -43.82 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.661 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.61 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 36.3 t70 -62.59 -41.72 99.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.365 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.21 -42.9 96.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.348 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 91.0 mt -61.55 -41.24 97.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.348 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.474 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 75.2 mtm180 -62.82 -39.77 95.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.771 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 90.6 mtt180 -63.16 -43.57 97.92 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.462 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -64.71 -44.02 91.58 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.14 85.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.34 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -64.65 -35.81 82.22 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.034 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . 0.59 ' NE2' ' HA ' ' A' ' 45' ' ' ARG . 49.8 tt0 -63.82 -41.87 97.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.349 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -72.19 -23.92 61.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.103 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -76.32 -3.83 38.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.284 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 139.68 -29.93 2.43 Favored Glycine 0 CA--C 1.501 -0.827 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.25 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 124.31 34.38 0.72 Allowed Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . 0.535 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 39.6 t-20 -73.83 118.11 16.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . 0.732 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 3.6 tm-20 -120.91 143.31 49.02 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 2.0 ptpp? 70.33 -38.93 0.43 Allowed 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 125.581 1.552 . . . . 0.0 113.019 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . 0.535 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.4 mm100 -73.85 -8.33 55.63 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.293 0.568 . . . . 0.0 110.767 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -67.13 -14.43 62.9 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.26 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.34 -36.39 83.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.468 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -71.39 -15.42 62.37 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.956 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.57 142.43 98.46 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.71 135.47 69.53 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.11 2.54 . . . . 0.0 112.898 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 27.7 ttt85 -70.42 -40.13 74.02 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.935 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -58.61 -34.59 71.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.55 -9.25 59.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.037 0.446 . . . . 0.0 111.755 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -114.57 -30.63 6.45 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.705 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -66.48 -34.21 77.42 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.98 -52.37 64.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.051 0.453 . . . . 0.0 110.707 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -70.46 -25.63 63.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.423 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.54 -42.28 99.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.329 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . 0.518 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.5 tttt -59.61 -47.12 86.84 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . 0.502 ' O ' HG23 ' B' ' 347' ' ' VAL . 17.3 mmt85 -63.57 -45.53 90.05 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -66.71 -38.88 87.6 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 341' ' ' ALA . 76.7 t -64.69 -43.0 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.655 0.264 . . . . 0.0 110.785 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 342' ' ' LYS . 78.1 t -60.05 -43.2 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.424 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.502 HG23 ' O ' ' B' ' 343' ' ' ARG . 88.0 t -59.68 -45.57 94.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.05 -42.28 99.64 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.313 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.71 -44.02 97.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 111.005 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.52 HD13 HD13 ' B' ' 294' ' ' LEU . 93.0 mt -64.14 -45.71 87.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.387 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.28 -40.66 90.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.027 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.92 -39.82 97.5 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.706 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.3 -38.74 88.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 110.836 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.28 -43.85 97.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.53 -43.78 98.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.882 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -68.54 -50.22 53.61 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.76 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 98.6 m -67.9 -47.16 69.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -85.79 -9.02 57.73 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.764 0.316 . . . . 0.0 110.964 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 59.42 73.0 0.5 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.684 0.754 . . . . 0.0 111.406 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.64 128.05 49.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 142.64 47.19 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.904 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -62.42 116.02 4.72 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . 0.471 ' O ' HG23 ' B' ' 367' ' ' VAL . 20.7 t70 -84.27 112.48 20.33 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.113 0.482 . . . . 0.0 110.846 -176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 17.0 mm-40 -58.06 -43.21 86.78 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.376 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -66.92 -37.82 85.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.826 0.346 . . . . 0.0 111.267 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -63.31 -41.71 98.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.039 0.447 . . . . 0.0 110.078 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 363' ' ' ASP . 97.6 t -64.06 -37.61 80.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.556 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.7 mmmt -56.4 -45.04 80.81 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.806 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.86 -38.22 95.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.094 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.44 -41.43 98.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.09 0.471 . . . . 0.0 110.388 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . 0.416 HG13 ' O ' ' B' ' 367' ' ' VAL . 62.2 mt -65.47 -42.98 94.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.509 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.38 -39.47 90.79 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.457 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -61.77 -43.13 99.45 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.079 0.466 . . . . 0.0 110.282 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 57.7 ttm -67.15 -39.25 86.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.913 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.0 -33.86 75.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.721 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 66.2 m -70.82 4.7 2.36 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -97.51 2.89 50.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.061 0.458 . . . . 0.0 110.712 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -122.24 174.89 6.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.733 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -61.95 -48.8 78.8 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.825 0.345 . . . . 0.0 111.002 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 27.0 t70 -123.79 115.22 28.07 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.48 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . 0.492 ' O ' HG13 ' B' ' 385' ' ' ILE . 37.3 Cg_endo -66.61 -29.56 43.61 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 122.231 1.954 . . . . 0.0 112.928 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.47 -42.9 91.77 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 12.3 pt-20 -64.34 -36.44 84.12 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.282 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.42 -42.01 92.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.388 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . 0.492 HG13 ' O ' ' B' ' 381' ' ' PRO . 89.6 mt -61.74 -44.1 98.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.985 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.35 -33.71 74.78 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.63 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -58.14 -47.05 84.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.277 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -69.44 -46.11 67.52 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 31.0 p -68.98 -18.1 64.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.75 7.15 46.4 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.926 0.393 . . . . 0.0 111.04 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -131.47 109.62 10.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.869 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -64.25 -38.51 91.32 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -59.9 -48.31 82.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.797 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.78 -39.86 95.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.048 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 90.8 mtp -62.58 -44.26 96.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.811 0.338 . . . . 0.0 110.905 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.74 -49.28 66.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.185 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.93 -43.23 96.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.546 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 44.0 tpp -64.22 -43.16 95.85 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.805 0.336 . . . . 0.0 111.084 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -66.27 -32.91 74.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.474 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.94 -44.75 96.82 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.769 0.319 . . . . 0.0 110.295 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 85.6 t -67.18 -43.65 88.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.458 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.31 93.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.958 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.81 -38.92 92.88 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.324 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.48 -43.24 97.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.872 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.48 -35.65 81.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.73 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -61.11 -42.74 99.07 Favored 'General case' 0 C--O 1.228 -0.06 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.402 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.85 -46.78 83.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.224 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 89.9 t -62.99 -46.18 96.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -67.03 -31.18 71.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.689 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.27 93.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.111 0.481 . . . . 0.0 110.311 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 407' ' ' ALA . 99.0 t -65.36 -41.53 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.168 177.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 97.9 mt -59.87 -27.05 66.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.206 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -78.17 -6.77 55.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 111.486 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -114.83 -22.95 9.39 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.881 0.372 . . . . 0.0 110.972 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.06 169.45 12.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.057 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -83.08 116.51 22.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.619 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 60.5 t -90.24 121.72 40.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.231 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . 0.402 HG23 ' HG3' ' B' ' 126' ' ' GLU . 9.1 t -124.04 137.79 54.54 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.1 125.2 50.91 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.576 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . 0.568 ' HE3' ' OE1' ' B' ' 126' ' ' GLU . 20.3 pttp -135.44 149.91 49.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.578 0.227 . . . . 0.0 110.653 176.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.11 159.2 20.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.8 t -158.96 172.23 18.59 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.782 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 17.0 p -85.26 164.6 17.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.015 0.436 . . . . 0.0 111.355 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -65.32 -26.21 67.95 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.543 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -61.29 -39.96 92.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.649 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.42 -36.17 82.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.419 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.51 -22.67 62.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.203 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.8 mmt -77.03 -5.75 50.01 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -76.67 78.53 3.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.34 0.591 . . . . 0.0 109.636 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -105.12 14.72 28.73 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.124 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -64.12 -37.54 87.83 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.092 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.213 178.505 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.236 0.368 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 17' ' ' ILE . 11.8 p -97.95 137.12 37.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.791 0.329 . . . . 0.0 110.736 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -153.83 138.4 9.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 69.7 mm-40 -122.4 152.56 40.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.112 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.1 m -107.35 121.5 44.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.757 0.313 . . . . 0.0 110.168 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 m -78.29 -67.36 0.74 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.461 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -170.2 110.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.629 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.65 -110.95 3.31 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.081 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.401 HD23 HG13 ' A' ' 111' ' ' VAL . 90.4 mt -64.12 -39.18 93.48 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 122.655 0.382 . . . . 0.0 111.31 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -69.23 138.15 30.48 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 115.086 0.794 . . . . 0.0 115.086 -174.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 12' ' ' GLY . 7.9 mpt_? -140.85 170.31 15.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.057 0.943 . . . . 0.0 110.532 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 6.2 ttm180 -134.42 137.99 44.46 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -95.4 -84.76 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.183 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 p 43.12 91.87 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.512 ' HA ' ' OG ' ' A' ' 4' ' ' SER . 85.0 mt -113.0 131.47 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.162 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.7 m -103.01 122.89 45.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.415 HG13 HG12 ' A' ' 24' ' ' ILE . 16.9 pt -129.1 162.48 36.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.522 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -70.04 150.57 46.48 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.264 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -59.34 -39.34 82.84 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -64.95 -25.34 67.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.472 . . . . 0.0 110.414 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -87.53 -32.23 19.51 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.55 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.1 mt -62.26 -50.41 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.956 0.408 . . . . 0.0 112.007 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.477 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 32.3 mm-40 -82.32 -5.02 58.3 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.7 m -100.29 -69.43 0.77 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.029 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.68 -47.58 72.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 96.3 t -63.86 -44.13 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.798 0.332 . . . . 0.0 111.349 -176.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 18.1 ttmm -61.43 -45.72 93.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.969 0.414 . . . . 0.0 110.74 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.527 ' O ' HG12 ' A' ' 33' ' ' VAL . 18.1 m -63.51 -41.29 98.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.415 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -61.23 -38.22 85.88 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.053 0.454 . . . . 0.0 110.4 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.78 -41.58 99.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.954 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 30' ' ' SER . 8.9 p -71.54 -31.65 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.569 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -62.85 -44.03 97.21 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.491 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -71.29 -31.28 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.93 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.96 -44.61 92.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.203 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.93 -33.84 76.76 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.675 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.0 -35.47 76.93 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 110.327 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.2 t -91.9 -4.88 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.321 0.581 . . . . 0.0 110.119 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 63.61 26.55 14.69 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.687 0.795 . . . . 0.0 111.435 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.17 4.55 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.851 0.358 . . . . 0.0 111.564 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.57 -33.82 76.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.936 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.65 -6.61 67.08 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.894 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -90.12 -1.0 57.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.864 0.364 . . . . 0.0 110.769 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.4 ttt-85 -94.22 82.83 4.16 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.264 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.5 94.06 6.17 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.4 101.44 2.73 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -170.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -65.36 -40.78 94.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 168.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.505 HG12 ' HB ' ' A' ' 54' ' ' VAL . 23.9 t -96.04 111.32 55.88 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.504 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.35 142.87 97.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.501 2.134 . . . . 0.0 111.65 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.647 ' HA ' HG12 ' A' ' 54' ' ' VAL . 24.1 ttt -64.43 -39.19 93.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.556 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -66.99 -20.89 65.96 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.142 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.608 HG12 HH11 ' B' ' 193' ' ' ARG . 1.7 mp -92.85 -46.56 13.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 51' ' ' MET . 9.0 p -63.79 -32.44 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 120.753 0.311 . . . . 0.0 111.358 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.43 82.15 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.66 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -93.05 -25.29 17.99 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.305 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -63.04 -43.43 98.69 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.853 0.359 . . . . 0.0 110.596 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.97 13.98 18.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.565 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.618 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -49.52 -73.07 0.39 Allowed Glycine 0 C--O 1.221 -0.703 0 CA-C-N 115.598 -0.728 . . . . 0.0 114.569 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.26 -19.3 62.37 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.862 0.331 . . . . 0.0 111.807 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 t -63.03 -45.63 91.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.032 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.4 p -123.91 17.14 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.317 0.58 . . . . 0.0 111.121 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.618 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 37.2 ttm180 -58.92 -26.62 64.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.758 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -61.86 -52.45 64.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.304 0.574 . . . . 0.0 110.232 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' HB2' HG22 ' A' ' 62' ' ' VAL . 1.2 m-20 -71.85 -27.05 62.63 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.563 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 62' ' ' VAL . 88.5 t -63.78 -43.63 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.11 -39.84 93.88 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.49 -42.7 99.82 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.788 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.752 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 31.1 t70 -63.54 -43.94 95.64 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.737 0.269 . . . . 0.0 111.033 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.08 -43.85 98.26 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.476 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -67.23 -37.28 83.3 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.082 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.4 m -61.75 -43.3 99.12 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.406 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.752 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 46.2 mtp85 -64.59 -42.96 95.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.086 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -64.65 -40.44 95.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.95 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -59.81 -49.53 77.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.731 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 tt -69.03 -39.66 79.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.789 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 21.8 t0 -66.9 -41.82 86.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.258 0.551 . . . . 0.0 109.896 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.67 -41.24 92.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.727 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -65.68 -32.22 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.234 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.73 -43.55 96.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.176 0.512 . . . . 0.0 109.811 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 77' ' ' ASP . 58.7 mttm -63.83 -42.07 97.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.774 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -86.52 -4.24 59.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.895 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 64.14 36.34 9.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.367 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 98.2 mt -88.49 123.45 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.636 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -106.79 107.66 60.67 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -78.82 134.17 11.82 Favored 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 121.88 1.72 . . . . 0.0 111.406 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.94 88.28 7.26 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.165 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.72 -102.95 2.86 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.325 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.94 128.45 21.52 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 120.593 0.235 . . . . 0.0 110.924 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.07 -20.32 57.01 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.804 2.336 . . . . 0.0 112.154 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 51.3 m 68.35 95.68 0.06 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.335 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.491 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 97.4 m-85 -81.12 113.28 19.18 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.025 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.29 107.6 30.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.752 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 69.4 Cg_endo -95.65 163.71 1.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.323 2.682 . . . . 0.0 112.187 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -100.02 176.93 28.61 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.384 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.06 134.41 41.37 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -90.38 103.09 15.81 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.75 117.44 25.51 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.54 107.76 1.0 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.347 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.52 -15.71 19.72 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.988 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.93 173.79 6.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.991 0.395 . . . . 0.0 111.42 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.91 145.62 48.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.036 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -106.6 138.83 42.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.281 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.6 m -123.32 134.7 54.02 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.041 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -130.87 168.03 17.96 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.561 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.516 ' O ' HG12 ' A' ' 107' ' ' VAL . 37.7 m -87.04 -80.46 0.25 Allowed 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 106' ' ' SER . 3.7 p 56.37 121.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 C-N-CA 124.524 1.13 . . . . 0.0 111.376 -172.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -116.54 145.64 43.2 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.878 -0.513 . . . . 0.0 112.313 -172.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -155.4 -88.37 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -134.74 161.3 35.56 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -175.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.401 HG13 HD23 ' A' ' 11' ' ' LEU . 35.3 m -135.88 164.63 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.076 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -136.58 92.42 15.06 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -97.99 162.9 0.82 Allowed 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.471 2.781 . . . . 0.0 114.804 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.34 149.36 33.65 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.2 t -127.18 135.72 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -101.99 127.73 48.72 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.929 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.0 mt -118.33 134.79 54.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.603 0.239 . . . . 0.0 110.456 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -129.84 158.37 39.65 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.12 12.29 82.61 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.536 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.12 -41.24 97.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.945 0.402 . . . . 0.0 111.491 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -75.39 -8.29 56.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.051 0.453 . . . . 0.0 111.269 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.07 7.86 44.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.583 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 74.7 mt -83.89 119.0 32.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.01 0.433 . . . . 0.0 110.672 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -110.56 114.03 27.11 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.61 136.82 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.882 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -85.4 135.64 33.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.293 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HB3' HG13 ' A' ' 417' ' ' VAL . 83.8 tttt -127.39 95.97 34.58 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.42 121.55 8.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.161 1.908 . . . . 0.0 112.1 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.2 mm -103.79 112.64 38.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.49 159.83 37.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.784 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.71 165.45 27.23 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.415 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -84.72 110.75 19.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.2 p -92.06 173.59 7.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.396 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -62.99 -36.67 84.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.668 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.14 -36.11 80.8 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.893 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -62.78 -39.27 93.69 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.741 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.02 -43.58 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.085 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -59.4 -44.94 92.73 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.347 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.69 -41.26 99.85 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.013 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.626 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.3 tpt -62.19 -46.78 87.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.716 0.293 . . . . 0.0 110.605 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.08 -42.17 99.59 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.266 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.45 -45.74 92.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.527 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.0 m -63.64 -43.61 96.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.669 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 140' ' ' MET . 98.5 mt -61.32 -44.64 96.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.067 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -70.48 -37.81 74.29 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.994 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.35 -36.98 85.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.428 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -84.79 33.92 0.53 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -122.78 115.64 22.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.447 0.641 . . . . 0.0 111.877 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.08 -170.44 3.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.482 ' CB ' ' H ' ' A' ' 247' ' ' GLU . 15.3 m -141.91 167.48 22.04 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.695 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 21.8 p-90 -105.1 132.5 51.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 120.678 0.275 . . . . 0.0 111.376 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -160.55 -47.19 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.335 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -154.26 -175.67 5.51 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' A' ' 240' ' ' VAL . 33.0 mmtp -52.75 154.67 2.63 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 76.22 -168.85 0.08 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.307 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 243' ' ' ARG . . . 113.5 0.74 24.78 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.504 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 74.41 -40.51 0.45 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.891 0.876 . . . . 0.0 112.407 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.3 t 73.32 -61.19 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.399 0.68 . . . . 0.0 112.447 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.53 ' HB2' ' HG2' ' A' ' 203' ' ' LYS . 10.2 pt-20 54.15 -166.18 0.09 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.905 1.282 . . . . 0.0 112.729 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.467 ' HB1' ' CA ' ' A' ' 190' ' ' GLY . . . -78.6 93.18 4.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.784 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -151.13 -65.71 0.19 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.327 0.584 . . . . 0.0 111.181 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -110.93 -168.76 1.34 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.381 -172.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 20.2 ptt180 -106.11 133.5 50.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.841 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.4 m -128.58 144.74 37.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.137 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.5 m -78.69 111.28 14.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.047 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.5 mt -123.63 122.07 64.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.02 0.438 . . . . 0.0 111.058 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.35 78.84 2.24 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -97.42 153.64 17.98 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.293 0.568 . . . . 0.0 112.183 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.3 m -119.05 128.38 54.29 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.877 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.58 126.42 9.11 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.742 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 21.1 p -137.27 134.32 36.0 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.93 -84.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.889 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -108.86 -0.04 20.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.399 0.618 . . . . 0.0 109.959 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.2 -21.82 0.97 Allowed Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.927 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -99.93 151.88 20.81 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -81.12 153.81 27.09 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.697 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -118.05 167.67 11.25 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.708 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -57.95 -32.26 67.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.57 -175.29 32.55 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.35 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.17 30.47 46.22 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.187 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.36 104.5 14.24 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -121.09 142.4 49.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.271 0.558 . . . . 0.0 112.197 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.7 m -147.1 118.4 7.84 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.252 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.83 33.68 23.5 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.596 0.56 . . . . 0.0 110.798 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -91.88 124.68 36.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.22 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 6.6 m -93.61 116.16 34.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.388 0.614 . . . . 0.0 110.992 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 163' ' ' ARG . 63.4 tp -101.88 117.57 35.12 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.804 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.568 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -91.01 108.15 19.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 76.9 mtm -89.83 149.56 22.62 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.808 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.467 ' CA ' ' HB1' ' A' ' 160' ' ' ALA . . . 98.38 12.19 45.83 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.275 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -127.21 -1.93 6.37 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.431 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 75.53 57.97 4.03 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.646 HH11 HG12 ' B' ' 53' ' ' ILE . 33.8 mmm-85 -103.72 -3.88 24.44 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.463 0.649 . . . . 0.0 109.613 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.482 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -142.66 176.29 9.15 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.997 177.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.4 mm -58.27 130.47 83.96 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.29 130.15 27.92 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.301 2.001 . . . . 0.0 111.993 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.45 -36.62 4.21 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.937 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -63.81 -47.43 80.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.175 0.487 . . . . 0.0 111.664 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.71 -8.86 59.49 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.255 0.55 . . . . 0.0 111.212 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -92.62 -31.74 15.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.605 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -65.32 -30.23 77.19 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.912 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.74 -25.97 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.912 0.387 . . . . 0.0 111.043 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.53 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 54.1 mtpt -55.95 132.71 50.53 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.397 0.679 . . . . 0.0 111.552 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.35 -12.78 66.35 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.674 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -84.71 154.73 22.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.984 0.421 . . . . 0.0 112.133 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -93.86 163.98 13.29 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.32 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.17 92.73 1.76 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.119 0.485 . . . . 0.0 110.429 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.544 ' H ' HD22 ' A' ' 237' ' ' LEU . . . 113.19 18.35 7.27 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.52 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -102.19 116.02 31.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.915 0.388 . . . . 0.0 110.795 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -95.95 119.25 34.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.611 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -138.41 -15.17 1.26 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 30.1 p 60.98 162.79 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.978 0.911 . . . . 0.0 112.292 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -149.03 133.07 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.826 0.346 . . . . 0.0 110.729 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.54 112.09 16.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.96 0.41 . . . . 0.0 111.207 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 65.1 t -113.21 129.3 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 3.2 m -95.62 -22.98 17.24 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -173.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 229' ' ' LYS . 89.1 m-85 67.74 154.47 0.14 Allowed Pre-proline 0 N--CA 1.489 1.51 0 CA-C-O 121.005 0.431 . . . . 0.0 111.452 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.66 158.11 28.31 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.309 2.006 . . . . 0.0 111.54 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -66.21 -37.55 85.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.216 0.532 . . . . 0.0 110.08 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.31 45.96 1.31 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.058 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 21.5 t80 -82.72 135.87 34.88 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -60.16 -22.25 62.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.404 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -99.24 105.27 17.29 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 42.2 tt0 -60.99 -24.57 66.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.22 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -73.65 -24.21 59.96 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.512 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.0 mt -113.01 3.11 16.02 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.4 ptmt -68.27 118.11 10.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.731 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.83 29.0 74.13 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.389 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.432 ' O ' ' HD1' ' A' ' 217' ' ' PHE . 99.4 mttt -124.63 140.39 52.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 117.139 0.47 . . . . 0.0 110.483 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -85.74 130.2 34.62 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.7 130.71 56.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.734 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -72.12 -39.35 68.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 59.64 105.27 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.107 0.479 . . . . 0.0 112.031 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.55 -45.82 88.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.995 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.3 mm 60.75 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.766 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -106.3 125.99 51.68 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.677 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.544 HD22 ' H ' ' A' ' 208' ' ' GLY . 4.3 mp -98.55 114.5 26.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.95 0.405 . . . . 0.0 110.867 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -94.86 -59.35 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.594 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -91.06 -88.87 0.18 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.526 ' O ' ' HE2' ' A' ' 154' ' ' LYS . 58.5 t 65.61 120.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 122.829 0.452 . . . . 0.0 110.351 -175.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -79.17 -99.96 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -166.91 155.03 9.74 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.695 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 14.2 ptp180 169.11 77.48 0.0 OUTLIER 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.668 1.187 . . . . 0.0 112.856 171.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.01 158.64 43.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.4 tp 71.95 107.53 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 123.831 0.852 . . . . 0.0 111.773 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.2 109.11 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.194 1.929 . . . . 0.0 112.368 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.482 ' H ' ' CB ' ' A' ' 150' ' ' THR . 7.8 tp10 -111.37 -21.2 11.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.053 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 42.8 tp 74.47 126.53 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.558 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.441 ' H ' ' HE2' ' A' ' 252' ' ' PHE . 4.8 m -130.7 -110.68 0.26 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.904 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -175.29 -44.82 0.01 OUTLIER 'General case' 0 C--N 1.352 0.702 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.06 -29.43 65.38 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.441 ' HE2' ' H ' ' A' ' 249' ' ' THR . 55.4 p90 -66.55 -17.65 64.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.772 0.32 . . . . 0.0 111.711 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.09 -42.8 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 110.998 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.55 ' HD2' ' H ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -95.99 21.47 8.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.004 -177.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -69.12 -17.02 63.79 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.506 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.481 ' CE1' HD21 ' A' ' 266' ' ' LEU . 80.7 m-85 -59.02 -35.43 73.27 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.74 -28.44 15.41 Favored Glycine 0 C--N 1.322 -0.202 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.76 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.16 83.88 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.51 ' HG2' ' H ' ' A' ' 260' ' ' ASP . 13.8 tt0 55.09 -163.91 0.13 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.157 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . 0.51 ' H ' ' HG2' ' A' ' 259' ' ' GLU . 4.0 p-10 -124.94 110.2 13.94 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.031 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -93.15 164.97 27.56 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.622 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.6 p -87.06 -173.26 4.35 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 122.465 0.306 . . . . 0.0 110.267 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.9 -47.74 92.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 120.862 0.363 . . . . 0.0 111.289 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.2 OUTLIER -88.2 -34.25 17.86 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.768 0.318 . . . . 0.0 111.02 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.66 -40.11 98.24 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.352 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.481 HD21 ' CE1' ' A' ' 256' ' ' PHE . 53.5 tp -62.46 -42.55 99.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.505 0.193 . . . . 0.0 111.092 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -60.89 -43.83 97.93 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.953 0.406 . . . . 0.0 110.083 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -67.88 -42.25 81.52 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.236 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 24.9 tp10 -66.74 -39.98 88.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.963 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.47 ' O ' ' HG2' ' A' ' 274' ' ' MET . 75.2 t -65.03 -43.22 96.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.943 0.402 . . . . 0.0 110.054 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -58.13 -47.39 83.45 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.127 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 16.3 ptmt -67.93 -41.5 82.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.622 0.249 . . . . 0.0 111.357 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -64.12 -39.24 93.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 270' ' ' VAL . 98.8 mmm -63.5 -41.92 98.53 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.567 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -67.68 -35.04 78.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.855 0.36 . . . . 0.0 110.228 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -61.56 -43.7 98.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 109.977 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -68.88 -37.49 79.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.064 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 38.9 tp -63.17 -38.62 91.91 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.794 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -56.1 -45.62 79.37 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.151 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.5 m -61.51 -40.52 94.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.496 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.56 -45.74 92.87 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.912 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.58 -45.21 98.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 110.179 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.496 ' HD2' ' OE2' ' A' ' 405' ' ' GLU . 0.8 OUTLIER -59.77 -46.71 88.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.136 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -64.91 -41.56 95.48 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.667 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -65.32 -41.43 94.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.873 0.368 . . . . 0.0 111.404 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.92 -44.06 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.166 0.508 . . . . 0.0 109.857 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.6 -47.54 83.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.629 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 55.2 p -62.41 -43.91 97.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -64.24 -42.15 96.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.768 0.318 . . . . 0.0 111.059 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.6 85.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 37.9 mm -65.42 -44.39 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.427 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.499 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 20.0 tp10 -62.56 -42.87 99.82 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.607 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.3 -43.51 98.98 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.98 -43.21 96.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.0 -44.99 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.391 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . 0.499 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 67.5 mttm -64.33 -41.42 96.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.548 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.22 -43.96 69.56 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -127.59 98.8 5.34 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.683 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -93.23 103.15 15.43 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.2 tp -107.98 139.27 30.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.975 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -67.73 131.34 45.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.213 0.53 . . . . 0.0 110.706 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.16 135.75 21.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.062 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.0 138.35 85.53 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.388 2.058 . . . . 0.0 111.987 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.37 85.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.307 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.38 -45.85 80.36 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.025 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.68 -43.3 93.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.84 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 71.4 mt -62.34 -49.98 81.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.66 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -41.63 98.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.949 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 24.6 m -61.94 -45.63 92.86 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.616 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.644 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 27.2 mm-40 -73.11 -38.05 66.48 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -176.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.501 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 82.0 mt -61.74 -43.8 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -175.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 24.9 t70 -61.45 -42.62 99.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.097 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.4 -42.55 93.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 90.3 mt -62.15 -39.67 93.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.43 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 82.5 mtm180 -62.6 -37.46 86.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.071 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 91.3 mtt180 -64.09 -38.95 92.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -63.09 -46.1 88.98 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.383 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.8 -39.53 91.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.657 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.51 94.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.409 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -65.02 -38.86 92.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.175 0.512 . . . . 0.0 110.234 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.84 -17.93 59.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.922 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -78.16 -3.57 43.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.317 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.56 -11.27 4.62 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.356 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 111.88 34.62 1.99 Allowed Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.241 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -74.75 126.6 31.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.953 0.406 . . . . 0.0 110.097 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.48 159.36 36.53 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.538 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.1 OUTLIER 69.17 -47.07 0.58 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.27 -4.9 55.13 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.18 -24.64 66.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.442 0.639 . . . . 0.0 109.807 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.402 HD12 HH12 ' A' ' 315' ' ' ARG . 38.7 tp -63.94 -33.75 76.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.705 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -80.47 -9.58 59.76 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.905 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 94.4 mt -63.83 129.03 93.57 Favored Pre-proline 0 C--O 1.24 0.572 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.476 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 52.5 Cg_exo -54.84 127.24 25.39 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.848 2.365 . . . . 0.0 113.142 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -65.51 -43.97 88.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.002 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.4 pm0 -65.25 -24.76 67.41 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.0 -10.32 55.28 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -118.1 -15.95 9.82 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.976 0.417 . . . . 0.0 111.251 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.22 -25.17 65.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.497 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.8 -50.78 67.6 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.705 0.288 . . . . 0.0 111.06 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -78.91 -20.72 48.67 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.208 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.98 -41.85 98.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.444 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -60.41 -44.24 95.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.031 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 347' ' ' VAL . 17.9 mmt85 -62.41 -42.78 99.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.068 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.492 ' NH2' HD22 ' A' ' 314' ' ' LEU . 73.4 mtt180 -64.81 -41.77 95.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.675 0.274 . . . . 0.0 111.061 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 89.2 t -64.89 -44.62 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.769 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 342' ' ' LYS . 72.5 t -61.13 -44.22 97.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.934 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 343' ' ' ARG . 77.4 t -60.5 -44.67 96.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.09 99.73 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.175 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 93.7 mt -63.47 -42.71 98.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.899 0.38 . . . . 0.0 110.614 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.6 mt -63.13 -44.95 94.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.763 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.38 -42.02 96.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.968 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.18 -42.53 99.72 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.131 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.54 -39.24 85.02 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 117.053 0.426 . . . . 0.0 111.287 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 350' ' ' LEU . 73.0 t -60.79 -45.05 98.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.93 -44.22 97.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.687 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -65.48 -46.55 79.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 37.5 m -73.11 -44.25 60.57 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -89.27 0.63 56.63 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.777 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 56.99 67.01 1.05 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.304 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 91.0 mt -98.83 153.77 18.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.777 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -132.96 155.35 49.28 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.806 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.15 100.24 8.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 171.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 367' ' ' VAL . 26.8 t70 -83.16 115.96 22.14 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.127 0.489 . . . . 0.0 112.269 -173.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 68.7 mm-40 -61.35 -35.52 77.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.299 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.441 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 65.4 mm-40 -64.39 -41.71 96.53 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.093 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -63.13 -39.15 93.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.18 0.514 . . . . 0.0 109.842 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.539 HG21 ' HG2' ' A' ' 399' ' ' ARG . 89.6 t -61.78 -39.64 84.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.332 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.5 mmmt -57.68 -44.31 85.68 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.487 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.51 -40.09 98.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.848 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.6 -43.05 99.78 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.981 0.419 . . . . 0.0 110.281 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.27 -43.92 97.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.406 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.15 -41.0 97.33 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.56 -37.25 84.55 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.351 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 48.4 ttm -66.98 -43.61 82.6 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.091 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.87 75.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.123 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.6 m -68.27 -5.29 17.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.839 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -83.45 -12.48 56.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.498 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -106.35 172.99 6.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.533 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.24 -47.31 83.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.825 0.345 . . . . 0.0 110.985 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -123.62 113.55 28.86 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.548 ' O ' HG13 ' A' ' 385' ' ' ILE . 38.1 Cg_endo -66.75 -31.19 40.12 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.229 1.953 . . . . 0.0 113.402 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -66.27 -42.96 87.71 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.28 -36.19 83.3 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.994 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.38 -42.56 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.234 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 381' ' ' PRO . 68.1 mt -61.23 -46.76 95.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.279 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 46.2 mt-10 -63.32 -44.0 96.19 Favored 'General case' 0 C--O 1.215 -0.752 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.773 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.61 -46.76 86.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -66.28 -40.84 90.34 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.429 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 51.3 p -81.58 -2.44 50.05 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 98.6 mttt -103.48 10.64 37.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.049 0.452 . . . . 0.0 110.789 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -134.42 117.51 16.39 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.259 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -63.78 -40.64 97.17 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -58.1 -49.48 76.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.674 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.55 -42.73 98.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.2 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.526 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 89.5 mtp -63.9 -48.3 77.16 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -73.58 -39.39 64.68 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -174.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -62.36 -40.72 97.35 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 44.4 tpp -64.13 -41.47 97.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.66 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.539 ' HG2' HG21 ' A' ' 367' ' ' VAL . 69.1 mtm180 -64.35 -36.44 84.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.008 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -60.95 -43.77 98.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.583 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.17 -44.09 88.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.488 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -61.65 -41.83 98.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.95 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.87 -39.5 94.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.683 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.66 -43.93 93.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.906 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.496 ' OE2' ' HD2' ' A' ' 283' ' ' ARG . 29.7 mt-10 -65.18 -37.44 87.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.541 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -60.45 -43.35 96.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.526 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.42 -44.35 91.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.968 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 86.5 t -64.73 -45.11 96.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.989 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -65.32 -33.56 76.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.32 97.49 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.865 0.364 . . . . 0.0 110.482 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.91 -42.74 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.076 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.0 mt -61.45 -41.85 97.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.183 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.04 -23.85 67.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.706 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -95.18 -8.27 36.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.32 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.53 179.43 4.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.139 0.495 . . . . 0.0 111.757 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -82.41 133.46 35.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.689 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 127' ' ' LYS . 57.8 t -122.09 131.34 73.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -131.49 138.81 49.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.1 0.476 . . . . 0.0 110.921 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -93.58 118.82 31.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.663 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -136.33 132.93 36.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.843 0.354 . . . . 0.0 111.368 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -81.01 153.23 27.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.165 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 12.9 t -157.72 171.66 19.92 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 26.2 p -81.34 165.54 21.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.772 0.32 . . . . 0.0 110.21 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -66.04 -18.13 65.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.021 0.438 . . . . 0.0 111.26 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -62.25 -39.45 92.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.97 -38.31 90.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.19 0.519 . . . . 0.0 110.057 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.35 -36.2 83.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.488 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 5.9 mmt -65.31 -14.28 60.41 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.301 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -75.6 83.37 2.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -103.64 6.48 37.13 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.315 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -72.32 -44.83 62.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.532 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.149 -178.548 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.92 103.86 2.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 111.361 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.86 161.59 38.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.396 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.493 ' OG ' ' HA ' ' B' ' 17' ' ' ILE . 7.9 p -101.59 130.56 47.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.787 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.78 133.66 13.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.479 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 57.9 mm-40 -118.45 149.75 40.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.962 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 98.0 m -106.6 122.71 46.86 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 27.7 m -78.74 -68.54 0.64 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.363 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -166.23 110.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.582 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.81 -106.55 1.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.354 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.441 HD23 HG13 ' B' ' 111' ' ' VAL . 83.8 mt -70.34 -36.69 74.39 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.708 0.403 . . . . 0.0 112.048 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.453 ' C ' ' HD2' ' B' ' 13' ' ' ARG . . . -70.09 135.81 26.39 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 114.486 0.554 . . . . 0.0 114.486 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.453 ' HD2' ' C ' ' B' ' 12' ' ' GLY . 7.6 mpt_? -138.13 171.26 14.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.69 0.796 . . . . 0.0 110.415 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 9.8 ttm180 -135.75 138.54 42.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.77 -83.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.038 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p 42.23 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.493 ' HA ' ' OG ' ' B' ' 4' ' ' SER . 83.8 mt -110.91 130.56 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.23 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 37.6 m -103.17 123.61 47.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 20.6 pt -129.08 163.23 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.0 111.979 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.511 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -71.93 152.69 42.34 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.087 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.434 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -59.98 -36.65 77.62 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -63.02 -32.3 73.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.241 0.544 . . . . 0.0 110.217 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 17.3 m -82.51 -32.99 28.44 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.034 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.511 HG13 ' O ' ' B' ' 20' ' ' ALA . 81.5 mt -60.59 -49.98 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 120.881 0.372 . . . . 0.0 111.834 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.495 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 28.0 mm-40 -82.99 -7.51 59.66 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 53.2 m -97.97 -69.34 0.76 Allowed 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.41 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.99 -48.3 66.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 89.7 t -64.17 -43.62 97.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.513 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.495 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.1 ttmm -61.33 -46.49 90.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 0.0 110.564 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.501 ' O ' HG12 ' B' ' 33' ' ' VAL . 21.2 m -63.53 -40.39 96.92 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.451 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -60.68 -38.93 86.59 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.021 0.438 . . . . 0.0 110.609 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.78 -41.85 99.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.839 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.501 HG12 ' O ' ' B' ' 30' ' ' SER . 9.2 p -70.93 -32.9 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 120.224 -0.591 . . . . 0.0 110.894 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -63.56 -43.84 95.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.431 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 25.7 m -70.69 -31.76 47.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.054 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.64 -42.54 98.12 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.989 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.21 -33.68 76.3 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.689 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.07 -36.63 80.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.942 0.401 . . . . 0.0 110.447 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 t -89.34 -6.39 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.3 0.571 . . . . 0.0 109.967 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 63.05 30.4 16.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.939 0.896 . . . . 0.0 111.215 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -105.72 4.11 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -64.35 -34.19 77.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.808 0.337 . . . . 0.0 110.799 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.78 -19.72 65.57 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.686 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -80.69 -3.48 50.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.677 0.275 . . . . 0.0 111.502 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 66.4 ttt-85 -91.88 83.46 5.23 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 119.946 -0.701 . . . . 0.0 112.026 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.55 95.99 6.01 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.12 98.1 2.23 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 115.319 0.888 . . . . 0.0 115.319 -171.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -64.67 -40.8 96.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.486 HG12 ' HB ' ' B' ' 54' ' ' VAL . 14.7 t -94.06 111.34 52.8 Favored Pre-proline 0 N--CA 1.437 -1.121 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.245 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.76 141.54 92.19 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.413 2.076 . . . . 0.0 111.665 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.704 ' HA ' HG12 ' B' ' 54' ' ' VAL . 26.1 ttt -65.63 -38.92 90.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.699 -175.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -67.47 -18.36 65.04 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.646 HG12 HH11 ' A' ' 193' ' ' ARG . 1.8 mp -96.76 -46.05 12.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.52 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.704 HG12 ' HA ' ' B' ' 51' ' ' MET . 8.4 p -63.85 -32.19 56.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 111.093 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.29 81.46 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.464 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -95.19 -20.84 18.9 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.34 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -63.99 -44.0 94.0 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.769 0.318 . . . . 0.0 110.513 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -113.9 12.32 18.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.242 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.656 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -50.72 -69.25 1.15 Allowed Glycine 0 C--O 1.218 -0.845 0 CA-C-N 115.488 -0.778 . . . . 0.0 114.75 -175.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.65 -18.19 61.59 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 117.0 0.4 . . . . 0.0 111.759 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 29.2 t -67.37 -52.68 37.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.969 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.487 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.3 p -114.02 17.03 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.468 0.651 . . . . 0.0 111.193 -175.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.656 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 36.3 ttm180 -59.1 -33.26 70.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.986 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -59.28 -50.68 73.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.023 0.44 . . . . 0.0 110.275 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . 0.46 ' HB2' HG22 ' B' ' 62' ' ' VAL . 1.8 m-20 -67.61 -34.03 76.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.36 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.487 HG23 ' O ' ' B' ' 62' ' ' VAL . 81.6 t -61.16 -43.66 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.62 -39.59 91.82 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.27 -41.99 99.72 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.707 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . 0.701 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 28.4 t70 -64.22 -43.48 94.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.613 0.244 . . . . 0.0 111.076 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.37 -44.02 96.02 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.383 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -66.44 -37.24 84.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.101 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.6 m -62.25 -42.86 99.7 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.233 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.701 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 44.3 mtp85 -63.36 -43.71 96.87 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.031 0.443 . . . . 0.0 110.205 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -64.89 -40.75 95.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.092 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.8 -49.27 78.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.034 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.6 tt -68.63 -39.6 80.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.716 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.517 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 7.7 t0 -65.91 -42.51 90.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.293 0.568 . . . . 0.0 109.88 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.23 93.96 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.762 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 pt -66.53 -31.71 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.149 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.83 -43.31 96.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.112 0.482 . . . . 0.0 109.837 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' B' ' 77' ' ' ASP . 64.5 mttm -63.43 -45.2 92.01 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.849 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -81.62 -9.19 59.73 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.308 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 69.47 33.36 3.15 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.628 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 96.1 mt -84.84 128.87 38.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.955 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -112.29 101.4 52.08 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.632 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.42 143.62 53.1 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.503 2.135 . . . . 0.0 111.461 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.31 88.56 4.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.032 0.444 . . . . 0.0 110.752 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.22 -98.28 2.15 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.465 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.15 129.16 19.8 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.574 0.226 . . . . 0.0 110.948 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.78 -19.56 46.95 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.795 2.33 . . . . 0.0 112.034 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 34.1 m 71.02 95.51 0.07 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.192 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.492 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 98.5 m-85 -81.67 110.98 17.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.023 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.3 t -93.95 107.9 31.34 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.977 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 68.9 Cg_endo -96.2 159.28 1.33 Allowed 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 123.208 2.605 . . . . 0.0 111.707 177.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.94 177.6 34.19 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.089 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.48 136.16 44.14 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -88.14 106.43 18.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.659 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.65 117.09 28.27 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.68 111.35 2.71 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.006 0.432 . . . . 0.0 110.725 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.73 -10.58 35.09 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.023 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -114.44 175.68 5.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.998 0.399 . . . . 0.0 111.663 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -72.35 144.43 48.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.803 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -106.79 137.51 44.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.358 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.5 m -122.84 135.26 54.47 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.36 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -131.77 166.63 21.1 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.485 ' O ' HG12 ' B' ' 107' ' ' VAL . 32.1 m -84.16 -81.04 0.18 Allowed 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.485 HG12 ' O ' ' B' ' 106' ' ' SER . 3.6 p 55.62 117.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 C-N-CA 124.441 1.096 . . . . 0.0 111.709 -173.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -112.45 150.86 30.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -157.36 -90.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -134.42 162.32 32.56 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.441 HG13 HD23 ' B' ' 11' ' ' LEU . 33.8 m -137.32 164.97 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.89 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -138.9 94.84 9.89 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -97.57 163.43 0.89 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.52 2.814 . . . . 0.0 114.495 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -145.71 146.28 31.2 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 61.1 t -125.34 133.1 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.94 126.11 44.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.551 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 88.1 mt -115.03 136.07 53.53 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -132.31 159.44 39.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.489 0.185 . . . . 0.0 110.503 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.02 13.62 82.84 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.382 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.5 -40.18 95.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.012 0.434 . . . . 0.0 111.539 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -74.52 -4.91 39.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.321 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.33 12.75 35.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.853 0.359 . . . . 0.0 110.976 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 80.5 mt -87.3 114.7 26.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.163 0.506 . . . . 0.0 110.832 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -108.98 116.65 32.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 28.5 t -116.64 135.4 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.871 -173.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -79.67 143.2 34.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.187 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -133.37 98.08 15.62 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -67.77 118.44 5.6 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.321 2.014 . . . . 0.0 112.259 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.7 mm -102.82 114.34 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.25 161.15 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.851 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -141.72 155.06 45.66 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.876 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.04 120.92 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.9 p -103.49 177.67 4.77 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.206 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -62.29 -36.9 83.53 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.229 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.74 84.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.484 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -63.18 -39.73 95.48 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.401 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.7 t -63.34 -44.69 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.812 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -58.93 -47.37 85.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.347 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.95 -41.3 99.65 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.071 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.676 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.1 OUTLIER -62.33 -45.67 92.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.672 0.273 . . . . 0.0 110.534 178.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 94.4 mt -63.12 -42.26 99.51 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.949 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -59.07 -49.09 79.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.464 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.9 m -63.48 -43.85 96.11 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.796 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' B' ' 140' ' ' MET . 97.5 mt -61.14 -45.04 96.28 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -175.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -71.08 -37.86 72.43 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.893 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -61.78 -36.31 80.71 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.028 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -82.21 29.95 0.41 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.244 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -118.51 114.34 22.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.356 0.598 . . . . 0.0 112.179 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.92 -167.35 2.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.24 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . 0.532 ' CB ' ' H ' ' B' ' 247' ' ' GLU . 22.8 m -144.38 165.98 26.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . 0.667 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 15.3 p-90 -102.08 131.97 48.22 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 120.723 0.297 . . . . 0.0 111.336 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 5.9 mtpp -162.48 -50.55 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.44 -175.09 4.95 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' B' ' 240' ' ' VAL . 34.2 mmtp -54.26 155.29 3.83 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 73.98 -168.33 0.11 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.487 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' B' ' 243' ' ' ARG . . . 113.86 1.18 24.19 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.548 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . 75.11 -40.3 0.43 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.834 0.853 . . . . 0.0 112.239 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 57.7 t 71.39 -59.73 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.584 0.754 . . . . 0.0 112.768 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . 0.546 ' HB2' ' HG2' ' B' ' 203' ' ' LYS . 9.4 pt-20 53.02 -164.73 0.08 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.688 1.195 . . . . 0.0 112.787 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . 0.407 ' HB1' ' CA ' ' B' ' 190' ' ' GLY . . . -80.75 92.8 6.09 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.699 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.97 -64.03 0.23 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.297 0.57 . . . . 0.0 110.902 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -111.0 -167.89 1.24 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.291 -173.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' B' ' 187' ' ' LEU . 24.0 ptt180 -107.79 132.17 53.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.818 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.92 140.85 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.63 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 9.5 m -76.15 109.93 10.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.217 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 84.3 mt -124.4 119.14 55.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.911 0.386 . . . . 0.0 110.794 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -95.47 75.99 3.32 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -90.59 150.64 21.64 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.349 0.595 . . . . 0.0 112.279 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 34.3 m -117.18 127.33 54.01 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.283 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.84 131.58 11.5 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.677 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 30.6 p -140.28 133.15 29.17 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 30.3 t -81.95 -84.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.954 0.407 . . . . 0.0 110.791 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -103.96 -21.3 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.505 0.669 . . . . 0.0 109.546 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.05 -16.41 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.808 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -100.34 148.53 24.59 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -82.69 149.34 27.39 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -116.37 172.18 7.36 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.35 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.31 -33.86 71.63 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.81 -178.23 32.15 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.546 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.05 29.49 41.46 Favored Glycine 0 C--O 1.224 -0.47 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.968 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.37 101.71 11.23 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -117.46 143.13 46.35 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 50.8 m -147.48 119.74 8.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.172 176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 58.07 29.97 18.6 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.429 0.456 . . . . 0.0 110.758 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -90.35 123.4 34.07 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.453 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 6.7 m -94.6 117.08 37.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.396 0.617 . . . . 0.0 110.832 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' B' ' 163' ' ' ARG . 55.2 tp -100.35 118.67 37.09 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.731 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' B' ' 193' ' ' ARG . . . -92.79 112.46 24.43 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 77.2 mtm -95.14 149.4 21.34 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.935 0.398 . . . . 0.0 111.906 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.407 ' CA ' ' HB1' ' B' ' 160' ' ' ALA . . . 101.55 4.28 52.63 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.396 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -119.24 -4.21 10.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.42 4.31 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.972 -1.109 . . . . 0.0 110.422 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.608 HH11 HG12 ' A' ' 53' ' ' ILE . 33.5 mmm-85 -100.89 -2.76 31.16 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.474 0.654 . . . . 0.0 109.925 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.452 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -142.63 175.07 10.09 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.981 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 45.4 mm -57.5 130.31 81.15 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.59 131.14 32.15 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.251 1.967 . . . . 0.0 111.793 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.42 -37.38 3.76 Favored Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.114 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -63.6 -47.76 80.12 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.051 0.426 . . . . 0.0 111.591 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.89 -9.42 59.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.038 0.446 . . . . 0.0 111.111 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -93.6 -30.07 15.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.247 0.546 . . . . 0.0 109.848 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.32 73.23 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.699 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.5 -26.06 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.065 0.46 . . . . 0.0 110.896 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.546 ' HG2' ' HB2' ' B' ' 159' ' ' GLU . 49.7 mtpt -54.73 130.73 41.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.571 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.55 -9.13 66.66 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.64 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.416 ' HA ' ' OE1' ' B' ' 209' ' ' GLU . 50.4 m80 -88.57 151.0 22.78 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 122.453 -0.44 . . . . 0.0 111.876 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -91.86 165.89 13.01 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.537 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.68 102.87 4.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . 0.571 ' H ' HD22 ' B' ' 237' ' ' LEU . . . 106.48 2.07 37.76 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' B' ' 205' ' ' HIS . 45.5 tt0 -87.95 119.44 28.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.162 0.506 . . . . 0.0 110.973 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.52 136.32 38.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.24 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -156.18 -15.2 0.1 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 30.0 p 61.6 159.17 0.05 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.959 0.904 . . . . 0.0 112.087 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.0 tp -146.47 129.96 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.984 0.421 . . . . 0.0 110.522 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -78.58 115.63 18.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.596 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 67.2 t -113.8 132.08 63.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 7.1 m -96.05 -30.57 13.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' B' ' 216' ' ' THR . 74.6 m-85 72.7 151.06 0.14 Allowed Pre-proline 0 N--CA 1.484 1.267 0 C-N-CA 122.708 0.403 . . . . 0.0 111.084 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.67 159.2 25.07 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.284 1.99 . . . . 0.0 111.49 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -65.0 -39.05 92.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.3 0.572 . . . . 0.0 109.987 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -88.75 52.45 2.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.66 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 25.7 t80 -91.26 132.94 35.81 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.441 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -90.87 103.61 16.3 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 45.4 tt0 -59.25 -30.42 68.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.323 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.481 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 31.2 p-10 -67.58 -24.43 65.5 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.671 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.8 mt -112.5 3.0 16.56 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.6 ptmt -66.89 112.75 4.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.129 -177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.06 23.18 76.15 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.045 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 99.1 mttt -117.98 128.85 55.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.9 0.35 . . . . 0.0 110.407 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -70.94 137.84 49.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.142 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.86 127.49 47.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.491 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -69.76 -40.24 76.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 58.95 103.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.045 0.45 . . . . 0.0 111.981 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.5 83.96 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.755 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 45.5 mm 62.58 83.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.739 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -109.0 128.08 54.64 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.564 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . 0.571 HD22 ' H ' ' B' ' 208' ' ' GLY . 3.8 mp -100.65 120.28 39.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.629 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -98.66 -56.25 2.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.439 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -94.86 -89.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.4 ' O ' ' HE2' ' B' ' 154' ' ' LYS . 59.3 t 67.43 120.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 120.994 0.426 . . . . 0.0 110.177 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -77.46 -92.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -174.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -173.04 155.78 3.11 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.667 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 14.8 ptp180 166.92 78.12 0.0 OUTLIER 'General case' 0 C--N 1.364 1.207 0 C-N-CA 124.782 1.233 . . . . 0.0 113.129 170.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.08 160.49 40.13 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.414 ' HA ' ' HD2' ' B' ' 246' ' ' PRO . 55.4 tp 70.1 108.06 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 123.67 0.788 . . . . 0.0 111.92 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' B' ' 245' ' ' LEU . 41.6 Cg_endo -68.44 111.51 2.55 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.251 1.967 . . . . 0.0 112.082 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . 0.532 ' H ' ' CB ' ' B' ' 150' ' ' THR . 6.4 tp10 -117.77 -13.09 10.16 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.438 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 41.7 tp 71.41 130.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.29 1.036 . . . . 0.0 112.848 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . 0.526 HG22 ' H ' ' B' ' 250' ' ' ALA . 0.5 OUTLIER -142.96 -163.28 1.6 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.526 ' H ' HG22 ' B' ' 249' ' ' THR . . . -130.3 -21.63 2.88 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.59 -35.6 80.59 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . 0.444 ' HE2' ' H ' ' B' ' 249' ' ' THR . 55.7 p90 -65.41 -17.29 64.42 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.95 -42.57 97.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.968 0.413 . . . . 0.0 111.195 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' LYS . . . . . 0.572 ' H ' ' HD2' ' B' ' 254' ' ' LYS . 0.0 OUTLIER -97.76 18.58 15.37 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -68.9 -16.83 63.86 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.007 0.432 . . . . 0.0 111.61 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 256' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' B' ' 266' ' ' LEU . 85.3 m-85 -59.74 -30.63 68.96 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.1 -31.14 9.05 Favored Glycine 0 CA--C 1.51 -0.245 0 C-N-CA 120.196 -1.002 . . . . 0.0 114.048 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 26.2 t -81.23 85.57 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . 0.505 ' HG2' ' H ' ' B' ' 260' ' ' ASP . 12.5 tt0 53.72 -163.88 0.1 Allowed 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.681 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . 0.505 ' H ' ' HG2' ' B' ' 259' ' ' GLU . 1.4 p-10 -123.31 113.07 18.38 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.621 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -95.74 169.77 27.42 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.367 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 15.1 p -89.62 -173.75 4.07 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.9 t -60.53 -48.57 87.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.901 0.381 . . . . 0.0 111.339 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' B' ' 264' ' ' GLU . 0.1 OUTLIER -86.42 -34.09 20.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.905 0.383 . . . . 0.0 110.523 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.96 -39.98 98.73 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.481 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.436 HD21 ' CE1' ' B' ' 256' ' ' PHE . 54.8 tp -62.62 -43.28 99.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.736 0.303 . . . . 0.0 110.846 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -62.4 -44.01 97.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.83 -43.83 87.38 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.053 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -66.35 -40.79 90.05 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.433 ' O ' ' HG2' ' B' ' 274' ' ' MET . 73.6 t -64.85 -43.32 96.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.034 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -57.47 -49.32 76.66 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.616 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 16.1 ptmt -67.41 -41.92 84.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.65 0.262 . . . . 0.0 111.581 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -64.58 -39.39 93.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.789 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.0 mmm -62.33 -41.61 98.7 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -68.69 -34.94 76.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.752 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -61.85 -43.91 97.9 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -69.0 -38.21 79.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.199 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 45.0 tp -62.35 -38.34 89.14 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.79 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -56.55 -44.26 80.74 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.197 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 20.4 m -62.13 -41.59 98.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.533 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.27 93.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.84 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . 0.41 ' O ' HG23 ' B' ' 286' ' ' VAL . 67.8 mt -63.04 -45.71 98.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.271 178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . 0.515 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.9 OUTLIER -59.47 -45.84 90.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.05 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -63.91 -42.73 97.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.725 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -66.11 -39.58 90.04 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.54 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' 282' ' ' ILE . 97.9 t -65.78 -44.39 93.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.178 0.514 . . . . 0.0 110.01 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.28 -46.85 84.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.373 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 76.6 p -62.87 -42.78 99.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -64.05 -42.81 96.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 111.101 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.32 82.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.061 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . 0.442 ' O ' HG23 ' B' ' 295' ' ' VAL . 38.0 mm -65.28 -44.19 95.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.318 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . 0.407 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 18.1 tp10 -62.83 -43.48 98.67 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.972 0.415 . . . . 0.0 110.853 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.22 98.14 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.527 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 51.8 mt -63.25 -43.08 99.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 291' ' ' ILE . 84.1 t -65.34 -44.67 94.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.45 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . 0.407 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 67.3 mttm -64.35 -41.95 96.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.332 . . . . 0.0 111.685 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.88 82.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.651 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -127.6 96.6 4.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.643 0.259 . . . . 0.0 111.538 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -91.24 93.54 9.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.319 0.58 . . . . 0.0 109.591 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.0 tp -100.95 136.9 30.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.66 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.81 135.06 50.58 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.161 0.505 . . . . 0.0 110.54 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.08 134.09 20.59 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.194 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.58 134.98 67.16 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 122.353 2.035 . . . . 0.0 112.244 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.85 78.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.151 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.86 -45.2 82.61 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.002 0.43 . . . . 0.0 111.035 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.97 -43.08 88.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.93 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . 0.413 ' O ' HG13 ' B' ' 311' ' ' ILE . 71.7 mt -62.45 -49.55 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.731 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.22 -42.98 99.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.82 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 42.7 m -62.48 -45.84 91.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.903 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . 0.639 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 65.2 mm-40 -72.01 -36.68 69.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.474 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 85.0 mt -61.82 -43.94 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.568 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 25.2 t70 -60.99 -42.75 99.03 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.718 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.25 -42.65 91.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.655 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 91.0 mt -61.94 -39.9 93.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.813 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 84.1 mtm180 -62.62 -36.77 83.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.097 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 93.0 mtt180 -63.4 -39.81 95.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.576 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -63.16 -44.74 94.65 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.455 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.59 -39.66 88.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.749 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.84 92.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.4 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.9 -40.38 94.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.287 0.565 . . . . 0.0 110.143 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -72.38 -19.72 61.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.939 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -76.09 -6.78 52.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.744 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 136.85 -12.46 3.92 Favored Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.939 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 113.21 35.61 1.6 Allowed Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.102 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -76.48 123.26 25.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.978 0.418 . . . . 0.0 110.007 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . 0.402 ' CB ' HH22 ' A' ' 73' ' ' ARG . 0.1 OUTLIER -125.25 160.43 29.26 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.555 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.1 OUTLIER 69.49 -52.24 0.61 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.157 0.583 . . . . 0.0 112.534 -178.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . 0.435 ' HG3' ' HB3' ' A' ' 65' ' ' ASP . 15.4 mm100 -74.82 -4.32 37.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.96 -24.7 64.6 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.354 0.597 . . . . 0.0 109.624 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.45 HD12 HH12 ' B' ' 315' ' ' ARG . 39.1 tp -63.83 -33.89 76.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.623 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -80.99 -9.97 59.77 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.034 -177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . 0.444 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 93.9 mt -63.53 128.66 92.92 Favored Pre-proline 0 C--O 1.242 0.708 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.032 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.38 126.82 23.8 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.744 2.296 . . . . 0.0 113.025 -176.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -65.13 -44.03 89.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.062 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.89 -24.74 67.62 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.9 -8.02 57.65 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.829 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -121.21 -17.22 7.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.922 0.392 . . . . 0.0 111.506 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.05 -25.65 65.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.619 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.4 -51.53 68.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.822 0.344 . . . . 0.0 110.522 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -76.79 -23.06 52.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.124 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.469 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -61.74 -40.59 95.65 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.121 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . 0.445 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.2 tttt -59.82 -45.3 92.78 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.89 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . 0.517 ' O ' HG23 ' B' ' 347' ' ' VAL . 19.0 mmt85 -62.94 -43.21 99.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.246 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . 0.489 ' NH2' HD22 ' B' ' 314' ' ' LEU . 90.8 mtt180 -64.62 -41.36 96.24 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.114 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 90.5 t -65.2 -44.16 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.588 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 342' ' ' LYS . 76.6 t -61.5 -43.62 97.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.802 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 343' ' ' ARG . 70.4 t -60.22 -45.5 95.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.79 99.66 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.961 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 93.3 mt -63.28 -43.66 97.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.786 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.429 ' O ' HG23 ' B' ' 354' ' ' VAL . 97.6 mt -63.6 -45.64 89.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.967 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.1 -41.54 94.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.091 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.74 -42.86 99.81 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.115 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -67.48 -37.81 83.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.851 0.325 . . . . 0.0 110.948 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 350' ' ' LEU . 70.9 t -61.0 -45.54 98.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.18 -44.68 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.915 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.6 -51.8 56.94 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 96.6 m -66.47 -45.83 78.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -86.58 -6.86 58.77 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -175.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 63.37 69.57 0.56 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.295 0.569 . . . . 0.0 111.516 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.1 mt -101.25 160.03 14.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.87 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -137.07 155.0 50.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.461 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.64 104.61 11.28 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 171.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . 0.511 ' O ' HG23 ' B' ' 367' ' ' VAL . 32.8 t70 -87.05 114.74 23.92 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -173.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 57.8 mm-40 -59.73 -36.63 76.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.059 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . 0.442 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 6.1 mm-40 -63.31 -42.51 99.03 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 111.013 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -63.24 -39.72 95.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.091 0.472 . . . . 0.0 110.072 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . 0.536 HG21 ' HG2' ' B' ' 399' ' ' ARG . 70.5 t -62.81 -37.32 78.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.416 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.2 mmmt -57.4 -44.71 84.78 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.6 -38.85 96.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.082 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.76 -43.06 99.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.65 -44.19 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.095 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.51 -42.18 98.5 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.15 -37.65 81.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.894 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.4 ttm -65.83 -42.21 90.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.049 0.452 . . . . 0.0 110.719 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.28 72.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.044 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 50.6 m -71.6 -4.58 27.89 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.918 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -88.96 -4.02 58.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.877 0.37 . . . . 0.0 111.637 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -112.04 172.64 6.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.217 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.64 -48.38 72.35 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.717 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 21.4 t70 -127.82 116.4 20.78 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.041 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.48 -31.07 42.88 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.368 2.045 . . . . 0.0 113.165 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.1 -43.74 86.38 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 11.4 pt-20 -62.96 -38.86 92.8 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.891 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.91 -42.11 93.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.602 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.19 -44.19 98.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.413 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 36.7 mt-10 -64.95 -44.96 87.72 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.85 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.94 -45.77 89.62 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.16 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -66.59 -39.87 88.64 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.745 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 58.3 p -81.58 -3.36 53.1 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.3 mttt -104.13 13.34 32.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.003 0.43 . . . . 0.0 110.98 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -138.49 118.04 12.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.272 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.64 -41.52 98.24 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -56.17 -50.26 71.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.968 0.413 . . . . 0.0 110.93 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.07 -42.1 99.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.397 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.441 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.2 mtp -64.68 -53.94 39.49 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.05 -39.54 83.01 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -61.98 -40.67 96.41 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 48.6 tpp -65.26 -40.63 94.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.838 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.536 ' HG2' HG21 ' B' ' 367' ' ' VAL . 66.8 mtm180 -64.06 -36.21 83.25 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.121 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -61.39 -42.84 99.37 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.728 0.299 . . . . 0.0 110.206 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.33 -44.85 94.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.447 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.98 -41.3 99.51 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.097 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.31 -40.09 96.39 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.649 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.45 -43.44 96.85 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . 0.515 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 26.6 mt-10 -65.13 -38.17 89.79 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.616 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.73 -43.32 94.25 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 120.803 0.335 . . . . 0.0 110.38 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.95 90.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.224 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.32 -44.89 94.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.16 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 45.2 mt-10 -66.03 -33.12 75.07 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.004 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.02 96.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.386 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 95.4 t -67.45 -42.92 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.324 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.54 -41.21 97.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.002 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.83 -20.88 66.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.708 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -97.4 -6.87 33.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.301 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -111.21 179.98 3.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.267 0.556 . . . . 0.0 111.801 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.12 130.39 35.11 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.357 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 70.4 t -117.82 130.34 72.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 6.0 t -129.87 135.74 48.73 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.089 0.471 . . . . 0.0 110.674 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -93.32 123.56 36.69 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.238 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -138.88 133.41 31.91 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.807 0.337 . . . . 0.0 111.155 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -83.64 150.53 25.84 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.795 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -157.29 170.65 21.98 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 20.0 p -79.34 164.3 24.18 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.745 0.307 . . . . 0.0 110.284 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -64.33 -19.47 65.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.059 0.457 . . . . 0.0 111.009 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -61.31 -38.02 85.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.831 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -65.13 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.1 0.476 . . . . 0.0 110.238 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 8.2 mp -73.63 -20.47 60.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.7 mmt -78.25 -9.87 59.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -78.21 83.16 4.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.286 0.565 . . . . 0.0 109.841 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -106.09 4.02 28.72 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.532 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -67.47 -44.86 77.55 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.607 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.951 -179.536 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.235 0.295 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.8 m -125.43 97.33 5.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.896 0.379 . . . . 0.0 111.286 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.79 140.65 23.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.742 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.598 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 41.1 tt0 -145.18 169.95 17.18 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.6 t -103.93 157.16 17.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.806 0.276 . . . . 0.0 111.204 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.4 m -123.87 -71.19 0.73 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.835 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -153.56 120.76 5.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.45 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.74 -120.38 20.05 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.733 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 6.8 mp -87.75 -5.5 58.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -71.22 130.1 18.5 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.78 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 4.7 tpp180 -119.03 -161.81 0.87 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -146.38 128.32 15.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.29 -94.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.056 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 m 52.89 87.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.12 0.486 . . . . 0.0 111.603 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 tp -108.65 139.2 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.935 0.398 . . . . 0.0 111.567 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.6 m -106.65 125.73 51.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.1 pt -127.83 157.87 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.703 0.287 . . . . 0.0 111.587 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.538 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -77.3 161.83 27.78 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.479 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.03 -49.06 76.99 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.09 -34.7 78.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.961 0.41 . . . . 0.0 110.608 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -62.21 -40.1 94.97 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.758 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.3 mt -62.13 -48.96 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.168 0.508 . . . . 0.0 110.812 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -67.64 -40.11 84.6 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.008 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -79.65 -67.73 0.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.37 79.28 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -172.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.429 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 98.0 t -61.81 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.688 0.28 . . . . 0.0 111.694 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -63.4 -44.89 93.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.032 0.444 . . . . 0.0 110.306 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.5 m -62.79 -42.24 99.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.254 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -63.51 -36.41 83.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.776 0.322 . . . . 0.0 110.584 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.2 mt -62.48 -43.55 98.54 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.706 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.46 -35.02 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.936 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -63.49 -43.07 98.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.46 -29.32 34.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.923 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.95 -39.7 87.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.004 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.43 -21.55 58.1 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.075 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.81 -44.45 96.85 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.06 0.457 . . . . 0.0 109.876 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.4 t -91.75 -2.33 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.075 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 63.37 26.81 15.12 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.998 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.8 pp -101.12 7.64 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.578 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -63.57 -33.56 75.87 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.952 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.53 -0.58 67.96 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.749 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -94.47 -3.74 49.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.764 0.316 . . . . 0.0 111.192 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -88.04 122.66 31.88 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -66.92 -7.24 20.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -173.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.55 -34.95 3.7 Favored Glycine 0 C--N 1.315 -0.62 0 C-N-CA 120.381 -0.914 . . . . 0.0 114.212 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -63.69 133.87 54.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 117.49 0.645 . . . . 0.0 109.36 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.572 HG12 HG12 ' A' ' 54' ' ' VAL . 20.0 t 64.27 72.62 0.5 Allowed Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.565 ' O ' HG13 ' A' ' 54' ' ' VAL . 58.8 Cg_endo -69.62 161.42 45.98 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.381 2.72 . . . . 0.0 113.691 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.827 ' HA ' HG22 ' A' ' 54' ' ' VAL . 49.3 mtt -62.32 -34.65 77.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -175.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -62.96 -25.61 68.44 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.541 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -92.73 -39.6 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.183 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.827 HG22 ' HA ' ' A' ' 51' ' ' MET . 8.6 m -62.59 -33.05 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 120.659 0.266 . . . . 0.0 111.118 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.43 -32.9 72.88 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.707 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -100.33 -34.35 10.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.619 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -65.54 -43.08 91.08 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -125.61 20.54 7.87 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.737 0.303 . . . . 0.0 111.117 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.655 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -57.38 -45.64 92.69 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 114.536 0.575 . . . . 0.0 114.536 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.02 -19.64 20.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 117.538 0.669 . . . . 0.0 111.369 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 t -63.13 -44.68 94.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.125 -177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.5 p -120.58 19.47 5.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.496 0.665 . . . . 0.0 110.702 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 39.5 ttm180 -58.12 -29.51 65.57 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.627 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -61.08 -50.48 73.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.538 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.99 -20.74 57.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.046 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.7 t -63.66 -44.2 98.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 99.2 mt -62.63 -40.43 96.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.173 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.2 -43.85 98.54 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.283 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.713 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 37.2 t70 -64.16 -43.23 95.81 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.983 0.391 . . . . 0.0 110.279 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 98.1 mt -61.11 -42.25 98.19 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.871 0.367 . . . . 0.0 110.265 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.3 ttp -61.4 -45.56 93.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.815 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 m -62.43 -44.62 95.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.042 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.713 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 37.6 mtp85 -65.86 -43.65 87.77 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.078 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -65.87 -40.5 91.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.061 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -61.17 -48.16 82.83 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.502 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.0 tt -68.53 -39.47 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.498 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.449 ' O ' ' HE3' ' A' ' 81' ' ' LYS . 10.6 t70 -62.35 -41.68 98.78 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.332 0.587 . . . . 0.0 109.431 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -66.05 -45.62 80.74 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.703 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.2 pt -65.46 -29.75 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.933 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.26 -44.22 97.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.096 0.474 . . . . 0.0 110.766 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 16.2 ptpt -81.79 -24.41 35.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.59 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -87.82 -5.96 58.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.99 0.424 . . . . 0.0 110.437 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 64.2 40.55 6.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.669 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.4 mt -101.75 118.82 49.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.408 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -107.7 102.29 44.24 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.153 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.87 141.59 65.74 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.517 2.145 . . . . 0.0 112.159 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.98 90.5 8.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.375 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.1 -109.89 3.49 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.029 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.14 127.62 24.27 Favored Pre-proline 0 C--N 1.318 -0.775 0 O-C-N 122.852 -0.205 . . . . 0.0 110.991 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.64 161.39 45.42 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.737 2.291 . . . . 0.0 111.298 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -93.61 116.09 28.58 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.316 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.456 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 93.0 m-85 -94.11 127.66 40.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.62 98.31 36.58 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 120.893 0.377 . . . . 0.0 111.334 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 90.6 Cg_endo -97.3 171.69 0.77 Allowed 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 123.471 2.78 . . . . 0.0 110.981 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.66 -175.97 22.4 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.46 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -85.07 135.07 34.15 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -90.95 125.34 35.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.391 0.615 . . . . 0.0 110.876 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 97.8 mttt -113.49 124.05 51.48 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.1 tp -69.77 123.51 21.62 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.32 -16.3 56.91 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.231 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 50.4 mt-10 -113.34 178.83 4.14 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -86.44 168.64 13.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.972 0.415 . . . . 0.0 111.549 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -124.0 146.88 48.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.094 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.0 m -131.54 143.21 50.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.958 0.408 . . . . 0.0 111.241 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -138.43 154.12 48.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.571 ' O ' HG12 ' A' ' 107' ' ' VAL . 21.1 m -93.79 -74.87 0.52 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -175.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 65.41 142.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 124.012 0.925 . . . . 0.0 110.119 -172.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 42.8 mt-10 -119.87 129.9 54.61 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -164.17 146.01 8.82 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 64.31 158.76 0.09 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 175.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.48 156.42 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.548 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -158.19 106.12 1.71 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -82.9 151.63 14.41 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.897 2.398 . . . . 0.0 113.983 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -123.36 145.74 48.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.44 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.75 131.04 73.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.779 0.323 . . . . 0.0 111.801 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -108.22 -85.49 0.52 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.815 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.9 mt 57.44 114.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -132.34 153.66 50.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.146 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.06 19.16 70.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.52 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.43 -41.28 98.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.135 0.493 . . . . 0.0 111.079 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -73.9 -4.72 36.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.565 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -105.41 16.27 25.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.794 0.33 . . . . 0.0 110.99 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 89.7 mt -90.86 122.48 42.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.135 0.493 . . . . 0.0 111.091 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -110.47 124.06 51.06 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.54 133.91 62.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.772 0.32 . . . . 0.0 111.425 -175.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.38 134.0 36.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.54 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -128.0 98.2 27.76 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.871 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.86 126.95 11.76 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.358 2.039 . . . . 0.0 112.386 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.2 mm -109.94 120.92 61.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.622 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.59 162.55 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.334 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -136.7 149.85 48.13 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.088 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.2 t -76.03 127.48 37.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.2 p -113.84 177.25 4.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.245 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -63.29 -34.75 78.37 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.719 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.03 90.91 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.402 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -63.47 -41.99 98.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.572 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.44 -45.5 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.403 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.93 -43.12 99.06 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.543 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.81 99.72 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.307 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.591 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 3.3 tpt -62.65 -46.93 85.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.846 0.355 . . . . 0.0 110.621 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.75 -42.04 97.9 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.598 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -62.14 -43.32 99.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.148 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.7 m -62.66 -41.55 99.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.151 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.2 mt -61.23 -42.67 99.0 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -71.26 -22.17 62.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.369 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.77 -0.55 54.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.519 0.676 . . . . 0.0 110.077 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -116.47 20.95 13.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.954 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -122.33 95.68 4.74 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.526 ' HB3' ' OE1' ' A' ' 159' ' ' GLU . . . -140.68 159.08 42.98 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 173.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 247' ' ' GLU . 6.9 m -122.37 142.82 50.11 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.194 -1.003 . . . . 0.0 112.055 -175.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 41.0 p-90 -74.43 132.12 41.67 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.253 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 244' ' ' GLU . 64.5 tttp -162.84 -63.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 242' ' ' GLU . 40.8 mt-10 -116.17 -96.28 0.46 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -176.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 155' ' ' ASP . 23.3 tptm -92.34 -113.34 0.09 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -167.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 3.5 t70 -152.84 154.93 36.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.529 -172.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 164.22 -34.61 0.28 Allowed Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -152.76 140.2 19.65 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.437 ' HA ' ' HD2' ' A' ' 243' ' ' ARG . 58.1 t -129.9 125.98 61.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.225 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.526 ' OE1' ' HB3' ' A' ' 149' ' ' ALA . 4.4 mp0 -88.48 158.86 18.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.22 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -83.39 52.62 2.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.826 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.402 ' CD ' HH11 ' A' ' 255' ' ' ARG . 1.2 pp20? -162.53 9.1 0.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.181 0.515 . . . . 0.0 110.665 177.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 163' ' ' ARG . 15.8 t70 -104.12 -172.89 2.19 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.528 -175.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.402 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 42.8 ttm180 -121.96 117.44 26.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.601 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.11 130.03 63.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.449 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 55.9 m -86.76 117.56 25.59 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 83.5 mt -126.89 123.04 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.099 0.476 . . . . 0.0 111.702 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -95.13 105.47 17.4 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -124.52 149.58 46.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.476 0.655 . . . . 0.0 112.438 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.5 m -124.52 128.37 48.85 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.423 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.63 142.98 18.95 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.887 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 m -139.53 146.25 39.69 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.54 -86.21 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.328 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -99.44 -45.65 5.76 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.026 0.441 . . . . 0.0 110.003 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.2 15.29 0.23 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.766 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -138.81 148.63 44.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.561 0.219 . . . . 0.0 110.564 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.91 161.79 30.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.468 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -131.31 177.55 7.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.033 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.86 -35.19 72.55 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -105.39 -172.59 24.01 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.863 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.68 32.54 41.01 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.502 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -113.47 114.57 26.74 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.99 146.47 49.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.947 0.404 . . . . 0.0 111.534 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -143.03 122.08 12.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.727 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 59.99 34.82 21.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.665 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -89.08 132.52 34.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.847 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 88.3 t -96.19 124.46 48.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.901 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 63.5 tp -111.5 123.96 51.31 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.019 0.438 . . . . 0.0 111.285 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -111.22 112.23 23.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 73.0 mtm -84.64 160.04 20.46 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.684 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.34 -24.83 28.99 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.411 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -91.36 -6.34 53.12 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.25 46.12 13.47 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.035 -1.079 . . . . 0.0 111.662 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -85.44 -11.75 53.62 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.22 170.51 12.92 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.425 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.641 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.2 mp -55.66 132.31 71.92 Favored Pre-proline 0 C--N 1.323 -0.559 0 O-C-N 123.385 0.428 . . . . 0.0 110.063 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -48.36 129.31 19.16 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.264 1.976 . . . . 0.0 111.681 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.68 -33.86 5.91 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.699 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -62.27 -44.7 95.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.602 0.239 . . . . 0.0 110.655 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.56 -40.55 95.76 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.93 -33.25 75.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.006 0.431 . . . . 0.0 110.847 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.03 -22.77 70.82 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.183 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.16 -43.46 97.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -52.17 115.78 1.89 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.446 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 113.78 -10.81 23.22 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.188 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.625 ' HA ' ' OE1' ' A' ' 209' ' ' GLU . 47.7 m80 -98.6 139.03 34.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.036 0.418 . . . . 0.0 111.201 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -98.26 168.94 9.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.62 132.16 48.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.5 33.13 61.35 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.118 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.625 ' OE1' ' HA ' ' A' ' 205' ' ' HIS . 41.9 tt0 -117.86 117.37 29.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.173 0.511 . . . . 0.0 110.388 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -105.1 130.81 53.2 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.815 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -153.36 -23.02 0.15 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.463 HG22 ' HA ' ' A' ' 234' ' ' ALA . 80.4 p 60.05 167.88 0.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.776 0.831 . . . . 0.0 112.031 -175.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 19.2 tt -160.41 144.68 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.225 -0.297 . . . . 0.0 110.896 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.99 108.46 15.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.805 0.336 . . . . 0.0 111.381 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.55 122.54 64.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 16.3 p -90.36 -22.69 21.38 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -173.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 70.6 m-85 67.89 140.37 0.07 OUTLIER Pre-proline 0 N--CA 1.483 1.219 0 CA-C-O 121.068 0.461 . . . . 0.0 111.581 -176.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 14.4 Cg_exo -69.54 150.4 69.52 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.455 2.103 . . . . 0.0 112.0 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.436 ' O ' ' HE2' ' A' ' 227' ' ' LYS . 81.0 mm-40 -66.56 -38.56 87.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.992 0.425 . . . . 0.0 110.171 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -86.45 33.3 0.63 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.732 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.515 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 10.9 t80 -70.01 131.4 44.3 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -65.02 -17.23 64.26 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.515 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -98.95 99.62 10.69 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 38.9 tt0 -56.52 -33.07 65.69 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.897 -175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -66.24 -18.41 65.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.904 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.24 -1.11 9.25 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 14.1 ptmm? -67.81 121.44 15.99 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.397 0.617 . . . . 0.0 112.301 -175.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 82.06 8.43 86.56 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.589 -0.732 . . . . 0.0 114.097 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -118.48 137.94 52.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.528 0.664 . . . . 0.0 110.879 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -91.21 155.4 18.61 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.49 144.57 32.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.733 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 3.4 mppt? -98.74 -15.82 19.19 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 56.37 -149.96 0.45 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.133 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.463 ' HA ' HG22 ' A' ' 212' ' ' THR . . . -141.0 -68.43 0.4 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.753 0.311 . . . . 0.0 110.56 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.2 mt 64.74 91.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.954 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -98.19 -27.68 14.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.291 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.0 tp 52.1 67.01 1.04 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.882 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -65.34 -43.44 90.87 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.433 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 30.7 mtpp -96.98 -80.02 0.45 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -173.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 85.4 t 77.96 139.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -171.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -91.6 -84.05 0.27 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -172.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 153' ' ' GLU . 43.0 tt0 -165.23 103.8 0.75 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 19.6 ttm-85 -166.81 113.92 0.82 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 175.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -177.92 155.24 0.97 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 42.3 tp 67.89 100.8 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.321 0 O-C-N 124.135 0.897 . . . . 0.0 111.18 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 42.1 Cg_endo -69.01 111.93 2.8 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.229 1.953 . . . . 0.0 112.889 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.582 ' O ' HG21 ' A' ' 150' ' ' THR . 44.5 tt0 -137.13 147.64 46.14 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.5 mp -73.48 98.88 2.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.984 0.421 . . . . 0.0 111.108 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.9 p -95.24 -89.02 0.25 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.428 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -170.79 -51.41 0.02 OUTLIER 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.9 0.381 . . . . 0.0 111.342 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -81.14 89.39 5.99 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.994 0.426 . . . . 0.0 111.882 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.486 ' CD1' HG23 ' A' ' 253' ' ' ILE . 51.5 p90 -159.02 -13.48 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.214 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.486 HG23 ' CD1' ' A' ' 252' ' ' PHE . 19.0 pt -121.17 -41.28 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.022 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -83.36 -2.95 56.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.35 0.595 . . . . 0.0 110.327 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.402 HH11 ' CD ' ' A' ' 161' ' ' GLU . 54.2 ttp180 -124.7 98.26 5.64 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -148.72 -61.2 0.24 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -166.0 -75.64 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.54 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 68.0 t -104.25 117.74 50.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 122.832 -0.216 . . . . 0.0 111.12 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 58.1 -170.0 0.11 Allowed 'General case' 0 CA--C 1.544 0.733 0 O-C-N 123.989 0.806 . . . . 0.0 110.656 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -104.7 112.71 25.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.323 0.582 . . . . 0.0 109.789 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -98.01 167.72 23.02 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.203 -0.998 . . . . 0.0 113.774 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 56.1 p -108.63 -167.39 1.22 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.91 -54.17 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.358 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.2 OUTLIER -80.3 -38.81 29.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 -178.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.26 98.18 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.634 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 270' ' ' VAL . 49.0 tp -63.89 -43.21 96.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.555 0.216 . . . . 0.0 110.59 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -63.54 -40.41 96.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.391 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.23 -44.11 89.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.802 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -68.07 -38.12 82.04 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.133 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 266' ' ' LEU . 79.3 t -64.0 -43.35 97.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.656 0.265 . . . . 0.0 110.507 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -59.27 -46.37 88.71 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.993 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.5 ptmt -66.34 -44.49 83.15 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -63.95 -39.47 94.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 270' ' ' VAL . 99.3 mmm -64.47 -40.67 96.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.76 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.99 -35.3 79.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 110.795 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -62.71 -41.77 99.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.759 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -64.61 -37.49 87.75 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.734 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 46.0 tp -61.83 -38.29 87.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.876 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -57.58 -45.53 85.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.861 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.9 m -62.35 -42.39 99.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.605 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.13 82.95 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.057 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.85 -43.73 97.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.297 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.496 ' HD3' ' HG2' ' A' ' 405' ' ' GLU . 1.4 tpm_? -59.54 -46.99 87.27 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.022 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -65.61 -40.69 92.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.398 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -61.09 -43.34 99.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.26 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.43 -44.12 90.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.348 0.594 . . . . 0.0 110.19 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.46 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.5 tttt -62.05 -48.84 78.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.264 -177.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.9 p -64.63 -41.38 96.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -65.86 -42.3 90.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.46 -47.23 82.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.959 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 287' ' ' LYS . 48.0 mm -64.57 -44.18 96.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.41 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.445 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 17.1 tp10 -60.16 -45.11 94.21 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 110.681 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.74 -42.7 98.51 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.246 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.48 -41.69 96.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 291' ' ' ILE . 71.3 t -63.16 -45.09 99.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.452 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . 0.445 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.7 mttm -63.83 -42.54 97.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 111.064 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.32 -42.7 62.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -118.75 92.52 3.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -98.54 99.22 10.35 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -106.1 159.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.742 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -64.13 137.5 57.99 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.22 128.52 25.54 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.242 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.437 ' O ' HG13 ' A' ' 307' ' ' ILE . 47.0 Cg_exo -56.6 128.5 30.3 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.344 2.029 . . . . 0.0 111.712 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.37 83.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.735 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.5 -41.53 90.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.9 mt -67.88 -41.65 82.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.501 ' O ' HG13 ' A' ' 311' ' ' ILE . 69.4 mt -61.93 -51.27 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.704 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.85 -43.81 98.1 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 41.6 m -61.6 -45.47 93.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.601 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.68 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 72.9 mm-40 -71.58 -34.1 69.64 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 307' ' ' ILE . 95.1 mt -61.4 -43.79 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.663 0.268 . . . . 0.0 110.723 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.504 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.7 t70 -62.3 -40.98 98.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.1 t -62.98 -44.67 99.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.275 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 46.1 mt -63.03 -39.39 94.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.956 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.504 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 83.9 mtm180 -63.08 -39.82 95.84 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.902 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 84.3 mtt180 -66.02 -38.98 89.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.786 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.58 -43.02 99.86 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.109 0.481 . . . . 0.0 109.943 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.49 -36.62 79.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.326 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -62.54 -36.94 84.2 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.628 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . 0.401 HE22 ' HB2' ' B' ' 46' ' ' LYS . 35.6 tt0 -62.07 -42.29 99.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.434 0.635 . . . . 0.0 109.876 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -78.23 -6.96 56.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.599 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -91.37 -3.74 56.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.313 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 135.33 -21.41 3.65 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.519 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 118.15 34.11 1.17 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.455 -0.878 . . . . 0.0 111.241 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.471 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 42.0 t-20 -71.97 126.87 30.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.7 tm-20 -127.8 150.57 49.77 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 6.5 ptpp? 61.94 -39.38 0.14 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.667 1.587 . . . . 0.0 114.057 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.471 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 16.0 mm100 -71.79 -11.58 60.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.271 0.558 . . . . 0.0 110.438 177.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.69 -21.23 66.28 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.987 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.47 HD12 HH12 ' A' ' 315' ' ' ARG . 63.1 tp -62.54 -37.48 86.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.131 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -80.97 -2.85 49.5 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.864 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 74.8 mt -69.42 149.08 97.26 Favored Pre-proline 0 C--O 1.239 0.541 0 O-C-N 122.265 -0.272 . . . . 0.0 110.394 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.6 143.77 99.46 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.658 2.239 . . . . 0.0 113.113 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 25.5 ttt85 -83.31 -42.17 17.44 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.808 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -57.99 -43.74 86.78 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.424 ' HB2' ' OE2' ' A' ' 224' ' ' GLU . 88.7 mt -85.74 -3.27 58.85 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.808 -176.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -104.64 -27.58 11.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.948 0.404 . . . . 0.0 110.151 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.1 -25.56 67.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.661 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -60.14 -48.04 83.38 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.845 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -80.79 -22.11 40.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.599 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.29 -41.95 99.03 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.429 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.8 tttt -60.06 -46.2 90.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.16 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.549 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.0 mmt85 -62.01 -45.64 92.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.428 ' NH2' HD22 ' A' ' 314' ' ' LEU . 91.1 mtt180 -67.14 -38.09 84.94 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.451 -178.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 341' ' ' ALA . 78.7 t -64.44 -44.24 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.648 0.261 . . . . 0.0 110.599 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 342' ' ' LYS . 69.5 t -61.71 -43.34 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.572 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 343' ' ' ARG . 76.4 t -60.17 -45.2 96.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.9 -42.53 99.75 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.141 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.77 -44.75 92.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.659 0.266 . . . . 0.0 111.334 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 354' ' ' VAL . 96.2 mt -64.03 -46.71 83.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.275 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.26 -38.69 78.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.412 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.72 -42.92 96.6 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.196 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.08 -36.48 79.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.831 0.316 . . . . 0.0 110.881 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 350' ' ' LEU . 86.6 t -60.81 -44.67 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.63 -44.23 98.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.841 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -69.87 -46.25 65.92 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.9 m -66.73 -44.98 80.12 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -90.71 4.77 50.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.967 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 53.06 47.61 24.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.109 0.48 . . . . 0.0 111.632 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.9 mt -73.37 140.26 46.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.877 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -119.86 153.63 35.53 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.851 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.13 110.04 15.16 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.498 ' O ' HG23 ' A' ' 367' ' ' VAL . 23.1 t70 -83.46 112.46 19.98 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.918 -174.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.57 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 15.7 mm-40 -59.36 -38.73 81.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.629 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.76 -42.85 90.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.431 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -62.33 -38.32 89.0 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.517 HG21 ' HG2' ' A' ' 399' ' ' ARG . 99.0 t -64.42 -40.08 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.632 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.8 mmmt -56.65 -44.54 81.44 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.59 -40.14 98.35 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.197 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.97 -42.26 99.78 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.694 0.283 . . . . 0.0 110.639 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.13 -44.3 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.713 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.11 -39.23 89.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.45 -36.14 80.61 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.488 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 51.0 ttm -65.61 -39.8 91.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.103 0.478 . . . . 0.0 110.202 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -61.54 -29.79 70.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.86 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 13.2 m -72.53 -5.58 37.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.585 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.51 -8.73 52.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 0.0 110.843 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -107.36 171.09 7.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.235 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.28 -36.78 85.23 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.338 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -133.67 109.12 12.06 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 120.878 0.37 . . . . 0.0 110.736 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.425 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 53.0 Cg_exo -56.96 -39.64 89.95 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.058 2.505 . . . . 0.0 113.728 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -64.36 -42.69 96.06 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.28 -37.96 87.5 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.061 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.24 -43.43 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.0 -44.94 99.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.463 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 53.9 mt-10 -68.75 -42.12 77.99 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.976 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -59.36 -46.52 88.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.828 0.347 . . . . 0.0 111.119 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.18 -41.43 94.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.664 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 32.9 p -80.23 -6.47 57.9 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 97.9 mttt -101.0 5.23 43.03 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.876 0.37 . . . . 0.0 111.0 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -126.06 119.38 27.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -62.62 -43.69 98.17 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -57.67 -49.82 75.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.762 0.315 . . . . 0.0 111.169 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.2 -42.64 99.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.545 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.435 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.2 mtp -65.44 -44.38 87.46 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.52 -42.23 71.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.459 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.99 -41.56 99.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.57 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 51.4 tpp -62.98 -41.37 99.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.843 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.517 ' HG2' HG21 ' A' ' 367' ' ' VAL . 73.4 mtm180 -65.38 -37.49 87.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.908 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.55 -44.32 96.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.41 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.65 -45.2 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.083 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.51 94.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.728 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 51.3 tp -63.08 -40.49 97.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.327 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.45 -42.56 98.95 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.598 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.496 ' HG2' ' HD3' ' A' ' 283' ' ' ARG . 29.0 mt-10 -64.96 -40.21 94.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.737 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -59.93 -41.67 92.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.554 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.33 87.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.024 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.58 -43.87 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.191 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.45 -33.58 76.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.439 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.77 98.21 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.98 0.419 . . . . 0.0 110.149 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 97.4 t -65.44 -43.07 94.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.329 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.17 -39.82 91.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -70.3 -13.02 61.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.462 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -108.83 3.04 22.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.102 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.37 173.27 6.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.337 0.589 . . . . 0.0 111.766 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -84.84 107.42 16.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.245 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.2 133.37 36.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.383 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.8 t -137.48 148.4 46.03 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.118 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -97.57 128.47 44.33 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.009 0.433 . . . . 0.0 110.965 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -134.52 127.98 32.44 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.627 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -101.16 144.12 30.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.388 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.4 t -152.4 -176.27 5.63 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.871 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.8 p -81.66 162.58 22.98 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.961 0.41 . . . . 0.0 110.836 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -67.89 -17.78 64.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.804 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -61.53 -41.67 97.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.928 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.39 -26.74 63.84 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.518 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.1 -21.35 59.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.158 0.504 . . . . 0.0 110.064 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.5 mmt -79.65 -7.11 58.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.997 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -80.48 87.39 5.69 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.503 0.668 . . . . 0.0 109.659 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -120.73 30.43 6.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.105 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -65.9 -37.14 85.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.948 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.753 179.551 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.553 0.216 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -83.77 101.29 11.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.82 160.55 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.928 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -114.42 106.59 14.48 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.858 0.361 . . . . 0.0 110.777 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -155.55 136.99 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.61 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.569 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 43.5 tt0 -142.99 169.27 17.88 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.0 t -101.02 153.8 19.24 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 117.705 0.23 . . . . 0.0 111.218 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 57.7 m -120.44 -65.76 1.12 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -162.1 123.95 2.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.465 0.174 . . . . 0.0 110.549 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.1 -120.09 18.46 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.814 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' B' ' 108' ' ' GLU . 6.8 mp -89.23 -5.86 57.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' B' ' 107' ' ' VAL . . . -70.52 132.57 22.82 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.088 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 3.5 tpp180 -121.25 -162.64 0.98 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -145.45 127.78 15.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.64 -94.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.135 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m 52.28 89.29 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.202 0.525 . . . . 0.0 111.479 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 tp -111.22 136.29 47.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.014 0.435 . . . . 0.0 111.693 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 46.1 m -101.72 126.9 48.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 17.2 pt -126.24 160.8 33.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.869 0.366 . . . . 0.0 111.794 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.573 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -81.02 161.27 24.29 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.333 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.81 77.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.322 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -65.8 -35.62 81.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.999 0.428 . . . . 0.0 110.407 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -63.01 -40.13 96.84 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.02 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.573 HG13 ' O ' ' B' ' 20' ' ' ALA . 74.8 mt -61.52 -48.65 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.328 0.585 . . . . 0.0 110.552 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -68.72 -44.39 73.98 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.133 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 12.3 m -77.69 -56.86 4.17 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.11 -46.84 55.1 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 97.6 t -63.03 -45.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -62.92 -45.7 91.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.993 0.425 . . . . 0.0 110.695 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 20.8 m -64.42 -36.64 84.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.287 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.4 -39.91 92.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.213 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 95.1 mt -62.41 -43.24 99.3 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.714 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -70.3 -37.7 71.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.181 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.47 -41.39 96.53 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.19 -32.22 50.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.804 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.23 -40.99 94.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.021 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.03 -28.21 65.29 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.402 177.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.52 -44.35 89.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.69 -3.33 9.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.358 0.599 . . . . 0.0 109.939 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 63.67 27.48 14.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.909 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.9 pp -103.18 6.94 10.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.056 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -64.83 -29.15 70.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.951 0.405 . . . . 0.0 110.888 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.82 -2.62 82.12 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.603 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -92.98 -4.17 53.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.696 0.284 . . . . 0.0 111.533 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -87.37 128.93 35.19 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.401 ' HB2' HE22 ' A' ' 320' ' ' GLN . 68.5 mttm -73.78 -2.31 22.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -173.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.97 -37.23 2.84 Favored Glycine 0 C--N 1.314 -0.69 0 C-N-CA 120.473 -0.87 . . . . 0.0 114.246 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -61.26 132.48 53.75 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 117.482 0.641 . . . . 0.0 109.525 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.573 HG12 HG12 ' B' ' 54' ' ' VAL . 21.3 t 64.5 71.69 0.55 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -172.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.548 ' O ' HG13 ' B' ' 54' ' ' VAL . 59.0 Cg_endo -69.59 161.4 46.06 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.373 2.715 . . . . 0.0 113.755 -176.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.76 ' HA ' HG22 ' B' ' 54' ' ' VAL . 50.6 mtt -61.94 -33.97 75.24 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -63.14 -24.43 67.89 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.552 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 99.1 mt -95.45 -38.9 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.465 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.76 HG22 ' HA ' ' B' ' 51' ' ' MET . 10.2 m -62.46 -33.78 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.329 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.427 ' O ' ' HA3' ' B' ' 59' ' ' GLY . . . -60.33 -32.91 71.69 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.645 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -100.64 -34.05 10.04 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.688 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -65.7 -42.82 90.73 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -126.33 19.03 7.56 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.682 0.277 . . . . 0.0 110.979 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.649 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -57.21 -47.97 83.64 Favored Glycine 0 C--O 1.222 -0.629 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.281 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.8 -23.14 22.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.283 0.541 . . . . 0.0 111.683 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -62.08 -45.65 92.57 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.149 -176.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.521 ' O ' HG23 ' B' ' 66' ' ' VAL . 10.5 p -119.11 21.45 5.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.545 0.688 . . . . 0.0 110.592 -177.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.649 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 35.1 ttm180 -59.86 -26.65 66.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.737 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -63.33 -49.59 73.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.451 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . 0.462 ' HB2' HG22 ' B' ' 62' ' ' VAL . 2.9 m-20 -75.84 -21.52 57.17 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.027 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.521 HG23 ' O ' ' B' ' 62' ' ' VAL . 79.6 t -63.24 -44.1 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.5 -40.39 96.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.345 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.53 -43.27 99.26 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.361 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . 0.76 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 37.6 t70 -64.06 -43.63 94.89 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 117.085 0.442 . . . . 0.0 110.192 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.15 -42.64 98.92 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 110.245 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.5 ttp -60.92 -45.31 95.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.862 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -62.34 -44.69 95.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.117 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.76 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 34.2 mtp85 -66.66 -43.16 85.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.046 -176.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -65.13 -40.97 95.18 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.88 0.371 . . . . 0.0 111.073 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.3 -48.25 82.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.499 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 20.1 tt -68.51 -38.75 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.36 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.411 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 11.2 t70 -62.91 -41.92 99.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.185 0.516 . . . . 0.0 109.81 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' B' ' 81' ' ' LYS . . . -66.08 -45.57 80.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.595 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 46.0 pt -64.95 -30.67 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.99 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.59 -44.32 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.019 0.437 . . . . 0.0 110.773 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' B' ' 78' ' ' ALA . 16.4 ptpt -81.03 -28.71 35.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.633 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -81.82 -6.88 59.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.971 0.415 . . . . 0.0 110.248 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 65.5 38.87 5.36 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.509 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.421 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 84.4 mt -100.58 118.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.678 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -106.78 100.88 33.79 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.356 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 24.0 Cg_exo -63.63 139.83 71.74 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.591 2.194 . . . . 0.0 112.208 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.64 94.13 8.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.024 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.92 -125.34 7.15 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.642 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.67 127.19 27.1 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-O 120.517 0.199 . . . . 0.0 110.935 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.77 158.11 53.88 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.618 2.212 . . . . 0.0 110.98 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 54.2 m -92.2 118.84 31.26 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.189 0.518 . . . . 0.0 110.744 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.481 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.7 m-85 -98.14 125.35 43.12 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.42 102.09 42.39 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-O 120.899 0.381 . . . . 0.0 110.971 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.8 Cg_endo -96.75 -167.81 0.12 Allowed 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 123.228 2.619 . . . . 0.0 110.854 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -130.36 -176.28 14.36 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -86.06 126.89 34.51 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -85.76 127.95 34.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.095 0.474 . . . . 0.0 110.852 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 98.6 mttt -113.63 140.99 47.74 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 38.0 tp -85.56 112.06 20.59 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.16 -177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.85 -7.68 27.62 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.688 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 48.9 mt-10 -120.37 172.63 7.67 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -82.16 168.44 17.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.297 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -121.28 143.68 49.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.45 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 85.6 m -125.67 136.86 53.68 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.007 0.432 . . . . 0.0 111.601 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -134.71 154.22 51.65 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.569 ' O ' HG12 ' B' ' 107' ' ' VAL . 21.4 m -95.97 -74.17 0.57 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.569 HG12 ' O ' ' B' ' 106' ' ' SER . 0.3 OUTLIER 65.36 142.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.9 0.88 . . . . 0.0 110.251 -172.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 11' ' ' LEU . 45.2 mt-10 -119.18 130.79 55.69 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -173.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -164.62 143.67 7.1 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.759 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.66 157.19 0.06 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 m -136.04 162.29 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.75 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -161.5 106.26 1.2 Allowed Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.399 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.29 154.43 41.12 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.261 2.64 . . . . 0.0 113.923 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -127.54 142.63 51.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.078 0.951 . . . . 0.0 108.77 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 64.2 t -126.77 131.68 70.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.847 0.356 . . . . 0.0 111.746 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -110.67 -86.22 0.54 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.699 176.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 97.5 mt 59.32 121.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -137.6 157.39 46.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.147 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.48 19.63 77.85 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.909 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.91 -39.91 95.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.282 0.563 . . . . 0.0 110.672 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -74.25 -5.71 43.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.346 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -105.82 17.28 23.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.94 0.4 . . . . 0.0 110.93 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 86.9 mt -91.62 119.39 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.242 0.544 . . . . 0.0 111.199 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -108.52 122.8 47.81 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.43 135.5 57.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.625 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -78.7 138.6 38.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.568 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -133.28 97.75 16.04 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.73 121.12 6.8 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.232 1.955 . . . . 0.0 112.418 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.8 mm -105.67 116.01 48.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.859 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.405 HG21 HD21 ' B' ' 427' ' ' LEU . 27.5 m -131.82 163.49 37.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.352 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -136.51 156.77 48.12 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.96 125.84 39.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.4 p -111.89 175.08 5.57 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.458 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.02 -36.59 82.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.4 82.97 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.635 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.86 -42.09 97.63 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.367 0.604 . . . . 0.0 109.569 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.78 -45.43 98.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.517 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.3 -43.01 99.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.867 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.58 -41.94 99.75 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.449 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.567 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 3.5 tpt -62.55 -46.76 86.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.796 0.332 . . . . 0.0 110.452 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.52 -41.66 98.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.3 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.67 -44.19 96.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.318 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.9 m -62.83 -41.92 99.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.261 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.3 mt -60.9 -42.57 98.28 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -70.93 -20.44 62.47 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.451 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.68 1.28 54.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.375 0.607 . . . . 0.0 110.096 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.5 23.57 11.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.817 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -125.31 86.27 2.52 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . 0.52 ' HB3' ' OE1' ' B' ' 159' ' ' GLU . . . -131.54 159.42 38.22 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 172.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . 0.568 HG21 ' O ' ' B' ' 247' ' ' GLU . 6.3 m -121.1 143.39 49.11 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.112 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . 0.604 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 44.7 p-90 -74.74 132.28 41.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.034 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . 0.525 ' HG2' ' HG3' ' B' ' 153' ' ' GLU . 65.1 tttp -163.19 -64.71 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . 0.525 ' HG3' ' HG2' ' B' ' 152' ' ' LYS . 64.3 mt-10 -117.42 -92.6 0.52 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' B' ' 155' ' ' ASP . 22.2 tptm -94.5 -117.85 0.1 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -169.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . 0.419 ' N ' ' HG3' ' B' ' 154' ' ' LYS . 14.2 t70 -147.52 154.87 41.28 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 122.923 0.489 . . . . 0.0 110.85 -174.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 166.21 -34.56 0.23 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.238 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.35 140.44 18.4 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.459 ' HA ' ' HD2' ' B' ' 243' ' ' ARG . 59.3 t -129.35 127.5 65.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.354 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . 0.52 ' OE1' ' HB3' ' B' ' 149' ' ' ALA . 4.7 mp0 -88.38 159.2 18.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.184 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.26 49.3 1.63 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.776 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -158.49 6.39 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.78 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.46 ' CG ' ' H ' ' B' ' 163' ' ' ARG . 13.1 t70 -102.53 -170.38 1.8 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.601 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . 0.46 ' H ' ' CG ' ' B' ' 162' ' ' ASP . 42.7 ttm180 -124.13 117.98 25.88 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.115 0.566 . . . . 0.0 110.727 -176.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.29 128.49 64.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.289 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 73.1 m -84.23 116.9 23.19 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 87.3 mt -126.27 124.52 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.126 0.489 . . . . 0.0 111.835 -176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . 0.471 ' OD2' ' HA ' ' B' ' 183' ' ' SER . 6.2 m-20 -95.24 109.35 21.48 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -127.67 150.54 49.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.444 0.64 . . . . 0.0 112.439 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.6 m -124.88 128.05 48.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.571 177.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.7 141.06 20.8 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.747 -0.74 . . . . 0.0 113.672 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 41.1 m -141.02 144.27 34.9 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 42.0 t -84.44 -83.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.94 0.4 . . . . 0.0 110.841 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -105.38 -40.58 5.77 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.18 0.514 . . . . 0.0 110.054 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.5 21.05 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.259 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -142.8 149.6 38.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 120.779 0.323 . . . . 0.0 110.404 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.41 151.49 32.73 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.976 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -120.69 -179.23 3.93 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.457 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.52 -42.54 87.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.03 -172.07 31.32 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.972 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.37 29.65 48.64 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.551 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -110.48 113.81 26.73 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -137.39 147.02 45.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.042 0.449 . . . . 0.0 111.59 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.471 ' HA ' ' OD2' ' B' ' 167' ' ' ASP . 67.8 m -146.51 129.41 16.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.313 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 58.56 31.85 21.49 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.564 0.54 . . . . 0.0 110.126 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -89.63 135.26 33.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.709 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 93.1 t -99.69 123.52 52.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.922 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.81 122.73 48.56 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.129 0.49 . . . . 0.0 111.457 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . 0.443 ' HB3' ' CZ ' ' B' ' 193' ' ' ARG . . . -111.33 111.6 22.76 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 73.9 mtm -83.86 163.69 19.93 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.303 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.54 -13.86 60.99 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.606 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -102.67 -8.22 21.09 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 79.15 48.56 6.83 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 119.928 -1.13 . . . . 0.0 111.403 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.443 ' CZ ' ' HB3' ' B' ' 188' ' ' ALA . 95.0 mtt180 -89.53 -10.35 46.5 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.405 ' CE ' ' HA ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -129.51 170.32 13.87 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.06 178.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.622 ' H ' HD12 ' B' ' 195' ' ' ILE . 4.1 mp -54.84 133.18 66.43 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 123.347 0.404 . . . . 0.0 110.162 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -48.55 129.93 20.95 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.359 2.04 . . . . 0.0 111.776 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.04 -32.66 6.64 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.913 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -62.27 -44.38 96.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.677 0.275 . . . . 0.0 110.639 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.75 -40.63 97.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.734 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.85 -34.8 78.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.086 0.469 . . . . 0.0 110.676 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -63.52 -26.43 69.67 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.366 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.62 -43.35 98.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 109.676 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -50.86 119.59 4.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.477 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 108.2 -10.62 36.76 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.598 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.649 ' HA ' ' OE1' ' B' ' 209' ' ' GLU . 46.6 m80 -96.2 141.09 29.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.11 0.455 . . . . 0.0 111.422 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.407 ' HG2' ' OE2' ' B' ' 209' ' ' GLU . 17.1 mmtm -100.46 166.69 10.81 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' B' ' 240' ' ' VAL . . . -61.8 131.98 51.63 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.02 27.55 70.19 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.701 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . 0.649 ' OE1' ' HA ' ' B' ' 205' ' ' HIS . 44.5 tt0 -112.27 111.7 22.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.273 0.559 . . . . 0.0 110.365 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.14 129.31 44.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.687 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -148.94 -26.51 0.3 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.492 HG22 ' HA ' ' B' ' 234' ' ' ALA . 50.8 p 60.67 160.33 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.935 0.894 . . . . 0.0 111.975 -176.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' B' ' 232' ' ' LYS . 18.9 tt -153.06 148.65 13.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 122.135 -0.353 . . . . 0.0 110.825 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -81.27 109.59 15.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.217 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 59.8 t -112.87 122.81 67.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 11.9 p -93.5 -21.62 19.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 68.12 137.4 0.05 OUTLIER Pre-proline 0 N--CA 1.482 1.142 0 CA-C-O 121.037 0.446 . . . . 0.0 111.75 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' B' ' 221' ' ' TYR . 16.5 Cg_exo -67.72 149.57 78.83 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.433 2.089 . . . . 0.0 112.006 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . 0.445 ' O ' ' HE2' ' B' ' 227' ' ' LYS . 75.1 mm-40 -66.71 -39.36 88.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.522 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -86.03 32.51 0.61 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.895 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 9.2 t80 -66.72 134.63 52.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -67.66 -15.32 63.59 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.459 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -101.18 105.0 16.09 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.43 ' OE1' ' HG2' ' B' ' 333' ' ' PRO . 42.1 tt0 -60.11 -33.24 71.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.672 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -66.82 -19.03 65.66 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.064 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.7 mt -121.39 0.62 10.05 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' B' ' 219' ' ' GLU . 14.9 ptmm? -68.34 119.27 12.58 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.48 0.657 . . . . 0.0 112.118 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.85 17.24 75.45 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.339 -0.846 . . . . 0.0 114.106 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -123.85 129.63 51.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.774 0.787 . . . . 0.0 111.182 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.39 153.16 29.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.005 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.96 143.55 31.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.315 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' B' ' 213' ' ' ILE . 3.9 mppt? -100.13 -14.31 18.6 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.401 ' HB3' ' H ' ' B' ' 234' ' ' ALA . 95.8 m-85 55.45 -148.67 0.48 Allowed 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.346 0.404 . . . . 0.0 111.516 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' B' ' 212' ' ' THR . . . -142.75 -69.22 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.893 0.378 . . . . 0.0 110.496 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 86.2 mt 65.89 87.25 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.992 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -92.35 -27.09 17.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.19 176.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 12.3 tp 51.65 66.92 1.05 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.806 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -66.09 -43.09 88.27 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . 0.427 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 29.9 mtpp -97.14 -77.78 0.49 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -173.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' B' ' 239' ' ' LYS . 87.7 t 76.62 142.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -95.3 -86.15 0.3 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -173.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -163.53 104.13 0.94 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 119.876 -0.729 . . . . 0.0 112.79 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 19.0 ttm-85 -168.72 115.1 0.63 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.954 0.407 . . . . 0.0 111.949 175.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' B' ' 152' ' ' LYS . 0.1 OUTLIER -178.31 155.4 0.9 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 46.8 tp 67.95 100.13 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 124.041 0.838 . . . . 0.0 111.343 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' B' ' 150' ' ' THR . 41.0 Cg_endo -68.15 111.3 2.43 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.523 2.149 . . . . 0.0 112.717 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . 0.568 ' O ' HG21 ' B' ' 150' ' ' THR . 43.1 tt0 -135.18 148.74 49.78 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.39 94.54 3.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.803 0.335 . . . . 0.0 111.173 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 22.1 p -91.09 -88.22 0.19 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.599 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -172.75 -47.97 0.02 OUTLIER 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.952 0.406 . . . . 0.0 111.218 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.97 94.77 7.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.076 0.465 . . . . 0.0 111.839 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . 0.531 ' CD1' HG23 ' B' ' 253' ' ' ILE . 51.5 p90 -164.89 -22.43 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.464 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 253' ' ' ILE . . . . . 0.531 HG23 ' CD1' ' B' ' 252' ' ' PHE . 19.6 pt -110.93 -42.39 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -82.06 -7.59 59.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.481 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -121.22 97.61 5.6 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -149.96 -59.77 0.2 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.161 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -164.61 -84.18 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.636 -1.269 . . . . 0.0 113.54 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 66.4 t -99.0 121.25 49.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.472 0.177 . . . . 0.0 111.038 -177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 57.91 -169.41 0.12 Allowed 'General case' 0 CA--C 1.547 0.831 0 O-C-N 123.975 0.797 . . . . 0.0 110.439 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -106.1 114.63 28.88 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -100.64 164.03 18.76 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.108 -1.044 . . . . 0.0 114.057 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 33.8 p -105.85 -175.43 2.79 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.68 -49.26 85.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.2 OUTLIER -85.06 -36.89 20.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 -178.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.0 -43.36 97.49 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.731 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.503 ' O ' HG23 ' B' ' 270' ' ' VAL . 49.6 tp -63.57 -43.4 97.11 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 120.612 0.244 . . . . 0.0 110.618 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -61.71 -43.01 99.67 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.786 0.327 . . . . 0.0 111.153 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.532 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.49 -44.66 86.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.064 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -67.74 -37.21 81.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.915 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.503 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.0 t -64.69 -43.08 96.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.595 0.236 . . . . 0.0 110.476 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -59.01 -46.82 87.23 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.4 ptmt -67.26 -43.66 81.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 0.0 111.62 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -64.48 -39.89 94.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.773 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.6 mmm -63.67 -42.06 98.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 110.736 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -68.97 -31.76 70.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.8 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 60.8 ttp180 -63.61 -41.78 98.28 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -65.8 -35.15 79.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.565 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 47.7 tp -61.95 -37.77 85.96 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.815 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 62.9 tttm -57.87 -44.98 86.97 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.805 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 19.4 m -61.86 -42.98 99.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.382 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.0 83.59 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.329 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.36 -44.12 98.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.795 0.331 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . 0.541 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.7 OUTLIER -60.14 -46.49 89.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.215 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -65.61 -40.29 92.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.523 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -60.69 -44.17 96.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.183 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.09 -44.62 91.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.177 0.513 . . . . 0.0 110.1 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.42 -48.17 82.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.856 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 74.8 p -65.01 -42.37 94.51 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -65.28 -42.88 92.72 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.025 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.63 -47.0 83.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.029 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . 0.459 ' O ' HG23 ' B' ' 295' ' ' VAL . 34.7 mm -64.41 -44.0 97.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.102 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -60.14 -46.19 90.49 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.925 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.24 -42.44 99.32 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.202 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.37 -41.46 96.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 291' ' ' ILE . 74.1 t -62.29 -45.33 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 O-C-N 123.114 0.259 . . . . 0.0 111.327 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -64.71 -41.95 95.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.852 0.358 . . . . 0.0 111.286 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.84 -39.65 63.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -121.7 82.92 2.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.63 94.44 9.03 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.9 tp -104.03 156.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.232 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.21 134.09 56.72 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 41.0 t -106.87 129.08 24.92 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.501 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.417 ' O ' HG13 ' B' ' 307' ' ' ILE . 50.0 Cg_exo -55.92 128.3 29.67 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.427 2.085 . . . . 0.0 111.832 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.51 85.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.195 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.32 87.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.376 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.75 -41.88 95.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.786 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . 0.498 ' O ' HG13 ' B' ' 311' ' ' ILE . 69.1 mt -62.03 -49.88 82.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.502 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -42.33 99.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.55 -176.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.3 m -62.99 -45.85 90.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.97 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . 0.677 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 63.6 mm-40 -70.86 -34.02 71.22 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.498 HG13 ' O ' ' B' ' 307' ' ' ILE . 95.2 mt -61.46 -44.29 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.836 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 35.5 t70 -63.17 -39.89 95.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.985 0.421 . . . . 0.0 110.826 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.04 -43.8 97.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.458 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 56.7 mt -62.74 -39.34 93.79 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.864 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 81.5 mtm180 -63.23 -38.92 93.05 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 87.5 mtt180 -65.49 -39.55 92.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.729 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -63.25 -43.21 98.64 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.172 0.51 . . . . 0.0 110.183 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.81 80.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.237 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -62.5 -37.06 84.54 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.769 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -62.41 -42.41 99.41 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.567 0.699 . . . . 0.0 109.691 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.16 -6.98 56.44 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.702 -177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -89.75 -3.46 58.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.885 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.62 -33.93 2.42 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.099 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 133.27 43.21 0.15 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . 0.476 ' HB3' ' HB1' ' B' ' 319' ' ' ALA . 42.5 t-20 -81.65 118.98 23.25 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.094 0.473 . . . . 0.0 109.861 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 2.4 tm-20 -120.53 151.28 39.59 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 5.7 ptpp? 61.66 -39.19 0.13 Allowed 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.774 1.63 . . . . 0.0 114.145 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . 0.472 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.3 mm100 -72.79 -11.27 60.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.349 0.595 . . . . 0.0 110.577 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -64.13 -20.91 66.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.171 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.464 HD12 HH12 ' B' ' 315' ' ' ARG . 52.3 tp -62.74 -36.88 84.47 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.077 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.14 -6.43 54.71 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.582 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . 0.469 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 77.4 mt -68.65 149.7 97.88 Favored Pre-proline 0 C--O 1.24 0.564 0 O-C-N 122.33 -0.231 . . . . 0.0 110.85 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . 0.43 ' HG2' ' OE1' ' B' ' 224' ' ' GLU . 38.7 Cg_exo -60.75 145.32 99.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.851 2.367 . . . . 0.0 113.281 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . 0.448 HH21 ' HD2' ' B' ' 334' ' ' ARG . 24.8 ttt85 -85.78 -41.62 14.91 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.417 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -57.96 -39.62 78.57 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -172.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . 0.415 ' HB2' ' OE2' ' B' ' 224' ' ' GLU . 93.6 mt -89.63 -3.88 58.06 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.757 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -105.63 -25.12 12.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.983 0.42 . . . . 0.0 110.206 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.2 -26.23 66.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.909 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.34 -51.26 70.26 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 120.931 0.396 . . . . 0.0 110.548 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -73.69 -27.28 61.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.659 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.463 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -60.95 -43.6 98.48 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . 0.488 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.8 tttt -59.73 -45.88 90.84 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . 0.578 ' O ' HG23 ' B' ' 347' ' ' VAL . 11.1 mmt85 -61.44 -46.25 90.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.833 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . 0.48 ' NH2' HD22 ' B' ' 314' ' ' LEU . 92.0 mtt180 -67.12 -37.63 84.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 341' ' ' ALA . 69.2 t -64.99 -44.03 96.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.708 0.289 . . . . 0.0 110.374 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 342' ' ' LYS . 74.3 t -61.61 -43.97 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.765 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.578 HG23 ' O ' ' B' ' 343' ' ' ARG . 85.8 t -59.65 -45.0 94.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.14 99.42 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.382 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.55 -44.14 95.05 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.679 0.276 . . . . 0.0 111.225 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.42 ' O ' HG23 ' B' ' 354' ' ' VAL . 96.2 mt -64.2 -46.77 82.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.18 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.06 -39.75 82.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.385 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.65 -41.47 97.4 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.971 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -67.3 -36.7 82.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.979 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . 0.42 HG23 ' O ' ' B' ' 350' ' ' LEU . 94.3 t -61.49 -44.37 98.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.379 0.609 . . . . 0.0 109.362 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.44 -44.42 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.932 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -70.38 -46.51 63.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.927 0.394 . . . . 0.0 112.02 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 100.0 m -65.7 -42.98 90.51 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -95.14 6.24 49.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 53.02 52.13 14.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.49 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 99.2 mt -77.23 133.8 38.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.116 0.484 . . . . 0.0 111.395 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -110.71 153.33 25.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.05 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.38 109.4 14.84 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . 0.505 ' O ' HG23 ' B' ' 367' ' ' VAL . 18.3 t70 -81.75 110.86 17.46 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.201 0.524 . . . . 0.0 112.039 -173.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 50.8 mm-40 -59.18 -40.73 86.6 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.237 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.51 -39.75 88.84 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.481 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -62.12 -38.81 90.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . 0.505 HG23 ' O ' ' B' ' 363' ' ' ASP . 99.1 t -63.76 -40.09 87.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.65 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 30.2 mmmt -56.49 -44.61 80.83 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.416 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.59 97.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.031 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.52 -42.47 99.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.905 0.384 . . . . 0.0 110.739 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.51 -45.1 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.28 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.81 -37.97 87.69 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -66.58 -39.45 88.45 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.524 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.7 ttm -64.54 -40.71 96.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.171 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . 0.438 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -61.86 -27.01 68.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.328 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 50.6 m -75.74 -3.41 34.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.286 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -94.08 -1.25 54.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.946 0.403 . . . . 0.0 110.928 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.54 169.88 8.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.267 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.72 -40.43 87.98 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.414 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 19.6 t70 -131.69 109.64 14.54 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-O 120.914 0.388 . . . . 0.0 111.041 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . 0.438 ' HA ' ' HB1' ' B' ' 375' ' ' ALA . 52.0 Cg_exo -56.28 -40.63 83.47 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.967 2.445 . . . . 0.0 114.297 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -64.84 -43.16 93.94 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 15.7 pt-20 -62.59 -37.17 85.2 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.324 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.93 -42.84 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.339 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.23 -44.43 99.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.419 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 44.9 mt-10 -66.88 -44.35 81.13 Favored 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.997 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -59.1 -46.51 88.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.58 -41.9 92.36 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.673 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 60.2 p -79.37 -6.84 57.68 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 98.8 mttt -103.04 7.47 38.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.027 0.441 . . . . 0.0 110.922 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -125.32 118.91 26.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.77 -42.3 97.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.171 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.68 -50.72 72.26 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.878 0.37 . . . . 0.0 111.0 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.72 -42.68 97.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.867 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.428 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 90.3 mtp -65.38 -45.15 85.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.62 -39.96 66.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.221 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -62.53 -41.98 99.22 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.625 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 49.4 tpp -63.28 -40.86 98.57 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.743 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.485 ' HG2' HG21 ' B' ' 367' ' ' VAL . 71.1 mtm180 -65.11 -37.12 86.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.846 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.24 -44.39 96.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.414 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 94.3 t -66.0 -45.17 91.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.758 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.23 93.9 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.6 -40.47 97.04 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.313 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.82 -43.04 99.64 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.707 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . 0.541 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 23.4 mt-10 -64.07 -40.69 96.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.467 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -60.0 -41.53 92.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.49 -46.29 86.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.128 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 95.2 t -65.94 -43.83 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.038 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.26 -34.1 77.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.0 96.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 110.198 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.25 -42.92 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.147 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.73 -39.36 91.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.952 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -68.68 -14.75 63.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.645 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -107.45 -6.59 16.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.532 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.95 170.04 9.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.169 0.509 . . . . 0.0 111.883 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -82.85 113.71 20.66 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.35 132.32 47.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.184 0.516 . . . . 0.0 111.705 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -136.1 145.28 45.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -96.38 135.03 38.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.626 0.251 . . . . 0.0 110.361 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -140.76 132.73 27.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.923 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.03 143.3 33.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.641 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.1 t -151.69 -176.84 5.78 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.633 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 50.0 p -80.48 165.51 22.1 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.099 0.476 . . . . 0.0 111.292 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -70.04 -16.7 63.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.879 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -61.74 -41.98 98.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.149 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -70.15 -27.83 64.85 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.832 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . 0.405 HD21 HG21 ' B' ' 130' ' ' VAL . 10.3 mp -71.0 -24.23 62.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.068 0.461 . . . . 0.0 109.891 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.5 mmt -79.29 -9.48 59.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.909 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -77.38 80.01 3.88 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.473 0.654 . . . . 0.0 109.928 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -115.17 29.58 7.93 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.143 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -65.91 -38.17 88.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.633 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.919 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.037 -179.33 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.452 -0.372 0 CA-C-O 120.911 0.386 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 m -86.23 106.63 17.46 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.685 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.7 137.24 27.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 34.6 tt0 -137.77 173.31 11.78 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.4 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 9.2 t -116.08 145.66 42.84 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 117.948 0.34 . . . . 0.0 111.599 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.6 m -102.87 -68.87 0.81 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -171.29 114.87 0.4 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.918 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.41 -111.94 4.59 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.718 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.34 -31.21 65.45 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 122.505 0.322 . . . . 0.0 111.456 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.55 137.07 42.09 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 116.008 -0.542 . . . . 0.0 114.127 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -141.21 157.13 45.67 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.222 0.609 . . . . 0.0 110.172 -178.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' A' ' 6' ' ' GLU . 28.8 ttm-85 -115.35 137.85 51.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.96 -86.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.456 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.2 m 49.88 84.88 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.111 0.482 . . . . 0.0 111.754 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 tp -93.32 134.4 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 120.949 0.404 . . . . 0.0 111.979 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.4 m -116.64 124.06 48.82 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.389 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 HG12 ' A' ' 24' ' ' ILE . 17.9 pt -135.28 169.02 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 122.558 0.343 . . . . 0.0 111.817 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.626 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.77 151.98 43.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.03 0.532 . . . . 0.0 111.871 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -55.79 -51.2 68.27 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.7 -36.14 83.33 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.978 0.418 . . . . 0.0 110.259 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -66.67 -35.74 80.87 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.528 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.626 HG13 ' O ' ' A' ' 20' ' ' ALA . 76.9 mt -60.33 -50.19 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 111.071 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -74.49 -42.88 58.21 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.78 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.9 m -70.44 -52.92 18.75 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.62 -44.6 66.88 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.29 -42.23 94.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.043 0.449 . . . . 0.0 110.589 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -60.78 -43.87 97.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.986 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 33' ' ' VAL . 25.4 m -63.03 -41.63 99.58 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.335 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.58 -40.44 96.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.236 0.541 . . . . 0.0 109.878 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.89 -41.91 99.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.024 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 30' ' ' SER . 12.0 p -69.16 -36.08 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.776 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -63.25 -43.48 97.87 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.13 -38.2 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.802 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.76 -47.93 81.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.61 -37.23 86.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.924 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.88 -33.81 76.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.8 t -91.43 -4.47 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-O 121.47 0.653 . . . . 0.0 109.791 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 63.5 27.2 15.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.636 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -104.41 3.95 10.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.126 0.489 . . . . 0.0 110.95 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -64.66 -34.23 77.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.426 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.63 -23.37 65.0 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.983 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -73.85 -13.57 60.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.746 0.308 . . . . 0.0 111.444 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.429 ' HG3' ' NE2' ' B' ' 320' ' ' GLN . 63.4 ttt-85 -80.75 92.18 6.01 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.268 0.556 . . . . 0.0 110.201 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.79 -43.39 98.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.005 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.99 69.98 1.25 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 115.719 1.048 . . . . 0.0 115.719 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -62.99 -41.89 99.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 54' ' ' VAL . 11.2 t -101.42 110.53 61.86 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.692 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.63 147.41 79.66 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.83 2.353 . . . . 0.0 112.066 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.522 ' HA ' HG12 ' A' ' 54' ' ' VAL . 15.3 ttt -67.11 -22.41 65.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -172.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -81.21 -8.57 59.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.872 0.368 . . . . 0.0 110.244 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.449 HD13 ' NH2' ' B' ' 193' ' ' ARG . 87.2 mt -107.74 -49.69 7.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.267 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 51' ' ' MET . 9.6 p -62.61 -40.25 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.557 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.15 94.9 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -84.91 -19.41 32.3 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.767 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.455 ' NH1' ' SD ' ' B' ' 194' ' ' MET . 61.7 ttt180 -85.65 -45.13 11.99 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.356 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -106.65 11.9 29.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.028 0.442 . . . . 0.0 110.522 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.581 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -57.39 -63.17 5.55 Favored Glycine 0 C--O 1.216 -0.978 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.181 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.55 -27.55 67.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.053 0.427 . . . . 0.0 111.631 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -61.02 -45.05 96.39 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.156 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 65' ' ' ASP . 8.3 p -131.64 21.34 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 CA-C-O 121.191 0.52 . . . . 0.0 112.098 -175.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.581 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 7.5 ttt180 -64.76 -19.98 66.1 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.628 -0.67 . . . . 0.0 111.405 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -64.77 -45.68 85.35 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.496 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.458 ' HB2' HG22 ' A' ' 62' ' ' VAL . 2.2 m-20 -73.65 -28.28 61.7 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.716 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -63.66 -44.74 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.38 -39.36 94.31 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.27 -40.77 97.83 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.043 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.76 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 29.3 t70 -62.45 -46.79 86.89 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.27 -41.88 97.69 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.911 0.386 . . . . 0.0 110.149 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 ttp -61.04 -43.96 98.11 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.6 m -62.36 -42.65 99.57 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.441 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.76 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 52.2 mtp85 -62.33 -46.49 88.49 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.751 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -65.73 -40.48 92.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.314 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.06 -48.49 81.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.668 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.4 tt -68.15 -39.1 80.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.855 0.36 . . . . 0.0 111.469 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.67 -40.36 92.3 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.234 0.54 . . . . 0.0 110.471 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.95 96.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.228 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.3 pt -67.14 -37.77 79.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.574 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.46 -44.09 98.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.082 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -75.57 -23.05 56.49 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -92.98 1.32 57.36 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.978 0.418 . . . . 0.0 110.674 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 63.38 32.79 14.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.325 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.8 mt -97.78 113.13 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -107.51 107.16 60.01 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.995 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.62 134.65 33.5 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.77 1.647 . . . . 0.0 111.315 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.52 87.17 4.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.238 0.542 . . . . 0.0 110.513 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.36 -114.8 4.54 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.804 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.29 135.2 26.73 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.25 152.17 79.81 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.705 2.27 . . . . 0.0 111.339 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.3 m -87.69 105.16 17.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.066 0.46 . . . . 0.0 111.437 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -107.65 113.78 27.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.24 96.89 48.64 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.68 145.65 26.12 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.21 1.94 . . . . 0.0 111.584 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.76 174.7 51.67 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.16 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.88 123.92 23.74 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.925 0.393 . . . . 0.0 110.23 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -86.13 133.72 33.85 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.185 0.517 . . . . 0.0 111.024 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -122.58 127.13 49.04 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.6 tp -72.42 106.53 4.57 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.132 0.492 . . . . 0.0 110.607 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.07 -8.62 14.2 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.462 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -118.37 -177.56 3.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.667 0.233 . . . . 0.0 110.73 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -76.65 160.04 29.72 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 111.269 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -126.34 138.04 53.53 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.148 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.0 m -118.08 135.71 54.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.932 0.396 . . . . 0.0 110.925 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -129.08 164.25 23.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.5 m -73.92 -83.74 0.05 OUTLIER 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.6 t 56.03 101.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.297 0.57 . . . . 0.0 111.311 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.59 126.95 34.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.28 -175.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.499 ' HB3' ' OE2' ' A' ' 110' ' ' GLU . 12.8 m-85 -127.32 -165.43 1.47 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.91 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.499 ' OE2' ' HB3' ' A' ' 109' ' ' PHE . 0.9 OUTLIER -73.12 177.97 4.7 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.048 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 305' ' ' ALA . 35.2 m -124.77 164.51 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.553 -176.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -124.9 116.48 26.16 Favored Pre-proline 0 N--CA 1.466 0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -88.56 144.43 5.57 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.895 2.396 . . . . 0.0 113.152 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -142.02 151.78 42.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.828 0.451 . . . . 0.0 109.804 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.4 t -130.44 133.06 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.896 0.379 . . . . 0.0 111.837 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -107.44 -88.24 0.47 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.746 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.0 mt 64.82 117.67 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.689 0.796 . . . . 0.0 112.481 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -137.84 150.95 47.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.492 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.14 18.65 74.04 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.944 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.77 -41.4 97.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 111.03 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.86 -3.62 23.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.252 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -106.79 17.44 23.17 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.878 0.37 . . . . 0.0 111.61 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.66 107.31 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.061 0.458 . . . . 0.0 109.952 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.32 101.73 13.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.966 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.07 133.29 36.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.935 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -87.64 124.36 33.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.456 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -122.73 96.14 45.72 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -63.92 135.61 48.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.012 1.808 . . . . 0.0 111.52 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.22 112.71 40.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.8 160.2 42.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.569 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -143.01 165.37 27.55 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.196 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.408 HG11 HH12 ' A' ' 271' ' ' ARG . 64.5 t -78.31 129.95 36.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.749 0.309 . . . . 0.0 110.435 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.5 p -112.38 176.86 4.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.772 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.09 -35.53 78.95 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 120.692 0.282 . . . . 0.0 111.623 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.15 84.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.256 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -63.43 -40.59 97.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.292 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 95.7 t -62.25 -49.54 83.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.652 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.85 -39.08 92.98 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.713 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.72 -40.63 99.05 Favored Glycine 0 C--O 1.237 0.331 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.743 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.575 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 5.1 tpt -63.28 -42.5 99.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.139 0.495 . . . . 0.0 109.795 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.9 mt -63.02 -40.11 96.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.573 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -56.65 -48.13 78.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.577 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.2 m -63.3 -40.75 98.23 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.366 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 140' ' ' MET . 85.3 mt -60.15 -42.23 94.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.818 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -79.79 -8.51 59.31 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.834 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -92.65 -12.59 31.17 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -90.92 -52.2 4.97 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.426 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -60.58 95.85 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.63 97.96 2.17 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 113.526 -1.67 . . . . 0.0 107.848 175.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 151' ' ' TRP . 0.2 OUTLIER -67.4 176.65 2.22 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.484 ' H ' HG22 ' A' ' 150' ' ' THR . 56.0 p-90 -99.88 161.85 13.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.453 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.587 ' H ' ' HA ' ' A' ' 243' ' ' ARG . 76.7 tttt -168.68 -79.59 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.758 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 242' ' ' GLU . 10.0 pt-20 -165.97 80.18 0.28 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 155' ' ' ASP . 54.8 tttt 176.65 -152.93 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.581 175.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.421 ' H ' ' HG2' ' A' ' 154' ' ' LYS . 8.9 p-10 -140.58 162.82 34.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.303 0.501 . . . . 0.0 111.054 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 119.44 -19.07 9.97 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.303 -0.951 . . . . 0.0 114.133 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -118.52 100.55 7.53 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.58 0.69 . . . . 0.0 111.947 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.8 t -132.29 136.97 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -97.79 -169.14 1.78 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.619 ' O ' ' HA3' ' A' ' 190' ' ' GLY . . . -95.6 23.99 5.64 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.775 ' HA ' ' O ' ' A' ' 189' ' ' MET . 11.1 pt-20 -158.88 27.64 0.22 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.436 0.636 . . . . 0.0 112.292 175.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 188' ' ' ALA . 13.0 m-20 -90.32 170.11 10.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.993 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 -106.96 123.7 48.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.96 128.74 74.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.805 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.4 m -78.84 106.39 10.82 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 72.1 mt -120.03 119.33 59.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.617 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -95.5 88.66 5.14 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -109.02 147.09 32.86 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.084 0.469 . . . . 0.0 111.834 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.0 m -116.78 127.42 54.32 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.45 123.69 6.37 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.172 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.8 m -140.65 128.6 21.97 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.469 HG23 ' CD2' ' A' ' 177' ' ' PHE . 98.0 t -102.89 108.93 25.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 60.34 -50.18 0.09 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.25 1.42 . . . . 0.0 114.121 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.89 -4.37 0.05 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.066 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.44 140.86 52.55 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.092 0.472 . . . . 0.0 110.956 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -79.33 156.56 27.97 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.469 ' CD2' HG23 ' A' ' 172' ' ' VAL . 35.4 p90 -125.37 169.28 12.5 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.534 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.86 -36.12 74.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.03 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.74 -177.49 33.79 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.65 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.27 22.06 61.42 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.163 -1.017 . . . . 0.0 113.322 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -100.81 112.1 24.45 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -136.26 145.69 45.88 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.986 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.6 m -140.5 125.18 18.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.423 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 55.89 30.59 16.21 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.578 0.548 . . . . 0.0 110.635 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -83.78 122.99 29.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.018 0.437 . . . . 0.0 110.397 -176.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.3 m -87.9 106.9 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.598 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.6 tp -94.55 121.54 36.22 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.184 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 193' ' ' ARG . . . -91.89 119.36 31.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.775 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 83.9 mtp -84.24 153.5 23.56 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.985 -175.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 160' ' ' ALA . . . 84.0 18.31 63.41 Favored Glycine 0 CA--C 1.505 -0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.872 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -122.54 -6.39 8.67 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.155 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.88 46.36 10.92 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.656 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 94.0 mtt180 -92.93 -6.77 47.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.475 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -131.58 167.88 18.65 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.715 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.88 134.82 92.65 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.93 129.89 18.71 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.385 2.056 . . . . 0.0 112.025 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.15 -38.97 3.04 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.358 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -65.35 -49.54 68.98 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.409 ' O ' ' HE3' ' A' ' 189' ' ' MET . 11.4 pt-20 -82.72 -9.73 59.23 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.226 0.536 . . . . 0.0 111.06 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -89.4 -32.01 17.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -74.56 -10.01 82.43 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.102 -0.953 . . . . 0.0 113.337 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.464 ' HB ' ' HE1' ' A' ' 189' ' ' MET . 44.4 mm -64.91 -42.89 96.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -53.01 125.93 18.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.629 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 101.28 -3.59 54.71 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.066 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -103.69 148.18 26.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.721 0.761 . . . . 0.0 111.991 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.17 166.17 12.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.491 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.28 120.52 19.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 89.12 17.71 55.29 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.678 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -105.01 117.37 33.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.121 0.486 . . . . 0.0 110.256 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -99.59 123.09 43.52 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.137 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -143.7 -15.44 0.63 Allowed 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 74.4 p 59.38 164.79 0.05 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 123.886 0.874 . . . . 0.0 112.596 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -146.95 142.58 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.858 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.97 109.1 16.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.047 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 49.3 t -117.55 108.23 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.148 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 21.2 m -71.9 -44.42 63.73 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 216' ' ' THR . 54.8 m-85 78.73 148.49 0.12 Allowed Pre-proline 0 N--CA 1.495 1.799 0 C-N-CA 123.241 0.617 . . . . 0.0 110.763 -174.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -72.0 153.79 57.85 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.708 2.272 . . . . 0.0 111.905 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.585 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 51.7 mm-40 -65.86 -39.11 90.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.419 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -95.58 39.0 1.13 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.252 0.549 . . . . 0.0 110.935 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -71.67 147.13 47.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.208 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -62.62 -19.65 63.98 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -101.6 117.04 34.09 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.545 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 2.2 tp10 -63.0 -32.7 74.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.992 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.5 -5.96 58.57 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -176.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 84.8 mt -117.81 -11.66 10.3 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.487 -0.485 . . . . 0.0 112.08 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.598 ' NZ ' HD13 ' A' ' 336' ' ' LEU . 18.4 ptmt -68.77 122.23 18.15 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.194 0.521 . . . . 0.0 112.205 -176.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.76 13.3 78.48 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.129 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.49 117.49 29.61 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.471 -0.429 . . . . 0.0 110.487 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -68.57 133.65 48.84 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.965 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -114.61 159.31 20.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.714 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -99.29 -33.11 10.86 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 53.05 99.17 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -73.85 91.88 2.01 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.143 0.497 . . . . 0.0 110.241 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.5 mm -95.18 115.4 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -112.76 -36.64 5.11 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.278 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.3 mt 67.76 152.96 0.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.265 0.626 . . . . 0.0 111.813 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -110.85 -80.64 0.58 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.665 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -111.79 -31.23 7.02 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 18.3 t 59.15 46.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 121.843 0.83 . . . . 0.0 109.528 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 60.7 -102.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.595 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . 15.2 pt-20 178.7 103.56 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.817 0.847 . . . . 0.0 108.964 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.587 ' HA ' ' H ' ' A' ' 152' ' ' LYS . 11.1 ptm180 -157.52 122.88 4.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -179.42 165.83 1.42 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.1 mt 72.64 109.02 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.028 0.531 . . . . 0.0 111.509 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.22 117.64 3.52 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.784 2.323 . . . . 0.0 114.37 -176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.38 -179.26 5.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.646 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.5 mp -91.38 128.5 37.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.081 0.467 . . . . 0.0 111.548 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 9.3 m -136.16 142.15 44.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.43 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.79 92.11 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.12 50.5 0.21 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.327 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -132.68 -58.57 0.92 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.881 0.372 . . . . 0.0 110.8 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 261' ' ' GLY . 36.9 pt -68.97 -22.13 26.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.577 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -105.55 5.72 31.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.4 0.619 . . . . 0.0 109.923 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -111.61 -1.84 15.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.531 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -98.3 116.51 30.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.15 -173.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 51.03 -109.38 0.73 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 175.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.13 136.92 55.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.057 0.543 . . . . 0.0 110.707 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 260' ' ' ASP . 2.4 tp10 66.43 -160.16 0.25 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . 0.42 ' H ' ' HG3' ' A' ' 259' ' ' GLU . 4.9 p-10 -133.95 134.75 42.93 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.627 ' O ' ' HB ' ' A' ' 253' ' ' ILE . . . -125.65 158.25 19.92 Favored Glycine 0 C--N 1.316 -0.563 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.74 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 11.8 p -82.19 -179.43 7.4 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.665 0.386 . . . . 0.0 110.958 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.89 -47.76 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.255 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.38 -31.86 15.88 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.758 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.55 -44.24 96.87 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.042 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 270' ' ' VAL . 40.5 tp -64.78 -41.93 95.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -61.64 -43.1 99.5 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.366 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.39 -40.82 96.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.912 0.387 . . . . 0.0 110.586 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -66.63 -41.75 87.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.376 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 266' ' ' LEU . 85.7 t -63.75 -42.77 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.408 HH12 HG11 ' A' ' 132' ' ' VAL . 9.4 tpt180 -55.69 -47.6 76.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.301 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 0.1 OUTLIER -70.27 -40.89 74.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -64.53 -41.25 96.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.687 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 95.1 mmm -65.04 -41.63 95.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.628 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.41 -34.86 78.11 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.815 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.56 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 53.4 ttp180 -63.65 -43.64 96.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.393 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -68.32 -34.68 76.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.048 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.413 ' O ' HG13 ' A' ' 282' ' ' ILE . 50.2 tp -62.62 -37.94 88.26 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.56 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 50.7 tttm -55.98 -46.78 78.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.165 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.9 m -62.37 -40.89 97.91 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.708 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.59 -42.71 99.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.929 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 278' ' ' LEU . 64.1 mt -65.35 -43.29 94.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.828 0.347 . . . . 0.0 110.482 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.549 ' HD2' ' OE2' ' A' ' 405' ' ' GLU . 1.1 tpm_? -58.96 -44.52 91.5 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.392 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.24 -42.74 96.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.224 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -61.86 -44.47 96.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.946 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.49 -44.69 86.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.008 0.432 . . . . 0.0 110.749 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.0 tttt -61.6 -47.18 86.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.539 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.7 p -62.31 -41.08 98.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.23 -41.78 94.06 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.762 0.315 . . . . 0.0 110.791 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.37 -48.26 76.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.039 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 287' ' ' LYS . 49.4 mm -63.2 -47.91 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.513 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.548 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 26.4 tp10 -61.87 -43.02 99.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.097 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.29 -42.93 93.83 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.702 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.81 -44.49 96.03 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.54 -44.79 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.256 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . 0.548 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 64.0 mttm -61.63 -40.52 95.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.582 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.3 80.84 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.719 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -126.45 101.47 6.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -94.78 113.85 25.67 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.4 tp -119.75 153.26 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.502 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -61.75 142.68 57.12 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.952 0.406 . . . . 0.0 110.515 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 54.2 t -120.83 126.28 26.74 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.644 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.1 131.94 48.36 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.216 1.944 . . . . 0.0 111.715 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.72 -38.23 89.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.066 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . 0.406 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -56.87 -44.2 82.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.023 0.439 . . . . 0.0 111.402 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.63 -41.8 95.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.446 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 311' ' ' ILE . 68.6 mt -61.75 -48.17 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.73 -46.15 84.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.159 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 48.9 m -61.03 -44.95 96.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.685 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.424 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 56.1 mm-40 -71.42 -35.35 70.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.45 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 94.3 mt -62.42 -44.42 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.69 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 13.1 t70 -64.32 -40.98 97.0 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.268 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.61 -43.94 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.978 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 96.9 mt -62.37 -41.99 99.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.684 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.495 HH12 HD12 ' A' ' 330' ' ' LEU . 79.8 mtm180 -63.59 -39.56 94.7 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.084 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 66.6 mtt180 -64.34 -40.29 95.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.261 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -64.61 -42.64 95.39 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.291 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.47 -38.43 81.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.516 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.24 -34.92 79.21 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.979 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . 0.412 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 52.3 tt0 -60.25 -37.11 79.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.408 0.623 . . . . 0.0 109.852 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -79.11 -7.56 58.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.593 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -100.8 2.29 41.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 135.4 -3.56 3.99 Favored Glycine 0 CA--C 1.509 -0.344 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.114 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 93.9 28.97 10.26 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.638 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.505 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 45.8 t-20 -70.82 130.6 42.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.975 0.417 . . . . 0.0 110.622 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.0 tm-20 -129.95 158.25 40.06 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 6.7 ptpp? 60.04 -40.06 0.09 Allowed 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 125.682 1.593 . . . . 0.0 114.473 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.505 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 15.6 mm100 -73.0 -12.7 61.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.382 0.611 . . . . 0.0 109.806 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.45 -17.55 62.81 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.762 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.495 HD12 HH12 ' A' ' 315' ' ' ARG . 56.4 tp -61.59 -32.29 72.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.252 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.88 -15.39 60.21 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.756 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.485 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 89.9 mt -66.59 138.07 95.41 Favored Pre-proline 0 C--O 1.238 0.488 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.953 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.78 119.21 6.08 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.344 2.696 . . . . 0.0 113.593 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.446 ' HG3' HD13 ' A' ' 311' ' ' ILE . 21.5 ttt180 -63.07 -45.37 92.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.356 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 0.9 OUTLIER -66.14 -18.61 65.46 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.401 -173.138 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.598 HD13 ' NZ ' ' A' ' 227' ' ' LYS . 85.7 mt -94.2 -5.76 46.28 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -117.35 -2.32 11.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.408 0.623 . . . . 0.0 109.731 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.444 ' HG3' HD11 ' A' ' 311' ' ' ILE . 40.5 tt0 -83.34 -16.69 45.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.534 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.92 -48.74 67.73 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.045 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -74.65 -24.72 58.86 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.197 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -60.27 -44.87 94.95 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.499 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.3 tttt -60.38 -46.91 88.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.427 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.52 ' O ' HG23 ' A' ' 347' ' ' VAL . 20.3 mmt85 -62.51 -44.22 96.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -66.29 -38.62 88.19 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.721 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 76.1 t -64.2 -44.1 97.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.753 0.311 . . . . 0.0 110.335 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.52 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 75.6 t -61.5 -43.29 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.644 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 343' ' ' ARG . 72.1 t -59.92 -44.44 94.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.21 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.55 -41.2 99.52 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.98 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 91.1 mt -63.1 -43.8 97.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.955 0.407 . . . . 0.0 111.095 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.0 mt -62.8 -47.36 83.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.122 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.99 -39.44 83.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.852 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.63 -43.27 96.31 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.541 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -68.18 -37.91 81.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.356 0.578 . . . . 0.0 111.042 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.06 -45.79 97.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.74 -44.2 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.018 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -66.07 -49.79 66.39 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.912 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.4 m -66.74 -44.16 82.25 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -82.19 -4.35 56.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.853 0.359 . . . . 0.0 111.063 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 60.02 38.22 20.83 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.347 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.38 152.92 39.46 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.098 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -129.29 158.96 37.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.108 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -81.48 105.6 12.78 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 367' ' ' VAL . 26.6 t70 -81.18 114.47 20.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.169 0.509 . . . . 0.0 112.257 -173.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.543 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 66.4 mm-40 -62.02 -37.3 84.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.255 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 63.4 mm-40 -61.92 -45.74 92.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.286 0.565 . . . . 0.0 110.179 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -63.07 -39.15 93.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.074 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 363' ' ' ASP . 93.2 t -62.96 -40.82 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.784 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.2 mmmt -57.77 -44.13 85.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.413 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.92 -38.79 97.16 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.767 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.79 -42.19 99.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.05 0.452 . . . . 0.0 110.014 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.19 -43.39 97.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.961 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.66 -44.11 97.1 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -65.63 -39.09 91.08 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.533 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 55.7 ttm -65.09 -42.87 93.66 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.096 0.474 . . . . 0.0 110.967 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 377' ' ' ALA . . . -63.31 -31.35 72.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.562 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 37.4 m -73.68 23.84 0.07 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.939 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' A' ' 375' ' ' ALA . . . -123.43 0.72 8.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.737 0.303 . . . . 0.0 110.765 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.47 175.33 5.47 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.576 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -59.29 -42.22 90.77 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.835 0.35 . . . . 0.0 110.824 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -134.06 116.17 13.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.476 ' O ' HG13 ' A' ' 385' ' ' ILE . 51.4 Cg_endo -69.5 -31.99 20.55 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.272 1.982 . . . . 0.0 113.702 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -66.62 -43.76 83.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.48 -35.02 79.66 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.576 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.82 -42.66 97.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.244 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 381' ' ' PRO . 74.5 mt -61.19 -46.72 96.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.461 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 43.0 mt-10 -65.33 -43.46 90.89 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.82 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -57.0 -46.87 81.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.832 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.439 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 3.5 t80 -64.89 -42.31 94.89 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.204 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 65.4 p -76.06 -10.44 59.42 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 99.6 mttt -98.35 6.3 47.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.024 0.44 . . . . 0.0 111.005 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 24.2 t-20 -130.64 111.8 12.54 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.854 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -63.38 -36.6 84.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.239 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . 0.407 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 25.7 tp10 -56.95 -53.15 61.31 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.96 0.409 . . . . 0.0 110.283 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.68 -41.21 98.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.597 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.489 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 87.8 mtp -62.07 -46.74 87.75 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 120.836 0.35 . . . . 0.0 111.708 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.61 -39.55 64.49 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.076 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -63.36 -40.6 97.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.439 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 46.7 tpp -64.68 -40.27 95.11 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.982 0.42 . . . . 0.0 110.742 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 395' ' ' MET . 70.1 mtm180 -63.38 -33.4 75.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.092 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.6 -44.28 97.3 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.17 -45.52 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.177 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.7 99.54 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.496 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 46.3 tp -64.82 -37.61 88.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.422 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.01 -46.29 82.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.716 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.549 ' OE2' ' HD2' ' A' ' 283' ' ' ARG . 26.6 mt-10 -65.26 -38.69 91.1 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.634 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -60.5 -43.35 97.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.303 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.95 -45.36 89.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.433 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 96.2 t -63.89 -46.56 93.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.274 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -68.49 -30.56 69.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.897 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.39 98.93 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.48 -43.32 96.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.033 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.5 mt -61.95 -39.0 90.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.251 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.98 -33.05 72.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.963 0.411 . . . . 0.0 110.896 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -89.08 -10.94 45.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.846 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -93.65 176.94 6.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.295 0.569 . . . . 0.0 112.348 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -93.05 112.34 24.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.291 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.42 129.45 51.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.03 0.443 . . . . 0.0 110.945 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.5 t -118.27 139.95 50.56 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.858 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -105.29 120.05 40.6 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -137.31 145.01 42.93 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.712 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.86 148.4 26.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.98 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.9 t -150.34 177.95 9.48 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.046 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 19.7 p -86.41 159.96 19.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.991 0.424 . . . . 0.0 111.474 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -66.8 -33.37 75.47 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.2 0.524 . . . . 0.0 110.742 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 428' ' ' MET . 6.6 m-20 -60.74 -37.17 80.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.514 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.25 -32.66 74.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.558 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.16 -17.7 61.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.943 0.401 . . . . 0.0 110.474 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 425' ' ' ASN . 5.7 mmt -74.95 -8.05 55.35 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.167 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -76.72 75.8 3.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -103.73 15.25 29.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.057 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -63.89 -42.02 97.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.375 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.705 -0.664 . . . . 0.0 110.757 -179.65 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 CA--C 1.513 -0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -94.74 158.08 15.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.922 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.53 158.76 43.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.692 0.282 . . . . 0.0 110.718 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 6.4 m -86.09 107.34 17.78 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.491 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.51 138.45 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.978 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.535 ' HG2' ' H ' ' B' ' 7' ' ' THR . 25.1 tt0 -137.53 177.77 7.61 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.535 ' H ' ' HG2' ' B' ' 6' ' ' GLU . 13.1 t -118.09 152.13 36.18 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.89 0.376 . . . . 0.0 111.272 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 75.3 m -110.62 -70.74 0.79 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.074 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -168.03 111.16 0.61 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.022 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.23 -108.37 2.02 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.073 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.09 -31.92 68.42 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 122.462 0.305 . . . . 0.0 111.236 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.24 139.18 39.67 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 116.005 -0.543 . . . . 0.0 114.021 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 0.0 OUTLIER -142.17 161.23 38.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.466 0.706 . . . . 0.0 110.049 -178.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' B' ' 6' ' ' GLU . 32.0 ttm-85 -119.86 138.45 53.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 39.8 t -106.03 -86.94 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.343 176.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 17.9 m 51.1 87.29 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.331 0.586 . . . . 0.0 111.458 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 tp -94.16 136.91 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.941 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 91.7 m -117.33 121.51 41.34 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.101 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.536 HG13 HG12 ' B' ' 24' ' ' ILE . 14.3 pt -135.31 165.88 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.611 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.79 151.11 47.37 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.456 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -54.01 -53.03 58.58 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -173.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -65.42 -36.13 83.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.091 0.472 . . . . 0.0 110.441 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.9 m -63.65 -38.23 90.34 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.561 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.611 HG13 ' O ' ' B' ' 20' ' ' ALA . 74.9 mt -59.15 -51.04 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 111.21 -177.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -73.01 -42.59 63.05 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.856 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -67.61 -52.38 39.1 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.42 -44.59 67.6 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.78 -43.06 96.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.734 0.302 . . . . 0.0 111.307 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -61.7 -44.92 96.01 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.082 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.449 ' O ' HG12 ' B' ' 33' ' ' VAL . 19.6 m -63.92 -40.83 97.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.638 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -62.6 -41.84 99.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.031 0.443 . . . . 0.0 110.454 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.48 -41.61 98.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.086 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.449 HG12 ' O ' ' B' ' 30' ' ' SER . 9.9 p -67.99 -36.5 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.316 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -63.47 -42.78 98.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.232 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.03 -36.97 77.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.335 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.77 -48.1 80.64 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.105 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.68 -36.96 85.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.906 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.48 -34.63 75.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.666 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.46 -7.52 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.368 0.604 . . . . 0.0 109.707 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 65.91 27.84 10.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.865 0.866 . . . . 0.0 111.57 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.01 3.53 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.325 0.583 . . . . 0.0 111.001 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -65.4 -32.83 74.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.072 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -7.4 58.01 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.69 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -89.04 -6.83 56.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.834 0.35 . . . . 0.0 110.35 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 65.9 ttt-85 -87.58 91.66 8.82 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.054 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -63.17 -43.58 97.85 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.61 72.66 0.7 Allowed Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 115.997 1.159 . . . . 0.0 115.997 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.92 -43.17 98.97 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 171.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.82 112.52 63.93 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.775 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -57.41 147.49 77.51 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 111.912 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.551 ' HA ' HG12 ' B' ' 54' ' ' VAL . 19.7 ttt -67.38 -24.75 65.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.543 -172.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -77.63 -10.24 59.4 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.447 HD13 ' CZ ' ' A' ' 193' ' ' ARG . 81.5 mt -108.26 -47.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.488 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' B' ' 51' ' ' MET . 12.4 p -62.89 -38.88 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.032 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.8 92.21 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -88.41 -9.22 53.35 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.052 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.44 ' NH1' ' SD ' ' A' ' 194' ' ' MET . 62.2 ttt180 -97.36 -41.47 8.22 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.238 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.61 9.87 27.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.965 0.412 . . . . 0.0 109.893 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -57.57 -63.84 4.92 Favored Glycine 0 C--O 1.211 -1.343 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.115 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.63 -27.76 66.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.978 0.389 . . . . 0.0 111.748 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.3 t -61.61 -45.09 95.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.797 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.428 HG22 ' O ' ' B' ' 62' ' ' VAL . 7.6 p -131.0 21.39 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 120.996 0.427 . . . . 0.0 111.902 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.59 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 6.7 ttt180 -64.65 -21.49 66.74 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.782 -0.574 . . . . 0.0 110.914 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -62.08 -50.3 72.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.64 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' B' ' 62' ' ' VAL . 1.1 m-20 -73.6 -25.0 60.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.1 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.93 -43.74 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.1 -39.67 95.38 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.37 -40.3 97.36 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.634 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . 0.764 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 30.6 t70 -61.29 -46.15 91.51 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.67 -42.31 98.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.495 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 60.2 ttp -61.94 -42.4 99.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -62.54 -42.85 99.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.764 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 52.3 mtp85 -63.32 -44.98 93.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.535 -176.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -65.31 -41.33 94.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.228 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -61.3 -48.05 83.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.763 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.14 -39.07 80.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.885 0.374 . . . . 0.0 111.117 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.73 -41.24 96.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.186 0.517 . . . . 0.0 110.532 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.51 -46.42 86.16 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.989 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 41.1 pt -65.35 -38.0 81.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.85 -43.62 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.126 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -76.77 -26.26 54.3 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -88.19 3.26 49.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.399 . . . . 0.0 110.793 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 63.9 28.38 14.55 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.125 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.2 mt -94.29 114.68 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -112.09 104.36 55.96 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.01 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.53 140.77 64.32 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.175 1.917 . . . . 0.0 111.695 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.54 96.32 7.3 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.857 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.29 -112.48 4.48 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.789 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.81 139.04 31.12 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.502 0.151 . . . . 0.0 110.657 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . 0.491 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 55.7 Cg_endo -68.48 155.89 67.5 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.629 2.219 . . . . 0.0 111.29 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -90.06 99.01 12.1 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.938 0.399 . . . . 0.0 111.558 -175.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.491 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 66.8 m-85 -102.95 110.96 23.07 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.4 t -115.83 98.83 51.79 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.95 145.97 25.5 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.359 2.039 . . . . 0.0 111.958 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.76 171.9 45.62 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.131 -1.033 . . . . 0.0 110.898 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.5 123.14 20.5 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.057 0.456 . . . . 0.0 110.597 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -84.44 134.19 34.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.261 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -121.78 122.11 38.77 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 46.3 tp -69.76 106.48 3.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.975 0.417 . . . . 0.0 110.716 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.98 -18.35 9.05 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.486 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -110.27 -175.33 2.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -79.7 164.42 23.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.934 0.397 . . . . 0.0 111.707 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -131.18 141.74 50.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.459 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.2 m -120.05 133.78 55.43 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.912 0.387 . . . . 0.0 111.118 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -125.28 165.28 18.6 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.139 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.9 m -75.5 -82.76 0.07 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 46.8 t 54.27 103.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 122.955 0.502 . . . . 0.0 111.315 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -88.33 123.5 32.97 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . 0.494 ' HB3' ' OE1' ' B' ' 110' ' ' GLU . 13.7 m-85 -123.36 -167.47 1.62 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.769 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.494 ' OE1' ' HB3' ' B' ' 109' ' ' PHE . 1.0 OUTLIER -72.37 176.34 5.4 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -176.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' B' ' 305' ' ' ALA . 32.1 m -125.43 166.14 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.473 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' B' ' 113' ' ' PRO . 69.9 m-85 -123.61 121.06 26.74 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.796 -178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 112' ' ' TYR . 73.8 Cg_endo -90.97 134.77 1.8 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 122.87 2.38 . . . . 0.0 113.136 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -135.42 144.79 46.7 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.36 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 76.5 t -126.2 134.22 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -107.52 -86.98 0.49 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.861 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 85.0 mt 62.52 120.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.197 0.999 . . . . 0.0 113.553 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -140.18 153.07 46.5 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.948 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.68 21.85 73.73 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.584 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.55 -40.67 95.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.964 0.411 . . . . 0.0 111.486 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.55 -8.73 57.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.363 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.96 8.19 44.33 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 64.7 mt -88.4 108.8 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.197 0.522 . . . . 0.0 110.089 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.36 103.95 15.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.505 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.02 133.08 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.21 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -85.57 122.96 30.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.44 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -120.78 97.08 48.59 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -69.49 130.24 19.32 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.578 1.519 . . . . 0.0 111.823 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -102.69 115.39 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 24.2 m -132.78 159.46 43.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.299 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.43 160.72 37.9 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 66.8 t -76.25 127.7 37.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 41.3 p -105.27 173.46 6.3 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.814 0.34 . . . . 0.0 110.194 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -67.56 -25.49 65.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.162 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.55 -40.36 96.79 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.122 0.487 . . . . 0.0 109.891 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -63.66 -40.8 97.75 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.026 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.0 t -61.75 -48.43 88.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.414 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.32 -38.42 90.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.901 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.7 -40.95 99.46 Favored Glycine 0 C--O 1.237 0.294 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.565 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 4.1 tpt -63.27 -41.84 99.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.15 0.5 . . . . 0.0 109.826 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 87.2 mt -63.16 -40.31 97.19 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.801 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -58.98 -46.88 87.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.568 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.7 m -63.39 -41.1 98.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' B' ' 140' ' ' MET . 89.5 mt -60.56 -42.86 97.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.718 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -79.07 -8.71 59.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.773 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -94.86 -5.46 44.95 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -97.73 -55.82 2.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.149 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' B' ' 148' ' ' GLN . 8.1 mm-40 -58.09 96.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.07 106.55 3.64 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.901 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . 0.608 HG22 ' H ' ' B' ' 151' ' ' TRP . 0.2 OUTLIER -73.07 175.13 6.99 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -173.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . 0.608 ' H ' HG22 ' B' ' 150' ' ' THR . 53.2 p-90 -99.43 161.21 13.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.526 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . 0.588 ' H ' ' HA ' ' B' ' 243' ' ' ARG . 76.6 tttt -170.98 -81.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.584 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' B' ' 242' ' ' GLU . 11.8 pt-20 -164.24 76.16 0.33 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . 0.462 ' HG2' ' H ' ' B' ' 155' ' ' ASP . 49.7 tttt 178.06 -160.79 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . 0.462 ' H ' ' HG2' ' B' ' 154' ' ' LYS . 12.2 p-10 -135.38 163.05 30.91 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 117.996 0.362 . . . . 0.0 111.153 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 119.87 -18.97 9.71 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.182 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -115.36 100.23 7.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 117.393 0.596 . . . . 0.0 112.174 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 55.0 t -130.26 136.34 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . 0.5 ' HB2' ' OD2' ' B' ' 162' ' ' ASP . 3.4 mm-40 -95.6 -170.58 2.18 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.164 0.507 . . . . 0.0 111.899 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . 0.648 ' O ' ' HA3' ' B' ' 190' ' ' GLY . . . -98.94 24.32 7.87 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . 0.791 ' HA ' ' O ' ' B' ' 189' ' ' MET . 13.4 pt-20 -158.85 25.27 0.22 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.34 0.591 . . . . 0.0 112.422 175.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' B' ' 188' ' ' ALA . 12.8 m-20 -87.81 170.7 10.97 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.398 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -108.15 121.13 44.22 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.3 t -116.74 128.26 74.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.251 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 20.7 m -76.75 104.88 7.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.97 117.99 56.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.002 0.43 . . . . 0.0 111.393 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.95 88.44 5.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -109.14 150.92 27.14 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.332 0.587 . . . . 0.0 112.182 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 46.3 m -119.97 128.28 53.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.937 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.9 114.09 3.89 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.488 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 39.2 m -131.94 124.19 28.93 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . 0.537 HG23 ' CD2' ' B' ' 177' ' ' PHE . 93.9 t -100.14 106.77 19.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 35.2 t70 67.6 -75.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.939 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -145.37 9.95 1.72 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.608 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -132.48 139.02 47.79 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.521 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.13 148.25 26.22 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . 0.537 ' CD2' HG23 ' B' ' 172' ' ' VAL . 31.9 p90 -115.84 171.41 7.79 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.442 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -59.39 -36.83 76.54 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.62 -174.45 33.82 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.04 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.73 24.31 60.53 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.991 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -103.56 106.58 17.13 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -124.73 144.78 50.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.194 0.521 . . . . 0.0 112.144 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 42.9 m -138.35 119.55 14.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.843 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 55.01 31.11 15.43 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 123.587 0.555 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -81.17 124.54 29.34 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.441 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.72 107.48 18.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.763 0.792 . . . . 0.0 110.708 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 55.1 tp -95.08 122.17 37.46 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.6 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . 0.578 ' HB3' ' CZ ' ' B' ' 193' ' ' ARG . . . -92.1 116.69 29.16 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . 0.791 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 54.1 mtp -84.54 154.28 22.76 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.91 -175.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.648 ' HA3' ' O ' ' B' ' 160' ' ' ALA . . . 89.28 4.31 74.32 Favored Glycine 0 CA--C 1.501 -0.831 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.71 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -111.33 -4.33 14.96 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.312 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.27 47.65 8.91 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.018 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.578 ' CZ ' ' HB3' ' B' ' 188' ' ' ALA . 96.2 mtt180 -95.47 -3.62 46.47 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.288 0.566 . . . . 0.0 109.568 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.455 ' SD ' ' NH1' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -134.54 168.74 18.42 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.942 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 43.7 mm -61.74 135.46 94.34 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.25 129.5 19.14 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.356 2.037 . . . . 0.0 111.85 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.44 -36.63 4.28 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.343 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -67.31 -50.95 58.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.33 0.565 . . . . 0.0 112.015 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . 0.456 ' O ' ' HE3' ' B' ' 189' ' ' MET . 10.5 pt-20 -81.48 -10.95 59.37 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.005 0.431 . . . . 0.0 111.427 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -90.72 -25.86 19.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.153 0.502 . . . . 0.0 109.705 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.21 -10.93 85.98 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.143 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.5 mm -64.27 -43.0 97.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -55.41 114.6 1.89 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.905 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 115.03 -9.11 21.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.923 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -99.4 146.64 26.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 117.319 0.56 . . . . 0.0 112.158 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.49 168.84 11.53 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.007 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.34 129.28 37.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 78.29 33.36 40.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.68 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -119.77 118.94 32.19 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.913 0.387 . . . . 0.0 110.378 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -101.67 116.62 33.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.284 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -138.29 -16.21 1.23 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 62.7 p 59.66 167.86 0.07 Allowed 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 123.712 0.805 . . . . 0.0 112.844 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -151.17 144.21 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.968 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -80.21 110.91 16.07 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.687 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 43.1 t -118.77 105.5 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 21.0 m -71.99 -43.54 64.93 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' B' ' 216' ' ' THR . 66.3 m-85 76.67 146.91 0.12 Allowed Pre-proline 0 N--CA 1.488 1.449 0 C-N-CA 123.044 0.538 . . . . 0.0 110.748 -174.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.7 153.82 68.74 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.788 2.325 . . . . 0.0 111.863 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . 0.515 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 65.0 mm-40 -66.7 -38.12 86.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.236 0.541 . . . . 0.0 110.069 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -94.49 40.8 1.09 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.62 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -75.15 143.88 43.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.154 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -60.96 -17.63 52.66 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.39 118.48 36.85 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.441 ' HA ' ' CD ' ' B' ' 227' ' ' LYS . 5.2 tp10 -61.86 -33.23 73.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.856 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -88.96 -5.11 58.2 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 87.7 mt -117.93 -14.72 10.02 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.029 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.668 ' NZ ' HD13 ' B' ' 336' ' ' LEU . 19.7 ptmt -63.96 122.58 16.86 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.121 0.486 . . . . 0.0 111.884 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.58 9.94 66.05 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.097 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -110.92 120.4 42.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.197 0.498 . . . . 0.0 110.485 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -72.51 134.45 45.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.871 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.56 156.52 26.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.659 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.25 -31.68 13.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 51.59 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -74.52 95.4 2.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.509 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm -96.53 114.64 33.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.57 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -108.46 -31.59 7.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.212 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.2 mt 65.5 170.41 0.21 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.407 0.683 . . . . 0.0 111.382 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -128.62 -79.61 0.57 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.122 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -115.42 -31.13 6.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.4 ' O ' HG12 ' B' ' 240' ' ' VAL . 17.1 t 59.89 41.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 122.13 0.967 . . . . 0.0 109.085 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 63.67 -101.1 0.09 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.765 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.538 ' HB2' ' HA ' ' B' ' 153' ' ' GLU . 9.5 pt-20 179.9 96.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.962 0.905 . . . . 0.0 109.095 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.588 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 10.5 ptm180 -152.19 120.94 6.51 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -173.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 179.46 164.89 1.02 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 98.2 mt 70.85 112.17 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.985 0 CA-C-O 121.285 0.564 . . . . 0.0 111.617 -176.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.37 118.18 2.54 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.527 2.151 . . . . 0.0 114.471 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -144.64 167.23 23.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.501 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.82 134.68 38.99 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.045 0.45 . . . . 0.0 112.19 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 8.0 m -138.07 154.91 49.23 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -79.44 -36.49 38.81 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.808 0.337 . . . . 0.0 111.642 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -75.6 56.41 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.758 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -136.09 -56.92 0.77 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.937 0.399 . . . . 0.0 110.498 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 253' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' B' ' 261' ' ' GLY . 36.4 pt -68.86 -22.81 26.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.163 0.506 . . . . 0.0 110.92 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -105.85 7.83 32.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.666 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -115.12 -1.06 13.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.391 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -99.66 116.75 32.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.208 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 46.59 -115.86 2.08 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 83.2 t -113.65 136.51 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.522 0.729 . . . . 0.0 110.926 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' B' ' 260' ' ' ASP . 3.0 tp10 69.18 -173.05 0.18 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . 0.449 ' H ' ' HG3' ' B' ' 259' ' ' GLU . 5.1 p-10 -125.98 117.99 24.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' B' ' 253' ' ' ILE . . . -103.2 162.27 16.08 Favored Glycine 0 C--N 1.316 -0.552 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.174 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 12.0 p -85.37 -178.99 6.87 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.72 -47.98 90.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.918 0.389 . . . . 0.0 111.065 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.1 -32.02 17.73 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.782 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.02 -42.35 96.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.533 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.507 ' O ' HG23 ' B' ' 270' ' ' VAL . 47.5 tp -64.33 -42.4 96.3 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.633 0.216 . . . . 0.0 110.435 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -60.86 -44.64 96.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.638 0.256 . . . . 0.0 111.155 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.16 -41.23 97.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.003 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -69.4 -38.79 78.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.507 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.1 t -63.83 -42.0 94.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -53.15 -54.83 30.09 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.498 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 12.7 ptmt -64.59 -42.61 95.48 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -63.65 -40.71 97.53 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.473 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.6 -41.41 92.82 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.195 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -66.68 -35.08 79.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.949 0.404 . . . . 0.0 110.883 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 56.3 ttp180 -62.78 -42.63 99.78 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.385 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.34 -37.29 83.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.985 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.23 -37.81 86.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.541 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 52.5 tttm -56.34 -45.94 80.17 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.37 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 42.5 m -61.83 -41.0 97.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.592 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.2 -44.91 96.53 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.158 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.35 -44.22 98.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.285 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . 0.453 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.5 OUTLIER -60.41 -44.88 95.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 178.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -64.44 -41.87 96.31 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.672 0.272 . . . . 0.0 110.927 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -61.48 -44.64 96.73 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.099 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.15 -43.27 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.988 0.423 . . . . 0.0 110.582 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.43 -47.72 84.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.806 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 73.7 p -61.94 -41.55 98.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.738 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -64.53 -44.83 89.59 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.824 0.345 . . . . 0.0 111.073 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.38 78.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.535 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . 0.428 ' O ' HG23 ' B' ' 295' ' ' VAL . 37.5 mm -64.09 -44.24 97.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.734 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . 0.512 ' HG3' ' HE2' ' B' ' 296' ' ' LYS . 30.6 tp10 -62.91 -45.11 94.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.513 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.43 95.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.7 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.404 HD13 HD13 ' B' ' 350' ' ' LEU . 1.8 tt -62.81 -43.15 99.56 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 291' ' ' ILE . 98.8 t -66.28 -43.38 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.075 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . 0.512 ' HE2' ' HG3' ' B' ' 292' ' ' GLU . 64.3 mttm -62.21 -39.22 92.05 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.593 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.24 -37.71 66.28 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.364 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -125.45 98.53 5.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.06 115.28 27.95 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -120.28 153.64 23.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.475 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.13 142.25 58.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.151 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.85 127.42 26.0 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.207 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.5 134.0 60.56 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.568 2.179 . . . . 0.0 111.896 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.37 87.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.808 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . 0.433 ' HB2' HG11 ' B' ' 111' ' ' VAL . . . -57.46 -42.75 83.14 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.474 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.65 -41.75 95.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.286 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.2 -47.45 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.114 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.12 -47.54 80.85 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.258 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 48.4 m -60.29 -44.79 95.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.897 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . 0.474 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 67.0 mm-40 -71.81 -36.69 70.33 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.552 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 92.7 mt -61.94 -44.22 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.085 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.498 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 15.0 t70 -63.34 -42.52 98.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.906 0.384 . . . . 0.0 110.322 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.34 -43.85 98.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.23 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 92.9 mt -61.91 -41.23 97.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.762 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 82.6 mtm180 -63.88 -38.64 91.83 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.141 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 62.0 mtt-85 -64.25 -40.69 96.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.926 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.1 -43.03 96.59 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.455 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.84 76.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.971 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.18 77.36 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.965 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . 0.436 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 50.7 tt0 -60.99 -34.22 74.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.332 0.587 . . . . 0.0 110.019 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -82.08 -9.22 59.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.121 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -97.09 -0.58 46.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.688 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 135.38 0.52 3.33 Favored Glycine 0 C--O 1.226 -0.403 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.85 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 90.98 29.57 12.6 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.875 -1.155 . . . . 0.0 111.822 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 42.5 t-20 -71.6 125.38 26.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.126 0.489 . . . . 0.0 111.136 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 3.0 tm-20 -124.5 157.13 36.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 6.6 ptpp? 60.12 -38.67 0.09 Allowed 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 125.882 1.673 . . . . 0.0 114.681 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . 0.435 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.2 mm100 -75.24 -10.02 59.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.19 0.519 . . . . 0.0 110.362 177.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -65.88 -12.73 56.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.353 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.519 HD12 HH12 ' B' ' 315' ' ' ARG . 62.6 tp -61.62 -34.8 76.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.883 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -76.98 -11.59 59.82 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.808 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . 0.464 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 84.3 mt -66.92 134.76 94.03 Favored Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.621 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -49.93 122.26 8.79 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.445 2.763 . . . . 0.0 113.69 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . 0.482 ' HG3' HD13 ' B' ' 311' ' ' ILE . 21.9 ttt180 -65.37 -44.56 87.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.018 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -68.38 -17.35 64.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.58 -172.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . 0.668 HD13 ' NZ ' ' B' ' 227' ' ' LYS . 92.1 mt -93.53 -5.86 48.07 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -117.36 -11.83 10.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.688 0.756 . . . . 0.0 109.767 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.98 -21.99 61.5 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.944 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -65.4 -48.64 72.14 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.907 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -75.18 -25.82 58.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.681 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.433 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -59.06 -44.95 91.88 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.506 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . 0.472 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.7 tttt -60.37 -45.25 94.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.255 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . 0.467 ' O ' HG23 ' B' ' 347' ' ' VAL . 18.4 mmt85 -62.68 -43.75 98.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -64.97 -38.83 92.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 121.189 -0.204 . . . . 0.0 111.059 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 341' ' ' ALA . 81.5 t -64.49 -44.14 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.436 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.512 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 70.3 t -61.8 -43.98 98.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.467 HG23 ' O ' ' B' ' 343' ' ' ARG . 74.0 t -59.83 -45.21 95.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.676 0.274 . . . . 0.0 110.496 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.37 -41.25 99.76 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.805 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.5 -43.2 99.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' B' ' 346' ' ' VAL . 96.2 mt -62.91 -46.43 87.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.021 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.5 -39.31 85.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.776 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.95 -45.63 93.48 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.409 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -68.84 -37.29 79.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.218 0.509 . . . . 0.0 111.234 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.24 -46.25 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.7 -44.29 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.547 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -65.89 -50.07 65.8 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 97.3 m -65.79 -45.97 80.46 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -81.9 -7.22 59.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.694 0.283 . . . . 0.0 111.547 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 63.22 45.03 5.29 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.162 0.506 . . . . 0.0 111.317 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.01 155.95 28.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.977 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -132.22 158.65 41.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.5 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -84.85 102.48 13.12 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 26.1 t70 -81.69 118.6 22.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . 0.594 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 54.8 mm-40 -61.59 -39.07 89.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.299 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . 0.552 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 63.4 mm-40 -58.44 -48.04 82.01 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.271 0.557 . . . . 0.0 110.275 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -62.36 -40.3 95.98 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.275 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 363' ' ' ASP . 97.1 t -63.56 -41.52 92.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.036 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 29.8 mmmt -56.97 -44.61 82.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.777 0.322 . . . . 0.0 110.135 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.38 -38.38 96.3 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.103 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.84 -42.27 99.67 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.288 0.566 . . . . 0.0 110.153 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.84 -43.31 97.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.529 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -61.33 -44.19 97.62 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -66.68 -40.0 88.37 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.937 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 55.6 ttm -64.63 -42.57 95.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.964 0.412 . . . . 0.0 110.75 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.81 -29.2 70.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.256 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 44.3 m -70.37 -7.28 41.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.955 0.407 . . . . 0.0 111.581 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.12 -2.5 58.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.441 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -108.98 174.26 5.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.053 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.62 -44.45 89.99 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.316 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -132.34 113.99 14.6 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -67.61 -30.43 35.04 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.332 2.021 . . . . 0.0 113.373 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.96 -44.35 80.76 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.69 -34.73 78.89 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.933 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.85 -43.02 97.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.438 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.37 -44.86 99.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.89 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 49.9 mt-10 -66.14 -45.0 82.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.124 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -57.1 -46.78 82.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.939 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . 0.433 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 4.4 t80 -63.52 -44.37 94.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.887 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 77.4 p -72.56 -14.12 61.56 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.1 mttt -94.46 5.82 50.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.893 0.377 . . . . 0.0 111.697 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -131.39 113.87 14.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.167 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -63.63 -37.11 86.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -56.91 -51.25 69.84 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.774 0.321 . . . . 0.0 110.533 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.83 -41.02 97.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.901 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 93.4 mtp -60.83 -51.77 67.9 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -72.69 -36.15 67.8 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.369 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.63 -41.03 98.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.988 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . 0.433 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 50.1 tpp -63.74 -40.79 97.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.631 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.442 ' HG2' HG21 ' B' ' 367' ' ' VAL . 25.8 mtm180 -62.89 -34.3 77.13 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.745 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -61.02 -45.32 95.29 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.768 0.318 . . . . 0.0 110.452 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.49 -44.99 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.07 0.462 . . . . 0.0 110.791 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.22 97.46 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.645 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.75 -36.92 85.45 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.658 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . 0.419 ' O ' HG23 ' B' ' 408' ' ' VAL . 36.3 tt0 -58.86 -43.9 90.93 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.648 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . 0.453 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 32.2 mt-10 -65.23 -40.55 94.21 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.559 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -58.37 -44.34 88.83 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.559 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.39 -42.5 96.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 89.3 t -64.8 -46.29 92.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -67.53 -31.5 71.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.312 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.68 98.08 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.855 0.359 . . . . 0.0 110.107 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 95.9 t -66.51 -42.5 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.864 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 89.6 mt -61.56 -40.15 93.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.091 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.51 -21.79 65.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.564 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -102.06 -2.56 29.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.895 0.378 . . . . 0.0 110.952 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -101.66 173.14 6.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.147 0.499 . . . . 0.0 111.704 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -88.95 114.06 25.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.425 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.22 127.03 53.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.336 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 10.1 t -118.83 131.71 56.09 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.141 0.496 . . . . 0.0 109.92 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -98.62 113.26 25.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.662 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -129.02 146.67 50.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.846 0.355 . . . . 0.0 110.464 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -89.88 146.4 24.44 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.42 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -147.99 -175.67 4.98 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.342 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 67.6 p -94.78 159.92 14.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.33 . . . . 0.0 111.37 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.76 -34.29 77.99 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.05 0.453 . . . . 0.0 110.752 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -58.97 -39.18 80.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.409 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.0 -31.48 72.06 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 120.871 0.367 . . . . 0.0 110.854 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.21 -16.94 61.4 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.852 0.358 . . . . 0.0 110.529 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.3 mmt -75.95 -8.54 57.18 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.086 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -75.72 72.17 2.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -101.12 9.95 41.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.302 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -62.2 -46.62 88.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.917 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.623 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.104 -179.904 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 11.7 p -76.42 -170.71 1.57 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.958 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 4' ' ' SER . 0.6 OUTLIER 87.48 143.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.775 0.83 . . . . 0.0 111.901 177.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -140.74 156.35 46.21 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 m -88.56 129.24 35.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.9 0.381 . . . . 0.0 111.79 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.2 m -88.42 -70.59 0.63 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.069 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -166.27 122.16 1.25 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.891 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.12 -106.16 1.24 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.078 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.8 mt -92.91 -7.91 44.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.615 0.245 . . . . 0.0 110.976 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.524 ' O ' ' HD3' ' A' ' 13' ' ' ARG . . . -81.56 137.9 18.17 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.241 -0.504 . . . . 0.0 114.23 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.524 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -134.12 148.22 50.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.062 0.945 . . . . 0.0 110.84 179.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -110.81 137.96 47.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.4 t -96.73 -83.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.665 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 p 25.06 93.91 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.0 tp -123.56 139.76 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.871 0.367 . . . . 0.0 111.965 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.2 p -68.99 139.43 55.0 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.688 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.472 HD13 HG12 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -126.79 141.61 45.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -174.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.641 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -75.51 148.73 38.74 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.073 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -57.15 -40.22 76.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -175.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.55 -3.58 47.53 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.878 0.37 . . . . 0.0 111.449 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -105.71 -25.63 12.14 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.914 0.388 . . . . 0.0 110.624 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.641 HG13 ' O ' ' A' ' 20' ' ' ALA . 74.8 mt -60.56 -49.37 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.153 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.411 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 71.4 mm-40 -102.23 3.47 38.3 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -175.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.7 m -96.66 -72.14 0.65 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.265 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.84 89.0 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.403 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 99.1 t -62.87 -45.34 99.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.879 0.371 . . . . 0.0 111.132 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 20.2 ttmm -63.15 -45.58 91.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.7 m -62.72 -39.71 94.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.194 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.5 tp10 -66.23 -40.55 90.34 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.53 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.8 mt -62.28 -43.11 99.58 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.34 -39.11 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.908 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -65.48 -38.29 89.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.244 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 31' ' ' GLU . 96.0 t -62.46 -42.13 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 110.369 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.29 -41.81 94.17 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 110.223 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.87 -30.75 71.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.096 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 35' ' ' VAL . 24.5 ttmm -57.78 -41.94 83.08 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.171 0.588 . . . . 0.0 110.255 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 t -89.29 -4.48 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.005 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 64.96 33.9 9.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.646 0.778 . . . . 0.0 111.178 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.73 13.03 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.921 0.391 . . . . 0.0 111.741 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.99 -32.75 74.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.351 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.5 -3.4 58.1 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.148 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -86.47 -6.68 58.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.917 0.389 . . . . 0.0 110.834 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.9 ttt-85 -91.61 108.16 19.71 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.812 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.12 -39.49 92.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.635 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.95 29.66 22.61 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.254 -0.974 . . . . 0.0 114.757 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -60.98 -44.69 97.0 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.05 110.06 56.84 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.476 ' O ' HG13 ' A' ' 54' ' ' VAL . 53.1 Cg_exo -56.85 141.5 92.89 Favored 'Trans proline' 0 N--CA 1.477 0.557 0 C-N-CA 122.762 2.308 . . . . 0.0 112.135 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.503 ' HA ' HG22 ' A' ' 54' ' ' VAL . 16.1 ttt -68.33 -27.76 66.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -172.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -72.35 -17.4 61.84 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.095 0.474 . . . . 0.0 110.151 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.524 HD13 ' NH2' ' B' ' 193' ' ' ARG . 84.3 mt -99.75 -34.6 4.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.864 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' A' ' 51' ' ' MET . 21.4 m -60.76 -40.15 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 120.917 0.389 . . . . 0.0 111.012 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.77 -25.94 65.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -94.16 -32.5 13.7 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.066 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.425 HH12 HD13 ' B' ' 187' ' ' LEU . 15.3 tpp180 -64.68 -41.55 95.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.767 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.61 22.5 14.96 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.644 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.75 147.96 49.84 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.835 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.71 -39.69 0.45 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.468 0.707 . . . . 0.0 112.487 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 t -60.68 -47.93 84.04 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 122.678 0.391 . . . . 0.0 111.956 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.8 p -118.29 10.58 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.288 0.566 . . . . 0.0 110.733 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -60.31 -38.81 84.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.481 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 27.2 tt0 -60.08 -45.9 91.37 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.987 0.422 . . . . 0.0 110.83 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -68.1 -34.07 75.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.242 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 62' ' ' VAL . 79.2 t -60.9 -33.82 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 109.714 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 98.0 mt -61.68 -38.77 89.04 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.77 -40.27 99.0 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.498 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.91 -45.31 93.12 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.971 0.415 . . . . 0.0 110.915 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.34 -42.17 98.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.2 ttp -61.27 -46.31 90.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.316 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.3 m -64.4 -53.01 55.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.448 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -69.55 -39.44 77.42 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -65.12 -40.51 94.59 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.486 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -61.43 -48.42 81.24 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.406 ' O ' HG13 ' A' ' 79' ' ' ILE . 16.3 tt -67.78 -39.73 82.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 120.71 0.29 . . . . 0.0 111.154 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.37 -42.75 99.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.157 0.504 . . . . 0.0 110.699 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.98 87.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.309 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.7 pp -68.44 -31.13 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.12 -44.47 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.334 0.588 . . . . 0.0 110.655 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -82.93 -18.96 38.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.888 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -88.14 -7.7 56.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.325 0.583 . . . . 0.0 109.551 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 67.51 35.96 3.98 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.149 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.2 mt -100.37 116.16 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -103.35 105.44 46.65 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.455 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.92 142.89 83.84 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.403 2.069 . . . . 0.0 111.382 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.04 99.24 9.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.046 0.45 . . . . 0.0 110.836 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.08 -104.31 3.16 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.88 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.15 130.41 9.28 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.492 0.187 . . . . 0.0 110.728 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.93 154.03 37.88 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.39 2.06 . . . . 0.0 110.97 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -99.48 120.15 39.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.138 0.494 . . . . 0.0 110.49 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.464 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 97.2 m-85 -97.81 97.5 9.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.621 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.15 107.66 39.41 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.377 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 85.2 Cg_endo -89.01 157.84 5.84 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.907 2.405 . . . . 0.0 111.089 175.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.04 178.41 33.27 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.494 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.3 112.88 9.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.272 0.558 . . . . 0.0 110.038 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -79.35 127.55 32.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.522 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -107.42 119.98 40.91 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.12 117.74 9.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.015 0.436 . . . . 0.0 110.676 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.81 -5.79 54.09 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.665 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -119.97 179.59 4.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.695 0.283 . . . . 0.0 110.764 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -72.44 157.24 38.01 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 111.254 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -123.03 136.63 54.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.934 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.8 m -120.59 137.04 54.62 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.746 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -140.29 167.8 21.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.56 0.344 . . . . 0.0 111.066 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.2 m -78.31 -86.84 0.06 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.2 t 57.21 97.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.299 0.571 . . . . 0.0 110.117 -172.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -100.82 136.04 41.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -157.7 167.42 30.14 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.802 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -52.39 145.21 11.61 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -173.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.4 m -137.89 165.27 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.904 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -121.1 103.97 41.77 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -89.03 160.4 5.88 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.074 2.516 . . . . 0.0 113.531 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.08 138.85 52.71 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.28 141.62 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.636 0.255 . . . . 0.0 111.103 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -108.68 142.21 39.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.674 0.273 . . . . 0.0 110.98 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.3 mt -118.97 146.25 45.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -134.41 147.07 50.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 111.172 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.08 14.79 80.07 Favored Glycine 0 C--N 1.33 0.227 0 N-CA-C 114.273 0.469 . . . . 0.0 114.273 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.77 -38.2 90.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.177 0.513 . . . . 0.0 110.851 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.3 mp0 -73.0 -8.25 54.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.807 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.39 11.07 39.83 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.917 0.389 . . . . 0.0 111.398 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.449 ' CD1' HD21 ' A' ' 294' ' ' LEU . 75.0 mt -88.95 125.64 42.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.2 119.53 38.67 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.7 t -112.19 132.6 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 111.432 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -88.57 140.66 29.23 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.538 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -130.19 106.46 16.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -68.61 118.05 5.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.059 1.839 . . . . 0.0 111.419 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -104.2 109.48 27.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.97 161.07 40.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.558 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -133.66 166.24 23.06 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.25 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.88 113.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.4 p -95.97 173.23 7.54 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.199 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.6 -32.6 73.63 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.887 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.23 -41.93 97.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.421 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.5 -39.73 95.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.831 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.79 -46.05 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.261 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -45.1 94.9 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.545 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.65 99.61 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.083 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.601 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.2 tpt -60.9 -47.41 86.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.673 0.273 . . . . 0.0 110.765 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.7 -42.0 98.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.43 -45.31 94.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.0 m -63.39 -40.75 98.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.849 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.4 mt -61.14 -40.08 92.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.162 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -74.68 -9.99 59.1 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 110.805 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.59 9.51 43.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.52 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -118.62 27.11 9.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.892 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -138.86 106.69 5.65 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.12 150.06 36.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.791 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 151' ' ' TRP . 0.2 OUTLIER -118.17 -176.44 3.06 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.002 -176.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.572 ' H ' HG22 ' A' ' 150' ' ' THR . 57.7 p-90 -108.66 145.04 35.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -161.67 -71.01 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.41 -127.76 0.25 Allowed 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.289 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.486 ' HE3' ' HG2' ' A' ' 242' ' ' GLU . 9.6 ptpp? -143.25 144.04 31.98 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.236 0.925 . . . . 0.0 113.426 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 156' ' ' GLY . 12.1 t70 -164.95 -151.51 0.15 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.573 ' HA3' ' HD3' ' A' ' 206' ' ' LYS . . . -104.51 59.95 0.44 Allowed Glycine 0 CA--C 1.509 -0.32 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.311 -178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.4 115.8 14.44 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.17 129.28 70.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.437 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -84.5 158.54 20.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.022 0.439 . . . . 0.0 111.962 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.4 28.7 0.24 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.74 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -170.03 21.11 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.633 0.773 . . . . 0.0 109.045 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.474 ' CG ' ' HE ' ' A' ' 243' ' ' ARG . 46.1 t0 -64.45 -42.32 96.04 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 55.7 ttp180 68.85 86.85 0.13 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.445 HG13 ' H ' ' A' ' 241' ' ' GLU . 48.9 t -113.88 131.86 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.875 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.4 m -67.93 106.8 2.43 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 86.4 mt -118.12 130.22 73.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -174.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -101.5 109.15 20.91 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.422 0.63 . . . . 0.0 109.551 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -137.29 154.43 50.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.065 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 37.3 m -127.15 131.97 50.64 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.266 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -69.46 125.22 17.17 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.983 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.3 m -138.67 131.01 28.61 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.2 t -79.78 -77.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -114.47 -60.78 1.84 Allowed 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -144.99 22.95 1.94 Allowed Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -132.57 143.91 50.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -94.1 146.61 23.85 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -111.96 173.46 6.35 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.448 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.17 -38.08 75.95 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.28 -178.45 37.2 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.045 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.38 22.63 56.27 Favored Glycine 0 C--N 1.319 -0.381 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.895 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.89 99.32 9.51 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -119.91 138.77 53.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.163 0.506 . . . . 0.0 111.743 -176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 m -142.3 122.5 13.83 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.368 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 60.06 31.68 20.7 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.459 0.475 . . . . 0.0 110.843 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -90.72 121.09 32.31 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.836 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.7 m -91.02 114.39 28.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.5 0.666 . . . . 0.0 110.464 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.44 HD13 HH12 ' B' ' 57' ' ' ARG . 61.4 tp -101.74 116.05 31.87 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.391 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.71 ' HB3' ' NH1' ' A' ' 193' ' ' ARG . . . -99.96 102.64 14.07 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 50.4 mtm -75.32 171.33 14.4 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.054 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.57 5.64 71.6 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.159 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -118.03 -8.21 10.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 120.787 0.327 . . . . 0.0 111.062 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 75.4 47.47 12.57 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.215 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.71 ' NH1' ' HB3' ' A' ' 188' ' ' ALA . 49.8 mtm180 -104.79 6.29 33.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.443 0.64 . . . . 0.0 111.06 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.518 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -128.75 159.47 35.58 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.183 173.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.456 HG13 ' CE2' ' A' ' 217' ' ' PHE . 43.6 mm -54.78 131.75 65.85 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.12 123.6 5.34 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.706 2.27 . . . . 0.0 112.32 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.95 -37.33 3.88 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.36 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -62.39 -48.2 80.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.93 0.365 . . . . 0.0 111.887 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.54 -9.33 59.3 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -93.11 -27.94 16.63 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.274 0.559 . . . . 0.0 110.063 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.48 -16.43 73.73 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.629 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.52 -43.01 98.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -57.95 114.73 2.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.31 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 114.71 2.26 22.6 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.48 -0.866 . . . . 0.0 113.596 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -111.06 146.52 36.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.156 0.478 . . . . 0.0 111.593 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.573 ' HD3' ' HA3' ' A' ' 156' ' ' GLY . 75.4 mmtt -83.97 165.02 18.99 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.877 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.03 111.2 3.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.715 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 84.45 35.01 15.02 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.235 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -111.86 127.2 55.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.13 0.49 . . . . 0.0 111.641 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -92.28 142.48 27.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.58 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.434 ' O ' ' HB ' ' A' ' 212' ' ' THR . 75.4 t80 -159.48 -30.89 0.06 Allowed 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 35.5 m 78.46 142.06 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.623 0.369 . . . . 0.0 110.905 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.3 tp -138.28 127.54 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 121.062 0.458 . . . . 0.0 111.229 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -79.79 107.09 12.29 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.461 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 67.8 t -112.34 114.22 46.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.279 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 14.0 m -72.88 -41.61 64.5 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -176.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.544 ' HB2' ' O ' ' A' ' 216' ' ' THR . 68.7 m-85 80.81 143.45 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 123.539 0.736 . . . . 0.0 110.935 -174.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.68 152.44 53.35 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.437 2.091 . . . . 0.0 112.099 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -65.39 -35.68 81.68 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -87.34 23.98 1.73 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.648 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 8.3 t80 -67.94 133.71 49.56 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.044 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -67.95 -18.49 64.77 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.462 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -88.81 102.5 15.08 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 175.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.504 ' OE2' HD12 ' A' ' 336' ' ' LEU . 42.6 tt0 -57.05 -33.26 67.06 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.663 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -78.07 -11.39 59.91 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 90.2 mt -121.12 -4.7 9.51 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 21.8 ptmt -68.1 116.65 8.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.173 0.511 . . . . 0.0 111.71 -177.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.2 21.85 70.42 Favored Glycine 0 C--O 1.24 0.526 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.033 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -121.92 112.16 17.96 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.4 142.98 57.41 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -174.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -127.94 144.08 51.1 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.782 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -100.58 -31.79 11.08 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 61.85 126.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -81.32 -40.94 22.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.769 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.2 mm 67.97 129.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.847 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.527 ' ND2' ' HG3' ' A' ' 238' ' ' LYS . 7.6 t30 -107.08 -67.38 0.95 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.453 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 98.0 mt 62.31 94.39 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.527 ' HG3' ' ND2' ' A' ' 236' ' ' ASN . 62.2 mttp -100.66 -37.87 8.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.136 0.493 . . . . 0.0 110.045 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 24.0 mmtm -95.4 -88.43 0.26 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 92.0 t 73.39 126.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.585 0.553 . . . . 0.0 110.197 -173.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.445 ' H ' HG13 ' A' ' 164' ' ' VAL . 42.9 mt-10 -73.8 -179.48 3.68 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.486 ' HG2' ' HE3' ' A' ' 154' ' ' LYS . 42.3 mt-10 -113.97 112.4 23.24 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -168.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 8.9 ptp180 -148.41 143.89 27.09 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.751 167.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -172.95 156.79 3.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 4.9 tt 69.77 109.26 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.199 0.6 . . . . 0.0 111.315 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -86.42 120.23 1.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.594 2.196 . . . . 0.0 112.743 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -147.18 177.57 9.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.984 0.421 . . . . 0.0 110.451 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 248' ' ' LEU . 5.8 mp -93.06 78.1 4.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.238 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.419 ' OG1' HG21 ' A' ' 150' ' ' THR . 7.2 m -92.12 -63.16 1.27 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.882 0.372 . . . . 0.0 111.392 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -162.05 -32.1 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.045 0.45 . . . . 0.0 110.805 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -72.08 0.5 9.39 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.215 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -103.38 -26.1 13.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.173 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 44.8 pt -103.66 -8.28 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -171.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -159.61 7.22 0.1 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 119.526 -0.87 . . . . 0.0 113.089 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -120.61 135.82 54.99 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.574 0.226 . . . . 0.0 110.445 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -177.09 36.81 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 81.0 20.3 65.48 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.6 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 24.9 t -127.7 160.04 37.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -57.47 -50.9 71.56 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.033 0.444 . . . . 0.0 110.23 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -176.68 156.74 1.48 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.846 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -170.92 174.75 44.74 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.058 -1.067 . . . . 0.0 112.674 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.6 p -98.03 -173.86 2.71 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 122.716 0.406 . . . . 0.0 110.233 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 14.8 t -70.4 -71.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 111.191 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.518 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.1 pm0 -70.19 -37.02 75.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.866 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.5 -39.65 97.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.079 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 63.8 tp -63.25 -43.8 97.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.489 0.185 . . . . 0.0 110.995 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -62.62 -42.74 99.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.957 0.408 . . . . 0.0 110.282 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.54 -45.61 82.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.44 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 30.8 tp10 -66.34 -39.81 89.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.864 0.364 . . . . 0.0 110.974 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.01 -43.7 96.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.25 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.405 HH21 ' HD3' ' A' ' 271' ' ' ARG . 9.0 tpt180 -59.17 -48.56 81.14 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.03 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.8 ptmt -64.89 -44.32 90.02 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 111.198 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -65.12 -37.57 87.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.955 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 89.4 mmm -61.93 -42.85 99.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.825 0.345 . . . . 0.0 110.224 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.37 -32.14 69.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 55.3 ttp180 -63.45 -42.0 98.63 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -65.56 -35.8 81.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.855 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 44.2 tp -61.44 -36.78 81.32 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.905 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 58.1 tttm -54.81 -47.96 73.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.862 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 20.1 m -63.83 -42.44 97.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.037 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.39 -49.4 77.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.318 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 86.1 mt -64.02 -43.02 97.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.471 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -45.12 93.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.219 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -65.41 -41.37 93.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.26 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . 0.492 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.8 tpm_? -60.83 -44.13 97.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.785 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.3 t -68.88 -44.42 81.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.93 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.509 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.1 tttt -61.99 -48.44 80.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.82 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.8 p -63.62 -42.36 98.19 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.95 -39.56 90.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.204 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.03 93.95 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.851 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 287' ' ' LYS . 48.6 mm -65.11 -44.22 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.2 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.487 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 16.0 tp10 -60.02 -42.66 94.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.51 -45.82 92.03 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.709 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.449 HD21 ' CD1' ' A' ' 123' ' ' ILE . 26.5 mt -62.86 -42.17 99.65 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.8 -43.78 96.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.716 0.293 . . . . 0.0 110.849 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . 0.487 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 67.9 mttm -62.77 -41.92 99.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.037 0.446 . . . . 0.0 110.936 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.03 -46.01 65.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.917 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -123.91 100.39 6.73 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -95.86 113.7 25.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.7 tp -122.11 156.96 26.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.17 120.07 11.41 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.978 0.418 . . . . 0.0 110.057 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.86 128.12 42.75 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.449 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.448 ' O ' HG13 ' A' ' 307' ' ' ILE . 49.9 Cg_exo -55.6 129.92 37.69 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.654 2.236 . . . . 0.0 112.215 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.22 86.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.021 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.79 -45.46 82.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.011 0.434 . . . . 0.0 111.026 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.36 -41.88 93.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.988 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.505 ' O ' HG13 ' A' ' 311' ' ' ILE . 73.4 mt -61.54 -49.85 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.472 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.09 -42.73 99.51 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 30.1 m -62.23 -45.52 92.98 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.5 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.466 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 65.6 mm-40 -71.01 -35.0 71.88 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 307' ' ' ILE . 94.7 mt -61.94 -43.16 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.629 0.252 . . . . 0.0 111.117 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.541 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.8 t70 -59.53 -44.26 93.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.55 -42.9 96.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.127 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 84.4 mt -62.09 -40.68 96.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.541 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.8 mtm180 -61.27 -42.43 98.62 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -64.19 -38.64 91.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.916 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -62.84 -42.72 99.85 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.159 0.505 . . . . 0.0 110.116 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.1 80.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.201 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.33 -37.05 86.14 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.225 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -63.62 -37.92 89.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.306 0.574 . . . . 0.0 109.646 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.94 -7.81 57.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.864 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -97.4 -0.9 45.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.246 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.06 7.61 2.25 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.168 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.18 38.84 8.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.479 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.433 ' HB3' ' HB1' ' A' ' 319' ' ' ALA . 25.7 t-20 -84.6 135.23 34.28 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.874 0.369 . . . . 0.0 111.137 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.79 162.92 33.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.401 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.1 OUTLIER 71.9 -54.21 0.68 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.102 0.561 . . . . 0.0 111.178 -178.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.08 -17.78 63.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.84 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.58 -22.49 45.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.78 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.08 -34.6 76.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.546 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 331' ' ' GLU . 36.3 tt0 -85.88 10.19 14.61 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.672 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 77.9 mt -82.68 149.37 60.25 Favored Pre-proline 0 C--O 1.239 0.52 0 O-C-N 122.008 -0.433 . . . . 0.0 110.737 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.406 ' O ' ' HD1' ' A' ' 337' ' ' PHE . 40.4 Cg_exo -56.5 124.39 16.14 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.114 2.543 . . . . 0.0 113.111 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -70.43 -43.3 70.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.536 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -58.54 -40.59 83.41 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -170.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.504 HD12 ' OE2' ' A' ' 224' ' ' GLU . 60.7 mt -86.41 -0.32 55.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 333' ' ' PRO . 47.5 m-85 -107.45 -29.33 9.29 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -65.48 -32.49 74.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.252 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.87 -50.27 74.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -77.92 -21.86 50.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.55 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -62.45 -40.93 98.2 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.016 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.464 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.2 tttt -59.79 -45.02 93.6 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.201 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.3 mmt85 -61.68 -46.33 90.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.737 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -66.74 -37.51 84.79 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.466 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 341' ' ' ALA . 73.2 t -64.8 -43.64 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.607 0.241 . . . . 0.0 110.406 176.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 342' ' ' LYS . 76.1 t -61.48 -41.77 91.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 343' ' ' ARG . 69.1 t -58.64 -44.77 90.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.3 -40.31 98.84 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.181 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.46 -44.38 94.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 110.934 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.2 mt -63.44 -48.5 77.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.883 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.86 -41.07 87.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.488 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.73 99.81 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.254 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.38 -35.83 78.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.643 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 350' ' ' LEU . 70.4 t -61.05 -44.9 99.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.21 -45.44 98.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -67.46 -51.72 48.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.0 m -65.33 -46.86 78.6 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -83.68 -5.97 59.32 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.351 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 61.23 55.52 2.95 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.095 0.474 . . . . 0.0 111.622 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 97.1 mt -88.85 160.19 17.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.459 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -140.88 155.61 46.28 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.901 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -75.42 104.98 6.22 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 367' ' ' VAL . 29.6 t70 -79.08 119.35 22.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.979 0.418 . . . . 0.0 111.341 -175.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 44.7 mm-40 -61.87 -42.74 99.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.347 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -64.89 -43.34 93.2 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.79 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 40.1 ttt85 -60.64 -42.93 97.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.238 0.542 . . . . 0.0 109.649 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.456 HG21 ' HG2' ' A' ' 399' ' ' ARG . 87.2 t -65.96 -36.89 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.371 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.0 mmmt -56.31 -43.74 79.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.719 0.295 . . . . 0.0 110.58 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.01 95.54 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.739 -0.744 . . . . 0.0 111.935 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.2 -42.51 96.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.062 0.458 . . . . 0.0 110.2 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.96 -43.5 97.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.526 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.83 -41.4 99.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.581 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -66.46 -37.86 86.06 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.589 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.5 ttm -64.31 -43.36 94.95 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 121.027 0.442 . . . . 0.0 110.332 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.2 -29.53 70.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.392 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 44.7 m -73.0 -7.78 52.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.5 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.86 -2.37 58.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.391 0.615 . . . . 0.0 110.036 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.12 171.63 7.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.611 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -64.02 -49.09 73.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.992 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 32.9 t70 -118.79 107.63 42.14 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.779 0.323 . . . . 0.0 110.148 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.02 -34.86 99.23 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.937 2.424 . . . . 0.0 112.959 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -63.76 -45.21 90.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 10.7 pt-20 -63.45 -38.97 93.17 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.802 0.334 . . . . 0.0 110.654 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.77 -43.21 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.16 -43.78 99.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 120.826 0.346 . . . . 0.0 110.534 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.435 ' HB3' ' HE3' ' A' ' 390' ' ' LYS . 45.6 mt-10 -66.56 -38.97 88.22 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.735 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -58.07 -46.64 85.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.885 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -33.46 71.19 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 35.3 p -88.58 -5.04 58.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 386' ' ' GLU . 98.4 mttt -98.32 -0.66 43.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.941 0.401 . . . . 0.0 110.952 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -123.53 114.84 20.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.778 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -63.7 -39.77 95.13 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -58.76 -46.78 86.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.85 0.357 . . . . 0.0 110.52 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.66 -40.77 97.67 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.091 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 92.6 mtp -62.6 -44.66 95.75 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.01 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -64.57 -45.87 85.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.9 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -64.36 -44.17 92.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.537 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 46.2 tpp -63.51 -42.57 98.48 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.923 0.392 . . . . 0.0 111.323 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.456 ' HG2' HG21 ' A' ' 367' ' ' VAL . 77.2 mtm180 -65.75 -34.37 78.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.127 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -63.38 -43.02 98.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.707 0.289 . . . . 0.0 110.407 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.77 -46.1 95.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.912 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.84 88.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.38 -38.33 90.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.823 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.4 -43.99 96.14 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.341 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -66.34 -37.46 85.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.959 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -59.79 -42.66 93.89 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.45 90.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.064 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.99 -45.94 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -67.79 -30.35 69.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.558 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.16 99.35 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.69 -43.76 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.412 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.58 -38.67 88.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.237 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.25 -29.88 70.11 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.025 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.23 -22.31 18.5 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.889 0.376 . . . . 0.0 111.419 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.16 174.56 7.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.191 0.52 . . . . 0.0 111.327 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -84.28 133.27 34.56 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 66.8 t -118.14 128.88 75.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -119.3 144.25 46.91 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 120.989 0.423 . . . . 0.0 110.699 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -101.53 130.48 47.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.18 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -151.61 141.53 22.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.334 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -97.09 139.36 33.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.066 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.9 t -146.72 179.24 7.71 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.8 p -80.99 156.49 25.89 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.031 0.443 . . . . 0.0 111.372 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.3 -40.07 96.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.89 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -57.23 -34.77 68.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.177 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.04 -31.86 72.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.865 0.364 . . . . 0.0 111.237 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.6 mp -83.98 -7.81 59.31 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.026 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.7 mmt -79.28 -6.86 57.64 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.082 0.467 . . . . 0.0 110.497 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -76.15 81.4 2.96 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.453 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -106.46 13.63 28.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.824 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -66.05 -37.49 85.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.944 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.308 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.102 179.7 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.486 0.184 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -70.11 116.04 10.01 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.647 0.737 . . . . 0.0 112.172 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.17 172.47 14.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.177 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.441 ' O ' ' HB ' ' B' ' 5' ' ' VAL . 9.4 p -72.7 -175.34 1.65 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.287 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' B' ' 4' ' ' SER . 0.5 OUTLIER 89.32 141.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.908 0.883 . . . . 0.0 111.705 179.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -139.5 156.06 47.16 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 90.8 m -89.54 129.91 35.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.872 0.368 . . . . 0.0 111.766 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 75.1 m -89.11 -70.19 0.67 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -166.54 124.25 1.37 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.134 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.13 -110.6 3.47 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.648 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 85.9 mt -90.29 -6.82 54.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.519 0.199 . . . . 0.0 111.203 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.548 ' O ' ' HD3' ' B' ' 13' ' ' ARG . . . -84.27 137.54 16.02 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 114.41 0.524 . . . . 0.0 114.41 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.548 ' HD3' ' O ' ' B' ' 12' ' ' GLY . 0.0 OUTLIER -133.44 146.69 51.4 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.035 0.934 . . . . 0.0 110.619 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.42 HH21 ' HD2' ' B' ' 14' ' ' ARG . 30.5 ttm180 -108.68 138.3 45.23 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.815 0.446 . . . . 0.0 110.051 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.81 -85.91 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.684 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.4 p 27.84 94.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 tp -123.07 140.11 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.913 0.387 . . . . 0.0 111.857 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -73.01 138.15 45.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.746 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.476 HD13 HG12 ' B' ' 24' ' ' ILE . 0.9 OUTLIER -126.17 152.42 33.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -175.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.681 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -87.3 151.64 22.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.277 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.39 84.33 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -77.37 -3.14 38.63 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.187 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 15.4 t -107.56 -28.4 9.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.628 0.251 . . . . 0.0 111.075 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.681 HG13 ' O ' ' B' ' 20' ' ' ALA . 71.3 mt -60.25 -49.6 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 121.027 0.441 . . . . 0.0 112.097 -175.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.474 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 69.2 mm-40 -101.32 8.61 42.28 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -175.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 40.0 m -103.74 -70.49 0.76 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.137 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.09 -47.48 79.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.824 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.455 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 86.0 t -62.11 -45.22 99.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.7 ttmm -63.33 -45.17 92.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 60.0 m -62.8 -41.52 99.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.367 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.572 ' O ' HG23 ' B' ' 35' ' ' VAL . 10.4 tp10 -66.44 -39.05 88.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.72 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 89.3 mt -61.81 -43.02 99.67 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -66.0 -38.22 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.535 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.07 -38.65 91.84 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 31' ' ' GLU . 89.3 t -63.17 -43.04 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.545 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.32 97.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.432 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.02 -30.06 70.04 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.068 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' B' ' 35' ' ' VAL . 23.1 ttmm -59.51 -44.75 93.04 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.202 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.16 -2.97 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 63.52 31.39 14.83 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.329 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.82 10.8 8.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.08 -25.62 67.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.13 -4.37 78.21 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.808 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -86.67 -5.4 59.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.459 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 64.0 ttt-85 -93.21 108.26 19.92 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.841 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.18 -38.12 87.88 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.293 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.42 33.16 20.56 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.247 -0.978 . . . . 0.0 114.205 175.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -63.53 -40.98 98.44 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 t -117.18 112.47 39.76 Favored Pre-proline 0 N--CA 1.448 -0.557 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.44 ' HG2' HD12 ' B' ' 53' ' ' ILE . 42.4 Cg_exo -57.53 142.77 95.53 Favored 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.687 2.258 . . . . 0.0 112.255 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.493 ' HA ' HG22 ' B' ' 54' ' ' VAL . 18.7 ttt -67.01 -29.38 69.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.55 -172.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . 0.422 ' OD1' HG13 ' B' ' 53' ' ' ILE . 29.1 p-10 -71.85 -16.43 62.15 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.094 0.473 . . . . 0.0 110.361 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.617 HD13 ' NH2' ' A' ' 193' ' ' ARG . 78.0 mt -99.76 -36.07 5.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.789 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' B' ' 51' ' ' MET . 23.6 m -60.58 -40.71 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.785 0.326 . . . . 0.0 111.286 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.14 -30.0 70.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.354 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -91.79 -32.77 15.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.377 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.44 HH12 HD13 ' A' ' 187' ' ' LEU . 15.1 tpp180 -64.61 -41.61 96.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.869 0.366 . . . . 0.0 110.436 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -110.48 23.57 14.07 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.27 0.557 . . . . 0.0 110.509 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.94 147.5 50.34 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.781 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 71.24 -41.06 0.49 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.392 0.677 . . . . 0.0 112.296 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.3 t -58.28 -53.44 58.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.758 0.423 . . . . 0.0 111.865 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.501 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -114.76 10.61 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.296 0.57 . . . . 0.0 110.827 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -60.14 -38.95 84.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.647 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -59.44 -45.51 91.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.688 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.5 -33.2 73.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.754 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 62' ' ' VAL . 77.3 t -60.97 -35.19 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.47 -39.43 90.88 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.31 -39.81 98.22 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.699 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.34 -46.37 88.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.966 0.413 . . . . 0.0 110.882 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.57 -42.08 98.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.453 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 55.0 ttp -60.78 -46.5 90.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.216 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 52.0 m -64.21 -52.28 59.62 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.463 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -70.11 -39.37 75.52 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -64.98 -40.53 95.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.642 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -61.09 -47.85 84.38 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.798 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . 0.419 ' O ' HG13 ' B' ' 79' ' ' ILE . 14.8 tt -68.13 -39.19 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.869 0.366 . . . . 0.0 111.035 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.12 -43.91 97.79 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.565 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.62 89.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.234 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.419 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.6 pp -67.12 -35.39 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.44 -43.94 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.997 0.427 . . . . 0.0 110.987 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -82.58 -19.65 38.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.006 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -88.13 -8.32 55.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.357 0.599 . . . . 0.0 109.54 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 69.56 34.4 2.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.172 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 73.6 mt -99.17 116.72 42.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -103.78 108.53 59.94 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.847 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.49 141.84 57.17 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.383 2.056 . . . . 0.0 111.394 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.45 104.45 15.39 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.058 0.456 . . . . 0.0 110.589 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.33 -109.2 3.36 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.188 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.09 124.93 13.3 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-O 120.51 0.195 . . . . 0.0 110.616 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.84 157.55 54.86 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.371 2.047 . . . . 0.0 111.023 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 20.2 m -98.16 115.67 28.78 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.029 0.442 . . . . 0.0 110.558 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -96.16 98.19 10.14 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.02 110.69 58.66 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -91.07 165.44 3.77 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.163 2.575 . . . . 0.0 111.112 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.28 179.48 25.83 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.517 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.13 114.02 10.82 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -81.69 124.81 29.92 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.202 0.525 . . . . 0.0 111.54 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.65 117.51 34.24 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.43 123.36 18.54 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.657 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.56 -17.82 56.09 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.498 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -106.32 -170.51 1.74 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.615 0.245 . . . . 0.0 111.229 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -81.12 165.45 21.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -128.83 135.99 49.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.872 0.368 . . . . 0.0 110.877 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 45.9 m -119.84 136.49 54.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.687 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -141.66 167.03 23.13 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.925 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -78.82 -84.95 0.08 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 99.1 t 56.7 93.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-O 121.171 0.51 . . . . 0.0 109.975 -172.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.48 135.44 38.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -158.65 170.45 22.14 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.971 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -50.77 145.88 6.49 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.56 165.42 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.521 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -121.67 106.6 37.11 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 120.894 0.378 . . . . 0.0 110.197 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -91.96 161.27 3.3 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.242 2.628 . . . . 0.0 113.805 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -131.56 134.39 46.02 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.996 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.87 136.3 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.657 0.265 . . . . 0.0 111.306 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.05 141.51 32.78 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.093 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 97.6 mt -119.1 141.86 48.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -129.84 145.38 51.59 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.96 18.62 78.56 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.097 -0.502 . . . . 0.0 114.127 174.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -63.51 -40.52 97.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.052 0.453 . . . . 0.0 111.339 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.97 -19.04 65.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.856 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.43 8.17 29.17 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.503 ' CD1' HD21 ' B' ' 294' ' ' LEU . 77.6 mt -86.26 127.66 40.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.064 0.459 . . . . 0.0 110.949 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -112.37 125.04 53.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.73 132.41 68.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.987 0.423 . . . . 0.0 111.635 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.28 137.14 32.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.389 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -126.37 105.76 24.43 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.67 119.41 6.42 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.088 1.859 . . . . 0.0 111.832 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.438 HG13 ' HG2' ' B' ' 419' ' ' GLU . 48.6 mm -104.63 108.24 24.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.42 159.28 40.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.51 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.24 161.07 37.2 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.194 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 46.1 t -69.68 121.25 18.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.766 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.4 p -105.92 -180.0 4.1 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.773 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.6 -34.82 77.77 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.303 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.61 94.87 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.559 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -64.95 -40.9 95.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.655 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.02 -47.43 92.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.798 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -61.81 -44.39 96.95 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.32 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.04 -41.33 99.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.18 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.617 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.8 tpt -60.98 -46.85 89.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.782 0.325 . . . . 0.0 110.838 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.28 -41.94 96.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.39 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.92 -43.13 99.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.828 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 18.5 m -63.24 -39.86 95.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.66 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.5 mt -60.22 -41.64 93.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.779 -176.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -72.23 -16.69 61.94 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.107 0.479 . . . . 0.0 111.11 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.31 8.11 43.04 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.568 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -117.79 24.79 10.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.74 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -138.17 106.51 5.8 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.25 147.43 31.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.594 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . 0.574 HG22 ' H ' ' B' ' 151' ' ' TRP . 0.3 OUTLIER -111.85 -163.16 0.83 Allowed 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.104 -176.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . 0.574 ' H ' HG22 ' B' ' 150' ' ' THR . 48.4 p-90 -123.2 146.64 47.64 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.058 0.456 . . . . 0.0 112.024 -176.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -168.03 -61.81 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.01 -142.27 0.22 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.773 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . 0.489 ' HE3' ' HG2' ' B' ' 242' ' ' GLU . 9.1 ptpp? -134.5 143.06 47.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.282 0.947 . . . . 0.0 112.874 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -164.56 -152.13 0.17 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' B' ' 206' ' ' LYS . . . -99.93 63.32 0.66 Allowed Glycine 0 C--O 1.235 0.193 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.49 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.47 118.9 12.18 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.74 129.8 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -86.45 157.94 19.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.085 0.469 . . . . 0.0 112.085 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.99 26.27 0.26 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.84 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -167.55 20.17 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.422 ' CG ' ' HE ' ' B' ' 243' ' ' ARG . 45.2 t0 -64.09 -45.43 88.71 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.362 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' B' ' 187' ' ' LEU . 53.4 ttp180 72.18 88.38 0.1 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.49 132.62 64.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.077 0.465 . . . . 0.0 112.016 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 24.6 m -69.0 104.19 2.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.844 173.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 88.2 mt -116.77 128.45 74.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.906 0.384 . . . . 0.0 111.934 -175.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -102.16 110.09 21.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.47 0.652 . . . . 0.0 109.381 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -137.01 154.01 50.51 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.3 m -124.04 130.18 52.14 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.023 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -70.05 131.44 22.96 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.99 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -145.6 129.59 17.41 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 43.3 t -77.91 -76.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -113.93 -70.5 0.8 Allowed 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -135.77 23.31 3.4 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -136.09 140.55 43.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.128 -0.536 . . . . 0.0 109.647 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -91.83 146.25 23.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -106.86 174.54 5.84 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.092 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.57 -37.39 78.34 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.6 -174.68 36.95 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.786 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.84 22.91 54.49 Favored Glycine 0 C--N 1.32 -0.352 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.281 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -103.1 101.25 11.21 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -123.64 140.26 53.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.114 0.483 . . . . 0.0 111.946 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 34.6 m -141.14 121.16 13.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.539 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.81 33.17 22.9 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.55 0.531 . . . . 0.0 111.15 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -87.91 123.22 32.43 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.753 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 13.8 m -92.86 113.31 27.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.566 0.698 . . . . 0.0 110.716 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . 0.425 HD13 HH12 ' A' ' 57' ' ' ARG . 52.1 tp -102.53 116.22 32.17 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.322 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . 0.713 ' HB3' ' NH1' ' B' ' 193' ' ' ARG . . . -99.9 105.37 17.08 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 41.9 mtm -76.17 168.88 19.25 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.129 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.9 -16.41 61.01 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.876 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -98.84 -3.46 35.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.599 -0.3 . . . . 0.0 111.455 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.16 44.6 59.76 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.176 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.713 ' NH1' ' HB3' ' B' ' 188' ' ' ALA . 47.8 mtm180 -98.32 4.63 48.68 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.417 0.627 . . . . 0.0 111.672 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.506 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -128.04 159.97 33.4 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 172.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.487 HG13 ' CE2' ' B' ' 217' ' ' PHE . 43.3 mm -54.42 133.56 62.42 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -48.09 126.22 13.01 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.359 2.039 . . . . 0.0 112.326 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.46 -34.15 6.01 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.261 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -64.32 -51.06 65.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.82 -16.65 60.69 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 121.015 0.436 . . . . 0.0 112.107 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -87.69 -21.59 25.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.173 0.511 . . . . 0.0 110.034 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.45 -10.82 85.52 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.63 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.0 mm -64.81 -42.85 96.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -55.32 124.81 18.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.762 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.5 1.59 40.56 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.793 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -111.13 148.6 32.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.313 0.557 . . . . 0.0 111.586 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.472 ' HD3' ' HA3' ' B' ' 156' ' ' GLY . 75.6 mmtt -86.83 163.42 17.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.412 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.56 112.21 3.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.344 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.24 39.4 11.32 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.863 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -113.92 126.4 55.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.999 0.428 . . . . 0.0 111.035 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -92.13 136.51 33.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.619 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . 0.48 ' O ' ' HB ' ' B' ' 212' ' ' THR . 65.0 t80 -155.64 -28.26 0.1 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' B' ' 211' ' ' PHE . 91.3 m 75.92 143.83 0.08 Allowed 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 120.665 0.269 . . . . 0.0 110.749 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -138.17 128.07 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.075 0.464 . . . . 0.0 111.233 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -82.72 111.92 19.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.166 0.507 . . . . 0.0 111.522 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 73.3 t -118.19 130.92 72.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 9.9 m -94.24 -29.75 14.92 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -174.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' B' ' 216' ' ' THR . 69.1 m-85 74.3 141.35 0.08 OUTLIER Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 122.702 0.401 . . . . 0.0 111.085 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.89 151.89 51.39 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.303 2.002 . . . . 0.0 111.867 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -65.44 -34.62 78.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.73 26.87 1.05 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.28 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 7.2 t80 -70.73 133.95 47.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -67.71 -17.67 64.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.439 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -91.28 104.69 17.2 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 33.6 tt0 -57.79 -36.1 71.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.33 -175.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.431 ' O ' ' HD3' ' B' ' 229' ' ' LYS . 28.6 p-10 -72.92 -13.26 61.22 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.4 mt -120.13 -1.54 10.32 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.1 ptmt -69.95 114.14 7.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.301 0.572 . . . . 0.0 111.592 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.26 21.81 75.94 Favored Glycine 0 C--O 1.237 0.292 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.214 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' B' ' 225' ' ' ASN . 9.7 mtpm? -122.28 109.91 15.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.87 145.54 55.36 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -128.44 146.23 50.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.772 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -100.97 -29.16 12.35 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -173.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 57.32 107.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -67.2 -40.23 86.44 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.832 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 48.8 mm 69.3 133.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.352 0.661 . . . . 0.0 111.338 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . 0.573 ' ND2' ' HG3' ' B' ' 238' ' ' LYS . 9.7 t30 -109.01 -65.44 1.14 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.843 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.8 mt 61.04 95.99 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . 0.573 ' HG3' ' ND2' ' B' ' 236' ' ' ASN . 64.1 mttp -102.13 -31.35 10.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.799 175.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -102.55 -87.13 0.42 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 85.4 t 72.36 121.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 123.532 0.52 . . . . 0.0 109.971 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.15 179.79 3.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.489 ' HG2' ' HE3' ' B' ' 154' ' ' LYS . 36.4 mt-10 -112.38 114.79 27.71 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -167.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 7.4 ptp180 -149.64 141.82 24.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.134 167.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.501 ' H ' ' HA ' ' B' ' 151' ' ' TRP . 1.0 OUTLIER -172.82 162.22 4.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 3.9 tt 67.57 106.45 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.229 0.611 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -85.63 118.5 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.592 2.195 . . . . 0.0 112.802 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -145.41 179.03 7.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.075 0.464 . . . . 0.0 110.733 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . 0.439 ' N ' HD12 ' B' ' 248' ' ' LEU . 4.8 mp -93.55 74.36 4.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.38 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . 0.441 ' OG1' HG21 ' B' ' 150' ' ' THR . 11.6 m -85.51 -72.71 0.47 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.815 0.34 . . . . 0.0 111.258 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -154.69 -34.91 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.421 . . . . 0.0 111.12 -177.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -62.3 -35.32 78.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.672 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -64.84 -28.98 69.92 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.036 0.935 . . . . 0.0 113.505 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 43.1 pt -99.41 -4.52 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -160.23 -11.9 0.05 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 119.055 -1.058 . . . . 0.0 113.621 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -102.86 134.6 46.0 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.876 0.37 . . . . 0.0 111.255 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -172.67 36.91 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.28 20.67 69.05 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.7 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.6 161.32 35.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -52.02 -59.17 4.66 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 122.894 0.477 . . . . 0.0 109.832 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -173.78 162.46 4.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.824 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -173.31 178.42 45.27 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.583 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 93.1 p -102.56 -171.25 1.93 Allowed 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 122.263 0.225 . . . . 0.0 110.508 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.8 -57.18 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.962 0.411 . . . . 0.0 112.023 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -35.74 23.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.0 111.049 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.28 -39.14 97.51 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.391 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.402 ' O ' HG23 ' B' ' 270' ' ' VAL . 54.0 tp -62.86 -45.43 92.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.569 0.223 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -64.29 -42.27 96.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.587 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.518 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.34 -45.15 89.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.314 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -67.12 -39.1 86.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.452 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 266' ' ' LEU . 66.3 t -64.7 -44.13 96.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.606 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -60.09 -47.56 85.39 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 17.7 ptmt -64.55 -45.41 87.21 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.909 0.385 . . . . 0.0 111.077 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -65.06 -36.25 83.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 89.5 mmm -61.82 -42.67 99.31 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.031 0.443 . . . . 0.0 109.98 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -70.15 -31.43 68.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.798 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . 0.519 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 57.6 ttp180 -64.73 -42.17 95.41 Favored 'General case' 0 CA--C 1.527 0.074 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -66.85 -34.03 76.9 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.69 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.53 -38.01 85.85 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.719 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 55.4 tttm -55.84 -47.16 77.74 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.303 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 20.4 m -63.47 -42.28 98.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.907 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.02 -47.45 86.39 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.062 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.18 -43.62 97.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.234 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -44.62 96.99 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.83 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.17 -41.37 97.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.035 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' B' ' 285' ' ' ARG . 4.2 tpm_? -60.42 -43.86 96.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.886 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.31 -44.12 80.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.135 0.493 . . . . 0.0 111.063 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.33 -48.58 79.19 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.938 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.6 p -65.15 -41.31 94.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.72 -40.89 92.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.642 0.258 . . . . 0.0 111.274 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.06 95.33 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.091 0.472 . . . . 0.0 110.653 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 36.7 mm -65.04 -43.49 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . 0.46 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 20.5 tp10 -61.87 -42.55 99.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.682 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.82 98.31 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.51 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.503 HD21 ' CD1' ' B' ' 123' ' ' ILE . 24.8 mt -63.73 -42.71 97.85 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.26 -42.16 93.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.731 0.3 . . . . 0.0 111.339 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . 0.46 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 66.4 mttm -61.95 -40.47 95.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.698 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.3 -47.46 19.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.904 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -114.89 96.02 5.51 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -99.94 105.54 17.25 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -116.71 159.4 16.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.604 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.6 130.11 43.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 42.6 t -105.48 127.53 28.38 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.029 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.37 128.6 30.76 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.461 2.107 . . . . 0.0 111.882 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.61 80.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.754 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.66 -48.05 72.82 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.338 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 66.3 mt -67.03 -40.52 87.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.002 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . 0.487 ' O ' HG13 ' B' ' 311' ' ' ILE . 75.7 mt -61.04 -49.82 83.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.391 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.13 -43.27 99.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.566 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 38.9 m -63.11 -45.25 92.9 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.643 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . 0.419 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 70.2 mm-40 -71.22 -34.44 70.81 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.51 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 89.9 mt -61.74 -43.05 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.027 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.586 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 31.0 t70 -59.32 -44.92 92.54 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.961 0.41 . . . . 0.0 110.805 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.39 -43.93 98.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.163 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 79.3 mt -62.92 -40.38 97.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.268 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.586 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 83.1 mtm180 -61.33 -42.56 98.87 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -65.08 -37.91 89.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.703 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -62.87 -42.68 99.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.206 0.527 . . . . 0.0 109.88 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.59 -37.47 79.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.523 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -63.9 -37.35 87.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.929 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -63.43 -37.08 85.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.364 0.602 . . . . 0.0 109.482 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -79.51 -3.36 46.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.898 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -101.68 4.22 40.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.953 0.406 . . . . 0.0 111.13 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 128.01 7.1 4.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.936 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 87.96 46.01 4.92 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.396 -0.906 . . . . 0.0 111.776 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . 0.474 ' HB3' ' HB1' ' B' ' 319' ' ' ALA . 26.2 t-20 -91.25 135.14 34.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 -177.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.87 160.99 38.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.44 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.1 OUTLIER 72.66 -53.57 0.7 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.05 0.54 . . . . 0.0 111.214 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.66 -16.83 63.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.849 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.86 -22.91 50.47 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.81 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.54 -35.78 78.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.912 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -79.51 -5.25 54.43 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.214 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.01 152.6 96.74 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.009 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . 0.479 ' O ' ' HD1' ' B' ' 337' ' ' PHE . 32.9 Cg_exo -59.86 140.53 93.54 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.817 2.344 . . . . 0.0 112.854 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -86.08 -43.78 12.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.898 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.6 pm0 -59.18 -39.38 82.37 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 62.1 mt -86.21 0.31 54.0 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.826 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . 0.479 ' HD1' ' O ' ' B' ' 333' ' ' PRO . 50.8 m-85 -107.75 -29.55 9.05 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.31 -31.7 72.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.964 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -58.92 -49.08 79.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.044 0.449 . . . . 0.0 110.795 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -83.5 -21.03 32.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.012 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.445 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.85 -40.48 97.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . 0.43 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.7 tttt -59.35 -44.37 92.67 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.194 177.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . 0.562 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.5 mmt85 -61.35 -45.22 95.32 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.772 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -67.22 -38.72 85.75 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.306 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 341' ' ' ALA . 74.2 t -64.53 -43.58 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.36 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 342' ' ' LYS . 57.7 t -61.32 -42.49 93.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.44 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 343' ' ' ARG . 79.4 t -59.87 -44.86 95.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.51 -41.69 99.61 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.928 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.96 -44.54 95.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.748 0.308 . . . . 0.0 110.982 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.457 ' O ' HG23 ' B' ' 354' ' ' VAL . 92.7 mt -63.53 -47.2 82.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.997 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.54 -41.29 88.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.487 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.21 99.73 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.195 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.22 -35.75 78.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.061 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 350' ' ' LEU . 76.1 t -60.61 -45.08 97.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 77.7 mt -63.4 -46.2 95.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.68 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.1 -54.26 32.7 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 47.7 m -65.21 -44.94 86.7 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -83.44 -8.47 59.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.265 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 65.43 45.39 2.83 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.271 0.558 . . . . 0.0 111.267 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 97.6 mt -78.79 156.3 28.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.768 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -139.02 153.45 48.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.516 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -75.07 105.77 6.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -80.83 116.48 20.84 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.978 0.418 . . . . 0.0 111.464 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 60.3 mm-40 -58.75 -42.61 89.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.308 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -62.42 -44.49 96.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.678 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -61.35 -42.64 99.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.207 0.527 . . . . 0.0 109.792 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . 0.435 HG21 ' HG2' ' B' ' 399' ' ' ARG . 94.7 t -65.96 -36.23 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.316 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.5 mmmt -56.31 -42.68 78.01 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.803 0.335 . . . . 0.0 110.663 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.95 -38.48 96.66 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.086 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.88 -42.04 97.6 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.1 0.476 . . . . 0.0 110.221 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 65.3 mt -65.7 -43.62 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.148 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -61.67 -40.0 93.39 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.693 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -67.28 -38.57 85.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.001 0.429 . . . . 0.0 110.412 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 58.1 ttm -64.28 -41.84 96.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.132 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . 0.433 ' HA ' HG11 ' B' ' 384' ' ' VAL . . . -64.39 -32.62 74.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.29 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 49.6 m -71.23 -8.02 50.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.454 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.85 -1.89 57.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.033 0.444 . . . . 0.0 110.507 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -117.81 173.23 6.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.123 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -65.87 -49.83 66.68 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -116.18 107.76 47.04 Favored Pre-proline 0 CA--C 1.518 -0.251 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.39 -29.21 71.81 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.106 1.871 . . . . 0.0 113.26 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -64.55 -45.12 88.47 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.89 -36.23 82.82 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.771 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' B' ' 375' ' ' ALA . 57.9 t -65.11 -43.84 95.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.605 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.59 -43.89 98.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.983 0.421 . . . . 0.0 109.916 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -65.93 -38.13 87.86 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.928 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -58.34 -46.66 85.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.541 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.08 -42.1 76.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 41.9 p -78.27 -8.36 58.28 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.23 9.28 42.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.847 0.356 . . . . 0.0 111.259 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -134.66 111.27 9.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.061 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -61.66 -39.85 92.85 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -59.99 -45.07 93.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.771 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.89 -40.63 96.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.686 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 94.8 mtp -62.13 -45.41 93.59 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.265 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.39 -44.16 79.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.008 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -64.09 -44.91 90.9 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.27 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 40.7 tpp -63.03 -42.54 99.81 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.926 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.435 ' HG2' HG21 ' B' ' 367' ' ' VAL . 84.1 mtm180 -66.12 -34.8 78.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.616 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -63.02 -42.63 99.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.796 0.332 . . . . 0.0 110.383 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.75 -46.02 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.792 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.21 88.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.693 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.45 -38.95 93.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.529 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.12 -43.33 99.05 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.38 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -65.7 -37.52 86.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.645 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -59.54 -43.86 93.39 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.642 0.258 . . . . 0.0 110.437 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.91 89.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.25 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.21 -46.24 93.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.004 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.86 -30.8 70.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.745 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.48 -40.05 94.94 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.914 0.388 . . . . 0.0 110.139 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.15 -42.84 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.188 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.33 -39.79 91.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.305 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.47 68.42 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.549 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -96.89 -9.76 27.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.53 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.01 -170.25 1.79 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.182 0.515 . . . . 0.0 110.921 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -102.57 120.0 39.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.417 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 66.4 t -106.74 126.98 62.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 13.6 t -118.27 146.72 44.09 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.134 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . 0.438 ' HG2' HG13 ' B' ' 129' ' ' ILE . 41.4 mt-10 -107.84 123.22 48.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.298 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -144.64 147.76 33.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.751 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -97.11 147.72 23.77 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.451 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -155.46 178.48 10.19 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 22.1 p -82.21 153.38 25.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.988 0.423 . . . . 0.0 111.37 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -63.13 -34.07 76.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.835 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -60.6 -35.78 76.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.448 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.25 -32.0 73.45 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.944 0.402 . . . . 0.0 111.169 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.36 -7.95 59.49 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.86 0.362 . . . . 0.0 111.1 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.3 mmt -80.26 -6.9 58.65 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.05 0.452 . . . . 0.0 110.613 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -74.48 81.14 1.94 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.395 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -106.04 13.4 29.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.806 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -65.82 -40.53 91.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.034 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.751 -179.828 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.233 0.23 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 t -111.1 102.26 10.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.859 0.361 . . . . 0.0 110.255 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.29 139.49 26.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.916 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 45.7 mt-10 -124.84 177.18 6.15 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.839 0.352 . . . . 0.0 110.808 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 94.4 m -124.91 131.74 53.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.909 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 45.3 m -79.86 -70.38 0.52 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 177.83 139.01 0.08 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.517 0.727 . . . . 0.0 109.569 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.85 -121.19 25.05 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.242 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.579 HD23 HG13 ' A' ' 111' ' ' VAL . 81.0 mt -65.12 -39.74 93.51 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.9 0.48 . . . . 0.0 110.943 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.6 ' HA2' ' HG2' ' A' ' 108' ' ' GLU . . . -68.78 140.45 34.74 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 115.857 1.103 . . . . 0.0 115.857 -173.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -129.69 -163.57 1.32 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -160.28 116.94 2.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 117.888 0.313 . . . . 0.0 110.647 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t -95.77 -90.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.194 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m 51.1 83.79 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.224 0.535 . . . . 0.0 111.0 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 tp -113.58 145.15 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.6 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.0 p -99.64 129.78 45.81 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.557 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 24' ' ' ILE . 6.5 pt -131.46 157.49 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -79.87 154.55 28.3 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.851 0.461 . . . . 0.0 112.04 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.76 -50.63 69.91 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.22 -37.33 86.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.487 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -63.24 -43.41 98.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.103 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 20' ' ' ALA . 67.0 mt -62.71 -52.34 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.232 0.539 . . . . 0.0 111.742 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.04 -38.38 72.57 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.453 -173.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -79.23 -59.29 2.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.71 -48.12 70.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -173.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.5 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 94.4 t -63.98 -43.89 97.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.48 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -61.55 -45.28 94.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.321 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 m -63.89 -41.64 97.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.726 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 35' ' ' VAL . 34.8 tp10 -66.55 -36.11 81.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.794 0.331 . . . . 0.0 111.102 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 91.9 mt -61.54 -42.31 98.64 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.63 -37.81 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.025 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -63.11 -41.42 99.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.817 0.342 . . . . 0.0 110.769 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 31' ' ' GLU . 91.1 t -63.74 -43.99 98.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.426 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.55 93.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.885 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.74 -33.01 74.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.231 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -59.0 -45.7 90.0 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 110.38 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.3 t -87.74 -2.68 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.265 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 64.1 27.52 14.11 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.131 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.416 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.8 pp -105.38 8.67 9.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.002 0.43 . . . . 0.0 111.535 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.54 -34.08 77.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.322 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.86 -5.16 56.88 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.435 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -84.87 -10.26 57.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.907 0.353 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -88.55 110.1 20.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.338 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.71 -41.38 97.53 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.1 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.07 42.56 76.45 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 115.898 1.119 . . . . 0.0 115.898 172.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -61.81 -43.72 98.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.274 1.037 . . . . 0.0 108.717 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.476 HG12 ' HB ' ' A' ' 54' ' ' VAL . 3.5 t -108.24 100.81 39.04 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 173.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.543 ' HG2' HD12 ' A' ' 53' ' ' ILE . 30.9 Cg_endo -63.76 158.09 48.47 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.657 2.238 . . . . 0.0 112.543 -176.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.488 ' HA ' HG12 ' A' ' 54' ' ' VAL . 82.9 mtp -61.82 -32.63 72.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.981 -174.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -69.16 -18.74 63.97 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.208 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.584 HD13 ' NH2' ' B' ' 193' ' ' ARG . 89.5 mt -105.66 -48.26 9.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 51' ' ' MET . 14.8 p -63.09 -35.15 70.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 120.988 0.423 . . . . 0.0 111.138 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.61 81.36 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.297 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -91.54 -7.19 51.01 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.464 HH12 HD12 ' B' ' 187' ' ' LEU . 67.9 mtt180 -97.3 -30.33 13.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.177 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -111.74 12.72 21.06 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.678 0.751 . . . . 0.0 109.531 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 61' ' ' SER . . . -65.54 150.54 51.78 Favored Glycine 0 CA--C 1.493 -1.312 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.417 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.47 -41.5 0.5 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.356 0.663 . . . . 0.0 111.388 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 59' ' ' GLY . 39.1 t -60.01 -46.79 88.34 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.07 0.548 . . . . 0.0 111.151 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.4 p -124.52 14.2 4.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.456 0.646 . . . . 0.0 110.892 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -64.73 -19.11 65.59 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.985 0.422 . . . . 0.0 110.948 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -62.02 -52.32 64.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.623 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.87 -17.6 59.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.244 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 62' ' ' VAL . 77.7 t -64.64 -42.71 95.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 173.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.72 -39.61 94.61 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' ' 71' ' ' MET . . . -60.31 -41.14 98.28 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.563 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.731 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 30.8 t70 -63.37 -43.83 96.5 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.45 -43.43 98.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.91 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' A' ' 68' ' ' GLY . 24.8 ptt? -63.65 -40.74 97.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.6 m -64.17 -40.26 95.73 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.091 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 43.9 mtp85 -63.03 -43.57 98.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.165 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -64.26 -41.06 97.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.695 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.87 -48.57 79.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.914 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 79' ' ' ILE . 19.3 tt -67.81 -40.76 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.466 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.79 -43.01 97.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.128 0.489 . . . . 0.0 110.221 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.86 95.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.093 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.6 pp -67.01 -40.92 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.974 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.73 -44.59 96.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.537 0.684 . . . . 0.0 109.765 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -64.71 -45.35 86.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.086 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -86.69 0.66 54.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.708 0.29 . . . . 0.0 111.416 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm 63.76 52.23 2.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.751 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.11 126.29 64.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.738 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -101.27 109.66 59.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.552 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.21 117.98 4.23 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.331 2.021 . . . . 0.0 112.034 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.08 93.68 8.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.135 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.14 -159.01 17.83 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.992 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.74 123.67 59.09 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.69 112.5 2.21 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.115 1.877 . . . . 0.0 110.704 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -96.26 114.88 26.61 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.237 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.579 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 91.3 m-85 -87.66 137.39 32.37 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.99 96.91 16.0 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-O 120.873 0.368 . . . . 0.0 111.792 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 93.1 Cg_endo -103.43 -172.12 0.07 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 123.473 2.782 . . . . 0.0 111.418 175.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -118.76 -172.0 15.26 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.65 145.96 25.37 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -95.17 126.76 40.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.15 0.5 . . . . 0.0 111.044 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.66 128.5 54.23 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.6 tp -67.03 114.49 5.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.892 0.377 . . . . 0.0 110.851 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.62 1.89 55.37 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.915 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -123.17 167.76 13.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.939 0.369 . . . . 0.0 110.99 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -71.34 141.87 50.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.743 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -95.7 137.31 34.95 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.7 m -119.62 131.19 55.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.826 0.346 . . . . 0.0 111.334 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -129.94 148.11 51.77 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.077 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 107' ' ' VAL . 50.1 m -102.46 -65.74 0.97 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 70.65 152.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 124.12 0.968 . . . . 0.0 111.047 -175.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.6 ' HG2' ' HA2' ' A' ' 12' ' ' GLY . 25.0 mt-10 -133.26 151.23 51.91 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 122.239 -0.288 . . . . 0.0 110.47 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -154.85 -73.03 0.12 Allowed 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -112.4 162.56 15.44 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -171.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.579 HG13 HD23 ' A' ' 11' ' ' LEU . 3.9 m -136.82 143.22 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.224 177.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -145.64 98.48 4.53 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 121.083 0.468 . . . . 0.0 110.546 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.88 149.56 20.48 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.086 2.524 . . . . 0.0 114.213 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -144.36 120.15 10.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.979 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 66.5 t -123.42 135.44 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.635 0.255 . . . . 0.0 111.12 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -121.81 142.04 50.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.58 153.14 38.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.59 0.234 . . . . 0.0 110.859 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -136.94 158.15 45.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.59 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.34 17.53 68.81 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.563 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.52 -39.84 94.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.185 0.517 . . . . 0.0 111.004 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.78 -17.2 64.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.681 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.18 12.2 29.63 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.869 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.1 mt -87.81 111.89 22.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.18 0.514 . . . . 0.0 110.32 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -105.73 120.89 42.85 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.7 t -118.3 133.01 66.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.629 0.252 . . . . 0.0 110.861 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -81.09 142.64 33.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.579 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.47 93.36 40.88 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.31 113.47 3.47 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.23 1.953 . . . . 0.0 112.123 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.29 115.53 43.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.037 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.07 158.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.675 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -133.99 157.4 46.17 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.598 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -70.82 127.14 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 71.7 p -110.84 176.64 4.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.738 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -62.68 -33.92 76.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.348 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.24 -40.99 96.1 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.886 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -64.5 -47.45 78.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.116 0.484 . . . . 0.0 110.385 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.08 -45.76 95.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.757 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.93 -46.28 91.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.479 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.22 97.82 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.817 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.563 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.8 tpt -61.71 -46.51 89.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.616 0.246 . . . . 0.0 110.841 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.76 -41.66 97.95 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.972 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.85 -45.34 94.92 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.369 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 m -63.51 -42.83 98.46 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.177 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.4 mt -60.71 -43.41 97.83 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -65.85 -33.36 75.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.926 0.393 . . . . 0.0 110.964 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.7 -13.81 60.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.914 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -90.02 -54.32 4.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -56.42 125.68 23.07 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.82 -167.41 2.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.525 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 151' ' ' TRP . 4.4 m -146.43 170.74 16.21 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.543 ' H ' HG22 ' A' ' 150' ' ' THR . 6.8 p-90 -120.38 145.91 46.7 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 151' ' ' TRP . 56.3 tttp 173.55 -59.61 0.01 OUTLIER 'General case' 0 C--N 1.351 0.639 0 O-C-N 123.862 0.726 . . . . 0.0 110.531 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -109.64 177.14 4.82 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 120.692 0.282 . . . . 0.0 111.498 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -84.15 147.11 27.5 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 69.48 116.88 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.978 0.911 . . . . 0.0 113.259 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -167.9 -98.74 0.12 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.436 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.35 145.79 29.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.3 126.48 67.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -95.54 -176.7 3.84 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.765 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.81 -66.89 0.48 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.492 ' OE2' ' HA ' ' A' ' 256' ' ' PHE . 13.9 pt-20 -78.52 7.35 6.85 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 188' ' ' ALA . 31.1 t70 -72.74 147.66 45.39 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.354 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 163' ' ' ARG . 16.8 ptp180 -101.87 116.7 33.28 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.59 127.14 74.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.586 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.1 m -74.93 109.54 8.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.6 124.37 66.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.061 0.457 . . . . 0.0 111.633 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.13 91.1 6.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -111.81 149.34 31.89 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.349 0.595 . . . . 0.0 111.885 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 40.5 m -128.15 129.75 47.02 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.121 177.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.85 134.65 12.65 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.827 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.3 m -142.84 144.35 32.49 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 120.83 0.347 . . . . 0.0 110.731 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.2 t -98.76 94.12 3.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 64.75 -70.39 0.08 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.331 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -137.06 5.82 3.65 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.77 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -130.24 139.15 50.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.585 0.692 . . . . 0.0 111.169 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.37 153.1 30.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.144 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -117.62 -177.31 3.21 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -53.78 -49.57 67.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.833 0.853 . . . . 0.0 113.194 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -103.0 -164.97 25.84 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.016 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . 82.25 28.22 41.38 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.861 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -114.03 106.73 14.75 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.67 145.9 50.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.836 0.35 . . . . 0.0 111.263 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 69.1 m -139.43 130.37 26.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.713 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 55.34 32.24 18.34 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.717 0.636 . . . . 0.0 110.513 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -93.2 133.49 36.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.965 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.6 m -94.04 119.48 41.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.52 0.676 . . . . 0.0 111.376 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.5 HD12 HH12 ' B' ' 57' ' ' ARG . 29.8 tp -111.37 123.58 50.5 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.106 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.73 ' HB3' ' NH1' ' A' ' 193' ' ' ARG . . . -110.91 131.52 54.97 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 173.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.449 ' SD ' ' HB ' ' A' ' 202' ' ' ILE . 70.8 mtm -98.43 177.08 5.46 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.218 0.532 . . . . 0.0 112.032 -171.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.53 23.32 67.92 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.498 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -131.85 -15.04 3.08 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 121.096 -0.241 . . . . 0.0 111.561 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.4 42.48 9.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.063 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.73 ' NH1' ' HB3' ' A' ' 188' ' ' ALA . 70.9 mtm180 -100.69 -0.38 37.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.316 0.579 . . . . 0.0 110.754 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.479 ' HE2' ' HA ' ' A' ' 194' ' ' MET . 0.7 OUTLIER -132.01 168.7 17.48 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 175.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 195' ' ' ILE . 3.4 mp -58.75 129.92 85.32 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.3 133.62 42.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.399 2.066 . . . . 0.0 111.929 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.84 -43.47 1.67 Allowed Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.089 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -63.54 -46.56 85.42 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.46 0.172 . . . . 0.0 111.053 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -86.68 14.17 7.47 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 121.184 0.516 . . . . 0.0 111.126 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.614 ' O ' ' HE2' ' A' ' 203' ' ' LYS . 17.3 t70 -113.62 -41.05 3.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.137 0.494 . . . . 0.0 109.866 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.9 -17.58 67.65 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.577 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.449 ' HB ' ' SD ' ' A' ' 189' ' ' MET . 69.9 mt -67.44 -26.31 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 122.632 -0.334 . . . . 0.0 111.316 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.614 ' HE2' ' O ' ' A' ' 200' ' ' ASP . 46.5 mtmt -57.9 132.74 54.28 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.971 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.6 -12.65 64.57 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.744 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -88.07 160.08 17.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.055 0.427 . . . . 0.0 111.679 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -88.02 176.18 7.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.943 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -91.31 53.29 2.28 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.429 0.633 . . . . 0.0 111.101 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 150.75 44.58 0.02 OUTLIER Glycine 0 C--N 1.307 -1.056 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -125.72 131.39 52.57 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.133 -0.534 . . . . 0.0 110.518 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -108.96 112.06 24.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.032 0.444 . . . . 0.0 109.931 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -132.39 -4.51 3.38 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.949 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 69.4 p 58.34 169.24 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.887 0.875 . . . . 0.0 112.473 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.5 tp -156.48 143.71 10.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.874 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.413 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 28.2 m-20 -95.28 114.89 26.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.373 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 67.9 t -117.99 129.9 73.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 8.7 m -91.31 -24.49 19.8 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -174.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 216' ' ' THR . 64.5 m-85 69.62 158.13 0.15 Allowed Pre-proline 0 N--CA 1.485 1.291 0 CA-C-O 120.849 0.357 . . . . 0.0 110.866 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -86.62 156.32 9.06 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 122.22 1.946 . . . . 0.0 112.089 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.52 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 67.5 mm-40 -66.16 -42.58 88.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.02 65.72 9.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.022 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -103.62 139.93 38.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.671 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -64.92 -18.91 65.63 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.74 110.43 22.52 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.563 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 43.2 tt0 -64.57 -35.14 80.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.019 0.437 . . . . 0.0 111.745 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -70.47 -15.7 62.84 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.554 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.1 mt -114.91 -3.95 12.65 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.5 ptmt -71.72 126.53 29.96 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.696 -176.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.08 29.2 74.23 Favored Glycine 0 C--O 1.24 0.483 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.459 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -125.62 135.48 52.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.907 0.354 . . . . 0.0 110.956 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -79.8 131.89 36.01 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.951 0.405 . . . . 0.0 110.347 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -117.12 157.99 24.98 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.559 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.413 ' HE2' ' OD1' ' A' ' 214' ' ' ASP . 34.4 mmtp -116.0 106.89 14.29 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -83.0 111.71 19.1 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.3 0.571 . . . . 0.0 110.564 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -81.74 90.9 6.39 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.486 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm -88.04 116.93 30.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -104.8 -52.61 2.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.351 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 98.9 mt 65.78 132.75 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.632 0.773 . . . . 0.0 112.557 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -111.44 -66.33 1.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.195 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -100.16 -67.86 0.83 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.387 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 17.1 t 71.08 155.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.279 0.632 . . . . 0.0 111.225 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -80.52 -179.13 7.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.982 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.33 143.79 50.99 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.301 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -175.49 104.63 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.964 0.506 . . . . 0.0 112.322 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -171.83 163.55 6.34 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.431 HD12 ' HD2' ' A' ' 246' ' ' PRO . 35.9 tp 75.67 111.13 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 123.933 0.893 . . . . 0.0 110.721 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.541 ' HA ' HG21 ' A' ' 150' ' ' THR . 92.6 Cg_endo -81.76 140.07 11.42 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.495 2.13 . . . . 0.0 114.315 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -136.16 10.44 3.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.446 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 8.5 mp 70.39 109.55 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.467 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 251' ' ' GLU . 30.6 m -125.93 131.9 52.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.112 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -70.84 -18.77 62.71 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 249' ' ' THR . 47.8 mt-10 -61.89 -45.41 93.89 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -76.33 -26.14 55.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.766 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 250' ' ' ALA . 11.2 tp -73.36 -35.38 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.689 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 22.8 ptmt -92.12 -20.53 21.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -123.5 119.44 29.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.28 0.562 . . . . 0.0 111.953 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.492 ' HA ' ' OE2' ' A' ' 161' ' ' GLU . 56.1 t80 -156.43 83.54 0.98 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.03 -48.96 3.42 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -175.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.36 150.56 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 123.187 0.595 . . . . 0.0 109.877 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.27 -48.73 79.54 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.517 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.88 131.33 4.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.979 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -134.1 -142.86 4.78 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.748 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 21.6 p -142.38 -169.86 3.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.4 -66.14 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.374 0.607 . . . . 0.0 110.512 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.53 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.6 OUTLIER -70.91 -39.91 72.46 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.249 -178.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.28 -39.15 96.78 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.642 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.407 ' O ' HG23 ' A' ' 270' ' ' VAL . 52.2 tp -62.41 -43.92 97.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.616 0.246 . . . . 0.0 110.812 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -63.26 -42.46 99.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.171 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -67.89 -43.02 80.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.65 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -67.94 -39.06 83.52 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.991 0.424 . . . . 0.0 110.71 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 266' ' ' LEU . 75.1 t -64.79 -41.73 92.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -55.22 -52.12 64.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.749 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.1 ptmt -65.33 -42.03 93.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.712 0.291 . . . . 0.0 111.689 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.92 -39.78 94.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.701 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 90.7 mmm -63.52 -42.66 98.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.59 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -69.45 -33.48 72.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.62 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -62.45 -43.39 98.94 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.319 0.58 . . . . 0.0 109.661 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -69.42 -33.57 73.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.053 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.64 -40.78 96.1 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.495 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -57.61 -44.4 85.46 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.058 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.2 m -62.69 -42.88 99.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.72 98.84 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.327 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.93 -43.74 97.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.983 0.421 . . . . 0.0 110.031 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -44.61 97.09 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.087 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -64.37 -41.92 96.45 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.449 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . 0.442 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 2.0 tpm_? -60.92 -43.78 98.13 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.032 0.444 . . . . 0.0 110.447 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 94.0 t -68.44 -44.64 83.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.715 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.5 -46.32 88.99 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.122 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.7 p -61.87 -42.64 99.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -67.2 -41.11 86.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.997 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.81 86.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.812 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 295' ' ' VAL . 35.9 mm -64.09 -43.65 97.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.519 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.479 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 19.9 tp10 -61.23 -44.15 97.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.171 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.33 99.28 Favored Glycine 0 C--O 1.24 0.526 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.692 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.78 -42.13 95.31 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 291' ' ' ILE . 85.1 t -63.93 -44.36 97.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.914 -178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . 0.479 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.6 mttm -62.63 -37.64 87.1 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.78 0.324 . . . . 0.0 111.657 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.59 -30.03 27.3 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -128.84 92.21 3.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -91.28 98.46 11.73 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -103.25 149.11 7.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.391 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.04 135.37 57.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.907 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.64 120.54 44.81 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.068 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.99 131.52 44.07 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.592 2.195 . . . . 0.0 112.471 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.13 75.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.282 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.43 -29.18 63.94 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.681 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.592 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 90.4 mt -93.31 -31.76 14.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.826 0.346 . . . . 0.0 110.855 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 311' ' ' ILE . 95.6 mt -63.68 -46.91 93.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.759 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.12 -39.0 93.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 35.6 p -69.02 -42.38 76.46 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.724 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.655 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 24.6 mm-40 -72.69 -35.74 67.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.48 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 77.4 mt -61.7 -43.8 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.304 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.557 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 30.6 t70 -61.64 -41.94 98.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.928 0.394 . . . . 0.0 111.022 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.0 t -62.1 -43.87 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.899 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 61.7 mt -63.05 -39.28 94.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.818 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.557 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.5 mtm180 -62.04 -42.64 99.39 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -64.08 -37.86 88.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.668 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -61.5 -46.15 91.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.198 0.523 . . . . 0.0 110.043 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.29 -37.2 71.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.429 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.54 72.57 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 120.98 0.419 . . . . 0.0 111.223 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . 0.479 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 49.2 tt0 -62.33 -37.81 87.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.458 0.647 . . . . 0.0 109.956 176.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.36 -15.75 59.23 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.583 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -93.56 6.59 47.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.699 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . 0.454 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . 134.44 -22.69 3.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.521 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 109.6 37.53 1.89 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.337 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.431 HD21 ' HB2' ' A' ' 328' ' ' GLN . 27.3 t-20 -79.14 135.9 36.96 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.858 0.361 . . . . 0.0 110.792 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . 0.608 ' OE1' ' HG3' ' A' ' 327' ' ' LYS . 1.7 tm-20 -136.71 152.42 50.35 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.608 ' HG3' ' OE1' ' A' ' 326' ' ' GLU . 32.0 mtmm 70.89 -46.34 0.63 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.553 0.741 . . . . 0.0 112.419 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.431 ' HB2' HD21 ' A' ' 325' ' ' ASN . 17.3 mm100 -68.54 -16.69 63.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.252 0.548 . . . . 0.0 110.065 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.58 -19.05 34.95 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.859 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.522 HD12 HH12 ' A' ' 315' ' ' ARG . 52.8 tp -61.15 -38.7 87.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.774 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -75.34 -19.47 59.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.775 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 81.2 mt -55.52 136.75 70.26 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.425 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.68 127.73 23.81 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.93 2.42 . . . . 0.0 113.057 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.402 HH21 ' HD2' ' A' ' 334' ' ' ARG . 24.8 ttt180 -68.31 -42.17 79.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.263 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -59.07 -36.18 74.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.129 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.88 -39.02 93.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.471 ' CD1' ' HG2' ' A' ' 315' ' ' ARG . 96.9 m-85 -97.06 -15.78 20.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -68.84 -31.6 70.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.81 0.338 . . . . 0.0 111.197 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -61.32 -50.89 71.13 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.823 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -70.64 -28.83 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.838 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.06 -42.17 97.99 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.21 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.8 tttt -59.83 -47.2 86.67 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.187 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.547 ' O ' HG23 ' A' ' 347' ' ' VAL . 13.0 mmt85 -62.94 -44.89 94.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.142 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.468 ' NH2' HD22 ' A' ' 314' ' ' LEU . 93.5 mtt180 -66.58 -38.43 87.03 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.2 t -65.31 -43.17 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.78 0.324 . . . . 0.0 110.35 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 342' ' ' LYS . 74.2 t -60.69 -42.82 93.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.482 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 343' ' ' ARG . 76.5 t -59.68 -44.72 94.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.29 99.59 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.202 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.96 -43.82 97.75 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.891 0.376 . . . . 0.0 110.841 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.31 -44.56 94.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.934 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.16 -41.67 94.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.285 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.97 -42.59 99.75 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.217 -0.516 . . . . 0.0 113.254 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 356' ' ' ARG . 32.1 tp10 -63.23 -44.3 95.62 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.866 0.365 . . . . 0.0 110.759 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.34 -46.26 95.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.029 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.66 -44.72 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.918 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . 0.403 HH22 ' CD ' ' A' ' 353' ' ' GLU . 7.5 tmm_? -69.68 -45.41 68.4 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.8 m -68.89 -43.24 75.68 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -86.15 -1.52 57.5 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.909 0.385 . . . . 0.0 110.663 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 57.63 44.76 20.27 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.08 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.66 149.3 34.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.399 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.77 148.41 32.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.728 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.38 126.75 29.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 367' ' ' VAL . 18.4 t70 -94.44 115.86 28.12 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.769 -176.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 54.3 mm-40 -60.52 -40.22 90.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.564 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.95 -40.11 91.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 110.883 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -64.02 -39.14 93.44 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.598 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 363' ' ' ASP . 90.5 t -62.68 -39.69 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.922 176.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.0 mmmt -57.11 -43.29 82.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.037 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.5 -40.68 99.42 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.035 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.04 -41.09 99.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 109.995 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.67 -42.95 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.453 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.99 -41.59 96.77 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.709 0.29 . . . . 0.0 111.046 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -65.37 -40.29 93.34 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 109.857 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 50.1 ttm -65.71 -41.64 92.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.646 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.9 -27.42 68.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.991 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.3 m -75.76 -3.08 32.89 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.548 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -96.4 4.39 52.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.836 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -125.59 -176.6 3.65 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.737 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.37 -52.83 60.05 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.404 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.596 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 21.3 t70 -125.68 125.58 24.96 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.501 ' O ' HG13 ' A' ' 385' ' ' ILE . 33.7 Cg_endo -64.64 -32.69 57.51 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 121.969 1.779 . . . . 0.0 113.102 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -68.22 -41.55 81.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 13.0 pt-20 -61.17 -38.21 85.69 Favored 'General case' 0 N--CA 1.46 0.068 0 CA-C-O 120.745 0.307 . . . . 0.0 110.177 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.99 -44.01 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.325 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 381' ' ' PRO . 74.0 mt -60.75 -46.86 95.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.4 -43.09 86.77 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.515 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -59.41 -46.82 87.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.946 0.403 . . . . 0.0 110.869 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -68.52 -41.86 79.33 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.813 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.9 p -80.18 -8.03 59.24 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.22 7.96 45.49 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.174 0.511 . . . . 0.0 110.563 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -133.38 110.96 10.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.798 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -62.33 -38.01 87.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.354 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.9 -50.68 71.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.035 0.445 . . . . 0.0 110.394 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.29 -41.98 96.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.442 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.515 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 88.9 mtp -63.33 -48.61 77.29 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.8 -39.46 66.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.612 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.91 -41.15 97.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.466 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 47.7 tpp -65.25 -40.03 93.46 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 395' ' ' MET . 79.2 mtm180 -63.09 -33.56 75.7 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.71 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.68 -41.83 98.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.127 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.15 -45.57 93.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.448 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.39 90.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.915 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 57.3 tp -62.58 -39.36 93.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.498 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 408' ' ' VAL . 38.4 tt0 -61.05 -43.75 98.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -65.78 -35.98 82.23 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.126 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -60.81 -41.52 95.84 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.207 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.36 94.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.687 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.428 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 90.6 t -64.2 -45.4 96.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.014 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.78 -35.87 82.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.535 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.28 98.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.914 0.388 . . . . 0.0 110.4 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 95.4 t -67.75 -43.45 86.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 94.5 mt -61.51 -41.5 97.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.998 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.8 -24.29 67.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.587 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -99.06 -1.99 38.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.334 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.49 172.27 6.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.982 0.42 . . . . 0.0 111.739 -177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.15 127.35 31.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.573 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.21 116.09 46.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 120.882 0.372 . . . . 0.0 110.588 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 10.0 t -115.54 128.84 56.26 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -112.88 123.57 50.63 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.1 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -145.23 150.4 36.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.795 0.331 . . . . 0.0 111.561 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -84.46 162.52 19.89 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.628 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.5 t -158.54 -176.71 6.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.798 0.332 . . . . 0.0 110.631 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 16.5 p -81.76 157.9 24.35 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.274 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -67.53 -35.63 79.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.175 0.512 . . . . 0.0 110.842 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -60.63 -35.85 77.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.109 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -66.37 -30.73 71.17 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.098 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.39 -15.99 58.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.968 0.413 . . . . 0.0 110.788 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 8.8 mmt -78.07 -6.3 54.2 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.77 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -76.18 68.51 2.61 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.509 0.671 . . . . 0.0 109.358 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -99.42 16.01 24.53 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.327 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -63.22 -39.52 94.85 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.754 0 CA-C-O 118.286 -0.864 . . . . 0.0 109.825 179.278 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.727 0.299 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.58 133.8 34.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.345 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.67 162.32 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.675 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 33.8 t -103.47 105.9 16.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.918 0.389 . . . . 0.0 110.326 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 p -146.77 139.52 19.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.728 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 61.2 mt-10 -129.06 172.83 11.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.699 0.285 . . . . 0.0 111.119 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 94.1 m -121.82 129.44 52.63 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.245 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 33.3 m -77.17 -68.8 0.58 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 175.79 139.53 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.512 0.725 . . . . 0.0 109.717 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.84 -122.62 28.26 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.379 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.59 HD23 HG13 ' B' ' 111' ' ' VAL . 78.1 mt -65.79 -39.56 91.08 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 122.868 0.467 . . . . 0.0 110.907 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.582 ' HA2' ' HG2' ' B' ' 108' ' ' GLU . . . -69.39 137.74 29.69 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 115.63 1.012 . . . . 0.0 115.63 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 1.5 tpp180 -126.04 -161.66 1.07 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -161.94 116.27 1.9 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 t -94.26 -91.86 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.138 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m 52.69 85.24 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 CA-C-O 121.28 0.562 . . . . 0.0 110.787 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 tp -114.68 144.84 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.683 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 14.4 p -100.34 126.44 46.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.971 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.45 ' CD1' HG12 ' B' ' 24' ' ' ILE . 6.6 pt -131.22 153.71 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.663 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -75.92 151.27 37.36 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.889 0.476 . . . . 0.0 112.0 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.17 -50.19 69.94 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -65.15 -37.54 87.73 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.596 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -63.71 -43.48 96.45 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.035 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.663 HG13 ' O ' ' B' ' 20' ' ' ALA . 68.8 mt -61.77 -52.58 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.242 0.544 . . . . 0.0 111.517 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -70.05 -39.22 75.84 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.16 -172.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 10.9 m -77.24 -55.7 5.19 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.38 -47.54 60.43 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 96.0 t -64.17 -43.34 97.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.194 -176.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -61.31 -45.22 95.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.39 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 40.4 m -63.07 -42.35 99.64 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.528 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.424 ' O ' HG23 ' B' ' 35' ' ' VAL . 49.0 tp10 -65.93 -36.63 83.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.369 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 91.9 mt -61.93 -42.1 98.71 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.24 -36.63 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.207 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -63.39 -41.13 98.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.621 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 31' ' ' GLU . 96.7 t -63.81 -44.12 98.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.437 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.74 93.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.113 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.04 -33.48 75.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.273 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -59.58 -41.73 90.91 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.642 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 10.8 t -91.08 -1.86 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.23 0.538 . . . . 0.0 110.343 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 65.14 25.13 12.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.259 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -103.93 6.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.622 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -65.84 -29.0 69.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.291 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.7 -3.86 68.78 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.281 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -86.48 -5.76 59.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.456 ' HG3' ' NE2' ' A' ' 320' ' ' GLN . 37.2 ttt85 -93.39 110.67 22.22 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.797 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.72 -42.84 99.49 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.488 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.13 46.1 67.37 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 115.906 1.122 . . . . 0.0 115.906 172.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -61.39 -44.61 96.85 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.174 0.987 . . . . 0.0 108.469 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.451 HG12 ' HB ' ' B' ' 54' ' ' VAL . 3.4 t -105.39 103.84 44.73 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 174.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' B' ' 53' ' ' ILE . 36.2 Cg_endo -64.07 156.36 59.39 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.736 2.291 . . . . 0.0 112.711 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.511 ' HA ' HG12 ' B' ' 54' ' ' VAL . 92.2 mtp -63.45 -24.99 68.07 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -174.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -79.15 -10.02 59.71 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.834 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.637 HD13 ' NH2' ' A' ' 193' ' ' ARG . 93.9 mt -114.94 -46.1 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' B' ' 51' ' ' MET . 14.6 p -63.66 -34.61 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.955 0.407 . . . . 0.0 110.797 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.0 82.89 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.168 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -88.9 -14.97 35.52 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.5 HH12 HD12 ' A' ' 187' ' ' LEU . 67.6 mtt180 -89.87 -30.62 17.77 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.41 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.62 13.3 22.56 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.653 0.739 . . . . 0.0 109.632 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.46 149.45 51.63 Favored Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.447 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.59 -40.89 0.48 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.299 0.64 . . . . 0.0 111.559 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.7 t -60.71 -46.59 89.82 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.734 0.414 . . . . 0.0 110.973 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -123.15 13.08 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.313 0.577 . . . . 0.0 110.845 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -64.1 -19.52 65.32 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.132 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -62.9 -52.69 62.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.817 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.93 -18.38 60.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.08 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 62' ' ' VAL . 75.9 t -64.39 -42.68 96.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 173.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.58 -39.56 94.08 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' B' ' 71' ' ' MET . . . -60.37 -41.28 98.41 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.522 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . 0.748 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 30.7 t70 -63.51 -44.27 94.79 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.39 -43.62 98.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.988 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' B' ' 68' ' ' GLY . 24.8 ptt? -63.71 -40.43 96.77 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 44.6 m -64.45 -39.38 93.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.081 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.748 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 51.1 mtp85 -62.59 -43.81 97.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.996 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -64.02 -41.9 97.28 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.32 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.71 -48.39 80.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.306 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . 0.476 ' O ' HG13 ' B' ' 79' ' ' ILE . 19.2 tt -67.52 -40.53 84.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.484 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.82 -42.27 95.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.999 0.428 . . . . 0.0 110.139 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.73 -42.28 97.93 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.057 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.476 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.6 pp -67.35 -40.95 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.642 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.95 -44.63 96.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.628 0.728 . . . . 0.0 109.798 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -65.54 -44.63 86.27 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.891 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -89.26 2.14 54.72 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 62.79 52.8 2.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.047 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.0 mt -109.13 126.6 66.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -103.2 108.38 58.68 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.512 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.29 116.26 3.86 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.199 1.933 . . . . 0.0 111.724 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.9 86.58 6.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.069 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 132.04 -168.41 22.49 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.878 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.93 123.11 74.17 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 110.526 -0.176 . . . . 0.0 110.526 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.92 113.72 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.121 1.881 . . . . 0.0 110.713 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 18.3 m -94.96 117.29 29.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.175 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.548 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.3 m-85 -92.04 134.35 34.9 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.44 97.93 25.29 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 90.1 Cg_endo -103.99 -167.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 123.668 2.912 . . . . 0.0 111.159 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -121.07 -174.09 14.85 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.17 146.89 25.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.479 0.639 . . . . 0.0 109.535 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -91.89 127.82 37.5 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.095 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -105.43 126.33 52.0 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 46.6 tp -65.94 113.57 4.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.021 0.439 . . . . 0.0 110.914 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.04 -8.72 42.45 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.12 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -112.55 177.3 4.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 117.415 0.607 . . . . 0.0 111.215 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -80.9 141.52 34.49 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.555 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -93.07 136.42 33.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.97 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 33.1 m -118.58 130.96 56.18 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.955 0.407 . . . . 0.0 111.265 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -130.41 149.06 52.27 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.287 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.5 ' O ' HG12 ' B' ' 107' ' ' VAL . 58.4 m -101.77 -66.01 0.95 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.5 HG12 ' O ' ' B' ' 106' ' ' SER . 0.3 OUTLIER 71.17 150.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 124.17 0.988 . . . . 0.0 110.964 -175.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.582 ' HG2' ' HA2' ' B' ' 12' ' ' GLY . 28.6 mt-10 -132.96 149.47 52.23 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.222 -0.299 . . . . 0.0 110.333 -175.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -155.47 -75.26 0.1 Allowed 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -108.61 162.87 13.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -171.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.59 HG13 HD23 ' B' ' 11' ' ' LEU . 3.6 m -135.68 158.83 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.125 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -161.45 104.61 1.21 Allowed Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.572 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.59 147.91 12.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.026 2.484 . . . . 0.0 114.411 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -140.32 112.54 7.76 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.428 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.4 133.92 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 111.34 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -122.37 141.36 51.65 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.333 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -120.02 150.8 39.98 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.596 0.236 . . . . 0.0 110.698 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -135.46 156.66 48.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.661 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.55 16.96 69.6 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.216 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.7 -38.96 92.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.279 0.561 . . . . 0.0 110.838 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.95 -14.73 63.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.192 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.0 21.52 13.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.878 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 76.5 mt -94.61 109.39 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.417 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -102.33 121.07 41.56 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.38 132.91 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.767 0.317 . . . . 0.0 110.844 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -83.16 139.15 33.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.406 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -123.74 94.11 46.48 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.82 113.46 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.265 1.977 . . . . 0.0 112.095 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.5 mm -102.56 118.31 49.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.048 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.87 160.61 41.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.724 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -133.7 150.27 51.52 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.943 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.71 123.37 19.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 65.2 p -106.99 176.88 5.03 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.854 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.18 -34.77 77.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.602 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.42 97.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.156 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -63.34 -45.46 91.14 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.148 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.7 -45.08 92.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.744 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -59.47 -48.71 80.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.742 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.29 -39.22 96.83 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.036 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.55 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 2.6 tpt -60.91 -47.43 86.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 0.0 110.65 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.66 -41.6 98.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.986 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -60.95 -46.41 90.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.922 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 29.0 m -61.64 -41.74 97.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.643 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.3 mt -60.87 -41.93 96.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.758 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -71.48 -20.47 62.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.779 0.324 . . . . 0.0 111.124 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -89.05 -3.01 58.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.508 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -103.42 -48.22 4.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -62.3 124.03 19.79 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -175.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.87 -167.55 1.97 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.582 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . 0.558 HG21 ' HA ' ' B' ' 246' ' ' PRO . 5.5 m -146.16 169.32 18.97 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . 0.53 ' H ' HG22 ' B' ' 150' ' ' THR . 7.1 p-90 -117.78 145.41 44.53 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -175.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' B' ' 151' ' ' TRP . 54.2 tttp 173.41 -65.79 0.01 OUTLIER 'General case' 0 C--N 1.344 0.367 0 O-C-N 123.94 0.775 . . . . 0.0 110.36 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -102.39 175.97 5.33 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 120.861 0.362 . . . . 0.0 111.836 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -83.57 147.2 27.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.959 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 68.44 113.61 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -165.05 -95.21 0.1 Allowed Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.651 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.02 149.69 31.56 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 62.8 t -114.35 128.15 71.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -98.11 -170.86 2.04 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.081 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.99 -67.84 0.44 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -73.96 1.51 10.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' B' ' 188' ' ' ALA . 32.1 t70 -69.61 144.86 52.87 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.629 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -102.83 119.14 38.31 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.737 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 42.1 t -117.15 126.71 74.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.561 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 24.4 m -74.4 106.32 5.96 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 88.2 mt -122.26 122.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.669 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -92.9 90.35 6.95 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -112.85 149.62 32.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.325 0.583 . . . . 0.0 112.16 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 41.5 m -128.8 128.99 45.04 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.19 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.44 135.46 13.31 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.729 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 51.0 m -142.48 145.8 34.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 120.863 0.363 . . . . 0.0 110.909 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.95 94.98 3.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.03 -68.4 0.09 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.96 0.788 . . . . 0.0 112.718 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -140.86 12.09 2.88 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.797 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -136.91 138.33 40.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.491 0.646 . . . . 0.0 110.89 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -79.38 148.98 31.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.253 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -110.89 -174.55 2.5 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -57.31 -48.87 77.84 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -103.35 -162.15 25.34 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.057 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' B' ' 169' ' ' THR . . . 78.78 29.68 50.97 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.676 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -114.85 103.05 10.57 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -131.38 141.52 49.89 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.792 0.33 . . . . 0.0 111.575 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 27.7 m -136.02 133.46 37.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.651 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 55.45 33.09 20.22 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.377 0.423 . . . . 0.0 110.91 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -98.51 133.27 43.11 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.287 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.1 m -94.3 120.68 44.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-O 121.57 0.7 . . . . 0.0 111.282 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . 0.464 HD12 HH12 ' A' ' 57' ' ' ARG . 30.0 tp -111.37 125.0 53.4 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.073 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . 0.73 ' HB3' ' NH1' ' B' ' 193' ' ' ARG . . . -111.34 132.75 54.16 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 173.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . 0.461 ' SD ' ' HB ' ' B' ' 202' ' ' ILE . 69.3 mtm -100.29 176.74 5.27 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.226 0.536 . . . . 0.0 112.287 -171.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 79.22 18.78 73.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.593 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -127.54 -17.94 4.5 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.68 0.276 . . . . 0.0 111.604 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.39 43.38 7.44 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.128 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.73 ' NH1' ' HB3' ' B' ' 188' ' ' ALA . 69.4 mtm180 -100.19 1.11 41.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.369 0.604 . . . . 0.0 110.934 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.469 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.5 OUTLIER -134.19 169.16 17.59 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.637 175.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.461 ' H ' HD12 ' B' ' 195' ' ' ILE . 3.1 mp -58.07 131.04 83.61 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.03 134.76 50.33 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.216 1.944 . . . . 0.0 111.56 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.56 -43.2 1.76 Allowed Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -63.78 -47.55 80.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 120.447 0.165 . . . . 0.0 111.174 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -86.54 14.51 6.72 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.262 0.553 . . . . 0.0 110.923 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . 0.665 ' O ' ' HE2' ' B' ' 203' ' ' LYS . 21.2 t70 -113.22 -38.76 4.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.221 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -71.13 -15.51 74.51 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.546 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.461 ' HB ' ' SD ' ' B' ' 189' ' ' MET . 69.7 mt -68.63 -25.99 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 O-C-N 122.596 -0.355 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.665 ' HE2' ' O ' ' B' ' 200' ' ' ASP . 45.0 mtmt -58.09 131.33 50.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.42 -8.09 66.51 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.731 -0.747 . . . . 0.0 114.018 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -89.73 161.08 16.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.302 0.551 . . . . 0.0 111.636 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.69 176.19 7.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.061 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -91.33 55.61 2.86 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.224 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 147.68 43.16 0.03 OUTLIER Glycine 0 C--N 1.308 -0.996 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -125.36 131.41 52.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.254 -0.473 . . . . 0.0 110.766 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -105.45 112.87 26.13 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.679 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -134.09 -3.74 2.79 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.102 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 66.3 p 58.72 169.89 0.06 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.932 0.893 . . . . 0.0 112.421 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.6 tp -157.81 143.93 8.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.59 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -97.65 113.68 25.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.515 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 61.2 t -116.43 130.1 71.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 7.3 m -92.59 -23.94 18.87 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.9 m-85 69.51 159.57 0.15 Allowed Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.885 -175.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -88.3 156.92 6.77 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.177 1.918 . . . . 0.0 111.755 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . 0.451 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 70.7 mm-40 -67.61 -39.71 84.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -84.99 72.0 10.87 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.671 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -115.52 138.11 51.37 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -63.92 -19.83 65.4 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -100.78 107.56 19.15 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 37.8 tt0 -64.0 -33.17 75.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.49 -175.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -74.71 -11.63 60.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.82 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -117.92 -4.3 11.1 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.8 ptmt -69.23 125.07 25.55 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.127 0.489 . . . . 0.0 111.743 -176.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 63.65 27.12 70.53 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.572 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.14 133.57 55.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.323 0.562 . . . . 0.0 110.974 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -75.26 134.81 41.02 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.957 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.47 154.44 37.8 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.399 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -111.33 107.19 16.37 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -83.56 109.72 17.63 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.2 0.524 . . . . 0.0 110.486 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.93 98.27 7.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.509 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.2 mm -97.11 114.55 34.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.154 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -104.18 -51.89 3.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.035 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 96.1 mt 65.75 144.02 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.549 0.739 . . . . 0.0 112.076 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.04 -63.86 1.22 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.612 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -99.64 -69.36 0.77 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.668 0.27 . . . . 0.0 111.582 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 15.5 t 70.8 154.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.412 0.685 . . . . 0.0 111.166 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.42 -179.64 7.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.905 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.36 141.04 50.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.182 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.433 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 1.4 ptp180 -174.71 105.33 0.1 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.139 0.495 . . . . 0.0 112.228 177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -170.71 163.52 8.01 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 30.6 tp 74.75 114.95 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 123.76 0.824 . . . . 0.0 110.83 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . 0.558 ' HA ' HG21 ' B' ' 150' ' ' THR . 90.9 Cg_endo -84.0 134.65 6.22 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.477 2.118 . . . . 0.0 114.624 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -130.38 13.97 5.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.528 173.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 8.3 mp 66.26 105.68 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.876 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . 0.605 HG22 ' H ' ' B' ' 251' ' ' GLU . 27.6 m -123.6 133.99 53.86 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.021 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.425 ' O ' HG22 ' B' ' 253' ' ' ILE . . . -74.6 -12.98 60.59 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.605 ' H ' HG22 ' B' ' 249' ' ' THR . 51.7 mt-10 -62.44 -43.48 98.71 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -85.08 -8.95 58.44 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 253' ' ' ILE . . . . . 0.425 HG22 ' O ' ' B' ' 250' ' ' ALA . 10.9 tp -91.66 -17.52 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.498 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 254' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' B' ' 260' ' ' ASP . 21.9 ptmt -106.37 -16.49 14.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.765 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -125.18 127.9 47.52 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.043 0.449 . . . . 0.0 112.095 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -168.33 82.21 0.17 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 78.25 -47.02 2.84 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.583 -175.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.49 152.23 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 122.961 0.505 . . . . 0.0 110.264 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -58.35 -51.56 69.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' B' ' 254' ' ' LYS . 2.8 p-10 -160.95 126.18 3.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.124 0.488 . . . . 0.0 109.95 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -130.98 -154.51 7.92 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.737 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 30.7 p -127.08 -164.02 1.31 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 122.53 0.332 . . . . 0.0 110.215 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.48 -63.5 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.173 0.511 . . . . 0.0 110.536 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.2 OUTLIER -72.86 -39.59 66.37 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.934 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.25 -38.46 95.93 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.463 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.97 -43.87 97.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.679 0.276 . . . . 0.0 110.543 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -64.23 -42.02 96.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.995 0.426 . . . . 0.0 110.155 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -68.43 -41.9 79.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.6 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -68.55 -40.11 80.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 110.701 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.36 -41.32 92.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -54.44 -51.5 64.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.624 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 15.9 ptmt -67.1 -40.25 86.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.67 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.39 -39.24 93.48 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.446 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.1 mmm -63.39 -43.61 97.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.61 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.75 -33.45 72.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.924 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -60.15 -44.37 95.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.388 0.613 . . . . 0.0 109.351 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.19 -35.07 75.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.017 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . 0.422 ' O ' HG13 ' B' ' 282' ' ' ILE . 54.2 tp -61.59 -41.26 97.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.785 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -57.78 -43.51 85.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.084 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 24.6 m -62.0 -42.66 99.4 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.511 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.46 96.13 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.435 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 278' ' ' LEU . 63.8 mt -63.31 -44.23 99.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.465 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.93 -44.57 94.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.84 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -64.89 -42.32 94.9 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.388 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -60.71 -43.88 97.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.639 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 98.3 t -69.36 -44.44 80.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.641 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . 0.416 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.0 tttt -62.5 -46.57 87.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.928 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 69.8 p -61.79 -43.39 98.94 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -66.46 -40.42 89.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.817 0.341 . . . . 0.0 111.156 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.14 -47.43 84.58 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.729 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . 0.447 ' O ' HG23 ' B' ' 295' ' ' VAL . 48.2 mm -64.35 -44.17 97.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.888 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -60.54 -44.08 96.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.288 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.67 99.25 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.323 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.16 -42.19 93.97 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 291' ' ' ILE . 76.1 t -63.82 -44.2 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.612 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.6 -41.92 99.26 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.169 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -72.25 -39.13 68.66 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -126.68 98.39 5.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -92.77 96.08 9.93 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.9 tp -100.98 148.17 7.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.828 -175.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -61.7 134.93 57.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.225 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.3 122.71 38.79 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.939 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.19 131.59 46.05 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.735 2.29 . . . . 0.0 112.555 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.98 79.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.181 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.07 67.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.443 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . 0.435 ' O ' ' HG2' ' B' ' 310' ' ' GLU . 92.7 mt -87.01 -33.83 19.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.413 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . 0.417 ' O ' HG13 ' B' ' 311' ' ' ILE . 97.0 mt -62.65 -48.28 88.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.787 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.05 -42.13 99.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -176.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 32.2 p -65.75 -39.98 91.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.731 0.3 . . . . 0.0 111.702 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . 0.627 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 62.3 mm-40 -72.79 -36.87 67.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 81.1 mt -62.14 -43.45 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.556 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 35.9 t70 -61.26 -41.87 97.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.869 0.366 . . . . 0.0 111.024 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.12 -43.93 99.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.991 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 64.2 mt -63.08 -38.86 92.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.894 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.556 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 74.5 mtm180 -61.36 -42.53 98.85 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -64.1 -38.54 91.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.651 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.01 -45.33 94.07 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.221 0.534 . . . . 0.0 110.31 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.8 -37.49 70.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.413 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.08 72.37 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.061 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 49.2 tt0 -62.52 -39.64 94.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.337 0.589 . . . . 0.0 109.943 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -73.25 -20.38 60.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.562 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -89.95 3.87 51.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.012 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 136.42 -21.93 3.4 Favored Glycine 0 CA--C 1.508 -0.39 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.843 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 109.84 36.27 2.06 Favored Glycine 0 CA--C 1.502 -0.764 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.211 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . 0.454 HD21 ' HB2' ' B' ' 328' ' ' GLN . 26.9 t-20 -77.56 133.9 38.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.793 0.33 . . . . 0.0 110.527 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . 0.633 ' OE1' ' HG3' ' B' ' 327' ' ' LYS . 1.8 tm-20 -135.89 151.12 49.68 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.633 ' HG3' ' OE1' ' B' ' 326' ' ' GLU . 31.5 mtmm 71.39 -45.54 0.62 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.552 0.741 . . . . 0.0 112.259 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . 0.454 ' HB2' HD21 ' B' ' 325' ' ' ASN . 17.1 mm100 -70.16 -13.74 62.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.262 0.553 . . . . 0.0 110.0 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.74 -17.81 57.27 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.622 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.37 -38.02 85.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.476 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -78.03 -15.51 58.87 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.756 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 76.6 mt -57.61 137.37 82.32 Favored Pre-proline 0 C--O 1.238 0.5 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.982 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -51.3 125.62 16.97 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.051 2.501 . . . . 0.0 112.92 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -68.03 -40.78 82.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.619 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.7 pm0 -60.39 -35.58 76.07 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.224 0.454 . . . . 0.0 112.224 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.45 -39.26 94.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.934 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -95.64 -17.13 21.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.38 -32.07 72.74 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.78 -51.04 68.65 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.686 0.279 . . . . 0.0 111.056 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -70.0 -29.32 66.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.729 0.299 . . . . 0.0 110.798 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.442 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -60.58 -43.99 96.73 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . 0.476 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.6 tttt -59.58 -46.55 88.6 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.469 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . 0.528 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.0 mmt85 -62.03 -45.3 94.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . 0.413 ' NH2' HD22 ' B' ' 314' ' ' LEU . 94.9 mtt180 -66.57 -38.34 86.85 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.519 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 341' ' ' ALA . 73.4 t -64.77 -43.46 96.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 120.724 0.297 . . . . 0.0 110.393 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 342' ' ' LYS . 79.4 t -60.7 -43.15 94.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.364 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.528 HG23 ' O ' ' B' ' 343' ' ' ARG . 69.5 t -59.76 -44.8 94.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.41 -41.38 99.52 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.15 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.78 -43.48 98.68 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.732 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 97.6 mt -63.73 -44.29 94.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.891 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.5 -42.46 95.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.507 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.16 -41.69 99.63 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.431 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -64.68 -42.83 95.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.04 -45.14 97.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.82 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.42 -44.73 99.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.797 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -70.8 -45.42 64.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.958 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 98.5 m -67.48 -44.97 77.25 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -86.81 -5.25 59.17 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.604 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 57.69 74.21 0.43 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.981 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.97 144.98 31.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.13 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.63 146.99 35.07 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.205 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.84 115.31 5.19 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . 0.539 ' O ' HG23 ' B' ' 367' ' ' VAL . 16.1 t70 -84.0 117.79 23.62 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.3 -176.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 47.0 mm-40 -60.45 -39.53 87.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.313 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -65.73 -40.18 91.91 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.699 0.285 . . . . 0.0 110.759 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -62.91 -38.47 91.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.092 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . 0.539 HG23 ' O ' ' B' ' 363' ' ' ASP . 95.4 t -63.56 -40.92 90.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.636 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 29.6 mmmt -57.61 -43.43 84.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.306 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.9 -41.77 99.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.798 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.97 -41.24 99.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.398 . . . . 0.0 110.03 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.4 -43.21 98.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.375 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.44 -40.38 96.41 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.421 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.48 -39.66 88.9 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.914 0.388 . . . . 0.0 110.35 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 50.5 ttm -65.17 -40.66 94.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.562 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . 0.41 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -62.1 -28.59 69.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.796 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 30.5 m -79.5 16.2 1.11 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.161 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -114.18 4.49 15.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.164 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -126.63 -172.58 2.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.186 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -62.88 -62.11 1.94 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.449 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 18.9 t70 -119.03 127.24 26.62 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.075 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . 0.41 ' HA ' ' HB1' ' B' ' 375' ' ' ALA . 35.5 Cg_endo -66.14 -31.76 44.51 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.156 1.904 . . . . 0.0 112.818 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -67.06 -43.08 83.59 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 11.9 pt-20 -61.39 -37.86 84.97 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.56 -43.21 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.982 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.2 -44.59 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.854 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.88 -45.07 79.19 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.159 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -58.98 -46.76 87.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.856 0.36 . . . . 0.0 111.201 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -68.57 -41.9 79.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.919 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 70.3 p -78.3 -10.82 59.83 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.53 6.17 49.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.096 0.474 . . . . 0.0 110.623 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -129.27 111.9 13.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.327 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.75 -39.75 95.12 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -57.63 -51.06 71.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.899 0.381 . . . . 0.0 110.638 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.51 -41.71 98.52 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.386 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.545 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 88.6 mtp -63.36 -47.65 81.2 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -73.25 -40.52 64.57 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.825 -174.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -62.75 -41.25 99.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.211 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 46.9 tpp -64.22 -39.98 95.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.647 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' B' ' 395' ' ' MET . 77.3 mtm180 -64.15 -34.26 77.67 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.771 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.63 -42.7 99.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.823 0.344 . . . . 0.0 110.083 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.58 -44.78 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.512 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.29 -38.91 93.02 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.838 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.38 -38.89 92.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.343 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . 0.402 ' O ' HG23 ' B' ' 408' ' ' VAL . 39.8 tt0 -59.38 -43.75 92.87 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.452 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.44 -35.89 80.11 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.051 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -60.12 -41.68 93.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.921 0.391 . . . . 0.0 110.397 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.06 96.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.552 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 93.3 t -64.53 -45.61 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -65.92 -35.63 81.14 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.69 92.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.936 0.398 . . . . 0.0 110.242 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.38 -43.38 84.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.496 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 94.5 mt -61.6 -41.33 97.29 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.264 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.61 -19.53 64.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.744 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -102.83 1.47 34.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.185 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -113.09 172.31 7.02 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.111 0.482 . . . . 0.0 111.589 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -79.3 129.44 34.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.456 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 36.3 t -104.02 109.83 28.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.979 0.418 . . . . 0.0 110.943 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 6.7 t -108.2 128.52 54.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.929 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -116.59 121.17 40.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.252 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -144.82 153.06 41.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.22 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -86.79 163.62 17.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -159.0 -178.22 7.07 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 21.5 p -82.91 157.16 23.16 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.9 0.381 . . . . 0.0 111.263 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -67.8 -27.7 66.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.159 0.504 . . . . 0.0 110.311 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -61.9 -39.77 93.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.834 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.49 -31.23 71.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.104 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.56 -13.45 59.82 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.893 0.377 . . . . 0.0 111.022 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.8 mmt -80.39 -5.07 55.89 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.041 0.448 . . . . 0.0 110.589 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -76.28 69.47 2.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.57 0.7 . . . . 0.0 109.507 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -100.47 18.5 18.89 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.013 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -68.2 -33.38 74.31 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.989 0.423 . . . . 0.0 110.304 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.642 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.502 -179.693 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.24 0.581 0 CA-C-O 120.611 0.243 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.9 p -84.65 87.19 7.27 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.19 136.44 55.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -119.95 153.87 35.31 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.523 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 77.9 m -98.09 123.39 42.1 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.499 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 m -79.34 -56.14 4.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.138 0.494 . . . . 0.0 111.47 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -169.08 100.35 0.37 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.22 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.7 -106.21 1.21 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.863 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 109' ' ' PHE . 7.3 mp -67.36 -38.66 85.13 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 122.4 0.28 . . . . 0.0 111.081 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 106' ' ' SER . . . -57.94 137.02 50.3 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.51 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -140.69 144.3 35.56 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.532 0.206 . . . . 0.0 110.793 -177.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -115.88 129.04 56.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.5 t -89.52 -87.81 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.71 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.8 p 43.4 80.46 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 89.4 mt -109.81 132.09 58.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.5 m -97.72 123.78 41.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.8 pt -123.54 164.05 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.67 0.271 . . . . 0.0 111.474 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.487 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.24 152.18 44.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.822 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.61 -44.71 81.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.648 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.96 -36.43 84.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.203 0.525 . . . . 0.0 110.386 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 m -66.23 -34.4 77.93 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.45 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.5 mt -61.37 -48.94 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 111.624 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.513 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 55.4 mm-40 -81.47 -13.59 58.0 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -93.13 -59.83 1.94 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.099 -0.641 . . . . 0.0 111.5 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.41 -50.04 35.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 98.8 t -63.35 -43.89 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.584 0.23 . . . . 0.0 111.478 -175.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 17.1 ttmm -61.71 -45.99 91.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.54 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.8 m -66.88 -40.65 87.87 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.739 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -62.85 -41.08 99.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.731 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.4 mt -62.77 -42.64 99.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.767 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.34 -35.89 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.201 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -64.04 -42.88 96.91 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.03 -29.87 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.907 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.36 -43.19 95.31 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.52 -37.39 86.64 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.679 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -60.48 -35.57 76.23 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.471 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 t -93.02 -5.35 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 121.414 0.626 . . . . 0.0 109.939 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 62.79 28.56 16.52 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.601 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.8 pp -101.83 6.1 10.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.45 0.643 . . . . 0.0 111.158 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -64.6 -29.83 70.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.71 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.6 -1.14 70.15 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.448 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -94.49 6.41 48.89 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.53 -0.394 . . . . 0.0 111.73 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.2 ttt85 -111.61 98.65 7.58 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.222 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -65.57 -43.44 89.79 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.515 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.63 70.74 1.19 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 173.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -65.63 -41.58 92.49 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 171.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.28 107.81 60.59 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.956 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD2' HD12 ' A' ' 53' ' ' ILE . 46.1 Cg_exo -56.55 151.06 48.32 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.083 2.522 . . . . 0.0 113.114 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.524 ' HA ' HG22 ' A' ' 54' ' ' VAL . 14.6 ttt -60.81 -39.39 88.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.018 -173.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -66.59 -20.74 66.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.057 0.456 . . . . 0.0 110.837 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.492 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 97.4 mt -92.22 -37.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.701 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.524 HG22 ' HA ' ' A' ' 51' ' ' MET . 25.3 m -63.98 -36.37 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.491 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.94 -37.36 87.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.864 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.604 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.6 pt20 -80.47 -19.53 45.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.668 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.604 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 63.3 mtt180 -106.9 -27.14 10.89 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -175.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -107.74 5.31 26.56 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.519 0.675 . . . . 0.0 109.854 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 61' ' ' SER . . . -70.66 153.03 51.2 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 176.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.411 ' H ' ' HB2' ' A' ' 63' ' ' ARG . . . 70.32 -24.84 0.16 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.211 0.604 . . . . 0.0 111.928 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 59' ' ' GLY . 36.1 t -78.2 -61.88 1.86 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.887 0.375 . . . . 0.0 110.371 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.4 p -103.77 12.15 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.449 0.642 . . . . 0.0 110.142 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HB2' ' H ' ' A' ' 60' ' ' ALA . 41.3 ttm180 -58.96 -30.14 67.68 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.738 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -57.57 -50.28 73.64 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.063 0.459 . . . . 0.0 110.473 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.39 -23.08 54.06 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.503 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 62' ' ' VAL . 73.1 t -64.47 -43.73 96.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 174.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.06 -39.76 95.69 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.415 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.07 99.69 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.717 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 11.5 t70 -62.0 -45.6 92.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.888 0.375 . . . . 0.0 110.29 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.69 -41.87 99.33 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.458 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.9 tpt -61.57 -42.12 98.39 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -60.98 -43.04 99.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.738 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 96.9 mtt-85 -66.05 -40.61 91.1 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.333 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -63.48 -42.43 98.56 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.405 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -61.64 -51.02 70.21 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.896 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.57 -41.69 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.6 -39.97 88.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.058 0.456 . . . . 0.0 110.302 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -68.69 -42.85 77.19 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 pp -64.97 -32.06 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.895 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.7 -43.92 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.909 0.385 . . . . 0.0 110.886 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 17.8 ptpt -78.38 -26.96 46.73 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.667 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -86.5 -5.14 59.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.892 0.377 . . . . 0.0 110.642 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 66.57 40.28 3.47 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.517 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 84.6 mt -102.23 122.22 54.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -106.73 110.76 63.9 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.48 114.55 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.288 1.992 . . . . 0.0 111.416 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.24 126.19 30.52 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.711 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.19 -116.53 7.23 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.852 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.77 114.46 6.02 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.48 156.82 60.67 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 122.635 2.223 . . . . 0.0 111.378 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.6 m -104.3 119.08 38.17 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.51 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -74.41 -21.42 59.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.234 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t 48.42 80.04 0.32 Allowed Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 123.968 0.907 . . . . 0.0 112.894 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.98 122.03 6.08 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.255 1.97 . . . . 0.0 110.725 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.84 -176.35 51.44 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.295 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.39 121.82 25.63 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.116 0.484 . . . . 0.0 110.258 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -82.6 111.9 19.0 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.488 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 98.6 mttt -91.17 129.97 37.1 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.5 tp -75.69 114.07 13.86 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.03 0.443 . . . . 0.0 110.611 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.02 4.82 59.91 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.326 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.8 mt-10 -127.38 168.32 14.99 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.717 -0.284 . . . . 0.0 110.568 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.68 142.89 54.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.074 0.464 . . . . 0.0 111.832 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -102.46 147.72 26.39 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.468 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.2 m -122.74 132.07 54.07 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -147.01 161.09 41.53 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.544 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 33.1 p -96.6 -84.48 0.36 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 106' ' ' SER . 86.9 t 75.35 112.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -173.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -103.99 122.93 46.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.08 -173.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.438 ' N ' HD23 ' A' ' 11' ' ' LEU 0.253 19.7 p90 -138.29 -95.23 0.19 Allowed 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 174.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -157.69 147.16 19.98 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.0 0.818 . . . . 0.0 111.862 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.9 m -141.28 167.81 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.078 0.551 . . . . 0.0 111.824 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -109.61 107.15 59.19 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.433 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -93.06 153.99 2.63 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.992 2.462 . . . . 0.0 112.924 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.74 143.43 17.23 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.5 t -132.23 137.8 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -175.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -84.78 141.47 30.49 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.557 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.01 143.62 50.81 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -138.38 154.33 48.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.616 0.246 . . . . 0.0 111.089 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.84 15.73 79.5 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 114.089 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.96 -40.74 97.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.974 0.416 . . . . 0.0 111.512 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -73.69 -3.68 29.76 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.704 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.59 4.99 43.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.968 0.413 . . . . 0.0 111.131 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.7 mt -87.39 126.59 41.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.53 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -107.45 116.79 32.56 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.16 133.84 47.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.136 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -85.72 144.06 28.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.478 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -132.89 101.27 14.03 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.41 138.09 58.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.251 1.967 . . . . 0.0 111.506 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 421' ' ' GLU . 48.4 mm -116.17 121.14 66.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.9 161.2 41.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.391 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -152.76 166.09 33.31 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.881 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.42 128.98 38.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.097 0.475 . . . . 0.0 111.337 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 65.8 p -109.36 173.83 6.14 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.535 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.82 -35.11 79.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.72 -37.42 81.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.374 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -63.43 -40.57 97.54 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.549 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.32 -46.04 96.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.516 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.37 -44.65 95.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.356 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.68 -41.52 99.81 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.653 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.606 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.4 tpt -61.26 -48.46 81.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.687 0.28 . . . . 0.0 110.543 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.96 -42.27 97.33 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.074 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.49 -47.64 85.25 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.945 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.6 m -62.84 -41.5 99.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.694 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 140' ' ' MET . 87.5 mt -61.34 -40.26 93.6 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -72.57 -17.09 61.74 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.978 0.418 . . . . 0.0 111.135 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.83 -0.45 55.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.901 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -116.28 30.93 7.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.662 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -134.65 79.22 1.79 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.29 121.24 37.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.322 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.626 HG21 ' H ' ' A' ' 247' ' ' GLU . 35.4 m -74.72 159.93 31.41 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.398 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 36.8 t-105 -80.28 124.84 29.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.126 0.488 . . . . 0.0 110.894 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.409 ' HG3' ' OE2' ' A' ' 153' ' ' GLU . 18.5 tptm -143.53 169.13 18.28 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.409 ' OE2' ' HG3' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -82.52 -3.21 55.54 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -175.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 155' ' ' ASP . 21.8 pttp -163.78 -172.9 3.03 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.719 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 0.6 OUTLIER 91.46 122.19 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.332 1.453 . . . . 0.0 112.683 177.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -68.15 93.99 0.3 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 114.71 -1.132 . . . . 0.0 114.766 -174.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -151.01 127.44 10.7 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.83 122.2 60.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -103.86 157.76 16.87 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.5 26.36 0.17 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.928 0.491 . . . . 0.0 112.22 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -139.68 -4.87 1.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.213 0.53 . . . . 0.0 109.91 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -83.58 158.17 22.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.352 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -102.72 98.46 8.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.795 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.5 t -97.86 123.01 50.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.73 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.1 m -79.49 107.49 12.31 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.1 mt -121.42 123.27 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 121.095 0.474 . . . . 0.0 111.929 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.495 ' HB2' ' HD3' ' A' ' 238' ' ' LYS . 23.5 m-20 -96.28 108.43 20.92 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -126.23 147.87 49.58 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.616 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.6 m -119.74 129.19 54.38 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.114 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.11 122.37 5.73 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.299 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.3 p -136.59 124.49 22.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.04 -85.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.787 0.327 . . . . 0.0 110.787 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -103.06 2.98 35.54 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.503 0.668 . . . . 0.0 110.006 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.26 -3.93 2.51 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.376 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -113.47 143.3 44.73 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.21 157.1 33.0 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.721 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -129.39 -177.77 4.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.246 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.19 -41.61 88.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.168 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.1 -178.59 38.85 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.312 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.05 24.99 50.73 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.449 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.0 98.89 8.52 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -130.34 143.79 50.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.095 0.474 . . . . 0.0 111.8 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.4 m -148.73 122.54 9.31 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.996 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 60.51 31.42 20.28 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.334 0.588 . . . . 0.0 109.968 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -86.18 137.68 32.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.909 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.0 m -105.01 125.33 60.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.604 0.716 . . . . 0.0 111.175 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.49 ' CD1' HH12 ' B' ' 57' ' ' ARG . 49.5 tp -114.42 118.19 33.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.212 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -93.86 110.86 22.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 63.0 mtp -83.25 152.9 24.97 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.839 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.9 -20.97 45.58 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.051 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -89.08 -10.91 45.63 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.92 50.95 4.97 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.15 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 188' ' ' ALA . 35.2 mmm-85 -90.49 -11.44 40.24 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.911 -0.644 . . . . 0.0 110.106 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.35 -176.74 4.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.716 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.2 mm -63.58 133.71 95.62 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.904 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.41 120.89 5.55 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.066 2.511 . . . . 0.0 112.679 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.52 -36.19 4.57 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.488 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -62.5 -48.02 81.38 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -78.85 -9.24 59.41 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.8 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -91.49 -29.26 17.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.253 0.549 . . . . 0.0 109.648 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.9 -22.63 75.78 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.881 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.21 -42.49 96.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.97 0.414 . . . . 0.0 110.171 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -53.76 131.17 38.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.118 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.67 -7.99 39.58 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.689 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -96.94 160.09 14.55 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.03 156.43 16.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.652 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.5 129.73 41.44 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.913 0.387 . . . . 0.0 110.713 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 73.63 50.99 10.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.711 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -136.02 140.96 44.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.674 0.273 . . . . 0.0 110.705 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -115.93 135.41 54.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -153.25 -13.61 0.15 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.409 -0.516 . . . . 0.0 112.276 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 30.3 p 61.71 166.87 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.97 0.908 . . . . 0.0 112.064 -175.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.6 tp -156.15 114.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.083 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.09 106.53 7.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.986 0.422 . . . . 0.0 110.873 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 78.4 t -108.95 118.91 57.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.536 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 4.8 m -69.48 -35.06 75.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 216' ' ' THR . 70.5 m-85 75.69 150.99 0.13 Allowed Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 123.133 0.573 . . . . 0.0 109.498 -172.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.18 153.67 32.03 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.641 1.56 . . . . 0.0 111.474 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.561 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 64.3 mm-40 -64.02 -33.72 76.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 109.842 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -87.92 28.17 1.07 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.332 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 10.1 t80 -73.42 132.85 43.44 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -64.89 -17.42 64.3 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.503 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -94.76 110.51 22.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 36.0 tt0 -61.56 -38.59 88.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.859 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.434 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 28.2 p30 -71.98 -9.51 58.48 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.434 ' HG ' ' OD1' ' A' ' 225' ' ' ASN . 95.5 mt -122.57 0.85 9.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.561 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.8 ptmt -70.93 110.81 5.88 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.521 0.677 . . . . 0.0 112.733 -175.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.77 12.64 83.98 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.498 -0.774 . . . . 0.0 114.097 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -118.26 127.93 54.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.357 0.578 . . . . 0.0 110.732 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -71.32 136.24 47.76 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.7 139.37 47.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.324 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -70.51 -43.37 69.8 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 212' ' ' THR . 79.5 m-85 58.39 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.078 0.551 . . . . 0.0 112.133 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.67 -50.81 72.02 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.9 mm 62.69 81.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.133 0.492 . . . . 0.0 111.235 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -66.06 -40.89 91.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.229 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.472 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 10.5 tp 50.6 82.96 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.722 0.809 . . . . 0.0 110.612 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.495 ' HD3' ' HB2' ' A' ' 167' ' ' ASP . 52.5 mtpt -93.51 -51.0 5.16 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -173.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -100.27 -92.04 0.29 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.0 t 75.43 129.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.165 0.586 . . . . 0.0 111.086 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -69.01 -35.67 76.92 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.501 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 155' ' ' ASP . 13.1 pt-20 57.86 117.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 125.34 1.456 . . . . 0.0 114.175 177.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -143.5 124.12 14.08 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.154 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 245' ' ' LEU . 0.3 OUTLIER -148.36 -175.6 4.98 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.46 ' H ' ' CD ' ' A' ' 244' ' ' GLU . 66.1 mt 73.21 105.47 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 111.099 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.597 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 64.1 Cg_endo -78.87 111.77 3.01 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.408 2.072 . . . . 0.0 113.76 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.626 ' H ' HG21 ' A' ' 150' ' ' THR . 12.6 pt-20 -135.77 17.82 3.29 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.135 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 52.7 tp 77.13 132.74 0.05 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 176.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 251' ' ' GLU . 23.0 m -142.16 137.96 31.23 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.228 176.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -77.74 -9.12 58.84 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . 0.428 ' H ' HG22 ' A' ' 249' ' ' THR . 39.6 mt-10 -85.26 -25.12 27.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -176.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -65.24 -22.24 66.85 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 119.779 -0.769 . . . . 0.0 113.034 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 34.8 pt -74.05 -9.57 13.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -137.67 25.67 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.919 0.39 . . . . 0.0 111.731 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -115.54 15.67 16.63 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.208 0.528 . . . . 0.0 111.63 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -94.49 14.96 19.11 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.31 -31.34 8.77 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.123 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.8 144.38 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -53.46 -47.91 69.32 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.264 0.353 . . . . 0.0 111.93 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -173.64 157.33 3.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.1 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -160.37 172.41 36.78 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.617 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 80.5 p -96.53 -134.99 0.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.711 0.255 . . . . 0.0 110.83 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 52.8 t -103.33 -68.8 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.12 0.486 . . . . 0.0 109.95 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.2 OUTLIER -70.34 -37.29 74.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.864 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.22 -37.52 94.64 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.763 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.62 -43.8 97.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.868 0.365 . . . . 0.0 110.091 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -62.73 -40.77 98.24 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.688 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.65 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.47 -47.16 85.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.146 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 272' ' ' LYS . 41.6 tp10 -65.85 -40.91 92.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.926 0.394 . . . . 0.0 111.182 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 80.2 t -64.66 -42.92 96.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.374 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -59.34 -48.82 80.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.835 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 10.0 ptmt -62.96 -44.03 97.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.756 0.312 . . . . 0.0 111.206 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -64.97 -39.25 93.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.372 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 90.5 mmm -63.8 -41.7 97.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 110.672 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.85 -35.72 80.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.417 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.5 -41.26 96.53 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.321 0.581 . . . . 0.0 109.603 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -66.59 -36.86 83.65 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.703 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 45.5 tp -62.39 -38.89 91.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.048 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -57.17 -44.14 83.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.198 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.6 m -61.7 -42.8 99.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.649 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.56 97.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.261 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.04 -44.09 97.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.175 0.512 . . . . 0.0 110.013 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -61.57 -44.47 96.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.657 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -64.04 -42.15 97.17 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.899 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . 0.508 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.4 tpm_? -61.34 -43.57 98.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.526 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 85.4 t -70.32 -44.39 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.272 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.8 -48.81 80.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.557 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 65.2 p -65.37 -42.89 92.28 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -65.81 -41.1 92.29 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.7 0.286 . . . . 0.0 111.712 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.89 80.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 295' ' ' VAL . 36.9 mm -66.05 -43.57 92.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.511 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -57.87 -44.47 86.63 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.217 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.43 -41.89 99.74 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.807 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.4 -43.31 97.92 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 291' ' ' ILE . 97.0 t -62.66 -45.74 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.35 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.37 -42.3 99.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.969 0.414 . . . . 0.0 110.987 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.74 -38.64 80.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.782 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -124.83 90.88 3.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -93.43 94.39 8.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 301' ' ' ASP . 10.9 tp -103.26 163.75 3.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.742 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.448 ' N ' HG13 ' A' ' 300' ' ' ILE . 3.8 m-20 -65.37 140.06 58.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.15 123.38 37.76 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.539 ' O ' HG13 ' A' ' 307' ' ' ILE . 46.6 Cg_exo -55.93 129.77 36.74 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.499 2.132 . . . . 0.0 111.977 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.38 -35.55 79.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.093 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.22 84.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.993 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.22 -34.5 56.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.954 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 303' ' ' PRO . 75.6 mt -61.87 -50.97 77.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.919 0.39 . . . . 0.0 111.612 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.31 -40.44 95.93 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 65.5 p -64.52 -45.94 85.08 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.519 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 43.3 mm-40 -72.01 -35.09 69.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.962 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 83.7 mt -62.08 -44.12 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.715 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.591 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 32.0 t70 -63.39 -40.85 98.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.844 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.9 t -64.05 -43.72 97.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.174 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 87.6 mt -62.53 -40.15 95.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.909 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.509 HH12 HD12 ' A' ' 330' ' ' LEU . 80.3 mtm180 -63.12 -38.91 93.06 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.266 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 90.5 mtt180 -63.73 -41.09 98.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.701 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -62.86 -44.04 97.18 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.641 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.34 -39.54 81.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.033 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.82 88.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.241 0.543 . . . . 0.0 110.435 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -62.11 -38.44 88.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.986 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.96 -37.79 79.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.07 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -74.39 39.1 0.12 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.138 0.975 . . . . 0.0 112.302 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . 0.407 ' HA2' ' HB ' ' B' ' 54' ' ' VAL . . . 99.75 -2.87 57.24 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.155 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 92.94 33.58 7.28 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.159 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -71.47 132.0 44.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.721 0.296 . . . . 0.0 110.216 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.09 160.88 36.42 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.0 OUTLIER 68.77 -52.08 0.57 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.318 0.647 . . . . 0.0 112.102 -178.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.96 -3.58 29.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.12 -23.93 65.88 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.483 0.658 . . . . 0.0 109.714 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.509 HD12 HH12 ' A' ' 315' ' ' ARG . 42.2 tp -63.36 -35.15 79.44 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.266 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.94 -33.48 74.76 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.66 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 82.7 mt -47.56 133.99 10.39 Favored Pre-proline 0 N--CA 1.474 0.753 0 O-C-N 123.613 0.57 . . . . 0.0 112.458 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.441 ' HB2' HD13 ' A' ' 336' ' ' LEU . 50.7 Cg_exo -54.24 129.62 35.48 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.962 2.441 . . . . 0.0 112.786 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -66.2 -43.42 86.85 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.303 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -63.46 -33.8 76.36 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.441 HD13 ' HB2' ' A' ' 333' ' ' PRO . 10.8 mp -63.55 -37.18 86.35 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.643 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.54 -13.06 19.61 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.58 -30.09 67.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.675 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -62.0 -51.26 68.77 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.716 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -71.19 -27.1 63.28 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.809 0.338 . . . . 0.0 110.431 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.436 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.88 -43.06 99.61 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.781 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.415 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -59.66 -45.69 91.28 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 347' ' ' VAL . 8.3 mmt180 -61.43 -47.3 86.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.263 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.12 -37.73 84.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 341' ' ' ALA . 72.1 t -63.31 -44.44 99.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.255 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.48 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 70.3 t -62.0 -44.64 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.496 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 343' ' ' ARG . 70.4 t -60.53 -44.81 97.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.838 0.351 . . . . 0.0 110.137 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.79 -42.14 99.39 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.134 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.41 -43.9 96.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.734 0.302 . . . . 0.0 110.859 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.0 mt -62.81 -47.91 81.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.953 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.404 ' O ' HG13 ' A' ' 355' ' ' ILE . 94.3 mt -66.95 -40.43 87.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.159 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.96 -45.05 96.55 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.833 -0.622 . . . . 0.0 113.796 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -68.89 -35.12 76.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.293 0.547 . . . . 0.0 110.713 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 350' ' ' LEU . 78.5 t -60.47 -45.13 97.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 351' ' ' LEU . 80.4 mt -62.97 -46.5 96.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.916 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -67.45 -47.69 69.4 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 98.0 m -64.49 -44.83 89.75 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -87.6 -0.9 57.51 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.501 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 63.15 39.85 9.46 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.91 0.386 . . . . 0.0 111.626 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.7 mt -77.25 145.15 37.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.226 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.57 149.99 39.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.272 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.76 116.5 5.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 367' ' ' VAL . 27.3 t70 -86.24 116.07 24.19 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.532 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 25.7 mm-40 -59.52 -39.42 83.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.965 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -65.22 -42.52 93.34 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.018 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -63.74 -38.98 93.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.063 0.459 . . . . 0.0 109.954 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 363' ' ' ASP . 89.3 t -64.04 -38.95 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.485 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 26.8 mmmt -55.58 -45.3 77.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.428 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -64.21 -37.22 94.23 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.43 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.63 -42.11 98.18 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.337 0.589 . . . . 0.0 110.253 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.21 -43.21 97.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.792 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -60.59 -39.74 89.18 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.54 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.91 -40.14 87.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.777 0.322 . . . . 0.0 110.772 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.3 ttm -64.24 -41.73 96.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.0 0.428 . . . . 0.0 110.169 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.39 -27.22 69.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.572 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.7 m -75.27 -4.86 41.53 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.383 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -93.05 -0.54 57.1 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.204 0.526 . . . . 0.0 110.483 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -117.3 168.27 10.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.07 -50.22 72.82 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -117.95 117.62 35.28 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.837 0.351 . . . . 0.0 110.307 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.64 -28.91 25.25 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.345 2.03 . . . . 0.0 113.08 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -65.92 -43.89 86.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.22 -37.7 88.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.587 0.232 . . . . 0.0 110.911 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.86 -42.93 96.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.585 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.68 -44.53 99.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.254 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -67.25 -40.68 86.27 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 120.857 0.36 . . . . 0.0 110.197 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -58.43 -47.98 82.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.49 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 3.4 t80 -70.46 -40.25 73.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.12 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 59.4 p -77.7 -8.38 57.85 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -101.03 6.7 43.54 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.239 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -125.67 114.12 18.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.073 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -62.95 -41.45 99.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.373 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.11 -48.11 83.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 110.775 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.73 -40.63 97.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.626 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 94.1 mtp -61.96 -46.34 89.72 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.02 0.438 . . . . 0.0 110.997 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.87 -44.17 86.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.331 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -63.81 -40.92 97.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.573 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.49 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 53.1 tpp -62.95 -45.08 94.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.123 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.441 ' HG2' HG21 ' A' ' 367' ' ' VAL . 47.4 mtm180 -65.05 -29.22 70.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.567 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -62.24 -44.41 96.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.17 -44.26 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.817 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.37 94.75 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.986 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.68 -38.06 89.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.695 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.08 -44.81 91.92 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.905 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.51 -38.21 89.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.808 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -59.43 -41.66 90.08 Favored 'General case' 0 CA--C 1.526 0.032 0 CA-C-O 120.736 0.303 . . . . 0.0 110.62 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.07 79.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.39 -46.15 93.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.482 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -68.56 -30.55 69.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.498 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.33 -38.13 89.95 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.019 0.438 . . . . 0.0 109.93 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 91.5 t -64.69 -42.53 95.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.919 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.41 -40.13 93.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.82 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.65 67.48 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.495 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -99.38 -3.6 33.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.023 0.439 . . . . 0.0 110.962 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -107.85 178.87 4.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.45 107.86 19.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.559 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 97.0 t -99.9 118.66 46.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.902 -0.406 . . . . 0.0 109.902 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.5 t -120.81 158.35 27.76 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -104.82 132.78 50.64 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.077 0.465 . . . . 0.0 111.728 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -147.57 120.97 9.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.861 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 91.1 mt-10 -84.81 151.93 24.0 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.183 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.7 t -157.01 175.31 14.27 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.815 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 62.8 p -85.66 163.76 18.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.931 0.396 . . . . 0.0 111.392 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -64.56 -26.71 68.53 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.055 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -62.22 -39.7 93.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.781 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.6 -33.43 75.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.724 0.297 . . . . 0.0 111.468 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.57 -14.18 57.13 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.645 0.26 . . . . 0.0 111.262 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 2.9 mmt -76.84 -9.91 59.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.188 0.518 . . . . 0.0 110.331 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -80.68 85.65 6.03 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.387 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -105.84 29.27 6.79 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.214 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -66.52 -24.04 66.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.22 0.534 . . . . 0.0 109.912 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.377 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.451 178.389 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -78.03 134.13 37.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.185 0.517 . . . . 0.0 111.582 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 24.1 m -118.57 145.7 24.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.356 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.4 p -91.08 84.28 5.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 m -132.85 135.28 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -119.74 154.79 33.63 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.798 0.332 . . . . 0.0 111.557 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.512 ' HA ' ' HD3' ' B' ' 13' ' ' ARG . 90.3 m -99.47 118.08 35.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.522 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 14.9 m -72.66 -51.41 19.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.387 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -174.92 100.71 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.275 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.86 -107.43 1.54 Allowed Glycine 0 C--O 1.223 -0.567 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.136 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.449 HD23 ' N ' ' B' ' 109' ' ' PHE . 7.2 mp -66.77 -39.08 87.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.713 0.292 . . . . 0.0 110.919 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' B' ' 106' ' ' SER . . . -59.2 135.08 51.94 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.282 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.512 ' HD3' ' HA ' ' B' ' 7' ' ' THR . 0.0 OUTLIER -140.3 144.17 36.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.474 0.178 . . . . 0.0 110.749 -177.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -114.78 130.04 56.79 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.82 -89.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.729 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p 43.0 82.74 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 88.6 mt -112.88 131.38 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 60.5 m -95.47 126.85 41.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.966 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 41.6 pt -125.51 165.85 22.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.421 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.453 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.79 151.75 45.93 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.299 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.416 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -57.27 -43.1 82.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.63 -176.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.75 -38.05 89.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.479 . . . . 0.0 110.194 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 23.0 m -63.3 -36.27 83.11 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.219 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.5 ' O ' ' HB ' ' B' ' 28' ' ' VAL . 75.7 mt -61.47 -50.8 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.282 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.536 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 50.2 mm-40 -75.59 -22.37 56.99 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -86.06 -68.57 0.73 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.693 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.62 -48.64 71.56 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 99.0 t -62.89 -45.33 99.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.523 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.536 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 16.4 ttmm -61.89 -44.85 95.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.503 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.6 m -65.34 -41.68 93.67 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.814 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -64.66 -38.27 90.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.701 0.286 . . . . 0.0 110.788 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 91.0 mt -62.31 -42.48 99.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.569 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -71.5 -35.26 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.991 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -64.32 -42.68 96.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.638 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -68.53 -32.45 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.129 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.66 98.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.66 -38.32 88.98 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.955 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -59.61 -37.18 77.9 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 18.0 t -87.79 -13.87 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 120.959 0.409 . . . . 0.0 110.038 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 70.83 28.63 3.3 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.756 0.823 . . . . 0.0 111.276 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.43 7.45 9.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.131 0.491 . . . . 0.0 111.598 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.3 -24.74 66.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.826 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.05 -1.83 88.12 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.955 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -94.44 7.38 45.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.712 0.291 . . . . 0.0 111.607 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 34.6 ttt85 -114.88 100.71 8.41 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.455 -0.498 . . . . 0.0 112.178 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -67.15 -46.72 73.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.675 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.86 65.92 1.62 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 116.561 1.384 . . . . 0.0 116.561 172.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -63.5 -42.68 98.49 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 t -107.34 106.06 57.42 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 114.725 -1.125 . . . . 0.0 107.997 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.442 ' HB2' ' OD1' ' B' ' 52' ' ' ASN . 28.0 Cg_exo -60.86 155.51 49.05 Favored 'Trans proline' 0 N--CA 1.476 0.476 0 C-N-CA 123.28 2.653 . . . . 0.0 112.969 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.656 ' HA ' HG22 ' B' ' 54' ' ' VAL . 92.3 mtp -61.18 -39.16 89.09 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . 0.442 ' OD1' ' HB2' ' B' ' 50' ' ' PRO . 33.4 p-10 -65.7 -17.65 64.76 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.998 0.428 . . . . 0.0 110.859 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.433 HD12 ' HD2' ' B' ' 50' ' ' PRO . 89.0 mt -99.48 -36.29 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.004 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.656 HG22 ' HA ' ' B' ' 51' ' ' MET . 23.2 m -64.98 -37.46 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.633 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.07 83.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.227 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . 0.457 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 7.1 pt20 -82.04 -18.67 42.42 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.49 HH12 ' CD1' ' A' ' 187' ' ' LEU . 62.9 mtt-85 -107.37 -27.51 10.43 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.7 6.63 23.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.517 0.675 . . . . 0.0 110.164 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' B' ' 61' ' ' SER . . . -70.25 157.46 53.52 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 175.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.402 ' H ' ' HB2' ' B' ' 63' ' ' ARG . . . 70.71 -40.72 0.48 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.082 0.553 . . . . 0.0 111.499 -177.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 59' ' ' GLY . 42.9 t -64.99 -63.2 1.17 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.925 0.49 . . . . 0.0 111.296 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.469 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.5 p -101.41 10.44 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.469 0.652 . . . . 0.0 110.206 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.402 ' HB2' ' H ' ' B' ' 60' ' ' ALA . 41.8 ttm180 -59.6 -26.07 65.15 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.693 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -62.63 -49.1 76.53 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.926 0.393 . . . . 0.0 110.382 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -77.32 -21.74 53.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.813 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.469 HG23 ' O ' ' B' ' 62' ' ' VAL . 77.0 t -63.94 -43.74 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.0 -39.4 94.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.216 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.7 -42.26 99.72 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.776 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . 0.434 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 11.5 t70 -62.31 -45.36 93.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.998 0.428 . . . . 0.0 110.378 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.42 -41.7 98.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.367 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 15.5 tpt -61.69 -42.33 98.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 51.2 m -60.98 -43.61 98.56 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.836 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 96.4 mtt-85 -65.68 -42.0 91.77 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.497 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -63.65 -41.3 98.24 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.646 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -61.67 -50.95 70.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.962 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 tt -69.93 -41.8 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.441 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 7.8 t70 -64.57 -40.52 95.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.171 0.51 . . . . 0.0 110.098 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.38 -43.1 78.08 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.66 -33.64 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.012 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.57 -44.07 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.893 0.377 . . . . 0.0 110.899 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 17.4 ptpt -77.59 -28.3 51.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.548 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -83.38 -4.56 58.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.635 0.255 . . . . 0.0 110.84 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 66.5 36.93 4.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.366 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.1 mt -99.65 120.95 49.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.832 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -107.55 112.03 62.55 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.71 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -75.14 127.24 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.059 1.84 . . . . 0.0 111.523 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.22 100.22 9.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.069 0.461 . . . . 0.0 111.016 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.98 -109.84 3.25 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.148 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.69 113.75 8.57 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.684 0.278 . . . . 0.0 111.093 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.39 160.23 45.11 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.72 2.28 . . . . 0.0 111.066 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.4 m -107.04 118.74 37.51 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.814 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -73.38 -25.07 60.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.556 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 26.0 t 49.54 79.17 0.36 Allowed Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 123.788 0.835 . . . . 0.0 112.879 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.51 126.59 8.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.301 2.0 . . . . 0.0 110.627 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.62 -172.2 48.53 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.593 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.7 121.08 26.8 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.949 0.404 . . . . 0.0 109.998 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -82.2 118.18 22.89 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.148 0.499 . . . . 0.0 110.805 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -98.7 123.69 43.07 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 tp -68.35 105.82 2.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.577 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.42 3.31 44.1 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.588 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -126.87 172.31 10.52 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.83 0.347 . . . . 0.0 111.222 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.52 141.99 57.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.733 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -105.28 144.74 31.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.948 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 34.8 m -119.98 131.2 55.09 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.011 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.94 162.1 38.56 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.564 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 46.2 p -97.9 -83.78 0.4 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -174.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' B' ' 106' ' ' SER . 94.3 t 75.02 113.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -173.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -104.94 121.94 44.79 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -172.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . 0.449 ' N ' HD23 ' B' ' 11' ' ' LEU 0.255 26.3 p90 -138.71 -92.88 0.19 Allowed 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 175.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -159.43 149.15 18.61 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.018 0.826 . . . . 0.0 112.194 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.78 168.59 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.47 0.708 . . . . 0.0 111.619 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -111.28 104.42 56.13 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.425 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -91.44 154.27 3.63 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.924 2.416 . . . . 0.0 113.139 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -158.06 139.81 13.86 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 62.2 t -127.69 136.17 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.164 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -84.84 142.23 29.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.6 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.11 146.52 47.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.746 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -139.2 154.01 47.97 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.663 0.268 . . . . 0.0 111.388 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.3 20.61 76.88 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.068 -0.515 . . . . 0.0 113.857 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.73 -40.86 92.58 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.953 0.406 . . . . 0.0 111.811 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.2 -5.12 39.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.279 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.09 12.96 36.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.814 0.34 . . . . 0.0 111.057 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.49 124.02 46.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.125 0.488 . . . . 0.0 110.346 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.84 121.9 44.64 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.336 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.1 134.43 53.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.807 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -84.65 143.71 29.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.464 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -133.41 97.44 16.12 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.94 138.08 55.82 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.409 2.072 . . . . 0.0 111.427 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' B' ' 421' ' ' GLU . 48.8 mm -117.64 124.46 73.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.78 162.11 39.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.607 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -148.29 -178.77 6.49 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 80.8 t -100.02 127.6 52.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 120.875 0.369 . . . . 0.0 110.776 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 59.2 p -104.83 171.6 7.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.771 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -64.0 -34.12 77.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.608 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.6 86.05 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.498 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -62.85 -39.66 95.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.878 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.41 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.5 t -63.11 -45.57 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.179 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.76 -44.89 96.0 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.138 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.5 -40.94 99.74 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.397 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.612 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.1 tpt -61.77 -48.63 79.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.688 0.28 . . . . 0.0 110.5 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 91.9 mt -63.64 -42.1 98.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.224 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.46 -49.13 78.96 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.406 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.5 m -62.79 -41.61 99.35 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.763 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' B' ' 140' ' ' MET . 89.3 mt -60.63 -35.53 76.39 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -78.3 -15.11 59.07 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.54 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.3 -6.27 41.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.313 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -107.95 30.24 6.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.865 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -134.95 94.83 3.21 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -112.0 120.11 40.75 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.705 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . 0.642 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 52.7 m -71.73 158.89 35.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.826 0.346 . . . . 0.0 111.318 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -78.89 122.56 26.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' B' ' 152' ' ' LYS . 17.1 tptm -143.53 170.07 16.5 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' B' ' 153' ' ' GLU . 0.6 OUTLIER -86.29 0.29 54.19 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -165.23 -175.78 3.79 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.983 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' B' ' 242' ' ' GLU . 0.9 OUTLIER 93.2 127.76 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.829 1.651 . . . . 0.0 111.822 176.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -71.45 90.02 0.45 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 115.324 0.89 . . . . 0.0 115.324 -172.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.77 135.36 18.41 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.72 128.31 70.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -108.35 158.6 17.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.921 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.49 24.44 0.2 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.033 0.533 . . . . 0.0 112.235 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -138.11 -3.73 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.155 0.503 . . . . 0.0 109.886 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -85.3 159.54 20.02 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.49 0.662 . . . . 0.0 112.626 -172.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' B' ' 163' ' ' ARG . 12.0 ptp180 -104.6 103.11 12.72 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.663 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.54 120.17 51.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.699 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 26.6 m -77.78 105.11 8.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.75 123.59 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.547 -174.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . 0.479 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 18.1 m-20 -95.15 107.05 19.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -125.03 147.7 48.83 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.605 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 29.8 m -120.13 130.3 54.55 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.759 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.63 119.52 4.89 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.45 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 25.4 p -134.94 126.52 28.8 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 t -75.36 -90.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.499 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -98.91 -4.61 32.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.378 0.609 . . . . 0.0 109.739 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.41 -18.1 0.44 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.732 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.95 146.07 27.11 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.925 0.393 . . . . 0.0 110.205 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -81.6 156.01 25.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.987 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -125.96 -175.72 3.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.521 0.2 . . . . 0.0 111.537 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.3 -38.79 84.75 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.74 -176.89 32.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.481 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.08 26.53 36.73 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.623 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -108.01 98.25 7.84 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.27 140.04 51.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.035 0.445 . . . . 0.0 111.894 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.479 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 48.8 m -148.48 125.12 11.09 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 61.16 30.66 19.46 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.596 0.56 . . . . 0.0 110.276 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -88.82 128.82 35.66 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.027 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 16.9 m -99.34 122.69 51.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.462 0.648 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . 0.519 HD12 HH12 ' A' ' 57' ' ' ARG . 35.2 tp -111.62 120.2 41.27 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.941 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.74 112.2 24.07 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . 0.615 ' HE3' ' O ' ' B' ' 199' ' ' GLU . 84.8 mtp -83.42 152.32 25.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.008 -175.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.49 -14.2 62.25 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.055 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . 0.418 ' HB2' ' HG2' ' B' ' 193' ' ' ARG . 97.8 mt-30 -95.19 -11.76 27.51 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -176.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.24 48.14 6.14 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.25 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.418 ' HG2' ' HB2' ' B' ' 191' ' ' GLN . 34.8 mmm-85 -88.23 -12.39 43.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.864 -0.668 . . . . 0.0 109.796 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.18 -179.58 5.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.908 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 49.6 mm -61.05 134.04 92.8 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.85 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.81 128.4 21.43 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.837 2.358 . . . . 0.0 112.352 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.48 -39.39 2.76 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.24 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -62.54 -47.64 82.98 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . 0.615 ' O ' ' HE3' ' B' ' 189' ' ' MET . 12.1 pt-20 -79.11 -10.05 59.72 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.09 -177.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.5 -28.3 16.88 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.952 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.77 -21.86 71.47 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.659 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.92 -41.91 94.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -54.92 134.1 48.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.665 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 100.35 3.67 55.36 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.658 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -108.4 151.93 25.36 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 120.967 0.413 . . . . 0.0 110.901 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -92.81 155.61 17.53 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.053 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.12 134.99 56.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.79 50.3 25.1 Favored Glycine 0 C--O 1.236 0.222 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.944 -178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . 0.402 ' H ' HD23 ' B' ' 237' ' ' LEU . 44.3 tt0 -135.65 133.54 38.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.086 0.469 . . . . 0.0 111.264 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -108.54 127.02 53.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -144.82 -12.8 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 44.1 p 60.27 166.72 0.08 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.79 0.836 . . . . 0.0 111.926 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -155.59 119.71 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.256 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.06 106.76 11.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.83 0.347 . . . . 0.0 110.829 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 97.7 t -109.23 115.57 49.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.108 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . 0.526 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 8.2 m -64.09 -41.03 97.45 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.526 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.8 m-85 77.88 141.74 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 123.113 0.565 . . . . 0.0 109.809 -172.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.63 152.23 53.33 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.818 1.679 . . . . 0.0 111.878 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . 0.555 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 39.9 mm-40 -62.67 -33.52 75.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.999 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -86.77 24.78 1.39 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.113 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . 0.509 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 9.0 t80 -73.82 135.22 43.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.496 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -67.69 -14.69 63.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.509 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -98.65 108.71 21.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 36.5 tt0 -60.86 -36.79 80.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.428 ' OD1' ' HG ' ' B' ' 226' ' ' LEU . 25.7 p30 -72.65 -11.9 60.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.428 ' HG ' ' OD1' ' B' ' 225' ' ' ASN . 94.6 mt -120.55 -0.01 10.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.555 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.9 ptmt -70.73 108.36 4.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.573 0.701 . . . . 0.0 112.76 -175.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.33 17.1 78.55 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.799 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -121.19 123.51 42.44 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -68.02 136.16 53.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -110.96 137.04 49.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.182 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -70.08 -41.23 74.37 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -175.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' B' ' 212' ' ' THR . 74.4 m-85 57.62 100.94 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.915 0.486 . . . . 0.0 112.122 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.411 ' HA ' HG22 ' B' ' 212' ' ' THR . . . -58.55 -49.77 76.21 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 61.81 77.97 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.092 0.472 . . . . 0.0 111.051 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -65.85 -39.94 91.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.886 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . 0.402 HD23 ' H ' ' B' ' 209' ' ' GLU . 12.5 tp 51.71 83.56 0.05 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.921 0.888 . . . . 0.0 111.142 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . 0.472 ' HD3' ' HB2' ' B' ' 167' ' ' ASP . 51.9 mtpt -89.98 -64.68 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -174.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -88.52 -89.75 0.14 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 42.9 t 73.42 129.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.888 0.475 . . . . 0.0 111.07 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -69.13 -35.39 76.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.962 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' B' ' 155' ' ' ASP . 12.9 pt-20 57.49 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.432 1.493 . . . . 0.0 114.061 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -139.41 125.73 20.21 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.197 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' B' ' 245' ' ' LEU . 0.9 OUTLIER -150.68 -173.85 4.6 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.549 ' H ' ' CD ' ' B' ' 244' ' ' GLU . 46.3 mt 73.6 102.37 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 123.216 0.606 . . . . 0.0 111.042 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . 0.642 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 72.2 Cg_endo -78.97 109.89 2.66 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.569 2.179 . . . . 0.0 113.857 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . 0.581 ' H ' HG21 ' B' ' 150' ' ' THR . 12.5 pt-20 -138.11 23.34 2.8 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.632 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 51.6 tp 77.0 139.08 0.07 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . 0.504 HG22 ' H ' ' B' ' 251' ' ' GLU . 27.7 m -149.78 141.51 23.62 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.145 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -80.05 -9.99 59.74 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.504 ' H ' HG22 ' B' ' 249' ' ' THR . 41.4 mt-10 -84.66 -25.19 28.65 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -63.62 -28.21 69.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 41.2 pt -70.44 -9.41 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.815 0.34 . . . . 0.0 111.89 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -136.7 30.11 2.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.846 0.355 . . . . 0.0 111.55 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -118.24 12.16 13.38 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-O 121.095 0.474 . . . . 0.0 111.49 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -96.3 27.6 3.66 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.19 -40.28 2.99 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.42 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 28.0 t -68.94 137.65 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -43.63 -59.65 2.1 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.912 0.758 . . . . 0.0 111.986 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -166.81 157.84 12.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.789 0.328 . . . . 0.0 111.087 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -156.54 -171.02 22.29 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.872 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 56.8 p -111.49 -141.3 0.38 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 59.8 t -98.16 -71.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 110.025 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.2 OUTLIER -68.51 -37.07 79.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.243 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.97 93.7 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.191 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 270' ' ' VAL . 53.1 tp -63.08 -43.42 98.59 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -61.59 -42.11 98.39 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.459 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -62.27 -46.01 90.69 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.204 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 38.4 tp10 -66.55 -40.07 88.87 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.853 0.358 . . . . 0.0 111.176 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 266' ' ' LEU . 90.9 t -65.25 -43.26 95.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.413 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -60.48 -46.98 88.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 14.1 ptmt -63.19 -44.36 95.58 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.898 0.38 . . . . 0.0 111.0 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -65.21 -38.29 89.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.406 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.8 mmm -63.82 -42.4 97.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.672 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -69.02 -33.32 73.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.059 0.457 . . . . 0.0 110.585 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -63.27 -42.49 99.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.683 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -67.37 -36.39 81.27 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.002 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . 0.459 ' O ' HG13 ' B' ' 282' ' ' ILE . 44.8 tp -62.3 -38.56 89.88 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.789 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -56.3 -45.66 80.15 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.263 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 19.4 m -61.63 -42.28 98.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.837 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.56 -42.93 99.85 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.138 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 278' ' ' LEU . 66.5 mt -64.36 -44.36 97.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.301 178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -60.21 -44.1 95.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.452 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -63.64 -42.79 98.11 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.166 0.291 . . . . 0.0 111.404 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -60.54 -44.74 95.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.073 0.463 . . . . 0.0 110.729 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.61 -45.2 78.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.32 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.92 -48.91 78.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.806 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -63.57 -43.4 97.1 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -65.29 -42.18 93.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.485 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.58 -47.95 81.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.994 0.426 . . . . 0.0 111.09 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . 0.499 HG21 HG22 ' B' ' 347' ' ' VAL . 51.2 mm -66.68 -43.44 90.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.92 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . 0.414 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 19.9 tp10 -57.82 -45.4 86.21 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.134 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.77 -40.62 99.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.116 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.447 HD13 HD13 ' B' ' 350' ' ' LEU . 4.8 tt -63.6 -43.9 95.56 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.32 -43.98 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.247 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . 0.414 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 66.1 mttm -60.33 -35.18 75.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.934 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.16 -11.76 40.19 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -138.63 81.01 1.82 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -91.54 93.27 8.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -105.26 157.93 5.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.58 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.22 138.25 58.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.465 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 35.0 t -106.63 126.01 31.4 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.861 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.503 ' O ' HG13 ' B' ' 307' ' ' ILE . 51.6 Cg_exo -55.99 129.19 33.58 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.428 2.086 . . . . 0.0 111.914 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.28 83.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.476 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.99 84.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.52 -38.06 83.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.507 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . 0.503 HG13 ' O ' ' B' ' 303' ' ' PRO . 73.6 mt -61.07 -50.12 81.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.248 -177.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.16 -37.53 87.67 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 63.6 p -67.6 -45.17 76.23 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.501 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . 0.554 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 66.8 mm-40 -71.81 -36.32 70.21 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.494 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 87.3 mt -62.38 -44.46 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.12 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.569 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 36.6 t70 -63.24 -41.86 99.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.823 0.344 . . . . 0.0 110.965 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.47 -43.16 98.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.298 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 84.2 mt -62.21 -39.91 94.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.693 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 79.1 mtm180 -63.37 -39.04 93.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.235 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 90.2 mtt180 -62.82 -42.23 99.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.842 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -62.95 -43.16 99.55 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.496 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.05 -39.94 82.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.964 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.44 91.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.07 0.462 . . . . 0.0 110.39 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -62.15 -37.15 84.13 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.052 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -70.56 -36.95 73.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.412 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.02 42.37 0.25 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.986 0.915 . . . . 0.0 112.172 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.77 -0.11 59.24 Favored Glycine 0 C--N 1.318 -0.465 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.033 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 89.49 30.65 13.08 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.195 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -68.6 136.35 52.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.899 0.38 . . . . 0.0 110.533 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . 0.423 ' HB3' HH11 ' A' ' 73' ' ' ARG . 0.9 OUTLIER -137.98 162.29 34.47 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.574 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.0 OUTLIER 68.57 -53.43 0.55 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.298 0.639 . . . . 0.0 112.359 -178.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -73.99 -3.7 30.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.44 -24.32 65.11 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.278 0.561 . . . . 0.0 109.705 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.427 HD12 HH12 ' B' ' 315' ' ' ARG . 41.9 tp -63.23 -36.23 82.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.324 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.07 -26.02 65.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.877 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . 0.424 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 80.0 mt -54.3 132.89 61.54 Favored Pre-proline 0 C--O 1.238 0.481 0 CA-C-O 120.706 0.288 . . . . 0.0 111.556 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . 0.449 ' HB2' HD13 ' B' ' 336' ' ' LEU . 50.5 Cg_exo -54.67 133.19 55.78 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.986 2.457 . . . . 0.0 113.338 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . 0.42 HH21 ' HD2' ' B' ' 334' ' ' ARG . 26.1 ttt85 -67.03 -43.81 81.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.056 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -63.85 -33.01 74.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -174.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . 0.449 HD13 ' HB2' ' B' ' 333' ' ' PRO . 10.8 mp -64.29 -36.57 84.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.473 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -101.36 -13.82 17.85 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . 0.402 ' HG3' HD11 ' B' ' 311' ' ' ILE . 39.9 tt0 -68.52 -30.4 69.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.734 0.302 . . . . 0.0 111.482 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.66 -49.85 74.87 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.792 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -72.25 -29.43 63.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 110.71 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.466 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -61.72 -43.66 98.42 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.108 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . 0.443 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.6 tttt -59.47 -45.19 92.35 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . 0.53 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.7 mmt85 -62.44 -45.52 92.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -66.0 -37.89 87.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 341' ' ' ALA . 82.6 t -63.4 -44.72 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.787 0.327 . . . . 0.0 110.33 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 342' ' ' LYS . 71.7 t -61.23 -45.1 99.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.513 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 343' ' ' ARG . 85.4 t -61.24 -44.57 98.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.281 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.59 -42.32 99.15 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.15 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.04 -44.03 97.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 110.701 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.473 ' O ' HG23 ' B' ' 354' ' ' VAL . 96.2 mt -63.24 -49.45 74.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.0 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.7 -41.21 88.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.6 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.39 -42.44 98.92 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.265 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.7 -35.65 75.25 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.956 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 350' ' ' LEU . 71.8 t -60.15 -44.73 95.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.74 -44.15 98.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.127 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -68.58 -49.03 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 39.2 m -64.48 -44.9 89.56 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -88.56 5.93 40.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.367 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 56.43 45.27 22.96 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.032 0.444 . . . . 0.0 111.528 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 98.8 mt -81.48 143.77 31.84 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.125 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.23 150.53 42.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.109 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.02 120.55 13.34 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . 0.554 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.1 t70 -89.59 113.59 25.05 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.032 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 58.8 mm-40 -59.0 -38.38 79.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.449 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -65.46 -41.54 93.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.839 0.352 . . . . 0.0 110.785 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -64.92 -38.66 91.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.784 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . 0.554 HG23 ' O ' ' B' ' 363' ' ' ASP . 96.0 t -63.08 -38.77 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.389 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.4 mmmt -56.35 -44.35 80.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.53 96.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.012 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.81 -42.42 99.71 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.114 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.02 -43.22 97.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.832 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -60.83 -38.95 87.22 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.197 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -65.94 -39.0 90.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.306 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 53.8 ttm -66.39 -41.77 88.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.368 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.57 -28.24 69.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.804 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 48.7 m -75.13 -5.77 46.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.562 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -93.08 -1.34 56.59 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.946 0.403 . . . . 0.0 111.234 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -114.29 169.05 9.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.156 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -64.96 -44.09 90.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.961 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -119.65 118.88 31.79 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.798 0.332 . . . . 0.0 110.198 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.83 -30.62 21.67 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.421 2.08 . . . . 0.0 113.258 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -66.14 -43.37 87.24 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.44 -37.36 85.59 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.706 0.289 . . . . 0.0 110.851 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.44 -43.25 96.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.515 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 90.4 mt -62.33 -44.25 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.943 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 48.3 mt-10 -65.66 -44.48 86.15 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.838 178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.5 -47.82 82.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.122 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . 0.48 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 2.8 t80 -69.52 -39.88 77.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.051 -177.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 62.7 p -78.93 -8.06 58.55 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.4 mttt -99.32 1.7 44.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.967 0.413 . . . . 0.0 111.536 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . 0.434 ' OD1' HD13 ' B' ' 394' ' ' LEU . 24.6 t-20 -123.9 115.25 20.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.232 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 42.1 ttmt -63.9 -40.87 97.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.407 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.23 -49.49 76.9 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.094 0.473 . . . . 0.0 110.781 -176.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . 0.434 HD13 ' OD1' ' B' ' 391' ' ' ASN . 10.3 mp -63.61 -40.18 96.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.47 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 89.7 mtp -62.55 -45.46 92.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 111.526 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.79 -43.66 75.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.223 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -62.8 -39.81 95.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.636 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . 0.48 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 55.5 tpp -62.82 -44.07 97.12 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.868 0.366 . . . . 0.0 110.751 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.406 ' HG2' HG21 ' B' ' 367' ' ' VAL . 56.1 mtm180 -64.65 -31.69 73.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.014 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -61.24 -45.63 93.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.78 -43.83 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.043 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.2 -41.0 96.06 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.003 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.75 -37.04 86.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.693 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.2 -45.18 91.76 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.999 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -65.74 -37.81 87.39 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.656 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -58.92 -43.12 91.03 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.868 0.366 . . . . 0.0 110.421 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.407 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -64.71 -47.28 78.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.599 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 94.9 t -64.12 -45.62 95.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.413 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -67.57 -32.0 72.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.555 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.69 91.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.879 0.371 . . . . 0.0 110.253 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 407' ' ' ALA . 93.6 t -64.35 -42.64 95.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.957 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.0 -38.54 86.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.749 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.32 -23.46 66.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -99.25 -2.51 36.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.916 0.389 . . . . 0.0 110.855 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -110.15 174.46 5.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.189 0.519 . . . . 0.0 111.614 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -87.39 108.06 18.82 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.692 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 65.0 t -100.41 118.93 47.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.218 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -119.97 159.57 24.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -108.17 122.16 46.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.873 0.368 . . . . 0.0 111.504 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -134.72 123.7 24.08 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.079 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' B' ' 129' ' ' ILE . 75.3 mt-10 -84.65 154.25 22.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.908 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.0 t -158.2 176.12 12.9 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.599 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 75.0 p -85.4 165.41 17.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.895 0.379 . . . . 0.0 111.231 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -66.72 -26.5 67.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.581 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -62.58 -39.57 94.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.36 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.56 -35.77 81.03 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.361 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -78.16 -14.21 59.56 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.823 0.345 . . . . 0.0 111.461 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.4 mmt -76.69 -9.5 58.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.924 0.392 . . . . 0.0 110.703 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -80.0 87.11 5.42 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -108.82 29.61 7.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.907 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -65.6 -27.35 68.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.376 0.608 . . . . 0.0 109.584 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.478 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.52 178.265 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t -135.4 131.03 35.79 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.818 0.342 . . . . 0.0 110.163 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.6 p -153.06 139.71 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.546 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -131.73 154.76 48.7 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 m -102.84 126.13 49.86 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.5 m -97.4 -58.8 1.92 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.441 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -174.3 130.42 0.37 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.571 0.224 . . . . 0.0 110.781 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.44 -112.78 5.05 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.815 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 11' ' ' LEU . 5.4 mp -93.61 -8.78 40.17 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.673 0.273 . . . . 0.0 110.731 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.38 122.14 5.62 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.995 -0.622 . . . . 0.0 113.646 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.05 147.5 46.63 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.432 0.693 . . . . 0.0 109.255 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -110.11 139.32 45.38 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.9 t -95.99 -89.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.9 m 68.04 100.2 0.05 Allowed 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -173.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tp -133.02 143.72 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.012 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 m -126.45 130.57 50.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.506 ' HB ' HG12 ' A' ' 24' ' ' ILE . 9.6 mt -125.79 162.11 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -177.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.557 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.7 150.09 49.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.301 0.24 . . . . 0.0 111.132 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.33 -57.08 9.87 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -174.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.11 -35.35 79.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 111.224 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 t -62.74 -41.82 99.38 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.487 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 20' ' ' ALA . 76.4 mt -60.21 -51.98 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.155 0.503 . . . . 0.0 111.354 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -70.04 -46.91 64.02 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.547 -174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.2 m -67.3 -51.33 54.01 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.93 66.5 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.87 -43.29 97.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.964 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -61.32 -45.45 94.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.16 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.2 m -62.18 -42.18 99.03 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.841 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.0 tp10 -70.16 -42.03 73.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.494 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.54 -44.65 96.67 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.94 -35.43 64.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.014 0.435 . . . . 0.0 110.701 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -65.68 -41.31 92.6 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.54 HG11 ' HD3' ' A' ' 73' ' ' ARG . 90.2 t -65.68 -41.46 90.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.398 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.34 80.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.285 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.421 ' O ' ' HD3' ' A' ' 40' ' ' ARG . 99.0 mttt -64.58 -37.58 88.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.059 177.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -61.0 -41.91 97.4 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.883 0.373 . . . . 0.0 110.598 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.87 -4.23 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.388 0.613 . . . . 0.0 110.156 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 25.6 mmt180 62.62 30.95 17.0 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.049 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -112.83 7.15 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.764 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -64.01 -35.92 82.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.081 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.23 -1.64 70.15 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.688 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -91.72 -5.19 54.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.921 0.391 . . . . 0.0 110.734 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -90.36 110.59 21.67 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.01 -39.1 91.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.615 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.519 ' H ' HE22 ' B' ' 320' ' ' GLN . . . 56.83 56.45 24.76 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 173.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -62.66 -41.29 98.98 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.91 109.69 58.81 Favored Pre-proline 0 C--O 1.246 0.902 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.462 ' HG2' HD12 ' A' ' 53' ' ' ILE . 47.4 Cg_exo -57.3 149.35 65.25 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.925 2.417 . . . . 0.0 112.543 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.555 ' HA ' HG12 ' A' ' 54' ' ' VAL . 15.0 ttt -60.29 -39.16 85.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.455 -173.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -69.12 -23.42 63.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.844 0.354 . . . . 0.0 110.987 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.462 HD12 ' HG2' ' A' ' 50' ' ' PRO . 96.6 mt -92.53 -41.72 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 51' ' ' MET . 12.7 p -66.02 -38.78 82.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 120.936 0.398 . . . . 0.0 110.817 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.444 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -66.84 -37.37 84.36 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.43 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 9.7 pt20 -72.78 -15.01 61.65 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.724 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.501 HH12 ' CD1' ' B' ' 187' ' ' LEU . 67.2 mtt180 -108.59 -52.41 2.77 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.437 ' O ' HG12 ' A' ' 62' ' ' VAL . 18.8 m-85 -108.66 -1.24 19.66 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.182 0.515 . . . . 0.0 110.646 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -63.87 -35.76 92.43 Favored Glycine 0 C--O 1.218 -0.863 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.753 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.93 -43.94 67.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.802 0.301 . . . . 0.0 111.312 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.5 m -61.19 -43.29 99.11 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.129 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 65' ' ' ASP . 8.0 p -105.32 20.3 4.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.246 0.546 . . . . 0.0 110.776 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 14.1 ttm180 -63.97 -19.9 65.49 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.048 0.452 . . . . 0.0 110.147 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.37 -53.05 58.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.24 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.528 ' HB2' HG22 ' A' ' 62' ' ' VAL . 17.6 m-20 -71.02 -26.15 62.99 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.501 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 62' ' ' VAL . 91.7 t -62.05 -45.24 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.74 -40.06 95.81 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.352 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.03 99.39 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.23 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.51 -44.67 93.62 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.39 -42.76 99.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.036 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.1 ttp -60.48 -50.08 75.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.34 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.3 m -65.27 -46.38 80.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.679 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.54 ' HD3' HG11 ' A' ' 35' ' ' VAL . 58.4 ttm-85 -66.27 -46.63 76.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.792 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -66.14 -40.4 90.6 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -59.88 -48.36 81.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.908 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 79' ' ' ILE . 20.0 tt -68.17 -38.9 80.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.883 0.373 . . . . 0.0 111.271 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.19 -38.54 88.24 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.384 0.611 . . . . 0.0 109.767 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.69 83.73 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.766 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.7 pp -65.07 -37.33 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.076 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.32 -42.33 95.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.718 0.77 . . . . 0.0 109.156 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -59.55 -47.86 83.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.16 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -89.38 -1.43 58.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -175.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm 70.46 38.95 1.27 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.47 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 92.5 mt -93.84 121.28 44.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -110.52 101.41 48.66 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.588 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.92 131.31 6.97 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.53 2.153 . . . . 0.0 112.452 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.7 90.95 4.42 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.997 0.427 . . . . 0.0 110.4 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.46 -144.21 15.29 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.18 129.47 25.05 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 116.588 0.194 . . . . 0.0 110.678 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HG2' ' CE1' ' A' ' 92' ' ' TYR . 60.5 Cg_endo -70.21 160.2 50.4 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.827 2.352 . . . . 0.0 111.398 178.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.2 m -101.09 91.72 4.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.12 0.486 . . . . 0.0 112.17 -175.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.42 ' CE1' ' HG2' ' A' ' 90' ' ' PRO . 87.5 m-85 -84.05 117.77 23.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.6 t -111.26 96.93 33.3 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 120.86 0.362 . . . . 0.0 111.967 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -87.99 145.14 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 122.592 2.194 . . . . 0.0 110.81 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.96 174.83 42.81 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.638 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.52 130.86 42.3 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -85.34 104.04 14.81 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.153 0.501 . . . . 0.0 110.911 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.95 111.7 19.49 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.11 112.7 2.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.118 0.485 . . . . 0.0 110.484 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.97 -14.91 19.15 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.135 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -119.0 -178.1 3.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.623 0.249 . . . . 0.0 111.035 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.52 161.18 28.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.359 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -108.8 138.81 44.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.776 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -118.31 134.54 54.95 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.198 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -136.39 162.67 32.39 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.835 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.9 m -121.8 148.78 44.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.762 0.315 . . . . 0.0 111.112 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.88 139.96 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.417 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.41 132.81 46.81 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -155.72 -159.33 0.9 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -45.96 155.22 0.2 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.557 1.543 . . . . 0.0 113.327 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.5 m -129.93 159.19 42.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.445 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -145.55 99.32 4.48 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.253 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.22 143.73 10.25 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.515 2.143 . . . . 0.0 113.124 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -159.01 125.59 4.62 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.93 162.62 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.891 0.376 . . . . 0.0 111.709 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -119.64 136.35 54.43 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.6 mt -114.23 135.3 54.2 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -128.09 133.46 49.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.626 0.251 . . . . 0.0 111.649 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.1 22.43 52.31 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.882 -0.675 . . . . 0.0 114.251 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.89 -41.42 99.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.24 0.543 . . . . 0.0 110.511 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.67 -16.77 61.88 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.619 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.05 6.98 47.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.49 127.53 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.375 0.607 . . . . 0.0 111.093 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -110.04 132.2 54.37 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.935 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.5 t -120.76 133.6 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.142 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -90.26 120.26 31.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.049 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -122.31 93.5 48.48 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.76 140.73 56.93 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.176 1.917 . . . . 0.0 112.446 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.2 mm -106.37 119.84 56.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.378 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.41 160.43 42.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.293 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.3 158.77 43.36 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.855 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.4 t -84.72 126.4 40.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.698 0.285 . . . . 0.0 110.491 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.2 p -97.74 170.02 9.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -68.57 -22.68 64.46 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.284 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.69 -38.89 92.54 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.151 0.501 . . . . 0.0 109.652 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -65.15 -36.74 85.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.336 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.45 -45.36 98.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.468 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.09 -40.48 95.99 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.438 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.81 -42.67 99.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.663 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.532 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 5.0 tpt -63.72 -45.17 91.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.922 0.391 . . . . 0.0 110.306 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.43 -41.4 98.67 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.957 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.1 -45.89 89.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.386 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.0 m -62.62 -39.55 94.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.329 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.7 mt -61.49 -41.75 97.75 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.701 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -69.43 -21.54 63.74 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.087 0.47 . . . . 0.0 110.802 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -86.56 4.13 41.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.223 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -119.8 28.54 8.06 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.664 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -138.33 95.39 3.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.57 155.99 47.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.96 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 243' ' ' ARG . 0.7 OUTLIER -122.29 172.35 8.37 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.766 -177.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.468 ' H ' HG22 ' A' ' 150' ' ' THR . 8.9 p-90 -55.0 136.41 47.78 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.052 0.541 . . . . 0.0 112.311 -176.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -170.32 113.87 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -73.86 85.58 1.72 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -153.0 -78.31 0.11 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.837 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -163.19 -68.21 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.434 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 243' ' ' ARG . . . 64.54 -126.92 33.59 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.198 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -146.34 -165.44 2.22 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 203' ' ' LYS . 61.2 t -119.38 126.54 75.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 57.1 mm-40 -87.88 177.93 6.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.263 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.17 -58.25 3.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 255' ' ' ARG . 6.7 pt-20 -89.58 34.98 0.82 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.304 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.656 ' OD2' ' HD3' ' A' ' 243' ' ' ARG . 11.4 t70 -57.22 -48.7 78.14 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.412 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 65.82 88.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.617 HG22 ' OD1' ' A' ' 162' ' ' ASP . 2.9 t -109.94 132.31 58.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.694 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 m -81.15 104.62 11.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 79.7 mt -117.1 132.82 65.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -171.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -99.26 107.92 20.34 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -130.68 146.91 52.28 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.621 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 37.6 m -128.55 131.46 48.22 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.085 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.97 105.84 1.96 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.603 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.9 m -127.26 121.69 31.85 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.6 t -72.64 -76.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -109.28 -70.34 0.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.172 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -136.87 18.9 3.54 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.228 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -136.84 148.79 47.33 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -93.32 149.37 21.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.643 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -111.39 -177.8 3.29 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.24 -45.01 92.31 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.732 -176.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -93.24 -171.58 39.9 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.173 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.62 36.87 58.27 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.865 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -115.17 101.42 8.95 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.2 151.53 34.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.144 0.497 . . . . 0.0 111.54 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.8 m -139.04 126.42 21.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.471 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 56.69 38.3 29.43 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.13 0.49 . . . . 0.0 110.768 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -87.7 136.1 33.1 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.619 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.53 120.15 37.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.715 0.769 . . . . 0.0 112.15 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.461 ' CD1' HH12 ' B' ' 57' ' ' ARG . 49.0 tp -113.27 119.42 37.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.595 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.648 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -102.21 129.04 48.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 56.9 mtm -106.83 167.65 9.73 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.768 -173.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.17 14.08 61.0 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.708 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.432 ' HB2' ' HG2' ' A' ' 193' ' ' ARG . 98.2 mt-30 -126.62 -10.06 6.2 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.661 0.267 . . . . 0.0 111.445 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.53 40.45 9.86 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.424 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 188' ' ' ALA . 39.5 mmm-85 -79.12 -22.04 45.72 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.38 0.672 . . . . 0.0 109.939 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.436 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.1 OUTLIER -128.95 -170.0 2.19 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.185 179.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.2 mp -68.33 134.52 91.13 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.63 132.43 45.74 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.256 1.971 . . . . 0.0 111.918 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.47 -39.88 2.63 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.795 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -62.34 -46.31 89.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.554 0.216 . . . . 0.0 111.244 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.95 10.85 5.76 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.088 0.47 . . . . 0.0 111.894 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -114.37 -33.64 5.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.121 0.486 . . . . 0.0 110.115 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.76 -17.88 75.46 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.246 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.57 -41.97 94.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.061 0.457 . . . . 0.0 110.322 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.436 ' HA ' ' HB ' ' A' ' 158' ' ' VAL . 41.5 mtpt -52.08 132.27 32.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.654 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.76 8.74 55.52 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.767 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.432 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 38.0 m80 -115.38 150.18 36.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.031 0.416 . . . . 0.0 110.72 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -87.26 163.39 16.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.169 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.95 135.49 47.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.01 15.35 79.14 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.77 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.432 ' OE2' ' HD2' ' A' ' 205' ' ' HIS . 40.7 tt0 -99.19 119.89 38.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.33 0.585 . . . . 0.0 111.362 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 235' ' ' ILE . 25.4 mt-10 -98.9 115.62 29.28 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.408 ' O ' ' HB ' ' A' ' 212' ' ' THR . 64.0 t80 -133.74 -26.09 1.6 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -173.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 77.0 m 72.42 129.96 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 120.893 0.378 . . . . 0.0 110.344 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.42 -41.07 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 70.75 97.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 122.791 0.436 . . . . 0.0 111.32 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 68.6 t -115.59 126.92 73.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.049 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.56 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 18.5 m -65.89 -41.95 90.88 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -176.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.56 ' HB2' ' O ' ' A' ' 216' ' ' THR . 27.8 m-85 77.81 134.53 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 122.957 0.503 . . . . 0.0 110.32 -173.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.16 155.7 51.84 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.369 2.046 . . . . 0.0 112.679 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -66.09 -33.78 76.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.601 0.715 . . . . 0.0 109.305 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.12 22.81 1.66 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.851 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -70.52 142.1 51.88 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.514 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -63.09 -30.37 71.54 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.67 123.62 33.3 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.419 -0.512 . . . . 0.0 109.741 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.526 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 1.5 tp10 -65.33 -31.54 72.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.381 -175.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -86.15 -5.32 59.22 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.37 -11.57 10.0 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.526 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 18.7 ptmt -71.53 119.98 16.47 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.206 0.527 . . . . 0.0 111.063 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 75.9 19.0 79.25 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.755 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -125.34 121.64 34.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.391 . . . . 0.0 110.766 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.55 138.9 45.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.615 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.54 135.47 53.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.845 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.52 -48.22 28.34 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -173.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 212' ' ' THR . 66.1 m-85 54.67 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.91 94.46 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 210' ' ' GLU . 91.6 mt 68.62 99.2 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.804 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -86.94 -51.7 5.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 32.4 tp 55.78 91.0 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.976 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -73.55 -79.33 0.08 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 54.1 mtmt -79.01 -79.11 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -170.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 92.0 t 76.9 152.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-O 120.832 0.349 . . . . 0.0 110.615 -175.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -99.12 56.53 1.04 Allowed 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -36.47 141.17 0.12 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -173.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.656 ' HD3' ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -144.6 144.83 31.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.944 177.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.404 ' HB2' ' CA ' ' A' ' 156' ' ' GLY . 38.2 tt0 -158.94 155.58 27.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 9.1 tt 72.09 128.03 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 123.475 0.484 . . . . 0.0 111.136 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 245' ' ' LEU . 61.2 Cg_endo -87.74 113.99 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.216 1.944 . . . . 0.0 113.632 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -131.37 176.24 8.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.89 111.6 23.92 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 15.6 p -104.51 -86.19 0.46 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.66 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -176.61 -49.93 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.996 0.427 . . . . 0.0 111.896 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.73 -45.11 91.39 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -62.35 -30.37 71.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 263' ' ' VAL . 19.6 tt -85.93 -16.12 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -117.29 8.34 13.12 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.345 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 161' ' ' GLU . 60.5 ttp180 -134.71 133.17 39.7 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.915 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -167.7 37.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 99.43 -31.54 8.2 Favored Glycine 0 C--N 1.318 -0.452 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.07 149.31 5.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.61 -47.25 80.05 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.199 0.312 . . . . 0.0 110.545 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -175.76 163.63 2.85 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.258 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -172.62 175.62 45.67 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.307 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.3 p -83.5 175.33 9.87 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.43 0.292 . . . . 0.0 110.301 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . 0.433 HG22 HD11 ' A' ' 253' ' ' ILE . 67.4 t -61.97 -51.23 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.005 0.431 . . . . 0.0 111.054 -177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -81.06 -32.95 33.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.335 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.07 -43.24 99.42 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.19 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 270' ' ' VAL . 65.1 tp -63.14 -44.02 96.7 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.627 0.251 . . . . 0.0 110.52 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -64.12 -42.38 96.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.382 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.536 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.3 -45.02 81.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.29 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 35.5 tp10 -65.71 -38.57 89.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.998 0.427 . . . . 0.0 110.434 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 266' ' ' LEU . 75.8 t -65.49 -43.4 94.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.228 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -59.21 -46.74 87.64 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.673 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.5 ptmt -66.46 -42.62 87.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.669 0.271 . . . . 0.0 111.163 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -65.79 -37.43 86.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.5 mmm -63.52 -42.81 98.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.045 0.45 . . . . 0.0 110.111 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -70.17 -30.82 68.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.204 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -61.61 -43.79 98.19 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.39 -32.98 74.9 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.875 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.8 tp -60.8 -39.64 89.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.951 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -58.12 -46.9 84.78 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 50.4 m -62.52 -44.68 95.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.033 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.3 -51.0 69.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.83 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.45 -44.36 97.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.039 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.544 HH12 ' HG3' ' A' ' 409' ' ' GLU . 6.5 tpt180 -63.03 -45.31 92.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.79 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.43 -40.19 95.27 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.472 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -59.13 -44.4 92.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.014 0.435 . . . . 0.0 110.269 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 86.3 t -70.24 -43.11 78.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.4 tttt -59.3 -47.66 84.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.046 -177.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 74.1 p -62.88 -41.89 99.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -64.2 -42.35 96.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.583 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 294' ' ' LEU . . . -65.27 -42.6 93.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.762 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 287' ' ' LYS . 33.5 mm -64.07 -43.34 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.563 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -60.74 -43.37 98.0 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.114 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.01 -40.85 97.39 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.414 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 290' ' ' ALA . 98.5 mt -62.54 -43.13 99.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.802 0.334 . . . . 0.0 110.802 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 291' ' ' ILE . 96.0 t -65.31 -43.78 94.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.198 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -64.23 -40.59 96.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.068 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.26 -42.74 79.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.962 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -127.21 96.34 4.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.8 105.55 17.49 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 301' ' ' ASP . 11.4 tp -120.1 168.68 12.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.574 -174.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 300' ' ' ILE . 7.3 m-20 -60.78 139.0 58.06 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.385 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.96 119.63 28.78 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.94 131.44 45.49 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.437 2.092 . . . . 0.0 111.89 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.66 84.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.102 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.55 91.1 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 111.565 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.7 mt -66.46 -40.74 89.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.833 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.417 ' O ' HG13 ' A' ' 311' ' ' ILE . 68.7 mt -61.66 -47.95 90.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.992 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.3 -43.04 92.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.873 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 51.0 m -62.25 -45.26 94.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.869 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.6 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 65.9 mm-40 -66.17 -39.48 89.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.234 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.54 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 95.8 mt -61.96 -43.82 98.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.621 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.6 t70 -61.62 -46.62 89.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.913 0.387 . . . . 0.0 111.306 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 91.7 t -63.35 -43.51 98.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.251 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 75.0 mt -62.49 -40.46 96.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.621 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 85.1 mtm180 -62.91 -42.15 99.69 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.132 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -64.79 -38.66 91.74 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -63.35 -44.53 94.57 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.252 0.548 . . . . 0.0 109.937 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.7 80.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.58 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -62.31 -36.29 81.7 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.944 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . 0.481 HE22 ' H ' ' B' ' 47' ' ' GLY . 45.8 tt0 -63.2 -40.5 97.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.281 0.563 . . . . 0.0 109.584 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -75.06 -9.6 58.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.343 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -92.2 -7.36 48.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.845 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . 136.69 -14.33 3.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.82 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 113.12 44.11 0.82 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.879 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 35.6 t-20 -87.22 127.98 35.15 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.88 0.372 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . 0.549 ' OE1' ' HG3' ' A' ' 327' ' ' LYS . 1.8 tm-20 -130.7 145.26 51.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.549 ' HG3' ' OE1' ' A' ' 326' ' ' GLU . 35.2 mtmm 72.22 -46.05 0.63 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.646 0.779 . . . . 0.0 112.422 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.503 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 12.3 mm100 -70.0 -10.98 60.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.207 0.527 . . . . 0.0 110.446 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.85 -22.54 64.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.411 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.432 HD12 HH12 ' A' ' 315' ' ' ARG . 60.0 tp -61.61 -33.93 74.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.679 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -79.27 -6.29 56.34 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.573 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 75.9 mt -69.24 145.63 96.17 Favored Pre-proline 0 C--O 1.241 0.623 0 O-C-N 122.186 -0.321 . . . . 0.0 110.997 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.36 127.08 23.43 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.893 2.396 . . . . 0.0 113.339 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.484 ' HG3' HD13 ' A' ' 311' ' ' ILE . 21.9 ttt180 -70.49 -41.0 73.25 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.405 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -52.16 -46.41 65.45 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -173.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.469 HD12 ' CD ' ' A' ' 224' ' ' GLU . 74.7 mt -92.27 10.13 30.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -115.72 -28.2 6.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.132 0.492 . . . . 0.0 110.228 172.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.7 -30.67 70.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.711 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -60.97 -48.24 82.75 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.471 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -78.32 -20.86 50.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.713 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.95 -40.87 97.43 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.505 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.8 tttt -59.82 -45.16 93.23 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.567 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.1 mmt85 -60.27 -45.8 92.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.031 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -67.46 -38.92 85.18 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.164 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 341' ' ' ALA . 82.8 t -64.27 -43.86 97.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.658 0.266 . . . . 0.0 110.351 176.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 342' ' ' LYS . 73.0 t -60.74 -43.8 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.531 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 343' ' ' ARG . 82.7 t -59.93 -45.6 94.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.45 -43.34 99.18 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.93 -43.73 94.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.59 0.233 . . . . 0.0 111.478 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.43 -44.79 93.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.924 0.393 . . . . 0.0 110.506 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 355' ' ' ILE . 95.8 mt -66.59 -39.93 88.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.816 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.84 -41.76 96.25 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.583 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -66.06 -40.46 90.92 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.889 0.344 . . . . 0.0 110.646 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.76 -45.89 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.937 178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 351' ' ' LEU . 73.6 mt -62.96 -46.98 94.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.224 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -64.07 -62.75 1.43 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.7 m -66.29 -43.86 85.14 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.3 -12.15 60.46 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.246 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 66.44 47.6 1.69 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.008 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.17 142.16 33.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.884 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.06 146.13 51.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.67 114.47 5.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.487 ' O ' HG23 ' A' ' 367' ' ' VAL . 26.8 t70 -87.01 111.48 20.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.064 0.459 . . . . 0.0 111.077 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 58.1 mm-40 -61.4 -35.04 76.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.995 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.63 -42.09 91.9 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.845 0.355 . . . . 0.0 110.764 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -63.01 -40.05 96.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.11 0.481 . . . . 0.0 110.149 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 363' ' ' ASP . 89.2 t -61.26 -39.41 82.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.335 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.0 mmmt -57.23 -43.41 82.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.508 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.65 99.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.204 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.65 -42.96 99.89 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.124 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.84 -44.85 92.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.121 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.73 -41.47 98.05 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -65.17 -42.31 93.83 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.436 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 49.6 ttp -65.25 -40.69 94.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -62.97 -23.45 67.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.568 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 39.6 m -73.85 -5.73 42.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.481 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -90.86 0.15 57.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.328 0.585 . . . . 0.0 110.315 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.86 170.84 8.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.542 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.06 -44.13 85.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.81 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -124.63 113.23 27.28 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.764 0.316 . . . . 0.0 110.616 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.428 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 40.1 Cg_exo -58.24 -35.95 98.22 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.948 2.432 . . . . 0.0 113.221 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.28 -43.7 85.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.48 -35.8 81.67 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.884 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.93 -43.24 96.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 109.978 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.11 -43.48 98.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.88 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.45 -36.75 84.84 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.743 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -58.63 -47.43 84.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.335 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' A' ' 395' ' ' MET . 5.7 m-85 -70.66 -44.46 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 29.9 p -68.32 -15.91 63.74 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -100.77 4.74 43.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.591 0.234 . . . . 0.0 111.214 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -128.97 112.94 14.58 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 110.699 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.13 -40.56 96.43 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -56.81 -51.38 69.19 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.043 0.449 . . . . 0.0 110.794 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.37 -40.14 95.24 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.838 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 388' ' ' TYR . 87.9 mtp -61.7 -45.63 93.17 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.638 0.256 . . . . 0.0 111.681 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.18 -44.25 63.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.367 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -63.31 -42.69 99.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.049 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 50.3 tpp -63.56 -42.07 98.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.991 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.463 ' HG2' HG21 ' A' ' 367' ' ' VAL . 83.2 mtm180 -65.59 -34.53 78.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.195 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -61.81 -42.72 99.37 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 110.106 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.99 -43.41 89.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.694 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.31 97.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.724 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.5 -36.7 84.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.489 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.22 -45.32 91.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.812 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 40.7 mt-10 -64.85 -38.46 91.06 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.419 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -60.39 -43.39 96.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.492 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.88 96.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.31 -43.51 95.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.544 ' HG3' HH12 ' A' ' 283' ' ' ARG . 80.5 mt-10 -66.02 -34.34 77.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.291 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.22 -39.12 91.74 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.15 0.5 . . . . 0.0 110.21 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.78 -42.85 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.176 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.56 -40.36 94.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.458 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.8 -27.76 68.27 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.941 0.4 . . . . 0.0 111.356 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -94.16 -8.22 40.05 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 110.821 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.35 -179.94 5.09 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.239 0.542 . . . . 0.0 111.835 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -103.41 106.39 16.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.031 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 63.9 t -92.51 132.61 36.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 120.768 0.318 . . . . 0.0 110.382 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.4 t -124.63 146.64 48.97 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.907 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.67 130.84 53.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.822 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -148.14 136.36 21.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.026 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -87.22 153.86 21.16 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.6 t -158.01 178.57 10.07 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 18.0 p -87.3 162.2 17.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.918 0.389 . . . . 0.0 111.549 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.9 -36.51 82.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.281 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -57.59 -36.94 72.39 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.893 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.2 -33.67 76.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.871 0.367 . . . . 0.0 110.939 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.5 mp -81.06 -12.45 59.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.905 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 3.2 mmt -78.49 -8.3 58.39 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -78.32 84.01 4.53 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.925 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -109.41 23.16 14.86 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.411 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -82.12 -9.0 59.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.515 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.59 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.265 -179.678 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.403 ' HG2' ' H ' ' B' ' 2' ' ' GLN . 53.3 ttm . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . 0.403 ' H ' ' HG2' ' B' ' 1' ' ' MET . 26.0 tt0 -53.58 109.8 0.49 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.981 0.419 . . . . 0.0 111.887 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.49 161.78 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.818 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 43.7 t -136.79 130.56 32.07 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 p -152.78 137.89 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.856 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 41.3 mt-10 -128.17 161.06 30.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.269 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 49.9 m -110.0 125.56 53.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 16.8 m -96.66 -58.62 2.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.447 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -174.41 129.07 0.35 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.207 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.82 -114.6 6.92 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.708 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 mp -91.14 -9.84 44.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.711 0.291 . . . . 0.0 110.783 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.34 120.68 5.64 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.736 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.05 146.98 48.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 54.7 ttp180 -110.08 139.72 44.92 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.58 -90.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . 0.402 ' OG1' HG23 ' B' ' 104' ' ' THR . 34.9 m 68.24 99.69 0.05 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.1 tp -134.15 144.02 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.881 0.372 . . . . 0.0 111.796 -175.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.4 m -127.79 129.87 47.73 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.673 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.55 ' HB ' HG12 ' B' ' 24' ' ' ILE . 16.8 mt -123.67 162.14 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -176.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.592 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.29 148.03 52.41 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.259 0.224 . . . . 0.0 110.811 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.37 -61.54 2.12 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -66.74 -32.28 73.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.798 0.332 . . . . 0.0 110.943 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 38.6 t -63.04 -41.07 99.41 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.241 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.592 HG13 ' O ' ' B' ' 20' ' ' ALA . 76.3 mt -60.1 -52.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.124 0.488 . . . . 0.0 110.935 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -69.45 -46.11 67.48 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.594 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 21.1 m -65.46 -51.2 61.79 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.57 -47.81 62.36 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.18 -43.28 98.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.075 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -60.34 -46.51 89.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.391 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 25.4 m -62.45 -42.5 99.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.647 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.45 ' O ' HG23 ' B' ' 35' ' ' VAL . 10.0 tp10 -68.87 -42.98 76.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.571 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.96 -44.43 96.77 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -69.61 -34.51 61.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.96 0.41 . . . . 0.0 110.762 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -65.08 -42.21 94.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.56 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.565 HG11 ' HD3' ' B' ' 73' ' ' ARG . 88.2 t -65.95 -41.74 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.096 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.76 -40.76 84.84 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.377 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.455 ' O ' ' HD3' ' B' ' 40' ' ' ARG . 98.6 mttt -65.37 -37.16 86.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.279 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.79 -44.3 96.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 110.593 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 19.7 t -78.94 -4.44 6.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.488 0.661 . . . . 0.0 109.969 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' B' ' 37' ' ' LYS . 25.6 mmt180 64.53 25.85 13.28 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.44 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.7 11.39 8.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -63.46 -34.53 77.97 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.184 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.33 0.98 83.15 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.6 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -93.48 -1.67 55.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.042 0.448 . . . . 0.0 110.783 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -95.09 110.59 22.51 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -62.2 -38.49 89.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.371 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . 0.481 ' H ' HE22 ' A' ' 320' ' ' GLN . . . 57.29 56.4 25.26 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 173.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -63.52 -41.66 98.5 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.0 t -100.44 110.01 58.83 Favored Pre-proline 0 C--O 1.248 0.999 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.46 ' HG2' HD12 ' B' ' 53' ' ' ILE . 48.9 Cg_exo -57.01 149.04 64.71 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.822 2.348 . . . . 0.0 112.349 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.538 ' HA ' HG12 ' B' ' 54' ' ' VAL . 21.4 ttt -61.1 -37.19 81.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.182 -173.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -69.26 -24.82 64.03 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.929 0.395 . . . . 0.0 111.112 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.46 HD12 ' HG2' ' B' ' 50' ' ' PRO . 96.8 mt -92.69 -41.5 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' B' ' 51' ' ' MET . 13.1 p -65.16 -38.74 83.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.067 0.461 . . . . 0.0 111.019 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.442 ' O ' ' HA3' ' B' ' 59' ' ' GLY . . . -67.38 -37.37 83.05 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 9.5 pt20 -74.67 -11.73 60.25 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.38 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.461 HH12 ' CD1' ' A' ' 187' ' ' LEU . 62.8 mtt-85 -109.42 -50.17 3.02 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . 0.42 ' O ' HG12 ' B' ' 62' ' ' VAL . 20.5 m-85 -112.64 1.25 15.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.082 0.468 . . . . 0.0 110.811 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -64.99 -37.25 94.04 Favored Glycine 0 C--O 1.217 -0.941 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.074 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.86 76.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.727 0.298 . . . . 0.0 111.249 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 48.5 m -62.15 -44.55 96.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.052 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' B' ' 65' ' ' ASP . 8.3 p -105.09 19.99 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.352 0.596 . . . . 0.0 111.118 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 12.7 ttm180 -63.05 -20.64 65.52 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.116 0.484 . . . . 0.0 110.182 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -64.07 -53.31 51.74 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.349 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . 0.524 ' HB2' HG22 ' B' ' 62' ' ' VAL . 20.7 m-20 -69.91 -27.39 64.74 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.847 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 62' ' ' VAL . 93.6 t -61.64 -45.09 99.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -64.01 -39.87 95.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.412 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.64 -41.31 98.85 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.162 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.04 -44.69 95.18 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.33 -42.1 98.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.005 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.8 ttp -60.16 -50.77 72.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.183 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 24.4 m -65.28 -46.02 82.11 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.788 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.565 ' HD3' HG11 ' B' ' 35' ' ' VAL . 59.0 ttm-85 -66.34 -46.61 76.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.745 -175.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -66.47 -40.11 89.17 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -60.34 -48.67 80.75 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . 0.453 ' O ' HG13 ' B' ' 79' ' ' ILE . 19.9 tt -67.45 -38.95 81.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.965 0.412 . . . . 0.0 111.259 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -66.17 -40.25 90.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.338 0.59 . . . . 0.0 109.88 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.11 85.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.828 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.453 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.7 pp -66.1 -37.2 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.37 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 -42.59 96.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.696 0.76 . . . . 0.0 109.172 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -59.95 -46.46 89.33 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.533 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -90.02 2.43 55.19 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.7 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm 65.83 41.43 3.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.69 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 87.0 mt -96.66 119.99 45.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.882 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -108.17 103.6 50.86 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -85.21 127.45 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.538 2.159 . . . . 0.0 112.328 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.46 97.94 10.51 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.069 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.64 -141.78 15.85 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.514 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.04 132.42 23.72 Favored Pre-proline 0 C--N 1.317 -0.806 0 O-C-N 122.853 -0.204 . . . . 0.0 110.695 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . 0.442 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 64.0 Cg_endo -71.78 162.02 43.32 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.826 2.351 . . . . 0.0 111.272 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 18.7 m -99.34 109.07 21.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.282 0.563 . . . . 0.0 111.17 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.442 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 87.9 m-85 -99.96 115.58 30.02 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.65 94.58 19.98 Favored Pre-proline 0 C--N 1.32 -0.717 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.931 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 90.9 Cg_endo -87.01 146.16 7.68 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.552 2.168 . . . . 0.0 110.523 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.98 172.18 39.91 Favored Glycine 0 N--CA 1.437 -1.295 0 C-N-CA 120.0 -1.095 . . . . 0.0 111.168 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.16 136.12 47.96 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -87.03 103.93 15.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.383 0.611 . . . . 0.0 111.544 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.46 111.16 18.23 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 49.3 tp -64.9 109.13 1.99 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.1 0.476 . . . . 0.0 110.408 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.06 -11.32 13.26 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.344 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.74 -177.69 3.81 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.708 0.29 . . . . 0.0 111.548 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -76.08 143.32 41.39 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.8 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -91.61 140.93 29.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.708 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.405 HG21 ' HD2' ' B' ' 14' ' ' ARG . 59.1 m -119.77 136.61 54.38 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.053 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -139.65 162.1 35.91 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.056 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 5.1 m -121.53 149.84 42.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.785 0.326 . . . . 0.0 111.227 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 10.8 p -133.97 142.72 40.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.307 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -105.58 128.17 53.46 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -149.68 -158.54 0.93 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -48.77 155.8 0.54 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.998 1.319 . . . . 0.0 113.318 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.18 160.81 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.114 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -144.98 97.08 4.9 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.741 0.305 . . . . 0.0 110.783 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.62 145.98 33.76 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.849 2.366 . . . . 0.0 112.801 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -164.48 123.55 1.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.5 164.86 31.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.827 0.346 . . . . 0.0 111.583 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -121.44 135.69 55.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.937 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.26 136.01 53.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -130.48 138.82 50.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.658 0.266 . . . . 0.0 111.107 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.15 19.3 61.13 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.912 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.05 -41.15 99.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.118 0.459 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.54 -5.33 32.46 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.483 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.03 13.86 27.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.903 0.382 . . . . 0.0 111.097 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 81.7 mt -102.17 128.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.152 0.501 . . . . 0.0 110.613 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -109.79 128.92 55.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.927 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 62.5 t -117.86 133.28 65.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.988 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -90.94 128.21 36.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.937 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.81 94.0 32.84 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.35 141.06 60.59 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.412 2.075 . . . . 0.0 112.503 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.7 mm -108.33 118.58 56.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.236 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.01 158.53 43.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.359 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -141.35 159.82 41.43 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.179 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -79.74 129.17 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.611 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.9 p -105.07 176.18 5.25 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.689 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -62.0 -38.09 87.3 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.35 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.95 -37.38 84.52 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.874 0.369 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -63.81 -39.03 93.26 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 89.3 t -63.65 -44.72 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.234 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.62 -42.41 92.6 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.247 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.53 98.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.959 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.525 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 4.6 tpt -63.11 -45.27 92.78 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.858 0.361 . . . . 0.0 110.231 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.86 -41.59 97.75 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.036 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.98 -45.46 92.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.664 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 26.5 m -61.97 -41.16 97.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.952 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.1 mt -61.21 -41.42 96.81 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.459 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -68.83 -22.5 64.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.058 0.456 . . . . 0.0 110.741 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -85.46 2.48 44.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.228 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -119.31 31.44 6.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.394 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -139.16 89.61 2.36 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.22 155.77 49.56 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . 0.499 HG22 ' H ' ' B' ' 151' ' ' TRP . 1.2 m -124.04 172.14 9.22 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.676 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . 0.499 ' H ' HG22 ' B' ' 150' ' ' THR . 8.6 p-90 -53.18 137.11 34.95 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -172.71 119.45 0.37 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.88 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' B' ' 154' ' ' LYS . 7.5 pt-20 -77.5 89.72 3.86 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.44 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' B' ' 153' ' ' GLU . 63.5 mmtt -158.44 -72.08 0.09 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.921 0.888 . . . . 0.0 110.736 177.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -169.52 -70.91 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.318 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' B' ' 243' ' ' ARG . . . 66.45 -128.93 30.72 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.798 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -145.53 -165.76 2.27 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' B' ' 203' ' ' LYS . 50.5 t -117.43 124.73 73.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' B' ' 162' ' ' ASP . 62.0 mm-40 -87.9 174.44 8.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.068 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.3 -52.79 23.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.198 0.523 . . . . 0.0 109.821 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . 0.435 ' CD ' ' HE ' ' B' ' 255' ' ' ARG . 6.8 pt-20 -92.91 32.66 1.24 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.46 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.61 ' OD2' ' HD3' ' B' ' 243' ' ' ARG . 9.2 t70 -57.36 -48.85 77.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.378 -174.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 21.8 ttp85 66.0 88.47 0.11 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.791 0.805 . . . . 0.0 109.24 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.554 HG22 ' OD1' ' B' ' 162' ' ' ASP . 3.0 t -111.49 133.0 58.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.005 -174.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.9 m -80.29 104.51 10.89 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 79.7 mt -116.83 131.0 70.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -97.86 106.21 18.48 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -128.56 146.6 50.79 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.441 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 36.1 m -129.84 131.46 46.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.208 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.38 110.75 3.23 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.562 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 14.6 m -130.67 122.37 27.24 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.47 -76.09 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -110.65 -71.91 0.74 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.817 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -134.37 16.02 4.4 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.067 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -135.17 147.59 49.45 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.916 0.389 . . . . 0.0 110.402 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -91.29 150.58 21.25 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.688 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -112.48 179.15 4.07 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.83 -42.12 88.5 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.1 -175.45 39.31 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.032 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 73.72 36.51 53.25 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.861 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -114.43 102.17 9.83 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.68 154.27 38.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.032 0.444 . . . . 0.0 111.744 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -142.56 133.4 25.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 56.27 35.22 25.42 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.377 0.423 . . . . 0.0 110.845 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . 0.41 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 42.4 t80 -88.22 134.52 33.77 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.085 -175.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 15.7 m -90.58 120.97 40.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.634 0.731 . . . . 0.0 112.01 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . 0.501 ' CD1' HH12 ' A' ' 57' ' ' ARG . 29.0 tp -114.32 121.28 43.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.502 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . 0.598 ' O ' ' HG3' ' B' ' 193' ' ' ARG . . . -101.64 132.18 47.46 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 172.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 57.5 mtm -109.91 165.78 11.45 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.084 -173.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.13 0.33 65.83 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.967 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . 0.436 ' HB2' ' HG2' ' B' ' 193' ' ' ARG . 97.7 mt-30 -112.94 -8.38 13.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.43 36.35 17.36 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.677 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' B' ' 188' ' ' ALA . 39.7 mmm-85 -74.49 -25.41 59.36 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.379 0.672 . . . . 0.0 110.138 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . 0.439 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.1 OUTLIER -124.75 -171.27 2.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.522 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.444 ' H ' HD12 ' B' ' 195' ' ' ILE . 3.7 mp -68.54 136.92 90.69 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.67 132.86 47.88 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.164 1.909 . . . . 0.0 112.054 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.35 -39.79 2.69 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.05 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -62.39 -45.54 92.69 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.0 8.93 11.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -113.21 -33.67 5.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.179 0.514 . . . . 0.0 109.765 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.94 -19.26 73.44 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.396 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 98.6 mt -64.95 -33.54 64.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.262 0.554 . . . . 0.0 110.225 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.404 ' HA ' ' HB ' ' B' ' 158' ' ' VAL . 44.6 mtpt -60.03 135.27 57.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.143 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.58 3.61 58.39 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.451 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.471 ' HD2' ' OE2' ' B' ' 209' ' ' GLU . 39.1 m80 -111.62 147.85 34.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 117.013 0.407 . . . . 0.0 110.934 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -85.01 163.63 18.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.073 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.62 137.0 51.91 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.29 20.55 77.03 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.968 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . 0.471 ' OE2' ' HD2' ' B' ' 205' ' ' HIS . 42.6 tt0 -101.37 121.81 42.59 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.23 0.538 . . . . 0.0 110.946 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' B' ' 236' ' ' ASN . 33.4 mt-10 -101.92 113.58 26.91 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -133.44 -27.62 1.54 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 30.8 m 74.56 130.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 120.9 0.381 . . . . 0.0 110.455 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.79 -40.53 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 70.38 97.93 0.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.199 0.523 . . . . 0.0 111.842 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 62.6 t -116.07 128.21 73.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 19.4 m -68.69 -40.78 79.88 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -176.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.542 ' HB2' ' O ' ' B' ' 216' ' ' THR . 32.6 m-85 77.8 134.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 123.025 0.53 . . . . 0.0 110.699 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.46 156.1 50.21 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.606 2.204 . . . . 0.0 112.584 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -65.44 -34.93 79.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.525 0.678 . . . . 0.0 110.008 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -87.14 30.12 0.79 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.616 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -74.65 140.98 44.63 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -61.65 -29.13 69.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.05 121.9 33.25 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.971 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.582 ' HA ' ' CD ' ' B' ' 227' ' ' LYS . 1.4 tp10 -62.93 -33.66 75.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.562 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.476 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 30.8 p-10 -84.22 -5.9 59.32 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.61 -12.94 9.68 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.582 ' CD ' ' HA ' ' B' ' 224' ' ' GLU . 18.1 ptmt -69.19 118.72 12.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.275 0.559 . . . . 0.0 111.205 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.4 18.17 78.29 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.926 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 99.2 mttt -122.59 124.19 42.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.077 0.438 . . . . 0.0 110.698 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.5 140.57 44.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.298 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -126.86 134.45 50.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.915 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -73.2 -48.9 31.27 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -173.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' B' ' 212' ' ' THR . 61.6 m-85 55.03 98.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.657 0.383 . . . . 0.0 112.012 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.6 90.94 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 91.2 mt 67.71 98.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.167 0.587 . . . . 0.0 111.85 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . 0.469 ' HA ' ' HG2' ' B' ' 210' ' ' GLU . 28.6 t-20 -86.26 -51.0 6.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 33.4 tp 53.07 90.55 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.052 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 27.3 mttp -74.79 -78.37 0.1 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . 0.457 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 52.2 mtmt -75.46 -81.03 0.08 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.381 1.622 . . . . 0.0 115.381 -170.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.632 HG12 ' H ' ' B' ' 242' ' ' GLU . 67.7 t 75.22 139.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -174.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' B' ' 242' ' ' GLU . 86.3 mt-10 -68.73 -27.82 66.27 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.082 -0.386 . . . . 0.0 111.312 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' B' ' 241' ' ' GLU . 2.7 pt-20 64.51 132.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.552 1.541 . . . . 0.0 113.933 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.61 ' HD3' ' OD2' ' B' ' 162' ' ' ASP . 0.0 OUTLIER -154.35 144.1 21.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.358 178.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -159.54 153.89 23.87 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 tt 72.18 123.75 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.068 0.547 . . . . 0.0 111.352 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -84.21 115.91 2.01 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.546 2.164 . . . . 0.0 113.484 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -135.67 167.47 21.06 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.35 110.57 21.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 10.7 p -103.56 -83.55 0.48 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.92 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . 0.404 ' O ' HG22 ' B' ' 253' ' ' ILE . . . -177.69 -53.62 0.01 OUTLIER 'General case' 0 C--N 1.343 0.319 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.65 -47.14 86.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -61.6 -26.98 68.32 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -173.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 253' ' ' ILE . . . . . 0.404 HG22 ' O ' ' B' ' 250' ' ' ALA . 18.9 tt -91.13 -5.89 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -127.91 6.88 6.08 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.032 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 255' ' ' ARG . . . . . 0.435 ' HE ' ' CD ' ' B' ' 161' ' ' GLU . 60.0 ttp180 -131.24 134.82 46.81 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.538 0.209 . . . . 0.0 110.545 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -172.87 34.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.92 -32.28 7.7 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 42.0 t -80.65 150.84 4.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.38 -51.87 65.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.375 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -175.43 163.81 3.05 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.257 173.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -172.77 177.53 45.25 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.377 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.9 p -82.12 175.8 10.03 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.33 0.252 . . . . 0.0 111.096 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.24 -49.13 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.396 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.41 -32.22 21.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.588 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.12 -43.01 99.73 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.984 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 270' ' ' VAL . 63.5 tp -62.86 -43.79 97.87 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.622 0.249 . . . . 0.0 110.445 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -64.25 -41.96 96.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.882 0.372 . . . . 0.0 110.367 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -66.62 -44.95 80.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.309 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 37.2 tp10 -66.3 -39.39 89.3 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.094 0.473 . . . . 0.0 110.57 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 266' ' ' LEU . 70.7 t -65.01 -42.85 95.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.089 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -59.71 -46.54 88.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.8 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 18.3 ptmt -66.09 -42.5 89.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.843 0.354 . . . . 0.0 111.007 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -66.0 -37.16 85.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.016 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.2 mmm -63.97 -43.24 96.36 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 110.496 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -70.98 -29.52 65.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.112 0.482 . . . . 0.0 110.08 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -61.86 -43.69 98.34 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -65.1 -32.33 73.97 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.823 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 57.5 tp -60.96 -39.48 89.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.017 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -58.19 -47.79 82.33 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 177.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 17.3 m -62.59 -44.04 97.3 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.866 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.26 69.21 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.795 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.22 -45.72 92.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.607 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . 0.519 HH12 ' HG3' ' B' ' 409' ' ' GLU . 8.1 tpt180 -61.7 -45.64 93.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.898 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -64.87 -39.94 94.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.46 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -59.04 -44.42 91.76 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.046 0.45 . . . . 0.0 110.382 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.13 -42.81 79.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.537 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . 0.435 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.8 tttt -59.67 -48.13 82.88 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.081 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.7 p -62.23 -41.91 98.83 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.769 0.319 . . . . 0.0 111.542 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -65.06 -41.88 94.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.813 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' B' ' 294' ' ' LEU . . . -65.61 -42.57 91.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.998 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . 0.435 HG12 ' O ' ' B' ' 287' ' ' LYS . 32.2 mm -63.8 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.573 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . 0.416 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 27.8 tp10 -59.8 -43.78 94.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.235 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.8 -40.33 97.27 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.276 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' B' ' 290' ' ' ALA . 95.5 mt -62.85 -42.63 99.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.682 0.277 . . . . 0.0 110.926 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 291' ' ' ILE . 91.4 t -65.61 -43.59 93.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.049 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . 0.416 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 68.4 mttm -63.49 -41.94 98.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.127 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.62 -41.89 78.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.055 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -126.92 94.66 4.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -93.73 106.52 18.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . 0.437 HG13 ' N ' ' B' ' 301' ' ' ASP . 11.4 tp -122.07 166.18 17.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.005 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . 0.437 ' N ' HG13 ' B' ' 300' ' ' ILE . 33.0 m-20 -61.3 135.51 57.74 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.578 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.09 122.06 30.78 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.745 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.36 131.21 43.38 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.64 2.227 . . . . 0.0 111.939 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.05 -36.43 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.975 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.02 -43.11 91.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.298 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.06 -40.54 90.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.903 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . 0.418 ' O ' HG13 ' B' ' 311' ' ' ILE . 97.0 mt -62.75 -45.99 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.754 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.17 -41.53 98.41 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.19 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 46.8 m -62.46 -45.49 92.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.316 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . 0.555 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 62.9 mm-40 -68.25 -37.99 81.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.536 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.0 mt -62.13 -43.68 98.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.625 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.578 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 17.2 t70 -60.46 -47.14 87.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.792 0.33 . . . . 0.0 111.012 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.46 -44.33 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.536 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 84.7 mt -62.76 -40.38 97.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.578 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 85.2 mtm180 -62.18 -42.4 99.24 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 32.5 mtt85 -64.91 -38.47 91.07 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -63.1 -45.16 93.35 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.074 0.464 . . . . 0.0 109.87 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.27 -36.32 79.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.745 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -61.89 -36.18 80.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.123 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . 0.519 HE22 ' H ' ' A' ' 47' ' ' GLY . 47.3 tt0 -63.13 -39.43 94.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.424 0.63 . . . . 0.0 109.506 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -76.25 -9.91 59.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.41 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -91.21 -7.79 50.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.817 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 137.14 -12.12 3.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.809 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 112.53 42.18 0.98 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.005 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . 0.546 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 33.5 t-20 -85.27 127.04 34.17 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.876 0.369 . . . . 0.0 110.356 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . 0.47 ' OE1' ' HG3' ' B' ' 327' ' ' LYS . 2.0 tm-20 -130.2 144.49 51.39 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.47 ' HG3' ' OE1' ' B' ' 326' ' ' GLU . 35.5 mtmm 71.33 -47.92 0.66 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.627 0.771 . . . . 0.0 112.215 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . 0.546 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 14.2 mm100 -65.9 -13.06 58.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.083 0.468 . . . . 0.0 110.707 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.38 -21.81 60.44 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.643 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.42 HD12 HH12 ' B' ' 315' ' ' ARG . 57.4 tp -61.84 -33.43 74.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.638 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -79.5 -10.04 59.73 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.591 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 75.5 mt -65.14 147.41 98.57 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.61 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.23 141.18 97.58 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.574 2.183 . . . . 0.0 112.884 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . 0.472 ' HG3' HD13 ' B' ' 311' ' ' ILE . 27.2 ttt85 -85.27 -36.33 20.96 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.511 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -56.74 -46.39 81.39 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . 0.523 HD12 ' CD ' ' B' ' 224' ' ' GLU . 73.3 mt -91.86 12.08 22.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -117.96 -28.56 5.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.131 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -66.49 -31.7 72.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.714 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.61 -49.53 77.16 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.03 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -75.94 -22.47 55.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.702 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.435 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.42 -41.96 98.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . 0.51 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.3 tttt -60.72 -44.56 96.46 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . 0.574 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.1 mmt85 -59.93 -46.18 90.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.983 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.29 -39.29 85.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.255 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 341' ' ' ALA . 87.8 t -64.78 -43.31 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.436 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.51 HG23 ' O ' ' B' ' 342' ' ' LYS . 73.8 t -60.33 -43.12 93.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.404 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 343' ' ' ARG . 91.1 t -60.02 -45.68 95.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.34 -42.78 99.7 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.204 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.7 -44.27 94.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.43 -45.21 92.0 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.695 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.461 ' O ' HG13 ' B' ' 355' ' ' ILE . 94.4 mt -66.66 -39.62 88.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.915 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.21 -42.53 97.25 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.628 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -64.3 -39.79 94.62 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.978 0.389 . . . . 0.0 110.559 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.3 -46.36 96.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.042 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . 0.461 HG13 ' O ' ' B' ' 351' ' ' LEU . 71.0 mt -63.6 -46.29 95.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.399 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -64.6 -64.73 0.8 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 38.5 m -65.96 -43.24 88.5 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.76 -11.42 60.16 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.168 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 62.38 64.86 0.91 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.718 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.9 mt -98.02 136.97 37.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.203 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.09 150.22 45.29 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.195 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.92 120.02 13.53 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . 0.496 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.5 t70 -90.17 108.34 19.68 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.939 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 66.2 mm-40 -61.68 -34.65 76.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.67 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -66.03 -41.58 90.73 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.49 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . 0.416 HH12 ' CD ' ' B' ' 409' ' ' GLU . 45.9 ttt180 -62.47 -40.79 97.79 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.001 0.429 . . . . 0.0 110.137 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . 0.496 HG23 ' O ' ' B' ' 363' ' ' ASP . 88.4 t -61.28 -39.71 83.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.236 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.2 mmmt -56.64 -44.07 80.9 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.511 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.21 -40.2 98.81 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.2 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.33 -42.88 98.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 110.239 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.64 -43.68 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.797 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -64.04 -41.96 97.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.76 -41.73 91.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.053 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 48.6 ttp -65.43 -39.7 92.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.028 0.442 . . . . 0.0 110.511 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -63.28 -24.67 67.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.596 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 44.9 m -73.47 -6.34 45.78 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.45 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.02 -2.09 58.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.532 0.682 . . . . 0.0 110.284 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -113.08 172.78 6.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.976 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -65.7 -47.69 74.54 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -121.76 116.24 30.44 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.803 0.335 . . . . 0.0 110.999 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . 0.461 ' O ' HG13 ' B' ' 385' ' ' ILE . 46.5 Cg_exo -58.21 -36.49 97.74 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.909 2.406 . . . . 0.0 113.116 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -64.72 -43.42 93.48 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -174.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.81 -36.81 84.4 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.933 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.44 -42.96 94.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.302 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . 0.461 HG13 ' O ' ' B' ' 381' ' ' PRO . 65.7 mt -62.23 -44.83 99.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.335 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -64.93 -37.87 89.07 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.765 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -58.75 -47.06 85.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.443 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . 0.44 ' O ' ' HG3' ' B' ' 395' ' ' MET . 2.8 m-85 -69.67 -44.78 69.81 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 18.9 p -68.88 -16.26 63.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.19 4.6 48.94 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.746 0.307 . . . . 0.0 111.19 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -129.57 112.04 13.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 110.532 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -64.72 -37.5 87.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.263 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -57.23 -53.38 58.74 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.021 0.439 . . . . 0.0 110.558 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.47 -40.5 95.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.737 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' B' ' 388' ' ' TYR . 89.1 mtp -61.62 -46.18 90.92 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.89 -44.18 64.17 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.415 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -64.13 -42.13 96.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.374 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 52.3 tpp -63.1 -41.17 99.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.838 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' B' ' 395' ' ' MET . 83.0 mtm180 -65.76 -34.8 79.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.917 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.44 -42.33 99.38 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 90.4 t -66.22 -43.77 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.622 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.44 94.99 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.544 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.25 -37.14 86.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.48 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -58.29 -47.21 84.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.855 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.09 -38.14 89.98 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.564 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -61.71 -42.25 98.69 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.209 0.318 . . . . 0.0 110.672 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.53 97.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.047 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.39 -43.14 91.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.572 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . 0.519 ' HG3' HH12 ' B' ' 283' ' ' ARG . 96.6 mt-10 -63.95 -35.84 82.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.17 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.57 94.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.474 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.0 -43.06 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.474 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.21 -39.42 92.72 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.531 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.76 67.55 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.987 0.422 . . . . 0.0 111.311 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -98.08 -7.62 29.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.697 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.37 169.58 9.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.316 0.579 . . . . 0.0 112.261 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -90.78 99.41 12.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.808 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 68.4 t -86.75 131.68 34.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.697 0.284 . . . . 0.0 110.751 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.9 t -124.28 155.3 38.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.941 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -113.41 130.71 56.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.844 0.354 . . . . 0.0 110.749 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -147.48 141.25 25.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.201 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.2 150.9 19.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.335 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.1 t -158.0 174.96 14.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.361 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 17.4 p -85.63 163.67 18.16 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 111.81 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -65.01 -36.42 84.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.449 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -57.38 -38.33 74.08 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.84 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.68 -32.8 74.56 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.858 0.361 . . . . 0.0 111.166 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.25 -12.7 59.04 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.8 mmt -78.28 -8.48 58.43 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.13 0.491 . . . . 0.0 110.785 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -75.71 79.84 2.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.193 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -108.13 26.56 10.26 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.556 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -85.06 -11.79 54.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.853 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.677 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.025 -179.537 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ptp . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 120.534 0.207 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.2 tm0? -95.24 105.45 17.4 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.61 159.81 34.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.322 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.3 m -124.1 116.87 23.48 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.661 0.267 . . . . 0.0 110.881 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -134.93 135.87 52.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 47.8 mt-10 -111.7 175.86 5.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.102 0.477 . . . . 0.0 111.727 -178.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 t -124.27 141.46 52.05 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.674 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.0 m -99.71 -75.91 0.56 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.917 0.389 . . . . 0.0 111.197 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -162.21 148.23 13.14 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.52 -123.02 29.75 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.037 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.547 HD11 HG12 ' A' ' 111' ' ' VAL . 1.2 mm? -100.27 4.54 44.25 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 120.974 0.416 . . . . 0.0 110.072 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -75.26 139.82 25.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.596 -0.729 . . . . 0.0 113.085 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -133.93 151.67 51.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.048 0.539 . . . . 0.0 109.895 -178.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -120.32 130.15 54.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t -104.51 -89.95 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.276 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.5 p 40.17 81.27 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.7 tp -107.85 134.5 49.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.219 0.533 . . . . 0.0 111.897 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.0 p -94.37 126.51 39.67 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.771 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.494 HG13 HG12 ' A' ' 24' ' ' ILE . 14.2 pt -126.69 161.21 33.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.356 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -70.67 155.07 41.21 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.379 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.5 -39.39 83.66 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.952 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.61 -25.66 65.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.3 t -80.64 -42.2 22.54 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.428 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 20' ' ' ALA . 75.0 mt -59.16 -69.85 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.321 -176.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.508 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 77.1 mm-40 -67.37 -6.95 21.27 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.5 m -95.64 -64.19 1.08 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.988 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.21 66.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.5 t -65.01 -43.87 96.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.354 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 22.3 ttmm -61.78 -47.2 86.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.602 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.6 m -68.85 -36.59 78.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.811 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -60.93 -39.05 87.97 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.113 0.483 . . . . 0.0 110.652 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.56 -38.44 90.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.819 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.22 -44.02 99.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.171 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.76 -43.64 98.28 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.136 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.38 -35.68 74.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.24 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.24 94.9 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.068 0.461 . . . . 0.0 110.285 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.34 -34.09 77.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.013 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -61.09 -35.92 78.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.955 0.407 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 t -90.61 -5.85 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.412 0.625 . . . . 0.0 109.77 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 64.96 27.5 12.68 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.329 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.402 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.7 pp -103.67 7.98 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.069 0.461 . . . . 0.0 111.457 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.62 -34.81 79.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.514 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.02 -4.54 86.15 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.816 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -89.17 -8.2 54.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.792 0.329 . . . . 0.0 111.463 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -92.38 95.79 9.88 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.82 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -78.29 109.35 12.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.57 96.77 1.62 Allowed Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 115.734 1.054 . . . . 0.0 115.734 -169.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -66.52 -43.24 85.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.457 HG12 ' HB ' ' A' ' 54' ' ' VAL . 11.6 t -104.79 115.12 63.11 Favored Pre-proline 0 N--CA 1.44 -0.929 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.265 176.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.12 139.95 86.25 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.188 1.926 . . . . 0.0 111.124 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.586 ' HA ' HG12 ' A' ' 54' ' ' VAL . 22.7 ttt -61.39 -40.08 93.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.507 -173.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -60.81 -47.77 84.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.047 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.497 HD13 HH22 ' B' ' 193' ' ' ARG . 74.9 mt -69.42 -44.97 79.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 51' ' ' MET . 14.6 p -64.11 -44.35 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.7 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.416 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -66.73 -24.06 66.18 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.381 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -85.61 -36.92 20.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.127 0.489 . . . . 0.0 110.3 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -76.54 -49.27 16.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.499 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -105.21 9.58 34.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.883 0.373 . . . . 0.0 110.483 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.628 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -59.18 -47.51 90.46 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.9 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.0 -25.49 65.43 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -61.84 -44.99 95.73 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.813 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 65' ' ' ASP . 10.7 p -126.98 24.89 2.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.564 0.697 . . . . 0.0 110.703 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.628 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 21.1 ttm180 -58.8 -33.19 70.07 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.506 -177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -60.49 -50.02 75.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.535 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.521 ' HB2' HG22 ' A' ' 62' ' ' VAL . 1.7 m-20 -75.24 -21.61 58.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.04 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 62' ' ' VAL . 66.7 t -63.58 -43.77 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 173.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.62 -39.01 92.43 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.107 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.97 -42.61 99.81 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.238 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.71 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 32.0 t70 -63.01 -43.91 97.43 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.197 0.498 . . . . 0.0 110.006 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.7 -41.3 97.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.299 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 49.5 ttp -60.69 -43.22 98.01 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -62.55 -44.05 97.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.284 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.71 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 32.7 mtp85 -66.08 -41.5 90.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.932 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -66.07 -41.09 91.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.388 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -60.4 -48.08 83.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.678 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.0 tt -67.41 -39.7 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.201 0.524 . . . . 0.0 111.347 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.11 -40.85 91.03 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.388 0.613 . . . . 0.0 110.185 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.94 -43.68 87.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.633 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.3 pt -64.21 -39.27 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.913 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.97 -44.09 99.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 120.638 0.256 . . . . 0.0 111.275 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.89 -29.32 60.96 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -86.54 -2.57 58.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.946 0.403 . . . . 0.0 110.803 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 66.22 34.55 6.54 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.242 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.1 mt -96.06 113.43 30.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -110.48 100.84 46.65 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.908 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.14 136.34 9.01 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.076 1.85 . . . . 0.0 111.347 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.93 132.98 36.57 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.62 -125.09 7.4 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.055 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.22 130.07 18.13 Favored Pre-proline 0 C--N 1.313 -1.018 0 O-C-N 122.834 -0.215 . . . . 0.0 110.455 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.88 150.07 60.77 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.132 1.888 . . . . 0.0 110.828 177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.3 m -94.96 116.81 29.16 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.108 0.48 . . . . 0.0 110.021 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.564 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 95.9 m-85 -91.82 114.24 26.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.94 99.56 23.27 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.138 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 58.5 Cg_endo -95.52 161.8 1.52 Allowed 'Trans proline' 0 N--CA 1.437 -1.826 0 C-N-CA 123.461 2.774 . . . . 0.0 111.65 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.82 -174.86 33.61 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.176 -1.011 . . . . 0.0 110.874 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.72 133.47 38.31 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -89.24 125.4 35.07 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.938 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -102.48 131.31 49.25 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.4 tp -81.48 102.42 10.55 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.14 -27.54 5.32 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.243 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -103.0 177.02 4.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.677 0.275 . . . . 0.0 110.707 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -81.61 168.17 18.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -125.28 139.99 53.22 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.095 0.474 . . . . 0.0 111.313 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.0 m -120.01 134.4 55.26 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.158 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -140.51 167.16 22.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.572 0.225 . . . . 0.0 111.582 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -87.05 -91.01 0.11 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.406 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 67.2 t 64.92 100.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.358 0.599 . . . . 0.0 110.564 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -99.65 146.09 26.87 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.588 -175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.409 ' H ' ' HB3' ' A' ' 11' ' ' LEU . 10.6 p90 -159.39 -87.39 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -90.12 156.64 18.21 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.547 HG12 HD11 ' A' ' 11' ' ' LEU . 28.8 m -125.82 161.56 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.846 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -166.14 102.44 0.7 Allowed Pre-proline 0 N--CA 1.479 0.99 0 CA-C-O 120.577 0.227 . . . . 0.0 111.272 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -94.39 158.49 2.02 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 C-N-CA 123.39 2.727 . . . . 0.0 114.373 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -143.29 139.64 30.24 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.735 0.814 . . . . 0.0 109.888 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 116' ' ' GLU . 20.6 t -133.9 160.89 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 120.897 0.379 . . . . 0.0 111.78 -176.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 115' ' ' VAL . 43.5 mt-10 -140.66 153.03 45.84 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.842 0.857 . . . . 0.0 109.209 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.8 mt -112.47 130.58 55.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -141.85 154.4 45.13 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.133 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.54 22.91 74.46 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.903 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.49 -39.94 95.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.916 0.389 . . . . 0.0 111.199 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -70.24 -10.78 59.92 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.87 1.48 55.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.147 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.57 109.01 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.124 0.488 . . . . 0.0 109.957 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -104.37 119.64 39.41 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.062 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.83 127.07 59.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.883 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.7 119.04 32.19 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.571 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.556 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 78.6 tttt -111.62 106.29 56.77 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -74.43 128.61 12.1 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.962 1.775 . . . . 0.0 111.639 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.38 114.67 39.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.17 161.58 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -150.73 166.19 31.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.553 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -94.3 127.44 46.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.722 0.296 . . . . 0.0 110.25 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.0 p -108.15 176.41 5.14 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.394 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.86 -38.94 87.3 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.019 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.67 80.2 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.7 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -64.94 -43.38 92.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.327 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.49 -47.24 92.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.955 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.04 -42.61 99.36 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.003 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.26 -42.58 99.26 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.611 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.534 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -61.83 -44.92 95.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.695 0.284 . . . . 0.0 110.59 178.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.43 -42.44 98.69 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.272 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.87 -43.84 98.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.82 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.9 m -63.0 -41.2 99.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.553 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.6 mt -60.82 -42.23 97.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.448 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -66.14 -37.21 85.13 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.05 0.453 . . . . 0.0 110.518 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -68.46 -13.92 62.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.162 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -89.62 -6.92 55.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.432 0.634 . . . . 0.0 110.151 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -89.59 93.47 9.5 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.726 0.774 . . . . 0.0 111.952 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.81 126.17 10.07 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.421 ' OG1' ' HG2' ' A' ' 247' ' ' GLU . 23.6 p -100.43 -163.76 1.05 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -173.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.505 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 4.4 p-90 -70.17 119.68 14.72 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 151' ' ' TRP . 26.5 mttp -174.52 168.34 3.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.691 1.197 . . . . 0.0 109.132 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -114.92 164.21 14.46 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -172.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 153' ' ' GLU . 9.9 pttp 71.28 -179.42 0.23 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.861 1.665 . . . . 0.0 113.807 175.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 13.0 t70 72.92 -90.32 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 124.966 1.306 . . . . 0.0 111.055 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 142.76 102.48 0.44 Allowed Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.954 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -132.75 64.51 1.61 Allowed 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.58 127.05 28.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.122 -176.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.666 ' HB3' ' HB2' ' A' ' 162' ' ' ASP . 9.2 tp10 -95.63 154.11 17.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.75 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.89 13.8 6.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 189' ' ' MET . 37.8 tt0 -155.47 26.08 0.4 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.585 0.707 . . . . 0.0 110.511 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.666 ' HB2' ' HB3' ' A' ' 159' ' ' GLU . 2.9 t70 -109.39 -170.2 1.61 Allowed 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.781 -0.575 . . . . 0.0 111.036 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -103.55 118.71 37.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.4 t -114.72 121.66 67.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.002 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.4 m -83.4 109.66 17.5 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.9 mt -115.08 128.46 72.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.106 0.479 . . . . 0.0 112.141 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.484 ' OD2' ' HB3' ' A' ' 236' ' ' ASN . 5.0 p-10 -103.03 113.33 26.72 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 172.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -142.46 162.57 35.13 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.228 0.537 . . . . 0.0 112.216 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.1 m -133.6 134.09 42.84 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.219 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.31 103.56 1.84 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.209 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 29.0 m -128.1 121.31 29.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 46.1 t -94.13 -87.13 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.833 0.349 . . . . 0.0 111.147 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -94.38 42.08 1.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.207 0.527 . . . . 0.0 109.822 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 81.33 12.45 82.09 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -123.99 139.28 54.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -92.09 137.42 32.38 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.372 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -107.26 -176.88 3.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.655 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.38 -39.74 88.38 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.402 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.21 -175.52 39.15 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.964 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 84.63 16.68 65.47 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.138 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -105.74 97.87 7.64 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.02 145.8 32.44 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.844 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 38.3 m -136.1 145.29 45.75 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.803 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 54.41 31.15 14.03 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.801 0.688 . . . . 0.0 110.543 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -85.98 127.31 34.61 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.3 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.5 115.03 39.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.49 0.662 . . . . 0.0 110.336 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 56.7 tp -103.33 126.22 50.37 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.98 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -90.65 111.88 23.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.56 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.2 mtp -81.24 150.68 28.48 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.95 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.38 -14.62 64.25 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.595 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -95.13 0.49 54.28 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.802 0.334 . . . . 0.0 111.207 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.97 55.98 6.8 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.421 HH22 HD13 ' B' ' 53' ' ' ILE . 19.3 mmt85 -100.01 -5.96 27.26 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.197 0.522 . . . . 0.0 110.55 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.5 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -135.5 178.13 7.28 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.076 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.7 mm -68.38 133.87 91.12 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.37 134.55 45.31 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.095 1.864 . . . . 0.0 111.499 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.77 -42.87 1.79 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.958 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -67.45 -52.92 33.62 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -74.2 -17.21 60.93 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.847 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.51 -30.0 22.29 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.891 0.377 . . . . 0.0 110.512 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.7 -19.05 76.31 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.008 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.4 mt -62.39 -38.07 80.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-O 120.883 0.373 . . . . 0.0 110.407 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -51.51 131.26 29.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.7 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.42 -10.66 63.23 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.353 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -95.26 159.23 15.11 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -103.21 156.41 17.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.104 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.57 134.69 51.69 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.941 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 78.86 34.56 33.91 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.637 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -124.68 130.17 51.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.879 0.371 . . . . 0.0 111.06 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' A' ' 236' ' ' ASN . 79.0 mt-10 -102.42 118.17 36.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.529 ' O ' ' HB ' ' A' ' 212' ' ' THR . 44.3 t80 -135.24 -36.84 0.79 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 99.6 m 77.65 143.94 0.08 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.339 0.256 . . . . 0.0 110.423 -176.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.2 tp -130.11 144.61 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.934 0.397 . . . . 0.0 110.909 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.79 104.68 16.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.092 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 65.7 t -119.31 128.5 75.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.5 m -98.42 -16.84 19.1 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -175.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 66.62 154.43 0.13 Allowed Pre-proline 0 N--CA 1.487 1.381 0 CA-C-O 121.117 0.484 . . . . 0.0 111.615 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.33 150.87 53.43 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.154 1.903 . . . . 0.0 111.532 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -65.82 -38.44 88.92 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.18 77.1 7.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.602 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -120.06 140.61 50.76 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -61.06 -29.86 69.98 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.76 108.1 20.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.2 tt0 -63.42 -33.59 75.88 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.427 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 30.8 p-10 -63.97 -25.16 68.01 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.737 0.303 . . . . 0.0 110.995 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 90.4 mt -109.8 -3.39 16.72 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.6 ptmt -67.85 119.12 12.02 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.951 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.8 21.91 71.56 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.94 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 225' ' ' ASN . 35.0 mmtp -100.93 135.52 42.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -86.26 110.38 19.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.004 0.43 . . . . 0.0 110.85 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -99.36 149.54 23.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.082 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -105.21 -47.17 4.04 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -175.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 58.59 104.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 121.02 0.438 . . . . 0.0 111.041 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.55 -49.2 77.15 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.0 mm 62.8 93.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 123.493 0.496 . . . . 0.0 110.842 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.484 ' HB3' ' OD2' ' A' ' 167' ' ' ASP . 9.6 t-20 -82.99 -47.29 11.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.55 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 12.6 tp 57.46 86.8 0.07 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.151 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.25 -58.06 2.67 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -101.49 -78.97 0.52 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 24.9 t 70.43 142.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 123.482 0.489 . . . . 0.0 110.512 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -75.1 -46.79 32.26 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.277 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 64.75 163.24 0.14 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -162.0 94.18 0.91 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 10.1 tp10 -123.37 157.14 33.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.379 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.1 tt 72.72 118.5 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.456 0.703 . . . . 0.0 110.932 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -87.03 115.74 1.2 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.879 2.386 . . . . 0.0 113.82 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.421 ' HG2' ' OG1' ' A' ' 150' ' ' THR . 12.5 pt-20 -130.28 -161.54 1.13 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 8.0 mp -87.02 102.91 14.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.299 0.571 . . . . 0.0 111.892 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 251' ' ' GLU . 37.9 m -134.39 132.43 39.41 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -90.15 7.28 38.75 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.494 ' H ' HG22 ' A' ' 249' ' ' THR . 45.9 mt-10 -88.15 -15.22 36.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -73.3 -7.31 51.01 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 119.263 -0.975 . . . . 0.0 112.293 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 261' ' ' GLY . 41.8 pt -105.13 -4.3 9.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.629 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -136.96 11.52 3.1 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -129.92 8.25 5.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.062 0.458 . . . . 0.0 109.939 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -124.43 137.0 54.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.742 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 67.79 -129.9 27.65 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 116.13 -0.486 . . . . 0.0 114.041 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.4 t -116.98 131.69 68.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 122.693 0.397 . . . . 0.0 110.932 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.628 ' HG2' ' H ' ' A' ' 260' ' ' ASP . 22.1 tt0 58.28 -155.01 0.35 Allowed 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.795 0.684 . . . . 0.0 109.222 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . 0.628 ' H ' ' HG2' ' A' ' 259' ' ' GLU . 1.7 p-10 -128.89 136.93 51.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 253' ' ' ILE . . . -131.82 171.74 21.2 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.238 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.0 p -82.85 177.44 8.65 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.076 0.55 . . . . 0.0 110.44 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 94.9 t -60.7 -48.24 89.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.116 0.484 . . . . 0.0 110.791 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.2 pm0 -81.4 -33.5 32.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.766 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.1 -40.3 99.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.374 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 270' ' ' VAL . 54.2 tp -62.16 -45.3 94.05 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -62.89 -44.96 94.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.577 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.573 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.27 -47.34 79.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.347 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -66.66 -38.61 87.22 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 266' ' ' LEU . 67.1 t -65.13 -42.7 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.232 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -57.94 -48.1 80.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.792 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.7 ptmt -66.33 -42.91 87.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.763 0.316 . . . . 0.0 111.413 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.31 -36.64 83.44 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.6 mmm -62.88 -42.28 99.71 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.207 0.527 . . . . 0.0 109.964 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 278' ' ' LEU . 56.9 mt-10 -69.36 -30.88 68.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.27 177.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 55.0 ttp180 -62.57 -43.42 98.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.609 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -69.93 -28.21 65.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.114 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 275' ' ' GLU . 65.3 tp -61.08 -37.72 83.71 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 60.8 tttm -58.14 -45.84 86.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.73 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.3 m -61.79 -45.06 95.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.432 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.58 -50.67 72.61 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.663 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.8 -45.17 95.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.17 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.604 HH12 ' HG3' ' A' ' 409' ' ' GLU . 2.2 tpt180 -61.44 -46.37 90.39 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.897 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -64.14 -39.85 94.91 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.242 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.564 HH21 ' CG ' ' A' ' 285' ' ' ARG . 0.0 OUTLIER -60.27 -44.22 95.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.587 179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.03 -43.55 85.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.001 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -61.12 -45.79 93.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.39 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 22.6 p -59.73 -43.64 94.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.03 -41.17 91.25 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.856 0.36 . . . . 0.0 111.189 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.55 87.03 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.8 mm -64.65 -44.46 96.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.466 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.534 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 33.1 tp10 -62.58 -40.73 97.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.95 0.405 . . . . 0.0 110.588 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.38 -43.73 97.87 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.495 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.5 -42.87 98.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.68 -46.98 93.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.227 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . 0.534 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.0 mttm -65.41 -41.57 93.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.898 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.76 -41.2 79.21 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -122.64 98.43 5.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.025 0.441 . . . . 0.0 112.182 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.52 114.7 27.31 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 301' ' ' ASP . 10.7 tp -128.43 161.65 36.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.553 0.216 . . . . 0.0 110.984 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.439 ' N ' HG13 ' A' ' 300' ' ' ILE . 25.4 m-20 -65.26 140.54 58.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.846 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.7 t -115.04 123.6 31.57 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.283 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.53 124.21 14.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.211 1.941 . . . . 0.0 111.535 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.89 85.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.46 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.07 -42.34 76.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.268 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.24 -41.26 85.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.552 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.14 -46.2 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.855 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.46 -43.49 88.88 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.635 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.478 ' O ' HG23 ' A' ' 313' ' ' VAL . 49.9 m -60.89 -45.92 92.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.201 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.574 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 60.2 mm-40 -69.05 -37.44 78.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.409 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 95.8 mt -62.29 -44.14 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.115 0.483 . . . . 0.0 109.975 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.41 -39.3 93.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.647 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 309' ' ' SER . 86.2 t -65.52 -43.09 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.296 176.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 80.4 mt -61.21 -39.01 88.65 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.812 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.475 ' NH1' HD12 ' A' ' 330' ' ' LEU . 65.9 mtm180 -61.41 -37.91 85.16 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.625 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -64.63 -43.05 94.95 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.771 0.319 . . . . 0.0 111.037 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -64.74 -41.81 95.67 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.21 0.528 . . . . 0.0 110.511 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.75 -41.93 78.21 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.159 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.72 -35.43 80.73 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 120.999 0.428 . . . . 0.0 110.979 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -56.21 -44.08 79.14 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.759 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.68 -36.63 60.02 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.931 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -60.1 -45.05 94.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.324 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . 0.502 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . -170.61 17.64 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.096 -1.05 . . . . 0.0 112.857 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 70.79 26.65 73.66 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.209 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -97.9 154.03 17.93 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.292 0.568 . . . . 0.0 112.306 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.0 -178.49 5.47 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 70.28 -60.98 0.47 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.124 0.57 . . . . 0.0 111.592 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -69.83 -15.33 63.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.112 0.482 . . . . 0.0 110.856 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.443 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -61.66 -19.48 62.36 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.584 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.475 HD12 ' NH1' ' A' ' 315' ' ' ARG . 45.3 tp -62.19 -34.67 76.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.771 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -77.92 -0.54 27.91 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.961 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.62 144.2 85.83 Favored Pre-proline 0 C--O 1.238 0.454 0 O-C-N 122.142 -0.349 . . . . 0.0 110.715 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.431 ' HB2' HD13 ' A' ' 336' ' ' LEU . 48.1 Cg_exo -56.65 132.43 51.7 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.777 2.318 . . . . 0.0 113.114 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -67.24 -44.46 79.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.521 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.8 pm0 -64.6 -31.55 72.82 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 333' ' ' PRO . 10.9 mp -65.62 -28.62 69.25 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.584 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -107.6 -20.62 13.18 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.08 -33.26 75.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.9 -44.77 96.11 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.129 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -80.83 -24.63 38.32 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.259 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.35 -38.4 90.89 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.329 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.3 tttt -57.92 -44.92 87.15 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.733 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.508 ' O ' HG23 ' A' ' 347' ' ' VAL . 9.1 mmt180 -62.28 -44.21 97.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.947 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -65.51 -39.99 92.47 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.097 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.8 t -63.29 -45.96 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.101 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 342' ' ' LYS . 98.5 t -63.74 -43.64 98.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 343' ' ' ARG . 78.0 t -60.43 -45.5 96.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.543 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.6 -42.84 99.83 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.02 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.47 -44.13 95.3 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.638 0.256 . . . . 0.0 111.313 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.97 -45.59 88.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.059 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.56 -39.98 88.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.022 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.48 -40.23 97.42 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.125 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.59 -36.62 83.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.148 0.499 . . . . 0.0 110.648 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.91 -43.57 96.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.26 -44.33 99.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.894 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -68.2 -48.92 63.93 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.8 m -64.73 -44.61 89.61 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -88.14 -7.69 56.53 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.735 0.303 . . . . 0.0 111.142 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 60.58 60.31 1.98 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.122 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.1 mt -79.29 153.61 29.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.529 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -130.43 154.15 48.03 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.968 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -78.72 105.98 10.39 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 172.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.524 ' O ' HG23 ' A' ' 367' ' ' VAL . 31.7 t70 -82.18 111.5 18.34 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.376 -0.529 . . . . 0.0 112.054 -173.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 5.1 mm-40 -62.73 -34.33 76.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.038 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -63.64 -44.11 94.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -65.48 -38.88 91.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.193 0.521 . . . . 0.0 109.978 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 363' ' ' ASP . 84.2 t -61.64 -36.77 75.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.578 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 27.2 mmmt -54.81 -47.87 73.5 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.633 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.95 -41.26 99.93 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.521 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.94 -42.86 99.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 0.0 110.713 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.58 -43.43 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.253 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.45 -37.77 87.88 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.276 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -65.38 -41.23 93.94 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.546 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.4 ttm -64.82 -42.42 95.0 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.011 0.434 . . . . 0.0 110.548 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.68 -24.4 67.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.756 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 55.0 m -75.19 -5.13 42.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.65 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.52 5.44 49.52 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.903 0.383 . . . . 0.0 111.18 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -116.93 171.75 7.71 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.762 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -60.61 -44.69 96.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.013 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -130.04 114.41 17.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.793 0.33 . . . . 0.0 110.239 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.69 -27.27 27.02 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.499 2.133 . . . . 0.0 113.123 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -65.1 -45.72 84.04 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.8 -36.29 83.09 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.567 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.74 -42.39 94.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.473 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.77 -44.18 98.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 50.2 mt-10 -66.05 -43.21 88.15 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.56 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.34 -47.84 82.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.959 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -65.64 -45.66 82.17 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.433 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 59.1 p -73.17 -16.38 61.44 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 99.3 mttt -91.06 9.08 32.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.115 0.483 . . . . 0.0 111.291 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -131.24 113.36 13.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.489 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.37 -41.69 98.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.72 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -60.69 -45.3 94.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.041 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 9.8 mp -63.1 -42.68 99.63 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.482 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.554 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 94.5 mtp -63.16 -45.47 91.71 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.051 0.453 . . . . 0.0 110.56 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.407 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 15.1 t70 -64.98 -43.98 90.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.268 -177.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -62.83 -41.76 99.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.395 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 49.0 tpp -63.98 -40.3 96.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.775 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 395' ' ' MET . 73.1 mtm180 -63.63 -35.15 79.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.837 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -62.8 -42.9 99.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.098 177.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.52 -43.57 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -61.4 -39.69 91.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.605 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 40.8 tp -63.79 -38.71 92.1 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.033 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 408' ' ' VAL . 75.2 tt0 -54.53 -50.9 66.78 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.267 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 35.2 mt-10 -66.78 -36.34 82.19 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 120.091 -0.643 . . . . 0.0 111.45 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -61.61 -44.83 96.27 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.833 0.349 . . . . 0.0 110.701 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -62.81 -41.85 99.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.719 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.571 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 89.1 t -65.73 -43.7 93.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.753 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.604 ' HG3' HH12 ' A' ' 283' ' ' ARG . 96.3 mt-10 -63.21 -36.79 84.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.199 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.12 -41.32 99.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.145 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 407' ' ' ALA . 97.7 t -65.38 -42.51 93.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.313 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 68.4 mt -60.3 -42.02 94.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.734 -176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.15 -23.28 67.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.771 0.32 . . . . 0.0 111.432 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -97.98 -3.97 37.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.464 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -109.51 -179.57 3.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.393 0.616 . . . . 0.0 112.399 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.69 102.24 13.95 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.215 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.8 t -94.81 128.45 46.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.373 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -120.34 128.96 53.74 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.556 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 40.1 mt-10 -100.55 118.79 37.43 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.382 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -130.03 134.51 47.45 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.097 0.475 . . . . 0.0 111.543 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.87 142.23 46.04 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -149.1 170.06 19.26 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.554 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 67.7 p -86.63 164.31 16.89 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.28 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -67.05 -26.11 66.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.982 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -61.88 -38.61 88.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.694 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -67.02 -30.11 70.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.778 0.323 . . . . 0.0 110.838 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.6 mp -80.92 -8.56 59.77 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 111.363 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.0 mmt -81.2 -7.3 59.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.133 0.492 . . . . 0.0 110.529 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -78.19 71.79 4.68 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.543 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -121.71 28.86 7.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.609 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 -66.62 -38.35 86.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.52 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.765 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.465 -179.494 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.661 0.267 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -100.03 105.04 16.66 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.88 162.44 38.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.857 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 47.2 m -124.91 119.3 28.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.887 0.375 . . . . 0.0 111.23 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -136.73 137.08 47.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 49.8 mt-10 -114.3 176.35 5.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.01 0.433 . . . . 0.0 111.125 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' B' ' 13' ' ' ARG . 9.7 t -124.21 148.8 47.03 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.46 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 24.1 m -107.46 -82.12 0.55 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.868 0.366 . . . . 0.0 110.949 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -155.74 146.77 22.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.25 -123.65 28.2 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.141 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.531 HD11 HG12 ' B' ' 111' ' ' VAL . 1.2 mm? -100.08 5.84 44.96 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' B' ' 107' ' ' VAL . . . -73.48 142.6 31.52 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.429 -0.805 . . . . 0.0 113.376 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 0.3 OUTLIER -137.14 149.94 47.64 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.079 0.551 . . . . 0.0 109.938 -178.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -116.74 128.9 55.75 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.44 -92.31 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.039 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.1 p 40.75 81.66 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.031 0.532 . . . . 0.0 112.294 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 8.4 tp -108.0 136.84 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.05 0.452 . . . . 0.0 111.725 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 9.2 p -96.13 130.5 43.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.122 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.421 HG13 HG12 ' B' ' 24' ' ' ILE . 14.6 pt -131.43 162.45 39.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.501 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.539 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -74.28 157.53 35.64 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.304 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.35 -41.61 80.4 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -65.91 -37.95 87.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.69 0.281 . . . . 0.0 110.662 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t -65.71 -43.62 88.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.933 0.397 . . . . 0.0 110.671 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.539 HG13 ' O ' ' B' ' 20' ' ' ALA . 77.0 mt -58.42 -69.04 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.26 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.523 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 76.7 mm-40 -68.53 -7.94 36.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -172.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 45.9 m -96.13 -63.98 1.1 Allowed 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.946 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.2 -45.43 73.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.03 -43.42 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.925 0.393 . . . . 0.0 110.935 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.523 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.6 ttmm -61.97 -46.9 87.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.928 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.4 m -69.73 -36.39 75.83 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.468 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.85 -38.35 90.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.941 0.4 . . . . 0.0 110.725 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.33 -38.68 90.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.88 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.76 -43.46 97.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.108 0.48 . . . . 0.0 109.905 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -63.14 -42.73 99.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.49 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 33.8 m -69.07 -33.98 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.309 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.83 96.13 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.18 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' B' ' 40' ' ' ARG . 98.5 mttt -65.63 -34.25 77.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.97 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.56 -37.18 82.86 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.779 0.323 . . . . 0.0 111.001 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 t -87.97 -8.42 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.243 0.544 . . . . 0.0 109.835 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' B' ' 37' ' ' LYS . 35.1 mmt180 66.26 31.44 8.54 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.216 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.81 6.34 9.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.399 . . . . 0.0 111.51 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.23 -35.22 80.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.512 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.64 -3.52 79.07 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.942 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -91.15 -8.67 48.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.701 0.251 . . . . 0.0 111.646 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -91.81 93.25 8.76 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.742 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -76.82 106.45 8.5 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.23 99.36 2.1 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 -169.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.99 -45.89 79.98 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' B' ' 54' ' ' VAL . 15.1 t -100.27 115.22 65.68 Favored Pre-proline 0 C--O 1.249 1.044 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.311 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.0 139.76 85.26 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.428 2.085 . . . . 0.0 111.143 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.549 ' HA ' HG12 ' B' ' 54' ' ' VAL . 23.5 ttt -63.28 -38.57 91.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.596 -174.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' B' ' 29' ' ' LYS . 31.3 p-10 -64.28 -32.02 73.45 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.331 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.421 HD13 HH22 ' A' ' 193' ' ' ARG . 92.5 mt -87.51 -45.05 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.822 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' B' ' 51' ' ' MET . 12.0 p -62.55 -42.2 94.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.711 0.291 . . . . 0.0 111.382 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.87 -14.67 62.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.8 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -97.09 -41.28 8.43 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.164 0.507 . . . . 0.0 109.686 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.441 ' NH1' ' SD ' ' A' ' 194' ' ' MET . 67.9 ttt180 -70.87 -44.91 65.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.166 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -110.0 10.83 24.15 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 120.924 0.392 . . . . 0.0 110.09 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.646 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -58.75 -45.69 94.49 Favored Glycine 0 C--O 1.215 -1.054 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.147 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.06 -24.86 60.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 37.4 t -61.64 -44.17 97.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.34 . . . . 0.0 111.511 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.51 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.1 p -123.25 21.85 4.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.312 0.577 . . . . 0.0 110.75 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.646 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 23.5 ttm180 -59.09 -33.21 70.56 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.728 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -61.18 -49.65 76.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.972 0.415 . . . . 0.0 110.515 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . 0.429 ' HB2' HG22 ' B' ' 62' ' ' VAL . 1.0 OUTLIER -74.5 -22.77 58.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.538 -179.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.51 HG23 ' O ' ' B' ' 62' ' ' VAL . 53.8 t -63.89 -43.88 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 99.4 mt -62.77 -39.21 93.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.018 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.04 -42.7 99.88 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.202 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . 0.727 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 33.8 t70 -63.66 -44.01 95.06 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.972 0.386 . . . . 0.0 109.989 177.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.35 -41.34 96.91 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.063 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 49.9 ttp -60.91 -41.88 96.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.502 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -62.97 -44.37 96.23 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.925 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.727 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 32.8 mtp85 -66.68 -40.95 88.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.928 -177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -65.31 -41.33 94.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.192 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.56 -48.86 79.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.798 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 18.7 tt -68.0 -40.15 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.873 0.368 . . . . 0.0 111.705 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -65.69 -39.79 91.64 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.284 0.564 . . . . 0.0 110.134 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.14 -47.02 75.43 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.662 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 45.5 pt -62.45 -36.75 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.05 -43.97 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 120.686 0.279 . . . . 0.0 111.139 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.52 -28.03 46.11 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.617 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.88 -4.43 58.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.655 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 62.85 42.45 7.8 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.933 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.3 mt -105.05 118.31 52.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -112.46 109.94 53.3 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.404 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -88.44 124.23 1.64 Allowed 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 122.544 2.163 . . . . 0.0 111.274 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.65 117.76 29.56 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.977 0.418 . . . . 0.0 110.505 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.7 -130.18 10.15 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.67 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.45 123.79 17.74 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-O 120.433 0.158 . . . . 0.0 110.625 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.31 131.46 19.11 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.797 1.664 . . . . 0.0 110.554 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 11.3 m -78.38 111.92 14.87 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.628 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.65 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 96.2 m-85 -83.9 105.19 14.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.14 102.73 11.51 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.47 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.4 Cg_endo -98.61 170.06 0.6 Allowed 'Trans proline' 0 N--CA 1.439 -1.723 0 C-N-CA 123.429 2.753 . . . . 0.0 111.402 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.43 -174.06 26.08 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -79.95 133.36 36.19 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -87.9 128.41 35.36 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.007 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.98 133.76 49.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 tp -86.79 88.61 7.72 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.328 0.585 . . . . 0.0 110.138 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.59 -20.9 3.65 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.174 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -108.54 178.07 4.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.496 0.189 . . . . 0.0 110.719 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -80.53 165.3 22.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.007 0.432 . . . . 0.0 111.185 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -124.1 141.92 51.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.957 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 27.7 m -122.91 135.82 54.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.041 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -142.69 165.51 27.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.366 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.8 m -85.4 -90.9 0.1 Allowed 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.442 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 85.3 t 64.94 99.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.347 0.594 . . . . 0.0 110.672 -175.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -101.11 145.6 28.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.702 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -158.11 -80.34 0.06 Allowed 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.4 ' O ' HD12 ' B' ' 11' ' ' LEU . 59.3 mt-10 -95.97 157.02 16.09 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -173.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.531 HG12 HD11 ' B' ' 11' ' ' LEU . 24.9 m -124.97 163.98 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.925 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -171.24 101.02 0.4 Allowed Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 122.252 0.221 . . . . 0.0 110.961 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -96.37 162.82 1.22 Allowed 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 123.701 2.934 . . . . 0.0 114.306 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -143.19 147.29 34.66 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.738 0.815 . . . . 0.0 110.765 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.8 156.68 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 120.675 0.274 . . . . 0.0 111.072 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.14 153.13 51.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.83 131.89 55.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -144.71 155.07 43.37 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.46 22.89 78.15 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.33 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.05 -42.1 99.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.093 0.473 . . . . 0.0 111.232 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.11 -15.7 63.88 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.201 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.33 0.41 57.26 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.427 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 81.4 mt -79.73 113.82 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.11 0.481 . . . . 0.0 109.791 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -106.42 117.53 34.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.647 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 57.7 t -103.4 126.36 57.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.78 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -93.13 119.01 31.88 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.532 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.504 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 77.3 tttt -113.39 105.86 54.85 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.26 130.11 13.75 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.967 1.778 . . . . 0.0 111.9 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -101.46 115.37 43.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.44 161.29 41.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.941 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -150.37 159.57 44.36 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.852 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.67 131.05 35.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.159 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 81.7 p -110.77 175.53 5.39 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.924 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -62.16 -35.75 79.77 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.755 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.57 -39.06 89.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.601 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.18 -42.17 99.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.716 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -63.86 -46.76 93.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.793 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.78 -44.19 97.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.624 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.88 -41.58 98.7 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.085 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.483 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.0 OUTLIER -62.68 -46.0 90.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.904 0.383 . . . . 0.0 110.683 179.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.9 mt -63.61 -40.76 97.74 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.675 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.32 -45.96 91.58 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.382 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.0 m -63.13 -41.61 99.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.813 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' B' ' 140' ' ' MET . 97.7 mt -60.67 -43.56 97.53 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.618 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 51.5 mtm180 -67.18 -35.97 80.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.874 0.369 . . . . 0.0 110.936 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -67.19 -21.04 65.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.089 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -85.56 -4.98 59.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 110.544 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -90.27 90.55 8.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.704 0.764 . . . . 0.0 112.216 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.88 132.49 18.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.373 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.5 ' OG1' ' HG2' ' B' ' 247' ' ' GLU . 20.5 p -103.63 -165.97 1.21 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . 0.481 ' O ' ' HG3' ' B' ' 152' ' ' LYS . 6.0 p-90 -68.6 127.94 34.84 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.345 -174.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' B' ' 151' ' ' TRP . 21.4 mttp -178.36 -167.84 0.14 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.231 1.012 . . . . 0.0 109.896 176.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' B' ' 154' ' ' LYS . 0.0 OUTLIER -132.59 163.71 28.27 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 -172.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' B' ' 153' ' ' GLU . 11.2 pttp 66.13 -178.61 0.2 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.884 1.674 . . . . 0.0 114.323 174.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . 0.4 ' N ' ' HG3' ' B' ' 154' ' ' LYS . 14.8 t70 71.54 -94.48 0.03 OUTLIER 'General case' 0 C--N 1.341 0.235 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.189 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 148.63 97.8 0.19 Allowed Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.551 -1.309 . . . . 0.0 113.463 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -128.21 67.41 1.36 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 23.1 t -72.0 127.67 34.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.428 -176.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' B' ' 162' ' ' ASP . 8.9 tp10 -93.53 153.54 18.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.87 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . 0.401 ' O ' ' HA3' ' B' ' 190' ' ' GLY . . . -89.52 23.2 2.68 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.622 -177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' B' ' 189' ' ' MET . 34.1 tt0 -163.28 25.81 0.09 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.406 0.622 . . . . 0.0 110.539 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.597 ' HB2' ' HB3' ' B' ' 159' ' ' GLU . 3.7 t70 -113.08 -172.16 2.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.316 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -99.39 124.67 44.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.6 t -120.14 126.42 75.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 120.054 -0.659 . . . . 0.0 109.337 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 10.3 m -87.58 109.8 19.91 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 67.6 mt -114.45 126.59 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.142 0.496 . . . . 0.0 112.264 -174.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' B' ' 236' ' ' ASN . 3.5 p-10 -101.05 110.2 22.19 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -139.53 160.29 40.21 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.385 0.612 . . . . 0.0 112.11 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.9 m -131.79 136.26 47.4 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.884 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.46 104.86 2.31 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.697 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 33.2 m -130.04 124.67 33.43 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.63 -89.66 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.003 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -99.62 44.74 1.01 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.197 0.522 . . . . 0.0 110.149 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.91 12.85 67.79 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.297 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -126.8 138.95 53.42 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.39 134.68 34.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.719 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . 0.404 ' HD1' ' H ' ' B' ' 179' ' ' GLY . 32.9 p90 -105.34 -178.28 3.61 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.776 0.322 . . . . 0.0 111.82 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.74 -39.92 82.32 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.076 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . 0.404 ' H ' ' HD1' ' B' ' 177' ' ' PHE . . . -95.14 -176.17 37.73 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.147 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.49 16.8 67.8 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.073 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -105.17 94.77 5.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -144.68 144.46 31.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.68 0.276 . . . . 0.0 110.976 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -135.4 146.74 48.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.085 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 56.46 30.18 16.61 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 123.589 0.556 . . . . 0.0 110.786 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -83.94 126.54 33.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.463 -175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 17.3 m -98.76 115.47 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.955 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 63.7 tp -106.1 127.8 53.44 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.361 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.29 106.72 18.66 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . 0.622 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 68.1 mtp -78.95 148.38 32.66 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.758 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' B' ' 160' ' ' ALA . . . 96.3 -15.05 63.55 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.039 175.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -94.97 -1.15 53.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.799 0.333 . . . . 0.0 111.384 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.88 56.71 5.22 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.738 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.497 HH22 HD13 ' A' ' 53' ' ' ILE . 17.8 mmt85 -99.64 -6.31 27.48 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.198 0.523 . . . . 0.0 109.789 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.483 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -136.27 173.02 12.16 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.904 -178.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 31.2 mm -62.83 131.32 94.43 Favored Pre-proline 0 N--CA 1.437 -1.12 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.82 125.74 11.78 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.495 2.13 . . . . 0.0 111.956 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.14 -42.7 1.89 Allowed Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.288 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -63.32 -52.22 62.77 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.055 0.427 . . . . 0.0 111.866 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.79 -31.23 66.38 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.854 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.85 -39.56 76.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.888 0.375 . . . . 0.0 111.098 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -62.97 -20.34 62.28 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.688 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 67.1 mt -62.5 -41.74 93.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 120.804 0.335 . . . . 0.0 110.289 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -47.5 128.39 12.39 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.8 0.84 . . . . 0.0 111.671 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.51 -19.44 45.1 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.165 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -87.53 163.68 16.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.867 0.365 . . . . 0.0 111.816 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -105.78 155.12 19.6 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.989 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.18 137.47 57.02 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' B' ' 237' ' ' LEU . . . 74.41 38.19 45.68 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.504 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -127.64 128.48 45.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.224 0.535 . . . . 0.0 111.783 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -99.23 120.17 39.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.68 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . 0.477 ' O ' ' HB ' ' B' ' 212' ' ' THR . 36.0 t80 -139.65 -35.71 0.53 Allowed 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -176.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' B' ' 211' ' ' PHE . 94.8 m 75.32 142.46 0.07 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.706 0.288 . . . . 0.0 110.799 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -132.56 141.07 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 111.594 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.19 109.47 18.33 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.681 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 64.5 t -121.38 122.3 66.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 3.4 m -92.01 -21.15 20.67 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -174.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' B' ' 216' ' ' THR . 44.0 m-85 68.05 149.52 0.12 Allowed Pre-proline 0 N--CA 1.482 1.156 0 CA-C-O 120.779 0.323 . . . . 0.0 110.839 -175.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 15.6 Cg_exo -71.15 150.4 59.68 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.311 2.007 . . . . 0.0 111.767 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.43 -37.45 87.56 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.84 76.47 6.33 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.206 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -121.6 141.98 50.56 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -62.93 -29.09 70.52 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.98 110.9 22.75 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.609 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 43.8 tt0 -65.23 -33.54 76.25 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.728 -176.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' B' ' 229' ' ' LYS . 30.4 p-10 -66.33 -23.37 66.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.118 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.7 mt -110.69 -4.25 15.46 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.9 ptmt -69.05 119.74 13.81 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.875 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.89 34.6 90.32 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.327 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' B' ' 225' ' ' ASN . 34.7 mmtp -114.91 133.87 55.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 0.0 110.95 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -84.16 107.72 16.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.901 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.37 148.21 22.69 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.142 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.18 -48.99 3.71 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 58.98 102.52 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.169 0.509 . . . . 0.0 110.892 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.47 89.82 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm 61.54 102.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 123.175 0.59 . . . . 0.0 112.095 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . 0.406 ' HB3' ' OD2' ' B' ' 167' ' ' ASP . 6.4 t-20 -90.17 -51.51 5.41 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . 0.559 ' O ' ' HA2' ' B' ' 208' ' ' GLY . 13.0 tp 61.99 81.66 0.19 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.27 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -82.36 -48.58 10.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -110.18 -79.82 0.58 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 21.8 t 70.18 142.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.096 0.559 . . . . 0.0 110.839 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -73.76 -47.23 40.6 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.094 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 65.58 162.18 0.14 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -158.69 91.4 1.06 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.254 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' B' ' 152' ' ' LYS . 7.8 tp10 -122.79 153.4 39.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.188 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 9.0 tt 76.24 116.07 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.462 0 C-N-CA 124.027 0.931 . . . . 0.0 110.58 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.38 113.12 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.543 2.162 . . . . 0.0 113.653 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . 0.5 ' HG2' ' OG1' ' B' ' 150' ' ' THR . 12.6 pt-20 -125.89 -163.57 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.0 mp -89.25 104.42 16.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.342 0.591 . . . . 0.0 111.817 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 34.2 m -132.67 133.64 43.82 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -91.99 15.4 13.31 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.06 -12.21 25.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -75.16 -2.51 28.07 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.821 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' B' ' 261' ' ' GLY . 43.5 pt -109.93 -3.63 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.576 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -138.76 10.56 2.66 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -131.64 13.83 4.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.041 0.448 . . . . 0.0 109.97 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -131.42 138.56 49.12 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.361 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 69.5 -129.06 22.13 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 121.212 -0.518 . . . . 0.0 114.073 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 75.8 t -121.03 130.02 75.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . 0.669 ' HG2' ' H ' ' B' ' 260' ' ' ASP . 22.0 tt0 59.5 -166.79 0.17 Allowed 'General case' 0 CA--C 1.552 1.039 0 O-C-N 123.709 0.63 . . . . 0.0 110.091 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . 0.669 ' H ' ' HG2' ' B' ' 259' ' ' GLU . 5.1 p-10 -110.24 144.9 38.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . 0.515 ' O ' ' HB ' ' B' ' 253' ' ' ILE . . . -146.43 166.19 28.19 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.138 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 12.8 p -80.32 176.89 9.36 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 122.768 0.427 . . . . 0.0 111.205 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.81 -48.0 90.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.749 0.309 . . . . 0.0 110.942 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' B' ' 264' ' ' GLU . 1.0 OUTLIER -82.11 -33.3 29.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 110.591 178.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.54 -41.35 99.8 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.061 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.442 ' O ' HG23 ' B' ' 270' ' ' VAL . 63.6 tp -61.58 -46.33 90.3 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 120.522 0.201 . . . . 0.0 110.595 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -65.04 -41.72 94.94 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.728 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.616 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.16 -45.92 86.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -67.88 -38.76 83.44 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 266' ' ' LEU . 58.8 t -64.38 -42.11 94.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.35 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . 0.405 HH21 ' HD3' ' B' ' 271' ' ' ARG . 9.4 tpt180 -58.04 -48.41 80.17 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.611 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 11.9 ptmt -66.65 -42.61 86.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.741 0.305 . . . . 0.0 111.292 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -64.6 -38.26 90.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.37 -0.377 . . . . 0.0 112.007 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.8 mmm -63.33 -42.14 98.95 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.994 0.426 . . . . 0.0 109.997 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' B' ' 278' ' ' LEU . 79.1 mt-10 -70.51 -28.77 65.21 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.738 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -64.41 -42.74 95.91 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -67.59 -27.94 67.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.711 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' B' ' 275' ' ' GLU . 63.9 tp -61.02 -38.72 87.09 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.37 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -58.21 -46.76 85.27 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.626 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 32.2 m -62.22 -44.76 95.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.895 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.71 72.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.339 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.29 -44.06 97.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.062 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . 0.566 HH12 ' HG3' ' B' ' 409' ' ' GLU . 1.7 tpt180 -62.25 -46.16 90.06 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.781 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -64.69 -39.88 94.43 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . 0.59 HH21 ' CG ' ' B' ' 285' ' ' ARG . 0.0 OUTLIER -60.85 -43.78 97.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.074 0.464 . . . . 0.0 110.588 179.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 76.1 t -67.75 -43.91 86.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.946 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.63 -46.47 90.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.22 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 32.2 p -60.37 -43.47 96.51 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -66.53 -41.14 89.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.363 . . . . 0.0 111.137 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.65 -48.22 78.12 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.46 -44.52 97.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.322 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -62.65 -40.28 96.55 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.61 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.34 -42.75 99.1 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.12 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.33 -42.22 98.96 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.03 -45.34 96.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 123.201 0.313 . . . . 0.0 111.196 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.87 -41.96 95.24 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.379 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -69.77 -43.13 72.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -117.89 100.83 7.83 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -96.65 113.58 25.16 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . 0.415 HG13 ' N ' ' B' ' 301' ' ' ASP . 10.6 tp -126.98 160.52 35.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.8 0.333 . . . . 0.0 111.117 -176.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . 0.415 ' N ' HG13 ' B' ' 300' ' ' ILE . 14.1 m-20 -65.71 135.95 55.63 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.629 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 16.0 t -112.64 123.07 34.7 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.533 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.66 123.96 14.08 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.141 1.894 . . . . 0.0 111.527 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.81 81.65 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.714 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.62 -45.6 73.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.113 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.79 -41.85 95.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.718 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.67 -45.74 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.727 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.0 -43.54 86.71 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.527 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . 0.459 ' O ' HG23 ' B' ' 313' ' ' VAL . 20.3 m -62.59 -45.39 93.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.205 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 55.3 mm-40 -66.17 -39.19 89.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.051 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.17 -44.22 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.995 0.426 . . . . 0.0 110.345 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.69 -38.02 89.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.811 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 309' ' ' SER . 96.9 t -66.6 -42.48 89.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.955 176.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 90.3 mt -61.42 -39.88 92.37 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.03 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.454 ' NH1' HD12 ' B' ' 330' ' ' LEU . 63.5 mtm180 -61.74 -37.68 85.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.316 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 -63.38 -43.89 96.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.795 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.99 -41.49 95.35 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.335 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.87 -42.5 76.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.372 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.2 -37.01 84.56 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 120.862 0.363 . . . . 0.0 111.319 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -55.4 -42.95 74.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.578 0.704 . . . . 0.0 109.539 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -74.41 -38.22 63.15 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.885 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -58.12 -46.87 84.85 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.169 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . 0.412 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . -168.95 17.56 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.063 -1.065 . . . . 0.0 112.435 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 72.2 25.54 74.3 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.168 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -94.07 151.0 19.83 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -175.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -135.58 -179.7 5.8 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 68.8 -62.85 0.38 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.32 0.648 . . . . 0.0 112.084 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -67.02 -16.61 64.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.99 0.424 . . . . 0.0 111.141 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . 0.413 ' O ' ' HD2' ' B' ' 315' ' ' ARG . . . -60.85 -18.74 57.7 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.621 176.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.454 HD12 ' NH1' ' B' ' 315' ' ' ARG . 45.7 tp -61.88 -37.56 85.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.809 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -74.43 -6.17 46.72 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.976 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 78.7 mt -66.6 140.6 96.54 Favored Pre-proline 0 C--O 1.241 0.606 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.934 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . 0.453 ' HB2' HD13 ' B' ' 336' ' ' LEU . 46.4 Cg_exo -55.08 130.62 41.74 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.951 2.434 . . . . 0.0 113.296 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 26.5 ttt85 -65.74 -44.01 87.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.074 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.5 pm0 -66.53 -24.48 66.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' B' ' 333' ' ' PRO . 11.0 mp -76.06 -18.94 59.0 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -116.09 -20.61 9.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -64.43 -32.22 73.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -63.49 -46.7 84.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.537 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -76.9 -26.56 54.3 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.734 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.415 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.77 -38.96 93.05 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.614 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . 0.428 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.8 tttt -57.76 -44.87 86.42 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.939 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . 0.504 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.2 mmt85 -61.64 -44.1 97.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.783 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -65.63 -39.45 91.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.597 0.237 . . . . 0.0 111.242 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 341' ' ' ALA . 77.6 t -63.58 -45.72 96.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.148 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 342' ' ' LYS . 96.9 t -63.37 -44.25 98.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 343' ' ' ARG . 78.6 t -60.54 -45.26 97.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.445 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.11 -43.08 99.87 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.368 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.09 -44.11 93.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.664 0.269 . . . . 0.0 111.359 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.85 -44.84 91.97 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.757 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.04 -39.25 89.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.05 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.53 97.83 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.015 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.29 -35.25 79.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.967 0.383 . . . . 0.0 110.851 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.18 -44.59 95.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.1 -44.13 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.704 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -68.73 -47.28 66.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 26.4 m -65.51 -45.42 83.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -88.47 -9.4 52.61 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.916 0.389 . . . . 0.0 111.069 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 60.94 61.51 1.62 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.077 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.1 mt -78.76 156.54 28.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.304 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -131.25 158.86 39.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.672 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -81.28 108.2 14.7 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 172.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . 0.52 ' O ' HG23 ' B' ' 367' ' ' VAL . 18.0 t70 -81.72 107.57 14.56 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.327 0.584 . . . . 0.0 111.825 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 5.6 mm-40 -61.39 -35.25 76.97 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.846 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.17 -43.28 92.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.967 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -64.27 -39.37 93.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.302 0.572 . . . . 0.0 109.836 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . 0.531 HG21 ' HG2' ' B' ' 399' ' ' ARG . 94.6 t -61.81 -39.54 83.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.633 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 24.9 mmmt -55.89 -46.53 78.31 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.035 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.59 -42.26 99.72 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.333 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 98.5 mt -63.09 -42.13 99.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.854 0.359 . . . . 0.0 110.705 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 92.1 mt -63.92 -43.09 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.286 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.27 -40.94 97.89 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.94 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -64.89 -40.02 94.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.798 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 59.9 ttm -66.65 -41.46 88.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.074 0.464 . . . . 0.0 110.796 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.75 -25.1 68.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.861 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 47.9 m -75.74 3.32 10.05 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.987 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -103.02 11.24 37.54 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.324 0.583 . . . . 0.0 110.827 178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -118.18 170.8 8.58 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.118 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.2 -35.02 79.43 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.543 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -138.22 111.8 8.59 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.024 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.91 -30.77 32.52 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.352 2.035 . . . . 0.0 113.223 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.78 -44.27 90.54 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -65.64 -36.02 82.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.747 0.308 . . . . 0.0 110.383 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.13 -41.47 91.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.606 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.6 mt -61.43 -44.25 98.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.802 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 52.9 mt-10 -66.54 -42.32 87.36 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.559 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -58.05 -46.91 84.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.958 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -67.97 -44.07 77.52 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.656 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 41.7 p -73.75 -17.69 61.07 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.5 mttt -89.06 1.66 55.22 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.901 0.381 . . . . 0.0 111.253 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -123.11 112.61 17.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.719 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.71 -41.89 98.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.507 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -61.91 -45.18 94.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 5.8 mp -62.65 -43.06 99.77 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.675 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.539 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.8 mtp -63.2 -46.82 85.27 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.032 0.444 . . . . 0.0 110.963 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . 0.504 ' HA ' ' HE ' ' B' ' 399' ' ' ARG . 19.5 t70 -65.01 -43.95 90.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.784 -176.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -63.55 -40.34 96.76 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.742 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 47.4 tpp -62.78 -39.83 95.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 395' ' ' MET . 80.8 mtm180 -64.13 -35.51 81.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.695 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.11 -43.31 99.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 98.0 t -66.53 -44.04 90.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.586 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.73 95.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.943 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 47.5 tp -62.82 -38.33 90.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.03 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . 0.503 ' O ' HG23 ' B' ' 408' ' ' VAL . 43.8 tt0 -54.47 -51.39 65.16 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.07 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.89 -37.98 87.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.453 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -60.4 -43.54 96.58 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.576 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.442 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -64.23 -42.56 96.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.634 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . 0.58 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 93.0 t -65.34 -43.3 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.583 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . 0.566 ' HG3' HH12 ' B' ' 283' ' ' ARG . 95.2 mt-10 -63.91 -35.69 81.5 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.064 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.2 98.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.089 0.471 . . . . 0.0 110.286 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 407' ' ' ALA . 92.1 t -65.27 -42.64 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.421 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 81.4 mt -61.15 -40.68 94.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.532 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.49 -16.78 64.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.617 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -102.75 -22.76 13.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.44 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.44 179.55 5.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.257 0.551 . . . . 0.0 112.001 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.18 108.03 20.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.33 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.3 127.29 52.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.73 0.3 . . . . 0.0 110.254 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 13.6 t -119.96 130.94 55.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . 0.504 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 41.5 mt-10 -102.3 120.7 40.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.356 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -131.85 138.62 48.54 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.418 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.26 144.91 35.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 13.4 t -151.3 171.72 17.02 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.231 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 36.1 p -86.95 166.1 15.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.338 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -67.34 -25.95 66.25 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -62.9 -38.42 90.86 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.86 -31.67 72.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 0.0 110.672 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.24 -12.95 60.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 5.5 mmt -81.03 -7.3 59.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.001 0.429 . . . . 0.0 110.995 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -78.1 78.27 4.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.309 0.576 . . . . 0.0 110.509 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -126.06 23.63 7.09 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.63 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -66.39 -30.15 70.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.234 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.826 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.691 -178.673 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 CA--C 1.545 0.752 0 CA-C-O 120.695 0.283 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -65.5 137.7 57.6 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.858 0.361 . . . . 0.0 111.183 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.33 158.31 41.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.504 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.7 t -117.41 113.63 22.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.935 0.398 . . . . 0.0 110.821 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 p -154.72 140.65 11.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -122.34 157.69 31.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.981 0.419 . . . . 0.0 111.204 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 m -104.44 115.56 30.59 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.857 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 9' ' ' GLN . 15.7 m -68.2 -53.42 25.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.738 0.304 . . . . 0.0 111.01 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 8' ' ' THR . 58.1 tp60 168.31 130.05 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.82 0.848 . . . . 0.0 109.586 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.22 -105.7 1.36 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.784 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 305' ' ' ALA . 4.0 mp -97.04 -16.01 20.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.692 0.282 . . . . 0.0 110.343 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 13' ' ' ARG . . . -71.79 133.58 21.15 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.635 -175.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -135.92 143.44 44.95 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -116.23 134.02 55.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 t -79.56 -94.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.8 m 54.54 91.48 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.336 0.589 . . . . 0.0 110.85 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 tp -106.87 134.32 48.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.004 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.3 p -81.3 132.62 35.35 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.515 HD13 HD11 ' A' ' 24' ' ' ILE . 1.9 pp -129.56 161.88 38.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.674 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -108.11 155.85 19.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.005 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.17 -53.15 57.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.4 -34.39 74.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.987 0.422 . . . . 0.0 110.662 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.6 t -63.01 -34.44 77.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.038 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 20' ' ' ALA . 62.7 mt -59.62 -70.2 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.207 0.527 . . . . 0.0 111.269 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.71 -44.87 92.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.724 -172.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.3 m -64.66 -49.01 72.68 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.4 -45.25 18.01 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.0 t -63.32 -44.47 99.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.531 0.196 . . . . 0.0 111.531 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -61.32 -46.7 89.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.832 0.348 . . . . 0.0 110.735 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.9 m -61.72 -41.58 97.8 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.085 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.8 tp10 -65.45 -42.6 92.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.984 0.421 . . . . 0.0 110.567 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.433 ' CD2' HH22 ' A' ' 73' ' ' ARG . 97.1 mt -63.81 -44.09 94.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.24 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -68.05 -37.6 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -62.79 -39.67 94.95 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.463 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 31' ' ' GLU . 79.1 t -63.49 -44.16 98.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.822 0.344 . . . . 0.0 110.311 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.05 87.48 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.945 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.9 -34.11 77.07 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.833 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -59.29 -42.83 92.21 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.834 0.35 . . . . 0.0 110.483 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.1 t -85.99 -4.72 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.056 0.455 . . . . 0.0 110.16 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 62.74 27.56 16.15 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.457 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.72 5.29 10.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -64.46 -30.51 71.55 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.986 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.15 -23.65 68.15 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.339 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -74.83 -12.2 60.33 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.443 ' HG3' ' NE2' ' B' ' 320' ' ' GLN . 71.8 ttt-85 -91.06 103.08 15.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.58 -176.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.13 109.6 13.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.81 67.61 2.12 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 115.949 1.139 . . . . 0.0 115.949 -170.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.62 -44.16 91.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 170.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.3 t -98.33 102.74 15.1 Favored Pre-proline 0 N--CA 1.438 -1.033 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HB2' ' OD1' ' A' ' 52' ' ' ASN . 13.4 Cg_endo -57.36 144.03 92.41 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.315 2.01 . . . . 0.0 111.779 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.534 ' HA ' HG12 ' A' ' 54' ' ' VAL . 17.5 ttt -61.13 -38.57 86.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.244 -173.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.518 ' OD1' ' HB2' ' A' ' 50' ' ' PRO . 16.7 p-10 -62.56 -43.21 99.37 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.833 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.536 HG21 ' HD2' ' B' ' 193' ' ' ARG . 1.8 mp -68.67 -44.12 82.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.556 HG22 ' HA2' ' B' ' 323' ' ' GLY . 2.6 p -63.84 -36.85 78.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 120.63 0.252 . . . . 0.0 111.619 -176.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.19 89.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.258 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -83.45 -32.69 25.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.371 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -63.44 -42.47 98.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.177 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -109.91 17.83 20.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.391 0.615 . . . . 0.0 111.186 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.18 145.81 49.91 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.072 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 72.66 -35.06 0.31 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.378 0.671 . . . . 0.0 112.555 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -61.23 -45.89 92.66 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.405 HG22 ' HB2' ' A' ' 65' ' ' ASP . 7.5 p -122.97 22.17 4.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.903 0.858 . . . . 0.0 110.246 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -63.87 -23.25 67.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.374 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -63.83 -45.17 90.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.847 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' HB2' HG22 ' A' ' 62' ' ' VAL . 9.1 m-20 -75.2 -24.01 57.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.129 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.88 -42.22 94.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.0 mt -61.91 -38.41 88.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.935 175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.7 -41.06 98.85 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.658 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.459 ' OD1' ' HE2' ' B' ' 327' ' ' LYS . 20.9 t70 -60.75 -46.34 90.81 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.954 0.407 . . . . 0.0 110.434 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.18 -42.59 99.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.282 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.6 ttp -63.32 -42.87 99.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.976 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -62.83 -44.04 97.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.331 0.586 . . . . 0.0 110.997 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.433 HH22 ' CD2' ' A' ' 32' ' ' LEU . 69.7 mtp180 -64.42 -40.77 96.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.046 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -63.93 -40.24 96.0 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 120.954 0.407 . . . . 0.0 110.519 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -62.43 -48.28 80.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.874 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 79' ' ' ILE . 15.7 tt -68.96 -41.48 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.879 -178.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -65.16 -37.91 88.88 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.141 0.496 . . . . 0.0 110.095 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.66 83.16 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.922 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.8 pp -65.64 -30.5 50.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.541 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.0 mt -65.44 -43.63 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.932 0.396 . . . . 0.0 111.034 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -81.24 -32.57 33.3 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.901 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -83.27 -2.94 56.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.124 0.487 . . . . 0.0 110.407 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt 64.23 38.93 7.78 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.674 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 81.3 mt -102.66 123.87 56.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.827 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -110.32 103.56 54.16 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.388 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.65 146.59 34.39 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.51 2.14 . . . . 0.0 112.295 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.14 98.23 11.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.049 0.452 . . . . 0.0 111.424 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.55 -106.48 2.25 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.591 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.09 129.71 24.65 Favored Pre-proline 0 C--N 1.317 -0.841 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.468 ' HG2' ' CE1' ' A' ' 92' ' ' TYR . 81.0 Cg_endo -73.95 156.42 47.8 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.681 2.254 . . . . 0.0 111.928 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.0 m -76.94 119.39 20.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.017 0.437 . . . . 0.0 111.534 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.468 ' CE1' ' HG2' ' A' ' 90' ' ' PRO . 73.6 m-85 -113.82 118.81 35.3 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.8 t -115.01 100.57 53.84 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.443 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -90.19 145.31 4.26 Favored 'Trans proline' 0 N--CA 1.438 -1.77 0 C-N-CA 122.555 2.17 . . . . 0.0 111.29 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.98 175.3 41.5 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.301 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.72 125.17 26.43 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -80.51 127.82 32.88 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.971 0.415 . . . . 0.0 110.563 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -117.56 115.52 25.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.595 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.4 tp -65.37 107.27 1.59 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.334 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.47 -8.71 13.43 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.383 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.93 173.39 8.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.803 0.335 . . . . 0.0 111.026 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.87 141.25 44.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.558 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -98.08 141.18 31.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.385 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.8 m -124.26 133.99 53.35 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.161 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -141.03 154.91 46.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.255 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 m -84.21 -86.44 0.12 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.0 t 68.89 111.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 122.98 0.512 . . . . 0.0 110.498 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -113.95 137.66 51.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.825 -175.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -151.34 -74.75 0.15 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -143.24 157.49 44.44 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.553 0.615 . . . . 0.0 111.297 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.432 ' CG1' ' HG ' ' A' ' 11' ' ' LEU . 28.8 m -128.78 -172.46 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -140.25 118.02 8.27 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.88 147.32 39.02 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.821 2.347 . . . . 0.0 114.623 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -135.87 143.06 44.85 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.597 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.6 t -128.37 132.17 68.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -104.7 -90.15 0.4 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.519 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.0 mt 64.1 130.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.114 0.966 . . . . 0.0 113.397 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -136.97 152.34 50.04 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.818 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.96 22.14 74.85 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 113.418 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.8 mt -67.66 -28.8 68.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.808 0.337 . . . . 0.0 111.897 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -83.16 -9.02 59.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.852 0.358 . . . . 0.0 111.28 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -102.51 17.29 24.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.911 0.386 . . . . 0.0 111.342 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.2 mt -90.47 123.7 42.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.908 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -108.99 127.02 53.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 53.3 t -115.16 136.07 53.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.017 0.437 . . . . 0.0 112.073 -172.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -86.99 139.1 30.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.844 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -134.47 101.03 12.23 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.5 137.79 40.37 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.046 1.831 . . . . 0.0 111.527 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.98 123.13 70.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.919 0.39 . . . . 0.0 110.481 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.99 162.25 39.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.534 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -142.35 158.99 43.11 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.6 t -81.17 116.77 26.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.1 p -100.39 176.36 5.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.665 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -65.02 -30.62 71.61 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.476 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.54 97.72 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.895 0.378 . . . . 0.0 110.355 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -64.21 -44.43 91.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.949 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.487 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 90.1 t -64.47 -46.13 93.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.433 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.71 -48.4 81.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.721 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.63 -39.48 97.61 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.945 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.488 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -63.07 -44.79 94.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 0.0 110.337 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 86.6 mt -63.2 -42.26 99.28 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.729 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.74 -45.15 93.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.367 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.8 m -62.95 -42.72 99.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.614 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -60.92 -42.54 98.3 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -72.81 -20.89 61.06 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.418 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.17 -12.4 59.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.079 0.466 . . . . 0.0 110.608 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -93.61 2.99 56.19 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.498 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -117.14 75.09 0.95 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.888 0.852 . . . . 0.0 111.976 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.71 73.24 0.76 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 151' ' ' TRP . 4.1 m -144.76 173.01 12.22 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.903 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.503 ' H ' HG22 ' A' ' 150' ' ' THR . 31.5 t-105 80.72 17.52 0.57 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.395 1.078 . . . . 0.0 112.315 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' A' ' 245' ' ' LEU . 6.3 mptp? -101.89 160.01 14.85 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -94.93 4.88 53.29 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -142.23 154.37 44.73 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.986 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 78.2 -175.22 0.09 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.733 1.213 . . . . 0.0 111.304 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -138.29 99.45 0.28 Allowed Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 119.577 -1.297 . . . . 0.0 114.865 -174.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . . . -110.45 -57.0 2.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 169.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.5 t 60.89 123.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 114.592 -1.186 . . . . 0.0 113.589 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -99.95 158.14 16.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.753 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.84 86.39 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -77.12 -0.12 23.7 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.53 142.38 27.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.508 0.194 . . . . 0.0 110.757 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -91.61 120.09 32.08 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.95 129.98 74.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.754 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.0 m -75.91 110.32 10.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 79.9 mt -122.37 120.28 60.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.348 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -98.48 101.4 12.83 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -120.15 154.22 35.08 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.074 0.464 . . . . 0.0 111.667 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 30.8 m -123.43 129.73 51.69 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.662 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.35 125.43 7.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.903 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 25.2 m -142.38 125.83 16.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 60.1 t -86.45 -78.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.653 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -132.77 80.31 1.89 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.55 7.3 73.43 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.096 -0.574 . . . . 0.0 112.903 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -140.69 143.72 35.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.793 0.33 . . . . 0.0 110.12 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -87.27 156.73 19.52 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.193 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -122.64 174.04 7.34 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.71 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.21 -38.84 74.34 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -101.19 -178.22 28.91 Favored Glycine 0 C--N 1.318 -0.435 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.091 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.02 30.5 38.07 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.704 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -107.18 102.92 12.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -124.45 142.67 51.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 111.948 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.4 m -150.52 132.24 14.96 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.2 31.04 20.9 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.374 0.421 . . . . 0.0 110.343 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -95.84 123.42 39.41 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.99 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.2 m -91.48 116.5 32.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.539 0.685 . . . . 0.0 110.598 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 56.3 tp -110.13 130.51 55.53 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.396 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.687 ' HB3' ' NH1' ' A' ' 193' ' ' ARG . . . -121.22 135.29 55.16 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 73.9 mtm -102.19 178.21 4.66 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.149 0.5 . . . . 0.0 112.001 -172.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.61 -10.64 73.73 Favored Glycine 0 CA--C 1.505 -0.531 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.235 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -102.83 -9.23 20.11 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.618 0.247 . . . . 0.0 111.173 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.63 42.45 21.65 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.853 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.687 ' NH1' ' HB3' ' A' ' 188' ' ' ALA . 48.3 mtm180 -93.27 0.41 57.01 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.343 0.592 . . . . 0.0 110.632 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.502 ' HB2' ' HG3' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -130.17 172.95 11.23 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.445 173.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.635 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.4 mp -69.07 137.47 89.56 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.98 134.75 49.94 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.984 1.789 . . . . 0.0 111.416 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.91 -38.94 2.9 Favored Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.511 ' O ' HG12 ' A' ' 202' ' ' ILE . 47.9 t80 -63.57 -49.77 72.08 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.502 ' HG3' ' HB2' ' A' ' 194' ' ' MET . 88.0 mt-10 -67.11 -36.11 81.22 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.492 0.663 . . . . 0.0 109.938 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.85 -36.08 82.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.627 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.16 -8.95 77.64 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.889 -0.672 . . . . 0.0 114.095 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 198' ' ' PHE . 47.8 mm -65.14 -45.27 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 117.275 0.538 . . . . 0.0 111.194 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -58.99 130.54 47.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.167 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.9 -15.02 48.85 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.451 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -83.37 143.51 30.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 117.06 0.43 . . . . 0.0 111.724 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -96.01 160.51 14.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.274 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.47 121.44 14.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.563 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 82.51 24.13 54.59 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.393 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -105.8 113.07 26.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.374 0.607 . . . . 0.0 111.482 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -91.37 130.94 37.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.559 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.479 ' O ' ' HB ' ' A' ' 212' ' ' THR . 61.5 t80 -150.52 -29.84 0.21 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -176.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 91.1 m 79.77 143.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.839 0.455 . . . . 0.0 110.279 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.3 tp -115.75 -42.01 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 72.12 100.11 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.329 0.585 . . . . 0.0 112.03 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 63.8 t -121.89 133.96 66.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.891 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 9.4 m -93.1 -23.49 18.6 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.45 ' CE2' HG12 ' A' ' 195' ' ' ILE . 96.4 m-85 71.94 145.59 0.11 Allowed Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 122.817 0.447 . . . . 0.0 111.459 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.56 154.02 60.09 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.621 2.214 . . . . 0.0 111.846 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -65.38 -40.04 93.01 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.947 0.403 . . . . 0.0 110.775 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -88.11 32.34 0.76 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.486 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -69.25 132.71 46.91 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.728 -0.389 . . . . 0.0 109.994 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -56.67 -40.4 75.45 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.57 101.85 7.62 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -61.53 -33.26 73.52 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -68.36 -14.11 62.76 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.18 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.0 mt -117.48 -0.34 11.95 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -71.54 124.21 24.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.311 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.91 17.96 77.3 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.544 -0.753 . . . . 0.0 114.492 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -127.5 132.05 50.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.711 0.755 . . . . 0.0 110.663 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.21 151.71 25.54 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.73 135.89 33.6 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.501 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.92 -48.05 67.04 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 54.46 91.83 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.082 0.468 . . . . 0.0 111.067 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.88 89.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mm 69.7 90.14 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.106 0.479 . . . . 0.0 111.522 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -67.88 -47.5 68.68 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.29 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.456 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 8.0 tp 55.26 100.37 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.86 0.864 . . . . 0.0 113.034 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -95.58 -70.91 0.69 Allowed 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 34.0 mmtp -80.5 -86.87 0.08 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -176.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 242' ' ' GLU . 65.6 t 76.84 140.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.111 0.564 . . . . 0.0 111.053 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.52 ' HB3' ' NH1' ' A' ' 243' ' ' ARG . 50.8 mm-40 -64.16 -37.03 85.98 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.344 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.538 ' H ' HG12 ' A' ' 240' ' ' VAL . 36.2 mt-10 66.97 129.3 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.535 0.734 . . . . 0.0 111.881 -176.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.52 ' NH1' ' HB3' ' A' ' 241' ' ' GLU . 8.6 ptp180 173.55 114.27 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.967 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 157' ' ' ALA . 0.4 OUTLIER -142.66 -153.96 0.49 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.473 ' HB2' ' HG2' ' A' ' 152' ' ' LYS . 10.5 mp 70.18 146.09 0.11 Allowed Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.528 ' O ' ' HG2' ' A' ' 247' ' ' GLU . 95.7 Cg_endo -82.94 -159.08 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.175 2.583 . . . . 0.0 112.931 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 246' ' ' PRO . 3.4 pt-20 87.96 -176.47 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.188 1.795 . . . . 0.0 111.043 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.76 135.73 48.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.105 0.479 . . . . 0.0 111.639 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 41.2 p -88.39 -168.52 2.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.036 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.23 -51.39 66.75 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.931 0.396 . . . . 0.0 109.935 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -132.54 94.23 3.38 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 173.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -72.97 -10.22 59.56 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.297 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 253' ' ' ILE . 3.8 mp -65.25 -44.55 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.72 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.531 ' HD2' ' HB2' ' A' ' 260' ' ' ASP . 58.2 pttt -150.88 151.74 32.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.879 0.371 . . . . 0.0 111.756 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' A' ' 256' ' ' PHE . 28.1 tpt180 -168.93 -175.21 2.28 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -174.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.572 ' H ' ' HG3' ' A' ' 255' ' ' ARG . 91.9 m-85 90.47 -39.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.356 1.062 . . . . 0.0 113.67 172.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 133.43 -132.13 6.37 Favored Glycine 0 C--N 1.313 -0.695 0 C-N-CA 119.326 -1.416 . . . . 0.0 113.234 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.7 m 38.18 48.26 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.933 0.893 . . . . 0.0 111.389 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 260' ' ' ASP . 33.6 tt0 66.94 -84.8 0.03 OUTLIER 'General case' 0 C--O 1.235 0.329 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.334 -174.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . 0.531 ' HB2' ' HD2' ' A' ' 254' ' ' LYS . 4.0 p30 174.2 151.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.112 0.565 . . . . 0.0 110.434 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.39 -171.76 31.03 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.933 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.2 p -79.81 168.74 18.89 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.604 0.362 . . . . 0.0 110.911 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 94.0 t -61.94 -49.56 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.785 0.326 . . . . 0.0 111.578 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.4 pm0 -71.14 -41.33 70.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.129 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.27 95.6 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.389 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 270' ' ' VAL . 58.1 tp -61.8 -45.67 92.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.555 0.217 . . . . 0.0 111.117 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 263' ' ' VAL . 66.1 mtp180 -66.73 -41.41 87.93 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.573 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.91 -43.3 83.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.202 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -66.5 -39.81 88.89 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.705 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 266' ' ' LEU . 76.0 t -64.35 -42.35 95.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.938 176.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -57.56 -47.62 81.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.564 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 12.8 ptmt -66.99 -39.62 87.2 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -63.79 -41.03 98.01 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.987 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 98.7 mmm -64.43 -41.87 96.33 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.852 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.22 -34.92 75.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.762 0.315 . . . . 0.0 111.122 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -61.96 -43.09 99.58 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -67.07 -37.96 84.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.494 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.6 tp -61.96 -41.07 97.57 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.834 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -57.7 -46.12 84.77 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.654 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.3 m -63.65 -44.72 93.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.576 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.74 93.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.076 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.62 -43.94 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.24 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -62.53 -42.62 99.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.893 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -62.97 -41.34 99.52 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.104 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -60.26 -44.1 95.59 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.117 0.484 . . . . 0.0 110.327 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.0 t -70.02 -43.79 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.946 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.96 -47.39 86.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.299 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.9 p -62.25 -43.23 99.29 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.643 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -65.79 -42.49 90.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.842 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.628 ' O ' ' HG ' ' A' ' 294' ' ' LEU . . . -64.26 -45.62 87.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.044 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 295' ' ' VAL . 35.1 mm -63.98 -43.99 97.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.058 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.511 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 29.7 tp10 -60.52 -43.68 96.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.438 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.52 -40.3 98.6 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.278 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 290' ' ' ALA . 69.8 mt -63.38 -43.07 98.64 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.711 0.291 . . . . 0.0 111.155 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 291' ' ' ILE . 93.7 t -65.01 -44.8 95.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.941 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . 0.511 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.1 mttm -64.37 -39.8 94.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.326 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.97 95.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.921 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -137.93 102.27 4.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -90.02 107.38 19.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 8.7 tp -114.48 140.04 37.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.82 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -68.72 129.01 38.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.477 0.656 . . . . 0.0 110.05 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 94.0 t -99.56 135.54 20.58 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.687 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.74 132.81 53.86 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.498 2.132 . . . . 0.0 111.828 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.0 87.54 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.46 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' A' ' 11' ' ' LEU . . . -58.0 -41.74 83.7 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 111.537 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.2 -42.3 93.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.31 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 64.6 mt -64.02 -44.58 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.817 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.09 -42.56 85.89 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.873 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.1 m -62.04 -44.64 96.27 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.055 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.499 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 74.0 mm-40 -69.37 -38.79 78.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.707 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.522 HD13 ' HG3' ' A' ' 334' ' ' ARG . 94.2 mt -62.19 -44.34 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -177.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.485 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 26.9 t70 -62.55 -43.1 99.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.037 0.446 . . . . 0.0 110.638 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.11 -43.31 95.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.293 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 95.8 mt -62.41 -41.81 98.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.037 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.485 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 85.3 mtm180 -63.72 -42.25 97.96 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -64.34 -41.14 96.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.554 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -63.46 -40.92 98.4 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.004 0.431 . . . . 0.0 110.603 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.42 91.76 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.223 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.92 -37.09 86.48 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.799 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.44 ' NE2' ' HG3' ' B' ' 45' ' ' ARG . 47.1 tt0 -60.64 -39.39 88.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.77 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -89.74 2.29 55.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.693 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -99.0 -2.95 36.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.342 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . 0.546 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . 139.98 -1.55 2.26 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.567 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 91.71 29.13 12.37 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.461 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.511 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 43.7 t-20 -72.39 124.04 24.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.654 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 0.6 OUTLIER -119.61 153.45 35.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 0.1 OUTLIER 61.37 -30.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 126.03 1.732 . . . . 0.0 114.608 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.511 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 15.9 mm100 -79.8 -5.31 55.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.301 0.572 . . . . 0.0 110.38 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.58 -18.39 63.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.38 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.92 -37.93 86.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.503 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.83 -20.13 65.13 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.853 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 81.6 mt -62.02 147.03 91.01 Favored Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.275 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.444 ' O ' ' HD1' ' A' ' 337' ' ' PHE . 32.5 Cg_exo -61.04 142.08 96.22 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.804 2.336 . . . . 0.0 112.82 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.522 ' HG3' HD13 ' A' ' 311' ' ' ILE . 21.4 ttt180 -84.49 -41.07 16.93 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.836 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -60.14 -39.48 86.48 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 76.9 mt -86.05 -2.88 58.73 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.444 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.444 ' HD1' ' O ' ' A' ' 333' ' ' PRO . 60.2 m-85 -109.83 -21.33 12.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.132 0.491 . . . . 0.0 109.875 173.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.74 -29.22 67.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.08 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -60.8 -47.44 86.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 110.639 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -78.42 -22.88 47.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.598 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -62.68 -41.77 99.27 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.197 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.8 tttt -59.73 -48.29 82.26 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 347' ' ' VAL . 13.4 mmt85 -61.25 -45.32 95.0 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.038 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.422 HH21 ' HD3' ' A' ' 344' ' ' ARG . 67.7 mtt-85 -65.89 -38.94 90.1 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 341' ' ' ALA . 97.4 t -66.63 -43.23 90.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.031 0.444 . . . . 0.0 109.998 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 342' ' ' LYS . 59.7 t -60.24 -43.48 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.566 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 343' ' ' ARG . 71.0 t -59.51 -45.09 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.32 -43.89 98.44 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.032 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.97 -42.77 97.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.557 0.218 . . . . 0.0 111.437 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.9 mt -62.75 -45.92 90.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.94 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.12 -38.91 82.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.241 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.57 97.07 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.146 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.78 -35.05 79.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.886 0.374 . . . . 0.0 110.837 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.62 -43.69 95.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.93 -44.89 99.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.899 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -69.48 -46.28 67.0 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.0 m -63.31 -44.18 95.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -97.11 5.71 49.78 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.059 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 52.83 53.19 12.51 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.846 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.91 145.57 32.59 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.7 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.25 148.26 44.54 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.765 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.88 127.54 32.91 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 367' ' ' VAL . 25.2 t70 -96.9 110.68 23.14 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.784 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -59.23 -34.6 72.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.775 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.449 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 46.7 mm-40 -67.05 -40.93 87.21 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.12 0.486 . . . . 0.0 110.591 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -63.4 -38.97 93.19 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 363' ' ' ASP . 93.6 t -62.51 -41.03 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.087 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 372' ' ' GLU . 25.9 mmmt -55.34 -45.15 76.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.066 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.16 -41.31 99.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.399 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.93 -42.66 99.87 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.09 0.471 . . . . 0.0 110.38 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.79 -44.04 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.738 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 368' ' ' LYS . 47.5 mt-10 -64.87 -40.26 94.85 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.718 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.91 -38.35 86.05 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.491 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 57.6 ttm -65.49 -41.49 93.2 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.076 0.465 . . . . 0.0 110.34 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -63.23 -26.3 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.844 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.8 m -72.35 -6.77 45.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.29 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -92.09 1.25 57.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.913 0.387 . . . . 0.0 110.789 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -119.87 172.59 7.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.843 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.23 -46.2 78.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.758 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 26.7 t70 -120.97 108.82 36.21 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.958 0.409 . . . . 0.0 110.576 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.467 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 51.8 Cg_exo -56.55 -39.41 91.53 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.91 2.406 . . . . 0.0 113.233 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.84 -43.84 91.72 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 9.4 pt-20 -62.88 -37.78 88.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.451 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.45 -42.73 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.217 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.48 -44.92 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.212 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.14 -38.6 78.9 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.265 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -58.97 -46.52 87.88 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.936 0.398 . . . . 0.0 110.355 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.488 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 4.6 t80 -68.65 -44.22 74.6 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.527 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.9 p -73.45 -17.32 61.26 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -176.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.12 4.14 54.51 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.108 0.48 . . . . 0.0 111.076 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 395' ' ' MET . 16.2 t-20 -122.51 111.45 16.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.033 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -61.39 -42.08 98.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -58.56 -48.89 79.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.776 0.322 . . . . 0.0 110.636 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.27 -40.44 97.4 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.492 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.437 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 95.9 mtp -61.72 -48.86 78.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.712 0.292 . . . . 0.0 111.62 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.51 -37.65 74.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 -175.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -62.25 -44.06 97.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.203 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.488 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 51.6 tpp -66.29 -39.74 89.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.146 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.481 ' HG2' HG21 ' A' ' 367' ' ' VAL . 55.7 mtm180 -64.17 -35.96 82.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.797 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -61.74 -43.84 98.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.001 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.2 -44.48 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.912 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.72 -40.48 97.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.903 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 45.9 tp -64.47 -37.74 88.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.462 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.84 -44.27 90.92 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.165 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -65.96 -37.0 84.88 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.595 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -60.06 -42.25 94.11 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.47 82.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.926 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 85.1 t -63.55 -46.41 95.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.02 -33.06 74.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.383 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.93 96.08 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 110.569 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 93.7 t -65.16 -42.23 93.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.314 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 95.5 mt -60.49 -40.16 90.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.643 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.58 -22.61 66.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.352 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -94.39 -40.44 9.93 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.919 0.39 . . . . 0.0 111.423 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -80.36 177.99 8.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.372 0.606 . . . . 0.0 112.36 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -87.25 118.23 26.54 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.362 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.1 t -103.36 105.95 19.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.1 t -105.13 134.72 47.76 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.975 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.19 111.57 23.25 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.757 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -117.79 128.13 54.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.992 0.425 . . . . 0.0 110.893 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -72.06 147.43 46.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.167 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -157.13 169.64 24.32 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 120.834 0.35 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 29.6 p -91.29 165.34 13.49 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.339 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -66.35 -30.34 70.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.479 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -62.46 -38.27 89.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.862 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.57 -33.5 75.81 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.08 0.466 . . . . 0.0 110.364 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 11.2 mp -72.43 -21.34 61.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.562 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.9 mmt -73.46 -6.65 47.7 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.031 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -78.79 71.69 5.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -102.49 17.42 23.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.268 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -64.17 -39.79 94.75 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.441 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.218 178.823 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 120.95 0.405 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.14 134.67 56.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.193 0.52 . . . . 0.0 111.711 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.02 159.76 42.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.27 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 40.2 t -115.85 107.73 15.4 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.998 0.428 . . . . 0.0 110.582 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 p -145.83 139.88 21.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.137 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -122.15 154.45 37.4 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.974 0.416 . . . . 0.0 111.137 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 61.5 m -104.35 119.79 39.74 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.912 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.8 m -70.67 -66.09 0.65 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.039 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -179.46 131.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.577 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.22 -106.37 1.65 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.507 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.453 ' HG ' ' CG1' ' B' ' 111' ' ' VAL . 2.5 mp -96.99 -14.5 21.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.687 0.28 . . . . 0.0 110.364 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.1 132.62 19.35 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.552 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.9 143.83 47.16 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 122.703 0.401 . . . . 0.0 109.997 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -117.9 133.94 55.44 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 19.8 t -81.04 -93.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.1 m 55.58 90.35 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.27 0.557 . . . . 0.0 110.679 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.1 tp -106.59 133.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.075 0.464 . . . . 0.0 111.921 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 25.5 p -81.76 132.09 35.28 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.824 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.5 HD13 HD11 ' B' ' 24' ' ' ILE . 1.8 pp -128.58 164.76 29.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.66 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -111.12 156.6 21.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.14 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.25 -52.87 57.61 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -173.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -71.05 -34.14 70.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.907 0.384 . . . . 0.0 110.963 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 33.4 t -64.87 -29.1 70.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.443 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.66 HG13 ' O ' ' B' ' 20' ' ' ALA . 64.9 mt -63.25 -71.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.29 0.567 . . . . 0.0 111.302 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.35 -42.72 96.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.646 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 18.1 m -63.1 -47.43 82.87 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.06 -44.3 15.33 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -174.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 81.4 t -62.44 -44.66 99.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.55 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -61.71 -47.16 86.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.706 0.289 . . . . 0.0 111.036 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 21.8 m -61.75 -42.42 98.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.467 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.426 ' O ' HG23 ' B' ' 35' ' ' VAL . 13.6 tp10 -65.25 -40.99 94.72 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.868 0.366 . . . . 0.0 110.562 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 96.2 mt -63.71 -44.07 94.7 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.67 -37.2 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.74 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.16 -40.49 97.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.288 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 31' ' ' GLU . 83.9 t -64.05 -44.07 97.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.794 0.331 . . . . 0.0 110.511 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -46.37 89.97 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.855 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.74 -33.99 76.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.088 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.83 -43.84 90.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.854 0.359 . . . . 0.0 110.448 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 t -84.84 -4.7 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 121.289 0.566 . . . . 0.0 110.314 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 61.98 28.53 17.33 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.499 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.419 ' H ' HG13 ' B' ' 41' ' ' ILE . 2.8 pp -105.04 5.77 10.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.974 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -65.06 -28.61 69.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.264 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.2 -19.26 72.03 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.273 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -76.24 -17.55 59.44 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.44 ' HG3' ' NE2' ' A' ' 320' ' ' GLN . 71.5 ttt-85 -87.15 93.54 9.4 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.115 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -69.37 115.85 9.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.94 70.74 0.49 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 115.97 1.148 . . . . 0.0 115.97 -170.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.19 -44.56 83.63 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.61 105.96 26.64 Favored Pre-proline 0 N--CA 1.439 -1.005 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.125 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.484 ' HB2' ' OD1' ' B' ' 52' ' ' ASN . 14.0 Cg_endo -58.44 145.74 93.07 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.198 1.932 . . . . 0.0 111.396 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.551 ' HA ' HG12 ' B' ' 54' ' ' VAL . 19.4 ttt -63.47 -38.84 92.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.151 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . 0.484 ' OD1' ' HB2' ' B' ' 50' ' ' PRO . 21.8 p-10 -62.02 -43.25 99.23 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.899 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.511 HG12 HH21 ' A' ' 193' ' ' ARG . 1.8 mp -68.5 -44.64 82.91 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' B' ' 51' ' ' MET . 4.3 p -63.89 -37.35 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.502 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.49 87.41 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.341 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -84.27 -33.66 23.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -62.53 -42.82 99.77 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.982 0.42 . . . . 0.0 110.946 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -108.6 18.21 21.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.412 0.625 . . . . 0.0 110.805 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.43 145.68 49.74 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.426 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 72.75 -33.98 0.28 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.458 0.703 . . . . 0.0 112.263 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.7 t -61.63 -47.27 86.17 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.68 21.34 5.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 122.079 0.943 . . . . 0.0 109.899 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -63.27 -21.3 66.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.035 -177.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -64.02 -47.06 81.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.774 0.321 . . . . 0.0 110.807 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.94 -23.86 55.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.268 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 90.1 t -64.74 -42.16 94.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.0 -38.47 88.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.17 -41.71 98.3 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.637 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . 0.569 ' OD1' ' HE2' ' A' ' 327' ' ' LYS . 21.1 t70 -60.23 -46.92 88.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.22 -42.91 99.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.409 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 61.0 ttp -63.03 -43.09 99.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.174 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -62.17 -43.8 98.02 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.256 0.551 . . . . 0.0 110.807 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.405 ' NH1' HG21 ' B' ' 35' ' ' VAL . 71.5 mtp180 -64.78 -40.61 95.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.314 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -63.85 -40.8 97.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.898 0.38 . . . . 0.0 110.473 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -61.09 -48.98 79.19 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.099 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.462 ' O ' HG13 ' B' ' 79' ' ' ILE . 15.5 tt -68.74 -41.25 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.39 -38.0 89.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.212 0.529 . . . . 0.0 110.072 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.66 -47.22 84.65 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.092 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.462 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.8 pp -66.69 -29.55 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.865 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.5 mt -65.46 -43.95 94.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.782 0.325 . . . . 0.0 111.07 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 65.8 pttt -81.31 -33.06 32.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -80.18 -7.91 59.17 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.064 0.459 . . . . 0.0 110.388 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt 66.93 38.08 3.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.262 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.9 mt -101.19 121.44 52.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.473 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -107.54 102.72 45.85 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.835 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.71 146.79 38.98 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 122.376 2.051 . . . . 0.0 112.085 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.35 100.63 12.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.609 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.59 -118.11 6.45 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.012 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.27 130.65 23.44 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-O 120.544 0.212 . . . . 0.0 110.883 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . 0.436 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 73.1 Cg_endo -75.25 161.6 37.78 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.982 2.455 . . . . 0.0 111.984 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -77.98 117.71 19.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.127 0.489 . . . . 0.0 111.899 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.436 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 81.6 m-85 -112.22 122.0 46.49 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 52.7 t -120.89 99.89 46.61 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-O 120.878 0.37 . . . . 0.0 110.713 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -89.66 145.24 4.72 Favored 'Trans proline' 0 N--CA 1.438 -1.791 0 C-N-CA 122.412 2.074 . . . . 0.0 111.213 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.14 174.92 40.92 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.326 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.63 126.42 29.29 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -81.27 125.19 30.03 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.023 0.44 . . . . 0.0 110.352 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -112.95 112.46 23.94 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.036 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 48.5 tp -65.43 107.11 1.56 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.047 0.451 . . . . 0.0 110.105 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.73 -16.32 8.37 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.257 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.37 -179.74 4.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.957 0.408 . . . . 0.0 111.629 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -79.8 138.52 37.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.744 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -96.11 143.1 27.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.473 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 45.4 m -124.92 134.67 52.57 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -140.68 155.7 46.42 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.392 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 3.0 m -84.66 -86.06 0.13 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 84.0 t 67.86 108.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.992 0.517 . . . . 0.0 110.692 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -111.51 138.69 47.71 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.639 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -152.81 -75.13 0.13 Allowed 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -142.43 157.2 45.03 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.798 -0.564 . . . . 0.0 111.32 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.453 ' CG1' ' HG ' ' B' ' 11' ' ' LEU . 27.5 m -129.94 -175.2 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 121.351 0.596 . . . . 0.0 112.342 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -138.16 119.32 10.37 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.01 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.72 148.54 32.71 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.019 2.479 . . . . 0.0 114.583 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -138.74 142.25 38.87 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.38 133.21 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -103.0 -92.25 0.34 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.451 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.4 mt 64.13 133.79 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.898 0.879 . . . . 0.0 113.337 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -141.83 152.47 43.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.469 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.2 19.42 78.47 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.465 175.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 75.3 mt -63.62 -37.2 86.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.986 0.422 . . . . 0.0 111.352 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' B' ' 121' ' ' GLU . 1.6 mp0 -72.64 -12.91 61.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.593 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.44 18.0 18.89 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.878 0.37 . . . . 0.0 111.37 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 83.6 mt -92.66 122.23 43.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -104.37 133.11 49.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.45 136.0 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.979 0.419 . . . . 0.0 112.027 -172.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -87.21 139.21 30.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.915 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -134.3 99.88 13.07 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 174.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.8 137.18 37.68 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.968 1.779 . . . . 0.0 111.492 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.72 123.66 69.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.848 0.356 . . . . 0.0 110.349 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.14 162.86 39.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.233 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -145.24 159.16 43.44 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.815 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.46 118.0 28.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 69.9 p -101.03 174.96 5.77 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.991 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.45 -31.81 72.59 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.657 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.13 99.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.481 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -65.08 -44.61 88.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.274 0.559 . . . . 0.0 110.268 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.4 t -63.8 -46.91 93.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.723 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -64.12 -42.71 96.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.646 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.75 -39.96 95.49 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.095 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.562 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.0 OUTLIER -62.68 -42.97 99.91 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 94.4 mt -63.63 -41.13 98.29 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.842 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -59.23 -48.72 80.56 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.68 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.9 m -61.8 -40.55 95.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.63 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.1 mt -61.04 -41.76 97.19 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.457 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -74.02 -18.05 60.9 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.467 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.5 -8.66 59.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.256 0.551 . . . . 0.0 110.394 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -95.83 4.61 52.7 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.342 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -119.07 75.33 1.03 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.754 0.788 . . . . 0.0 112.052 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -157.31 74.66 0.78 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.463 HG22 ' H ' ' B' ' 151' ' ' TRP . 4.9 m -145.83 171.86 14.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.102 -172.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . 0.463 ' H ' HG22 ' B' ' 150' ' ' THR . 44.8 t-105 82.02 10.68 0.73 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.79 1.236 . . . . 0.0 112.393 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.535 ' HG2' ' HB2' ' B' ' 245' ' ' LEU . 6.1 mptp? -94.3 158.16 15.71 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.048 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.27 -1.56 58.1 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -141.05 156.32 46.03 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 120.444 -0.503 . . . . 0.0 112.02 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 4.6 t70 82.98 178.08 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.065 1.346 . . . . 0.0 111.136 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.0 89.62 0.26 Allowed Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 119.403 -1.379 . . . . 0.0 115.134 -173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' B' ' 244' ' ' GLU . . . -103.38 -59.92 1.64 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 58.5 t 62.6 125.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.872 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -101.06 160.16 14.62 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.963 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.86 86.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -76.45 -4.38 42.19 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.79 143.48 32.82 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -96.82 121.23 38.45 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 49.5 t -119.53 129.46 75.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.773 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 25.5 m -76.42 104.28 6.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 77.1 mt -117.27 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.869 0.366 . . . . 0.0 111.582 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 16.5 m-20 -99.04 91.9 5.24 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -110.78 154.17 24.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 111.462 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 38.8 m -124.72 129.54 50.68 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.646 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.35 127.38 9.17 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.84 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 27.2 m -143.26 124.61 14.67 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.93 -78.22 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.609 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -133.41 81.03 1.91 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.101 0.477 . . . . 0.0 111.423 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.3 2.72 80.25 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.247 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -140.82 149.7 42.37 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 117.043 0.422 . . . . 0.0 110.874 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -89.16 150.18 22.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.9 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -115.74 177.14 4.78 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.164 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -57.28 -40.43 77.75 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.892 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -102.2 -173.28 27.45 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.061 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.14 30.53 46.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.785 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -106.82 107.47 18.5 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -126.6 141.64 51.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.071 0.462 . . . . 0.0 111.957 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.4 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 50.0 m -149.34 130.44 14.45 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 57.08 31.33 19.77 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.594 0.559 . . . . 0.0 110.6 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -96.06 124.25 39.99 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.561 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 5.7 m -91.78 117.2 34.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.535 0.683 . . . . 0.0 110.645 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 53.2 tp -110.91 131.74 54.79 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.619 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . 0.68 ' HB3' ' NH1' ' B' ' 193' ' ' ARG . . . -121.42 137.39 54.73 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 71.1 mtm -103.65 179.14 4.36 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.153 0.501 . . . . 0.0 112.002 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 92.46 -20.36 44.65 Favored Glycine 0 CA--C 1.503 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.009 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -91.25 -13.69 32.29 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.767 0.317 . . . . 0.0 111.248 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.72 40.58 10.62 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.095 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.68 ' NH1' ' HB3' ' B' ' 188' ' ' ALA . 51.8 mtm180 -94.47 0.52 55.42 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.432 0.634 . . . . 0.0 110.962 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.481 ' HB2' ' HG3' ' B' ' 199' ' ' GLU . 0.0 OUTLIER -129.26 165.73 20.82 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.389 173.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.682 ' H ' HD12 ' B' ' 195' ' ' ILE . 4.5 mp -61.23 136.59 94.07 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.71 133.67 51.06 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 121.957 1.771 . . . . 0.0 111.434 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.13 -39.01 2.88 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.193 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . 0.52 ' O ' HG12 ' B' ' 202' ' ' ILE . 52.1 t80 -62.35 -48.69 78.69 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . 0.481 ' HG3' ' HB2' ' B' ' 194' ' ' MET . 93.0 mt-10 -67.0 -36.44 82.15 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.283 0.563 . . . . 0.0 110.416 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.76 -35.71 81.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.218 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.38 -7.95 71.87 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.838 -0.696 . . . . 0.0 114.324 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.52 HG12 ' O ' ' B' ' 198' ' ' PHE . 48.1 mm -64.96 -44.23 96.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 117.57 0.685 . . . . 0.0 110.984 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -60.01 133.62 56.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.087 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.26 -15.04 51.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.179 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -84.24 141.18 31.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.26 0.552 . . . . 0.0 111.905 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -90.94 161.32 15.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.889 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.83 130.1 42.77 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' B' ' 237' ' ' LEU . . . 69.98 34.27 70.81 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.498 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -113.65 114.05 25.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.251 0.548 . . . . 0.0 111.59 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -91.24 137.35 32.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -156.48 -27.34 0.1 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 28.0 m 77.48 135.59 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.906 0.482 . . . . 0.0 110.988 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -106.58 -40.3 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 68.26 96.41 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.242 0.544 . . . . 0.0 112.364 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 66.4 t -119.25 135.71 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.071 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 6.5 m -93.78 -23.08 18.31 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.462 ' CE2' HG12 ' B' ' 195' ' ' ILE . 95.2 m-85 71.81 142.93 0.09 OUTLIER Pre-proline 0 N--CA 1.497 1.906 0 C-N-CA 122.892 0.477 . . . . 0.0 111.992 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 11.6 Cg_exo -71.42 153.58 60.91 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.737 2.291 . . . . 0.0 111.899 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.29 -40.77 94.27 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.867 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -84.81 29.73 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.318 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -68.6 133.25 48.23 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.945 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -57.63 -40.65 79.67 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.61 101.24 8.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.34 -32.38 71.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.793 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -67.52 -14.24 62.76 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 94.7 mt -119.21 3.29 11.39 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -73.76 125.45 28.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 119.736 -0.785 . . . . 0.0 112.372 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.95 16.04 76.41 Favored Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.418 -0.81 . . . . 0.0 114.283 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -125.44 128.88 48.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 117.59 0.695 . . . . 0.0 111.244 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.94 150.53 30.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -139.59 137.22 35.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.614 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -68.53 -48.31 64.66 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 54.39 91.93 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.165 0.507 . . . . 0.0 111.266 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.81 92.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 48.4 mm 70.38 90.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 122.869 0.468 . . . . 0.0 111.249 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.65 -48.19 67.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.322 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . 0.526 ' O ' ' HA2' ' B' ' 208' ' ' GLY . 8.1 tp 57.42 110.49 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.987 0.915 . . . . 0.0 112.917 176.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -105.36 -75.59 0.62 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . 0.411 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 34.3 mmtp -77.86 -83.76 0.08 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.5 HG12 ' H ' ' B' ' 242' ' ' GLU . 86.2 t 74.51 139.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.368 0.604 . . . . 0.0 111.288 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.522 ' HB3' ' NH1' ' B' ' 243' ' ' ARG . 56.3 mm-40 -63.48 -40.15 96.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.206 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.5 ' H ' HG12 ' B' ' 240' ' ' VAL . 31.1 mt-10 66.76 129.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.303 0.641 . . . . 0.0 111.809 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.522 ' NH1' ' HB3' ' B' ' 241' ' ' GLU . 5.6 ptp180 174.44 109.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.054 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.493 ' HG3' ' HB2' ' B' ' 157' ' ' ALA . 2.4 tt0 -137.03 -150.88 0.38 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.535 ' HB2' ' HG2' ' B' ' 152' ' ' LYS . 10.0 mp 69.16 145.76 0.11 Allowed Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 123.538 0.735 . . . . 0.0 112.714 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . 0.551 ' O ' ' HG2' ' B' ' 247' ' ' GLU . 84.5 Cg_endo -83.28 -158.79 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.059 2.506 . . . . 0.0 112.47 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' B' ' 246' ' ' PRO . 4.0 pt-20 85.68 -176.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.934 1.694 . . . . 0.0 111.004 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.13 136.0 49.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.124 0.487 . . . . 0.0 111.824 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 20.0 p -89.78 -170.14 2.7 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.213 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.61 -52.85 62.41 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.015 0.436 . . . . 0.0 110.017 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -131.09 92.18 3.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.482 0.658 . . . . 0.0 109.241 173.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -70.63 -13.64 62.16 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.563 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . 0.442 ' H ' HD12 ' B' ' 253' ' ' ILE . 4.0 mp -63.3 -44.51 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.493 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . 0.546 ' HD2' ' HB2' ' B' ' 260' ' ' ASP . 54.9 pttt -149.84 150.84 32.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 111.459 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.596 ' HG3' ' H ' ' B' ' 256' ' ' PHE . 27.5 tpt180 -166.02 -174.61 3.05 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -175.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . 0.596 ' H ' ' HG3' ' B' ' 255' ' ' ARG . 94.1 m-85 88.85 -41.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.463 1.105 . . . . 0.0 113.395 172.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 133.51 -129.86 5.5 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.304 -1.427 . . . . 0.0 113.183 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 26.8 m 37.85 49.58 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.669 0.788 . . . . 0.0 111.458 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' B' ' 260' ' ' ASP . 34.9 tt0 67.68 -85.17 0.03 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.518 -175.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . 0.546 ' HB2' ' HD2' ' B' ' 254' ' ' LYS . 2.6 p30 174.26 150.34 0.09 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.276 0.63 . . . . 0.0 109.959 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.5 -177.89 37.5 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.098 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 22.9 p -75.38 167.29 22.19 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 122.79 0.436 . . . . 0.0 110.859 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . 0.521 ' O ' ' HG3' ' B' ' 267' ' ' ARG . 99.4 t -61.93 -48.89 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -70.82 -40.3 72.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.769 0.319 . . . . 0.0 111.021 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -67.34 -40.69 91.77 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.425 ' O ' HG23 ' B' ' 270' ' ' VAL . 51.2 tp -61.78 -46.07 91.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.614 0.245 . . . . 0.0 110.961 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' B' ' 263' ' ' VAL . 44.8 mtp180 -66.17 -40.39 90.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.402 -177.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -68.34 -42.57 79.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.295 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -67.0 -40.15 87.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.646 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.425 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.1 t -64.35 -41.87 93.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -56.97 -47.82 79.83 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.47 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 16.2 ptmt -67.48 -38.6 84.63 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -63.67 -41.45 98.18 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.927 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.9 mmm -65.11 -42.42 93.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.973 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.19 -35.76 78.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.873 0.368 . . . . 0.0 110.973 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -63.3 -42.81 99.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -65.94 -38.64 89.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.491 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.78 -40.77 96.36 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.699 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -57.29 -48.61 78.48 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.164 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.3 m -62.9 -44.26 96.57 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.776 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.75 95.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.067 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.58 -44.25 98.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 120.969 0.414 . . . . 0.0 110.347 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -62.15 -42.53 99.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.88 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -62.9 -41.35 99.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 0.0 110.916 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -60.96 -43.92 98.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.479 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 94.9 t -69.49 -43.85 80.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.926 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . 0.422 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.1 tttt -61.12 -46.81 89.05 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.145 -176.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 75.4 p -62.04 -43.36 99.01 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -64.88 -43.73 91.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.779 0.323 . . . . 0.0 110.685 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . 0.67 ' O ' ' HG ' ' B' ' 294' ' ' LEU . . . -63.45 -46.84 84.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.076 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . 0.422 HG12 ' O ' ' B' ' 287' ' ' LYS . 38.1 mm -64.04 -44.16 97.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.646 0.26 . . . . 0.0 110.648 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . 0.496 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 32.8 tp10 -60.22 -42.61 95.53 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.352 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.91 99.16 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.382 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' B' ' 290' ' ' ALA . 65.6 mt -63.5 -42.53 98.5 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.552 0.215 . . . . 0.0 111.413 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 86.4 t -64.92 -44.57 96.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.957 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.496 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 67.8 mttm -63.78 -39.57 94.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.073 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -65.09 -40.76 95.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.125 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -137.06 100.86 4.39 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.05 98.81 11.98 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 8.6 tp -104.64 142.6 17.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.193 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.21 135.7 54.85 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.097 0.475 . . . . 0.0 109.799 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 90.3 t -109.88 132.91 21.14 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.37 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.58 132.27 51.1 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.421 2.081 . . . . 0.0 111.885 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.06 86.57 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.404 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.58 82.01 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.882 0.372 . . . . 0.0 111.399 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.29 -41.87 93.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.437 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . 0.4 ' O ' HG13 ' B' ' 311' ' ' ILE . 65.3 mt -65.12 -44.55 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.947 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -43.82 82.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.016 0.436 . . . . 0.0 110.958 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 31.8 m -61.56 -44.43 97.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.125 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . 0.539 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 52.0 mm-40 -68.29 -39.05 82.23 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.882 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.485 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.2 mt -62.29 -44.39 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.429 -177.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.499 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 20.3 t70 -62.38 -43.13 99.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.011 0.434 . . . . 0.0 110.872 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 91.5 t -64.88 -43.47 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.252 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 95.0 mt -62.24 -40.43 96.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.499 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 85.9 mtm180 -63.34 -40.94 98.68 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . 0.4 HH21 ' HD2' ' B' ' 316' ' ' ARG . 31.7 mtt180 -63.83 -39.93 95.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.717 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -63.02 -40.16 96.92 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.278 0.561 . . . . 0.0 109.914 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 -42.99 81.07 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -65.29 -37.35 86.88 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.333 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . 0.443 ' NE2' ' HG3' ' A' ' 45' ' ' ARG . 48.3 tt0 -62.43 -39.6 93.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.139 0.495 . . . . 0.0 110.431 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -86.99 -0.62 56.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.59 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -97.57 -2.41 41.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.166 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . 0.556 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 140.01 -6.51 2.86 Favored Glycine 0 C--O 1.223 -0.585 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.608 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 95.22 29.16 9.15 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.71 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . 0.483 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 43.5 t-20 -72.38 123.33 22.83 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . 0.661 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 0.7 OUTLIER -116.72 152.71 33.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 0.1 OUTLIER 62.06 -34.3 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.832 1.653 . . . . 0.0 114.773 177.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . 0.483 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.9 mm100 -76.72 -5.62 48.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.259 0.552 . . . . 0.0 110.454 177.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -66.23 -13.76 60.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.273 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.411 HD12 HH12 ' B' ' 315' ' ' ARG . 54.2 tp -62.99 -35.97 81.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.417 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -66.86 -24.55 66.15 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.707 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.479 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 72.3 mt -58.2 142.43 80.84 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.707 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . 0.477 ' O ' ' HD1' ' B' ' 337' ' ' PHE . 36.5 Cg_exo -60.86 137.62 73.73 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.287 2.658 . . . . 0.0 113.778 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . 0.457 ' HG3' HD13 ' B' ' 311' ' ' ILE . 26.7 ttt85 -74.14 -43.42 57.52 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.143 177.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.1 -37.42 85.02 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -170.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 71.5 mt -87.01 -3.57 59.1 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.524 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . 0.477 ' HD1' ' O ' ' B' ' 333' ' ' PRO . 56.5 m-85 -108.48 -22.09 12.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.084 0.468 . . . . 0.0 110.34 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.55 -29.1 67.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.33 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.66 -46.93 87.64 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.826 0.346 . . . . 0.0 110.814 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -76.72 -25.43 53.53 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.33 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.449 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.97 -42.09 99.73 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.469 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . 0.518 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.1 tttt -59.55 -47.09 86.9 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . 0.538 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.7 mmt85 -61.87 -45.3 94.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.201 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -66.6 -37.85 85.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 341' ' ' ALA . 96.0 t -65.2 -43.71 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 342' ' ' LYS . 71.1 t -60.78 -43.52 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.661 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.538 HG23 ' O ' ' B' ' 343' ' ' ARG . 75.1 t -59.23 -45.31 93.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.3 -43.92 98.4 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.069 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.83 -43.0 97.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.62 0.248 . . . . 0.0 111.448 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' B' ' 346' ' ' VAL . 97.0 mt -62.76 -46.26 88.87 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.895 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.39 -39.14 85.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.186 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.74 -42.15 97.85 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.357 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -67.26 -34.32 77.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.942 0.371 . . . . 0.0 110.923 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.2 -43.43 93.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.29 -44.51 99.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.748 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -70.64 -45.91 64.28 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 96.2 m -63.68 -45.0 92.09 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -95.23 4.17 53.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.245 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 53.48 54.19 10.46 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.95 0.5 . . . . 0.0 112.019 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.97 147.85 27.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.427 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.45 149.51 45.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.63 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.79 128.2 35.81 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . 0.526 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.6 t70 -95.9 111.25 23.29 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.403 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 52.9 mm-40 -61.64 -33.26 73.63 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.814 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . 0.419 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 68.3 mm-40 -66.99 -40.26 87.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.937 0.399 . . . . 0.0 110.366 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -64.14 -38.19 90.18 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.664 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 363' ' ' ASP . 97.8 t -61.82 -41.16 89.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.788 176.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.8 mmmt -56.56 -44.26 80.79 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.269 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.8 -41.53 99.63 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.245 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.2 -42.8 99.36 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.808 0.337 . . . . 0.0 110.252 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.55 -44.43 96.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.775 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.38 -42.79 98.84 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.763 -178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.89 -38.32 86.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.988 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 58.6 ttm -65.79 -40.91 92.4 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.972 0.415 . . . . 0.0 110.289 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -63.0 -26.59 68.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.69 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.2 m -71.89 -7.17 46.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.031 0.443 . . . . 0.0 111.229 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.0 -0.27 57.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.711 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -118.23 173.56 6.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.802 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.16 -45.89 83.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.979 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 21.4 t70 -122.54 109.37 32.77 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 121.017 0.437 . . . . 0.0 110.663 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . 0.455 ' HA ' ' HB1' ' B' ' 375' ' ' ALA . 52.7 Cg_exo -56.01 -41.36 77.82 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.692 2.262 . . . . 0.0 113.132 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' B' ' 382' ' ' LYS . 32.1 mmtp -65.75 -41.99 91.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 15.9 pt-20 -62.47 -39.07 92.25 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.029 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 91.3 t -67.19 -42.64 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.784 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.17 -44.53 99.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.28 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.46 -39.26 77.85 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.826 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.95 -42.12 84.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.248 0.547 . . . . 0.0 110.018 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . 0.506 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 5.0 t80 -73.75 -41.72 62.11 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.005 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 31.3 p -80.33 -7.85 59.24 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.88 4.9 45.36 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.368 0.604 . . . . 0.0 110.721 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -124.47 112.65 17.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.857 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.56 -41.11 96.89 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -60.23 -48.91 79.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.631 0.253 . . . . 0.0 111.199 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.45 -40.85 98.23 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.371 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.569 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 93.5 mtp -60.94 -48.16 83.08 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.352 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.03 -38.82 72.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.264 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.98 -42.86 99.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.5 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . 0.506 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 53.7 tpp -65.31 -39.48 92.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.668 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' B' ' 395' ' ' MET . 70.2 mtm180 -64.1 -36.48 84.15 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.755 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.1 -44.05 97.49 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.19 -45.45 90.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.864 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.95 -40.79 98.72 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.932 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 46.9 tp -64.16 -38.08 89.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.647 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.39 -43.13 96.94 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.441 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -65.48 -38.01 88.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.424 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -59.27 -41.34 88.66 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 120.758 0.313 . . . . 0.0 110.327 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.443 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.8 -47.36 81.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.086 178.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.17 -45.66 95.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.948 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -65.65 -34.54 78.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.117 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.03 -40.18 94.45 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.923 0.392 . . . . 0.0 110.638 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 407' ' ' ALA . 94.3 t -64.92 -42.29 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.338 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.67 -37.8 82.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.172 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -67.8 -14.94 63.37 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.913 0.387 . . . . 0.0 111.537 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -100.74 -37.89 8.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 110.86 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.65 175.66 9.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.156 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -85.47 113.98 22.16 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.094 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.9 t -99.22 107.86 21.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.039 0.447 . . . . 0.0 109.878 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -110.43 134.66 52.12 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -94.06 114.1 26.2 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.153 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -116.26 131.84 56.83 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.905 0.383 . . . . 0.0 110.598 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -76.92 147.63 36.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.229 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.0 t -157.58 165.83 34.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.61 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 26.7 p -86.73 166.51 15.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.967 0.413 . . . . 0.0 110.98 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -64.05 -28.61 69.9 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.8 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -62.41 -39.29 92.8 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.921 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.27 -33.94 76.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.029 0.442 . . . . 0.0 110.628 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.85 -31.09 69.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.686 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.5 mmt -65.6 -10.44 35.59 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.809 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -74.93 69.58 1.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.5 0.667 . . . . 0.0 109.21 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -100.77 17.88 20.88 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.519 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -63.99 -40.64 96.83 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.143 178.486 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 120.627 0.251 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -98.72 115.09 27.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.796 0.331 . . . . 0.0 110.555 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.55 135.34 62.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.044 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 p -115.63 145.84 42.34 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.799 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.9 -52.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 66.5 179.21 0.21 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.114 0.483 . . . . 0.0 110.862 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 m -136.72 128.58 29.17 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.235 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.6 m -76.59 -68.49 0.59 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.831 0.348 . . . . 0.0 110.743 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -177.42 128.62 0.15 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.085 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.45 -115.94 8.46 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.932 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.42 -7.83 57.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 106' ' ' SER . . . -68.64 126.69 21.99 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.541 -177.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -135.59 159.22 42.28 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 122.909 0.484 . . . . 0.0 110.055 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.438 ' HG3' ' CE2' ' A' ' 105' ' ' TYR . 58.7 ttp180 -131.65 149.36 52.52 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.0 -83.64 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.006 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 m 46.84 79.31 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.059 0.457 . . . . 0.0 111.184 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.4 tp -113.33 135.25 53.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.894 0.378 . . . . 0.0 111.261 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.5 m -101.9 124.24 47.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.111 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.8 pt -128.92 160.68 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.552 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -73.17 155.78 39.28 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.905 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.69 83.79 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -64.18 -39.21 93.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.205 0.526 . . . . 0.0 110.446 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -65.8 -40.33 91.8 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.69 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 20' ' ' ALA . 77.3 mt -61.24 -48.83 87.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.53 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.03 -50.87 66.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.647 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.0 m -68.68 -51.06 45.98 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.6 -49.19 22.59 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -173.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.7 t -64.21 -43.39 97.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.59 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -58.98 -48.98 79.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.936 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -62.85 -42.14 99.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.266 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -66.62 -42.03 87.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.997 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.63 -42.86 99.83 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -68.89 -39.6 80.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.212 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -64.91 -42.0 95.11 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.5 m -67.05 -33.72 65.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.139 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.92 -41.12 95.82 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.087 0.47 . . . . 0.0 109.91 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.13 -29.57 69.33 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.37 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -58.75 -42.84 89.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.83 0.347 . . . . 0.0 110.593 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 t -92.27 -1.57 10.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.18 0.514 . . . . 0.0 110.241 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 61.62 29.72 18.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.844 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -101.51 5.56 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.914 0.388 . . . . 0.0 111.598 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -63.92 -31.24 72.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.601 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.68 -22.1 65.76 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.824 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -80.76 -6.11 58.04 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.59 ' HA ' ' NE2' ' B' ' 320' ' ' GLN . 22.7 ttt180 -97.46 90.57 5.1 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -92.59 76.43 5.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 169.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.69 105.65 3.12 Favored Glycine 0 N--CA 1.428 -1.841 0 CA-C-N 114.992 -1.003 . . . . 0.0 114.629 -172.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 88.4 tttt -64.46 -34.99 79.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 171.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' A' ' 54' ' ' VAL . 16.2 t -99.52 100.08 9.94 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.439 175.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 48' ' ' LYS . 17.2 Cg_exo -66.66 159.34 51.53 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.044 2.496 . . . . 0.0 112.495 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.549 ' HA ' HG12 ' A' ' 54' ' ' VAL . 45.7 mtt -60.05 -40.97 91.29 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -65.92 -21.04 66.41 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.17 -50.16 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.9 0.381 . . . . 0.0 110.928 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.612 ' HB ' HG12 ' A' ' 49' ' ' VAL . 12.6 p -67.46 -36.86 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.33 83.38 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -89.83 -1.71 58.05 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.571 -0.451 . . . . 0.0 112.212 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -101.33 -42.99 6.1 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 120.715 0.293 . . . . 0.0 111.556 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -97.49 5.1 50.13 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.469 0.652 . . . . 0.0 110.114 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.87 145.83 49.74 Favored Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.56 ' H ' ' HB2' ' A' ' 63' ' ' ARG . . . 72.52 -41.09 0.49 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.219 0.608 . . . . 0.0 111.699 -177.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 t -60.68 -46.62 89.65 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.856 0.462 . . . . 0.0 111.303 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 65' ' ' ASP . 8.1 p -124.97 18.77 4.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.662 0.744 . . . . 0.0 110.045 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.56 ' HB2' ' H ' ' A' ' 60' ' ' ALA . 13.2 ttt180 -65.89 -20.24 66.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.393 -174.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.58 -48.53 77.03 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.46 ' HB2' HG22 ' A' ' 62' ' ' VAL . 6.5 m-20 -67.3 -31.0 71.01 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.068 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.35 -43.34 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 99.3 mt -62.3 -39.72 93.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.77 97.7 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.446 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -62.69 -45.67 91.68 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 120.773 0.32 . . . . 0.0 110.984 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.64 -41.97 98.23 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.3 ttp -61.22 -46.06 91.97 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.965 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.2 m -63.37 -51.54 65.44 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.338 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -69.41 -38.21 77.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -65.37 -39.24 92.05 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.932 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.45 -47.17 87.27 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.46 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.6 tt -66.16 -38.63 82.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.85 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.25 -41.98 99.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.93 -45.33 89.74 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.435 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.4 pt -65.74 -41.35 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.47 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.43 -42.11 95.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 121.472 0.653 . . . . 0.0 109.379 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -59.41 -47.85 83.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.273 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -89.82 -0.86 57.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.425 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 65.4 36.8 6.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.81 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.404 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 98.1 mt -86.64 124.62 40.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.603 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -110.15 98.18 33.89 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.576 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 84' ' ' ILE . 19.7 Cg_exo -66.94 141.75 59.68 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.531 2.154 . . . . 0.0 111.819 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.29 103.3 15.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.913 0.387 . . . . 0.0 110.538 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -127.72 8.88 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.897 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.66 128.44 25.62 Favored Pre-proline 0 C--N 1.318 -0.786 0 O-C-N 122.916 -0.167 . . . . 0.0 110.613 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.16 144.76 82.59 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.451 2.101 . . . . 0.0 111.542 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.7 m -102.46 109.04 20.56 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.586 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 94.9 m-85 -86.45 91.59 8.58 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.68 106.59 2.54 Favored Pre-proline 0 C--N 1.324 -0.532 0 O-C-N 123.546 0.529 . . . . 0.0 111.189 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 91.0 Cg_endo -97.94 166.87 0.77 Allowed 'Trans proline' 0 N--CA 1.43 -2.214 0 C-N-CA 123.026 2.484 . . . . 0.0 111.299 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.06 -136.11 6.7 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 174.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.93 130.44 51.26 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -80.8 106.37 12.75 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.246 0.546 . . . . 0.0 110.771 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 101' ' ' GLU . 97.7 mttt -84.87 147.71 26.65 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.65 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.6 tp -82.93 116.42 22.21 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.081 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.0 21.98 53.94 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.363 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 98' ' ' LYS . 37.0 tt0 -140.01 161.6 37.22 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.289 0.544 . . . . 0.0 109.793 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.97 142.79 54.58 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.853 0.359 . . . . 0.0 111.296 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -102.34 145.01 30.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.152 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.2 m -121.84 136.54 54.93 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.561 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 43.0 p90 -136.87 162.16 34.01 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.968 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.486 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 14.9 m -93.69 -69.9 0.73 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.2 p 49.28 101.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.179 0.99 . . . . 0.0 111.888 -173.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.32 113.98 23.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -172.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -156.27 145.8 20.84 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.858 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 65.97 143.64 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.4 m -129.4 157.44 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.842 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -165.11 100.79 0.8 Allowed Pre-proline 0 N--CA 1.466 0.372 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -88.23 158.91 6.95 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.973 2.449 . . . . 0.0 113.991 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -130.95 134.17 46.49 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -125.34 132.86 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -103.8 -78.92 0.55 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.549 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.6 mt 66.55 125.9 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.707 0.803 . . . . 0.0 112.964 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.22 155.47 47.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.4 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.11 9.56 86.5 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.04 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.22 -39.8 94.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.201 0.524 . . . . 0.0 110.885 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.4 mp0 -72.2 -10.51 59.88 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.116 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.61 13.42 33.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.746 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 94.8 mt -81.76 125.49 39.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.24 0.543 . . . . 0.0 110.936 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.24 122.58 47.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.35 134.01 67.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.621 ' OE1' ' HE3' ' A' ' 420' ' ' LYS . 41.1 tt0 -82.13 146.93 29.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.499 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -135.2 91.86 18.71 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -69.47 113.97 3.5 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.237 1.958 . . . . 0.0 112.1 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.9 mm -97.19 112.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.74 155.91 18.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.129 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -129.93 145.31 51.62 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.304 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.12 123.46 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.882 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 64.0 p -107.81 175.59 5.43 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.583 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -67.38 -23.61 65.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.7 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.57 97.0 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.106 0.479 . . . . 0.0 109.95 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.41 -40.73 97.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.454 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.07 -45.24 99.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.703 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.24 -43.13 96.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.52 0.2 . . . . 0.0 111.068 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.33 -42.83 99.08 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.602 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.58 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.8 tpt -63.38 -46.43 86.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.641 0.258 . . . . 0.0 110.803 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.58 -41.84 98.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.483 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -59.38 -47.68 84.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.218 0.532 . . . . 0.0 110.399 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.8 m -63.24 -41.06 99.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.909 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 140' ' ' MET . 92.6 mt -60.48 -42.44 96.26 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -73.06 -14.59 61.44 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.172 0.51 . . . . 0.0 111.11 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.18 -10.23 33.8 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.802 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -99.83 -27.9 13.4 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.626 ' OE1' ' HG2' ' A' ' 255' ' ' ARG . 11.3 mm-40 -137.38 168.14 20.23 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -168.77 -90.18 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 113.429 -1.714 . . . . 0.0 108.45 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.574 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 23.7 m -162.61 159.16 24.24 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.438 ' HA ' ' CB ' ' A' ' 243' ' ' ARG . 20.5 p-90 -109.02 147.62 32.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.632 ' H ' ' HA ' ' A' ' 243' ' ' ARG . 84.0 tttt -170.41 -75.88 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.48 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -172.27 163.98 5.82 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 43.2 tttp 58.59 62.45 1.94 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.968 1.307 . . . . 0.0 114.516 174.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 244' ' ' GLU . 28.8 t70 -173.22 141.31 0.92 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.593 0.357 . . . . 0.0 110.901 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.32 53.59 0.6 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.838 -177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.11 -28.58 15.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 117.225 0.513 . . . . 0.0 110.065 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.418 ' N ' ' HD2' ' A' ' 243' ' ' ARG . 23.7 t 66.62 135.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.106 0.962 . . . . 0.0 113.227 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.497 ' HG2' ' HG2' ' A' ' 243' ' ' ARG . 6.7 mm-40 -86.8 170.22 11.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.444 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.431 ' HB3' ' OE1' ' A' ' 161' ' ' GLU . . . -71.0 -64.61 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.173 0.511 . . . . 0.0 109.901 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.431 ' OE1' ' HB3' ' A' ' 160' ' ' ALA . 1.3 pm0 -86.94 37.54 0.76 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.291 0.567 . . . . 0.0 110.551 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.61 -42.83 99.81 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.926 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 64.24 72.32 0.46 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.153 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 17.4 t -84.06 127.38 39.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.825 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.3 m -78.2 103.98 8.49 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 62.6 mt -120.62 122.51 68.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.709 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.84 89.77 5.79 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 171.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -114.77 156.73 24.32 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.307 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 29.9 m -129.79 132.2 46.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.617 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.55 131.64 10.64 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.298 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.7 m -135.85 135.74 40.03 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.822 0.344 . . . . 0.0 110.769 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 90.6 t -111.86 103.16 15.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.566 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.405 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 78.0 m-20 53.16 34.88 18.43 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.957 177.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.2 -11.01 47.85 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.979 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.88 138.72 50.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.901 0.85 . . . . 0.0 110.949 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -86.31 148.08 25.77 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.456 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -110.75 179.65 4.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.426 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -55.8 -52.55 63.6 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -90.44 -159.78 35.9 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.888 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . 75.29 27.7 63.35 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.297 -0.954 . . . . 0.0 111.827 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -116.48 102.9 9.9 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.17 141.23 51.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.812 0.339 . . . . 0.0 111.065 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.2 m -138.61 128.08 24.61 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 59.93 29.83 19.38 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.005 0.431 . . . . 0.0 110.874 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -94.94 133.66 38.46 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.429 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.3 m -97.55 122.73 49.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.421 0.629 . . . . 0.0 111.283 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 54.6 tp -109.84 125.5 52.83 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.755 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -104.66 141.46 36.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 69.8 mtm -116.62 160.42 20.72 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.228 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.88 8.04 65.55 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.741 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.472 ' HB2' ' HG2' ' A' ' 193' ' ' ARG . 98.1 mt-30 -119.7 0.36 10.92 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.7 29.09 55.89 Favored Glycine 0 CA--C 1.51 -0.229 0 C-N-CA 120.067 -1.063 . . . . 0.0 111.128 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.472 ' HG2' ' HB2' ' A' ' 191' ' ' GLN . 32.0 mmm-85 -70.06 -30.35 67.59 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 123.248 0.619 . . . . 0.0 110.341 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.433 ' HE3' ' HA ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -120.02 169.6 10.05 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.773 -178.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.6 mm -50.76 132.66 28.23 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.987 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.68 124.39 8.23 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.669 2.246 . . . . 0.0 112.325 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.46 -37.76 3.58 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.771 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -62.21 -47.65 83.5 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -77.77 -10.14 59.39 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.719 -0.393 . . . . 0.0 111.805 -178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 203' ' ' LYS . 31.1 t70 -88.34 -34.3 17.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.165 0.507 . . . . 0.0 109.874 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.62 -28.83 73.96 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.461 -0.791 . . . . 0.0 113.581 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.88 -26.33 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.853 0.358 . . . . 0.0 110.956 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 200' ' ' ASP . 3.4 mtpm? -57.46 125.21 21.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.126 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 93.95 3.45 63.91 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.711 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -97.71 134.97 40.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.423 0.63 . . . . 0.0 111.883 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -90.77 160.24 15.9 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.258 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.88 138.26 57.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 110.706 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 73.53 24.04 75.7 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.039 -0.6 . . . . 0.0 111.898 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -118.74 101.95 8.47 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.398 0.618 . . . . 0.0 110.745 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -91.4 110.23 21.52 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.611 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -127.01 -10.78 5.97 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 75.3 p 57.24 164.78 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.792 0.837 . . . . 0.0 112.617 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 215' ' ' VAL . 10.9 tp -143.55 160.77 16.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -94.89 107.27 19.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.723 0.297 . . . . 0.0 110.645 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 71.3 t -121.49 122.41 67.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 6.5 m -95.55 -28.98 14.6 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -175.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 216' ' ' THR . 54.4 m-85 68.62 147.39 0.11 Allowed Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 121.009 0.433 . . . . 0.0 111.121 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.44 151.77 65.39 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.236 1.957 . . . . 0.0 111.926 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -65.12 -35.53 81.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.198 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.86 25.49 2.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.996 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -64.88 134.95 55.11 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -59.92 -15.64 23.31 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.78 105.68 17.85 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -56.61 -35.39 68.23 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.412 0.685 . . . . 0.0 111.158 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.445 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 16.0 p30 -76.91 -15.86 59.55 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.445 ' HG ' ' OD1' ' A' ' 225' ' ' ASN . 91.6 mt -115.37 5.68 14.65 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -69.53 114.53 7.84 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.434 0.635 . . . . 0.0 112.255 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 67.25 22.06 72.51 Favored Glycine 0 C--O 1.238 0.366 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.584 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 225' ' ' ASN . 99.1 mttt -107.7 138.77 43.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.981 0.391 . . . . 0.0 110.679 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.619 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -81.31 128.62 34.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.424 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -112.67 134.05 54.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.929 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.405 ' HE2' ' OD1' ' A' ' 173' ' ' ASP . 68.8 mttm -81.01 -44.57 17.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 212' ' ' THR . 76.0 m-85 56.58 95.73 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 121.057 0.456 . . . . 0.0 111.858 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.94 -50.58 72.83 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.3 mm 61.87 92.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.109 0.564 . . . . 0.0 111.882 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -74.61 -43.48 55.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.117 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 13.2 tp 47.99 77.31 0.1 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.563 0.745 . . . . 0.0 111.567 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -71.18 -48.82 49.4 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -112.93 -81.17 0.59 Allowed 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.564 HG12 ' H ' ' A' ' 242' ' ' GLU . 41.2 t 81.23 150.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.713 0.805 . . . . 0.0 109.015 -173.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.79 -33.55 72.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.801 0.334 . . . . 0.0 110.466 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.564 ' H ' HG12 ' A' ' 240' ' ' VAL . 63.6 mt-10 74.62 152.75 0.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.089 0.955 . . . . 0.0 112.669 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.632 ' HA ' ' H ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -153.03 114.17 4.17 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 155' ' ' ASP . 39.1 tt0 -159.58 171.15 20.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 150' ' ' THR . 6.4 mp 70.81 108.17 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 123.59 0.756 . . . . 0.0 111.305 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.574 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 61.4 Cg_endo -81.16 101.02 1.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.026 1.817 . . . . 0.0 112.269 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.91 162.35 33.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.367 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.9 mp -84.28 88.55 7.24 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.822 0.344 . . . . 0.0 111.214 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 7.4 m -85.26 -75.89 0.34 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.724 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -177.95 -56.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.989 0.423 . . . . 0.0 110.558 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -73.71 14.64 0.35 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -78.06 -15.26 59.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.058 0.456 . . . . 0.0 110.302 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 43.0 pt -88.35 -14.23 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.098 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -138.34 94.11 2.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.628 0.728 . . . . 0.0 111.654 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.626 ' HG2' ' OE1' ' A' ' 148' ' ' GLN . 7.0 tpp180 -140.01 30.12 2.03 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.31 1.052 . . . . 0.0 108.923 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.15 15.16 9.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.201 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 77.02 15.97 81.19 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.119 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 55.9 t -99.87 141.29 17.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -54.86 -51.17 66.78 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 123.02 0.2 . . . . 0.0 111.069 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -175.61 162.44 2.77 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.265 0.353 . . . . 0.0 110.515 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -174.65 168.22 40.8 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.762 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 86.8 p -88.14 173.81 8.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.45 -48.7 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.56 -33.5 21.7 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.935 0.398 . . . . 0.0 110.322 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.4 -41.23 99.44 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.381 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.17 -44.45 96.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.588 0.233 . . . . 0.0 110.906 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -63.95 -42.64 97.26 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.211 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.4 -42.93 87.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.438 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -67.27 -40.14 86.15 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.906 0.384 . . . . 0.0 110.811 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 78.8 t -64.85 -42.75 95.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.785 0.326 . . . . 0.0 110.15 176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -55.76 -51.94 65.67 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.674 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.7 ptmt -65.63 -42.7 91.21 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -64.12 -39.45 94.05 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 96.5 mmm -63.9 -41.66 97.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 110.73 178.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -69.59 -31.65 69.93 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.972 0.415 . . . . 0.0 110.656 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -62.36 -42.2 99.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.98 -37.42 87.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.482 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 42.6 tp -62.39 -38.97 91.69 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.295 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -55.88 -46.92 78.16 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.209 0.528 . . . . 0.0 109.691 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.0 m -63.67 -43.92 95.27 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.65 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.56 92.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.184 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.47 -44.47 98.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.91 0.386 . . . . 0.0 110.465 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -64.64 -42.35 95.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.049 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -62.96 -41.32 99.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.155 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.511 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.2 tpm_? -60.18 -44.53 95.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.938 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.14 -43.85 78.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.903 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.95 -47.41 84.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.418 -176.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 75.1 p -62.2 -44.38 96.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -65.96 -41.51 91.15 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.134 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.61 87.45 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.651 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 295' ' ' VAL . 32.5 mm -64.32 -44.02 97.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.307 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.4 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 19.5 tp10 -61.08 -46.35 91.02 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.615 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.91 -40.23 95.33 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.363 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 350' ' ' LEU . 0.7 OUTLIER -63.86 -42.61 97.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.443 0.297 . . . . 0.0 111.121 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 291' ' ' ILE . 75.1 t -64.13 -42.98 97.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 120.962 0.411 . . . . 0.0 110.687 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . 0.4 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 68.4 mttm -62.71 -38.77 91.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.686 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.83 -47.7 77.03 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.069 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -130.03 99.35 5.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.656 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -94.82 107.74 19.76 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.3 tp -110.73 143.12 21.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.725 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -73.44 121.97 21.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.236 0.541 . . . . 0.0 109.807 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 43.9 t -86.74 134.18 38.04 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.066 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.09 138.12 84.33 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.527 2.152 . . . . 0.0 112.118 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.32 -29.99 70.84 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.904 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.01 68.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.619 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.4 mt -91.34 -34.19 14.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.27 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 71.4 mt -63.21 -51.88 65.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.723 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.36 -37.8 88.78 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 68.0 p -65.22 -46.65 79.78 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.72 0.295 . . . . 0.0 111.518 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.548 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 17.9 mm-40 -72.04 -33.21 67.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.431 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 70.7 mt -61.58 -43.74 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.516 0.198 . . . . 0.0 111.194 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.597 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 33.2 t70 -62.95 -40.93 99.15 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.687 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.54 -42.77 96.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.257 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 90.2 mt -61.64 -41.28 97.28 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.136 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 66.0 mtm180 -62.55 -39.72 94.51 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.916 178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 90.8 mtt180 -63.27 -43.28 98.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.397 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -65.05 -44.67 88.26 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.03 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.53 -39.7 88.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.401 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.62 -36.27 83.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.779 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.696 ' NE2' ' HA ' ' B' ' 45' ' ' ARG . 48.1 tt0 -62.83 -43.27 99.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.549 177.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.49 -23.6 61.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.183 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -77.29 -4.02 42.85 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.77 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 140.5 -22.58 2.7 Favored Glycine 0 CA--C 1.502 -0.733 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.687 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 116.25 29.45 2.33 Favored Glycine 0 CA--C 1.497 -1.066 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.547 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 41.6 t-20 -70.72 124.0 23.24 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.721 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.7 tm-20 -127.24 145.5 50.75 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 1.7 ptpp? 69.4 -37.97 0.39 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 125.574 1.55 . . . . 0.0 113.158 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.547 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 14.7 mm100 -73.63 -9.06 58.29 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.299 0.571 . . . . 0.0 110.369 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -64.02 -18.9 64.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.332 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.49 -37.63 86.73 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.22 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.88 -16.44 63.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.904 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.7 145.58 98.7 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.14 134.74 57.87 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 123.018 2.479 . . . . 0.0 112.951 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.41 HH21 ' HD2' ' A' ' 334' ' ' ARG . 21.4 ttt180 -70.7 -39.49 73.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.133 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -58.83 -33.79 70.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.06 -6.5 57.74 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.963 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -117.13 -30.78 5.55 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.608 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.55 -34.95 79.44 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -63.06 -51.06 68.16 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.995 0.426 . . . . 0.0 110.822 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.72 -28.0 65.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.22 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.48 -41.75 97.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.416 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.2 tttt -59.87 -47.14 86.96 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.55 ' O ' HG23 ' A' ' 347' ' ' VAL . 18.6 mmt85 -63.25 -45.59 90.8 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -66.42 -38.65 87.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.0 t -64.76 -43.34 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.645 0.259 . . . . 0.0 110.706 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 342' ' ' LYS . 77.3 t -60.31 -42.9 92.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.519 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 343' ' ' ARG . 87.4 t -59.53 -45.68 93.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.44 -42.69 98.97 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.412 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.92 -44.44 96.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.82 0.343 . . . . 0.0 111.19 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 294' ' ' LEU . 96.5 mt -63.92 -45.14 90.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.094 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.77 -40.99 92.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.9 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.5 98.59 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.86 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -66.3 -38.8 88.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.802 0.301 . . . . 0.0 110.723 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.96 -44.43 98.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.37 -43.83 98.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.805 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -66.54 -52.46 45.44 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.686 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.7 m -66.58 -46.17 76.86 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -87.35 -5.02 59.05 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.628 0.252 . . . . 0.0 111.377 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 59.11 70.22 0.66 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.276 0.56 . . . . 0.0 110.81 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.8 mt -101.46 124.36 47.02 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.783 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 144.15 44.06 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.082 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.04 114.96 4.48 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 367' ' ' VAL . 17.7 t70 -84.19 110.6 18.65 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.278 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 65.8 mm-40 -58.8 -39.1 80.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.068 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -64.65 -43.65 92.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.841 0.353 . . . . 0.0 110.789 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -61.59 -41.25 97.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.021 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 363' ' ' ASP . 93.2 t -64.11 -35.62 74.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.704 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 31.0 mmmt -57.81 -45.01 86.7 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.657 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.88 -38.07 95.57 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.979 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.0 -42.68 99.91 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.068 0.461 . . . . 0.0 110.16 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.7 -43.3 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.939 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.48 -39.96 89.55 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.729 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.79 -40.72 92.23 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.702 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.8 ttm -66.59 -40.11 88.75 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 110.446 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.86 -27.14 69.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.657 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 49.3 m -74.98 4.23 6.96 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.686 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -97.62 3.94 50.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.796 0.331 . . . . 0.0 110.979 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -120.85 177.42 5.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.014 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -62.15 -46.14 90.29 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.642 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -128.92 120.11 20.24 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.274 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.56 -29.65 30.0 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.486 2.124 . . . . 0.0 112.896 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -65.83 -43.17 89.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -64.0 -37.39 87.25 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.349 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.35 -42.09 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.488 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.8 -44.24 98.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.093 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.86 -32.54 72.28 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -58.56 -46.72 86.29 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.128 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -68.49 -46.64 69.14 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.5 p -68.77 -17.01 63.96 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.4 7.91 45.09 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.074 0.464 . . . . 0.0 110.896 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -132.84 108.61 9.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.336 178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -62.98 -38.17 90.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -58.92 -50.76 72.82 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.827 0.346 . . . . 0.0 110.7 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.71 -39.56 94.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.399 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 90.9 mtp -61.69 -44.02 97.74 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.781 0.324 . . . . 0.0 111.278 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.57 -45.52 65.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.31 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -63.88 -42.58 97.45 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.008 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 43.6 tpp -64.9 -43.23 93.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.897 0.379 . . . . 0.0 111.132 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -66.02 -33.23 75.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.267 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.77 -44.96 93.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.26 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.5 t -67.52 -43.63 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.118 0.485 . . . . 0.0 110.57 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.63 -40.72 95.86 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.169 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.32 -38.46 91.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.625 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -59.84 -43.97 94.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.72 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -65.42 -35.15 80.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.763 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -60.99 -43.97 98.09 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.59 -45.9 84.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.165 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.1 -45.85 97.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.188 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -68.57 -27.99 66.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.018 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.54 -37.96 88.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.137 0.494 . . . . 0.0 109.84 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 89.6 t -66.19 -41.44 89.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.137 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.09 -26.44 66.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.019 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -77.39 -9.14 58.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.363 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -113.45 -31.73 6.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.82 169.23 18.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.674 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -84.59 108.61 17.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.788 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 64.4 t -84.58 128.72 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.122 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -130.38 146.8 52.01 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -121.91 123.18 41.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.705 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . 0.621 ' HE3' ' OE1' ' A' ' 126' ' ' GLU . 20.7 pttp -132.68 145.83 51.38 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.68 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -82.85 153.02 25.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -155.64 172.32 18.48 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 27.1 p -84.96 165.04 17.94 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.907 0.384 . . . . 0.0 111.161 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -64.78 -26.04 68.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.343 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -62.33 -40.42 96.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.608 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -65.77 -33.05 74.97 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.837 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.0 mp -74.66 -18.54 60.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.346 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.3 mmt -83.03 3.78 28.86 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -82.88 74.51 9.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.368 0.604 . . . . 0.0 109.607 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -101.28 17.75 21.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.238 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -69.93 -25.58 63.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.238 0.542 . . . . 0.0 109.685 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.729 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.69 179.392 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 120.685 0.279 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -108.68 114.85 28.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.087 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 22.4 m -123.68 135.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.092 0.472 . . . . 0.0 111.723 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 29.6 p -113.87 148.61 36.4 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.506 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.444 HG13 ' H ' ' B' ' 6' ' ' GLU . 6.4 p -151.41 -61.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.444 ' H ' HG13 ' B' ' 5' ' ' VAL . 54.2 mt-10 69.09 169.0 0.29 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.241 0.543 . . . . 0.0 111.494 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.3 m -128.78 127.76 42.62 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.171 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 23.0 m -74.51 -69.95 0.43 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.504 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -178.37 129.99 0.13 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.756 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.1 -119.03 11.0 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.697 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.66 -9.25 56.42 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' B' ' 106' ' ' SER . . . -67.49 126.62 25.19 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.283 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' B' ' 12' ' ' GLY . 0.0 OUTLIER -135.14 158.88 43.23 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 122.937 0.495 . . . . 0.0 109.898 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -129.04 151.38 49.8 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 54.1 t -102.52 -82.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.016 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m 46.51 82.38 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.184 0.516 . . . . 0.0 111.457 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 tp -116.77 135.14 58.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.985 0.421 . . . . 0.0 111.096 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.5 m -104.52 126.03 51.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.932 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 16.8 pt -129.27 160.18 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.702 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.575 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -73.2 156.02 38.99 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.573 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -56.07 -46.01 79.12 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -64.82 -38.66 91.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.387 . . . . 0.0 110.354 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 35.5 m -63.75 -39.73 94.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.718 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.575 HG13 ' O ' ' B' ' 20' ' ' ALA . 81.0 mt -61.23 -49.67 83.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.807 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.73 -48.24 69.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.729 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 20.0 m -65.83 -50.95 62.76 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.96 -49.34 18.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.21 -43.13 97.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -59.03 -48.67 80.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.719 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 33.3 m -63.07 -42.82 99.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.891 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -68.37 -40.08 81.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.761 0.315 . . . . 0.0 110.899 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.6 mt -62.32 -43.1 99.62 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 p -68.68 -39.82 80.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.057 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -64.85 -42.01 95.23 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.59 -32.51 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.132 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.18 92.58 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.069 0.461 . . . . 0.0 110.033 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.88 -30.5 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.286 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -57.98 -41.52 83.12 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.038 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 t -95.8 -0.05 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.188 0.518 . . . . 0.0 110.407 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 61.09 29.1 18.71 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.405 ' H ' HG13 ' B' ' 41' ' ' ILE . 2.8 pp -101.57 4.94 10.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.143 0.497 . . . . 0.0 111.425 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.06 -33.02 74.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.598 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.14 -22.62 63.07 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.941 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -80.33 -6.56 58.17 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.63 0.252 . . . . 0.0 111.525 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.696 ' HA ' ' NE2' ' A' ' 320' ' ' GLN . 47.2 ttt85 -94.73 88.35 5.34 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 119.408 -0.917 . . . . 0.0 113.13 -177.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -89.86 86.53 6.66 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 169.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.15 102.59 2.91 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-N 115.134 -0.939 . . . . 0.0 114.84 -170.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.451 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 88.2 tttt -65.44 -34.95 79.5 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.566 HG12 ' HB ' ' B' ' 54' ' ' VAL . 19.3 t -101.87 100.2 14.08 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.278 175.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' B' ' 48' ' ' LYS . 18.6 Cg_exo -65.96 158.43 54.16 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.045 2.497 . . . . 0.0 112.607 -177.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.532 ' HA ' HG12 ' B' ' 54' ' ' VAL . 44.3 mtt -58.69 -41.69 86.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -65.99 -20.08 66.08 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.812 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -91.68 -50.33 12.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.079 0.466 . . . . 0.0 110.931 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.566 ' HB ' HG12 ' B' ' 49' ' ' VAL . 13.0 p -67.51 -36.76 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.41 -37.38 87.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -90.61 -1.64 57.88 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.497 -0.481 . . . . 0.0 112.281 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -100.53 -42.15 6.69 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.638 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -98.17 5.37 48.58 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.545 0.688 . . . . 0.0 109.946 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.97 146.87 49.76 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.527 ' H ' ' HB2' ' B' ' 63' ' ' ARG . . . 72.76 -41.56 0.51 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.154 0.582 . . . . 0.0 111.443 -176.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 47.0 t -60.52 -48.74 80.43 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.813 0.445 . . . . 0.0 111.428 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 p -122.03 18.64 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.771 0.796 . . . . 0.0 109.859 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.527 ' HB2' ' H ' ' B' ' 60' ' ' ALA . 12.6 ttt180 -65.58 -20.23 66.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.59 -174.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.68 -49.53 70.6 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.78 -32.41 73.93 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.93 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.58 -43.42 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.99 -40.01 94.16 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.79 -39.32 97.31 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.728 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.96 -44.99 94.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.681 0.277 . . . . 0.0 111.072 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.65 -41.93 98.2 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.7 ttp -60.65 -45.99 92.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.86 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 55.3 m -64.2 -51.75 62.2 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.375 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -69.32 -38.06 78.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -65.06 -39.53 93.4 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.597 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -60.26 -47.21 86.96 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.54 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 17.7 tt -66.02 -38.57 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.143 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.37 -41.67 98.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.76 93.0 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.597 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -66.73 -41.25 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.46 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.69 -42.64 96.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.573 0.701 . . . . 0.0 109.419 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -60.16 -47.78 84.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.576 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -89.24 -2.03 58.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.616 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 63.24 46.64 4.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.928 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.452 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 91.4 mt -98.45 122.21 49.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.118 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -107.46 100.1 32.07 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.709 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 22.8 Cg_exo -65.17 142.74 75.1 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.434 2.089 . . . . 0.0 111.443 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.37 110.89 23.35 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.882 0.373 . . . . 0.0 110.39 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.6 -113.99 4.0 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.121 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.43 125.67 14.52 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.55 144.34 78.68 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.428 2.086 . . . . 0.0 111.586 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 46.8 m -103.47 111.91 24.57 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.056 0.455 . . . . 0.0 109.824 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.503 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.1 m-85 -87.58 89.91 8.17 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.5 t -69.98 108.97 3.91 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.539 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.9 Cg_endo -100.98 169.3 0.35 Allowed 'Trans proline' 0 N--CA 1.433 -2.081 0 C-N-CA 123.178 2.585 . . . . 0.0 111.256 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.82 -120.73 3.17 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -141.94 133.04 26.15 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -80.08 107.58 12.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.366 0.603 . . . . 0.0 111.066 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' B' ' 101' ' ' GLU . 98.8 mttt -81.79 145.68 30.32 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 38.7 tp -82.78 108.31 16.04 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.868 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.49 14.64 49.87 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.778 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' B' ' 98' ' ' LYS . 39.7 tt0 -134.06 161.29 35.24 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.409 0.605 . . . . 0.0 109.923 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -66.73 143.03 57.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.011 0.434 . . . . 0.0 111.53 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -103.44 144.45 31.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.15 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.1 m -121.51 135.91 54.99 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.748 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -135.55 161.95 34.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.059 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.444 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 12.6 m -92.72 -70.44 0.7 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -175.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p 47.88 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.132 0.968 . . . . 0.0 111.811 -173.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.55 116.61 24.79 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -172.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -157.98 147.52 19.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.562 173.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 65.02 143.16 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.08 157.0 42.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.75 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -165.64 97.08 0.8 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.054 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -84.56 158.58 12.46 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.972 2.448 . . . . 0.0 113.348 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -132.82 135.22 45.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 70.3 t -123.47 136.13 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -103.61 -79.74 0.53 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.537 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 94.7 mt 65.53 128.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.888 0.875 . . . . 0.0 113.113 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -143.39 156.51 44.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.047 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.73 8.46 87.69 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.05 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.83 -39.82 95.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.598 . . . . 0.0 110.229 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' B' ' 121' ' ' GLU . 1.3 mp0 -66.55 -21.23 66.15 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.497 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.27 13.76 34.09 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 96.8 mt -77.65 125.41 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.223 0.535 . . . . 0.0 110.683 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -113.52 123.25 49.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.146 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.7 144.65 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.653 0.263 . . . . 0.0 111.263 -174.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . 0.568 ' OE1' ' HE3' ' B' ' 420' ' ' LYS . 38.4 tt0 -93.75 142.8 26.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.594 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -128.93 93.23 37.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.63 112.64 3.28 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.218 1.945 . . . . 0.0 111.903 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 48.6 mm -95.43 111.47 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.63 158.39 16.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.116 -178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -132.79 146.52 51.91 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.035 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 85.5 t -85.22 123.1 39.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 72.8 p -107.28 177.73 4.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.981 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -66.04 -28.42 68.84 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.8 -40.07 93.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.025 0.441 . . . . 0.0 110.361 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.01 -41.53 99.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.606 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.48 -44.94 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.016 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.38 -44.22 92.8 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.84 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.83 -42.0 98.63 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.763 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.567 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.8 tpt -63.02 -45.45 92.27 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.603 0.239 . . . . 0.0 110.967 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.17 -42.54 99.43 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.499 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -61.83 -45.57 93.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' B' ' 147' ' ' GLN . 20.6 m -63.45 -41.21 98.64 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.833 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' B' ' 140' ' ' MET . 91.8 mt -60.43 -42.22 95.61 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -72.08 -17.34 62.01 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.066 0.46 . . . . 0.0 111.335 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.92 -9.28 40.64 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.801 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' B' ' 143' ' ' THR . 63.4 mt-30 -100.48 -27.55 13.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . 0.605 ' OE1' ' HG2' ' B' ' 255' ' ' ARG . 9.8 mm-40 -137.79 167.87 20.85 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -167.56 -90.97 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.664 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 26.8 m -163.15 155.28 18.09 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . 0.487 ' HA ' ' CB ' ' B' ' 243' ' ' ARG . 26.3 p-90 -106.28 147.66 28.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.62 ' H ' ' HA ' ' B' ' 243' ' ' ARG . 83.9 tttt -170.62 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.602 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -172.21 164.29 5.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 46.4 tttp 58.0 66.39 1.12 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.838 1.255 . . . . 0.0 114.281 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . 0.522 ' HB2' ' HB2' ' B' ' 244' ' ' GLU . 27.8 t70 -177.96 146.48 0.42 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.182 0.593 . . . . 0.0 110.65 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.53 47.05 1.06 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.51 -0.853 . . . . 0.0 114.095 -176.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.03 -29.96 21.55 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.186 174.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.455 ' N ' ' HD2' ' B' ' 243' ' ' ARG . 22.5 t 67.31 135.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.267 1.027 . . . . 0.0 113.172 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . 0.495 ' HG2' ' HG2' ' B' ' 243' ' ' ARG . 6.8 mm-40 -87.67 169.36 12.19 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.833 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . 0.407 ' HB3' ' OE1' ' B' ' 161' ' ' GLU . . . -70.53 -66.17 0.64 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . 0.407 ' OE1' ' HB3' ' B' ' 160' ' ' ALA . 1.7 pm0 -86.06 40.18 0.85 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.447 0.641 . . . . 0.0 110.282 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.95 -43.46 95.75 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.305 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 63.65 74.75 0.41 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.952 -174.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 17.3 t -87.55 125.82 41.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.745 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.2 m -74.91 103.6 5.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 71.0 mt -119.52 123.27 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.044 0.45 . . . . 0.0 111.598 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . 0.506 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 23.9 m-20 -96.41 88.28 4.69 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 172.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -112.49 156.12 23.13 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.633 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 36.7 m -130.54 131.71 45.2 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.849 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.2 128.94 8.72 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.181 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 18.5 m -136.19 131.38 34.54 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.828 0.347 . . . . 0.0 110.786 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.48 105.32 18.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.823 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . 0.517 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 69.5 m-20 52.64 30.36 8.58 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.09 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 108.5 -12.26 36.08 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.858 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -110.7 142.48 42.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.784 0.792 . . . . 0.0 110.422 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -88.94 148.45 23.8 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.33 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -113.25 177.2 4.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.194 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -55.88 -49.37 73.56 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -89.18 -165.16 40.92 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.798 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' B' ' 169' ' ' THR . . . 77.2 24.65 65.62 Favored Glycine 0 C--O 1.22 -0.734 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.245 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -115.52 102.45 9.8 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.7 144.16 48.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.847 0.356 . . . . 0.0 110.933 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.506 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 47.2 m -139.6 132.54 29.36 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.646 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 59.97 30.55 20.04 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.684 0.615 . . . . 0.0 111.415 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -95.69 133.88 39.26 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.801 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.7 122.59 50.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.352 0.596 . . . . 0.0 111.325 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 61.4 tp -109.43 127.72 54.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.758 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -106.39 140.75 38.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 71.6 mtm -116.24 162.53 17.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.883 0.373 . . . . 0.0 111.445 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 88.21 13.8 63.31 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . 0.459 ' HB2' ' HG2' ' B' ' 193' ' ' ARG . 97.9 mt-30 -125.33 -3.16 7.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.519 0.199 . . . . 0.0 111.376 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.16 33.21 33.16 Favored Glycine 0 CA--C 1.508 -0.37 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.89 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' B' ' 191' ' ' GLN . 37.8 mmm-85 -76.33 -24.41 54.27 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.486 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.9 169.65 11.38 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.288 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 47.0 mm -51.67 133.41 36.39 Favored Pre-proline 0 C--O 1.239 0.532 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.04 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -47.18 126.33 11.47 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.526 2.151 . . . . 0.0 112.118 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.66 -38.03 3.4 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.718 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -62.5 -48.58 78.94 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.112 0.456 . . . . 0.0 112.203 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -78.08 -9.95 59.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 111.826 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . 0.413 ' O ' ' HD3' ' B' ' 203' ' ' LYS . 31.0 t70 -90.45 -26.35 19.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.17 0.509 . . . . 0.0 110.204 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.23 -22.78 67.26 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.285 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 70.6 mt -68.92 -26.86 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.602 -0.352 . . . . 0.0 111.093 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' B' ' 200' ' ' ASP . 24.3 mtpt -55.1 126.68 25.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.038 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.48 -9.06 71.83 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.757 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -85.86 134.47 33.9 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 117.466 0.633 . . . . 0.0 111.584 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' B' ' 209' ' ' GLU . 29.6 mmtp -91.6 161.38 14.95 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.354 -176.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.55 139.29 58.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.723 0.297 . . . . 0.0 110.325 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 75.89 17.65 79.95 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.798 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' B' ' 206' ' ' LYS . 42.3 tt0 -113.45 97.4 6.44 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.547 0.689 . . . . 0.0 111.141 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -88.91 108.06 19.34 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.947 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -129.13 -11.09 4.72 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -173.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 58.2 p 58.89 166.87 0.05 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.73 0.812 . . . . 0.0 112.655 -176.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.6 tp -146.0 153.81 13.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.465 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -88.1 105.88 17.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.771 0.319 . . . . 0.0 111.259 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 76.2 t -118.22 129.31 74.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 10.3 m -100.45 -34.95 9.73 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -175.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.6 m-85 70.64 144.08 0.1 Allowed Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 122.71 0.404 . . . . 0.0 110.917 -175.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 15.1 Cg_exo -69.02 152.18 73.17 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.259 1.973 . . . . 0.0 111.795 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -67.15 -33.46 75.48 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.411 0.624 . . . . 0.0 109.709 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -88.44 21.93 2.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.655 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -65.75 134.73 53.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.019 0.438 . . . . 0.0 110.57 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -61.53 -10.21 7.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.11 105.31 15.59 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' B' ' 227' ' ' LYS . 4.7 tp10 -56.04 -36.48 68.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.41 0.684 . . . . 0.0 111.685 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.436 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 18.7 p30 -80.38 -11.81 59.65 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.413 ' HG ' ' OD1' ' B' ' 225' ' ' ASN . 93.3 mt -115.47 1.69 13.7 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.422 ' HD2' ' HA ' ' B' ' 224' ' ' GLU . 20.4 ptmt -66.69 116.38 7.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.232 0.539 . . . . 0.0 111.722 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.26 26.51 70.58 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.928 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.436 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 98.9 mttt -111.74 134.9 53.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.083 0.441 . . . . 0.0 110.585 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -77.29 131.82 38.34 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.897 0.38 . . . . 0.0 111.245 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.02 135.17 54.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.484 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . 0.517 ' HE2' ' OD1' ' B' ' 173' ' ' ASP . 68.9 mttm -80.8 -44.8 17.95 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' B' ' 212' ' ' THR . 76.4 m-85 56.35 95.09 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.015 0.436 . . . . 0.0 111.894 -177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.422 ' HA ' HG22 ' B' ' 212' ' ' THR . . . -61.36 -50.17 74.0 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.8 mm 61.52 91.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 123.472 0.482 . . . . 0.0 111.953 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -72.69 -42.48 64.18 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.338 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 12.4 tp 48.21 84.83 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.821 0.848 . . . . 0.0 111.295 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.76 -59.74 2.66 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -174.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -102.55 -79.23 0.53 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.548 HG12 ' H ' ' B' ' 242' ' ' GLU . 39.3 t 77.32 150.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -172.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -69.97 -33.35 71.96 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.737 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.548 ' H ' HG12 ' B' ' 240' ' ' VAL . 62.5 mt-10 73.89 154.33 0.15 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.721 0.808 . . . . 0.0 112.168 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.62 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 0.0 OUTLIER -156.1 110.36 2.81 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' B' ' 155' ' ' ASP . 31.9 tt0 -153.42 170.25 21.17 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' B' ' 150' ' ' THR . 6.4 mp 73.64 112.23 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 123.582 0.753 . . . . 0.0 111.557 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . 0.529 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 74.5 Cg_endo -83.07 97.28 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.292 1.994 . . . . 0.0 112.711 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . 0.451 ' H ' HG21 ' B' ' 150' ' ' THR . 11.2 pt-20 -132.12 163.47 28.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.733 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 7.2 mp -86.32 90.2 8.1 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.049 0.452 . . . . 0.0 110.797 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 5.3 m -85.88 -75.52 0.37 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.719 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 177.74 -50.5 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.06 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.3 3.44 3.66 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.642 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -71.49 -17.92 62.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.221 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 40.5 pt -87.15 -15.85 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.117 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -138.06 90.92 2.52 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.608 0.718 . . . . 0.0 111.986 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.605 ' HG2' ' OE1' ' B' ' 148' ' ' GLN . 6.9 tpp180 -137.36 35.43 2.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.284 1.04 . . . . 0.0 108.968 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -127.87 17.65 6.76 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.825 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 72.98 23.63 77.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.545 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.12 137.21 40.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -52.7 -49.37 65.49 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.517 0.51 . . . . 0.0 111.378 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.6 p30 176.95 152.93 0.21 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.847 0.459 . . . . 0.0 111.043 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -169.39 167.32 40.4 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.983 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 26.9 p -83.38 170.93 14.01 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.597 0.199 . . . . 0.0 110.691 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 96.9 t -62.13 -51.85 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.0 OUTLIER -77.6 -36.38 51.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.04 0.448 . . . . 0.0 110.618 -178.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.77 -39.79 97.81 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.48 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.42 ' O ' HG23 ' B' ' 270' ' ' VAL . 54.7 tp -61.7 -45.3 94.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.6 0.238 . . . . 0.0 110.861 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -64.72 -41.24 96.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.661 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.578 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -67.76 -43.29 80.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.556 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -67.89 -39.89 83.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.823 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.42 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.2 t -64.83 -41.72 92.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -55.43 -51.8 65.69 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.589 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.5 ptmt -66.0 -42.84 89.23 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -64.9 -38.26 90.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.0 mmm -63.67 -41.35 98.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.877 0.37 . . . . 0.0 110.164 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -69.3 -31.27 69.64 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.558 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -61.87 -42.77 99.46 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.4 -38.13 89.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.34 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.04 -38.2 87.84 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.272 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -56.51 -47.5 79.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.014 0.435 . . . . 0.0 109.947 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.2 m -64.61 -43.76 92.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.809 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.05 87.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.262 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.24 -44.56 99.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.968 0.413 . . . . 0.0 110.471 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -65.02 -42.01 94.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.58 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -62.82 -40.85 98.65 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.674 0.273 . . . . 0.0 110.859 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' B' ' 285' ' ' ARG . 1.5 tpm_? -59.7 -44.43 93.69 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.642 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 99.4 t -70.22 -43.61 78.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.871 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.92 -47.52 84.54 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.333 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 78.0 p -61.94 -44.82 95.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.69 -41.24 92.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.32 -46.62 87.9 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.539 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . 0.48 ' O ' HG23 ' B' ' 295' ' ' VAL . 33.1 mm -64.9 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.201 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . 0.468 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 34.6 tp10 -60.29 -48.19 82.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.36 -41.06 96.75 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.515 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.52 HD13 HD13 ' B' ' 350' ' ' LEU . 4.0 tt -63.33 -42.07 98.94 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 0.48 HG23 ' O ' ' B' ' 291' ' ' ILE . 78.0 t -63.98 -42.74 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.954 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.468 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 68.4 mttm -62.53 -40.83 98.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.871 0.367 . . . . 0.0 110.544 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.6 -50.23 67.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.533 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.47 99.86 6.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.713 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -96.5 112.03 23.92 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.5 tp -116.26 144.02 24.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.6 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.54 127.14 31.92 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.33 132.83 31.07 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.464 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -57.45 135.59 70.79 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.367 2.045 . . . . 0.0 112.042 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.45 -28.96 69.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.171 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.77 79.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.817 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 99.2 mt -82.42 -36.8 26.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.628 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . 0.454 ' O ' HG13 ' B' ' 311' ' ' ILE . 73.8 mt -61.93 -50.62 79.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.689 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.59 -38.76 92.11 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 59.0 p -64.1 -44.9 90.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.952 0.406 . . . . 0.0 111.165 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . 0.525 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 52.2 mm-40 -72.86 -32.48 65.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.275 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.454 HG13 ' O ' ' B' ' 307' ' ' ILE . 85.4 mt -62.11 -43.82 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.661 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.61 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 36.3 t70 -62.59 -41.72 99.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.365 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.21 -42.9 96.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.348 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 91.0 mt -61.55 -41.24 97.06 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.348 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.474 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 75.2 mtm180 -62.82 -39.77 95.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.771 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 90.6 mtt180 -63.16 -43.57 97.92 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.462 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -64.71 -44.02 91.58 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.14 85.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.34 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -64.65 -35.81 82.22 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.034 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . 0.59 ' NE2' ' HA ' ' A' ' 45' ' ' ARG . 49.8 tt0 -63.82 -41.87 97.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.349 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -72.19 -23.92 61.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.103 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -76.32 -3.83 38.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.284 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 139.68 -29.93 2.43 Favored Glycine 0 CA--C 1.501 -0.827 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.25 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 124.31 34.38 0.72 Allowed Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . 0.535 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 39.6 t-20 -73.83 118.11 16.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . 0.732 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 3.6 tm-20 -120.91 143.31 49.02 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 2.0 ptpp? 70.33 -38.93 0.43 Allowed 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 125.581 1.552 . . . . 0.0 113.019 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . 0.535 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.4 mm100 -73.85 -8.33 55.63 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.293 0.568 . . . . 0.0 110.767 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -67.13 -14.43 62.9 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.26 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.34 -36.39 83.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.468 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -71.39 -15.42 62.37 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.956 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.57 142.43 98.46 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -57.71 135.47 69.53 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.11 2.54 . . . . 0.0 112.898 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 27.7 ttt85 -70.42 -40.13 74.02 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.935 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -58.61 -34.59 71.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.55 -9.25 59.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.037 0.446 . . . . 0.0 111.755 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -114.57 -30.63 6.45 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.705 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -66.48 -34.21 77.42 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.98 -52.37 64.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.051 0.453 . . . . 0.0 110.707 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -70.46 -25.63 63.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.423 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.54 -42.28 99.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.329 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . 0.518 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.5 tttt -59.61 -47.12 86.84 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . 0.502 ' O ' HG23 ' B' ' 347' ' ' VAL . 17.3 mmt85 -63.57 -45.53 90.05 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -66.71 -38.88 87.6 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 341' ' ' ALA . 76.7 t -64.69 -43.0 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.655 0.264 . . . . 0.0 110.785 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 342' ' ' LYS . 78.1 t -60.05 -43.2 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.424 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.502 HG23 ' O ' ' B' ' 343' ' ' ARG . 88.0 t -59.68 -45.57 94.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.05 -42.28 99.64 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.313 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.71 -44.02 97.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 111.005 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.52 HD13 HD13 ' B' ' 294' ' ' LEU . 93.0 mt -64.14 -45.71 87.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.387 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 86.9 mt -66.28 -40.66 90.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.027 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.92 -39.82 97.5 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.706 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.3 -38.74 88.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.763 0.316 . . . . 0.0 110.836 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 84.8 t -61.28 -43.85 97.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.53 -43.78 98.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.882 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -68.54 -50.22 53.61 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.76 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 98.6 m -67.9 -47.16 69.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -85.79 -9.02 57.73 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.764 0.316 . . . . 0.0 110.964 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 59.42 73.0 0.5 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.684 0.754 . . . . 0.0 111.406 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.64 128.05 49.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 142.64 47.19 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.904 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -62.42 116.02 4.72 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . 0.471 ' O ' HG23 ' B' ' 367' ' ' VAL . 20.7 t70 -84.27 112.48 20.33 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.113 0.482 . . . . 0.0 110.846 -176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 17.0 mm-40 -58.06 -43.21 86.78 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.376 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -66.92 -37.82 85.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.826 0.346 . . . . 0.0 111.267 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -63.31 -41.71 98.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.039 0.447 . . . . 0.0 110.078 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 363' ' ' ASP . 97.6 t -64.06 -37.61 80.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.556 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.7 mmmt -56.4 -45.04 80.81 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.806 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.86 -38.22 95.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.094 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.44 -41.43 98.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.09 0.471 . . . . 0.0 110.388 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . 0.416 HG13 ' O ' ' B' ' 367' ' ' VAL . 62.2 mt -65.47 -42.98 94.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.509 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.38 -39.47 90.79 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.457 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -61.77 -43.13 99.45 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.079 0.466 . . . . 0.0 110.282 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 57.7 ttm -67.15 -39.25 86.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.913 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.0 -33.86 75.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.721 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 66.2 m -70.82 4.7 2.36 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -97.51 2.89 50.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.061 0.458 . . . . 0.0 110.712 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -122.24 174.89 6.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.733 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -61.95 -48.8 78.8 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.825 0.345 . . . . 0.0 111.002 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 27.0 t70 -123.79 115.22 28.07 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.48 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . 0.492 ' O ' HG13 ' B' ' 385' ' ' ILE . 37.3 Cg_endo -66.61 -29.56 43.61 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 122.231 1.954 . . . . 0.0 112.928 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.47 -42.9 91.77 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 12.3 pt-20 -64.34 -36.44 84.12 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.282 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.42 -42.01 92.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.388 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . 0.492 HG13 ' O ' ' B' ' 381' ' ' PRO . 89.6 mt -61.74 -44.1 98.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.985 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.35 -33.71 74.78 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.63 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -58.14 -47.05 84.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.277 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -69.44 -46.11 67.52 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 31.0 p -68.98 -18.1 64.02 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.75 7.15 46.4 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.926 0.393 . . . . 0.0 111.04 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -131.47 109.62 10.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.869 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -64.25 -38.51 91.32 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -59.9 -48.31 82.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.797 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.78 -39.86 95.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.048 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 90.8 mtp -62.58 -44.26 96.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.811 0.338 . . . . 0.0 110.905 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -66.74 -49.28 66.5 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.185 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.93 -43.23 96.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.546 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 44.0 tpp -64.22 -43.16 95.85 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.805 0.336 . . . . 0.0 111.084 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -66.27 -32.91 74.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.474 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.94 -44.75 96.82 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.769 0.319 . . . . 0.0 110.295 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 85.6 t -67.18 -43.65 88.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.458 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.36 -40.31 93.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.958 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.81 -38.92 92.88 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.324 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.48 -43.24 97.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.872 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.48 -35.65 81.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.73 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -61.11 -42.74 99.07 Favored 'General case' 0 C--O 1.228 -0.06 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.402 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.85 -46.78 83.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.224 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 89.9 t -62.99 -46.18 96.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -67.03 -31.18 71.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.689 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.27 93.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.111 0.481 . . . . 0.0 110.311 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 407' ' ' ALA . 99.0 t -65.36 -41.53 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.168 177.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 97.9 mt -59.87 -27.05 66.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.206 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -78.17 -6.77 55.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 111.486 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -114.83 -22.95 9.39 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.881 0.372 . . . . 0.0 110.972 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.06 169.45 12.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.057 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -83.08 116.51 22.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.619 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 60.5 t -90.24 121.72 40.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.231 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . 0.402 HG23 ' HG3' ' B' ' 126' ' ' GLU . 9.1 t -124.04 137.79 54.54 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.1 125.2 50.91 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.576 -177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . 0.568 ' HE3' ' OE1' ' B' ' 126' ' ' GLU . 20.3 pttp -135.44 149.91 49.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.578 0.227 . . . . 0.0 110.653 176.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.11 159.2 20.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.8 t -158.96 172.23 18.59 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.782 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 17.0 p -85.26 164.6 17.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.015 0.436 . . . . 0.0 111.355 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -65.32 -26.21 67.95 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.543 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -61.29 -39.96 92.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.649 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.42 -36.17 82.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.419 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.51 -22.67 62.61 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.203 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.8 mmt -77.03 -5.75 50.01 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -76.67 78.53 3.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.34 0.591 . . . . 0.0 109.636 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -105.12 14.72 28.73 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.124 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -64.12 -37.54 87.83 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.092 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.213 178.505 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 mmt . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.29 102.68 5.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.852 0.358 . . . . 0.0 110.536 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -136.04 159.2 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.328 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 17' ' ' ILE . 11.8 p -97.95 137.12 37.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.791 0.329 . . . . 0.0 110.736 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -153.83 138.4 9.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 69.7 mm-40 -122.4 152.56 40.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.112 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.1 m -107.35 121.5 44.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.757 0.313 . . . . 0.0 110.168 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 m -78.29 -67.36 0.74 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.461 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -170.2 110.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.629 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.65 -110.95 3.31 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.081 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.401 HD23 HG13 ' A' ' 111' ' ' VAL . 90.4 mt -64.12 -39.18 93.48 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 122.655 0.382 . . . . 0.0 111.31 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -69.23 138.15 30.48 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 115.086 0.794 . . . . 0.0 115.086 -174.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 12' ' ' GLY . 7.9 mpt_? -140.85 170.31 15.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.057 0.943 . . . . 0.0 110.532 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 6.2 ttm180 -134.42 137.99 44.46 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -95.4 -84.76 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.183 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 p 43.12 91.87 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.512 ' HA ' ' OG ' ' A' ' 4' ' ' SER . 85.0 mt -113.0 131.47 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.162 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.7 m -103.01 122.89 45.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.415 HG13 HG12 ' A' ' 24' ' ' ILE . 16.9 pt -129.1 162.48 36.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.522 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -70.04 150.57 46.48 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.264 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -59.34 -39.34 82.84 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -64.95 -25.34 67.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.472 . . . . 0.0 110.414 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -87.53 -32.23 19.51 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.55 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.1 mt -62.26 -50.41 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.956 0.408 . . . . 0.0 112.007 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.477 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 32.3 mm-40 -82.32 -5.02 58.3 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.7 m -100.29 -69.43 0.77 Allowed 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.029 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.68 -47.58 72.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 96.3 t -63.86 -44.13 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.798 0.332 . . . . 0.0 111.349 -176.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 18.1 ttmm -61.43 -45.72 93.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.969 0.414 . . . . 0.0 110.74 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.527 ' O ' HG12 ' A' ' 33' ' ' VAL . 18.1 m -63.51 -41.29 98.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.415 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -61.23 -38.22 85.88 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.053 0.454 . . . . 0.0 110.4 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.78 -41.58 99.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.954 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 30' ' ' SER . 8.9 p -71.54 -31.65 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.569 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -62.85 -44.03 97.21 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.491 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -71.29 -31.28 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.93 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.96 -44.61 92.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.203 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.93 -33.84 76.76 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.675 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.0 -35.47 76.93 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 110.327 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.2 t -91.9 -4.88 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.321 0.581 . . . . 0.0 110.119 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 63.61 26.55 14.69 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.687 0.795 . . . . 0.0 111.435 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.17 4.55 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.851 0.358 . . . . 0.0 111.564 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.57 -33.82 76.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.936 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.65 -6.61 67.08 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.894 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -90.12 -1.0 57.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.864 0.364 . . . . 0.0 110.769 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.4 ttt-85 -94.22 82.83 4.16 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.264 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.5 94.06 6.17 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.4 101.44 2.73 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -170.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -65.36 -40.78 94.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 168.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.505 HG12 ' HB ' ' A' ' 54' ' ' VAL . 23.9 t -96.04 111.32 55.88 Favored Pre-proline 0 N--CA 1.439 -0.987 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.504 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.35 142.87 97.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.501 2.134 . . . . 0.0 111.65 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.647 ' HA ' HG12 ' A' ' 54' ' ' VAL . 24.1 ttt -64.43 -39.19 93.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.556 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -66.99 -20.89 65.96 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.142 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.608 HG12 HH11 ' B' ' 193' ' ' ARG . 1.7 mp -92.85 -46.56 13.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 176.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 51' ' ' MET . 9.0 p -63.79 -32.44 57.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 120.753 0.311 . . . . 0.0 111.358 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.43 82.15 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.66 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -93.05 -25.29 17.99 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.305 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -63.04 -43.43 98.69 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.853 0.359 . . . . 0.0 110.596 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.97 13.98 18.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.565 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.618 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -49.52 -73.07 0.39 Allowed Glycine 0 C--O 1.221 -0.703 0 CA-C-N 115.598 -0.728 . . . . 0.0 114.569 -175.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.26 -19.3 62.37 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.862 0.331 . . . . 0.0 111.807 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 t -63.03 -45.63 91.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.032 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.4 p -123.91 17.14 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.317 0.58 . . . . 0.0 111.121 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.618 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 37.2 ttm180 -58.92 -26.62 64.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.758 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -61.86 -52.45 64.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.304 0.574 . . . . 0.0 110.232 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' HB2' HG22 ' A' ' 62' ' ' VAL . 1.2 m-20 -71.85 -27.05 62.63 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.563 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 62' ' ' VAL . 88.5 t -63.78 -43.63 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.11 -39.84 93.88 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.49 -42.7 99.82 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.788 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.752 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 31.1 t70 -63.54 -43.94 95.64 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.737 0.269 . . . . 0.0 111.033 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.08 -43.85 98.26 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.476 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -67.23 -37.28 83.3 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.082 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.4 m -61.75 -43.3 99.12 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.406 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.752 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 46.2 mtp85 -64.59 -42.96 95.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.086 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -64.65 -40.44 95.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.95 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -59.81 -49.53 77.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.731 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 tt -69.03 -39.66 79.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.789 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 21.8 t0 -66.9 -41.82 86.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.258 0.551 . . . . 0.0 109.896 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.67 -41.24 92.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.727 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -65.68 -32.22 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.234 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.73 -43.55 96.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.176 0.512 . . . . 0.0 109.811 176.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 77' ' ' ASP . 58.7 mttm -63.83 -42.07 97.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.774 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -86.52 -4.24 59.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.895 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 64.14 36.34 9.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.367 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 98.2 mt -88.49 123.45 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.636 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -106.79 107.66 60.67 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.622 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -78.82 134.17 11.82 Favored 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 121.88 1.72 . . . . 0.0 111.406 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.94 88.28 7.26 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.165 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.72 -102.95 2.86 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.325 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.94 128.45 21.52 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 120.593 0.235 . . . . 0.0 110.924 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.07 -20.32 57.01 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.804 2.336 . . . . 0.0 112.154 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 51.3 m 68.35 95.68 0.06 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.335 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.491 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 97.4 m-85 -81.12 113.28 19.18 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.025 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.29 107.6 30.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.752 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 69.4 Cg_endo -95.65 163.71 1.45 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.323 2.682 . . . . 0.0 112.187 177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -100.02 176.93 28.61 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.384 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.06 134.41 41.37 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -90.38 103.09 15.81 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.75 117.44 25.51 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.54 107.76 1.0 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.347 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.52 -15.71 19.72 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.988 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -107.93 173.79 6.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.991 0.395 . . . . 0.0 111.42 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -71.91 145.62 48.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.036 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -106.6 138.83 42.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.281 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.6 m -123.32 134.7 54.02 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.041 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -130.87 168.03 17.96 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.561 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.516 ' O ' HG12 ' A' ' 107' ' ' VAL . 37.7 m -87.04 -80.46 0.25 Allowed 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -174.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 106' ' ' SER . 3.7 p 56.37 121.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 C-N-CA 124.524 1.13 . . . . 0.0 111.376 -172.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -116.54 145.64 43.2 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.878 -0.513 . . . . 0.0 112.313 -172.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -155.4 -88.37 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -134.74 161.3 35.56 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -175.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.401 HG13 HD23 ' A' ' 11' ' ' LEU . 35.3 m -135.88 164.63 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.076 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -136.58 92.42 15.06 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -97.99 162.9 0.82 Allowed 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.471 2.781 . . . . 0.0 114.804 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.34 149.36 33.65 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.2 t -127.18 135.72 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -101.99 127.73 48.72 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.929 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.0 mt -118.33 134.79 54.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.603 0.239 . . . . 0.0 110.456 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -129.84 158.37 39.65 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.12 12.29 82.61 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.536 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.12 -41.24 97.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.945 0.402 . . . . 0.0 111.491 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -75.39 -8.29 56.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.051 0.453 . . . . 0.0 111.269 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.07 7.86 44.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.583 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 74.7 mt -83.89 119.0 32.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.01 0.433 . . . . 0.0 110.672 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -110.56 114.03 27.11 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.61 136.82 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.882 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -85.4 135.64 33.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.293 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HB3' HG13 ' A' ' 417' ' ' VAL . 83.8 tttt -127.39 95.97 34.58 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.42 121.55 8.84 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.161 1.908 . . . . 0.0 112.1 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.2 mm -103.79 112.64 38.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.49 159.83 37.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.784 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.71 165.45 27.23 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.415 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -84.72 110.75 19.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.2 p -92.06 173.59 7.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.396 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -62.99 -36.67 84.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.668 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.14 -36.11 80.8 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.893 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -62.78 -39.27 93.69 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.741 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.02 -43.58 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.085 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -59.4 -44.94 92.73 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.347 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.69 -41.26 99.85 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.013 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.626 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.3 tpt -62.19 -46.78 87.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.716 0.293 . . . . 0.0 110.605 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.08 -42.17 99.59 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.266 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.45 -45.74 92.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.527 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.0 m -63.64 -43.61 96.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.669 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 140' ' ' MET . 98.5 mt -61.32 -44.64 96.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.067 -174.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -70.48 -37.81 74.29 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.994 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -63.35 -36.98 85.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.428 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -84.79 33.92 0.53 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -122.78 115.64 22.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.447 0.641 . . . . 0.0 111.877 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -151.08 -170.44 3.66 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.482 ' CB ' ' H ' ' A' ' 247' ' ' GLU . 15.3 m -141.91 167.48 22.04 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.695 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 21.8 p-90 -105.1 132.5 51.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 120.678 0.275 . . . . 0.0 111.376 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -160.55 -47.19 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.335 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -154.26 -175.67 5.51 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' A' ' 240' ' ' VAL . 33.0 mmtp -52.75 154.67 2.63 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 76.22 -168.85 0.08 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.307 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 243' ' ' ARG . . . 113.5 0.74 24.78 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.504 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 74.41 -40.51 0.45 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.891 0.876 . . . . 0.0 112.407 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.3 t 73.32 -61.19 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.399 0.68 . . . . 0.0 112.447 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.53 ' HB2' ' HG2' ' A' ' 203' ' ' LYS . 10.2 pt-20 54.15 -166.18 0.09 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.905 1.282 . . . . 0.0 112.729 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.467 ' HB1' ' CA ' ' A' ' 190' ' ' GLY . . . -78.6 93.18 4.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.784 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -151.13 -65.71 0.19 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.327 0.584 . . . . 0.0 111.181 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -110.93 -168.76 1.34 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.381 -172.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 20.2 ptt180 -106.11 133.5 50.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.841 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 10.4 m -128.58 144.74 37.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.137 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.5 m -78.69 111.28 14.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.047 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.5 mt -123.63 122.07 64.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.02 0.438 . . . . 0.0 111.058 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -99.35 78.84 2.24 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -97.42 153.64 17.98 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.293 0.568 . . . . 0.0 112.183 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.3 m -119.05 128.38 54.29 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.877 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.58 126.42 9.11 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.742 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 21.1 p -137.27 134.32 36.0 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.93 -84.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.889 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -108.86 -0.04 20.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.399 0.618 . . . . 0.0 109.959 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.2 -21.82 0.97 Allowed Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.927 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -99.93 151.88 20.81 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -81.12 153.81 27.09 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.697 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -118.05 167.67 11.25 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.708 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -57.95 -32.26 67.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.57 -175.29 32.55 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.35 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.17 30.47 46.22 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.187 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.36 104.5 14.24 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -121.09 142.4 49.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.271 0.558 . . . . 0.0 112.197 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.7 m -147.1 118.4 7.84 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.252 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 57.83 33.68 23.5 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.596 0.56 . . . . 0.0 110.798 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -91.88 124.68 36.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.22 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 6.6 m -93.61 116.16 34.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.388 0.614 . . . . 0.0 110.992 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 163' ' ' ARG . 63.4 tp -101.88 117.57 35.12 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.804 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.568 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -91.01 108.15 19.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 76.9 mtm -89.83 149.56 22.62 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.808 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.467 ' CA ' ' HB1' ' A' ' 160' ' ' ALA . . . 98.38 12.19 45.83 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.275 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -127.21 -1.93 6.37 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.431 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 75.53 57.97 4.03 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.646 HH11 HG12 ' B' ' 53' ' ' ILE . 33.8 mmm-85 -103.72 -3.88 24.44 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.463 0.649 . . . . 0.0 109.613 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.482 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -142.66 176.29 9.15 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.997 177.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.4 mm -58.27 130.47 83.96 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.29 130.15 27.92 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.301 2.001 . . . . 0.0 111.993 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.45 -36.62 4.21 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.937 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -63.81 -47.43 80.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.175 0.487 . . . . 0.0 111.664 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.71 -8.86 59.49 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.255 0.55 . . . . 0.0 111.212 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -92.62 -31.74 15.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.605 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -65.32 -30.23 77.19 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.912 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 72.2 mt -64.74 -25.97 39.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.912 0.387 . . . . 0.0 111.043 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.53 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 54.1 mtpt -55.95 132.71 50.53 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.397 0.679 . . . . 0.0 111.552 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.35 -12.78 66.35 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.674 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -84.71 154.73 22.28 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.984 0.421 . . . . 0.0 112.133 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -93.86 163.98 13.29 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.32 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.17 92.73 1.76 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.119 0.485 . . . . 0.0 110.429 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.544 ' H ' HD22 ' A' ' 237' ' ' LEU . . . 113.19 18.35 7.27 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.52 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -102.19 116.02 31.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.915 0.388 . . . . 0.0 110.795 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -95.95 119.25 34.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.611 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -138.41 -15.17 1.26 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 30.1 p 60.98 162.79 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.978 0.911 . . . . 0.0 112.292 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -149.03 133.07 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.826 0.346 . . . . 0.0 110.729 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.54 112.09 16.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.96 0.41 . . . . 0.0 111.207 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 65.1 t -113.21 129.3 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 3.2 m -95.62 -22.98 17.24 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -173.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 229' ' ' LYS . 89.1 m-85 67.74 154.47 0.14 Allowed Pre-proline 0 N--CA 1.489 1.51 0 CA-C-O 121.005 0.431 . . . . 0.0 111.452 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.66 158.11 28.31 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.309 2.006 . . . . 0.0 111.54 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -66.21 -37.55 85.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.216 0.532 . . . . 0.0 110.08 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.31 45.96 1.31 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.058 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 21.5 t80 -82.72 135.87 34.88 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -60.16 -22.25 62.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.404 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -99.24 105.27 17.29 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 42.2 tt0 -60.99 -24.57 66.23 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.22 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -73.65 -24.21 59.96 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.512 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.0 mt -113.01 3.11 16.02 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.4 ptmt -68.27 118.11 10.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.731 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.83 29.0 74.13 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.389 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.432 ' O ' ' HD1' ' A' ' 217' ' ' PHE . 99.4 mttt -124.63 140.39 52.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 117.139 0.47 . . . . 0.0 110.483 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -85.74 130.2 34.62 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -115.7 130.71 56.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.734 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -72.12 -39.35 68.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -176.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 59.64 105.27 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.107 0.479 . . . . 0.0 112.031 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.55 -45.82 88.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.995 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.3 mm 60.75 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.766 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -106.3 125.99 51.68 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.677 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.544 HD22 ' H ' ' A' ' 208' ' ' GLY . 4.3 mp -98.55 114.5 26.95 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.95 0.405 . . . . 0.0 110.867 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -94.86 -59.35 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.594 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -91.06 -88.87 0.18 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.526 ' O ' ' HE2' ' A' ' 154' ' ' LYS . 58.5 t 65.61 120.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 122.829 0.452 . . . . 0.0 110.351 -175.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -79.17 -99.96 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -166.91 155.03 9.74 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.695 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 14.2 ptp180 169.11 77.48 0.0 OUTLIER 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.668 1.187 . . . . 0.0 112.856 171.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.01 158.64 43.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.092 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.4 tp 71.95 107.53 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 123.831 0.852 . . . . 0.0 111.773 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.2 109.11 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.194 1.929 . . . . 0.0 112.368 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.482 ' H ' ' CB ' ' A' ' 150' ' ' THR . 7.8 tp10 -111.37 -21.2 11.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.053 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 42.8 tp 74.47 126.53 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.558 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.441 ' H ' ' HE2' ' A' ' 252' ' ' PHE . 4.8 m -130.7 -110.68 0.26 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.904 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -175.29 -44.82 0.01 OUTLIER 'General case' 0 C--N 1.352 0.702 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.06 -29.43 65.38 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.441 ' HE2' ' H ' ' A' ' 249' ' ' THR . 55.4 p90 -66.55 -17.65 64.93 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.772 0.32 . . . . 0.0 111.711 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.09 -42.8 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 110.998 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.55 ' HD2' ' H ' ' A' ' 254' ' ' LYS . 0.0 OUTLIER -95.99 21.47 8.67 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.004 -177.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -69.12 -17.02 63.79 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.506 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.481 ' CE1' HD21 ' A' ' 266' ' ' LEU . 80.7 m-85 -59.02 -35.43 73.27 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.74 -28.44 15.41 Favored Glycine 0 C--N 1.322 -0.202 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.76 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.16 83.88 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.51 ' HG2' ' H ' ' A' ' 260' ' ' ASP . 13.8 tt0 55.09 -163.91 0.13 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.157 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . 0.51 ' H ' ' HG2' ' A' ' 259' ' ' GLU . 4.0 p-10 -124.94 110.2 13.94 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.031 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -93.15 164.97 27.56 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.622 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.6 p -87.06 -173.26 4.35 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 122.465 0.306 . . . . 0.0 110.267 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.9 -47.74 92.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 120.862 0.363 . . . . 0.0 111.289 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.2 OUTLIER -88.2 -34.25 17.86 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.768 0.318 . . . . 0.0 111.02 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.66 -40.11 98.24 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.352 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.481 HD21 ' CE1' ' A' ' 256' ' ' PHE . 53.5 tp -62.46 -42.55 99.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.505 0.193 . . . . 0.0 111.092 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -60.89 -43.83 97.93 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.953 0.406 . . . . 0.0 110.083 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -67.88 -42.25 81.52 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.236 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 24.9 tp10 -66.74 -39.98 88.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.963 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.47 ' O ' ' HG2' ' A' ' 274' ' ' MET . 75.2 t -65.03 -43.22 96.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.943 0.402 . . . . 0.0 110.054 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -58.13 -47.39 83.45 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.127 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 16.3 ptmt -67.93 -41.5 82.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.622 0.249 . . . . 0.0 111.357 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -64.12 -39.24 93.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 270' ' ' VAL . 98.8 mmm -63.5 -41.92 98.53 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.567 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -67.68 -35.04 78.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.855 0.36 . . . . 0.0 110.228 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -61.56 -43.7 98.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.188 0.518 . . . . 0.0 109.977 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -68.88 -37.49 79.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.064 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 38.9 tp -63.17 -38.62 91.91 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.794 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -56.1 -45.62 79.37 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.151 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.5 m -61.51 -40.52 94.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.496 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.56 -45.74 92.87 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.912 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.58 -45.21 98.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 110.179 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.496 ' HD2' ' OE2' ' A' ' 405' ' ' GLU . 0.8 OUTLIER -59.77 -46.71 88.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.136 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -64.91 -41.56 95.48 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.667 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -65.32 -41.43 94.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.873 0.368 . . . . 0.0 111.404 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.92 -44.06 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.166 0.508 . . . . 0.0 109.857 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.6 -47.54 83.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.629 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 55.2 p -62.41 -43.91 97.7 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -64.24 -42.15 96.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.768 0.318 . . . . 0.0 111.059 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.6 85.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 37.9 mm -65.42 -44.39 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.427 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.499 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 20.0 tp10 -62.56 -42.87 99.82 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.607 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.3 -43.51 98.98 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.514 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.98 -43.21 96.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 92.5 t -65.0 -44.99 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.391 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . 0.499 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 67.5 mttm -64.33 -41.42 96.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.548 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.22 -43.96 69.56 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -127.59 98.8 5.34 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.683 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -93.23 103.15 15.43 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.2 tp -107.98 139.27 30.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.975 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -67.73 131.34 45.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.213 0.53 . . . . 0.0 110.706 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.16 135.75 21.78 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.062 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -58.0 138.35 85.53 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.388 2.058 . . . . 0.0 111.987 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.37 85.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.307 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.38 -45.85 80.36 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.025 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.68 -43.3 93.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.84 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 71.4 mt -62.34 -49.98 81.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.66 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.31 -41.63 98.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.949 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 24.6 m -61.94 -45.63 92.86 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.616 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.644 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 27.2 mm-40 -73.11 -38.05 66.48 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -176.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.501 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 82.0 mt -61.74 -43.8 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -175.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 24.9 t70 -61.45 -42.62 99.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.097 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.4 -42.55 93.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 90.3 mt -62.15 -39.67 93.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.43 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 82.5 mtm180 -62.6 -37.46 86.33 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.071 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 91.3 mtt180 -64.09 -38.95 92.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -63.09 -46.1 88.98 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.383 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.8 -39.53 91.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.657 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.51 94.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.409 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -65.02 -38.86 92.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.175 0.512 . . . . 0.0 110.234 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.84 -17.93 59.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.922 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -78.16 -3.57 43.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.317 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.56 -11.27 4.62 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.356 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 111.88 34.62 1.99 Allowed Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.241 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -74.75 126.6 31.24 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.953 0.406 . . . . 0.0 110.097 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.48 159.36 36.53 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.538 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.1 OUTLIER 69.17 -47.07 0.58 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -80.27 -4.9 55.13 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.18 -24.64 66.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.442 0.639 . . . . 0.0 109.807 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.402 HD12 HH12 ' A' ' 315' ' ' ARG . 38.7 tp -63.94 -33.75 76.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.705 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -80.47 -9.58 59.76 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.905 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 94.4 mt -63.83 129.03 93.57 Favored Pre-proline 0 C--O 1.24 0.572 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.476 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 52.5 Cg_exo -54.84 127.24 25.39 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.848 2.365 . . . . 0.0 113.142 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -65.51 -43.97 88.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.002 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.4 pm0 -65.25 -24.76 67.41 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.0 -10.32 55.28 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -118.1 -15.95 9.82 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.976 0.417 . . . . 0.0 111.251 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.22 -25.17 65.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.497 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.8 -50.78 67.6 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.705 0.288 . . . . 0.0 111.06 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -78.91 -20.72 48.67 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.208 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.98 -41.85 98.49 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.444 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -60.41 -44.24 95.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.031 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 347' ' ' VAL . 17.9 mmt85 -62.41 -42.78 99.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.068 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.492 ' NH2' HD22 ' A' ' 314' ' ' LEU . 73.4 mtt180 -64.81 -41.77 95.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.675 0.274 . . . . 0.0 111.061 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 89.2 t -64.89 -44.62 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.769 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 342' ' ' LYS . 72.5 t -61.13 -44.22 97.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.934 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 343' ' ' ARG . 77.4 t -60.5 -44.67 96.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.09 99.73 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.175 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 93.7 mt -63.47 -42.71 98.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.899 0.38 . . . . 0.0 110.614 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.6 mt -63.13 -44.95 94.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.763 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.38 -42.02 96.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.968 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.18 -42.53 99.72 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.131 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.54 -39.24 85.02 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 117.053 0.426 . . . . 0.0 111.287 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 350' ' ' LEU . 73.0 t -60.79 -45.05 98.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.93 -44.22 97.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.687 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -65.48 -46.55 79.34 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 37.5 m -73.11 -44.25 60.57 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -89.27 0.63 56.63 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.777 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 56.99 67.01 1.05 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.304 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 91.0 mt -98.83 153.77 18.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.777 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -132.96 155.35 49.28 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.806 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.15 100.24 8.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 171.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 367' ' ' VAL . 26.8 t70 -83.16 115.96 22.14 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.127 0.489 . . . . 0.0 112.269 -173.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 68.7 mm-40 -61.35 -35.52 77.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.299 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.441 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 65.4 mm-40 -64.39 -41.71 96.53 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.093 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -63.13 -39.15 93.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.18 0.514 . . . . 0.0 109.842 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.539 HG21 ' HG2' ' A' ' 399' ' ' ARG . 89.6 t -61.78 -39.64 84.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.332 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.5 mmmt -57.68 -44.31 85.68 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.487 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.51 -40.09 98.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.848 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.6 -43.05 99.78 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.981 0.419 . . . . 0.0 110.281 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.27 -43.92 97.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.406 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.15 -41.0 97.33 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.56 -37.25 84.55 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.351 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 48.4 ttm -66.98 -43.61 82.6 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.091 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.87 75.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.123 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.6 m -68.27 -5.29 17.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.839 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -83.45 -12.48 56.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.498 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -106.35 172.99 6.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.533 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -58.24 -47.31 83.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.825 0.345 . . . . 0.0 110.985 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -123.62 113.55 28.86 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.548 ' O ' HG13 ' A' ' 385' ' ' ILE . 38.1 Cg_endo -66.75 -31.19 40.12 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.229 1.953 . . . . 0.0 113.402 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -66.27 -42.96 87.71 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -64.28 -36.19 83.3 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.994 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.38 -42.56 93.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.234 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 381' ' ' PRO . 68.1 mt -61.23 -46.76 95.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.279 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 46.2 mt-10 -63.32 -44.0 96.19 Favored 'General case' 0 C--O 1.215 -0.752 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.773 177.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.61 -46.76 86.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -66.28 -40.84 90.34 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.429 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 51.3 p -81.58 -2.44 50.05 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 98.6 mttt -103.48 10.64 37.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.049 0.452 . . . . 0.0 110.789 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -134.42 117.51 16.39 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.259 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -63.78 -40.64 97.17 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -58.1 -49.48 76.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.858 0.361 . . . . 0.0 110.674 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.55 -42.73 98.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.2 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.526 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 89.5 mtp -63.9 -48.3 77.16 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -73.58 -39.39 64.68 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -174.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -62.36 -40.72 97.35 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 44.4 tpp -64.13 -41.47 97.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.66 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.539 ' HG2' HG21 ' A' ' 367' ' ' VAL . 69.1 mtm180 -64.35 -36.44 84.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.008 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -60.95 -43.77 98.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.583 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.17 -44.09 88.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.488 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 406' ' ' GLN . . . -61.65 -41.83 98.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.95 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.87 -39.5 94.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.683 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.66 -43.93 93.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.906 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.496 ' OE2' ' HD2' ' A' ' 283' ' ' ARG . 29.7 mt-10 -65.18 -37.44 87.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.541 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 402' ' ' ALA . 28.5 mt-30 -60.45 -43.35 96.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.526 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.42 -44.35 91.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.968 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 86.5 t -64.73 -45.11 96.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.989 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -65.32 -33.56 76.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.32 97.49 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.865 0.364 . . . . 0.0 110.482 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.91 -42.74 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.076 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.0 mt -61.45 -41.85 97.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.183 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.04 -23.85 67.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.706 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -95.18 -8.27 36.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.32 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.53 179.43 4.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.139 0.495 . . . . 0.0 111.757 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -82.41 133.46 35.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.689 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 127' ' ' LYS . 57.8 t -122.09 131.34 73.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -131.49 138.81 49.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.1 0.476 . . . . 0.0 110.921 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -93.58 118.82 31.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.663 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -136.33 132.93 36.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.843 0.354 . . . . 0.0 111.368 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -81.01 153.23 27.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.165 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 12.9 t -157.72 171.66 19.92 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 26.2 p -81.34 165.54 21.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.772 0.32 . . . . 0.0 110.21 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -66.04 -18.13 65.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.021 0.438 . . . . 0.0 111.26 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -62.25 -39.45 92.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -63.97 -38.31 90.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.19 0.519 . . . . 0.0 110.057 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.35 -36.2 83.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.488 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 5.9 mmt -65.31 -14.28 60.41 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.301 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -75.6 83.37 2.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -103.64 6.48 37.13 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.315 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -72.32 -44.83 62.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.532 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.149 -178.548 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.92 103.86 2.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 111.361 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.86 161.59 38.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.396 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.493 ' OG ' ' HA ' ' B' ' 17' ' ' ILE . 7.9 p -101.59 130.56 47.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.787 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.78 133.66 13.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.479 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 57.9 mm-40 -118.45 149.75 40.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.962 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 98.0 m -106.6 122.71 46.86 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 27.7 m -78.74 -68.54 0.64 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.363 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -166.23 110.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.582 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.81 -106.55 1.22 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.354 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.441 HD23 HG13 ' B' ' 111' ' ' VAL . 83.8 mt -70.34 -36.69 74.39 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 122.708 0.403 . . . . 0.0 112.048 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.453 ' C ' ' HD2' ' B' ' 13' ' ' ARG . . . -70.09 135.81 26.39 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 114.486 0.554 . . . . 0.0 114.486 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.453 ' HD2' ' C ' ' B' ' 12' ' ' GLY . 7.6 mpt_? -138.13 171.26 14.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.69 0.796 . . . . 0.0 110.415 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 9.8 ttm180 -135.75 138.54 42.78 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.77 -83.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.038 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.1 p 42.23 89.86 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.493 ' HA ' ' OG ' ' B' ' 4' ' ' SER . 83.8 mt -110.91 130.56 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.23 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 37.6 m -103.17 123.61 47.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 20.6 pt -129.08 163.23 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.0 111.979 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.511 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -71.93 152.69 42.34 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.087 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.434 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -59.98 -36.65 77.62 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -63.02 -32.3 73.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.241 0.544 . . . . 0.0 110.217 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 17.3 m -82.51 -32.99 28.44 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.034 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.511 HG13 ' O ' ' B' ' 20' ' ' ALA . 81.5 mt -60.59 -49.98 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 120.881 0.372 . . . . 0.0 111.834 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.495 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 28.0 mm-40 -82.99 -7.51 59.66 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 53.2 m -97.97 -69.34 0.76 Allowed 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.41 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.99 -48.3 66.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 89.7 t -64.17 -43.62 97.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.513 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.495 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.1 ttmm -61.33 -46.49 90.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 0.0 110.564 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.501 ' O ' HG12 ' B' ' 33' ' ' VAL . 21.2 m -63.53 -40.39 96.92 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.451 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -60.68 -38.93 86.59 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.021 0.438 . . . . 0.0 110.609 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.78 -41.85 99.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.839 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.501 HG12 ' O ' ' B' ' 30' ' ' SER . 9.2 p -70.93 -32.9 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 120.224 -0.591 . . . . 0.0 110.894 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -63.56 -43.84 95.84 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.431 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 25.7 m -70.69 -31.76 47.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.054 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.64 -42.54 98.12 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.989 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.21 -33.68 76.3 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.689 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.07 -36.63 80.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.942 0.401 . . . . 0.0 110.447 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 t -89.34 -6.39 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 121.3 0.571 . . . . 0.0 109.967 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 63.05 30.4 16.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.939 0.896 . . . . 0.0 111.215 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -105.72 4.11 10.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -64.35 -34.19 77.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.808 0.337 . . . . 0.0 110.799 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.78 -19.72 65.57 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.686 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -80.69 -3.48 50.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.677 0.275 . . . . 0.0 111.502 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 66.4 ttt-85 -91.88 83.46 5.23 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 119.946 -0.701 . . . . 0.0 112.026 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.55 95.99 6.01 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.12 98.1 2.23 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 115.319 0.888 . . . . 0.0 115.319 -171.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -64.67 -40.8 96.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.486 HG12 ' HB ' ' B' ' 54' ' ' VAL . 14.7 t -94.06 111.34 52.8 Favored Pre-proline 0 N--CA 1.437 -1.121 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.245 175.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.76 141.54 92.19 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.413 2.076 . . . . 0.0 111.665 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.704 ' HA ' HG12 ' B' ' 54' ' ' VAL . 26.1 ttt -65.63 -38.92 90.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.699 -175.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -67.47 -18.36 65.04 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.646 HG12 HH11 ' A' ' 193' ' ' ARG . 1.8 mp -96.76 -46.05 12.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.52 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.704 HG12 ' HA ' ' B' ' 51' ' ' MET . 8.4 p -63.85 -32.19 56.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 111.093 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.29 81.46 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.464 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -95.19 -20.84 18.9 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.34 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -63.99 -44.0 94.0 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.769 0.318 . . . . 0.0 110.513 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -113.9 12.32 18.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.242 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.656 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -50.72 -69.25 1.15 Allowed Glycine 0 C--O 1.218 -0.845 0 CA-C-N 115.488 -0.778 . . . . 0.0 114.75 -175.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.65 -18.19 61.59 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 117.0 0.4 . . . . 0.0 111.759 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 29.2 t -67.37 -52.68 37.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.969 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.487 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.3 p -114.02 17.03 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.468 0.651 . . . . 0.0 111.193 -175.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.656 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 36.3 ttm180 -59.1 -33.26 70.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.986 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -59.28 -50.68 73.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.023 0.44 . . . . 0.0 110.275 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . 0.46 ' HB2' HG22 ' B' ' 62' ' ' VAL . 1.8 m-20 -67.61 -34.03 76.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.36 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.487 HG23 ' O ' ' B' ' 62' ' ' VAL . 81.6 t -61.16 -43.66 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.62 -39.59 91.82 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.27 -41.99 99.72 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.707 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . 0.701 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 28.4 t70 -64.22 -43.48 94.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.613 0.244 . . . . 0.0 111.076 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.37 -44.02 96.02 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.383 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -66.44 -37.24 84.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.101 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.6 m -62.25 -42.86 99.7 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.233 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.701 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 44.3 mtp85 -63.36 -43.71 96.87 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.031 0.443 . . . . 0.0 110.205 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -64.89 -40.75 95.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.092 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -59.8 -49.27 78.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.034 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.6 tt -68.63 -39.6 80.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.716 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.517 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 7.7 t0 -65.91 -42.51 90.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.293 0.568 . . . . 0.0 109.88 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.23 93.96 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.762 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 pt -66.53 -31.71 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.149 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.83 -43.31 96.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.112 0.482 . . . . 0.0 109.837 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' B' ' 77' ' ' ASP . 64.5 mttm -63.43 -45.2 92.01 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.849 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -81.62 -9.19 59.73 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.308 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 69.47 33.36 3.15 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.628 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 96.1 mt -84.84 128.87 38.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.955 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -112.29 101.4 52.08 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.632 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.42 143.62 53.1 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.503 2.135 . . . . 0.0 111.461 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.31 88.56 4.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.032 0.444 . . . . 0.0 110.752 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.22 -98.28 2.15 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.465 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.15 129.16 19.8 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.574 0.226 . . . . 0.0 110.948 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.78 -19.56 46.95 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.795 2.33 . . . . 0.0 112.034 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 34.1 m 71.02 95.51 0.07 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.192 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.492 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 98.5 m-85 -81.67 110.98 17.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.023 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.3 t -93.95 107.9 31.34 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.977 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 68.9 Cg_endo -96.2 159.28 1.33 Allowed 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 123.208 2.605 . . . . 0.0 111.707 177.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.94 177.6 34.19 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.089 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.48 136.16 44.14 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -88.14 106.43 18.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.659 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.65 117.09 28.27 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.68 111.35 2.71 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.006 0.432 . . . . 0.0 110.725 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.73 -10.58 35.09 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.023 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -114.44 175.68 5.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.998 0.399 . . . . 0.0 111.663 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -72.35 144.43 48.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.803 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -106.79 137.51 44.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.358 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.5 m -122.84 135.26 54.47 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.36 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -131.77 166.63 21.1 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.485 ' O ' HG12 ' B' ' 107' ' ' VAL . 32.1 m -84.16 -81.04 0.18 Allowed 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.485 HG12 ' O ' ' B' ' 106' ' ' SER . 3.6 p 55.62 117.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 C-N-CA 124.441 1.096 . . . . 0.0 111.709 -173.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -112.45 150.86 30.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -157.36 -90.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -134.42 162.32 32.56 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.441 HG13 HD23 ' B' ' 11' ' ' LEU . 33.8 m -137.32 164.97 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.89 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -138.9 94.84 9.89 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -97.57 163.43 0.89 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.52 2.814 . . . . 0.0 114.495 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -145.71 146.28 31.2 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 61.1 t -125.34 133.1 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.94 126.11 44.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.551 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 88.1 mt -115.03 136.07 53.53 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -132.31 159.44 39.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.489 0.185 . . . . 0.0 110.503 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.02 13.62 82.84 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.382 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.5 -40.18 95.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.012 0.434 . . . . 0.0 111.539 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -74.52 -4.91 39.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.321 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.33 12.75 35.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.853 0.359 . . . . 0.0 110.976 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 80.5 mt -87.3 114.7 26.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.163 0.506 . . . . 0.0 110.832 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -108.98 116.65 32.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 28.5 t -116.64 135.4 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.871 -173.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -79.67 143.2 34.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.187 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -133.37 98.08 15.62 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -67.77 118.44 5.6 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.321 2.014 . . . . 0.0 112.259 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.7 mm -102.82 114.34 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.25 161.15 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.851 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -141.72 155.06 45.66 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.876 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.04 120.92 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.9 p -103.49 177.67 4.77 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.206 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -62.29 -36.9 83.53 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.229 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.74 84.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.484 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -63.18 -39.73 95.48 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.401 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.7 t -63.34 -44.69 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.812 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -58.93 -47.37 85.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.347 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.95 -41.3 99.65 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.071 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.676 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 0.1 OUTLIER -62.33 -45.67 92.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.672 0.273 . . . . 0.0 110.534 178.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 94.4 mt -63.12 -42.26 99.51 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.949 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -59.07 -49.09 79.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.464 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 19.9 m -63.48 -43.85 96.11 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.796 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' B' ' 140' ' ' MET . 97.5 mt -61.14 -45.04 96.28 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -175.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -71.08 -37.86 72.43 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.893 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -61.78 -36.31 80.71 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.028 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -82.21 29.95 0.41 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.244 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -118.51 114.34 22.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.356 0.598 . . . . 0.0 112.179 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.92 -167.35 2.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.24 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.532 ' CB ' ' H ' ' B' ' 247' ' ' GLU . 22.8 m -144.38 165.98 26.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . 0.667 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 15.3 p-90 -102.08 131.97 48.22 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 120.723 0.297 . . . . 0.0 111.336 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 5.9 mtpp -162.48 -50.55 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.44 -175.09 4.95 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' B' ' 240' ' ' VAL . 34.2 mmtp -54.26 155.29 3.83 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 73.98 -168.33 0.11 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.495 -1.229 . . . . 0.0 112.487 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' B' ' 243' ' ' ARG . . . 113.86 1.18 24.19 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.548 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . 75.11 -40.3 0.43 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.834 0.853 . . . . 0.0 112.239 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 57.7 t 71.39 -59.73 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.584 0.754 . . . . 0.0 112.768 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . 0.546 ' HB2' ' HG2' ' B' ' 203' ' ' LYS . 9.4 pt-20 53.02 -164.73 0.08 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.688 1.195 . . . . 0.0 112.787 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . 0.407 ' HB1' ' CA ' ' B' ' 190' ' ' GLY . . . -80.75 92.8 6.09 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.699 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.97 -64.03 0.23 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.297 0.57 . . . . 0.0 110.902 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -111.0 -167.89 1.24 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.291 -173.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' B' ' 187' ' ' LEU . 24.0 ptt180 -107.79 132.17 53.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.818 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.92 140.85 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.63 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 9.5 m -76.15 109.93 10.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.217 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 84.3 mt -124.4 119.14 55.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.911 0.386 . . . . 0.0 110.794 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -95.47 75.99 3.32 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -90.59 150.64 21.64 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.349 0.595 . . . . 0.0 112.279 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 34.3 m -117.18 127.33 54.01 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.283 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.84 131.58 11.5 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.677 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 30.6 p -140.28 133.15 29.17 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 30.3 t -81.95 -84.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.954 0.407 . . . . 0.0 110.791 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -103.96 -21.3 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.505 0.669 . . . . 0.0 109.546 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.05 -16.41 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.808 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -100.34 148.53 24.59 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -82.69 149.34 27.39 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -116.37 172.18 7.36 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.35 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.31 -33.86 71.63 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.81 -178.23 32.15 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.546 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.05 29.49 41.46 Favored Glycine 0 C--O 1.224 -0.47 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.968 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.37 101.71 11.23 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -117.46 143.13 46.35 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 50.8 m -147.48 119.74 8.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.172 176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 58.07 29.97 18.6 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.429 0.456 . . . . 0.0 110.758 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -90.35 123.4 34.07 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.453 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 6.7 m -94.6 117.08 37.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.396 0.617 . . . . 0.0 110.832 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' B' ' 163' ' ' ARG . 55.2 tp -100.35 118.67 37.09 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.731 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' B' ' 193' ' ' ARG . . . -92.79 112.46 24.43 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 77.2 mtm -95.14 149.4 21.34 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.935 0.398 . . . . 0.0 111.906 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.407 ' CA ' ' HB1' ' B' ' 160' ' ' ALA . . . 101.55 4.28 52.63 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.396 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -119.24 -4.21 10.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.42 4.31 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.972 -1.109 . . . . 0.0 110.422 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.608 HH11 HG12 ' A' ' 53' ' ' ILE . 33.5 mmm-85 -100.89 -2.76 31.16 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.474 0.654 . . . . 0.0 109.925 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.452 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -142.63 175.07 10.09 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.981 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 45.4 mm -57.5 130.31 81.15 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.59 131.14 32.15 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.251 1.967 . . . . 0.0 111.793 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.42 -37.38 3.76 Favored Glycine 0 N--CA 1.435 -1.378 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.114 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -63.6 -47.76 80.12 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.051 0.426 . . . . 0.0 111.591 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.89 -9.42 59.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.038 0.446 . . . . 0.0 111.111 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -93.6 -30.07 15.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.247 0.546 . . . . 0.0 109.848 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.32 73.23 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.699 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.5 -26.06 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.065 0.46 . . . . 0.0 110.896 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.546 ' HG2' ' HB2' ' B' ' 159' ' ' GLU . 49.7 mtpt -54.73 130.73 41.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.571 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.55 -9.13 66.66 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.64 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.416 ' HA ' ' OE1' ' B' ' 209' ' ' GLU . 50.4 m80 -88.57 151.0 22.78 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 122.453 -0.44 . . . . 0.0 111.876 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -91.86 165.89 13.01 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.537 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.68 102.87 4.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . 0.571 ' H ' HD22 ' B' ' 237' ' ' LEU . . . 106.48 2.07 37.76 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' B' ' 205' ' ' HIS . 45.5 tt0 -87.95 119.44 28.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.162 0.506 . . . . 0.0 110.973 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.52 136.32 38.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.24 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -156.18 -15.2 0.1 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 30.0 p 61.6 159.17 0.05 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.959 0.904 . . . . 0.0 112.087 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.0 tp -146.47 129.96 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.984 0.421 . . . . 0.0 110.522 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -78.58 115.63 18.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.596 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 67.2 t -113.8 132.08 63.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 7.1 m -96.05 -30.57 13.49 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -173.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' B' ' 216' ' ' THR . 74.6 m-85 72.7 151.06 0.14 Allowed Pre-proline 0 N--CA 1.484 1.267 0 C-N-CA 122.708 0.403 . . . . 0.0 111.084 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.67 159.2 25.07 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.284 1.99 . . . . 0.0 111.49 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -65.0 -39.05 92.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.3 0.572 . . . . 0.0 109.987 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -88.75 52.45 2.43 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.66 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 25.7 t80 -91.26 132.94 35.81 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -56.49 -31.87 64.48 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.441 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -90.87 103.61 16.3 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 45.4 tt0 -59.25 -30.42 68.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.323 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.481 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 31.2 p-10 -67.58 -24.43 65.5 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.671 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.8 mt -112.5 3.0 16.56 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.6 ptmt -66.89 112.75 4.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.129 -177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.06 23.18 76.15 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.045 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 99.1 mttt -117.98 128.85 55.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.9 0.35 . . . . 0.0 110.407 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -70.94 137.84 49.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.142 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.86 127.49 47.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.491 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -69.76 -40.24 76.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 58.95 103.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.045 0.45 . . . . 0.0 111.981 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.5 83.96 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.755 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 45.5 mm 62.58 83.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.739 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -109.0 128.08 54.64 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.564 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . 0.571 HD22 ' H ' ' B' ' 208' ' ' GLY . 3.8 mp -100.65 120.28 39.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.629 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -98.66 -56.25 2.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.439 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -94.86 -89.84 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.4 ' O ' ' HE2' ' B' ' 154' ' ' LYS . 59.3 t 67.43 120.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 120.994 0.426 . . . . 0.0 110.177 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -77.46 -92.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -174.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -173.04 155.78 3.11 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.667 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 14.8 ptp180 166.92 78.12 0.0 OUTLIER 'General case' 0 C--N 1.364 1.207 0 C-N-CA 124.782 1.233 . . . . 0.0 113.129 170.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.08 160.49 40.13 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.414 ' HA ' ' HD2' ' B' ' 246' ' ' PRO . 55.4 tp 70.1 108.06 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 123.67 0.788 . . . . 0.0 111.92 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' B' ' 245' ' ' LEU . 41.6 Cg_endo -68.44 111.51 2.55 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.251 1.967 . . . . 0.0 112.082 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . 0.532 ' H ' ' CB ' ' B' ' 150' ' ' THR . 6.4 tp10 -117.77 -13.09 10.16 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.438 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 41.7 tp 71.41 130.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.29 1.036 . . . . 0.0 112.848 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . 0.526 HG22 ' H ' ' B' ' 250' ' ' ALA . 0.5 OUTLIER -142.96 -163.28 1.6 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.526 ' H ' HG22 ' B' ' 249' ' ' THR . . . -130.3 -21.63 2.88 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.59 -35.6 80.59 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . 0.444 ' HE2' ' H ' ' B' ' 249' ' ' THR . 55.7 p90 -65.41 -17.29 64.42 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.95 -42.57 97.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.968 0.413 . . . . 0.0 111.195 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . 0.572 ' H ' ' HD2' ' B' ' 254' ' ' LYS . 0.0 OUTLIER -97.76 18.58 15.37 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -68.9 -16.83 63.86 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.007 0.432 . . . . 0.0 111.61 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . 0.436 ' CE1' HD21 ' B' ' 266' ' ' LEU . 85.3 m-85 -59.74 -30.63 68.96 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.1 -31.14 9.05 Favored Glycine 0 CA--C 1.51 -0.245 0 C-N-CA 120.196 -1.002 . . . . 0.0 114.048 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 26.2 t -81.23 85.57 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . 0.505 ' HG2' ' H ' ' B' ' 260' ' ' ASP . 12.5 tt0 53.72 -163.88 0.1 Allowed 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.681 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . 0.505 ' H ' ' HG2' ' B' ' 259' ' ' GLU . 1.4 p-10 -123.31 113.07 18.38 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.621 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -95.74 169.77 27.42 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.367 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 15.1 p -89.62 -173.75 4.07 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.9 t -60.53 -48.57 87.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.901 0.381 . . . . 0.0 111.339 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' B' ' 264' ' ' GLU . 0.1 OUTLIER -86.42 -34.09 20.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.905 0.383 . . . . 0.0 110.523 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.96 -39.98 98.73 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.481 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.436 HD21 ' CE1' ' B' ' 256' ' ' PHE . 54.8 tp -62.62 -43.28 99.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.736 0.303 . . . . 0.0 110.846 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -62.4 -44.01 97.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.83 -43.83 87.38 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.053 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -66.35 -40.79 90.05 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.433 ' O ' ' HG2' ' B' ' 274' ' ' MET . 73.6 t -64.85 -43.32 96.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.034 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -57.47 -49.32 76.66 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.616 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 16.1 ptmt -67.41 -41.92 84.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.65 0.262 . . . . 0.0 111.581 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -64.58 -39.39 93.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.789 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.0 mmm -62.33 -41.61 98.7 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -68.69 -34.94 76.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.752 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -61.85 -43.91 97.9 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -69.0 -38.21 79.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.199 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 45.0 tp -62.35 -38.34 89.14 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.79 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -56.55 -44.26 80.74 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.197 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 20.4 m -62.13 -41.59 98.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.533 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.27 93.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.84 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . 0.41 ' O ' HG23 ' B' ' 286' ' ' VAL . 67.8 mt -63.04 -45.71 98.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.271 178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . 0.515 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.9 OUTLIER -59.47 -45.84 90.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.05 179.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -63.91 -42.73 97.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.725 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -66.11 -39.58 90.04 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.54 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' 282' ' ' ILE . 97.9 t -65.78 -44.39 93.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.178 0.514 . . . . 0.0 110.01 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.28 -46.85 84.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.373 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 76.6 p -62.87 -42.78 99.89 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -64.05 -42.81 96.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 111.101 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.32 82.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.061 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . 0.442 ' O ' HG23 ' B' ' 295' ' ' VAL . 38.0 mm -65.28 -44.19 95.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.318 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . 0.407 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 18.1 tp10 -62.83 -43.48 98.67 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.972 0.415 . . . . 0.0 110.853 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.22 98.14 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.527 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 51.8 mt -63.25 -43.08 99.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 291' ' ' ILE . 84.1 t -65.34 -44.67 94.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.45 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.407 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 67.3 mttm -64.35 -41.95 96.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.796 0.332 . . . . 0.0 111.685 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.88 82.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.651 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -127.6 96.6 4.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.643 0.259 . . . . 0.0 111.538 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -91.24 93.54 9.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.319 0.58 . . . . 0.0 109.591 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.0 tp -100.95 136.9 30.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.66 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.81 135.06 50.58 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.161 0.505 . . . . 0.0 110.54 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.08 134.09 20.59 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.194 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.58 134.98 67.16 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 122.353 2.035 . . . . 0.0 112.244 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.85 78.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.151 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.86 -45.2 82.61 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.002 0.43 . . . . 0.0 111.035 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.97 -43.08 88.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.93 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . 0.413 ' O ' HG13 ' B' ' 311' ' ' ILE . 71.7 mt -62.45 -49.55 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.731 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.22 -42.98 99.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.82 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 42.7 m -62.48 -45.84 91.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.903 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . 0.639 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 65.2 mm-40 -72.01 -36.68 69.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.474 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 85.0 mt -61.82 -43.94 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.568 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 25.2 t70 -60.99 -42.75 99.03 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.718 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.25 -42.65 91.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.655 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 91.0 mt -61.94 -39.9 93.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.813 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 84.1 mtm180 -62.62 -36.77 83.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.097 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 93.0 mtt180 -63.4 -39.81 95.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.576 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -63.16 -44.74 94.65 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.455 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.59 -39.66 88.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.749 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.84 92.45 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.4 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.9 -40.38 94.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.287 0.565 . . . . 0.0 110.143 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -72.38 -19.72 61.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.939 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -76.09 -6.78 52.74 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.744 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 136.85 -12.46 3.92 Favored Glycine 0 CA--C 1.502 -0.781 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.939 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 113.21 35.61 1.6 Allowed Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.102 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -76.48 123.26 25.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.978 0.418 . . . . 0.0 110.007 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . 0.402 ' CB ' HH22 ' A' ' 73' ' ' ARG . 0.1 OUTLIER -125.25 160.43 29.26 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.555 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.1 OUTLIER 69.49 -52.24 0.61 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.157 0.583 . . . . 0.0 112.534 -178.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . 0.435 ' HG3' ' HB3' ' A' ' 65' ' ' ASP . 15.4 mm100 -74.82 -4.32 37.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.96 -24.7 64.6 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.354 0.597 . . . . 0.0 109.624 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.45 HD12 HH12 ' B' ' 315' ' ' ARG . 39.1 tp -63.83 -33.89 76.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.623 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -80.99 -9.97 59.77 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.034 -177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.444 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 93.9 mt -63.53 128.66 92.92 Favored Pre-proline 0 C--O 1.242 0.708 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.032 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.38 126.82 23.8 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.744 2.296 . . . . 0.0 113.025 -176.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -65.13 -44.03 89.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.062 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.89 -24.74 67.62 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.9 -8.02 57.65 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.829 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -121.21 -17.22 7.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.922 0.392 . . . . 0.0 111.506 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.05 -25.65 65.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.619 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.4 -51.53 68.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.822 0.344 . . . . 0.0 110.522 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -76.79 -23.06 52.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.124 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.469 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -61.74 -40.59 95.65 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.121 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . 0.445 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.2 tttt -59.82 -45.3 92.78 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.89 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . 0.517 ' O ' HG23 ' B' ' 347' ' ' VAL . 19.0 mmt85 -62.94 -43.21 99.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.246 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . 0.489 ' NH2' HD22 ' B' ' 314' ' ' LEU . 90.8 mtt180 -64.62 -41.36 96.24 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.114 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 90.5 t -65.2 -44.16 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.588 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 342' ' ' LYS . 76.6 t -61.5 -43.62 97.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.802 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 343' ' ' ARG . 70.4 t -60.22 -45.5 95.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.79 99.66 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.961 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 93.3 mt -63.28 -43.66 97.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.786 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.429 ' O ' HG23 ' B' ' 354' ' ' VAL . 97.6 mt -63.6 -45.64 89.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.967 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.1 -41.54 94.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.091 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.74 -42.86 99.81 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.115 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -67.48 -37.81 83.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.851 0.325 . . . . 0.0 110.948 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 350' ' ' LEU . 70.9 t -61.0 -45.54 98.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.18 -44.68 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.915 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.6 -51.8 56.94 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 96.6 m -66.47 -45.83 78.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -86.58 -6.86 58.77 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -175.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 63.37 69.57 0.56 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.295 0.569 . . . . 0.0 111.516 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.1 mt -101.25 160.03 14.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.87 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -137.07 155.0 50.19 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.461 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.64 104.61 11.28 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 171.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . 0.511 ' O ' HG23 ' B' ' 367' ' ' VAL . 32.8 t70 -87.05 114.74 23.92 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -173.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 57.8 mm-40 -59.73 -36.63 76.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.059 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . 0.442 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 6.1 mm-40 -63.31 -42.51 99.03 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 111.013 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -63.24 -39.72 95.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.091 0.472 . . . . 0.0 110.072 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . 0.536 HG21 ' HG2' ' B' ' 399' ' ' ARG . 70.5 t -62.81 -37.32 78.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.416 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.2 mmmt -57.4 -44.71 84.78 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.6 -38.85 96.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.082 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.76 -43.06 99.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.65 -44.19 96.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.095 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.51 -42.18 98.5 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.15 -37.65 81.26 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.894 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.4 ttm -65.83 -42.21 90.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.049 0.452 . . . . 0.0 110.719 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.79 -31.28 72.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.044 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 50.6 m -71.6 -4.58 27.89 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.918 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -88.96 -4.02 58.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.877 0.37 . . . . 0.0 111.637 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -112.04 172.64 6.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.217 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.64 -48.38 72.35 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.717 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 21.4 t70 -127.82 116.4 20.78 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.041 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.48 -31.07 42.88 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.368 2.045 . . . . 0.0 113.165 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.1 -43.74 86.38 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 11.4 pt-20 -62.96 -38.86 92.8 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.891 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.91 -42.11 93.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.602 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.19 -44.19 98.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.413 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 36.7 mt-10 -64.95 -44.96 87.72 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.85 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.94 -45.77 89.62 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.16 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -66.59 -39.87 88.64 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.745 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 58.3 p -81.58 -3.36 53.1 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -175.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.3 mttt -104.13 13.34 32.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.003 0.43 . . . . 0.0 110.98 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -138.49 118.04 12.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.272 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.64 -41.52 98.24 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -56.17 -50.26 71.69 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.968 0.413 . . . . 0.0 110.93 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.07 -42.1 99.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.397 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.441 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.2 mtp -64.68 -53.94 39.49 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.05 -39.54 83.01 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -61.98 -40.67 96.41 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 48.6 tpp -65.26 -40.63 94.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.838 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.536 ' HG2' HG21 ' B' ' 367' ' ' VAL . 66.8 mtm180 -64.06 -36.21 83.25 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.121 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -61.39 -42.84 99.37 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.728 0.299 . . . . 0.0 110.206 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.33 -44.85 94.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.447 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.98 -41.3 99.51 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.097 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.31 -40.09 96.39 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.649 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.45 -43.44 96.85 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . 0.515 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 26.6 mt-10 -65.13 -38.17 89.79 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.616 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.73 -43.32 94.25 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-O 120.803 0.335 . . . . 0.0 110.38 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.97 -43.95 90.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.224 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.32 -44.89 94.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.16 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 45.2 mt-10 -66.03 -33.12 75.07 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.004 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.02 96.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.386 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 95.4 t -67.45 -42.92 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.324 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.54 -41.21 97.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.002 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -66.83 -20.88 66.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.708 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -97.4 -6.87 33.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.301 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -111.21 179.98 3.88 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.267 0.556 . . . . 0.0 111.801 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.12 130.39 35.11 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.357 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 70.4 t -117.82 130.34 72.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 6.0 t -129.87 135.74 48.73 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.089 0.471 . . . . 0.0 110.674 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -93.32 123.56 36.69 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.238 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -138.88 133.41 31.91 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.807 0.337 . . . . 0.0 111.155 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -83.64 150.53 25.84 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.795 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -157.29 170.65 21.98 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 20.0 p -79.34 164.3 24.18 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.745 0.307 . . . . 0.0 110.284 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -64.33 -19.47 65.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.059 0.457 . . . . 0.0 111.009 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -61.31 -38.02 85.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.831 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -65.13 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.1 0.476 . . . . 0.0 110.238 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 8.2 mp -73.63 -20.47 60.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 4.7 mmt -78.25 -9.87 59.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -78.21 83.16 4.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.286 0.565 . . . . 0.0 109.841 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -106.09 4.02 28.72 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.532 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -67.47 -44.86 77.55 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.607 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.951 -179.536 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.792 0.329 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -84.55 95.14 8.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.081 0.467 . . . . 0.0 110.903 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.0 m -134.4 167.51 25.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.007 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.8 m -125.43 97.33 5.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.896 0.379 . . . . 0.0 111.286 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.79 140.65 23.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.742 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.598 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 41.1 tt0 -145.18 169.95 17.18 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.6 t -103.93 157.16 17.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.806 0.276 . . . . 0.0 111.204 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.4 m -123.87 -71.19 0.73 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.835 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -153.56 120.76 5.78 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.45 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.74 -120.38 20.05 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.733 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 6.8 mp -87.75 -5.5 58.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 107' ' ' VAL . . . -71.22 130.1 18.5 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.78 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 4.7 tpp180 -119.03 -161.81 0.87 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.8 ttm-85 -146.38 128.32 15.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.29 -94.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.056 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.0 m 52.89 87.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.12 0.486 . . . . 0.0 111.603 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 tp -108.65 139.2 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.935 0.398 . . . . 0.0 111.567 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.6 m -106.65 125.73 51.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.1 pt -127.83 157.87 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.703 0.287 . . . . 0.0 111.587 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.538 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -77.3 161.83 27.78 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.479 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.03 -49.06 76.99 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.09 -34.7 78.66 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.961 0.41 . . . . 0.0 110.608 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m -62.21 -40.1 94.97 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.758 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.3 mt -62.13 -48.96 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.168 0.508 . . . . 0.0 110.812 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -67.64 -40.11 84.6 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.008 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -79.65 -67.73 0.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.46 -47.37 79.28 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -172.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.429 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 98.0 t -61.81 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.688 0.28 . . . . 0.0 111.694 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -63.4 -44.89 93.39 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.032 0.444 . . . . 0.0 110.306 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.5 m -62.79 -42.24 99.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.254 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -63.51 -36.41 83.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.776 0.322 . . . . 0.0 110.584 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 94.2 mt -62.48 -43.55 98.54 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.706 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.46 -35.02 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.936 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -63.49 -43.07 98.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.46 -29.32 34.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.923 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.95 -39.7 87.33 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.004 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.43 -21.55 58.1 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.075 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.81 -44.45 96.85 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.06 0.457 . . . . 0.0 109.876 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.4 t -91.75 -2.33 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.075 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 63.37 26.81 15.12 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.998 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.8 pp -101.12 7.64 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.578 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -63.57 -33.56 75.87 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.952 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.53 -0.58 67.96 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.749 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -94.47 -3.74 49.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.764 0.316 . . . . 0.0 111.192 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -88.04 122.66 31.88 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -66.92 -7.24 20.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -173.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.55 -34.95 3.7 Favored Glycine 0 C--N 1.315 -0.62 0 C-N-CA 120.381 -0.914 . . . . 0.0 114.212 174.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -63.69 133.87 54.37 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 117.49 0.645 . . . . 0.0 109.36 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.572 HG12 HG12 ' A' ' 54' ' ' VAL . 20.0 t 64.27 72.62 0.5 Allowed Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.565 ' O ' HG13 ' A' ' 54' ' ' VAL . 58.8 Cg_endo -69.62 161.42 45.98 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.381 2.72 . . . . 0.0 113.691 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.827 ' HA ' HG22 ' A' ' 54' ' ' VAL . 49.3 mtt -62.32 -34.65 77.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -175.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -62.96 -25.61 68.44 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.541 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -92.73 -39.6 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.183 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.827 HG22 ' HA ' ' A' ' 51' ' ' MET . 8.6 m -62.59 -33.05 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 120.659 0.266 . . . . 0.0 111.118 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.43 -32.9 72.88 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.707 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -100.33 -34.35 10.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.619 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -65.54 -43.08 91.08 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -125.61 20.54 7.87 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.737 0.303 . . . . 0.0 111.117 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.655 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -57.38 -45.64 92.69 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 114.536 0.575 . . . . 0.0 114.536 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.02 -19.64 20.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 117.538 0.669 . . . . 0.0 111.369 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 t -63.13 -44.68 94.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.125 -177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.5 p -120.58 19.47 5.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.496 0.665 . . . . 0.0 110.702 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 39.5 ttm180 -58.12 -29.51 65.57 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.627 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -61.08 -50.48 73.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.538 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.99 -20.74 57.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.046 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.7 t -63.66 -44.2 98.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 99.2 mt -62.63 -40.43 96.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.173 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.2 -43.85 98.54 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.283 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.713 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 37.2 t70 -64.16 -43.23 95.81 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.983 0.391 . . . . 0.0 110.279 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 98.1 mt -61.11 -42.25 98.19 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.871 0.367 . . . . 0.0 110.265 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.3 ttp -61.4 -45.56 93.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.815 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 m -62.43 -44.62 95.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.042 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.713 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 37.6 mtp85 -65.86 -43.65 87.77 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.078 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -65.87 -40.5 91.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.061 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -61.17 -48.16 82.83 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.502 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.0 tt -68.53 -39.47 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.498 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.449 ' O ' ' HE3' ' A' ' 81' ' ' LYS . 10.6 t70 -62.35 -41.68 98.78 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.332 0.587 . . . . 0.0 109.431 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -66.05 -45.62 80.74 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.703 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.2 pt -65.46 -29.75 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.933 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.26 -44.22 97.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.096 0.474 . . . . 0.0 110.766 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 16.2 ptpt -81.79 -24.41 35.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.59 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -87.82 -5.96 58.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.99 0.424 . . . . 0.0 110.437 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 64.2 40.55 6.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.669 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.4 mt -101.75 118.82 49.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.408 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -107.7 102.29 44.24 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.153 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.87 141.59 65.74 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.517 2.145 . . . . 0.0 112.159 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.98 90.5 8.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.375 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.1 -109.89 3.49 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.029 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.14 127.62 24.27 Favored Pre-proline 0 C--N 1.318 -0.775 0 O-C-N 122.852 -0.205 . . . . 0.0 110.991 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.64 161.39 45.42 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.737 2.291 . . . . 0.0 111.298 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -93.61 116.09 28.58 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.316 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.456 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 93.0 m-85 -94.11 127.66 40.05 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.62 98.31 36.58 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 120.893 0.377 . . . . 0.0 111.334 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 90.6 Cg_endo -97.3 171.69 0.77 Allowed 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 123.471 2.78 . . . . 0.0 110.981 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.66 -175.97 22.4 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.46 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -85.07 135.07 34.15 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -90.95 125.34 35.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.391 0.615 . . . . 0.0 110.876 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 97.8 mttt -113.49 124.05 51.48 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.1 tp -69.77 123.51 21.62 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.32 -16.3 56.91 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.231 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 50.4 mt-10 -113.34 178.83 4.14 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -86.44 168.64 13.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.972 0.415 . . . . 0.0 111.549 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -124.0 146.88 48.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.094 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.0 m -131.54 143.21 50.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.958 0.408 . . . . 0.0 111.241 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -138.43 154.12 48.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.571 ' O ' HG12 ' A' ' 107' ' ' VAL . 21.1 m -93.79 -74.87 0.52 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -175.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 65.41 142.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 124.012 0.925 . . . . 0.0 110.119 -172.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 42.8 mt-10 -119.87 129.9 54.61 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -164.17 146.01 8.82 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.273 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 64.31 158.76 0.09 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 175.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.48 156.42 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.548 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -158.19 106.12 1.71 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -82.9 151.63 14.41 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.897 2.398 . . . . 0.0 113.983 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -123.36 145.74 48.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.44 176.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.75 131.04 73.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.779 0.323 . . . . 0.0 111.801 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -108.22 -85.49 0.52 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.815 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.9 mt 57.44 114.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -132.34 153.66 50.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.146 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.06 19.16 70.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.52 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.43 -41.28 98.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.135 0.493 . . . . 0.0 111.079 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -73.9 -4.72 36.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.565 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -105.41 16.27 25.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.794 0.33 . . . . 0.0 110.99 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 89.7 mt -90.86 122.48 42.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.135 0.493 . . . . 0.0 111.091 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -110.47 124.06 51.06 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.54 133.91 62.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.772 0.32 . . . . 0.0 111.425 -175.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.38 134.0 36.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.54 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -128.0 98.2 27.76 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.871 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.86 126.95 11.76 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.358 2.039 . . . . 0.0 112.386 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.2 mm -109.94 120.92 61.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.622 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.59 162.55 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.334 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -136.7 149.85 48.13 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.088 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.2 t -76.03 127.48 37.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.2 p -113.84 177.25 4.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.245 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -63.29 -34.75 78.37 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.719 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.03 90.91 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.402 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -63.47 -41.99 98.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.572 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.44 -45.5 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.403 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.93 -43.12 99.06 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.543 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.81 99.72 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.307 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.591 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 3.3 tpt -62.65 -46.93 85.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.846 0.355 . . . . 0.0 110.621 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.75 -42.04 97.9 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.598 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -62.14 -43.32 99.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.148 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.7 m -62.66 -41.55 99.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.151 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.2 mt -61.23 -42.67 99.0 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -71.26 -22.17 62.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.369 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -84.77 -0.55 54.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.519 0.676 . . . . 0.0 110.077 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -116.47 20.95 13.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.954 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -122.33 95.68 4.74 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.526 ' HB3' ' OE1' ' A' ' 159' ' ' GLU . . . -140.68 159.08 42.98 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 173.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 247' ' ' GLU . 6.9 m -122.37 142.82 50.11 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.194 -1.003 . . . . 0.0 112.055 -175.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 41.0 p-90 -74.43 132.12 41.67 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.253 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 244' ' ' GLU . 64.5 tttp -162.84 -63.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 242' ' ' GLU . 40.8 mt-10 -116.17 -96.28 0.46 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -176.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 155' ' ' ASP . 23.3 tptm -92.34 -113.34 0.09 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -167.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 3.5 t70 -152.84 154.93 36.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.529 -172.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 164.22 -34.61 0.28 Allowed Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -152.76 140.2 19.65 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.437 ' HA ' ' HD2' ' A' ' 243' ' ' ARG . 58.1 t -129.9 125.98 61.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.225 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.526 ' OE1' ' HB3' ' A' ' 149' ' ' ALA . 4.4 mp0 -88.48 158.86 18.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.22 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -83.39 52.62 2.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.826 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.402 ' CD ' HH11 ' A' ' 255' ' ' ARG . 1.2 pp20? -162.53 9.1 0.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.181 0.515 . . . . 0.0 110.665 177.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 163' ' ' ARG . 15.8 t70 -104.12 -172.89 2.19 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.528 -175.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.402 ' H ' ' CG ' ' A' ' 162' ' ' ASP . 42.8 ttm180 -121.96 117.44 26.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.601 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.11 130.03 63.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.449 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 55.9 m -86.76 117.56 25.59 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 83.5 mt -126.89 123.04 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.099 0.476 . . . . 0.0 111.702 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -95.13 105.47 17.4 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -124.52 149.58 46.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.476 0.655 . . . . 0.0 112.438 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 89.5 m -124.52 128.37 48.85 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.423 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.63 142.98 18.95 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.887 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 m -139.53 146.25 39.69 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.6 t -81.54 -86.21 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.328 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -99.44 -45.65 5.76 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.026 0.441 . . . . 0.0 110.003 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.2 15.29 0.23 Allowed Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.766 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -138.81 148.63 44.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.561 0.219 . . . . 0.0 110.564 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.91 161.79 30.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.468 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -131.31 177.55 7.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.033 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.86 -35.19 72.55 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -105.39 -172.59 24.01 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.863 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.68 32.54 41.01 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.502 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -113.47 114.57 26.74 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.99 146.47 49.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.947 0.404 . . . . 0.0 111.534 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -143.03 122.08 12.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.727 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 59.99 34.82 21.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.665 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -89.08 132.52 34.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.847 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 88.3 t -96.19 124.46 48.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.901 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 63.5 tp -111.5 123.96 51.31 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.019 0.438 . . . . 0.0 111.285 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -111.22 112.23 23.87 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 73.0 mtm -84.64 160.04 20.46 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.684 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.34 -24.83 28.99 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.411 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -91.36 -6.34 53.12 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.25 46.12 13.47 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.035 -1.079 . . . . 0.0 111.662 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -85.44 -11.75 53.62 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.22 170.51 12.92 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.425 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.641 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.2 mp -55.66 132.31 71.92 Favored Pre-proline 0 C--N 1.323 -0.559 0 O-C-N 123.385 0.428 . . . . 0.0 110.063 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -48.36 129.31 19.16 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.264 1.976 . . . . 0.0 111.681 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.68 -33.86 5.91 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.699 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -62.27 -44.7 95.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.602 0.239 . . . . 0.0 110.655 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.56 -40.55 95.76 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.93 -33.25 75.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.006 0.431 . . . . 0.0 110.847 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.03 -22.77 70.82 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.183 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 45.6 mm -64.16 -43.46 97.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -52.17 115.78 1.89 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.446 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 113.78 -10.81 23.22 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.188 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.625 ' HA ' ' OE1' ' A' ' 209' ' ' GLU . 47.7 m80 -98.6 139.03 34.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.036 0.418 . . . . 0.0 111.201 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -98.26 168.94 9.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.62 132.16 48.99 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.5 33.13 61.35 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.118 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.625 ' OE1' ' HA ' ' A' ' 205' ' ' HIS . 41.9 tt0 -117.86 117.37 29.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.173 0.511 . . . . 0.0 110.388 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -105.1 130.81 53.2 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.815 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -153.36 -23.02 0.15 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.463 HG22 ' HA ' ' A' ' 234' ' ' ALA . 80.4 p 60.05 167.88 0.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.776 0.831 . . . . 0.0 112.031 -175.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 232' ' ' LYS . 19.2 tt -160.41 144.68 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.225 -0.297 . . . . 0.0 110.896 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.99 108.46 15.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.805 0.336 . . . . 0.0 111.381 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.55 122.54 64.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 16.3 p -90.36 -22.69 21.38 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -173.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 70.6 m-85 67.89 140.37 0.07 OUTLIER Pre-proline 0 N--CA 1.483 1.219 0 CA-C-O 121.068 0.461 . . . . 0.0 111.581 -176.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 14.4 Cg_exo -69.54 150.4 69.52 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.455 2.103 . . . . 0.0 112.0 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.436 ' O ' ' HE2' ' A' ' 227' ' ' LYS . 81.0 mm-40 -66.56 -38.56 87.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.992 0.425 . . . . 0.0 110.171 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -86.45 33.3 0.63 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.732 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.515 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 10.9 t80 -70.01 131.4 44.3 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -65.02 -17.23 64.26 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.515 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -98.95 99.62 10.69 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 38.9 tt0 -56.52 -33.07 65.69 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.897 -175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -66.24 -18.41 65.34 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.904 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.24 -1.11 9.25 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 14.1 ptmm? -67.81 121.44 15.99 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.397 0.617 . . . . 0.0 112.301 -175.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 82.06 8.43 86.56 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.589 -0.732 . . . . 0.0 114.097 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -118.48 137.94 52.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 117.528 0.664 . . . . 0.0 110.879 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -91.21 155.4 18.61 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.49 144.57 32.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.733 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 213' ' ' ILE . 3.4 mppt? -98.74 -15.82 19.19 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 56.37 -149.96 0.45 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.133 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.463 ' HA ' HG22 ' A' ' 212' ' ' THR . . . -141.0 -68.43 0.4 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.753 0.311 . . . . 0.0 110.56 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.2 mt 64.74 91.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.954 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -98.19 -27.68 14.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.291 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.0 tp 52.1 67.01 1.04 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.882 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -65.34 -43.44 90.87 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.433 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 30.7 mtpp -96.98 -80.02 0.45 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -173.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 85.4 t 77.96 139.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -171.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -91.6 -84.05 0.27 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -172.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 153' ' ' GLU . 43.0 tt0 -165.23 103.8 0.75 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 19.6 ttm-85 -166.81 113.92 0.82 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 175.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -177.92 155.24 0.97 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 42.3 tp 67.89 100.8 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.321 0 O-C-N 124.135 0.897 . . . . 0.0 111.18 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 42.1 Cg_endo -69.01 111.93 2.8 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.229 1.953 . . . . 0.0 112.889 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.582 ' O ' HG21 ' A' ' 150' ' ' THR . 44.5 tt0 -137.13 147.64 46.14 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.5 mp -73.48 98.88 2.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.984 0.421 . . . . 0.0 111.108 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.9 p -95.24 -89.02 0.25 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.428 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -170.79 -51.41 0.02 OUTLIER 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.9 0.381 . . . . 0.0 111.342 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -81.14 89.39 5.99 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.994 0.426 . . . . 0.0 111.882 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.486 ' CD1' HG23 ' A' ' 253' ' ' ILE . 51.5 p90 -159.02 -13.48 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.214 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.486 HG23 ' CD1' ' A' ' 252' ' ' PHE . 19.0 pt -121.17 -41.28 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.022 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -83.36 -2.95 56.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.35 0.595 . . . . 0.0 110.327 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.402 HH11 ' CD ' ' A' ' 161' ' ' GLU . 54.2 ttp180 -124.7 98.26 5.64 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -148.72 -61.2 0.24 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -166.0 -75.64 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.54 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 68.0 t -104.25 117.74 50.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 122.832 -0.216 . . . . 0.0 111.12 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 58.1 -170.0 0.11 Allowed 'General case' 0 CA--C 1.544 0.733 0 O-C-N 123.989 0.806 . . . . 0.0 110.656 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -104.7 112.71 25.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.323 0.582 . . . . 0.0 109.789 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -98.01 167.72 23.02 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.203 -0.998 . . . . 0.0 113.774 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 56.1 p -108.63 -167.39 1.22 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.91 -54.17 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.358 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.2 OUTLIER -80.3 -38.81 29.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 -178.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.26 98.18 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.634 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 270' ' ' VAL . 49.0 tp -63.89 -43.21 96.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.555 0.216 . . . . 0.0 110.59 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -63.54 -40.41 96.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.391 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.23 -44.11 89.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.802 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -68.07 -38.12 82.04 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.133 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 266' ' ' LEU . 79.3 t -64.0 -43.35 97.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.656 0.265 . . . . 0.0 110.507 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -59.27 -46.37 88.71 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.993 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.5 ptmt -66.34 -44.49 83.15 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -63.95 -39.47 94.22 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 270' ' ' VAL . 99.3 mmm -64.47 -40.67 96.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.76 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.99 -35.3 79.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 110.795 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 -62.71 -41.77 99.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.759 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -64.61 -37.49 87.75 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.734 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 46.0 tp -61.83 -38.29 87.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.876 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -57.58 -45.53 85.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.861 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.9 m -62.35 -42.39 99.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.605 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.13 82.95 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.057 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.85 -43.73 97.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.297 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.496 ' HD3' ' HG2' ' A' ' 405' ' ' GLU . 1.4 tpm_? -59.54 -46.99 87.27 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.022 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -65.61 -40.69 92.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.398 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -61.09 -43.34 99.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.26 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.43 -44.12 90.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.348 0.594 . . . . 0.0 110.19 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.46 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.5 tttt -62.05 -48.84 78.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.264 -177.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.9 p -64.63 -41.38 96.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -65.86 -42.3 90.58 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.46 -47.23 82.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.959 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 287' ' ' LYS . 48.0 mm -64.57 -44.18 96.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.41 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.445 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 17.1 tp10 -60.16 -45.11 94.21 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 110.681 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.74 -42.7 98.51 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.246 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.48 -41.69 96.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 291' ' ' ILE . 71.3 t -63.16 -45.09 99.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.452 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . 0.445 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.7 mttm -63.83 -42.54 97.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 111.064 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.32 -42.7 62.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -118.75 92.52 3.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -98.54 99.22 10.35 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -106.1 159.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.742 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -64.13 137.5 57.99 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 38.9 t -108.22 128.52 25.54 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.242 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.437 ' O ' HG13 ' A' ' 307' ' ' ILE . 47.0 Cg_exo -56.6 128.5 30.3 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.344 2.029 . . . . 0.0 111.712 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.37 83.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.735 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.5 -41.53 90.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.916 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.9 mt -67.88 -41.65 82.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.501 ' O ' HG13 ' A' ' 311' ' ' ILE . 69.4 mt -61.93 -51.27 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.704 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.85 -43.81 98.1 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 41.6 m -61.6 -45.47 93.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.601 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.68 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 72.9 mm-40 -71.58 -34.1 69.64 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 307' ' ' ILE . 95.1 mt -61.4 -43.79 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.663 0.268 . . . . 0.0 110.723 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.504 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.7 t70 -62.3 -40.98 98.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.1 t -62.98 -44.67 99.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.275 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 46.1 mt -63.03 -39.39 94.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.956 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.504 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 83.9 mtm180 -63.08 -39.82 95.84 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.902 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 84.3 mtt180 -66.02 -38.98 89.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.786 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.58 -43.02 99.86 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.109 0.481 . . . . 0.0 109.943 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.49 -36.62 79.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.326 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -62.54 -36.94 84.2 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.628 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.401 HE22 ' HB2' ' B' ' 46' ' ' LYS . 35.6 tt0 -62.07 -42.29 99.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.434 0.635 . . . . 0.0 109.876 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -78.23 -6.96 56.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.599 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -91.37 -3.74 56.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.313 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 135.33 -21.41 3.65 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.519 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 118.15 34.11 1.17 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.455 -0.878 . . . . 0.0 111.241 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.471 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 42.0 t-20 -71.97 126.87 30.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.7 tm-20 -127.8 150.57 49.77 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 6.5 ptpp? 61.94 -39.38 0.14 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.667 1.587 . . . . 0.0 114.057 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.471 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 16.0 mm100 -71.79 -11.58 60.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.271 0.558 . . . . 0.0 110.438 177.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.69 -21.23 66.28 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.987 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.47 HD12 HH12 ' A' ' 315' ' ' ARG . 63.1 tp -62.54 -37.48 86.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.131 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -80.97 -2.85 49.5 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.864 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 74.8 mt -69.42 149.08 97.26 Favored Pre-proline 0 C--O 1.239 0.541 0 O-C-N 122.265 -0.272 . . . . 0.0 110.394 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.6 143.77 99.46 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.658 2.239 . . . . 0.0 113.113 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 25.5 ttt85 -83.31 -42.17 17.44 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.808 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -57.99 -43.74 86.78 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.424 ' HB2' ' OE2' ' A' ' 224' ' ' GLU . 88.7 mt -85.74 -3.27 58.85 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.808 -176.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -104.64 -27.58 11.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.948 0.404 . . . . 0.0 110.151 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.1 -25.56 67.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.661 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -60.14 -48.04 83.38 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.845 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -80.79 -22.11 40.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.599 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.29 -41.95 99.03 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.429 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.8 tttt -60.06 -46.2 90.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.16 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.549 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.0 mmt85 -62.01 -45.64 92.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.428 ' NH2' HD22 ' A' ' 314' ' ' LEU . 91.1 mtt180 -67.14 -38.09 84.94 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.451 -178.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 341' ' ' ALA . 78.7 t -64.44 -44.24 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.648 0.261 . . . . 0.0 110.599 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 342' ' ' LYS . 69.5 t -61.71 -43.34 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.572 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 343' ' ' ARG . 76.4 t -60.17 -45.2 96.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.9 -42.53 99.75 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.141 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.77 -44.75 92.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.659 0.266 . . . . 0.0 111.334 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 354' ' ' VAL . 96.2 mt -64.03 -46.71 83.23 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.275 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.26 -38.69 78.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.412 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.72 -42.92 96.6 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.196 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.08 -36.48 79.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.831 0.316 . . . . 0.0 110.881 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 350' ' ' LEU . 86.6 t -60.81 -44.67 98.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.63 -44.23 98.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.841 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -69.87 -46.25 65.92 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.9 m -66.73 -44.98 80.12 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -90.71 4.77 50.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.967 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 53.06 47.61 24.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.109 0.48 . . . . 0.0 111.632 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.9 mt -73.37 140.26 46.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.877 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -119.86 153.63 35.53 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.851 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.13 110.04 15.16 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.498 ' O ' HG23 ' A' ' 367' ' ' VAL . 23.1 t70 -83.46 112.46 19.98 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.918 -174.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.57 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 15.7 mm-40 -59.36 -38.73 81.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.629 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.76 -42.85 90.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.431 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -62.33 -38.32 89.0 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.517 HG21 ' HG2' ' A' ' 399' ' ' ARG . 99.0 t -64.42 -40.08 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.632 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.8 mmmt -56.65 -44.54 81.44 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.59 -40.14 98.35 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.197 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.97 -42.26 99.78 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.694 0.283 . . . . 0.0 110.639 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.13 -44.3 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.713 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.11 -39.23 89.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.45 -36.14 80.61 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.488 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 51.0 ttm -65.61 -39.8 91.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.103 0.478 . . . . 0.0 110.202 175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -61.54 -29.79 70.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.86 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 13.2 m -72.53 -5.58 37.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.585 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.51 -8.73 52.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 0.0 110.843 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -107.36 171.09 7.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.235 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.28 -36.78 85.23 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.338 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -133.67 109.12 12.06 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 120.878 0.37 . . . . 0.0 110.736 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.425 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 53.0 Cg_exo -56.96 -39.64 89.95 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.058 2.505 . . . . 0.0 113.728 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -64.36 -42.69 96.06 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.28 -37.96 87.5 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.061 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.24 -43.43 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.0 -44.94 99.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.463 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 53.9 mt-10 -68.75 -42.12 77.99 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.976 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -59.36 -46.52 88.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.828 0.347 . . . . 0.0 111.119 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.18 -41.43 94.6 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.664 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 32.9 p -80.23 -6.47 57.9 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 97.9 mttt -101.0 5.23 43.03 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.876 0.37 . . . . 0.0 111.0 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -126.06 119.38 27.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -62.62 -43.69 98.17 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -57.67 -49.82 75.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.762 0.315 . . . . 0.0 111.169 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.2 -42.64 99.34 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.545 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.435 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.2 mtp -65.44 -44.38 87.46 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.52 -42.23 71.54 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.459 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.99 -41.56 99.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.57 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 51.4 tpp -62.98 -41.37 99.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.843 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.517 ' HG2' HG21 ' A' ' 367' ' ' VAL . 73.4 mtm180 -65.38 -37.49 87.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.908 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.55 -44.32 96.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.41 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.65 -45.2 88.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.083 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.51 94.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.728 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 51.3 tp -63.08 -40.49 97.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.327 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.45 -42.56 98.95 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.598 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.496 ' HG2' ' HD3' ' A' ' 283' ' ' ARG . 29.0 mt-10 -64.96 -40.21 94.65 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.737 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -59.93 -41.67 92.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.554 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.33 87.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.024 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.58 -43.87 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.191 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.45 -33.58 76.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.439 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.77 98.21 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.98 0.419 . . . . 0.0 110.149 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 97.4 t -65.44 -43.07 94.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.329 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.17 -39.82 91.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.048 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -70.3 -13.02 61.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.462 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -108.83 3.04 22.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.102 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.37 173.27 6.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.337 0.589 . . . . 0.0 111.766 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -84.84 107.42 16.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.245 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.2 133.37 36.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.383 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.8 t -137.48 148.4 46.03 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.118 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -97.57 128.47 44.33 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.009 0.433 . . . . 0.0 110.965 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -134.52 127.98 32.44 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.627 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -101.16 144.12 30.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.388 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.4 t -152.4 -176.27 5.63 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.871 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.8 p -81.66 162.58 22.98 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.961 0.41 . . . . 0.0 110.836 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -67.89 -17.78 64.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.804 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -61.53 -41.67 97.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.928 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.39 -26.74 63.84 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.518 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.1 -21.35 59.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.158 0.504 . . . . 0.0 110.064 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 4.5 mmt -79.65 -7.11 58.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.997 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -80.48 87.39 5.69 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.503 0.668 . . . . 0.0 109.659 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -120.73 30.43 6.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.105 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -65.9 -37.14 85.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.948 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.753 179.551 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 120.553 0.216 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -83.77 101.29 11.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.82 160.55 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.928 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -114.42 106.59 14.48 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.858 0.361 . . . . 0.0 110.777 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -155.55 136.99 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.61 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.569 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 43.5 tt0 -142.99 169.27 17.88 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.0 t -101.02 153.8 19.24 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 117.705 0.23 . . . . 0.0 111.218 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 57.7 m -120.44 -65.76 1.12 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -162.1 123.95 2.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.465 0.174 . . . . 0.0 110.549 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.1 -120.09 18.46 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.814 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' B' ' 108' ' ' GLU . 6.8 mp -89.23 -5.86 57.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' B' ' 107' ' ' VAL . . . -70.52 132.57 22.82 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.088 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 3.5 tpp180 -121.25 -162.64 0.98 Allowed 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -145.45 127.78 15.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.64 -94.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.135 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m 52.28 89.29 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.202 0.525 . . . . 0.0 111.479 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 tp -111.22 136.29 47.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.014 0.435 . . . . 0.0 111.693 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 46.1 m -101.72 126.9 48.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 17.2 pt -126.24 160.8 33.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.869 0.366 . . . . 0.0 111.794 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.573 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -81.02 161.27 24.29 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.333 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.81 77.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.322 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -65.8 -35.62 81.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.999 0.428 . . . . 0.0 110.407 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -63.01 -40.13 96.84 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.02 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.573 HG13 ' O ' ' B' ' 20' ' ' ALA . 74.8 mt -61.52 -48.65 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.328 0.585 . . . . 0.0 110.552 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -68.72 -44.39 73.98 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.133 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 12.3 m -77.69 -56.86 4.17 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.11 -46.84 55.1 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 97.6 t -63.03 -45.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -62.92 -45.7 91.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.993 0.425 . . . . 0.0 110.695 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 20.8 m -64.42 -36.64 84.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.287 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.4 -39.91 92.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.213 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 95.1 mt -62.41 -43.24 99.3 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.714 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -70.3 -37.7 71.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.181 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.47 -41.39 96.53 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.19 -32.22 50.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.804 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.23 -40.99 94.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.021 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.03 -28.21 65.29 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.402 177.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.52 -44.35 89.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.69 -3.33 9.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.358 0.599 . . . . 0.0 109.939 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 63.67 27.48 14.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.909 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.9 pp -103.18 6.94 10.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.056 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -64.83 -29.15 70.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.951 0.405 . . . . 0.0 110.888 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.82 -2.62 82.12 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.603 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -92.98 -4.17 53.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.696 0.284 . . . . 0.0 111.533 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -87.37 128.93 35.19 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.401 ' HB2' HE22 ' A' ' 320' ' ' GLN . 68.5 mttm -73.78 -2.31 22.96 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -173.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.97 -37.23 2.84 Favored Glycine 0 C--N 1.314 -0.69 0 C-N-CA 120.473 -0.87 . . . . 0.0 114.246 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -61.26 132.48 53.75 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 117.482 0.641 . . . . 0.0 109.525 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.573 HG12 HG12 ' B' ' 54' ' ' VAL . 21.3 t 64.5 71.69 0.55 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -172.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.548 ' O ' HG13 ' B' ' 54' ' ' VAL . 59.0 Cg_endo -69.59 161.4 46.06 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 123.373 2.715 . . . . 0.0 113.755 -176.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.76 ' HA ' HG22 ' B' ' 54' ' ' VAL . 50.6 mtt -61.94 -33.97 75.24 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -63.14 -24.43 67.89 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.552 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 99.1 mt -95.45 -38.9 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.465 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.76 HG22 ' HA ' ' B' ' 51' ' ' MET . 10.2 m -62.46 -33.78 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.329 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.427 ' O ' ' HA3' ' B' ' 59' ' ' GLY . . . -60.33 -32.91 71.69 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.645 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -100.64 -34.05 10.04 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.688 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -65.7 -42.82 90.73 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -126.33 19.03 7.56 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.682 0.277 . . . . 0.0 110.979 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.649 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -57.21 -47.97 83.64 Favored Glycine 0 C--O 1.222 -0.629 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.281 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.8 -23.14 22.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.283 0.541 . . . . 0.0 111.683 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -62.08 -45.65 92.57 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.149 -176.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.521 ' O ' HG23 ' B' ' 66' ' ' VAL . 10.5 p -119.11 21.45 5.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.545 0.688 . . . . 0.0 110.592 -177.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.649 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 35.1 ttm180 -59.86 -26.65 66.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.737 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -63.33 -49.59 73.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.451 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . 0.462 ' HB2' HG22 ' B' ' 62' ' ' VAL . 2.9 m-20 -75.84 -21.52 57.17 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.027 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.521 HG23 ' O ' ' B' ' 62' ' ' VAL . 79.6 t -63.24 -44.1 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.5 -40.39 96.56 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.345 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.53 -43.27 99.26 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.361 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . 0.76 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 37.6 t70 -64.06 -43.63 94.89 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 117.085 0.442 . . . . 0.0 110.192 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.15 -42.64 98.92 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 110.245 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.5 ttp -60.92 -45.31 95.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.862 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -62.34 -44.69 95.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.117 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.76 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 34.2 mtp85 -66.66 -43.16 85.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.046 -176.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -65.13 -40.97 95.18 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.88 0.371 . . . . 0.0 111.073 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.3 -48.25 82.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.499 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 20.1 tt -68.51 -38.75 79.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.36 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.411 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 11.2 t70 -62.91 -41.92 99.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.185 0.516 . . . . 0.0 109.81 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' B' ' 81' ' ' LYS . . . -66.08 -45.57 80.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.595 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 46.0 pt -64.95 -30.67 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.99 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.59 -44.32 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.019 0.437 . . . . 0.0 110.773 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' B' ' 78' ' ' ALA . 16.4 ptpt -81.03 -28.71 35.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.633 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -81.82 -6.88 59.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.971 0.415 . . . . 0.0 110.248 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 65.5 38.87 5.36 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.509 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.421 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 84.4 mt -100.58 118.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.678 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -106.78 100.88 33.79 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.356 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 24.0 Cg_exo -63.63 139.83 71.74 Favored 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 122.591 2.194 . . . . 0.0 112.208 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.64 94.13 8.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.024 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.92 -125.34 7.15 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.642 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -113.67 127.19 27.1 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-O 120.517 0.199 . . . . 0.0 110.935 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.77 158.11 53.88 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.618 2.212 . . . . 0.0 110.98 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 54.2 m -92.2 118.84 31.26 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.189 0.518 . . . . 0.0 110.744 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.481 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.7 m-85 -98.14 125.35 43.12 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 47.5 t -107.42 102.09 42.39 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-O 120.899 0.381 . . . . 0.0 110.971 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 96.8 Cg_endo -96.75 -167.81 0.12 Allowed 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 123.228 2.619 . . . . 0.0 110.854 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -130.36 -176.28 14.36 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -86.06 126.89 34.51 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -85.76 127.95 34.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.095 0.474 . . . . 0.0 110.852 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 98.6 mttt -113.63 140.99 47.74 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 38.0 tp -85.56 112.06 20.59 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.16 -177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.85 -7.68 27.62 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.688 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 48.9 mt-10 -120.37 172.63 7.67 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -82.16 168.44 17.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.297 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -121.28 143.68 49.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.45 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 85.6 m -125.67 136.86 53.68 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.007 0.432 . . . . 0.0 111.601 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -134.71 154.22 51.65 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.569 ' O ' HG12 ' B' ' 107' ' ' VAL . 21.4 m -95.97 -74.17 0.57 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.569 HG12 ' O ' ' B' ' 106' ' ' SER . 0.3 OUTLIER 65.36 142.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.9 0.88 . . . . 0.0 110.251 -172.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 11' ' ' LEU . 45.2 mt-10 -119.18 130.79 55.69 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -173.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -164.62 143.67 7.1 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.759 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 62.66 157.19 0.06 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 m -136.04 162.29 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.75 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -161.5 106.26 1.2 Allowed Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.399 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.29 154.43 41.12 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.261 2.64 . . . . 0.0 113.923 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -127.54 142.63 51.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.078 0.951 . . . . 0.0 108.77 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 64.2 t -126.77 131.68 70.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.847 0.356 . . . . 0.0 111.746 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -110.67 -86.22 0.54 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.699 176.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 97.5 mt 59.32 121.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -137.6 157.39 46.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.147 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.48 19.63 77.85 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.909 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 95.1 mt -63.91 -39.91 95.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.282 0.563 . . . . 0.0 110.672 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -74.25 -5.71 43.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.346 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -105.82 17.28 23.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.94 0.4 . . . . 0.0 110.93 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 86.9 mt -91.62 119.39 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.242 0.544 . . . . 0.0 111.199 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -108.52 122.8 47.81 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.43 135.5 57.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.625 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -78.7 138.6 38.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.568 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -133.28 97.75 16.04 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.73 121.12 6.8 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.232 1.955 . . . . 0.0 112.418 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.8 mm -105.67 116.01 48.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.859 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.405 HG21 HD21 ' B' ' 427' ' ' LEU . 27.5 m -131.82 163.49 37.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.352 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -136.51 156.77 48.12 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.96 125.84 39.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.4 p -111.89 175.08 5.57 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.458 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.02 -36.59 82.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.4 82.97 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.635 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.86 -42.09 97.63 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.367 0.604 . . . . 0.0 109.569 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.78 -45.43 98.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.517 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.3 -43.01 99.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.867 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.58 -41.94 99.75 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.449 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.567 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 3.5 tpt -62.55 -46.76 86.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.796 0.332 . . . . 0.0 110.452 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.52 -41.66 98.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.3 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -60.67 -44.19 96.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.318 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.9 m -62.83 -41.92 99.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.261 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.3 mt -60.9 -42.57 98.28 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -70.93 -20.44 62.47 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.451 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.68 1.28 54.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.375 0.607 . . . . 0.0 110.096 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -118.5 23.57 11.44 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.817 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -125.31 86.27 2.52 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . 0.52 ' HB3' ' OE1' ' B' ' 159' ' ' GLU . . . -131.54 159.42 38.22 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 172.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.568 HG21 ' O ' ' B' ' 247' ' ' GLU . 6.3 m -121.1 143.39 49.11 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.183 -1.007 . . . . 0.0 112.112 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . 0.604 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 44.7 p-90 -74.74 132.28 41.5 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.034 177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.525 ' HG2' ' HG3' ' B' ' 153' ' ' GLU . 65.1 tttp -163.19 -64.71 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . 0.525 ' HG3' ' HG2' ' B' ' 152' ' ' LYS . 64.3 mt-10 -117.42 -92.6 0.52 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -174.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' B' ' 155' ' ' ASP . 22.2 tptm -94.5 -117.85 0.1 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -169.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . 0.419 ' N ' ' HG3' ' B' ' 154' ' ' LYS . 14.2 t70 -147.52 154.87 41.28 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 122.923 0.489 . . . . 0.0 110.85 -174.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 166.21 -34.56 0.23 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.238 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.35 140.44 18.4 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.459 ' HA ' ' HD2' ' B' ' 243' ' ' ARG . 59.3 t -129.35 127.5 65.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.354 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . 0.52 ' OE1' ' HB3' ' B' ' 149' ' ' ALA . 4.7 mp0 -88.38 159.2 18.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.184 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.26 49.3 1.63 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.776 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -158.49 6.39 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.78 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.46 ' CG ' ' H ' ' B' ' 163' ' ' ARG . 13.1 t70 -102.53 -170.38 1.8 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.601 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . 0.46 ' H ' ' CG ' ' B' ' 162' ' ' ASP . 42.7 ttm180 -124.13 117.98 25.88 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.115 0.566 . . . . 0.0 110.727 -176.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.29 128.49 64.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.289 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 73.1 m -84.23 116.9 23.19 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 87.3 mt -126.27 124.52 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.126 0.489 . . . . 0.0 111.835 -176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . 0.471 ' OD2' ' HA ' ' B' ' 183' ' ' SER . 6.2 m-20 -95.24 109.35 21.48 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 172.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -127.67 150.54 49.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.444 0.64 . . . . 0.0 112.439 -175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 57.6 m -124.88 128.05 48.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.689 -1.142 . . . . 0.0 108.571 177.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.7 141.06 20.8 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.747 -0.74 . . . . 0.0 113.672 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 41.1 m -141.02 144.27 34.9 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 42.0 t -84.44 -83.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.94 0.4 . . . . 0.0 110.841 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -105.38 -40.58 5.77 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.18 0.514 . . . . 0.0 110.054 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.5 21.05 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.259 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -142.8 149.6 38.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 120.779 0.323 . . . . 0.0 110.404 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.41 151.49 32.73 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.976 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -120.69 -179.23 3.93 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.457 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.52 -42.54 87.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.03 -172.07 31.32 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.972 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.37 29.65 48.64 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.551 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -110.48 113.81 26.73 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -137.39 147.02 45.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.042 0.449 . . . . 0.0 111.59 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.471 ' HA ' ' OD2' ' B' ' 167' ' ' ASP . 67.8 m -146.51 129.41 16.33 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.313 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 58.56 31.85 21.49 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.564 0.54 . . . . 0.0 110.126 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -89.63 135.26 33.71 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.709 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 93.1 t -99.69 123.52 52.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.922 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.1 tp -110.81 122.73 48.56 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.129 0.49 . . . . 0.0 111.457 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . 0.443 ' HB3' ' CZ ' ' B' ' 193' ' ' ARG . . . -111.33 111.6 22.76 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 73.9 mtm -83.86 163.69 19.93 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.303 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.54 -13.86 60.99 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.606 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -102.67 -8.22 21.09 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 79.15 48.56 6.83 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 119.928 -1.13 . . . . 0.0 111.403 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.443 ' CZ ' ' HB3' ' B' ' 188' ' ' ALA . 95.0 mtt180 -89.53 -10.35 46.5 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.405 ' CE ' ' HA ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -129.51 170.32 13.87 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.06 178.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.622 ' H ' HD12 ' B' ' 195' ' ' ILE . 4.1 mp -54.84 133.18 66.43 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 123.347 0.404 . . . . 0.0 110.162 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -48.55 129.93 20.95 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.359 2.04 . . . . 0.0 111.776 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.04 -32.66 6.64 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.913 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -62.27 -44.38 96.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.677 0.275 . . . . 0.0 110.639 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.75 -40.63 97.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.734 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.85 -34.8 78.98 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.086 0.469 . . . . 0.0 110.676 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -63.52 -26.43 69.67 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.366 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.6 mm -62.62 -43.35 98.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 109.676 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -50.86 119.59 4.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.477 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 108.2 -10.62 36.76 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.598 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.649 ' HA ' ' OE1' ' B' ' 209' ' ' GLU . 46.6 m80 -96.2 141.09 29.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 117.11 0.455 . . . . 0.0 111.422 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.407 ' HG2' ' OE2' ' B' ' 209' ' ' GLU . 17.1 mmtm -100.46 166.69 10.81 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' B' ' 240' ' ' VAL . . . -61.8 131.98 51.63 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.02 27.55 70.19 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.701 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . 0.649 ' OE1' ' HA ' ' B' ' 205' ' ' HIS . 44.5 tt0 -112.27 111.7 22.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.273 0.559 . . . . 0.0 110.365 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -97.14 129.31 44.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.687 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -148.94 -26.51 0.3 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.492 HG22 ' HA ' ' B' ' 234' ' ' ALA . 50.8 p 60.67 160.33 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.935 0.894 . . . . 0.0 111.975 -176.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' B' ' 232' ' ' LYS . 18.9 tt -153.06 148.65 13.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 122.135 -0.353 . . . . 0.0 110.825 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -81.27 109.59 15.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.217 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 59.8 t -112.87 122.81 67.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 11.9 p -93.5 -21.62 19.35 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 68.12 137.4 0.05 OUTLIER Pre-proline 0 N--CA 1.482 1.142 0 CA-C-O 121.037 0.446 . . . . 0.0 111.75 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' B' ' 221' ' ' TYR . 16.5 Cg_exo -67.72 149.57 78.83 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.433 2.089 . . . . 0.0 112.006 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . 0.445 ' O ' ' HE2' ' B' ' 227' ' ' LYS . 75.1 mm-40 -66.71 -39.36 88.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.522 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -86.03 32.51 0.61 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.895 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 9.2 t80 -66.72 134.63 52.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -67.66 -15.32 63.59 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.459 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -101.18 105.0 16.09 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.43 ' OE1' ' HG2' ' B' ' 333' ' ' PRO . 42.1 tt0 -60.11 -33.24 71.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.672 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -66.82 -19.03 65.66 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.064 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.7 mt -121.39 0.62 10.05 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' B' ' 219' ' ' GLU . 14.9 ptmm? -68.34 119.27 12.58 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.48 0.657 . . . . 0.0 112.118 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.85 17.24 75.45 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.339 -0.846 . . . . 0.0 114.106 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -123.85 129.63 51.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.774 0.787 . . . . 0.0 111.182 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -79.39 153.16 29.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.005 -176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -143.96 143.55 31.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.315 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' B' ' 213' ' ' ILE . 3.9 mppt? -100.13 -14.31 18.6 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.401 ' HB3' ' H ' ' B' ' 234' ' ' ALA . 95.8 m-85 55.45 -148.67 0.48 Allowed 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.346 0.404 . . . . 0.0 111.516 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' B' ' 212' ' ' THR . . . -142.75 -69.22 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.893 0.378 . . . . 0.0 110.496 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 86.2 mt 65.89 87.25 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.992 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -92.35 -27.09 17.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.19 176.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 12.3 tp 51.65 66.92 1.05 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.806 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -66.09 -43.09 88.27 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . 0.427 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 29.9 mtpp -97.14 -77.78 0.49 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -173.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' B' ' 239' ' ' LYS . 87.7 t 76.62 142.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -95.3 -86.15 0.3 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -173.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -163.53 104.13 0.94 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 119.876 -0.729 . . . . 0.0 112.79 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 19.0 ttm-85 -168.72 115.1 0.63 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.954 0.407 . . . . 0.0 111.949 175.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' B' ' 152' ' ' LYS . 0.1 OUTLIER -178.31 155.4 0.9 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 46.8 tp 67.95 100.13 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 124.041 0.838 . . . . 0.0 111.343 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' B' ' 150' ' ' THR . 41.0 Cg_endo -68.15 111.3 2.43 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.523 2.149 . . . . 0.0 112.717 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . 0.568 ' O ' HG21 ' B' ' 150' ' ' THR . 43.1 tt0 -135.18 148.74 49.78 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.39 94.54 3.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.803 0.335 . . . . 0.0 111.173 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 22.1 p -91.09 -88.22 0.19 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.599 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -172.75 -47.97 0.02 OUTLIER 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.952 0.406 . . . . 0.0 111.218 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -81.97 94.77 7.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.076 0.465 . . . . 0.0 111.839 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . 0.531 ' CD1' HG23 ' B' ' 253' ' ' ILE . 51.5 p90 -164.89 -22.43 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.464 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . 0.531 HG23 ' CD1' ' B' ' 252' ' ' PHE . 19.6 pt -110.93 -42.39 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -82.06 -7.59 59.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 110.481 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -121.22 97.61 5.6 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -149.96 -59.77 0.2 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.161 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -164.61 -84.18 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.636 -1.269 . . . . 0.0 113.54 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 66.4 t -99.0 121.25 49.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.472 0.177 . . . . 0.0 111.038 -177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 57.91 -169.41 0.12 Allowed 'General case' 0 CA--C 1.547 0.831 0 O-C-N 123.975 0.797 . . . . 0.0 110.439 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -106.1 114.63 28.88 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -100.64 164.03 18.76 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.108 -1.044 . . . . 0.0 114.057 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 33.8 p -105.85 -175.43 2.79 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.68 -49.26 85.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.2 OUTLIER -85.06 -36.89 20.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 -178.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.0 -43.36 97.49 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.731 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.503 ' O ' HG23 ' B' ' 270' ' ' VAL . 49.6 tp -63.57 -43.4 97.11 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 120.612 0.244 . . . . 0.0 110.618 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -61.71 -43.01 99.67 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.786 0.327 . . . . 0.0 111.153 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.532 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.49 -44.66 86.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.064 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -67.74 -37.21 81.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.915 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.503 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.0 t -64.69 -43.08 96.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.595 0.236 . . . . 0.0 110.476 176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -59.01 -46.82 87.23 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.4 ptmt -67.26 -43.66 81.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 0.0 111.62 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -64.48 -39.89 94.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.773 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.6 mmm -63.67 -42.06 98.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 110.736 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -68.97 -31.76 70.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.8 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 60.8 ttp180 -63.61 -41.78 98.28 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -65.8 -35.15 79.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.565 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 47.7 tp -61.95 -37.77 85.96 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.815 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 62.9 tttm -57.87 -44.98 86.97 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.805 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 19.4 m -61.86 -42.98 99.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.382 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.0 83.59 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.329 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.36 -44.12 98.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.795 0.331 . . . . 0.0 110.204 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . 0.541 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.7 OUTLIER -60.14 -46.49 89.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.215 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -65.61 -40.29 92.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.523 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -60.69 -44.17 96.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.183 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.09 -44.62 91.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.177 0.513 . . . . 0.0 110.1 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.42 -48.17 82.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.856 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 74.8 p -65.01 -42.37 94.51 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -65.28 -42.88 92.72 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.025 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.63 -47.0 83.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.029 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . 0.459 ' O ' HG23 ' B' ' 295' ' ' VAL . 34.7 mm -64.41 -44.0 97.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.102 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -60.14 -46.19 90.49 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.925 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.24 -42.44 99.32 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.202 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.37 -41.46 96.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 0.459 HG23 ' O ' ' B' ' 291' ' ' ILE . 74.1 t -62.29 -45.33 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 O-C-N 123.114 0.259 . . . . 0.0 111.327 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -64.71 -41.95 95.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.852 0.358 . . . . 0.0 111.286 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.84 -39.65 63.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -121.7 82.92 2.01 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.63 94.44 9.03 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.9 tp -104.03 156.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.232 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.21 134.09 56.72 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 41.0 t -106.87 129.08 24.92 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.501 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.417 ' O ' HG13 ' B' ' 307' ' ' ILE . 50.0 Cg_exo -55.92 128.3 29.67 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.427 2.085 . . . . 0.0 111.832 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.51 85.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.195 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.32 87.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.376 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.75 -41.88 95.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.786 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . 0.498 ' O ' HG13 ' B' ' 311' ' ' ILE . 69.1 mt -62.03 -49.88 82.32 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.502 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -42.33 99.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.55 -176.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.3 m -62.99 -45.85 90.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.97 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . 0.677 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 63.6 mm-40 -70.86 -34.02 71.22 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.498 HG13 ' O ' ' B' ' 307' ' ' ILE . 95.2 mt -61.46 -44.29 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.836 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 35.5 t70 -63.17 -39.89 95.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.985 0.421 . . . . 0.0 110.826 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.9 t -64.04 -43.8 97.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.458 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 56.7 mt -62.74 -39.34 93.79 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.864 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 81.5 mtm180 -63.23 -38.92 93.05 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 87.5 mtt180 -65.49 -39.55 92.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.729 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -63.25 -43.21 98.64 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.172 0.51 . . . . 0.0 110.183 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.81 80.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.237 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -62.5 -37.06 84.54 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.769 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -62.41 -42.41 99.41 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.567 0.699 . . . . 0.0 109.691 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.16 -6.98 56.44 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.702 -177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -89.75 -3.46 58.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.885 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.62 -33.93 2.42 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.099 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 133.27 43.21 0.15 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . 0.476 ' HB3' ' HB1' ' B' ' 319' ' ' ALA . 42.5 t-20 -81.65 118.98 23.25 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.094 0.473 . . . . 0.0 109.861 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 2.4 tm-20 -120.53 151.28 39.59 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 5.7 ptpp? 61.66 -39.19 0.13 Allowed 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.774 1.63 . . . . 0.0 114.145 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . 0.472 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.3 mm100 -72.79 -11.27 60.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.349 0.595 . . . . 0.0 110.577 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -64.13 -20.91 66.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.171 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.464 HD12 HH12 ' B' ' 315' ' ' ARG . 52.3 tp -62.74 -36.88 84.47 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.077 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.14 -6.43 54.71 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.582 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.469 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 77.4 mt -68.65 149.7 97.88 Favored Pre-proline 0 C--O 1.24 0.564 0 O-C-N 122.33 -0.231 . . . . 0.0 110.85 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . 0.43 ' HG2' ' OE1' ' B' ' 224' ' ' GLU . 38.7 Cg_exo -60.75 145.32 99.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.851 2.367 . . . . 0.0 113.281 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . 0.448 HH21 ' HD2' ' B' ' 334' ' ' ARG . 24.8 ttt85 -85.78 -41.62 14.91 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.417 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -57.96 -39.62 78.57 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -172.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . 0.415 ' HB2' ' OE2' ' B' ' 224' ' ' GLU . 93.6 mt -89.63 -3.88 58.06 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.757 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -105.63 -25.12 12.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.983 0.42 . . . . 0.0 110.206 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.2 -26.23 66.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.909 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.34 -51.26 70.26 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 120.931 0.396 . . . . 0.0 110.548 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -73.69 -27.28 61.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.659 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.463 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -60.95 -43.6 98.48 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . 0.488 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.8 tttt -59.73 -45.88 90.84 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . 0.578 ' O ' HG23 ' B' ' 347' ' ' VAL . 11.1 mmt85 -61.44 -46.25 90.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.833 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . 0.48 ' NH2' HD22 ' B' ' 314' ' ' LEU . 92.0 mtt180 -67.12 -37.63 84.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 341' ' ' ALA . 69.2 t -64.99 -44.03 96.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.708 0.289 . . . . 0.0 110.374 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 342' ' ' LYS . 74.3 t -61.61 -43.97 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.765 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.578 HG23 ' O ' ' B' ' 343' ' ' ARG . 85.8 t -59.65 -45.0 94.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.14 99.42 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.382 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.55 -44.14 95.05 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.679 0.276 . . . . 0.0 111.225 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.42 ' O ' HG23 ' B' ' 354' ' ' VAL . 96.2 mt -64.2 -46.77 82.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.18 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.06 -39.75 82.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.385 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.65 -41.47 97.4 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.971 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -67.3 -36.7 82.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.979 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . 0.42 HG23 ' O ' ' B' ' 350' ' ' LEU . 94.3 t -61.49 -44.37 98.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.379 0.609 . . . . 0.0 109.362 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.44 -44.42 98.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.932 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -70.38 -46.51 63.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.927 0.394 . . . . 0.0 112.02 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 100.0 m -65.7 -42.98 90.51 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -95.14 6.24 49.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 53.02 52.13 14.43 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.49 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 99.2 mt -77.23 133.8 38.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.116 0.484 . . . . 0.0 111.395 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -110.71 153.33 25.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.05 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.38 109.4 14.84 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 172.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . 0.505 ' O ' HG23 ' B' ' 367' ' ' VAL . 18.3 t70 -81.75 110.86 17.46 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.201 0.524 . . . . 0.0 112.039 -173.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 50.8 mm-40 -59.18 -40.73 86.6 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.237 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -66.51 -39.75 88.84 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.481 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -62.12 -38.81 90.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . 0.505 HG23 ' O ' ' B' ' 363' ' ' ASP . 99.1 t -63.76 -40.09 87.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.65 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 30.2 mmmt -56.49 -44.61 80.83 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.416 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.59 97.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.031 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.52 -42.47 99.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.905 0.384 . . . . 0.0 110.739 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.51 -45.1 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.28 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.81 -37.97 87.69 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -66.58 -39.45 88.45 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.524 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.7 ttm -64.54 -40.71 96.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.171 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . 0.438 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -61.86 -27.01 68.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.328 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 50.6 m -75.74 -3.41 34.66 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.286 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -94.08 -1.25 54.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.946 0.403 . . . . 0.0 110.928 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.54 169.88 8.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.267 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.72 -40.43 87.98 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.414 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 19.6 t70 -131.69 109.64 14.54 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-O 120.914 0.388 . . . . 0.0 111.041 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . 0.438 ' HA ' ' HB1' ' B' ' 375' ' ' ALA . 52.0 Cg_exo -56.28 -40.63 83.47 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.967 2.445 . . . . 0.0 114.297 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -64.84 -43.16 93.94 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 15.7 pt-20 -62.59 -37.17 85.2 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.324 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.93 -42.84 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.339 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.23 -44.43 99.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.419 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 44.9 mt-10 -66.88 -44.35 81.13 Favored 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.997 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -59.1 -46.51 88.13 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -65.58 -41.9 92.36 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.673 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 60.2 p -79.37 -6.84 57.68 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 98.8 mttt -103.04 7.47 38.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.027 0.441 . . . . 0.0 110.922 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -125.32 118.91 26.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.77 -42.3 97.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.171 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.68 -50.72 72.26 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.878 0.37 . . . . 0.0 111.0 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.72 -42.68 97.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.867 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.428 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 90.3 mtp -65.38 -45.15 85.22 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.62 -39.96 66.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.221 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -62.53 -41.98 99.22 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.625 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 49.4 tpp -63.28 -40.86 98.57 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.743 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.485 ' HG2' HG21 ' B' ' 367' ' ' VAL . 71.1 mtm180 -65.11 -37.12 86.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.846 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -62.24 -44.39 96.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.414 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 94.3 t -66.0 -45.17 91.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.758 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.23 93.9 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.6 -40.47 97.04 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.313 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.82 -43.04 99.64 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.707 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . 0.541 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 23.4 mt-10 -64.07 -40.69 96.81 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.467 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -60.0 -41.53 92.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.49 -46.29 86.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.128 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 95.2 t -65.94 -43.83 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.038 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.26 -34.1 77.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.88 -40.0 96.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 110.198 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.25 -42.92 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.147 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.73 -39.36 91.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.952 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -68.68 -14.75 63.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.645 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -107.45 -6.59 16.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.532 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.95 170.04 9.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.169 0.509 . . . . 0.0 111.883 -176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -82.85 113.71 20.66 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.35 132.32 47.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.184 0.516 . . . . 0.0 111.705 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 7.2 t -136.1 145.28 45.74 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -96.38 135.03 38.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.626 0.251 . . . . 0.0 110.361 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -140.76 132.73 27.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.923 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.03 143.3 33.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.641 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.1 t -151.69 -176.84 5.78 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.633 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 50.0 p -80.48 165.51 22.1 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.099 0.476 . . . . 0.0 111.292 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -70.04 -16.7 63.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.879 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -61.74 -41.98 98.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.149 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -70.15 -27.83 64.85 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.832 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . 0.405 HD21 HG21 ' B' ' 130' ' ' VAL . 10.3 mp -71.0 -24.23 62.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.068 0.461 . . . . 0.0 109.891 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.5 mmt -79.29 -9.48 59.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.909 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -77.38 80.01 3.88 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.473 0.654 . . . . 0.0 109.928 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -115.17 29.58 7.93 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.143 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -65.91 -38.17 88.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.633 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.919 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.037 -179.33 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.828 0.346 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -104.84 151.59 23.64 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.949 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.8 m -125.58 159.74 32.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.911 0.386 . . . . 0.0 111.072 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 m -86.23 106.63 17.46 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.685 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.7 137.24 27.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 34.6 tt0 -137.77 173.31 11.78 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.4 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 9.2 t -116.08 145.66 42.84 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 117.948 0.34 . . . . 0.0 111.599 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.6 m -102.87 -68.87 0.81 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -171.29 114.87 0.4 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.918 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.41 -111.94 4.59 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.718 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.34 -31.21 65.45 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 122.505 0.322 . . . . 0.0 111.456 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.55 137.07 42.09 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 116.008 -0.542 . . . . 0.0 114.127 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -141.21 157.13 45.67 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.222 0.609 . . . . 0.0 110.172 -178.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' A' ' 6' ' ' GLU . 28.8 ttm-85 -115.35 137.85 51.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.96 -86.34 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.456 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.2 m 49.88 84.88 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.111 0.482 . . . . 0.0 111.754 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 tp -93.32 134.4 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 120.949 0.404 . . . . 0.0 111.979 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.4 m -116.64 124.06 48.82 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.389 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 HG12 ' A' ' 24' ' ' ILE . 17.9 pt -135.28 169.02 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 122.558 0.343 . . . . 0.0 111.817 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.626 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.77 151.98 43.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.03 0.532 . . . . 0.0 111.871 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -55.79 -51.2 68.27 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.7 -36.14 83.33 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.978 0.418 . . . . 0.0 110.259 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -66.67 -35.74 80.87 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.528 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.626 HG13 ' O ' ' A' ' 20' ' ' ALA . 76.9 mt -60.33 -50.19 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 111.071 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -74.49 -42.88 58.21 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.78 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.9 m -70.44 -52.92 18.75 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.62 -44.6 66.88 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.29 -42.23 94.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.043 0.449 . . . . 0.0 110.589 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -60.78 -43.87 97.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.986 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 33' ' ' VAL . 25.4 m -63.03 -41.63 99.58 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.335 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.58 -40.44 96.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.236 0.541 . . . . 0.0 109.878 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.89 -41.91 99.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.024 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 30' ' ' SER . 12.0 p -69.16 -36.08 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.776 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -63.25 -43.48 97.87 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -66.13 -38.2 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.802 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.76 -47.93 81.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.61 -37.23 86.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.924 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.88 -33.81 76.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.8 t -91.43 -4.47 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 CA-C-O 121.47 0.653 . . . . 0.0 109.791 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 63.5 27.2 15.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.636 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -104.41 3.95 10.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.126 0.489 . . . . 0.0 110.95 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -64.66 -34.23 77.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.426 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.63 -23.37 65.0 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.983 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -73.85 -13.57 60.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.746 0.308 . . . . 0.0 111.444 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.429 ' HG3' ' NE2' ' B' ' 320' ' ' GLN . 63.4 ttt-85 -80.75 92.18 6.01 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.268 0.556 . . . . 0.0 110.201 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.79 -43.39 98.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.005 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.99 69.98 1.25 Allowed Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 115.719 1.048 . . . . 0.0 115.719 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -62.99 -41.89 99.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 54' ' ' VAL . 11.2 t -101.42 110.53 61.86 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.692 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.63 147.41 79.66 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.83 2.353 . . . . 0.0 112.066 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.522 ' HA ' HG12 ' A' ' 54' ' ' VAL . 15.3 ttt -67.11 -22.41 65.81 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -172.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -81.21 -8.57 59.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.872 0.368 . . . . 0.0 110.244 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.449 HD13 ' NH2' ' B' ' 193' ' ' ARG . 87.2 mt -107.74 -49.69 7.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.267 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 51' ' ' MET . 9.6 p -62.61 -40.25 87.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.557 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.15 94.9 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -84.91 -19.41 32.3 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.767 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' NH1' ' SD ' ' B' ' 194' ' ' MET . 61.7 ttt180 -85.65 -45.13 11.99 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.356 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -106.65 11.9 29.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.028 0.442 . . . . 0.0 110.522 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.581 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -57.39 -63.17 5.55 Favored Glycine 0 C--O 1.216 -0.978 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.181 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.55 -27.55 67.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.053 0.427 . . . . 0.0 111.631 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.9 t -61.02 -45.05 96.39 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.156 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 65' ' ' ASP . 8.3 p -131.64 21.34 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 CA-C-O 121.191 0.52 . . . . 0.0 112.098 -175.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.581 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 7.5 ttt180 -64.76 -19.98 66.1 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.628 -0.67 . . . . 0.0 111.405 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -64.77 -45.68 85.35 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.496 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.458 ' HB2' HG22 ' A' ' 62' ' ' VAL . 2.2 m-20 -73.65 -28.28 61.7 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.716 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -63.66 -44.74 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.38 -39.36 94.31 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.27 -40.77 97.83 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.043 177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.76 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 29.3 t70 -62.45 -46.79 86.89 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.27 -41.88 97.69 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.911 0.386 . . . . 0.0 110.149 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.7 ttp -61.04 -43.96 98.11 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.6 m -62.36 -42.65 99.57 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.441 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.76 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 52.2 mtp85 -62.33 -46.49 88.49 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.751 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -65.73 -40.48 92.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.314 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.06 -48.49 81.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.668 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.4 tt -68.15 -39.1 80.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.855 0.36 . . . . 0.0 111.469 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.67 -40.36 92.3 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.234 0.54 . . . . 0.0 110.471 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.95 96.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.228 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.3 pt -67.14 -37.77 79.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.574 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.46 -44.09 98.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.082 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -75.57 -23.05 56.49 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -92.98 1.32 57.36 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.978 0.418 . . . . 0.0 110.674 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 63.38 32.79 14.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.325 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.8 mt -97.78 113.13 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -107.51 107.16 60.01 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.995 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.62 134.65 33.5 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.77 1.647 . . . . 0.0 111.315 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.52 87.17 4.67 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.238 0.542 . . . . 0.0 110.513 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.36 -114.8 4.54 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.804 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.29 135.2 26.73 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.25 152.17 79.81 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.705 2.27 . . . . 0.0 111.339 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.3 m -87.69 105.16 17.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.066 0.46 . . . . 0.0 111.437 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -107.65 113.78 27.31 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.24 96.89 48.64 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.68 145.65 26.12 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.21 1.94 . . . . 0.0 111.584 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.76 174.7 51.67 Favored Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.16 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.88 123.92 23.74 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.925 0.393 . . . . 0.0 110.23 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -86.13 133.72 33.85 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.185 0.517 . . . . 0.0 111.024 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -122.58 127.13 49.04 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.6 tp -72.42 106.53 4.57 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.132 0.492 . . . . 0.0 110.607 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.07 -8.62 14.2 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.462 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -118.37 -177.56 3.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.667 0.233 . . . . 0.0 110.73 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -76.65 160.04 29.72 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 111.269 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -126.34 138.04 53.53 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.148 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.0 m -118.08 135.71 54.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.932 0.396 . . . . 0.0 110.925 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -129.08 164.25 23.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.088 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.5 m -73.92 -83.74 0.05 OUTLIER 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.6 t 56.03 101.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.297 0.57 . . . . 0.0 111.311 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.59 126.95 34.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.28 -175.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.499 ' HB3' ' OE2' ' A' ' 110' ' ' GLU . 12.8 m-85 -127.32 -165.43 1.47 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.91 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.499 ' OE2' ' HB3' ' A' ' 109' ' ' PHE . 0.9 OUTLIER -73.12 177.97 4.7 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.048 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 305' ' ' ALA . 35.2 m -124.77 164.51 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.553 -176.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -124.9 116.48 26.16 Favored Pre-proline 0 N--CA 1.466 0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.821 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -88.56 144.43 5.57 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.895 2.396 . . . . 0.0 113.152 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -142.02 151.78 42.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.828 0.451 . . . . 0.0 109.804 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 99.4 t -130.44 133.06 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.896 0.379 . . . . 0.0 111.837 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -107.44 -88.24 0.47 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.746 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.0 mt 64.82 117.67 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.689 0.796 . . . . 0.0 112.481 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -137.84 150.95 47.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.492 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.14 18.65 74.04 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.944 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.77 -41.4 97.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 111.03 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.86 -3.62 23.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.252 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -106.79 17.44 23.17 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.878 0.37 . . . . 0.0 111.61 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.66 107.31 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.061 0.458 . . . . 0.0 109.952 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.32 101.73 13.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.966 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.07 133.29 36.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.935 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -87.64 124.36 33.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.456 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -122.73 96.14 45.72 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -63.92 135.61 48.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.012 1.808 . . . . 0.0 111.52 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.22 112.71 40.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.8 160.2 42.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.569 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -143.01 165.37 27.55 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.196 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.408 HG11 HH12 ' A' ' 271' ' ' ARG . 64.5 t -78.31 129.95 36.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.749 0.309 . . . . 0.0 110.435 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.5 p -112.38 176.86 4.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.772 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.09 -35.53 78.95 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 120.692 0.282 . . . . 0.0 111.623 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.15 84.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.256 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -63.43 -40.59 97.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.292 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 95.7 t -62.25 -49.54 83.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.652 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.85 -39.08 92.98 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.713 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.72 -40.63 99.05 Favored Glycine 0 C--O 1.237 0.331 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.743 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.575 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 5.1 tpt -63.28 -42.5 99.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.139 0.495 . . . . 0.0 109.795 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.9 mt -63.02 -40.11 96.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.573 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -56.65 -48.13 78.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.577 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.2 m -63.3 -40.75 98.23 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.366 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 140' ' ' MET . 85.3 mt -60.15 -42.23 94.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.818 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -79.79 -8.51 59.31 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.834 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -92.65 -12.59 31.17 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -90.92 -52.2 4.97 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.426 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -60.58 95.85 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -153.63 97.96 2.17 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 113.526 -1.67 . . . . 0.0 107.848 175.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 151' ' ' TRP . 0.2 OUTLIER -67.4 176.65 2.22 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.484 ' H ' HG22 ' A' ' 150' ' ' THR . 56.0 p-90 -99.88 161.85 13.36 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.453 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.587 ' H ' ' HA ' ' A' ' 243' ' ' ARG . 76.7 tttt -168.68 -79.59 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.758 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 242' ' ' GLU . 10.0 pt-20 -165.97 80.18 0.28 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 155' ' ' ASP . 54.8 tttt 176.65 -152.93 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.581 175.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.421 ' H ' ' HG2' ' A' ' 154' ' ' LYS . 8.9 p-10 -140.58 162.82 34.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.303 0.501 . . . . 0.0 111.054 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 119.44 -19.07 9.97 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.303 -0.951 . . . . 0.0 114.133 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -118.52 100.55 7.53 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.58 0.69 . . . . 0.0 111.947 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.8 t -132.29 136.97 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -97.79 -169.14 1.78 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.619 ' O ' ' HA3' ' A' ' 190' ' ' GLY . . . -95.6 23.99 5.64 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.775 ' HA ' ' O ' ' A' ' 189' ' ' MET . 11.1 pt-20 -158.88 27.64 0.22 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.436 0.636 . . . . 0.0 112.292 175.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 188' ' ' ALA . 13.0 m-20 -90.32 170.11 10.53 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.993 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 -106.96 123.7 48.56 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.96 128.74 74.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.805 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.4 m -78.84 106.39 10.82 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 72.1 mt -120.03 119.33 59.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.617 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -95.5 88.66 5.14 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -109.02 147.09 32.86 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.084 0.469 . . . . 0.0 111.834 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.0 m -116.78 127.42 54.32 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.45 123.69 6.37 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.172 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.8 m -140.65 128.6 21.97 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.469 HG23 ' CD2' ' A' ' 177' ' ' PHE . 98.0 t -102.89 108.93 25.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 60.34 -50.18 0.09 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.25 1.42 . . . . 0.0 114.121 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.89 -4.37 0.05 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.066 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.44 140.86 52.55 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.092 0.472 . . . . 0.0 110.956 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -79.33 156.56 27.97 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.469 ' CD2' HG23 ' A' ' 172' ' ' VAL . 35.4 p90 -125.37 169.28 12.5 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.534 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.86 -36.12 74.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.03 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.74 -177.49 33.79 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.65 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.27 22.06 61.42 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.163 -1.017 . . . . 0.0 113.322 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -100.81 112.1 24.45 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -136.26 145.69 45.88 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.986 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.6 m -140.5 125.18 18.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.423 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 55.89 30.59 16.21 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.578 0.548 . . . . 0.0 110.635 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -83.78 122.99 29.41 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.018 0.437 . . . . 0.0 110.397 -176.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.3 m -87.9 106.9 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.598 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.6 tp -94.55 121.54 36.22 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.184 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 193' ' ' ARG . . . -91.89 119.36 31.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.775 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 83.9 mtp -84.24 153.5 23.56 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.985 -175.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 160' ' ' ALA . . . 84.0 18.31 63.41 Favored Glycine 0 CA--C 1.505 -0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.872 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -122.54 -6.39 8.67 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.155 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.88 46.36 10.92 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.656 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 188' ' ' ALA . 94.0 mtt180 -92.93 -6.77 47.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.475 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -131.58 167.88 18.65 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.715 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.88 134.82 92.65 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.93 129.89 18.71 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.385 2.056 . . . . 0.0 112.025 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.15 -38.97 3.04 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.358 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -65.35 -49.54 68.98 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.409 ' O ' ' HE3' ' A' ' 189' ' ' MET . 11.4 pt-20 -82.72 -9.73 59.23 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.226 0.536 . . . . 0.0 111.06 -178.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -89.4 -32.01 17.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -74.56 -10.01 82.43 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.102 -0.953 . . . . 0.0 113.337 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.464 ' HB ' ' HE1' ' A' ' 189' ' ' MET . 44.4 mm -64.91 -42.89 96.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -53.01 125.93 18.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.629 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 101.28 -3.59 54.71 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.066 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -103.69 148.18 26.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.721 0.761 . . . . 0.0 111.991 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.17 166.17 12.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.491 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.28 120.52 19.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 89.12 17.71 55.29 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.678 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -105.01 117.37 33.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.121 0.486 . . . . 0.0 110.256 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -99.59 123.09 43.52 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.137 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -143.7 -15.44 0.63 Allowed 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 74.4 p 59.38 164.79 0.05 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 123.886 0.874 . . . . 0.0 112.596 -175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -146.95 142.58 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.858 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.97 109.1 16.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.047 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 49.3 t -117.55 108.23 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.148 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 21.2 m -71.9 -44.42 63.73 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 216' ' ' THR . 54.8 m-85 78.73 148.49 0.12 Allowed Pre-proline 0 N--CA 1.495 1.799 0 C-N-CA 123.241 0.617 . . . . 0.0 110.763 -174.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -72.0 153.79 57.85 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.708 2.272 . . . . 0.0 111.905 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.585 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 51.7 mm-40 -65.86 -39.11 90.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.419 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -95.58 39.0 1.13 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.252 0.549 . . . . 0.0 110.935 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -71.67 147.13 47.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.208 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -62.62 -19.65 63.98 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -101.6 117.04 34.09 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.545 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 2.2 tp10 -63.0 -32.7 74.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.992 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -87.5 -5.96 58.57 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -176.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 84.8 mt -117.81 -11.66 10.3 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.487 -0.485 . . . . 0.0 112.08 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.598 ' NZ ' HD13 ' A' ' 336' ' ' LEU . 18.4 ptmt -68.77 122.23 18.15 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.194 0.521 . . . . 0.0 112.205 -176.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.76 13.3 78.48 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.129 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.49 117.49 29.61 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.471 -0.429 . . . . 0.0 110.487 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -68.57 133.65 48.84 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.965 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -114.61 159.31 20.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.714 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -99.29 -33.11 10.86 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 53.05 99.17 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -73.85 91.88 2.01 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.143 0.497 . . . . 0.0 110.241 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.5 mm -95.18 115.4 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -112.76 -36.64 5.11 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.278 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.3 mt 67.76 152.96 0.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.265 0.626 . . . . 0.0 111.813 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -110.85 -80.64 0.58 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.665 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -111.79 -31.23 7.02 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 18.3 t 59.15 46.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 121.843 0.83 . . . . 0.0 109.528 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 60.7 -102.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.595 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . 15.2 pt-20 178.7 103.56 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.817 0.847 . . . . 0.0 108.964 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.587 ' HA ' ' H ' ' A' ' 152' ' ' LYS . 11.1 ptm180 -157.52 122.88 4.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -179.42 165.83 1.42 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.1 mt 72.64 109.02 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.028 0.531 . . . . 0.0 111.509 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.22 117.64 3.52 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.784 2.323 . . . . 0.0 114.37 -176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.38 -179.26 5.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.646 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 6.5 mp -91.38 128.5 37.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.081 0.467 . . . . 0.0 111.548 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 9.3 m -136.16 142.15 44.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.43 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.79 92.11 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -72.12 50.5 0.21 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.327 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -132.68 -58.57 0.92 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.881 0.372 . . . . 0.0 110.8 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 261' ' ' GLY . 36.9 pt -68.97 -22.13 26.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.577 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -105.55 5.72 31.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.4 0.619 . . . . 0.0 109.923 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -111.61 -1.84 15.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.531 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -98.3 116.51 30.68 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.15 -173.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 51.03 -109.38 0.73 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 175.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.13 136.92 55.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.057 0.543 . . . . 0.0 110.707 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' A' ' 260' ' ' ASP . 2.4 tp10 66.43 -160.16 0.25 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . 0.42 ' H ' ' HG3' ' A' ' 259' ' ' GLU . 4.9 p-10 -133.95 134.75 42.93 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.627 ' O ' ' HB ' ' A' ' 253' ' ' ILE . . . -125.65 158.25 19.92 Favored Glycine 0 C--N 1.316 -0.563 0 C-N-CA 120.077 -1.059 . . . . 0.0 113.74 -176.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 11.8 p -82.19 -179.43 7.4 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.665 0.386 . . . . 0.0 110.958 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.89 -47.76 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.255 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.38 -31.86 15.88 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.758 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.55 -44.24 96.87 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.042 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 270' ' ' VAL . 40.5 tp -64.78 -41.93 95.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -61.64 -43.1 99.5 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.366 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.39 -40.82 96.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.912 0.387 . . . . 0.0 110.586 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -66.63 -41.75 87.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.376 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 266' ' ' LEU . 85.7 t -63.75 -42.77 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.408 HH12 HG11 ' A' ' 132' ' ' VAL . 9.4 tpt180 -55.69 -47.6 76.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.301 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 0.1 OUTLIER -70.27 -40.89 74.07 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -64.53 -41.25 96.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.687 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 95.1 mmm -65.04 -41.63 95.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.628 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.41 -34.86 78.11 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.815 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.56 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 53.4 ttp180 -63.65 -43.64 96.17 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.393 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -68.32 -34.68 76.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.048 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.413 ' O ' HG13 ' A' ' 282' ' ' ILE . 50.2 tp -62.62 -37.94 88.26 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.56 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 50.7 tttm -55.98 -46.78 78.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.165 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.9 m -62.37 -40.89 97.91 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.708 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.59 -42.71 99.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.929 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 278' ' ' LEU . 64.1 mt -65.35 -43.29 94.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.828 0.347 . . . . 0.0 110.482 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.549 ' HD2' ' OE2' ' A' ' 405' ' ' GLU . 1.1 tpm_? -58.96 -44.52 91.5 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.392 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.24 -42.74 96.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.224 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -61.86 -44.47 96.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.946 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.49 -44.69 86.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.008 0.432 . . . . 0.0 110.749 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.0 tttt -61.6 -47.18 86.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.539 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.7 p -62.31 -41.08 98.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.23 -41.78 94.06 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.762 0.315 . . . . 0.0 110.791 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.37 -48.26 76.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.039 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 287' ' ' LYS . 49.4 mm -63.2 -47.91 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.513 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.548 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 26.4 tp10 -61.87 -43.02 99.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.097 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.29 -42.93 93.83 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.702 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.81 -44.49 96.03 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.54 -44.79 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.256 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . 0.548 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 64.0 mttm -61.63 -40.52 95.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.582 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.3 80.84 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.719 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -126.45 101.47 6.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -94.78 113.85 25.67 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.4 tp -119.75 153.26 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.502 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -61.75 142.68 57.12 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.952 0.406 . . . . 0.0 110.515 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 54.2 t -120.83 126.28 26.74 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.644 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -57.1 131.94 48.36 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.216 1.944 . . . . 0.0 111.715 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.72 -38.23 89.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.066 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . 0.406 ' HB2' HG11 ' A' ' 111' ' ' VAL . . . -56.87 -44.2 82.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.023 0.439 . . . . 0.0 111.402 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.63 -41.8 95.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.446 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 311' ' ' ILE . 68.6 mt -61.75 -48.17 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.73 -46.15 84.84 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.159 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 48.9 m -61.03 -44.95 96.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.685 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.424 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 56.1 mm-40 -71.42 -35.35 70.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.45 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 94.3 mt -62.42 -44.42 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.69 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 13.1 t70 -64.32 -40.98 97.0 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.268 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.61 -43.94 98.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.978 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 96.9 mt -62.37 -41.99 99.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.684 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.495 HH12 HD12 ' A' ' 330' ' ' LEU . 79.8 mtm180 -63.59 -39.56 94.7 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.084 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 66.6 mtt180 -64.34 -40.29 95.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.261 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -64.61 -42.64 95.39 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.291 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.47 -38.43 81.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.516 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.24 -34.92 79.21 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.979 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.412 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 52.3 tt0 -60.25 -37.11 79.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.408 0.623 . . . . 0.0 109.852 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -79.11 -7.56 58.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.593 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -100.8 2.29 41.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 135.4 -3.56 3.99 Favored Glycine 0 CA--C 1.509 -0.344 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.114 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 93.9 28.97 10.26 Favored Glycine 0 C--O 1.226 -0.353 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.638 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.505 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 45.8 t-20 -70.82 130.6 42.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.975 0.417 . . . . 0.0 110.622 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 327' ' ' LYS . 3.0 tm-20 -129.95 158.25 40.06 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 6.7 ptpp? 60.04 -40.06 0.09 Allowed 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 125.682 1.593 . . . . 0.0 114.473 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.505 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 15.6 mm100 -73.0 -12.7 61.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.382 0.611 . . . . 0.0 109.806 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.45 -17.55 62.81 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.762 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.495 HD12 HH12 ' A' ' 315' ' ' ARG . 56.4 tp -61.59 -32.29 72.39 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.252 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.88 -15.39 60.21 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.756 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.485 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 89.9 mt -66.59 138.07 95.41 Favored Pre-proline 0 C--O 1.238 0.488 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.953 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.78 119.21 6.08 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.344 2.696 . . . . 0.0 113.593 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.446 ' HG3' HD13 ' A' ' 311' ' ' ILE . 21.5 ttt180 -63.07 -45.37 92.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.356 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 0.9 OUTLIER -66.14 -18.61 65.46 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.401 -173.138 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.598 HD13 ' NZ ' ' A' ' 227' ' ' LYS . 85.7 mt -94.2 -5.76 46.28 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -117.35 -2.32 11.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.408 0.623 . . . . 0.0 109.731 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.444 ' HG3' HD11 ' A' ' 311' ' ' ILE . 40.5 tt0 -83.34 -16.69 45.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.534 -175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.92 -48.74 67.73 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.045 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -74.65 -24.72 58.86 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.197 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -60.27 -44.87 94.95 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.499 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.3 tttt -60.38 -46.91 88.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.427 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.52 ' O ' HG23 ' A' ' 347' ' ' VAL . 20.3 mmt85 -62.51 -44.22 96.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -66.29 -38.62 88.19 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.721 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 76.1 t -64.2 -44.1 97.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.753 0.311 . . . . 0.0 110.335 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.52 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 75.6 t -61.5 -43.29 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.644 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 343' ' ' ARG . 72.1 t -59.92 -44.44 94.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.21 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.55 -41.2 99.52 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.98 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 91.1 mt -63.1 -43.8 97.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.955 0.407 . . . . 0.0 111.095 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.0 mt -62.8 -47.36 83.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.122 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.99 -39.44 83.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.852 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.63 -43.27 96.31 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.541 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -68.18 -37.91 81.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.356 0.578 . . . . 0.0 111.042 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.06 -45.79 97.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.74 -44.2 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.018 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -66.07 -49.79 66.39 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.912 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.4 m -66.74 -44.16 82.25 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -82.19 -4.35 56.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.853 0.359 . . . . 0.0 111.063 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 60.02 38.22 20.83 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.347 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.38 152.92 39.46 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.098 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -129.29 158.96 37.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.108 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -81.48 105.6 12.78 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 367' ' ' VAL . 26.6 t70 -81.18 114.47 20.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.169 0.509 . . . . 0.0 112.257 -173.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.543 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 66.4 mm-40 -62.02 -37.3 84.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.255 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 63.4 mm-40 -61.92 -45.74 92.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.286 0.565 . . . . 0.0 110.179 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -63.07 -39.15 93.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.074 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 363' ' ' ASP . 93.2 t -62.96 -40.82 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.784 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.2 mmmt -57.77 -44.13 85.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.413 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.92 -38.79 97.16 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.767 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.79 -42.19 99.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.05 0.452 . . . . 0.0 110.014 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.19 -43.39 97.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.961 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.66 -44.11 97.1 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -65.63 -39.09 91.08 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.533 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 55.7 ttm -65.09 -42.87 93.66 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.096 0.474 . . . . 0.0 110.967 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 377' ' ' ALA . . . -63.31 -31.35 72.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.562 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 37.4 m -73.68 23.84 0.07 Allowed 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.939 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' A' ' 375' ' ' ALA . . . -123.43 0.72 8.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.737 0.303 . . . . 0.0 110.765 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.47 175.33 5.47 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.576 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -59.29 -42.22 90.77 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.835 0.35 . . . . 0.0 110.824 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -134.06 116.17 13.29 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.476 ' O ' HG13 ' A' ' 385' ' ' ILE . 51.4 Cg_endo -69.5 -31.99 20.55 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.272 1.982 . . . . 0.0 113.702 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -66.62 -43.76 83.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.48 -35.02 79.66 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.576 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.82 -42.66 97.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.244 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 381' ' ' PRO . 74.5 mt -61.19 -46.72 96.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.461 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 390' ' ' LYS . 43.0 mt-10 -65.33 -43.46 90.89 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.82 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -57.0 -46.87 81.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.832 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.439 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 3.5 t80 -64.89 -42.31 94.89 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.204 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 65.4 p -76.06 -10.44 59.42 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 386' ' ' GLU . 99.6 mttt -98.35 6.3 47.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.024 0.44 . . . . 0.0 111.005 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 24.2 t-20 -130.64 111.8 12.54 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.854 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -63.38 -36.6 84.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.239 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . 0.407 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 25.7 tp10 -56.95 -53.15 61.31 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.96 0.409 . . . . 0.0 110.283 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.68 -41.21 98.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.597 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.489 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 87.8 mtp -62.07 -46.74 87.75 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 120.836 0.35 . . . . 0.0 111.708 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -73.61 -39.55 64.49 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.076 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -63.36 -40.6 97.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.439 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 46.7 tpp -64.68 -40.27 95.11 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.982 0.42 . . . . 0.0 110.742 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 395' ' ' MET . 70.1 mtm180 -63.38 -33.4 75.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.092 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.6 -44.28 97.3 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.17 -45.52 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.177 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.7 99.54 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.496 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 46.3 tp -64.82 -37.61 88.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.422 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.01 -46.29 82.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.716 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.549 ' OE2' ' HD2' ' A' ' 283' ' ' ARG . 26.6 mt-10 -65.26 -38.69 91.1 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.634 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -60.5 -43.35 97.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.303 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.95 -45.36 89.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.433 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 96.2 t -63.89 -46.56 93.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.274 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -68.49 -30.56 69.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.897 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.23 -43.39 98.93 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.48 -43.32 96.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.033 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.5 mt -61.95 -39.0 90.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.251 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.98 -33.05 72.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.963 0.411 . . . . 0.0 110.896 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -89.08 -10.94 45.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.846 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -93.65 176.94 6.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.295 0.569 . . . . 0.0 112.348 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -93.05 112.34 24.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.291 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 96.6 t -100.42 129.45 51.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.03 0.443 . . . . 0.0 110.945 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.5 t -118.27 139.95 50.56 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.858 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -105.29 120.05 40.6 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -137.31 145.01 42.93 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.712 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.86 148.4 26.3 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.98 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.9 t -150.34 177.95 9.48 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.046 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 19.7 p -86.41 159.96 19.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.991 0.424 . . . . 0.0 111.474 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -66.8 -33.37 75.47 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.2 0.524 . . . . 0.0 110.742 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 428' ' ' MET . 6.6 m-20 -60.74 -37.17 80.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.514 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.25 -32.66 74.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.558 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.16 -17.7 61.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.943 0.401 . . . . 0.0 110.474 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 425' ' ' ASN . 5.7 mmt -74.95 -8.05 55.35 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.167 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -76.72 75.8 3.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -103.73 15.25 29.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.057 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -63.89 -42.02 97.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.375 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.705 -0.664 . . . . 0.0 110.757 -179.65 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 CA--C 1.513 -0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -94.74 158.08 15.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.922 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.53 158.76 43.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.692 0.282 . . . . 0.0 110.718 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 6.4 m -86.09 107.34 17.78 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.491 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.51 138.45 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.978 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.535 ' HG2' ' H ' ' B' ' 7' ' ' THR . 25.1 tt0 -137.53 177.77 7.61 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.535 ' H ' ' HG2' ' B' ' 6' ' ' GLU . 13.1 t -118.09 152.13 36.18 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.89 0.376 . . . . 0.0 111.272 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 75.3 m -110.62 -70.74 0.79 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.074 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -168.03 111.16 0.61 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.022 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.23 -108.37 2.02 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.073 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.09 -31.92 68.42 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 122.462 0.305 . . . . 0.0 111.236 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.24 139.18 39.67 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 116.005 -0.543 . . . . 0.0 114.021 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 0.0 OUTLIER -142.17 161.23 38.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.466 0.706 . . . . 0.0 110.049 -178.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' B' ' 6' ' ' GLU . 32.0 ttm-85 -119.86 138.45 53.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 39.8 t -106.03 -86.94 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.343 176.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 17.9 m 51.1 87.29 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.331 0.586 . . . . 0.0 111.458 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.1 tp -94.16 136.91 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.941 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 91.7 m -117.33 121.51 41.34 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.101 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.536 HG13 HG12 ' B' ' 24' ' ' ILE . 14.3 pt -135.31 165.88 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.611 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.79 151.11 47.37 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.456 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -54.01 -53.03 58.58 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -173.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -65.42 -36.13 83.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.091 0.472 . . . . 0.0 110.441 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.9 m -63.65 -38.23 90.34 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.561 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.611 HG13 ' O ' ' B' ' 20' ' ' ALA . 74.9 mt -59.15 -51.04 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 111.21 -177.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -73.01 -42.59 63.05 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.856 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -67.61 -52.38 39.1 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.42 -44.59 67.6 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.78 -43.06 96.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.734 0.302 . . . . 0.0 111.307 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -61.7 -44.92 96.01 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.082 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.449 ' O ' HG12 ' B' ' 33' ' ' VAL . 19.6 m -63.92 -40.83 97.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.638 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -62.6 -41.84 99.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.031 0.443 . . . . 0.0 110.454 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.48 -41.61 98.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.086 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.449 HG12 ' O ' ' B' ' 30' ' ' SER . 9.9 p -67.99 -36.5 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.316 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -63.47 -42.78 98.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.232 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.03 -36.97 77.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.335 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.77 -48.1 80.64 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.105 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.68 -36.96 85.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.906 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -61.48 -34.63 75.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.666 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.46 -7.52 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.368 0.604 . . . . 0.0 109.707 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 65.91 27.84 10.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.865 0.866 . . . . 0.0 111.57 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.01 3.53 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.325 0.583 . . . . 0.0 111.001 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -65.4 -32.83 74.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.072 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -7.4 58.01 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.69 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -89.04 -6.83 56.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.834 0.35 . . . . 0.0 110.35 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 65.9 ttt-85 -87.58 91.66 8.82 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.054 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -63.17 -43.58 97.85 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.61 72.66 0.7 Allowed Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 115.997 1.159 . . . . 0.0 115.997 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.92 -43.17 98.97 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 171.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.82 112.52 63.93 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.775 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -57.41 147.49 77.51 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 111.912 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.551 ' HA ' HG12 ' B' ' 54' ' ' VAL . 19.7 ttt -67.38 -24.75 65.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.543 -172.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -77.63 -10.24 59.4 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.447 HD13 ' CZ ' ' A' ' 193' ' ' ARG . 81.5 mt -108.26 -47.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.488 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' B' ' 51' ' ' MET . 12.4 p -62.89 -38.88 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.032 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.8 92.21 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -88.41 -9.22 53.35 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.052 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.44 ' NH1' ' SD ' ' A' ' 194' ' ' MET . 62.2 ttt180 -97.36 -41.47 8.22 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.238 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.61 9.87 27.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.965 0.412 . . . . 0.0 109.893 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -57.57 -63.84 4.92 Favored Glycine 0 C--O 1.211 -1.343 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.115 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.63 -27.76 66.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.978 0.389 . . . . 0.0 111.748 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.3 t -61.61 -45.09 95.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.797 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.428 HG22 ' O ' ' B' ' 62' ' ' VAL . 7.6 p -131.0 21.39 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 120.996 0.427 . . . . 0.0 111.902 -175.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.59 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 6.7 ttt180 -64.65 -21.49 66.74 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.782 -0.574 . . . . 0.0 110.914 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -62.08 -50.3 72.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.64 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' B' ' 62' ' ' VAL . 1.1 m-20 -73.6 -25.0 60.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.1 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.93 -43.74 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.1 -39.67 95.38 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.37 -40.3 97.36 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.634 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . 0.764 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 30.6 t70 -61.29 -46.15 91.51 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.67 -42.31 98.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.495 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 60.2 ttp -61.94 -42.4 99.07 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -62.54 -42.85 99.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.764 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 52.3 mtp85 -63.32 -44.98 93.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.535 -176.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -65.31 -41.33 94.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.228 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -61.3 -48.05 83.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.763 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.14 -39.07 80.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.885 0.374 . . . . 0.0 111.117 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.73 -41.24 96.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.186 0.517 . . . . 0.0 110.532 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.51 -46.42 86.16 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.989 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 41.1 pt -65.35 -38.0 81.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.85 -43.62 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.126 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -76.77 -26.26 54.3 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -88.19 3.26 49.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.399 . . . . 0.0 110.793 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 63.9 28.38 14.55 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.125 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.2 mt -94.29 114.68 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -112.09 104.36 55.96 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.01 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.53 140.77 64.32 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.175 1.917 . . . . 0.0 111.695 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.54 96.32 7.3 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.857 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.29 -112.48 4.48 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.789 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.81 139.04 31.12 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.502 0.151 . . . . 0.0 110.657 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . 0.491 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 55.7 Cg_endo -68.48 155.89 67.5 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.629 2.219 . . . . 0.0 111.29 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -90.06 99.01 12.1 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.938 0.399 . . . . 0.0 111.558 -175.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.491 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 66.8 m-85 -102.95 110.96 23.07 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.4 t -115.83 98.83 51.79 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.95 145.97 25.5 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.359 2.039 . . . . 0.0 111.958 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.76 171.9 45.62 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.131 -1.033 . . . . 0.0 110.898 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.5 123.14 20.5 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.057 0.456 . . . . 0.0 110.597 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -84.44 134.19 34.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.261 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -121.78 122.11 38.77 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 46.3 tp -69.76 106.48 3.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.975 0.417 . . . . 0.0 110.716 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.98 -18.35 9.05 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.486 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -110.27 -175.33 2.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -79.7 164.42 23.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.934 0.397 . . . . 0.0 111.707 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -131.18 141.74 50.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.459 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.2 m -120.05 133.78 55.43 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.912 0.387 . . . . 0.0 111.118 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -125.28 165.28 18.6 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.139 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.9 m -75.5 -82.76 0.07 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 46.8 t 54.27 103.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 122.955 0.502 . . . . 0.0 111.315 -175.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -88.33 123.5 32.97 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . 0.494 ' HB3' ' OE1' ' B' ' 110' ' ' GLU . 13.7 m-85 -123.36 -167.47 1.62 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.769 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.494 ' OE1' ' HB3' ' B' ' 109' ' ' PHE . 1.0 OUTLIER -72.37 176.34 5.4 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -176.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' B' ' 305' ' ' ALA . 32.1 m -125.43 166.14 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.473 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' B' ' 113' ' ' PRO . 69.9 m-85 -123.61 121.06 26.74 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.796 -178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 112' ' ' TYR . 73.8 Cg_endo -90.97 134.77 1.8 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 122.87 2.38 . . . . 0.0 113.136 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -135.42 144.79 46.7 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.36 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 76.5 t -126.2 134.22 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -107.52 -86.98 0.49 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.861 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 85.0 mt 62.52 120.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.197 0.999 . . . . 0.0 113.553 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -140.18 153.07 46.5 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.948 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.68 21.85 73.73 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.584 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.55 -40.67 95.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.964 0.411 . . . . 0.0 111.486 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.55 -8.73 57.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.363 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.96 8.19 44.33 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 64.7 mt -88.4 108.8 19.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.197 0.522 . . . . 0.0 110.089 -178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -96.36 103.95 15.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.505 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.02 133.08 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.21 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -85.57 122.96 30.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.44 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -120.78 97.08 48.59 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -69.49 130.24 19.32 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.578 1.519 . . . . 0.0 111.823 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -102.69 115.39 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 24.2 m -132.78 159.46 43.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.299 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.43 160.72 37.9 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 66.8 t -76.25 127.7 37.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 41.3 p -105.27 173.46 6.3 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.814 0.34 . . . . 0.0 110.194 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -67.56 -25.49 65.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.162 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.55 -40.36 96.79 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.122 0.487 . . . . 0.0 109.891 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -63.66 -40.8 97.75 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.026 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.0 t -61.75 -48.43 88.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.414 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.32 -38.42 90.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.901 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.7 -40.95 99.46 Favored Glycine 0 C--O 1.237 0.294 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.565 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 4.1 tpt -63.27 -41.84 99.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.15 0.5 . . . . 0.0 109.826 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 87.2 mt -63.16 -40.31 97.19 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.801 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -58.98 -46.88 87.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.568 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.7 m -63.39 -41.1 98.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' B' ' 140' ' ' MET . 89.5 mt -60.56 -42.86 97.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.718 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -79.07 -8.71 59.19 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.773 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -94.86 -5.46 44.95 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -97.73 -55.82 2.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.149 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' B' ' 148' ' ' GLN . 8.1 mm-40 -58.09 96.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -149.07 106.55 3.64 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.901 174.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.608 HG22 ' H ' ' B' ' 151' ' ' TRP . 0.2 OUTLIER -73.07 175.13 6.99 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -173.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . 0.608 ' H ' HG22 ' B' ' 150' ' ' THR . 53.2 p-90 -99.43 161.21 13.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.526 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.588 ' H ' ' HA ' ' B' ' 243' ' ' ARG . 76.6 tttt -170.98 -81.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.584 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' B' ' 242' ' ' GLU . 11.8 pt-20 -164.24 76.16 0.33 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.462 ' HG2' ' H ' ' B' ' 155' ' ' ASP . 49.7 tttt 178.06 -160.79 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . 0.462 ' H ' ' HG2' ' B' ' 154' ' ' LYS . 12.2 p-10 -135.38 163.05 30.91 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 117.996 0.362 . . . . 0.0 111.153 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 119.87 -18.97 9.71 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.704 -0.76 . . . . 0.0 114.182 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -115.36 100.23 7.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 117.393 0.596 . . . . 0.0 112.174 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 55.0 t -130.26 136.34 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . 0.5 ' HB2' ' OD2' ' B' ' 162' ' ' ASP . 3.4 mm-40 -95.6 -170.58 2.18 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.164 0.507 . . . . 0.0 111.899 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . 0.648 ' O ' ' HA3' ' B' ' 190' ' ' GLY . . . -98.94 24.32 7.87 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . 0.791 ' HA ' ' O ' ' B' ' 189' ' ' MET . 13.4 pt-20 -158.85 25.27 0.22 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.34 0.591 . . . . 0.0 112.422 175.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' B' ' 188' ' ' ALA . 12.8 m-20 -87.81 170.7 10.97 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.398 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -108.15 121.13 44.22 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.3 t -116.74 128.26 74.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.251 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 20.7 m -76.75 104.88 7.49 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 67.7 mt -117.97 117.99 56.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.002 0.43 . . . . 0.0 111.393 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.95 88.44 5.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -109.14 150.92 27.14 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.332 0.587 . . . . 0.0 112.182 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 46.3 m -119.97 128.28 53.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.937 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.9 114.09 3.89 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.488 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 39.2 m -131.94 124.19 28.93 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . 0.537 HG23 ' CD2' ' B' ' 177' ' ' PHE . 93.9 t -100.14 106.77 19.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 35.2 t70 67.6 -75.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.939 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -145.37 9.95 1.72 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.608 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -132.48 139.02 47.79 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.521 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.13 148.25 26.22 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . 0.537 ' CD2' HG23 ' B' ' 172' ' ' VAL . 31.9 p90 -115.84 171.41 7.79 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.442 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -59.39 -36.83 76.54 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.62 -174.45 33.82 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 120.304 -0.95 . . . . 0.0 112.04 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.73 24.31 60.53 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.991 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -103.56 106.58 17.13 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -124.73 144.78 50.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.194 0.521 . . . . 0.0 112.144 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 42.9 m -138.35 119.55 14.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.843 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 55.01 31.11 15.43 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 123.587 0.555 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -81.17 124.54 29.34 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.441 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.72 107.48 18.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.763 0.792 . . . . 0.0 110.708 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 55.1 tp -95.08 122.17 37.46 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.6 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . 0.578 ' HB3' ' CZ ' ' B' ' 193' ' ' ARG . . . -92.1 116.69 29.16 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . 0.791 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 54.1 mtp -84.54 154.28 22.76 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.91 -175.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.648 ' HA3' ' O ' ' B' ' 160' ' ' ALA . . . 89.28 4.31 74.32 Favored Glycine 0 CA--C 1.501 -0.831 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.71 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -111.33 -4.33 14.96 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.312 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.27 47.65 8.91 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.018 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.578 ' CZ ' ' HB3' ' B' ' 188' ' ' ALA . 96.2 mtt180 -95.47 -3.62 46.47 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.288 0.566 . . . . 0.0 109.568 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.455 ' SD ' ' NH1' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -134.54 168.74 18.42 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.942 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 43.7 mm -61.74 135.46 94.34 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.25 129.5 19.14 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.356 2.037 . . . . 0.0 111.85 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.44 -36.63 4.28 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.343 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -67.31 -50.95 58.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.33 0.565 . . . . 0.0 112.015 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . 0.456 ' O ' ' HE3' ' B' ' 189' ' ' MET . 10.5 pt-20 -81.48 -10.95 59.37 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.005 0.431 . . . . 0.0 111.427 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -90.72 -25.86 19.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.153 0.502 . . . . 0.0 109.705 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.21 -10.93 85.98 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.143 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.5 mm -64.27 -43.0 97.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -55.41 114.6 1.89 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.905 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 115.03 -9.11 21.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.923 177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -99.4 146.64 26.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 117.319 0.56 . . . . 0.0 112.158 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -90.49 168.84 11.53 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.007 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.34 129.28 37.68 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 78.29 33.36 40.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.68 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -119.77 118.94 32.19 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.913 0.387 . . . . 0.0 110.378 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -101.67 116.62 33.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.284 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -138.29 -16.21 1.23 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 62.7 p 59.66 167.86 0.07 Allowed 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 123.712 0.805 . . . . 0.0 112.844 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -151.17 144.21 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.968 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -80.21 110.91 16.07 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.687 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 43.1 t -118.77 105.5 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 21.0 m -71.99 -43.54 64.93 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' B' ' 216' ' ' THR . 66.3 m-85 76.67 146.91 0.12 Allowed Pre-proline 0 N--CA 1.488 1.449 0 C-N-CA 123.044 0.538 . . . . 0.0 110.748 -174.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.7 153.82 68.74 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.788 2.325 . . . . 0.0 111.863 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . 0.515 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 65.0 mm-40 -66.7 -38.12 86.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.236 0.541 . . . . 0.0 110.069 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -94.49 40.8 1.09 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.62 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -75.15 143.88 43.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.154 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -60.96 -17.63 52.66 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.39 118.48 36.85 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.441 ' HA ' ' CD ' ' B' ' 227' ' ' LYS . 5.2 tp10 -61.86 -33.23 73.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.856 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -88.96 -5.11 58.2 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 87.7 mt -117.93 -14.72 10.02 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.029 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.668 ' NZ ' HD13 ' B' ' 336' ' ' LEU . 19.7 ptmt -63.96 122.58 16.86 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.121 0.486 . . . . 0.0 111.884 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 70.58 9.94 66.05 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.097 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -110.92 120.4 42.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.197 0.498 . . . . 0.0 110.485 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -72.51 134.45 45.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.871 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.56 156.52 26.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.659 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.25 -31.68 13.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 51.59 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -74.52 95.4 2.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.509 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm -96.53 114.64 33.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.57 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -108.46 -31.59 7.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.212 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.2 mt 65.5 170.41 0.21 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.407 0.683 . . . . 0.0 111.382 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -128.62 -79.61 0.57 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.122 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -115.42 -31.13 6.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.4 ' O ' HG12 ' B' ' 240' ' ' VAL . 17.1 t 59.89 41.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 122.13 0.967 . . . . 0.0 109.085 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 63.67 -101.1 0.09 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.765 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.538 ' HB2' ' HA ' ' B' ' 153' ' ' GLU . 9.5 pt-20 179.9 96.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.962 0.905 . . . . 0.0 109.095 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.588 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 10.5 ptm180 -152.19 120.94 6.51 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -173.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 179.46 164.89 1.02 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 98.2 mt 70.85 112.17 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.985 0 CA-C-O 121.285 0.564 . . . . 0.0 111.617 -176.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.37 118.18 2.54 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.527 2.151 . . . . 0.0 114.471 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -144.64 167.23 23.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.501 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.82 134.68 38.99 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.045 0.45 . . . . 0.0 112.19 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 8.0 m -138.07 154.91 49.23 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -79.44 -36.49 38.81 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.808 0.337 . . . . 0.0 111.642 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -75.6 56.41 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.758 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -136.09 -56.92 0.77 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.937 0.399 . . . . 0.0 110.498 176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' B' ' 261' ' ' GLY . 36.4 pt -68.86 -22.81 26.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.163 0.506 . . . . 0.0 110.92 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -105.85 7.83 32.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.666 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -115.12 -1.06 13.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.391 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -99.66 116.75 32.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.208 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 46.59 -115.86 2.08 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 115.711 1.044 . . . . 0.0 115.711 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 83.2 t -113.65 136.51 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.522 0.729 . . . . 0.0 110.926 -174.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' B' ' 260' ' ' ASP . 3.0 tp10 69.18 -173.05 0.18 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . 0.449 ' H ' ' HG3' ' B' ' 259' ' ' GLU . 5.1 p-10 -125.98 117.99 24.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' B' ' 253' ' ' ILE . . . -103.2 162.27 16.08 Favored Glycine 0 C--N 1.316 -0.552 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.174 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 12.0 p -85.37 -178.99 6.87 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.72 -47.98 90.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.918 0.389 . . . . 0.0 111.065 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.1 -32.02 17.73 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.782 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.02 -42.35 96.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.533 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.507 ' O ' HG23 ' B' ' 270' ' ' VAL . 47.5 tp -64.33 -42.4 96.3 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.633 0.216 . . . . 0.0 110.435 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -60.86 -44.64 96.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.638 0.256 . . . . 0.0 111.155 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.16 -41.23 97.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.003 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -69.4 -38.79 78.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.507 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.1 t -63.83 -42.0 94.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -53.15 -54.83 30.09 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.498 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 12.7 ptmt -64.59 -42.61 95.48 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -63.65 -40.71 97.53 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.473 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.6 -41.41 92.82 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.195 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -66.68 -35.08 79.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.949 0.404 . . . . 0.0 110.883 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 56.3 ttp180 -62.78 -42.63 99.78 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.385 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -67.34 -37.29 83.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.985 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.23 -37.81 86.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.541 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 52.5 tttm -56.34 -45.94 80.17 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.37 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 42.5 m -61.83 -41.0 97.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.592 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.2 -44.91 96.53 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.158 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.35 -44.22 98.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.285 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . 0.453 ' HD2' ' OE2' ' B' ' 405' ' ' GLU . 0.5 OUTLIER -60.41 -44.88 95.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 178.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -64.44 -41.87 96.31 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.672 0.272 . . . . 0.0 110.927 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -61.48 -44.64 96.73 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.099 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.15 -43.27 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.988 0.423 . . . . 0.0 110.582 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.43 -47.72 84.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.806 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 73.7 p -61.94 -41.55 98.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.738 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -64.53 -44.83 89.59 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.824 0.345 . . . . 0.0 111.073 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.38 78.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.535 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . 0.428 ' O ' HG23 ' B' ' 295' ' ' VAL . 37.5 mm -64.09 -44.24 97.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.734 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . 0.512 ' HG3' ' HE2' ' B' ' 296' ' ' LYS . 30.6 tp10 -62.91 -45.11 94.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.513 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.43 95.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.7 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.404 HD13 HD13 ' B' ' 350' ' ' LEU . 1.8 tt -62.81 -43.15 99.56 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 291' ' ' ILE . 98.8 t -66.28 -43.38 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.075 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.512 ' HE2' ' HG3' ' B' ' 292' ' ' GLU . 64.3 mttm -62.21 -39.22 92.05 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.593 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -73.24 -37.71 66.28 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.364 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -125.45 98.53 5.64 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -93.06 115.28 27.95 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -120.28 153.64 23.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.475 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.13 142.25 58.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.151 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.85 127.42 26.0 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.207 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.5 134.0 60.56 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.568 2.179 . . . . 0.0 111.896 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.03 -37.37 87.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.808 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . 0.433 ' HB2' HG11 ' B' ' 111' ' ' VAL . . . -57.46 -42.75 83.14 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.474 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.65 -41.75 95.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.286 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.2 -47.45 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.114 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.12 -47.54 80.85 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.258 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 48.4 m -60.29 -44.79 95.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.897 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . 0.474 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 67.0 mm-40 -71.81 -36.69 70.33 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.552 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 92.7 mt -61.94 -44.22 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.085 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.498 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 15.0 t70 -63.34 -42.52 98.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.906 0.384 . . . . 0.0 110.322 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.34 -43.85 98.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.23 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 92.9 mt -61.91 -41.23 97.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.762 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 82.6 mtm180 -63.88 -38.64 91.83 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.141 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 62.0 mtt-85 -64.25 -40.69 96.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.926 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.1 -43.03 96.59 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.455 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.84 76.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.971 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.18 77.36 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.965 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . 0.436 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 50.7 tt0 -60.99 -34.22 74.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.332 0.587 . . . . 0.0 110.019 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -82.08 -9.22 59.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.121 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -97.09 -0.58 46.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.688 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 135.38 0.52 3.33 Favored Glycine 0 C--O 1.226 -0.403 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.85 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 90.98 29.57 12.6 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.875 -1.155 . . . . 0.0 111.822 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 42.5 t-20 -71.6 125.38 26.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.126 0.489 . . . . 0.0 111.136 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' B' ' 327' ' ' LYS . 3.0 tm-20 -124.5 157.13 36.01 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' B' ' 326' ' ' GLU . 6.6 ptpp? 60.12 -38.67 0.09 Allowed 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 125.882 1.673 . . . . 0.0 114.681 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . 0.435 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 15.2 mm100 -75.24 -10.02 59.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.19 0.519 . . . . 0.0 110.362 177.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -65.88 -12.73 56.74 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.353 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.519 HD12 HH12 ' B' ' 315' ' ' ARG . 62.6 tp -61.62 -34.8 76.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.883 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -76.98 -11.59 59.82 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.808 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.464 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 84.3 mt -66.92 134.76 94.03 Favored Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.621 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -49.93 122.26 8.79 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.445 2.763 . . . . 0.0 113.69 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . 0.482 ' HG3' HD13 ' B' ' 311' ' ' ILE . 21.9 ttt180 -65.37 -44.56 87.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.018 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -68.38 -17.35 64.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.58 -172.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . 0.668 HD13 ' NZ ' ' B' ' 227' ' ' LYS . 92.1 mt -93.53 -5.86 48.07 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -117.36 -11.83 10.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.688 0.756 . . . . 0.0 109.767 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.98 -21.99 61.5 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.944 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -65.4 -48.64 72.14 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.907 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -75.18 -25.82 58.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.681 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.433 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -59.06 -44.95 91.88 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.506 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . 0.472 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.7 tttt -60.37 -45.25 94.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.255 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . 0.467 ' O ' HG23 ' B' ' 347' ' ' VAL . 18.4 mmt85 -62.68 -43.75 98.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -64.97 -38.83 92.26 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 121.189 -0.204 . . . . 0.0 111.059 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 341' ' ' ALA . 81.5 t -64.49 -44.14 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.436 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.512 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 70.3 t -61.8 -43.98 98.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.467 HG23 ' O ' ' B' ' 343' ' ' ARG . 74.0 t -59.83 -45.21 95.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.676 0.274 . . . . 0.0 110.496 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.37 -41.25 99.76 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.805 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.5 -43.2 99.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.378 . . . . 0.0 110.772 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' B' ' 346' ' ' VAL . 96.2 mt -62.91 -46.43 87.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.021 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.5 -39.31 85.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.776 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.95 -45.63 93.48 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.409 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -68.84 -37.29 79.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.218 0.509 . . . . 0.0 111.234 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.24 -46.25 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.7 -44.29 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.547 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -65.89 -50.07 65.8 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 97.3 m -65.79 -45.97 80.46 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -81.9 -7.22 59.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.694 0.283 . . . . 0.0 111.547 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 63.22 45.03 5.29 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.162 0.506 . . . . 0.0 111.317 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.01 155.95 28.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.977 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -132.22 158.65 41.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.5 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -84.85 102.48 13.12 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 26.1 t70 -81.69 118.6 22.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . 0.594 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 54.8 mm-40 -61.59 -39.07 89.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.299 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . 0.552 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 63.4 mm-40 -58.44 -48.04 82.01 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.271 0.557 . . . . 0.0 110.275 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -62.36 -40.3 95.98 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.275 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 363' ' ' ASP . 97.1 t -63.56 -41.52 92.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.036 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 29.8 mmmt -56.97 -44.61 82.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.777 0.322 . . . . 0.0 110.135 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.38 -38.38 96.3 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.103 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.84 -42.27 99.67 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.288 0.566 . . . . 0.0 110.153 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.84 -43.31 97.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.529 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -61.33 -44.19 97.62 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -66.68 -40.0 88.37 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.937 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 55.6 ttm -64.63 -42.57 95.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.964 0.412 . . . . 0.0 110.75 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.81 -29.2 70.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.256 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 44.3 m -70.37 -7.28 41.66 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.955 0.407 . . . . 0.0 111.581 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.12 -2.5 58.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.441 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -108.98 174.26 5.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.053 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.62 -44.45 89.99 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.316 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -132.34 113.99 14.6 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -67.61 -30.43 35.04 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.332 2.021 . . . . 0.0 113.373 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.96 -44.35 80.76 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.69 -34.73 78.89 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.933 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.85 -43.02 97.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.438 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.37 -44.86 99.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.89 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 49.9 mt-10 -66.14 -45.0 82.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.124 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -57.1 -46.78 82.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.939 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . 0.433 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 4.4 t80 -63.52 -44.37 94.47 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.887 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 77.4 p -72.56 -14.12 61.56 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.1 mttt -94.46 5.82 50.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.893 0.377 . . . . 0.0 111.697 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -131.39 113.87 14.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.167 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -63.63 -37.11 86.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -56.91 -51.25 69.84 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.774 0.321 . . . . 0.0 110.533 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.83 -41.02 97.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.901 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 93.4 mtp -60.83 -51.77 67.9 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -72.69 -36.15 67.8 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.369 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.63 -41.03 98.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.988 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . 0.433 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 50.1 tpp -63.74 -40.79 97.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.631 177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.442 ' HG2' HG21 ' B' ' 367' ' ' VAL . 25.8 mtm180 -62.89 -34.3 77.13 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.745 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -61.02 -45.32 95.29 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.768 0.318 . . . . 0.0 110.452 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.49 -44.99 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.07 0.462 . . . . 0.0 110.791 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.22 97.46 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.645 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.75 -36.92 85.45 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.658 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . 0.419 ' O ' HG23 ' B' ' 408' ' ' VAL . 36.3 tt0 -58.86 -43.9 90.93 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.648 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . 0.453 ' OE2' ' HD2' ' B' ' 283' ' ' ARG . 32.2 mt-10 -65.23 -40.55 94.21 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.559 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -58.37 -44.34 88.83 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.559 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.39 -42.5 96.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 89.3 t -64.8 -46.29 92.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.027 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -67.53 -31.5 71.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.312 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.68 98.08 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.855 0.359 . . . . 0.0 110.107 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 95.9 t -66.51 -42.5 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.864 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 89.6 mt -61.56 -40.15 93.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.091 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.51 -21.79 65.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.564 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -102.06 -2.56 29.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.895 0.378 . . . . 0.0 110.952 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -101.66 173.14 6.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.147 0.499 . . . . 0.0 111.704 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -88.95 114.06 25.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.425 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.22 127.03 53.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.336 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 10.1 t -118.83 131.71 56.09 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.141 0.496 . . . . 0.0 109.92 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -98.62 113.26 25.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.662 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -129.02 146.67 50.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.846 0.355 . . . . 0.0 110.464 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -89.88 146.4 24.44 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.42 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -147.99 -175.67 4.98 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.342 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 67.6 p -94.78 159.92 14.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.33 . . . . 0.0 111.37 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.76 -34.29 77.99 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.05 0.453 . . . . 0.0 110.752 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -58.97 -39.18 80.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.409 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.0 -31.48 72.06 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 120.871 0.367 . . . . 0.0 110.854 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.21 -16.94 61.4 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.852 0.358 . . . . 0.0 110.529 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.3 mmt -75.95 -8.54 57.18 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.086 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -75.72 72.17 2.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -101.12 9.95 41.47 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.302 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -62.2 -46.62 88.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.917 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.623 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.104 -179.904 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.0 mtt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -66.36 120.33 13.13 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.643 0.735 . . . . 0.0 112.782 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.11 174.87 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.631 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 11.7 p -76.42 -170.71 1.57 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.958 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 4' ' ' SER . 0.6 OUTLIER 87.48 143.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.775 0.83 . . . . 0.0 111.901 177.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -140.74 156.35 46.21 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 m -88.56 129.24 35.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.9 0.381 . . . . 0.0 111.79 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.2 m -88.42 -70.59 0.63 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.069 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -166.27 122.16 1.25 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.891 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.12 -106.16 1.24 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.078 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.8 mt -92.91 -7.91 44.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.615 0.245 . . . . 0.0 110.976 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.524 ' O ' ' HD3' ' A' ' 13' ' ' ARG . . . -81.56 137.9 18.17 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.241 -0.504 . . . . 0.0 114.23 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.524 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -134.12 148.22 50.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.062 0.945 . . . . 0.0 110.84 179.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -110.81 137.96 47.81 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.4 t -96.73 -83.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.665 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 p 25.06 93.91 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.0 tp -123.56 139.76 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.871 0.367 . . . . 0.0 111.965 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.2 p -68.99 139.43 55.0 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.688 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.472 HD13 HG12 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -126.79 141.61 45.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -174.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.641 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -75.51 148.73 38.74 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.073 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -57.15 -40.22 76.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -175.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.55 -3.58 47.53 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.878 0.37 . . . . 0.0 111.449 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -105.71 -25.63 12.14 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.914 0.388 . . . . 0.0 110.624 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.641 HG13 ' O ' ' A' ' 20' ' ' ALA . 74.8 mt -60.56 -49.37 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.153 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.411 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 71.4 mm-40 -102.23 3.47 38.3 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -175.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.7 m -96.66 -72.14 0.65 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.265 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.84 89.0 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -176.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.403 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 99.1 t -62.87 -45.34 99.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.879 0.371 . . . . 0.0 111.132 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 20.2 ttmm -63.15 -45.58 91.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.7 m -62.72 -39.71 94.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.194 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.5 tp10 -66.23 -40.55 90.34 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.53 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.8 mt -62.28 -43.11 99.58 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.34 -39.11 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.908 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -65.48 -38.29 89.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.244 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 31' ' ' GLU . 96.0 t -62.46 -42.13 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 110.369 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.29 -41.81 94.17 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 110.223 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.87 -30.75 71.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.096 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 35' ' ' VAL . 24.5 ttmm -57.78 -41.94 83.08 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.171 0.588 . . . . 0.0 110.255 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.8 t -89.29 -4.48 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.005 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 64.96 33.9 9.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.646 0.778 . . . . 0.0 111.178 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.73 13.03 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.921 0.391 . . . . 0.0 111.741 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.99 -32.75 74.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.351 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.5 -3.4 58.1 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.148 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -86.47 -6.68 58.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.917 0.389 . . . . 0.0 110.834 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.9 ttt-85 -91.61 108.16 19.71 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.812 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.12 -39.49 92.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.635 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.95 29.66 22.61 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.254 -0.974 . . . . 0.0 114.757 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -60.98 -44.69 97.0 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.05 110.06 56.84 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.476 ' O ' HG13 ' A' ' 54' ' ' VAL . 53.1 Cg_exo -56.85 141.5 92.89 Favored 'Trans proline' 0 N--CA 1.477 0.557 0 C-N-CA 122.762 2.308 . . . . 0.0 112.135 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.503 ' HA ' HG22 ' A' ' 54' ' ' VAL . 16.1 ttt -68.33 -27.76 66.56 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -172.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -72.35 -17.4 61.84 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.095 0.474 . . . . 0.0 110.151 177.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.524 HD13 ' NH2' ' B' ' 193' ' ' ARG . 84.3 mt -99.75 -34.6 4.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.864 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' A' ' 51' ' ' MET . 21.4 m -60.76 -40.15 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 120.917 0.389 . . . . 0.0 111.012 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.77 -25.94 65.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -94.16 -32.5 13.7 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.066 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.425 HH12 HD13 ' B' ' 187' ' ' LEU . 15.3 tpp180 -64.68 -41.55 95.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.767 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.61 22.5 14.96 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.644 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.75 147.96 49.84 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.835 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.71 -39.69 0.45 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.468 0.707 . . . . 0.0 112.487 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 t -60.68 -47.93 84.04 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 122.678 0.391 . . . . 0.0 111.956 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.8 p -118.29 10.58 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.288 0.566 . . . . 0.0 110.733 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -60.31 -38.81 84.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.481 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 27.2 tt0 -60.08 -45.9 91.37 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.987 0.422 . . . . 0.0 110.83 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -68.1 -34.07 75.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.242 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 62' ' ' VAL . 79.2 t -60.9 -33.82 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.284 0.564 . . . . 0.0 109.714 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 98.0 mt -61.68 -38.77 89.04 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.77 -40.27 99.0 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.498 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.91 -45.31 93.12 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.971 0.415 . . . . 0.0 110.915 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.34 -42.17 98.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.2 ttp -61.27 -46.31 90.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.316 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.3 m -64.4 -53.01 55.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.448 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -69.55 -39.44 77.42 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -65.12 -40.51 94.59 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.486 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -61.43 -48.42 81.24 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.406 ' O ' HG13 ' A' ' 79' ' ' ILE . 16.3 tt -67.78 -39.73 82.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 120.71 0.29 . . . . 0.0 111.154 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.37 -42.75 99.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.157 0.504 . . . . 0.0 110.699 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.98 87.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.309 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.7 pp -68.44 -31.13 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.12 -44.47 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.334 0.588 . . . . 0.0 110.655 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -82.93 -18.96 38.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.888 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -88.14 -7.7 56.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.325 0.583 . . . . 0.0 109.551 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 67.51 35.96 3.98 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.149 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.2 mt -100.37 116.16 43.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -103.35 105.44 46.65 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.455 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.92 142.89 83.84 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.403 2.069 . . . . 0.0 111.382 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.04 99.24 9.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.046 0.45 . . . . 0.0 110.836 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.08 -104.31 3.16 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.88 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.15 130.41 9.28 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.492 0.187 . . . . 0.0 110.728 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.93 154.03 37.88 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.39 2.06 . . . . 0.0 110.97 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -99.48 120.15 39.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.138 0.494 . . . . 0.0 110.49 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.464 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 97.2 m-85 -97.81 97.5 9.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.621 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.15 107.66 39.41 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.377 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 85.2 Cg_endo -89.01 157.84 5.84 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.907 2.405 . . . . 0.0 111.089 175.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.04 178.41 33.27 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.494 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.3 112.88 9.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.272 0.558 . . . . 0.0 110.038 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -79.35 127.55 32.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.522 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -107.42 119.98 40.91 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.9 tp -67.12 117.74 9.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.015 0.436 . . . . 0.0 110.676 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.81 -5.79 54.09 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.665 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -119.97 179.59 4.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.695 0.283 . . . . 0.0 110.764 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -72.44 157.24 38.01 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 111.254 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -123.03 136.63 54.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.934 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.8 m -120.59 137.04 54.62 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.746 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -140.29 167.8 21.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.56 0.344 . . . . 0.0 111.066 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.2 m -78.31 -86.84 0.06 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -174.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.2 t 57.21 97.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.299 0.571 . . . . 0.0 110.117 -172.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -100.82 136.04 41.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -157.7 167.42 30.14 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.802 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -52.39 145.21 11.61 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -173.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.4 m -137.89 165.27 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.904 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -121.1 103.97 41.77 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -89.03 160.4 5.88 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.074 2.516 . . . . 0.0 113.531 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.08 138.85 52.71 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.28 141.62 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.636 0.255 . . . . 0.0 111.103 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -108.68 142.21 39.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.674 0.273 . . . . 0.0 110.98 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.3 mt -118.97 146.25 45.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -134.41 147.07 50.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 111.172 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.08 14.79 80.07 Favored Glycine 0 C--N 1.33 0.227 0 N-CA-C 114.273 0.469 . . . . 0.0 114.273 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.77 -38.2 90.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.177 0.513 . . . . 0.0 110.851 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.3 mp0 -73.0 -8.25 54.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.807 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.39 11.07 39.83 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.917 0.389 . . . . 0.0 111.398 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.449 ' CD1' HD21 ' A' ' 294' ' ' LEU . 75.0 mt -88.95 125.64 42.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.621 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -112.2 119.53 38.67 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.7 t -112.19 132.6 60.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 111.432 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -88.57 140.66 29.23 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.538 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -130.19 106.46 16.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -68.61 118.05 5.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.059 1.839 . . . . 0.0 111.419 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.7 mm -104.2 109.48 27.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.97 161.07 40.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.558 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -133.66 166.24 23.06 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.25 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.88 113.76 13.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.4 p -95.97 173.23 7.54 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.199 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.6 -32.6 73.63 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.887 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.23 -41.93 97.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.421 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -63.5 -39.73 95.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.831 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.79 -46.05 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.261 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -45.1 94.9 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.545 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.65 99.61 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.083 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.601 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 1.2 tpt -60.9 -47.41 86.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.673 0.273 . . . . 0.0 110.765 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.7 -42.0 98.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.43 -45.31 94.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.679 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.0 m -63.39 -40.75 98.05 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.849 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.4 mt -61.14 -40.08 92.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.162 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -74.68 -9.99 59.1 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.246 0.546 . . . . 0.0 110.805 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.59 9.51 43.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.52 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -118.62 27.11 9.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.892 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -138.86 106.69 5.65 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.12 150.06 36.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.791 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 151' ' ' TRP . 0.2 OUTLIER -118.17 -176.44 3.06 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.002 -176.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.572 ' H ' HG22 ' A' ' 150' ' ' THR . 57.7 p-90 -108.66 145.04 35.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -161.67 -71.01 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.41 -127.76 0.25 Allowed 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.289 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.486 ' HE3' ' HG2' ' A' ' 242' ' ' GLU . 9.6 ptpp? -143.25 144.04 31.98 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.236 0.925 . . . . 0.0 113.426 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 156' ' ' GLY . 12.1 t70 -164.95 -151.51 0.15 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.573 ' HA3' ' HD3' ' A' ' 206' ' ' LYS . . . -104.51 59.95 0.44 Allowed Glycine 0 CA--C 1.509 -0.32 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.311 -178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -134.4 115.8 14.44 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 3.9 t -127.17 129.28 70.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.437 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -84.5 158.54 20.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.022 0.439 . . . . 0.0 111.962 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.4 28.7 0.24 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.74 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -170.03 21.11 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.633 0.773 . . . . 0.0 109.045 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.474 ' CG ' ' HE ' ' A' ' 243' ' ' ARG . 46.1 t0 -64.45 -42.32 96.04 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 187' ' ' LEU . 55.7 ttp180 68.85 86.85 0.13 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.445 HG13 ' H ' ' A' ' 241' ' ' GLU . 48.9 t -113.88 131.86 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.875 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.4 m -67.93 106.8 2.43 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 86.4 mt -118.12 130.22 73.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -174.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -101.5 109.15 20.91 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.422 0.63 . . . . 0.0 109.551 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -137.29 154.43 50.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.065 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 37.3 m -127.15 131.97 50.64 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.266 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -69.46 125.22 17.17 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.983 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.3 m -138.67 131.01 28.61 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.2 t -79.78 -77.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -114.47 -60.78 1.84 Allowed 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -144.99 22.95 1.94 Allowed Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -132.57 143.91 50.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -94.1 146.61 23.85 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -111.96 173.46 6.35 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.448 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.17 -38.08 75.95 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.28 -178.45 37.2 Favored Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.045 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.38 22.63 56.27 Favored Glycine 0 C--N 1.319 -0.381 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.895 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.89 99.32 9.51 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -119.91 138.77 53.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.163 0.506 . . . . 0.0 111.743 -176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 m -142.3 122.5 13.83 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.368 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 60.06 31.68 20.7 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 123.459 0.475 . . . . 0.0 110.843 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -90.72 121.09 32.31 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.836 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.7 m -91.02 114.39 28.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.5 0.666 . . . . 0.0 110.464 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.44 HD13 HH12 ' B' ' 57' ' ' ARG . 61.4 tp -101.74 116.05 31.87 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.391 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.71 ' HB3' ' NH1' ' A' ' 193' ' ' ARG . . . -99.96 102.64 14.07 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 50.4 mtm -75.32 171.33 14.4 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.054 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.57 5.64 71.6 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.159 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -118.03 -8.21 10.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 120.787 0.327 . . . . 0.0 111.062 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 75.4 47.47 12.57 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.215 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.71 ' NH1' ' HB3' ' A' ' 188' ' ' ALA . 49.8 mtm180 -104.79 6.29 33.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.443 0.64 . . . . 0.0 111.06 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.518 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.0 OUTLIER -128.75 159.47 35.58 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.183 173.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.456 HG13 ' CE2' ' A' ' 217' ' ' PHE . 43.6 mm -54.78 131.75 65.85 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.12 123.6 5.34 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.706 2.27 . . . . 0.0 112.32 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 106.95 -37.33 3.88 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.36 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -62.39 -48.2 80.79 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.93 0.365 . . . . 0.0 111.887 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.54 -9.33 59.3 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -93.11 -27.94 16.63 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.274 0.559 . . . . 0.0 110.063 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.48 -16.43 73.73 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.629 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.52 -43.01 98.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -57.95 114.73 2.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.31 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 114.71 2.26 22.6 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.48 -0.866 . . . . 0.0 113.596 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -111.06 146.52 36.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 117.156 0.478 . . . . 0.0 111.593 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.573 ' HD3' ' HA3' ' A' ' 156' ' ' GLY . 75.4 mmtt -83.97 165.02 18.99 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.877 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.03 111.2 3.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.715 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 84.45 35.01 15.02 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.235 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -111.86 127.2 55.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.13 0.49 . . . . 0.0 111.641 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -92.28 142.48 27.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.58 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.434 ' O ' ' HB ' ' A' ' 212' ' ' THR . 75.4 t80 -159.48 -30.89 0.06 Allowed 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 211' ' ' PHE . 35.5 m 78.46 142.06 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.623 0.369 . . . . 0.0 110.905 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.3 tp -138.28 127.54 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 121.062 0.458 . . . . 0.0 111.229 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -79.79 107.09 12.29 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.461 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 67.8 t -112.34 114.22 46.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.279 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 14.0 m -72.88 -41.61 64.5 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -176.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.544 ' HB2' ' O ' ' A' ' 216' ' ' THR . 68.7 m-85 80.81 143.45 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 123.539 0.736 . . . . 0.0 110.935 -174.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.68 152.44 53.35 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.437 2.091 . . . . 0.0 112.099 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -65.39 -35.68 81.68 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -87.34 23.98 1.73 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.648 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 8.3 t80 -67.94 133.71 49.56 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.044 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -67.95 -18.49 64.77 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.462 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -88.81 102.5 15.08 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 175.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.504 ' OE2' HD12 ' A' ' 336' ' ' LEU . 42.6 tt0 -57.05 -33.26 67.06 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.663 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -78.07 -11.39 59.91 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 90.2 mt -121.12 -4.7 9.51 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 21.8 ptmt -68.1 116.65 8.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.173 0.511 . . . . 0.0 111.71 -177.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 66.2 21.85 70.42 Favored Glycine 0 C--O 1.24 0.526 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.033 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -121.92 112.16 17.96 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.4 142.98 57.41 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -174.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -127.94 144.08 51.1 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.782 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -100.58 -31.79 11.08 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 61.85 126.72 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -81.32 -40.94 22.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.769 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.2 mm 67.97 129.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.847 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.527 ' ND2' ' HG3' ' A' ' 238' ' ' LYS . 7.6 t30 -107.08 -67.38 0.95 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.453 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 98.0 mt 62.31 94.39 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.527 ' HG3' ' ND2' ' A' ' 236' ' ' ASN . 62.2 mttp -100.66 -37.87 8.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.136 0.493 . . . . 0.0 110.045 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 24.0 mmtm -95.4 -88.43 0.26 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 92.0 t 73.39 126.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.585 0.553 . . . . 0.0 110.197 -173.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.445 ' H ' HG13 ' A' ' 164' ' ' VAL . 42.9 mt-10 -73.8 -179.48 3.68 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.486 ' HG2' ' HE3' ' A' ' 154' ' ' LYS . 42.3 mt-10 -113.97 112.4 23.24 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -168.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 8.9 ptp180 -148.41 143.89 27.09 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.751 167.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -172.95 156.79 3.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 4.9 tt 69.77 109.26 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.199 0.6 . . . . 0.0 111.315 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -86.42 120.23 1.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.594 2.196 . . . . 0.0 112.743 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -147.18 177.57 9.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.984 0.421 . . . . 0.0 110.451 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 248' ' ' LEU . 5.8 mp -93.06 78.1 4.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.238 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.419 ' OG1' HG21 ' A' ' 150' ' ' THR . 7.2 m -92.12 -63.16 1.27 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.882 0.372 . . . . 0.0 111.392 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -162.05 -32.1 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.045 0.45 . . . . 0.0 110.805 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -72.08 0.5 9.39 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.215 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -103.38 -26.1 13.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.173 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 44.8 pt -103.66 -8.28 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -171.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -159.61 7.22 0.1 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 119.526 -0.87 . . . . 0.0 113.089 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -120.61 135.82 54.99 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.574 0.226 . . . . 0.0 110.445 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -177.09 36.81 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 81.0 20.3 65.48 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.6 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 24.9 t -127.7 160.04 37.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -57.47 -50.9 71.56 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.033 0.444 . . . . 0.0 110.23 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -176.68 156.74 1.48 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.846 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -170.92 174.75 44.74 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.058 -1.067 . . . . 0.0 112.674 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.6 p -98.03 -173.86 2.71 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 122.716 0.406 . . . . 0.0 110.233 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 14.8 t -70.4 -71.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 111.191 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.518 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.1 pm0 -70.19 -37.02 75.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.866 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.5 -39.65 97.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.079 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 63.8 tp -63.25 -43.8 97.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.489 0.185 . . . . 0.0 110.995 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -62.62 -42.74 99.76 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.957 0.408 . . . . 0.0 110.282 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.54 -45.61 82.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.44 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 30.8 tp10 -66.34 -39.81 89.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.864 0.364 . . . . 0.0 110.974 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 74.1 t -65.01 -43.7 96.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.25 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.405 HH21 ' HD3' ' A' ' 271' ' ' ARG . 9.0 tpt180 -59.17 -48.56 81.14 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.03 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.8 ptmt -64.89 -44.32 90.02 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 111.198 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -65.12 -37.57 87.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.955 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 89.4 mmm -61.93 -42.85 99.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.825 0.345 . . . . 0.0 110.224 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.37 -32.14 69.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 279' ' ' LYS . 55.3 ttp180 -63.45 -42.0 98.63 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 175.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -65.56 -35.8 81.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.855 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 44.2 tp -61.44 -36.78 81.32 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.905 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 276' ' ' ARG . 58.1 tttm -54.81 -47.96 73.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.862 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 20.1 m -63.83 -42.44 97.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.037 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.39 -49.4 77.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.318 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 86.1 mt -64.02 -43.02 97.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.471 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.03 -45.12 93.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.219 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -65.41 -41.37 93.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.26 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.492 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.8 tpm_? -60.83 -44.13 97.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.785 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.3 t -68.88 -44.42 81.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.93 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.509 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.1 tttt -61.99 -48.44 80.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.82 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.8 p -63.62 -42.36 98.19 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.95 -39.56 90.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.204 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.03 93.95 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.851 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 287' ' ' LYS . 48.6 mm -65.11 -44.22 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.2 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.487 ' OE2' ' HE2' ' A' ' 296' ' ' LYS . 16.0 tp10 -60.02 -42.66 94.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.51 -45.82 92.03 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.709 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.449 HD21 ' CD1' ' A' ' 123' ' ' ILE . 26.5 mt -62.86 -42.17 99.65 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.8 -43.78 96.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.716 0.293 . . . . 0.0 110.849 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . 0.487 ' HE2' ' OE2' ' A' ' 292' ' ' GLU . 67.9 mttm -62.77 -41.92 99.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.037 0.446 . . . . 0.0 110.936 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.03 -46.01 65.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.917 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -123.91 100.39 6.73 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -95.86 113.7 25.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.7 tp -122.11 156.96 26.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.17 120.07 11.41 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.978 0.418 . . . . 0.0 110.057 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.86 128.12 42.75 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.449 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.448 ' O ' HG13 ' A' ' 307' ' ' ILE . 49.9 Cg_exo -55.6 129.92 37.69 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.654 2.236 . . . . 0.0 112.215 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.22 86.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.021 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.79 -45.46 82.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.011 0.434 . . . . 0.0 111.026 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.36 -41.88 93.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.988 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.505 ' O ' HG13 ' A' ' 311' ' ' ILE . 73.4 mt -61.54 -49.85 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.472 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.09 -42.73 99.51 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 30.1 m -62.23 -45.52 92.98 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.5 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.466 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 65.6 mm-40 -71.01 -35.0 71.88 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 307' ' ' ILE . 94.7 mt -61.94 -43.16 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.629 0.252 . . . . 0.0 111.117 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.541 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.8 t70 -59.53 -44.26 93.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.55 -42.9 96.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.127 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 84.4 mt -62.09 -40.68 96.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.541 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.8 mtm180 -61.27 -42.43 98.62 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -64.19 -38.64 91.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.916 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -62.84 -42.72 99.85 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.159 0.505 . . . . 0.0 110.116 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.1 80.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.201 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -64.33 -37.05 86.14 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.225 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -63.62 -37.92 89.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.306 0.574 . . . . 0.0 109.646 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.94 -7.81 57.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.864 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -97.4 -0.9 45.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.246 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 134.06 7.61 2.25 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.168 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.18 38.84 8.22 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.094 -1.05 . . . . 0.0 111.479 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.433 ' HB3' ' HB1' ' A' ' 319' ' ' ALA . 25.7 t-20 -84.6 135.23 34.28 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.874 0.369 . . . . 0.0 111.137 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.79 162.92 33.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.401 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.1 OUTLIER 71.9 -54.21 0.68 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.102 0.561 . . . . 0.0 111.178 -178.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.08 -17.78 63.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.84 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.58 -22.49 45.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.78 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.08 -34.6 76.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.546 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 331' ' ' GLU . 36.3 tt0 -85.88 10.19 14.61 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.672 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 77.9 mt -82.68 149.37 60.25 Favored Pre-proline 0 C--O 1.239 0.52 0 O-C-N 122.008 -0.433 . . . . 0.0 110.737 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.406 ' O ' ' HD1' ' A' ' 337' ' ' PHE . 40.4 Cg_exo -56.5 124.39 16.14 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.114 2.543 . . . . 0.0 113.111 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -70.43 -43.3 70.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.536 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -58.54 -40.59 83.41 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -170.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.504 HD12 ' OE2' ' A' ' 224' ' ' GLU . 60.7 mt -86.41 -0.32 55.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 333' ' ' PRO . 47.5 m-85 -107.45 -29.33 9.29 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 172.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -65.48 -32.49 74.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.252 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.87 -50.27 74.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -77.92 -21.86 50.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.55 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -62.45 -40.93 98.2 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.016 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.464 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.2 tttt -59.79 -45.02 93.6 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.201 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.3 mmt85 -61.68 -46.33 90.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.737 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -66.74 -37.51 84.79 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.466 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 341' ' ' ALA . 73.2 t -64.8 -43.64 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.607 0.241 . . . . 0.0 110.406 176.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 342' ' ' LYS . 76.1 t -61.48 -41.77 91.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 343' ' ' ARG . 69.1 t -58.64 -44.77 90.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.3 -40.31 98.84 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.181 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.46 -44.38 94.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 110.934 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.2 mt -63.44 -48.5 77.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.883 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.86 -41.07 87.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.488 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.73 99.81 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.254 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.38 -35.83 78.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.643 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 350' ' ' LEU . 70.4 t -61.05 -44.9 99.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.21 -45.44 98.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -67.46 -51.72 48.02 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.0 m -65.33 -46.86 78.6 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -83.68 -5.97 59.32 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.351 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 61.23 55.52 2.95 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.095 0.474 . . . . 0.0 111.622 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 97.1 mt -88.85 160.19 17.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.459 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -140.88 155.61 46.28 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.901 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -75.42 104.98 6.22 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 367' ' ' VAL . 29.6 t70 -79.08 119.35 22.08 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.979 0.418 . . . . 0.0 111.341 -175.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 44.7 mm-40 -61.87 -42.74 99.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.347 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -64.89 -43.34 93.2 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.79 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 40.1 ttt85 -60.64 -42.93 97.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.238 0.542 . . . . 0.0 109.649 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.456 HG21 ' HG2' ' A' ' 399' ' ' ARG . 87.2 t -65.96 -36.89 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.371 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.0 mmmt -56.31 -43.74 79.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.719 0.295 . . . . 0.0 110.58 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.01 95.54 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.739 -0.744 . . . . 0.0 111.935 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.2 -42.51 96.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.062 0.458 . . . . 0.0 110.2 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.96 -43.5 97.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.526 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.83 -41.4 99.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.581 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -66.46 -37.86 86.06 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.589 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 59.5 ttm -64.31 -43.36 94.95 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 121.027 0.442 . . . . 0.0 110.332 176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.2 -29.53 70.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.392 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 44.7 m -73.0 -7.78 52.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.5 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.86 -2.37 58.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.391 0.615 . . . . 0.0 110.036 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -117.12 171.63 7.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.611 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -64.02 -49.09 73.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.992 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 32.9 t70 -118.79 107.63 42.14 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.779 0.323 . . . . 0.0 110.148 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.02 -34.86 99.23 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.937 2.424 . . . . 0.0 112.959 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -63.76 -45.21 90.86 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 10.7 pt-20 -63.45 -38.97 93.17 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.802 0.334 . . . . 0.0 110.654 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.77 -43.21 86.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.16 -43.78 99.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 120.826 0.346 . . . . 0.0 110.534 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.435 ' HB3' ' HE3' ' A' ' 390' ' ' LYS . 45.6 mt-10 -66.56 -38.97 88.22 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.735 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -58.07 -46.64 85.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.885 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -33.46 71.19 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 35.3 p -88.58 -5.04 58.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 386' ' ' GLU . 98.4 mttt -98.32 -0.66 43.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.941 0.401 . . . . 0.0 110.952 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -123.53 114.84 20.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.778 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -63.7 -39.77 95.13 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -58.76 -46.78 86.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.85 0.357 . . . . 0.0 110.52 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.66 -40.77 97.67 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.091 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 92.6 mtp -62.6 -44.66 95.75 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.01 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -64.57 -45.87 85.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.9 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -64.36 -44.17 92.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.537 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 46.2 tpp -63.51 -42.57 98.48 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.923 0.392 . . . . 0.0 111.323 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.456 ' HG2' HG21 ' A' ' 367' ' ' VAL . 77.2 mtm180 -65.75 -34.37 78.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.127 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -63.38 -43.02 98.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.707 0.289 . . . . 0.0 110.407 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.77 -46.1 95.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.912 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.84 88.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.38 -38.33 90.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.823 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.4 -43.99 96.14 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.341 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -66.34 -37.46 85.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.959 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -59.79 -42.66 93.89 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.86 0.362 . . . . 0.0 110.48 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.45 90.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.064 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.99 -45.94 95.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -67.79 -30.35 69.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.558 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.16 99.35 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.69 -43.76 93.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.412 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.58 -38.67 88.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.237 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.25 -29.88 70.11 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.025 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.23 -22.31 18.5 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.889 0.376 . . . . 0.0 111.419 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.16 174.56 7.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.191 0.52 . . . . 0.0 111.327 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -84.28 133.27 34.56 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 66.8 t -118.14 128.88 75.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 15.3 t -119.3 144.25 46.91 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 120.989 0.423 . . . . 0.0 110.699 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -101.53 130.48 47.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.18 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -151.61 141.53 22.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.334 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -97.09 139.36 33.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.066 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.9 t -146.72 179.24 7.71 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.8 p -80.99 156.49 25.89 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.031 0.443 . . . . 0.0 111.372 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.3 -40.07 96.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.89 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -57.23 -34.77 68.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.177 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.04 -31.86 72.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.865 0.364 . . . . 0.0 111.237 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.6 mp -83.98 -7.81 59.31 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.026 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 1.7 mmt -79.28 -6.86 57.64 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.082 0.467 . . . . 0.0 110.497 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -76.15 81.4 2.96 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.453 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -106.46 13.63 28.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.824 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -66.05 -37.49 85.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.944 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.308 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.102 179.7 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.486 0.184 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -70.11 116.04 10.01 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.647 0.737 . . . . 0.0 112.172 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.17 172.47 14.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.177 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.441 ' O ' ' HB ' ' B' ' 5' ' ' VAL . 9.4 p -72.7 -175.34 1.65 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.287 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' B' ' 4' ' ' SER . 0.5 OUTLIER 89.32 141.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.908 0.883 . . . . 0.0 111.705 179.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -139.5 156.06 47.16 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 90.8 m -89.54 129.91 35.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.872 0.368 . . . . 0.0 111.766 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 75.1 m -89.11 -70.19 0.67 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -166.54 124.25 1.37 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.134 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.13 -110.6 3.47 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.648 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 85.9 mt -90.29 -6.82 54.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.519 0.199 . . . . 0.0 111.203 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.548 ' O ' ' HD3' ' B' ' 13' ' ' ARG . . . -84.27 137.54 16.02 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 114.41 0.524 . . . . 0.0 114.41 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.548 ' HD3' ' O ' ' B' ' 12' ' ' GLY . 0.0 OUTLIER -133.44 146.69 51.4 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.035 0.934 . . . . 0.0 110.619 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.42 HH21 ' HD2' ' B' ' 14' ' ' ARG . 30.5 ttm180 -108.68 138.3 45.23 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.815 0.446 . . . . 0.0 110.051 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.81 -85.91 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.684 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.4 p 27.84 94.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.2 tp -123.07 140.11 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.913 0.387 . . . . 0.0 111.857 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -73.01 138.15 45.82 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.746 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.476 HD13 HG12 ' B' ' 24' ' ' ILE . 0.9 OUTLIER -126.17 152.42 33.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -175.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.681 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -87.3 151.64 22.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.277 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.39 84.33 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -77.37 -3.14 38.63 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.187 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 15.4 t -107.56 -28.4 9.79 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.628 0.251 . . . . 0.0 111.075 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.681 HG13 ' O ' ' B' ' 20' ' ' ALA . 71.3 mt -60.25 -49.6 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 121.027 0.441 . . . . 0.0 112.097 -175.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.474 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 69.2 mm-40 -101.32 8.61 42.28 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -175.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 40.0 m -103.74 -70.49 0.76 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.137 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.09 -47.48 79.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.824 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.455 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 86.0 t -62.11 -45.22 99.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.722 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 19.7 ttmm -63.33 -45.17 92.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 60.0 m -62.8 -41.52 99.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.367 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.572 ' O ' HG23 ' B' ' 35' ' ' VAL . 10.4 tp10 -66.44 -39.05 88.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.72 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 89.3 mt -61.81 -43.02 99.67 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -66.0 -38.22 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.535 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.07 -38.65 91.84 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 31' ' ' GLU . 89.3 t -63.17 -43.04 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.545 177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.32 97.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.432 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.02 -30.06 70.04 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.068 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' B' ' 35' ' ' VAL . 23.1 ttmm -59.51 -44.75 93.04 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.202 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.16 -2.97 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 63.52 31.39 14.83 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.329 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.82 10.8 8.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.08 -25.62 67.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.13 -4.37 78.21 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.808 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -86.67 -5.4 59.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.459 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 64.0 ttt-85 -93.21 108.26 19.92 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.841 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.18 -38.12 87.88 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.293 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.42 33.16 20.56 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.247 -0.978 . . . . 0.0 114.205 175.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -63.53 -40.98 98.44 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 t -117.18 112.47 39.76 Favored Pre-proline 0 N--CA 1.448 -0.557 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.44 ' HG2' HD12 ' B' ' 53' ' ' ILE . 42.4 Cg_exo -57.53 142.77 95.53 Favored 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.687 2.258 . . . . 0.0 112.255 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.493 ' HA ' HG22 ' B' ' 54' ' ' VAL . 18.7 ttt -67.01 -29.38 69.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.55 -172.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . 0.422 ' OD1' HG13 ' B' ' 53' ' ' ILE . 29.1 p-10 -71.85 -16.43 62.15 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.094 0.473 . . . . 0.0 110.361 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.617 HD13 ' NH2' ' A' ' 193' ' ' ARG . 78.0 mt -99.76 -36.07 5.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.789 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' B' ' 51' ' ' MET . 23.6 m -60.58 -40.71 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.785 0.326 . . . . 0.0 111.286 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.14 -30.0 70.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.354 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -91.79 -32.77 15.25 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.377 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.44 HH12 HD13 ' A' ' 187' ' ' LEU . 15.1 tpp180 -64.61 -41.61 96.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.869 0.366 . . . . 0.0 110.436 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -110.48 23.57 14.07 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 121.27 0.557 . . . . 0.0 110.509 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.94 147.5 50.34 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.781 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 71.24 -41.06 0.49 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.392 0.677 . . . . 0.0 112.296 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.3 t -58.28 -53.44 58.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.758 0.423 . . . . 0.0 111.865 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.501 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -114.76 10.61 7.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.296 0.57 . . . . 0.0 110.827 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -60.14 -38.95 84.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.647 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -59.44 -45.51 91.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.688 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.5 -33.2 73.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.754 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 62' ' ' VAL . 77.3 t -60.97 -35.19 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.47 -39.43 90.88 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.31 -39.81 98.22 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.699 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.34 -46.37 88.99 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.966 0.413 . . . . 0.0 110.882 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.57 -42.08 98.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.453 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 55.0 ttp -60.78 -46.5 90.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.216 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 52.0 m -64.21 -52.28 59.62 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.463 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -70.11 -39.37 75.52 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -64.98 -40.53 95.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.642 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -61.09 -47.85 84.38 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.798 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.419 ' O ' HG13 ' B' ' 79' ' ' ILE . 14.8 tt -68.13 -39.19 80.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.869 0.366 . . . . 0.0 111.035 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.12 -43.91 97.79 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.565 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.62 89.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.234 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.419 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.6 pp -67.12 -35.39 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.44 -43.94 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.997 0.427 . . . . 0.0 110.987 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -82.58 -19.65 38.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.006 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -88.13 -8.32 55.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.357 0.599 . . . . 0.0 109.54 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 69.56 34.4 2.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.172 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 73.6 mt -99.17 116.72 42.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -103.78 108.53 59.94 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.847 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.49 141.84 57.17 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.383 2.056 . . . . 0.0 111.394 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.45 104.45 15.39 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.058 0.456 . . . . 0.0 110.589 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.33 -109.2 3.36 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.188 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.09 124.93 13.3 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-O 120.51 0.195 . . . . 0.0 110.616 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.84 157.55 54.86 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.371 2.047 . . . . 0.0 111.023 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 20.2 m -98.16 115.67 28.78 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.029 0.442 . . . . 0.0 110.558 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -96.16 98.19 10.14 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.02 110.69 58.66 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -91.07 165.44 3.77 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.163 2.575 . . . . 0.0 111.112 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.28 179.48 25.83 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.517 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.13 114.02 10.82 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -81.69 124.81 29.92 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.202 0.525 . . . . 0.0 111.54 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.65 117.51 34.24 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.43 123.36 18.54 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.657 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.56 -17.82 56.09 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.498 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -106.32 -170.51 1.74 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.615 0.245 . . . . 0.0 111.229 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -81.12 165.45 21.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -128.83 135.99 49.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.872 0.368 . . . . 0.0 110.877 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 45.9 m -119.84 136.49 54.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.687 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -141.66 167.03 23.13 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.925 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -78.82 -84.95 0.08 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 99.1 t 56.7 93.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-O 121.171 0.51 . . . . 0.0 109.975 -172.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.48 135.44 38.36 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -173.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -158.65 170.45 22.14 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.971 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -50.77 145.88 6.49 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.56 165.42 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.521 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -121.67 106.6 37.11 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 120.894 0.378 . . . . 0.0 110.197 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -91.96 161.27 3.3 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.242 2.628 . . . . 0.0 113.805 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -131.56 134.39 46.02 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.996 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.87 136.3 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.657 0.265 . . . . 0.0 111.306 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.05 141.51 32.78 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.093 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 97.6 mt -119.1 141.86 48.4 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -129.84 145.38 51.59 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.96 18.62 78.56 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.097 -0.502 . . . . 0.0 114.127 174.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -63.51 -40.52 97.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.052 0.453 . . . . 0.0 111.339 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.97 -19.04 65.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.856 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.43 8.17 29.17 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.503 ' CD1' HD21 ' B' ' 294' ' ' LEU . 77.6 mt -86.26 127.66 40.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.064 0.459 . . . . 0.0 110.949 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -112.37 125.04 53.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.73 132.41 68.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.987 0.423 . . . . 0.0 111.635 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.28 137.14 32.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.389 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -126.37 105.76 24.43 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.67 119.41 6.42 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.088 1.859 . . . . 0.0 111.832 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.438 HG13 ' HG2' ' B' ' 419' ' ' GLU . 48.6 mm -104.63 108.24 24.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.42 159.28 40.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.51 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.24 161.07 37.2 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.194 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 46.1 t -69.68 121.25 18.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.766 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.4 p -105.92 -180.0 4.1 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.773 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.6 -34.82 77.77 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.303 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.61 94.87 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.559 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -64.95 -40.9 95.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.655 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.02 -47.43 92.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.798 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -61.81 -44.39 96.95 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.32 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.04 -41.33 99.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.18 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.617 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.8 tpt -60.98 -46.85 89.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.782 0.325 . . . . 0.0 110.838 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.28 -41.94 96.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.39 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.92 -43.13 99.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.828 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 18.5 m -63.24 -39.86 95.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.66 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.5 mt -60.22 -41.64 93.49 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.779 -176.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -72.23 -16.69 61.94 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.107 0.479 . . . . 0.0 111.11 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.31 8.11 43.04 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.568 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -117.79 24.79 10.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.74 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -138.17 106.51 5.8 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -146.25 147.43 31.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.594 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.574 HG22 ' H ' ' B' ' 151' ' ' TRP . 0.3 OUTLIER -111.85 -163.16 0.83 Allowed 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.104 -176.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . 0.574 ' H ' HG22 ' B' ' 150' ' ' THR . 48.4 p-90 -123.2 146.64 47.64 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.058 0.456 . . . . 0.0 112.024 -176.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -168.03 -61.81 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.01 -142.27 0.22 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.773 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.489 ' HE3' ' HG2' ' B' ' 242' ' ' GLU . 9.1 ptpp? -134.5 143.06 47.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.282 0.947 . . . . 0.0 112.874 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -164.56 -152.13 0.17 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' B' ' 206' ' ' LYS . . . -99.93 63.32 0.66 Allowed Glycine 0 C--O 1.235 0.193 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.49 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -140.47 118.9 12.18 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.74 129.8 64.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -86.45 157.94 19.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.085 0.469 . . . . 0.0 112.085 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.99 26.27 0.26 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.84 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -167.55 20.17 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.422 ' CG ' ' HE ' ' B' ' 243' ' ' ARG . 45.2 t0 -64.09 -45.43 88.71 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.362 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' B' ' 187' ' ' LEU . 53.4 ttp180 72.18 88.38 0.1 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.49 132.62 64.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.077 0.465 . . . . 0.0 112.016 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 24.6 m -69.0 104.19 2.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.844 173.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 88.2 mt -116.77 128.45 74.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.906 0.384 . . . . 0.0 111.934 -175.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -102.16 110.09 21.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.47 0.652 . . . . 0.0 109.381 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -137.01 154.01 50.51 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.3 m -124.04 130.18 52.14 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.023 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -70.05 131.44 22.96 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.99 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -145.6 129.59 17.41 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 43.3 t -77.91 -76.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -113.93 -70.5 0.8 Allowed 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -135.77 23.31 3.4 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -136.09 140.55 43.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.128 -0.536 . . . . 0.0 109.647 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -91.83 146.25 23.91 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -106.86 174.54 5.84 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.092 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.57 -37.39 78.34 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.6 -174.68 36.95 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.786 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.84 22.91 54.49 Favored Glycine 0 C--N 1.32 -0.352 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.281 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -103.1 101.25 11.21 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -123.64 140.26 53.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.114 0.483 . . . . 0.0 111.946 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 34.6 m -141.14 121.16 13.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.539 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.81 33.17 22.9 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.55 0.531 . . . . 0.0 111.15 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -87.91 123.22 32.43 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.753 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 13.8 m -92.86 113.31 27.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.566 0.698 . . . . 0.0 110.716 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.425 HD13 HH12 ' A' ' 57' ' ' ARG . 52.1 tp -102.53 116.22 32.17 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.322 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . 0.713 ' HB3' ' NH1' ' B' ' 193' ' ' ARG . . . -99.9 105.37 17.08 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 41.9 mtm -76.17 168.88 19.25 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.129 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.9 -16.41 61.01 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.876 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -98.84 -3.46 35.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.599 -0.3 . . . . 0.0 111.455 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.16 44.6 59.76 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.176 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.713 ' NH1' ' HB3' ' B' ' 188' ' ' ALA . 47.8 mtm180 -98.32 4.63 48.68 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 121.417 0.627 . . . . 0.0 111.672 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.506 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.0 OUTLIER -128.04 159.97 33.4 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 172.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.487 HG13 ' CE2' ' B' ' 217' ' ' PHE . 43.3 mm -54.42 133.56 62.42 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -48.09 126.22 13.01 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.359 2.039 . . . . 0.0 112.326 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.46 -34.15 6.01 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.261 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -64.32 -51.06 65.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.82 -16.65 60.69 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 121.015 0.436 . . . . 0.0 112.107 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -87.69 -21.59 25.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.173 0.511 . . . . 0.0 110.034 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.45 -10.82 85.52 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.63 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 44.0 mm -64.81 -42.85 96.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -55.32 124.81 18.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.762 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.5 1.59 40.56 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.793 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -111.13 148.6 32.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.313 0.557 . . . . 0.0 111.586 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.472 ' HD3' ' HA3' ' B' ' 156' ' ' GLY . 75.6 mmtt -86.83 163.42 17.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.412 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.56 112.21 3.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.344 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.24 39.4 11.32 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.863 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -113.92 126.4 55.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.999 0.428 . . . . 0.0 111.035 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -92.13 136.51 33.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.619 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . 0.48 ' O ' ' HB ' ' B' ' 212' ' ' THR . 65.0 t80 -155.64 -28.26 0.1 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' B' ' 211' ' ' PHE . 91.3 m 75.92 143.83 0.08 Allowed 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 120.665 0.269 . . . . 0.0 110.749 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -138.17 128.07 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.075 0.464 . . . . 0.0 111.233 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -82.72 111.92 19.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.166 0.507 . . . . 0.0 111.522 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 73.3 t -118.19 130.92 72.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 9.9 m -94.24 -29.75 14.92 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -174.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' B' ' 216' ' ' THR . 69.1 m-85 74.3 141.35 0.08 OUTLIER Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 122.702 0.401 . . . . 0.0 111.085 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.89 151.89 51.39 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.303 2.002 . . . . 0.0 111.867 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -65.44 -34.62 78.72 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.73 26.87 1.05 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.28 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 7.2 t80 -70.73 133.95 47.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -67.71 -17.67 64.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.439 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -91.28 104.69 17.2 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 33.6 tt0 -57.79 -36.1 71.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.33 -175.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.431 ' O ' ' HD3' ' B' ' 229' ' ' LYS . 28.6 p-10 -72.92 -13.26 61.22 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 95.4 mt -120.13 -1.54 10.32 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.1 ptmt -69.95 114.14 7.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.301 0.572 . . . . 0.0 111.592 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 69.26 21.81 75.94 Favored Glycine 0 C--O 1.237 0.292 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.214 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' B' ' 225' ' ' ASN . 9.7 mtpm? -122.28 109.91 15.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.87 145.54 55.36 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -128.44 146.23 50.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.772 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -100.97 -29.16 12.35 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -173.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 57.32 107.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -67.2 -40.23 86.44 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.832 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 48.8 mm 69.3 133.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.352 0.661 . . . . 0.0 111.338 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . 0.573 ' ND2' ' HG3' ' B' ' 238' ' ' LYS . 9.7 t30 -109.01 -65.44 1.14 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.843 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.8 mt 61.04 95.99 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . 0.573 ' HG3' ' ND2' ' B' ' 236' ' ' ASN . 64.1 mttp -102.13 -31.35 10.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.799 175.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm -102.55 -87.13 0.42 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 85.4 t 72.36 121.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 O-C-N 123.532 0.52 . . . . 0.0 109.971 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.15 179.79 3.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.489 ' HG2' ' HE3' ' B' ' 154' ' ' LYS . 36.4 mt-10 -112.38 114.79 27.71 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -167.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 7.4 ptp180 -149.64 141.82 24.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.134 167.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.501 ' H ' ' HA ' ' B' ' 151' ' ' TRP . 1.0 OUTLIER -172.82 162.22 4.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 3.9 tt 67.57 106.45 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.229 0.611 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -85.63 118.5 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.592 2.195 . . . . 0.0 112.802 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -145.41 179.03 7.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.075 0.464 . . . . 0.0 110.733 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . 0.439 ' N ' HD12 ' B' ' 248' ' ' LEU . 4.8 mp -93.55 74.36 4.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.38 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . 0.441 ' OG1' HG21 ' B' ' 150' ' ' THR . 11.6 m -85.51 -72.71 0.47 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.815 0.34 . . . . 0.0 111.258 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -154.69 -34.91 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.421 . . . . 0.0 111.12 -177.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -62.3 -35.32 78.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.672 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -64.84 -28.98 69.92 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.036 0.935 . . . . 0.0 113.505 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 43.1 pt -99.41 -4.52 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -160.23 -11.9 0.05 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 119.055 -1.058 . . . . 0.0 113.621 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -102.86 134.6 46.0 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.876 0.37 . . . . 0.0 111.255 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -172.67 36.91 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.28 20.67 69.05 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.7 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.6 161.32 35.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -52.02 -59.17 4.66 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 122.894 0.477 . . . . 0.0 109.832 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -173.78 162.46 4.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.824 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -173.31 178.42 45.27 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.583 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 93.1 p -102.56 -171.25 1.93 Allowed 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 122.263 0.225 . . . . 0.0 110.508 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.8 -57.18 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.962 0.411 . . . . 0.0 112.023 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.91 -35.74 23.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.0 111.049 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.28 -39.14 97.51 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.391 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.402 ' O ' HG23 ' B' ' 270' ' ' VAL . 54.0 tp -62.86 -45.43 92.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.569 0.223 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -64.29 -42.27 96.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.587 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.518 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.34 -45.15 89.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.314 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -67.12 -39.1 86.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.452 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 266' ' ' LEU . 66.3 t -64.7 -44.13 96.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.606 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -60.09 -47.56 85.39 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 17.7 ptmt -64.55 -45.41 87.21 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.909 0.385 . . . . 0.0 111.077 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -65.06 -36.25 83.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 89.5 mmm -61.82 -42.67 99.31 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.031 0.443 . . . . 0.0 109.98 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -70.15 -31.43 68.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.798 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . 0.519 ' O ' ' HB3' ' B' ' 279' ' ' LYS . 57.6 ttp180 -64.73 -42.17 95.41 Favored 'General case' 0 CA--C 1.527 0.074 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -66.85 -34.03 76.9 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.69 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.53 -38.01 85.85 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.719 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' B' ' 276' ' ' ARG . 55.4 tttm -55.84 -47.16 77.74 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.303 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 20.4 m -63.47 -42.28 98.6 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.907 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.02 -47.45 86.39 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.062 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.18 -43.62 97.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.234 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -44.62 96.99 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.83 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.17 -41.37 97.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.035 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' B' ' 285' ' ' ARG . 4.2 tpm_? -60.42 -43.86 96.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.886 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 98.5 t -69.31 -44.12 80.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.135 0.493 . . . . 0.0 111.063 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.33 -48.58 79.19 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.938 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.6 p -65.15 -41.31 94.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.72 -40.89 92.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.642 0.258 . . . . 0.0 111.274 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.06 95.33 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.091 0.472 . . . . 0.0 110.653 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 36.7 mm -65.04 -43.49 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . 0.46 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 20.5 tp10 -61.87 -42.55 99.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.682 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.82 98.31 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.51 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.503 HD21 ' CD1' ' B' ' 123' ' ' ILE . 24.8 mt -63.73 -42.71 97.85 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.26 -42.16 93.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.731 0.3 . . . . 0.0 111.339 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.46 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 66.4 mttm -61.95 -40.47 95.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.698 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -77.3 -47.46 19.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.904 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -114.89 96.02 5.51 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -99.94 105.54 17.25 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -116.71 159.4 16.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.604 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.6 130.11 43.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 42.6 t -105.48 127.53 28.38 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.029 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.37 128.6 30.76 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.461 2.107 . . . . 0.0 111.882 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.06 -35.61 80.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.754 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.66 -48.05 72.82 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.338 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 66.3 mt -67.03 -40.52 87.23 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.002 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . 0.487 ' O ' HG13 ' B' ' 311' ' ' ILE . 75.7 mt -61.04 -49.82 83.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.391 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.13 -43.27 99.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.566 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 38.9 m -63.11 -45.25 92.9 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.643 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . 0.419 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 70.2 mm-40 -71.22 -34.44 70.81 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.51 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 89.9 mt -61.74 -43.05 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.027 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.586 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 31.0 t70 -59.32 -44.92 92.54 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.961 0.41 . . . . 0.0 110.805 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.39 -43.93 98.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.163 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 79.3 mt -62.92 -40.38 97.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.268 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.586 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 83.1 mtm180 -61.33 -42.56 98.87 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -65.08 -37.91 89.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.703 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -62.87 -42.68 99.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.206 0.527 . . . . 0.0 109.88 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.59 -37.47 79.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.523 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -63.9 -37.35 87.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.929 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -63.43 -37.08 85.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.364 0.602 . . . . 0.0 109.482 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -79.51 -3.36 46.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.898 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -101.68 4.22 40.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.953 0.406 . . . . 0.0 111.13 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 128.01 7.1 4.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.936 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 87.96 46.01 4.92 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.396 -0.906 . . . . 0.0 111.776 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . 0.474 ' HB3' ' HB1' ' B' ' 319' ' ' ALA . 26.2 t-20 -91.25 135.14 34.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 -177.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.87 160.99 38.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.44 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.1 OUTLIER 72.66 -53.57 0.7 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.05 0.54 . . . . 0.0 111.214 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.66 -16.83 63.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.849 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.86 -22.91 50.47 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.81 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.54 -35.78 78.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.912 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -79.51 -5.25 54.43 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.214 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.01 152.6 96.74 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.009 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . 0.479 ' O ' ' HD1' ' B' ' 337' ' ' PHE . 32.9 Cg_exo -59.86 140.53 93.54 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.817 2.344 . . . . 0.0 112.854 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -86.08 -43.78 12.81 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.898 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.6 pm0 -59.18 -39.38 82.37 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 62.1 mt -86.21 0.31 54.0 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.826 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . 0.479 ' HD1' ' O ' ' B' ' 333' ' ' PRO . 50.8 m-85 -107.75 -29.55 9.05 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -65.31 -31.7 72.97 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.964 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -58.92 -49.08 79.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.044 0.449 . . . . 0.0 110.795 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -83.5 -21.03 32.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.012 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.445 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -62.85 -40.48 97.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . 0.43 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.7 tttt -59.35 -44.37 92.67 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.194 177.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . 0.562 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.5 mmt85 -61.35 -45.22 95.32 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.772 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -67.22 -38.72 85.75 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.306 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 341' ' ' ALA . 74.2 t -64.53 -43.58 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.36 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 342' ' ' LYS . 57.7 t -61.32 -42.49 93.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.44 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 343' ' ' ARG . 79.4 t -59.87 -44.86 95.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.51 -41.69 99.61 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.928 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.96 -44.54 95.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.748 0.308 . . . . 0.0 110.982 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.457 ' O ' HG23 ' B' ' 354' ' ' VAL . 92.7 mt -63.53 -47.2 82.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.997 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.54 -41.29 88.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.487 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.21 99.73 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.195 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.22 -35.75 78.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.061 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 350' ' ' LEU . 76.1 t -60.61 -45.08 97.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 77.7 mt -63.4 -46.2 95.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.68 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -65.1 -54.26 32.7 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 47.7 m -65.21 -44.94 86.7 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -83.44 -8.47 59.37 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.265 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 65.43 45.39 2.83 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.271 0.558 . . . . 0.0 111.267 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 97.6 mt -78.79 156.3 28.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.768 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 36.2 pttt -139.02 153.45 48.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.516 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -75.07 105.77 6.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -80.83 116.48 20.84 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.978 0.418 . . . . 0.0 111.464 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 60.3 mm-40 -58.75 -42.61 89.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.308 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -62.42 -44.49 96.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.678 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -61.35 -42.64 99.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.207 0.527 . . . . 0.0 109.792 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . 0.435 HG21 ' HG2' ' B' ' 399' ' ' ARG . 94.7 t -65.96 -36.23 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.316 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 27.5 mmmt -56.31 -42.68 78.01 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.803 0.335 . . . . 0.0 110.663 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.95 -38.48 96.66 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.086 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.88 -42.04 97.6 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.1 0.476 . . . . 0.0 110.221 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 65.3 mt -65.7 -43.62 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.148 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -61.67 -40.0 93.39 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.693 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -67.28 -38.57 85.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.001 0.429 . . . . 0.0 110.412 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 58.1 ttm -64.28 -41.84 96.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.132 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . 0.433 ' HA ' HG11 ' B' ' 384' ' ' VAL . . . -64.39 -32.62 74.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.29 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 49.6 m -71.23 -8.02 50.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.454 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.85 -1.89 57.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.033 0.444 . . . . 0.0 110.507 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -117.81 173.23 6.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.123 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -65.87 -49.83 66.68 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -116.18 107.76 47.04 Favored Pre-proline 0 CA--C 1.518 -0.251 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.39 -29.21 71.81 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.106 1.871 . . . . 0.0 113.26 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -64.55 -45.12 88.47 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.89 -36.23 82.82 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.771 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' B' ' 375' ' ' ALA . 57.9 t -65.11 -43.84 95.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.605 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -62.59 -43.89 98.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.983 0.421 . . . . 0.0 109.916 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -65.93 -38.13 87.86 Favored 'General case' 0 C--O 1.216 -0.673 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.928 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -58.34 -46.66 85.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.541 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.08 -42.1 76.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 41.9 p -78.27 -8.36 58.28 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.23 9.28 42.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.847 0.356 . . . . 0.0 111.259 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -134.66 111.27 9.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.061 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -61.66 -39.85 92.85 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -59.99 -45.07 93.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.771 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.89 -40.63 96.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.686 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 94.8 mtp -62.13 -45.41 93.59 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.265 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.39 -44.16 79.56 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.008 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -64.09 -44.91 90.9 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.27 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 40.7 tpp -63.03 -42.54 99.81 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.926 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.435 ' HG2' HG21 ' B' ' 367' ' ' VAL . 84.1 mtm180 -66.12 -34.8 78.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.616 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -63.02 -42.63 99.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.796 0.332 . . . . 0.0 110.383 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.75 -46.02 93.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.792 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.21 88.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.693 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.45 -38.95 93.13 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.529 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.12 -43.33 99.05 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.38 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -65.7 -37.52 86.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.645 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -59.54 -43.86 93.39 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.642 0.258 . . . . 0.0 110.437 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.91 89.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.25 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.21 -46.24 93.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.004 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.86 -30.8 70.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.745 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.48 -40.05 94.94 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.914 0.388 . . . . 0.0 110.139 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.15 -42.84 95.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.188 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.33 -39.79 91.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.305 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.47 68.42 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.549 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -96.89 -9.76 27.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.53 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.01 -170.25 1.79 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.182 0.515 . . . . 0.0 110.921 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -102.57 120.0 39.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.417 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 66.4 t -106.74 126.98 62.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 13.6 t -118.27 146.72 44.09 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.134 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . 0.438 ' HG2' HG13 ' B' ' 129' ' ' ILE . 41.4 mt-10 -107.84 123.22 48.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.298 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -144.64 147.76 33.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.751 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -97.11 147.72 23.77 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.451 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 15.3 t -155.46 178.48 10.19 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 22.1 p -82.21 153.38 25.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.988 0.423 . . . . 0.0 111.37 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -63.13 -34.07 76.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.835 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -60.6 -35.78 76.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.448 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.25 -32.0 73.45 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.944 0.402 . . . . 0.0 111.169 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.36 -7.95 59.49 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.86 0.362 . . . . 0.0 111.1 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.3 mmt -80.26 -6.9 58.65 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.05 0.452 . . . . 0.0 110.613 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -74.48 81.14 1.94 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.395 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -106.04 13.4 29.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.806 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 19.1 mp0 -65.82 -40.53 91.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.034 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.181 -0.914 . . . . 0.0 109.751 -179.828 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.576 0.227 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -86.6 130.27 34.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.9 0.381 . . . . 0.0 110.349 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.56 164.95 32.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.183 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.8 t -111.1 102.26 10.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.859 0.361 . . . . 0.0 110.255 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.29 139.49 26.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.916 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 45.7 mt-10 -124.84 177.18 6.15 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.839 0.352 . . . . 0.0 110.808 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 94.4 m -124.91 131.74 53.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.909 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 45.3 m -79.86 -70.38 0.52 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 177.83 139.01 0.08 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.517 0.727 . . . . 0.0 109.569 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.85 -121.19 25.05 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.242 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.579 HD23 HG13 ' A' ' 111' ' ' VAL . 81.0 mt -65.12 -39.74 93.51 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.9 0.48 . . . . 0.0 110.943 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.6 ' HA2' ' HG2' ' A' ' 108' ' ' GLU . . . -68.78 140.45 34.74 Favored Glycine 0 CA--C 1.507 -0.414 0 N-CA-C 115.857 1.103 . . . . 0.0 115.857 -173.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -129.69 -163.57 1.32 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -160.28 116.94 2.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 117.888 0.313 . . . . 0.0 110.647 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t -95.77 -90.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.194 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 m 51.1 83.79 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.224 0.535 . . . . 0.0 111.0 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 tp -113.58 145.15 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.6 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.0 p -99.64 129.78 45.81 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.557 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 24' ' ' ILE . 6.5 pt -131.46 157.49 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -79.87 154.55 28.3 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.851 0.461 . . . . 0.0 112.04 -177.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.76 -50.63 69.91 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.22 -37.33 86.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.487 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -63.24 -43.41 98.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.103 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 20' ' ' ALA . 67.0 mt -62.71 -52.34 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.232 0.539 . . . . 0.0 111.742 -178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.04 -38.38 72.57 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.569 -0.742 . . . . 0.0 112.453 -173.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -79.23 -59.29 2.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.71 -48.12 70.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -173.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.5 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 94.4 t -63.98 -43.89 97.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.48 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -61.55 -45.28 94.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.321 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.7 m -63.89 -41.64 97.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.726 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 35' ' ' VAL . 34.8 tp10 -66.55 -36.11 81.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.794 0.331 . . . . 0.0 111.102 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 91.9 mt -61.54 -42.31 98.64 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.63 -37.81 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.025 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -63.11 -41.42 99.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.817 0.342 . . . . 0.0 110.769 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 31' ' ' GLU . 91.1 t -63.74 -43.99 98.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.426 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.55 93.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.885 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.74 -33.01 74.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.231 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -59.0 -45.7 90.0 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 110.38 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.3 t -87.74 -2.68 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.265 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 64.1 27.52 14.11 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.131 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.416 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.8 pp -105.38 8.67 9.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.002 0.43 . . . . 0.0 111.535 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.54 -34.08 77.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.322 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.86 -5.16 56.88 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.435 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -84.87 -10.26 57.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.907 0.353 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -88.55 110.1 20.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.338 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.71 -41.38 97.53 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.1 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.07 42.56 76.45 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 115.898 1.119 . . . . 0.0 115.898 172.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -61.81 -43.72 98.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.274 1.037 . . . . 0.0 108.717 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.476 HG12 ' HB ' ' A' ' 54' ' ' VAL . 3.5 t -108.24 100.81 39.04 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 173.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.543 ' HG2' HD12 ' A' ' 53' ' ' ILE . 30.9 Cg_endo -63.76 158.09 48.47 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.657 2.238 . . . . 0.0 112.543 -176.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.488 ' HA ' HG12 ' A' ' 54' ' ' VAL . 82.9 mtp -61.82 -32.63 72.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.981 -174.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -69.16 -18.74 63.97 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.208 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.584 HD13 ' NH2' ' B' ' 193' ' ' ARG . 89.5 mt -105.66 -48.26 9.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 51' ' ' MET . 14.8 p -63.09 -35.15 70.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 120.988 0.423 . . . . 0.0 111.138 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.17 -35.61 81.36 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.297 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -91.54 -7.19 51.01 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.464 HH12 HD12 ' B' ' 187' ' ' LEU . 67.9 mtt180 -97.3 -30.33 13.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.177 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -111.74 12.72 21.06 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.678 0.751 . . . . 0.0 109.531 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 61' ' ' SER . . . -65.54 150.54 51.78 Favored Glycine 0 CA--C 1.493 -1.312 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.417 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.47 -41.5 0.5 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.356 0.663 . . . . 0.0 111.388 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 59' ' ' GLY . 39.1 t -60.01 -46.79 88.34 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.07 0.548 . . . . 0.0 111.151 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.4 p -124.52 14.2 4.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.456 0.646 . . . . 0.0 110.892 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -64.73 -19.11 65.59 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.985 0.422 . . . . 0.0 110.948 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -62.02 -52.32 64.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.623 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.87 -17.6 59.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.244 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 62' ' ' VAL . 77.7 t -64.64 -42.71 95.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 173.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.72 -39.61 94.61 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' ' 71' ' ' MET . . . -60.31 -41.14 98.28 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.563 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.731 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 30.8 t70 -63.37 -43.83 96.5 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.45 -43.43 98.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.91 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' A' ' 68' ' ' GLY . 24.8 ptt? -63.65 -40.74 97.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.6 m -64.17 -40.26 95.73 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.091 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 43.9 mtp85 -63.03 -43.57 98.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.165 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -64.26 -41.06 97.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.695 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.87 -48.57 79.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.914 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 79' ' ' ILE . 19.3 tt -67.81 -40.76 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.466 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -63.79 -43.01 97.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.128 0.489 . . . . 0.0 110.221 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.53 -43.86 95.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.093 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.6 pp -67.01 -40.92 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.974 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.73 -44.59 96.5 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.537 0.684 . . . . 0.0 109.765 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -64.71 -45.35 86.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.086 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -86.69 0.66 54.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.708 0.29 . . . . 0.0 111.416 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm 63.76 52.23 2.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.751 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.11 126.29 64.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.738 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -101.27 109.66 59.3 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.552 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.21 117.98 4.23 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.331 2.021 . . . . 0.0 112.034 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.08 93.68 8.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.135 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.14 -159.01 17.83 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.992 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.74 123.67 59.09 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.69 112.5 2.21 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.115 1.877 . . . . 0.0 110.704 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -96.26 114.88 26.61 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.237 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.579 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 91.3 m-85 -87.66 137.39 32.37 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.99 96.91 16.0 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-O 120.873 0.368 . . . . 0.0 111.792 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 93.1 Cg_endo -103.43 -172.12 0.07 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 123.473 2.782 . . . . 0.0 111.418 175.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -118.76 -172.0 15.26 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.65 145.96 25.37 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -95.17 126.76 40.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.15 0.5 . . . . 0.0 111.044 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.66 128.5 54.23 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.6 tp -67.03 114.49 5.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.892 0.377 . . . . 0.0 110.851 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.62 1.89 55.37 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.915 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -123.17 167.76 13.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.939 0.369 . . . . 0.0 110.99 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -71.34 141.87 50.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.743 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -95.7 137.31 34.95 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.7 m -119.62 131.19 55.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.826 0.346 . . . . 0.0 111.334 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -129.94 148.11 51.77 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.077 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 107' ' ' VAL . 50.1 m -102.46 -65.74 0.97 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 70.65 152.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 124.12 0.968 . . . . 0.0 111.047 -175.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.6 ' HG2' ' HA2' ' A' ' 12' ' ' GLY . 25.0 mt-10 -133.26 151.23 51.91 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 122.239 -0.288 . . . . 0.0 110.47 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -154.85 -73.03 0.12 Allowed 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -112.4 162.56 15.44 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -171.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.579 HG13 HD23 ' A' ' 11' ' ' LEU . 3.9 m -136.82 143.22 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.224 177.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -145.64 98.48 4.53 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 121.083 0.468 . . . . 0.0 110.546 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.88 149.56 20.48 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.086 2.524 . . . . 0.0 114.213 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -144.36 120.15 10.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.979 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 66.5 t -123.42 135.44 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.635 0.255 . . . . 0.0 111.12 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -121.81 142.04 50.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.58 153.14 38.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.59 0.234 . . . . 0.0 110.859 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -136.94 158.15 45.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.59 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.34 17.53 68.81 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.563 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.52 -39.84 94.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.185 0.517 . . . . 0.0 111.004 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.78 -17.2 64.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.681 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.18 12.2 29.63 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.869 -177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.1 mt -87.81 111.89 22.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.18 0.514 . . . . 0.0 110.32 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -105.73 120.89 42.85 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.7 t -118.3 133.01 66.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.629 0.252 . . . . 0.0 110.861 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -81.09 142.64 33.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.579 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.47 93.36 40.88 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.31 113.47 3.47 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.23 1.953 . . . . 0.0 112.123 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.29 115.53 43.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.037 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.07 158.8 43.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.675 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -133.99 157.4 46.17 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.598 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.3 t -70.82 127.14 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 71.7 p -110.84 176.64 4.95 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.738 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -62.68 -33.92 76.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.348 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.24 -40.99 96.1 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.886 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -64.5 -47.45 78.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.116 0.484 . . . . 0.0 110.385 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.08 -45.76 95.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.757 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.93 -46.28 91.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.479 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.22 97.82 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.817 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.563 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.8 tpt -61.71 -46.51 89.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.616 0.246 . . . . 0.0 110.841 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.76 -41.66 97.95 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.972 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -60.85 -45.34 94.92 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.369 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 m -63.51 -42.83 98.46 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.177 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.4 mt -60.71 -43.41 97.83 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -65.85 -33.36 75.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.926 0.393 . . . . 0.0 110.964 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.7 -13.81 60.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.914 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -90.02 -54.32 4.09 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -56.42 125.68 23.07 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.82 -167.41 2.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.525 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 151' ' ' TRP . 4.4 m -146.43 170.74 16.21 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.543 ' H ' HG22 ' A' ' 150' ' ' THR . 6.8 p-90 -120.38 145.91 46.7 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 151' ' ' TRP . 56.3 tttp 173.55 -59.61 0.01 OUTLIER 'General case' 0 C--N 1.351 0.639 0 O-C-N 123.862 0.726 . . . . 0.0 110.531 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -109.64 177.14 4.82 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 120.692 0.282 . . . . 0.0 111.498 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -84.15 147.11 27.5 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 69.48 116.88 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.978 0.911 . . . . 0.0 113.259 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -167.9 -98.74 0.12 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.436 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.35 145.79 29.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.3 126.48 67.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -95.54 -176.7 3.84 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.765 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.81 -66.89 0.48 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.492 ' OE2' ' HA ' ' A' ' 256' ' ' PHE . 13.9 pt-20 -78.52 7.35 6.85 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 188' ' ' ALA . 31.1 t70 -72.74 147.66 45.39 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.354 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 163' ' ' ARG . 16.8 ptp180 -101.87 116.7 33.28 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.59 127.14 74.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.586 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.1 m -74.93 109.54 8.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.6 124.37 66.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.061 0.457 . . . . 0.0 111.633 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.13 91.1 6.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -111.81 149.34 31.89 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.349 0.595 . . . . 0.0 111.885 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 40.5 m -128.15 129.75 47.02 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.121 177.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.85 134.65 12.65 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.827 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.3 m -142.84 144.35 32.49 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 120.83 0.347 . . . . 0.0 110.731 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.2 t -98.76 94.12 3.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 64.75 -70.39 0.08 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.331 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -137.06 5.82 3.65 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.77 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -130.24 139.15 50.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.585 0.692 . . . . 0.0 111.169 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.37 153.1 30.01 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.144 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -117.62 -177.31 3.21 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -53.78 -49.57 67.97 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.833 0.853 . . . . 0.0 113.194 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -103.0 -164.97 25.84 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.016 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . 82.25 28.22 41.38 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.178 -1.011 . . . . 0.0 112.861 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -114.03 106.73 14.75 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.67 145.9 50.37 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.836 0.35 . . . . 0.0 111.263 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 69.1 m -139.43 130.37 26.31 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.713 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 55.34 32.24 18.34 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.717 0.636 . . . . 0.0 110.513 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -93.2 133.49 36.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.965 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.6 m -94.04 119.48 41.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.52 0.676 . . . . 0.0 111.376 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.5 HD12 HH12 ' B' ' 57' ' ' ARG . 29.8 tp -111.37 123.58 50.5 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.106 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.73 ' HB3' ' NH1' ' A' ' 193' ' ' ARG . . . -110.91 131.52 54.97 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 173.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.449 ' SD ' ' HB ' ' A' ' 202' ' ' ILE . 70.8 mtm -98.43 177.08 5.46 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.218 0.532 . . . . 0.0 112.032 -171.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.53 23.32 67.92 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.498 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -131.85 -15.04 3.08 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 121.096 -0.241 . . . . 0.0 111.561 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.4 42.48 9.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.063 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.73 ' NH1' ' HB3' ' A' ' 188' ' ' ALA . 70.9 mtm180 -100.69 -0.38 37.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.316 0.579 . . . . 0.0 110.754 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.479 ' HE2' ' HA ' ' A' ' 194' ' ' MET . 0.7 OUTLIER -132.01 168.7 17.48 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 175.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 195' ' ' ILE . 3.4 mp -58.75 129.92 85.32 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.3 133.62 42.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.399 2.066 . . . . 0.0 111.929 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.84 -43.47 1.67 Allowed Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.089 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -63.54 -46.56 85.42 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.46 0.172 . . . . 0.0 111.053 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -86.68 14.17 7.47 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 121.184 0.516 . . . . 0.0 111.126 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.614 ' O ' ' HE2' ' A' ' 203' ' ' LYS . 17.3 t70 -113.62 -41.05 3.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.137 0.494 . . . . 0.0 109.866 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.9 -17.58 67.65 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.577 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.449 ' HB ' ' SD ' ' A' ' 189' ' ' MET . 69.9 mt -67.44 -26.31 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 122.632 -0.334 . . . . 0.0 111.316 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.614 ' HE2' ' O ' ' A' ' 200' ' ' ASP . 46.5 mtmt -57.9 132.74 54.28 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.971 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.6 -12.65 64.57 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.744 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -88.07 160.08 17.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.055 0.427 . . . . 0.0 111.679 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -88.02 176.18 7.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.943 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -91.31 53.29 2.28 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.429 0.633 . . . . 0.0 111.101 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 150.75 44.58 0.02 OUTLIER Glycine 0 C--N 1.307 -1.056 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -125.72 131.39 52.57 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.133 -0.534 . . . . 0.0 110.518 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -108.96 112.06 24.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.032 0.444 . . . . 0.0 109.931 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -132.39 -4.51 3.38 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.949 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 69.4 p 58.34 169.24 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.887 0.875 . . . . 0.0 112.473 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.5 tp -156.48 143.71 10.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.874 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.413 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 28.2 m-20 -95.28 114.89 26.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.373 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 67.9 t -117.99 129.9 73.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 8.7 m -91.31 -24.49 19.8 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -174.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 216' ' ' THR . 64.5 m-85 69.62 158.13 0.15 Allowed Pre-proline 0 N--CA 1.485 1.291 0 CA-C-O 120.849 0.357 . . . . 0.0 110.866 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -86.62 156.32 9.06 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 122.22 1.946 . . . . 0.0 112.089 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.52 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 67.5 mm-40 -66.16 -42.58 88.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.02 65.72 9.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.022 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -103.62 139.93 38.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.671 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -64.92 -18.91 65.63 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -103.74 110.43 22.52 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.563 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 43.2 tt0 -64.57 -35.14 80.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.019 0.437 . . . . 0.0 111.745 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -70.47 -15.7 62.84 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.554 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 95.1 mt -114.91 -3.95 12.65 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.5 ptmt -71.72 126.53 29.96 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.696 -176.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.08 29.2 74.23 Favored Glycine 0 C--O 1.24 0.483 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.459 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -125.62 135.48 52.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.907 0.354 . . . . 0.0 110.956 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -79.8 131.89 36.01 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.951 0.405 . . . . 0.0 110.347 178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -117.12 157.99 24.98 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.559 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.413 ' HE2' ' OD1' ' A' ' 214' ' ' ASP . 34.4 mmtp -116.0 106.89 14.29 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -83.0 111.71 19.1 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.3 0.571 . . . . 0.0 110.564 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -81.74 90.9 6.39 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.486 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm -88.04 116.93 30.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -104.8 -52.61 2.83 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.351 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 98.9 mt 65.78 132.75 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.632 0.773 . . . . 0.0 112.557 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -111.44 -66.33 1.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.195 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -100.16 -67.86 0.83 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.387 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 17.1 t 71.08 155.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.279 0.632 . . . . 0.0 111.225 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -80.52 -179.13 7.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.982 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.33 143.79 50.99 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.301 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -175.49 104.63 0.08 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.964 0.506 . . . . 0.0 112.322 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -171.83 163.55 6.34 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.431 HD12 ' HD2' ' A' ' 246' ' ' PRO . 35.9 tp 75.67 111.13 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 123.933 0.893 . . . . 0.0 110.721 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.541 ' HA ' HG21 ' A' ' 150' ' ' THR . 92.6 Cg_endo -81.76 140.07 11.42 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.495 2.13 . . . . 0.0 114.315 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -136.16 10.44 3.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.446 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 8.5 mp 70.39 109.55 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.467 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 251' ' ' GLU . 30.6 m -125.93 131.9 52.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.112 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -70.84 -18.77 62.71 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 249' ' ' THR . 47.8 mt-10 -61.89 -45.41 93.89 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -76.33 -26.14 55.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.766 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 250' ' ' ALA . 11.2 tp -73.36 -35.38 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.689 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 22.8 ptmt -92.12 -20.53 21.16 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -123.5 119.44 29.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.28 0.562 . . . . 0.0 111.953 -176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.492 ' HA ' ' OE2' ' A' ' 161' ' ' GLU . 56.1 t80 -156.43 83.54 0.98 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 79.03 -48.96 3.42 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -175.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.36 150.56 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 123.187 0.595 . . . . 0.0 109.877 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.27 -48.73 79.54 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.517 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.88 131.33 4.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.979 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -134.1 -142.86 4.78 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.748 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 21.6 p -142.38 -169.86 3.06 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 48.5 t -81.4 -66.14 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.374 0.607 . . . . 0.0 110.512 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.53 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.6 OUTLIER -70.91 -39.91 72.46 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.249 -178.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.28 -39.15 96.78 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.642 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.407 ' O ' HG23 ' A' ' 270' ' ' VAL . 52.2 tp -62.41 -43.92 97.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.616 0.246 . . . . 0.0 110.812 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -63.26 -42.46 99.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.171 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -67.89 -43.02 80.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.65 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -67.94 -39.06 83.52 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.991 0.424 . . . . 0.0 110.71 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 266' ' ' LEU . 75.1 t -64.79 -41.73 92.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -55.22 -52.12 64.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.749 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.1 ptmt -65.33 -42.03 93.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.712 0.291 . . . . 0.0 111.689 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.92 -39.78 94.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.701 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 90.7 mmm -63.52 -42.66 98.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.919 0.39 . . . . 0.0 110.59 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -69.45 -33.48 72.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.62 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -62.45 -43.39 98.94 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.319 0.58 . . . . 0.0 109.661 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -69.42 -33.57 73.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.053 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.64 -40.78 96.1 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.495 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -57.61 -44.4 85.46 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.058 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.2 m -62.69 -42.88 99.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.712 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.72 98.84 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.327 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.93 -43.74 97.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.983 0.421 . . . . 0.0 110.031 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -44.61 97.09 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.087 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -64.37 -41.92 96.45 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.449 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.442 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 2.0 tpm_? -60.92 -43.78 98.13 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.032 0.444 . . . . 0.0 110.447 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 94.0 t -68.44 -44.64 83.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.715 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.5 -46.32 88.99 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.122 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.7 p -61.87 -42.64 99.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -67.2 -41.11 86.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.997 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.81 86.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.812 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.463 ' O ' HG23 ' A' ' 295' ' ' VAL . 35.9 mm -64.09 -43.65 97.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.519 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.479 ' HG3' ' HE2' ' A' ' 296' ' ' LYS . 19.9 tp10 -61.23 -44.15 97.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.171 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.33 99.28 Favored Glycine 0 C--O 1.24 0.526 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.692 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.78 -42.13 95.31 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 291' ' ' ILE . 85.1 t -63.93 -44.36 97.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.914 -178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . 0.479 ' HE2' ' HG3' ' A' ' 292' ' ' GLU . 68.6 mttm -62.63 -37.64 87.1 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.78 0.324 . . . . 0.0 111.657 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.59 -30.03 27.3 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -128.84 92.21 3.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -91.28 98.46 11.73 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -103.25 149.11 7.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.391 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.04 135.37 57.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.907 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.64 120.54 44.81 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.068 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.99 131.52 44.07 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.592 2.195 . . . . 0.0 112.471 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.13 75.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.282 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.43 -29.18 63.94 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.681 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.592 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 90.4 mt -93.31 -31.76 14.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.826 0.346 . . . . 0.0 110.855 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 311' ' ' ILE . 95.6 mt -63.68 -46.91 93.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.759 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.12 -39.0 93.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 35.6 p -69.02 -42.38 76.46 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.724 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.655 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 24.6 mm-40 -72.69 -35.74 67.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.48 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 77.4 mt -61.7 -43.8 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.304 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.557 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 30.6 t70 -61.64 -41.94 98.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.928 0.394 . . . . 0.0 111.022 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.0 t -62.1 -43.87 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.899 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 61.7 mt -63.05 -39.28 94.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.818 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.557 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.5 mtm180 -62.04 -42.64 99.39 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -64.08 -37.86 88.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.668 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -61.5 -46.15 91.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.198 0.523 . . . . 0.0 110.043 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.29 -37.2 71.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.429 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.54 72.57 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 120.98 0.419 . . . . 0.0 111.223 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.479 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 49.2 tt0 -62.33 -37.81 87.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.458 0.647 . . . . 0.0 109.956 176.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.36 -15.75 59.23 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.583 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -93.56 6.59 47.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.699 -177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . 0.454 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . 134.44 -22.69 3.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.521 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 109.6 37.53 1.89 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.337 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.431 HD21 ' HB2' ' A' ' 328' ' ' GLN . 27.3 t-20 -79.14 135.9 36.96 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.858 0.361 . . . . 0.0 110.792 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.608 ' OE1' ' HG3' ' A' ' 327' ' ' LYS . 1.7 tm-20 -136.71 152.42 50.35 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.608 ' HG3' ' OE1' ' A' ' 326' ' ' GLU . 32.0 mtmm 70.89 -46.34 0.63 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.553 0.741 . . . . 0.0 112.419 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.431 ' HB2' HD21 ' A' ' 325' ' ' ASN . 17.3 mm100 -68.54 -16.69 63.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.252 0.548 . . . . 0.0 110.065 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.58 -19.05 34.95 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.859 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.522 HD12 HH12 ' A' ' 315' ' ' ARG . 52.8 tp -61.15 -38.7 87.35 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.774 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -75.34 -19.47 59.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.775 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 81.2 mt -55.52 136.75 70.26 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.425 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.68 127.73 23.81 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.93 2.42 . . . . 0.0 113.057 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.402 HH21 ' HD2' ' A' ' 334' ' ' ARG . 24.8 ttt180 -68.31 -42.17 79.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.263 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -59.07 -36.18 74.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.129 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.88 -39.02 93.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.471 ' CD1' ' HG2' ' A' ' 315' ' ' ARG . 96.9 m-85 -97.06 -15.78 20.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -68.84 -31.6 70.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.81 0.338 . . . . 0.0 111.197 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -61.32 -50.89 71.13 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.823 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -70.64 -28.83 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.838 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.06 -42.17 97.99 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.21 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.8 tttt -59.83 -47.2 86.67 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.187 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.547 ' O ' HG23 ' A' ' 347' ' ' VAL . 13.0 mmt85 -62.94 -44.89 94.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.142 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.468 ' NH2' HD22 ' A' ' 314' ' ' LEU . 93.5 mtt180 -66.58 -38.43 87.03 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 341' ' ' ALA . 71.2 t -65.31 -43.17 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.78 0.324 . . . . 0.0 110.35 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 342' ' ' LYS . 74.2 t -60.69 -42.82 93.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.482 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 343' ' ' ARG . 76.5 t -59.68 -44.72 94.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.29 99.59 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.202 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.96 -43.82 97.75 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.891 0.376 . . . . 0.0 110.841 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.31 -44.56 94.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.934 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.5 mt -65.16 -41.67 94.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.285 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.97 -42.59 99.75 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.217 -0.516 . . . . 0.0 113.254 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 356' ' ' ARG . 32.1 tp10 -63.23 -44.3 95.62 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 120.866 0.365 . . . . 0.0 110.759 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.34 -46.26 95.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.029 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.66 -44.72 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.918 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.403 HH22 ' CD ' ' A' ' 353' ' ' GLU . 7.5 tmm_? -69.68 -45.41 68.4 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.8 m -68.89 -43.24 75.68 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -86.15 -1.52 57.5 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.909 0.385 . . . . 0.0 110.663 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 57.63 44.76 20.27 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.08 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.66 149.3 34.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.399 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.77 148.41 32.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.728 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.38 126.75 29.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 367' ' ' VAL . 18.4 t70 -94.44 115.86 28.12 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.769 -176.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 54.3 mm-40 -60.52 -40.22 90.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.564 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.95 -40.11 91.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 110.883 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -64.02 -39.14 93.44 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.598 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 363' ' ' ASP . 90.5 t -62.68 -39.69 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.922 176.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 29.0 mmmt -57.11 -43.29 82.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.037 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.5 -40.68 99.42 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.035 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.04 -41.09 99.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 109.995 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.67 -42.95 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.453 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.99 -41.59 96.77 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.709 0.29 . . . . 0.0 111.046 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -65.37 -40.29 93.34 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 109.857 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 50.1 ttm -65.71 -41.64 92.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.646 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.9 -27.42 68.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.991 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 43.3 m -75.76 -3.08 32.89 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.548 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -96.4 4.39 52.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.836 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -125.59 -176.6 3.65 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.737 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.37 -52.83 60.05 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.404 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.596 ' O ' ' HG2' ' A' ' 383' ' ' GLU . 21.3 t70 -125.68 125.58 24.96 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.501 ' O ' HG13 ' A' ' 385' ' ' ILE . 33.7 Cg_endo -64.64 -32.69 57.51 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 121.969 1.779 . . . . 0.0 113.102 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -68.22 -41.55 81.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 380' ' ' ASP . 13.0 pt-20 -61.17 -38.21 85.69 Favored 'General case' 0 N--CA 1.46 0.068 0 CA-C-O 120.745 0.307 . . . . 0.0 110.177 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.99 -44.01 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.325 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 381' ' ' PRO . 74.0 mt -60.75 -46.86 95.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.4 -43.09 86.77 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.515 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -59.41 -46.82 87.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.946 0.403 . . . . 0.0 110.869 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -68.52 -41.86 79.33 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.813 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.9 p -80.18 -8.03 59.24 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.22 7.96 45.49 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.174 0.511 . . . . 0.0 110.563 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -133.38 110.96 10.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.798 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -62.33 -38.01 87.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.354 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.9 -50.68 71.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.035 0.445 . . . . 0.0 110.394 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.29 -41.98 96.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.442 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.515 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 88.9 mtp -63.33 -48.61 77.29 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.8 -39.46 66.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.612 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -63.91 -41.15 97.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.466 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 47.7 tpp -65.25 -40.03 93.46 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 395' ' ' MET . 79.2 mtm180 -63.09 -33.56 75.7 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.71 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -61.68 -41.83 98.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.127 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.15 -45.57 93.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.448 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.39 90.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.915 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 57.3 tp -62.58 -39.36 93.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.498 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 408' ' ' VAL . 38.4 tt0 -61.05 -43.75 98.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -65.78 -35.98 82.23 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.126 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -60.81 -41.52 95.84 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.207 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.36 94.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.687 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.428 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 90.6 t -64.2 -45.4 96.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.014 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.78 -35.87 82.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.535 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.28 98.25 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.914 0.388 . . . . 0.0 110.4 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 95.4 t -67.75 -43.45 86.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 94.5 mt -61.51 -41.5 97.4 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.998 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.8 -24.29 67.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.587 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -99.06 -1.99 38.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.334 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.49 172.27 6.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.982 0.42 . . . . 0.0 111.739 -177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.15 127.35 31.92 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.573 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.21 116.09 46.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 120.882 0.372 . . . . 0.0 110.588 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 10.0 t -115.54 128.84 56.26 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -112.88 123.57 50.63 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.1 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -145.23 150.4 36.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.795 0.331 . . . . 0.0 111.561 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -84.46 162.52 19.89 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.628 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.5 t -158.54 -176.71 6.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.798 0.332 . . . . 0.0 110.631 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 16.5 p -81.76 157.9 24.35 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.274 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -67.53 -35.63 79.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.175 0.512 . . . . 0.0 110.842 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -60.63 -35.85 77.19 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.109 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -66.37 -30.73 71.17 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.098 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.39 -15.99 58.1 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.968 0.413 . . . . 0.0 110.788 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 8.8 mmt -78.07 -6.3 54.2 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.77 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -76.18 68.51 2.61 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.509 0.671 . . . . 0.0 109.358 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -99.42 16.01 24.53 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.327 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -63.22 -39.52 94.85 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.754 0 CA-C-O 118.286 -0.864 . . . . 0.0 109.825 179.278 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.476 0.846 0 CA-C-O 120.727 0.299 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.58 133.8 34.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.345 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.67 162.32 38.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.675 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 33.8 t -103.47 105.9 16.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.918 0.389 . . . . 0.0 110.326 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 p -146.77 139.52 19.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.728 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' B' ' 13' ' ' ARG . 61.2 mt-10 -129.06 172.83 11.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.699 0.285 . . . . 0.0 111.119 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 94.1 m -121.82 129.44 52.63 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.245 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 33.3 m -77.17 -68.8 0.58 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 175.79 139.53 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.512 0.725 . . . . 0.0 109.717 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.84 -122.62 28.26 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.379 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.59 HD23 HG13 ' B' ' 111' ' ' VAL . 78.1 mt -65.79 -39.56 91.08 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 122.868 0.467 . . . . 0.0 110.907 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.582 ' HA2' ' HG2' ' B' ' 108' ' ' GLU . . . -69.39 137.74 29.69 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 115.63 1.012 . . . . 0.0 115.63 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 6' ' ' GLU . 1.5 tpp180 -126.04 -161.66 1.07 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -161.94 116.27 1.9 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 t -94.26 -91.86 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.138 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m 52.69 85.24 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 CA-C-O 121.28 0.562 . . . . 0.0 110.787 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 tp -114.68 144.84 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.683 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 14.4 p -100.34 126.44 46.69 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.971 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.45 ' CD1' HG12 ' B' ' 24' ' ' ILE . 6.6 pt -131.22 153.71 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.663 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -75.92 151.27 37.36 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.889 0.476 . . . . 0.0 112.0 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.17 -50.19 69.94 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -65.15 -37.54 87.73 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.596 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 19.8 m -63.71 -43.48 96.45 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.035 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.663 HG13 ' O ' ' B' ' 20' ' ' ALA . 68.8 mt -61.77 -52.58 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.242 0.544 . . . . 0.0 111.517 -177.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -70.05 -39.22 75.84 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.16 -172.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 10.9 m -77.24 -55.7 5.19 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.38 -47.54 60.43 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' B' ' 32' ' ' LEU . 96.0 t -64.17 -43.34 97.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.194 -176.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -61.31 -45.22 95.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.39 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 40.4 m -63.07 -42.35 99.64 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.528 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.424 ' O ' HG23 ' B' ' 35' ' ' VAL . 49.0 tp10 -65.93 -36.63 83.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.369 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 91.9 mt -61.93 -42.1 98.71 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.24 -36.63 77.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.207 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -63.39 -41.13 98.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.621 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 31' ' ' GLU . 96.7 t -63.81 -44.12 98.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.437 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.74 93.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.113 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.04 -33.48 75.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.273 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -59.58 -41.73 90.91 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.642 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 10.8 t -91.08 -1.86 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.23 0.538 . . . . 0.0 110.343 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 65.14 25.13 12.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.259 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -103.93 6.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.622 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -65.84 -29.0 69.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.291 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.7 -3.86 68.78 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.281 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -86.48 -5.76 59.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.829 0.347 . . . . 0.0 111.315 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.456 ' HG3' ' NE2' ' A' ' 320' ' ' GLN . 37.2 ttt85 -93.39 110.67 22.22 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.797 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.72 -42.84 99.49 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.488 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.13 46.1 67.37 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 115.906 1.122 . . . . 0.0 115.906 172.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -61.39 -44.61 96.85 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.174 0.987 . . . . 0.0 108.469 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.451 HG12 ' HB ' ' B' ' 54' ' ' VAL . 3.4 t -105.39 103.84 44.73 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 174.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' B' ' 53' ' ' ILE . 36.2 Cg_endo -64.07 156.36 59.39 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.736 2.291 . . . . 0.0 112.711 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.511 ' HA ' HG12 ' B' ' 54' ' ' VAL . 92.2 mtp -63.45 -24.99 68.07 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -174.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -79.15 -10.02 59.71 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.834 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.637 HD13 ' NH2' ' A' ' 193' ' ' ARG . 93.9 mt -114.94 -46.1 4.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' B' ' 51' ' ' MET . 14.6 p -63.66 -34.61 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.955 0.407 . . . . 0.0 110.797 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.0 82.89 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.168 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -88.9 -14.97 35.52 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.5 HH12 HD12 ' A' ' 187' ' ' LEU . 67.6 mtt180 -89.87 -30.62 17.77 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.41 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.62 13.3 22.56 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.653 0.739 . . . . 0.0 109.632 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.46 149.45 51.63 Favored Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.447 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . 70.59 -40.89 0.48 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.299 0.64 . . . . 0.0 111.559 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 38.7 t -60.71 -46.59 89.82 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.734 0.414 . . . . 0.0 110.973 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -123.15 13.08 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.313 0.577 . . . . 0.0 110.845 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -64.1 -19.52 65.32 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.132 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -62.9 -52.69 62.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.817 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.93 -18.38 60.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.08 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 62' ' ' VAL . 75.9 t -64.39 -42.68 96.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 173.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.58 -39.56 94.08 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' B' ' 71' ' ' MET . . . -60.37 -41.28 98.41 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.522 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . 0.748 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 30.7 t70 -63.51 -44.27 94.79 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.39 -43.62 98.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.988 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' B' ' 68' ' ' GLY . 24.8 ptt? -63.71 -40.43 96.77 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 44.6 m -64.45 -39.38 93.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.081 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.748 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 51.1 mtp85 -62.59 -43.81 97.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.996 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -64.02 -41.9 97.28 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.32 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -61.71 -48.39 80.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.306 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.476 ' O ' HG13 ' B' ' 79' ' ' ILE . 19.2 tt -67.52 -40.53 84.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.484 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -64.82 -42.27 95.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.999 0.428 . . . . 0.0 110.139 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.73 -42.28 97.93 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.057 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.476 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.6 pp -67.35 -40.95 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.642 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.95 -44.63 96.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-O 121.628 0.728 . . . . 0.0 109.798 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -65.54 -44.63 86.27 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.891 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -89.26 2.14 54.72 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 62.79 52.8 2.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.047 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 81.0 mt -109.13 126.6 66.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -103.2 108.38 58.68 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.512 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -78.29 116.26 3.86 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.199 1.933 . . . . 0.0 111.724 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.9 86.58 6.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.069 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 132.04 -168.41 22.49 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.878 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.93 123.11 74.17 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 110.526 -0.176 . . . . 0.0 110.526 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.92 113.72 2.12 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.121 1.881 . . . . 0.0 110.713 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 18.3 m -94.96 117.29 29.89 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.175 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.548 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 94.3 m-85 -92.04 134.35 34.9 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.44 97.93 25.29 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 90.1 Cg_endo -103.99 -167.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 123.668 2.912 . . . . 0.0 111.159 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -121.07 -174.09 14.85 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -87.17 146.89 25.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.479 0.639 . . . . 0.0 109.535 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -91.89 127.82 37.5 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.095 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -105.43 126.33 52.0 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 46.6 tp -65.94 113.57 4.5 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.021 0.439 . . . . 0.0 110.914 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.04 -8.72 42.45 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.12 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -112.55 177.3 4.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 117.415 0.607 . . . . 0.0 111.215 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -80.9 141.52 34.49 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.555 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -93.07 136.42 33.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.97 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 33.1 m -118.58 130.96 56.18 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.955 0.407 . . . . 0.0 111.265 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -130.41 149.06 52.27 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.287 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.5 ' O ' HG12 ' B' ' 107' ' ' VAL . 58.4 m -101.77 -66.01 0.95 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.5 HG12 ' O ' ' B' ' 106' ' ' SER . 0.3 OUTLIER 71.17 150.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 124.17 0.988 . . . . 0.0 110.964 -175.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.582 ' HG2' ' HA2' ' B' ' 12' ' ' GLY . 28.6 mt-10 -132.96 149.47 52.23 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.222 -0.299 . . . . 0.0 110.333 -175.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -155.47 -75.26 0.1 Allowed 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -108.61 162.87 13.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -171.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.59 HG13 HD23 ' B' ' 11' ' ' LEU . 3.6 m -135.68 158.83 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.125 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -161.45 104.61 1.21 Allowed Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.572 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -83.59 147.91 12.49 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.026 2.484 . . . . 0.0 114.411 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -140.32 112.54 7.76 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.428 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.4 133.92 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.762 0.315 . . . . 0.0 111.34 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -122.37 141.36 51.65 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.333 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -120.02 150.8 39.98 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.596 0.236 . . . . 0.0 110.698 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -135.46 156.66 48.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.661 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.55 16.96 69.6 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.216 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.7 -38.96 92.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.279 0.561 . . . . 0.0 110.838 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.95 -14.73 63.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.192 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.0 21.52 13.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.878 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 76.5 mt -94.61 109.39 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.417 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -102.33 121.07 41.56 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.38 132.91 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.767 0.317 . . . . 0.0 110.844 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -83.16 139.15 33.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.406 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -123.74 94.11 46.48 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.82 113.46 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.265 1.977 . . . . 0.0 112.095 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.5 mm -102.56 118.31 49.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.048 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.87 160.61 41.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.724 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -133.7 150.27 51.52 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.943 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 59.9 t -66.71 123.37 19.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 65.2 p -106.99 176.88 5.03 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.854 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.18 -34.77 77.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.602 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.42 97.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.156 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -63.34 -45.46 91.14 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.148 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.7 -45.08 92.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.744 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -59.47 -48.71 80.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.742 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.29 -39.22 96.83 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.036 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.55 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 2.6 tpt -60.91 -47.43 86.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 0.0 110.65 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.66 -41.6 98.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.986 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -60.95 -46.41 90.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.922 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 29.0 m -61.64 -41.74 97.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.643 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' B' ' 140' ' ' MET . 94.3 mt -60.87 -41.93 96.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.758 -176.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -71.48 -20.47 62.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.779 0.324 . . . . 0.0 111.124 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -89.05 -3.01 58.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.508 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -103.42 -48.22 4.05 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -62.3 124.03 19.79 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -175.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.87 -167.55 1.97 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.582 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.558 HG21 ' HA ' ' B' ' 246' ' ' PRO . 5.5 m -146.16 169.32 18.97 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . 0.53 ' H ' HG22 ' B' ' 150' ' ' THR . 7.1 p-90 -117.78 145.41 44.53 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -175.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' B' ' 151' ' ' TRP . 54.2 tttp 173.41 -65.79 0.01 OUTLIER 'General case' 0 C--N 1.344 0.367 0 O-C-N 123.94 0.775 . . . . 0.0 110.36 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -102.39 175.97 5.33 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 120.861 0.362 . . . . 0.0 111.836 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -83.57 147.2 27.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.959 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 68.44 113.61 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -165.05 -95.21 0.1 Allowed Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.651 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.02 149.69 31.56 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 62.8 t -114.35 128.15 71.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -98.11 -170.86 2.04 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.081 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.99 -67.84 0.44 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -73.96 1.51 10.69 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' B' ' 188' ' ' ALA . 32.1 t70 -69.61 144.86 52.87 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.629 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -102.83 119.14 38.31 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.737 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 42.1 t -117.15 126.71 74.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.561 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 24.4 m -74.4 106.32 5.96 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 88.2 mt -122.26 122.6 66.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.669 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -92.9 90.35 6.95 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -112.85 149.62 32.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.325 0.583 . . . . 0.0 112.16 -175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' B' ' 180' ' ' GLY . 41.5 m -128.8 128.99 45.04 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.19 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.44 135.46 13.31 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.729 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 51.0 m -142.48 145.8 34.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 120.863 0.363 . . . . 0.0 110.909 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.95 94.98 3.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.03 -68.4 0.09 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.96 0.788 . . . . 0.0 112.718 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -140.86 12.09 2.88 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.797 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -136.91 138.33 40.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.491 0.646 . . . . 0.0 110.89 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -79.38 148.98 31.81 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.253 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -110.89 -174.55 2.5 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -57.31 -48.87 77.84 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -103.35 -162.15 25.34 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.057 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' B' ' 169' ' ' THR . . . 78.78 29.68 50.97 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.676 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -114.85 103.05 10.57 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -131.38 141.52 49.89 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.792 0.33 . . . . 0.0 111.575 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 27.7 m -136.02 133.46 37.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.651 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 55.45 33.09 20.22 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.377 0.423 . . . . 0.0 110.91 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -98.51 133.27 43.11 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.287 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.1 m -94.3 120.68 44.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-O 121.57 0.7 . . . . 0.0 111.282 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.464 HD12 HH12 ' A' ' 57' ' ' ARG . 30.0 tp -111.37 125.0 53.4 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.073 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . 0.73 ' HB3' ' NH1' ' B' ' 193' ' ' ARG . . . -111.34 132.75 54.16 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 173.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . 0.461 ' SD ' ' HB ' ' B' ' 202' ' ' ILE . 69.3 mtm -100.29 176.74 5.27 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.226 0.536 . . . . 0.0 112.287 -171.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 79.22 18.78 73.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.593 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -127.54 -17.94 4.5 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.68 0.276 . . . . 0.0 111.604 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.39 43.38 7.44 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.128 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.73 ' NH1' ' HB3' ' B' ' 188' ' ' ALA . 69.4 mtm180 -100.19 1.11 41.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.369 0.604 . . . . 0.0 110.934 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.469 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.5 OUTLIER -134.19 169.16 17.59 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.637 175.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.461 ' H ' HD12 ' B' ' 195' ' ' ILE . 3.1 mp -58.07 131.04 83.61 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.03 134.76 50.33 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.216 1.944 . . . . 0.0 111.56 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.56 -43.2 1.76 Allowed Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -63.78 -47.55 80.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 120.447 0.165 . . . . 0.0 111.174 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -86.54 14.51 6.72 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.262 0.553 . . . . 0.0 110.923 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . 0.665 ' O ' ' HE2' ' B' ' 203' ' ' LYS . 21.2 t70 -113.22 -38.76 4.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.221 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -71.13 -15.51 74.51 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.546 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.461 ' HB ' ' SD ' ' B' ' 189' ' ' MET . 69.7 mt -68.63 -25.99 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 O-C-N 122.596 -0.355 . . . . 0.0 111.141 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.665 ' HE2' ' O ' ' B' ' 200' ' ' ASP . 45.0 mtmt -58.09 131.33 50.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.42 -8.09 66.51 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.731 -0.747 . . . . 0.0 114.018 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -89.73 161.08 16.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.302 0.551 . . . . 0.0 111.636 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.69 176.19 7.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.061 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -91.33 55.61 2.86 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.224 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 147.68 43.16 0.03 OUTLIER Glycine 0 C--N 1.308 -0.996 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -125.36 131.41 52.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.254 -0.473 . . . . 0.0 110.766 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -105.45 112.87 26.13 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.679 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -134.09 -3.74 2.79 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.102 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 66.3 p 58.72 169.89 0.06 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.932 0.893 . . . . 0.0 112.421 -177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.6 tp -157.81 143.93 8.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.59 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -97.65 113.68 25.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.515 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 61.2 t -116.43 130.1 71.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 7.3 m -92.59 -23.94 18.87 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.9 m-85 69.51 159.57 0.15 Allowed Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.885 -175.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -88.3 156.92 6.77 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.177 1.918 . . . . 0.0 111.755 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . 0.451 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 70.7 mm-40 -67.61 -39.71 84.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -84.99 72.0 10.87 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.671 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -115.52 138.11 51.37 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -63.92 -19.83 65.4 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -100.78 107.56 19.15 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 37.8 tt0 -64.0 -33.17 75.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.49 -175.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -74.71 -11.63 60.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.82 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -117.92 -4.3 11.1 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.8 ptmt -69.23 125.07 25.55 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.127 0.489 . . . . 0.0 111.743 -176.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 63.65 27.12 70.53 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.572 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.14 133.57 55.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.323 0.562 . . . . 0.0 110.974 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -75.26 134.81 41.02 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.957 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -122.47 154.44 37.8 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.399 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -111.33 107.19 16.37 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -83.56 109.72 17.63 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.2 0.524 . . . . 0.0 110.486 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.93 98.27 7.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.509 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.2 mm -97.11 114.55 34.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.154 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -104.18 -51.89 3.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.035 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 96.1 mt 65.75 144.02 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.549 0.739 . . . . 0.0 112.076 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.04 -63.86 1.22 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.612 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -99.64 -69.36 0.77 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.668 0.27 . . . . 0.0 111.582 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 15.5 t 70.8 154.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.412 0.685 . . . . 0.0 111.166 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.42 -179.64 7.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.905 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.36 141.04 50.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.182 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.433 ' HA ' ' H ' ' B' ' 152' ' ' LYS . 1.4 ptp180 -174.71 105.33 0.1 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.139 0.495 . . . . 0.0 112.228 177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -170.71 163.52 8.01 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 30.6 tp 74.75 114.95 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 123.76 0.824 . . . . 0.0 110.83 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . 0.558 ' HA ' HG21 ' B' ' 150' ' ' THR . 90.9 Cg_endo -84.0 134.65 6.22 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.477 2.118 . . . . 0.0 114.624 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -130.38 13.97 5.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.528 173.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 8.3 mp 66.26 105.68 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.876 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . 0.605 HG22 ' H ' ' B' ' 251' ' ' GLU . 27.6 m -123.6 133.99 53.86 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.021 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.425 ' O ' HG22 ' B' ' 253' ' ' ILE . . . -74.6 -12.98 60.59 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.605 ' H ' HG22 ' B' ' 249' ' ' THR . 51.7 mt-10 -62.44 -43.48 98.71 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -85.08 -8.95 58.44 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . 0.425 HG22 ' O ' ' B' ' 250' ' ' ALA . 10.9 tp -91.66 -17.52 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.498 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' B' ' 260' ' ' ASP . 21.9 ptmt -106.37 -16.49 14.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.765 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -125.18 127.9 47.52 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.043 0.449 . . . . 0.0 112.095 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -168.33 82.21 0.17 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 78.25 -47.02 2.84 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.583 -175.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 19.0 t -78.49 152.23 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 122.961 0.505 . . . . 0.0 110.264 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -58.35 -51.56 69.31 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' B' ' 254' ' ' LYS . 2.8 p-10 -160.95 126.18 3.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.124 0.488 . . . . 0.0 109.95 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -130.98 -154.51 7.92 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.737 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 30.7 p -127.08 -164.02 1.31 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 122.53 0.332 . . . . 0.0 110.215 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.48 -63.5 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.173 0.511 . . . . 0.0 110.536 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.2 OUTLIER -72.86 -39.59 66.37 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.934 -179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.25 -38.46 95.93 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.463 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.97 -43.87 97.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.679 0.276 . . . . 0.0 110.543 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -64.23 -42.02 96.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.995 0.426 . . . . 0.0 110.155 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -68.43 -41.9 79.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.6 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -68.55 -40.11 80.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.965 0.412 . . . . 0.0 110.701 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.36 -41.32 92.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -54.44 -51.5 64.77 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.624 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 15.9 ptmt -67.1 -40.25 86.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.67 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.39 -39.24 93.48 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.446 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.1 mmm -63.39 -43.61 97.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.61 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.75 -33.45 72.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.924 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -60.15 -44.37 95.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.388 0.613 . . . . 0.0 109.351 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.19 -35.07 75.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.017 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.422 ' O ' HG13 ' B' ' 282' ' ' ILE . 54.2 tp -61.59 -41.26 97.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.785 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -57.78 -43.51 85.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.084 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 24.6 m -62.0 -42.66 99.4 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.511 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.46 96.13 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.435 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 278' ' ' LEU . 63.8 mt -63.31 -44.23 99.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.465 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.93 -44.57 94.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.84 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -64.89 -42.32 94.9 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.388 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -60.71 -43.88 97.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.639 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 98.3 t -69.36 -44.44 80.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.641 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . 0.416 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.0 tttt -62.5 -46.57 87.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.928 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 69.8 p -61.79 -43.39 98.94 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -66.46 -40.42 89.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.817 0.341 . . . . 0.0 111.156 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.14 -47.43 84.58 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.729 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . 0.447 ' O ' HG23 ' B' ' 295' ' ' VAL . 48.2 mm -64.35 -44.17 97.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.888 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -60.54 -44.08 96.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.288 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.67 99.25 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.323 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.16 -42.19 93.97 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 291' ' ' ILE . 76.1 t -63.82 -44.2 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.612 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.6 -41.92 99.26 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.169 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -72.25 -39.13 68.66 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -126.68 98.39 5.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -92.77 96.08 9.93 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.9 tp -100.98 148.17 7.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.828 -175.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -61.7 134.93 57.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.225 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.3 122.71 38.79 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.939 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.19 131.59 46.05 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.735 2.29 . . . . 0.0 112.555 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.98 79.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.181 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.23 -33.07 67.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.443 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . 0.435 ' O ' ' HG2' ' B' ' 310' ' ' GLU . 92.7 mt -87.01 -33.83 19.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.413 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . 0.417 ' O ' HG13 ' B' ' 311' ' ' ILE . 97.0 mt -62.65 -48.28 88.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.787 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.05 -42.13 99.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -176.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 32.2 p -65.75 -39.98 91.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.731 0.3 . . . . 0.0 111.702 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . 0.627 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 62.3 mm-40 -72.79 -36.87 67.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 81.1 mt -62.14 -43.45 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.556 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 35.9 t70 -61.26 -41.87 97.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.869 0.366 . . . . 0.0 111.024 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.12 -43.93 99.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.991 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 64.2 mt -63.08 -38.86 92.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.894 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.556 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 74.5 mtm180 -61.36 -42.53 98.85 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -64.1 -38.54 91.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.651 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -62.01 -45.33 94.07 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.221 0.534 . . . . 0.0 110.31 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -71.8 -37.49 70.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.413 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.08 72.37 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.061 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 49.2 tt0 -62.52 -39.64 94.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.337 0.589 . . . . 0.0 109.943 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -73.25 -20.38 60.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.562 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -89.95 3.87 51.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.012 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 136.42 -21.93 3.4 Favored Glycine 0 CA--C 1.508 -0.39 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.843 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 109.84 36.27 2.06 Favored Glycine 0 CA--C 1.502 -0.764 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.211 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . 0.454 HD21 ' HB2' ' B' ' 328' ' ' GLN . 26.9 t-20 -77.56 133.9 38.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.793 0.33 . . . . 0.0 110.527 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . 0.633 ' OE1' ' HG3' ' B' ' 327' ' ' LYS . 1.8 tm-20 -135.89 151.12 49.68 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.633 ' HG3' ' OE1' ' B' ' 326' ' ' GLU . 31.5 mtmm 71.39 -45.54 0.62 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.552 0.741 . . . . 0.0 112.259 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . 0.454 ' HB2' HD21 ' B' ' 325' ' ' ASN . 17.1 mm100 -70.16 -13.74 62.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.262 0.553 . . . . 0.0 110.0 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.74 -17.81 57.27 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.622 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.37 -38.02 85.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.476 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -78.03 -15.51 58.87 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.756 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 76.6 mt -57.61 137.37 82.32 Favored Pre-proline 0 C--O 1.238 0.5 0 C-N-CA 121.22 -0.192 . . . . 0.0 110.982 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -51.3 125.62 16.97 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.051 2.501 . . . . 0.0 112.92 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -68.03 -40.78 82.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.619 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.456 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.7 pm0 -60.39 -35.58 76.07 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.224 0.454 . . . . 0.0 112.224 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.45 -39.26 94.0 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.934 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -95.64 -17.13 21.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.38 -32.07 72.74 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.78 -51.04 68.65 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.686 0.279 . . . . 0.0 111.056 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -70.0 -29.32 66.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.729 0.299 . . . . 0.0 110.798 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.442 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -60.58 -43.99 96.73 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.956 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . 0.476 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.6 tttt -59.58 -46.55 88.6 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.469 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . 0.528 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.0 mmt85 -62.03 -45.3 94.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . 0.413 ' NH2' HD22 ' B' ' 314' ' ' LEU . 94.9 mtt180 -66.57 -38.34 86.85 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.519 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 341' ' ' ALA . 73.4 t -64.77 -43.46 96.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 120.724 0.297 . . . . 0.0 110.393 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 342' ' ' LYS . 79.4 t -60.7 -43.15 94.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.364 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.528 HG23 ' O ' ' B' ' 343' ' ' ARG . 69.5 t -59.76 -44.8 94.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.41 -41.38 99.52 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.15 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.78 -43.48 98.68 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.732 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 97.6 mt -63.73 -44.29 94.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.891 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.5 -42.46 95.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.507 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.16 -41.69 99.63 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.431 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -64.68 -42.83 95.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.785 0.326 . . . . 0.0 110.876 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.04 -45.14 97.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.82 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.42 -44.73 99.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.797 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -70.8 -45.42 64.69 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.958 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 98.5 m -67.48 -44.97 77.25 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -86.81 -5.25 59.17 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.604 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 57.69 74.21 0.43 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.981 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.3 mt -105.97 144.98 31.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.13 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.63 146.99 35.07 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.205 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.84 115.31 5.19 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . 0.539 ' O ' HG23 ' B' ' 367' ' ' VAL . 16.1 t70 -84.0 117.79 23.62 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.3 -176.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 47.0 mm-40 -60.45 -39.53 87.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.313 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -65.73 -40.18 91.91 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.699 0.285 . . . . 0.0 110.759 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -62.91 -38.47 91.1 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.092 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . 0.539 HG23 ' O ' ' B' ' 363' ' ' ASP . 95.4 t -63.56 -40.92 90.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.636 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 29.6 mmmt -57.61 -43.43 84.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.306 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.9 -41.77 99.68 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.798 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.97 -41.24 99.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.398 . . . . 0.0 110.03 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.4 -43.21 98.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.375 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.44 -40.38 96.41 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.421 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.48 -39.66 88.9 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.914 0.388 . . . . 0.0 110.35 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 50.5 ttm -65.17 -40.66 94.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.562 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . 0.41 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -62.1 -28.59 69.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.796 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 30.5 m -79.5 16.2 1.11 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.161 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -114.18 4.49 15.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.164 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -126.63 -172.58 2.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.186 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -62.88 -62.11 1.94 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.449 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' B' ' 383' ' ' GLU . 18.9 t70 -119.03 127.24 26.62 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.075 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . 0.41 ' HA ' ' HB1' ' B' ' 375' ' ' ALA . 35.5 Cg_endo -66.14 -31.76 44.51 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.156 1.904 . . . . 0.0 112.818 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -67.06 -43.08 83.59 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' B' ' 380' ' ' ASP . 11.9 pt-20 -61.39 -37.86 84.97 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.56 -43.21 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.982 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.2 -44.59 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.854 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.88 -45.07 79.19 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.159 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -58.98 -46.76 87.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.856 0.36 . . . . 0.0 111.201 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -68.57 -41.9 79.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.919 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 70.3 p -78.3 -10.82 59.83 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.53 6.17 49.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.096 0.474 . . . . 0.0 110.623 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -129.27 111.9 13.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.327 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.75 -39.75 95.12 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -57.63 -51.06 71.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.899 0.381 . . . . 0.0 110.638 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.51 -41.71 98.52 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.386 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.545 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 88.6 mtp -63.36 -47.65 81.2 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -73.25 -40.52 64.57 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.825 -174.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -62.75 -41.25 99.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.211 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 46.9 tpp -64.22 -39.98 95.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.647 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' B' ' 395' ' ' MET . 77.3 mtm180 -64.15 -34.26 77.67 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.771 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.63 -42.7 99.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.823 0.344 . . . . 0.0 110.083 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.58 -44.78 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.512 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -63.29 -38.91 93.02 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.838 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.38 -38.89 92.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.343 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . 0.402 ' O ' HG23 ' B' ' 408' ' ' VAL . 39.8 tt0 -59.38 -43.75 92.87 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.452 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.44 -35.89 80.11 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.051 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -60.12 -41.68 93.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.921 0.391 . . . . 0.0 110.397 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.06 96.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.552 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 93.3 t -64.53 -45.61 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -65.92 -35.63 81.14 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -60.65 -40.69 92.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.936 0.398 . . . . 0.0 110.242 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.38 -43.38 84.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.496 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 94.5 mt -61.6 -41.33 97.29 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.264 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.61 -19.53 64.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.744 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -102.83 1.47 34.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.185 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -113.09 172.31 7.02 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.111 0.482 . . . . 0.0 111.589 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -79.3 129.44 34.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.456 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 36.3 t -104.02 109.83 28.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 120.979 0.418 . . . . 0.0 110.943 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 6.7 t -108.2 128.52 54.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.929 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -116.59 121.17 40.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.252 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -144.82 153.06 41.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.22 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -86.79 163.62 17.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 12.4 t -159.0 -178.22 7.07 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 21.5 p -82.91 157.16 23.16 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.9 0.381 . . . . 0.0 111.263 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -67.8 -27.7 66.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.159 0.504 . . . . 0.0 110.311 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -61.9 -39.77 93.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.834 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.49 -31.23 71.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.104 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.5 mp -78.56 -13.45 59.82 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.893 0.377 . . . . 0.0 111.022 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 6.8 mmt -80.39 -5.07 55.89 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.041 0.448 . . . . 0.0 110.589 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -76.28 69.47 2.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.57 0.7 . . . . 0.0 109.507 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -100.47 18.5 18.89 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.013 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -68.2 -33.38 74.31 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.989 0.423 . . . . 0.0 110.304 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.642 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.502 -179.693 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -97.37 136.44 37.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.87 0.367 . . . . 0.0 111.019 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.91 137.04 56.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.436 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.9 p -84.65 87.19 7.27 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.19 136.44 55.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -119.95 153.87 35.31 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.523 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 77.9 m -98.09 123.39 42.1 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.499 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 m -79.34 -56.14 4.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.138 0.494 . . . . 0.0 111.47 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.1 tp60 -169.08 100.35 0.37 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.22 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.7 -106.21 1.21 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.863 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 109' ' ' PHE . 7.3 mp -67.36 -38.66 85.13 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 122.4 0.28 . . . . 0.0 111.081 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 106' ' ' SER . . . -57.94 137.02 50.3 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.51 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HD3' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -140.69 144.3 35.56 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.532 0.206 . . . . 0.0 110.793 -177.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -115.88 129.04 56.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.5 t -89.52 -87.81 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.71 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.8 p 43.4 80.46 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 89.4 mt -109.81 132.09 58.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.5 m -97.72 123.78 41.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.8 pt -123.54 164.05 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.67 0.271 . . . . 0.0 111.474 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.487 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.24 152.18 44.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.822 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.61 -44.71 81.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.648 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.96 -36.43 84.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.203 0.525 . . . . 0.0 110.386 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 m -66.23 -34.4 77.93 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.45 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.5 mt -61.37 -48.94 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.854 0.359 . . . . 0.0 111.624 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.513 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 55.4 mm-40 -81.47 -13.59 58.0 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -93.13 -59.83 1.94 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.099 -0.641 . . . . 0.0 111.5 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.41 -50.04 35.91 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 98.8 t -63.35 -43.89 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.584 0.23 . . . . 0.0 111.478 -175.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HE2' ' O ' ' A' ' 25' ' ' GLU . 17.1 ttmm -61.71 -45.99 91.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.54 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.8 m -66.88 -40.65 87.87 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.739 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -62.85 -41.08 99.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.731 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.4 mt -62.77 -42.64 99.78 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.767 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.34 -35.89 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.201 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -64.04 -42.88 96.91 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.03 -29.87 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.907 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.36 -43.19 95.31 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.52 -37.39 86.64 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.679 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -60.48 -35.57 76.23 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.471 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 t -93.02 -5.35 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 121.414 0.626 . . . . 0.0 109.939 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 62.79 28.56 16.52 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.601 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 41' ' ' ILE . 2.8 pp -101.83 6.1 10.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.45 0.643 . . . . 0.0 111.158 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -64.6 -29.83 70.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.71 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.6 -1.14 70.15 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.448 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -94.49 6.41 48.89 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.53 -0.394 . . . . 0.0 111.73 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.2 ttt85 -111.61 98.65 7.58 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.222 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -65.57 -43.44 89.79 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.515 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.63 70.74 1.19 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 173.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -65.63 -41.58 92.49 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 171.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.28 107.81 60.59 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.437 -1.256 . . . . 0.0 107.956 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD2' HD12 ' A' ' 53' ' ' ILE . 46.1 Cg_exo -56.55 151.06 48.32 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.083 2.522 . . . . 0.0 113.114 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.524 ' HA ' HG22 ' A' ' 54' ' ' VAL . 14.6 ttt -60.81 -39.39 88.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.018 -173.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -66.59 -20.74 66.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.057 0.456 . . . . 0.0 110.837 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.492 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 97.4 mt -92.22 -37.9 9.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.701 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.524 HG22 ' HA ' ' A' ' 51' ' ' MET . 25.3 m -63.98 -36.37 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.491 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.94 -37.36 87.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.864 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.604 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.6 pt20 -80.47 -19.53 45.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.668 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.604 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 63.3 mtt180 -106.9 -27.14 10.89 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -175.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -107.74 5.31 26.56 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.519 0.675 . . . . 0.0 109.854 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 61' ' ' SER . . . -70.66 153.03 51.2 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 176.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.411 ' H ' ' HB2' ' A' ' 63' ' ' ARG . . . 70.32 -24.84 0.16 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.211 0.604 . . . . 0.0 111.928 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 59' ' ' GLY . 36.1 t -78.2 -61.88 1.86 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.887 0.375 . . . . 0.0 110.371 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.4 p -103.77 12.15 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.449 0.642 . . . . 0.0 110.142 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HB2' ' H ' ' A' ' 60' ' ' ALA . 41.3 ttm180 -58.96 -30.14 67.68 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.738 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -57.57 -50.28 73.64 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.063 0.459 . . . . 0.0 110.473 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.39 -23.08 54.06 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.503 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 62' ' ' VAL . 73.1 t -64.47 -43.73 96.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 174.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.06 -39.76 95.69 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.415 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.07 99.69 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.717 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 11.5 t70 -62.0 -45.6 92.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.888 0.375 . . . . 0.0 110.29 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.69 -41.87 99.33 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.458 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.9 tpt -61.57 -42.12 98.39 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -60.98 -43.04 99.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.738 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 96.9 mtt-85 -66.05 -40.61 91.1 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.333 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -63.48 -42.43 98.56 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.405 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -61.64 -51.02 70.21 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.896 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.6 tt -69.57 -41.69 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.6 -39.97 88.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.058 0.456 . . . . 0.0 110.302 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -68.69 -42.85 77.19 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 pp -64.97 -32.06 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.895 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.7 -43.92 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.909 0.385 . . . . 0.0 110.886 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 17.8 ptpt -78.38 -26.96 46.73 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.667 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -86.5 -5.14 59.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.892 0.377 . . . . 0.0 110.642 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 66.57 40.28 3.47 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.517 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 84.6 mt -102.23 122.22 54.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -106.73 110.76 63.9 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.48 114.55 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.288 1.992 . . . . 0.0 111.416 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.24 126.19 30.52 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.711 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 69.19 -116.53 7.23 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.852 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.77 114.46 6.02 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.48 156.82 60.67 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 122.635 2.223 . . . . 0.0 111.378 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.6 m -104.3 119.08 38.17 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.51 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -74.41 -21.42 59.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.234 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t 48.42 80.04 0.32 Allowed Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 123.968 0.907 . . . . 0.0 112.894 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.98 122.03 6.08 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.255 1.97 . . . . 0.0 110.725 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.84 -176.35 51.44 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.295 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.39 121.82 25.63 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.116 0.484 . . . . 0.0 110.258 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -82.6 111.9 19.0 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.488 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 98.6 mttt -91.17 129.97 37.1 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.5 tp -75.69 114.07 13.86 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.03 0.443 . . . . 0.0 110.611 -176.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.02 4.82 59.91 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.326 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.8 mt-10 -127.38 168.32 14.99 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.717 -0.284 . . . . 0.0 110.568 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.68 142.89 54.92 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.074 0.464 . . . . 0.0 111.832 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -102.46 147.72 26.39 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.468 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.2 m -122.74 132.07 54.07 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -147.01 161.09 41.53 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.544 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 33.1 p -96.6 -84.48 0.36 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 106' ' ' SER . 86.9 t 75.35 112.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -173.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -103.99 122.93 46.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.101 -0.499 . . . . 0.0 112.08 -173.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.438 ' N ' HD23 ' A' ' 11' ' ' LEU 0.253 19.7 p90 -138.29 -95.23 0.19 Allowed 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 174.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -157.69 147.16 19.98 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.0 0.818 . . . . 0.0 111.862 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.9 m -141.28 167.81 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.078 0.551 . . . . 0.0 111.824 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -109.61 107.15 59.19 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.433 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -93.06 153.99 2.63 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.992 2.462 . . . . 0.0 112.924 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.74 143.43 17.23 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.5 t -132.23 137.8 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -175.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -84.78 141.47 30.49 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.557 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.01 143.62 50.81 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -138.38 154.33 48.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.616 0.246 . . . . 0.0 111.089 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.84 15.73 79.5 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 114.089 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.96 -40.74 97.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.974 0.416 . . . . 0.0 111.512 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -73.69 -3.68 29.76 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.704 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.59 4.99 43.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.968 0.413 . . . . 0.0 111.131 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.7 mt -87.39 126.59 41.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.53 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -107.45 116.79 32.56 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.4 t -104.16 133.84 47.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.136 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -85.72 144.06 28.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.478 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -132.89 101.27 14.03 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.41 138.09 58.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.251 1.967 . . . . 0.0 111.506 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 421' ' ' GLU . 48.4 mm -116.17 121.14 66.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.9 161.2 41.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.391 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -152.76 166.09 33.31 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.881 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.42 128.98 38.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.097 0.475 . . . . 0.0 111.337 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 65.8 p -109.36 173.83 6.14 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.535 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.82 -35.11 79.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.108 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.72 -37.42 81.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.374 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -63.43 -40.57 97.54 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.549 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.32 -46.04 96.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.516 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.37 -44.65 95.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.356 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.68 -41.52 99.81 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.653 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.606 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 2.4 tpt -61.26 -48.46 81.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.687 0.28 . . . . 0.0 110.543 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.96 -42.27 97.33 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.074 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.49 -47.64 85.25 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.945 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.6 m -62.84 -41.5 99.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.694 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 140' ' ' MET . 87.5 mt -61.34 -40.26 93.6 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -177.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -72.57 -17.09 61.74 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.978 0.418 . . . . 0.0 111.135 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.83 -0.45 55.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.901 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -116.28 30.93 7.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.662 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -134.65 79.22 1.79 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.29 121.24 37.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.322 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.626 HG21 ' H ' ' A' ' 247' ' ' GLU . 35.4 m -74.72 159.93 31.41 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.398 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 36.8 t-105 -80.28 124.84 29.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.126 0.488 . . . . 0.0 110.894 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.409 ' HG3' ' OE2' ' A' ' 153' ' ' GLU . 18.5 tptm -143.53 169.13 18.28 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.409 ' OE2' ' HG3' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -82.52 -3.21 55.54 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -175.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 155' ' ' ASP . 21.8 pttp -163.78 -172.9 3.03 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.719 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 0.6 OUTLIER 91.46 122.19 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.332 1.453 . . . . 0.0 112.683 177.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -68.15 93.99 0.3 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 114.71 -1.132 . . . . 0.0 114.766 -174.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -151.01 127.44 10.7 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.83 122.2 60.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -103.86 157.76 16.87 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.5 26.36 0.17 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.928 0.491 . . . . 0.0 112.22 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -139.68 -4.87 1.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.213 0.53 . . . . 0.0 109.91 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -83.58 158.17 22.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.352 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -102.72 98.46 8.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.795 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.5 t -97.86 123.01 50.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.73 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.1 m -79.49 107.49 12.31 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.1 mt -121.42 123.27 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 121.095 0.474 . . . . 0.0 111.929 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.495 ' HB2' ' HD3' ' A' ' 238' ' ' LYS . 23.5 m-20 -96.28 108.43 20.92 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -126.23 147.87 49.58 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.616 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.6 m -119.74 129.19 54.38 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.114 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.11 122.37 5.73 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.299 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.3 p -136.59 124.49 22.71 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.04 -85.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.787 0.327 . . . . 0.0 110.787 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -103.06 2.98 35.54 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.503 0.668 . . . . 0.0 110.006 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.26 -3.93 2.51 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.376 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -113.47 143.3 44.73 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.21 157.1 33.0 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.721 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -129.39 -177.77 4.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.246 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.19 -41.61 88.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.168 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.1 -178.59 38.85 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.312 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.05 24.99 50.73 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.449 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.0 98.89 8.52 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -130.34 143.79 50.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.095 0.474 . . . . 0.0 111.8 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.4 m -148.73 122.54 9.31 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.996 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 60.51 31.42 20.28 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.334 0.588 . . . . 0.0 109.968 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -86.18 137.68 32.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.909 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.0 m -105.01 125.33 60.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.604 0.716 . . . . 0.0 111.175 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.49 ' CD1' HH12 ' B' ' 57' ' ' ARG . 49.5 tp -114.42 118.19 33.12 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.212 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -93.86 110.86 22.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 63.0 mtp -83.25 152.9 24.97 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.839 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 100.9 -20.97 45.58 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.051 175.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -89.08 -10.91 45.63 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.92 50.95 4.97 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.15 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 188' ' ' ALA . 35.2 mmm-85 -90.49 -11.44 40.24 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.911 -0.644 . . . . 0.0 110.106 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.35 -176.74 4.18 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.716 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.2 mm -63.58 133.71 95.62 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.904 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.41 120.89 5.55 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.066 2.511 . . . . 0.0 112.679 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.52 -36.19 4.57 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.488 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -62.5 -48.02 81.38 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -78.85 -9.24 59.41 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.8 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -91.49 -29.26 17.1 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.253 0.549 . . . . 0.0 109.648 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.9 -22.63 75.78 Favored Glycine 0 CA--C 1.522 0.477 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.881 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.21 -42.49 96.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.97 0.414 . . . . 0.0 110.171 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -53.76 131.17 38.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.118 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.67 -7.99 39.58 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.689 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -96.94 160.09 14.55 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.921 0.391 . . . . 0.0 111.322 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.03 156.43 16.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.652 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.5 129.73 41.44 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.913 0.387 . . . . 0.0 110.713 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . 73.63 50.99 10.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.711 -178.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -136.02 140.96 44.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.674 0.273 . . . . 0.0 110.705 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -115.93 135.41 54.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -153.25 -13.61 0.15 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.409 -0.516 . . . . 0.0 112.276 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 30.3 p 61.71 166.87 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.97 0.908 . . . . 0.0 112.064 -175.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.6 tp -156.15 114.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.083 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.09 106.53 7.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.986 0.422 . . . . 0.0 110.873 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 230' ' ' ALA . 78.4 t -108.95 118.91 57.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.536 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 4.8 m -69.48 -35.06 75.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 216' ' ' THR . 70.5 m-85 75.69 150.99 0.13 Allowed Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 123.133 0.573 . . . . 0.0 109.498 -172.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.18 153.67 32.03 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.641 1.56 . . . . 0.0 111.474 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.561 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 64.3 mm-40 -64.02 -33.72 76.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.27 0.557 . . . . 0.0 109.842 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -87.92 28.17 1.07 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.332 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 10.1 t80 -73.42 132.85 43.44 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -64.89 -17.42 64.3 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.503 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -94.76 110.51 22.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 36.0 tt0 -61.56 -38.59 88.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.859 -173.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.434 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 28.2 p30 -71.98 -9.51 58.48 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.434 ' HG ' ' OD1' ' A' ' 225' ' ' ASN . 95.5 mt -122.57 0.85 9.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.561 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.8 ptmt -70.93 110.81 5.88 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.521 0.677 . . . . 0.0 112.733 -175.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.77 12.64 83.98 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.498 -0.774 . . . . 0.0 114.097 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -118.26 127.93 54.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.357 0.578 . . . . 0.0 110.732 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -71.32 136.24 47.76 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -111.7 139.37 47.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.324 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -70.51 -43.37 69.8 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 212' ' ' THR . 79.5 m-85 58.39 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.078 0.551 . . . . 0.0 112.133 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.67 -50.81 72.02 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.9 mm 62.69 81.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.133 0.492 . . . . 0.0 111.235 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -66.06 -40.89 91.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.229 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.472 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 10.5 tp 50.6 82.96 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.722 0.809 . . . . 0.0 110.612 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.495 ' HD3' ' HB2' ' A' ' 167' ' ' ASP . 52.5 mtpt -93.51 -51.0 5.16 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -173.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -100.27 -92.04 0.29 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.0 t 75.43 129.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.165 0.586 . . . . 0.0 111.086 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -69.01 -35.67 76.92 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.501 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 155' ' ' ASP . 13.1 pt-20 57.86 117.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 125.34 1.456 . . . . 0.0 114.175 177.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -143.5 124.12 14.08 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.154 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 245' ' ' LEU . 0.3 OUTLIER -148.36 -175.6 4.98 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.46 ' H ' ' CD ' ' A' ' 244' ' ' GLU . 66.1 mt 73.21 105.47 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 111.099 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.597 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 64.1 Cg_endo -78.87 111.77 3.01 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.408 2.072 . . . . 0.0 113.76 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.626 ' H ' HG21 ' A' ' 150' ' ' THR . 12.6 pt-20 -135.77 17.82 3.29 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.135 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 52.7 tp 77.13 132.74 0.05 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 176.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 251' ' ' GLU . 23.0 m -142.16 137.96 31.23 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.228 176.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -77.74 -9.12 58.84 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.428 ' H ' HG22 ' A' ' 249' ' ' THR . 39.6 mt-10 -85.26 -25.12 27.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -176.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -65.24 -22.24 66.85 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 119.779 -0.769 . . . . 0.0 113.034 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 34.8 pt -74.05 -9.57 13.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -137.67 25.67 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.919 0.39 . . . . 0.0 111.731 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -115.54 15.67 16.63 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-O 121.208 0.528 . . . . 0.0 111.63 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -94.49 14.96 19.11 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.31 -31.34 8.77 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.123 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.8 144.38 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -53.46 -47.91 69.32 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.264 0.353 . . . . 0.0 111.93 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -173.64 157.33 3.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.1 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -160.37 172.41 36.78 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.617 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 80.5 p -96.53 -134.99 0.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.711 0.255 . . . . 0.0 110.83 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 52.8 t -103.33 -68.8 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.12 0.486 . . . . 0.0 109.95 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.2 OUTLIER -70.34 -37.29 74.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.864 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.22 -37.52 94.64 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.763 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.62 -43.8 97.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.868 0.365 . . . . 0.0 110.091 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -62.73 -40.77 98.24 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.688 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.65 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.47 -47.16 85.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.146 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 272' ' ' LYS . 41.6 tp10 -65.85 -40.91 92.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.926 0.394 . . . . 0.0 111.182 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 80.2 t -64.66 -42.92 96.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.374 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -59.34 -48.82 80.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.835 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 10.0 ptmt -62.96 -44.03 97.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.756 0.312 . . . . 0.0 111.206 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -64.97 -39.25 93.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.372 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 90.5 mmm -63.8 -41.7 97.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 110.672 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.85 -35.72 80.68 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.417 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.5 -41.26 96.53 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.321 0.581 . . . . 0.0 109.603 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -66.59 -36.86 83.65 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.703 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 45.5 tp -62.39 -38.89 91.36 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.048 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -57.17 -44.14 83.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.198 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.6 m -61.7 -42.8 99.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.649 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.56 97.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.261 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.04 -44.09 97.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.175 0.512 . . . . 0.0 110.013 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -61.57 -44.47 96.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.657 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -64.04 -42.15 97.17 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.899 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.508 ' HE ' ' HA ' ' A' ' 285' ' ' ARG . 1.4 tpm_? -61.34 -43.57 98.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.526 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 85.4 t -70.32 -44.39 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.272 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.8 -48.81 80.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.557 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 65.2 p -65.37 -42.89 92.28 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -65.81 -41.1 92.29 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.7 0.286 . . . . 0.0 111.712 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.89 80.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.112 0.482 . . . . 0.0 110.88 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 295' ' ' VAL . 36.9 mm -66.05 -43.57 92.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.511 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -57.87 -44.47 86.63 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.217 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.43 -41.89 99.74 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.807 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.4 -43.31 97.92 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 291' ' ' ILE . 97.0 t -62.66 -45.74 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.35 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.37 -42.3 99.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.969 0.414 . . . . 0.0 110.987 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.74 -38.64 80.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.782 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -124.83 90.88 3.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -93.43 94.39 8.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 301' ' ' ASP . 10.9 tp -103.26 163.75 3.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.742 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.448 ' N ' HG13 ' A' ' 300' ' ' ILE . 3.8 m-20 -65.37 140.06 58.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.15 123.38 37.76 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.539 ' O ' HG13 ' A' ' 307' ' ' ILE . 46.6 Cg_exo -55.93 129.77 36.74 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.499 2.132 . . . . 0.0 111.977 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.38 -35.55 79.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.093 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.22 84.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.993 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.22 -34.5 56.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.954 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 303' ' ' PRO . 75.6 mt -61.87 -50.97 77.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.919 0.39 . . . . 0.0 111.612 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.31 -40.44 95.93 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 65.5 p -64.52 -45.94 85.08 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.519 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 43.3 mm-40 -72.01 -35.09 69.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.962 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 83.7 mt -62.08 -44.12 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.715 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.591 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 32.0 t70 -63.39 -40.85 98.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.844 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.9 t -64.05 -43.72 97.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.174 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 87.6 mt -62.53 -40.15 95.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.909 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.509 HH12 HD12 ' A' ' 330' ' ' LEU . 80.3 mtm180 -63.12 -38.91 93.06 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.266 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 90.5 mtt180 -63.73 -41.09 98.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.701 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -62.86 -44.04 97.18 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.641 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.34 -39.54 81.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.033 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.82 88.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.241 0.543 . . . . 0.0 110.435 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -62.11 -38.44 88.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.986 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.96 -37.79 79.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.07 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -74.39 39.1 0.12 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.138 0.975 . . . . 0.0 112.302 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . 0.407 ' HA2' ' HB ' ' B' ' 54' ' ' VAL . . . 99.75 -2.87 57.24 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.155 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 92.94 33.58 7.28 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.159 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -71.47 132.0 44.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.721 0.296 . . . . 0.0 110.216 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.09 160.88 36.42 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 327' ' ' LYS . 0.0 OUTLIER 68.77 -52.08 0.57 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.318 0.647 . . . . 0.0 112.102 -178.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -73.96 -3.58 29.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.12 -23.93 65.88 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.483 0.658 . . . . 0.0 109.714 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.509 HD12 HH12 ' A' ' 315' ' ' ARG . 42.2 tp -63.36 -35.15 79.44 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.266 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.94 -33.48 74.76 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.66 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 82.7 mt -47.56 133.99 10.39 Favored Pre-proline 0 N--CA 1.474 0.753 0 O-C-N 123.613 0.57 . . . . 0.0 112.458 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.441 ' HB2' HD13 ' A' ' 336' ' ' LEU . 50.7 Cg_exo -54.24 129.62 35.48 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.962 2.441 . . . . 0.0 112.786 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -66.2 -43.42 86.85 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.303 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -63.46 -33.8 76.36 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.441 HD13 ' HB2' ' A' ' 333' ' ' PRO . 10.8 mp -63.55 -37.18 86.35 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.643 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.54 -13.06 19.61 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.58 -30.09 67.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.675 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -62.0 -51.26 68.77 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.716 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -71.19 -27.1 63.28 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.809 0.338 . . . . 0.0 110.431 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.436 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -61.88 -43.06 99.61 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.781 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.415 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -59.66 -45.69 91.28 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.504 ' O ' HG23 ' A' ' 347' ' ' VAL . 8.3 mmt180 -61.43 -47.3 86.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.263 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.12 -37.73 84.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 341' ' ' ALA . 72.1 t -63.31 -44.44 99.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.255 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.48 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 70.3 t -62.0 -44.64 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.496 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 343' ' ' ARG . 70.4 t -60.53 -44.81 97.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.838 0.351 . . . . 0.0 110.137 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.79 -42.14 99.39 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.134 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.41 -43.9 96.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.734 0.302 . . . . 0.0 110.859 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.0 mt -62.81 -47.91 81.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.953 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.404 ' O ' HG13 ' A' ' 355' ' ' ILE . 94.3 mt -66.95 -40.43 87.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.159 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.96 -45.05 96.55 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.833 -0.622 . . . . 0.0 113.796 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -68.89 -35.12 76.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.293 0.547 . . . . 0.0 110.713 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 350' ' ' LEU . 78.5 t -60.47 -45.13 97.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 351' ' ' LEU . 80.4 mt -62.97 -46.5 96.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.916 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -67.45 -47.69 69.4 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 98.0 m -64.49 -44.83 89.75 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -87.6 -0.9 57.51 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.501 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 63.15 39.85 9.46 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.91 0.386 . . . . 0.0 111.626 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.7 mt -77.25 145.15 37.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.226 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.57 149.99 39.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.272 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.76 116.5 5.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 367' ' ' VAL . 27.3 t70 -86.24 116.07 24.19 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.532 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 25.7 mm-40 -59.52 -39.42 83.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.965 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -65.22 -42.52 93.34 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 111.018 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -63.74 -38.98 93.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.063 0.459 . . . . 0.0 109.954 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 363' ' ' ASP . 89.3 t -64.04 -38.95 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.485 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 26.8 mmmt -55.58 -45.3 77.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.428 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -64.21 -37.22 94.23 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.43 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.63 -42.11 98.18 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.337 0.589 . . . . 0.0 110.253 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.21 -43.21 97.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.792 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -60.59 -39.74 89.18 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.54 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.91 -40.14 87.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.777 0.322 . . . . 0.0 110.772 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.3 ttm -64.24 -41.73 96.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.0 0.428 . . . . 0.0 110.169 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.39 -27.22 69.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.572 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.7 m -75.27 -4.86 41.53 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.383 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -93.05 -0.54 57.1 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.204 0.526 . . . . 0.0 110.483 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -117.3 168.27 10.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.07 -50.22 72.82 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -117.95 117.62 35.28 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.837 0.351 . . . . 0.0 110.307 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.64 -28.91 25.25 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.345 2.03 . . . . 0.0 113.08 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -65.92 -43.89 86.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.22 -37.7 88.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.587 0.232 . . . . 0.0 110.911 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.86 -42.93 96.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.585 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.68 -44.53 99.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.254 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -67.25 -40.68 86.27 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 120.857 0.36 . . . . 0.0 110.197 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -58.43 -47.98 82.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.872 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.49 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 3.4 t80 -70.46 -40.25 73.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.12 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 59.4 p -77.7 -8.38 57.85 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -101.03 6.7 43.54 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.239 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -125.67 114.12 18.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.073 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -62.95 -41.45 99.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.373 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.11 -48.11 83.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 110.775 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.73 -40.63 97.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.626 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 94.1 mtp -61.96 -46.34 89.72 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.02 0.438 . . . . 0.0 110.997 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.87 -44.17 86.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.331 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -63.81 -40.92 97.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.573 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.49 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 53.1 tpp -62.95 -45.08 94.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.123 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.441 ' HG2' HG21 ' A' ' 367' ' ' VAL . 47.4 mtm180 -65.05 -29.22 70.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.567 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -62.24 -44.41 96.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.17 -44.26 84.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.817 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.37 94.75 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.986 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.68 -38.06 89.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.695 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -59.08 -44.81 91.92 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.905 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.51 -38.21 89.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.808 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -59.43 -41.66 90.08 Favored 'General case' 0 CA--C 1.526 0.032 0 CA-C-O 120.736 0.303 . . . . 0.0 110.62 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.07 79.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.39 -46.15 93.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.482 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -68.56 -30.55 69.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.498 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.33 -38.13 89.95 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.019 0.438 . . . . 0.0 109.93 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 91.5 t -64.69 -42.53 95.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.919 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.41 -40.13 93.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.82 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.65 67.48 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.495 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -99.38 -3.6 33.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.023 0.439 . . . . 0.0 110.962 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -107.85 178.87 4.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.45 107.86 19.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.559 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 97.0 t -99.9 118.66 46.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.902 -0.406 . . . . 0.0 109.902 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.5 t -120.81 158.35 27.76 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -104.82 132.78 50.64 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.077 0.465 . . . . 0.0 111.728 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -147.57 120.97 9.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.861 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 91.1 mt-10 -84.81 151.93 24.0 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.183 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.7 t -157.01 175.31 14.27 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.815 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 62.8 p -85.66 163.76 18.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.931 0.396 . . . . 0.0 111.392 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -64.56 -26.71 68.53 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.055 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -62.22 -39.7 93.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.781 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.6 -33.43 75.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.724 0.297 . . . . 0.0 111.468 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.57 -14.18 57.13 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.645 0.26 . . . . 0.0 111.262 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 2.9 mmt -76.84 -9.91 59.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.188 0.518 . . . . 0.0 110.331 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -80.68 85.65 6.03 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.387 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -105.84 29.27 6.79 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.214 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -66.52 -24.04 66.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.22 0.534 . . . . 0.0 109.912 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.377 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.451 178.389 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -78.03 134.13 37.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.185 0.517 . . . . 0.0 111.582 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 24.1 m -118.57 145.7 24.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.356 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.4 p -91.08 84.28 5.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 m -132.85 135.28 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -119.74 154.79 33.63 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.798 0.332 . . . . 0.0 111.557 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.512 ' HA ' ' HD3' ' B' ' 13' ' ' ARG . 90.3 m -99.47 118.08 35.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.522 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 14.9 m -72.66 -51.41 19.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.387 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -174.92 100.71 0.08 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.275 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.86 -107.43 1.54 Allowed Glycine 0 C--O 1.223 -0.567 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.136 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.449 HD23 ' N ' ' B' ' 109' ' ' PHE . 7.2 mp -66.77 -39.08 87.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.713 0.292 . . . . 0.0 110.919 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' B' ' 106' ' ' SER . . . -59.2 135.08 51.94 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.282 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.512 ' HD3' ' HA ' ' B' ' 7' ' ' THR . 0.0 OUTLIER -140.3 144.17 36.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.474 0.178 . . . . 0.0 110.749 -177.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -114.78 130.04 56.79 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.82 -89.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.729 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p 43.0 82.74 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 88.6 mt -112.88 131.38 64.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 60.5 m -95.47 126.85 41.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.966 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 41.6 pt -125.51 165.85 22.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.421 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.453 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.79 151.75 45.93 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.299 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.416 ' HA ' HD12 ' B' ' 24' ' ' ILE . . . -57.27 -43.1 82.79 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.63 -176.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.75 -38.05 89.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.479 . . . . 0.0 110.194 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 23.0 m -63.3 -36.27 83.11 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.219 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.5 ' O ' ' HB ' ' B' ' 28' ' ' VAL . 75.7 mt -61.47 -50.8 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.282 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.536 ' O ' ' HE2' ' B' ' 29' ' ' LYS . 50.2 mm-40 -75.59 -22.37 56.99 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 25.5 m -86.06 -68.57 0.73 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.693 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.62 -48.64 71.56 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' B' ' 24' ' ' ILE . 99.0 t -62.89 -45.33 99.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.523 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.536 ' HE2' ' O ' ' B' ' 25' ' ' GLU . 16.4 ttmm -61.89 -44.85 95.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.503 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.6 m -65.34 -41.68 93.67 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.814 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -64.66 -38.27 90.41 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.701 0.286 . . . . 0.0 110.788 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' B' ' 28' ' ' VAL . 91.0 mt -62.31 -42.48 99.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.569 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.5 p -71.5 -35.26 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.991 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -64.32 -42.68 96.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.638 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -68.53 -32.45 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.129 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.66 98.19 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.66 -38.32 88.98 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.955 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -59.61 -37.18 77.9 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 18.0 t -87.79 -13.87 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 120.959 0.409 . . . . 0.0 110.038 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 70.83 28.63 3.3 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.756 0.823 . . . . 0.0 111.276 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -104.43 7.45 9.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.131 0.491 . . . . 0.0 111.598 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.3 -24.74 66.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.826 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.05 -1.83 88.12 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.955 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -94.44 7.38 45.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.712 0.291 . . . . 0.0 111.607 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 34.6 ttt85 -114.88 100.71 8.41 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.455 -0.498 . . . . 0.0 112.178 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -67.15 -46.72 73.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.675 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.86 65.92 1.62 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 116.561 1.384 . . . . 0.0 116.561 172.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -63.5 -42.68 98.49 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 t -107.34 106.06 57.42 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 114.725 -1.125 . . . . 0.0 107.997 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.442 ' HB2' ' OD1' ' B' ' 52' ' ' ASN . 28.0 Cg_exo -60.86 155.51 49.05 Favored 'Trans proline' 0 N--CA 1.476 0.476 0 C-N-CA 123.28 2.653 . . . . 0.0 112.969 -177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.656 ' HA ' HG22 ' B' ' 54' ' ' VAL . 92.3 mtp -61.18 -39.16 89.09 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . 0.442 ' OD1' ' HB2' ' B' ' 50' ' ' PRO . 33.4 p-10 -65.7 -17.65 64.76 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.998 0.428 . . . . 0.0 110.859 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.433 HD12 ' HD2' ' B' ' 50' ' ' PRO . 89.0 mt -99.48 -36.29 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.004 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.656 HG22 ' HA ' ' B' ' 51' ' ' MET . 23.2 m -64.98 -37.46 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.633 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.07 83.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.227 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.457 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 7.1 pt20 -82.04 -18.67 42.42 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.49 HH12 ' CD1' ' A' ' 187' ' ' LEU . 62.9 mtt-85 -107.37 -27.51 10.43 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.7 6.63 23.85 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.517 0.675 . . . . 0.0 110.164 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' B' ' 61' ' ' SER . . . -70.25 157.46 53.52 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 175.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.402 ' H ' ' HB2' ' B' ' 63' ' ' ARG . . . 70.71 -40.72 0.48 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.082 0.553 . . . . 0.0 111.499 -177.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . 0.406 ' H ' ' C ' ' B' ' 59' ' ' GLY . 42.9 t -64.99 -63.2 1.17 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.925 0.49 . . . . 0.0 111.296 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.469 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.5 p -101.41 10.44 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.469 0.652 . . . . 0.0 110.206 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.402 ' HB2' ' H ' ' B' ' 60' ' ' ALA . 41.8 ttm180 -59.6 -26.07 65.15 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.693 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -62.63 -49.1 76.53 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.926 0.393 . . . . 0.0 110.382 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -77.32 -21.74 53.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.813 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.469 HG23 ' O ' ' B' ' 62' ' ' VAL . 77.0 t -63.94 -43.74 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.0 -39.4 94.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.216 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.7 -42.26 99.72 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.776 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . 0.434 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 11.5 t70 -62.31 -45.36 93.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.998 0.428 . . . . 0.0 110.378 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.42 -41.7 98.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.367 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 15.5 tpt -61.69 -42.33 98.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 51.2 m -60.98 -43.61 98.56 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.836 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 96.4 mtt-85 -65.68 -42.0 91.77 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.497 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -63.65 -41.3 98.24 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.646 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -61.67 -50.95 70.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.962 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 tt -69.93 -41.8 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.441 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 7.8 t70 -64.57 -40.52 95.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.171 0.51 . . . . 0.0 110.098 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.38 -43.1 78.08 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.66 -33.64 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.012 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.57 -44.07 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.893 0.377 . . . . 0.0 110.899 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 17.4 ptpt -77.59 -28.3 51.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.548 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -83.38 -4.56 58.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.635 0.255 . . . . 0.0 110.84 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 66.5 36.93 4.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.366 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.1 mt -99.65 120.95 49.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.832 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -107.55 112.03 62.55 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.71 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -75.14 127.24 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.059 1.84 . . . . 0.0 111.523 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.22 100.22 9.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.069 0.461 . . . . 0.0 111.016 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.98 -109.84 3.25 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.148 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.69 113.75 8.57 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.684 0.278 . . . . 0.0 111.093 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.39 160.23 45.11 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.72 2.28 . . . . 0.0 111.066 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 14.4 m -107.04 118.74 37.51 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.814 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -73.38 -25.07 60.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.556 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 26.0 t 49.54 79.17 0.36 Allowed Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 123.788 0.835 . . . . 0.0 112.879 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.51 126.59 8.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.301 2.0 . . . . 0.0 110.627 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -83.62 -172.2 48.53 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.593 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.7 121.08 26.8 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.949 0.404 . . . . 0.0 109.998 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -82.2 118.18 22.89 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.148 0.499 . . . . 0.0 110.805 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -98.7 123.69 43.07 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 tp -68.35 105.82 2.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.577 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.42 3.31 44.1 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.588 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -126.87 172.31 10.52 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.83 0.347 . . . . 0.0 111.222 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.52 141.99 57.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.733 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -105.28 144.74 31.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.948 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 34.8 m -119.98 131.2 55.09 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.011 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.94 162.1 38.56 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.564 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 46.2 p -97.9 -83.78 0.4 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -174.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' B' ' 106' ' ' SER . 94.3 t 75.02 113.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -173.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -104.94 121.94 44.79 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -172.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . 0.449 ' N ' HD23 ' B' ' 11' ' ' LEU 0.255 26.3 p90 -138.71 -92.88 0.19 Allowed 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 175.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -159.43 149.15 18.61 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.018 0.826 . . . . 0.0 112.194 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.78 168.59 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.47 0.708 . . . . 0.0 111.619 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -111.28 104.42 56.13 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.425 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -91.44 154.27 3.63 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.924 2.416 . . . . 0.0 113.139 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -158.06 139.81 13.86 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 62.2 t -127.69 136.17 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.164 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -84.84 142.23 29.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.6 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 96.1 mt -123.11 146.52 47.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.746 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -139.2 154.01 47.97 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.663 0.268 . . . . 0.0 111.388 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.3 20.61 76.88 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.068 -0.515 . . . . 0.0 113.857 175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.73 -40.86 92.58 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.953 0.406 . . . . 0.0 111.811 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.2 -5.12 39.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.279 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.09 12.96 36.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.814 0.34 . . . . 0.0 111.057 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.49 124.02 46.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.125 0.488 . . . . 0.0 110.346 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.84 121.9 44.64 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.336 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.1 134.43 53.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.807 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -84.65 143.71 29.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.464 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -133.41 97.44 16.12 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.94 138.08 55.82 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.409 2.072 . . . . 0.0 111.427 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' B' ' 421' ' ' GLU . 48.8 mm -117.64 124.46 73.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.78 162.11 39.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.607 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -148.29 -178.77 6.49 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 80.8 t -100.02 127.6 52.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 120.875 0.369 . . . . 0.0 110.776 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 59.2 p -104.83 171.6 7.24 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.771 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -64.0 -34.12 77.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.608 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.6 86.05 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.498 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -62.85 -39.66 95.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.878 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.41 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 96.5 t -63.11 -45.57 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.179 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.76 -44.89 96.0 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.138 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.5 -40.94 99.74 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.397 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.612 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 1.1 tpt -61.77 -48.63 79.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.688 0.28 . . . . 0.0 110.5 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 91.9 mt -63.64 -42.1 98.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.224 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -59.46 -49.13 78.96 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.406 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.5 m -62.79 -41.61 99.35 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.763 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' B' ' 140' ' ' MET . 89.3 mt -60.63 -35.53 76.39 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -78.3 -15.11 59.07 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.54 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.3 -6.27 41.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.313 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -107.95 30.24 6.54 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.865 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -134.95 94.83 3.21 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -112.0 120.11 40.75 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.705 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.642 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 52.7 m -71.73 158.89 35.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.826 0.346 . . . . 0.0 111.318 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -78.89 122.56 26.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' B' ' 152' ' ' LYS . 17.1 tptm -143.53 170.07 16.5 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' B' ' 153' ' ' GLU . 0.6 OUTLIER -86.29 0.29 54.19 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -165.23 -175.78 3.79 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.983 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' B' ' 242' ' ' GLU . 0.9 OUTLIER 93.2 127.76 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.829 1.651 . . . . 0.0 111.822 176.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -71.45 90.02 0.45 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 115.324 0.89 . . . . 0.0 115.324 -172.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -149.77 135.36 18.41 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.72 128.31 70.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -108.35 158.6 17.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.921 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -77.49 24.44 0.2 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.033 0.533 . . . . 0.0 112.235 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -138.11 -3.73 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.155 0.503 . . . . 0.0 109.886 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -85.3 159.54 20.02 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.49 0.662 . . . . 0.0 112.626 -172.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' B' ' 163' ' ' ARG . 12.0 ptp180 -104.6 103.11 12.72 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.663 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.54 120.17 51.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.699 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 26.6 m -77.78 105.11 8.75 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.75 123.59 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.547 -174.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . 0.479 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 18.1 m-20 -95.15 107.05 19.12 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -125.03 147.7 48.83 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.605 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 29.8 m -120.13 130.3 54.55 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.759 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.63 119.52 4.89 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.45 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 25.4 p -134.94 126.52 28.8 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 t -75.36 -90.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.499 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -98.91 -4.61 32.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.378 0.609 . . . . 0.0 109.739 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.41 -18.1 0.44 Allowed Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.732 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.95 146.07 27.11 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.925 0.393 . . . . 0.0 110.205 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -81.6 156.01 25.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.987 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -125.96 -175.72 3.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.521 0.2 . . . . 0.0 111.537 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.3 -38.79 84.75 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.74 -176.89 32.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.481 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.08 26.53 36.73 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.623 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -108.01 98.25 7.84 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -129.27 140.04 51.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.035 0.445 . . . . 0.0 111.894 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.479 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 48.8 m -148.48 125.12 11.09 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 61.16 30.66 19.46 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.596 0.56 . . . . 0.0 110.276 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -88.82 128.82 35.66 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.027 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 16.9 m -99.34 122.69 51.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.462 0.648 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.519 HD12 HH12 ' A' ' 57' ' ' ARG . 35.2 tp -111.62 120.2 41.27 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.941 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.74 112.2 24.07 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . 0.615 ' HE3' ' O ' ' B' ' 199' ' ' GLU . 84.8 mtp -83.42 152.32 25.06 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.008 -175.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.49 -14.2 62.25 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.055 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . 0.418 ' HB2' ' HG2' ' B' ' 193' ' ' ARG . 97.8 mt-30 -95.19 -11.76 27.51 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -176.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.24 48.14 6.14 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.25 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.418 ' HG2' ' HB2' ' B' ' 191' ' ' GLN . 34.8 mmm-85 -88.23 -12.39 43.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.864 -0.668 . . . . 0.0 109.796 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.18 -179.58 5.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.908 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 49.6 mm -61.05 134.04 92.8 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.85 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.81 128.4 21.43 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.837 2.358 . . . . 0.0 112.352 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.48 -39.39 2.76 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.24 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -62.54 -47.64 82.98 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . 0.615 ' O ' ' HE3' ' B' ' 189' ' ' MET . 12.1 pt-20 -79.11 -10.05 59.72 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.09 -177.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -92.5 -28.3 16.88 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.952 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.77 -21.86 71.47 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.659 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.92 -41.91 94.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -54.92 134.1 48.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.665 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 100.35 3.67 55.36 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.658 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -108.4 151.93 25.36 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 120.967 0.413 . . . . 0.0 110.901 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -92.81 155.61 17.53 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.053 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.12 134.99 56.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.79 50.3 25.1 Favored Glycine 0 C--O 1.236 0.222 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.944 -178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . 0.402 ' H ' HD23 ' B' ' 237' ' ' LEU . 44.3 tt0 -135.65 133.54 38.29 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.086 0.469 . . . . 0.0 111.264 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -108.54 127.02 53.57 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -144.82 -12.8 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 44.1 p 60.27 166.72 0.08 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.79 0.836 . . . . 0.0 111.926 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -155.59 119.71 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.256 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -79.06 106.76 11.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.83 0.347 . . . . 0.0 110.829 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' B' ' 230' ' ' ALA . 97.7 t -109.23 115.57 49.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.108 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . 0.526 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 8.2 m -64.09 -41.03 97.45 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.526 ' HB2' ' O ' ' B' ' 216' ' ' THR . 61.8 m-85 77.88 141.74 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 123.113 0.565 . . . . 0.0 109.809 -172.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.63 152.23 53.33 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.818 1.679 . . . . 0.0 111.878 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . 0.555 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 39.9 mm-40 -62.67 -33.52 75.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.999 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -86.77 24.78 1.39 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.113 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . 0.509 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 9.0 t80 -73.82 135.22 43.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.496 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -67.69 -14.69 63.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.509 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -98.65 108.71 21.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 36.5 tt0 -60.86 -36.79 80.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.428 ' OD1' ' HG ' ' B' ' 226' ' ' LEU . 25.7 p30 -72.65 -11.9 60.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.428 ' HG ' ' OD1' ' B' ' 225' ' ' ASN . 94.6 mt -120.55 -0.01 10.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.555 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.9 ptmt -70.73 108.36 4.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.573 0.701 . . . . 0.0 112.76 -175.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.33 17.1 78.55 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.799 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -121.19 123.51 42.44 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' B' ' 215' ' ' VAL . . . -68.02 136.16 53.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -175.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -110.96 137.04 49.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.182 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -70.08 -41.23 74.37 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -175.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' B' ' 212' ' ' THR . 74.4 m-85 57.62 100.94 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.915 0.486 . . . . 0.0 112.122 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.411 ' HA ' HG22 ' B' ' 212' ' ' THR . . . -58.55 -49.77 76.21 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 61.81 77.97 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.092 0.472 . . . . 0.0 111.051 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -65.85 -39.94 91.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.886 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . 0.402 HD23 ' H ' ' B' ' 209' ' ' GLU . 12.5 tp 51.71 83.56 0.05 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.921 0.888 . . . . 0.0 111.142 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . 0.472 ' HD3' ' HB2' ' B' ' 167' ' ' ASP . 51.9 mtpt -89.98 -64.68 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -174.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -88.52 -89.75 0.14 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 42.9 t 73.42 129.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.888 0.475 . . . . 0.0 111.07 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -69.13 -35.39 76.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.962 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' B' ' 155' ' ' ASP . 12.9 pt-20 57.49 113.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.432 1.493 . . . . 0.0 114.061 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -139.41 125.73 20.21 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.197 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' B' ' 245' ' ' LEU . 0.9 OUTLIER -150.68 -173.85 4.6 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.549 ' H ' ' CD ' ' B' ' 244' ' ' GLU . 46.3 mt 73.6 102.37 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 123.216 0.606 . . . . 0.0 111.042 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . 0.642 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 72.2 Cg_endo -78.97 109.89 2.66 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.569 2.179 . . . . 0.0 113.857 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . 0.581 ' H ' HG21 ' B' ' 150' ' ' THR . 12.5 pt-20 -138.11 23.34 2.8 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.632 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 51.6 tp 77.0 139.08 0.07 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . 0.504 HG22 ' H ' ' B' ' 251' ' ' GLU . 27.7 m -149.78 141.51 23.62 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.145 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . -80.05 -9.99 59.74 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.504 ' H ' HG22 ' B' ' 249' ' ' THR . 41.4 mt-10 -84.66 -25.19 28.65 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -63.62 -28.21 69.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 41.2 pt -70.44 -9.41 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.815 0.34 . . . . 0.0 111.89 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -136.7 30.11 2.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.846 0.355 . . . . 0.0 111.55 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -118.24 12.16 13.38 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-O 121.095 0.474 . . . . 0.0 111.49 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -96.3 27.6 3.66 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.19 -40.28 2.99 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.42 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 28.0 t -68.94 137.65 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -43.63 -59.65 2.1 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.912 0.758 . . . . 0.0 111.986 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -166.81 157.84 12.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.789 0.328 . . . . 0.0 111.087 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -156.54 -171.02 22.29 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.872 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 56.8 p -111.49 -141.3 0.38 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 59.8 t -98.16 -71.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 110.025 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.2 OUTLIER -68.51 -37.07 79.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.243 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.97 -36.97 93.7 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.191 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 270' ' ' VAL . 53.1 tp -63.08 -43.42 98.59 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -61.59 -42.11 98.39 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.459 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -62.27 -46.01 90.69 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.204 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 38.4 tp10 -66.55 -40.07 88.87 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.853 0.358 . . . . 0.0 111.176 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 266' ' ' LEU . 90.9 t -65.25 -43.26 95.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.413 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -60.48 -46.98 88.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 14.1 ptmt -63.19 -44.36 95.58 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.898 0.38 . . . . 0.0 111.0 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -65.21 -38.29 89.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.406 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.8 mmm -63.82 -42.4 97.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.672 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -69.02 -33.32 73.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.059 0.457 . . . . 0.0 110.585 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -63.27 -42.49 99.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.683 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -67.37 -36.39 81.27 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.002 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.459 ' O ' HG13 ' B' ' 282' ' ' ILE . 44.8 tp -62.3 -38.56 89.88 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.789 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -56.3 -45.66 80.15 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.263 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 19.4 m -61.63 -42.28 98.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.837 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.56 -42.93 99.85 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.138 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 278' ' ' LEU . 66.5 mt -64.36 -44.36 97.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.301 178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -60.21 -44.1 95.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.452 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -63.64 -42.79 98.11 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.166 0.291 . . . . 0.0 111.404 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -60.54 -44.74 95.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.073 0.463 . . . . 0.0 110.729 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 86.5 t -69.61 -45.2 78.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.32 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.92 -48.91 78.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.806 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -63.57 -43.4 97.1 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -65.29 -42.18 93.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.485 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -62.58 -47.95 81.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.994 0.426 . . . . 0.0 111.09 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . 0.499 HG21 HG22 ' B' ' 347' ' ' VAL . 51.2 mm -66.68 -43.44 90.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.92 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . 0.414 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 19.9 tp10 -57.82 -45.4 86.21 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.134 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.77 -40.62 99.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.116 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.447 HD13 HD13 ' B' ' 350' ' ' LEU . 4.8 tt -63.6 -43.9 95.56 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.32 -43.98 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.247 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.414 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 66.1 mttm -60.33 -35.18 75.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.934 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.16 -11.76 40.19 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -138.63 81.01 1.82 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -91.54 93.27 8.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -105.26 157.93 5.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.58 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.22 138.25 58.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.465 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 35.0 t -106.63 126.01 31.4 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.861 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.503 ' O ' HG13 ' B' ' 307' ' ' ILE . 51.6 Cg_exo -55.99 129.19 33.58 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.428 2.086 . . . . 0.0 111.914 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.28 83.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.476 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.99 84.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.52 -38.06 83.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.507 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . 0.503 HG13 ' O ' ' B' ' 303' ' ' PRO . 73.6 mt -61.07 -50.12 81.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.248 -177.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.16 -37.53 87.67 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 63.6 p -67.6 -45.17 76.23 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.501 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . 0.554 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 66.8 mm-40 -71.81 -36.32 70.21 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.494 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 87.3 mt -62.38 -44.46 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.12 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.569 ' O ' ' HG3' ' B' ' 316' ' ' ARG . 36.6 t70 -63.24 -41.86 99.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.823 0.344 . . . . 0.0 110.965 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.47 -43.16 98.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.298 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 84.2 mt -62.21 -39.91 94.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.693 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 79.1 mtm180 -63.37 -39.04 93.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.235 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' B' ' 312' ' ' ASP . 90.2 mtt180 -62.82 -42.23 99.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.842 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -62.95 -43.16 99.55 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.496 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.05 -39.94 82.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.964 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.44 91.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.07 0.462 . . . . 0.0 110.39 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -62.15 -37.15 84.13 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.052 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -70.56 -36.95 73.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.412 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.02 42.37 0.25 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.986 0.915 . . . . 0.0 112.172 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . 97.77 -0.11 59.24 Favored Glycine 0 C--N 1.318 -0.465 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.033 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 89.49 30.65 13.08 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.195 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -68.6 136.35 52.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.899 0.38 . . . . 0.0 110.533 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . 0.423 ' HB3' HH11 ' A' ' 73' ' ' ARG . 0.9 OUTLIER -137.98 162.29 34.47 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.574 ' HA ' ' HE3' ' B' ' 327' ' ' LYS . 0.0 OUTLIER 68.57 -53.43 0.55 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.298 0.639 . . . . 0.0 112.359 -178.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -73.99 -3.7 30.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.44 -24.32 65.11 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.278 0.561 . . . . 0.0 109.705 175.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.427 HD12 HH12 ' B' ' 315' ' ' ARG . 41.9 tp -63.23 -36.23 82.98 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.324 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.07 -26.02 65.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.877 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.424 ' HB2' ' HD2' ' B' ' 315' ' ' ARG . 80.0 mt -54.3 132.89 61.54 Favored Pre-proline 0 C--O 1.238 0.481 0 CA-C-O 120.706 0.288 . . . . 0.0 111.556 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . 0.449 ' HB2' HD13 ' B' ' 336' ' ' LEU . 50.5 Cg_exo -54.67 133.19 55.78 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.986 2.457 . . . . 0.0 113.338 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . 0.42 HH21 ' HD2' ' B' ' 334' ' ' ARG . 26.1 ttt85 -67.03 -43.81 81.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.056 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -63.85 -33.01 74.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -174.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . 0.449 HD13 ' HB2' ' B' ' 333' ' ' PRO . 10.8 mp -64.29 -36.57 84.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.473 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -101.36 -13.82 17.85 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . 0.402 ' HG3' HD11 ' B' ' 311' ' ' ILE . 39.9 tt0 -68.52 -30.4 69.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.734 0.302 . . . . 0.0 111.482 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.66 -49.85 74.87 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.792 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -72.25 -29.43 63.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 110.71 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.466 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -61.72 -43.66 98.42 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.108 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . 0.443 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.6 tttt -59.47 -45.19 92.35 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . 0.53 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.7 mmt85 -62.44 -45.52 92.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -66.0 -37.89 87.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 341' ' ' ALA . 82.6 t -63.4 -44.72 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.787 0.327 . . . . 0.0 110.33 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 342' ' ' LYS . 71.7 t -61.23 -45.1 99.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.513 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 343' ' ' ARG . 85.4 t -61.24 -44.57 98.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.281 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.59 -42.32 99.15 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.15 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.04 -44.03 97.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.951 0.405 . . . . 0.0 110.701 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.473 ' O ' HG23 ' B' ' 354' ' ' VAL . 96.2 mt -63.24 -49.45 74.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.0 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.7 -41.21 88.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.6 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.39 -42.44 98.92 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.265 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.7 -35.65 75.25 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.956 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 350' ' ' LEU . 71.8 t -60.15 -44.73 95.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.74 -44.15 98.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.127 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -68.58 -49.03 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 39.2 m -64.48 -44.9 89.56 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -88.56 5.93 40.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.367 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 56.43 45.27 22.96 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.032 0.444 . . . . 0.0 111.528 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 98.8 mt -81.48 143.77 31.84 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.125 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.23 150.53 42.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.109 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.02 120.55 13.34 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . 0.554 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.1 t70 -89.59 113.59 25.05 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.032 -176.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 58.8 mm-40 -59.0 -38.38 79.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.449 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -65.46 -41.54 93.27 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.839 0.352 . . . . 0.0 110.785 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -64.92 -38.66 91.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.784 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . 0.554 HG23 ' O ' ' B' ' 363' ' ' ASP . 96.0 t -63.08 -38.77 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.389 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.4 mmmt -56.35 -44.35 80.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.493 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.53 96.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.012 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.81 -42.42 99.71 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.23 0.538 . . . . 0.0 110.114 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.02 -43.22 97.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.832 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -60.83 -38.95 87.22 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.197 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -65.94 -39.0 90.09 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.306 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 53.8 ttm -66.39 -41.77 88.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.368 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.57 -28.24 69.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.804 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 48.7 m -75.13 -5.77 46.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.562 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -93.08 -1.34 56.59 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.946 0.403 . . . . 0.0 111.234 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -114.29 169.05 9.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.156 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -64.96 -44.09 90.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.961 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -119.65 118.88 31.79 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.798 0.332 . . . . 0.0 110.198 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.83 -30.62 21.67 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.421 2.08 . . . . 0.0 113.258 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -66.14 -43.37 87.24 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.44 -37.36 85.59 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.706 0.289 . . . . 0.0 110.851 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.44 -43.25 96.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.515 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 90.4 mt -62.33 -44.25 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.943 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' B' ' 390' ' ' LYS . 48.3 mt-10 -65.66 -44.48 86.15 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.838 178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.5 -47.82 82.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.122 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . 0.48 ' OH ' ' HB2' ' B' ' 398' ' ' MET . 2.8 t80 -69.52 -39.88 77.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.051 -177.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 62.7 p -78.93 -8.06 58.55 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' B' ' 386' ' ' GLU . 99.4 mttt -99.32 1.7 44.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.967 0.413 . . . . 0.0 111.536 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . 0.434 ' OD1' HD13 ' B' ' 394' ' ' LEU . 24.6 t-20 -123.9 115.25 20.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.232 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 42.1 ttmt -63.9 -40.87 97.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.407 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.23 -49.49 76.9 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.094 0.473 . . . . 0.0 110.781 -176.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . 0.434 HD13 ' OD1' ' B' ' 391' ' ' ASN . 10.3 mp -63.61 -40.18 96.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.47 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . . . . . . . . . 89.7 mtp -62.55 -45.46 92.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 111.526 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -68.79 -43.66 75.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.223 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -62.8 -39.81 95.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.636 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . 0.48 ' HB2' ' OH ' ' B' ' 388' ' ' TYR . 55.5 tpp -62.82 -44.07 97.12 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.868 0.366 . . . . 0.0 110.751 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.406 ' HG2' HG21 ' B' ' 367' ' ' VAL . 56.1 mtm180 -64.65 -31.69 73.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.014 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -61.24 -45.63 93.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.78 -43.83 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.043 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -61.2 -41.0 96.06 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.003 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.75 -37.04 86.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.693 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.2 -45.18 91.76 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.999 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -65.74 -37.81 87.39 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.656 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -58.92 -43.12 91.03 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.868 0.366 . . . . 0.0 110.421 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.407 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -64.71 -47.28 78.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.599 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 94.9 t -64.12 -45.62 95.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.413 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -67.57 -32.0 72.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.555 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.69 91.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.879 0.371 . . . . 0.0 110.253 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 407' ' ' ALA . 93.6 t -64.35 -42.64 95.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.957 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.0 -38.54 86.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.749 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.32 -23.46 66.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -99.25 -2.51 36.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.916 0.389 . . . . 0.0 110.855 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -110.15 174.46 5.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.189 0.519 . . . . 0.0 111.614 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -87.39 108.06 18.82 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.692 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 65.0 t -100.41 118.93 47.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.218 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -119.97 159.57 24.45 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -108.17 122.16 46.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.873 0.368 . . . . 0.0 111.504 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -134.72 123.7 24.08 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.079 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' B' ' 129' ' ' ILE . 75.3 mt-10 -84.65 154.25 22.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.908 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.0 t -158.2 176.12 12.9 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.599 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 75.0 p -85.4 165.41 17.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.895 0.379 . . . . 0.0 111.231 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -66.72 -26.5 67.03 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.581 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -62.58 -39.57 94.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.36 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.56 -35.77 81.03 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.361 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 11.1 mp -78.16 -14.21 59.56 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.823 0.345 . . . . 0.0 111.461 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.4 mmt -76.69 -9.5 58.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.924 0.392 . . . . 0.0 110.703 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -80.0 87.11 5.42 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -108.82 29.61 7.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.907 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -65.6 -27.35 68.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.376 0.608 . . . . 0.0 109.584 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.478 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.52 178.265 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HG2' ' H ' ' A' ' 2' ' ' GLN . 50.8 ttm . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.453 ' H ' ' HG2' ' A' ' 1' ' ' MET . 27.8 tt0 -57.53 108.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.159 0.504 . . . . 0.0 111.553 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 m -134.85 160.93 41.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.649 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 t -135.4 131.03 35.79 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.818 0.342 . . . . 0.0 110.163 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.6 p -153.06 139.71 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.546 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -131.73 154.76 48.7 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 m -102.84 126.13 49.86 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.5 m -97.4 -58.8 1.92 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.441 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -174.3 130.42 0.37 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.571 0.224 . . . . 0.0 110.781 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.44 -112.78 5.05 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.815 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 11' ' ' LEU . 5.4 mp -93.61 -8.78 40.17 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.673 0.273 . . . . 0.0 110.731 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.38 122.14 5.62 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.995 -0.622 . . . . 0.0 113.646 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.05 147.5 46.63 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.432 0.693 . . . . 0.0 109.255 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -110.11 139.32 45.38 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.9 t -95.99 -89.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.9 m 68.04 100.2 0.05 Allowed 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -173.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tp -133.02 143.72 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.012 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 m -126.45 130.57 50.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.506 ' HB ' HG12 ' A' ' 24' ' ' ILE . 9.6 mt -125.79 162.11 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -177.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.557 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -65.7 150.09 49.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.301 0.24 . . . . 0.0 111.132 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.33 -57.08 9.87 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -174.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.11 -35.35 79.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 111.224 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 t -62.74 -41.82 99.38 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.487 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 20' ' ' ALA . 76.4 mt -60.21 -51.98 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.155 0.503 . . . . 0.0 111.354 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -70.04 -46.91 64.02 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.547 -174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.2 m -67.3 -51.33 54.01 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.93 66.5 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.87 -43.29 97.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.964 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -61.32 -45.45 94.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.16 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.2 m -62.18 -42.18 99.03 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.841 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.0 tp10 -70.16 -42.03 73.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.494 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.54 -44.65 96.67 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.94 -35.43 64.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.014 0.435 . . . . 0.0 110.701 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -65.68 -41.31 92.6 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.54 HG11 ' HD3' ' A' ' 73' ' ' ARG . 90.2 t -65.68 -41.46 90.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.398 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.34 80.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.285 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.421 ' O ' ' HD3' ' A' ' 40' ' ' ARG . 99.0 mttt -64.58 -37.58 88.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.059 177.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -61.0 -41.91 97.4 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.883 0.373 . . . . 0.0 110.598 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.87 -4.23 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.388 0.613 . . . . 0.0 110.156 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 25.6 mmt180 62.62 30.95 17.0 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.049 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -112.83 7.15 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.764 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -64.01 -35.92 82.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.081 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.23 -1.64 70.15 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.688 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -91.72 -5.19 54.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.921 0.391 . . . . 0.0 110.734 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -90.36 110.59 21.67 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.01 -39.1 91.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.615 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.519 ' H ' HE22 ' B' ' 320' ' ' GLN . . . 56.83 56.45 24.76 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 173.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -62.66 -41.29 98.98 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.91 109.69 58.81 Favored Pre-proline 0 C--O 1.246 0.902 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.462 ' HG2' HD12 ' A' ' 53' ' ' ILE . 47.4 Cg_exo -57.3 149.35 65.25 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.925 2.417 . . . . 0.0 112.543 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.555 ' HA ' HG12 ' A' ' 54' ' ' VAL . 15.0 ttt -60.29 -39.16 85.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.455 -173.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -69.12 -23.42 63.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.844 0.354 . . . . 0.0 110.987 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.462 HD12 ' HG2' ' A' ' 50' ' ' PRO . 96.6 mt -92.53 -41.72 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 51' ' ' MET . 12.7 p -66.02 -38.78 82.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 120.936 0.398 . . . . 0.0 110.817 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.444 ' O ' ' HA3' ' A' ' 59' ' ' GLY . . . -66.84 -37.37 84.36 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.43 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 9.7 pt20 -72.78 -15.01 61.65 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.724 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.501 HH12 ' CD1' ' B' ' 187' ' ' LEU . 67.2 mtt180 -108.59 -52.41 2.77 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.437 ' O ' HG12 ' A' ' 62' ' ' VAL . 18.8 m-85 -108.66 -1.24 19.66 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.182 0.515 . . . . 0.0 110.646 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 63' ' ' ARG . . . -63.87 -35.76 92.43 Favored Glycine 0 C--O 1.218 -0.863 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.753 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.93 -43.94 67.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.802 0.301 . . . . 0.0 111.312 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.5 m -61.19 -43.29 99.11 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.129 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 65' ' ' ASP . 8.0 p -105.32 20.3 4.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.246 0.546 . . . . 0.0 110.776 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 14.1 ttm180 -63.97 -19.9 65.49 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.048 0.452 . . . . 0.0 110.147 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.37 -53.05 58.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.24 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.528 ' HB2' HG22 ' A' ' 62' ' ' VAL . 17.6 m-20 -71.02 -26.15 62.99 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.501 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 62' ' ' VAL . 91.7 t -62.05 -45.24 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -63.74 -40.06 95.81 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.352 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.03 99.39 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.23 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.51 -44.67 93.62 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.39 -42.76 99.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.036 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.1 ttp -60.48 -50.08 75.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.34 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.3 m -65.27 -46.38 80.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.679 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.54 ' HD3' HG11 ' A' ' 35' ' ' VAL . 58.4 ttm-85 -66.27 -46.63 76.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.792 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -66.14 -40.4 90.6 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -59.88 -48.36 81.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.908 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 79' ' ' ILE . 20.0 tt -68.17 -38.9 80.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.883 0.373 . . . . 0.0 111.271 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.19 -38.54 88.24 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.384 0.611 . . . . 0.0 109.767 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.69 83.73 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.766 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 76' ' ' ILE . 2.7 pp -65.07 -37.33 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.076 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.32 -42.33 95.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.718 0.77 . . . . 0.0 109.156 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -59.55 -47.86 83.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.16 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -89.38 -1.43 58.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -175.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm 70.46 38.95 1.27 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.47 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 92.5 mt -93.84 121.28 44.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -110.52 101.41 48.66 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.588 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.92 131.31 6.97 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.53 2.153 . . . . 0.0 112.452 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.7 90.95 4.42 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.997 0.427 . . . . 0.0 110.4 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.46 -144.21 15.29 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.18 129.47 25.05 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 116.588 0.194 . . . . 0.0 110.678 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HG2' ' CE1' ' A' ' 92' ' ' TYR . 60.5 Cg_endo -70.21 160.2 50.4 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.827 2.352 . . . . 0.0 111.398 178.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.2 m -101.09 91.72 4.67 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.12 0.486 . . . . 0.0 112.17 -175.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.42 ' CE1' ' HG2' ' A' ' 90' ' ' PRO . 87.5 m-85 -84.05 117.77 23.64 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 49.6 t -111.26 96.93 33.3 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 120.86 0.362 . . . . 0.0 111.967 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -87.99 145.14 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 122.592 2.194 . . . . 0.0 110.81 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.96 174.83 42.81 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.638 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.52 130.86 42.3 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -85.34 104.04 14.81 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.153 0.501 . . . . 0.0 110.911 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.95 111.7 19.49 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.11 112.7 2.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.118 0.485 . . . . 0.0 110.484 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.97 -14.91 19.15 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.135 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -119.0 -178.1 3.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.623 0.249 . . . . 0.0 111.035 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.52 161.18 28.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.359 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -108.8 138.81 44.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.776 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -118.31 134.54 54.95 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.198 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -136.39 162.67 32.39 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.835 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.9 m -121.8 148.78 44.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.762 0.315 . . . . 0.0 111.112 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.88 139.96 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.417 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -101.41 132.81 46.81 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -155.72 -159.33 0.9 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -45.96 155.22 0.2 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.557 1.543 . . . . 0.0 113.327 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.5 m -129.93 159.19 42.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.445 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -145.55 99.32 4.48 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.253 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.22 143.73 10.25 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.515 2.143 . . . . 0.0 113.124 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -159.01 125.59 4.62 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.1 m -135.93 162.62 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.891 0.376 . . . . 0.0 111.709 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -119.64 136.35 54.43 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.6 mt -114.23 135.3 54.2 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -128.09 133.46 49.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.626 0.251 . . . . 0.0 111.649 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.1 22.43 52.31 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.882 -0.675 . . . . 0.0 114.251 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.89 -41.42 99.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.24 0.543 . . . . 0.0 110.511 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.67 -16.77 61.88 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.619 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.05 6.98 47.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 82.3 mt -95.49 127.53 47.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.375 0.607 . . . . 0.0 111.093 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -110.04 132.2 54.37 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.935 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.5 t -120.76 133.6 66.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.142 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -90.26 120.26 31.27 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.049 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -122.31 93.5 48.48 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.76 140.73 56.93 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.176 1.917 . . . . 0.0 112.446 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.2 mm -106.37 119.84 56.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.378 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.41 160.43 42.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.293 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.3 158.77 43.36 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.855 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.4 t -84.72 126.4 40.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.698 0.285 . . . . 0.0 110.491 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.2 p -97.74 170.02 9.28 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -68.57 -22.68 64.46 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.284 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.69 -38.89 92.54 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.151 0.501 . . . . 0.0 109.652 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -65.15 -36.74 85.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.336 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.45 -45.36 98.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.468 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.09 -40.48 95.99 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.438 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.81 -42.67 99.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.663 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.532 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 5.0 tpt -63.72 -45.17 91.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.922 0.391 . . . . 0.0 110.306 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.43 -41.4 98.67 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.957 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.1 -45.89 89.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.386 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.0 m -62.62 -39.55 94.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.329 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 140' ' ' MET . 94.7 mt -61.49 -41.75 97.75 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.701 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -69.43 -21.54 63.74 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.087 0.47 . . . . 0.0 110.802 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -86.56 4.13 41.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.223 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -119.8 28.54 8.06 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.664 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -138.33 95.39 3.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -138.57 155.99 47.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.96 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 243' ' ' ARG . 0.7 OUTLIER -122.29 172.35 8.37 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.766 -177.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.468 ' H ' HG22 ' A' ' 150' ' ' THR . 8.9 p-90 -55.0 136.41 47.78 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.052 0.541 . . . . 0.0 112.311 -176.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -170.32 113.87 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -73.86 85.58 1.72 Allowed 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -153.0 -78.31 0.11 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.837 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -163.19 -68.21 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.434 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 243' ' ' ARG . . . 64.54 -126.92 33.59 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 121.23 -0.51 . . . . 0.0 113.198 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -146.34 -165.44 2.22 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 203' ' ' LYS . 61.2 t -119.38 126.54 75.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 57.1 mm-40 -87.88 177.93 6.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.263 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.17 -58.25 3.72 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 255' ' ' ARG . 6.7 pt-20 -89.58 34.98 0.82 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.304 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.656 ' OD2' ' HD3' ' A' ' 243' ' ' ARG . 11.4 t70 -57.22 -48.7 78.14 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.412 -174.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 65.82 88.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.617 HG22 ' OD1' ' A' ' 162' ' ' ASP . 2.9 t -109.94 132.31 58.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.694 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 m -81.15 104.62 11.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 79.7 mt -117.1 132.82 65.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -171.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -99.26 107.92 20.34 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -130.68 146.91 52.28 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.621 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 37.6 m -128.55 131.46 48.22 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.085 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.97 105.84 1.96 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.603 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.9 m -127.26 121.69 31.85 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.6 t -72.64 -76.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -109.28 -70.34 0.81 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.172 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -136.87 18.9 3.54 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.228 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -136.84 148.79 47.33 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -93.32 149.37 21.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.643 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -111.39 -177.8 3.29 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.24 -45.01 92.31 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.732 -176.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -93.24 -171.58 39.9 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.173 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.62 36.87 58.27 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.865 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -115.17 101.42 8.95 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.2 151.53 34.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.144 0.497 . . . . 0.0 111.54 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.8 m -139.04 126.42 21.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.471 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 56.69 38.3 29.43 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.13 0.49 . . . . 0.0 110.768 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -87.7 136.1 33.1 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.619 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.53 120.15 37.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.715 0.769 . . . . 0.0 112.15 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.461 ' CD1' HH12 ' B' ' 57' ' ' ARG . 49.0 tp -113.27 119.42 37.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.595 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.648 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -102.21 129.04 48.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 56.9 mtm -106.83 167.65 9.73 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.768 -173.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.17 14.08 61.0 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.708 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.432 ' HB2' ' HG2' ' A' ' 193' ' ' ARG . 98.2 mt-30 -126.62 -10.06 6.2 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.661 0.267 . . . . 0.0 111.445 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.53 40.45 9.86 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.424 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 188' ' ' ALA . 39.5 mmm-85 -79.12 -22.04 45.72 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.38 0.672 . . . . 0.0 109.939 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.436 ' HA ' ' CE ' ' A' ' 194' ' ' MET . 0.1 OUTLIER -128.95 -170.0 2.19 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.185 179.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 195' ' ' ILE . 4.2 mp -68.33 134.52 91.13 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.63 132.43 45.74 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.256 1.971 . . . . 0.0 111.918 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.47 -39.88 2.63 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.795 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -62.34 -46.31 89.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.554 0.216 . . . . 0.0 111.244 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.95 10.85 5.76 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.088 0.47 . . . . 0.0 111.894 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -114.37 -33.64 5.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.121 0.486 . . . . 0.0 110.115 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -70.76 -17.88 75.46 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.246 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.57 -41.97 94.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.061 0.457 . . . . 0.0 110.322 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.436 ' HA ' ' HB ' ' A' ' 158' ' ' VAL . 41.5 mtpt -52.08 132.27 32.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.654 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.76 8.74 55.52 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.767 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.432 ' HD2' ' OE2' ' A' ' 209' ' ' GLU . 38.0 m80 -115.38 150.18 36.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.031 0.416 . . . . 0.0 110.72 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -87.26 163.39 16.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.169 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.95 135.49 47.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 80.01 15.35 79.14 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.77 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.432 ' OE2' ' HD2' ' A' ' 205' ' ' HIS . 40.7 tt0 -99.19 119.89 38.62 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.33 0.585 . . . . 0.0 111.362 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 235' ' ' ILE . 25.4 mt-10 -98.9 115.62 29.28 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.408 ' O ' ' HB ' ' A' ' 212' ' ' THR . 64.0 t80 -133.74 -26.09 1.6 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -173.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 77.0 m 72.42 129.96 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 120.893 0.378 . . . . 0.0 110.344 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.42 -41.07 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 70.75 97.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 122.791 0.436 . . . . 0.0 111.32 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 68.6 t -115.59 126.92 73.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.049 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.56 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 18.5 m -65.89 -41.95 90.88 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -176.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.56 ' HB2' ' O ' ' A' ' 216' ' ' THR . 27.8 m-85 77.81 134.53 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 122.957 0.503 . . . . 0.0 110.32 -173.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.16 155.7 51.84 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.369 2.046 . . . . 0.0 112.679 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -66.09 -33.78 76.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.601 0.715 . . . . 0.0 109.305 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.12 22.81 1.66 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.851 -177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -70.52 142.1 51.88 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.514 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -63.09 -30.37 71.54 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.67 123.62 33.3 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.419 -0.512 . . . . 0.0 109.741 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.526 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 1.5 tp10 -65.33 -31.54 72.72 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.381 -175.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -86.15 -5.32 59.22 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.37 -11.57 10.0 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.526 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 18.7 ptmt -71.53 119.98 16.47 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.206 0.527 . . . . 0.0 111.063 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 75.9 19.0 79.25 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.755 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -125.34 121.64 34.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.391 . . . . 0.0 110.766 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.55 138.9 45.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.615 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -124.54 135.47 53.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.845 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.52 -48.22 28.34 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -173.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 212' ' ' THR . 66.1 m-85 54.67 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.91 94.46 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 210' ' ' GLU . 91.6 mt 68.62 99.2 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.804 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -86.94 -51.7 5.89 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 32.4 tp 55.78 91.0 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.976 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -73.55 -79.33 0.08 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.502 ' O ' ' HB ' ' A' ' 240' ' ' VAL . 54.1 mtmt -79.01 -79.11 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -170.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 239' ' ' LYS . 92.0 t 76.9 152.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-O 120.832 0.349 . . . . 0.0 110.615 -175.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -99.12 56.53 1.04 Allowed 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -36.47 141.17 0.12 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -173.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.656 ' HD3' ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -144.6 144.83 31.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.944 177.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.404 ' HB2' ' CA ' ' A' ' 156' ' ' GLY . 38.2 tt0 -158.94 155.58 27.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 9.1 tt 72.09 128.03 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 123.475 0.484 . . . . 0.0 111.136 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 245' ' ' LEU . 61.2 Cg_endo -87.74 113.99 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.216 1.944 . . . . 0.0 113.632 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -131.37 176.24 8.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.89 111.6 23.92 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 15.6 p -104.51 -86.19 0.46 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.66 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -176.61 -49.93 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.996 0.427 . . . . 0.0 111.896 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.73 -45.11 91.39 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -62.35 -30.37 71.13 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 263' ' ' VAL . 19.6 tt -85.93 -16.12 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -117.29 8.34 13.12 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.345 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 161' ' ' GLU . 60.5 ttp180 -134.71 133.17 39.7 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.915 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -167.7 37.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 99.43 -31.54 8.2 Favored Glycine 0 C--N 1.318 -0.452 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.07 149.31 5.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.61 -47.25 80.05 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.199 0.312 . . . . 0.0 110.545 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -175.76 163.63 2.85 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.258 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -172.62 175.62 45.67 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.307 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 12.3 p -83.5 175.33 9.87 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.43 0.292 . . . . 0.0 110.301 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . 0.433 HG22 HD11 ' A' ' 253' ' ' ILE . 67.4 t -61.97 -51.23 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.005 0.431 . . . . 0.0 111.054 -177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -81.06 -32.95 33.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.335 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.07 -43.24 99.42 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.19 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 270' ' ' VAL . 65.1 tp -63.14 -44.02 96.7 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.627 0.251 . . . . 0.0 110.52 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -64.12 -42.38 96.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.382 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.536 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -66.3 -45.02 81.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.29 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 35.5 tp10 -65.71 -38.57 89.54 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.998 0.427 . . . . 0.0 110.434 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 266' ' ' LEU . 75.8 t -65.49 -43.4 94.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.228 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -59.21 -46.74 87.64 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.673 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.5 ptmt -66.46 -42.62 87.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.669 0.271 . . . . 0.0 111.163 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -65.79 -37.43 86.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.5 mmm -63.52 -42.81 98.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.045 0.45 . . . . 0.0 110.111 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -70.17 -30.82 68.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.204 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -61.61 -43.79 98.19 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -65.39 -32.98 74.9 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.875 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.8 tp -60.8 -39.64 89.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.951 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -58.12 -46.9 84.78 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 50.4 m -62.52 -44.68 95.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.033 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.3 -51.0 69.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.83 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.45 -44.36 97.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.039 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.544 HH12 ' HG3' ' A' ' 409' ' ' GLU . 6.5 tpt180 -63.03 -45.31 92.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.79 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.43 -40.19 95.27 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.472 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -59.13 -44.4 92.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.014 0.435 . . . . 0.0 110.269 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 86.3 t -70.24 -43.11 78.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.4 tttt -59.3 -47.66 84.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.046 -177.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 74.1 p -62.88 -41.89 99.57 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -64.2 -42.35 96.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.583 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 294' ' ' LEU . . . -65.27 -42.6 93.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.762 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 287' ' ' LYS . 33.5 mm -64.07 -43.34 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.563 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -60.74 -43.37 98.0 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.114 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.01 -40.85 97.39 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.414 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 290' ' ' ALA . 98.5 mt -62.54 -43.13 99.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.802 0.334 . . . . 0.0 110.802 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 291' ' ' ILE . 96.0 t -65.31 -43.78 94.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.198 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -64.23 -40.59 96.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.068 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.26 -42.74 79.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.962 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -127.21 96.34 4.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.8 105.55 17.49 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 301' ' ' ASP . 11.4 tp -120.1 168.68 12.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.574 -174.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 300' ' ' ILE . 7.3 m-20 -60.78 139.0 58.06 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.385 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 42.8 t -121.96 119.63 28.78 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.899 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.94 131.44 45.49 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.437 2.092 . . . . 0.0 111.89 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.66 84.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.102 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.55 91.1 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.854 0.359 . . . . 0.0 111.565 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.7 mt -66.46 -40.74 89.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.833 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.417 ' O ' HG13 ' A' ' 311' ' ' ILE . 68.7 mt -61.66 -47.95 90.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.992 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.3 -43.04 92.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.873 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 51.0 m -62.25 -45.26 94.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.869 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.6 ' O ' ' HG ' ' A' ' 314' ' ' LEU . 65.9 mm-40 -66.17 -39.48 89.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.234 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.54 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 95.8 mt -61.96 -43.82 98.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.621 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.6 t70 -61.62 -46.62 89.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.913 0.387 . . . . 0.0 111.306 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 91.7 t -63.35 -43.51 98.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.251 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 75.0 mt -62.49 -40.46 96.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.621 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 85.1 mtm180 -62.91 -42.15 99.69 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.132 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -64.79 -38.66 91.74 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -63.35 -44.53 94.57 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.252 0.548 . . . . 0.0 109.937 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.7 80.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.58 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -62.31 -36.29 81.7 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.944 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.481 HE22 ' H ' ' B' ' 47' ' ' GLY . 45.8 tt0 -63.2 -40.5 97.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.281 0.563 . . . . 0.0 109.584 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -75.06 -9.6 58.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.343 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -92.2 -7.36 48.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.845 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' B' ' 54' ' ' VAL . . . 136.69 -14.33 3.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.82 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 113.12 44.11 0.82 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.879 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 35.6 t-20 -87.22 127.98 35.15 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.88 0.372 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.549 ' OE1' ' HG3' ' A' ' 327' ' ' LYS . 1.8 tm-20 -130.7 145.26 51.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.549 ' HG3' ' OE1' ' A' ' 326' ' ' GLU . 35.2 mtmm 72.22 -46.05 0.63 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.646 0.779 . . . . 0.0 112.422 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.503 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 12.3 mm100 -70.0 -10.98 60.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.207 0.527 . . . . 0.0 110.446 177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.85 -22.54 64.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.411 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.432 HD12 HH12 ' A' ' 315' ' ' ARG . 60.0 tp -61.61 -33.93 74.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.679 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -79.27 -6.29 56.34 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.573 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 75.9 mt -69.24 145.63 96.17 Favored Pre-proline 0 C--O 1.241 0.623 0 O-C-N 122.186 -0.321 . . . . 0.0 110.997 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.36 127.08 23.43 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.893 2.396 . . . . 0.0 113.339 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.484 ' HG3' HD13 ' A' ' 311' ' ' ILE . 21.9 ttt180 -70.49 -41.0 73.25 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.405 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -52.16 -46.41 65.45 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -173.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.469 HD12 ' CD ' ' A' ' 224' ' ' GLU . 74.7 mt -92.27 10.13 30.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -115.72 -28.2 6.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.132 0.492 . . . . 0.0 110.228 172.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.7 -30.67 70.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.711 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -60.97 -48.24 82.75 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.471 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -78.32 -20.86 50.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.713 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -63.95 -40.87 97.43 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.505 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.8 tttt -59.82 -45.16 93.23 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.567 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.1 mmt85 -60.27 -45.8 92.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.031 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -67.46 -38.92 85.18 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.164 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 341' ' ' ALA . 82.8 t -64.27 -43.86 97.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.658 0.266 . . . . 0.0 110.351 176.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 342' ' ' LYS . 73.0 t -60.74 -43.8 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.531 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 343' ' ' ARG . 82.7 t -59.93 -45.6 94.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.45 -43.34 99.18 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.93 -43.73 94.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.59 0.233 . . . . 0.0 111.478 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.43 -44.79 93.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.924 0.393 . . . . 0.0 110.506 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 355' ' ' ILE . 95.8 mt -66.59 -39.93 88.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.816 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -58.84 -41.76 96.25 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.583 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -66.06 -40.46 90.92 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.889 0.344 . . . . 0.0 110.646 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.76 -45.89 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.937 178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 351' ' ' LEU . 73.6 mt -62.96 -46.98 94.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.224 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -64.07 -62.75 1.43 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.7 m -66.29 -43.86 85.14 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.3 -12.15 60.46 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.246 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 66.44 47.6 1.69 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.008 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.17 142.16 33.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.884 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.06 146.13 51.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.67 114.47 5.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.487 ' O ' HG23 ' A' ' 367' ' ' VAL . 26.8 t70 -87.01 111.48 20.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.064 0.459 . . . . 0.0 111.077 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 58.1 mm-40 -61.4 -35.04 76.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.995 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.63 -42.09 91.9 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.845 0.355 . . . . 0.0 110.764 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -63.01 -40.05 96.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.11 0.481 . . . . 0.0 110.149 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 363' ' ' ASP . 89.2 t -61.26 -39.41 82.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.335 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 30.0 mmmt -57.23 -43.41 82.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.508 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.65 99.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.204 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.65 -42.96 99.89 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.124 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 65.0 mt -65.84 -44.85 92.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.121 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.73 -41.47 98.05 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -65.17 -42.31 93.83 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.436 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 49.6 ttp -65.25 -40.69 94.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -62.97 -23.45 67.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.568 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 39.6 m -73.85 -5.73 42.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.481 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -90.86 0.15 57.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.328 0.585 . . . . 0.0 110.315 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -115.86 170.84 8.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.542 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.06 -44.13 85.43 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.81 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -124.63 113.23 27.28 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.764 0.316 . . . . 0.0 110.616 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.428 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 40.1 Cg_exo -58.24 -35.95 98.22 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.948 2.432 . . . . 0.0 113.221 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.28 -43.7 85.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.48 -35.8 81.67 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.884 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.93 -43.24 96.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 109.978 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.11 -43.48 98.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.88 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.45 -36.75 84.84 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.743 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -58.63 -47.43 84.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.335 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.405 ' O ' ' HG3' ' A' ' 395' ' ' MET . 5.7 m-85 -70.66 -44.46 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 29.9 p -68.32 -15.91 63.74 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -100.77 4.74 43.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.591 0.234 . . . . 0.0 111.214 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -128.97 112.94 14.58 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 110.699 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.13 -40.56 96.43 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -56.81 -51.38 69.19 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.043 0.449 . . . . 0.0 110.794 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.37 -40.14 95.24 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.838 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 388' ' ' TYR . 87.9 mtp -61.7 -45.63 93.17 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.638 0.256 . . . . 0.0 111.681 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.18 -44.25 63.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.367 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -63.31 -42.69 99.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.049 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 50.3 tpp -63.56 -42.07 98.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.991 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.463 ' HG2' HG21 ' A' ' 367' ' ' VAL . 83.2 mtm180 -65.59 -34.53 78.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.195 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -61.81 -42.72 99.37 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.935 0.398 . . . . 0.0 110.106 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.99 -43.41 89.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.694 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.31 97.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.724 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.5 tp -65.5 -36.7 84.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.489 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.22 -45.32 91.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.812 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 40.7 mt-10 -64.85 -38.46 91.06 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.419 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -60.39 -43.39 96.69 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.492 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.88 96.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.31 -43.51 95.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.544 ' HG3' HH12 ' A' ' 283' ' ' ARG . 80.5 mt-10 -66.02 -34.34 77.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.291 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.22 -39.12 91.74 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.15 0.5 . . . . 0.0 110.21 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.78 -42.85 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.176 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.56 -40.36 94.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.458 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.8 -27.76 68.27 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.941 0.4 . . . . 0.0 111.356 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -94.16 -8.22 40.05 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.966 0.413 . . . . 0.0 110.821 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.35 -179.94 5.09 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.239 0.542 . . . . 0.0 111.835 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -103.41 106.39 16.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.031 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 63.9 t -92.51 132.61 36.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 120.768 0.318 . . . . 0.0 110.382 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.4 t -124.63 146.64 48.97 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.907 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.67 130.84 53.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.822 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -148.14 136.36 21.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.026 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -87.22 153.86 21.16 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.6 t -158.01 178.57 10.07 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 18.0 p -87.3 162.2 17.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.918 0.389 . . . . 0.0 111.549 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.9 -36.51 82.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.281 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -57.59 -36.94 72.39 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.893 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.2 -33.67 76.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.871 0.367 . . . . 0.0 110.939 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 10.5 mp -81.06 -12.45 59.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.905 0.383 . . . . 0.0 110.905 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 3.2 mmt -78.49 -8.3 58.39 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -78.32 84.01 4.53 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.925 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -109.41 23.16 14.86 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.411 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -82.12 -9.0 59.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.515 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.59 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.265 -179.678 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.403 ' HG2' ' H ' ' B' ' 2' ' ' GLN . 53.3 ttm . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.403 ' H ' ' HG2' ' B' ' 1' ' ' MET . 26.0 tt0 -53.58 109.8 0.49 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.981 0.419 . . . . 0.0 111.887 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.49 161.78 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.818 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 43.7 t -136.79 130.56 32.07 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 p -152.78 137.89 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.856 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 41.3 mt-10 -128.17 161.06 30.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.269 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 49.9 m -110.0 125.56 53.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 16.8 m -96.66 -58.62 2.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.447 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -174.41 129.07 0.35 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.207 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.82 -114.6 6.92 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.708 178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 mp -91.14 -9.84 44.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.711 0.291 . . . . 0.0 110.783 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.34 120.68 5.64 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.736 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.05 146.98 48.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 54.7 ttp180 -110.08 139.72 44.92 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.58 -90.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.402 ' OG1' HG23 ' B' ' 104' ' ' THR . 34.9 m 68.24 99.69 0.05 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.1 tp -134.15 144.02 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.881 0.372 . . . . 0.0 111.796 -175.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.4 m -127.79 129.87 47.73 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.673 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.55 ' HB ' HG12 ' B' ' 24' ' ' ILE . 16.8 mt -123.67 162.14 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -176.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.592 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.29 148.03 52.41 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.259 0.224 . . . . 0.0 110.811 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.37 -61.54 2.12 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -66.74 -32.28 73.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.798 0.332 . . . . 0.0 110.943 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 38.6 t -63.04 -41.07 99.41 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.241 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.592 HG13 ' O ' ' B' ' 20' ' ' ALA . 76.3 mt -60.1 -52.08 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.124 0.488 . . . . 0.0 110.935 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -69.45 -46.11 67.48 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.594 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 21.1 m -65.46 -51.2 61.79 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.57 -47.81 62.36 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.18 -43.28 98.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.075 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -60.34 -46.51 89.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.391 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 25.4 m -62.45 -42.5 99.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.647 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.45 ' O ' HG23 ' B' ' 35' ' ' VAL . 10.0 tp10 -68.87 -42.98 76.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.571 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.96 -44.43 96.77 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 p -69.61 -34.51 61.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.96 0.41 . . . . 0.0 110.762 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -65.08 -42.21 94.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.56 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.565 HG11 ' HD3' ' B' ' 73' ' ' ARG . 88.2 t -65.95 -41.74 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.096 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.76 -40.76 84.84 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.377 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.455 ' O ' ' HD3' ' B' ' 40' ' ' ARG . 98.6 mttt -65.37 -37.16 86.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.279 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.79 -44.3 96.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 110.593 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 19.7 t -78.94 -4.44 6.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.488 0.661 . . . . 0.0 109.969 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' B' ' 37' ' ' LYS . 25.6 mmt180 64.53 25.85 13.28 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.44 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.7 11.39 8.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -63.46 -34.53 77.97 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.184 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.33 0.98 83.15 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.6 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -93.48 -1.67 55.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.042 0.448 . . . . 0.0 110.783 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -95.09 110.59 22.51 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -62.2 -38.49 89.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.371 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.481 ' H ' HE22 ' A' ' 320' ' ' GLN . . . 57.29 56.4 25.26 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 173.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -63.52 -41.66 98.5 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.0 t -100.44 110.01 58.83 Favored Pre-proline 0 C--O 1.248 0.999 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.46 ' HG2' HD12 ' B' ' 53' ' ' ILE . 48.9 Cg_exo -57.01 149.04 64.71 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.822 2.348 . . . . 0.0 112.349 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.538 ' HA ' HG12 ' B' ' 54' ' ' VAL . 21.4 ttt -61.1 -37.19 81.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.182 -173.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -69.26 -24.82 64.03 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.929 0.395 . . . . 0.0 111.112 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.46 HD12 ' HG2' ' B' ' 50' ' ' PRO . 96.8 mt -92.69 -41.5 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' B' ' 51' ' ' MET . 13.1 p -65.16 -38.74 83.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 121.067 0.461 . . . . 0.0 111.019 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.442 ' O ' ' HA3' ' B' ' 59' ' ' GLY . . . -67.38 -37.37 83.05 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 9.5 pt20 -74.67 -11.73 60.25 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.38 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.461 HH12 ' CD1' ' A' ' 187' ' ' LEU . 62.8 mtt-85 -109.42 -50.17 3.02 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . 0.42 ' O ' HG12 ' B' ' 62' ' ' VAL . 20.5 m-85 -112.64 1.25 15.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.082 0.468 . . . . 0.0 110.811 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' B' ' 63' ' ' ARG . . . -64.99 -37.25 94.04 Favored Glycine 0 C--O 1.217 -0.941 0 CA-C-N 115.714 -0.676 . . . . 0.0 113.074 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.86 76.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.727 0.298 . . . . 0.0 111.249 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 48.5 m -62.15 -44.55 96.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.052 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' B' ' 65' ' ' ASP . 8.3 p -105.09 19.99 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.352 0.596 . . . . 0.0 111.118 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' B' ' 59' ' ' GLY . 12.7 ttm180 -63.05 -20.64 65.52 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.116 0.484 . . . . 0.0 110.182 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -64.07 -53.31 51.74 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.349 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . 0.524 ' HB2' HG22 ' B' ' 62' ' ' VAL . 20.7 m-20 -69.91 -27.39 64.74 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.847 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 62' ' ' VAL . 93.6 t -61.64 -45.09 99.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 98.8 mt -64.01 -39.87 95.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.412 175.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.64 -41.31 98.85 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.162 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.04 -44.69 95.18 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.33 -42.1 98.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.005 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 64.8 ttp -60.16 -50.77 72.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.183 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 24.4 m -65.28 -46.02 82.11 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.788 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.565 ' HD3' HG11 ' B' ' 35' ' ' VAL . 59.0 ttm-85 -66.34 -46.61 76.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.745 -175.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -66.47 -40.11 89.17 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -60.34 -48.67 80.75 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.938 0.348 . . . . 0.0 111.938 -177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.453 ' O ' HG13 ' B' ' 79' ' ' ILE . 19.9 tt -67.45 -38.95 81.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.965 0.412 . . . . 0.0 111.259 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -66.17 -40.25 90.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.338 0.59 . . . . 0.0 109.88 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.11 85.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.828 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.453 HG13 ' O ' ' B' ' 76' ' ' ILE . 2.7 pp -66.1 -37.2 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.37 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 -42.59 96.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.696 0.76 . . . . 0.0 109.172 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -59.95 -46.46 89.33 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.533 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -90.02 2.43 55.19 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.7 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm 65.83 41.43 3.85 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.69 177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 87.0 mt -96.66 119.99 45.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.882 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -108.17 103.6 50.86 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -85.21 127.45 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.538 2.159 . . . . 0.0 112.328 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.46 97.94 10.51 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.069 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.64 -141.78 15.85 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.514 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.04 132.42 23.72 Favored Pre-proline 0 C--N 1.317 -0.806 0 O-C-N 122.853 -0.204 . . . . 0.0 110.695 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . 0.442 ' HG2' ' CE1' ' B' ' 92' ' ' TYR . 64.0 Cg_endo -71.78 162.02 43.32 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.826 2.351 . . . . 0.0 111.272 177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 18.7 m -99.34 109.07 21.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.282 0.563 . . . . 0.0 111.17 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.442 ' CE1' ' HG2' ' B' ' 90' ' ' PRO . 87.9 m-85 -99.96 115.58 30.02 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.65 94.58 19.98 Favored Pre-proline 0 C--N 1.32 -0.717 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.931 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 90.9 Cg_endo -87.01 146.16 7.68 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.552 2.168 . . . . 0.0 110.523 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.98 172.18 39.91 Favored Glycine 0 N--CA 1.437 -1.295 0 C-N-CA 120.0 -1.095 . . . . 0.0 111.168 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.16 136.12 47.96 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -87.03 103.93 15.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.383 0.611 . . . . 0.0 111.544 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.46 111.16 18.23 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 49.3 tp -64.9 109.13 1.99 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.1 0.476 . . . . 0.0 110.408 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.06 -11.32 13.26 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.344 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.74 -177.69 3.81 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.708 0.29 . . . . 0.0 111.548 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -76.08 143.32 41.39 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.8 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -91.61 140.93 29.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.708 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.405 HG21 ' HD2' ' B' ' 14' ' ' ARG . 59.1 m -119.77 136.61 54.38 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.053 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -139.65 162.1 35.91 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.056 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 5.1 m -121.53 149.84 42.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.785 0.326 . . . . 0.0 111.227 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 10.8 p -133.97 142.72 40.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.307 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -105.58 128.17 53.46 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -149.68 -158.54 0.93 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -48.77 155.8 0.54 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.998 1.319 . . . . 0.0 113.318 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.18 160.81 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.114 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -144.98 97.08 4.9 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.741 0.305 . . . . 0.0 110.783 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.62 145.98 33.76 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.849 2.366 . . . . 0.0 112.801 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -164.48 123.55 1.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.5 164.86 31.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.827 0.346 . . . . 0.0 111.583 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -121.44 135.69 55.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.937 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.26 136.01 53.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -130.48 138.82 50.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.658 0.266 . . . . 0.0 111.107 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.15 19.3 61.13 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.912 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.05 -41.15 99.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.118 0.459 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.54 -5.33 32.46 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.483 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.03 13.86 27.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.903 0.382 . . . . 0.0 111.097 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 81.7 mt -102.17 128.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.152 0.501 . . . . 0.0 110.613 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -109.79 128.92 55.62 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.927 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 62.5 t -117.86 133.28 65.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.988 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -90.94 128.21 36.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.937 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.81 94.0 32.84 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.35 141.06 60.59 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.412 2.075 . . . . 0.0 112.503 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.7 mm -108.33 118.58 56.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.236 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.01 158.53 43.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.359 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -141.35 159.82 41.43 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.179 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -79.74 129.17 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.611 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 70.9 p -105.07 176.18 5.25 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.689 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -62.0 -38.09 87.3 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.35 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.95 -37.38 84.52 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.874 0.369 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -63.81 -39.03 93.26 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 89.3 t -63.65 -44.72 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.234 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.62 -42.41 92.6 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.247 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.53 98.51 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.959 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.525 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 4.6 tpt -63.11 -45.27 92.78 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.858 0.361 . . . . 0.0 110.231 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 94.4 mt -63.86 -41.59 97.75 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.036 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.98 -45.46 92.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.664 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 26.5 m -61.97 -41.16 97.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.952 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.1 mt -61.21 -41.42 96.81 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.459 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -68.83 -22.5 64.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.058 0.456 . . . . 0.0 110.741 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -85.46 2.48 44.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.228 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -119.31 31.44 6.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.394 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -139.16 89.61 2.36 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -134.22 155.77 49.56 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.499 HG22 ' H ' ' B' ' 151' ' ' TRP . 1.2 m -124.04 172.14 9.22 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.676 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . 0.499 ' H ' HG22 ' B' ' 150' ' ' THR . 8.6 p-90 -53.18 137.11 34.95 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -172.71 119.45 0.37 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.88 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' B' ' 154' ' ' LYS . 7.5 pt-20 -77.5 89.72 3.86 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.44 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' B' ' 153' ' ' GLU . 63.5 mmtt -158.44 -72.08 0.09 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.921 0.888 . . . . 0.0 110.736 177.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -169.52 -70.91 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.318 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' B' ' 243' ' ' ARG . . . 66.45 -128.93 30.72 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.798 178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -145.53 -165.76 2.27 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' B' ' 203' ' ' LYS . 50.5 t -117.43 124.73 73.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' B' ' 162' ' ' ASP . 62.0 mm-40 -87.9 174.44 8.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.068 -178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.3 -52.79 23.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.198 0.523 . . . . 0.0 109.821 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . 0.435 ' CD ' ' HE ' ' B' ' 255' ' ' ARG . 6.8 pt-20 -92.91 32.66 1.24 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.46 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.61 ' OD2' ' HD3' ' B' ' 243' ' ' ARG . 9.2 t70 -57.36 -48.85 77.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.378 -174.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 21.8 ttp85 66.0 88.47 0.11 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.791 0.805 . . . . 0.0 109.24 -174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.554 HG22 ' OD1' ' B' ' 162' ' ' ASP . 3.0 t -111.49 133.0 58.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.005 -174.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.9 m -80.29 104.51 10.89 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 79.7 mt -116.83 131.0 70.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -97.86 106.21 18.48 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -128.56 146.6 50.79 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.441 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 36.1 m -129.84 131.46 46.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.208 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.38 110.75 3.23 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.562 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 14.6 m -130.67 122.37 27.24 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.47 -76.09 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -110.65 -71.91 0.74 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.817 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -134.37 16.02 4.4 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.067 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -135.17 147.59 49.45 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.916 0.389 . . . . 0.0 110.402 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -91.29 150.58 21.25 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.688 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -112.48 179.15 4.07 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.83 -42.12 88.5 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -94.1 -175.45 39.31 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.032 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 73.72 36.51 53.25 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.861 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -114.43 102.17 9.83 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.68 154.27 38.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.032 0.444 . . . . 0.0 111.744 -177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 20.3 m -142.56 133.4 25.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 56.27 35.22 25.42 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.377 0.423 . . . . 0.0 110.845 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . 0.41 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 42.4 t80 -88.22 134.52 33.77 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.085 -175.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 15.7 m -90.58 120.97 40.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.634 0.731 . . . . 0.0 112.01 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . 0.501 ' CD1' HH12 ' A' ' 57' ' ' ARG . 29.0 tp -114.32 121.28 43.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.502 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . 0.598 ' O ' ' HG3' ' B' ' 193' ' ' ARG . . . -101.64 132.18 47.46 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 172.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 57.5 mtm -109.91 165.78 11.45 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.084 -173.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.13 0.33 65.83 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.967 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . 0.436 ' HB2' ' HG2' ' B' ' 193' ' ' ARG . 97.7 mt-30 -112.94 -8.38 13.69 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.43 36.35 17.36 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 119.861 -1.161 . . . . 0.0 110.677 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' B' ' 188' ' ' ALA . 39.7 mmm-85 -74.49 -25.41 59.36 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.379 0.672 . . . . 0.0 110.138 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . 0.439 ' HA ' ' CE ' ' B' ' 194' ' ' MET . 0.1 OUTLIER -124.75 -171.27 2.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.522 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.444 ' H ' HD12 ' B' ' 195' ' ' ILE . 3.7 mp -68.54 136.92 90.69 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.67 132.86 47.88 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.164 1.909 . . . . 0.0 112.054 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.35 -39.79 2.69 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.05 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -62.39 -45.54 92.69 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.0 8.93 11.33 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -113.21 -33.67 5.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.179 0.514 . . . . 0.0 109.765 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -68.94 -19.26 73.44 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.396 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 98.6 mt -64.95 -33.54 64.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.262 0.554 . . . . 0.0 110.225 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.404 ' HA ' ' HB ' ' B' ' 158' ' ' VAL . 44.6 mtpt -60.03 135.27 57.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.143 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.58 3.61 58.39 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.451 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.471 ' HD2' ' OE2' ' B' ' 209' ' ' GLU . 39.1 m80 -111.62 147.85 34.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 117.013 0.407 . . . . 0.0 110.934 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -85.01 163.63 18.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.073 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.62 137.0 51.91 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.29 20.55 77.03 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.968 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . 0.471 ' OE2' ' HD2' ' B' ' 205' ' ' HIS . 42.6 tt0 -101.37 121.81 42.59 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.23 0.538 . . . . 0.0 110.946 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' B' ' 236' ' ' ASN . 33.4 mt-10 -101.92 113.58 26.91 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -133.44 -27.62 1.54 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 30.8 m 74.56 130.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 120.9 0.381 . . . . 0.0 110.455 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.79 -40.53 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 70.38 97.93 0.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.199 0.523 . . . . 0.0 111.842 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 62.6 t -116.07 128.21 73.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 19.4 m -68.69 -40.78 79.88 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -176.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.542 ' HB2' ' O ' ' B' ' 216' ' ' THR . 32.6 m-85 77.8 134.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 123.025 0.53 . . . . 0.0 110.699 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.46 156.1 50.21 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.606 2.204 . . . . 0.0 112.584 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -65.44 -34.93 79.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.525 0.678 . . . . 0.0 110.008 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -87.14 30.12 0.79 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.616 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -74.65 140.98 44.63 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -61.65 -29.13 69.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.05 121.9 33.25 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.971 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.582 ' HA ' ' CD ' ' B' ' 227' ' ' LYS . 1.4 tp10 -62.93 -33.66 75.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.562 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.476 ' O ' ' HD2' ' B' ' 229' ' ' LYS . 30.8 p-10 -84.22 -5.9 59.32 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.4 mt -118.61 -12.94 9.68 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.582 ' CD ' ' HA ' ' B' ' 224' ' ' GLU . 18.1 ptmt -69.19 118.72 12.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.275 0.559 . . . . 0.0 111.205 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.4 18.17 78.29 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.926 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' B' ' 225' ' ' ASN . 99.2 mttt -122.59 124.19 42.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.077 0.438 . . . . 0.0 110.698 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.5 140.57 44.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.298 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -126.86 134.45 50.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.915 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -73.2 -48.9 31.27 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -173.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' B' ' 212' ' ' THR . 61.6 m-85 55.03 98.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.657 0.383 . . . . 0.0 112.012 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.6 90.94 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 91.2 mt 67.71 98.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.167 0.587 . . . . 0.0 111.85 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . 0.469 ' HA ' ' HG2' ' B' ' 210' ' ' GLU . 28.6 t-20 -86.26 -51.0 6.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 33.4 tp 53.07 90.55 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.052 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 27.3 mttp -74.79 -78.37 0.1 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . 0.457 ' O ' ' HB ' ' B' ' 240' ' ' VAL . 52.2 mtmt -75.46 -81.03 0.08 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.381 1.622 . . . . 0.0 115.381 -170.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.632 HG12 ' H ' ' B' ' 242' ' ' GLU . 67.7 t 75.22 139.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -174.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' B' ' 242' ' ' GLU . 86.3 mt-10 -68.73 -27.82 66.27 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.082 -0.386 . . . . 0.0 111.312 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' B' ' 241' ' ' GLU . 2.7 pt-20 64.51 132.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.552 1.541 . . . . 0.0 113.933 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.61 ' HD3' ' OD2' ' B' ' 162' ' ' ASP . 0.0 OUTLIER -154.35 144.1 21.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.358 178.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -159.54 153.89 23.87 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 tt 72.18 123.75 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.068 0.547 . . . . 0.0 111.352 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -84.21 115.91 2.01 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.546 2.164 . . . . 0.0 113.484 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -135.67 167.47 21.06 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.35 110.57 21.97 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 10.7 p -103.56 -83.55 0.48 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.92 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.404 ' O ' HG22 ' B' ' 253' ' ' ILE . . . -177.69 -53.62 0.01 OUTLIER 'General case' 0 C--N 1.343 0.319 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.65 -47.14 86.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -61.6 -26.98 68.32 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -173.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . 0.404 HG22 ' O ' ' B' ' 250' ' ' ALA . 18.9 tt -91.13 -5.89 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -127.91 6.88 6.08 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.032 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.435 ' HE ' ' CD ' ' B' ' 161' ' ' GLU . 60.0 ttp180 -131.24 134.82 46.81 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.538 0.209 . . . . 0.0 110.545 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -172.87 34.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.92 -32.28 7.7 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 42.0 t -80.65 150.84 4.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -55.38 -51.87 65.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.375 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -175.43 163.81 3.05 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.257 173.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -172.77 177.53 45.25 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.377 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.9 p -82.12 175.8 10.03 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.33 0.252 . . . . 0.0 111.096 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.24 -49.13 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.864 0.364 . . . . 0.0 111.396 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.41 -32.22 21.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.588 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -62.12 -43.01 99.73 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.984 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 270' ' ' VAL . 63.5 tp -62.86 -43.79 97.87 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.622 0.249 . . . . 0.0 110.445 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -64.25 -41.96 96.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.882 0.372 . . . . 0.0 110.367 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -66.62 -44.95 80.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.309 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 37.2 tp10 -66.3 -39.39 89.3 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.094 0.473 . . . . 0.0 110.57 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 266' ' ' LEU . 70.7 t -65.01 -42.85 95.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.089 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -59.71 -46.54 88.79 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.8 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 18.3 ptmt -66.09 -42.5 89.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.843 0.354 . . . . 0.0 111.007 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -66.0 -37.16 85.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.016 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 92.2 mmm -63.97 -43.24 96.36 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 110.496 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -70.98 -29.52 65.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.112 0.482 . . . . 0.0 110.08 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -61.86 -43.69 98.34 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -65.1 -32.33 73.97 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.823 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 57.5 tp -60.96 -39.48 89.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.017 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -58.19 -47.79 82.33 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 177.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 17.3 m -62.59 -44.04 97.3 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.866 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.26 69.21 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.795 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.22 -45.72 92.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.607 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . 0.519 HH12 ' HG3' ' B' ' 409' ' ' GLU . 8.1 tpt180 -61.7 -45.64 93.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.898 -177.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -64.87 -39.94 94.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.46 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -59.04 -44.42 91.76 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.046 0.45 . . . . 0.0 110.382 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.13 -42.81 79.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.537 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . 0.435 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.8 tttt -59.67 -48.13 82.88 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.081 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.7 p -62.23 -41.91 98.83 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.769 0.319 . . . . 0.0 111.542 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -65.06 -41.88 94.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.813 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' B' ' 294' ' ' LEU . . . -65.61 -42.57 91.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.998 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . 0.435 HG12 ' O ' ' B' ' 287' ' ' LYS . 32.2 mm -63.8 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.573 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . 0.416 ' OE2' ' HE2' ' B' ' 296' ' ' LYS . 27.8 tp10 -59.8 -43.78 94.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.235 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.8 -40.33 97.27 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.276 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' B' ' 290' ' ' ALA . 95.5 mt -62.85 -42.63 99.82 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.682 0.277 . . . . 0.0 110.926 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 291' ' ' ILE . 91.4 t -65.61 -43.59 93.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.049 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . 0.416 ' HE2' ' OE2' ' B' ' 292' ' ' GLU . 68.4 mttm -63.49 -41.94 98.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.127 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -68.62 -41.89 78.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.055 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -126.92 94.66 4.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -93.73 106.52 18.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . 0.437 HG13 ' N ' ' B' ' 301' ' ' ASP . 11.4 tp -122.07 166.18 17.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.005 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . 0.437 ' N ' HG13 ' B' ' 300' ' ' ILE . 33.0 m-20 -61.3 135.51 57.74 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.578 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.09 122.06 30.78 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.745 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.36 131.21 43.38 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.64 2.227 . . . . 0.0 111.939 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.05 -36.43 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.975 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.02 -43.11 91.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.298 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.8 mt -66.06 -40.54 90.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.903 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . 0.418 ' O ' HG13 ' B' ' 311' ' ' ILE . 97.0 mt -62.75 -45.99 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.754 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.17 -41.53 98.41 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.19 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 46.8 m -62.46 -45.49 92.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.316 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . 0.555 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 62.9 mm-40 -68.25 -37.99 81.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.536 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.0 mt -62.13 -43.68 98.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.625 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.578 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 17.2 t70 -60.46 -47.14 87.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.792 0.33 . . . . 0.0 111.012 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.46 -44.33 98.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.536 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 84.7 mt -62.76 -40.38 97.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.578 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 85.2 mtm180 -62.18 -42.4 99.24 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 32.5 mtt85 -64.91 -38.47 91.07 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -63.1 -45.16 93.35 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.074 0.464 . . . . 0.0 109.87 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.27 -36.32 79.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.745 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' B' ' 325' ' ' ASN . . . -61.89 -36.18 80.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.123 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . 0.519 HE22 ' H ' ' A' ' 47' ' ' GLY . 47.3 tt0 -63.13 -39.43 94.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.424 0.63 . . . . 0.0 109.506 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -76.25 -9.91 59.0 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.41 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -91.21 -7.79 50.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.817 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 54' ' ' VAL . . . 137.14 -12.12 3.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.809 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 112.53 42.18 0.98 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.005 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . 0.546 ' OD1' ' HB2' ' B' ' 328' ' ' GLN . 33.5 t-20 -85.27 127.04 34.17 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.876 0.369 . . . . 0.0 110.356 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . 0.47 ' OE1' ' HG3' ' B' ' 327' ' ' LYS . 2.0 tm-20 -130.2 144.49 51.39 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.47 ' HG3' ' OE1' ' B' ' 326' ' ' GLU . 35.5 mtmm 71.33 -47.92 0.66 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.627 0.771 . . . . 0.0 112.215 -177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . 0.546 ' HB2' ' OD1' ' B' ' 325' ' ' ASN . 14.2 mm100 -65.9 -13.06 58.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.083 0.468 . . . . 0.0 110.707 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.38 -21.81 60.44 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.643 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.42 HD12 HH12 ' B' ' 315' ' ' ARG . 57.4 tp -61.84 -33.43 74.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.638 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -79.5 -10.04 59.73 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.591 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 75.5 mt -65.14 147.41 98.57 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.61 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.23 141.18 97.58 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.574 2.183 . . . . 0.0 112.884 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . 0.472 ' HG3' HD13 ' B' ' 311' ' ' ILE . 27.2 ttt85 -85.27 -36.33 20.96 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.511 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -56.74 -46.39 81.39 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . 0.523 HD12 ' CD ' ' B' ' 224' ' ' GLU . 73.3 mt -91.86 12.08 22.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -117.96 -28.56 5.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.131 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -66.49 -31.7 72.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.714 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.61 -49.53 77.16 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.03 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -75.94 -22.47 55.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.702 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.435 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.42 -41.96 98.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . 0.51 ' O ' HG23 ' B' ' 346' ' ' VAL . 87.3 tttt -60.72 -44.56 96.46 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . 0.574 ' O ' HG23 ' B' ' 347' ' ' VAL . 10.1 mmt85 -59.93 -46.18 90.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.983 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.29 -39.29 85.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.255 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 341' ' ' ALA . 87.8 t -64.78 -43.31 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.436 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.51 HG23 ' O ' ' B' ' 342' ' ' LYS . 73.8 t -60.33 -43.12 93.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.404 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 343' ' ' ARG . 91.1 t -60.02 -45.68 95.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.34 -42.78 99.7 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.204 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.7 -44.27 94.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 99.0 mt -63.43 -45.21 92.0 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.976 0.417 . . . . 0.0 110.695 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.461 ' O ' HG13 ' B' ' 355' ' ' ILE . 94.4 mt -66.66 -39.62 88.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.915 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -59.21 -42.53 97.25 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.628 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -64.3 -39.79 94.62 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.978 0.389 . . . . 0.0 110.559 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.3 -46.36 96.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.042 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . 0.461 HG13 ' O ' ' B' ' 351' ' ' LEU . 71.0 mt -63.6 -46.29 95.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.399 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -64.6 -64.73 0.8 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 38.5 m -65.96 -43.24 88.5 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.76 -11.42 60.16 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.168 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 62.38 64.86 0.91 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.718 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.9 mt -98.02 136.97 37.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.203 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.09 150.22 45.29 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.195 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.92 120.02 13.53 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . 0.496 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.5 t70 -90.17 108.34 19.68 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.939 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 66.2 mm-40 -61.68 -34.65 76.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.67 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -66.03 -41.58 90.73 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.49 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . 0.416 HH12 ' CD ' ' B' ' 409' ' ' GLU . 45.9 ttt180 -62.47 -40.79 97.79 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.001 0.429 . . . . 0.0 110.137 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . 0.496 HG23 ' O ' ' B' ' 363' ' ' ASP . 88.4 t -61.28 -39.71 83.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.236 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 28.2 mmmt -56.64 -44.07 80.9 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.511 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.21 -40.2 98.81 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.2 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.33 -42.88 98.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 110.239 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.64 -43.68 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.797 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -64.04 -41.96 97.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.76 -41.73 91.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.053 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 48.6 ttp -65.43 -39.7 92.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.028 0.442 . . . . 0.0 110.511 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' B' ' 381' ' ' PRO . . . -63.28 -24.67 67.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.596 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 44.9 m -73.47 -6.34 45.78 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.45 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.02 -2.09 58.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.532 0.682 . . . . 0.0 110.284 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -113.08 172.78 6.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.976 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -65.7 -47.69 74.54 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -121.76 116.24 30.44 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.803 0.335 . . . . 0.0 110.999 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . 0.461 ' O ' HG13 ' B' ' 385' ' ' ILE . 46.5 Cg_exo -58.21 -36.49 97.74 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.909 2.406 . . . . 0.0 113.116 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -64.72 -43.42 93.48 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -174.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.81 -36.81 84.4 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.933 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.44 -42.96 94.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.302 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . 0.461 HG13 ' O ' ' B' ' 381' ' ' PRO . 65.7 mt -62.23 -44.83 99.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.335 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -64.93 -37.87 89.07 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.765 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -58.75 -47.06 85.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.443 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . 0.44 ' O ' ' HG3' ' B' ' 395' ' ' MET . 2.8 m-85 -69.67 -44.78 69.81 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 18.9 p -68.88 -16.26 63.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.19 4.6 48.94 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.746 0.307 . . . . 0.0 111.19 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -129.57 112.04 13.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 110.532 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -64.72 -37.5 87.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.263 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -57.23 -53.38 58.74 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.021 0.439 . . . . 0.0 110.558 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.47 -40.5 95.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.737 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' B' ' 388' ' ' TYR . 89.1 mtp -61.62 -46.18 90.92 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.89 -44.18 64.17 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.415 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -64.13 -42.13 96.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.374 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 52.3 tpp -63.1 -41.17 99.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.838 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' B' ' 395' ' ' MET . 83.0 mtm180 -65.76 -34.8 79.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.917 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.44 -42.33 99.38 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 90.4 t -66.22 -43.77 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.622 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.44 94.99 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.544 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.25 -37.14 86.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.48 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -58.29 -47.21 84.37 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.855 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.09 -38.14 89.98 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.564 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -61.71 -42.25 98.69 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.209 0.318 . . . . 0.0 110.672 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.96 -42.53 97.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.047 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.39 -43.14 91.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.572 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . 0.519 ' HG3' HH12 ' B' ' 283' ' ' ARG . 96.6 mt-10 -63.95 -35.84 82.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.17 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.57 94.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.474 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.0 -43.06 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.474 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.21 -39.42 92.72 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.531 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.76 67.55 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.987 0.422 . . . . 0.0 111.311 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -98.08 -7.62 29.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.697 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.37 169.58 9.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.316 0.579 . . . . 0.0 112.261 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -90.78 99.41 12.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.808 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 68.4 t -86.75 131.68 34.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.697 0.284 . . . . 0.0 110.751 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.9 t -124.28 155.3 38.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.941 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -113.41 130.71 56.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.844 0.354 . . . . 0.0 110.749 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -147.48 141.25 25.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.201 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.2 150.9 19.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.335 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 14.1 t -158.0 174.96 14.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.361 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 17.4 p -85.63 163.67 18.16 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.165 0.507 . . . . 0.0 111.81 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -65.01 -36.42 84.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.449 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -57.38 -38.33 74.08 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.84 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.68 -32.8 74.56 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.858 0.361 . . . . 0.0 111.166 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.25 -12.7 59.04 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 3.8 mmt -78.28 -8.48 58.43 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.13 0.491 . . . . 0.0 110.785 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -75.71 79.84 2.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.193 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -108.13 26.56 10.26 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.556 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -85.06 -11.79 54.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.853 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.677 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.025 -179.537 . . . . . . . . 0 0 . 1 stop_ save_